Citrus Sinensis ID: 001527

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------1050------1060
Protein Sequence
MKLFRLLVLSLYFLSSVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHcccccHHHHHHHHHHHHccccccccccccccccccccccccccccEEEEcccccEEEEEcccccccEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccEEEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHccccccccEEEcccccccccccHHHHccccccEEEcccccccccccccccccccccccEEEcccccccccccccccccccccccEEcccccccEEccccccccccccEEEccccEEEEcccccccccccccccEEEccccccEEEccHHHHHccccEEccccEEEcccccccccccEEEccccccEEEcccccccccccEEEccccEEcccccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHHccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccEEcccccccccccHHHHcccccccEEccccccccccccHHHccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHEEEccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccccHHHHHHHHHcccccccccccccccccHHHHHHHHcccccccccccccccccccccccHHHHccccccEEcccccccEEEEEEccccEEEEEEEccccccHHHHHHHHHHHHccccccccccEEEEEEcccccEEEEEEcccccccHHHHHccccccccccccHHHHHHHHHHHHHHHcccccccccccccccccccccccccccEEEccccccccccccccEEEEEccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHHcccccccEEEcccccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHcccccccccccccccccccccccccccEEEEEccccEEEEEEccccccccccHHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccHHHHEEEEccccccccccccccHccccccEEEEEcccccccccccccccccccEEEEccccccccccHHHcccccccEEEEEcccccccccccHHHHHHHcEEEcccccccccccHHHccccEEEEcccccccccccccccccEEEEEEccccccccccHHHcccccccEEEEccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHHHcccEEEcccccccccccHHHccccHHHHHHHcccccccccccccccccHHHHccHHHcEEEcccccccccccHHHHHcEEEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHcccccccccccccccccccccccccccHHHHHHccccEEEcccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHccccccHEEEEEEEEccccccEEEEEEccccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHcccccEEEcccccccEEEcccccHHHHHHHcHHHHccccccccccccccccccccHHHHHcccccccHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccHHHccHHHcccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHcc
Coil and Loop (DISEMBL)
MKLFRLLVLSLYFLssvgqlpsQDILALLEFKkgikndptgfvlnswneesidfdgcpsswngivcnggNVAGVVLDNlglsaaadlSVFSNLSMLVKLSMsnnsisgvipdnigdfkslefldvsdnlfssslpsgigkleSLQNlslagnnfsglipdsvsGLVSIqsldlshnsfsgslppaltrlnNLVYLnlssngfskripRGFELILGLQvldfhgnkldghldgefflltnashidfsgnmfvgsssqkflpglSQSVQYLNLSLNQLtgslvnggelqlfenlkVLDLSynqltgelpgfnFVYELQVLKLSnnrfsgfipndllkgdsllltdldlsannlsgSVSMILSTNLHMLnlssngltgelplltgscavldlsnnqfeGNLSRILkwgnieyldlsrnhltgsipeetpqFLRLNHlnlshnslssslpkVIIQYQKLRVLDlsfnhldgpfltnllnsstlqelhladnlltgvldfsppsvsnlqvldlshnrlngyfpdrlgslTGLKVLCLagnnisgslptsmaNMTSLSSLVIsqnhftgplpnnlpnsletFNVSyndfsgavpenlrkfpsssfypgnsklsfpggapgsgnfpaensngkpisTIVKVIIIVSCVIALIILILLAIFIHYVrisrrmppahttdkdihghtltippgstgtgnggALVVSAEDLvaskkgsssgilspdekAAVVsgispsknshlswspesgdsftaenlarldvrspdrlvgelhflddtltltpeelsrapaevlgrsshgtsyratLENGMFLTVKWLREGVAKQRKEFAKEAKKFanirhpnvvglrgyywgptqheklilsdyispgslasflydrpgrkgppltwAQRLKIAVDVARGlnylhfdravphgnlkatnilldgpdlnaRVADYCLHRLMTQAGTIEQILDagvlgyrapelaaskkphpsfksdvYAFGVILLELLTGrcagdvisgegagvdltdWMQLKVaeghgsdcfdaavmpemvnpaaEKGMKEVLGIALRCIRsvserpgikTIYEDLSSI
Flexible Loop (DISEMBL)
MKLFRLLVLSLYFLSSVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKkgsssgilspdeKAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFlddtltltpEELSrapaevlgrsshgtsyratlengMFLTVKWLREGVAKQRKEFAKEAkkfanirhpnvvGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELaaskkphpsfkSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRcirsvserpgiktiyedlssi
Low Complexity Region (SEG)
MKlfrllvlslyflssvGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRlnnlvylnlssnGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPndllkgdsllltdldlsannlsGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRlnhlnlshnslssslPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGAPGSGNFPAENSNGKPistivkviiivscvialiilillaifiHYVRISRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFlddtltltPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRkefakeakkfaNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI
Disordered region (IsUnstruct)
**LFRLLVLSLYFLSSVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSL**********SSLVISQNHFTG*********LETFNVSYNDF********************************************ISTIVKVIIIVSCVIALIILILLAIFIHYVRISRR**********************************************************************************************RLVGELHFLDDTLTLT*******************SYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELA********FKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIY******
Disordered Region (DISOPRED)
MKLFRLLVLSLYFLSSVGQLPSQDILALLEFKKGIKN*PTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSF*************************VIIIVSCVIALIILILLAIFIHYVRISRRMPPAHTTDKDIHGHTLTIPPGSTGTGN********************GILSPDEKAAVVSGISPSKNSHLSWSPESGDSFT*****************ELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVA***KEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI
Disordered Region (DISEMBL)
MKLFRLLVLSLYFLSSVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI
Disordered Region (DISPRO)
MKLFRLLVLSLYFLSSVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGISPSKNSHLSWSPESGDSFTA****************ELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKLFRLLVLSLYFLSSVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1060	2.2.26 [Sep-21-2011]
C0LGQ9	1037	Probable LRR receptor-lik	yes	no	0.975	0.997	0.738	0.0
Q0WR59	1048	Probable inactive recepto	no	no	0.921	0.932	0.411	0.0
Q9SGP2	996	Receptor-like protein kin	no	no	0.859	0.914	0.295	2e-84
Q8LPB4	1021	Phytosulfokine receptor 1	N/A	no	0.869	0.903	0.291	6e-77
C0LGJ1	1106	Probable LRR receptor-lik	no	no	0.808	0.774	0.300	4e-75
Q9SYQ8	980	Receptor protein kinase C	no	no	0.801	0.867	0.282	3e-72
Q8L899	1207	Systemin receptor SR160 O	N/A	no	0.812	0.713	0.299	1e-71
Q8GUQ5	1207	Brassinosteroid LRR recep	N/A	no	0.819	0.719	0.290	3e-70
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.803	0.730	0.293	4e-69
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.55	0.529	0.330	1e-60

>sp|C0LGQ9|Y4294_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g20940 OS=Arabidopsis thaliana GN=At4g20940 PE=1 SV=1

 Score = 1485 bits (3845), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 773/1047 (73%), Positives = 889/1047 (84%), Gaps = 13/1047 (1%)

Query: 17   VGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVL 76
            +GQLPSQDI+ALLEFKKGIK+DPTGFVLNSWN+ESIDF+GCPSSWNGIVCNGGNVAGVVL
Sbjct: 1    MGQLPSQDIMALLEFKKGIKHDPTGFVLNSWNDESIDFNGCPSSWNGIVCNGGNVAGVVL 60

Query: 77   DNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPS 136
            DNLGL+A AD S+FSNL+ LVKLSMSNNS+SGV+P+++G FKSL+FLD+SDNLFSSSLP 
Sbjct: 61   DNLGLTADADFSLFSNLTKLVKLSMSNNSLSGVLPNDLGSFKSLQFLDLSDNLFSSSLPK 120

Query: 137  GIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLN 196
             IG+  SL+NLSL+GNNFSG IP+S+ GL+S+QSLD+S NS SG LP +LTRLN+L+YLN
Sbjct: 121  EIGRSVSLRNLSLSGNNFSGEIPESMGGLISLQSLDMSSNSLSGPLPKSLTRLNDLLYLN 180

Query: 197  LSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQ 256
            LSSNGF+ ++PRGFELI  L+VLD HGN +DG+LDGEFFLLTNAS++D SGN  V ++S 
Sbjct: 181  LSSNGFTGKMPRGFELISSLEVLDLHGNSIDGNLDGEFFLLTNASYVDISGNRLV-TTSG 239

Query: 257  KFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQ 316
            K LPG+S+S+++LNLS NQL GSL +G   QLF+NLKVLDLSYN L+GELPGFN+VY+L+
Sbjct: 240  KLLPGVSESIKHLNLSHNQLEGSLTSG--FQLFQNLKVLDLSYNMLSGELPGFNYVYDLE 297

Query: 317  VLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGE 376
            VLKLSNNRFSG +PN+LLKGDSLLLT LDLS NNLSG VS I+ST LH L+LSSN LTGE
Sbjct: 298  VLKLSNNRFSGSLPNNLLKGDSLLLTTLDLSGNNLSGPVSSIMSTTLHTLDLSSNSLTGE 357

Query: 377  LPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNL 436
            LPLLTG C +LDLSNNQFEGNL+R  KW NIEYLDLS+NH TGS P+ TPQ LR NHLNL
Sbjct: 358  LPLLTGGCVLLDLSNNQFEGNLTRWSKWENIEYLDLSQNHFTGSFPDATPQLLRANHLNL 417

Query: 437  SHNSLSSSLPKVI-IQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDF 495
            S+N L+ SLP+ I   Y KLRVLD+S N L+GP    LL+  TL+E+HL +N +TG +  
Sbjct: 418  SYNKLTGSLPERIPTHYPKLRVLDISSNSLEGPIPGALLSMPTLEEIHLQNNGMTGNIGP 477

Query: 496  SPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLV 555
             P S S +++LDLSHNR +G  P   GSLT L+VL LA NN+SGSLP+SM ++ SLSSL 
Sbjct: 478  LPSSGSRIRLLDLSHNRFDGDLPGVFGSLTNLQVLNLAANNLSGSLPSSMNDIVSLSSLD 537

Query: 556  ISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGAPGS 615
            +SQNHFTGPLP+NL +++  FNVSYND SG VPENL+ FP  SFYPGNSKL  P G+PGS
Sbjct: 538  VSQNHFTGPLPSNLSSNIMAFNVSYNDLSGTVPENLKNFPPPSFYPGNSKLVLPAGSPGS 597

Query: 616  GNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRMPPAHTTDKDIHG 675
                +E S  K  + +VKV+IIVSC +ALIILIL+AI +  +  SRR      T K+ + 
Sbjct: 598  S--ASEASKNKSTNKLVKVVIIVSCAVALIILILVAILLFCICKSRRREERSITGKETNR 655

Query: 676  HTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGISPSKNSHLSWS 735
               TIP GS     GG +VVSAEDLVAS+KGSSS ILSPDEK AV +G SPSK S+LSWS
Sbjct: 656  RAQTIPSGS-----GGGMVVSAEDLVASRKGSSSEILSPDEKLAVATGFSPSKTSNLSWS 710

Query: 736  PESGDSFTA-ENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYR 794
            P SGDSF A + LARLDVRSPDRLVGELHFLDD++ LTPEELSRAPAEVLGRSSHGTSYR
Sbjct: 711  PGSGDSFPADQQLARLDVRSPDRLVGELHFLDDSIKLTPEELSRAPAEVLGRSSHGTSYR 770

Query: 795  ATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD 854
            ATL+NG+FLTVKWLREGVAKQRKEFAKE KKF+NIRHPNVV LRGYYWGPTQHEKLILSD
Sbjct: 771  ATLDNGVFLTVKWLREGVAKQRKEFAKEVKKFSNIRHPNVVTLRGYYWGPTQHEKLILSD 830

Query: 855  YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD 914
            YISPGSLASFLYDRPGRKGPPL W QRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD
Sbjct: 831  YISPGSLASFLYDRPGRKGPPLAWTQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD 890

Query: 915  GPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVIL 974
            G +LNARVADYCLHRLMTQAGT+EQILDAG+LGYRAPELAAS+KP PSFKSDVYAFGVIL
Sbjct: 891  GAELNARVADYCLHRLMTQAGTVEQILDAGILGYRAPELAASRKPLPSFKSDVYAFGVIL 950

Query: 975  LELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEM-VNPAAEKGMKEV 1033
            LE+LTGRCAGDVI+GE  GVDLTDW++L+VAEG G++CFD+ +  EM  +P  EKGMKEV
Sbjct: 951  LEILTGRCAGDVITGEQEGVDLTDWVRLRVAEGRGAECFDSVLTQEMGSDPVTEKGMKEV 1010

Query: 1034 LGIALRCIRSVSERPGIKTIYEDLSSI 1060
            LGIALRCIRSVSERPGIKTIYEDLSSI
Sbjct: 1011 LGIALRCIRSVSERPGIKTIYEDLSSI 1037

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q0WR59|Y5020_ARATH Probable inactive receptor kinase At5g10020 OS=Arabidopsis thaliana GN=At5g10020 PE=1 SV=2

 Score =  724 bits (1868), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 445/1081 (41%), Positives = 623/1081 (57%), Gaps = 104/1081 (9%)

Query: 24   DILALLEFKKGIKNDPTGFVLNSWNEES--IDFDGCPSSWNGIVCN--GGNVAGVVLDNL 79
            ++ +LLEF+KGI+ D T     SW++ S   D   CP+ W GI C+   G++  + LD  
Sbjct: 26   ELRSLLEFRKGIR-DETSHQRISWSDTSSLTDPSTCPNDWPGISCDPETGSIIAINLDRR 84

Query: 80   GLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIG 139
            GLS     S  S L+                                             
Sbjct: 85   GLSGELKFSTLSGLTR-------------------------------------------- 100

Query: 140  KLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSS 199
                L+NLSL+GN+FSG +  S+ G+ S+Q LDLS N F G +P  ++ L +L +LNLSS
Sbjct: 101  ----LRNLSLSGNSFSGRVVPSLGGISSLQHLDLSDNGFYGPIPGRISELWSLNHLNLSS 156

Query: 200  NGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSS--QK 257
            N F    P GF  +  L+ LD H N++ G +   F  L N   +D S N F G  S   +
Sbjct: 157  NKFEGGFPSGFRNLQQLRSLDLHKNEIWGDVGEIFTELKNVEFVDLSCNRFNGGLSLPME 216

Query: 258  FLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQV 317
             +  +S ++++LNLS N L G   +   +  F+NL+++DL  NQ+ GELP F     L++
Sbjct: 217  NISSISNTLRHLNLSHNALNGKFFSEESIGSFKNLEIVDLENNQINGELPHFGSQPSLRI 276

Query: 318  LKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGEL 377
            LKL+ N   G +P +LL+  S+ L +LDLS N  +GS+S I S+ L MLNLSSNGL+G+L
Sbjct: 277  LKLARNELFGLVPQELLQS-SIPLLELDLSRNGFTGSISEINSSTLTMLNLSSNGLSGDL 335

Query: 378  PLLTGSCAVLDLSNNQFEGNLSRILKW-GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNL 436
            P    SC+V+DLS N F G++S + KW    + LDLS N+L+GS+P  T  F RL+ L++
Sbjct: 336  PSSFKSCSVIDLSGNTFSGDVSVVQKWEATPDVLDLSSNNLSGSLPNFTSAFSRLSVLSI 395

Query: 437  SHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFS 496
             +NS+S SLP +    Q   V+DLS N   G    +    ++L+ L+L+ N L G + F 
Sbjct: 396  RNNSVSGSLPSLWGDSQ-FSVIDLSSNKFSGFIPVSFFTFASLRSLNLSRNNLEGPIPFR 454

Query: 497  PPSVSNL---------QVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMAN 547
                S L         ++LDLS N L G  P  +G++  +KVL LA N +SG LP+ +  
Sbjct: 455  GSRASELLVLNSYPQMELLDLSTNSLTGMLPGDIGTMEKIKVLNLANNKLSGELPSDLNK 514

Query: 548  MTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLS 607
            ++ L  L +S N F G +PN LP+ +  FNVSYND SG +PE+LR +P SSFYPGNSKLS
Sbjct: 515  LSGLLFLDLSNNTFKGQIPNKLPSQMVGFNVSYNDLSGIIPEDLRSYPPSSFYPGNSKLS 574

Query: 608  FPGGAP----GSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRIS--- 660
             PG  P    G  + P +  + K     +++ IIV+ V A I+++ +    H  ++    
Sbjct: 575  LPGRIPADSSGDLSLPGKKHHSK---LSIRIAIIVASVGAAIMILFVLFAYHRTQLKDFH 631

Query: 661  -RRMPPAHTTDKDIHGHTLTIPP----GSTGTGNGGALVVSAEDLVASKKGSSSGILSPD 715
             R       T +D      + P      S       +L  S + L+ +   S SGI  P 
Sbjct: 632  GRNRFTDQATTRDTKFGRSSRPSLFNFSSNVEQQSSSLSFSNDHLLTANSRSLSGI--PG 689

Query: 716  EKAAVVSGISPSKNSH---LSWSPESGDSFT-------------AENLARLDVRSPDRLV 759
             +A +    +P+ ++    L   P +    +             ++    LDV SPDRL 
Sbjct: 690  CEAEISEQGAPATSAPTNLLDDYPAASGRKSSSGGSPLSSSPRFSDQPVMLDVYSPDRLA 749

Query: 760  GELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEF 819
            GEL FLD +L LT EELSRAPAEVLGRSSHGT Y+ATL+NG  LTVKWLR G+ + +K+F
Sbjct: 750  GELFFLDVSLKLTAEELSRAPAEVLGRSSHGTLYKATLDNGHMLTVKWLRVGLVRHKKDF 809

Query: 820  AKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWA 879
            A+EAKK  +++HPN+V LR YYWGP + E+L+LSDY+   SLA  LY+   R+  P++++
Sbjct: 810  AREAKKIGSLKHPNIVPLRAYYWGPREQERLLLSDYLRGESLAMHLYETTPRRYSPMSFS 869

Query: 880  QRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ 939
            QRLK+AV+VA+ L YLH DRA+PHGNLK TNI+L  PD   R+ DYC+HRLMT +G  EQ
Sbjct: 870  QRLKVAVEVAQCLLYLH-DRAMPHGNLKPTNIILSSPDNTVRITDYCVHRLMTPSGVAEQ 928

Query: 940  ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDW 999
            IL+   LGY APEL+++ KP P+ KSDVYAFGVIL+ELLT R AGD+ISG+   VDLTDW
Sbjct: 929  ILNMSALGYSAPELSSASKPIPTLKSDVYAFGVILMELLTRRSAGDIISGQTGAVDLTDW 988

Query: 1000 MQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSS 1059
            ++L   EG   DC D  +          KGM++ L +A+RCI SV+ERP I+ + + L+S
Sbjct: 989  VRLCDQEGRRMDCIDRDIAG---GEEFSKGMEDALAVAIRCILSVNERPNIRQVLDHLTS 1045

Query: 1060 I 1060
            I
Sbjct: 1046 I 1046

Arabidopsis thaliana (taxid: 3702)

>sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1

 Score =  315 bits (806), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 317/1074 (29%), Positives = 488/1074 (45%), Gaps = 163/1074 (15%)

Query: 22   SQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNG--GNVAGVVLDNL 79
            +QD   L + K  + +DP  + L+SWN      D  P  W+G+ C G   +V  V L + 
Sbjct: 17   NQDGFILQQVKLSL-DDPDSY-LSSWNSN----DASPCRWSGVSCAGDFSSVTSVDLSSA 70

Query: 80   GLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIG 139
             L A    SV   LS L  LS+ NNSI+  +P NI   KSL+ LD+S NL +  LP  + 
Sbjct: 71   NL-AGPFPSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLA 129

Query: 140  KLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSS 199
             + +L +L L GNNFSG IP S     +++ L L +N   G++PP L  ++ L  LNLS 
Sbjct: 130  DIPTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSY 189

Query: 200  NGFS-KRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKF 258
            N FS  RIP  F  +  L+V+      L G +      L+    +D + N  VG      
Sbjct: 190  NPFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPS- 248

Query: 259  LPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVL 318
            L GL+  VQ + L  N LTG +    EL   ++L++LD S NQLTG+             
Sbjct: 249  LGGLTNVVQ-IELYNNSLTGEIP--PELGNLKSLRLLDASMNQLTGK------------- 292

Query: 319  KLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSV--SMILSTNLHMLNLSSNGLTGE 376
                      IP++L +   + L  L+L  NNL G +  S+ LS NL+ + +  N LTG 
Sbjct: 293  ----------IPDELCR---VPLESLNLYENNLEGELPASIALSPNLYEIRIFGNRLTGG 339

Query: 377  LPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNL 436
            LP   G               L+  L+W     LD+S N  +G +P +      L  L +
Sbjct: 340  LPKDLG---------------LNSPLRW-----LDVSENEFSGDLPADLCAKGELEELLI 379

Query: 437  SHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFS 496
             HNS S  +P+ +   + L  + L++N   G   T       +  L L +N  +G +  S
Sbjct: 380  IHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGEISKS 439

Query: 497  PPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVI 556
                SNL +L LS+N   G  P+ +GSL  L  L  +GN  SGSLP S+ ++  L +L +
Sbjct: 440  IGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGELGTLDL 499

Query: 557  SQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGAPG 614
              N F+G L + + +   L   N++ N+F+G +P+ +      ++   +  + F G  P 
Sbjct: 500  HGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNM-FSGKIP- 557

Query: 615  SGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRMPPAHTTDKDIH 674
                                       ++L  L L  + + Y R+S  +PP+    KD++
Sbjct: 558  ---------------------------VSLQSLKLNQLNLSYNRLSGDLPPSLA--KDMY 588

Query: 675  GHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVV--SGISPSKNSHL 732
             ++    PG  G   G    +   +  A K+G    + S    AA+V  +G++       
Sbjct: 589  KNSFIGNPGLCGDIKG----LCGSENEAKKRGYVWLLRSIFVLAAMVLLAGVA------- 637

Query: 733  SWSPESGDSFTAENLARLDVRSPDRLVG--ELHFLDDTLTLTPEELSRAPAEVLGRSSHG 790
             W      +F     AR   RS   L+   +L F +  +  + +E       V+G  + G
Sbjct: 638  -WFYFKYRTFKK---ARAMERSKWTLMSFHKLGFSEHEILESLDE-----DNVIGAGASG 688

Query: 791  TSYRATLENGMFLTVKWLREGVAK---------------QRKEFAKEAKKFANIRHPNVV 835
              Y+  L NG  + VK L  G  K               Q + F  E +    IRH N+V
Sbjct: 689  KVYKVVLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIV 748

Query: 836  GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
             L  +    T+  KL++ +Y+  GSL   L+     KG  L W  R KI +D A GL+YL
Sbjct: 749  KL--WCCCSTRDCKLLVYEYMPNGSLGDLLH---SSKGGMLGWQTRFKIILDAAEGLSYL 803

Query: 896  HFDRAVP--HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD--AGVLGYRAP 951
            H D   P  H ++K+ NIL+DG D  ARVAD+ + + +   G   + +   AG  GY AP
Sbjct: 804  HHDSVPPIVHRDIKSNNILIDG-DYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAP 862

Query: 952  ELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011
            E A + + +   KSD+Y+FGV++LE++T +   D   GE    DL  W+           
Sbjct: 863  EYAYTLRVNE--KSDIYSFGVVILEIVTRKRPVDPELGEK---DLVKWV---------CS 908

Query: 1012 CFDAAVMPEMVNPAAEKGMKE----VLGIALRCIRSVS-ERPGIKTIYEDLSSI 1060
              D   +  +++P  +   KE    +L + L C   +   RP ++ + + L  I
Sbjct: 909  TLDQKGIEHVIDPKLDSCFKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQEI 962

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1

 Score =  290 bits (741), Expect = 6e-77,   Method: Compositional matrix adjust.
 Identities = 320/1098 (29%), Positives = 481/1098 (43%), Gaps = 176/1098 (16%)

Query: 22   SQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNG------------G 69
            S D+ AL  F +G+++   G+    WNE S     C   W GI C              G
Sbjct: 31   SNDLKALEGFMRGLESSIDGW---KWNESSSFSSNC-CDWVGISCKSSVSLGLDDVNESG 86

Query: 70   NVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNL 129
             V  + L    LS     SV + L  L  L++++NS+SG I  ++ +  +LE LD+S N 
Sbjct: 87   RVVELELGRRKLSGKLSESV-AKLDQLKVLNLTHNSLSGSIAASLLNLSNLEVLDLSSND 145

Query: 130  FSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSV-SGLVSIQSLDLSHNSFSGSLPPALTR 188
            FS   PS I  L SL+ L++  N+F GLIP S+ + L  I+ +DL+ N F GS+P  +  
Sbjct: 146  FSGLFPSLI-NLPSLRVLNVYENSFHGLIPASLCNNLPRIREIDLAMNYFDGSIPVGIGN 204

Query: 189  LNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGN 248
             +++ YL L+SN  S  IP+    +  L VL    N+L G L  +   L+N   +D S N
Sbjct: 205  CSSVEYLGLASNNLSGSIPQELFQLSNLSVLALQNNRLSGALSSKLGKLSNLGRLDISSN 264

Query: 249  MFVGSSSQKFLP----------------------GLSQSVQYLNLSLNQLTGSL-VNGGE 285
             F G     FL                         S+S+  L+L  N L+G + +N   
Sbjct: 265  KFSGKIPDVFLELNKLWYFSAQSNLFNGEMPRSLSNSRSISLLSLRNNTLSGQIYLNCSA 324

Query: 286  LQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDL 344
            +    NL  LDL+ N  +G +P        L+ +  +  +F   IP       SL     
Sbjct: 325  MT---NLTSLDLASNSFSGSIPSNLPNCLRLKTINFAKIKFIAQIPESFKNFQSLTSLSF 381

Query: 345  DLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELP----LLTGSCAVLDLSNNQFEGNL 398
              S+     S   IL    NL  L L+ N    ELP    L   +  VL +++ Q  G +
Sbjct: 382  SNSSIQNISSALEILQHCQNLKTLVLTLNFQKEELPSVPSLQFKNLKVLIIASCQLRGTV 441

Query: 399  SRILKWG-NIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRV 457
             + L    +++ LDLS N L+G+IP        L +L+LS+N+    +P  +   Q L  
Sbjct: 442  PQWLSNSPSLQLLDLSWNQLSGTIPPWLGSLNSLFYLDLSNNTFIGEIPHSLTSLQSLVS 501

Query: 458  LDLSFNHL--DGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNG 515
             + +      D PF                 N   G L ++ PS S   ++DLS+N LNG
Sbjct: 502  KENAVEEPSPDFPFFK-------------KKNTNAGGLQYNQPS-SFPPMIDLSYNSLNG 547

Query: 516  YFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLP--NSL 573
                  G L  L VL L  NN+SG++P +++ MTSL  L +S N+ +G +P +L   + L
Sbjct: 548  SIWPEFGDLRQLHVLNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGNIPPSLVKLSFL 607

Query: 574  ETFNVSYNDFSGAVPE--NLRKFPSSSFYPGNSKLSFPGGAPGSGNFPAENSNGKPISTI 631
             TF+V+YN  SG +P     + FP+S         SF G     G   +           
Sbjct: 608  STFSVAYNKLSGPIPTGVQFQTFPNS---------SFEGNQGLCGEHAS----------- 647

Query: 632  VKVIIIVSCVIALIILILLAIFIHYVRISRRMPPAHTTDKDIHGHTLT-------IPPGS 684
                                             P H TD+  HG  +        I   +
Sbjct: 648  ---------------------------------PCHITDQSPHGSAVKSKKNIRKIVAVA 674

Query: 685  TGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGISPSKNSHLSWSPESGDSFTA 744
             GTG  G + +    L+   + +S G + P++KA        S++  L  + +S +  + 
Sbjct: 675  VGTG-LGTVFLLTVTLLIILRTTSRGEVDPEKKADADEIELGSRSVVLFHNKDSNNELS- 732

Query: 745  ENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLT 804
                                LDD L  T    S   A ++G    G  Y+ATL +G  + 
Sbjct: 733  --------------------LDDILKSTS---SFNQANIIGCGGFGLVYKATLPDGTKVA 769

Query: 805  VKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASF 864
            +K L     +  +EF  E +  +  +HPN+V L GY     +++KL++  Y+  GSL  +
Sbjct: 770  IKRLSGDTGQMDREFQAEVETLSRAQHPNLVHLLGYC--NYKNDKLLIYSYMDNGSLDYW 827

Query: 865  LYDRPGRKGPP-LTWAQRLKIAVDVARGLNYLH--FDRAVPHGNLKATNILLDGPDLNAR 921
            L+++    GPP L W  RL+IA   A GL YLH   +  + H ++K++NILL    + A 
Sbjct: 828  LHEK--VDGPPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTFV-AH 884

Query: 922  VADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            +AD+ L RL+    T       G LGY  PE   +     ++K DVY+FGV+LLELLTGR
Sbjct: 885  LADFGLARLILPYDTHVTTDLVGTLGYIPPEYGQASV--ATYKGDVYSFGVVLLELLTGR 942

Query: 982  CAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCI 1041
               DV    G+  DL  W+     E   S+ FD    P + +    + M  VL IA RC+
Sbjct: 943  RPMDVCKPRGSR-DLISWVLQMKTEKRESEIFD----PFIYDKDHAEEMLLVLEIACRCL 997

Query: 1042 RSVSERPGIKTIYEDLSS 1059
                E P  +   + L S
Sbjct: 998  ---GENPKTRPTTQQLVS 1012

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis.

Daucus carota (taxid: 4039)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGJ1|Y1743_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g74360 OS=Arabidopsis thaliana GN=At1g74360 PE=1 SV=1

 Score =  283 bits (725), Expect = 4e-75,   Method: Compositional matrix adjust.
 Identities = 304/1013 (30%), Positives = 445/1013 (43%), Gaps = 156/1013 (15%)

Query: 96   LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFS 155
            LV  ++S N+ +G I D     ++L+++D S N FS  + +G G+L      S+A N+ S
Sbjct: 184  LVVANLSTNNFTGRIDDIFNGCRNLKYVDFSSNRFSGEVWTGFGRLVEF---SVADNHLS 240

Query: 156  GLIPDSV-SGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELIL 214
            G I  S+  G  ++Q LDLS N+F G  P  ++   NL  LNL  N F+  IP     I 
Sbjct: 241  GNISASMFRGNCTLQMLDLSGNAFGGEFPGQVSNCQNLNVLNLWGNKFTGNIPAEIGSIS 300

Query: 215  GLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLN 274
             L+ L    N     +      LTN   +D S N F G   + F  G    V+YL L  N
Sbjct: 301  SLKGLYLGNNTFSRDIPETLLNLTNLVFLDLSRNKFGGDIQEIF--GRFTQVKYLVLHAN 358

Query: 275  QLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDL 333
               G  +N   +    NL  LDL YN  +G+LP   + +  L+ L L+ N FSG IP + 
Sbjct: 359  SYVGG-INSSNILKLPNLSRLDLGYNNFSGQLPTEISQIQSLKFLILAYNNFSGDIPQEY 417

Query: 334  LKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPLLTGSCAVL---D 388
              G+   L  LDLS N L+GS+       T+L  L L++N L+GE+P   G+C  L   +
Sbjct: 418  --GNMPGLQALDLSFNKLTGSIPASFGKLTSLLWLMLANNSLSGEIPREIGNCTSLLWFN 475

Query: 389  LSNNQFEG----------------------NLSRILKWGNIEYLDLSRNHLTGSIPEETP 426
            ++NNQ  G                      N  +I+  G+ E L + R      IP E P
Sbjct: 476  VANNQLSGRFHPELTRMGSNPSPTFEVNRQNKDKIIA-GSGECLAMKR-----WIPAEFP 529

Query: 427  QFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLAD 486
             F    +  L+  S  S    V+  Y    V         G  +  L  S+ LQ   L+ 
Sbjct: 530  PF-NFVYAILTKKSCRSLWDHVLKGYGLFPVCSA------GSTVRTLKISAYLQ---LSG 579

Query: 487  NLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMA 546
            N  +G +  S   +  L  L L  N   G  P  +G L  L  L L  NN SG +P  + 
Sbjct: 580  NKFSGEIPASISQMDRLSTLHLGFNEFEGKLPPEIGQLP-LAFLNLTRNNFSGEIPQEIG 638

Query: 547  NMTSLSSLVISQNHFTGPLPNNLP--NSLETFNVSYNDF-SGAVPE--NLRKFPSSSFYP 601
            N+  L +L +S N+F+G  P +L   N L  FN+SYN F SGA+P    +  F   SF  
Sbjct: 639  NLKCLQNLDLSFNNFSGNFPTSLNDLNELSKFNISYNPFISGAIPTTGQVATFDKDSFL- 697

Query: 602  GNSKLSFPGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISR 661
            GN  L FP     SGN      N + IS  V   +       L+I I LA+ + ++    
Sbjct: 698  GNPLLRFPSFFNQSGN------NTRKISNQV---LGNRPRTLLLIWISLALALAFI---- 744

Query: 662  RMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVV 721
                                           LVVS   L+  K            + A +
Sbjct: 745  -----------------------------ACLVVSGIVLMVVKA----------SREAEI 765

Query: 722  SGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLD-DTLTLTPEELSRAP 780
              +  SK  H   S   G S                L G++  +  D  T T  ++ +A 
Sbjct: 766  DLLDGSKTRHDMTSSSGGSS--------------PWLSGKIKVIRLDKSTFTYADILKAT 811

Query: 781  A-----EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKE-----AKKFANIR 830
            +      V+GR  +GT YR  L +G  + VK L+    +  KEF  E     A  F +  
Sbjct: 812  SNFSEERVVGRGGYGTVYRGVLPDGREVAVKKLQREGTEAEKEFRAEMEVLSANAFGDWA 871

Query: 831  HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
            HPN+V  R Y W     EK+++ +Y+  GSL   + D+       L W +R+ IA DVAR
Sbjct: 872  HPNLV--RLYGWCLDGSEKILVHEYMGGGSLEELITDK-----TKLQWKKRIDIATDVAR 924

Query: 891  GLNYLHFDR--AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
            GL +LH +   ++ H ++KA+N+LLD    NARV D+ L RL+    +    + AG +GY
Sbjct: 925  GLVFLHHECYPSIVHRDVKASNVLLDKHG-NARVTDFGLARLLNVGDSHVSTVIAGTIGY 983

Query: 949  RAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008
             APE   + +   + + DVY++GV+ +EL TGR A D     G    L +W + +V  G+
Sbjct: 984  VAPEYGQTWQ--ATTRGDVYSYGVLTMELATGRRAVD-----GGEECLVEWAR-RVMTGN 1035

Query: 1009 GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSE-RPGIKTIYEDLSSI 1060
             +       +         + M E+L I ++C     + RP +K +   L  I
Sbjct: 1036 MTAKGSPITLSGTKPGNGAEQMTELLKIGVKCTADHPQARPNMKEVLAMLVKI 1088

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3

 Score =  274 bits (700), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 287/1016 (28%), Positives = 449/1016 (44%), Gaps = 166/1016 (16%)

Query: 94   SMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGN- 152
            + ++ L++S   + G I   IG    L  L ++ N F+  LP  +  L SL+ L+++ N 
Sbjct: 70   ARVISLNVSFTPLFGTISPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNG 129

Query: 153  NFSGLIPDSV-SGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFE 211
            N +G  P  +   +V ++ LD  +N+F+G LPP ++ L  L YL+   N FS  IP  + 
Sbjct: 130  NLTGTFPGEILKAMVDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYG 189

Query: 212  LILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNL 271
             I  L+ L  +G  L G        L N         M++G                   
Sbjct: 190  DIQSLEYLGLNGAGLSGKSPAFLSRLKNLRE------MYIG------------------- 224

Query: 272  SLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNNRFSGFIP 330
              N  TG +    E      L++LD++   LTGE+P   + +  L  L L  N  +G IP
Sbjct: 225  YYNSYTGGV--PPEFGGLTKLEILDMASCTLTGEIPTSLSNLKHLHTLFLHINNLTGHIP 282

Query: 331  NDLLKGDSLLLTDLDLSANNLSGSV--SMILSTNLHMLNLSSNGLTGELPLLTGSCAVLD 388
             +L     + L  LDLS N L+G +  S I   N+ ++NL  N L G++P   G    L+
Sbjct: 283  PEL--SGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLFRNNLYGQIPEAIGELPKLE 340

Query: 389  L----SNN---QFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSL 441
            +     NN   Q   NL R    GN+  LD+S NHLTG IP++  +  +L  L LS+N  
Sbjct: 341  VFEVWENNFTLQLPANLGR---NGNLIKLDVSDNHLTGLIPKDLCRGEKLEMLILSNNFF 397

Query: 442  SSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTG---------V 492
               +P+ + + + L  + +  N L+G     L N   +  + L DN  +G         V
Sbjct: 398  FGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELTDNFFSGELPVTMSGDV 457

Query: 493  LD--------FS---PPSVS---NLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNIS 538
            LD        FS   PP++    NLQ L L  NR  G  P  +  L  L  +  + NNI+
Sbjct: 458  LDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREIFELKHLSRINTSANNIT 517

Query: 539  GSLPTSMANMTSLSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLRKFPS 596
            G +P S++  ++L S+ +S+N   G +P  + N  +L T N+S N  +G++P  +    S
Sbjct: 518  GGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNISGNQLTGSIPTGIGNMTS 577

Query: 597  SSFYPGNSKLSF---PGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIF 653
             +       LSF    G  P  G F   N      +T + +   VSC             
Sbjct: 578  LT----TLDLSFNDLSGRVPLGGQFLVFNETSFAGNTYLCLPHRVSCPTR---------- 623

Query: 654  IHYVRISRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILS 713
                       P  T+D   H HT    P                 +V +   + +G++ 
Sbjct: 624  -----------PGQTSD---HNHTALFSPSR---------------IVITVIAAITGLIL 654

Query: 714  PDEKAAVVSGISPSKNSH-LSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLT 772
                +  +  ++  KN   L+W        TA    +LD +S           +D L   
Sbjct: 655  ---ISVAIRQMNKKKNQKSLAW------KLTA--FQKLDFKS-----------EDVLECL 692

Query: 773  PEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRH 831
             EE       ++G+   G  YR ++ N + + +K L   G  +    F  E +    IRH
Sbjct: 693  KEE------NIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRSDHGFTAEIQTLGRIRH 746

Query: 832  PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
             ++V L GY     +   L+L +Y+  GSL   L+   G KG  L W  R ++AV+ A+G
Sbjct: 747  RHIVRLLGYV--ANKDTNLLLYEYMPNGSLGELLH---GSKGGHLQWETRHRVAVEAAKG 801

Query: 892  LNYLHFDRA--VPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD-AGVLGY 948
            L YLH D +  + H ++K+ NILLD  D  A VAD+ L + +      E +   AG  GY
Sbjct: 802  LCYLHHDCSPLILHRDVKSNNILLDS-DFEAHVADFGLAKFLVDGAASECMSSIAGSYGY 860

Query: 949  RAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008
             APE A + K     KSDVY+FGV+LLEL+ G+     +   G GVD+  W+  +  E  
Sbjct: 861  IAPEYAYTLKVDE--KSDVYSFGVVLLELIAGK---KPVGEFGEGVDIVRWV--RNTEEE 913

Query: 1009 GSDCFDAAVMPEMVNPAAE----KGMKEVLGIALRCI-RSVSERPGIKTIYEDLSS 1059
             +   DAA++  +V+P         +  V  IA+ C+    + RP ++ +   L++
Sbjct: 914  ITQPSDAAIVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHMLTN 969

Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1

 Score =  272 bits (696), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 302/1009 (29%), Positives = 460/1009 (45%), Gaps = 148/1009 (14%)

Query: 99   LSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLI 158
             S+  N ++G IP+   DFK+L +LD+S N FS+  PS      +LQ+L L+ N F G I
Sbjct: 217  FSIKGNKLAGSIPE--LDFKNLSYLDLSANNFSTVFPS-FKDCSNLQHLDLSSNKFYGDI 273

Query: 159  PDSVS----------------GLV------SIQSLDLSHNSFSGSLPPALTRL-NNLVYL 195
              S+S                GLV      S+Q L L  N F G  P  L  L   +V L
Sbjct: 274  GSSLSSCGKLSFLNLTNNQFVGLVPKLPSESLQYLYLRGNDFQGVYPNQLADLCKTVVEL 333

Query: 196  NLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFL-LTNASHIDFSGNMFVGSS 254
            +LS N FS  +P        L+++D   N   G L  +  L L+N   +  S N FVG  
Sbjct: 334  DLSYNNFSGMVPESLGECSSLELVDISNNNFSGKLPVDTLLKLSNIKTMVLSFNKFVGGL 393

Query: 255  SQKF--LPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNF 311
               F  LP L    + L++S N LTG + +G       NLKVL L  N   G +P   + 
Sbjct: 394  PDSFSNLPKL----ETLDMSSNNLTGIIPSGICKDPMNNLKVLYLQNNLFKGPIPDSLSN 449

Query: 312  VYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSV--SMILSTNLHMLNLS 369
              +L  L LS N  +G IP+ L  G    L DL L  N LSG +   ++    L  L L 
Sbjct: 450  CSQLVSLDLSFNYLTGSIPSSL--GSLSKLKDLILWLNQLSGEIPQELMYLQALENLILD 507

Query: 370  SNGLTGELPLLTGSCAVLD---LSNNQFEGNLSRIL-KWGNIEYLDLSRNHLTGSIPEET 425
             N LTG +P    +C  L+   LSNNQ  G +   L +  N+  L L  N ++G+IP E 
Sbjct: 508  FNDLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLGRLSNLAILKLGNNSISGNIPAEL 567

Query: 426  PQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLA 485
                 L  L+L+ N L+ S+P  + +       +++   L G     + N  + +E H A
Sbjct: 568  GNCQSLIWLDLNTNFLNGSIPPPLFKQSG----NIAVALLTGKRYVYIKNDGS-KECHGA 622

Query: 486  DNLLT--GV----LD----------------FSPPSVSN---LQVLDLSHNRLNGYFPDR 520
             NLL   G+    LD                 + P+ ++   +  LDLS+N+L G  P  
Sbjct: 623  GNLLEFGGIRQEQLDRISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKE 682

Query: 521  LGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNS--LETFNV 578
            LG++  L +L L  N++SG +P  +  + +++ L +S N F G +PN+L +   L   ++
Sbjct: 683  LGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDL 742

Query: 579  SYNDFSGAVPEN--LRKFPSSSFYPGNSKLSFPGGAPGSGNFPAENSNGKPISTIVKVII 636
            S N+ SG +PE+     FP   F   NS   +P   P S   P  ++N    S   +  +
Sbjct: 743  SNNNLSGMIPESAPFDTFPDYRF-ANNSLCGYPLPLPCSSG-PKSDANQHQKSHRRQASL 800

Query: 637  IVSCVIALIILILLAIFIHYVRISRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVS 696
              S  + L+   L  IF                                     G ++V+
Sbjct: 801  AGSVAMGLL-FSLFCIF-------------------------------------GLIIVA 822

Query: 697  AEDLVASKKGSSSGILSPDEKAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPD 756
             E     +K  ++         A + G S S  ++ +W   S     + NLA  +   P 
Sbjct: 823  IETKKRRRKKEAA-------LEAYMDGHSHSATANSAWKFTSAREALSINLAAFE--KPL 873

Query: 757  RLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQR 816
            R +     L+ T     + L       +G    G  Y+A L++G  + +K L     +  
Sbjct: 874  RKLTFADLLEATNGFHNDSL-------VGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGD 926

Query: 817  KEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPL 876
            +EF  E +    I+H N+V L GY       E+L++ +Y+  GSL   L+DR  + G  L
Sbjct: 927  REFTAEMETIGKIKHRNLVPLLGYC--KVGEERLLVYEYMKYGSLEDVLHDRK-KTGIKL 983

Query: 877  TWAQRLKIAVDVARGLNYLHFDRAVP---HGNLKATNILLDGPDLNARVADYCLHRLMTQ 933
             W  R KIA+  ARGL +LH +  +P   H ++K++N+LLD  +L ARV+D+ + RLM+ 
Sbjct: 984  NWPARRKIAIGAARGLAFLHHN-CIPHIIHRDMKSSNVLLD-ENLEARVSDFGMARLMSA 1041

Query: 934  AGTIEQILD-AGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGA 992
              T   +   AG  GY  PE   S +   S K DVY++GV+LLELLTG+   D  S +  
Sbjct: 1042 MDTHLSVSTLAGTPGYVPPEYYQSFR--CSTKGDVYSYGVVLLELLTGKQPTD--SADFG 1097

Query: 993  GVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCI 1041
              +L  W++L  A+G  +D FD  ++ E  + + E  + + L +A  C+
Sbjct: 1098 DNNLVGWVKLH-AKGKITDVFDRELLKE--DASIEIELLQHLKVACACL 1143

Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development.

Solanum peruvianum (taxid: 4082)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1

 Score =  267 bits (683), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 283/974 (29%), Positives = 460/974 (47%), Gaps = 105/974 (10%)

Query: 90   FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKL--ESLQNL 147
            F + S L  L +S+N   G I  ++     L FL++++N F   +P    KL  ESLQ L
Sbjct: 253  FKDCSNLQHLDLSSNKFYGDIGSSLSSCGKLSFLNLTNNQFVGLVP----KLPSESLQYL 308

Query: 148  SLAGNNFSGLIPDSVSGLV-SIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRI 206
             L GN+F G+ P+ ++ L  ++  LDLS+N+FSG +P +L   ++L  +++S N FS ++
Sbjct: 309  YLRGNDFQGVYPNQLADLCKTVVELDLSYNNFSGMVPESLGECSSLELVDISYNNFSGKL 368

Query: 207  P-RGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
            P      +  ++ +    NK  G L   F  L     +D S N   G            +
Sbjct: 369  PVDTLSKLSNIKTMVLSFNKFVGGLPDSFSNLLKLETLDMSSNNLTGVIPSGICKDPMNN 428

Query: 266  VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNR 324
            ++ L L  N   G + +   L     L  LDLS+N LTG +P     + +L+ L L  N+
Sbjct: 429  LKVLYLQNNLFKGPIPD--SLSNCSQLVSLDLSFNYLTGSIPSSLGSLSKLKDLILWLNQ 486

Query: 325  FSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPLLTG 382
             SG IP +L+   +L   +L L  N+L+G +   LS  T L+ ++LS+N L+GE+P   G
Sbjct: 487  LSGEIPQELMYLQAL--ENLILDFNDLTGPIPASLSNCTKLNWISLSNNQLSGEIPASLG 544

Query: 383  ---SCAVLDLSNNQFEGNLSRILKWGNIE---YLDLSRNHLTGSIPEETPQFLRLNHLNL 436
               + A+L L NN   GN+   L  GN +   +LDL+ N L GSIP   P F +  ++ +
Sbjct: 545  RLSNLAILKLGNNSISGNIPAEL--GNCQSLIWLDLNTNFLNGSIPP--PLFKQSGNIAV 600

Query: 437  SHNSLSSSLPKVIIQYQKLRVLDLSFNHLD-GPFLTNLLNSSTLQELHLADNLLTGVLDF 495
            +   L +    V I+    +    + N L+ G      L+  + +       +  G+   
Sbjct: 601  A---LLTGKRYVYIKNDGSKECHGAGNLLEFGGIRQEQLDRISTRHPCNFTRVYRGITQP 657

Query: 496  SPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLV 555
            +     ++  LDLS+N+L G  P  LG++  L +L L  N++SG +P  +  + +++ L 
Sbjct: 658  TFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILD 717

Query: 556  ISQNHFTGPLPNNLPNS--LETFNVSYNDFSGAVPEN--LRKFPSSSFYPGNSKLSFPGG 611
            +S N F G +PN+L +   L   ++S N+ SG +PE+     FP   F   NS   +P  
Sbjct: 718  LSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRF-ANNSLCGYPLP 776

Query: 612  APGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRMPPAHTTDK 671
             P S   P  ++N    S   +  +  S  + L+   L  IF                  
Sbjct: 777  IPCSSG-PKSDANQHQKSHRRQASLAGSVAMGLL-FSLFCIF------------------ 816

Query: 672  DIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGISPSKNSH 731
                               G ++V+ E     +K  ++         A + G S S  ++
Sbjct: 817  -------------------GLIIVAIETKKRRRKKEAA-------LEAYMDGHSHSATAN 850

Query: 732  LSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGT 791
             +W   S     + NLA  +   P R +     L+ T     + L       +G    G 
Sbjct: 851  SAWKFTSAREALSINLAAFE--KPLRKLTFADLLEATNGFHNDSL-------VGSGGFGD 901

Query: 792  SYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLI 851
             Y+A L++G  + +K L     +  +EF  E +    I+H N+V L GY       E+L+
Sbjct: 902  VYKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYC--KVGEERLL 959

Query: 852  LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP---HGNLKA 908
            + +Y+  GSL   L+DR  + G  L W  R KIA+  ARGL +LH +  +P   H ++K+
Sbjct: 960  VYEYMKYGSLEDVLHDRK-KIGIKLNWPARRKIAIGAARGLAFLHHN-CIPHIIHRDMKS 1017

Query: 909  TNILLDGPDLNARVADYCLHRLMTQAGTIEQILD-AGVLGYRAPELAASKKPHPSFKSDV 967
            +N+LLD  +L ARV+D+ + RLM+   T   +   AG  GY  PE   S +   S K DV
Sbjct: 1018 SNVLLD-ENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFR--CSTKGDV 1074

Query: 968  YAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAE 1027
            Y++GV+LLELLTG+   D  S +    +L  W++L  A+G  +D FD  ++ E  + + E
Sbjct: 1075 YSYGVVLLELLTGKQPTD--SADFGDNNLVGWVKLH-AKGKITDVFDRELLKE--DASIE 1129

Query: 1028 KGMKEVLGIALRCI 1041
              + + L +A  C+
Sbjct: 1130 IELLQHLKVACACL 1143

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants.

Solanum lycopersicum (taxid: 4081)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  263 bits (673), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 297/1012 (29%), Positives = 465/1012 (45%), Gaps = 160/1012 (15%)

Query: 90   FSNLSM-----LVKLSMSNNSISG-VIPDNIGDFKSLEFLDVSDNLFSSSLPSG--IGKL 141
            FS+LS      L   S+S N++SG   P  + + K LE L++S N  +  +P+G   G  
Sbjct: 217  FSDLSFGICGNLTFFSLSQNNLSGDKFPITLPNCKFLETLNISRNNLAGKIPNGEYWGSF 276

Query: 142  ESLQNLSLAGNNFSGLIPDSVSGLV-SIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN 200
            ++L+ LSLA N  SG IP  +S L  ++  LDLS N+FSG LP   T    L  LNL +N
Sbjct: 277  QNLKQLSLAHNRLSGEIPPELSLLCKTLVILDLSGNTFSGELPSQFTACVWLQNLNLGNN 336

Query: 201  GFSKR-IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFL 259
              S   +      I G+  L    N + G +       +N   +D S N F G+    F 
Sbjct: 337  YLSGDFLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSNGFTGNVPSGFC 396

Query: 260  PGLSQSV-QYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVY-ELQV 317
               S  V + + ++ N L+G++    EL   ++LK +DLS+N+LTG +P   ++   L  
Sbjct: 397  SLQSSPVLEKILIANNYLSGTVPM--ELGKCKSLKTIDLSFNELTGPIPKEIWMLPNLSD 454

Query: 318  LKLSNNRFSGFIPNDL-LKGDSLLLTDLDLSANNLSGSV--SMILSTNLHMLNLSSNGLT 374
            L +  N  +G IP  + +KG +L    L L+ N L+GS+  S+   TN+  ++LSSN LT
Sbjct: 455  LVMWANNLTGTIPEGVCVKGGNL--ETLILNNNLLTGSIPESISRCTNMIWISLSSNRLT 512

Query: 375  GELPLLTGSC---AVLDLSNNQFEGNLSRILKWGNIE---YLDLSRNHLTGSIPEE---- 424
            G++P   G+    A+L L NN   GN+ R L  GN +   +LDL+ N+LTG +P E    
Sbjct: 513  GKIPSGIGNLSKLAILQLGNNSLSGNVPRQL--GNCKSLIWLDLNSNNLTGDLPGELASQ 570

Query: 425  ----TPQFLRLNHLNLSHNSLSSSLPKV--IIQYQKLRVLDL----------SFNHLDGP 468
                 P  +         N   +       +++++ +R   L          +     G 
Sbjct: 571  AGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRAERLERLPMVHSCPATRIYSGM 630

Query: 469  FLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSN---LQVLDLSHNRLNGYFPDRLGSLT 525
             +     + ++    ++ N ++G   F PP   N   LQVL+L HNR+ G  PD  G L 
Sbjct: 631  TMYTFSANGSMIYFDISYNAVSG---FIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLK 687

Query: 526  GLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSG 585
             + VL L+ NN+ G LP S+ +++ LS L +S N+ TGP+P                F G
Sbjct: 688  AIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIP----------------FGG 731

Query: 586  AVPENLRKFPSSSFYPGNSKLSFPGGAPGSGNFPAENSNGKPISTIV--KVIIIVSCVIA 643
                 L  FP S  Y  NS L    G P     P  ++  +PI++ +  K   + + VIA
Sbjct: 732  ----QLTTFPVSR-YANNSGLC---GVPLR---PCGSAPRRPITSRIHAKKQTVATAVIA 780

Query: 644  LIILILLAIFIHYVRISRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVAS 703
             I    +  F+  V    R+      ++    +  ++P                      
Sbjct: 781  GIAFSFMC-FVMLVMALYRVRKVQKKEQKREKYIESLP---------------------- 817

Query: 704  KKGSSSGILSPDEKAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELH 763
                +SG                      SW   S     + N+A  +   P R +   H
Sbjct: 818  ----TSG--------------------SCSWKLSSVPEPLSINVATFE--KPLRKLTFAH 851

Query: 764  FLDDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEA 823
             L+ T   + E +       +G    G  Y+A L +G  + +K L     +  +EF  E 
Sbjct: 852  LLEATNGFSAETM-------VGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEM 904

Query: 824  KKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGP-PLTWAQRL 882
            +    I+H N+V L GY       E+L++ +Y+  GSL + L+++  +KG   L WA R 
Sbjct: 905  ETIGKIKHRNLVPLLGYC--KVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAARK 962

Query: 883  KIAVDVARGLNYLHFDRAVP---HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ 939
            KIA+  ARGL +LH    +P   H ++K++N+LLD  D  ARV+D+ + RL++   T   
Sbjct: 963  KIAIGAARGLAFLHHS-CIPHIIHRDMKSSNVLLD-EDFEARVSDFGMARLVSALDTHLS 1020

Query: 940  ILD-AGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGE-GAGVDLT 997
            +   AG  GY  PE   S +   + K DVY++GVILLELL+G+   D   GE G   +L 
Sbjct: 1021 VSTLAGTPGYVPPEYYQSFR--CTAKGDVYSYGVILLELLSGKKPID--PGEFGEDNNLV 1076

Query: 998  DWMQLKVAEGHGSDCFDAAVMPEMV-NPAAEKGMKEVLGIALRCIRSVSERP 1048
             W +    E  G++  D    PE+V + + +  +   L IA +C+    +RP
Sbjct: 1077 GWAKQLYREKRGAEILD----PELVTDKSGDVELFHYLKIASQCL---DDRP 1121

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  235 bits (600), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 208/630 (33%), Positives = 301/630 (47%), Gaps = 47/630 (7%)

Query: 92  NLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAG 151
           NL  L +L   +N+ISG +P +IG+ K L       N+ S SLPS IG  ESL  L LA 
Sbjct: 167 NLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQ 226

Query: 152 NNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFE 211
           N  SG +P  +  L  +  + L  N FSG +P  ++   +L  L L  N     IP+   
Sbjct: 227 NQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELG 286

Query: 212 LILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNL 271
            +  L+ L  + N L+G +  E   L+ A  IDFS N   G    +   G  + ++ L L
Sbjct: 287 DLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLEL--GNIEGLELLYL 344

Query: 272 SLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNNRFSGFIP 330
             NQLTG++    EL   +NL  LDLS N LTG +P GF ++  L +L+L  N  SG IP
Sbjct: 345 FENQLTGTIPV--ELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIP 402

Query: 331 NDLLKGDSLLLTDLDLSANNLSGSVS--MILSTNLHMLNLSSNGLTGELPLLTGSCAVL- 387
             L     L +  LD+S N+LSG +   + L +N+ +LNL +N L+G +P    +C  L 
Sbjct: 403 PKLGWYSDLWV--LDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLV 460

Query: 388 --DLSNNQFEGNL-SRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSS 444
              L+ N   G   S + K  N+  ++L +N   GSIP E      L  L L+ N  +  
Sbjct: 461 QLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGE 520

Query: 445 LPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQ 504
           LP+ I    +L  L++S N L G   + + N   LQ L +  N  +G L     S+  L+
Sbjct: 521 LPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLE 580

Query: 505 VLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLS-SLVISQNHFTG 563
           +L LS+N L+G  P  LG+L+ L  L + GN  +GS+P  + ++T L  +L +S N  TG
Sbjct: 581 LLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTG 640

Query: 564 PLPNNLPN--------------------------SLETFNVSYNDFSGAVPENLRKFPSS 597
            +P  L N                          SL  +N SYN  +G +P  LR    S
Sbjct: 641 EIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPL-LRNISMS 699

Query: 598 SFYPGNSKLSFP--GGAPGSGNFPAENSNGKPISTI-VKVIIIVSCVIALIILILLAIFI 654
           SF  GN  L  P       +  F    S GKP      K+I I + VI  + L+L+A+ +
Sbjct: 700 SFI-GNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIV 758

Query: 655 HYVRISRRMPPAHTTDKDIHGHTLTI--PP 682
           + +R   R   +   D      +L I  PP
Sbjct: 759 YLMRRPVRTVASSAQDGQPSEMSLDIYFPP 788

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1060
255564373	1060	protein binding protein, putative [Ricin	0.998	0.998	0.806	0.0
224122142	1056	predicted protein [Populus trichocarpa]	0.984	0.988	0.794	0.0
449435524	1061	PREDICTED: probable LRR receptor-like se	0.997	0.996	0.765	0.0
449488532	1061	PREDICTED: LOW QUALITY PROTEIN: probable	0.997	0.996	0.764	0.0
356533075	1062	PREDICTED: probable LRR receptor-like se	0.998	0.996	0.771	0.0
225444065	1064	PREDICTED: probable LRR receptor-like se	0.985	0.982	0.787	0.0
357448529	1048	hypothetical protein MTR_2g030380 [Medic	0.984	0.996	0.752	0.0
224061613	998	predicted protein [Populus trichocarpa]	0.939	0.997	0.754	0.0
147839340	1561	hypothetical protein VITISV_003240 [Viti	0.978	0.664	0.770	0.0
264664505	1037	RecName: Full=Probable LRR receptor-like	0.975	0.997	0.738	0.0

>gi|255564373|ref|XP_002523183.1| protein binding protein, putative [Ricinus communis] gi|223537590|gb|EEF39214.1| protein binding protein, putative [Ricinus communis]

 Score = 1665 bits (4311), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 856/1062 (80%), Positives = 950/1062 (89%), Gaps = 4/1062 (0%)

Query: 1    MKLFRLLVLSLYFLSSVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSS 60
            MKLFRLLVLSLYFLS++GQLPSQDILALLEFKKGIK+DPTG+VL SWNEESIDFDGCPSS
Sbjct: 1    MKLFRLLVLSLYFLSAMGQLPSQDILALLEFKKGIKHDPTGYVLQSWNEESIDFDGCPSS 60

Query: 61   WNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSL 120
            WNGIVCNGGNVA VVLDNLGLSA ADLS+F+NL+ LV+LSM NN I+G +PDNI +F+SL
Sbjct: 61   WNGIVCNGGNVAAVVLDNLGLSADADLSIFANLTKLVRLSMHNNFITGKLPDNIANFRSL 120

Query: 121  EFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSG 180
            EFLDVS+NLFSS+LP G GKL SL+NLSLAGNNFSG IPDS+SGLVS+QSLDLS NSFSG
Sbjct: 121  EFLDVSNNLFSSALPIGFGKLGSLKNLSLAGNNFSGSIPDSISGLVSVQSLDLSRNSFSG 180

Query: 181  SLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNA 240
             LP +LTRLNNLVYLNLSSNGF+KRIP+G E I GLQVLD HGN  DG LDGEFFLLTN 
Sbjct: 181  LLPASLTRLNNLVYLNLSSNGFTKRIPKGLESISGLQVLDLHGNMFDGPLDGEFFLLTNV 240

Query: 241  SHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYN 300
            S++D S N+  GSS +K LPG+S+S+++LNLS NQLTGSLV+  EL+LF +LKVLDLSYN
Sbjct: 241  SYVDLSLNLLAGSSPEKLLPGISESIKHLNLSHNQLTGSLVS--ELRLFASLKVLDLSYN 298

Query: 301  QLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS 360
            QL+G+LPGF+F YELQVL+LSNNRFSGF+PNDLLKGDSLLLT+LDLS NNLSG VSMI+S
Sbjct: 299  QLSGDLPGFDFAYELQVLRLSNNRFSGFVPNDLLKGDSLLLTELDLSTNNLSGPVSMIMS 358

Query: 361  TNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGS 420
            T L +L+LSSNGLTGELP++TGSCAVLDLSNN+FEGNL+RI KWGN+EYLDLS+N L GS
Sbjct: 359  TTLRVLDLSSNGLTGELPIVTGSCAVLDLSNNEFEGNLTRIAKWGNLEYLDLSQNRLKGS 418

Query: 421  IPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQ 480
             PE  PQFLRLN+LNLSHNS SSSLPK   QY KL+VLD+S N LDGP LT+ L   TLQ
Sbjct: 419  FPEVLPQFLRLNYLNLSHNSFSSSLPKAFAQYPKLQVLDMSSNQLDGPLLTDFLTLPTLQ 478

Query: 481  ELHLADNLLTGVLDFSPPS--VSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNIS 538
            ELHL +NLL G ++FSPPS   SNL V+DLSHN+L+GYFPDR GSLTGL+VL LAGNN+S
Sbjct: 479  ELHLENNLLNGAIEFSPPSNNESNLLVIDLSHNQLDGYFPDRFGSLTGLQVLSLAGNNLS 538

Query: 539  GSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSS 598
            GSLP+SM+ MTSL +L +SQNHFTGP+PNNL N+L +FNV+ ND SG VPENL KFP SS
Sbjct: 539  GSLPSSMSGMTSLIALDLSQNHFTGPVPNNLTNTLGSFNVTNNDLSGFVPENLMKFPDSS 598

Query: 599  FYPGNSKLSFPGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVR 658
            F+PGNS+L  P G PGSGNFPAENS  KPI+TIVKV++IVSCVIA+I+LI+ AIFIHY+R
Sbjct: 599  FHPGNSRLHLPSGPPGSGNFPAENSRRKPINTIVKVVVIVSCVIAVILLIMFAIFIHYIR 658

Query: 659  ISRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKA 718
            ISRR PP H T K I  HT T P G +GT +GGALVVSAEDLV S+KGSSS I+SPDEK 
Sbjct: 659  ISRRSPPDHVTSKGIRRHTATNPSGVSGTESGGALVVSAEDLVTSRKGSSSEIISPDEKM 718

Query: 719  AVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEELSR 778
            A V+G SPSK SHLSWSPESGDSF AE LARLDVRSP+RLVGEL+FLDDT+TLTPEELSR
Sbjct: 719  AAVTGFSPSKRSHLSWSPESGDSFPAETLARLDVRSPERLVGELYFLDDTITLTPEELSR 778

Query: 779  APAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
            APAEVLGRSSHGTSYRATL+NGMFLTVKWLREGVAKQ+KEFAKEAKKFANIRHPNVVGLR
Sbjct: 779  APAEVLGRSSHGTSYRATLDNGMFLTVKWLREGVAKQKKEFAKEAKKFANIRHPNVVGLR 838

Query: 839  GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
            GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD
Sbjct: 839  GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898

Query: 899  RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK 958
            RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAA+KK
Sbjct: 899  RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAATKK 958

Query: 959  PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018
            P PSFKSDVYAFGVILLELLTGRCAGDVISGE  GVDLTDW+QL+V EG GSDCFD A++
Sbjct: 959  PLPSFKSDVYAFGVILLELLTGRCAGDVISGEAGGVDLTDWVQLRVTEGRGSDCFDPALL 1018

Query: 1019 PEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI 1060
            P++  PA EKG KEVLG+ALRCIRSVSERPGIKTIYEDLSSI
Sbjct: 1019 PDIGIPAVEKGTKEVLGLALRCIRSVSERPGIKTIYEDLSSI 1060

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224122142|ref|XP_002330551.1| predicted protein [Populus trichocarpa] gi|222872109|gb|EEF09240.1| predicted protein [Populus trichocarpa]

 Score = 1644 bits (4258), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 839/1056 (79%), Positives = 941/1056 (89%), Gaps = 12/1056 (1%)

Query: 17   VGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVL 76
            +GQLPSQDILALLEFKKGIK+DPTG+VL SWNEESIDF+GCPSSWNGIVCNGGNVAGVVL
Sbjct: 1    MGQLPSQDILALLEFKKGIKHDPTGYVLESWNEESIDFNGCPSSWNGIVCNGGNVAGVVL 60

Query: 77   DNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPS 136
            DNLGLSA  DLSVF+NL++LVK+SM+NNSI+G IPDNIGDFKSL+F+DVS+NLFSSSLP 
Sbjct: 61   DNLGLSADVDLSVFANLTLLVKVSMANNSITGEIPDNIGDFKSLQFMDVSNNLFSSSLPP 120

Query: 137  GIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLN 196
            GIGKL SL+NLSLAGNN SG +PDS+SGL SIQSLDLS NSFSGSLP +LTRLNNLVYLN
Sbjct: 121  GIGKLGSLRNLSLAGNNLSGSLPDSISGLASIQSLDLSRNSFSGSLPTSLTRLNNLVYLN 180

Query: 197  LSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQ 256
            LSSNGF KRIP+GFEL   LQVLD HGN  DGHLDG FFLLTNASH+D SGNM V SSSQ
Sbjct: 181  LSSNGFGKRIPKGFELNSNLQVLDLHGNMFDGHLDGMFFLLTNASHVDLSGNMLVSSSSQ 240

Query: 257  KFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQ 316
            K LPG+S+S++ LNLS NQL+GSL+NG +LQLF ++KVLDLSYNQLTGELPGF+F YELQ
Sbjct: 241  KLLPGMSESIKVLNLSHNQLSGSLLNGSDLQLFASVKVLDLSYNQLTGELPGFDFAYELQ 300

Query: 317  VLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGS----------VSMILSTNLHML 366
            VLKLSNN+FSG IPNDLLKGDSLLLT+LDLSANNLSGS          +SMI+ST L +L
Sbjct: 301  VLKLSNNKFSGSIPNDLLKGDSLLLTELDLSANNLSGSSVITALAFWPISMIMSTTLSVL 360

Query: 367  NLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETP 426
            +LSSN L GELPL+TGSCAVLDLSNN+FEGNL+R++KWGNIEYLDLS+N LTG IPE  P
Sbjct: 361  DLSSNALVGELPLVTGSCAVLDLSNNRFEGNLTRMVKWGNIEYLDLSQNRLTGPIPEVAP 420

Query: 427  QFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLAD 486
            QFLRLN+LNLSHNS +S LPKVI QY KLRVLDLS N LDG  LT LL S TLQE+HL +
Sbjct: 421  QFLRLNYLNLSHNSFTSPLPKVITQYPKLRVLDLSSNQLDGSLLTELLMSPTLQEIHLEN 480

Query: 487  NLLTGVLDFSPPSV--SNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTS 544
            NLL G ++FSPPS   SNLQV+DLSHN+L+G+FP R  SL+GL+VL LAGNN+SGSLP+S
Sbjct: 481  NLLNGAIEFSPPSTTQSNLQVIDLSHNQLDGFFPGRFDSLSGLQVLNLAGNNLSGSLPSS 540

Query: 545  MANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNS 604
            MA+M+SLSSL +SQNHFTGPLPNNL  S+ +FNVSYND SG VPENLR+FP+SSFYPGN+
Sbjct: 541  MADMSSLSSLDLSQNHFTGPLPNNLSESIGSFNVSYNDLSGVVPENLRRFPTSSFYPGNN 600

Query: 605  KLSFPGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRMP 664
            +L  P   PGS N P  NS  +PI+TIVKV++IV+CVIALIILI+LAIFI  +RI RR P
Sbjct: 601  RLRLPAVPPGSNNLPGRNSGRRPINTIVKVVVIVACVIALIILIMLAIFILCIRIRRRNP 660

Query: 665  PAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGI 724
            P   T+K I  HT T P G++GTG+GGAL+VSAEDLVASKKGSSS I+SPDEK A V+G 
Sbjct: 661  PGQVTNKGIRRHTQTNPSGTSGTGSGGALIVSAEDLVASKKGSSSEIISPDEKMAAVTGF 720

Query: 725  SPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVL 784
            SPSK+ HLSWSPESGDSF AE  ARLDVRSPDRLVGEL+FLDDT+T+TPEELSRAPAEVL
Sbjct: 721  SPSKHGHLSWSPESGDSFPAETFARLDVRSPDRLVGELYFLDDTITMTPEELSRAPAEVL 780

Query: 785  GRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGP 844
            GRSSHGTSYRATL+NG+F+TVKWLREGVAKQRK+F+KEAKKFANIRHPNVVGLRGYYWGP
Sbjct: 781  GRSSHGTSYRATLDNGVFITVKWLREGVAKQRKDFSKEAKKFANIRHPNVVGLRGYYWGP 840

Query: 845  TQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHG 904
            TQHEKLILSDYISPGSL +FLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHG
Sbjct: 841  TQHEKLILSDYISPGSLTNFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHG 900

Query: 905  NLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFK 964
            NLKATN+LLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELA+SKKP PSFK
Sbjct: 901  NLKATNVLLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELASSKKPLPSFK 960

Query: 965  SDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNP 1024
            SDVYAFGV++LELLTGRCAGDVI+GEG  VDLTDW++L+V EG G+DCFD A++PE+VNP
Sbjct: 961  SDVYAFGVMMLELLTGRCAGDVITGEGGSVDLTDWVRLRVTEGRGTDCFDPALLPEIVNP 1020

Query: 1025 AAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI 1060
              +KGMKEVLGIALRCIRSVS+RPGIKTIYEDLSSI
Sbjct: 1021 TVDKGMKEVLGIALRCIRSVSDRPGIKTIYEDLSSI 1056

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449435524|ref|XP_004135545.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g20940-like [Cucumis sativus]

 Score = 1618 bits (4191), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 814/1064 (76%), Positives = 916/1064 (86%), Gaps = 7/1064 (0%)

Query: 1    MKLFRLLVLSLYFLSSVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSS 60
            M+  R+L +S   +S++ QLPSQDILALLEFKKGIK+DPTGFV++SWNEESIDFDGCPSS
Sbjct: 1    MRALRILAVSFMLVSAMAQLPSQDILALLEFKKGIKHDPTGFVVSSWNEESIDFDGCPSS 60

Query: 61   WNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSL 120
            WNGIVCN G+VAGVVLD LGLSA  DL+VFSNL+ L KLS+SNNSI+G +PDNI +F+SL
Sbjct: 61   WNGIVCNSGSVAGVVLDGLGLSADVDLNVFSNLTKLAKLSLSNNSITGKMPDNIAEFQSL 120

Query: 121  EFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSG 180
            EFLD+S+NLFSSSLP G G+L SLQNLSLAGNNFSG I D ++ L SI+SLDLSHNSFSG
Sbjct: 121  EFLDISNNLFSSSLPQGFGRLTSLQNLSLAGNNFSGNI-DPIADLQSIRSLDLSHNSFSG 179

Query: 181  SLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNA 240
            SLP ALT+L NLVYL+LS NGF+ RIP+GFEL+  L+VLD HGN LDG LD EFF L+ A
Sbjct: 180  SLPTALTKLTNLVYLDLSFNGFTDRIPKGFELLSELEVLDLHGNMLDGTLDVEFFTLSGA 239

Query: 241  SHIDFSGNMFVGSS--SQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLS 298
            +H+DFS NM   S     KFLP LS S+++LNLS NQLTGSLVNGGEL LFENLK LDLS
Sbjct: 240  THVDFSNNMLTSSDMGHGKFLPRLSDSIKHLNLSHNQLTGSLVNGGELSLFENLKTLDLS 299

Query: 299  YNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMI 358
            YNQ +GELPGF+FVY+LQ+LKLSNNRFSG IPN+LLKGD+ +LT+LDLSANNLSG VSMI
Sbjct: 300  YNQFSGELPGFSFVYDLQILKLSNNRFSGDIPNNLLKGDASVLTELDLSANNLSGPVSMI 359

Query: 359  LSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLT 418
             ST L +LNLSSN LTGELPLLTGSCAVLDLSNNQF+GNL+R++KWGN+E+LDLS+N LT
Sbjct: 360  TSTTLLVLNLSSNQLTGELPLLTGSCAVLDLSNNQFKGNLTRMIKWGNLEFLDLSQNLLT 419

Query: 419  GSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSST 478
            G IPE TPQFLRLN LNLSHN+LSSSLP  I +Y KLRVLDLS N  DGP L +LL  ST
Sbjct: 420  GPIPELTPQFLRLNFLNLSHNTLSSSLPSAITKYPKLRVLDLSSNQFDGPLLADLLTMST 479

Query: 479  LQELHLADNLLTGVLDFSPPS--VSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNN 536
            L+EL+L +NLL G + F  PS   +NL+VLDLSHN+L+GYFPD   SLTGL +L +AGNN
Sbjct: 480  LEELYLENNLLNGAVKFLLPSPGKANLEVLDLSHNQLDGYFPDEFVSLTGLTMLNIAGNN 539

Query: 537  ISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPS 596
             SGSLPTSM+++++L SL +SQNHFTGPLP+NL + ++ FNVS ND SG VPENLRKFP 
Sbjct: 540  FSGSLPTSMSDLSALISLDMSQNHFTGPLPSNLSSDIQNFNVSSNDLSGTVPENLRKFPR 599

Query: 597  SSFYPGNSKLSFPGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHY 656
            S+F+PGNSKL+ P G PGS N     S  K ++TIVKVIIIVSCVIAL+I++LLAIF HY
Sbjct: 600  SAFFPGNSKLNLPNG-PGSSNNQDGRSGRKKMNTIVKVIIIVSCVIALVIIVLLAIFFHY 658

Query: 657  VRISRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDE 716
            + ISR+ PP   + KD   H+        GTG G  LVVSAEDLV S+KGSSS I+SPDE
Sbjct: 659  ICISRKNPPELASTKDTRRHSSLSSSAIGGTGAGSNLVVSAEDLVTSRKGSSSEIISPDE 718

Query: 717  KAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEEL 776
            K AV +G SP+KNSH SWSPESGDSFTAENLARLDVRSPDRLVGELHFLDD+++LTPEEL
Sbjct: 719  KLAVGTGFSPAKNSHFSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDSISLTPEEL 778

Query: 777  SRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVG 836
            SRAPAEVLGRSSHGTSYRATLE+GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVG
Sbjct: 779  SRAPAEVLGRSSHGTSYRATLESGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVG 838

Query: 837  LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
            LRGYYWGPTQHEKLILSDYISPGSLA FLYDRP RKG PLTWAQRLKIAVD+ARGLNYLH
Sbjct: 839  LRGYYWGPTQHEKLILSDYISPGSLAVFLYDRPSRKG-PLTWAQRLKIAVDIARGLNYLH 897

Query: 897  FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
            FDRAVPHGNLKATN+LLDG DLNARVADYCLHRLMT AGTIEQILDAGVLGYRAPELAAS
Sbjct: 898  FDRAVPHGNLKATNVLLDGADLNARVADYCLHRLMTHAGTIEQILDAGVLGYRAPELAAS 957

Query: 957  KKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016
            KKP PSFKSDVYAFGVILLELLTGRCAGDVISGE  GVDLTDW++L+VAEG GSDCFD  
Sbjct: 958  KKPQPSFKSDVYAFGVILLELLTGRCAGDVISGEEGGVDLTDWVRLRVAEGRGSDCFDTL 1017

Query: 1017 VMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI 1060
            ++PEM N AAEKGMKEVLGIALRCIR+VSERPGIKTIYEDLSSI
Sbjct: 1018 LLPEMSNAAAEKGMKEVLGIALRCIRTVSERPGIKTIYEDLSSI 1061

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449488532|ref|XP_004158073.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase At4g20940-like [Cucumis sativus]

 Score = 1615 bits (4182), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 813/1064 (76%), Positives = 914/1064 (85%), Gaps = 7/1064 (0%)

Query: 1    MKLFRLLVLSLYFLSSVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSS 60
            M+  R+L +S   +S++ QLPSQDILALLEFKKGIK+DPTGFV++SWNEESIDFDGCPSS
Sbjct: 1    MRALRILAVSFMLVSAMAQLPSQDILALLEFKKGIKHDPTGFVVSSWNEESIDFDGCPSS 60

Query: 61   WNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSL 120
            WNGIVCN G+VAGVVLD LGLSA  DL+VFSNL+ L KLS+SNNSI+G +PDNI +F+SL
Sbjct: 61   WNGIVCNSGSVAGVVLDGLGLSADVDLNVFSNLTKLAKLSLSNNSITGKMPDNIAEFQSL 120

Query: 121  EFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSG 180
            EFLD+S+NLFSSSLP G G+L SLQNLSLAGNNFSG I D ++ L SI+SLDLSHNSFSG
Sbjct: 121  EFLDISNNLFSSSLPQGFGRLTSLQNLSLAGNNFSGNI-DPIADLQSIRSLDLSHNSFSG 179

Query: 181  SLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNA 240
            SLP ALT+L NLVYL+LS NGF+ RIP+GFEL+  L+VLD HGN LDG LD EFF L+ A
Sbjct: 180  SLPTALTKLTNLVYLDLSFNGFTDRIPKGFELLSELEVLDLHGNMLDGTLDVEFFTLSGA 239

Query: 241  SHIDFSGNMFVGSS--SQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLS 298
            +H+DFS NM   S     KFLP LS S ++LNLS NQLTGSLVNGGEL LFENLK LDLS
Sbjct: 240  THVDFSNNMLTSSDMGHGKFLPRLSDSTKHLNLSHNQLTGSLVNGGELSLFENLKTLDLS 299

Query: 299  YNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMI 358
            YNQ +GELPGF+FVY+LQ+LKLSNNRFSG IPN+LLKGD+ +LT+LDLSANNLSG VSMI
Sbjct: 300  YNQFSGELPGFSFVYDLQILKLSNNRFSGDIPNNLLKGDASVLTELDLSANNLSGPVSMI 359

Query: 359  LSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLT 418
             ST L +LNLSSN LTGELPLLTGSCAVLDLSNNQF+GNL+R++KWGN+E+LDLS+N LT
Sbjct: 360  TSTTLLVLNLSSNQLTGELPLLTGSCAVLDLSNNQFKGNLTRMIKWGNLEFLDLSQNLLT 419

Query: 419  GSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSST 478
            G IPE TPQFLRLN LNLSHN+LSSSLP  I +Y KLRVLDLS N  DGP L +LL  ST
Sbjct: 420  GPIPELTPQFLRLNFLNLSHNTLSSSLPSAITKYPKLRVLDLSSNQFDGPLLADLLTMST 479

Query: 479  LQELHLADNLLTGVLDFSPPS--VSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNN 536
            L+EL+L +NLL G + F  PS   +NL+VLDLSHN+L+GYFPD   SLTGL +L +AGNN
Sbjct: 480  LEELYLENNLLNGAVKFLLPSPGKANLEVLDLSHNQLDGYFPDEFVSLTGLTMLNIAGNN 539

Query: 537  ISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPS 596
             SGSLPTSM+++++L SL +SQNHFTGPLP+NL + ++ FNVS ND SG VPENLRKFP 
Sbjct: 540  FSGSLPTSMSDLSALISLDMSQNHFTGPLPSNLSSDIQNFNVSSNDLSGTVPENLRKFPR 599

Query: 597  SSFYPGNSKLSFPGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHY 656
            S+F+PGNSKL+ P G PGS N     S  K ++TIVKVIIIVSCVIAL+I++LLAIF HY
Sbjct: 600  SAFFPGNSKLNLPNG-PGSSNNQDGRSGRKKMNTIVKVIIIVSCVIALVIIVLLAIFFHY 658

Query: 657  VRISRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDE 716
            + ISR+ PP   + KD   H+        GTG G  LVVSAEDLV S+KGSSS I+SPDE
Sbjct: 659  ICISRKNPPELASTKDTRRHSSLSSSAIGGTGAGSNLVVSAEDLVTSRKGSSSEIISPDE 718

Query: 717  KAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEEL 776
            K AV +G SP+K SH SWSPESGDSFTAENLARLDVRSPDRLVGELHFLDD+++LTPEEL
Sbjct: 719  KLAVGTGFSPAKXSHFSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDSISLTPEEL 778

Query: 777  SRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVG 836
            SRAPAEVLGRSSHGTSYRATLE+GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVG
Sbjct: 779  SRAPAEVLGRSSHGTSYRATLESGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVG 838

Query: 837  LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
            LRGYYWGPTQHEKLILSDYISPGSLA FLYDRP RKG PLTWAQRLKIAVD+ARGLNYLH
Sbjct: 839  LRGYYWGPTQHEKLILSDYISPGSLAVFLYDRPSRKG-PLTWAQRLKIAVDIARGLNYLH 897

Query: 897  FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
            FDRAVPHGNLKATN+LLDG DLNARVADYCLHRLMT AGTIEQILDAGVLGYRAPELAAS
Sbjct: 898  FDRAVPHGNLKATNVLLDGADLNARVADYCLHRLMTHAGTIEQILDAGVLGYRAPELAAS 957

Query: 957  KKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016
            KKP PSFKSDVYAFGVILLELLTGRCAGDVISGE  GVDLTDW++L+VAEG GSDCFD  
Sbjct: 958  KKPQPSFKSDVYAFGVILLELLTGRCAGDVISGEEGGVDLTDWVRLRVAEGRGSDCFDTL 1017

Query: 1017 VMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI 1060
            ++PEM N AAEKGMKEVLGIALRCIR+VSERPGIKTIYEDLSSI
Sbjct: 1018 LLPEMSNAAAEKGMKEVLGIALRCIRTVSERPGIKTIYEDLSSI 1061

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356533075|ref|XP_003535094.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g20940-like [Glycine max]

 Score = 1605 bits (4156), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 821/1064 (77%), Positives = 918/1064 (86%), Gaps = 6/1064 (0%)

Query: 1    MKLFRLLVLSLYFLSSVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSS 60
            MK F LLVLSLYF S VGQLPSQDIL LLEFKKGIK+DPTG+VLNSWNEESIDFDGCPSS
Sbjct: 1    MKPFSLLVLSLYFFSVVGQLPSQDILTLLEFKKGIKHDPTGYVLNSWNEESIDFDGCPSS 60

Query: 61   WNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSL 120
            WNG++CNGGNVAGVVLDNLGLSA  DLSVF+NL+ LVKLS+SNNSISG + D+I DFKSL
Sbjct: 61   WNGVLCNGGNVAGVVLDNLGLSADTDLSVFTNLTKLVKLSLSNNSISGTLLDSIADFKSL 120

Query: 121  EFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSG 180
            EFLD+S NLFSSSLP GIGKL SLQNLSLAGNNFSG IPDS+S + SI+SLDLS N+FSG
Sbjct: 121  EFLDISYNLFSSSLPLGIGKLGSLQNLSLAGNNFSGPIPDSISEMASIKSLDLSCNAFSG 180

Query: 181  SLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNA 240
             LP +LT+  +LV LNLS NGF+ +IP+G ELI  L+ LD HGN L+G+LD  F L ++A
Sbjct: 181  MLPASLTKTISLVSLNLSHNGFNGKIPKGLELIPALEKLDLHGNMLEGNLDVVFMLSSSA 240

Query: 241  SHIDFSGNMFVGS-SSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSY 299
            S++D S NM   S S+QKFLP +S+S+++LNLS N+LTGSL +G    +FENLKVLDLSY
Sbjct: 241  SYVDLSENMLSSSDSNQKFLPRISESIKHLNLSHNKLTGSLASGAAEPVFENLKVLDLSY 300

Query: 300  NQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMIL 359
            NQL GELPGF+FVY+L+VLKLSNNRFSGFIPN LLKGDSL+LT+LDLSANNLSG +S+I 
Sbjct: 301  NQLDGELPGFDFVYDLEVLKLSNNRFSGFIPNGLLKGDSLVLTELDLSANNLSGPLSIIT 360

Query: 360  STNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTG 419
            ST LH LNLSSN  TG++PLLTGSCAVLDLSNN+ EGNL+R+LKWGNIE+LDLSRNHLTG
Sbjct: 361  STTLHSLNLSSNEFTGDMPLLTGSCAVLDLSNNKLEGNLTRMLKWGNIEFLDLSRNHLTG 420

Query: 420  SIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTL 479
            +IPEETPQFLRLN+LNLSHNSLSSSLPKV+ QY KLRVLD+SFN LDG    NLL   TL
Sbjct: 421  AIPEETPQFLRLNYLNLSHNSLSSSLPKVLTQYPKLRVLDISFNQLDGLLPANLLTLPTL 480

Query: 480  QELHLADNLLTGVLDFSP-PSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNIS 538
            QEL L +N+++G + FS  P  S+LQ+LDLSHN+LNGYFPD  GSLTGLKVL +AGNN S
Sbjct: 481  QELRLENNMISGGIKFSSSPDQSDLQILDLSHNQLNGYFPDEFGSLTGLKVLNIAGNNFS 540

Query: 539  GSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSS 598
            GSLPT++A+M+SL SL IS+NHFTGPLP+N+P  L+ FN S ND SG VPE LRKFPSSS
Sbjct: 541  GSLPTTIADMSSLDSLDISENHFTGPLPSNMPKGLQNFNASQNDLSGVVPEVLRKFPSSS 600

Query: 599  FYPGNSKLSFPGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVR 658
            F+PGN+KL FP G PGS + PAE+S  K ++TIVKVIIIVSCV+AL ILILLA+FIHY+R
Sbjct: 601  FFPGNTKLHFPNGPPGSISSPAESSKRKHMNTIVKVIIIVSCVVALFILILLAVFIHYIR 660

Query: 659  ISRRMPPAHTTDKDIHGHTLTI--PPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDE 716
            ISR  PP + T KDIH H   I   P  T  G GGALVVSAEDLV S+K S S I+S DE
Sbjct: 661  ISRS-PPEYETSKDIHRHPQPIISAPVRTTDG-GGALVVSAEDLVTSRKESPSEIISSDE 718

Query: 717  KAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEEL 776
            K A V+G SPSK SH SWSPESGDS + ENLARLD RSPDRLVGELHFLDDT+TLTPEEL
Sbjct: 719  KMAAVTGFSPSKQSHFSWSPESGDSLSGENLARLDTRSPDRLVGELHFLDDTITLTPEEL 778

Query: 777  SRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVG 836
            SRAPAEVLGRSSHGTSY+ATLENG+ L VKWLREGVAKQRKEF KE KKFANIRHPNVVG
Sbjct: 779  SRAPAEVLGRSSHGTSYKATLENGLLLRVKWLREGVAKQRKEFVKETKKFANIRHPNVVG 838

Query: 837  LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
            LRGYYWGPTQHEKLILSDYIS GSLASFLYDRPGRKGPPLTW QRLKIAVDVARGLNYLH
Sbjct: 839  LRGYYWGPTQHEKLILSDYISLGSLASFLYDRPGRKGPPLTWTQRLKIAVDVARGLNYLH 898

Query: 897  FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
            FDRAVPHGNLKATN+LLD  D+NARVADYCLHRLMTQAGTIEQILDAGVLGY APELAAS
Sbjct: 899  FDRAVPHGNLKATNVLLDTTDMNARVADYCLHRLMTQAGTIEQILDAGVLGYCAPELAAS 958

Query: 957  KKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016
            KKP PSFKSDVYAFGVILLELLTGRCAGDVIS E  GVDLTDW++L+VAEG GS+CF+A 
Sbjct: 959  KKPMPSFKSDVYAFGVILLELLTGRCAGDVISSEEGGVDLTDWVRLRVAEGRGSECFEAT 1018

Query: 1017 VMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI 1060
            +MPEM NP  EKGMKEVLGIA+RCIRS+SERPGIKTIYEDLSSI
Sbjct: 1019 LMPEMSNPVVEKGMKEVLGIAMRCIRSISERPGIKTIYEDLSSI 1062

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225444065|ref|XP_002264039.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g20940-like isoform 1 [Vitis vinifera]

 Score = 1597 bits (4135), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 825/1048 (78%), Positives = 913/1048 (87%), Gaps = 3/1048 (0%)

Query: 16   SVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVV 75
            ++GQLPSQDILALLEFKKGIK+DPTG+VLNSWNEESIDF+GCPSSWNGIVCNG NVAGVV
Sbjct: 17   AMGQLPSQDILALLEFKKGIKHDPTGYVLNSWNEESIDFNGCPSSWNGIVCNGVNVAGVV 76

Query: 76   LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLP 135
            LD+ GLSA  DLSVFSNL+MLVKLSMS NSISG IPDNIGD KSLE+LD+SDNLF SSLP
Sbjct: 77   LDHQGLSADVDLSVFSNLTMLVKLSMSGNSISGKIPDNIGDLKSLEYLDLSDNLFFSSLP 136

Query: 136  SGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYL 195
             GIGKL +L+NLSLAGNNFSG IPDS+ GL SIQSLD S NSFSG +  +LT+L NLV L
Sbjct: 137  PGIGKLANLKNLSLAGNNFSGSIPDSILGLESIQSLDFSRNSFSGDMAASLTKLTNLVSL 196

Query: 196  NLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSS 255
            NLS NGF  +IP+GFEL+  L++LD HGN L GHLD EF   ++A H+DFSGNM V S  
Sbjct: 197  NLSLNGFESKIPKGFELLSKLEILDLHGNMLSGHLDEEFLRFSSAIHVDFSGNMLVNSGL 256

Query: 256  QK--FLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVY 313
            QK  FL G+S +V YLNLS NQL GSLV+GG      NLKVLDLSYNQL+GELPGFNF+Y
Sbjct: 257  QKQNFLSGISSTVAYLNLSHNQLMGSLVSGGGPLELANLKVLDLSYNQLSGELPGFNFLY 316

Query: 314  ELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGL 373
             L+VLKLSNNRF+GFIPNDLLKGD L+LT+LDLSANNLSG ++MI ST L++LNLSSNGL
Sbjct: 317  ALEVLKLSNNRFTGFIPNDLLKGDPLVLTELDLSANNLSGLINMITSTTLNILNLSSNGL 376

Query: 374  TGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNH 433
            +GELPLLTGSC VLDLSNN+FEGNL+++LKWGNIE+LDLS+N LTG+ PEET QFLRLN+
Sbjct: 377  SGELPLLTGSCTVLDLSNNEFEGNLTKLLKWGNIEFLDLSQNRLTGAFPEETSQFLRLNY 436

Query: 434  LNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVL 493
            LNLSHNSL SSLPKV+  Y KLRVLDLS N  DGP L +LL   TLQEL+L +NL  G +
Sbjct: 437  LNLSHNSLRSSLPKVLTLYPKLRVLDLSSNQFDGPLLADLLTLPTLQELYLENNLFAGAI 496

Query: 494  DFSPPSV-SNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLS 552
            +FSPPSV S+L+ LDLS N LNGYFPD+ GSLT L+ L LA NN+SGSLPTSM+ M SLS
Sbjct: 497  EFSPPSVNSSLKFLDLSQNHLNGYFPDQFGSLTALQRLNLAANNLSGSLPTSMSEMNSLS 556

Query: 553  SLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGA 612
            SL ISQN+FTGPLPNN  NSLE+FN SYND SG VPE+LRKFPSSSF+PGNS L  PGG 
Sbjct: 557  SLDISQNNFTGPLPNNFSNSLESFNASYNDLSGTVPESLRKFPSSSFFPGNSGLHLPGGP 616

Query: 613  PGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRMPPAHTTDKD 672
            PGS + P++ S  KPI TI+KV+IIVSCV+A++I ILLAIFIHY+R+SRR    H T KD
Sbjct: 617  PGSTSSPSDFSKRKPIKTIIKVVIIVSCVVAVLIFILLAIFIHYIRLSRRSTQEHVTRKD 676

Query: 673  IHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGISPSKNSHL 732
            IH      P G  G  +GGALVVSAEDL+AS+KGSSS I+S DEK AVV+G SPSK SHL
Sbjct: 677  IHKGAPQNPSGFNGRESGGALVVSAEDLLASRKGSSSEIISSDEKMAVVTGFSPSKTSHL 736

Query: 733  SWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTS 792
            SWSPESGDSFTAENLARLDVRSPD+L GELHFLDDT+TLTPEELSRAPAEVLGRSSHGTS
Sbjct: 737  SWSPESGDSFTAENLARLDVRSPDQLAGELHFLDDTITLTPEELSRAPAEVLGRSSHGTS 796

Query: 793  YRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLIL 852
            YRATLENG+FLTVKWLREGVAK+RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLIL
Sbjct: 797  YRATLENGVFLTVKWLREGVAKERKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLIL 856

Query: 853  SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNIL 912
            SDYISPG+LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNIL
Sbjct: 857  SDYISPGNLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNIL 916

Query: 913  LDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGV 972
            LDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP PSFKSDVYAFGV
Sbjct: 917  LDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPIPSFKSDVYAFGV 976

Query: 973  ILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKE 1032
            +LLELLTG+CAGDV+SGE  GVDLTDW++L+VAEG G DC D AV PEM NPAAEKG+KE
Sbjct: 977  VLLELLTGKCAGDVVSGEEGGVDLTDWVRLRVAEGRGLDCLDPAVAPEMGNPAAEKGVKE 1036

Query: 1033 VLGIALRCIRSVSERPGIKTIYEDLSSI 1060
            VLGIALRCIRSVSERPGIKTIYEDLSSI
Sbjct: 1037 VLGIALRCIRSVSERPGIKTIYEDLSSI 1064

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357448529|ref|XP_003594540.1| hypothetical protein MTR_2g030380 [Medicago truncatula] gi|355483588|gb|AES64791.1| hypothetical protein MTR_2g030380 [Medicago truncatula]

 Score = 1580 bits (4091), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 789/1048 (75%), Positives = 890/1048 (84%), Gaps = 4/1048 (0%)

Query: 17   VGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVL 76
            +GQLPSQDILALLEFKK IK+DPTG+VLNSWNEESIDFDGCPSSWNG++CNGGNVAGVVL
Sbjct: 1    MGQLPSQDILALLEFKKCIKHDPTGYVLNSWNEESIDFDGCPSSWNGVLCNGGNVAGVVL 60

Query: 77   DNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPS 136
            DNLGLSA +DLSVFSNLS LVKLSMSNNSISG +P+NI DFKSLEFLD+S+NLFSSS+P+
Sbjct: 61   DNLGLSADSDLSVFSNLSKLVKLSMSNNSISGKLPNNIADFKSLEFLDISNNLFSSSIPA 120

Query: 137  GIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLN 196
            GIGK  SLQNLSLAGNNFSG IP+S+S + SI+SLDLS N+ SG+LP +L +LN+LV LN
Sbjct: 121  GIGKFGSLQNLSLAGNNFSGPIPNSISEMASIKSLDLSRNALSGALPSSLPKLNSLVSLN 180

Query: 197  LSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQ 256
            LS N  + +IP+GFELI  L  LD HGN  DG LD EF LL++AS++D S NM + SSS 
Sbjct: 181  LSYNRLTGKIPKGFELISSLDKLDLHGNMFDGPLDVEFMLLSSASYVDLSDNMLLSSSSG 240

Query: 257  KFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQ 316
            KFLPG+S+S++YLNLS NQLTG LV G E  +F++LKVLDLSYNQL GELPGF+FVY+LQ
Sbjct: 241  KFLPGISESIKYLNLSHNQLTGILVGGAEQPVFQDLKVLDLSYNQLNGELPGFDFVYDLQ 300

Query: 317  VLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGE 376
            +LKLSNNRFSGFIPN LLKGDSL+LT+LDLSANNLSG +SMI ST LH LNLSSNG TGE
Sbjct: 301  ILKLSNNRFSGFIPNGLLKGDSLVLTELDLSANNLSGPLSMITSTTLHFLNLSSNGFTGE 360

Query: 377  LPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNL 436
            LPLLTGSCAVLDLSNN+FEGNL+R+LKWGNIEYLDL RN L G++PE TPQFLRLN+LNL
Sbjct: 361  LPLLTGSCAVLDLSNNKFEGNLTRMLKWGNIEYLDLGRNRLAGNVPEVTPQFLRLNYLNL 420

Query: 437  SHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFS 496
            S+N LS  LPKV+ QY KLRVLD+S N L G  LT L    TLQELHL +NL+ G ++ S
Sbjct: 421  SNNRLSDDLPKVLTQYPKLRVLDISSNQLKGVLLTELFTMPTLQELHLENNLINGGINLS 480

Query: 497  PP-SVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLV 555
                 S+LQVLDLSHN+L+ +FPD  GSLT L+VL +AGNN +GSLPT++A+M+SL+SL 
Sbjct: 481  SSLDQSHLQVLDLSHNQLSSFFPDEFGSLTSLRVLNIAGNNFAGSLPTTIADMSSLNSLD 540

Query: 556  ISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGAPGS 615
            IS N FTGPLPN++P  L  FN S ND SG VPE LR FPSSSF+PGN+KL FP   PGS
Sbjct: 541  ISNNRFTGPLPNSMPKGLRDFNASENDLSGVVPEILRNFPSSSFFPGNAKLHFPNSPPGS 600

Query: 616  GNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRMPPAH--TTDKDI 673
               P ++S GK +ST VKVIIIVSCV+AL ILILLA+FIHY+R+SR     +   T KD 
Sbjct: 601  TVSPTKSSKGKSMSTAVKVIIIVSCVVALFILILLAVFIHYIRMSRSSTSEYDTATGKDT 660

Query: 674  HGHTLTIPPGSTG-TGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGISPSKNSHL 732
             G    +  G    T  G  LVVSAEDLVAS+KGS S I+SPD K A V+G SPSK+S  
Sbjct: 661  RGRPQPVISGPIRPTERGAPLVVSAEDLVASRKGSPSEIISPDAKTAAVAGFSPSKHSQF 720

Query: 733  SWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTS 792
            SWSPESGDS TAENL RLD RSPDRL+GELHFLDDT++LTPEELSRAPAEVLGRSSHGTS
Sbjct: 721  SWSPESGDSLTAENLTRLDTRSPDRLIGELHFLDDTISLTPEELSRAPAEVLGRSSHGTS 780

Query: 793  YRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLIL 852
            Y+ATL+NG+ L VKWLREGVAKQRKEF KE +KFANIRHPNVVGL+GYYWGPTQHEKLIL
Sbjct: 781  YKATLDNGLLLRVKWLREGVAKQRKEFVKEIRKFANIRHPNVVGLKGYYWGPTQHEKLIL 840

Query: 853  SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNIL 912
            SDYISPGSLASFLYDRPGR GPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATN+L
Sbjct: 841  SDYISPGSLASFLYDRPGRNGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNVL 900

Query: 913  LDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGV 972
            LD  D+NARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP PSFKSDVYAFGV
Sbjct: 901  LDTADMNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPMPSFKSDVYAFGV 960

Query: 973  ILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKE 1032
            ILLELLTGRCAGDVI+GE  GVDLTDW++L+VAEG GS+CFDA +M EM NP  EKGMKE
Sbjct: 961  ILLELLTGRCAGDVITGEEGGVDLTDWLRLRVAEGRGSECFDATLMSEMGNPVVEKGMKE 1020

Query: 1033 VLGIALRCIRSVSERPGIKTIYEDLSSI 1060
            VLGIA+RCIRSVSERPGIKTIYEDLSSI
Sbjct: 1021 VLGIAIRCIRSVSERPGIKTIYEDLSSI 1048

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224061613|ref|XP_002300567.1| predicted protein [Populus trichocarpa] gi|222847825|gb|EEE85372.1| predicted protein [Populus trichocarpa]

 Score = 1561 bits (4042), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 794/1052 (75%), Positives = 887/1052 (84%), Gaps = 56/1052 (5%)

Query: 11   LYFLSSVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGN 70
            L+FLS++GQLPSQDILALLEFKKGIK+DPTG+VL SWNEES+DF GCPSSWNGIVCNG N
Sbjct: 1    LFFLSAMGQLPSQDILALLEFKKGIKHDPTGYVLESWNEESVDFGGCPSSWNGIVCNGEN 60

Query: 71   VAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLF 130
            VAGVVLDN  L  +AD+                            D +            
Sbjct: 61   VAGVVLDN--LGLSADV----------------------------DLR------------ 78

Query: 131  SSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLN 190
                   IGKL  L+NLSLAGNNFSG +PDS+SG  SIQSLDLS NSFSGSLP +LTRLN
Sbjct: 79   -------IGKLGRLRNLSLAGNNFSGSLPDSISGFASIQSLDLSRNSFSGSLPMSLTRLN 131

Query: 191  NLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMF 250
            NLVYLNLSSNGF+K IP+GFELI  LQVLD H N  DGHLDG FFL TNASH+D SGNM 
Sbjct: 132  NLVYLNLSSNGFTKMIPKGFELISSLQVLDLHENMFDGHLDGMFFLETNASHVDLSGNML 191

Query: 251  VGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFN 310
            V SSSQ+ LPG+S+S++ LNLS NQL+GSL+NGG++QLF ++KVLDLSYNQL+GELPGF+
Sbjct: 192  VSSSSQRLLPGMSESIKLLNLSHNQLSGSLLNGGDMQLFASVKVLDLSYNQLSGELPGFD 251

Query: 311  FVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSS 370
            F YELQVL+LSNN+FSG+IPNDLLKGDSLLL +LDLSANNLSG +SMI+ST L +L+LSS
Sbjct: 252  FAYELQVLRLSNNKFSGYIPNDLLKGDSLLLNELDLSANNLSGPISMIMSTTLRVLDLSS 311

Query: 371  NGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLR 430
            N L GELPL+TGSCAVLDLSNN+FEGNL+R++KWG+IEYLDLS+NHLTG IPE  PQFLR
Sbjct: 312  NVLVGELPLVTGSCAVLDLSNNRFEGNLTRMVKWGDIEYLDLSQNHLTGPIPEIAPQFLR 371

Query: 431  LNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLT 490
            LN+LNLSHNSL+SSLPKVI QY KLRVLDLS N L G  LT+LL S TLQE+HL  NLL 
Sbjct: 372  LNYLNLSHNSLTSSLPKVITQYPKLRVLDLSSNQLGGSMLTDLLMSPTLQEIHLEKNLLD 431

Query: 491  GVLDFSPPS--VSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANM 548
            G + FSPPS   SNLQV+DLSHN+L+GYFPDR  SL GL+VL L+GNN+SGSLP+SMA+M
Sbjct: 432  GSILFSPPSNSKSNLQVIDLSHNQLDGYFPDRFESLAGLQVLNLSGNNLSGSLPSSMADM 491

Query: 549  TSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSF 608
            +SL SL +SQNHFTGPLPNNL  S+ +FNVSYND SG VPENLR+FPSSSFYPGN++LS 
Sbjct: 492  SSLISLDLSQNHFTGPLPNNLSESIGSFNVSYNDLSGVVPENLRRFPSSSFYPGNNRLSL 551

Query: 609  PGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRMPPAHT 668
            P G PG  N P  N  GKPI+TIVKV++IV+CV ALIILI+LAIFI Y+RI RR PP   
Sbjct: 552  PNGPPGPNNLPGGNRGGKPINTIVKVVVIVACVTALIILIMLAIFILYIRIRRRNPPGQV 611

Query: 669  TDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGISPSK 728
            T+  I  H  T P G++GTG  GALVVSAEDLV SKKGSSS I+SPDEK A V+G SP+K
Sbjct: 612  TNTGIRRHIQTNPSGTSGTGKAGALVVSAEDLVTSKKGSSSEIISPDEKMAAVTGFSPTK 671

Query: 729  NSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSS 788
            +SHLSWSP+SGDSF AE LARLDV SPDRLVGEL+FLDDT+T+TPEELSRAPAEVLGRSS
Sbjct: 672  HSHLSWSPQSGDSFAAETLARLDVGSPDRLVGELYFLDDTITMTPEELSRAPAEVLGRSS 731

Query: 789  HGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHE 848
            HGTSYRATL+NG+F+TVKWLREGVAKQRKEFAKEAKKF NIRHPNVVGLRGYYWGPTQHE
Sbjct: 732  HGTSYRATLDNGVFITVKWLREGVAKQRKEFAKEAKKFTNIRHPNVVGLRGYYWGPTQHE 791

Query: 849  KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKA 908
            KLILSDYISPGSLASFLYDRPGRKGPPLTW QRLKIAVDVARGLNYLHFDRAVPHGNLKA
Sbjct: 792  KLILSDYISPGSLASFLYDRPGRKGPPLTWVQRLKIAVDVARGLNYLHFDRAVPHGNLKA 851

Query: 909  TNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVY 968
            TNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP PSFKSDVY
Sbjct: 852  TNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPLPSFKSDVY 911

Query: 969  AFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEK 1028
            AFG+I+LELLTGRCAGDVISGEG  VDLTDW++L+       DCFD A++PEMVNPA +K
Sbjct: 912  AFGMIMLELLTGRCAGDVISGEGGSVDLTDWVRLRAM-----DCFDPALVPEMVNPAVDK 966

Query: 1029 GMKEVLGIALRCIRSVSERPGIKTIYEDLSSI 1060
            GMKEVLGIALRCIRSVS+RPGIKTIYEDLSSI
Sbjct: 967  GMKEVLGIALRCIRSVSDRPGIKTIYEDLSSI 998

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147839340|emb|CAN61261.1| hypothetical protein VITISV_003240 [Vitis vinifera]

 Score = 1555 bits (4026), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 812/1054 (77%), Positives = 900/1054 (85%), Gaps = 17/1054 (1%)

Query: 17   VGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVL 76
            +GQLPSQDILALLEFKKGIK+DPTG+VLNSWNEESIDF+GCPSSWNGIVCNG NVAGVVL
Sbjct: 1    MGQLPSQDILALLEFKKGIKHDPTGYVLNSWNEESIDFNGCPSSWNGIVCNGVNVAGVVL 60

Query: 77   DNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPS 136
            D+ GLSA  DLSVFSNL+MLVKLSMS NSISG IPDNIGD KSLE+LD+SDNLF SSLP 
Sbjct: 61   DHQGLSADVDLSVFSNLTMLVKLSMSGNSISGKIPDNIGDLKSLEYLDLSDNLFFSSLPP 120

Query: 137  GIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLN 196
            GIGKL +L+NLSLAGNNFSG IPDS+ GL SIQSLD S NSFSG +  +LT+L NLV LN
Sbjct: 121  GIGKLANLKNLSLAGNNFSGSIPDSILGLESIQSLDFSRNSFSGDMAASLTKLTNLVSLN 180

Query: 197  LSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQ 256
            LS NGF  +IP+GFEL+  L++LD HGN L GHLD EF   ++A H+DFSGNM V S  Q
Sbjct: 181  LSLNGFESKIPKGFELLSKLEILDLHGNMLSGHLDEEFLRFSSAIHVDFSGNMLVNSGLQ 240

Query: 257  K--FLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYE 314
            K  FL  +S +V YLNLS NQL GSLV+GG      NLKVLDLSYNQL+GELPGFNF+Y 
Sbjct: 241  KQNFLSXISSTVXYLNLSHNQLMGSLVSGGGPLELANLKVLDLSYNQLSGELPGFNFLYA 300

Query: 315  LQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLS--------------GSVSMILS 360
            L+VLKLSNNRF+GFIPNDLLKGD L+LT+LDLSANNLS              G ++MI S
Sbjct: 301  LEVLKLSNNRFTGFIPNDLLKGDPLVLTELDLSANNLSDFLFAISHIPVGFTGLINMITS 360

Query: 361  TNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGS 420
            T L++LNLSSNGL+GELPLLTGSC VLDLSNN+FEGNL+++LKWGNIE+LDLS+N LTG+
Sbjct: 361  TTLNILNLSSNGLSGELPLLTGSCTVLDLSNNEFEGNLTKLLKWGNIEFLDLSQNRLTGA 420

Query: 421  IPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQ 480
             PEET QFLRLN+LNLSHNSL SSLPKV+  Y KLRVLDLS N  DG  L +LL   TLQ
Sbjct: 421  FPEETSQFLRLNYLNLSHNSLRSSLPKVLTLYPKLRVLDLSSNQFDGLLLADLLTLPTLQ 480

Query: 481  ELHLADNLLTGVLDFSPPSV-SNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISG 539
            EL+L +NL  G ++FSPPSV S+L+ LDLS N LNGYFPD+ GSLT L+ L LA NN+SG
Sbjct: 481  ELYLENNLFAGAIEFSPPSVNSSLKFLDLSQNHLNGYFPDQFGSLTALQRLNLAANNLSG 540

Query: 540  SLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSF 599
            SLPTSM+ M SLSSL ISQN+FTGPLPNN  NSLE+FN SYND SG VPENLRKFPSSSF
Sbjct: 541  SLPTSMSEMNSLSSLDISQNNFTGPLPNNFSNSLESFNASYNDLSGTVPENLRKFPSSSF 600

Query: 600  YPGNSKLSFPGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRI 659
            +PGNS L  PGG PGS + P++ S  KPI TI+KV+IIVSCV+A++I ILLAIFIHY+R+
Sbjct: 601  FPGNSGLHLPGGPPGSTSSPSDFSKRKPIKTIIKVVIIVSCVVAVLIFILLAIFIHYIRL 660

Query: 660  SRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAA 719
            SRR    H T KDIH      P G  G  +GGALVVSAEDL+AS+KGSSS I+S DEK A
Sbjct: 661  SRRSTQEHVTRKDIHKGAPQNPSGFNGRESGGALVVSAEDLLASRKGSSSEIISSDEKMA 720

Query: 720  VVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRA 779
            VV+G SPSK SHLSWSPESGDSFTAENLARLDVRSPD+L GELHFLDDT+TLTPEELSRA
Sbjct: 721  VVTGFSPSKTSHLSWSPESGDSFTAENLARLDVRSPDQLAGELHFLDDTITLTPEELSRA 780

Query: 780  PAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
            PAEVLGRSSHGTSYRATLENG+FLTVKWLREGVAK+RKEFAKEAKKFANIRHPNVVGLRG
Sbjct: 781  PAEVLGRSSHGTSYRATLENGVFLTVKWLREGVAKERKEFAKEAKKFANIRHPNVVGLRG 840

Query: 840  YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
            YYWGPTQHEKLILSDYISPG+LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR
Sbjct: 841  YYWGPTQHEKLILSDYISPGNLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 900

Query: 900  AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
            AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP
Sbjct: 901  AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 960

Query: 960  HPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019
             PSFKSDVYAFGV+LLELLTG+CAGDV+SGE  GVDLTDW++L+VAEG G DC D AV P
Sbjct: 961  IPSFKSDVYAFGVVLLELLTGKCAGDVVSGEEGGVDLTDWVRLRVAEGRGLDCLDPAVAP 1020

Query: 1020 EMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTI 1053
            EM NPAAEKG+KEVLGIALRCIRSVSERP +  +
Sbjct: 1021 EMGNPAAEKGVKEVLGIALRCIRSVSERPDLNML 1054

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|264664505|sp|C0LGQ9.1|Y4294_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At4g20940 gi|224589622|gb|ACN59344.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana]

 Score = 1485 bits (3845), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 773/1047 (73%), Positives = 889/1047 (84%), Gaps = 13/1047 (1%)

Query: 17   VGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVL 76
            +GQLPSQDI+ALLEFKKGIK+DPTGFVLNSWN+ESIDF+GCPSSWNGIVCNGGNVAGVVL
Sbjct: 1    MGQLPSQDIMALLEFKKGIKHDPTGFVLNSWNDESIDFNGCPSSWNGIVCNGGNVAGVVL 60

Query: 77   DNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPS 136
            DNLGL+A AD S+FSNL+ LVKLSMSNNS+SGV+P+++G FKSL+FLD+SDNLFSSSLP 
Sbjct: 61   DNLGLTADADFSLFSNLTKLVKLSMSNNSLSGVLPNDLGSFKSLQFLDLSDNLFSSSLPK 120

Query: 137  GIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLN 196
             IG+  SL+NLSL+GNNFSG IP+S+ GL+S+QSLD+S NS SG LP +LTRLN+L+YLN
Sbjct: 121  EIGRSVSLRNLSLSGNNFSGEIPESMGGLISLQSLDMSSNSLSGPLPKSLTRLNDLLYLN 180

Query: 197  LSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQ 256
            LSSNGF+ ++PRGFELI  L+VLD HGN +DG+LDGEFFLLTNAS++D SGN  V ++S 
Sbjct: 181  LSSNGFTGKMPRGFELISSLEVLDLHGNSIDGNLDGEFFLLTNASYVDISGNRLV-TTSG 239

Query: 257  KFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQ 316
            K LPG+S+S+++LNLS NQL GSL +G   QLF+NLKVLDLSYN L+GELPGFN+VY+L+
Sbjct: 240  KLLPGVSESIKHLNLSHNQLEGSLTSG--FQLFQNLKVLDLSYNMLSGELPGFNYVYDLE 297

Query: 317  VLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGE 376
            VLKLSNNRFSG +PN+LLKGDSLLLT LDLS NNLSG VS I+ST LH L+LSSN LTGE
Sbjct: 298  VLKLSNNRFSGSLPNNLLKGDSLLLTTLDLSGNNLSGPVSSIMSTTLHTLDLSSNSLTGE 357

Query: 377  LPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNL 436
            LPLLTG C +LDLSNNQFEGNL+R  KW NIEYLDLS+NH TGS P+ TPQ LR NHLNL
Sbjct: 358  LPLLTGGCVLLDLSNNQFEGNLTRWSKWENIEYLDLSQNHFTGSFPDATPQLLRANHLNL 417

Query: 437  SHNSLSSSLPKVI-IQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDF 495
            S+N L+ SLP+ I   Y KLRVLD+S N L+GP    LL+  TL+E+HL +N +TG +  
Sbjct: 418  SYNKLTGSLPERIPTHYPKLRVLDISSNSLEGPIPGALLSMPTLEEIHLQNNGMTGNIGP 477

Query: 496  SPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLV 555
             P S S +++LDLSHNR +G  P   GSLT L+VL LA NN+SGSLP+SM ++ SLSSL 
Sbjct: 478  LPSSGSRIRLLDLSHNRFDGDLPGVFGSLTNLQVLNLAANNLSGSLPSSMNDIVSLSSLD 537

Query: 556  ISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGAPGS 615
            +SQNHFTGPLP+NL +++  FNVSYND SG VPENL+ FP  SFYPGNSKL  P G+PGS
Sbjct: 538  VSQNHFTGPLPSNLSSNIMAFNVSYNDLSGTVPENLKNFPPPSFYPGNSKLVLPAGSPGS 597

Query: 616  GNFPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRMPPAHTTDKDIHG 675
                +E S  K  + +VKV+IIVSC +ALIILIL+AI +  +  SRR      T K+ + 
Sbjct: 598  S--ASEASKNKSTNKLVKVVIIVSCAVALIILILVAILLFCICKSRRREERSITGKETNR 655

Query: 676  HTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGISPSKNSHLSWS 735
               TIP GS     GG +VVSAEDLVAS+KGSSS ILSPDEK AV +G SPSK S+LSWS
Sbjct: 656  RAQTIPSGS-----GGGMVVSAEDLVASRKGSSSEILSPDEKLAVATGFSPSKTSNLSWS 710

Query: 736  PESGDSFTA-ENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYR 794
            P SGDSF A + LARLDVRSPDRLVGELHFLDD++ LTPEELSRAPAEVLGRSSHGTSYR
Sbjct: 711  PGSGDSFPADQQLARLDVRSPDRLVGELHFLDDSIKLTPEELSRAPAEVLGRSSHGTSYR 770

Query: 795  ATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD 854
            ATL+NG+FLTVKWLREGVAKQRKEFAKE KKF+NIRHPNVV LRGYYWGPTQHEKLILSD
Sbjct: 771  ATLDNGVFLTVKWLREGVAKQRKEFAKEVKKFSNIRHPNVVTLRGYYWGPTQHEKLILSD 830

Query: 855  YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD 914
            YISPGSLASFLYDRPGRKGPPL W QRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD
Sbjct: 831  YISPGSLASFLYDRPGRKGPPLAWTQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD 890

Query: 915  GPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVIL 974
            G +LNARVADYCLHRLMTQAGT+EQILDAG+LGYRAPELAAS+KP PSFKSDVYAFGVIL
Sbjct: 891  GAELNARVADYCLHRLMTQAGTVEQILDAGILGYRAPELAASRKPLPSFKSDVYAFGVIL 950

Query: 975  LELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEM-VNPAAEKGMKEV 1033
            LE+LTGRCAGDVI+GE  GVDLTDW++L+VAEG G++CFD+ +  EM  +P  EKGMKEV
Sbjct: 951  LEILTGRCAGDVITGEQEGVDLTDWVRLRVAEGRGAECFDSVLTQEMGSDPVTEKGMKEV 1010

Query: 1034 LGIALRCIRSVSERPGIKTIYEDLSSI 1060
            LGIALRCIRSVSERPGIKTIYEDLSSI
Sbjct: 1011 LGIALRCIRSVSERPGIKTIYEDLSSI 1037

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1060
TAIR|locus:2184058	1048	AT5G10020 [Arabidopsis thalian	0.317	0.321	0.520	6.1e-170
TAIR|locus:2059253	1020	AT2G27060 [Arabidopsis thalian	0.286	0.298	0.480	2.1e-139
TAIR|locus:2091353	1016	AT3G28040 [Arabidopsis thalian	0.555	0.579	0.286	4.6e-84
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.533	0.451	0.301	6.1e-83
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.529	0.449	0.299	3.7e-82
TAIR|locus:2122239	1136	AT4G36180 [Arabidopsis thalian	0.489	0.456	0.298	1.3e-79
UNIPROTKB|P93194	1109	INRPK1 "Receptor-like protein	0.545	0.521	0.287	3.6e-79
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.526	0.468	0.293	3.8e-79
TAIR|locus:2154344	1135	AT5G48940 [Arabidopsis thalian	0.522	0.488	0.293	1.6e-77
TAIR|locus:2007918	1088	PEPR2 "PEP1 receptor 2" [Arabi	0.552	0.538	0.296	3e-77

TAIR|locus:2184058 AT5G10020 [Arabidopsis thaliana (taxid:3702)]

 Score = 878 (314.1 bits), Expect = 6.1e-170, Sum P(2) = 6.1e-170
 Identities = 180/346 (52%), Positives = 228/346 (65%)

Query:   715 DEKAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFXXXXXXXXPE 774
             D+  A     S S  S LS SP   D         LDV SPDRL GEL F         E
Sbjct:   710 DDYPAASGRKSSSGGSPLSSSPRFSDQ-----PVMLDVYSPDRLAGELFFLDVSLKLTAE 764

Query:   775 ELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNV 834
             ELSRAPAEVLGRSSHGT Y+ATL+NG  LTVKWLR G+ + +           +++HPN+
Sbjct:   765 ELSRAPAEVLGRSSHGTLYKATLDNGHMLTVKWLRVGLVRHKKDFAREAKKIGSLKHPNI 824

Query:   835 VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
             V LR YYWGP + E+L+LSDY+   SLA  LY+   R+  P++++QRLK+AV+VA+ L Y
Sbjct:   825 VPLRAYYWGPREQERLLLSDYLRGESLAMHLYETTPRRYSPMSFSQRLKVAVEVAQCLLY 884

Query:   895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELA 954
             LH DRA+PHGNLK TNI+L  PD   R+ DYC+HRLMT +G  EQIL+   LGY APEL+
Sbjct:   885 LH-DRAMPHGNLKPTNIILSSPDNTVRITDYCVHRLMTPSGVAEQILNMSALGYSAPELS 943

Query:   955 ASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014
             ++ KP P+ KSDVYAFGVIL+ELLT R AGD+ISG+   VDLTDW++L   EG   DC D
Sbjct:   944 SASKPIPTLKSDVYAFGVILMELLTRRSAGDIISGQTGAVDLTDWVRLCDQEGRRMDCID 1003

Query:  1015 AAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI 1060
               +          KGM++ L +A+RCI SV+ERP I+ + + L+SI
Sbjct:  1004 RDIAG---GEEFSKGMEDALAVAIRCILSVNERPNIRQVLDHLTSI 1046

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2059253 AT2G27060 [Arabidopsis thaliana (taxid:3702)]

 Score = 740 (265.6 bits), Expect = 2.1e-139, Sum P(2) = 2.1e-139
 Identities = 146/304 (48%), Positives = 192/304 (63%)

Query:   757 RLVGELHFXXXXXXXXPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQR 816
             RL G L+          EELSRAPAE +GRS HGT YRA L +   L VKWLREG AK +
Sbjct:   710 RLDGNLYIFDSSLKLTAEELSRAPAEAIGRSCHGTLYRAVLNSDSVLAVKWLREGTAKGK 769

Query:   817 XXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPL 876
                        NI HPN+V L+ YYWGP +HEKLI+S Y+    LA +L +      PPL
Sbjct:   770 KEFAREIKKLGNINHPNLVSLQAYYWGPKEHEKLIISRYMDAPCLAFYLQEAGQLNLPPL 829

Query:   877 TWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT 936
                 RLKI +D+A  L+YLH   A+PHGNLK+TN+LL  P+L A + DY LHRL+T   T
Sbjct:   830 LLENRLKITLDIASCLSYLHNGEAIPHGNLKSTNVLLKPPELTAHLTDYSLHRLITPEAT 889

Query:   937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDL 996
              EQ+L+A  LGY  PE A+S KP+PS KSDVYAFGVILLELLTG+ +GD++  +   V+L
Sbjct:   890 SEQVLNAAALGYCPPEFASSSKPYPSLKSDVYAFGVILLELLTGKVSGDIVCSDPGVVEL 949

Query:   997 TDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYED 1056
             T+W+ L V +   ++CFD +++    +      + +VL +AL CI    ERP +K + ++
Sbjct:   950 TEWVLLLVGQNRATECFDPSIVGSQGSRNPFGVLTDVLQVALSCISPAPERPDMKLVSQE 1009

Query:  1057 LSSI 1060
             LS I
Sbjct:  1010 LSRI 1013

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2091353 AT3G28040 [Arabidopsis thaliana (taxid:3702)]

 Score = 546 (197.3 bits), Expect = 4.6e-84, Sum P(2) = 4.6e-84
 Identities = 176/614 (28%), Positives = 268/614 (43%)

Query:    22 SQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNG--GNVAGVVLDNL 79
             + D+L L+ FK  + NDP    L SW E+    D  P SW+ + CN     V  + LD L
Sbjct:    34 NDDVLGLIVFKSDL-NDPFSH-LESWTED----DNTPCSWSYVKCNPKTSRVIELSLDGL 87

Query:    80 GLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIG 139
              L+   +  +   L  L  LS+SNN+ +G I + + +   L+ LD+S N  S  +PS +G
Sbjct:    88 ALTGKINRGI-QKLQRLKVLSLSNNNFTGNI-NALSNNNHLQKLDLSHNNLSGQIPSSLG 145

Query:   140 KLESLQNLSLAGNNFSGLIPDSV-SGLVSIQSLDLSHNSFSGSLPPALTRXXXXXXXXXX 198
              + SLQ+L L GN+FSG + D + +   S++ L LSHN   G +P  L R          
Sbjct:   146 SITSLQHLDLTGNSFSGTLSDDLFNNCSSLRYLSLSHNHLEGQIPSTLFRCSVLNSLNLS 205

Query:   199 XXGFSKR--IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQ 256
                FS       G   +  L+ LD   N L G +      L N   +    N F G+   
Sbjct:   206 RNRFSGNPSFVSGIWRLERLRALDLSSNSLSGSIPLGILSLHNLKELQLQRNQFSGALPS 265

Query:   257 KFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGF-NFVYEL 315
                 GL   +  ++LS N  +G L     LQ  ++L   D+S N L+G+ P +   +  L
Sbjct:   266 DI--GLCPHLNRVDLSSNHFSGELPR--TLQKLKSLNHFDVSNNLLSGDFPPWIGDMTGL 321

Query:   316 QVLKLSNNRFSGFIPXXXXXXXXXXXXXXXXXXXXXXGSVSMILSTNLHMLNLSSNGLTG 375
               L  S+N  +G +P                         S+     L ++ L  N  +G
Sbjct:   322 VHLDFSSNELTGKLPSSISNLRSLKDLNLSENKLSGEVPESLESCKELMIVQLKGNDFSG 381

Query:   376 ELP--LLTGSCAVLDLSNNQFEGNLSRILK--WGNIEYLDLSRNHLTGSIPEETPQFLRX 431
              +P          +D S N   G++ R     + ++  LDLS N LTGSIP E   F+  
Sbjct:   382 NIPDGFFDLGLQEMDFSGNGLTGSIPRGSSRLFESLIRLDLSHNSLTGSIPGEVGLFIHM 441

Query:   432 XXXXXXXXXXXXXXPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTG 491
                           P  I   Q L VLDL  + L G    ++  S +LQ L L  N LTG
Sbjct:   442 RYLNLSWNHFNTRVPPEIEFLQNLTVLDLRNSALIGSVPADICESQSLQILQLDGNSLTG 501

Query:   492 VLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSL 551
              +     + S+L++L LSHN L G  P  L +L  LK+L L  N +SG +P  + ++ +L
Sbjct:   502 SIPEGIGNCSSLKLLSLSHNNLTGPIPKSLSNLQELKILKLEANKLSGEIPKELGDLQNL 561

Query:   552 SSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGG 611
               + +S N   G LP  L +  ++ + S    +  +   L + P +   P    ++ P  
Sbjct:   562 LLVNVSFNRLIGRLP--LGDVFQSLDQSAIQGNLGICSPLLRGPCTLNVPKPLVIN-PNS 618

Query:   612 APGSGNFPAENSNG 625
                  N P   ++G
Sbjct:   619 YGNGNNMPGNRASG 632

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 587 (211.7 bits), Expect = 6.1e-83, Sum P(2) = 6.1e-83
 Identities = 177/588 (30%), Positives = 269/588 (45%)

Query:    18 GQLPSQ--DILALLEFKKG-IKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGV 74
             GQ P Q  D+  LLE K   I N     VL  WN  S  +  C  +W G+ C G  + G+
Sbjct:    22 GQ-PGQRDDLQTLLELKNSFITNPKEEDVLRDWNSGSPSY--C--NWTGVTCGGREIIGL 76

Query:    75 VLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKS-LEFLDVSDNLFSSS 133
              L  LGL+ +   S+    + L+ + +S+N + G IP  + +  S LE L +  NL S  
Sbjct:    77 NLSGLGLTGSISPSI-GRFNNLIHIDLSSNRLVGPIPTTLSNLSSSLESLHLFSNLLSGD 135

Query:   134 LPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRXXXXX 193
             +PS +G L +L++L L  N  +G IP++   LV++Q L L+    +G +P    R     
Sbjct:   136 IPSQLGSLVNLKSLKLGDNELNGTIPETFGNLVNLQMLALASCRLTGLIPSRFGRLVQLQ 195

Query:   194 XXXXXXXGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGS 253
                         IP        L +     N+L+G L  E   L N   ++   N F G 
Sbjct:   196 TLILQDNELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGE 255

Query:   254 SSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGEL-PGFNFV 312
                +   G   S+QYLNL  NQL G +     L    NL+ LDLS N LTG +   F  +
Sbjct:   256 IPSQL--GDLVSIQYLNLIGNQLQGLIPK--RLTELANLQTLDLSSNNLTGVIHEEFWRM 311

Query:   313 YELQVLKLSNNRFSGFIPXXXXXXXXXXXXXXXXXXXXXXGSVSMILST--NLHMLNLSS 370
              +L+ L L+ NR SG +P                      G +   +S   +L +L+LS+
Sbjct:   312 NQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLS-GEIPAEISNCQSLKLLDLSN 370

Query:   371 NGLTGELP---LLTGSCAVLDLSNNQFEGNLSR-ILKWGNIEYLDLSRNHLTGSIPEETP 426
             N LTG++P           L L+NN  EG LS  I    N++   L  N+L G +P+E  
Sbjct:   371 NTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIG 430

Query:   427 QFLRXXXXXXXXXXXXXXXPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLAD 486
                +               P  I    +L+ +D   N L G   +++     L  LHL +
Sbjct:   431 FLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRE 490

Query:   487 NLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMA 546
             N L G +  S  +   + V+DL+ N+L+G  P   G LT L++  +  N++ G+LP S+ 
Sbjct:   491 NELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLI 550

Query:   547 NMTSLSSLVISQNHFTGPL-PNNLPNSLETFNVSYNDFSGAVPENLRK 593
             N+ +L+ +  S N F G + P    +S  +F+V+ N F G +P  L K
Sbjct:   551 NLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGK 598

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 582 (209.9 bits), Expect = 3.7e-82, Sum P(2) = 3.7e-82
 Identities = 174/581 (29%), Positives = 271/581 (46%)

Query:    22 SQDILALLEFKKGIKNDPT-GFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNL- 79
             + D+  LLE KK +  +P     L  WN ++I++  C  SW G+ C+   +  V+  NL 
Sbjct:    24 NNDLQTLLEVKKSLVTNPQEDDPLRQWNSDNINY--C--SWTGVTCDNTGLFRVIALNLT 79

Query:    80 GLSAAADLSV-FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI 138
             GL     +S  F     L+ L +S+N++ G IP  + +  SLE L +  N  +  +PS +
Sbjct:    80 GLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGEIPSQL 139

Query:   139 GKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRXXXXXXXXXX 198
             G L ++++L +  N   G IP+++  LV++Q L L+    +G +P  L R          
Sbjct:   140 GSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQSLILQ 199

Query:   199 XXGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKF 258
                    IP        L V     N L+G +  E   L N   ++ + N   G    + 
Sbjct:   200 DNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQ- 258

Query:   259 LPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQV 317
             L  +SQ +QYL+L  NQL G +     L    NL+ LDLS N LTGE+P  F  + +L  
Sbjct:   259 LGEMSQ-LQYLSLMANQLQGLIPKS--LADLGNLQTLDLSANNLTGEIPEEFWNMSQLLD 315

Query:   318 LKLSNNRFSGFIPXXXXXXXXXXXXXXXXXXXXXXGSVSMILST--NLHMLNLSSNGLTG 375
             L L+NN  SG +P                      G + + LS   +L  L+LS+N L G
Sbjct:   316 LVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLS-GEIPVELSKCQSLKQLDLSNNSLAG 374

Query:   376 ELP-LLTGSCAVLDL--SNNQFEGNLS-RILKWGNIEYLDLSRNHLTGSIPEETPQFLRX 431
              +P  L     + DL   NN  EG LS  I    N+++L L  N+L G +P+E     + 
Sbjct:   375 SIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKL 434

Query:   432 XXXXXXXXXXXXXXPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTG 491
                           P+ I     L+++D+  NH +G    ++     L  LHL  N L G
Sbjct:   435 EVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVG 494

Query:   492 VLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSL 551
              L  S  +   L +LDL+ N+L+G  P   G L GL+ L L  N++ G+LP S+ ++ +L
Sbjct:   495 GLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNL 554

Query:   552 SSLVISQNHFTGPL-PNNLPNSLETFNVSYNDFSGAVPENL 591
             + + +S N   G + P    +S  +F+V+ N F   +P  L
Sbjct:   555 TRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLEL 595

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)]

 Score = 568 (205.0 bits), Expect = 1.3e-79, Sum P(2) = 1.3e-79
 Identities = 162/542 (29%), Positives = 259/542 (47%)

Query:    88 SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNL 147
             S  +NL+ L  L++S N ++G IP ++G+ +SL++L +  NL   +LPS I    SL +L
Sbjct:   180 SGLANLTQLQLLNLSYNQLTGEIPASLGNLQSLQYLWLDFNLLQGTLPSAISNCSSLVHL 239

Query:   148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRXXXXXXXXXXXXGFSKRI- 206
             S + N   G+IP +   L  ++ L LS+N+FSG++P +L               FS  + 
Sbjct:   240 SASENEIGGVIPAAYGALPKLEVLSLSNNNFSGTVPFSLFCNTSLTIVQLGFNAFSDIVR 299

Query:   207 PRGF-ELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
             P        GLQVLD   N++ G        + +  ++D SGN+F G        G  + 
Sbjct:   300 PETTANCRTGLQVLDLQENRISGRFPLWLTNILSLKNLDVSGNLFSGEIPPDI--GNLKR 357

Query:   266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGF-NFVYELQVLKLSNNR 324
             ++ L L+ N LTG +    E++   +L VLD   N L G++P F  ++  L+VL L  N 
Sbjct:   358 LEELKLANNSLTGEIPV--EIKQCGSLDVLDFEGNSLKGQIPEFLGYMKALKVLSLGRNS 415

Query:   325 FSGFIPXXXXXXXXXXXXXXXXXXXXXXGSVSMILSTNLHMLNLSSNGLTGELPLLTGSC 384
             FSG++P                        V ++  T+L  L+LS N  +G +P+   + 
Sbjct:   416 FSGYVPSSMVNLQQLERLNLGENNLNGSFPVELMALTSLSELDLSGNRFSGAVPVSISNL 475

Query:   385 A---VLDLSNNQFEGNLSRILKWGNI---EYLDLSRNHLTGSIPEETPQFLRXXXXXXXX 438
             +    L+LS N F G +   +  GN+     LDLS+ +++G +P E              
Sbjct:   476 SNLSFLNLSGNGFSGEIPASV--GNLFKLTALDLSKQNMSGEVPVELSGLPNVQVIALQG 533

Query:   439 XXXXXXXPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPP 498
                    P+       LR ++LS N   G           L  L L+DN ++G +   PP
Sbjct:   534 NNFSGVVPEGFSSLVSLRYVNLSSNSFSGEIPQTFGFLRLLVSLSLSDNHISGSI---PP 590

Query:   499 SVSN---LQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLV 555
              + N   L+VL+L  NRL G+ P  L  L  LKVL L  NN+SG +P  ++  +SL+SL 
Sbjct:   591 EIGNCSALEVLELRSNRLMGHIPADLSRLPRLKVLDLGQNNLSGEIPPEISQSSSLNSLS 650

Query:   556 ISQNHFTGPLPNNLP--NSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGAP 613
             +  NH +G +P +    ++L   ++S N+ +G +P +L    S+  Y   S  +  G  P
Sbjct:   651 LDHNHLSGVIPGSFSGLSNLTKMDLSVNNLTGEIPASLALISSNLVYFNVSSNNLKGEIP 710

Query:   614 GS 615
              S
Sbjct:   711 AS 712

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006260 "DNA replication" evidence=RCA

GO:0006306 "DNA methylation" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0008283 "cell proliferation" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0030244 "cellulose biosynthetic process" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)]

 Score = 534 (193.0 bits), Expect = 3.6e-79, Sum P(2) = 3.6e-79
 Identities = 174/606 (28%), Positives = 268/606 (44%)

Query:    22 SQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVV-LDNLG 80
             + D  ALL   +   + P+  +  SWN      D  P SW G+ C+       + L + G
Sbjct:    25 NSDGAALLSLTRHWTSIPSD-ITQSWNAS----DSTPCSWLGVECDRRQFVDTLNLSSYG 79

Query:    81 LSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGK 140
             +S      + S+L  L K+ +S N   G IP  +G+   LE +D+S N F+ ++P  +G 
Sbjct:    80 ISGEFGPEI-SHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGA 138

Query:   141 LESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRXXXXXXXXXXXX 200
             L++L+NLSL  N+  G  P+S+  +  ++++  + N  +GS+P  +              
Sbjct:   139 LQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDN 198

Query:   201 GFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP 260
              FS  +P     I  LQ L  + N L G L      L N  ++D   N  VG+    F+ 
Sbjct:   199 QFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFVS 258

Query:   261 GLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLK 319
                + +  ++LS NQ TG L  G  L    +L+        L+G +P  F  + +L  L 
Sbjct:   259 --CKQIDTISLSNNQFTGGLPPG--LGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLY 314

Query:   320 LSNNRFSGFIPXXXXXXXXXXXXXXXXXXXXXX--GSVSMILSTNLHMLNLSSNGLTGEL 377
             L+ N FSG IP                        G + M+  + L  L+L +N L+GE+
Sbjct:   315 LAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGML--SQLQYLHLYTNNLSGEV 372

Query:   378 PLLTG---SCAVLDLSNNQFEGNLS-RILKWGNIEYLDLSRNHLTGSIPEETPQFLRXXX 433
             PL      S   L L  N   G L   + +   +  L L  NH TG IP++         
Sbjct:   373 PLSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEV 432

Query:   434 XXXXXXXXXXXXPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVL 493
                         P  +   +KL+ L L +N+L+G   ++L   STL+ L L +N L G L
Sbjct:   433 LDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGL 492

Query:   494 -DFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLS 552
              DF      NL   DLS N   G  P  LG+L  +  + L+ N +SGS+P  + ++  L 
Sbjct:   493 PDFVEKQ--NLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLE 550

Query:   553 SLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLRKFPS-SSFYPGNSKLSFP 609
              L +S N   G LP+ L N   L   + S+N  +G++P  L      +    G +  SF 
Sbjct:   551 HLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGEN--SFS 608

Query:   610 GGAPGS 615
             GG P S
Sbjct:   609 GGIPTS 614

GO:0005524 "ATP binding" evidence=NAS

GO:0005576 "extracellular region" evidence=NAS

GO:0005886 "plasma membrane" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0019199 "transmembrane receptor protein kinase activity" evidence=NAS

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 524 (189.5 bits), Expect = 3.8e-79, Sum P(2) = 3.8e-79
 Identities = 173/589 (29%), Positives = 269/589 (45%)

Query:    22 SQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGL 81
             S +  +L+ FK+ ++N P+  +L+SWN  S     C   W G+ C  G V  + L +L L
Sbjct:    24 SSETTSLISFKRSLEN-PS--LLSSWNVSS-SASHC--DWVGVTCLLGRVNSLSLPSLSL 77

Query:    82 SAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKL 141
                    + S+L  L +L ++ N  SG IP  I + K L+ LD+S N  +  LP  + +L
Sbjct:    78 RGQIPKEI-SSLKNLRELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPRLLSEL 136

Query:   142 ESLQNLSLAGNNFSGLIPDSVS-GLVSIQSLDLSHNSFSGSLPPALTRXXXXXXXXXXXX 200
               L  L L+ N+FSG +P S    L ++ SLD+S+NS SG +PP + +            
Sbjct:   137 PQLLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNLYMGLN 196

Query:   201 GFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP 260
              FS +IP     I  L+         +G L  E   L + + +D S N    S  + F  
Sbjct:   197 SFSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSF-- 254

Query:   261 GLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKL 320
             G   ++  LNL   +L G +    EL   ++LK L LS+N L+G LP       L     
Sbjct:   255 GELHNLSILNLVSAELIGLIPP--ELGNCKSLKSLMLSFNSLSGPLPLELSEIPLLTFSA 312

Query:   321 SNNRFSGFIPXXXXXXXXXXXXXXXXXXXXXXGSVSMILSTNLHMLNLSSNGLTGELP-- 378
               N+ SG +P                          +     L  L+L+SN L+G +P  
Sbjct:   313 ERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRE 372

Query:   379 LL-TGSCAVLDLSNNQFEGNLSRILKW-GNIEYLDLSRNHLTGSIPEETPQFLRXXXXXX 436
             L  +GS   +DLS N   G +  +     ++  L L+ N + GSIPE+  + L       
Sbjct:   373 LCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWK-LPLMALDL 431

Query:   437 XXXXXXXXXPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFS 496
                      PK + +   L     S+N L+G     + N+++L+ L L+DN LTG +   
Sbjct:   432 DSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPRE 491

Query:   497 PPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVI 556
                +++L VL+L+ N   G  P  LG  T L  L L  NN+ G +P  +  +  L  LV+
Sbjct:   492 IGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVL 551

Query:   557 SQNHFTGPLPNN---------LPNS--LE---TFNVSYNDFSGAVPENL 591
             S N+ +G +P+          +P+   L+    F++SYN  SG +PE L
Sbjct:   552 SYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEEL 600

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)]

 Score = 553 (199.7 bits), Expect = 1.6e-77, Sum P(3) = 1.6e-77
 Identities = 172/587 (29%), Positives = 270/587 (45%)

Query:    22 SQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGN---VA--GVVL 76
             + ++ AL+ +     N P   V + WN    D    P  W  I C+  +   V    VV 
Sbjct:    37 TNEVSALISWLHS-SNSPPPSVFSGWNPSDSD----PCQWPYITCSSSDNKLVTEINVVS 91

Query:    77 DNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPS 136
               L L    ++S F++L  LV   +SN +++G I   IGD   L  +D+S N     +PS
Sbjct:    92 VQLALPFPPNISSFTSLQKLV---ISNTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPS 148

Query:   137 GIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRXXXXXXXX 196
              +GKL++LQ L L  N  +G IP  +   VS+++L++  N  S +LP  L +        
Sbjct:   149 SLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIR 208

Query:   197 XXXXG-FSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSS 255
                    S +IP        L+VL     K+ G L      L+    +     M  G   
Sbjct:   209 AGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIP 268

Query:   256 QKFLPGLSQSVQYLNLSL--NQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFV 312
             ++    L    + +NL L  N L+G+L    EL   +NL+ + L  N L G +P    F+
Sbjct:   269 KE----LGNCSELINLFLYDNDLSGTLPK--ELGKLQNLEKMLLWQNNLHGPIPEEIGFM 322

Query:   313 YELQVLKLSNNRFSGFIPXXXXXXXXXXXXXXXXXXXXXXGSVSMILS--TNLHMLNLSS 370
               L  + LS N FSG IP                      GS+  ILS  T L    + +
Sbjct:   323 KSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNIT--GSIPSILSNCTKLVQFQIDA 380

Query:   371 NGLTGELPLLTGSCAVLDLS---NNQFEGNL-SRILKWGNIEYLDLSRNHLTGSIPEETP 426
             N ++G +P   G    L++     N+ EGN+   +    N++ LDLS+N+LTGS+P    
Sbjct:   381 NQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLF 440

Query:   427 QFLRXXXXXXXXXXXXXXXPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLAD 486
             Q                  P  I     L  L L  N + G     +     L  L L++
Sbjct:   441 QLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSE 500

Query:   487 NLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMA 546
             N L+G +     +   LQ+L+LS+N L GY P  L SLT L+VL ++ N+++G +P S+ 
Sbjct:   501 NNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLG 560

Query:   547 NMTSLSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENL 591
             ++ SL+ L++S+N F G +P++L +  +L+  ++S N+ SG +PE L
Sbjct:   561 HLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEEL 607

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2007918 PEPR2 "PEP1 receptor 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 560 (202.2 bits), Expect = 3.0e-77, Sum P(2) = 3.0e-77
 Identities = 179/603 (29%), Positives = 271/603 (44%)

Query:    22 SQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCN-GGNVAGVV-LDNL 79
             + D LALL   K     P   V ++W E + +   C ++W G++C+  GNV   + L   
Sbjct:    28 NSDGLALLSLLKHFDKVPLE-VASTWKENTSETTPCNNNWFGVICDLSGNVVETLNLSAS 86

Query:    80 GLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIG 139
             GLS     S    L  LV L +S NS SG++P  +G+  SLE+LD+S+N FS  +P   G
Sbjct:    87 GLSGQLG-SEIGELKSLVTLDLSLNSFSGLLPSTLGNCTSLEYLDLSNNDFSGEVPDIFG 145

Query:   140 KLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRXXXXXXXXXXX 199
              L++L  L L  NN SGLIP SV GL+ +  L +S+N+ SG++P  L             
Sbjct:   146 SLQNLTFLYLDRNNLSGLIPASVGGLIELVDLRMSYNNLSGTIPELLGNCSKLEYLALNN 205

Query:   200 XGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFL 259
                +  +P    L+  L  L    N L G L            +D S N F G    +  
Sbjct:   206 NKLNGSLPASLYLLENLGELFVSNNSLGGRLHFGSSNCKKLVSLDLSFNDFQGGVPPEI- 264

Query:   260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVL 318
              G   S+  L +    LTG++ +   + +   + V+DLS N+L+G +P        L+ L
Sbjct:   265 -GNCSSLHSLVMVKCNLTGTIPSS--MGMLRKVSVIDLSDNRLSGNIPQELGNCSSLETL 321

Query:   319 KLSNNRFSGFIPXXXXXXXXXXXXXXXXXXXXXXGSVSMILSTNLHMLNLSSNGLTGELP 378
             KL++N+  G IP                        + +    +L  + + +N LTGELP
Sbjct:   322 KLNDNQLQGEIPPALSKLKKLQSLELFFNKLSGEIPIGIWKIQSLTQMLVYNNTLTGELP 381

Query:   379 L-LTG--SCAVLDLSNNQFEGNLSRILKWG-NIEYLDLSRNHLTGSIPEETPQFLRXXXX 434
             + +T       L L NN F G++   L    ++E +DL  N  TG IP       +    
Sbjct:   382 VEVTQLKHLKKLTLFNNGFYGDIPMSLGLNRSLEEVDLLGNRFTGEIPPHLCHGQKLRLF 441

Query:   435 XXXXXXXXXXXPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLD 494
                        P  I Q + L  + L  N L G  L     S +L  ++L  N   G + 
Sbjct:   442 ILGSNQLHGKIPASIRQCKTLERVRLEDNKLSG-VLPEFPESLSLSYVNLGSNSFEGSIP 500

Query:   495 FSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSL 554
              S  S  NL  +DLS N+L G  P  LG+L  L +L L+ N + G LP+ ++    L   
Sbjct:   501 RSLGSCKNLLTIDLSQNKLTGLIPPELGNLQSLGLLNLSHNYLEGPLPSQLSGCARLLYF 560

Query:   555 VISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGA 612
              +  N   G +P++  +  SL T  +S N+F GA+P+ L +    S     ++ +F G  
Sbjct:   561 DVGSNSLNGSIPSSFRSWKSLSTLVLSDNNFLGAIPQFLAELDRLSDLR-IARNAFGGKI 619

Query:   613 PGS 615
             P S
Sbjct:   620 PSS 622

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=IEP

GO:0009753 "response to jasmonic acid stimulus" evidence=IEP

GO:0042277 "peptide binding" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGQ9	Y4294_ARATH	2, ., 7, ., 1, 1, ., 1	0.7382	0.9754	0.9971	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1060
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-71
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-52
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-50
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-44
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-41
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-40
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-34
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-27
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-26
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-25
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-24
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-23
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-21
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-15
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-15
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-14
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-14
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-12
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-12
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-11
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-10
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-10
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-10
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-10
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-10
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	4e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-09
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	2e-09
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-09
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-09
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-09
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-09
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-08
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	3e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-08
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-08
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-08
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-08
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	6e-08
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-07
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-07
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-06
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-06
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-06
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-06
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-06
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-06
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-06
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-05
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-05
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-05
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-05
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	3e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-05
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-05
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-05
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-05
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-05
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	1e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-04
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-04
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-04
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-04
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-04
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-04
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-04
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-04
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-04
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-04
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-04
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-04
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-04
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-04
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	0.001
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	0.001
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	0.001
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	0.001
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	0.001
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	0.001
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	0.002
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	0.002
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	0.002
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	0.002
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	0.002
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.002
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.002
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	0.002
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.002
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.003
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	0.003
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	0.004
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	0.004
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  256 bits (656), Expect = 2e-71
 Identities = 198/594 (33%), Positives = 289/594 (48%), Gaps = 50/594 (8%)

Query: 6   LLVLSLYFLSSVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIV 65
           L+ +  +   +   L ++++  LL FK  I NDP  + L++WN  S D       W GI 
Sbjct: 12  LIFMLFFLFLNFSMLHAEELELLLSFKSSI-NDPLKY-LSNWNS-SADV----CLWQGIT 64

Query: 66  CN-----------GGNVAG--------------VVLDNLGLSAAADLSVFSNLSMLVKLS 100
           CN           G N++G              + L N  LS      +F+  S L  L+
Sbjct: 65  CNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLN 124

Query: 101 MSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPD 160
           +SNN+ +G IP   G   +LE LD+S+N+ S  +P+ IG   SL+ L L GN   G IP+
Sbjct: 125 LSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182

Query: 161 SVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLD 220
           S++ L S++ L L+ N   G +P  L ++ +L ++ L  N  S  IP     +  L  LD
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD 242

Query: 221 FHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSL 280
              N L G +      L N  ++    N   G         L + +  L+LS N L+G +
Sbjct: 243 LVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF-SLQKLIS-LDLSDNSLSGEI 300

Query: 281 VNGGELQL-FENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNNRFSGFIPNDLLKGDS 338
               EL +  +NL++L L  N  TG++P     +  LQVL+L +N+FSG IP +L K ++
Sbjct: 301 ---PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN 357

Query: 339 LLLTDLDLSANNLSGSV--SMILSTNLHMLNLSSNGLTGELPLLTGSCAVLD---LSNNQ 393
             LT LDLS NNL+G +   +  S NL  L L SN L GE+P   G+C  L    L +N 
Sbjct: 358 --LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415

Query: 394 FEGNLSR-ILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQY 452
           F G L     K   + +LD+S N+L G I         L  L+L+ N     LP      
Sbjct: 416 FSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD-SFGS 474

Query: 453 QKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNR 512
           ++L  LDLS N   G     L + S L +L L++N L+G +     S   L  LDLSHN+
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534

Query: 513 LNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLP 566
           L+G  P     +  L  L L+ N +SG +P ++ N+ SL  + IS NH  G LP
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  199 bits (507), Expect = 2e-52
 Identities = 151/456 (33%), Positives = 225/456 (49%), Gaps = 37/456 (8%)

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRL-NNLVYLNLSSNGFSKR 205
           + L+G N SG I  ++  L  IQ+++LS+N  SG +P  +    ++L YLNLS+N F+  
Sbjct: 74  IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQ- 264
           IPRG   I  L+ LD   N L G +  +    ++   +D  GN+ VG    K    L+  
Sbjct: 134 IPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVG----KIPNSLTNL 187

Query: 265 -SVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSN 322
            S+++L L+ NQL G +    EL   ++LK + L YN L+GE+P     +  L  L L  
Sbjct: 188 TSLEFLTLASNQLVGQIPR--ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245

Query: 323 NRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSV--SMILSTNLHMLNLSSNGLTGELPLL 380
           N  +G IP+ L  G+   L  L L  N LSG +  S+     L  L+LS N L+GE+P L
Sbjct: 246 NNLTGPIPSSL--GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL 303

Query: 381 TGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNS 440
                               +++  N+E L L  N+ TG IP       RL  L L  N 
Sbjct: 304 --------------------VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343

Query: 441 LSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSV 500
            S  +PK + ++  L VLDLS N+L G     L +S  L +L L  N L G +  S  + 
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403

Query: 501 SNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNH 560
            +L+ + L  N  +G  P     L  +  L ++ NN+ G + +   +M SL  L +++N 
Sbjct: 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463

Query: 561 FTGPLPNNLPNS-LETFNVSYNDFSGAVPENLRKFP 595
           F G LP++  +  LE  ++S N FSGAVP  L    
Sbjct: 464 FFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS 499

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  193 bits (493), Expect = 1e-50
 Identities = 141/399 (35%), Positives = 196/399 (49%), Gaps = 36/399 (9%)

Query: 104 NSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVS 163
           N++SG IP  IG   SL  LD+  N  +  +PS +G L++LQ L L  N  SG IP S+ 
Sbjct: 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF 281

Query: 164 GLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHG 223
            L  + SLDLS NS SG +P  + +L NL  L+L SN F+ +IP     +  LQVL    
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341

Query: 224 NKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNG 283
           NK  G +                              G   ++  L+LS N LTG +  G
Sbjct: 342 NKFSGEIPKNL--------------------------GKHNNLTVLDLSTNNLTGEIPEG 375

Query: 284 GELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLT 342
             L    NL  L L  N L GE+P        L+ ++L +N FSG +P++  K    L+ 
Sbjct: 376 --LCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLP--LVY 431

Query: 343 DLDLSANNLSGSVSMIL--STNLHMLNLSSNGLTGELPLLTGSCAV--LDLSNNQFEGNL 398
            LD+S NNL G ++       +L ML+L+ N   G LP   GS  +  LDLS NQF G +
Sbjct: 432 FLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAV 491

Query: 399 -SRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRV 457
             ++     +  L LS N L+G IP+E     +L  L+LSHN LS  +P    +   L  
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ 551

Query: 458 LDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFS 496
           LDLS N L G    NL N  +L +++++ N L G L  +
Sbjct: 552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  172 bits (437), Expect = 9e-44
 Identities = 127/367 (34%), Positives = 184/367 (50%), Gaps = 31/367 (8%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNL 147
           S   NL  L  L +  N +SG IP +I   + L  LD+SDN  S  +P  + +L++L+ L
Sbjct: 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEIL 313

Query: 148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIP 207
            L  NNF+G IP +++ L  +Q L L  N FSG +P  L + NNL  L+LS+N  +  IP
Sbjct: 314 HLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373

Query: 208 RG-------FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP 260
            G       F+LIL         N L+G +        +   +    N F G    +F  
Sbjct: 374 EGLCSSGNLFKLIL-------FSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426

Query: 261 GLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKL 320
                V +L++S N L G + N  +  +  +L++L L+ N+  G LP       L+ L L
Sbjct: 427 --LPLVYFLDISNNNLQGRI-NSRKWDM-PSLQMLSLARNKFFGGLPDSFGSKRLENLDL 482

Query: 321 SNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILST--NLHMLNLSSNGLTGELP 378
           S N+FSG +P  L     L+   L LS N LSG +   LS+   L  L+LS N L+G++P
Sbjct: 483 SRNQFSGAVPRKLGSLSELM--QLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540

Query: 379 LLTGSCAV---LDLSNNQFEGNLSRILKWGNIEYL---DLSRNHLTGSIPEETPQFLRLN 432
                  V   LDLS NQ  G + + L  GN+E L   ++S NHL GS+P  T  FL +N
Sbjct: 541 ASFSEMPVLSQLDLSQNQLSGEIPKNL--GNVESLVQVNISHNHLHGSLP-STGAFLAIN 597

Query: 433 HLNLSHN 439
              ++ N
Sbjct: 598 ASAVAGN 604

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  163 bits (414), Expect = 5e-41
 Identities = 129/435 (29%), Positives = 190/435 (43%), Gaps = 76/435 (17%)

Query: 168 IQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLD 227
           + S+DLS  + SG +  A+ RL  +  +NLS+N  S  IP                    
Sbjct: 71  VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIP-------------------- 110

Query: 228 GHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQ 287
              D  F   ++  +++ S N F GS  +  +P L    + L+LS N L+G + N  ++ 
Sbjct: 111 ---DDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNL----ETLDLSNNMLSGEIPN--DIG 161

Query: 288 LFENLKVLDLSYNQLTGELPGF-NFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDL 346
            F +LKVLDL  N L G++P     +  L+ L L++N+  G IP +L +           
Sbjct: 162 SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ----------- 210

Query: 347 SANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGN 406
                          +L  + L  N L+GE+P   G    L+                  
Sbjct: 211 -------------MKSLKWIYLGYNNLSGEIPYEIGGLTSLN------------------ 239

Query: 407 IEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLD 466
             +LDL  N+LTG IP        L +L L  N LS  +P  I   QKL  LDLS N L 
Sbjct: 240 --HLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS 297

Query: 467 GPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTG 526
           G     ++    L+ LHL  N  TG +  +  S+  LQVL L  N+ +G  P  LG    
Sbjct: 298 GEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNN 357

Query: 527 LKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLP--NSLETFNVSYNDFS 584
           L VL L+ NN++G +P  + +  +L  L++  N   G +P +L    SL    +  N FS
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417

Query: 585 GAVPENLRKFPSSSF 599
           G +P    K P   F
Sbjct: 418 GELPSEFTKLPLVYF 432

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  160 bits (405), Expect = 6e-40
 Identities = 114/314 (36%), Positives = 172/314 (54%), Gaps = 16/314 (5%)

Query: 289 FENLKVLDLSYNQLTGELPG--FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDL 346
              +  +DLS   ++G++    F   Y +Q + LSNN+ SG IP+D+    S L   L+L
Sbjct: 68  SSRVVSIDLSGKNISGKISSAIFRLPY-IQTINLSNNQLSGPIPDDIFTTSSSLRY-LNL 125

Query: 347 SANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCA---VLDLSNNQFEGNL-SRIL 402
           S NN +GS+      NL  L+LS+N L+GE+P   GS +   VLDL  N   G + + + 
Sbjct: 126 SNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185

Query: 403 KWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSF 462
              ++E+L L+ N L G IP E  Q   L  + L +N+LS  +P  I     L  LDL +
Sbjct: 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245

Query: 463 NHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQ---VLDLSHNRLNGYFPD 519
           N+L GP  ++L N   LQ L L  N L+G +   PPS+ +LQ    LDLS N L+G  P+
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI---PPSIFSLQKLISLDLSDNSLSGEIPE 302

Query: 520 RLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNL--PNSLETFN 577
            +  L  L++L L  NN +G +P ++ ++  L  L +  N F+G +P NL   N+L   +
Sbjct: 303 LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLD 362

Query: 578 VSYNDFSGAVPENL 591
           +S N+ +G +PE L
Sbjct: 363 LSTNNLTGEIPEGL 376

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  129 bits (327), Expect = 5e-34
 Identities = 60/196 (30%), Positives = 99/196 (50%), Gaps = 11/196 (5%)

Query: 784 LGRSSHGTSYRAT-LENGMFLTVK-WLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
           LG    GT Y A   + G  + +K   +E  +   +E  +E +    + HPN+V L G +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 842 WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
               ++   ++ +Y   GSL   L +  G     L+  + L+I + +  GL YLH    +
Sbjct: 61  E--DENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLH-SNGI 113

Query: 902 PHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHP 961
            H +LK  NILLD  +   ++AD+ L +L+T   ++ + +  G   Y APE+   K  + 
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYY- 171

Query: 962 SFKSDVYAFGVILLEL 977
           S KSD+++ GVIL EL
Sbjct: 172 SEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  111 bits (281), Expect = 3e-27
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 22/207 (10%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT-----VKWLREG-VAKQRKEFAKEAKKFANIRHPNVV 835
           + LG  + G  Y+  L+           VK L+E    +Q +EF +EA+    + HPNVV
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 836 GLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
            L G     T+ E L I+ +Y+  G L S+L     +  P L+ +  L  A+ +ARG+ Y
Sbjct: 65  KLLGVC---TEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEY 117

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APE 952
           L     + H +L A N L+   +L  +++D+ L R +       +    G L  R  APE
Sbjct: 118 LESKNFI-HRDLAARNCLVGE-NLVVKISDFGLSRDLYDDDYYRK--RGGKLPIRWMAPE 173

Query: 953 LAASKKPHPSFKSDVYAFGVILLELLT 979
             + K+   + KSDV++FGV+L E+ T
Sbjct: 174 --SLKEGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  110 bits (278), Expect = 7e-27
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 21/207 (10%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT-----VKWLREGV-AKQRKEFAKEAKKFANIRHPNVV 835
           + LG  + G  Y+ TL+           VK L+E    +Q +EF +EA+    + HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 836 GLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
            L G     T+ E L I+ +Y+  G L  +L      +   L+ +  L  A+ +ARG+ Y
Sbjct: 65  KLLGVC---TEEEPLMIVMEYMPGGDLLDYLRK---NRPKELSLSDLLSFALQIARGMEY 118

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APE 952
           L     + H +L A N L+   +L  +++D+ L R +      +     G L  R  APE
Sbjct: 119 LESKNFI-HRDLAARNCLVGE-NLVVKISDFGLSRDLYDDDYYKV--KGGKLPIRWMAPE 174

Query: 953 LAASKKPHPSFKSDVYAFGVILLELLT 979
             + K+   + KSDV++FGV+L E+ T
Sbjct: 175 --SLKEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 3e-26
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 20/210 (9%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT----VKWLREG-VAKQRKEFAKEAKKFANIRHPNVVG 836
           + LG  + G  Y+  L+     T    VK L+E    ++RK+F KEA+    + HPNVV 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 837 LRGYYWGPTQHEKL-ILSDYISPGSLASFL----YDRPGRKGPPLTWAQRLKIAVDVARG 891
           L G     T+ E L ++ +Y+  G L  +L       P  +   L+    L  A+ +A+G
Sbjct: 61  LLGVC---TEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR-- 949
           + YL   +   H +L A N L+   DL  +++D+ L R +       +    G L  R  
Sbjct: 118 MEYLA-SKKFVHRDLAARNCLVGE-DLVVKISDFGLSRDVYDDDYYRK-KTGGKLPIRWM 174

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLT 979
           APE  + K    + KSDV++FGV+L E+ T
Sbjct: 175 APE--SLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  105 bits (263), Expect = 5e-25
 Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 32/212 (15%)

Query: 782 EVLGRSSHGTSYRATLEN-GMFLTVK--WLREGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
             LG  S GT Y+A  +  G  + VK    R   +K+ +   +E +    + HPN+V L 
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 839 GYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
             +      + L ++ +Y   G L  +L      +G PL+  +  KIA+ + RGL YLH 
Sbjct: 65  DAF---EDKDHLYLVMEYCEGGDLFDYL-----SRGGPLSEDEAKKIALQILRGLEYLH- 115

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTIEQILDAGVLGYR 949
              + H +LK  NILLD  +   ++AD+ L          L T  GT           Y 
Sbjct: 116 SNGIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPW---------YM 165

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           APE+      +   K DV++ GVIL ELLTG+
Sbjct: 166 APEVLLGGNGY-GPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  104 bits (261), Expect = 1e-24
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 21/208 (10%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT-----VKWLREG-VAKQRKEFAKEAKKFANIRHPNVV 835
           + LG  + G  Y+ TL+     T     VK L+EG   ++R+EF +EA     + HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 836 GLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
            L G     TQ E L I+++Y+  G L  FL     + G  LT    L++A+ +A+G+ Y
Sbjct: 65  RLLGVC---TQGEPLYIVTEYMPGGDLLDFLR----KHGEKLTLKDLLQMALQIAKGMEY 117

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APE 952
           L   +   H +L A N L+   +L  +++D+ L R + +     +    G L  +  APE
Sbjct: 118 LE-SKNFVHRDLAARNCLVTE-NLVVKISDFGLSRDIYEDDY-YRKRGGGKLPIKWMAPE 174

Query: 953 LAASKKPHPSFKSDVYAFGVILLELLTG 980
                K   + KSDV++FGV+L E+ T 
Sbjct: 175 SLKDGK--FTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =   99 bits (250), Expect = 3e-23
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 35/212 (16%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           E LG  S G  Y A   + G  + +K ++ + + K R+   +E K    ++HPN+V L  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 840 YYWGPTQHEK---LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
            +    + E    L++ +Y   G L   L     +K   L+  +       +   L YLH
Sbjct: 65  VF----EDEDKLYLVM-EYCEGGDLFDLL-----KKRGRLSEDEARFYLRQILSALEYLH 114

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCL-------HRLMTQAGTIEQILDAGVLGYR 949
             + + H +LK  NILLD  D + ++AD+ L        +L T  GT E         Y 
Sbjct: 115 -SKGIVHRDLKPENILLDE-DGHVKLADFGLARQLDPGEKLTTFVGTPE---------YM 163

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           APE+    K +     D+++ GVIL ELLTG+
Sbjct: 164 APEVL-LGKGY-GKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 93.8 bits (234), Expect = 4e-21
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 13/204 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR--EGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
           E+LGR S G+ Y A   + G  + VK +       ++ +   +E +  ++++HPN+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
           G      ++   I  +Y+S GSL+S L     +K   L      K    +  GL YLH  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL-----KKFGKLPEPVIRKYTRQILEGLAYLH-S 119

Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD-AGVLGYRAPELAASK 957
             + H ++K  NIL+D  D   ++AD+   + +    T E      G   + APE+   +
Sbjct: 120 NGIVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178

Query: 958 KPHPSFKSDVYAFGVILLELLTGR 981
           +      +D+++ G  ++E+ TG+
Sbjct: 179 E--YGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 86.3 bits (212), Expect = 8e-18
 Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 17/210 (8%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKE---FAKEAKKFANIRHP-NVVGL 837
             LG  S G  Y A   +   + +K L + +  + KE   F +E +  A++ HP N+V L
Sbjct: 6   RKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
             ++         ++ +Y+  GSL   L     +   PL+ ++ L I   +   L YLH 
Sbjct: 64  YDFFQDEGSL--YLVMEYVDGGSLEDLLKKIGRKG--PLSESEALFILAQILSALEYLH- 118

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA-----GVLGYRAPE 952
            + + H ++K  NILLD      ++ D+ L +L+   G+   I        G  GY APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 953 LAASKK-PHPSFKSDVYAFGVILLELLTGR 981
           +       + S  SD+++ G+ L ELLTG 
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)

Query: 784 LGRSSHGTSYRATLEN-----GMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNVVGL 837
           LG    G       +      G  + VK L   G  + R +F +E +    + H N+V  
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
           +G    P      ++ +Y+  GSL  +L      +   +   + L  +  + +G++YL  
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHR-DQINLKRLLLFSSQICKGMDYLG- 126

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG---TIEQILDAGVLGYRAPE-L 953
            +   H +L A NIL++  +   +++D+ L +++ +      +++  ++ +  Y APE L
Sbjct: 127 SQRYIHRDLAARNILVES-EDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184

Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
             SK    S  SDV++FGV L EL T
Sbjct: 185 RTSKF---SSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 25/207 (12%)

Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWG 843
           LG    G  +  T      + VK L+ G     + F +EA+    +RH  +V L   Y  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP-EAFLQEAQIMKKLRHDKLVQL---YAV 69

Query: 844 PTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP 902
            ++ E + I+++Y+S GSL  FL    G+K   L   Q + +A  +A G+ YL     + 
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKK---LRLPQLVDMAAQIAEGMAYLESRNYI- 125

Query: 903 HGNLKATNILLDGPDLNARVADYCLHRL------MTQAGTIEQILDAGVLGYRAPELAAS 956
           H +L A NIL+ G +L  ++AD+ L RL        + G    I       + APE A  
Sbjct: 126 HRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAKFPI------KWTAPEAANY 178

Query: 957 KKPHPSFKSDVYAFGVILLELLT-GRC 982
            +   + KSDV++FG++L E++T GR 
Sbjct: 179 GRF--TIKSDVWSFGILLTEIVTYGRV 203

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 32/212 (15%)

Query: 782 EVLGRSSHGTSYRATL----ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVG 836
           +V+G    G   R  L    +  + + +K L+ G   KQR +F  EA       HPN++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 837 LRGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
           L G     T+   + I+++Y+  GSL  FL +  G+     T  Q + +   +A G+ YL
Sbjct: 70  LEGVV---TKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYL 122

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM--------TQAGTIEQILDAGVLG 947
             +    H +L A NIL++  +L  +V+D+ L R +        T+ G I        + 
Sbjct: 123 S-EMNYVHRDLAARNILVNS-NLVCKVSDFGLSRRLEDSEATYTTKGGKIP-------IR 173

Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           + APE  A +K   +  SDV++FG+++ E+++
Sbjct: 174 WTAPEAIAYRKFTSA--SDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 23/205 (11%)

Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWG 843
           LG    G  +     N   + VK L+ G     K+F  EA+    +RHP ++ L   Y  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQL---YAV 69

Query: 844 PTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP 902
            T  E + I+++ +  GSL  +L    GR    L   Q + +A  VA G+ YL     + 
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQVASGMAYLEAQNYI- 125

Query: 903 HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-----LGYRAPELAASK 957
           H +L A N+L+ G +   +VAD+ L R++      E I +A       + + APE A   
Sbjct: 126 HRDLAARNVLV-GENNICKVADFGLARVIK-----EDIYEAREGAKFPIKWTAPEAALYN 179

Query: 958 KPHPSFKSDVYAFGVILLELLT-GR 981
           +   S KSDV++FG++L E++T GR
Sbjct: 180 RF--SIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 78.2 bits (193), Expect = 8e-16
 Identities = 66/181 (36%), Positives = 98/181 (54%), Gaps = 21/181 (11%)

Query: 805 VKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLAS 863
           VK L++  +   + F  EA     +RHPN+V L G      Q   L I+++Y++ GSL  
Sbjct: 34  VKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVV---LQGNPLYIVTEYMAKGSLVD 89

Query: 864 FLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVA 923
           +L  R GR    +T AQ+L  A+DV  G+ YL     V H +L A N+L+   DL A+V+
Sbjct: 90  YLRSR-GRA--VITLAQQLGFALDVCEGMEYLEEKNFV-HRDLAARNVLVS-EDLVAKVS 144

Query: 924 DYCLHRLMTQAGTIEQILDAGVL--GYRAPELAASKKPHPSFKSDVYAFGVILLELLT-G 980
           D+ L      A    Q  D+G L   + APE  A ++   S KSDV++FG++L E+ + G
Sbjct: 145 DFGL------AKEASQGQDSGKLPVKWTAPE--ALREKKFSTKSDVWSFGILLWEIYSFG 196

Query: 981 R 981
           R
Sbjct: 197 R 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 27/221 (12%)

Query: 784 LGRSSHGTSYRATLEN-GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYW 842
           LG   +G  Y    +   + + VK L+E    + +EF KEA     I+HPN+V L G   
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV-- 70

Query: 843 GPTQHEK--LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
                E    I++++++ G+L  +L +   ++   +     L +A  ++  + YL   + 
Sbjct: 71  --CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE-KKN 124

Query: 901 VPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV---LGYRAPELAASK 957
             H +L A N L+ G +   +VAD+ L RLMT          AG    + + APE  A  
Sbjct: 125 FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAH---AGAKFPIKWTAPESLAYN 180

Query: 958 KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTD 998
           K   S KSDV+AFGV+L E+ T   +         G+DL+ 
Sbjct: 181 KF--SIKSDVWAFGVLLWEIATYGMS------PYPGIDLSQ 213

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 52/208 (25%), Positives = 99/208 (47%), Gaps = 27/208 (12%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           E +G+   G  Y+A     G  + +K ++    +++++   E +     +HPN+V   G 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 841 YWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
           Y    + ++L I+ ++ S GSL   L          LT +Q   +  ++ +GL YLH + 
Sbjct: 66  Y---LKKDELWIVMEFCSGGSLKDLLKSTNQ----TLTESQIAYVCKELLKGLEYLHSNG 118

Query: 900 AVPHGNLKATNILL--DGPDLNARVADYCLHRLMTQAGTIEQILD----AGVLGYRAPEL 953
            + H ++KA NILL  DG     ++ D+ L      +  +          G   + APE+
Sbjct: 119 II-HRDIKAANILLTSDG---EVKLIDFGL------SAQLSDTKARNTMVGTPYWMAPEV 168

Query: 954 AASKKPHPSFKSDVYAFGVILLELLTGR 981
             + KP+  +K+D+++ G+  +EL  G+
Sbjct: 169 I-NGKPY-DYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 80.2 bits (198), Expect = 3e-15
 Identities = 47/137 (34%), Positives = 69/137 (50%), Gaps = 9/137 (6%)

Query: 29  LEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLS 88
           L  + G   DP     + W+     FD     W         + G+ LDN GL      +
Sbjct: 386 LPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWF--------IDGLGLDNQGLRGFIP-N 436

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLS 148
             S L  L  +++S NSI G IP ++G   SLE LD+S N F+ S+P  +G+L SL+ L+
Sbjct: 437 DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496

Query: 149 LAGNNFSGLIPDSVSGL 165
           L GN+ SG +P ++ G 
Sbjct: 497 LNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 53/206 (25%), Positives = 102/206 (49%), Gaps = 22/206 (10%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           E +G+ + G  Y+  L+    + VK  R       +++F +EA+      HPN+V L G 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 841 YWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
                Q + + I+ + +  GSL +FL     +K   LT  + L++++D A G+ YL   +
Sbjct: 61  CV---QKQPIYIVMELVPGGSLLTFLR----KKKNRLTVKKLLQMSLDAAAGMEYLE-SK 112

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHR-----LMTQAGTIEQILDAGVLGYRAPELA 954
              H +L A N L+   ++  +++D+ + R     + T +  ++QI     + + APE  
Sbjct: 113 NCIHRDLAARNCLVGENNV-LKISDFGMSREEEGGIYTVSDGLKQI----PIKWTAPE-- 165

Query: 955 ASKKPHPSFKSDVYAFGVILLELLTG 980
           A      + +SDV+++G++L E  + 
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 51/288 (17%)

Query: 784  LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGL------ 837
            LG    G  +    +N + + +K L+     ++++F KE +    +RH +++ L      
Sbjct: 14   LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 838  -RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
                Y         I+++ +  GSL +FL    G+    L  A  + +A  VA G+ YL 
Sbjct: 74   GEPVY---------IITELMEKGSLLAFLRSPEGQV---LPVASLIDMACQVAEGMAYLE 121

Query: 897  FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELA 954
             ++   H +L A NIL+ G DL  +VAD+ L RL+ +   +        + Y+  APE A
Sbjct: 122  -EQNSIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVYLS---SDKKIPYKWTAPE-A 175

Query: 955  ASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013
            AS     S KSDV++FG++L E+ T G+         G           ++  G+     
Sbjct: 176  ASHG-TFSTKSDVWSFGILLYEMFTYGQV-----PYPGMNNHEV---YDQITAGY----- 221

Query: 1014 DAAVMPEMVNPAAEKGMKEVLGIALRCIRS-VSERPGIKTIYEDLSSI 1060
                   M  P   K  +E+  I L C  +   +RP  K + E+L +I
Sbjct: 222  ------RM--PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 23/230 (10%)

Query: 782  EVLGRSSHGTSYRATLE-NGMFLTVKW--LREGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
              +G+ S G  ++   + +     +K   L +   ++R+E   EA+  A +    ++   
Sbjct: 6    NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR-- 63

Query: 839  GYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
             YY       KL I+ +Y   G L   L  + GR   PL   Q  +  + +  GL +LH 
Sbjct: 64   -YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR---PLPEDQVWRFFIQILLGLAHLH- 118

Query: 898  DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASK 957
             + + H ++K+ N+ LD  D N ++ D  + +L++        +  G   Y +PEL    
Sbjct: 119  SKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELC-ED 175

Query: 958  KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG 1007
            KP+   KSDV+A GV+L E  TG+   D  + +GA +       LK+  G
Sbjct: 176  KPYNE-KSDVWALGVVLYECCTGKHPFDANN-QGALI-------LKIIRG 216

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 76.8 bits (189), Expect = 3e-14
 Identities = 34/74 (45%), Positives = 53/74 (71%)

Query: 134 LPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLV 193
           +P+ I KL  LQ+++L+GN+  G IP S+  + S++ LDLS+NSF+GS+P +L +L +L 
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 194 YLNLSSNGFSKRIP 207
            LNL+ N  S R+P
Sbjct: 494 ILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 12/199 (6%)

Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G     + F +EA+    +RH  +V L   Y  
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQL---YAV 69

Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 125

Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 126 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 182

Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 183 KSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 72.6 bits (178), Expect = 6e-14
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 11/177 (6%)

Query: 803 LTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLA 862
           + +K ++EG +    EF +EAK    + H  +V L G      Q    I+++Y+S G L 
Sbjct: 31  VAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVC--TKQRPIYIVTEYMSNGCLL 87

Query: 863 SFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARV 922
           ++L  R   K      +Q L++  DV  G+ YL   + + H +L A N L+D      +V
Sbjct: 88  NYL--REHGKRF--QPSQLLEMCKDVCEGMAYLESKQFI-HRDLAARNCLVDD-QGCVKV 141

Query: 923 ADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +D+ L R +        +     + +  PE+    K   S KSDV+AFGV++ E+ +
Sbjct: 142 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF--SSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 72.5 bits (179), Expect = 8e-14
 Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 31/213 (14%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKW--LREGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
           + +G+ S G  Y      +G    +K   L     K+R++   E K    + HPN++   
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 839 GYYWGPTQHEK--LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
             +    + +    I+ +Y   G L+  +  +  ++G P    Q L   V +   L YLH
Sbjct: 66  ESF----EEKGKLCIVMEYADGGDLSQKIKKQ-KKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM--------TQAGTIEQILDAGVLGY 948
             R + H ++K  NI L    L  ++ D+ + +++        T  GT           Y
Sbjct: 121 -SRKILHRDIKPQNIFLTSNGL-VKLGDFGISKVLSSTVDLAKTVVGTPY---------Y 169

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            +PEL    KP+ ++KSD+++ G +L EL T +
Sbjct: 170 LSPELC-QNKPY-NYKSDIWSLGCVLYELCTLK 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 72.3 bits (177), Expect = 8e-14
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 12/199 (6%)

Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWG 843
           LG    G  +  T      + VK L+ G     + F +EA+    +RH  +V L   Y  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQL---YAV 69

Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y+S GSL  FL D  GR    L     + +A  VA G+ Y+     + H
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKDGEGRA---LKLPNLVDMAAQVAAGMAYIERMNYI-H 125

Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L++ NIL+ G  L  ++AD+ L RL+       +      + + APE A   +   + 
Sbjct: 126 RDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 182

Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL+T GR
Sbjct: 183 KSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 69.2 bits (169), Expect = 8e-13
 Identities = 62/186 (33%), Positives = 94/186 (50%), Gaps = 23/186 (12%)

Query: 800 GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKL-ILSDYISP 858
           G  + VK ++  V  Q   F +E      + H N+V L G       H  L I+ + +S 
Sbjct: 29  GQKVAVKNIKCDVTAQ--AFLEETAVMTKLHHKNLVRLLGV----ILHNGLYIVMELMSK 82

Query: 859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDL 918
           G+L +FL  R GR    +   Q L+ ++DVA G+ YL   + V H +L A NIL+   D 
Sbjct: 83  GNLVNFLRTR-GRALVSV--IQLLQFSLDVAEGMEYLESKKLV-HRDLAARNILVS-EDG 137

Query: 919 NARVADYCLHRLMTQAGTIEQILDAGVL--GYRAPELAASKKPHPSFKSDVYAFGVILLE 976
            A+V+D+ L R+ +        +D   L   + APE  A K    S KSDV+++GV+L E
Sbjct: 138 VAKVSDFGLARVGSMG------VDNSKLPVKWTAPE--ALKHKKFSSKSDVWSYGVLLWE 189

Query: 977 LLT-GR 981
           + + GR
Sbjct: 190 VFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.8 bits (176), Expect = 9e-13
 Identities = 29/67 (43%), Positives = 47/67 (70%)

Query: 479 LQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNIS 538
           LQ ++L+ N + G +  S  S+++L+VLDLS+N  NG  P+ LG LT L++L L GN++S
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503

Query: 539 GSLPTSM 545
           G +P ++
Sbjct: 504 GRVPAAL 510

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.8 bits (176), Expect = 9e-13
 Identities = 32/88 (36%), Positives = 56/88 (63%)

Query: 99  LSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLI 158
           L + N  + G IP++I   + L+ +++S N    ++P  +G + SL+ L L+ N+F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 159 PDSVSGLVSIQSLDLSHNSFSGSLPPAL 186
           P+S+  L S++ L+L+ NS SG +P AL
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 72.2 bits (177), Expect = 1e-12
 Identities = 77/282 (27%), Positives = 130/282 (46%), Gaps = 33/282 (11%)

Query: 783  VLGRSSHGTSYRA-TLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
            V+ R   G SY+  +++NGM   VK + +  +    E A   K    ++HPN+V L G  
Sbjct: 697  VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK----LQHPNIVKLIGLC 752

Query: 842  WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF--DR 899
               ++    ++ +YI   +L+  L +        L+W +R KIA+ +A+ L +LH     
Sbjct: 753  --RSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSP 802

Query: 900  AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
            AV  GNL    I++DG D         L          +  + +    Y APE   +K  
Sbjct: 803  AVVVGNLSPEKIIIDGKD----EPHLRLSLPGLLCTDTKCFISSA---YVAPETRETKDI 855

Query: 960  HPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019
              + KSD+Y FG+IL+ELLTG+   D   G      + +W +   ++ H     D ++  
Sbjct: 856  --TEKSDIYGFGLILIELLTGKSPADAEFGVHG--SIVEWARYCYSDCHLDMWIDPSIRG 911

Query: 1020 EM-VNPAAEKGMKEVLGIALRCIRS-VSERPGIKTIYEDLSS 1059
            ++ VN   +  + EV+ +AL C  +  + RP    + + L S
Sbjct: 912  DVSVN---QNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950

Length = 968

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 70.8 bits (173), Expect = 1e-12
 Identities = 75/257 (29%), Positives = 114/257 (44%), Gaps = 13/257 (5%)

Query: 347 SANNLSGSVSMILSTNLHMLN---LSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILK 403
           S   L    S+    +L +L+   +SS   +  L  L      LDL+ N+   N+S +L+
Sbjct: 56  SNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLL-PLPSLDLNLNRLRSNISELLE 114

Query: 404 WGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFN 463
             N+  LDL  N++T   P        L  L+LS N +  SLP  +     L+ LDLSFN
Sbjct: 115 LTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFN 173

Query: 464 HLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPS--VSNLQVLDLSHNRLNGYFPDRL 521
            L       L N S L  L L+ N ++   D  P    +S L+ LDLS+N +       L
Sbjct: 174 DLSD-LPKLLSNLSNLNNLDLSGNKIS---DLPPEIELLSALEELDLSNNSIIE-LLSSL 228

Query: 522 GSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYN 581
            +L  L  L L+ N +   LP S+ N+++L +L +S N  +         +L   ++S N
Sbjct: 229 SNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGN 287

Query: 582 DFSGAVPENLRKFPSSS 598
             S A+P          
Sbjct: 288 SLSNALPLIALLLLLLE 304

Length = 394

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 15/202 (7%)

Query: 784 LGRSSHGTSYRAT-LENGMFLTVKW--LREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           LG+ S+G+ Y+   L +  F  +K   L     K+R++   E +  A++ HPN++    Y
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIIS---Y 64

Query: 841 YWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
                   KL I+ +Y   G L+  +  R  +K   +   +  +I + + RGL  LH ++
Sbjct: 65  KEAFLDGNKLCIVMEYAPFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALH-EQ 122

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
            + H +LK+ NILL   DL  ++ D  + +++ +     QI   G   Y APE+    +P
Sbjct: 123 KILHRDLKSANILLVANDL-VKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVW-KGRP 177

Query: 960 HPSFKSDVYAFGVILLELLTGR 981
           + S+KSD+++ G +L E+ T  
Sbjct: 178 Y-SYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 65/287 (22%), Positives = 126/287 (43%), Gaps = 50/287 (17%)

Query: 782  EVLGRSSHGTSYRAT-LENGMFLTVK---WLREGVAKQRK---EFAKEAKKFANIRHPNV 834
            + LG  +  + Y+A  ++ G  + VK   ++R   ++Q +      KE +  A + HP++
Sbjct: 6    QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 835  VGLRGYYWGPTQHEKL--ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGL 892
            + +     G T  +    +  ++++ GS++  L      K      A  +     + RGL
Sbjct: 66   IRM----LGATCEDSHFNLFVEWMAGGSVSHLL-----SKYGAFKEAVIINYTEQLLRGL 116

Query: 893  NYLHFDRAVPHGNLKATNILLDGPDLNARVADYC----LHRLMTQAGTIE-QILDAGVLG 947
            +YLH +  + H ++K  N+L+D      R+AD+     L    T AG  + Q+L  G + 
Sbjct: 117  SYLH-ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL--GTIA 173

Query: 948  YRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCA--GDVISGEGAGVDLTDWMQLKVA 1005
            + APE+   ++   S   DV++ G +++E+ T +     +  S   A       +  K+A
Sbjct: 174  FMAPEVLRGEQYGRS--CDVWSVGCVIIEMATAKPPWNAEKHSNHLA-------LIFKIA 224

Query: 1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSE-RPGIK 1051
                     A  +PE ++P        +  + LRC+    E RP  +
Sbjct: 225  SATT-----APSIPEHLSPG-------LRDVTLRCLELQPEDRPPSR 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 29/217 (13%)

Query: 782 EVLGRSSHGTSYRATL--ENGMFLT----VKWLREGVA-KQRKEFAKEAKKFANIRHPNV 834
           E LG  + G  Y+  L   N         +K L+E    K ++EF +EA+  ++++HPN+
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 835 VGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGP-----------PLTWAQRL 882
           V L G     T+ +   +L +Y++ G L  FL                     L  +  L
Sbjct: 71  VCLLGVC---TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 883 KIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD 942
            IA+ +A G+ YL       H +L A N L+ G  L  +++D+ L R +  A        
Sbjct: 128 HIAIQIAAGMEYLS-SHHFVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYYRV-QS 184

Query: 943 AGVLGYR--APELAASKKPHPSFKSDVYAFGVILLEL 977
             +L  R   PE     K     +SD+++FGV+L E+
Sbjct: 185 KSLLPVRWMPPEAILYGKFTT--ESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 24/207 (11%)

Query: 783 VLGRSSHGTSYRAT----LENGMF-LTVKWLREGVAKQ-RKEFAKEAKKFANIRHPNVVG 836
           VLG  + GT Y+       E     + +K LRE  + +  KE   EA   A++ HP+VV 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLNY 894
           L G           +++  +  G L  ++ +     G    L W       V +A+G++Y
Sbjct: 74  LLGICLSSQV---QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGMSY 124

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APE 952
           L   R V H +L A N+L+  P    ++ D+ L +L+      E   + G +  +  A E
Sbjct: 125 LEEKRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLL-DVDEKEYHAEGGKVPIKWMALE 181

Query: 953 LAASKKPHPSFKSDVYAFGVILLELLT 979
               +    + KSDV+++GV + EL+T
Sbjct: 182 SILHRIY--THKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 22/208 (10%)

Query: 784 LGRSSHGTSYRA-TLENGMFLTVKWLR--EGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           +G  + G  Y A  L+ G  + VK +R  +   K  KE A E K    ++HPN+V     
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---- 63

Query: 841 YWGPTQH--EKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
           Y+G   H  +  I  +Y S G+L   L    GR        +     + +  GL YLH  
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELL--EHGRI-LDEHVIRVY--TLQLLEGLAYLHSH 118

Query: 899 RAVPHGNLKATNILLDGPDLNARVADY-CLHRLM---TQAGTIEQILDAGVLGYRAPELA 954
             V H ++K  NI LD   +  ++ D+ C  +L    T  G   Q L AG   Y APE+ 
Sbjct: 119 GIV-HRDIKPANIFLDHNGV-IKLGDFGCAVKLKNNTTTMGEEVQSL-AGTPAYMAPEVI 175

Query: 955 ASKKPHPSFKS-DVYAFGVILLELLTGR 981
              K     ++ D+++ G ++LE+ TG+
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 53/181 (29%), Positives = 94/181 (51%), Gaps = 15/181 (8%)

Query: 803 LTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEK-LILSDYISPGS 860
           + +K L+ G   KQR++F  EA       HPN++ L G     T+ +  +I+++Y+  GS
Sbjct: 35  VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV---TKSKPVMIVTEYMENGS 91

Query: 861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNA 920
           L +FL    G+     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  
Sbjct: 92  LDAFLRKHDGQ----FTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILVNS-NLVC 145

Query: 921 RVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELL 978
           +V+D+ L R++            G +  R  APE  A +K   +  SDV+++G+++ E++
Sbjct: 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK--FTSASDVWSYGIVMWEVM 203

Query: 979 T 979
           +
Sbjct: 204 S 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)

Query: 782 EVLGRSSHGTSYRA-TLENGMFLTVK---WLREGVAKQR--KEFAKEAKKFANIRHPNVV 835
           E+LG  S G+ Y    L++G F  VK      +G   Q   K+  +E    + ++HPN+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 836 GLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
               Y     + + L I  + +  GSLA  L     +K               +  GL Y
Sbjct: 66  ---QYLGTEREEDNLYIFLELVPGGSLAKLL-----KKYGSFPEPVIRLYTRQILLGLEY 117

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELA 954
           LH DR   H ++K  NIL+D  +   ++AD+ + + + +    +     G   + APE+ 
Sbjct: 118 LH-DRNTVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSFAKSF--KGSPYWMAPEVI 173

Query: 955 ASKKPHPSFKSDVYAFGVILLELLTGR 981
           A +  +    +D+++ G  +LE+ TG+
Sbjct: 174 AQQGGY-GLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 24/209 (11%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRK-EFAKEAKKFANIRHPNVVGLRGY 840
           E+LG+ + G  ++ TL++   + VK  +E + ++ K +F  EA+      HPN+V L G 
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 841 YWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
               TQ + + I+ + +  G   SFL     +K   L   Q +K A+D A G+ YL    
Sbjct: 61  C---TQRQPIYIVMELVPGGDFLSFLR----KKKDELKTKQLVKFALDAAAGMAYLESKN 113

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHR-----LMTQAGTIEQILDAGVLGYRAPELA 954
            + H +L A N L+ G +   +++D+ + R     + + +G ++QI     + + APE  
Sbjct: 114 CI-HRDLAARNCLV-GENNVLKISDFGMSRQEDDGIYSSSG-LKQI----PIKWTAPE-- 164

Query: 955 ASKKPHPSFKSDVYAFGVILLELLT-GRC 982
           A      S +SDV+++G++L E  + G C
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFSLGVC 193

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 21/208 (10%)

Query: 782 EVLGRSSHGTSYRATLE----NGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVG 836
           EV+G    G   R  L+      +F+ +K L+ G   KQR++F  EA       HPN++ 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G          +I+++++  G+L SFL    G+     T  Q + +   +A G+ YL 
Sbjct: 70  LEGVV--TKSRPVMIITEFMENGALDSFLRQNDGQ----FTVIQLVGMLRGIAAGMKYLS 123

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG-----YRAP 951
            +    H +L A NIL++  +L  +V+D+ L R + +  T +    + + G     + AP
Sbjct: 124 -EMNYVHRDLAARNILVNS-NLVCKVSDFGLSRFL-EDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 952 ELAASKKPHPSFKSDVYAFGVILLELLT 979
           E  A +K   +  SDV+++G+++ E+++
Sbjct: 181 EAIAYRKFTSA--SDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
           + LG    G  +         + +K L++G +   + F  EA     ++HP +V L   Y
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRL---Y 67

Query: 842 WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
              TQ    I+++Y+  GSL  FL    G K   LT  + + +A  +A G+ ++   +  
Sbjct: 68  AVVTQEPIYIITEYMENGSLVDFLKTPEGIK---LTINKLIDMAAQIAEGMAFIE-RKNY 123

Query: 902 PHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHP 961
            H +L+A NIL+    L  ++AD+ L RL+       +      + + APE  A      
Sbjct: 124 IHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE--AINYGTF 180

Query: 962 SFKSDVYAFGVILLELLT-GR 981
           + KSDV++FG++L E++T GR
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 31/216 (14%)

Query: 783 VLGRSSHGTSY------RATLENGMFLTVKWLREGVAKQRKE--FAKEAKKFANIRHPNV 834
            LG  + G  Y      R      + + VK L E    ++ E  F  EA   +   H N+
Sbjct: 13  ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE-SCSEQDESDFLMEALIMSKFNHQNI 71

Query: 835 VGLRGYYWGPTQHEKLILSDYISPGSLASFLYD-RPGRKGP-PLTWAQRLKIAVDVARGL 892
           V L G  +   +  + IL + ++ G L SFL + RP  + P  LT    L  A DVA+G 
Sbjct: 72  VRLIGVSF--ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 893 NYLHFDRAVPHGNLKATNILLD--GPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRA 950
            YL  +  + H ++ A N LL   GP   A++AD+ + R + +A    +       G RA
Sbjct: 130 KYLEENHFI-HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK-------GGRA 181

Query: 951 PELAASKKPHPSF-------KSDVYAFGVILLELLT 979
             L     P  +F       K+DV++FGV+L E+ +
Sbjct: 182 -MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.3 bits (164), Expect = 6e-12
 Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 33/221 (14%)

Query: 782 EVLGRSSHGTSYRATL-----ENGMFLTVKWLRE-GVAKQRKEFAKEAKKFANIRHPNVV 835
           E LG  + G  Y+  L     ++   + +K L++    +Q  EF +EA   A + HPN+V
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 836 GLRGYYWGPTQHEKL-ILSDYISPGSLASFLY------------DRPGRKGPPLTWAQRL 882
            L G     TQ + + +L +Y++ G L  FL             D  G     L     L
Sbjct: 71  CLLGVV---TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 883 KIAVDVARGLNYL--HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI 940
            IA+ +A G+ YL  HF     H +L A NIL+ G  L+ +++D  L R +  A    ++
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILI-GEQLHVKISDLGLSREIYSADYY-RV 182

Query: 941 LDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
               +L  R   PE     K   S  SD+++FGV+L E+ +
Sbjct: 183 QPKSLLPIRWMPPEAIMYGK--FSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 66.2 bits (161), Expect = 8e-12
 Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 12/199 (6%)

Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G     + F +EA+    +RH  +V L   Y  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPL---YAV 69

Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++++  GSL  FL +  G+    L   Q + +A  +A G+ Y+     + H
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFLKEGDGKY---LKLPQLVDMAAQIADGMAYIERMNYI-H 125

Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  ++AD+ L RL+       +      + + APE A   +   + 
Sbjct: 126 RDLRAANILV-GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 182

Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL+T GR
Sbjct: 183 KSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 25/204 (12%)

Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWG 843
           LG    G  +       + + +K +REG   +  +F +EAK    + HPN+V L G    
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVC-- 68

Query: 844 PTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP 902
            T+   + I+++Y++ G L ++L +R G+ G        L +  DV   + YL       
Sbjct: 69  -TKQRPIFIVTEYMANGCLLNYLRERKGKLGT----EWLLDMCSDVCEAMEYLE-SNGFI 122

Query: 903 HGNLKATNILLDGPDLNARVADYCLHRLM------TQAGTIEQILDAGVLGYRAPELAAS 956
           H +L A N L+ G D   +V+D+ L R +      +  GT   +       +  PE+   
Sbjct: 123 HRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV------KWAPPEVFDY 175

Query: 957 KKPHPSFKSDVYAFGVILLELLTG 980
            +   S KSDV++FGV++ E+ + 
Sbjct: 176 SR--FSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 27/217 (12%)

Query: 782 EVLGRSSHGTSYRATLENG------MFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNV 834
             LG  + G  +     +         + VK L+E      RK+F +EA+   N +H N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 835 VGLRGYYWGPTQHEKLILS-DYISPGSLASFL---------YDRPGRKGPPLTWAQRLKI 884
           V   G     T+ +  I+  +Y+  G L  FL            P      LT +Q L+I
Sbjct: 71  VKFYGVC---TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 885 AVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG 944
           AV +A G+ YL     V H +L   N L+ G DL  ++ D+ + R +       ++    
Sbjct: 128 AVQIASGMVYLASQHFV-HRDLATRNCLV-GYDLVVKIGDFGMSRDVYTTDYY-RVGGHT 184

Query: 945 VLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           +L  R   PE    +K   + +SDV++FGV+L E+ T
Sbjct: 185 MLPIRWMPPESIMYRK--FTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 21/212 (9%)

Query: 782 EVLGRSSHGTSYRA-TLENGMFLTVKW--LREGVAKQRKEFAK--------EAKKFANIR 830
           E++G+ ++G  Y A  +  G  + VK   L   +A +     K        E +   ++ 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           H N+V   G+          I  +Y+  GS+ S      GR    L           V  
Sbjct: 67  HLNIVQYLGFETTEEYLS--IFLEYVPGGSIGS-CLRTYGRFEEQLVRF----FTEQVLE 119

Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA-GTIEQILDAGVLGYR 949
           GL YLH  + + H +LKA N+L+D  D   +++D+ + +         + +   G + + 
Sbjct: 120 GLAYLH-SKGILHRDLKADNLLVDA-DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           APE+  S     S K D+++ G ++LE+  GR
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 70/212 (33%), Positives = 104/212 (49%), Gaps = 22/212 (10%)

Query: 784 LGRSSHGTSYRATL-------ENGMFLTVKWLREGVAKQRK-EFAKEAKKFANIRHPNVV 835
           LG  + G  Y  T           + + VK LR+G   Q K EF KEA   +N  HPN+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYD-RPGRKGPP-LTWAQRLKIAVDVARGLN 893
            L G      + + +I+ + +  G L S+L D R  R GPP LT  + L I +DVA+G  
Sbjct: 63  KLLGVCL-LNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNAR----VADYCLHRLMTQAGTIEQILDAGVLGYR 949
           YL     + H +L A N L+     +A     + D+ L R + ++    +    G+L  R
Sbjct: 121 YLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY-RKEGEGLLPVR 178

Query: 950 --APELAASKKPHPSFKSDVYAFGVILLELLT 979
             APE     K   + +SDV++FGV++ E+LT
Sbjct: 179 WMAPESLLDGK--FTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 63.8 bits (155), Expect = 7e-11
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 19/216 (8%)

Query: 771 LTPEELSRAPAEVLGRSSHGTSYRATLE----NGMFLTVKWLREG-VAKQRKEFAKEAKK 825
           + P  +++   +V+G    G  +R  L+      + + +K L+ G   KQR++F  EA  
Sbjct: 2   IHPSHITKQ--KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASI 59

Query: 826 FANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIA 885
                H N++ L G          +I+++Y+  G+L  +L D  G         Q + + 
Sbjct: 60  MGQFSHHNIIRLEGVV--TKFKPAMIITEYMENGALDKYLRDHDGEFSS----YQLVGML 113

Query: 886 VDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV 945
             +A G+ YL  D    H +L A NIL++  +L  +V+D+ L R++            G 
Sbjct: 114 RGIAAGMKYLS-DMNYVHRDLAARNILVNS-NLECKVSDFGLSRVLEDDPEGTYTTSGGK 171

Query: 946 LGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  R  APE  A +K   +  SDV++FG+++ E+++
Sbjct: 172 IPIRWTAPEAIAYRKFTSA--SDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 16/210 (7%)

Query: 782 EVLGRSSHGTSYRATL--ENGMFL--TVKWLREGVAKQR--KEFAKEAKKFANIRHPNVV 835
           ++LG    G+     L  ++G  L   VK ++  +      +EF  EA    +  HPNV+
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 836 GLRGYYWGPTQHEK----LILSDYISPGSLASFL-YDRPGRKGPPLTWAQRLKIAVDVAR 890
            L G  +  +  +K    +++  ++  G L SFL Y R G     L     LK  VD+A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-LGYR 949
           G+ YL  +R   H +L A N +L   D+   VAD+ L + +       Q   A + + + 
Sbjct: 125 GMEYLS-NRNFIHRDLAARNCMLR-EDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLT 979
           A E  A +      KSDV+AFGV + E+ T
Sbjct: 183 AIESLADRVYTS--KSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 63.7 bits (155), Expect = 9e-11
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 31/221 (14%)

Query: 784 LGRSSHGTSYRATL------ENGMFLTVKWLREGVAKQ-RKEFAKEAKKFANIRHPNVVG 836
           +G+ + G  ++A        E    + VK L+E  +   + +F +EA   A   HPN+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDR-----------------PGRKGPPLTWA 879
           L G           +L +Y++ G L  FL  R                  G    PL+  
Sbjct: 73  LLGVC--AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 880 QRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE- 938
           ++L IA  VA G+ YL  +R   H +L   N L+ G ++  ++AD+ L R +  A   + 
Sbjct: 131 EQLCIAKQVAAGMAYLS-ERKFVHRDLATRNCLV-GENMVVKIADFGLSRNIYSADYYKA 188

Query: 939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
              DA  + +  PE     +   + +SDV+A+GV+L E+ +
Sbjct: 189 SENDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 62.9 bits (154), Expect = 1e-10
 Identities = 59/212 (27%), Positives = 88/212 (41%), Gaps = 36/212 (16%)

Query: 784 LGRSSHGTSY--RATLENGMFLTVKWLREGVAKQRKEFA---KEAKKFANIRHPNVVGLR 838
           LG+ S G     R      ++  +K L++    +RKE      E    + I HP +V L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLY-AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL- 58

Query: 839 GYYWGPTQHEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
             ++     EKL L  +Y   G L S L             A+    A ++   L YLH 
Sbjct: 59  --HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRF---SEERARF--YAAEIVLALEYLH- 110

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTIEQILDAGVLGYR 949
              + + +LK  NILLD  D + ++ D+ L         R  T  GT E         Y 
Sbjct: 111 SLGIIYRDLKPENILLDA-DGHIKLTDFGLAKELSSEGSRTNTFCGTPE---------YL 160

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           APE+    K +     D ++ GV+L E+LTG+
Sbjct: 161 APEVL-LGKGY-GKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 63.9 bits (155), Expect = 1e-10
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 18/215 (8%)

Query: 771 LTPEELSRAPAEVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRKEFAKEAK 824
           L   EL R   +VLG  + GT Y+   +  G    + + +K L E    K   EF  EA 
Sbjct: 4   LKETELKRV--KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61

Query: 825 KFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKI 884
             A++ HP++V L G    PT     +++  +  G L  ++++     G  L     L  
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQ---LVTQLMPHGCLLDYVHEHKDNIGSQLL----LNW 114

Query: 885 AVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG 944
            V +A+G+ YL  +R + H +L A N+L+  P+ + ++ D+ L RL+ +    E   D G
Sbjct: 115 CVQIAKGMMYLE-ERRLVHRDLAARNVLVKSPN-HVKITDFGLARLL-EGDEKEYNADGG 171

Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            +  +   L        + +SDV+++GV + EL+T
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 36/220 (16%)

Query: 782 EVLGRSSHGTSYRATLE---NGMFLTVKWLREGVAKQ-RKEFAKEAKKFANI-RHPNVVG 836
           +V+G  + G   RA ++     M   +K L+E  ++   ++FA E +    +  HPN++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 837 L------RGYYWGPTQHEKLILSDYISPGSLASFL-----------YDRPGRKGPPLTWA 879
           L      RGY +        I  +Y   G+L  FL           + +       LT  
Sbjct: 68  LLGACENRGYLY--------IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 880 QRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ 939
           Q L+ A DVA G+ YL  ++   H +L A N+L+ G +L +++AD+ L R   +   +++
Sbjct: 120 QLLQFASDVATGMQYLS-EKQFIHRDLAARNVLV-GENLASKIADFGLSR--GEEVYVKK 175

Query: 940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            +  G L  R   + +      + KSDV++FGV+L E+++
Sbjct: 176 TM--GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 52/184 (28%), Positives = 92/184 (50%), Gaps = 14/184 (7%)

Query: 800 GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG 859
           G  + VK L+   A+  ++F +E +   +++H N+V  +G  +   +    ++ +Y+  G
Sbjct: 33  GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92

Query: 860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLN 919
           SL  +L     R    L   + L  A  + +G+ YL   R V H +L   NIL++  +  
Sbjct: 93  SLRDYLQKHRER----LDHRKLLLYASQICKGMEYLGSKRYV-HRDLATRNILVES-ENR 146

Query: 920 ARVADYCLHRLMTQAGTIEQILDAG---VLGYRAPE-LAASKKPHPSFKSDVYAFGVILL 975
            ++ D+ L +++ Q     ++ + G   +  Y APE L  SK    S  SDV++FGV+L 
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKF---SVASDVWSFGVVLY 202

Query: 976 ELLT 979
           EL T
Sbjct: 203 ELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 24/206 (11%)

Query: 783 VLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQ-RKEFAKEAKKFANIRHPNVVGLRGY 840
            LG  + G   +      G  + VK +R  + +  +K+  +E         P +VG  G 
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKG-PPLTWAQRLKIAVDVARGLNYLHFDR 899
           ++     +  I  +Y+  GSL   L +  GR     L      KIAV V +GL YLH   
Sbjct: 68  FY--NNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKH 120

Query: 900 AVPHGNLKATNILLD--GPDLNARVADYCLHRLMTQ--AGTIEQILDAGVLGYRAPELAA 955
            + H ++K +NIL++  G     ++ D+ +   +    A T       G   Y APE   
Sbjct: 121 KIIHRDVKPSNILVNSRG---QIKLCDFGVSGQLVNSLAKT-----FVGTSSYMAPERIQ 172

Query: 956 SKKPHPSFKSDVYAFGVILLELLTGR 981
                 S KSD+++ G+ L+EL TGR
Sbjct: 173 G--NDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 16/207 (7%)

Query: 782 EVLGRSSHGTSYRA-TLENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           EV+G  +    Y A  L N   + +K +  E       E  KE +  +   HPNVV    
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK--- 63

Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKG-PPLTWAQRLKIAVDVARGLNYLHF 897
           YY      ++L ++  Y+S GSL   +     R G      A  LK   +V +GL YLH 
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK---EVLKGLEYLHS 120

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG---YRAPELA 954
           +  + H ++KA NILL   D + ++AD+ +   +   G   + +    +G   + APE+ 
Sbjct: 121 NGQI-HRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 955 ASKKPHPSFKSDVYAFGVILLELLTGR 981
                +  FK+D+++FG+  +EL TG 
Sbjct: 179 EQVHGY-DFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 63.0 bits (154), Expect = 1e-10
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 27/209 (12%)

Query: 783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGY 840
           VLG+ S G  Y+      G    +K +      + RK+  +E K   +   P VV   G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           +    + E  I+ +Y+  GSLA  L        P L       IA  + +GL+YLH  R 
Sbjct: 68  F--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHTKRH 120

Query: 901 VPHGNLKATNILL--DGPDLNARVADYCLHRLMTQAGTIEQILD-----AGVLGYRAPEL 953
           + H ++K +N+L+   G     ++AD+ +      +  +E  LD      G + Y +PE 
Sbjct: 121 IIHRDIKPSNLLINSKG---EVKIADFGI------SKVLENTLDQCNTFVGTVTYMSPER 171

Query: 954 AASKKPHPSFKSDVYAFGVILLELLTGRC 982
              +    S+ +D+++ G+ LLE   G+ 
Sbjct: 172 IQGE--SYSYAADIWSLGLTLLECALGKF 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 49/177 (27%), Positives = 77/177 (43%), Gaps = 32/177 (18%)

Query: 818 EFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFL----YDRPGRKG 873
           EF +E   F  + H NVV L G       H   ++ +Y   G L  FL          K 
Sbjct: 54  EFRRELDMFRKLSHKNVVRLLGLCREAEPH--YMILEYTDLGDLKQFLRATKSKDEKLKP 111

Query: 874 PPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVA---------- 923
           PPL+  Q++ +   +A G+++L   R V H +L A N L+       +V+          
Sbjct: 112 PPLSTKQKVALCTQIALGMDHLSNARFV-HRDLAARNCLVSS-QREVKVSLLSLSKDVYN 169

Query: 924 -DYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            +Y   R          ++    L + APE  A ++   S KSDV++FGV++ E+ T
Sbjct: 170 SEYYKLR--------NALIP---LRWLAPE--AVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 12/204 (5%)

Query: 783 VLGRSSHG--TSYRATLENGMFLTVKW-LREGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           V+G+ S+G  +  R   +   ++  K  LR    ++RK   +EA+  + ++HPN+V  R 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR- 65

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
             W        I+  +   G L   L +   +KG  L   Q ++  V +A  L YLH ++
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKE---QKGKLLPENQVVEWFVQIAMALQYLH-EK 121

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
            + H +LK  N+ L   ++  +V D  + R++     +   L  G   Y +PEL  S KP
Sbjct: 122 HILHRDLKTQNVFLTRTNI-IKVGDLGIARVLENQCDMASTL-IGTPYYMSPEL-FSNKP 178

Query: 960 HPSFKSDVYAFGVILLELLTGRCA 983
           + ++KSDV+A G  + E+ T + A
Sbjct: 179 Y-NYKSDVWALGCCVYEMATLKHA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 3e-10
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 27/209 (12%)

Query: 782 EVLGRSSHGTSYRA-TLENGMFLTVKWLR-EGVAKQR-KEFAKEAKKFANIRHPNVVGLR 838
           +++GR + G  Y+   LE G F+ +K +  E + ++  K   +E     N++HPN+V   
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA---RGLNYL 895
           G     T     I+ +Y   GSL   +  + G     L       +AV V    +GL YL
Sbjct: 66  GSI--ETSDSLYIILEYAENGSLRQ-IIKKFGPFPESL-------VAVYVYQVLQGLAYL 115

Query: 896 HFDRAVPHGNLKATNILL--DGPDLNARVADYCLH-RLMTQAGTIEQILDAGVLGYRAPE 952
           H ++ V H ++KA NIL   DG     ++AD+ +  +L   +     +   G   + APE
Sbjct: 116 H-EQGVIHRDIKAANILTTKDG---VVKLADFGVATKLNDVSKDDASV--VGTPYWMAPE 169

Query: 953 LAASKKPHPSFKSDVYAFGVILLELLTGR 981
                    S  SD+++ G  ++ELLTG 
Sbjct: 170 -VIEMSGA-STASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 62.0 bits (151), Expect = 4e-10
 Identities = 77/314 (24%), Positives = 102/314 (32%), Gaps = 63/314 (20%)

Query: 217 QVLDFHGNKL-DGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGL---SQSVQYLNLS 272
             L   G  L           L     +   GN  +G  + K L        S++ L LS
Sbjct: 1   LQLSLKGELLKTERATELLPKLLCLQVLRLEGNT-LGEEAAKALASALRPQPSLKELCLS 59

Query: 273 LNQLTGSLVN----GGELQLFENLKVLDLSYNQLTGELPG----FNFVYELQVLKLSNNR 324
           LN+              L     L+ LDLS N L  +  G          LQ LKL+NN 
Sbjct: 60  LNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNG 119

Query: 325 FSGFIPNDLLKGDSLL-----LTDLDLSANNLSGSVSMILS------TNLHMLNLSSNGL 373
                    L    L      L  L L  N L G+    L+       +L  LNL++NG+
Sbjct: 120 LGDRGLR--LLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGI 177

Query: 374 TGE-----LPLLTGSCA--VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETP 426
                      L  +C   VLDL+NN                           S   ET 
Sbjct: 178 GDAGIRALAEGLKANCNLEVLDLNNNGL--------------------TDEGASALAETL 217

Query: 427 QFLR-LNHLNLSHNSLSSS-----LPKVIIQYQKLRVLDLSFNHL--DG--PFLTNLLNS 476
             L+ L  LNL  N+L+ +        ++     L  L LS N +  DG       L   
Sbjct: 218 ASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEK 277

Query: 477 STLQELHLADNLLT 490
            +L EL L  N   
Sbjct: 278 ESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 61.9 bits (150), Expect = 5e-10
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 20/206 (9%)

Query: 782 EVLGRSSHGTSYRATL----EN-GMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVV 835
           +VLG  + GT Y+       E   + + +K LRE  + K  KE   EA   A++ +P+V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A+G+N
Sbjct: 73  RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 123

Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  +R + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 124 YLE-ERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-ADEKEYHAEGGKVPIKWMAL 180

Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 60.4 bits (147), Expect = 9e-10
 Identities = 56/180 (31%), Positives = 84/180 (46%), Gaps = 19/180 (10%)

Query: 805 VKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP-GSLA 862
           VK L++  +A  +KEF +EA   A + HP +V L G      + E L+L   ++P G L 
Sbjct: 28  VKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGV----CKGEPLMLVMELAPLGPLL 83

Query: 863 SFLYDRPGRKGPPLT-WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            +L  R       L   A +      VA G+ YL     V H +L A N+LL      A+
Sbjct: 84  KYLKKRREIPVSDLKELAHQ------VAMGMAYLESKHFV-HRDLAARNVLLVNRH-QAK 135

Query: 922 VADYCLHRLMTQAGTIEQILDAG--VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           ++D+ + R +       +   AG   L + APE     K   S KSDV+++GV L E  +
Sbjct: 136 ISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK--FSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 100/353 (28%), Positives = 147/353 (41%), Gaps = 25/353 (7%)

Query: 105 SISGVIPDNIGDFKSLEFL-DVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVS 163
           SI+   PD+  +  ++  L     +     LPS + +L SL  LS +G +       ++ 
Sbjct: 32  SINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSE-NLL 90

Query: 164 GLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHG 223
            L+ + SLDL+ N    ++   L  L NL  L+L +N  +   P    L   L+ LD   
Sbjct: 91  NLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSD 149

Query: 224 NKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNG 283
           NK+   L      L N  ++D S N     S    L     ++  L+LS N+++      
Sbjct: 150 NKI-ESLPSPLRNLPNLKNLDLSFN---DLSDLPKLLSNLSNLNNLDLSGNKIS---DLP 202

Query: 284 GELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTD 343
            E++L   L+ LDLS N +   L   + +  L  L+LSNN+           G+   L  
Sbjct: 203 PEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLP---ESIGNLSNLET 259

Query: 344 LDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPL--LTGSCAVLDLSNNQ----FEGN 397
           LDLS N +S   S+   TNL  L+LS N L+  LPL  L      L L+        E  
Sbjct: 260 LDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELK 319

Query: 398 LSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVII 450
           L+ IL   NI            S PE       LN+L    N+L  S     I
Sbjct: 320 LNSILLNNNILSN------GETSSPEALSILESLNNLWTLDNALDESNLNRYI 366

Length = 394

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 61.6 bits (149), Expect = 2e-09
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 22/209 (10%)

Query: 395 EGNLSRILKW--GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQY 452
              L+ I       I+ ++LS N +T  +PE  P  L+   L+L HN +S  LP+ + + 
Sbjct: 229 SNQLTSIPATLPDTIQEMELSINRIT-ELPERLPSALQ--SLDLFHNKISC-LPENLPE- 283

Query: 453 QKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNR 512
            +LR L +  N +    L   L S  +  L++  N LT + +  PP    L+ L+   N 
Sbjct: 284 -ELRYLSVYDNSIRT--LPAHLPSG-ITHLNVQSNSLTALPETLPP---GLKTLEAGENA 336

Query: 513 LNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNS 572
           L    P  L     L+VL ++ N I+  LP ++    ++++L +S+N  T  LP NLP +
Sbjct: 337 LTS-LPASLPP--ELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLPAA 389

Query: 573 LETFNVSYNDFSGAVPENLRKFPSSSFYP 601
           L+    S N+    +PE+L  F      P
Sbjct: 390 LQIMQASRNNLV-RLPESLPHFRGEGPQP 417

Length = 754

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 24/206 (11%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           E LG  S+G+ Y+A   E G  + +K +   V +  +E  KE         P +V   G 
Sbjct: 9   EKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGS 66

Query: 841 YWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
           Y+   ++  L I+ +Y   GS++  +          LT  +   I     +GL YLH ++
Sbjct: 67  YF---KNTDLWIVMEYCGAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 900 AVPHGNLKATNILLDGPDLNARVADYC----LHRLMTQAGTIEQILDAGVLGYRAPELAA 955
            + H ++KA NILL+  +  A++AD+     L   M +  T+      G   + APE+  
Sbjct: 120 KI-HRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTV-----IGTPFWMAPEV-I 171

Query: 956 SKKPHPSFKSDVYAFGVILLELLTGR 981
            +  + + K+D+++ G+  +E+  G+
Sbjct: 172 QEIGYNN-KADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 21/210 (10%)

Query: 784 LGRSSHGTSYRATLEN------GMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVG 836
           LG+ S G  Y    +          + +K + E  + ++R EF  EA         +VV 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLY-----DRPGRKGPPLTWAQRLKIAVDVARG 891
           L G     T    L++ + ++ G L S+L              P T  + +++A ++A G
Sbjct: 74  LLGVV--STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR-- 949
           + YL   +   H +L A N ++   DL  ++ D+ + R + +     +    G+L  R  
Sbjct: 132 MAYLA-AKKFVHRDLAARNCMVAE-DLTVKIGDFGMTRDIYETDYYRKG-GKGLLPVRWM 188

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLT 979
           APE  + K    + KSDV++FGV+L E+ T
Sbjct: 189 APE--SLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 16/187 (8%)

Query: 800 GMFLTVKWLREGVAKQRKE-FAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP 858
           G  + VK L+    +Q    + KE      + H N+V  +G           ++ +Y+  
Sbjct: 33  GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92

Query: 859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDL 918
           GSL  +L   P  K   L  AQ L  A  +  G+ YLH    + H +L A N+LLD   L
Sbjct: 93  GSLRDYL---PKHK---LNLAQLLLFAQQICEGMAYLHSQHYI-HRDLAARNVLLDNDRL 145

Query: 919 NARVADYCLHRLMTQAGTIEQILDAG---VLGYRAPELAASKKPHPSFKSDVYAFGVILL 975
             ++ D+ L + + +     ++ + G   V  Y A E     K   S+ SDV++FGV L 
Sbjct: 146 -VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKF--SYASDVWSFGVTLY 201

Query: 976 ELLTGRC 982
           ELLT  C
Sbjct: 202 ELLT-HC 207

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.4 bits (149), Expect = 2e-09
 Identities = 54/209 (25%), Positives = 84/209 (40%), Gaps = 44/209 (21%)

Query: 798 ENGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD 854
             G  + +K LR        QR  F +E    A + HPN+V              L+ S 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIV-------------ALLDSG 47

Query: 855 YISPGSLASFLYDRPGRKGPPLTWAQRL------------KIAVDVARGLNYLHFDRAVP 902
              PG L +     PGR     T  + L            ++ + V   L   H ++ + 
Sbjct: 48  EAPPGLLFAVFEYVPGR-----TLREVLAADGALPAGETGRLMLQVLDALACAH-NQGIV 101

Query: 903 HGNLKATNILLDGPDL--NARVADYCLHRLMTQAGTIE--QILDAG-VLG---YRAPELA 954
           H +LK  NI++    +  +A+V D+ +  L+      +   +     VLG   Y APE  
Sbjct: 102 HRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161

Query: 955 ASKKPHPSFKSDVYAFGVILLELLTGRCA 983
             +   P   SD+YA+G+I LE LTG+  
Sbjct: 162 RGEPVTP--NSDLYAWGLIFLECLTGQRV 188

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 59.3 bits (144), Expect = 3e-09
 Identities = 54/190 (28%), Positives = 82/190 (43%), Gaps = 28/190 (14%)

Query: 805 VKWLREGVAKQ-RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLA 862
           VK LR   +   R++F KE K  + +  PN+  L G     T    L ++ +Y+  G L 
Sbjct: 51  VKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVC---TVDPPLCMIMEYMENGDLN 107

Query: 863 SFLYDRPGRKG------PPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP 916
            FL                L+++  L +A  +A G+ YL     V H +L   N L+ G 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV-HRDLATRNCLV-GK 165

Query: 917 DLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF-------KSDVYA 969
           +   ++AD+ + R +  +       D   +  RAP L        S        KSDV+A
Sbjct: 166 NYTIKIADFGMSRNLYSS-------DYYRVQGRAP-LPIRWMAWESVLLGKFTTKSDVWA 217

Query: 970 FGVILLELLT 979
           FGV L E+LT
Sbjct: 218 FGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 15/211 (7%)

Query: 775 ELSRAPAEV---LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRH 831
           E+ R   ++   LG    G  + AT      + VK ++ G +   + F  EA     ++H
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQH 60

Query: 832 PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
             +V L       T+    I++++++ GSL  FL    G K P     + +  +  +A G
Sbjct: 61  DKLVKLHAVV---TKEPIYIITEFMAKGSLLDFLKSDEGSKQP---LPKLIDFSAQIAEG 114

Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAP 951
           + ++   R   H +L+A NIL+    L  ++AD+ L R++       +      + + AP
Sbjct: 115 MAFIE-QRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172

Query: 952 ELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
           E  A      + KSDV++FG++L+E++T GR
Sbjct: 173 E--AINFGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.2 bits (146), Expect = 4e-09
 Identities = 31/86 (36%), Positives = 49/86 (56%)

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRI 206
           L L      G IP+ +S L  +QS++LS NS  G++PP+L  + +L  L+LS N F+  I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 207 PRGFELILGLQVLDFHGNKLDGHLDG 232
           P     +  L++L+ +GN L G +  
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPA 508

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.2 bits (146), Expect = 4e-09
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 3/103 (2%)

Query: 482 LHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSL 541
           L L +  L G +      + +LQ ++LS N + G  P  LGS+T L+VL L+ N+ +GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 542 PTSMANMTSLSSLVISQNHFTGPLPNNLPNSL---ETFNVSYN 581
           P S+  +TSL  L ++ N  +G +P  L   L    +FN + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 58.7 bits (143), Expect = 4e-09
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 18/158 (11%)

Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           +RHPN+V L+       +    ++ +Y+    L   L D P  K    T +Q       +
Sbjct: 55  LRHPNIVRLKEIVTSKGKGSIYMVFEYM-DHDLTGLL-DSPEVK---FTESQIKCYMKQL 109

Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV--L 946
             GL YLH    + H ++K +NIL++  D   ++AD+ L R  T            V  L
Sbjct: 110 LEGLQYLH-SNGILHRDIKGSNILINN-DGVLKLADFGLARPYT--KRNSADYTNRVITL 165

Query: 947 GYRAPEL---AASKKPHPSFKSDVYAFGVILLELLTGR 981
            YR PEL   A    P    + D+++ G IL EL  G+
Sbjct: 166 WYRPPELLLGATRYGP----EVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 61/188 (32%), Positives = 95/188 (50%), Gaps = 25/188 (13%)

Query: 800 GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEK---LILSDYI 856
           G  + VK ++     Q   F  EA     +RH N+V L G        EK    I+++Y+
Sbjct: 29  GNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGV----IVEEKGGLYIVTEYM 82

Query: 857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP 916
           + GSL  +L  R GR    L     LK ++DV   + YL  +  V H +L A N+L+   
Sbjct: 83  AKGSLVDYLRSR-GRS--VLGGDCLLKFSLDVCEAMEYLEANNFV-HRDLAARNVLVSED 138

Query: 917 DLNARVADYCLHRLMTQAGTIEQILDAGVL--GYRAPELAASKKPHPSFKSDVYAFGVIL 974
           ++ A+V+D+ L +   +A + +   D G L   + APE    KK   S KSDV++FG++L
Sbjct: 139 NV-AKVSDFGLTK---EASSTQ---DTGKLPVKWTAPEALREKKF--STKSDVWSFGILL 189

Query: 975 LELLT-GR 981
            E+ + GR
Sbjct: 190 WEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 19/179 (10%)

Query: 805 VKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLAS 863
           +K + EG A   ++F +EAK    + HP +V L G     TQ + L I+++++  G L +
Sbjct: 33  IKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVC---TQQKPLYIVTEFMENGCLLN 88

Query: 864 FLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVA 923
           +L  R G+    +     L +  DV  G+ YL  +  + H +L A N L+    +  +V+
Sbjct: 89  YLRQRQGKLSKDML----LSMCQDVCEGMEYLERNSFI-HRDLAARNCLVSSTGV-VKVS 142

Query: 924 DYCLHRLMTQAGTIEQILDAGV---LGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           D+ + R +      E    +G    + +  PE+    K   S KSDV++FGV++ E+ T
Sbjct: 143 DFGMTRYVLDD---EYTSSSGAKFPVKWSPPEVFNFSKY--SSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 29/211 (13%)

Query: 780 PAEVLGRSSHG--TSYRATLENGMFLTVKW----LREGVAKQRKEFAKEAKKFANIRHPN 833
           P  VLG+ + G  T YR T ++ +   V W    L     K+R++   E    + ++HPN
Sbjct: 4   PIRVLGKGAFGEATLYRRTEDDSL---VVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60

Query: 834 VVGLRGYYWGPTQHEK--LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV--DVA 889
           ++     Y+     +   LI  +Y + G+L   +  + G       + + + +     + 
Sbjct: 61  IIA----YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG-----QLFEEEMVLWYLFQIV 111

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM-TQAGTIEQILDAGVLGY 948
             ++Y+H    + H ++K  NI L    L  ++ D+ + +++ ++    E ++  G   Y
Sbjct: 112 SAVSYIH-KAGILHRDIKTLNIFLTKAGL-IKLGDFGISKILGSEYSMAETVV--GTPYY 167

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            +PEL    K   +FKSD++A G +L ELLT
Sbjct: 168 MSPELCQGVKY--NFKSDIWALGCVLYELLT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 58.5 bits (142), Expect = 5e-09
 Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 13/156 (8%)

Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           N+RHPN+V L+    G    + + L        LAS L + P     P + +Q   + + 
Sbjct: 62  NLRHPNIVELKEVVVG-KHLDSIFLVMEYCEQDLASLLDNMPT----PFSESQVKCLMLQ 116

Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-- 945
           + RGL YLH +  + H +LK +N+LL       ++AD+ L R     G   + +   V  
Sbjct: 117 LLRGLQYLH-ENFIIHRDLKVSNLLLTDKGC-LKIADFGLARTY---GLPAKPMTPKVVT 171

Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L YRAPEL      + +   D++A G IL ELL  +
Sbjct: 172 LWYRAPELLLGCTTYTT-AIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 19/213 (8%)

Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWG 843
           LG    G  +     N   + VK L+ G     + F +EA     ++H  +V L   Y  
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRL---YAV 69

Query: 844 PTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP 902
            T+ E + I+++Y++ GSL  FL    G K   +   + +  +  +A G+ Y+     + 
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGK---VLLPKLIDFSAQIAEGMAYIERKNYI- 125

Query: 903 HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPS 962
           H +L+A N+L+    L  ++AD+ L R++       +      + + APE  A      +
Sbjct: 126 HRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE--AINFGSFT 182

Query: 963 FKSDVYAFGVILLELLT-------GRCAGDVIS 988
            KSDV++FG++L E++T       G    DV+S
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS 215

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 57.7 bits (139), Expect = 9e-09
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 20/205 (9%)

Query: 783 VLGRSSHGTSYRATL----EN-GMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVG 836
           VLG  + GT Y+       EN  + + +K LRE  + K  KE   EA   A +  P V  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLNY 894
           L G     T     +++  +  G L  ++ +   R G    L W       V +A+G++Y
Sbjct: 74  LLGICLTSTVQ---LVTQLMPYGCLLDYVRENKDRIGSQDLLNWC------VQIAKGMSY 124

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELA 954
           L   R V H +L A N+L+  P+ + ++ D+ L RL+    T E   D G +  +   L 
Sbjct: 125 LEEVRLV-HRDLAARNVLVKSPN-HVKITDFGLARLLDIDET-EYHADGGKVPIKWMALE 181

Query: 955 ASKKPHPSFKSDVYAFGVILLELLT 979
           +      + +SDV+++GV + EL+T
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 57/234 (24%), Positives = 105/234 (44%), Gaps = 22/234 (9%)

Query: 771 LTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR 830
           + P EL+    + +G    G  +         + +K +REG A   ++F +EA+    + 
Sbjct: 1   IHPSELTLV--QEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLS 57

Query: 831 HPNVVGLRGYYWGPTQHEKLILS-DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
           HP +V L G     T+   + L  +++  G L+ +L  + G+     +    L + +DV 
Sbjct: 58  HPKLVQLYGVC---TERSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVC 110

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR 949
            G+ YL     V H +L A N L+ G +   +V+D+ + R +              + + 
Sbjct: 111 EGMAYLE-SSNVIHRDLAARNCLV-GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS 168

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLT-------GRCAGDVISGEGAGVDL 996
           +PE+ +  K   S KSDV++FGV++ E+ +        R   +V+    AG  L
Sbjct: 169 SPEVFSFSKY--SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL 220

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 20/208 (9%)

Query: 781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQ-RKEFAKEAKKFANIRHPNVVGLRG 839
           AE LG  +     +  L     + VK LR  V K  R +F KE K  + +++PN++ L G
Sbjct: 30  AEFLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84

Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKG-------PPLTWAQRLKIAVDVARG 891
                   + L ++++Y+  G L  FL  R            P ++ A  L +AV +A G
Sbjct: 85  VC---VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASG 141

Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAP 951
           + YL     V H +L   N L+ G     ++AD+ + R +  +G   +I    VL  R  
Sbjct: 142 MKYLASLNFV-HRDLATRNCLV-GNHYTIKIADFGMSRNL-YSGDYYRIQGRAVLPIRWM 198

Query: 952 ELAASKKPHPSFKSDVYAFGVILLELLT 979
              +      +  SDV+AFGV L E+ T
Sbjct: 199 AWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 57/185 (30%), Positives = 90/185 (48%), Gaps = 15/185 (8%)

Query: 800 GMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNVVGLRGY-YWGPTQHEKLILSDYIS 857
           G  + VK L+ E       +  KE +   N+ H N+V  +G          KLI+ +++ 
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM-EFLP 91

Query: 858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPD 917
            GSL  +L     R    +   Q+LK AV + +G++YL   R   H +L A N+L++   
Sbjct: 92  SGSLKEYL----PRNKNKINLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEH 146

Query: 918 LNARVADYCLHR-LMTQAG--TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVIL 974
              ++ D+ L + + T     T++  LD+ V  Y APE     K +    SDV++FGV L
Sbjct: 147 Q-VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFY--IASDVWSFGVTL 202

Query: 975 LELLT 979
            ELLT
Sbjct: 203 YELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 18/170 (10%)

Query: 814 KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDR-PGRK 872
           K+R+E  KE    +N++HPN+V  +  +         I+ DY   G     LY +   ++
Sbjct: 41  KEREESRKEVAVLSNMKHPNIVQYQESF--EENGNLYIVMDYCEGGD----LYKKINAQR 94

Query: 873 GPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT 932
           G      Q L   V +   L ++H DR + H ++K+ NI L   D   ++ D+ + R++ 
Sbjct: 95  GVLFPEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLN 152

Query: 933 QAGTIEQILDAGVLG---YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
              T+E  L    +G   Y +PE+  + +P+ + KSD++A G +L E+ T
Sbjct: 153 S--TVE--LARTCIGTPYYLSPEICEN-RPYNN-KSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 36/220 (16%)

Query: 782 EVLGRSSHGTSYRATLENG---MFLTVKWLREGVAKQ-RKEFAKEAKKFANI-RHPNVVG 836
           +V+G  + G   +A ++     M   +K ++E  +K   ++FA E +    +  HPN++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 837 L------RGYYWGPTQHEKLILSDYISPGSLASFL-----------YDRPGRKGPPLTWA 879
           L      RGY +        +  +Y   G+L  FL           +         L+  
Sbjct: 61  LLGACEHRGYLY--------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 112

Query: 880 QRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ 939
           Q L  A DVARG++YL   +   H +L A NIL+ G +  A++AD+ L R   Q   +++
Sbjct: 113 QLLHFAADVARGMDYLS-QKQFIHRDLAARNILV-GENYVAKIADFGLSR--GQEVYVKK 168

Query: 940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            +  G L  R   + +      +  SDV+++GV+L E+++
Sbjct: 169 TM--GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 56.2 bits (136), Expect = 3e-08
 Identities = 67/271 (24%), Positives = 101/271 (37%), Gaps = 53/271 (19%)

Query: 341 LTDLDLSANNLSGSVSMILSTNLH------MLNLSSNGLTGELPLLTGSCA--------- 385
           L  L L  N L    +  L++ L        L LS N  TG +P    S           
Sbjct: 25  LQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQGLTKGCGL 83

Query: 386 -VLDLSNNQFE----GNLSRILKWGNIEYLDLSRN--------HLTGSIPEETPQFLRLN 432
             LDLS+N       G L  +L+  +++ L L+ N         L   + +  P    L 
Sbjct: 84  QELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPP---ALE 140

Query: 433 HLNLSHNSLSS----SLPKVIIQYQKLRVLDLSFNHLDGPFLTNLL----NSSTLQELHL 484
            L L  N L      +L K +   + L+ L+L+ N +    +  L      +  L+ L L
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200

Query: 485 ADNLLT--GVLDFS--PPSVSNLQVLDLSHNRLNGY-----FPDRLGSLTGLKVLCLAGN 535
            +N LT  G    +    S+ +L+VL+L  N L            L     L  L L+ N
Sbjct: 201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260

Query: 536 NI----SGSLPTSMANMTSLSSLVISQNHFT 562
           +I    +  L   +A   SL  L +  N F 
Sbjct: 261 DITDDGAKDLAEVLAEKESLLELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 35/215 (16%)

Query: 782 EVLGRSSHGTSYRATL----ENGMFLTVKWL-REGVAKQRKEFAKEAKKFANIRHPNVVG 836
            V+G+   G  Y  TL       +   VK L R    ++ ++F KE     +  HPNV+ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G    P++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ YL 
Sbjct: 61  LLGICL-PSEGSPLVVLPYMKHGDLRNFI--RSETHNP--TVKDLIGFGLQVAKGMEYLA 115

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
             + V H +L A N +LD      +VAD+ L R          I D     Y       +
Sbjct: 116 SKKFV-HRDLAARNCMLD-ESFTVKVADFGLAR---------DIYDKEY--YSVHNHTGA 162

Query: 957 KKPHP------------SFKSDVYAFGVILLELLT 979
           K P              + KSDV++FGV+L EL+T
Sbjct: 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.9 bits (135), Expect = 4e-08
 Identities = 82/320 (25%), Positives = 134/320 (41%), Gaps = 57/320 (17%)

Query: 769  LTLTPE-ELSRAPAEV---LGRSSHGTSYRATL------ENGMFLTVKWLREGVA-KQRK 817
            L L PE EL R    +   LG  + G   +A             + VK L++    K   
Sbjct: 1    LPLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS 60

Query: 818  EFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK- 872
            +   E +    I +H N++ L G     TQ   L ++ +Y + G+L  FL  R  PG   
Sbjct: 61   DLVSEMEMMKMIGKHKNIINLLG---VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117

Query: 873  --------GPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVAD 924
                       LT    +  A  VARG+ +L   + + H +L A N+L+   D   ++AD
Sbjct: 118  SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCI-HRDLAARNVLV-TEDHVMKIAD 175

Query: 925  YCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLTGRC 982
            + L R +       +  + G L  +  APE A   + + + +SDV++FGV+L E+ T   
Sbjct: 176  FGLARDIHHIDYYRKTTN-GRLPVKWMAPE-ALFDRVY-THQSDVWSFGVLLWEIFT--- 229

Query: 983  AGDVISGEG-AGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCI 1041
                + G    G+ + +  +L + EG+            M  P      +E+  +   C 
Sbjct: 230  ----LGGSPYPGIPVEELFKL-LKEGY-----------RMEKPQ--NCTQELYHLMRDCW 271

Query: 1042 RSV-SERPGIKTIYEDLSSI 1060
              V S+RP  K + EDL  +
Sbjct: 272  HEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 53/228 (23%)

Query: 784 LGRSSHGTSYRATLEN------GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGL 837
           LG  + G  + A   N       M + VK L+E     R++F +EA+    ++H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV-- 70

Query: 838 RGYYWGPTQHEKLILS-DYISPGSLASFLYDRPGRKGP--------------PLTWAQRL 882
             +Y   T+   L++  +Y+  G L  FL       GP               LT  Q L
Sbjct: 71  -RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSH----GPDAKILAGGEDVAPGQLTLGQML 125

Query: 883 KIAVDVARGLNY---LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ 939
            IA  +A G+ Y   LHF     H +L   N L+ G  L  ++ D+ + R +        
Sbjct: 126 AIASQIASGMVYLASLHF----VHRDLATRNCLV-GQGLVVKIGDFGMSRDIYST----- 175

Query: 940 ILDAGVLGYRA--------PELAASKKPHPSFKSDVYAFGVILLELLT 979
             D   +G R         PE    +K   + +SD+++FGV+L E+ T
Sbjct: 176 --DYYRVGGRTMLPIRWMPPESILYRK--FTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 24/216 (11%)

Query: 771 LTPEELSRAPAEVLGRSSHGTSYRA-TLENGMFLTVKWLREGVAKQRKEFAKEAKKFANI 829
           L PEE      E LG  + G  Y+A   E G+    K +     ++ +++  E    A+ 
Sbjct: 1   LNPEEFWEIIGE-LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC 59

Query: 830 RHPNVVGL-RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
            HPN+V L   +Y+   ++   IL ++ + G++ + + +       PLT  Q   +    
Sbjct: 60  DHPNIVKLLDAFYY---ENNLWILIEFCAGGAVDAVMLELE----RPLTEPQIRVVCKQT 112

Query: 889 ARGLNYLHFDRAVPHGNLKATNIL--LDGPDLNARVADYCLHRLMTQAGTIEQILDA--G 944
              LNYLH +  + H +LKA NIL  LDG   + ++AD+ +    T+  TI++  D+  G
Sbjct: 113 LEALNYLH-ENKIIHRDLKAGNILFTLDG---DIKLADFGVSAKNTR--TIQR-RDSFIG 165

Query: 945 VLGYRAPE--LAASKKPHP-SFKSDVYAFGVILLEL 977
              + APE  +  + K  P  +K+DV++ G+ L+E+
Sbjct: 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 19/206 (9%)

Query: 782 EVLGRSSHGTSYRATLENGMF----LTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNVVG 836
           + LG  S G   R            + VK L+ + ++    +F KEA    ++ H N++ 
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G       H  +++++    GSL   L             +     AV +A G+ YL 
Sbjct: 61  LYGVV---LTHPLMMVTELAPLGSLLDRLRKD---ALGHFLISTLCDYAVQIANGMRYLE 114

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG---TIEQILDAGVLGYRAPEL 953
             R + H +L A NILL   D   ++ D+ L R + Q      +E+ L      + APE 
Sbjct: 115 SKRFI-HRDLAARNILLASDDK-VKIGDFGLMRALPQNEDHYVMEEHLKVP-FAWCAPE- 170

Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            + +    S  SDV+ FGV L E+ T
Sbjct: 171 -SLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 12/153 (7%)

Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
            P +V   G +   +     I  +Y   GSL S +Y +  ++G  +      KIA  V +
Sbjct: 58  SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLK 116

Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL--HRLMTQAGTIEQILDAGVLGY 948
           GL+YLH  R + H ++K +NILL       ++ D+ +    + + AGT       G   Y
Sbjct: 117 GLSYLH-SRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNSLAGTF-----TGTSFY 169

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            APE     KP+ S  SDV++ G+ LLE+   R
Sbjct: 170 MAPE-RIQGKPY-SITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 55.5 bits (133), Expect = 6e-08
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 37/218 (16%)

Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFA--------------KEAKKFANI 829
           +GR ++G  Y+A  ++G             K  KE+A              +E      +
Sbjct: 9   VGRGTYGHVYKAKRKDG-------------KDEKEYALKQIEGTGISMSACREIALLREL 55

Query: 830 RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKG-PPLTWAQRL--KIAV 886
           +HPNV+ L+  +   +  +  +L DY          + R  +    P+   + +   +  
Sbjct: 56  KHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLY 115

Query: 887 DVARGLNYLHFDRAVPHGNLKATNILL--DGPDLN-ARVADYCLHRLMTQAGTIEQILDA 943
            +  G++YLH +  V H +LK  NIL+  +GP+    ++AD    RL          LD 
Sbjct: 116 QILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 944 GVLG--YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            V+   YRAPEL    + H +   D++A G I  ELLT
Sbjct: 175 VVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 49.2 bits (118), Expect = 6e-08
 Identities = 20/47 (42%), Positives = 26/47 (55%), Gaps = 5/47 (10%)

Query: 21 PSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCN 67
           + D  ALL FK  +  DP+G  L+SWN  S D    P SW G+ C+
Sbjct: 1  LNDDRDALLAFKSSLNGDPSG-ALSSWNPSSSD----PCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 55.1 bits (133), Expect = 6e-08
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 25/208 (12%)

Query: 784 LGRSSHGTSYRA-TLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGL-RGYY 841
           LG  + G  Y+A   E G+F   K ++    ++ ++F  E    +  +HPN+VGL   Y+
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 842 WGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           +      KL IL ++   G+L S +     R    LT  Q   +   +   LN+LH    
Sbjct: 73  YEN----KLWILIEFCDGGALDS-IMLELER---GLTEPQIRYVCRQMLEALNFLH-SHK 123

Query: 901 VPHGNLKATNILL--DGPDLNARVADYCLHRLMTQAGTIEQILDA--GVLGYRAPELAAS 956
           V H +LKA NILL  DG   + ++AD+ +           Q  D   G   + APE+ A 
Sbjct: 124 VIHRDLKAGNILLTLDG---DVKLADFGVSAKNKST---LQKRDTFIGTPYWMAPEVVAC 177

Query: 957 K--KPHP-SFKSDVYAFGVILLELLTGR 981
           +  K +P  +K+D+++ G+ L+EL    
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 54.9 bits (132), Expect = 6e-08
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 18/210 (8%)

Query: 783 VLGRSSHGTSYRATL--ENGMF--LTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVG 836
           +LG+   G+   A L  E+G F  + VK L+  +  +   +EF +EA       HPNV+ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 837 LRGYYWGPTQHEKLILSDYISP----GSLASFLY-DRPGRKGPPLTWAQR--LKIAVDVA 889
           L G         +L +   I P    G L +FL   R G +  P T   +  ++  +D+A
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEE--PFTLPLQTLVRFMIDIA 123

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR 949
            G+ YL   +   H +L A N +L+  ++   VAD+ L + +       Q   A  L  +
Sbjct: 124 SGMEYLS-SKNFIHRDLAARNCMLN-ENMTVCVADFGLSKKIYSGDYYRQGC-ASKLPVK 180

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLT 979
              L +      +  SDV+AFGV + E++T
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 54.5 bits (131), Expect = 8e-08
 Identities = 51/182 (28%), Positives = 88/182 (48%), Gaps = 19/182 (10%)

Query: 803 LTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +  LR G   KQR+ F  EA       H N+V L G       +  +I+++Y+S G+L
Sbjct: 36  VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI--TRGNTMMIVTEYMSNGAL 93

Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL    G+    L   Q + +   +A G+ YL  +    H  L A  +L++  DL  +
Sbjct: 94  DSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLS-EMGYVHKGLAAHKVLVNS-DLVCK 147

Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP----HPSFKSDVYAFGVILLEL 977
           ++ +   RL  Q    E I     +  ++P L A+ +     H S  SDV++FG+++ E+
Sbjct: 148 ISGF--RRL--QEDKSEAIYTT--MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201

Query: 978 LT 979
           ++
Sbjct: 202 MS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 54.7 bits (132), Expect = 9e-08
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 8/102 (7%)

Query: 883 KIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY--CLHRLMTQAGTIEQI 940
           KIAV   + LNYL  +  + H ++K +NILLD    N ++ D+      +     +I + 
Sbjct: 111 KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLV----DSIAKT 165

Query: 941 LDAGVLGYRAPE-LAASKKPHPSFKSDVYAFGVILLELLTGR 981
            DAG   Y APE +  S +     +SDV++ G+ L E+ TG+
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 26/208 (12%)

Query: 785 GRSSHGTSYRATLENGMFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYWG 843
           GR  +G            + VK +++  ++ Q     +E+     + H N++ +      
Sbjct: 20  GRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV--C 77

Query: 844 PTQHEK-LILSDYISPGSLASFLYD-RPGRKGPPLTWAQR--LKIAVDVARGLNYLHFDR 899
               E   +L  Y++ G+L  FL   R G    P   + +  + +A+ +A G++YLH  R
Sbjct: 78  IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-KR 136

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG---YR-----AP 951
            V H ++ A N ++D  +L  ++ D  L R +          D   LG    R     A 
Sbjct: 137 GVIHKDIAARNCVID-EELQVKITDNALSRDLFPM-------DYHCLGDNENRPVKWMAL 188

Query: 952 ELAASKKPHPSFKSDVYAFGVILLELLT 979
           E  +      S  SDV++FGV+L EL+T
Sbjct: 189 E--SLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 28/216 (12%)

Query: 784 LGRSSHGTSYRATLEN------GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGL 837
           LG  + G  + A   N       M + VK L++     RK+F +EA+   N++H ++V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV-- 70

Query: 838 RGYYWGPTQHEKLILS-DYISPGSLASFLY-----------DRPGRKGPPLTWAQRLKIA 885
             +Y      + LI+  +Y+  G L  FL             +P +    L  +Q L IA
Sbjct: 71  -KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 886 VDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV 945
             +A G+ YL     V H +L   N L+ G +L  ++ D+ + R +       ++    +
Sbjct: 130 SQIASGMVYLASQHFV-HRDLATRNCLV-GANLLVKIGDFGMSRDVYSTDYY-RVGGHTM 186

Query: 946 LGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           L  R   PE    +K   + +SDV++FGVIL E+ T
Sbjct: 187 LPIRWMPPESIMYRK--FTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 73/277 (26%), Positives = 118/277 (42%), Gaps = 37/277 (13%)

Query: 801  MFLTVKWLREGVAKQ-RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKL-ILSDYISP 858
            + + VK LR    K  R +F KE K  + ++ PN++ L G        + L ++++Y+  
Sbjct: 47   LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC---VDEDPLCMITEYMEN 103

Query: 859  GSLASFL--------------YDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHG 904
            G L  FL                 P    P ++++  L +A+ +A G+ YL     V H 
Sbjct: 104  GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV-HR 162

Query: 905  NLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFK 964
            +L   N L+ G +L  ++AD+ + R +  AG   +I    VL  R            +  
Sbjct: 163  DLATRNCLV-GENLTIKIADFGMSRNL-YAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220

Query: 965  SDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNP 1024
            SDV+AFGV L E+L        +  E    +LTD    +V E  G    D      +  P
Sbjct: 221  SDVWAFGVTLWEILM-------LCKEQPYGELTDE---QVIENAGEFFRDQGRQVYLFRP 270

Query: 1025 AA-EKGMKEVLGIALRC-IRSVSERPGIKTIYEDLSS 1059
                +G+ E++   L+C  R   ERP    I+  L+ 
Sbjct: 271  PPCPQGLYELM---LQCWSRDCRERPSFSDIHAFLTE 304

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 21/205 (10%)

Query: 784 LGRSSHGTSYRAT-LENGMF-----LTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGL 837
           +G  +HG  ++A   E G       + ++ L  G+  Q     +E K     +HP VV L
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ---ALREIKALQACQHPYVVKL 64

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
              +   +     +L     P  L+  L D       PL  AQ       + +G+ Y+H 
Sbjct: 65  LDVFPHGS---GFVLVMEYMPSDLSEVLRDEER----PLPEAQVKSYMRMLLKGVAYMHA 117

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPE-LAAS 956
           +  + H +LK  N+L+   D   ++AD+ L RL ++              YRAPE L  +
Sbjct: 118 NGIM-HRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 957 KKPHPSFKSDVYAFGVILLELLTGR 981
           +K  P    D++A G I  ELL G 
Sbjct: 176 RKYDPGV--DLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 23/203 (11%)

Query: 782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRK-EFAKEAKKFANIRHPNVVGLRG 839
           E +GR + G  +   L  +   + VK  RE +    K +F +EA+      HPN+V L G
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
                TQ + + I+ + +  G   +FL      +GP L   + +++  + A G+ YL   
Sbjct: 61  VC---TQKQPIYIVMELVQGGDFLTFLRT----EGPRLKVKELIQMVENAAAGMEYLESK 113

Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHR-----LMTQAGTIEQILDAGVLGYRAPEL 953
             + H +L A N L+   ++  +++D+ + R     +    G ++QI     + + APE 
Sbjct: 114 HCI-HRDLAARNCLVTEKNV-LKISDFGMSREEEDGVYASTGGMKQI----PVKWTAPE- 166

Query: 954 AASKKPHPSFKSDVYAFGVILLE 976
            A      S +SDV++FG++L E
Sbjct: 167 -ALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 9/103 (8%)

Query: 883 KIAVDVARGLNYLHFDRAVPHGNLKATNILLD--GPDLNARVADYCLHRLMTQAGTIEQI 940
           KIAV + + L YLH   +V H ++K +N+L++  G     ++ D+ +   +    ++ + 
Sbjct: 107 KIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG---QVKLCDFGISGYLVD--SVAKT 161

Query: 941 LDAGVLGYRAPEL--AASKKPHPSFKSDVYAFGVILLELLTGR 981
           +DAG   Y APE       +     KSDV++ G+ ++EL TGR
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 19/193 (9%)

Query: 798 ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS-DYI 856
           ++ + + VK L++     RK+F +EA+   N++H ++V    +Y    + + LI+  +Y+
Sbjct: 33  QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV---KFYGVCVEGDPLIMVFEYM 89

Query: 857 SPGSLASFLYDRP------GRKGPP--LTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKA 908
             G L  FL               P  LT +Q L IA  +A G+ YL     V H +L  
Sbjct: 90  KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFV-HRDLAT 148

Query: 909 TNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSD 966
            N L+ G +L  ++ D+ + R +       ++    +L  R   PE    +K   + +SD
Sbjct: 149 RNCLV-GENLLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRK--FTTESD 204

Query: 967 VYAFGVILLELLT 979
           V++ GV+L E+ T
Sbjct: 205 VWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 43/187 (22%)

Query: 810 EGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRP 869
              +  RK+  +E +     R P +V   G +    ++   +  +++  GSL     DR 
Sbjct: 41  GAKSSVRKQILRELQIMHECRSPYIVSFYGAFL--NENNICMCMEFMDCGSL-----DRI 93

Query: 870 GRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR 929
            +KG P+      KIAV V  GL YL+    + H ++K +NIL++               
Sbjct: 94  YKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS-------------- 139

Query: 930 LMTQAGTIEQILDAGVLG---------------YRAPELAASKKPHPSFKSDVYAFGVIL 974
                G I ++ D GV G               Y +PE     K   + KSDV++ G+ +
Sbjct: 140 ----RGQI-KLCDFGVSGELINSIADTFVGTSTYMSPERIQGGK--YTVKSDVWSLGISI 192

Query: 975 LELLTGR 981
           +EL  G+
Sbjct: 193 IELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 10/169 (5%)

Query: 817 KEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEK----LILSDYISPGSLASFL-YDRPGR 871
           ++F  EA       HPNV+ L G      + E     +++  ++  G L SFL Y R G 
Sbjct: 45  EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104

Query: 872 KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM 931
               L     +K   D+A G+ YL     + H +L A N +L+  ++N  VAD+ L + +
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYLSSKSFI-HRDLAARNCMLN-ENMNVCVADFGLSKKI 162

Query: 932 TQAGTIEQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
                  Q   A + + + A E  A +    + KSDV++FGV + E+ T
Sbjct: 163 YNGDYYRQGRIAKMPVKWIAIESLADRVY--TTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 36/220 (16%)

Query: 782 EVLGRSSHGTSYRATLENG---MFLTVKWLREGVAKQ-RKEFAKEAKKFANI-RHPNVVG 836
           +V+G  + G   +A ++     M   +K ++E  +K   ++FA E +    +  HPN++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 837 L------RGYYWGPTQHEKLILSDYISPGSLASFL-----------YDRPGRKGPPLTWA 879
           L      RGY +        +  +Y   G+L  FL           +         L+  
Sbjct: 73  LLGACEHRGYLY--------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124

Query: 880 QRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ 939
           Q L  A DVARG++YL   + + H +L A NIL+ G +  A++AD+ L R   Q   +++
Sbjct: 125 QLLHFAADVARGMDYLSQKQFI-HRDLAARNILV-GENYVAKIADFGLSR--GQEVYVKK 180

Query: 940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            +  G L  R   + +      +  SDV+++GV+L E+++
Sbjct: 181 TM--GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 42/167 (25%), Positives = 86/167 (51%), Gaps = 11/167 (6%)

Query: 814 KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRK 872
           K+++   KE    A ++HPN+V    ++    ++ +L I+ +Y   G L   +  +   +
Sbjct: 41  KEKEASKKEVILLAKMKHPNIVT---FFASFQENGRLFIVMEYCDGGDLMKRINRQ---R 94

Query: 873 GPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT 932
           G   +  Q L   V ++ GL ++H DR + H ++K+ NI L    + A++ D+ + R + 
Sbjct: 95  GVLFSEDQILSWFVQISLGLKHIH-DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153

Query: 933 QAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            +  +      G   Y +PE+  + +P+ + K+D+++ G +L EL T
Sbjct: 154 DSMELAYTC-VGTPYYLSPEICQN-RPYNN-KTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 52.8 bits (127), Expect = 4e-07
 Identities = 35/103 (33%), Positives = 58/103 (56%), Gaps = 9/103 (8%)

Query: 883 KIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLH-RLM-TQAGTIEQI 940
           K+ V + + L+YL     V H ++K +NILLD    N ++ D+ +  RL+ ++A T    
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA-SGNVKLCDFGISGRLVDSKAKT---- 172

Query: 941 LDAGVLGYRAPELAASKKPHPSF--KSDVYAFGVILLELLTGR 981
             AG   Y APE      P+P +  ++DV++ G+ L+EL TG+
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.4 bits (125), Expect = 6e-07
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 13/206 (6%)

Query: 784 LGRSSHGTSYRATLENGMFLTVKWLR--EGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
           +GR ++G  Y+A  ++G       L+  EG         +E      ++HPNV+ L+  +
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQKVF 67

Query: 842 WGPTQHEKLILSDYISPGSLASFLYDRPGR--KGP-PLTWAQRLKIAVDVARGLNYLHFD 898
                 +  +L DY          + R  +  K P  L       +   +  G++YLH +
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127

Query: 899 RAVPHGNLKATNILL--DGPDLN-ARVADYCLHRLMTQAGTIEQILDAGVLG--YRAPEL 953
             V H +LK  NIL+  +GP+    ++AD    RL          LD  V+   YRAPEL
Sbjct: 128 -WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 186

Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
               + H +   D++A G I  ELLT
Sbjct: 187 LLGAR-HYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 51.6 bits (123), Expect = 9e-07
 Identities = 65/228 (28%), Positives = 96/228 (42%), Gaps = 27/228 (11%)

Query: 756 DRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRA-TLENGMFLTVKWLREGVAK 814
           D  V EL F DD     PE+L     E+ G  S G  Y A  + N   + +K +     K
Sbjct: 1   DPDVAELFFKDD-----PEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYS-GK 53

Query: 815 QRKE----FAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPG 870
           Q  E      KE +    +RHPN +  RG Y    +H   ++ +Y   GS +  L     
Sbjct: 54  QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHTAWLVMEYCL-GSASDLLEVHK- 109

Query: 871 RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL 930
               PL   +   +     +GL YLH    + H ++KA NILL  P L  ++ D+    +
Sbjct: 110 ---KPLQEVEIAAVTHGALQGLAYLHSHNMI-HRDVKAGNILLSEPGL-VKLGDFGSASI 164

Query: 931 MTQAGTIEQILDAGVLGYRAPE-LAASKKPHPSFKSDVYAFGVILLEL 977
           M  A         G   + APE + A  +     K DV++ G+  +EL
Sbjct: 165 MAPANXF-----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 51.9 bits (124), Expect = 1e-06
 Identities = 52/152 (34%), Positives = 77/152 (50%), Gaps = 5/152 (3%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNL 147
            + SNLS L  L +S N IS  +P  I    +LE LD+S+N     L S +  L++L  L
Sbjct: 180 KLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS-IIELLSSLSNLKNLSGL 237

Query: 148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIP 207
            L+ NN    +P+S+  L ++++LDLS+N    S   +L  L NL  L+LS N  S  +P
Sbjct: 238 ELS-NNKLEDLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSGNSLSNALP 294

Query: 208 RGFELILGLQVLDFHGNKLDGHLDGEFFLLTN 239
               L+L L++L      L         +L N
Sbjct: 295 LIALLLLLLELLLNLLLTLKALELKLNSILLN 326

Length = 394

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 51.9 bits (124), Expect = 1e-06
 Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 22/174 (12%)

Query: 813 AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRK 872
           A QR   A EA     I HP+++ L+G +    +   LIL  Y +   L  +L  +  R 
Sbjct: 124 AGQRGGTATEAHILRAINHPSIIQLKGTF-TYNKFTCLILPRYKT--DLYCYLAAK--RN 178

Query: 873 GPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT 932
              +     L I   V R + YLH +R + H ++KA NI ++ P       D CL     
Sbjct: 179 ---IAICDILAIERSVLRAIQYLHENRII-HRDIKAENIFINHP------GDVCLGDFGA 228

Query: 933 QAGTIEQILD-----AGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
               ++   +     AG +   APEL A     P+   D+++ G++L E+ T  
Sbjct: 229 ACFPVDINANKYYGWAGTIATNAPELLARDPYGPAV--DIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 24/159 (15%)

Query: 829 IRHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +RHPN+V    YY    ++++L I+ D I    L    ++    K    T  +   I V 
Sbjct: 66  LRHPNIVR---YYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQ 121

Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR-------LMTQAGTIEQI 940
           +   L YLH ++ + H +L   NI+L G D    + D+ L +       L +  GTI   
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML-GEDDKVTITDFGLAKQKQPESKLTSVVGTIL-- 178

Query: 941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
                  Y  PE+  + +P+   K+DV+AFG IL ++ T
Sbjct: 179 -------YSCPEIVKN-EPYGE-KADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 15/201 (7%)

Query: 783 VLGRSSHGTSY---RATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           V+GR + G  +   R   +  + +    + +    +R     E +    + HPN++    
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIE--- 63

Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
           YY    + + L I+ +Y   G+LA ++  R        T    L   V +   L+++H  
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI---LHFFVQILLALHHVH-T 119

Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK 958
           + + H +LK  NILLD   +  ++ D+ + ++++       ++  G   Y +PEL   K 
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPELCEGK- 176

Query: 959 PHPSFKSDVYAFGVILLELLT 979
           P+   KSD++A G +L EL +
Sbjct: 177 PYNQ-KSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 18/211 (8%)

Query: 773 PEELSRAPAEVLGRSSHGTSYRATLENGM--FLTVKWLR-EGVAKQRKEFAKEAKKFANI 829
           PEEL     E +G+ S G  Y+  ++N     + +K +  E    + ++  +E    +  
Sbjct: 2   PEELF-TKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 830 RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
             P +    G Y   T+    I+ +Y+  GS    L  +PG    PL       I  ++ 
Sbjct: 60  DSPYITRYYGSYLKGTK--LWIIMEYLGGGSALDLL--KPG----PLEETYIATILREIL 111

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR 949
           +GL+YLH +R + H ++KA N+LL     + ++AD+ +   +T    I++    G   + 
Sbjct: 112 KGLDYLHSERKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDT-QIKRNTFVGTPFWM 168

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLTG 980
           APE+   K+    FK+D+++ G+  +EL  G
Sbjct: 169 APEVI--KQSAYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.7 bits (124), Expect = 2e-06
 Identities = 41/129 (31%), Positives = 48/129 (37%), Gaps = 44/129 (34%)

Query: 318 LKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGEL 377
           L L N    GFIPND+ K                          +L  +NLS N + G +
Sbjct: 423 LGLDNQGLRGFIPNDISK------------------------LRHLQSINLSGNSIRGNI 458

Query: 378 PLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLS 437
           P   GS   L                    E LDLS N   GSIPE   Q   L  LNL+
Sbjct: 459 PPSLGSITSL--------------------EVLDLSYNSFNGSIPESLGQLTSLRILNLN 498

Query: 438 HNSLSSSLP 446
            NSLS  +P
Sbjct: 499 GNSLSGRVP 507

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.4 bits (123), Expect = 2e-06
 Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 5/87 (5%)

Query: 295 LDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSG 353
           L L    L G +P   + +  LQ + LS N   G IP  L  G    L  LDLS N+ +G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL--GSITSLEVLDLSYNSFNG 480

Query: 354 SV--SMILSTNLHMLNLSSNGLTGELP 378
           S+  S+   T+L +LNL+ N L+G +P
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.2 bits (122), Expect = 2e-06
 Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 43/274 (15%)

Query: 803  LTVKWLRE-GVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKL-ILSDYISPG 859
            + VK L++    K   +   E +    I +H N++ L G     TQ   L +L +Y S G
Sbjct: 47   VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG---ACTQDGPLYVLVEYASKG 103

Query: 860  SLASFLYDR--PGR-------KGP--PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKA 908
            +L  +L  R  PG        K P   LT+   +  A  VARG+ YL   + + H +L A
Sbjct: 104  NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI-HRDLAA 162

Query: 909  TNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-LGYRAPELAASKKPHPSFKSDV 967
             N+L+   ++  ++AD+ L R +      ++  +  + + + APE    +    + +SDV
Sbjct: 163  RNVLVTEDNV-MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDV 219

Query: 968  YAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAE 1027
            ++FGV+L E+ T      +      G+ + +  +L + EGH            M  PA  
Sbjct: 220  WSFGVLLWEIFT------LGGSPYPGIPVEELFKL-LKEGH-----------RMDKPA-- 259

Query: 1028 KGMKEVLGIALRCIRSV-SERPGIKTIYEDLSSI 1060
                E+  I   C  +V S+RP  K + EDL  +
Sbjct: 260  NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 39/172 (22%), Positives = 71/172 (41%), Gaps = 26/172 (15%)

Query: 819 FAKEAKKFANIRHPNVVGLRGYYWG---PTQHEKLILSDYISPGSLASFLYDRPGRKGPP 875
              E K    I   N++ + G+            LIL +Y + G L   L      K   
Sbjct: 65  TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL-EYCTRGYLREVLD-----KEKD 118

Query: 876 LTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG 935
           L++  +L +A+D  +GL  L+     P+ NL + + L+          +Y L  +     
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE--------NYKLKII---CH 167

Query: 936 TIEQIL------DAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            +E+IL      +   + Y + ++        + K D+Y+ GV+L E+ TG+
Sbjct: 168 GLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 45/165 (27%), Positives = 73/165 (44%), Gaps = 29/165 (17%)

Query: 822 EAKKFANIRHPNVVGLRG-YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQ 880
           EA    N+ HP+V+ ++     G      ++L  Y S   L ++L  R      PL   Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITC--MVLPHYSS--DLYTYLTKRSR----PLPIDQ 158

Query: 881 RLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL-------MTQ 933
            L I   +  GL YLH  R + H ++K  NI ++  D    + D    +        +  
Sbjct: 159 ALIIEKQILEGLRYLHAQRII-HRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGL 216

Query: 934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELL 978
           AGT+E           APE+ A  K +   K+D+++ G++L E+L
Sbjct: 217 AGTVET---------NAPEVLARDKYNS--KADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 6/97 (6%)

Query: 885 AVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG 944
           A  +  GL +LH  R + + +LK  N+LLD    N R++D  L   +     I+    AG
Sbjct: 101 AAQIICGLEHLH-QRRIVYRDLKPENVLLDD-HGNVRISDLGLAVELKGGKKIKG--RAG 156

Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             GY APE+   +     F  D +A G  L E++ GR
Sbjct: 157 TPGYMAPEVL--QGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.2 bits (108), Expect = 3e-06
 Identities = 25/60 (41%), Positives = 35/60 (58%)

Query: 502 NLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHF 561
           NL+ LDLS+NRL          L  LKVL L+GNN++   P + + + SL SL +S N+ 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 49.5 bits (119), Expect = 3e-06
 Identities = 48/150 (32%), Positives = 68/150 (45%), Gaps = 15/150 (10%)

Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           +PN + L  YY   T    +++ DYI  G L   L     +K   L+ A+  KI   +  
Sbjct: 68  NPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFDLL-----KKEGKLSEAEVKKIIRQLVE 120

Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRA 950
            LN LH    + H ++K  N+L D       + DY L +++   GT     D G L Y +
Sbjct: 121 ALNDLHKHNII-HNDIKLENVLYDRAKDRIYLCDYGLCKII---GT-PSCYD-GTLDYFS 174

Query: 951 PELAASKKPHPSFKSDVYAFGVILLELLTG 980
           PE         SF  D +A GV+  ELLTG
Sbjct: 175 PEKIKGHNYDVSF--DWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 50.6 bits (121), Expect = 4e-06
 Identities = 27/91 (29%), Positives = 47/91 (51%), Gaps = 22/91 (24%)

Query: 506 LDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPL 565
           L L +  L G+ P+ +  L  L+ + L+GN+I G++P S+ ++TSL  L           
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL----------- 471

Query: 566 PNNLPNSLETFNVSYNDFSGAVPENLRKFPS 596
                      ++SYN F+G++PE+L +  S
Sbjct: 472 -----------DLSYNSFNGSIPESLGQLTS 491

Length = 623

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 49.2 bits (118), Expect = 4e-06
 Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 6/98 (6%)

Query: 884 IAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA 943
              ++   L YLH  + + H ++K  NILLD    +  + D+ +   +T          +
Sbjct: 105 WICEIVLALEYLH-SKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTST--S 160

Query: 944 GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           G  GY APE+   +    S   D ++ GV   E L G+
Sbjct: 161 GTPGYMAPEVLCRQGY--SVAVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 10/159 (6%)

Query: 821 KEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQ 880
           KEA   A ++HPN+V  +  +         I+ +Y   G L   +  + G+  P  T  Q
Sbjct: 47  KEAVLLAKMKHPNIVAFKESFEA--DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQ 104

Query: 881 RLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI 940
                V +  G+ ++H ++ V H ++K+ NI L   +   ++ D+   RL+T  G     
Sbjct: 105 WF---VQMCLGVQHIH-EKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACT 159

Query: 941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
              G   Y  PE+  +  P+ + KSD+++ G IL EL T
Sbjct: 160 Y-VGTPYYVPPEIWEN-MPYNN-KSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 49.3 bits (118), Expect = 5e-06
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 31/211 (14%)

Query: 783 VLGRSSHGTSYRATLEN-GMFLTVKWLREGVAKQRKEF---AKEAKKFANI-RHPNVVGL 837
           VLG+ S G    A L+       VK L++ V  Q  +      E +  A   +HP +  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
              +   T+     + +Y++ G L  F   R GR        +    A ++  GL +LH 
Sbjct: 62  HSCF--QTKDRLFFVMEYVNGGDLM-FHIQRSGR----FDEPRARFYAAEIVLGLQFLH- 113

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA-------GVLGYRA 950
           +R + + +LK  N+LLD  + + ++AD+ + +        E IL         G   Y A
Sbjct: 114 ERGIIYRDLKLDNVLLDS-EGHIKIADFGMCK--------EGILGGVTTSTFCGTPDYIA 164

Query: 951 PELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           PE+ + +   P+   D +A GV+L E+L G+
Sbjct: 165 PEILSYQPYGPAV--DWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 49.3 bits (117), Expect = 6e-06
 Identities = 61/246 (24%), Positives = 110/246 (44%), Gaps = 43/246 (17%)

Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +            +T
Sbjct: 79   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135

Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     VARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 136  FKDLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVTENNV-MKIADFGLARDVNNIDYY 193

Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV++ E+ T       + G    G+ 
Sbjct: 194  KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT-------LGGSPYPGIP 244

Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  PA      E+  +   C  ++ S RP  K + 
Sbjct: 245  VEELFKL-LKEGH-----------RMDKPA--NCTNELYMMMRDCWHAIPSHRPTFKQLV 290

Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 291  EDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 48.8 bits (116), Expect = 6e-06
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 26/213 (12%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWL------REGVAKQRKEFAKEAKKFANIRHPNVV 835
           EVLG+ ++GT Y      G  + VK +           K+ ++  +E     +++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 836 GLRGYYWGPTQHEKL--ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLN 893
                Y G    +    I  +++  GS++S L +R G    PL      K    +  G+ 
Sbjct: 66  Q----YLGTCLDDNTISIFMEFVPGGSISSIL-NRFG----PLPEPVFCKYTKQILDGVA 116

Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRL--MTQAGTIEQILDA--GVLGY 948
           YLH +  V H ++K  N++L  P+   ++ D+ C  RL  +   GT   +L +  G   +
Sbjct: 117 YLH-NNCVVHRDIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            APE+    +     KSD+++ G  + E+ TG+
Sbjct: 175 MAPEVI--NESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 49.2 bits (117), Expect = 6e-06
 Identities = 42/163 (25%), Positives = 81/163 (49%), Gaps = 20/163 (12%)

Query: 830 RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFL-----------YDRPGRKGPPLT 877
           +H N++ L G     TQ   L ++ +Y + G+L  FL           +D        L+
Sbjct: 76  KHKNIINLLGVC---TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132

Query: 878 WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
           +   +  A  VARG+ YL   R + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVTEDNV-MKIADFGLARGVHDIDYY 190

Query: 938 EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           ++  +  + + + APE A   + + + +SDV++FG+++ E+ T
Sbjct: 191 KKTSNGRLPVKWMAPE-ALFDRVY-THQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 48.7 bits (117), Expect = 7e-06
 Identities = 48/160 (30%), Positives = 70/160 (43%), Gaps = 31/160 (19%)

Query: 829 IRHPNVVGLRGYYWGPTQHEK---LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIA 885
           IRHP +V      +G  Q +    L++ +Y+  G L S L  + GR   P   A+    A
Sbjct: 58  IRHPFLV----NLYGSFQDDSNLYLVM-EYVPGGELFSHL-RKSGR--FPEPVARFY--A 107

Query: 886 VDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVAD-----YCLHRLMTQAGTIEQI 940
             V   L YLH    + + +LK  N+LLD  D   ++ D         R  T  GT E  
Sbjct: 108 AQVVLALEYLH-SLDIVYRDLKPENLLLDS-DGYIKITDFGFAKRVKGRTYTLCGTPE-- 163

Query: 941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
                  Y APE+  SK  +     D +A G+++ E+L G
Sbjct: 164 -------YLAPEIILSK-GY-GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 7e-06
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 23/204 (11%)

Query: 782 EVLGRSSHGTSYRA-TLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           + +G  ++G  Y+A  +  G  + +K ++       +   +E       RHPN+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           Y    + +  I+ +Y   GSL   +Y        PL+  Q   +  +  +GL YLH +  
Sbjct: 69  YLR--RDKLWIVMEYCGGGSLQD-IYQVTRG---PLSELQIAYVCRETLKGLAYLH-ETG 121

Query: 901 VPHGNLKATNILL--DGPDLNARVADYCLHRLMTQAGTIEQ----ILDAGVLGYRAPELA 954
             H ++K  NILL  DG   + ++AD+ +   +T   TI +    I   G   + APE+A
Sbjct: 122 KIHRDIKGANILLTEDG---DVKLADFGVSAQLTA--TIAKRKSFI---GTPYWMAPEVA 173

Query: 955 ASKKPHP-SFKSDVYAFGVILLEL 977
           A ++      K D++A G+  +EL
Sbjct: 174 AVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 48.4 bits (116), Expect = 7e-06
 Identities = 46/211 (21%), Positives = 82/211 (38%), Gaps = 20/211 (9%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLR 838
           E +G+ S GT  +     +G  L  K +  G    K++++   E      ++HPN+V   
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF- 897
                 +     I+ +Y   G LA  +  +  ++   +      +I   +   L   H  
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKERKYIEEEFIWRILTQLLLALYECHNR 124

Query: 898 ---DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ----AGTIEQILDAGVLGYRA 950
                 V H +LK  NI LD  + N ++ D+ L +++      A T       G   Y +
Sbjct: 125 SDPGNTVLHRDLKPANIFLDA-NNNVKLGDFGLAKILGHDSSFAKTY-----VGTPYYMS 178

Query: 951 PELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           PE           KSD+++ G ++ EL    
Sbjct: 179 PEQLNHMSYDE--KSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 27/218 (12%)

Query: 782 EVLGRSSHGTSYRATL------ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNV 834
           E LG    G  Y+  L      E    + +K L++      R+EF  EA   + ++HPN+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 835 VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKG-----------PPLTWAQRLK 883
           V L G      Q   +I S Y S   L  FL  R                  L  A  + 
Sbjct: 71  VCLLGVV-TKEQPLSMIFS-YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128

Query: 884 IAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA 943
           I   +A G+ +L     V H +L   N+L+    LN +++D  L R    A    +++  
Sbjct: 129 IVTQIAAGMEFLS-SHHVVHKDLATRNVLV-FDKLNVKISDLGLFR-EVYAADYYKLMGN 185

Query: 944 GVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
            +L  R  +PE     K   S  SD++++GV+L E+ +
Sbjct: 186 SLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 48.9 bits (116), Expect = 7e-06
 Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 27/231 (11%)

Query: 752 VRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRA----TLENGMFLTVKW 807
           ++ P+  + EL F +D     PE+L     E+ G  S G  Y A    T E      + +
Sbjct: 9   LKDPE--IAELFFKED-----PEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSY 60

Query: 808 LREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYD 867
             +   ++ ++  KE K    I+HPN +  +G Y    +H   ++ +Y   GS +  L  
Sbjct: 61  SGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL--REHTAWLVMEYCL-GSASDLLEV 117

Query: 868 RPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL 927
                  PL   +   I     +GL YLH    + H ++KA NILL  P    ++AD+  
Sbjct: 118 HK----KPLQEVEIAAITHGALQGLAYLHSHNMI-HRDIKAGNILLTEPG-QVKLADFGS 171

Query: 928 HRLMTQAGTIEQILDAGVLGYRAPE-LAASKKPHPSFKSDVYAFGVILLEL 977
             + + A +       G   + APE + A  +     K DV++ G+  +EL
Sbjct: 172 ASIASPANSF-----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.1 bits (105), Expect = 8e-06
 Identities = 27/61 (44%), Positives = 36/61 (59%), Gaps = 2/61 (3%)

Query: 406 NIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNH 464
           N++ LDLS N LT  IP+   + L  L  L+LS N+L+S  P+       LR LDLS N+
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 465 L 465
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.1 bits (105), Expect = 8e-06
 Identities = 19/58 (32%), Positives = 34/58 (58%)

Query: 143 SLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN 200
           +L++L L+ N  + +   +  GL +++ LDLS N+ +   P A + L +L  L+LS N
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 48.9 bits (116), Expect = 8e-06
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 12/157 (7%)

Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           HP +VGL   +   T+     + +Y++ G L   ++    ++  P   A+     + +A 
Sbjct: 55  HPFLVGLHSCF--QTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA- 108

Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRA 950
            LNYLH +R + + +LK  N+LLD  + + ++ DY + +   + G        G   Y A
Sbjct: 109 -LNYLH-ERGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTF-CGTPNYIA 164

Query: 951 PELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI 987
           PE+   +     F  D +A GV++ E++ GR   D++
Sbjct: 165 PEILRGEDY--GFSVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 48.6 bits (116), Expect = 9e-06
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 27/173 (15%)

Query: 816 RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP 875
           R +  +E K       P +VG  G ++  +  E  I  +++  GSL   L  +   + P 
Sbjct: 43  RNQIIRELKVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL--KKAGRIPE 98

Query: 876 LTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG 935
                  KI++ V RGL YL     + H ++K +NIL++      ++ D+         G
Sbjct: 99  NILG---KISIAVLRGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDF---------G 145

Query: 936 TIEQILDA------GVLGYRAPE-LAASKKPHPSFKSDVYAFGVILLELLTGR 981
              Q++D+      G   Y +PE L  +   H + +SD+++ G+ L+E+  GR
Sbjct: 146 VSGQLIDSMANSFVGTRSYMSPERLQGT---HYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.6 bits (116), Expect = 9e-06
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 4/94 (4%)

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG-- 947
           RGL Y+H    V H +LK  N+ ++  DL  ++ D+ L R++    + +  L  G++   
Sbjct: 125 RGLKYIH-SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183

Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           YR+P L  S   + +   D++A G I  E+LTG+
Sbjct: 184 YRSPRLLLSPN-NYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 48.4 bits (115), Expect = 9e-06
 Identities = 51/187 (27%), Positives = 87/187 (46%), Gaps = 14/187 (7%)

Query: 801 MFLTVKWLREGVAKQ-RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG 859
           + + VK LRE   K  R +F KE K  + ++ PN++ L       T     ++++Y+  G
Sbjct: 47  VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVC--ITSDPLCMITEYMENG 104

Query: 860 SLASFLYDRPGRKGPP-------LTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNIL 912
            L  FL  R   +          ++++  + +A  +A G+ YL     V H +L   N L
Sbjct: 105 DLNQFL-SRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFV-HRDLATRNCL 162

Query: 913 LDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGV 972
           + G +   ++AD+ + R +  +G   +I    VL  R     +      +  SDV+AFGV
Sbjct: 163 V-GKNYTIKIADFGMSRNL-YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220

Query: 973 ILLELLT 979
            L E+LT
Sbjct: 221 TLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 48.7 bits (117), Expect = 1e-05
 Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 15/100 (15%)

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG-- 947
           + L Y+H    V H +LK +NILL+  D   ++AD+ L R +++   +E+  +  VL   
Sbjct: 118 KALKYIH-SGNVIHRDLKPSNILLNS-DCRVKLADFGLARSLSE---LEENPENPVLTDY 172

Query: 948 -----YRAPE-LAASKKPHPSFKSDVYAFGVILLELLTGR 981
                YRAPE L  S     +   D+++ G IL E+L G+
Sbjct: 173 VATRWYRAPEILLGST--RYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.4 bits (118), Expect = 1e-05
 Identities = 54/210 (25%), Positives = 73/210 (34%), Gaps = 75/210 (35%)

Query: 816 RKEFAKEAKKFANIRHPNVV--------GLRGYYWGPTQHEKLILSDYISPGSLASFLYD 867
           +K F +EAK  A++ HP +V        G   YY  P          YI   +L S L  
Sbjct: 46  KKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP----------YIEGYTLKSLLKS 95

Query: 868 RPGRKGPPLTWAQR---------------LKIAVDVARGLNYLHFDRAVPHGNLKATNIL 912
                     W +                L I   +   + Y+H  + V H +LK  NIL
Sbjct: 96  ---------VWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH-SKGVLHRDLKPDNIL 145

Query: 913 L----------------------DGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRA 950
           L                      D  D++    + C    MT  G I      G   Y A
Sbjct: 146 LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS-MTIPGKI-----VGTPDYMA 199

Query: 951 PELAASKKPHP-SFKSDVYAFGVILLELLT 979
           PE        P S  +D+YA GVIL ++LT
Sbjct: 200 PE---RLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 48.0 bits (115), Expect = 1e-05
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 37/212 (17%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFA-KEAKKFANIRHPNVVG--- 836
           E +G  + G  Y+AT    G  + +K +R  + KQ KE    E     + +HPN+V    
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMR--LRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 837 ---LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLN 893
              +    W        ++ +Y+  GSL   +     +    +   Q   +  +V +GL 
Sbjct: 83  SYLVGDELW--------VVMEYMDGGSLTDIIT----QNFVRMNEPQIAYVCREVLQGLE 130

Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVAD--YCLHRLMTQAGTIEQILDAGVLG---Y 948
           YLH    V H ++K+ NILL   D + ++AD  +       Q  T E+     V+G   +
Sbjct: 131 YLHSQN-VIHRDIKSDNILL-SKDGSVKLADFGFA-----AQ-LTKEKSKRNSVVGTPYW 182

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            APE+   +K +   K D+++ G++ +E+  G
Sbjct: 183 MAPEVI-KRKDY-GPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 43/172 (25%), Positives = 79/172 (45%), Gaps = 25/172 (14%)

Query: 816 RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP 875
           R +  +E +       P +VG  G ++  +  E  I  +++  GSL   L  +  ++ P 
Sbjct: 47  RNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL--KEAKRIPE 102

Query: 876 LTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG 935
                  K+++ V RGL YL     + H ++K +NIL++      ++ D+         G
Sbjct: 103 EILG---KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDF---------G 149

Query: 936 TIEQILDA------GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
              Q++D+      G   Y +PE    +  H S +SD+++ G+ L+EL  GR
Sbjct: 150 VSGQLIDSMANSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 37/203 (18%)

Query: 803 LTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLIL-SDYISPGS 860
           + VK L+E  +  + ++   E      + HP+V+ L G     +Q   L+L  +Y   GS
Sbjct: 33  VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYG---ACSQDGPLLLIVEYAKYGS 89

Query: 861 LASFLYDRPGRK-GP--------------------PLTWAQRLKIAVDVARGLNYLHFDR 899
           L SFL  R  RK GP                     LT    +  A  ++RG+ YL   +
Sbjct: 90  LRSFL--RESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK 147

Query: 900 AVPHGNLKATNILL-DGPDLNARVADYCLHR-LMTQAGTIEQILDAGVLGYRAPELAASK 957
            V H +L A N+L+ +G  +  +++D+ L R +  +   +++      + + A E   S 
Sbjct: 148 LV-HRDLAARNVLVAEGRKM--KISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIE---SL 201

Query: 958 KPHP-SFKSDVYAFGVILLELLT 979
             H  + +SDV++FGV+L E++T
Sbjct: 202 FDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 2e-05
 Identities = 23/60 (38%), Positives = 38/60 (63%)

Query: 119 SLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF 178
           +L+ LD+S+N  +         L +L+ L L+GNN + + P++ SGL S++SLDLS N+ 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 21/206 (10%)

Query: 782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKE----FAKEAKKFANIRHPNVVG 836
           +V+G+ S G    A  + +G    VK L++ +   RKE     A+      N++HP +VG
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKI-AVDVARGLNYL 895
           L  +Y   T  +   + D+++ G L  F + +  R  P      R +  A ++A  L YL
Sbjct: 61  L--HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFP----EPRARFYAAEIASALGYL 112

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL-MTQAGTIEQILDAGVLGYRAPELA 954
           H    V + +LK  NILLD    +  + D+ L +  + Q+ T       G   Y APE+ 
Sbjct: 113 HSINIV-YRDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTTF--CGTPEYLAPEV- 167

Query: 955 ASKKPHPSFKSDVYAFGVILLELLTG 980
             K+P+ +   D +  G +L E+L G
Sbjct: 168 IRKQPYDN-TVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 49/216 (22%), Positives = 97/216 (44%), Gaps = 39/216 (18%)

Query: 783 VLGRSSHGTSYRA-TLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
           VLG+ ++G  Y A  L   + + +K + E  ++  +   +E    + ++H N+V     Y
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIV----QY 70

Query: 842 WGPTQHEK--LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKI--AVDVARGLNYLHF 897
            G         I  + +  GSL++ L  + G    PL   ++  I     +  GL YLH 
Sbjct: 71  LGSDSENGFFKIFMEQVPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLH- 125

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLM--------TQAGTIE----QILDAGV 945
           D  + H ++K  N+L++      +++D+   + +        T  GT++    +++D G 
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGP 185

Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            GY AP             +D+++ G  ++E+ TG+
Sbjct: 186 RGYGAP-------------ADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 10/132 (7%)

Query: 850 LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKAT 909
           LIL DY++ G L + LY R            R+ IA ++   L++LH    + + ++K  
Sbjct: 82  LIL-DYVNGGELFTHLYQREHFTES----EVRVYIA-EIVLALDHLH-QLGIIYRDIKLE 134

Query: 910 NILLDGPDLNARVADYCLHRLMTQAGTIEQILD-AGVLGYRAPELAASKKPHPSFKSDVY 968
           NILLD  + +  + D+ L +    A   E+     G + Y APE+            D +
Sbjct: 135 NILLDS-EGHVVLTDFGLSKEFL-AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWW 192

Query: 969 AFGVILLELLTG 980
           + GV+  ELLTG
Sbjct: 193 SLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 27/231 (11%)

Query: 752 VRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRAT--LENGMFLTVKWLR 809
           V+ P+  + +L + DD     PEE+     E+ G  S G  Y AT    N +    K   
Sbjct: 5   VKDPE--IADLFYKDD-----PEEIFVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMSY 56

Query: 810 EGVAKQRK--EFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYD 867
            G     K  +  KE K    ++HPN +  +G Y    +H   ++ +Y   GS +  L  
Sbjct: 57  SGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL--KEHTAWLVMEYCL-GSASDLLEV 113

Query: 868 RPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL 927
                  PL   +   I     +GL YLH    + H ++KA NILL  P    ++AD+  
Sbjct: 114 HK----KPLQEVEIAAITHGALQGLAYLH-SHNMIHRDIKAGNILLTEPG-QVKLADFGS 167

Query: 928 HRLMTQAGTIEQILDAGVLGYRAPE-LAASKKPHPSFKSDVYAFGVILLEL 977
               + A +       G   + APE + A  +     K DV++ G+  +EL
Sbjct: 168 ASKSSPANSF-----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 42/158 (26%), Positives = 75/158 (47%), Gaps = 12/158 (7%)

Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           +P +VGL   +   T     ++ +Y++ G L    + +  RK P          A ++  
Sbjct: 55  NPFLVGLHSCF--QTTSRLFLVIEYVNGGDL--MFHMQRQRKLPE---EHARFYAAEICI 107

Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRA 950
            LN+LH +R + + +LK  N+LLD  D + ++ DY + +     G        G   Y A
Sbjct: 108 ALNFLH-ERGIIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGPGDTTSTF-CGTPNYIA 164

Query: 951 PELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVIS 988
           PE+   ++    F  D +A GV++ E++ GR   D+I+
Sbjct: 165 PEILRGEEY--GFSVDWWALGVLMFEMMAGRSPFDIIT 200

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 47.0 bits (112), Expect = 3e-05
 Identities = 66/279 (23%), Positives = 96/279 (34%), Gaps = 75/279 (26%)

Query: 180 GSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELIL---GLQVLDFHGNKLDGHLDGEFFL 236
            SL   LT+   L  L+LS N          E +L    LQ L  + N L          
Sbjct: 71  QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGD-------- 122

Query: 237 LTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVN--GGELQLFENLKV 294
                     G   +       L  L  +++ L L  N+L G+        L+   +LK 
Sbjct: 123 ---------RGLRLLAKG----LKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKE 169

Query: 295 LDLSYNQLTGE-----LPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLL--------- 340
           L+L+ N +          G      L+VL L+NN        D  +G S L         
Sbjct: 170 LNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGL-----TD--EGASALAETLASLKS 222

Query: 341 LTDLDLSANNLSG-------SVSMILSTNLHMLNLSSNGLTG-----------ELPLLTG 382
           L  L+L  NNL+        S  +  + +L  L+LS N +T            E   L  
Sbjct: 223 LEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLL- 281

Query: 383 SCAVLDLSNNQF--EGN----LSRILKWGNIEYLDLSRN 415
               LDL  N+F  EG      S +     +E L +  +
Sbjct: 282 ---ELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDD 317

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.1 bits (100), Expect = 3e-05
 Identities = 24/59 (40%), Positives = 35/59 (59%)

Query: 479 LQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNI 537
           L+ L L++N LT + D +   + NL+VLDLS N L    P+    L  L+ L L+GNN+
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 46.8 bits (112), Expect = 3e-05
 Identities = 34/107 (31%), Positives = 47/107 (43%), Gaps = 24/107 (22%)

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL-------HRLMT-QAGTIEQIL 941
           RGL YLH    + H +LK  N+L+   D   ++AD+ L       +R MT Q  T     
Sbjct: 113 RGLEYLH-SNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVT----- 165

Query: 942 DAGVLGYRAPELA-ASKKPHPSFKSDVYAFGVILLELLTGR--CAGD 985
                 YRAPEL   ++        D+++ G I  ELL       GD
Sbjct: 166 ----RWYRAPELLFGARHYGVGV--DMWSVGCIFAELLLRVPFLPGD 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 16/207 (7%)

Query: 784 LGRSSHGTSYRATLENGMFLT---VKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRG 839
           +G    G         GM      VK LR      ++  F +E + +  + HPNV+   G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLY-DRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
                  +  L++ ++   G L ++L  +R              ++A +VA GL +LH  
Sbjct: 63  QCIESIPY--LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVL-QRMACEVASGLLWLHQA 119

Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCL-HRLMTQAGTIEQILDAGVLGYRAPELAAS- 956
             + H +L   N  L   DL+ ++ DY L      +   I +   A  L + APEL    
Sbjct: 120 DFI-HSDLALRNCQLTA-DLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 957 ----KKPHPSFKSDVYAFGVILLELLT 979
                    + KS++++ GV + EL T
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 46.7 bits (112), Expect = 3e-05
 Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 19/158 (12%)

Query: 828 NIRHPNVVGLRGYYWGPTQHEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV 886
            ++HPN+V L           KL L  +Y     L  +L  RPG    PL+      I  
Sbjct: 54  ELKHPNIVKLLDVI---HTERKLYLVFEYCDM-DLKKYLDKRPG----PLSPNLIKSIMY 105

Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT---QAGTIEQILDA 943
            + RGL Y H    + H +LK  NIL++  D   ++AD+ L R      +  T E +   
Sbjct: 106 QLLRGLAYCH-SHRILHRDLKPQNILINR-DGVLKLADFGLARAFGIPLRTYTHEVVT-- 161

Query: 944 GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             L YRAPE+    K + S   D+++ G I  E++TG+
Sbjct: 162 --LWYRAPEILLGSKHY-STAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 18/211 (8%)

Query: 773 PEELSRAPAEVLGRSSHGTSYRATLENGM--FLTVKWLR-EGVAKQRKEFAKEAKKFANI 829
           PEEL     E +G+ S G  ++  ++N     + +K +  E    + ++  +E    +  
Sbjct: 2   PEELF-TKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 830 RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
             P V    G Y   T+    I+ +Y+  GS    L   PG    PL   Q   I  ++ 
Sbjct: 60  DSPYVTKYYGSYLKDTK--LWIIMEYLGGGSALDLL--EPG----PLDETQIATILREIL 111

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR 949
           +GL+YLH ++ + H ++KA N+LL       ++AD+ +   +T    I++    G   + 
Sbjct: 112 KGLDYLHSEKKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDT-QIKRNTFVGTPFWM 168

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLTG 980
           APE+   K+     K+D+++ G+  +EL  G
Sbjct: 169 APEVI--KQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 46.5 bits (110), Expect = 4e-05
 Identities = 65/246 (26%), Positives = 111/246 (45%), Gaps = 43/246 (17%)

Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---GPPLTWAQRLK 883
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +    P     ++L 
Sbjct: 82   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138

Query: 884  I------AVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
                   A  VARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 139  FKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 196

Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV+L E+ T       + G    GV 
Sbjct: 197  KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT-------LGGSPYPGVP 247

Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH  D       P          M++       C  +V S+RP  K + 
Sbjct: 248  VEELFKL-LKEGHRMD------KPSNCTNELYMMMRD-------CWHAVPSQRPTFKQLV 293

Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 294  EDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 46.4 bits (110), Expect = 5e-05
 Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 31/176 (17%)

Query: 816 RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQH--EKLILSDYISPGSLASFLYDRPGRKG 873
           R++  +E +   ++ HPNVV     +     H  E  +L +++  GSL        G   
Sbjct: 116 RRQICREIEILRDVNHPNVVKCHDMF----DHNGEIQVLLEFMDGGSLE-------GTH- 163

Query: 874 PPLTWAQRLKIAVDVAR----GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR 929
                A    +A DVAR    G+ YLH  R + H ++K +N+L++    N ++AD+ + R
Sbjct: 164 ----IADEQFLA-DVARQILSGIAYLH-RRHIVHRDIKPSNLLINSAK-NVKIADFGVSR 216

Query: 930 LMTQAGTIEQILDA-GVLGYRAPELAASKKPHPSFKS---DVYAFGVILLELLTGR 981
           ++ Q  T++    + G + Y +PE   +   H ++     D+++ GV +LE   GR
Sbjct: 217 ILAQ--TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 21/210 (10%)

Query: 784 LGRSSHGTSYRATL------ENGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVG 836
           LG+ S G  Y          E    + +K + E  + ++R EF  EA         +VV 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLY-------DRPGRKGPPLTWAQRLKIAVDVA 889
           L G          L++ + ++ G L S+L        + P +  P L   + +++A ++A
Sbjct: 74  LLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK--KMIQMAGEIA 129

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR 949
            G+ YL+ ++ V H +L A N ++   D   ++ D+ + R + +     +    G+L  R
Sbjct: 130 DGMAYLNANKFV-HRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRK-GGKGLLPVR 186

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLT 979
                + K    +  SDV++FGV+L E+ T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.7 bits (111), Expect = 6e-05
 Identities = 28/93 (30%), Positives = 42/93 (45%)

Query: 160 DSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVL 219
           DS  G   I  L L +    G +P  +++L +L  +NLS N     IP     I  L+VL
Sbjct: 412 DSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL 471

Query: 220 DFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVG 252
           D   N  +G +      LT+   ++ +GN   G
Sbjct: 472 DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG 504

Length = 623

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 45.8 bits (108), Expect = 1e-04
 Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 26/204 (12%)

Query: 249 MFVGSSSQKFLPG-LSQSVQYLNLSLNQLTGSLVNGGEL--QLFENLKVLDLSYNQLTGE 305
           ++  S+    +P  L  ++Q + LS+N++T       EL  +L   L+ LDL +N+++  
Sbjct: 225 LYANSNQLTSIPATLPDTIQEMELSINRIT-------ELPERLPSALQSLDLFHNKISC- 276

Query: 306 LPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHM 365
           LP  N   EL+ L + +N     +P  L  G    +T L++ +N+L+ ++   L   L  
Sbjct: 277 LPE-NLPEELRYLSVYDNSIRT-LPAHLPSG----ITHLNVQSNSLT-ALPETLPPGLKT 329

Query: 366 LNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEET 425
           L    N LT     L     VLD+S NQ    L   L    I  LD+SRN LT ++PE  
Sbjct: 330 LEAGENALTSLPASLPPELQVLDVSKNQIT-VLPETLP-PTITTLDVSRNALT-NLPENL 386

Query: 426 PQFLRLNHLNLSHNSLS---SSLP 446
           P  L++  +  S N+L     SLP
Sbjct: 387 PAALQI--MQASRNNLVRLPESLP 408

Length = 754

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 45.5 bits (108), Expect = 1e-04
 Identities = 32/96 (33%), Positives = 45/96 (46%), Gaps = 8/96 (8%)

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ--AGTIEQILDAGVLG 947
           R L Y+H    V H +LK  NIL +  D   ++ D+ L R+        I          
Sbjct: 114 RALKYIH-TANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 948 YRAPELAAS--KKPHPSFKSDVYAFGVILLELLTGR 981
           YRAPEL  S   K  P+   D+++ G I  E+LTG+
Sbjct: 172 YRAPELCGSFFSKYTPAI--DIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 48/211 (22%), Positives = 87/211 (41%), Gaps = 34/211 (16%)

Query: 784 LGRSSHGTSYRA-TLENGMFLTVKWLR-----EGVAKQRKEFAKEAKKFANIRHPNVVGL 837
           +G  ++G  Y+A     G  + +K ++     EG+ K      +E K    + HPN++ L
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA---LREIKLLKELNHPNIIKL 63

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
              +        L+  +++    L   + DR       L  +        + +GL + H 
Sbjct: 64  LDVF-RHKGDLYLVF-EFMDT-DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCL-------HRLMTQAGTIEQILDAGVLGYRA 950
              + H +LK  N+L++   +  ++AD+ L        R  T       ++      YRA
Sbjct: 117 HGIL-HRDLKPENLLINTEGV-LKLADFGLARSFGSPVRPYT-----HYVV---TRWYRA 166

Query: 951 PELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           PEL    K + S   D+++ G I  ELL+ R
Sbjct: 167 PELLLGDKGY-STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 44.5 bits (106), Expect = 1e-04
 Identities = 53/228 (23%), Positives = 87/228 (38%), Gaps = 43/228 (18%)

Query: 782 EVLGRSSHGTSYRATL-ENGMFLTVKWL-REGVAKQRKEFA----KEAKKFANIRHPNVV 835
           +++G  S  T   A   E      +K L +  + K++K       KE     N  HP ++
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-GHPGII 65

Query: 836 GLRGYYWGPTQH--EKLILS-DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGL 892
            L  YY   T    E L    +Y   G L  ++              +    A ++   L
Sbjct: 66  KL--YY---TFQDEENLYFVLEYAPNGELLQYIRKYGSL---DEKCTRF--YAAEILLAL 115

Query: 893 NYLHFDRAVPHGNLKATNILLDGPDLNARVADY----CLHR-LMTQAGTIEQILDA---- 943
            YLH  + + H +LK  NILLD  D++ ++ D+     L      ++   +         
Sbjct: 116 EYLH-SKGIIHRDLKPENILLDK-DMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 944 ----------GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                     G   Y +PEL   K       SD++A G I+ ++LTG+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 24/216 (11%)

Query: 771 LTPEELSRAPAEVLGRSSHGTSYRA-TLENGMFLTVKWLREGVAKQRKEFAKEAKKFANI 829
           L P E+     E LG  + G  Y+A   E G     K +     ++ +++  E +  A  
Sbjct: 8   LDPNEVWEIIGE-LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC 66

Query: 830 RHPNVVGLRG-YYWGPTQHEKLILSDYISPGSLASFLY--DRPGRKGPPLTWAQRLKIAV 886
            HP +V L G +YW     +  I+ ++   G++ + +   DR       LT  Q   I  
Sbjct: 67  NHPYIVKLLGAFYW---DGKLWIMIEFCPGGAVDAIMLELDRG------LTEPQIQVICR 117

Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA--G 944
            +   L YLH  + + H +LKA N+LL   D + ++AD+ +     +     Q  D+  G
Sbjct: 118 QMLEALQYLHSMKII-HRDLKAGNVLLT-LDGDIKLADFGVSAKNVKT---LQRRDSFIG 172

Query: 945 VLGYRAPE--LAASKKPHP-SFKSDVYAFGVILLEL 977
              + APE  +  + K  P  +K+D+++ G+ L+E+
Sbjct: 173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 33/212 (15%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR-----EGVAKQRKEFAKEAKKFANIRH---P 832
           E++GR ++G  YR   +  G  + +K +      + V+  ++E A      + +R    P
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVAL----LSQLRQSQPP 62

Query: 833 NVVGLRGYYW-GPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV---DV 888
           N+    G Y  GP      I+ +Y   GS+ + +     + GP         I+V   +V
Sbjct: 63  NITKYYGSYLKGPRL---WIIMEYAEGGSVRTLM-----KAGP----IAEKYISVIIREV 110

Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
              L Y+H    V H ++KA NIL+     N ++ D+ +  L+ Q  + ++    G   +
Sbjct: 111 LVALKYIHKV-GVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQ-NSSKRSTFVGTPYW 167

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            APE+    K +   K+D+++ G+ + E+ TG
Sbjct: 168 MAPEVITEGKYY-DTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 44.5 bits (106), Expect = 2e-04
 Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 21/160 (13%)

Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            ++HPN+V ++    G    +  ++ +Y+    L S +         P   ++   + + 
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQ 114

Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR----VADYCLHRLMTQAGTIEQILDA 943
           +  G+ +LH D  + H +LK +N+LL     N R    + D+ L R   + G+  +    
Sbjct: 115 LLSGVAHLH-DNWILHRDLKTSNLLL-----NNRGILKICDFGLAR---EYGSPLKPYTQ 165

Query: 944 GV--LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            V  L YRAPEL    K + S   D+++ G I  ELLT +
Sbjct: 166 LVVTLWYRAPELLLGAKEY-STAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 65/230 (28%), Positives = 99/230 (43%), Gaps = 31/230 (13%)

Query: 756 DRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRAT--LENGMFLTVKWLREGVA 813
           D  + EL   DD     PE+L     E+ G  S G  Y A     N +    K    G  
Sbjct: 1   DPEIAELFSKDD-----PEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ 54

Query: 814 KQRK--EFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGR 871
              K  +  KE +    +RHPN +  +G Y    +H   ++ +Y   GS +  L     +
Sbjct: 55  SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL--REHTAWLVMEYCL-GSASDIL--EVHK 109

Query: 872 KGPPLTWAQRLKIAV---DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLH 928
           K  PL   Q ++IA       +GL YLH    + H ++KA NILL  P    ++AD+   
Sbjct: 110 K--PL---QEVEIAAICHGALQGLAYLHSHERI-HRDIKAGNILLTEPGT-VKLADFGSA 162

Query: 929 RLMTQAGTIEQILDAGVLGYRAPE-LAASKKPHPSFKSDVYAFGVILLEL 977
            L++ A +       G   + APE + A  +     K DV++ G+  +EL
Sbjct: 163 SLVSPANSF-----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 784 LGRSSHGTSYRATL------ENGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVG 836
           LG+ S G  Y          E    + VK + E  + ++R EF  EA         +VV 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLY-------DRPGRKGPPLTWAQRLKIAVDVA 889
           L G          L++ + ++ G L S+L        + PGR  PP T  + +++A ++A
Sbjct: 74  LLGVV--SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR--PPPTLQEMIQMAAEIA 129

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR 949
            G+ YL+  + V H +L A N ++   D   ++ D+ + R + +     +    G+L  R
Sbjct: 130 DGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYYRK-GGKGLLPVR 186

Query: 950 --APELAASKKPHPSFKSDVYAFGVILLELLT 979
             APE  + K    +  SD+++FGV+L E+ +
Sbjct: 187 WMAPE--SLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 37/214 (17%)

Query: 782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKE----FAKEAKKFANIRHPNVVG 836
           +V+G+ S G    A  + +G F  VK L++    ++KE     A+      N++HP +VG
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 837 LRGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKI-AVDVARGLNY 894
           L   +      EKL  + DY++ G L  F   R      P     R +  A +VA  + Y
Sbjct: 61  LHYSFQTA---EKLYFVLDYVNGGELF-FHLQRERCFLEP-----RARFYAAEVASAIGY 111

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD--------AGVL 946
           LH    + + +LK  NILLD             H ++T  G  ++ ++         G  
Sbjct: 112 LH-SLNIIYRDLKPENILLDSQG----------HVVLTDFGLCKEGVEPEETTSTFCGTP 160

Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            Y APE+   K+P+     D +  G +L E+L G
Sbjct: 161 EYLAPEV-LRKEPYDR-TVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 27/171 (15%)

Query: 817 KEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPL 876
           K   +E K   ++RH N++ L   +  P   E +     +    L   L  RP  K    
Sbjct: 54  KRTYRELKLLKHLRHENIISLSDIFISPL--EDIYFVTELLGTDLHRLLTSRPLEK---- 107

Query: 877 TWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT 936
            + Q       + RGL Y+H    V H +LK +NIL++  + + ++ D+ L R       
Sbjct: 108 QFIQYF--LYQILRGLKYVH-SAGVVHRDLKPSNILIN-ENCDLKICDFGLAR------- 156

Query: 937 IEQILDAGVLG------YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
              I D  + G      YRAPE+  + + +   + D+++ G I  E+L G+
Sbjct: 157 ---IQDPQMTGYVSTRYYRAPEIMLTWQKY-DVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 25/209 (11%)

Query: 782 EVLGRSSHG----TSYRATLENGMFLTVKWLREGVAKQRKEFA---KEAKKFANIRHPNV 834
           ++LG+ + G       +AT   G +  +K L++ V   + E A    E +   N RHP +
Sbjct: 1   KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57

Query: 835 VGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKI-AVDVARGL 892
             L+   +    H++L  + +Y + G L  F +    R    +    R +    ++   L
Sbjct: 58  TALK---YSFQTHDRLCFVMEYANGGEL--FFHLSRER----VFSEDRARFYGAEIVSAL 108

Query: 893 NYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPE 952
           +YLH ++ V + +LK  N++LD  D + ++ D+ L +   + G   +    G   Y APE
Sbjct: 109 DYLHSEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTF-CGTPEYLAPE 166

Query: 953 LAASKKPHPSFKSDVYAFGVILLELLTGR 981
           +        +   D +  GV++ E++ GR
Sbjct: 167 VLEDNDYGRAV--DWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 43.8 bits (103), Expect = 3e-04
 Identities = 39/164 (23%), Positives = 65/164 (39%), Gaps = 40/164 (24%)

Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           H  +V L G   G +     +++     GSL   +        P       L   V +A+
Sbjct: 68  HAYIVRLLGICPGASLQ---LVTQLSPLGSLLDHVRQHRDSLDPQRL----LNWCVQIAK 120

Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM---------TQAGT----- 936
           G+ YL   R V H NL A NILL       ++AD+ +  L+         ++  T     
Sbjct: 121 GMYYLEEHRMV-HRNLAARNILLKSD-SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178

Query: 937 -IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            +E IL               +  H   +SDV+++GV + E+++
Sbjct: 179 ALESIL-------------FGRYTH---QSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 43.8 bits (104), Expect = 3e-04
 Identities = 33/96 (34%), Positives = 51/96 (53%), Gaps = 9/96 (9%)

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGP-DLNARVADYCLHRLMTQAGTIEQILDAGVLG- 947
           RGL Y+H    V H +LK +N+LL+   DL  ++ D+ L R+          L   V   
Sbjct: 117 RGLKYIH-SANVLHRDLKPSNLLLNTNCDL--KICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 948 -YRAPELAASKKPHPSFKS-DVYAFGVILLELLTGR 981
            YRAPE+  + K +   K+ D+++ G IL E+L+ R
Sbjct: 174 WYRAPEIMLNSKGYT--KAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 26/205 (12%)

Query: 784 LGRSSHGTSYRAT-LENGMFLTVKWLR---EGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           +GR      YRAT L +G+ + +K ++      AK R +  KE      + HPNV+    
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI---K 66

Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFL--YDRPGRKGPPLT-WAQRLKIAVDVARGLNYL 895
           YY    +  +L I+ +    G L+  +  + +  R  P  T W    K  V +   L ++
Sbjct: 67  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW----KYFVQLCSALEHM 122

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAA 955
           H  R V H ++K  N+ +    +  ++ D  L R  +   T    L  G   Y +PE   
Sbjct: 123 H-SRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPE--- 176

Query: 956 SKKPHP---SFKSDVYAFGVILLEL 977
             + H    +FKSD+++ G +L E+
Sbjct: 177 --RIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 43.0 bits (102), Expect = 5e-04
 Identities = 39/139 (28%), Positives = 64/139 (46%), Gaps = 29/139 (20%)

Query: 851 ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV---DVARGLNYLHFDRAVPHGNLK 907
           I+ +Y   GS    L  +PG+            IA    +V  GL YLH +  + H ++K
Sbjct: 76  IIMEYCGGGSCLDLL--KPGKLDET-------YIAFILREVLLGLEYLHEEGKI-HRDIK 125

Query: 908 ATNILL--DGPDLNARVADYC----LHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHP 961
           A NILL  +G   + ++AD+     L   M++  T       G   + APE+   K+   
Sbjct: 126 AANILLSEEG---DVKLADFGVSGQLTSTMSKRNTF-----VGTPFWMAPEVI--KQSGY 175

Query: 962 SFKSDVYAFGVILLELLTG 980
             K+D+++ G+  +EL  G
Sbjct: 176 DEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 43.0 bits (102), Expect = 5e-04
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 33/210 (15%)

Query: 784 LGRSSHGTSYRAT-LENGMFLTVKWLR-----EGV-AKQRKEFA--KEAKKFANIRHPNV 834
           +G  ++GT Y+A  L  G F+ +K +R     EG+     +E A  K+ + F    HPN+
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE---HPNI 63

Query: 835 VGLRGYYWGPTQHEKLILS---DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
           V L     GP    +L L+   +++    LA++L   P    PP        +   + RG
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPP---ETIKDLMRQLLRG 119

Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV--LGYR 949
           +++LH  R V H +LK  NIL+   D   ++AD+ L R+     + E  L + V  L YR
Sbjct: 120 VDFLHSHRIV-HRDLKPQNILVTS-DGQVKIADFGLARIY----SFEMALTSVVVTLWYR 173

Query: 950 APE--LAASKKPHPSFKSDVYAFGVILLEL 977
           APE  L +S     +   D+++ G I  EL
Sbjct: 174 APEVLLQSSY----ATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 43.0 bits (101), Expect = 5e-04
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)

Query: 885 AVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY--CLHRLMTQAGTIEQILD 942
           A ++  GL +LH  + + + +LK  NILLD  D + ++AD+  C   ++  A T      
Sbjct: 102 AAEIICGLQFLH-SKGIVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTF--- 156

Query: 943 AGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            G   Y APE+   +K + S   D ++FGV+L E+L G+
Sbjct: 157 CGTPDYIAPEILLGQKYNTSV--DWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 42.9 bits (101), Expect = 5e-04
 Identities = 39/151 (25%), Positives = 63/151 (41%), Gaps = 20/151 (13%)

Query: 832 PNVVGLRGYYWGPTQHEKLIL-SDYISPGSLASFLYDRPGRKGP-PLTWAQRLKIAVDVA 889
           P V  L   Y+     + L L  +Y++ G  AS +       G  P  WA+  +   +V 
Sbjct: 57  PYVAKL---YYSFQSKDYLYLVMEYLNGGDCASLI----KTLGGLPEDWAK--QYIAEVV 107

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR 949
            G+  LH  R + H ++K  N+L+D    + ++ D+ L R     G   +    G   Y 
Sbjct: 108 LGVEDLH-QRGIIHRDIKPENLLIDQTG-HLKLTDFGLSR----NGLENKKF-VGTPDYL 160

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLTG 980
           APE            SD ++ G ++ E L G
Sbjct: 161 APETILGVGDDKM--SDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 42.8 bits (101), Expect = 7e-04
 Identities = 51/175 (29%), Positives = 75/175 (42%), Gaps = 26/175 (14%)

Query: 821 KEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQ 880
           +E K    I+H N++GL   Y    + + + L   I    L   + DR  R    LT +Q
Sbjct: 69  RELKIMNEIKHENIMGLVDVY---VEGDFINLVMDIMASDLKK-VVDRKIR----LTESQ 120

Query: 881 RLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR----------- 929
              I + +  GLN LH      H +L   NI ++   +  ++AD+ L R           
Sbjct: 121 VKCILLQILNGLNVLH-KWYFMHRDLSPANIFINSKGI-CKIADFGLARRYGYPPYSDTL 178

Query: 930 --LMTQAGTIEQILDAGVLGYRAPEL-AASKKPHPSFKSDVYAFGVILLELLTGR 981
               T     E       L YRAPEL   ++K H  F  D+++ G I  ELLTG+
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYH--FAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 42.7 bits (100), Expect = 7e-04
 Identities = 37/129 (28%), Positives = 68/129 (52%), Gaps = 12/129 (9%)

Query: 854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILL 913
           +Y++ G L  +   + G+   P    Q +  A +++ GL +LH  R + + +LK  N++L
Sbjct: 81  EYVNGGDLM-YHIQQVGKFKEP----QAVFYAAEISVGLFFLH-RRGIIYRDLKLDNVML 134

Query: 914 DGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKS-DVYAFGV 972
           D  + + ++AD+ + +     G   +    G   Y APE+ A +   P  KS D +A+GV
Sbjct: 135 DS-EGHIKIADFGMCKEHMVDGVTTRTF-CGTPDYIAPEIIAYQ---PYGKSVDWWAYGV 189

Query: 973 ILLELLTGR 981
           +L E+L G+
Sbjct: 190 LLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 42.2 bits (99), Expect = 8e-04
 Identities = 46/184 (25%), Positives = 87/184 (47%), Gaps = 22/184 (11%)

Query: 803 LTVKWLREGVAKQ-RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP-GS 860
           + +K L+    K  R E  +EA+    + +P +V + G      + E L+L   ++  G 
Sbjct: 25  VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGV----CEAEALMLVMEMASGGP 80

Query: 861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLN- 919
           L  FL      K   +T +  +++   V+ G+ YL   +   H +L A N+LL    +N 
Sbjct: 81  LNKFL----SGKKDEITVSNVVELMHQVSMGMKYLE-GKNFVHRDLAARNVLL----VNQ 131

Query: 920 --ARVADYCLHRLMTQAGTIEQILDAGV--LGYRAPELAASKKPHPSFKSDVYAFGVILL 975
             A+++D+ L + +    +  +   AG   L + APE    +K   S +SDV+++G+ + 
Sbjct: 132 HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF--SSRSDVWSYGITMW 189

Query: 976 ELLT 979
           E  +
Sbjct: 190 EAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 42.7 bits (100), Expect = 8e-04
 Identities = 41/172 (23%), Positives = 78/172 (45%), Gaps = 25/172 (14%)

Query: 816 RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP 875
           R +  +E +       P +VG  G ++  +  E  I  +++  GSL   L     +K   
Sbjct: 47  RNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL-----KKAGR 99

Query: 876 LTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG 935
           +      K+++ V +GL YL     + H ++K +NIL++      ++ D+         G
Sbjct: 100 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDF---------G 149

Query: 936 TIEQILDA------GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
              Q++D+      G   Y +PE    +  H S +SD+++ G+ L+E+  GR
Sbjct: 150 VSGQLIDSMANSFVGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 42.8 bits (101), Expect = 8e-04
 Identities = 30/100 (30%), Positives = 47/100 (47%), Gaps = 19/100 (19%)

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL--------MTQAGTIEQIL 941
           RGL YLH    + H ++K  N+L++  +   ++ D+ L R+        MTQ   + Q  
Sbjct: 114 RGLKYLHSAG-ILHRDIKPGNLLVNS-NCVLKICDFGLARVEEPDESKHMTQE-VVTQY- 169

Query: 942 DAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                 YRAPE+      H +   D+++ G I  ELL  R
Sbjct: 170 ------YRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 42.9 bits (101), Expect = 0.001
 Identities = 29/85 (34%), Positives = 43/85 (50%), Gaps = 7/85 (8%)

Query: 264 QSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSN 322
           + +Q +NLS N + G++     L    +L+VLDLSYN   G +P     +  L++L L+ 
Sbjct: 442 RHLQSINLSGNSIRGNI--PPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499

Query: 323 NRFSGFIPNDL----LKGDSLLLTD 343
           N  SG +P  L    L   S   TD
Sbjct: 500 NSLSGRVPAALGGRLLHRASFNFTD 524

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.9 bits (89), Expect = 0.001
 Identities = 20/59 (33%), Positives = 31/59 (52%)

Query: 96  LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNF 154
           L  L +SNN ++ +         +L+ LD+S N  +S  P     L SL++L L+GNN 
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 42.1 bits (100), Expect = 0.001
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 9/96 (9%)

Query: 890 RGLNYLHFDRA-VPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG- 947
           RGL YLH   A V H +LK +NIL++  + + ++ D+ L R +      +  L   V+  
Sbjct: 114 RGLKYLH--SANVIHRDLKPSNILVNS-NCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170

Query: 948 -YRAPELA-ASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL  +S +   +   D+++ G I  ELLT +
Sbjct: 171 WYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 41/198 (20%), Positives = 84/198 (42%), Gaps = 12/198 (6%)

Query: 784 LGRSSHGTSYRAT-LENGMFLTVKWLR--EGV-AKQRKEFAKEAKKFANIRHPNVVGLRG 839
           +G+      Y+A  L +G  + +K ++  E + AK R++  KE      + HPNV+    
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVI---K 66

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
           Y     ++ +L +   ++     S +     ++   +      K  V +   L ++H  +
Sbjct: 67  YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH-SK 125

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
            + H ++K  N+ +       ++ D  L R  +   T       G   Y +PE     + 
Sbjct: 126 RIMHRDIKPANVFI-TATGVVKLGDLGLGRFFSSK-TTAAHSLVGTPYYMSPERI--HEN 181

Query: 960 HPSFKSDVYAFGVILLEL 977
             +FKSD+++ G +L E+
Sbjct: 182 GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 42.1 bits (99), Expect = 0.001
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 7/98 (7%)

Query: 885 AVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG 944
           A ++A GL +LH  + + + +LK  N++LD  + + ++AD+ + +     G   +    G
Sbjct: 107 AAEIAIGLFFLH-SKGIIYRDLKLDNVMLDA-EGHIKIADFGMCKENIFGGKTTRTF-CG 163

Query: 945 VLGYRAPELAASKKPHPSFKS-DVYAFGVILLELLTGR 981
              Y APE+ A +   P  KS D +AFGV+L E+L G+
Sbjct: 164 TPDYIAPEIIAYQ---PYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 42.1 bits (99), Expect = 0.001
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 37/213 (17%)

Query: 783 VLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKE----FAKEAKKFANIRHPNVVGL 837
           V+G+ S G    A    +G F  VK L++    ++KE     A+      N++HP +VGL
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 838 RGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKI-AVDVARGLNYL 895
              +      +KL  + DY++ G L   L  R      P     R +  A ++A  L YL
Sbjct: 62  HYSFQTA---DKLYFVLDYVNGGELFFHL-QRERSFPEP-----RARFYAAEIASALGYL 112

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA--------GVLG 947
           H    + + +LK  NILLD             H ++T  G  ++ ++         G   
Sbjct: 113 H-SLNIIYRDLKPENILLDSQG----------HVVLTDFGLCKEGIEHSKTTSTFCGTPE 161

Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           Y APE+   K+P+     D +  G +L E+L G
Sbjct: 162 YLAPEV-LRKQPYDR-TVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 41.9 bits (99), Expect = 0.001
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 7/95 (7%)

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL---DAGVL 946
           RGL Y+H    V H +LK +N+L++  D   R+ D+ + R ++ + T  +          
Sbjct: 118 RGLKYIH-SANVIHRDLKPSNLLVNE-DCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL  S   + +   D+++ G I  E+L GR
Sbjct: 176 WYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GR 208

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 23/207 (11%)

Query: 782 EVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRK--EFAKEAKKFANI--RHPNVVG 836
            VLG+ S G    A L E+G    VK L++ V  Q    E     K+  ++   HP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L  Y    T      + ++++ G L   +     +K      A+    A ++   L +LH
Sbjct: 61  L--YCCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFDEARARFYAAEITSALMFLH 113

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG---YRAPEL 953
            D+ + + +LK  N+LLD  + + ++AD+     M + G       +   G   Y APE+
Sbjct: 114 -DKGIIYRDLKLDNVLLDH-EGHCKLADFG----MCKEGIFNGKTTSTFCGTPDYIAPEI 167

Query: 954 AASKKPHPSFKSDVYAFGVILLELLTG 980
                  PS   D +A GV+L E+L G
Sbjct: 168 LQEMLYGPSV--DWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 41.3 bits (97), Expect = 0.002
 Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 27/216 (12%)

Query: 775 ELSR---APAEVLGRSSHGTSYRATLEN----GMFLTVKWLREGVAKQRKE-FAKEAKKF 826
           E+ R        +G    G  Y+    +     + + VK  +   +   +E F +EA   
Sbjct: 2   EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61

Query: 827 ANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV 886
               HP++V L G     T++   I+ +    G L S+L          L  A  +  + 
Sbjct: 62  RQFDHPHIVKLIGVI---TENPVWIVMELAPLGELRSYLQVNKYS----LDLASLILYSY 114

Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV- 945
            ++  L YL   R V H ++ A N+L+  PD   ++ D+ L R +      E    A   
Sbjct: 115 QLSTALAYLESKRFV-HRDIAARNVLVSSPD-CVKLGDFGLSRYLED----ESYYKASKG 168

Query: 946 ---LGYRAPELAASKKPHPSFKSDVYAFGVILLELL 978
              + + APE    ++   +  SDV+ FGV + E+L
Sbjct: 169 KLPIKWMAPESINFRR--FTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 41.5 bits (97), Expect = 0.002
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 7/98 (7%)

Query: 885 AVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG 944
           A ++A GL +LH  + + + +LK  N++LD  + + ++AD+ + +     G   +    G
Sbjct: 107 AAEIAIGLFFLH-SKGIIYRDLKLDNVMLDS-EGHIKIADFGMCKENMWDGVTTKTF-CG 163

Query: 945 VLGYRAPELAASKKPHPSFKS-DVYAFGVILLELLTGR 981
              Y APE+ A +   P  KS D +AFGV+L E+L G+
Sbjct: 164 TPDYIAPEIIAYQ---PYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 41.1 bits (97), Expect = 0.002
 Identities = 40/167 (23%), Positives = 65/167 (38%), Gaps = 12/167 (7%)

Query: 816 RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS-DYISPGSLASFLYDRPGRKGP 874
           +K   +E K    +RH N+V L+  +    +  +L L  +Y+   +L   L   PG   P
Sbjct: 44  KKTALREVKVLRQLRHENIVNLKEAF---RRKGRLYLVFEYV-ERTLLELLEASPGGLPP 99

Query: 875 PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
                        + + + Y H    + H ++K  NIL+       ++ D+   R +   
Sbjct: 100 DAV----RSYIWQLLQAIAYCHSHNII-HRDIKPENILVS-ESGVLKLCDFGFARALRAR 153

Query: 935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                        YRAPEL      +     DV+A G I+ ELL G 
Sbjct: 154 PASPLTDYVATRWYRAPELLVGDTNY-GKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 41.0 bits (97), Expect = 0.002
 Identities = 35/122 (28%), Positives = 55/122 (45%), Gaps = 27/122 (22%)

Query: 871 RKGPPLTWAQRLKIAVDVARGLNYLH----FDRAVPHGNLKATNILLDGPDLNARVADYC 926
           RKG P + +    I   + +GL ++H    F     H +LK  N+L+ GP++  ++AD+ 
Sbjct: 91  RKGKPFSESVIRSIIYQILQGLAHIHKHGFF-----HRDLKPENLLVSGPEV-VKIADFG 144

Query: 927 LHRLMTQAGTIEQILDAGVLG-------YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           L R         +I              YRAPE+   +    S   D++A G I+ EL T
Sbjct: 145 LAR---------EIRSRPPYTDYVSTRWYRAPEILL-RSTSYSSPVDIWALGCIMAELYT 194

Query: 980 GR 981
            R
Sbjct: 195 LR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 41.3 bits (97), Expect = 0.002
 Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR---LMTQAGTIEQILDAGVL 946
           RG+ Y H  R V H +LK  N+L+D      ++AD+ L R   +  +  T E +     L
Sbjct: 113 RGIAYCHSHR-VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TL 167

Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPE+    + H S   D+++ G I  E++  +
Sbjct: 168 WYRAPEILLGSR-HYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.5 bits (97), Expect = 0.002
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 6/97 (6%)

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD-----AG 944
           RGLNYLH +  + H N+KA++IL+ G  L +      L+ L+      + + D       
Sbjct: 112 RGLNYLHQNGYI-HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS 170

Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           VL + +PEL        + KSD+Y+ G+   EL TGR
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.3 bits (97), Expect = 0.002
 Identities = 28/103 (27%), Positives = 54/103 (52%), Gaps = 5/103 (4%)

Query: 885 AVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG 944
           + +++  LN+LH +R + + +LK  N+LLD  + + ++ DY + +   + G        G
Sbjct: 102 SAEISLALNFLH-ERGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRPGDTTSTF-CG 158

Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI 987
              Y APE+   +     F  D +A GV++ E++ GR   D++
Sbjct: 159 TPNYIAPEILRGEDY--GFSVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 41.1 bits (97), Expect = 0.002
 Identities = 48/177 (27%), Positives = 70/177 (39%), Gaps = 50/177 (28%)

Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDY-------------------ISPGSLASFLYDRP 869
           ++H NVV L   +         +L DY                   I P  + S L+   
Sbjct: 59  LKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW--- 115

Query: 870 GRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILL--DGPDLNA-RVADYC 926
                     Q L        G++YLH    V H +LK  NIL+  +GP+    ++ D  
Sbjct: 116 ----------QILN-------GVHYLH-SNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157

Query: 927 LHRLMTQAGTIEQILDA-GV---LGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           L RL      ++ + D   V   + YRAPEL    + H +   D++A G I  ELLT
Sbjct: 158 LARLFNAP--LKPLADLDPVVVTIWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 43/174 (24%), Positives = 74/174 (42%), Gaps = 37/174 (21%)

Query: 819 FAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTW 878
           F + A     + H ++V L G        E +++ +++  G L  F++    RK   LT 
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVC--VRDVENIMVEEFVEFGPLDLFMH----RKSDVLTT 104

Query: 879 AQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILL--DGPDLNARVADYCLHRLMTQAGT 936
             + K+A  +A  L+YL  D+ + HGN+   NILL  +G D               + G 
Sbjct: 105 PWKFKVAKQLASALSYLE-DKDLVHGNVCTKNILLAREGID--------------GECGP 149

Query: 937 IEQILDAGV-------------LGYRAPELAASKKPHPSFKSDVYAFGVILLEL 977
             ++ D G+             + + APE     K + S  +D ++FG  L E+
Sbjct: 150 FIKLSDPGIPITVLSRQECVERIPWIAPECVEDSK-NLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 20/66 (30%), Positives = 41/66 (62%), Gaps = 5/66 (7%)

Query: 848 EKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLK 907
           E +++ +Y+  GSL ++L  +  +    ++W  +L++A  +A  L++L  D+ + HGN+ 
Sbjct: 73  ESIMVQEYVKFGSLDTYL--KKNKNLINISW--KLEVAKQLAWALHFLE-DKGLTHGNVC 127

Query: 908 ATNILL 913
           A N+LL
Sbjct: 128 AKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 40.8 bits (95), Expect = 0.003
 Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 16/168 (9%)

Query: 817 KEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEK---LILSDYISPGSLASFLYDRPGRKG 873
           K   +E +   +++H NV+GL   +      E+   + L  ++    L + +      K 
Sbjct: 61  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KC 114

Query: 874 PPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ 933
             LT      +   + RGL Y+H    + H +LK +N+ ++  D   ++ D+ L R    
Sbjct: 115 QKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVN-EDCELKILDFGLARHTDD 172

Query: 934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
               E         YRAPE+  +   H +   D+++ G I+ ELLTGR
Sbjct: 173 ----EMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 21/209 (10%)

Query: 781 AEVLGRSSHGTSYRA-TLENGMFLTVKWL-----REGVAKQRKEFAKEAKKFANIRHPNV 834
            ++LGR + G  Y     + G  L VK +      +  +K+      E +   N+RH  +
Sbjct: 7   GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66

Query: 835 VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
           V   G    P + +  I  +Y+  GS+   L     +    LT     +    + +G++Y
Sbjct: 67  VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-----KAYGALTENVTRRYTRQILQGVSY 121

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMT--QAGT-IEQILDAGVLGYRA 950
           LH +  V H ++K  NIL D    N ++ D+    R+ T   +GT I+ +   G   + +
Sbjct: 122 LHSNMIV-HRDIKGANILRDSAG-NVKLGDFGASKRIQTICMSGTGIKSV--TGTPYWMS 177

Query: 951 PELAASKKPHPSFKSDVYAFGVILLELLT 979
           PE+ + +      K+DV++    ++E+LT
Sbjct: 178 PEVISGEG--YGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 40.1 bits (93), Expect = 0.004
 Identities = 48/214 (22%), Positives = 100/214 (46%), Gaps = 28/214 (13%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEA---KKFANIRHPNVVGL 837
           E++G  ++G  Y+   ++ G    +K + +    + +E  +E    KK+++  H N+   
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSH--HRNIATY 68

Query: 838 RGYYWG---PTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLN 893
            G +     P   ++L ++ ++   GS+   + +    KG  L       I  ++ RGL+
Sbjct: 69  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLS 125

Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYC----LHRLMTQAGTIEQILDAGVLGYR 949
           +LH  + + H ++K  N+LL   +   ++ D+     L R + +  T       G   + 
Sbjct: 126 HLHQHKVI-HRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTF-----IGTPYWM 178

Query: 950 APE-LAASKKPHPS--FKSDVYAFGVILLELLTG 980
           APE +A  + P  +  FKSD+++ G+  +E+  G
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 40.3 bits (94), Expect = 0.004
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 39/218 (17%)

Query: 782 EVLGRSSHGTSY---RAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-----RHP 832
           +VLG  ++G  +   + T  + G    +K L++    Q+ +  +  +   N+     + P
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 833 NVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV-DVARG 891
            +V L  +Y   T+ +  ++ DY+S G + + LY R             ++    ++   
Sbjct: 66  FLVTL--HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS------EDEVRFYSGEIILA 117

Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL---------HRLMTQAGTIEQILD 942
           L +LH    + + ++K  NILLD  + +  + D+ L          R  +  GTIE    
Sbjct: 118 LEHLH-KLGIVYRDIKLENILLDS-EGHVVLTDFGLSKEFLSEEKERTYSFCGTIE---- 171

Query: 943 AGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
                Y APE+   K  H     D ++ G+++ ELLTG
Sbjct: 172 -----YMAPEIIRGKGGHGK-AVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1060
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.98
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.98
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.98
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.98
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.98
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.98
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.98
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.98
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.98
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.98
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.98
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.98
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.98
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.98
KOG0586	596	consensus Serine/threonine protein kinase [General	99.98
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.83
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.82
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.8
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.76
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.76
PRK10345	210	hypothetical protein; Provisional	99.75
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.74
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.73
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.71
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.7
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.69
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.69
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.68
smart00090	237	RIO RIO-like kinase.	99.68
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.67
PRK14879	211	serine/threonine protein kinase; Provisional	99.64
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.64
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.63
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.63
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.61
PLN03150	623	hypothetical protein; Provisional	99.57
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.54
PLN03150	623	hypothetical protein; Provisional	99.52
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.5
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.5
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.4
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.38
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.38
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.28
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.26
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.25
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.24
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.18
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.18
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.17
KOG1243	690	consensus Protein kinase [General function predict	99.13
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.13
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.12
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.04
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.02
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.02
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.01
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.0
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.0
KOG3087	229	consensus Serine/threonine protein kinase [General	98.95
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.95
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.94
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.87
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.86
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.86
COG4248	637	Uncharacterized protein with protein kinase and he	98.86
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.84
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.81
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.79
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.77
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.73
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.73
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.59
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.56
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.55
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.51
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.47
PRK09902	216	hypothetical protein; Provisional	98.46
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.46
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.4
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.38
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.31
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.3

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1e-107  Score=1054.59  Aligned_cols=906  Identities=30%  Similarity=0.461  Sum_probs=735.3

Q ss_pred             ChHHHHHHHHHHHhccCCCCCccCCCCCCCCCCCCCCCCccceEEecCCCeeEEEecCCCCccccCccc-ccCCCCCcEE
Q 001527           21 PSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSV-FSNLSMLVKL   99 (1060)
Q Consensus        21 ~~~~~~aLl~~k~~~~~~~~~~~l~sW~~~~~~~~~~~c~w~gv~C~~~~~~~~~l~~~~~~~~~~~~~-~~~l~~L~~L   99 (1060)
                      ...|+.||++||+++. +| ...+.+|+.     +.+||.|.||+|++ ..+|+.+++.++.+.+.++. |..+++|++|
T Consensus        27 ~~~~~~~l~~~~~~~~-~~-~~~~~~w~~-----~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L   98 (968)
T PLN00113         27 HAEELELLLSFKSSIN-DP-LKYLSNWNS-----SADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTI   98 (968)
T ss_pred             CHHHHHHHHHHHHhCC-CC-cccCCCCCC-----CCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEE
Confidence            4478999999999996 67 456889974     56799999999986 45899999999888877665 4499999999


Q ss_pred             ECcCCcccccCCCCcC-CCCCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEEEccCCCC
Q 001527          100 SMSNNSISGVIPDNIG-DFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF  178 (1060)
Q Consensus       100 ~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  178 (1060)
                      +|++|++++.+|..+. .+++|++|+|++|++++.+|.  +.+++|++|+|++|.+.+.+|..++++++|++|+|++|.+
T Consensus        99 ~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l  176 (968)
T PLN00113         99 NLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL  176 (968)
T ss_pred             ECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcc
Confidence            9999999988887654 999999999999999998886  5689999999999999999999999999999999999999


Q ss_pred             CCCCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCcCCccCchhhhccCCCCeecccCCccccCCCcCc
Q 001527          179 SGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKF  258 (1060)
Q Consensus       179 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  258 (1060)
                      ++.+|..|+++++|++|+|++|.+.+.+|..|+.+++|++|+|++|++.+.+|..|..+++|++|++++|.+.+..+..+
T Consensus       177 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l  256 (968)
T PLN00113        177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL  256 (968)
T ss_pred             cccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999986554432


Q ss_pred             CCCccccccEEEccCCcccccCCCCccccCCCCCCEEEccCCccccCCC-CccCCCCccEEEccCCcCcccCCcchhccC
Q 001527          259 LPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNNRFSGFIPNDLLKGD  337 (1060)
Q Consensus       259 l~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~  337 (1060)
                       . ...+|++|+|++|++++..+  ..+..+++|+.|+|++|.+.+.+| .+..+++|+.|++++|.+.+.+|. .+...
T Consensus       257 -~-~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~-~~~~l  331 (968)
T PLN00113        257 -G-NLKNLQYLFLYQNKLSGPIP--PSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV-ALTSL  331 (968)
T ss_pred             -h-CCCCCCEEECcCCeeeccCc--hhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCCh-hHhcC
Confidence             2 23569999999999998776  678899999999999999998888 688999999999999999998887 34444


Q ss_pred             CCCCCeEECCCCccccccCcccc--cCCcEEEccCCcCcccCCCCCC---CCCEEEccCCcccccccccc-CCCccCEEE
Q 001527          338 SLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPLLTG---SCAVLDLSNNQFEGNLSRIL-KWGNIEYLD  411 (1060)
Q Consensus       338 ~~~L~~L~Ls~N~l~~~~~~~~~--~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~Ls~N~l~~~~~~~~-~~~~L~~L~  411 (1060)
                      . .|+.|++++|.+.+.+|..+.  ++|+.|+|++|++++.+|..+.   +++.|++++|.+.+.++..+ .+++|+.|+
T Consensus       332 ~-~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~  410 (968)
T PLN00113        332 P-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVR  410 (968)
T ss_pred             C-CCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEE
Confidence            4 499999999999998887665  7999999999999999887654   57799999999998877654 459999999


Q ss_pred             cccCeecccCCCCCcccCCCCeEEccCCcCccccchhccccCCCcEEecCCccccCccccccccCCCcceEEccCccccc
Q 001527          412 LSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTG  491 (1060)
Q Consensus       412 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  491 (1060)
                      +++|++++.+|..+..++.|+.|+|++|++++.+|..+..+++|+.|++++|++.+.+|..+ ..++|+.|+|++|++++
T Consensus       411 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~  489 (968)
T PLN00113        411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSG  489 (968)
T ss_pred             CcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCC
Confidence            99999999999999999999999999999999999999999999999999999999888765 46899999999999999


Q ss_pred             cCCCCCCCCCCCcEEEccCCccccccCccccCCCCCcEEECCCCccccccCccccCCCCCCeEeccCCcccCCCCCCCc-
Q 001527          492 VLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLP-  570 (1060)
Q Consensus       492 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~-  570 (1060)
                      .+|..+..+++|+.|+|++|++++.+|..++++++|++|+|++|.++|.+|..+..+++|+.|||++|+++|.+|..+. 
T Consensus       490 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~  569 (968)
T PLN00113        490 AVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGN  569 (968)
T ss_pred             ccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999998753 


Q ss_pred             -cCCceeeCcCCcCccccCcc--ccCCCCccccCCCCCCCCCCCCCCCCCCCCCCCCCCccceeeEEEeehhHHHHHHHH
Q 001527          571 -NSLETFNVSYNDFSGAVPEN--LRKFPSSSFYPGNSKLSFPGGAPGSGNFPAENSNGKPISTIVKVIIIVSCVIALIIL  647 (1060)
Q Consensus       571 -~~l~~l~ls~N~l~g~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~v~~v~~~~~l  647 (1060)
                       .+|+.+++++|++.|.+|..  +..++..++.+|+.+|+.+....    .+......+..   ....++++++++++++
T Consensus       570 l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~----~~~c~~~~~~~---~~~~~~~~~~~~~~~~  642 (968)
T PLN00113        570 VESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG----LPPCKRVRKTP---SWWFYITCTLGAFLVL  642 (968)
T ss_pred             CcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC----CCCCccccccc---eeeeehhHHHHHHHHH
Confidence             57999999999999999975  67788889999999998643211    01101011111   1122222223333333


Q ss_pred             HHHHHhhheeeeccCCCCCCCCCCCcCCCccccCCCCCCCCCCCcccchhhhhccCcCCCCCCCCCcccccccccCCCCC
Q 001527          648 ILLAIFIHYVRISRRMPPAHTTDKDIHGHTLTIPPGSTGTGNGGALVVSAEDLVASKKGSSSGILSPDEKAAVVSGISPS  727 (1060)
Q Consensus       648 ~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  727 (1060)
                      ++++++++++|++++...+....            .   .+                                       
T Consensus       643 ~~~~~~~~~~~~~~~~~~~~~~~------------~---~~---------------------------------------  668 (968)
T PLN00113        643 ALVAFGFVFIRGRNNLELKRVEN------------E---DG---------------------------------------  668 (968)
T ss_pred             HHHHHHHHHHHhhhccccccccc------------c---cc---------------------------------------
Confidence            33333333333222111000000            0   00                                       


Q ss_pred             CCCCCcCCCCCCCcchhhcccccccCCCcccccceeeccCCCCCChhhhh--ccCCCeeccccceEEEEEEE-cCCcEEE
Q 001527          728 KNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEELS--RAPAEVLGRSSHGTSYRATL-ENGMFLT  804 (1060)
Q Consensus       728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~iG~G~~g~Vy~~~~-~~~~~va  804 (1060)
                           .|....-+   .+.                     ...++.+++.  +...++||+|+||.||+|+. .+++.||
T Consensus       669 -----~~~~~~~~---~~~---------------------~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~va  719 (968)
T PLN00113        669 -----TWELQFFD---SKV---------------------SKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFV  719 (968)
T ss_pred             -----cccccccc---ccc---------------------chhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEE
Confidence                 00000000   000                     0001111111  12346899999999999996 5799999


Q ss_pred             EEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHH
Q 001527          805 VKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKI  884 (1060)
Q Consensus       805 vK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i  884 (1060)
                      ||+++....    ...+|++.+++++|||||+++|+|.  +....++||||+++|+|.++++        .++|.++.+|
T Consensus       720 vK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~--~~~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i  785 (968)
T PLN00113        720 VKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCR--SEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKI  785 (968)
T ss_pred             EEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEE--cCCCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHH
Confidence            999875422    2235688999999999999999996  4567899999999999999994        2889999999


Q ss_pred             HHHHHHHHHHHhc--CCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeeeccCccccccchhcccCCCCCCC
Q 001527          885 AVDVARGLNYLHF--DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPS  962 (1060)
Q Consensus       885 ~~qia~gL~~LH~--~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s  962 (1060)
                      +.|+|+||+|||+  +++|+||||||+||+++ .+..+++. ||.+......     ....||..|+|||++.+..+  +
T Consensus       786 ~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~--~  856 (968)
T PLN00113        786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDI--T  856 (968)
T ss_pred             HHHHHHHHHHhccCCCCCeecCCCCHHhEEEC-CCCceEEE-eccccccccC-----CCccccccccCcccccCCCC--C
Confidence            9999999999993  45999999999999998 46677765 6654432221     11257899999999987765  8


Q ss_pred             CccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc
Q 001527          963 FKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR 1042 (1060)
Q Consensus       963 ~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~ 1042 (1060)
                      .++|||||||++|||+||+.||+....  ....+.+|++...........+|+.+.+...  ...+++.++.+++.+|++
T Consensus       857 ~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~  932 (968)
T PLN00113        857 EKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARYCYSDCHLDMWIDPSIRGDVS--VNQNEIVEVMNLALHCTA  932 (968)
T ss_pred             cccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHHhcCccchhheeCccccCCCC--ccHHHHHHHHHHHHhhCc
Confidence            899999999999999999999965332  3456888887766665556667776644322  234567788999999998


Q ss_pred             -CCCCCCCHHHHHHHhhcC
Q 001527         1043 -SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1043 -~p~~RPs~~evl~~L~~i 1060 (1060)
                       +|++||||+||+++|+++
T Consensus       933 ~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        933 TDPTARPCANDVLKTLESA  951 (968)
T ss_pred             CCchhCcCHHHHHHHHHHh
Confidence             799999999999999864

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.9e-57  Score=585.19  Aligned_cols=502  Identities=33%  Similarity=0.472  Sum_probs=452.7

Q ss_pred             eEEEecCCCCccccCccc--ccCCCCCcEEECcCCcccccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeec
Q 001527           72 AGVVLDNLGLSAAADLSV--FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSL  149 (1060)
Q Consensus        72 ~~~~l~~~~~~~~~~~~~--~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  149 (1060)
                      ....|++.++.+.+.++.  +..+++|++|+|++|++++.+|.  +.+++|++|+|++|.+++.+|..|+++++|++|+|
T Consensus        94 ~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L  171 (968)
T PLN00113         94 YIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDL  171 (968)
T ss_pred             CCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEEC
Confidence            345677777777776665  34899999999999999998885  56899999999999999999999999999999999


Q ss_pred             cccccCcccCCcccCCCcccEEEccCCCCCCCCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCcCCcc
Q 001527          150 AGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGH  229 (1060)
Q Consensus       150 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  229 (1060)
                      ++|.+.+.+|..|.++++|++|+|++|++++.+|..|+++++|++|+|++|++++.+|..|+.+++|++|+|++|++.+.
T Consensus       172 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~  251 (968)
T PLN00113        172 GGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGP  251 (968)
T ss_pred             ccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CchhhhccCCCCeecccCCccccCCCcCcCCCccccccEEEccCCcccccCCCCccccCCCCCCEEEccCCccccCCC-C
Q 001527          230 LDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-G  308 (1060)
Q Consensus       230 ~~~~~~~l~~L~~L~ls~N~l~~~~~~~~l~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~  308 (1060)
                      +|..|..+++|+.|++++|.+.+..+..+.  ..++|++|+|++|.+++.++  ..+..+++|+.|++++|.+++..| .
T Consensus       252 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~Ls~n~l~~~~p--~~~~~l~~L~~L~l~~n~~~~~~~~~  327 (968)
T PLN00113        252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSIF--SLQKLISLDLSDNSLSGEIP--ELVIQLQNLEILHLFSNNFTGKIPVA  327 (968)
T ss_pred             cChhHhCCCCCCEEECcCCeeeccCchhHh--hccCcCEEECcCCeeccCCC--hhHcCCCCCcEEECCCCccCCcCChh
Confidence            999999999999999999999875543331  23569999999999998776  678899999999999999998888 6


Q ss_pred             ccCCCCccEEEccCCcCcccCCcchhccCCCCCCeEECCCCccccccCcccc--cCCcEEEccCCcCcccCCCCC---CC
Q 001527          309 FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPLLT---GS  383 (1060)
Q Consensus       309 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~--~~L~~L~Ls~N~l~~~~p~~~---~~  383 (1060)
                      +..+++|+.|+|++|++.+.+|.. +.... .|+.|++++|++++..|..+.  ++|+.|++++|++.+.+|..+   .+
T Consensus       328 ~~~l~~L~~L~L~~n~l~~~~p~~-l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~  405 (968)
T PLN00113        328 LTSLPRLQVLQLWSNKFSGEIPKN-LGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS  405 (968)
T ss_pred             HhcCCCCCEEECcCCCCcCcCChH-HhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCC
Confidence            899999999999999999988874 34333 499999999999998887665  789999999999999998765   46


Q ss_pred             CCEEEccCCcccccccccc-CCCccCEEEcccCeecccCCCCCcccCCCCeEEccCCcCccccchhccccCCCcEEecCC
Q 001527          384 CAVLDLSNNQFEGNLSRIL-KWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSF  462 (1060)
Q Consensus       384 l~~L~Ls~N~l~~~~~~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  462 (1060)
                      ++.|+|++|++++.++..+ .+++|++|++++|++++.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++
T Consensus       406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~  484 (968)
T PLN00113        406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSR  484 (968)
T ss_pred             CCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcC
Confidence            7799999999998777654 45999999999999999999999999999999999999999998866 458999999999


Q ss_pred             ccccCccccccccCCCcceEEccCccccccCCCCCCCCCCCcEEEccCCccccccCccccCCCCCcEEECCCCccccccC
Q 001527          463 NHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLP  542 (1060)
Q Consensus       463 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip  542 (1060)
                      |++++.+|..+.++++|+.|+|++|.+++.+|..+..+++|++|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|
T Consensus       485 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  564 (968)
T PLN00113        485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP  564 (968)
T ss_pred             CccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCeEeccCCcccCCCCCCC-ccCCceeeCcCCc
Q 001527          543 TSMANMTSLSSLVISQNHFTGPLPNNL-PNSLETFNVSYND  582 (1060)
Q Consensus       543 ~~~~~l~~L~~L~ls~N~l~g~ip~~~-~~~l~~l~ls~N~  582 (1060)
                      ..+..+++|+.|++++|+++|.+|..- ...+....+.+|.
T Consensus       565 ~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~  605 (968)
T PLN00113        565 KNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNI  605 (968)
T ss_pred             hhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCc
Confidence            999999999999999999999999752 1233334455665

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-49  Score=441.22  Aligned_cols=278  Identities=36%  Similarity=0.655  Sum_probs=234.5

Q ss_pred             CCCChhhhhccC-----CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeC
Q 001527          769 LTLTPEELSRAP-----AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWG  843 (1060)
Q Consensus       769 ~~~~~~~l~~~~-----~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  843 (1060)
                      ..|+++|+..|+     .++||+|+||.||+|.+++|+.||||++........++|.+|++++.+++|||+|+++|||.+
T Consensus        63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e  142 (361)
T KOG1187|consen   63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLE  142 (361)
T ss_pred             ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence            457788887765     479999999999999999999999998876543214569999999999999999999999973


Q ss_pred             CCCC-ceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CcccCCCCCCCeEeeCCCCCe
Q 001527          844 PTQH-EKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR--AVPHGNLKATNILLDGPDLNA  920 (1060)
Q Consensus       844 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~--~ivHrDlkp~NILl~~~~~~~  920 (1060)
                        .+ +.+||||||++|+|.++|+.....   +++|.+|++||.++|+||+|||+..  .||||||||+|||+| +++++
T Consensus       143 --~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~a  216 (361)
T KOG1187|consen  143 --GGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNA  216 (361)
T ss_pred             --CCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCE
Confidence              44 699999999999999999875422   7899999999999999999999544  599999999999999 69999


Q ss_pred             EEcccccceeecc-CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHH
Q 001527          921 RVADYCLHRLMTQ-AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDW  999 (1060)
Q Consensus       921 kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~  999 (1060)
                      ||+|||+|+.... ........ .||.+|+|||++..+..  +.|+|||||||+++|++||+.|.+... ......+++|
T Consensus       217 KlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~l--t~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w  292 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKL--TEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEW  292 (361)
T ss_pred             EccCccCcccCCccccceeeec-CCCCccCChhhhccCCc--CcccccccchHHHHHHHhCCcccCCCC-CcccccHHHH
Confidence            9999999976554 22222211 79999999999987654  889999999999999999999988644 2334459999


Q ss_pred             HHHHHhcCCCCccccccccc-ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1000 MQLKVAEGHGSDCFDAAVMP-EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1000 ~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      +...+.+++..+++|+.+.. .+..   .+++.++..++.+|++ +|.+||+|.||+++|+.
T Consensus       293 ~~~~~~~~~~~eiiD~~l~~~~~~~---~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  293 AKPLLEEGKLREIVDPRLKEGEYPD---EKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             HHHHHHCcchhheeCCCccCCCCCh---HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            99999999999999999873 3211   1688889999999998 68999999999999964

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-44  Score=375.73  Aligned_cols=257  Identities=26%  Similarity=0.392  Sum_probs=205.8

Q ss_pred             CCChhhhhccCCCeeccccceEEEEEEEc-CCcEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCC
Q 001527          770 TLTPEELSRAPAEVLGRSSHGTSYRATLE-NGMFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQH  847 (1060)
Q Consensus       770 ~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  847 (1060)
                      .++..|+.+  .+.||+|..|+||+++++ +++.+|+|++... ....++++.+|++++++++||+||++||.|+.+.. 
T Consensus        75 ~i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-  151 (364)
T KOG0581|consen   75 GISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-  151 (364)
T ss_pred             ccCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-
Confidence            355666665  578999999999999976 7999999999543 34456889999999999999999999999985333 


Q ss_pred             ceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccc
Q 001527          848 EKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL  927 (1060)
Q Consensus       848 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~  927 (1060)
                      +..++||||++|||++++..     .+++++...-+|+.+|++||.|||.+++||||||||+|||++ ..+++||||||.
T Consensus       152 ~isI~mEYMDgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN-skGeVKicDFGV  225 (364)
T KOG0581|consen  152 EISICMEYMDGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN-SKGEVKICDFGV  225 (364)
T ss_pred             eEEeehhhcCCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec-cCCCEEeccccc
Confidence            69999999999999999953     356999999999999999999999669999999999999999 488999999999


Q ss_pred             ceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC
Q 001527          928 HRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG 1007 (1060)
Q Consensus       928 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 1007 (1060)
                      ++.+...   .....+||..|||||.+.+..|  +.++||||||++++|+.+|+.||....  .......+.+.....+.
T Consensus       226 S~~lvnS---~a~tfvGT~~YMsPERi~g~~Y--s~~sDIWSLGLsllE~a~GrfP~~~~~--~~~~~~~~Ll~~Iv~~p  298 (364)
T KOG0581|consen  226 SGILVNS---IANTFVGTSAYMSPERISGESY--SVKSDIWSLGLSLLELAIGRFPYPPPN--PPYLDIFELLCAIVDEP  298 (364)
T ss_pred             cHHhhhh---hcccccccccccChhhhcCCcC--CcccceecccHHHHHHhhCCCCCCCcC--CCCCCHHHHHHHHhcCC
Confidence            9987665   2223479999999999999876  779999999999999999999987541  11222333332222211


Q ss_pred             CCCcccccccccccCChhHH-HHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1008 HGSDCFDAAVMPEMVNPAAE-KGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1008 ~~~~~~d~~l~~~~~~~~~~-~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                       .     |.+        .. ....++..++..|++ +|.+||+++|++++
T Consensus       299 -p-----P~l--------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  299 -P-----PRL--------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             -C-----CCC--------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             0     111        11 255677888889998 79999999999763

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=393.11  Aligned_cols=261  Identities=32%  Similarity=0.487  Sum_probs=204.1

Q ss_pred             CCChhhhhccCCCeeccccceEEEEEEEcCCcEEEEEEcccchHH--HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCC
Q 001527          770 TLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAK--QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQH  847 (1060)
Q Consensus       770 ~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~  847 (1060)
                      .+..+++..  .+.||+|+||+||+|.++....||||++......  ..+.|.+|+.+|.+++|||||+++|+|..+. .
T Consensus        37 ~i~~~~l~~--~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-~  113 (362)
T KOG0192|consen   37 EIDPDELPI--EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-G  113 (362)
T ss_pred             ecChHHhhh--hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-C
Confidence            444555544  3569999999999999985555999999764322  2568999999999999999999999996322 2


Q ss_pred             ceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-cccCCCCCCCeEeeCCCC-CeEEccc
Q 001527          848 EKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA-VPHGNLKATNILLDGPDL-NARVADY  925 (1060)
Q Consensus       848 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~-ivHrDlkp~NILl~~~~~-~~kl~Df  925 (1060)
                      ..++||||+++|+|.++++..   ....+++..+++|+.|||+||.||| +.+ ||||||||+|||++ .++ ++||+||
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH-~~~~iIHrDLK~~NiLv~-~~~~~~KI~DF  188 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLH-SEGPIIHRDLKSDNILVD-LKGKTLKIADF  188 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHh-cCCCeeecccChhhEEEc-CCCCEEEECCC
Confidence            689999999999999999764   2457999999999999999999999 888 99999999999999 465 9999999


Q ss_pred             ccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHh
Q 001527          926 CLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA 1005 (1060)
Q Consensus       926 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 1005 (1060)
                      |+++........ .....||+.|||||++.+....++.|+|||||||++|||+||+.||.....       ...+.....
T Consensus       189 Glsr~~~~~~~~-~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~  260 (362)
T KOG0192|consen  189 GLSREKVISKTS-MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVV  260 (362)
T ss_pred             ccceeecccccc-ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHh
Confidence            999877654211 122479999999999995322248999999999999999999999986432       112222222


Q ss_pred             cCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1006 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ......+             .......+..++..||. +|.+||++.|++.+|+.
T Consensus       261 ~~~Rp~~-------------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~  302 (362)
T KOG0192|consen  261 GGLRPPI-------------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES  302 (362)
T ss_pred             cCCCCCC-------------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence            2111111             11245667888889998 79999999999999975

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-43  Score=373.00  Aligned_cols=249  Identities=19%  Similarity=0.299  Sum_probs=199.5

Q ss_pred             CCCeeccccceEEEEEE-EcCCcEEEEEEcccchHH-------HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEE
Q 001527          780 PAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAK-------QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLI  851 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~l  851 (1060)
                      ..+.+|+|+||.|-+|. ..+|+.||||++.+....       .....++|+++|++++|||||+++++|.  ..+..|+
T Consensus       176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~--~~ds~Ym  253 (475)
T KOG0615|consen  176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE--VPDSSYM  253 (475)
T ss_pred             eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee--cCCceEE
Confidence            46789999999999998 558999999999754221       1234579999999999999999999995  5667899


Q ss_pred             EEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeC--CCCCeEEcccccce
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG--PDLNARVADYCLHR  929 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~--~~~~~kl~Dfg~a~  929 (1060)
                      ||||++||+|.+.+-.+     +.+.+..-..+++|++.|+.||| ++||+||||||+|||+..  ++..+||+|||+|+
T Consensus       254 VlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH-~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  254 VLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLH-SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             EEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHH-HcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            99999999999999543     45778888999999999999999 999999999999999963  34789999999999


Q ss_pred             eeccCCceeeeccCccccccchhcccCCCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCC
Q 001527          930 LMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF-KSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008 (1060)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~-~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 1008 (1060)
                      .........+  .+||+.|.|||++.+..+.+.. ++|+||+|||+|-+++|.+||.....+.   .+.    ..+..++
T Consensus       328 ~~g~~sfm~T--lCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---sl~----eQI~~G~  398 (475)
T KOG0615|consen  328 VSGEGSFMKT--LCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---SLK----EQILKGR  398 (475)
T ss_pred             ccccceehhh--hcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---cHH----HHHhcCc
Confidence            8775443333  4899999999999876654444 8899999999999999999998644321   122    2233333


Q ss_pred             CCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1009 GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1009 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      +.          +.++.+.+..++.++++.+++. +|++|||++|+++
T Consensus       399 y~----------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  399 YA----------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cc----------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            32          1233455667778888889998 9999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=363.55  Aligned_cols=193  Identities=25%  Similarity=0.401  Sum_probs=170.8

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      +.||+|+||+||+|+++ ++..||||.+...  ..+..+.+..|+++|+.++|||||+++++++  .++..|+|||||.|
T Consensus        16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~--~~~~i~lVMEyC~g   93 (429)
T KOG0595|consen   16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE--DDDFIYLVMEYCNG   93 (429)
T ss_pred             hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe--cCCeEEEEEEeCCC
Confidence            45999999999999965 6899999999765  4556677889999999999999999999995  56789999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCC--C---CCeEEcccccceeecc
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP--D---LNARVADYCLHRLMTQ  933 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~--~---~~~kl~Dfg~a~~~~~  933 (1060)
                      |+|.+|++.+     +.+++.+++.++.|+|.||++|| +++||||||||.|||++..  .   -.+||+|||+|+....
T Consensus        94 GDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~-~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   94 GDLSDYIRRR-----GRLPEATARHFMQQLASALQFLH-ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            9999999654     36999999999999999999999 9999999999999999742  1   4689999999999886


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      .....+  .+|++.|||||+++.++|  +.|+|+||.|+++|++++|+.||+.
T Consensus       168 ~~~a~t--lcGSplYMAPEV~~~~~Y--dAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  168 GSMAET--LCGSPLYMAPEVIMSQQY--DAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhHHHH--hhCCccccCHHHHHhccc--cchhhHHHHHHHHHHHHhCCCCccc
Confidence            544433  389999999999998876  7799999999999999999999985

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-41  Score=376.63  Aligned_cols=244  Identities=24%  Similarity=0.427  Sum_probs=197.9

Q ss_pred             ccCCCeeccccceEEEEEEE-cCCcEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          778 RAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREG---VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      |..+++||+|||+.||+++. ..|+.||+|++.+.   ....++...+||++.++++|||||++++||  ++....|+|.
T Consensus        20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F--EDs~nVYivL   97 (592)
T KOG0575|consen   20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF--EDSNNVYIVL   97 (592)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe--ecCCceEEEE
Confidence            44578999999999999996 88999999999753   234567889999999999999999999999  4678999999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      |+|++++|..++.     ..+++++.+++.+++||+.||.||| +.+|+|||||-.|++++ +++++||+|||+|.....
T Consensus        98 ELC~~~sL~el~K-----rrk~ltEpEary~l~QIv~GlkYLH-~~~IiHRDLKLGNlfL~-~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLK-----RRKPLTEPEARYFLRQIVEGLKYLH-SLGIIHRDLKLGNLFLN-ENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHH-----hcCCCCcHHHHHHHHHHHHHHHHHH-hcCceecccchhheeec-CcCcEEecccceeeeecC
Confidence            9999999999995     3467999999999999999999999 99999999999999999 699999999999998876


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccc
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 1013 (1060)
                      ++....+ .+||+.|.|||++.....  ++.+||||+|||+|-|++|++||+..       .+.+-.+. ++..   +. 
T Consensus       171 ~~Erk~T-lCGTPNYIAPEVl~k~gH--sfEvDiWSlGcvmYtLL~G~PPFetk-------~vkety~~-Ik~~---~Y-  235 (592)
T KOG0575|consen  171 DGERKKT-LCGTPNYIAPEVLNKSGH--SFEVDIWSLGCVMYTLLVGRPPFETK-------TVKETYNK-IKLN---EY-  235 (592)
T ss_pred             cccccce-ecCCCcccChhHhccCCC--CCchhhhhhhhHHHhhhhCCCCcccc-------hHHHHHHH-HHhc---Cc-
Confidence            5443333 389999999999997664  88999999999999999999999852       12222221 1111   11 


Q ss_pred             ccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1014 DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1014 d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                         .++..       ....-.+++.+.++ +|.+|||+++|+.
T Consensus       236 ---~~P~~-------ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  236 ---SMPSH-------LSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ---ccccc-------cCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               11111       22233445556666 7999999999986

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-42  Score=376.68  Aligned_cols=261  Identities=31%  Similarity=0.446  Sum_probs=211.9

Q ss_pred             CCCCCChhhhhccCCCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCC
Q 001527          767 DTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ  846 (1060)
Q Consensus       767 ~~~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  846 (1060)
                      +.+.+..+++..  .+.||+|-||+||.|.+.....||+|.++... ...+.|.+|+++|++++|++||+++|+|.  .+
T Consensus       199 d~wei~r~~l~l--~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~--~~  273 (468)
T KOG0197|consen  199 DPWEIPREELKL--IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCT--KQ  273 (468)
T ss_pred             CCeeecHHHHHH--HHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEe--cC
Confidence            456677777765  57899999999999999888899999998763 33478889999999999999999999995  33


Q ss_pred             CceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccc
Q 001527          847 HEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYC  926 (1060)
Q Consensus       847 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg  926 (1060)
                      +..+||||||+.|+|.+||...   .+..+...+.+.++.|||+|++||+ ++++|||||.+.||||+ ++..+||+|||
T Consensus       274 ~piyIVtE~m~~GsLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLe-s~~~IHRDLAARNiLV~-~~~~vKIsDFG  348 (468)
T KOG0197|consen  274 EPIYIVTEYMPKGSLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLE-SKNYIHRDLAARNILVD-EDLVVKISDFG  348 (468)
T ss_pred             CceEEEEEecccCcHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHH-hCCccchhhhhhheeec-cCceEEEcccc
Confidence            4699999999999999999763   3456889999999999999999999 99999999999999998 68899999999


Q ss_pred             cceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHh
Q 001527          927 LHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVA 1005 (1060)
Q Consensus       927 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 1005 (1060)
                      +|+...++.........-...|.|||.+....+  +.|||||||||+||||+| |+.||..+.       ..+.+... .
T Consensus       349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~F--S~kSDVWSFGVlL~E~fT~G~~py~~ms-------n~ev~~~l-e  418 (468)
T KOG0197|consen  349 LARLIGDDEYTASEGGKFPIKWTAPEALNYGKF--SSKSDVWSFGVLLWELFTYGRVPYPGMS-------NEEVLELL-E  418 (468)
T ss_pred             cccccCCCceeecCCCCCCceecCHHHHhhCCc--ccccceeehhhhHHHHhccCCCCCCCCC-------HHHHHHHH-h
Confidence            999655544433333334567999999998887  889999999999999999 888987543       23333322 2


Q ss_pred             cCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1006 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      .+..             -|.+..++..+.+++..||+ +|++|||++.+...|+.+
T Consensus       419 ~GyR-------------lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  419 RGYR-------------LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             ccCc-------------CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            2211             12223466778899999998 799999999999888753

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-42  Score=347.11  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=200.9

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .++||+|+||+||++. ..+|..||.|.++-+  ..+.+++...|+.+|++++|||||+++++-..++..-.++|||||.
T Consensus        24 l~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~  103 (375)
T KOG0591|consen   24 LKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCD  103 (375)
T ss_pred             HHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhc
Confidence            4789999999999998 668999999998743  3455678999999999999999999998554444555899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--CC--cccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD--RA--VPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~--~~--ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      .|+|.+++...+ +..+.+++.++++++.|++.||.++| .  +.  |+||||||.||+++ .++.+||+|||+++.+..
T Consensus       104 ~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH-~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r~l~s  180 (375)
T KOG0591|consen  104 AGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCH-SKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGRFLSS  180 (375)
T ss_pred             ccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHh-ccccccceeeccCcchheEEc-CCCceeeccchhHhHhcc
Confidence            999999997654 44577999999999999999999999 5  33  88999999999999 588999999999998876


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccc
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 1013 (1060)
                      ..+... ..+|||.||+||.+.+.++  ++|+||||+||++|||+.=++||...       ++.+ ....+..+.+..+.
T Consensus       181 ~~tfA~-S~VGTPyYMSPE~i~~~~Y--~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~-L~~KI~qgd~~~~p  249 (375)
T KOG0591|consen  181 KTTFAH-SLVGTPYYMSPERIHESGY--NFKSDIWSLGCLLYEMCALQSPFYGD-------NLLS-LCKKIEQGDYPPLP  249 (375)
T ss_pred             hhHHHH-hhcCCCcccCHHHHhcCCC--CcchhHHHHHHHHHHHHhcCCCcccc-------cHHH-HHHHHHcCCCCCCc
Confidence            544332 3489999999999999986  88999999999999999999999742       2222 23334443332111


Q ss_pred             ccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHh
Q 001527         1014 DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDL 1057 (1060)
Q Consensus      1014 d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L 1057 (1060)
                                  ..-....+..++..|+. +|+.||+...++..+
T Consensus       250 ------------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  250 ------------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             ------------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                        12345667778889998 799999855555443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=345.45  Aligned_cols=206  Identities=23%  Similarity=0.359  Sum_probs=176.6

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .++||+|+||+||.++. ++++.+|+|++++...   ...+...+|..+|.+++||+||+++-.|  ++.+..|+|+||+
T Consensus        30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF--Qt~~kLylVld~~  107 (357)
T KOG0598|consen   30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF--QTEEKLYLVLDYL  107 (357)
T ss_pred             eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec--ccCCeEEEEEecc
Confidence            57999999999999995 4699999999986533   2456788999999999999999997666  6788999999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      .||.|..+|..     .+.+++..++.++.+|+.||.||| +.|||||||||+|||+| .+++++|+|||+|+..-..+.
T Consensus       108 ~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH-~~gIiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  108 NGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLH-SKGIIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             CCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHH-hCCeeeccCCHHHeeec-CCCcEEEeccccchhcccCCC
Confidence            99999999943     456999999999999999999999 99999999999999999 689999999999996555443


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHh
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA 1005 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 1005 (1060)
                      ...+ .+||+.|||||++.+.++  +.++|.||+||++|||++|.+||...       +...+......
T Consensus       181 ~t~t-fcGT~eYmAPEil~~~gy--~~~vDWWsLGillYeML~G~pPF~~~-------~~~~~~~~I~~  239 (357)
T KOG0598|consen  181 ATRT-FCGTPEYMAPEILLGKGY--DKAVDWWSLGILLYEMLTGKPPFYAE-------DVKKMYDKILK  239 (357)
T ss_pred             cccc-ccCCccccChHHHhcCCC--CcccchHhHHHHHHHHhhCCCCCcCc-------cHHHHHHHHhc
Confidence            3332 489999999999999876  78999999999999999999999742       44555554443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.6e-40  Score=378.94  Aligned_cols=261  Identities=26%  Similarity=0.423  Sum_probs=212.4

Q ss_pred             CCChhhhhccCCCeeccccceEEEEEEEc------CCcEEEEEEcccchHH-HHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 001527          770 TLTPEELSRAPAEVLGRSSHGTSYRATLE------NGMFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYW  842 (1060)
Q Consensus       770 ~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~  842 (1060)
                      .++..++.+  .+.||+|+||+||+|+..      +.+.||||.+++.... .+++|++|++.++.++|||||+++|.|.
T Consensus       482 ~i~r~~i~~--~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  482 EIPRSDIVF--KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             Eechhheee--hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            344444444  478999999999999843      4578999999977555 7789999999999999999999999995


Q ss_pred             CCCCCceEEEEEecCCCChHHHhhcCCCCC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEe
Q 001527          843 GPTQHEKLILSDYISPGSLASFLYDRPGRK---------GPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILL  913 (1060)
Q Consensus       843 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl  913 (1060)
                        .++..++|+|||..|||.+||..+..+.         ..+++..+.+.||.|||.|++||- ++.+|||||-.+|+||
T Consensus       560 --~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs-~~~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  560 --EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS-SHHFVHRDLATRNCLV  636 (774)
T ss_pred             --cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCcccccchhhhhcee
Confidence              6778999999999999999997654322         234899999999999999999999 9999999999999999


Q ss_pred             eCCCCCeEEcccccceeeccCCceeee-ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 001527          914 DGPDLNARVADYCLHRLMTQAGTIEQI-LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEG  991 (1060)
Q Consensus       914 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~  991 (1060)
                      . ++..|||+|||+++..-..+.+... ...-..+|||||.+..+++  |.++||||||||+||+++ |+.||...+.+ 
T Consensus       637 g-e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF--TteSDVWs~GVvLWEIFsyG~QPy~glSn~-  712 (774)
T KOG1026|consen  637 G-ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF--TTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-  712 (774)
T ss_pred             c-cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc--cchhhhhhhhhhhhhhhccccCcccccchH-
Confidence            7 6999999999999976554443321 1233578999999999887  889999999999999998 99998765433 


Q ss_pred             CccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527          992 AGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       992 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                         +.+    ..++.++..+             .++..+.++.+++..||+ .|.+||+++||-.+|++
T Consensus       713 ---EVI----e~i~~g~lL~-------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~  761 (774)
T KOG1026|consen  713 ---EVI----ECIRAGQLLS-------------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA  761 (774)
T ss_pred             ---HHH----HHHHcCCccc-------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence               222    3344443322             234677889999999998 69999999999999874

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.5e-40  Score=332.42  Aligned_cols=258  Identities=18%  Similarity=0.248  Sum_probs=192.7

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      -.++|+|+||+||+++.+ +|+.||||++.+..  ..-.+-..+|+++|++++|||+|.++.+|.  .....++|+|||+
T Consensus         7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr--rkrklhLVFE~~d   84 (396)
T KOG0593|consen    7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR--RKRKLHLVFEYCD   84 (396)
T ss_pred             hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH--hcceeEEEeeecc
Confidence            357999999999999965 69999999997543  334466789999999999999999999994  6678999999997


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      .- +.+-+...+    ..++...+.+|++|++.|+.|+| ++++|||||||+||||+ ..+.+||||||+|+.....+..
T Consensus        85 hT-vL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cH-k~n~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   85 HT-VLHELERYP----NGVPSELVKKYLYQLLKAIHFCH-KNNCIHRDIKPENILIT-QNGVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             hH-HHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhh-hcCeecccCChhheEEe-cCCcEEeccchhhHhhcCCcch
Confidence            64 444443332    34788999999999999999999 99999999999999998 6889999999999988743332


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHh------------
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA------------ 1005 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~------------ 1005 (1060)
                      . +..+.|.+|+|||.+.+... |...+||||+||++.||++|.+-|...++    .+..-.++..+.            
T Consensus       158 Y-TDYVATRWYRaPELLvGDtq-YG~pVDiWAiGCv~aEl~~G~pL~PG~SD----iDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  158 Y-TDYVATRWYRAPELLVGDTQ-YGKPVDIWAIGCVFAELLTGEPLWPGRSD----IDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             h-hhhhhhhhccChhhhcccCc-CCCcccchhhhHHHHHHhcCCcCCCCcch----HHHHHHHHHHHcccCHHHHHHhcc
Confidence            2 22368999999999998553 57899999999999999999998875432    222222222221            


Q ss_pred             cCCCCcccccccccccCCh---hHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1006 EGHGSDCFDAAVMPEMVNP---AAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1006 ~~~~~~~~d~~l~~~~~~~---~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ...+..+.-|..  +...+   ..+....-.++++..|++ ||++|++.+|++.
T Consensus       232 N~~F~Gv~lP~~--~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  232 NPFFHGVRLPEP--EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CCceeeeecCCC--CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111111111111  00111   111233457899999998 8999999999874

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=349.98  Aligned_cols=251  Identities=24%  Similarity=0.388  Sum_probs=193.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|+||+||++... +|...|||.+........+.+.+|+++|.+++|||||+++|.....+...++++|||+++|
T Consensus        22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G  101 (313)
T KOG0198|consen   22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG  101 (313)
T ss_pred             hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence            578999999999999965 4999999998765333367789999999999999999999975322223688999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc--CCce
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ--AGTI  937 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~--~~~~  937 (1060)
                      +|.+++....+    .+++..++++++||++||+||| ++|||||||||+|||++..++.+||+|||+++....  ....
T Consensus       102 sL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylH-s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~  176 (313)
T KOG0198|consen  102 SLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLH-SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD  176 (313)
T ss_pred             cHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHH-hCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence            99999965432    5999999999999999999999 999999999999999984368999999999987663  1112


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      ......||+.|||||++..+. ....++||||+||++.||+||++||...      ....+++-........     |. 
T Consensus       177 ~~~~~~Gtp~~maPEvi~~g~-~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~-----P~-  243 (313)
T KOG0198|consen  177 SELSVQGTPNYMAPEVIRNGE-VARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSL-----PE-  243 (313)
T ss_pred             ccccccCCccccCchhhcCCC-cCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCC-----CC-
Confidence            222357999999999998532 1245899999999999999999999752      1222222222221111     11 


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                             ..........+++..|++ +|++||||+|+++.
T Consensus       244 -------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  244 -------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             -------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence                   111233445667779998 89999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=353.32  Aligned_cols=262  Identities=20%  Similarity=0.252  Sum_probs=199.9

Q ss_pred             CCCeeccccceEEEEEE-EcCCcEEEEEEcccchHHHHH-HHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEEEEEec
Q 001527          780 PAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRK-EFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ..++||.|.||.||+|+ ..+|..||||++++......+ .-.+|++.|+++. |||||++.+++.+.+. ..++|||||
T Consensus        14 ~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~fVfE~M   92 (538)
T KOG0661|consen   14 VIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYFVFEFM   92 (538)
T ss_pred             HHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEeeeHHhh
Confidence            35789999999999998 567999999999865433322 3458999999998 9999999999975433 899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      + .+|.+.+.++    +..+++.+++.|++||++||+|+| .+|+.|||+||+|||+.+ ...+||+|||+||.......
T Consensus        93 d-~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiH-k~GfFHRDlKPENiLi~~-~~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   93 D-CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIH-KHGFFHRDLKPENILISG-NDVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             h-hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHH-hcCcccccCChhheEecc-cceeEecccccccccccCCC
Confidence            5 5999999775    367999999999999999999999 999999999999999984 67899999999999877666


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCc-----
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD----- 1011 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~----- 1011 (1060)
                      ....  +.|.+|+|||++....+ |+.+.||||+|||++|+.+=++-|.+...-+    ..--+-..+......+     
T Consensus       166 YTeY--VSTRWYRAPEvLLrs~~-Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D----qi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  166 YTEY--VSTRWYRAPEVLLRSGY-YSSPVDMWAVGCIMAELYSLRPLFPGASEID----QIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             cchh--hhcccccchHHhhhccc-cCCchHHHHHHHHHHHHHHhcccCCCCcHHH----HHHHHHHHhCCCccccchhHH
Confidence            5544  68999999999988775 6899999999999999999888876543211    1111111111110000     


Q ss_pred             -------ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1012 -------CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1012 -------~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                             +--|...+............+.++++.+|++ ||.+||||+|.+++
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                   0001111111111222355677888889998 89999999999864

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=355.18  Aligned_cols=263  Identities=27%  Similarity=0.422  Sum_probs=204.8

Q ss_pred             CCCCCChhhhhccCCCeeccccceEEEEEEEcCCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCC
Q 001527          767 DTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGP  844 (1060)
Q Consensus       767 ~~~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  844 (1060)
                      ..+.+.++|+..  ++.||+|+||+||||+|.+  .||||+++..  .....+.|++|+.++++-||.||+-+.|||.  
T Consensus       385 ~~WeIp~~ev~l--~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~--  458 (678)
T KOG0193|consen  385 EEWEIPPEEVLL--GERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM--  458 (678)
T ss_pred             cccccCHHHhhc--cceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc--
Confidence            356777787765  6899999999999999863  5999999754  3446789999999999999999999999995  


Q ss_pred             CCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcc
Q 001527          845 TQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVAD  924 (1060)
Q Consensus       845 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~D  924 (1060)
                       .....||+.+|+|.+|+.++|...    ..++..+.+.||+|||+|+.||| .++|||||||..||+++ ++..|||+|
T Consensus       459 -~p~~AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLH-AK~IIHrDLKSnNIFl~-~~~kVkIgD  531 (678)
T KOG0193|consen  459 -NPPLAIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLH-AKNIIHRDLKSNNIFLH-EDLKVKIGD  531 (678)
T ss_pred             -CCceeeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhh-hhhhhhhhccccceEEc-cCCcEEEec
Confidence             233499999999999999998654    45899999999999999999999 99999999999999998 578999999


Q ss_pred             cccceeecc-CCceeeeccCccccccchhcccCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHH
Q 001527          925 YCLHRLMTQ-AGTIEQILDAGVLGYRAPELAASK-KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQL 1002 (1060)
Q Consensus       925 fg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~ 1002 (1060)
                      ||++..... .+........|..-|||||+++.+ ...+++.+||||||+|+|||+||..||... ..+.    .-|   
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dq----Iif---  603 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQ----IIF---  603 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chhh----eEE---
Confidence            999865332 111122223688899999999743 334589999999999999999999998732 1111    001   


Q ss_pred             HHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1003 KVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1003 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ++  ++..-..|..       .......++|.+++..||. ++++||.+.+|+.+|+.
T Consensus       604 mV--GrG~l~pd~s-------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~  652 (678)
T KOG0193|consen  604 MV--GRGYLMPDLS-------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEE  652 (678)
T ss_pred             Ee--cccccCccch-------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHH
Confidence            11  1111111111       1223566788889999998 79999999999998865

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=336.90  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=201.5

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .++||.|..++||+|+ ...++.||||++.-... ...+.+++|+..|+.++||||++++..|.  .++..|+||.||.+
T Consensus        31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv--v~~~LWvVmpfMa~  108 (516)
T KOG0582|consen   31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV--VDSELWVVMPFMAG  108 (516)
T ss_pred             EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE--ecceeEEeehhhcC
Confidence            5789999999999999 45789999999975433 33588999999999999999999998885  57789999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ||+.+.+......   .+++..+..|.+++++||.||| .+|.||||||+.||||+ .++.+||+|||.+..+...+...
T Consensus       109 GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH-~~G~IHRdvKAgnILi~-~dG~VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  109 GSLLDIIKTYYPD---GLEEASIATILREVLKALDYLH-QNGHIHRDVKAGNILID-SDGTVKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             CcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHH-hcCceecccccccEEEc-CCCcEEEcCceeeeeecccCcee
Confidence            9999999775432   3899999999999999999999 99999999999999999 58999999999887766554222


Q ss_pred             e---eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          939 Q---ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       939 ~---~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      .   ....||+.|||||++.....+|++|+||||||++..|+.+|..||....+       .+.....+..... .. + 
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-------mkvLl~tLqn~pp-~~-~-  253 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-------MKVLLLTLQNDPP-TL-L-  253 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-------HHHHHHHhcCCCC-Cc-c-
Confidence            1   22379999999999776666779999999999999999999999986432       1222222222111 00 0 


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                        .............+.+.+++..|+. ||.+|||++++++
T Consensus       254 --t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 --TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             --cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence              1111111222344577888889997 8999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-39  Score=347.01  Aligned_cols=263  Identities=22%  Similarity=0.292  Sum_probs=199.6

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .++||+|.||.||+|+ ..+|+.||+|+++...  .....-..+||.+|++++||||+++.+...+......|+|+|||+
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd  201 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD  201 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence            4789999999999999 6689999999997543  223456679999999999999999999998666678999999997


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      . ||..++..    ....+++.++..+++|++.||+||| .+||+|||||.+||||| .++.+||+|||+|+++......
T Consensus       202 h-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH-~~gvlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~~  274 (560)
T KOG0600|consen  202 H-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCH-SRGVLHRDIKGSNILID-NNGVLKIADFGLARFYTPSGSA  274 (560)
T ss_pred             c-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHh-hcCeeeccccccceEEc-CCCCEEeccccceeeccCCCCc
Confidence            6 88888743    3456999999999999999999999 99999999999999999 6889999999999988876655


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC----CC-Ccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG----HG-SDC 1012 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~----~~-~~~ 1012 (1060)
                      ..+..+-|.+|+|||.+.|... |+.++|+||.|||+.||++|++.|....    +.+..+.+.......    |. ..+
T Consensus       275 ~~T~rVvTLWYRpPELLLG~t~-Yg~aVDlWS~GCIl~El~~gkPI~~G~t----EveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  275 PYTSRVVTLWYRPPELLLGATS-YGTAVDLWSVGCILAELFLGKPILQGRT----EVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             ccccceEEeeccChHHhcCCcc-cccceeehhhhHHHHHHHcCCCCcCCcc----HHHHHHHHHHHhCCCChhccccccC
Confidence            5555678999999999998774 6889999999999999999999876421    111112221111110    00 000


Q ss_pred             ccccc-cccc-CChhHH----HHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1013 FDAAV-MPEM-VNPAAE----KGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1013 ~d~~l-~~~~-~~~~~~----~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ..... .+.. ......    ......++++...+. ||.+|.||.++++
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            00000 0000 001111    223456777778887 8999999999875

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-40  Score=358.65  Aligned_cols=366  Identities=23%  Similarity=0.270  Sum_probs=272.5

Q ss_pred             CCcEEECcCCcccccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEEEcc
Q 001527           95 MLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLS  174 (1060)
Q Consensus        95 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  174 (1060)
                      .-+.||||+|.|..+-+..|.++++|++++|.+|.++ .+|...+...+|+.|+|.+|.|+..-..++..++.|++||||
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            4578999999999999999999999999999999999 788877777889999999999998888899999999999999


Q ss_pred             CCCCCCCCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCcCCccCchhhhccCCCCeecccCCccccCC
Q 001527          175 HNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSS  254 (1060)
Q Consensus       175 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~  254 (1060)
                      .|.|+.+.-..|..-.++++|+|++|+|+..--+.|.++.+|..|.|+.|+|+.+++..|.+|++|+.|+|..|++.-..
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive  237 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE  237 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence            99999777778888889999999999999888899999999999999999999999999999999777777777664222


Q ss_pred             CcCcCCCccccccEEEccCCcccccCCCCccccCCCCCCEEEccCCccccCCC-CccCCCCccEEEccCCcCcccCCcch
Q 001527          255 SQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNNRFSGFIPNDL  333 (1060)
Q Consensus       255 ~~~~l~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~  333 (1060)
                      .                            -.|..+++|+.|.|..|.|...-+ .|..+.++++|+|+.|+++..- +  
T Consensus       238 ~----------------------------ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn-~--  286 (873)
T KOG4194|consen  238 G----------------------------LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVN-E--  286 (873)
T ss_pred             h----------------------------hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhh-c--
Confidence            1                            345566667777777777765555 4666666666666666655211 1  


Q ss_pred             hccCCCCCCeEECCCCccccccCcccccCCcEEEccCCcCcccCCCCCCCCCEEEccCCccccccccccCCCccCEEEcc
Q 001527          334 LKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLS  413 (1060)
Q Consensus       334 ~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls  413 (1060)
                                                                                       .++++++.|+.|+||
T Consensus       287 -----------------------------------------------------------------g~lfgLt~L~~L~lS  301 (873)
T KOG4194|consen  287 -----------------------------------------------------------------GWLFGLTSLEQLDLS  301 (873)
T ss_pred             -----------------------------------------------------------------ccccccchhhhhccc
Confidence                                                                             112233455555555


Q ss_pred             cCeecccCCCCCcccCCCCeEEccCCcCccccchhccccCCCcEEecCCccccCccccccccCCCcceEEccCccccccC
Q 001527          414 RNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVL  493 (1060)
Q Consensus       414 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  493 (1060)
                      +|.|....++.+.-.++|++|+|++|+|+...+..|..+..|++|+|++|.++..-...|..+++|+.|||++|.|+..+
T Consensus       302 ~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~I  381 (873)
T KOG4194|consen  302 YNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCI  381 (873)
T ss_pred             hhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEE
Confidence            55555555555555666666666666666655666666666666666666666555555666666666666666666555


Q ss_pred             CC---CCCCCCCCcEEEccCCccccccCccccCCCCCcEEECCCCccccccCccccCCCCCCeEeccC
Q 001527          494 DF---SPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQ  558 (1060)
Q Consensus       494 ~~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~  558 (1060)
                      ..   .|..+++|+.|+|.+|+|..+.-..|.+|.+|+.|||.+|.|...-|.+|..| .|+.|-++.
T Consensus       382 EDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  382 EDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             ecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence            43   35567777777777777775444667777777777777777776777777777 677666553

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=355.88  Aligned_cols=245  Identities=22%  Similarity=0.357  Sum_probs=200.1

Q ss_pred             CCCeeccccceEEEEEE-EcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          780 PAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .-++||+|+.|.||.|+ ..+++.||||++.......++-+.+|+.+|+..+|+|||.+++.|.  .+++.|+|||||+|
T Consensus       277 ~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl--v~deLWVVMEym~g  354 (550)
T KOG0578|consen  277 DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL--VGDELWVVMEYMEG  354 (550)
T ss_pred             chhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc--ccceeEEEEeecCC
Confidence            34689999999999998 5679999999998766666777899999999999999999999886  45789999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      |+|.+.+...      .+++.++..|++++++||+||| .+||+|||||.+|||++ .++.+||+|||+|..+.......
T Consensus       355 gsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH-~~gIiHrDIKSDnILL~-~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  355 GSLTDVVTKT------RMTEGQIAAICREILQGLKFLH-ARGIIHRDIKSDNILLT-MDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             Cchhhhhhcc------cccHHHHHHHHHHHHHHHHHHH-hcceeeeccccceeEec-cCCcEEEeeeeeeeccccccCcc
Confidence            9999998543      4899999999999999999999 99999999999999998 58899999999999887766544


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      .+ .+||+.|||||+.....|  ++|+||||||++++||+-|++||-...      .+.. +. .++.....+     +.
T Consensus       427 ~T-mVGTPYWMAPEVvtrk~Y--G~KVDIWSLGIMaIEMveGEPPYlnE~------PlrA-ly-LIa~ng~P~-----lk  490 (550)
T KOG0578|consen  427 ST-MVGTPYWMAPEVVTRKPY--GPKVDIWSLGIMAIEMVEGEPPYLNEN------PLRA-LY-LIATNGTPK-----LK  490 (550)
T ss_pred             cc-ccCCCCccchhhhhhccc--CccccchhhhhHHHHHhcCCCCccCCC------hHHH-HH-HHhhcCCCC-----cC
Confidence            33 489999999999998887  779999999999999999999985311      1111 11 122111111     11


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                            ..+.....+.++..+|+. |+.+||+++|+++.
T Consensus       491 ------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  491 ------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence                  112334456677779998 89999999999863

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=349.73  Aligned_cols=249  Identities=26%  Similarity=0.425  Sum_probs=200.6

Q ss_pred             CCCCCChhhhhccCCCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCC
Q 001527          767 DTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ  846 (1060)
Q Consensus       767 ~~~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  846 (1060)
                      +.+++.+|++..  .+.+|.|+.|.||+|+++ ++.||||+++.-       -..+|+-|++|+||||+.+.|+|.  ..
T Consensus       117 e~WeiPFe~IsE--LeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCt--qs  184 (904)
T KOG4721|consen  117 ELWEIPFEEISE--LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCT--QS  184 (904)
T ss_pred             hhccCCHHHhhh--hhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeec--CC
Confidence            457788887765  578999999999999987 678999987642       235788999999999999999994  45


Q ss_pred             CceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccc
Q 001527          847 HEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYC  926 (1060)
Q Consensus       847 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg  926 (1060)
                      .-+|||||||..|-|...|+.     +.++.......|..+||.|+.||| .+.|||||||+-||||.. +..+||+|||
T Consensus       185 PcyCIiMEfCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH-~hKIIHRDLKSPNiLIs~-~d~VKIsDFG  257 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLH-LHKIIHRDLKSPNILISY-DDVVKISDFG  257 (904)
T ss_pred             ceeEEeeeccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHH-HhhHhhhccCCCceEeec-cceEEecccc
Confidence            578999999999999999954     456888889999999999999999 999999999999999984 6689999999


Q ss_pred             cceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhc
Q 001527          927 LHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAE 1006 (1060)
Q Consensus       927 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~ 1006 (1060)
                      .++......+.  ...+||..|||||++...+.  ++|+||||||||+|||+||..||.......     .-|       
T Consensus       258 TS~e~~~~STk--MSFaGTVaWMAPEvIrnePc--sEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIw-------  321 (904)
T KOG4721|consen  258 TSKELSDKSTK--MSFAGTVAWMAPEVIRNEPC--SEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIW-------  321 (904)
T ss_pred             chHhhhhhhhh--hhhhhhHhhhCHHHhhcCCc--ccccceehhHHHHHHHHhcCCCccccchhe-----eEE-------
Confidence            99876654332  33589999999999998876  899999999999999999999987543211     001       


Q ss_pred             CCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527         1007 GHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1007 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                      +-....    +    .-+....+.+.+.-++..||+ .|..||++.+++..|+
T Consensus       322 GVGsNs----L----~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  322 GVGSNS----L----HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             eccCCc----c----cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            000000    0    012234566677778889998 6999999999999875

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.5e-38  Score=349.36  Aligned_cols=261  Identities=17%  Similarity=0.299  Sum_probs=204.7

Q ss_pred             CCCCChhhhhccCCCeeccccceEEEEEEEcCCcEEEEEEcccchHH---HHHHHHHHHHHHhcCCCCceeeeeeEEeC-
Q 001527          768 TLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAK---QRKEFAKEAKKFANIRHPNVVGLRGYYWG-  843 (1060)
Q Consensus       768 ~~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  843 (1060)
                      ...++.+++.......||+|++|.||+|.+ +|+.||||+++.....   ..+.+.+|++++++++|||||+++|++.+ 
T Consensus        12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~   90 (283)
T PHA02988         12 IKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI   90 (283)
T ss_pred             ceecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence            445677888777678899999999999998 6889999999754322   24678899999999999999999999865 


Q ss_pred             -CCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEE
Q 001527          844 -PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARV  922 (1060)
Q Consensus       844 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl  922 (1060)
                       ......++||||+++|+|.+++...     ..+++..+.+++.|++.||+|||...+++||||||+||+++ +++.+||
T Consensus        91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~-~~~~~kl  164 (283)
T PHA02988         91 VDDLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT-ENYKLKI  164 (283)
T ss_pred             ccCCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC-CCCcEEE
Confidence             3345689999999999999999542     45889999999999999999999335899999999999998 5889999


Q ss_pred             cccccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHH
Q 001527          923 ADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQL 1002 (1060)
Q Consensus       923 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~ 1002 (1060)
                      +|||+++.......    ...|+..|+|||++.+....++.++|||||||++|||++|+.||....       ..++...
T Consensus       165 ~dfg~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-------~~~~~~~  233 (283)
T PHA02988        165 ICHGLEKILSSPPF----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-------TKEIYDL  233 (283)
T ss_pred             cccchHhhhccccc----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-------HHHHHHH
Confidence            99999986543221    236889999999997632234889999999999999999999997431       2222222


Q ss_pred             HHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1003 KVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1003 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ........     .. +       ......+.+++.+||+ +|.+|||++||++.|+.
T Consensus       234 i~~~~~~~-----~~-~-------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        234 IINKNNSL-----KL-P-------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             HHhcCCCC-----CC-C-------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            22211110     00 0       1233467788889998 79999999999999875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=344.42  Aligned_cols=195  Identities=24%  Similarity=0.355  Sum_probs=168.9

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccchH---HHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVA---KQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      ++.||+|+|++||+|+ .+.++.||||++.+.-.   ...+.+..|-.+|.+| .||.|++++-.|  ++....|+|+||
T Consensus        78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF--QD~~sLYFvLe~  155 (604)
T KOG0592|consen   78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF--QDEESLYFVLEY  155 (604)
T ss_pred             hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe--ecccceEEEEEe
Confidence            6899999999999999 55799999999965421   2235677899999999 899999998777  567789999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++|+|.++|+.     .+.+++...+.++.+|+.||+||| ++|||||||||+|||+| +++++||+|||.|+.+....
T Consensus       156 A~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH-~~GIIHRDlKPENILLd-~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  156 APNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLH-SNGIIHRDLKPENILLD-KDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             cCCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHH-hcCceeccCChhheeEc-CCCcEEEeeccccccCChhh
Confidence            999999999954     467999999999999999999999 99999999999999999 69999999999999876432


Q ss_pred             ce----------ee--eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          936 TI----------EQ--ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       936 ~~----------~~--~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ..          ..  ...+||..|.+||++.....  +..+|+|+|||++|+|+.|++||..
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~--~~~sDiWAlGCilyQmlaG~PPFra  289 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA--GPSSDLWALGCILYQMLAGQPPFRA  289 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCC--CcccchHHHHHHHHHHhcCCCCCcc
Confidence            11          11  23579999999999998876  6799999999999999999999975

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.8e-39  Score=336.59  Aligned_cols=267  Identities=18%  Similarity=0.246  Sum_probs=198.1

Q ss_pred             hhccCCCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCC---ceEE
Q 001527          776 LSRAPAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQH---EKLI  851 (1060)
Q Consensus       776 l~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~---~~~l  851 (1060)
                      +.+...+++|+|+||.||+|... +++.||||+.-...    +.-.+|+++|++++|||||++.-+|......   ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            34445689999999999999955 57999999886542    2234799999999999999999888743333   3458


Q ss_pred             EEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceee
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~  931 (1060)
                      |||||+. +|.++++... ..+..++...++-++.||++||+||| +.||+||||||.|+|+|.+.+.+||||||.|+..
T Consensus       100 VleymP~-tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh-~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLH-SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHHhchH-HHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHH-hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            9999975 9999997532 33456888889999999999999999 8999999999999999987899999999999998


Q ss_pred             ccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHH-------HH
Q 001527          932 TQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQL-------KV 1004 (1060)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~ 1004 (1060)
                      .........  ..|..|+|||.+.+... |+.+.||||.|||+.||+-|++-|...+.-   ..++..+..       .+
T Consensus       177 ~~~epniSY--icSRyYRaPELifga~~-Yt~~IDiWSaGCV~aELl~g~plFpG~s~~---dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  177 VKGEPNISY--ICSRYYRAPELIFGATE-YTTSIDIWSAGCVMAELLKGQPLFPGDSSV---DQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             ccCCCceeE--EEeccccCHHHHcCccc-cCceeEEhhhhHHHHHHhcCCcccCCCCHH---HHHHHHHHHhCCCCHHHH
Confidence            776655444  47889999999998874 688999999999999999999988753221   122222211       01


Q ss_pred             hcC--CCCcccccccccccCCh-hHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1005 AEG--HGSDCFDAAVMPEMVNP-AAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1005 ~~~--~~~~~~d~~l~~~~~~~-~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ...  ...+.-.+.+.+..... .......+.++++.++++ +|.+|.++.|++.
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            110  11111112222111100 112334567888889999 8999999999875

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.1e-38  Score=341.68  Aligned_cols=240  Identities=22%  Similarity=0.343  Sum_probs=193.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      -+.||+|+||.||+|+.+ +.+.||+|.+.+..  .++.+.+.+|++++++++|||||.++++|  ++..+.|+|+||+.
T Consensus         7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~vVte~a~   84 (808)
T KOG0597|consen    7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWVVTEYAV   84 (808)
T ss_pred             HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEEEehhhh
Confidence            468999999999999954 78999999986542  33456789999999999999999999999  57789999999997


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      | +|+.++.+     .+.++++.++.|++|++.||.||| +.+|+|||+||.|||++ .++.+|+||||+|+.+..... 
T Consensus        85 g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLh-s~rilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~t~-  155 (808)
T KOG0597|consen   85 G-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLH-SNRILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTNTS-  155 (808)
T ss_pred             h-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHH-hcCcccccCCcceeeec-CCCceeechhhhhhhcccCce-
Confidence            6 99999954     356999999999999999999999 99999999999999998 689999999999998876443 


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      ......||+-|||||...+..+  +..+|+||+||++||+++|++||...       .+.+.++....+        +..
T Consensus       156 vltsikGtPlYmAPElv~e~py--d~~sDlWslGcilYE~~~G~PPF~a~-------si~~Lv~~I~~d--------~v~  218 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPY--DHTSDLWSLGCILYELYVGQPPFYAR-------SITQLVKSILKD--------PVK  218 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCc--cchhhHHHHHHHHHHHhcCCCCchHH-------HHHHHHHHHhcC--------CCC
Confidence            3344589999999999998876  77999999999999999999998642       233344333322        111


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .+.       .....+..++..-+. ||.+|.+-.+++.
T Consensus       219 ~p~-------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 PPS-------TASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             Ccc-------cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            111       223344445445554 8999999888764

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.5e-42  Score=361.29  Aligned_cols=472  Identities=28%  Similarity=0.352  Sum_probs=377.4

Q ss_pred             EEecCCCCccccCcccccCCCCCcEEECcCCcccccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccccc
Q 001527           74 VVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNN  153 (1060)
Q Consensus        74 ~~l~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  153 (1060)
                      ..+++..+.+.-......+|..|..|++++|++. ..|.+++.+..++.|+.++|+++ .+|.+++.+.+|+.|+.++|.
T Consensus        48 ~~lils~N~l~~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~  125 (565)
T KOG0472|consen   48 QKLILSHNDLEVLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNE  125 (565)
T ss_pred             hhhhhccCchhhccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccc
Confidence            3455555554433344458999999999999998 67889999999999999999999 899999999999999999999


Q ss_pred             cCcccCCcccCCCcccEEEccCCCCCCCCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCcCCccCchh
Q 001527          154 FSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGE  233 (1060)
Q Consensus       154 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~  233 (1060)
                      +. ..|++++.+..|+.|+..+|+++ ..|..+.++.+|..|++.+|.+....|..+. ++.|++||...|-++ .+|..
T Consensus       126 ~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~  201 (565)
T KOG0472|consen  126 LK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPE  201 (565)
T ss_pred             ee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChh
Confidence            98 56888999999999999999999 7889999999999999999999876666665 999999999999887 56778


Q ss_pred             hhccCCCCeecccCCccccCCCcCcCCCccccccEEEccCCcccccCCCCccccCCCCCCEEEccCCccccCCCCccCCC
Q 001527          234 FFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVY  313 (1060)
Q Consensus       234 ~~~l~~L~~L~ls~N~l~~~~~~~~l~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~l~  313 (1060)
                      ++.+.+|..|++.+|++...+.   +|+ ...|.+|+++.|+|.-  .+......+.+|.+|||..|+++..+.....++
T Consensus       202 lg~l~~L~~LyL~~Nki~~lPe---f~g-cs~L~Elh~g~N~i~~--lpae~~~~L~~l~vLDLRdNklke~Pde~clLr  275 (565)
T KOG0472|consen  202 LGGLESLELLYLRRNKIRFLPE---FPG-CSLLKELHVGENQIEM--LPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLR  275 (565)
T ss_pred             hcchhhhHHHHhhhcccccCCC---CCc-cHHHHHHHhcccHHHh--hHHHHhcccccceeeeccccccccCchHHHHhh
Confidence            9999999999999999976552   222 2348999999999974  233566689999999999999997777899999


Q ss_pred             CccEEEccCCcCcccCCcchhccCCCCCCeEECCCCccccccCcccc----cCCcEEE-------ccCCc----CcccCC
Q 001527          314 ELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS----TNLHMLN-------LSSNG----LTGELP  378 (1060)
Q Consensus       314 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~----~~L~~L~-------Ls~N~----l~~~~p  378 (1060)
                      +|++||+|+|.|++..+.  ++..  +|+.|-+.+|.+...-.....    .-|++|.       ++.-.    =++..|
T Consensus       276 sL~rLDlSNN~is~Lp~s--Lgnl--hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~  351 (565)
T KOG0472|consen  276 SLERLDLSNNDISSLPYS--LGNL--HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLP  351 (565)
T ss_pred             hhhhhcccCCccccCCcc--cccc--eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCC
Confidence            999999999999975443  3333  599999999988643221111    1122221       11110    001111


Q ss_pred             CC-------CCCCCEEEccCCccccccccccCCCc---cCEEEcccCeecccCCCCCcccCCCCe-EEccCCcCccccch
Q 001527          379 LL-------TGSCAVLDLSNNQFEGNLSRILKWGN---IEYLDLSRNHLTGSIPEETPQFLRLNH-LNLSHNSLSSSLPK  447 (1060)
Q Consensus       379 ~~-------~~~l~~L~Ls~N~l~~~~~~~~~~~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~p~  447 (1060)
                      ..       +.+.+.|+++.-+++..+...+....   +...+++.|++. .+|..+..++.+.. +.+++|.++ .+|.
T Consensus       352 ~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~  429 (565)
T KOG0472|consen  352 SESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPL  429 (565)
T ss_pred             CCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchH
Confidence            11       12355889999999988888777643   788999999998 88988888877655 455555555 8999


Q ss_pred             hccccCCCcEEecCCccccCccccccccCCCcceEEccCccccccCCCCCCCCCCCcEEEccCCccccccCccccCCCCC
Q 001527          448 VIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGL  527 (1060)
Q Consensus       448 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  527 (1060)
                      .++.+++|..|+|++|.+. .+|..++.+..|+.|+++.|+|. .+|..+-.+..|+.+-.++|++....|+.+++|.+|
T Consensus       430 ~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL  507 (565)
T KOG0472|consen  430 ELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNL  507 (565)
T ss_pred             HHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhc
Confidence            9999999999999999987 58889999999999999999887 567666667778888888899987666779999999


Q ss_pred             cEEECCCCccccccCccccCCCCCCeEeccCCcccCCCCCC
Q 001527          528 KVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNN  568 (1060)
Q Consensus       528 ~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~  568 (1060)
                      ..|||.+|.|. .||+.+++|++|++|+|++|+|.  .|..
T Consensus       508 ~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr~  545 (565)
T KOG0472|consen  508 TTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPRH  545 (565)
T ss_pred             ceeccCCCchh-hCChhhccccceeEEEecCCccC--CCHH
Confidence            99999999998 89999999999999999999997  4543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=9.7e-38  Score=310.15  Aligned_cols=262  Identities=22%  Similarity=0.311  Sum_probs=197.1

Q ss_pred             CCCeeccccceEEEEEE-EcCCcEEEEEEcccchHHH--HHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          780 PAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQ--RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ..+++|+|.||.||+|+ ..+|+.||||+++.+...+  .....+|++.|+.++||||+.++++|  +......+|+|||
T Consensus         6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F--~~~~~l~lVfEfm   83 (318)
T KOG0659|consen    6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF--PHKSNLSLVFEFM   83 (318)
T ss_pred             hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc--cCCCceEEEEEec
Confidence            35789999999999999 5579999999998653331  24567999999999999999999999  5777899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      +. +|+..+++.    ...++..++..++.++++|++||| .+.|+||||||.|+|++ .++.+||+|||+|+.+.....
T Consensus        84 ~t-dLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H-~~~IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   84 PT-DLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCH-SKWILHRDLKPNNLLIS-SDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             cc-cHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHH-hhhhhcccCCccceEEc-CCCcEEeecccchhccCCCCc
Confidence            65 999999654    467999999999999999999999 99999999999999998 588999999999999876654


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCC------C
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHG------S 1010 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~------~ 1010 (1060)
                      ..... +-|.+|+|||.+.|... |+..+||||.||++.||+-|.+-|...+    +.+....+-........      .
T Consensus       157 ~~~~~-V~TRWYRAPELLfGsr~-Yg~~VDmWavGCI~AELllr~P~fpG~s----DidQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  157 IQTHQ-VVTRWYRAPELLFGSRQ-YGTGVDMWAVGCIFAELLLRVPFFPGDS----DIDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             ccccc-eeeeeccChHHhccchh-cCCcchhhhHHHHHHHHHccCCCCCCCc----hHHHHHHHHHHcCCCCcccCcccc
Confidence            44332 67899999999998774 5889999999999999999876655321    11111111111111100      0


Q ss_pred             cccccccccccCCh----hHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1011 DCFDAAVMPEMVNP----AAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1011 ~~~d~~l~~~~~~~----~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      +..|-.-...+..+    .........++++..++. +|.+|+++.|.+++
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11110000000000    111334456888889998 89999999999864

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-37  Score=333.35  Aligned_cols=256  Identities=23%  Similarity=0.344  Sum_probs=202.0

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHH-HHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQ-RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .++||+|-||.|..+....+..||||.++...... +++|.+|+++|.+++|||||+++|+|.  .++..++++|||++|
T Consensus       543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~--~DePicmI~EYmEnG  620 (807)
T KOG1094|consen  543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV--QDDPLCMITEYMENG  620 (807)
T ss_pred             hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee--cCCchHHHHHHHhcC
Confidence            68999999999999999888999999999875554 589999999999999999999999996  456789999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+|+..+..   +........+|+.|||.|++||. +.++||||+.+.|+|+| .++++||+|||+++-+-....+..
T Consensus       621 DLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLe-s~nfVHrd~a~rNcLv~-~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  621 DLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLE-SLNFVHRDLATRNCLVD-GEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             cHHHHHHhccC---cccccchhHHHHHHHHHHHHHHH-hhchhhccccccceeec-CcccEEecCcccccccccCCceee
Confidence            99999976532   22455666789999999999999 99999999999999999 589999999999996655444332


Q ss_pred             e-ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          940 I-LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT--GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       940 ~-~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt--G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      . ..+-..+|||||.+.-+++  +.++|||+||+++||+++  ...||....++    ..++-.......+....+.   
T Consensus       696 qgr~vlpiRwmawEsillgkF--ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e----~vven~~~~~~~~~~~~~l---  766 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKF--TTASDVWAFGVTLWEVFMLCREQPYSQLTDE----QVVENAGEFFRDQGRQVVL---  766 (807)
T ss_pred             ecceeeeeeehhHHHHHhccc--cchhhhhhhHHHHHHHHHHHhhCchhhhhHH----HHHHhhhhhcCCCCcceec---
Confidence            2 1234578999999988876  889999999999999865  77888765433    2222222222222111111   


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                             +.+.-+...+.++++.||. +..+||+++++...|.+
T Consensus       767 -------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  767 -------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             -------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence                   1112345678899999998 78999999999988764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-37  Score=353.09  Aligned_cols=255  Identities=27%  Similarity=0.412  Sum_probs=194.1

Q ss_pred             CCeeccccceEEEEEEE------cCCcEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEE
Q 001527          781 AEVLGRSSHGTSYRATL------ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv  852 (1060)
                      .++||+|+||.||+|..      .+++.||||+++... ....+.+.+|+++++++ +||||++++++|.. .....++|
T Consensus        12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~~lv   90 (338)
T cd05102          12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-PNGPLMVI   90 (338)
T ss_pred             eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC-CCCceEEE
Confidence            57899999999999974      235789999997543 23456789999999999 89999999998853 34568999


Q ss_pred             EEecCCCChHHHhhcCCCC---------------------------------------------------------CCCC
Q 001527          853 SDYISPGSLASFLYDRPGR---------------------------------------------------------KGPP  875 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~~  875 (1060)
                      |||+++|+|.+++......                                                         ...+
T Consensus        91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (338)
T cd05102          91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP  170 (338)
T ss_pred             EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence            9999999999999653210                                                         0235


Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce-eeeccCccccccchhcc
Q 001527          876 LTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI-EQILDAGVLGYRAPELA  954 (1060)
Q Consensus       876 l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~  954 (1060)
                      +++.++..++.||+.||+||| ++||+||||||+|||++ +++.+||+|||+++........ ......++..|+|||++
T Consensus       171 l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  248 (338)
T cd05102         171 LTMEDLICYSFQVARGMEFLA-SRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI  248 (338)
T ss_pred             CCHHHHHHHHHHHHHHHHHHH-HCCEECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence            888999999999999999999 99999999999999998 5789999999999865432221 11122456789999999


Q ss_pred             cCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHH
Q 001527          955 ASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEV 1033 (1060)
Q Consensus       955 ~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l 1033 (1060)
                      .+..+  +.++|||||||++|||++ |+.||......      ..+. .....+...     .. +       ......+
T Consensus       249 ~~~~~--~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~-~~~~~~~~~-----~~-~-------~~~~~~l  306 (338)
T cd05102         249 FDKVY--TTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFC-QRLKDGTRM-----RA-P-------ENATPEI  306 (338)
T ss_pred             hcCCC--CcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHH-HHHhcCCCC-----CC-C-------CCCCHHH
Confidence            87765  789999999999999997 99998753211      1111 112211110     00 0       1223467


Q ss_pred             HHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1034 LGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1034 ~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      .+++.+|++ +|.+|||+.||+++|+.+
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            889999998 799999999999999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.1e-38  Score=339.88  Aligned_cols=245  Identities=18%  Similarity=0.248  Sum_probs=194.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHH---HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAK---QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ..+||+|+||.||.|+-+ +|..+|+|++++....   +.+.+..|-++|...++|.||+++-.|  ++.+..||||||+
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF--QD~~~LYLiMEyl  223 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF--QDKEYLYLIMEYL  223 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe--cCCCeeEEEEEec
Confidence            478999999999999954 6999999999875433   456788999999999999999997776  6788999999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC--
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA--  934 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~--  934 (1060)
                      +||++..+|.     ....|++..++.++.+++.|++-+| +.|+|||||||+|+||| ..+++||+|||++......  
T Consensus       224 PGGD~mTLL~-----~~~~L~e~~arfYiaE~vlAI~~iH-~~gyIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  224 PGGDMMTLLM-----RKDTLTEDWARFYIAETVLAIESIH-QLGYIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             CCccHHHHHH-----hcCcCchHHHHHHHHHHHHHHHHHH-HcCcccccCChhheeec-CCCCEeeccccccchhhhhhh
Confidence            9999999994     3467999999999999999999999 99999999999999999 5899999999998532210  


Q ss_pred             ---------------------Cc----eeee-------------------ccCccccccchhcccCCCCCCCCccchHHH
Q 001527          935 ---------------------GT----IEQI-------------------LDAGVLGYRAPELAASKKPHPSFKSDVYAF  970 (1060)
Q Consensus       935 ---------------------~~----~~~~-------------------~~~gt~~y~aPE~~~~~~~~~s~~~DvwSl  970 (1060)
                                           ..    ....                   ..+|||.|||||++.+.++  +..+|+||+
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY--~~~cDwWSL  374 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY--GKECDWWSL  374 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC--CccccHHHH
Confidence                                 00    0000                   1369999999999999886  789999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhccCCCCCCC-
Q 001527          971 GVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPG- 1049 (1060)
Q Consensus       971 Gvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~~p~~RPs- 1049 (1060)
                      |||+|||+.|.+||......+....+..|.......                  .......+..++|.+|+.+|++|-. 
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP------------------~~~~~s~eA~DLI~rll~d~~~RLG~  436 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP------------------EEVDLSDEAKDLITRLLCDPENRLGS  436 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC------------------CcCcccHHHHHHHHHHhcCHHHhcCc
Confidence            999999999999998765544444555554321111                  1112224566778888889988864 


Q ss_pred             --HHHHH
Q 001527         1050 --IKTIY 1054 (1060)
Q Consensus      1050 --~~evl 1054 (1060)
                        ++||-
T Consensus       437 ~G~~EIK  443 (550)
T KOG0605|consen  437 KGAEEIK  443 (550)
T ss_pred             ccHHHHh
Confidence              55553

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6e-39  Score=359.62  Aligned_cols=249  Identities=26%  Similarity=0.453  Sum_probs=206.2

Q ss_pred             CCeeccccceEEEEEEEc----CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE----NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .++||.|.||+||+|+++    ....||||.+|.+. .+++.+|..|+.||.+++||||+++.|+..  ......+|+||
T Consensus       634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT--ks~PvMIiTEy  711 (996)
T KOG0196|consen  634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT--KSKPVMIITEY  711 (996)
T ss_pred             EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe--cCceeEEEhhh
Confidence            589999999999999975    25789999999764 456788999999999999999999999984  55678899999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      |++|+|+.||+.+.    +.+++.+...+.++||.|+.||- +.++|||||.+.|||++ .+..+|++|||+++...++.
T Consensus       712 MENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLs-dm~YVHRDLAARNILVN-snLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  712 MENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLS-DMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHh-hcCchhhhhhhhheeec-cceEEEeccccceeecccCC
Confidence            99999999997654    45999999999999999999999 99999999999999999 58999999999999886655


Q ss_pred             ceeeeccCc--cccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          936 TIEQILDAG--VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       936 ~~~~~~~~g--t~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ....+...|  ..+|.|||.+...++  +.++||||||||+||.++ |.+||-.++.+    +...    .+.       
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKF--TsASDVWSyGIVmWEVmSyGERPYWdmSNQ----dVIk----aIe-------  848 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKF--TSASDVWSYGIVMWEVMSYGERPYWDMSNQ----DVIK----AIE-------  848 (996)
T ss_pred             CccccccCCccceeecChhHhhhccc--CchhhccccceEEEEecccCCCcccccchH----HHHH----HHH-------
Confidence            333222223  468999999998887  789999999999999766 99998765432    1111    111       


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                            ..+.-|.+.+++..+.++++.||+ |-.+||++.||+..|.++
T Consensus       849 ------~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  849 ------QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             ------hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence                  123334456788899999999999 679999999999998753

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=348.64  Aligned_cols=243  Identities=26%  Similarity=0.377  Sum_probs=192.8

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccc----hH-HHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREG----VA-KQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .+.||+|+||.||.|.. .+++.||+|++...    .. ...+.+.+|+.++++++ ||||+++++++.  .....++||
T Consensus        22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~--t~~~~~ivm   99 (370)
T KOG0583|consen   22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA--TPTKIYIVM   99 (370)
T ss_pred             eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe--cCCeEEEEE
Confidence            57899999999999984 57899999987653    11 23456778999999999 999999999995  455699999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeec-
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT-  932 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~-  932 (1060)
                      ||+.+|+|.+++..     .+++.+.++.++++|++.|++||| ++||+||||||+|||+|...+.+||+|||++.... 
T Consensus       100 Ey~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H-~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen  100 EYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCH-SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             EecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHH-hCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            99999999999965     346888999999999999999999 99999999999999999532899999999999874 


Q ss_pred             cCCceeeeccCccccccchhcccCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          933 QAGTIEQILDAGVLGYRAPELAASKK-PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                      ......  ..+||+.|+|||++.+.. |. ..++||||+||++|.|++|+.||+..       +.....+. +..+... 
T Consensus       174 ~~~~l~--t~cGsp~Y~aPEvl~~~~~Y~-g~~aDvWS~GViLy~ml~G~~PF~d~-------~~~~l~~k-i~~~~~~-  241 (370)
T KOG0583|consen  174 EDGLLK--TFCGSPAYAAPEVLSGKGTYS-GKAADVWSLGVILYVLLCGRLPFDDS-------NVPNLYRK-IRKGEFK-  241 (370)
T ss_pred             CCCccc--CCCCCcccCCHHHhCCCCCcC-CchhhhhhhHHHHHHHHhCCCCCCCc-------cHHHHHHH-HhcCCcc-
Confidence            322222  348999999999999877 53 67999999999999999999999852       22222222 2221110 


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                            .+.+.     . ...+..++.+|+. +|.+|+|+.||++
T Consensus       242 ------~p~~~-----~-S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  242 ------IPSYL-----L-SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ------CCCCc-----C-CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                  11111     0 3456777778988 7999999999983

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-37  Score=307.46  Aligned_cols=199  Identities=24%  Similarity=0.359  Sum_probs=173.7

Q ss_pred             CChhhhhccCCCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCC
Q 001527          771 LTPEELSRAPAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ  846 (1060)
Q Consensus       771 ~~~~~l~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  846 (1060)
                      +.+++...  ...||.|+||+|.+++.+ +|..+|+|++++...   ++.+...+|..+|+.+.||+++++++.|  .+.
T Consensus        41 ~~l~dfe~--~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~--~d~  116 (355)
T KOG0616|consen   41 YSLQDFER--LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF--KDN  116 (355)
T ss_pred             cchhhhhh--eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee--ccC
Confidence            34444433  478999999999999954 799999999987643   3446677899999999999999999888  467


Q ss_pred             CceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccc
Q 001527          847 HEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYC  926 (1060)
Q Consensus       847 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg  926 (1060)
                      ...++||||++||.|..+++.     .+++++..++.+|.||+.||+||| +.+|++||+||+|||+| .++.+||+|||
T Consensus       117 ~~lymvmeyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH-~~~iiYRDLKPENiLlD-~~G~iKitDFG  189 (355)
T KOG0616|consen  117 SNLYMVMEYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLH-SLDIIYRDLKPENLLLD-QNGHIKITDFG  189 (355)
T ss_pred             CeEEEEEeccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHH-hcCeeeccCChHHeeec-cCCcEEEEecc
Confidence            789999999999999999954     456999999999999999999999 99999999999999999 68999999999


Q ss_pred             cceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          927 LHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       927 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      +|+.....    +...+||+.|+|||+++..++  ..++|.|||||++|||+.|.+||..
T Consensus       190 FAK~v~~r----T~TlCGTPeYLAPEii~sk~y--nkavDWWalGVLIYEMlaG~pPF~~  243 (355)
T KOG0616|consen  190 FAKRVSGR----TWTLCGTPEYLAPEIIQSKGY--NKAVDWWALGVLIYEMLAGYPPFYD  243 (355)
T ss_pred             ceEEecCc----EEEecCCccccChHHhhcCCC--CcchhHHHHHHHHHHHHcCCCCCcC
Confidence            99987654    223489999999999999886  7799999999999999999999975

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.9e-41  Score=352.94  Aligned_cols=471  Identities=28%  Similarity=0.393  Sum_probs=384.9

Q ss_pred             CCCCCcEEECcCCcccccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEE
Q 001527           92 NLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSL  171 (1060)
Q Consensus        92 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  171 (1060)
                      .-..|+.|++++|.++ .+...+.+|..|++|++.+|++. ..|.+++.+..++.|+.++|++. .+|..+..+.+|..|
T Consensus        43 ~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l  119 (565)
T KOG0472|consen   43 EQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKL  119 (565)
T ss_pred             hhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhh
Confidence            3456889999999999 45556889999999999999999 88999999999999999999998 679999999999999


Q ss_pred             EccCCCCCCCCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCcCCccCchhhhccCCCCeecccCCccc
Q 001527          172 DLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFV  251 (1060)
Q Consensus       172 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~  251 (1060)
                      +.++|.+. .+|+.++.+..|+.|+..+|+++ ..|+++..+.+|..|++.+|++...+|+.+. ++.|++||...|.+.
T Consensus       120 ~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~  196 (565)
T KOG0472|consen  120 DCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE  196 (565)
T ss_pred             hcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh
Confidence            99999999 78889999999999999999996 5788899999999999999999998888777 999999999999998


Q ss_pred             cCCCcCcCCCccccccEEEccCCcccccCCCCccccCCCCCCEEEccCCccccCCC-CccCCCCccEEEccCCcCcccCC
Q 001527          252 GSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNNRFSGFIP  330 (1060)
Q Consensus       252 ~~~~~~~l~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p  330 (1060)
                      .+++..   +...+|+.|+|.+|+|...    .+|..++.|++|+++.|+|...+. ...++.+|.+|||..|+++ ..|
T Consensus       197 tlP~~l---g~l~~L~~LyL~~Nki~~l----Pef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~P  268 (565)
T KOG0472|consen  197 TLPPEL---GGLESLELLYLRRNKIRFL----PEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVP  268 (565)
T ss_pred             cCChhh---cchhhhHHHHhhhcccccC----CCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCc
Confidence            766543   3346688999999999743    268888999999999999985544 3668999999999999998 567


Q ss_pred             cchhccCCCCCCeEECCCCccccccCcccccCCcEEEccCCcCcccCCCCCCC-----CCEEE-------ccCC------
Q 001527          331 NDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGS-----CAVLD-------LSNN------  392 (1060)
Q Consensus       331 ~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~-------Ls~N------  392 (1060)
                      ++....  .+|.+||+|+|.|++..+..-.-.|+.|-+.+|.+...--..+..     +++|.       +|.-      
T Consensus       269 de~clL--rsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~  346 (565)
T KOG0472|consen  269 DEICLL--RSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTET  346 (565)
T ss_pred             hHHHHh--hhhhhhcccCCccccCCcccccceeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccc
Confidence            655432  238899999999997665443357888999999875311100000     11110       1111      


Q ss_pred             ---ccccccccccCCCccCEEEcccCeecccCCCCCcccCC---CCeEEccCCcCccccchhccccCCCcE-EecCCccc
Q 001527          393 ---QFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLR---LNHLNLSHNSLSSSLPKVIIQYQKLRV-LDLSFNHL  465 (1060)
Q Consensus       393 ---~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l  465 (1060)
                         ...+..+......+.+.|+++.-+++ .+|+..+.-.+   ....+++.|++. .+|+.+..+..+.+ +++++|.+
T Consensus       347 ~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i  424 (565)
T KOG0472|consen  347 AMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI  424 (565)
T ss_pred             cCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc
Confidence               01122333444567899999999999 78888776665   889999999999 78998888877765 45666666


Q ss_pred             cCccccccccCCCcceEEccCccccccCCCCCCCCCCCcEEEccCCccccccCccccCCCCCcEEECCCCccccccCccc
Q 001527          466 DGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSM  545 (1060)
Q Consensus       466 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~  545 (1060)
                      + .+|..++.+++|..|+|++|-+. .+|.+++.+..|+.||+|+|+|. .+|..+-.+..|+.+-.++|++...-|+.+
T Consensus       425 s-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l  501 (565)
T KOG0472|consen  425 S-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGL  501 (565)
T ss_pred             c-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHh
Confidence            4 68888999999999999999887 57888999999999999999998 799999888889998888999985555559


Q ss_pred             cCCCCCCeEeccCCcccCCCCCCCc--cCCceeeCcCCcCc
Q 001527          546 ANMTSLSSLVISQNHFTGPLPNNLP--NSLETFNVSYNDFS  584 (1060)
Q Consensus       546 ~~l~~L~~L~ls~N~l~g~ip~~~~--~~l~~l~ls~N~l~  584 (1060)
                      .+|.+|.+|||.+|.+. .||+.+.  .+|.+|++++|+|.
T Consensus       502 ~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  502 KNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            99999999999999998 7887764  58999999999997

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-37  Score=340.78  Aligned_cols=242  Identities=27%  Similarity=0.389  Sum_probs=198.7

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++-||.|+.|.|..|+. .+|+.+|||++.+..   ......+.+|+-+|+-+.||||++++++|.  +..+.|+|.||+
T Consensus        17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe--~~~~lylvlEyv   94 (786)
T KOG0588|consen   17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE--NKQHLYLVLEYV   94 (786)
T ss_pred             cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec--cCceEEEEEEec
Confidence            56799999999999994 589999999996542   223457889999999999999999999994  677899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|-|++++..     .+++++.++.+++.||+.|+.|+| ..+|+|||+||+|+|+|. ...+||+|||+|..-.++..
T Consensus        95 ~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH-~~~icHRDLKpENlLLd~-~~nIKIADFGMAsLe~~gkl  167 (786)
T KOG0588|consen   95 PGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCH-AFNICHRDLKPENLLLDV-KNNIKIADFGMASLEVPGKL  167 (786)
T ss_pred             CCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHh-hhcceeccCCchhhhhhc-ccCEeeeccceeecccCCcc
Confidence            99999999954     356999999999999999999999 999999999999999995 56699999999987666554


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      ..+.  +|++.|.|||++.|.+|+ ..++||||+|||+|.|+||+.||++       .++.... ..++.+.++      
T Consensus       168 LeTS--CGSPHYA~PEIV~G~pYd-G~~sDVWSCGVILfALLtG~LPFdD-------dNir~LL-lKV~~G~f~------  230 (786)
T KOG0588|consen  168 LETS--CGSPHYAAPEIVSGRPYD-GRPSDVWSCGVILFALLTGKLPFDD-------DNIRVLL-LKVQRGVFE------  230 (786)
T ss_pred             cccc--CCCcccCCchhhcCCCCC-CCccccchhHHHHHHHHhCCCCCCC-------ccHHHHH-HHHHcCccc------
Confidence            4443  899999999999999985 8899999999999999999999983       1333332 333333332      


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                       ++.       ....+..+++.+++. ||++|.|++||++.
T Consensus       231 -MPs-------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  231 -MPS-------NISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -CCC-------cCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence             122       233345566667777 99999999999874

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=345.56  Aligned_cols=361  Identities=26%  Similarity=0.276  Sum_probs=272.4

Q ss_pred             cEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEEEccCCCCCCCCCccccCCCCccEEEeecC
Q 001527          121 EFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN  200 (1060)
Q Consensus       121 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  200 (1060)
                      +.||||+|.++.+-+..|.+|++|+.++|..|.++ .+|.......+|+.|+|.+|.|+..-...+..++.|+.||||.|
T Consensus        81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN  159 (873)
T KOG4194|consen   81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN  159 (873)
T ss_pred             eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence            45788888888777777778888888888777776 55655555556777777777777666667777777777777777


Q ss_pred             cccccCCcccccCCCCCEEEccCCcCCccCchhhhccCCCCeecccCCccccCCCcCcCCCccccccEEEccCCcccccC
Q 001527          201 GFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSL  280 (1060)
Q Consensus       201 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~l~~~~~~L~~L~Ls~N~l~~~~  280 (1060)
                      .|+.+.-..|..-.++++|+|++|+|+.+-.+.|.++.+                          |..|.|+.|+|+...
T Consensus       160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lns--------------------------L~tlkLsrNrittLp  213 (873)
T KOG4194|consen  160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNS--------------------------LLTLKLSRNRITTLP  213 (873)
T ss_pred             hhhcccCCCCCCCCCceEEeeccccccccccccccccch--------------------------heeeecccCcccccC
Confidence            777666666666667777777777777666666655554                          444444444444322


Q ss_pred             CCCccccCCCCCCEEEccCCccccCCC-CccCCCCccEEEccCCcCcccCCcchhccCCCCCCeEECCCCccccccCccc
Q 001527          281 VNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMIL  359 (1060)
Q Consensus       281 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~  359 (1060)
                      +  ..|..+++|+.|+|..|+|.-..- .|..+.+|+.|.|..|.+.. +.+                            
T Consensus       214 ~--r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~k-L~D----------------------------  262 (873)
T KOG4194|consen  214 Q--RSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISK-LDD----------------------------  262 (873)
T ss_pred             H--HHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccc-ccC----------------------------
Confidence            2  455566666666666666653322 45555555555555555542 111                            


Q ss_pred             ccCCcEEEccCCcCcccCCCCCCCCCEEEccCCccccccccccCCCccCEEEcccCeecccCCCCCcccCCCCeEEccCC
Q 001527          360 STNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHN  439 (1060)
Q Consensus       360 ~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  439 (1060)
                                                             ..+..+.+++.|+|+.|+++..-..++.++++|+.|+||+|
T Consensus       263 ---------------------------------------G~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~N  303 (873)
T KOG4194|consen  263 ---------------------------------------GAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYN  303 (873)
T ss_pred             ---------------------------------------cceeeecccceeecccchhhhhhcccccccchhhhhccchh
Confidence                                                   12334467788888888888777789999999999999999


Q ss_pred             cCccccchhccccCCCcEEecCCccccCccccccccCCCcceEEccCccccccCCCCCCCCCCCcEEEccCCccccccCc
Q 001527          440 SLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPD  519 (1060)
Q Consensus       440 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  519 (1060)
                      .|...-++.+.-+++|++|||++|+|+...+..|..+..|++|+|++|+++.+-...|..+++|+.|||++|.|++.|-+
T Consensus       304 aI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED  383 (873)
T KOG4194|consen  304 AIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED  383 (873)
T ss_pred             hhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence            99999999999999999999999999988889999999999999999999988888999999999999999999988765


Q ss_pred             ---cccCCCCCcEEECCCCccccccCccccCCCCCCeEeccCCcccCCCCCCCc-cCCceeeC
Q 001527          520 ---RLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLP-NSLETFNV  578 (1060)
Q Consensus       520 ---~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~~-~~l~~l~l  578 (1060)
                         .|..|++|+.|+|.+|+|...--.+|..+.+|+.|||-+|.+-..-|..+. ..|+.|-+
T Consensus       384 aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~  446 (873)
T KOG4194|consen  384 AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVM  446 (873)
T ss_pred             chhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhh
Confidence               477899999999999999944445899999999999999999866666642 24555444

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=304.35  Aligned_cols=262  Identities=22%  Similarity=0.268  Sum_probs=205.5

Q ss_pred             hccCCCeeccccceEEEEEE-EcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCC---CCCceEEE
Q 001527          777 SRAPAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGP---TQHEKLIL  852 (1060)
Q Consensus       777 ~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~---~~~~~~lv  852 (1060)
                      .|...+.+|+|||+.||.++ ..++..+|+|++.-...++.+...+|++..++++||||++++++...+   ...+.|++
T Consensus        22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll  101 (302)
T KOG2345|consen   22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLL  101 (302)
T ss_pred             eEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEE
Confidence            44557899999999999999 778999999999877777788899999999999999999999987632   34468999


Q ss_pred             EEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC--cccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          853 SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA--VPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~--ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      ++|...|+|.+.+.... .++..+++.+++.|+.+|++||++|| +..  ++||||||.|||+. +.+.+++.|||.+..
T Consensus       102 ~Pyy~~Gsl~d~i~~~k-~kg~~~sE~~iL~if~gic~gL~~lH-~~~~~yAH~DiKP~NILls-~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  102 LPYYKRGSLLDEIERLK-IKGNFVSEAQILWIFLGICRGLEALH-EKEPPYAHRDIKPANILLS-DSGLPVLMDLGSATQ  178 (302)
T ss_pred             eehhccccHHHHHHHHh-hcCCccCHHHHHHHHHHHHHHHHHHh-ccCCcccccCCCcceeEec-CCCceEEEeccCccc
Confidence            99999999999997654 34457999999999999999999999 665  99999999999998 578999999999876


Q ss_pred             eccCCce--------eeeccCccccccchhcccCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHH
Q 001527          931 MTQAGTI--------EQILDAGVLGYRAPELAASKK-PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQ 1001 (1060)
Q Consensus       931 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~ 1001 (1060)
                      ..-.-..        .......|..|+|||.+.-.. ...++++|||||||++|+|+.|..||+.....++...+     
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL-----  253 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL-----  253 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE-----
Confidence            5321110        011235789999999985321 23488999999999999999999999875543221111     


Q ss_pred             HHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1002 LKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1002 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                                   ....+.+..|......+.+.+++.+|++ ||.+||++.|++..+..
T Consensus       254 -------------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  254 -------------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             -------------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                         0001111112222356778889999998 89999999999998865

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-38  Score=331.93  Aligned_cols=244  Identities=21%  Similarity=0.305  Sum_probs=196.5

Q ss_pred             CCCeeccccceEEEEEEE-cCCcEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          780 PAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      ..++||+|+||.||+|.. ..++.||+|++.-... ...+++++|+.++.+++++||.++||.|.  .+...+++||||.
T Consensus        17 ~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl--~g~~LwiiMey~~   94 (467)
T KOG0201|consen   17 KLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL--KGTKLWIIMEYCG   94 (467)
T ss_pred             cchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee--ecccHHHHHHHhc
Confidence            347899999999999994 5799999999975433 34578999999999999999999999986  4668899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      ||++.+.+.     .+..+++..+.-|++++..|+.||| ..+.+|||||+.|||+. .++.+|++|||.+..+......
T Consensus        95 gGsv~~lL~-----~~~~~~E~~i~~ilre~l~~l~ylH-~~~kiHrDIKaanil~s-~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   95 GGSVLDLLK-----SGNILDEFEIAVILREVLKGLDYLH-SEKKIHRDIKAANILLS-ESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             Ccchhhhhc-----cCCCCccceeeeehHHHHHHhhhhh-hcceecccccccceeEe-ccCcEEEEecceeeeeechhhc
Confidence            999999993     3445688888889999999999999 89999999999999998 4689999999999887765544


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      . ...+||+.|||||++....|  +.|+||||+|++.+||.+|.+|+....+...-.        .+     ..-.-|.+
T Consensus       168 r-~tfvGTPfwMAPEVI~~~~Y--~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--------lI-----pk~~PP~L  231 (467)
T KOG0201|consen  168 R-KTFVGTPFWMAPEVIKQSGY--DTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--------LI-----PKSAPPRL  231 (467)
T ss_pred             c-ccccccccccchhhhccccc--cchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--------ec-----cCCCCCcc
Confidence            3 33489999999999996665  889999999999999999999987543311000        00     00111122


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .        ....+.+.+++..|+. +|+.||+|+++++.
T Consensus       232 ~--------~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  232 D--------GDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             c--------cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            1        1334557788889998 79999999999864

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-37  Score=326.76  Aligned_cols=249  Identities=22%  Similarity=0.292  Sum_probs=189.9

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccchHH--------------HHHHHHHHHHHHhcCCCCceeeeeeEEeCCC
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAK--------------QRKEFAKEAKKFANIRHPNVVGLRGYYWGPT  845 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  845 (1060)
                      .+.||+|.||.|-+|+. .+++.||+|++.+....              ..+...+|+.+|++++|||||+++.+.-++.
T Consensus       102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~  181 (576)
T KOG0585|consen  102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE  181 (576)
T ss_pred             hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence            56799999999999994 47999999998643211              1257889999999999999999999998888


Q ss_pred             CCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccc
Q 001527          846 QHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY  925 (1060)
Q Consensus       846 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Df  925 (1060)
                      .+..|+|+|||..|.+...=     .....+++.++++|+++++.||+||| .+|||||||||+|+|++ +++++||+||
T Consensus       182 s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH-~QgiiHRDIKPsNLLl~-~~g~VKIsDF  254 (576)
T KOG0585|consen  182 SDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLH-YQGIIHRDIKPSNLLLS-SDGTVKISDF  254 (576)
T ss_pred             cCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHH-hcCeeccccchhheEEc-CCCcEEeecc
Confidence            88999999999988764332     11223899999999999999999999 99999999999999998 5799999999


Q ss_pred             ccceeeccCCce----eeeccCccccccchhcccCCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHH
Q 001527          926 CLHRLMTQAGTI----EQILDAGVLGYRAPELAASKK--PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDW  999 (1060)
Q Consensus       926 g~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~  999 (1060)
                      |.+.........    .-...+||+.|+|||...++.  ...+++.||||+||++|.|+.|+.||-...       ..+.
T Consensus       255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-------~~~l  327 (576)
T KOG0585|consen  255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-------ELEL  327 (576)
T ss_pred             ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-------HHHH
Confidence            999876332111    111247999999999998732  234778999999999999999999986421       1111


Q ss_pred             HHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1000 MQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1000 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      ....+         ...+    ..|..++.-+.+.+++.+++. ||.+|.+..+|...
T Consensus       328 ~~KIv---------n~pL----~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  328 FDKIV---------NDPL----EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             HHHHh---------cCcc----cCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            11111         1111    112222445566777778886 79999999988643

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=361.93  Aligned_cols=253  Identities=29%  Similarity=0.427  Sum_probs=201.5

Q ss_pred             CCeeccccceEEEEEEEcC--Cc----EEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLEN--GM----FLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|++.+  |.    .||+|.+++.. .....+|.+|+.+|++++|||||+++|+|.+  ....++++
T Consensus       697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~~~~i~l  774 (1025)
T KOG1095|consen  697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SGPPLILL  774 (1025)
T ss_pred             eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CCCcEEEe
Confidence            5789999999999999653  43    48999998653 4566899999999999999999999999974  66789999


Q ss_pred             EecCCCChHHHhhcCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceee
Q 001527          854 DYISPGSLASFLYDRPGRK--GPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~  931 (1060)
                      |||++|+|..||++.+...  ...++..+.+.++.|||+|+.||+ ++++|||||..+|+|++ ....+||+|||+|+.+
T Consensus       775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe-~~~fvHRDLAaRNCLL~-~~r~VKIaDFGlArDi  852 (1025)
T KOG1095|consen  775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE-SKHFVHRDLAARNCLLD-ERRVVKIADFGLARDI  852 (1025)
T ss_pred             hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH-hCCCcCcchhhhheeec-ccCcEEEcccchhHhh
Confidence            9999999999998753222  345889999999999999999999 99999999999999999 5789999999999954


Q ss_pred             ccCCceeeecc-CccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCC
Q 001527          932 TQAGTIEQILD-AGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHG 1009 (1060)
Q Consensus       932 ~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 1009 (1060)
                      .....+..... .-...|||||.+..+.+  +.|+|||||||++||++| |..||......    ++   +......+++
T Consensus       853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iF--tskSDvWsFGVllWEifslG~~PY~~~~n~----~v---~~~~~~ggRL  923 (1025)
T KOG1095|consen  853 YDKDYYRKHGEAMLPVKWMPPESLKDGIF--TSKSDVWSFGVLLWEIFSLGATPYPSRSNF----EV---LLDVLEGGRL  923 (1025)
T ss_pred             hhchheeccCccccceecCCHHHHhhccc--ccccchhhhHHHHHHHHhCCCCCCCCcchH----HH---HHHHHhCCcc
Confidence            44433332221 22468999999998766  889999999999999999 88898753221    11   1112222211


Q ss_pred             CcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1010 SDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1010 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                          +          .+..+...+.+++.+||+ +|++||++..|++++.+|
T Consensus       924 ----~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  924 ----D----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             ----C----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence                1          123456778899999998 799999999999988654

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=341.69  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=203.8

Q ss_pred             CeeccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          782 EVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      -++|+|.||+||.|+. ++...+|||-+........+.+..|+..-++++|.|||+++|.+  ..++..-+.||.++||+
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecCCCCc
Confidence            4899999999999995 45778999999877677778899999999999999999999998  45667889999999999


Q ss_pred             hHHHhhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          861 LASFLYDRPGRKGPPL--TWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l--~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      |.+.++...    +++  .+.+.-.+.+||++||.||| +..|||||||-+|||++.-.+.+||+|||.++....-....
T Consensus       659 LSsLLrskW----GPlKDNEstm~fYtkQILeGLkYLH-en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T  733 (1226)
T KOG4279|consen  659 LSSLLRSKW----GPLKDNESTMNFYTKQILEGLKYLH-ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT  733 (1226)
T ss_pred             HHHHHHhcc----CCCccchhHHHHHHHHHHHHhhhhh-hcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence            999997654    345  77888899999999999999 99999999999999998778899999999998876544433


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      . ...||..|||||++..++.+|..++|||||||++.||.||++||......+.     .    +.+-+.+         
T Consensus       734 E-TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-----A----MFkVGmy---------  794 (1226)
T KOG4279|consen  734 E-TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-----A----MFKVGMY---------  794 (1226)
T ss_pred             c-ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-----h----hhhhcce---------
Confidence            2 2379999999999998888889999999999999999999999975432211     1    1111111         


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                       ...++.+++...+...++++|.. +|.+||+++++++
T Consensus       795 -KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  795 -KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             -ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence             11223445677788899999999 7999999999875

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=341.06  Aligned_cols=259  Identities=27%  Similarity=0.426  Sum_probs=198.8

Q ss_pred             CCCCChhhhhccCCCeeccccceEEEEEEEc--CC--cE-EEEEEccc---chHHHHHHHHHHHHHHhcCCCCceeeeee
Q 001527          768 TLTLTPEELSRAPAEVLGRSSHGTSYRATLE--NG--MF-LTVKWLRE---GVAKQRKEFAKEAKKFANIRHPNVVGLRG  839 (1060)
Q Consensus       768 ~~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~--~~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  839 (1060)
                      .+++.-+++...  ++||+|+||.||+|++.  ++  .. ||||..+.   ......++|.+|+++|++++|||||+++|
T Consensus       151 ~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG  228 (474)
T KOG0194|consen  151 KWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG  228 (474)
T ss_pred             ccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            344555555543  89999999999999965  23  23 89999884   23556789999999999999999999999


Q ss_pred             EEeCCCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCC
Q 001527          840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLN  919 (1060)
Q Consensus       840 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~  919 (1060)
                      ++.  .....++|||+|.||+|.+||....    ..++..++.+++.++|+||+||| ++++|||||-++|+|++ .+..
T Consensus       229 Va~--~~~Pl~ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh-~k~~IHRDIAARNcL~~-~~~~  300 (474)
T KOG0194|consen  229 VAV--LEEPLMLVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLH-SKNCIHRDIAARNCLYS-KKGV  300 (474)
T ss_pred             EEc--CCCccEEEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHH-HCCCcchhHhHHHheec-CCCe
Confidence            995  4567899999999999999996543    25999999999999999999999 99999999999999998 5677


Q ss_pred             eEEcccccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHH
Q 001527          920 ARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTD  998 (1060)
Q Consensus       920 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~  998 (1060)
                      +||+|||+++......... ....-...|+|||.+....+  ++++|||||||++||+++ |..||.....    ..+..
T Consensus       301 vKISDFGLs~~~~~~~~~~-~~~klPirWLAPEtl~~~~~--s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----~~v~~  373 (474)
T KOG0194|consen  301 VKISDFGLSRAGSQYVMKK-FLKKLPIRWLAPETLNTGIF--SFKTDVWSFGVLLWEIFENGAEPYPGMKN----YEVKA  373 (474)
T ss_pred             EEeCccccccCCcceeecc-ccccCcceecChhhhccCcc--ccccchhheeeeEEeeeccCCCCCCCCCH----HHHHH
Confidence            8999999988654211111 11124578999999998855  889999999999999999 8889875421    12222


Q ss_pred             HHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527          999 WMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       999 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ++   ...+....             ........+..++.+||. +|++||+|.+|.+.++.
T Consensus       374 kI---~~~~~r~~-------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~  419 (474)
T KOG0194|consen  374 KI---VKNGYRMP-------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEA  419 (474)
T ss_pred             HH---HhcCccCC-------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHH
Confidence            22   12221111             111334456666679998 79999999999999875

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.1e-35  Score=332.76  Aligned_cols=259  Identities=23%  Similarity=0.343  Sum_probs=193.9

Q ss_pred             CCeeccccceEEEEEEEcC-----------------CcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 001527          781 AEVLGRSSHGTSYRATLEN-----------------GMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYW  842 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  842 (1060)
                      .++||+|+||.||+|++++                 +..||+|+++... ....+++.+|++++++++||||+++++++.
T Consensus        10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   89 (304)
T cd05096          10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV   89 (304)
T ss_pred             eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence            5789999999999998532                 3479999987643 334567999999999999999999999995


Q ss_pred             CCCCCceEEEEEecCCCChHHHhhcCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCC
Q 001527          843 GPTQHEKLILSDYISPGSLASFLYDRPG--------------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKA  908 (1060)
Q Consensus       843 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp  908 (1060)
                        +.+..++||||+++|+|.+++.....              .....+++.++.+++.||+.||+||| +.||+||||||
T Consensus        90 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~ivH~dlkp  166 (304)
T cd05096          90 --DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS-SLNFVHRDLAT  166 (304)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH-HCCccccCcch
Confidence              45678999999999999999865321              11235788999999999999999999 99999999999


Q ss_pred             CCeEeeCCCCCeEEcccccceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh--CCCCCC
Q 001527          909 TNILLDGPDLNARVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT--GRCAGD  985 (1060)
Q Consensus       909 ~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt--G~~p~~  985 (1060)
                      +||+++ +++.+||+|||+++......... .....++..|+|||++.+..+  +.++|||||||++|||++  |..||.
T Consensus       167 ~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~~l~el~~~~~~~p~~  243 (304)
T cd05096         167 RNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF--TTASDVWAFGVTLWEILMLCKEQPYG  243 (304)
T ss_pred             hheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC--CchhhhHHHHHHHHHHHHccCCCCCC
Confidence            999998 58899999999998654433221 112245788999999877664  779999999999999987  556765


Q ss_pred             CCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527          986 VISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       986 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ....    ......+.......... .. .. .       .......+.+++.+|++ +|.+||||.||.+.|++
T Consensus       244 ~~~~----~~~~~~~~~~~~~~~~~-~~-~~-~-------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         244 ELTD----EQVIENAGEFFRDQGRQ-VY-LF-R-------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             cCCH----HHHHHHHHHHhhhcccc-cc-cc-C-------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            4321    12222222222211100 00 00 0       01233567889999998 79999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.2e-36  Score=329.08  Aligned_cols=249  Identities=26%  Similarity=0.414  Sum_probs=193.7

Q ss_pred             CCeeccccceEEEEEEEc----CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE----NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|.+.    .+..||+|.++... ....+.+.+|++.+++++||||+++++++.  .+...++||||
T Consensus        10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~   87 (266)
T cd05064          10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT--RGNTMMIVTEY   87 (266)
T ss_pred             eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe--cCCCcEEEEEe
Confidence            578999999999999853    36789999998653 234567899999999999999999999985  56789999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++|+|.+++...    ...+++.+++.++.|++.||+||| +++++||||||+||+++ ++..+|++|||.+.......
T Consensus        88 ~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH-~~~iiH~dikp~nili~-~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          88 MSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLS-EMGYVHKGLAAHKVLVN-SDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             CCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH-HCCEeeccccHhhEEEc-CCCcEEECCCcccccccccc
Confidence            9999999999643    235899999999999999999999 99999999999999998 58899999999876543222


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      ........++..|+|||++.+..+  +.++|||||||++||+++ |+.||.....       .+.+. ....+...    
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~ell~~g~~p~~~~~~-------~~~~~-~~~~~~~~----  227 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQYHHF--SSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIK-AVEDGFRL----  227 (266)
T ss_pred             hhcccCCCCceeecCHHHHhhCCc--cchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHH-HHHCCCCC----
Confidence            221112245678999999987665  779999999999999775 9999865321       11111 11111110    


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                               +........+.+++.+||+ +|.+||+++||.+.|+++
T Consensus       228 ---------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 ---------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                     0011234567888899998 799999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.3e-36  Score=344.06  Aligned_cols=253  Identities=24%  Similarity=0.362  Sum_probs=193.8

Q ss_pred             CCeeccccceEEEEEEE------cCCcEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEE
Q 001527          781 AEVLGRSSHGTSYRATL------ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv  852 (1060)
                      .+.||+|+||.||+|++      +++..||||+++... ....+.+.+|+++++.+ +||||++++++|.  .....++|
T Consensus        40 ~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~--~~~~~~lv  117 (375)
T cd05104          40 GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT--VGGPTLVI  117 (375)
T ss_pred             hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec--cCCcceee
Confidence            68999999999999973      246789999997542 33456788999999999 8999999999994  56678999


Q ss_pred             EEecCCCChHHHhhcCCCC-------------------------------------------------------------
Q 001527          853 SDYISPGSLASFLYDRPGR-------------------------------------------------------------  871 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~-------------------------------------------------------------  871 (1060)
                      |||+++|+|.+++......                                                             
T Consensus       118 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (375)
T cd05104         118 TEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQ  197 (375)
T ss_pred             ehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccc
Confidence            9999999999999653210                                                             


Q ss_pred             ---------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee-eec
Q 001527          872 ---------KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE-QIL  941 (1060)
Q Consensus       872 ---------~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~  941 (1060)
                               ....+++.++.+++.||+.||+||| +++|+||||||+||+++ ++..+||+|||+++......... ...
T Consensus       198 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~  275 (375)
T cd05104         198 DVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA-SKNCIHRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGN  275 (375)
T ss_pred             ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCchhhEEEE-CCCcEEEecCccceeccCcccccccCC
Confidence                     1135789999999999999999999 99999999999999998 57889999999998664432211 111


Q ss_pred             cCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccc
Q 001527          942 DAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPE 1020 (1060)
Q Consensus       942 ~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 1020 (1060)
                      ..++..|+|||++.+..+  +.++|||||||++|||++ |..||......   .....+    +..+....      .+.
T Consensus       276 ~~~~~~y~aPE~~~~~~~--~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~----~~~~~~~~------~~~  340 (375)
T cd05104         276 ARLPVKWMAPESIFNCVY--TFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKM----IKEGYRML------SPE  340 (375)
T ss_pred             CCCCcceeChhHhcCCCC--CCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHH----HHhCccCC------CCC
Confidence            234567999999987765  789999999999999998 88898653211   111111    11111100      001


Q ss_pred             cCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1021 MVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1021 ~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                             ....++.+++.+|++ +|++||+|+||+++|++
T Consensus       341 -------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         341 -------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             -------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                   123467788899998 79999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=367.97  Aligned_cols=434  Identities=30%  Similarity=0.388  Sum_probs=266.8

Q ss_pred             CcEEECcCCcccccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEEEccC
Q 001527           96 LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSH  175 (1060)
Q Consensus        96 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  175 (1060)
                      |+.|+++.|.+....-+.+...-+|+.|||++|++. ..|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|.|..
T Consensus        23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~  100 (1081)
T KOG0618|consen   23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKN  100 (1081)
T ss_pred             HHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheecc
Confidence            555666666554222223333334666666666665 55666666666666666666665 3455556666666666666


Q ss_pred             CCCCCCCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCcCCccCchhhhccCCCCeecccCCccccCCC
Q 001527          176 NSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSS  255 (1060)
Q Consensus       176 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~  255 (1060)
                      |++. ..|..+..+.+|++|+++.|.+ +.+|..+..++.++.+..++|......+.    ..                 
T Consensus       101 n~l~-~lP~~~~~lknl~~LdlS~N~f-~~~Pl~i~~lt~~~~~~~s~N~~~~~lg~----~~-----------------  157 (1081)
T KOG0618|consen  101 NRLQ-SLPASISELKNLQYLDLSFNHF-GPIPLVIEVLTAEEELAASNNEKIQRLGQ----TS-----------------  157 (1081)
T ss_pred             chhh-cCchhHHhhhcccccccchhcc-CCCchhHHhhhHHHHHhhhcchhhhhhcc----cc-----------------
Confidence            6665 5556666666666666666666 34555555555555555555511111111    11                 


Q ss_pred             cCcCCCccccccEEEccCCcccccCCCCccccCCCCCCEEEccCCccccCCCCccCCCCccEEEccCCcCcccCCcchhc
Q 001527          256 QKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLK  335 (1060)
Q Consensus       256 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  335 (1060)
                                ++.++|..|.+.+.++  ..+..+++  .|||++|.+.  .-.+..+.+|+.|....|+++...      
T Consensus       158 ----------ik~~~l~~n~l~~~~~--~~i~~l~~--~ldLr~N~~~--~~dls~~~~l~~l~c~rn~ls~l~------  215 (1081)
T KOG0618|consen  158 ----------IKKLDLRLNVLGGSFL--IDIYNLTH--QLDLRYNEME--VLDLSNLANLEVLHCERNQLSELE------  215 (1081)
T ss_pred             ----------chhhhhhhhhcccchh--cchhhhhe--eeecccchhh--hhhhhhccchhhhhhhhcccceEE------
Confidence                      3444444444444333  22333333  3555555544  223344445555555555554211      


Q ss_pred             cCCCCCCeEECCCCccccccCcccccCCcEEEccCCcCcccCCCCCC---CCCEEEccCCccccccccccCCCccCEEEc
Q 001527          336 GDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTG---SCAVLDLSNNQFEGNLSRILKWGNIEYLDL  412 (1060)
Q Consensus       336 ~~~~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~Ls~N~l~~~~~~~~~~~~L~~L~L  412 (1060)
                      .....++.|+.++|.+..........+|+++++++|++++. |.+.+   +++.++..+|+|...+.++....+|++|++
T Consensus       216 ~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~  294 (1081)
T KOG0618|consen  216 ISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLVALPLRISRITSLVSLSA  294 (1081)
T ss_pred             ecCcchheeeeccCcceeeccccccccceeeecchhhhhcc-hHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHh
Confidence            11112555555555555333333334555555555555532 24333   233455555555555555555555555555


Q ss_pred             ccCeecccCCCCCcccCCCCeEEccCCcCccccchhc--------------------------cccCCCcEEecCCcccc
Q 001527          413 SRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVI--------------------------IQYQKLRVLDLSFNHLD  466 (1060)
Q Consensus       413 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--------------------------~~l~~L~~L~Ls~N~l~  466 (1060)
                      .+|.+. .+|.....+++|++|+|..|+|. .+|+.+                          ..+..|+.|.+.+|.|+
T Consensus       295 ~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Lt  372 (1081)
T KOG0618|consen  295 AYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLT  372 (1081)
T ss_pred             hhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccc
Confidence            555555 44555555555555555555554 222211                          12456888999999999


Q ss_pred             CccccccccCCCcceEEccCccccccCCCCCCCCCCCcEEEccCCccccccCccccCCCCCcEEECCCCccccccCcccc
Q 001527          467 GPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMA  546 (1060)
Q Consensus       467 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~  546 (1060)
                      ...-+.+.+..+|+.|+|++|+|.......+.++..|+.|+||+|+|+ .+|+.+.++..|++|...+|+|. ..| .+.
T Consensus       373 d~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~  449 (1081)
T KOG0618|consen  373 DSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELA  449 (1081)
T ss_pred             ccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhh
Confidence            888888899999999999999999777777889999999999999999 78999999999999999999998 788 899


Q ss_pred             CCCCCCeEeccCCccc-CCCCCCCc-cCCceeeCcCCc
Q 001527          547 NMTSLSSLVISQNHFT-GPLPNNLP-NSLETFNVSYND  582 (1060)
Q Consensus       547 ~l~~L~~L~ls~N~l~-g~ip~~~~-~~l~~l~ls~N~  582 (1060)
                      .+++|+.+|+|.|+|+ +.+|...| ++|++||+++|.
T Consensus       450 ~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  450 QLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             hcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            9999999999999997 45677777 899999999997

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.7e-36  Score=330.38  Aligned_cols=246  Identities=22%  Similarity=0.301  Sum_probs=190.0

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||+||+|.. .+|+.||+|++.....   .....+.+|++++++++|++|+++++++.  +.+..++||||+
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~--~~~~~~lv~e~~   82 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE--TKDALCLVLTIM   82 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc--cCCeEEEEEEec
Confidence            46899999999999985 5799999999865322   22346788999999999999999999884  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++....   ...+++.++..++.|++.||+||| +.+|+||||||+|||++ +++.+||+|||++........
T Consensus        83 ~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH-~~~iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          83 NGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQ-RERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             CCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCCCe
Confidence            9999998886432   235899999999999999999999 99999999999999998 578999999999987543322


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      .  ....||..|+|||++.+..+  +.++|||||||++|||++|+.||.......    ..+-+.........       
T Consensus       158 ~--~~~~g~~~y~aPE~~~~~~~--~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~-------  222 (285)
T cd05631         158 V--RGRVGTVGYMAPEVINNEKY--TFSPDWWGLGCLIYEMIQGQSPFRKRKERV----KREEVDRRVKEDQE-------  222 (285)
T ss_pred             e--cCCCCCCCccCHhhhcCCCC--CcccCchhHHHHHHHHHhCCCCCCCCCcch----hHHHHHHHhhcccc-------
Confidence            2  22368999999999987765  779999999999999999999997532211    11111111111000       


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCC-----HHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPG-----IKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs-----~~evl~ 1055 (1060)
                         .    ........+.+++.+|++ +|.+||+     ++|+++
T Consensus       223 ---~----~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         223 ---E----YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ---c----CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence               0    011223456778889998 7999997     788775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=349.29  Aligned_cols=259  Identities=21%  Similarity=0.236  Sum_probs=202.6

Q ss_pred             hhhhhccCCCeeccccceEEEEEEEcCC-cEEEEEEcccchHHHHHHHHHHHHHHhcCC-CCceeeeee-EEeC---CC-
Q 001527          773 PEELSRAPAEVLGRSSHGTSYRATLENG-MFLTVKWLREGVAKQRKEFAKEAKKFANIR-HPNVVGLRG-YYWG---PT-  845 (1060)
Q Consensus       773 ~~~l~~~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~-~~~~---~~-  845 (1060)
                      .........++|.+|||+.||.|+...+ ..||+|++-.......+.+.+|+++|++|+ |||||.|+| ....   .. 
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3344444568999999999999997655 999999997777777889999999999996 999999999 3321   12 


Q ss_pred             CCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCcccCCCCCCCeEeeCCCCCeEEcc
Q 001527          846 QHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH-FDRAVPHGNLKATNILLDGPDLNARVAD  924 (1060)
Q Consensus       846 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH-~~~~ivHrDlkp~NILl~~~~~~~kl~D  924 (1060)
                      ..+++|.||||+||.|-+++..+..   ..|++.++++|++|+++|+++|| ....|||||||-+||||+ .++..||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCD  189 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCD  189 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCc
Confidence            3578899999999999999976542   34999999999999999999999 345699999999999998 577999999


Q ss_pred             cccceeeccCCcee--------eeccCccccccchhcccC-CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccC
Q 001527          925 YCLHRLMTQAGTIE--------QILDAGVLGYRAPELAAS-KKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVD  995 (1060)
Q Consensus       925 fg~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~  995 (1060)
                      ||.|..........        ......|+.|+|||++.- .....++|+||||+||+||.|+....||+....      
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------  263 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------  263 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence            99987543322111        011246899999999852 222348899999999999999999999985211      


Q ss_pred             hHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527          996 LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       996 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                                    ..    .+.+.|..|........|.++|..|++ +|.+||++.||+..+-.
T Consensus       264 --------------la----Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  264 --------------LA----ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             --------------ee----EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence                          01    122333334445677889999999998 79999999999988754

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.8e-36  Score=342.79  Aligned_cols=263  Identities=23%  Similarity=0.364  Sum_probs=196.9

Q ss_pred             CCChhhhhccCCCeeccccceEEEEEEEc------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 001527          770 TLTPEELSRAPAEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYY  841 (1060)
Q Consensus       770 ~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  841 (1060)
                      .+..+++.  ..+.||+|+||.||+|+..      ++..||+|+++... ....+.+.+|+++++.+ +|||||+++++|
T Consensus        34 ~~~~~~~~--~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          34 EFPRDNLQ--FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccHHHce--ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            34444443  3689999999999999742      34589999997542 33456788999999999 899999999998


Q ss_pred             eCCCCCceEEEEEecCCCChHHHhhcCCC---------------------------------------------------
Q 001527          842 WGPTQHEKLILSDYISPGSLASFLYDRPG---------------------------------------------------  870 (1060)
Q Consensus       842 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------  870 (1060)
                      .  .....++||||+++|+|.+++.....                                                   
T Consensus       112 ~--~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (374)
T cd05106         112 T--HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS  189 (374)
T ss_pred             c--CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence            5  56688999999999999999864210                                                   


Q ss_pred             --------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          871 --------------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       871 --------------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                                    ....++++.++.+|+.||+.||+||| ++||+||||||+|||++ ++..+||+|||+++.......
T Consensus       190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~giiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA-SKNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH-HCCEEeccCchheEEEe-CCCeEEEeeceeeeeccCCcc
Confidence                          01235788999999999999999999 99999999999999998 588999999999986544322


Q ss_pred             eee-eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          937 IEQ-ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       937 ~~~-~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      ... ....++..|+|||++.+..+  +.++|||||||++|||++ |+.||.......      .+.. ....+.     .
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~~--~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~-~~~~~~-----~  333 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYK-MVKRGY-----Q  333 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCCC--CccccHHHHHHHHHHHHhCCCCCCccccccH------HHHH-HHHccc-----C
Confidence            111 11235568999999977654  789999999999999997 999987532111      1111 111110     0


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      +. .+.       .....+.+++.+|++ +|++||++.||+++|+++
T Consensus       334 ~~-~~~-------~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         334 MS-RPD-------FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             cc-CCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            00 001       123467788889998 799999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-35  Score=324.54  Aligned_cols=249  Identities=24%  Similarity=0.395  Sum_probs=196.8

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.  ..+..++||||+++++
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~   87 (261)
T cd05072          11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT--KEEPIYIITEYMAKGS   87 (261)
T ss_pred             eeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCcEEEEecCCCCc
Confidence            57899999999999998888899999987543 23568899999999999999999999884  5667899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....   ...+++.++..++.|++.||+||| +.+++||||||+||+++ +++.+||+|||.++...........
T Consensus        88 L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH-~~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05072          88 LLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIE-RKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTARE  162 (261)
T ss_pred             HHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhhEEec-CCCcEEECCCccceecCCCceeccC
Confidence            999996532   345889999999999999999999 89999999999999998 5889999999999876543322222


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||++.+..+  +.++|||||||++|||++ |+.||.....    .....+    .......    +    
T Consensus       163 ~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~----~~~~~~~----~----  224 (261)
T cd05072         163 GAKFPIKWTAPEAINFGSF--TIKSDVWSFGILLYEIVTYGKIPYPGMSN----SDVMSA----LQRGYRM----P----  224 (261)
T ss_pred             CCccceecCCHHHhccCCC--ChhhhhhhhHHHHHHHHccCCCCCCCCCH----HHHHHH----HHcCCCC----C----
Confidence            2245678999999877654  779999999999999998 9999864211    111111    1111100    0    


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                           ........+.+++.+|++ +|++||+++++++.|+.+
T Consensus       225 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 -----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                 001233467888999998 799999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-36  Score=300.52  Aligned_cols=247  Identities=25%  Similarity=0.356  Sum_probs=199.7

Q ss_pred             CCCeeccccceEEEEEEE-cCCcEEEEEEcccc--------hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCce
Q 001527          780 PAEVLGRSSHGTSYRATL-ENGMFLTVKWLREG--------VAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEK  849 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~  849 (1060)
                      +.+++|+|..++|.++.. .+|..+|+|++...        ...-.+.-.+|+.+|+++ .||+|+++.++|  ++....
T Consensus        21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--es~sF~   98 (411)
T KOG0599|consen   21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--ESDAFV   98 (411)
T ss_pred             hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--cCcchh
Confidence            457899999999999875 47889999988532        122345667899999999 699999999999  467789


Q ss_pred             EEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccce
Q 001527          850 LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR  929 (1060)
Q Consensus       850 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~  929 (1060)
                      ++|+|.|+.|.|++|+..     ...+++...++|++|+..|++||| .+.||||||||+|||+| +++++||+|||++.
T Consensus        99 FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylH-a~~IVHRDLKpENILld-dn~~i~isDFGFa~  171 (411)
T KOG0599|consen   99 FLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLH-ARNIVHRDLKPENILLD-DNMNIKISDFGFAC  171 (411)
T ss_pred             hhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHH-HhhhhhcccChhheeec-cccceEEeccceee
Confidence            999999999999999954     456999999999999999999999 99999999999999999 69999999999999


Q ss_pred             eeccCCceeeeccCccccccchhccc----CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHh
Q 001527          930 LMTQAGTIEQILDAGVLGYRAPELAA----SKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA 1005 (1060)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 1005 (1060)
                      .+.++.....  .+||++|.|||.+.    ....+|+..+|+||+||++|.++.|.+||-.-.        .-.+...+.
T Consensus       172 ~l~~GekLre--lCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------QmlMLR~Im  241 (411)
T KOG0599|consen  172 QLEPGEKLRE--LCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------QMLMLRMIM  241 (411)
T ss_pred             ccCCchhHHH--hcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------HHHHHHHHH
Confidence            8877655433  38999999999985    233456889999999999999999999985310        001112233


Q ss_pred             cCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1006 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ++++          .+.+|...+......+++.+|++ ||.+|.|++|+++
T Consensus       242 eGky----------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  242 EGKY----------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             hccc----------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            3333          22344555667778899999998 8999999999875

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.3e-36  Score=306.43  Aligned_cols=198  Identities=26%  Similarity=0.322  Sum_probs=170.4

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccchHHH--HHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQ--RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.|++|+||.||+|+. ++++.||+|+++......  --.-.+||.+|.+++|||||.+..+..+.+-+..|+|||||+
T Consensus        81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E  160 (419)
T KOG0663|consen   81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE  160 (419)
T ss_pred             HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence            46899999999999995 478999999998543211  123568999999999999999999999888889999999997


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      . +|...++...    +++...++.-++.|+++|++||| .+.|+||||||+|+|+. ..+.+||+|||+|+.+......
T Consensus       161 h-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH-~~wilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~k~  233 (419)
T KOG0663|consen  161 H-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLH-DNWILHRDLKTSNLLLS-HKGILKIADFGLAREYGSPLKP  233 (419)
T ss_pred             h-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHh-hceeEecccchhheeec-cCCcEEecccchhhhhcCCccc
Confidence            6 9999996543    57999999999999999999999 99999999999999998 6889999999999998776433


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      .+ ..+-|.+|+|||.+.+.+. |+++.|+||+|||+.||+++++-|...
T Consensus       234 ~T-~lVVTLWYRaPELLLG~~t-yst~iDMWSvGCI~aE~l~~kPlf~G~  281 (419)
T KOG0663|consen  234 YT-PLVVTLWYRAPELLLGAKT-YSTAVDMWSVGCIFAELLTQKPLFPGK  281 (419)
T ss_pred             Cc-ceEEEeeecCHHHhcCCcc-cCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence            22 2356899999999998875 688999999999999999999887653

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.4e-35  Score=319.99  Aligned_cols=246  Identities=23%  Similarity=0.364  Sum_probs=193.3

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .+.||+|+||.||+|++.++..+|+|.++... ...+++.+|++++++++||||+++++++.  .....++||||+++|+
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~iv~e~~~~~~   85 (256)
T cd05114           9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT--QQKPLYIVTEFMENGC   85 (256)
T ss_pred             eeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEc--cCCCEEEEEEcCCCCc
Confidence            46799999999999998888899999987542 23467889999999999999999999984  5667899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.++++...    ..+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+|++|||.++...........
T Consensus        86 L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          86 LLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLE-RNSFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             HHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH-HCCccccccCcceEEEc-CCCeEEECCCCCccccCCCceeccC
Confidence            999996532    35889999999999999999999 99999999999999998 5889999999998865433222222


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||++.+..+  +.++||||||+++|||++ |+.||....       ..+.+..... +..  ...+.   
T Consensus       160 ~~~~~~~y~aPE~~~~~~~--~~~~Di~s~G~~l~el~~~g~~p~~~~~-------~~~~~~~i~~-~~~--~~~~~---  224 (256)
T cd05114         160 GAKFPVKWSPPEVFNFSKY--SSKSDVWSFGVLMWEVFTEGKMPFEKKS-------NYEVVEMISR-GFR--LYRPK---  224 (256)
T ss_pred             CCCCchhhCChhhcccCcc--chhhhhHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHHC-CCC--CCCCC---
Confidence            2245668999999987654  779999999999999999 899986431       1122221111 111  00111   


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                              .....+.+++.+|++ +|.+||+++|+++.|.
T Consensus       225 --------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 --------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             --------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                    123467889999998 7999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=336.50  Aligned_cols=193  Identities=25%  Similarity=0.397  Sum_probs=167.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      ..+||+|+||.|++|..+ +++.+|||+++++..   .+.+....|.+++... +||.++.++..|  ++.++.|+||||
T Consensus       373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~~~l~fvmey  450 (694)
T KOG0694|consen  373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTKEHLFFVMEY  450 (694)
T ss_pred             EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccCCeEEEEEEe
Confidence            479999999999999965 689999999987643   3456677888888777 599999999888  678899999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +.||++..+.+      ...+++..+..++..|+.||+||| ++|||+||||-+|||+| .++.+||+|||+++.....+
T Consensus       451 ~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH-~~~IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  451 VAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLH-ENGIIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             cCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHH-hcCceeeecchhheEEc-ccCcEEecccccccccCCCC
Confidence            99999554443      245999999999999999999999 99999999999999999 58899999999999755333


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      . .+...+||+.|||||++.+..|  +.++|.|||||++|||+.|+.||..
T Consensus       523 ~-~TsTfCGTpey~aPEil~e~~Y--t~aVDWW~lGVLlyeML~Gq~PF~g  570 (694)
T KOG0694|consen  523 D-RTSTFCGTPEFLAPEVLTEQSY--TRAVDWWGLGVLLYEMLVGESPFPG  570 (694)
T ss_pred             C-ccccccCChhhcChhhhccCcc--cchhhHHHHHHHHHHHHcCCCCCCC
Confidence            3 2334589999999999999886  8899999999999999999999985

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-36  Score=313.53  Aligned_cols=241  Identities=22%  Similarity=0.361  Sum_probs=196.8

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccchHH---HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAK---QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.+|+|.||.|-+|+ ...|+.||||.+++....   +.-.+++|+++|..++||||+.+|.+|  +..+...+||||.
T Consensus        58 ~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIvivMEYa  135 (668)
T KOG0611|consen   58 TETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIVIVMEYA  135 (668)
T ss_pred             HHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEEEEEEec
Confidence            4679999999999998 467999999999876443   344678999999999999999999999  5677899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      .+|.|.+|+.++     +.+++.+++.+++||..|+.|+| .++|+|||||.+|||+| ++..+||+|||++-.+.....
T Consensus       136 S~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCH-knrVvHRDLKLENILLD-~N~NiKIADFGLSNly~~~kf  208 (668)
T KOG0611|consen  136 SGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCH-KNRVVHRDLKLENILLD-QNNNIKIADFGLSNLYADKKF  208 (668)
T ss_pred             CCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHh-hccceecccchhheeec-CCCCeeeeccchhhhhccccH
Confidence            999999999654     46999999999999999999999 99999999999999999 688999999999988766554


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      ..+  .+|++-|.+||+..|.+|. .+.+|-||+||++|.++.|..|||..       +....+++. ..+.+.      
T Consensus       209 LqT--FCGSPLYASPEIvNG~PY~-GPEVDsWsLGvLLYtLVyGtMPFDG~-------Dhk~lvrQI-s~GaYr------  271 (668)
T KOG0611|consen  209 LQT--FCGSPLYASPEIVNGTPYK-GPEVDSWSLGVLLYTLVYGTMPFDGR-------DHKRLVRQI-SRGAYR------  271 (668)
T ss_pred             HHH--hcCCcccCCccccCCCCCC-CCccchhhHHHHHHHHhhcccccCCc-------hHHHHHHHh-hccccc------
Confidence            433  3899999999999998874 78999999999999999999999852       344444432 222221      


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                            .|..+.   .---++.+++. +|++|.|+.+|...
T Consensus       272 ------EP~~PS---dA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  272 ------EPETPS---DASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ------CCCCCc---hHHHHHHHHHhcCcccchhHHHHhhh
Confidence                  111111   12235557776 89999999999764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.5e-36  Score=336.01  Aligned_cols=240  Identities=21%  Similarity=0.296  Sum_probs=187.8

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      ++||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++||||+++++++.  ..+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ--THDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE--cCCEEEEEEeCCC
Confidence            46999999999999854 78999999997542   223456788999999999999999999885  5668999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +|+|.+++..     ...+++.++..++.||+.||+||| +.||+||||||+||+++ .++.+||+|||+++........
T Consensus        79 ~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH-~~~ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~  151 (323)
T cd05571          79 GGELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLH-SCDVVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCc
Confidence            9999999854     245899999999999999999999 99999999999999998 5789999999998754322221


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                       .....||+.|+|||++.+..+  +.++||||+||++|||++|+.||....       ....... ......      ..
T Consensus       152 -~~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlG~il~elltg~~Pf~~~~-------~~~~~~~-~~~~~~------~~  214 (323)
T cd05571         152 -MKTFCGTPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFEL-ILMEEI------RF  214 (323)
T ss_pred             -ccceecCccccChhhhcCCCC--CccccCcccchhhhhhhcCCCCCCCCC-------HHHHHHH-HHcCCC------CC
Confidence             122368999999999987765  779999999999999999999986421       1111111 111110      00


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYE 1055 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~ 1055 (1060)
                       +       ......+.+++.+|++ +|++||     ++.|+++
T Consensus       215 -p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         215 -P-------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -C-------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence             0       1223456778889998 799999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-35  Score=326.82  Aligned_cols=259  Identities=23%  Similarity=0.366  Sum_probs=196.9

Q ss_pred             CCeeccccceEEEEEEEc-----CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-----NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|..+     +++.||+|+++.......+.+.+|++++++++||||+++++++...+....++||||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   88 (284)
T cd05081           9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY   88 (284)
T ss_pred             eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence            578999999999999753     588999999987666666789999999999999999999998865556678999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++++|.+++....    ..+++..+..++.|++.||+||| ++||+||||||+||+++ +++.+||+|||+++......
T Consensus        89 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH-~~~i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          89 LPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLG-SKRYVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             cCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCHhhEEEC-CCCeEEECCCcccccccCCC
Confidence            99999999996432    35899999999999999999999 99999999999999998 57899999999998765433


Q ss_pred             ceee--eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC--------CccChHHHHHHHHh
Q 001527          936 TIEQ--ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG--------AGVDLTDWMQLKVA 1005 (1060)
Q Consensus       936 ~~~~--~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~--------~~~~l~~~~~~~~~ 1005 (1060)
                      ....  ....++..|+|||++.+..+  +.++|||||||++|||++|..|+.......        ..............
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTESKF--SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhccCCc--ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            2211  11123456999999977654  779999999999999999987754321100        00000000111111


Q ss_pred             cCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1006 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ..             ...+........+.+++.+|++ +|++||||+||+++|++|
T Consensus       241 ~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         241 NN-------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cC-------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            10             0001111234568889999998 799999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-36  Score=292.47  Aligned_cols=242  Identities=19%  Similarity=0.269  Sum_probs=195.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++.||+|.||.||.|+.+ ++-.||+|++.+...   ....++.+|+++-..++||||+++|+||.  +....|+++||.
T Consensus        27 gr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh--d~~riyLilEya  104 (281)
T KOG0580|consen   27 GRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH--DSKRIYLILEYA  104 (281)
T ss_pred             cccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee--ccceeEEEEEec
Confidence            689999999999999954 688999999865432   23467899999999999999999999996  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|++...|.+.+   ...+++.....++.|+|.||.|+| .++|+||||||+|+|++ -.+..|++|||.+..... ..
T Consensus       105 ~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h-~k~VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p~-~k  178 (281)
T KOG0580|consen  105 PRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCH-LKRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPS-NK  178 (281)
T ss_pred             CCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhc-cCCcccCCCCHHHhccC-CCCCeeccCCCceeecCC-CC
Confidence            9999999997643   356888899999999999999999 99999999999999998 477999999999876542 22


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                        ....+||..|.|||+..+...  +.++|+|++|++.||++.|.+||+....+           ..+++-...+..+|.
T Consensus       179 --R~tlcgt~dyl~pEmv~~~~h--d~~Vd~w~lgvl~yeflvg~ppFes~~~~-----------etYkrI~k~~~~~p~  243 (281)
T KOG0580|consen  179 --RKTLCGTLDYLPPEMVEGRGH--DKFVDLWSLGVLCYEFLVGLPPFESQSHS-----------ETYKRIRKVDLKFPS  243 (281)
T ss_pred             --ceeeecccccCCHhhcCCCCc--cchhhHHHHHHHHHHHHhcCCchhhhhhH-----------HHHHHHHHccccCCc
Confidence              223489999999999998876  77999999999999999999999864311           111111112233332


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                                 .......+++.+|+. +|.+|.+..||++.
T Consensus       244 -----------~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  244 -----------TISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -----------ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                       223456778889997 79999999999864

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.6e-35  Score=325.04  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=196.4

Q ss_pred             CCeeccccceEEEEEEEcC------CcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLEN------GMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|....      ...||+|.++... ....+.+.+|++++++++||||+++++++.  .....+++|
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~~~~~~   87 (283)
T cd05048          10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT--KEQPTCMLF   87 (283)
T ss_pred             hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc--CCCceEEEE
Confidence            5789999999999998542      2679999987543 334567899999999999999999999985  456789999


Q ss_pred             EecCCCChHHHhhcCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEE
Q 001527          854 DYISPGSLASFLYDRPGRK-----------GPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARV  922 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl  922 (1060)
                      ||+++++|.+++.......           ...+++.++..++.|++.||+||| +.+|+||||||+||+++ +++.+||
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH-~~~i~H~dlkp~Nil~~-~~~~~~L  165 (283)
T cd05048          88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS-SHHFVHRDLAARNCLVG-EGLTVKI  165 (283)
T ss_pred             ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccccceEEEc-CCCcEEE
Confidence            9999999999996542211           146889999999999999999999 99999999999999998 5789999


Q ss_pred             cccccceeeccCCce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHH
Q 001527          923 ADYCLHRLMTQAGTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWM 1000 (1060)
Q Consensus       923 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~ 1000 (1060)
                      +|||+++........ ......+++.|+|||++.+..+  +.++|||||||++|||++ |..||.....    .++... 
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~sDv~slG~il~el~~~g~~p~~~~~~----~~~~~~-  238 (283)
T cd05048         166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF--TTESDIWSFGVVLWEIFSYGLQPYYGFSN----QEVIEM-  238 (283)
T ss_pred             CCCcceeeccccccccccCCCcccccccCHHHhccCcC--chhhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH-
Confidence            999999865433221 1122356788999999877664  789999999999999998 9999875321    112111 


Q ss_pred             HHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1001 QLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1001 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                         +..+....             ........+.+++.+||+ +|.+||+++||+++|+++
T Consensus       239 ---i~~~~~~~-------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         239 ---IRSRQLLP-------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             ---HHcCCcCC-------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence               22211110             011334678889999998 799999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=331.89  Aligned_cols=238  Identities=20%  Similarity=0.239  Sum_probs=185.8

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          784 LGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       784 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      ||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|++++++++||||+++++++.  .....++||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ--SPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe--cCCeEEEEEcCCCCC
Confidence            699999999999965 68899999987532   233466788999999999999999999884  567899999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++..     ...+++..+..++.|++.||+||| +++|+||||||+||+++ .++.+||+|||+++........ .
T Consensus        79 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~-~  150 (312)
T cd05585          79 ELFHHLQR-----EGRFDLSRARFYTAELLCALENLH-KFNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDK-T  150 (312)
T ss_pred             cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCc-c
Confidence            99999954     245899999999999999999999 99999999999999998 5889999999998864332221 1


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ....||+.|+|||++.+..+  +.++||||+||++|||++|+.||...       ...+........ ..       ..+
T Consensus       151 ~~~~gt~~y~aPE~~~~~~~--~~~~DvwslGvil~el~tg~~pf~~~-------~~~~~~~~~~~~-~~-------~~~  213 (312)
T cd05585         151 NTFCGTPEYLAPELLLGHGY--TKAVDWWTLGVLLYEMLTGLPPFYDE-------NVNEMYRKILQE-PL-------RFP  213 (312)
T ss_pred             ccccCCcccCCHHHHcCCCC--CCccceechhHHHHHHHhCCCCcCCC-------CHHHHHHHHHcC-CC-------CCC
Confidence            22368999999999987765  78999999999999999999998642       122222222211 00       001


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCC---HHHHHH
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPG---IKTIYE 1055 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs---~~evl~ 1055 (1060)
                             ......+.+++.+|++ +|.+||+   +.|++.
T Consensus       214 -------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         214 -------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             -------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence                   1123456778889998 7999985   555543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4e-35  Score=320.81  Aligned_cols=249  Identities=29%  Similarity=0.405  Sum_probs=195.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|+||.||+|... .++.||+|+++.. ....+++.+|++++++++||||+++++++.  .....++||||++++
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~   87 (263)
T cd05052          11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYIITEFMTYG   87 (263)
T ss_pred             eeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc--CCCCcEEEEEeCCCC
Confidence            478999999999999965 5889999998754 334567889999999999999999999985  456789999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++....   ...+++.+++.++.|++.||+||| +.+++||||||+||+++ +++.+||+|||.+...........
T Consensus        88 ~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~~~~~~  162 (263)
T cd05052          88 NLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAH  162 (263)
T ss_pred             cHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccCcceEEEc-CCCcEEeCCCccccccccceeecc
Confidence            9999996532   245899999999999999999999 99999999999999998 588999999999987654332222


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      ....++..|+|||++.+..+  +.++|||||||++|||++ |..||...       ...++.... .....     +.. 
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~il~el~t~g~~p~~~~-------~~~~~~~~~-~~~~~-----~~~-  226 (263)
T cd05052         163 AGAKFPIKWTAPESLAYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQVYELL-EKGYR-----MER-  226 (263)
T ss_pred             CCCCCccccCCHHHhccCCC--CchhHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHH-HCCCC-----CCC-
Confidence            22234568999999877665  779999999999999998 99998642       122222221 11100     000 


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                             .......+.+++.+|++ +|++||++.|++++|+.+
T Consensus       227 -------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         227 -------PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                   01233567788899998 799999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-35  Score=322.56  Aligned_cols=247  Identities=30%  Similarity=0.520  Sum_probs=188.2

Q ss_pred             CCeeccccceEEEEEEEc-----CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-----NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .+.||.|.||.||+|++.     .+..|+||.++... ....+.+.+|++.+++++||||++++|++.  .....++|||
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~--~~~~~~lv~e   81 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI--ENEPLFLVME   81 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE--SSSSEEEEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc--cccccccccc
Confidence            367999999999999976     36889999996543 334788999999999999999999999997  4456899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++|+|.+++....   ...+++.++..|+.||++||+||| +.+++||||+++||+++ +++.+||+|||+++.....
T Consensus        82 ~~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh-~~~iiH~~l~~~nill~-~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLH-SNNIIHGNLSPSNILLD-SNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             --TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHH-HTTEEEST-SGGGEEEE-TTTEEEEESTTTGEETTTS
T ss_pred             ccccccccccccccc---cccccccccccccccccccccccc-ccccccccccccccccc-ccccccccccccccccccc
Confidence            999999999998752   346899999999999999999999 88999999999999999 5889999999999876332


Q ss_pred             Cce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          935 GTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       935 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ... ......+...|+|||.+....+  +.++||||||+++||+++ |+.||...       ...++.... .+..... 
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~--~~ksDVysfG~~l~ei~~~~~~p~~~~-------~~~~~~~~~-~~~~~~~-  225 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEY--TKKSDVYSFGMLLYEILTLGKFPFSDY-------DNEEIIEKL-KQGQRLP-  225 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEE--SHHHHHHHHHHHHHHHHTTSSGTTTTS-------CHHHHHHHH-HTTEETT-
T ss_pred             cccccccccccccccccccccccccc--ccccccccccccccccccccccccccc-------ccccccccc-cccccce-
Confidence            222 1122346778999999987764  889999999999999999 78887643       222333222 2111110 


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHh
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDL 1057 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L 1057 (1060)
                                  ........+.+++.+||+ +|++||+|.||++.|
T Consensus       226 ------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 ------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                        011234557788999998 799999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-35  Score=311.14  Aligned_cols=265  Identities=20%  Similarity=0.267  Sum_probs=192.6

Q ss_pred             CeeccccceEEEEEE-EcCCcEEEEEEcccchHH--HHHHHHHHHHHHhcCCCCc-eeeeeeEEeCCC----CCceEEEE
Q 001527          782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAK--QRKEFAKEAKKFANIRHPN-VVGLRGYYWGPT----QHEKLILS  853 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~----~~~~~lv~  853 (1060)
                      ++||+|+||+||+|+ ..+|+.||+|+++-....  ......+|+.++++++|+| ||.+++++...+    ....++|+
T Consensus        17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf   96 (323)
T KOG0594|consen   17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF   96 (323)
T ss_pred             HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence            569999999999999 457999999999754321  2244578999999999999 999999997432    12678999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||++ -+|.+++....... ..++...++.+++||+.||+||| +++|+||||||.||||+ +.+.+||+|||+|+....
T Consensus        97 e~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H-~~~IlHRDLKPQNlLi~-~~G~lKlaDFGlAra~~i  172 (323)
T KOG0594|consen   97 EFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH-SHGILHRDLKPQNLLIS-SSGVLKLADFGLARAFSI  172 (323)
T ss_pred             Eeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH-hCCeecccCCcceEEEC-CCCcEeeeccchHHHhcC
Confidence            9995 59999997654221 34677899999999999999999 99999999999999999 588999999999996653


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhc----CCC
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAE----GHG 1009 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~----~~~ 1009 (1060)
                      +... .+...+|.+|+|||++.+... |+...||||+||+++||++++.-|...+.    .+...-+-.....    .|.
T Consensus       173 p~~~-yt~evvTlWYRaPEvLlGs~~-Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  173 PMRT-YTPEVVTLWYRAPEVLLGSTS-YSTSVDIWSLGCIFAEMFTRRPLFPGDSE----IDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             Cccc-ccccEEEeeccCHHHhcCCCc-CCCCcchHhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHHHcCCCCccCCC
Confidence            3322 223368999999999999875 68899999999999999999988875432    1111111111111    111


Q ss_pred             Ccc----cccccc----cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1010 SDC----FDAAVM----PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1010 ~~~----~d~~l~----~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      ...    +++...    +...............+++.+|++ +|.+|.|++..+.+
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            100    010000    000001111112356788889998 79999999998875

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=308.86  Aligned_cols=198  Identities=24%  Similarity=0.330  Sum_probs=166.3

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEccc--chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeC---CCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLRE--GVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWG---PTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~---~~~~~~~lv~e  854 (1060)
                      .+.||+|+||.|+.|.. ++|+.||+|++..  ......++..+|+++++.++|+||+.+.+.+..   ..-...|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            36799999999999985 4799999999873  334456788899999999999999999999864   23457899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      +| +.+|.+.++.     ++.++...+..+++|+++||.|+| +.+|+|||+||+|++++ .+...||+|||+|+.....
T Consensus       107 lM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiH-SAnViHRDLKPsNll~n-~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  107 LM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIH-SANVIHRDLKPSNLLLN-ADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             HH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhh-cccccccccchhheeec-cCCCEEeccccceeecccc
Confidence            99 5699999943     345999999999999999999999 99999999999999999 5889999999999987643


Q ss_pred             Cce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          935 GTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       935 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      ... ..+..+.|.+|+|||++.... .|+.+.||||.||++.||++|++-|...
T Consensus       179 ~~~~~mTeYVaTRWYRAPElll~~~-~Yt~aiDiWSvGCI~AEmL~gkplFpG~  231 (359)
T KOG0660|consen  179 FEDGFMTEYVATRWYRAPELLLNSS-EYTKAIDIWSVGCILAEMLTGKPLFPGK  231 (359)
T ss_pred             CcccchhcceeeeeecCHHHHhccc-cccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence            111 112236799999999996654 4688999999999999999999988653

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.4e-34  Score=315.84  Aligned_cols=256  Identities=21%  Similarity=0.242  Sum_probs=189.8

Q ss_pred             eeccccceEEEEEEEcC---CcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          783 VLGRSSHGTSYRATLEN---GMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       783 ~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .||+|+||.||+|...+   +..+|+|.++... ......+.+|+.++++++||||+++++++.  +....++||||+++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~   79 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT--EVTPYLLVMEFCPL   79 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--CCCCcEEEEECCCC
Confidence            58999999999998643   4679999887543 234457889999999999999999999984  45678999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      |+|.+++...........++..+..++.|++.|++||| +.+++||||||+||+++ ++..+||+|||.++.........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-KNNFIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH-HCCEeccccCcceEEEc-CCCcEEECCccccccccCcceee
Confidence            99999997643333345678888999999999999999 99999999999999998 58899999999987544332211


Q ss_pred             -eeccCccccccchhcccCCC-----CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          939 -QILDAGVLGYRAPELAASKK-----PHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       939 -~~~~~gt~~y~aPE~~~~~~-----~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                       .....++..|+|||++.+..     ..++.++|||||||++|||++ |+.||......    ...   ...... ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~---~~~~~~-~~~~  229 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVL---TYTVRE-QQLK  229 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHH---HHHhhc-ccCC
Confidence             11235678899999986432     123679999999999999996 99999653211    111   111111 1111


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHhh
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~L~ 1058 (1060)
                      ..++.+..        .....+.+++..|+.+|++|||++||++.|+
T Consensus       230 ~~~~~~~~--------~~~~~~~~l~~~c~~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKPRLKL--------PLSDRWYEVMQFCWLQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCccCC--------CCChHHHHHHHHHhcCcccCCCHHHHHHHhc
Confidence            11221111        1223466677899988999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.6e-35  Score=326.72  Aligned_cols=260  Identities=18%  Similarity=0.231  Sum_probs=187.7

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .++||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++.  .....++||||+++
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~   87 (288)
T cd07871          10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH--TERCLTLVFEYLDS   87 (288)
T ss_pred             eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc--CCCeEEEEEeCCCc
Confidence            578999999999999865 689999999864322 22356778999999999999999999984  45678999999974


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                       +|.+++...    ...+++..+..++.||+.||+||| ++||+||||||+|||++ +++.+||+|||+++........ 
T Consensus        88 -~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~~~~~-  159 (288)
T cd07871          88 -DLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCH-KRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKT-  159 (288)
T ss_pred             -CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEC-CCCCEEECcCcceeeccCCCcc-
Confidence             999988543    235789999999999999999999 99999999999999998 5789999999999765432211 


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhc------------
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAE------------ 1006 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~------------ 1006 (1060)
                      .....+++.|+|||++.+.. .++.++||||+||++|||++|+.||......    .....+......            
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGST-EYSTPIDMWGVGCILYEMATGRPMFPGSTVK----EELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             ccCceecccccChHHhcCCc-ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChHHhhccccc
Confidence            12236789999999987543 2477999999999999999999998643211    111111111000            


Q ss_pred             CCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1007 GHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1007 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ........+...................+++.+|++ +|.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000000001100000000001123456788889998 8999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.2e-35  Score=336.43  Aligned_cols=254  Identities=22%  Similarity=0.330  Sum_probs=193.9

Q ss_pred             CCCeeccccceEEEEEEEc------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEE
Q 001527          780 PAEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLI  851 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~l  851 (1060)
                      ..++||+|+||.||+|+..      .+..||||+++... ....+.+.+|+++++++. |||||+++++|.  +....++
T Consensus        41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--~~~~~~l  118 (400)
T cd05105          41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--KSGPIYI  118 (400)
T ss_pred             hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc--cCCceEE
Confidence            3689999999999999852      23579999997543 334567899999999996 999999999994  5678999


Q ss_pred             EEEecCCCChHHHhhcCCCC------------------------------------------------------------
Q 001527          852 LSDYISPGSLASFLYDRPGR------------------------------------------------------------  871 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~------------------------------------------------------------  871 (1060)
                      ||||+++|+|.++++.....                                                            
T Consensus       119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (400)
T cd05105         119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS  198 (400)
T ss_pred             EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence            99999999999998653210                                                            


Q ss_pred             -------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCe
Q 001527          872 -------------------------------KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNA  920 (1060)
Q Consensus       872 -------------------------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~  920 (1060)
                                                     ....+++.++..++.|++.||+||| +.+|+||||||+||+++ ++..+
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivH~dikp~Nill~-~~~~~  276 (400)
T cd05105         199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA-SKNCVHRDLAARNVLLA-QGKIV  276 (400)
T ss_pred             hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChHhEEEe-CCCEE
Confidence                                           1134788899999999999999999 89999999999999998 57889


Q ss_pred             EEcccccceeeccCCce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHH
Q 001527          921 RVADYCLHRLMTQAGTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTD  998 (1060)
Q Consensus       921 kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~  998 (1060)
                      ||+|||+++........ ......++..|+|||++.+..+  +.++|||||||++|||++ |+.||......       +
T Consensus       277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~DiwSlGvil~ellt~g~~P~~~~~~~-------~  347 (400)
T cd05105         277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY--TTLSDVWSYGILLWEIFSLGGTPYPGMIVD-------S  347 (400)
T ss_pred             EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC--CchhhHHHHHHHHHHHHHCCCCCCcccchh-------H
Confidence            99999999865433221 1112246778999999987664  789999999999999997 99998753211       1


Q ss_pred             HHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527          999 WMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       999 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ........+...     .        ........+.+++.+|++ +|++||++.+|+++|+.
T Consensus       348 ~~~~~~~~~~~~-----~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         348 TFYNKIKSGYRM-----A--------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             HHHHHHhcCCCC-----C--------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence            111111111100     0        011234567889999998 79999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-35  Score=319.06  Aligned_cols=249  Identities=27%  Similarity=0.418  Sum_probs=195.8

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++.  ..+..++||||+++++
T Consensus        11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~   87 (261)
T cd05068          11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT--LEEPIYIVTELMKYGS   87 (261)
T ss_pred             EEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe--cCCCeeeeeecccCCc
Confidence            47899999999999998778899999987643 23567889999999999999999999884  5667899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....   ...+++.++..++.|++.||.||| +.||+||||||+||+++ +++.+||+|||+++...........
T Consensus        88 L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05068          88 LLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLE-AQNYIHRDLAARNVLVG-ENNICKVADFGLARVIKEDIYEARE  162 (261)
T ss_pred             HHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCcceEEEc-CCCCEEECCcceEEEccCCcccccC
Confidence            999996543   345899999999999999999999 99999999999999998 5789999999999876533222111


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ....+..|+|||+..+..+  +.++||||||+++|||++ |+.||....       ... ...........         
T Consensus       163 ~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~-~~~~~~~~~~~---------  223 (261)
T cd05068         163 GAKFPIKWTAPEAALYNRF--SIKSDVWSFGILLTEIVTYGRMPYPGMT-------NAE-VLQQVDQGYRM---------  223 (261)
T ss_pred             CCcCceeccCccccccCCC--CchhhHHHHHHHHHHHHhcCCCCCCCCC-------HHH-HHHHHHcCCCC---------
Confidence            1123457999999887654  789999999999999999 999986421       111 11111111100         


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                          +........+.+++.+|++ +|.+||+++++++.|+..
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 ----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                0011234567889999998 799999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=337.07  Aligned_cols=247  Identities=16%  Similarity=0.210  Sum_probs=191.1

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++....   ...+.+.+|++++.+++||||+++++++.  .....++||||+
T Consensus         6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~e~~   83 (333)
T cd05600           6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ--DDEYLYLAMEYV   83 (333)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE--cCCEEEEEEeCC
Confidence            478999999999999965 589999999975432   23457889999999999999999999885  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++..     ...+++.++..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||+++.....  
T Consensus        84 ~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~~--  154 (333)
T cd05600          84 PGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALH-ELGYIHRDLKPENFLID-ASGHIKLTDFGLSKGIVTY--  154 (333)
T ss_pred             CCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEC-CCCCEEEEeCcCCcccccc--
Confidence            99999999954     245889999999999999999999 99999999999999998 5889999999999865431  


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                        .....||+.|+|||++.+..+  +.++|||||||++|||++|+.||.....       .+.........   ..+...
T Consensus       155 --~~~~~gt~~y~aPE~~~~~~~--~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~---~~~~~~  220 (333)
T cd05600         155 --ANSVVGSPDYMAPEVLRGKGY--DFTVDYWSLGCMLYEFLCGFPPFSGSTP-------NETWENLKYWK---ETLQRP  220 (333)
T ss_pred             --cCCcccCccccChhHhcCCCC--CCccceecchHHHhhhhhCCCCCCCCCH-------HHHHHHHHhcc---ccccCC
Confidence              122368999999999987754  7899999999999999999999974321       11111111100   011100


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhccC-CCCCCCHHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIRS-VSERPGIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 1056 (1060)
                      ....    ........+.+++.+|+.+ |.+||+++|+++.
T Consensus       221 ~~~~----~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         221 VYDD----PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCc----cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0000    0012344567788899985 7889999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.8e-35  Score=329.05  Aligned_cols=240  Identities=22%  Similarity=0.314  Sum_probs=186.6

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      ++||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++||||+++++++.  ..+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe--cCCEEEEEEeCCC
Confidence            46999999999999854 68999999997542   223456778999999999999999999885  5668999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +|+|..++..     ...+++..+..++.||+.||+||| +.||+||||||+|||++ +++.+||+|||+++........
T Consensus        79 ~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~  151 (323)
T cd05595          79 GGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCc
Confidence            9999998854     235899999999999999999999 99999999999999998 5789999999998753322211


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                       .....||+.|+|||++.+..+  +.++|||||||++|||++|+.||.....       .......... ..      .+
T Consensus       152 -~~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~~~~~-~~------~~  214 (323)
T cd05595         152 -MKTFCGTPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILME-EI------RF  214 (323)
T ss_pred             -cccccCCcCcCCcccccCCCC--CchhchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcC-CC------CC
Confidence             122368999999999987765  7899999999999999999999864211       1111111111 00      00


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYE 1055 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~ 1055 (1060)
                       +       ......+.+++.+|++ +|.+||     ++.++++
T Consensus       215 -p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         215 -P-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -C-------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence             0       1123456678889998 799998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.9e-35  Score=331.01  Aligned_cols=241  Identities=20%  Similarity=0.294  Sum_probs=187.9

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      ++||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++||||+++++++.  ..+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ--TKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCEEEEEEeCCC
Confidence            36999999999999854 68999999997542   223467888999999999999999998884  5678999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +|+|.+++..     ...+++.++..++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+++........
T Consensus        79 ~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~  151 (328)
T cd05593          79 GGELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLH-SGKIVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAAT  151 (328)
T ss_pred             CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecccCHHHeEEC-CCCcEEEecCcCCccCCCcccc
Confidence            9999998853     245899999999999999999999 99999999999999998 5889999999998754322211


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                       .....||+.|+|||++.+..+  +.++|||||||++|||++|+.||....       ..+........ .      ..+
T Consensus       152 -~~~~~gt~~y~aPE~~~~~~~--~~~~DiwslGvil~elltG~~Pf~~~~-------~~~~~~~~~~~-~------~~~  214 (328)
T cd05593         152 -MKTFCGTPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILME-D------IKF  214 (328)
T ss_pred             -cccccCCcCccChhhhcCCCC--CccCCccccchHHHHHhhCCCCCCCCC-------HHHHHHHhccC-C------ccC
Confidence             122368999999999987765  789999999999999999999986421       11121111110 0      000


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYED 1056 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~~ 1056 (1060)
                       +       ......+.+++.+|++ +|.+||     ++.|+++.
T Consensus       215 -p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 -P-------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -C-------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence             0       1123456678889998 799997     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.1e-35  Score=321.77  Aligned_cols=246  Identities=21%  Similarity=0.273  Sum_probs=187.9

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEcccchHH---HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          784 LGRSSHGTSYRATLE-NGMFLTVKWLREGVAK---QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       784 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      ||+|+||+||++... +++.||+|++......   ..+.+..|++++++++||||+++.+++.  .....++||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ--TKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc--CCCeEEEEEeCCCCC
Confidence            699999999999854 7899999998654222   2356778999999999999999998884  566799999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++.... .....+++..+..++.||+.||+||| +.+|+||||||+||+++ +++.+||+|||.++......... 
T Consensus        79 ~L~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~-  154 (280)
T cd05608          79 DLRYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLH-QRRIIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKT-  154 (280)
T ss_pred             CHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccc-
Confidence            9998885432 23356899999999999999999999 99999999999999998 57889999999998665433221 


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ....||+.|+|||++.+..+  +.++|||||||++|||++|+.||.......   ..........         ....  
T Consensus       155 ~~~~g~~~y~aPE~~~~~~~--~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~---------~~~~--  218 (280)
T cd05608         155 KGYAGTPGFMAPELLQGEEY--DFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRIL---------NDSV--  218 (280)
T ss_pred             cccCCCcCccCHHHhcCCCC--CccccHHHHHHHHHHHHhCCCCCCCCCcch---hHHHHHHhhc---------ccCC--
Confidence            22368999999999988765  779999999999999999999997532111   1111111100         0000  


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHH
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYE 1055 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~ 1055 (1060)
                          .........+.+++.+|++ +|++||     +++|+++
T Consensus       219 ----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 ----TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ----CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence                0011233456788889997 799999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=326.07  Aligned_cols=239  Identities=20%  Similarity=0.259  Sum_probs=188.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.  +....++||||+
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~e~~   83 (291)
T cd05612           6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH--DQRFLYMLMEYV   83 (291)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc--cCCeEEEEEeCC
Confidence            478999999999999965 68999999986432   223466889999999999999999998884  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++..+..++.|++.||+||| ++||+||||||+||+++ +++.+||+|||+++.......
T Consensus        84 ~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~~~  156 (291)
T cd05612          84 PGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLH-SKEIVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTW  156 (291)
T ss_pred             CCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEEC-CCCCEEEEecCcchhccCCcc
Confidence            999999999543     45889999999999999999999 99999999999999998 578999999999986543221


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                          ...|++.|+|||++.+..+  +.++|||||||++|||++|+.||....       ..+....... +..      .
T Consensus       157 ----~~~gt~~y~aPE~~~~~~~--~~~~DiwSlG~il~~l~~g~~pf~~~~-------~~~~~~~i~~-~~~------~  216 (291)
T cd05612         157 ----TLCGTPEYLAPEVIQSKGH--NKAVDWWALGILIYEMLVGYPPFFDDN-------PFGIYEKILA-GKL------E  216 (291)
T ss_pred             ----cccCChhhcCHHHHcCCCC--CchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh-CCc------C
Confidence                2368999999999987765  789999999999999999999986421       1122222111 111      0


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCC-----HHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPG-----IKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs-----~~evl~~ 1056 (1060)
                      + +.       .....+.+++.+|++ +|.+||+     ++|+++.
T Consensus       217 ~-~~-------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         217 F-PR-------HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             C-Cc-------cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            0 00       112346778889998 7999995     8887653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.9e-35  Score=329.93  Aligned_cols=254  Identities=28%  Similarity=0.390  Sum_probs=194.0

Q ss_pred             CCeeccccceEEEEEEEc------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEE
Q 001527          781 AEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv  852 (1060)
                      .++||+|+||.||+|+..      +++.||+|+++... ....+.+.+|+++++++ +||||++++++|.. .+...+++
T Consensus        12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~-~~~~~~~v   90 (337)
T cd05054          12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK-PGGPLMVI   90 (337)
T ss_pred             hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec-CCCCEEEE
Confidence            588999999999999632      35789999987532 23346778899999999 89999999998863 45678899


Q ss_pred             EEecCCCChHHHhhcCCCC--------------------------------------------------------CCCCC
Q 001527          853 SDYISPGSLASFLYDRPGR--------------------------------------------------------KGPPL  876 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~--------------------------------------------------------~~~~l  876 (1060)
                      |||+++++|.+++......                                                        ...++
T Consensus        91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  170 (337)
T cd05054          91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL  170 (337)
T ss_pred             EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence            9999999999998643210                                                        01368


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee-eeccCccccccchhccc
Q 001527          877 TWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAA  955 (1060)
Q Consensus       877 ~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~  955 (1060)
                      ++..+.+++.||+.||+||| +.+|+||||||+||+++ +++.+||+|||+++.+....... .....++..|+|||++.
T Consensus       171 ~~~~~~~~~~qi~~aL~~lH-~~~ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~  248 (337)
T cd05054         171 TLEDLISYSFQVARGMEFLA-SRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIF  248 (337)
T ss_pred             CHHHHHHHHHHHHHHHHHHH-hCCeecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhc
Confidence            99999999999999999999 99999999999999998 57899999999998764332211 12224567899999998


Q ss_pred             CCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHH
Q 001527          956 SKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVL 1034 (1060)
Q Consensus       956 ~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~ 1034 (1060)
                      +..+  +.++|||||||++|||++ |+.||......       +........+....      .+       ......+.
T Consensus       249 ~~~~--~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~------~~-------~~~~~~~~  306 (337)
T cd05054         249 DKVY--TTQSDVWSFGVLLWEIFSLGASPYPGVQID-------EEFCRRLKEGTRMR------AP-------EYATPEIY  306 (337)
T ss_pred             CCCC--CccccHHHHHHHHHHHHHcCCCCCCCCCcc-------HHHHHHHhccCCCC------CC-------ccCCHHHH
Confidence            7765  789999999999999998 99998643211       11111111111100      00       12235678


Q ss_pred             HHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1035 GIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1035 ~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      +++.+|++ +|++||++.||+++|+.
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHH
Confidence            89999998 79999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-34  Score=326.73  Aligned_cols=193  Identities=22%  Similarity=0.367  Sum_probs=164.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+|+.. +|..||+|+++... ....+.+.+|++++++++||||+++++++.  ..+..++||||+++
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~   87 (331)
T cd06649          10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDG   87 (331)
T ss_pred             EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE--ECCEEEEEeecCCC
Confidence            478999999999999965 68899999987542 334567999999999999999999999985  45689999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      |+|.+++...     ..+++..+..++.|++.||.|||...+|+||||||+||+++ +++.+||+|||+++.......  
T Consensus        88 ~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~--  159 (331)
T cd06649          88 GSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA--  159 (331)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc-CCCcEEEccCccccccccccc--
Confidence            9999999543     35889999999999999999999335799999999999998 578999999999876543221  


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                       ....|+..|+|||++.+..+  +.++|||||||++|||++|+.||..
T Consensus       160 -~~~~g~~~y~aPE~~~~~~~--~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         160 -NSFVGTRSYMSPERLQGTHY--SVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             -ccCCCCcCcCCHhHhcCCCC--CchHhHHHHHHHHHHHHhCCCCCCC
Confidence             12368999999999987764  7899999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.4e-35  Score=321.62  Aligned_cols=264  Identities=23%  Similarity=0.311  Sum_probs=195.3

Q ss_pred             CCeeccccceEEEEEEE-----cCCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATL-----ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .+.||+|+||+||++.+     .+++.||+|.++... ....+.+.+|++++++++||||+++++++........++|||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (283)
T cd05080           9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME   88 (283)
T ss_pred             ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence            47899999999988753     357899999987543 234567889999999999999999999986545556899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++++|.+++...      .+++.++..++.|++.||+||| +++|+||||||+||+++ ++..+||+|||+++.....
T Consensus        89 ~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH-~~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          89 YVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLH-SQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             CCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHH-HCCeeccccChheEEEc-CCCcEEEeecccccccCCc
Confidence            99999999999542      4899999999999999999999 99999999999999998 5789999999999876543


Q ss_pred             Ccee--eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          935 GTIE--QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       935 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ....  .....++..|+|||+..+...  +.++|||||||++|||+||+.|+......-  .....+...........+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~--~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKF--SYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCC--CcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchhhhhhh
Confidence            2211  111235667999999877654  779999999999999999999986432110  0000000000000000011


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      .+.....    +........+.+++.+|++ +|.+|||+++|+++|+++
T Consensus       237 ~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         237 LERGMRL----PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhcCCCC----CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            1111110    1112334678889999998 799999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.1e-35  Score=344.29  Aligned_cols=249  Identities=20%  Similarity=0.210  Sum_probs=194.8

Q ss_pred             cCCCeeccccceEEEEEEEc-C-CcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          779 APAEVLGRSSHGTSYRATLE-N-GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       779 ~~~~~iG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ...+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++|||||++++++.  ..+..++||||+
T Consensus        70 ~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~--~~~~~~lv~E~~  147 (478)
T PTZ00267         70 VLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK--SDDKLLLIMEYG  147 (478)
T ss_pred             EEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE--ECCEEEEEEECC
Confidence            34578999999999999844 4 6788999876555555567889999999999999999999995  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++.... ....++++.++..++.||+.||+||| +++|+||||||+|||++ .++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlkp~NIll~-~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVH-SRKMMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHH-hCCEEECCcCHHhEEEC-CCCcEEEEeCcCceecCCccc
Confidence            9999999886542 22356899999999999999999999 99999999999999998 578999999999987654322


Q ss_pred             e-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          937 I-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       937 ~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      . ......||+.|+|||++.+..+  +.++|||||||++|||++|+.||...       ...+.+...... ...    +
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~--~~~~Dv~slG~~l~el~tg~~Pf~~~-------~~~~~~~~~~~~-~~~----~  290 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRY--SKKADMWSLGVILYELLTLHRPFKGP-------SQREIMQQVLYG-KYD----P  290 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCC--CcHHhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhC-CCC----C
Confidence            1 1223368999999999987765  78999999999999999999998642       112222222211 110    0


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                               ........+.+++..|++ +|++||+++|++.
T Consensus       291 ---------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 ---------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                     001123457788889998 7999999999875

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.9e-35  Score=319.80  Aligned_cols=249  Identities=28%  Similarity=0.432  Sum_probs=199.5

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .++||+|+||.||+|...+++.+|+|+++.........+.+|++++++++||||+++++++.  .....++||||+++++
T Consensus        11 ~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~   88 (261)
T cd05148          11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS--VGEPVYIITELMEKGS   88 (261)
T ss_pred             hhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe--cCCCeEEEEeecccCC
Confidence            57899999999999998889999999998766556678999999999999999999999985  5667899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....   ...+++.++.+++.|++.||+||| ++||+||||||+||+++ ++..+||+|||.+........... 
T Consensus        89 L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH-~~~i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~~~~~~~~~-  162 (261)
T cd05148          89 LLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLE-EQNSIHRDLAARNILVG-EDLVCKVADFGLARLIKEDVYLSS-  162 (261)
T ss_pred             HHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccCcceEEEc-CCceEEEccccchhhcCCcccccc-
Confidence            999997543   345899999999999999999999 99999999999999998 588999999999987644322211 


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||...+..+  +.++||||||+++|+|++ |+.||....       ..+..........      .    
T Consensus       163 ~~~~~~~~~~PE~~~~~~~--~~~~DiwslG~~l~~l~~~g~~p~~~~~-------~~~~~~~~~~~~~------~----  223 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTF--STKSDVWSFGILLYEMFTYGQVPYPGMN-------NHEVYDQITAGYR------M----  223 (261)
T ss_pred             CCCCceEecCHHHHccCCC--CchhhHHHHHHHHHHHHcCCCCCCCcCC-------HHHHHHHHHhCCc------C----
Confidence            2245678999999877654  779999999999999998 899986432       1111111111100      0    


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                          +........+.+++.+|++ +|.+|||++++++.|+++
T Consensus       224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 ----PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                0011234567789999998 799999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.1e-34  Score=315.99  Aligned_cols=246  Identities=24%  Similarity=0.401  Sum_probs=193.0

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .+.||+|+||.||+|+..++..+|+|.++... ...+.+.+|++++++++||||+++++++.  .....++||||+++|+
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~   85 (256)
T cd05113           9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT--KQRPIYIVTEYMSNGC   85 (256)
T ss_pred             eeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEc--cCCCcEEEEEcCCCCc
Confidence            46899999999999998777789999987543 23467899999999999999999999984  4567899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....    ..+++.+++.++.||+.||+||| +.+++||||||+||+++ +++.+||+|||.++...........
T Consensus        86 l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05113          86 LLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLE-SKQFIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSSV  159 (256)
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccCcceEEEc-CCCCEEECCCccceecCCCceeecC
Confidence            999996532    25899999999999999999999 99999999999999998 5789999999998865443322222


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||+..+..+  +.++|||||||++|||++ |+.||.....       .+..... ..+...  ..+    
T Consensus       160 ~~~~~~~y~~pe~~~~~~~--~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~-~~~~~~--~~~----  223 (256)
T cd05113         160 GSKFPVRWSPPEVLLYSKF--SSKSDVWAFGVLMWEVYSLGKMPYERFNN-------SETVEKV-SQGLRL--YRP----  223 (256)
T ss_pred             CCccChhhCCHHHHhcCcc--cchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHH-hcCCCC--CCC----
Confidence            2245678999999987654  779999999999999999 9999864321       1111111 111110  000    


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                             ......+.+++.+|++ +|.+||++.+|++.|+
T Consensus       224 -------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 -------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                   1123567889999998 7999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.7e-35  Score=328.94  Aligned_cols=248  Identities=21%  Similarity=0.359  Sum_probs=190.7

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++.++ +||||+++++++.  +....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~--~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ--TESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE--cCCEEEEEEeCC
Confidence            46999999999999965 68999999997542   22345678899999998 7999999999985  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++..     ...+++..+..++.|++.||+||| ++||+||||||+||+++ .++.+||+|||+++.......
T Consensus        79 ~~g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~  151 (329)
T cd05588          79 SGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLH-ERGIIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGD  151 (329)
T ss_pred             CCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEEC-CCCCEEECcCccccccccCCC
Confidence            99999998853     245899999999999999999999 99999999999999998 578999999999875322221


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC-CccChHHHHHHHHhcCCCCccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      . .....||..|+|||++.+..+  +.++|||||||++|||++|+.||+...... ......++...........     
T Consensus       152 ~-~~~~~gt~~y~aPE~~~~~~~--~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  223 (329)
T cd05588         152 T-TSTFCGTPNYIAPEILRGEDY--GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR-----  223 (329)
T ss_pred             c-cccccCCccccCHHHHcCCCC--CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-----
Confidence            1 122368999999999987765  779999999999999999999997533221 1222334443333322111     


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCC------HHHHHH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPG------IKTIYE 1055 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs------~~evl~ 1055 (1060)
                        .+.       .....+.+++.+|++ +|.+||+      ++|+++
T Consensus       224 --~p~-------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 --IPR-------SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             --CCC-------CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence              011       123456778889998 7999997      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.8e-34  Score=319.11  Aligned_cols=253  Identities=26%  Similarity=0.398  Sum_probs=197.8

Q ss_pred             CCeeccccceEEEEEEEc------CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE------NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+|+..      ++..+++|.++.......+.+.+|++++++++||||+++++++.  .....++|||
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e   87 (291)
T cd05094          10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG--DGDPLIMVFE   87 (291)
T ss_pred             eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc--cCCceEEEEe
Confidence            478999999999999742      35679999998766666678999999999999999999999985  5667899999


Q ss_pred             ecCCCChHHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEc
Q 001527          855 YISPGSLASFLYDRPG-----------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVA  923 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~  923 (1060)
                      |+++++|.+++.....           .....+++.++++++.||+.||+||| +++|+||||||+||+++ +++.+||+
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~Nil~~-~~~~~~l~  165 (291)
T cd05094          88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVG-ANLLVKIG  165 (291)
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccCcceEEEc-cCCcEEEC
Confidence            9999999999965321           12245899999999999999999999 99999999999999998 58899999


Q ss_pred             ccccceeeccCCce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHH
Q 001527          924 DYCLHRLMTQAGTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQ 1001 (1060)
Q Consensus       924 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~ 1001 (1060)
                      |||+++........ ......++..|+|||++.+..+  +.++|||||||++|||+| |+.||.....       .+...
T Consensus       166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~~~~  236 (291)
T cd05094         166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF--TTESDVWSFGVILWEIFTYGKQPWFQLSN-------TEVIE  236 (291)
T ss_pred             CCCcccccCCCceeecCCCCCcceeecChHHhccCCC--CchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH
Confidence            99999765433221 1122346788999999987664  779999999999999999 9999864321       11111


Q ss_pred             HHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1002 LKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1002 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                       ....+...+.             .......+.+++.+|++ +|.+||++++|+++|+++
T Consensus       237 -~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         237 -CITQGRVLER-------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             -HHhCCCCCCC-------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence             1111111110             01223567889999998 799999999999999753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.5e-35  Score=330.83  Aligned_cols=238  Identities=21%  Similarity=0.287  Sum_probs=188.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++....   ...+.+.+|++++++++||||+++++++.  +.+..++||||+
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~e~~  100 (329)
T PTZ00263         23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ--DENRVYFLLEFV  100 (329)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE--cCCEEEEEEcCC
Confidence            578999999999999965 689999999875422   23457889999999999999999999985  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++..+..++.|++.||+||| +.||+||||||+|||++ .++.+||+|||+++.......
T Consensus       101 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~  173 (329)
T PTZ00263        101 VGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLH-SKDIIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTF  173 (329)
T ss_pred             CCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHEEEC-CCCCEEEeeccCceEcCCCcc
Confidence            999999999542     35888999999999999999999 99999999999999998 588999999999987644322


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                          ...||+.|+|||++.+..+  +.++|||||||++|||++|+.||....       ..+... .+..+...      
T Consensus       174 ----~~~gt~~y~aPE~~~~~~~--~~~~DiwslG~il~elltg~~pf~~~~-------~~~~~~-~i~~~~~~------  233 (329)
T PTZ00263        174 ----TLCGTPEYLAPEVIQSKGH--GKAVDWWTMGVLLYEFIAGYPPFFDDT-------PFRIYE-KILAGRLK------  233 (329)
T ss_pred             ----eecCChhhcCHHHHcCCCC--CCcceeechHHHHHHHHcCCCCCCCCC-------HHHHHH-HHhcCCcC------
Confidence                2368999999999987765  789999999999999999999986421       111111 11111110      


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCC-----HHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPG-----IKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs-----~~evl~ 1055 (1060)
                       .+.       .....+.+++.+|++ +|.+||+     ++|+++
T Consensus       234 -~p~-------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        234 -FPN-------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             -CCC-------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence             011       112346678889998 7999997     577664

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-35  Score=323.50  Aligned_cols=246  Identities=20%  Similarity=0.321  Sum_probs=198.6

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+++|+|+||.++.++.+ ++..|++|.+.-..  ...++...+|+.++++++|||||.+.+.|.. ++...+|||+||+
T Consensus         9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~-~~~~l~Ivm~Y~e   87 (426)
T KOG0589|consen    9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE-DGQLLCIVMEYCE   87 (426)
T ss_pred             hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc-CCceEEEEEeecC
Confidence            578999999999999854 67889999886432  3344567899999999999999999999963 3334899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      ||++.+.+.+.+   +..++++.+.+|+.|++.|+.||| +..|+|||||+.||+++ .+..+||+|||+|+.+......
T Consensus        88 Gg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH-~~~iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   88 GGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLH-ENRVLHRDLKCANIFLT-KDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             CCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHH-hhhhhcccchhhhhhcc-ccCceeecchhhhhhcCCchhh
Confidence            999999997754   456999999999999999999999 99999999999999998 5777899999999998776522


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      .. ...||+.||.||++.+.+|  ..|+||||+||++|||++=+++|+..       ++...+....+..          
T Consensus       163 a~-tvvGTp~YmcPEil~d~pY--n~KSDiWsLGC~~yEm~~lk~aF~a~-------~m~~Li~ki~~~~----------  222 (426)
T KOG0589|consen  163 AS-TVVGTPYYMCPEILSDIPY--NEKSDIWSLGCCLYEMCTLKPAFKAS-------NMSELILKINRGL----------  222 (426)
T ss_pred             hh-eecCCCcccCHHHhCCCCC--CccCcchhhcchHHHHHhcccccCcc-------chHHHHHHHhhcc----------
Confidence            22 2389999999999999987  77999999999999999999998753       2333333222211          


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                          ..|........+..++..|++ +|+.||++.+++.+
T Consensus       223 ----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 ----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                112223345566777779998 69999999999875

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.6e-35  Score=328.47  Aligned_cols=264  Identities=14%  Similarity=0.156  Sum_probs=190.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++...  ....+.+.+|++++++++||||+++++++.  ..+..++||||++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~   83 (287)
T cd07848           6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR--RRGKLYLVFEYVE   83 (287)
T ss_pred             EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe--cCCEEEEEEecCC
Confidence            578999999999999975 68899999987532  223467889999999999999999999984  5668999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      ++.+..+...     ...+++.++..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||+++........
T Consensus        84 ~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          84 KNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCH-KNDIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEc-CCCcEEEeeccCcccccccccc
Confidence            8777655421     235899999999999999999999 99999999999999998 5789999999999876543322


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccC--------hHHHHHHHHhcCCC
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVD--------LTDWMQLKVAEGHG 1009 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~--------l~~~~~~~~~~~~~ 1009 (1060)
                      ......|+..|+|||++.+..+  +.++||||+||++|||++|+.||......+....        ..++..........
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~--~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         157 NYTEYVATRWYRSPELLLGAPY--GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccCCcHHHcCCCC--CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            2223368999999999987764  7799999999999999999999975321110000        00011100000000


Q ss_pred             Cccccccccccc--CChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1010 SDCFDAAVMPEM--VNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1010 ~~~~d~~l~~~~--~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .....+......  ...........+.+++.+|++ +|++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000  000001133468889999998 7999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.8e-34  Score=310.58  Aligned_cols=247  Identities=25%  Similarity=0.405  Sum_probs=193.3

Q ss_pred             CeeccccceEEEEEEEcCCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          782 EVLGRSSHGTSYRATLENGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      ++||+|+||.||+|...+++.+|+|+++... ......+.+|++++++++||||+++++++.  .....++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT--QRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe--cCCccEEEEECCCCCc
Confidence            4689999999999998889999999987653 233457889999999999999999999985  4567899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....    ..+++.++..++.|++.||.|+| ++|++||||||+||+++ +++.+|++|||++............
T Consensus        79 L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH-~~~~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          79 FLSFLRKKK----DELKTKQLVKFALDAAAGMAYLE-SKNCIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccChheEEEc-CCCeEEECCCccceeccccccccCC
Confidence            999986432    34789999999999999999999 99999999999999998 5889999999998764433222111


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||++.+..+  +.++||||||+++||+++ |..||.....       . .............     .  
T Consensus       153 ~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~ll~~~~~~g~~p~~~~~~-------~-~~~~~~~~~~~~~-----~--  215 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRY--SSESDVWSYGILLWETFSLGVCPYPGMTN-------Q-QAREQVEKGYRMS-----C--  215 (250)
T ss_pred             CCCCcccccCHHHhccCCC--CchhHHHHHHHHHHHHhcCCCCCCCCCCH-------H-HHHHHHHcCCCCC-----C--
Confidence            2234677999999977654  779999999999999998 9999864311       1 1111121111100     0  


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                            .......+.+++.+|++ +|++||++.|++++|.+
T Consensus       216 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  250 (250)
T cd05085         216 ------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA  250 (250)
T ss_pred             ------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhcC
Confidence                  01234568889999998 79999999999999863

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.7e-34  Score=315.36  Aligned_cols=247  Identities=27%  Similarity=0.419  Sum_probs=194.2

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .+.||+|+||.||+|...++..||+|.++.... ..+.+.+|++++++++||||+++++++.   ....++||||+++++
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e~~~~~~   86 (260)
T cd05070          11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS---EEPIYIVTEYMSKGS   86 (260)
T ss_pred             hheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC---CCCcEEEEEecCCCc
Confidence            578999999999999988888999999875432 3457899999999999999999999873   346799999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.++++...   ...+++.++..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||.+............
T Consensus        87 L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05070          87 LLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIE-RMNYIHRDLRSANILVG-DGLVCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCccceEEEe-CCceEEeCCceeeeeccCccccccc
Confidence            999996532   245899999999999999999999 89999999999999998 5789999999999876543322222


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||+..+..+  +.++||||||+++|||++ |+.||....       ..+..... ......         
T Consensus       162 ~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~~l~~~g~~p~~~~~-------~~~~~~~~-~~~~~~---------  222 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRF--TIKSDVWSFGILLTELVTKGRVPYPGMN-------NREVLEQV-ERGYRM---------  222 (260)
T ss_pred             CCCCCccccChHHHhcCCC--cchhhhHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHH-HcCCCC---------
Confidence            2235668999999876654  789999999999999999 888986421       11222111 111000         


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                          +........+.+++.+|+. +|.+|||+.++.+.|+.
T Consensus       223 ----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 ----PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                0011234568889999998 79999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-34  Score=316.38  Aligned_cols=249  Identities=27%  Similarity=0.440  Sum_probs=195.0

Q ss_pred             CCeeccccceEEEEEEEc----CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE----NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|++.    +...||+|+++... ....+++.+|+.++++++||||+++++++.  .....++||||
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~iv~e~   86 (266)
T cd05033           9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT--KSRPVMIITEY   86 (266)
T ss_pred             eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe--cCCceEEEEEc
Confidence            578999999999999864    24689999987543 334567899999999999999999999885  55678999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC-
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA-  934 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~-  934 (1060)
                      +++++|.+++....    ..+++.++.+++.|++.||+||| +++|+||||||+||+++ ++..+||+|||+++..... 
T Consensus        87 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh-~~~i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          87 MENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLS-EMNYVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             CCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCcceEEEc-CCCCEEECccchhhcccccc
Confidence            99999999996532    36899999999999999999999 99999999999999998 5789999999999877522 


Q ss_pred             CceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccc
Q 001527          935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 1013 (1060)
                      .........++..|+|||.+.+..+  +.++||||||+++|||++ |..||.....    ....+.    .......   
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~--~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----~~~~~~----~~~~~~~---  227 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKF--TSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVIKA----VEDGYRL---  227 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCC--ccccchHHHHHHHHHHHccCCCCCCCCCH----HHHHHH----HHcCCCC---
Confidence            2222222245678999999987654  779999999999999998 9999864321    111111    1111110   


Q ss_pred             ccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1014 DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1014 d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                       +         ........+.+++.+|++ +|++||+++||+++|+++
T Consensus       228 -~---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 -P---------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -C---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             0         011234567889999998 799999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.7e-34  Score=318.72  Aligned_cols=254  Identities=25%  Similarity=0.384  Sum_probs=197.1

Q ss_pred             CCCeeccccceEEEEEEE------cCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          780 PAEVLGRSSHGTSYRATL------ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      ..+.||+|+||.||++..      .++..+|+|.++.......+.+.+|++++++++||||+++++++.  .....++||
T Consensus         9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   86 (288)
T cd05093           9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV--EGDPLIMVF   86 (288)
T ss_pred             eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCccEEEE
Confidence            357899999999999974      235679999998765566678999999999999999999999985  566889999


Q ss_pred             EecCCCChHHHhhcCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccc
Q 001527          854 DYISPGSLASFLYDRPG--------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY  925 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Df  925 (1060)
                      ||+++++|.+++.....        .....+++.+++.++.|++.||+||| ++|++||||||+||+++ +++.+||+||
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH-~~~i~H~dlkp~Nili~-~~~~~kl~df  164 (288)
T cd05093          87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCLVG-ENLLVKIGDF  164 (288)
T ss_pred             EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccCcceEEEc-cCCcEEeccC
Confidence            99999999999965321        12245899999999999999999999 99999999999999998 5889999999


Q ss_pred             ccceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHH
Q 001527          926 CLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLK 1003 (1060)
Q Consensus       926 g~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 1003 (1060)
                      |+++......... .....++..|+|||++.+..+  +.++|||||||++|||++ |+.||.....       .+.. ..
T Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~sDiwslG~il~~l~t~g~~p~~~~~~-------~~~~-~~  234 (288)
T cd05093         165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF--TTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVI-EC  234 (288)
T ss_pred             CccccccCCceeecCCCCCccccccCHHHhccCCC--CchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHH-HH
Confidence            9998654332211 112245778999999987654  779999999999999998 8999864321       1111 11


Q ss_pred             HhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1004 VAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1004 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ...+.....      +       ......+.+++.+|++ +|.+|||+.||.+.|+++
T Consensus       235 i~~~~~~~~------~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         235 ITQGRVLQR------P-------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             HHcCCcCCC------C-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            222111110      0       1123457889999998 799999999999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.8e-34  Score=327.88  Aligned_cols=244  Identities=21%  Similarity=0.377  Sum_probs=185.6

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++.  ..+..++||||+++
T Consensus        79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~  156 (353)
T PLN00034         79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD--HNGEIQVLLEFMDG  156 (353)
T ss_pred             hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec--cCCeEEEEEecCCC
Confidence            478999999999999965 68999999986542 334567899999999999999999999984  56788999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      |+|.+..         ..++..+..++.||+.||+||| +.+|+||||||+|||++ +++.+||+|||+++........ 
T Consensus       157 ~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~-  224 (353)
T PLN00034        157 GSLEGTH---------IADEQFLADVARQILSGIAYLH-RRHIVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDP-  224 (353)
T ss_pred             Ccccccc---------cCCHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEc-CCCCEEEcccccceeccccccc-
Confidence            9986532         2567788899999999999999 99999999999999998 5889999999999876533221 


Q ss_pred             eeccCccccccchhcccCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          939 QILDAGVLGYRAPELAASK---KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      .....||..|+|||++...   ....+.++|||||||++|||++|+.||.....       .+|...........   .+
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~---~~  294 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-------GDWASLMCAICMSQ---PP  294 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-------ccHHHHHHHHhccC---CC
Confidence            1223689999999987532   11235689999999999999999999973211       12222111110000   00


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      ..        .......+.+++.+|++ +|++||++.||++.
T Consensus       295 ~~--------~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        295 EA--------PATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CC--------CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00        01233467788889998 79999999999864

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-34  Score=333.27  Aligned_cols=191  Identities=20%  Similarity=0.269  Sum_probs=159.8

Q ss_pred             ccCCCeeccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          778 RAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      |...+.||+|+||.||+|.. .+++.||+|...      .+.+.+|++++++++|||||++++++.  .....++|+||+
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~lv~e~~  165 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT--YNKFTCLILPRY  165 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE--ECCeeEEEEecC
Confidence            34457899999999999985 468999999753      235678999999999999999999985  456789999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      . ++|.+++...     ..+++.+++.|+.||+.||+||| +.||+||||||+|||++ .++.+||+|||+++.......
T Consensus       166 ~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH-~~~IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        166 K-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLH-ENRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             C-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHhEEEc-CCCCEEEEeCCcccccccccc
Confidence            5 7898888542     35889999999999999999999 89999999999999998 578999999999975433222


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      .......||+.|+|||++.+..+  +.++|||||||++|||++|+.||..
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPY--GPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             cccccccCccCCCChhhhcCCCC--CcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            22223469999999999987765  7899999999999999999988653

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4e-34  Score=314.12  Aligned_cols=256  Identities=22%  Similarity=0.267  Sum_probs=188.6

Q ss_pred             eeccccceEEEEEEEcC---CcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          783 VLGRSSHGTSYRATLEN---GMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       783 ~iG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .||+|+||.||+|+..+   ...+|+|.+.... ......+.+|++.++.++||||+++++++.  .....++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~--~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI--ESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCceEEEEEeCCC
Confidence            58999999999997543   4578888876432 334467889999999999999999999985  56678999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      |+|.+++...........++.....++.||+.||+||| +.+|+||||||+||+++ +++.+||+|||+++.........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QADFIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH-hcCEecccccHhheEec-CCCcEEEeccccccccccchhee
Confidence            99999997654333345678888999999999999999 99999999999999998 58899999999987543322111


Q ss_pred             -eeccCccccccchhcccCC-----CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          939 -QILDAGVLGYRAPELAASK-----KPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       939 -~~~~~gt~~y~aPE~~~~~-----~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                       .....++..|+|||+....     ...++.++|||||||++|||++ |+.||.....       .+-........ ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~~~~-~~~  229 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-------EQVLKQVVREQ-DIK  229 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhhcc-Ccc
Confidence             1222456789999997532     1234779999999999999999 7888764311       11111112211 111


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHhh
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~L~ 1058 (1060)
                      ..++.+.        ......+.+++..|+.+|++|||++||++.|.
T Consensus       230 ~~~~~~~--------~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKPQLD--------LKYSDRWYEVMQFCWLDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCCccc--------ccCCHHHHHHHHHHhcCcccccCHHHHHHHhc
Confidence            1111111        12234556677789989999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.6e-35  Score=327.12  Aligned_cols=248  Identities=24%  Similarity=0.366  Sum_probs=191.7

Q ss_pred             CCCeeccccceEEEEEEEc-CCc----EEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGM----FLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      ..+.||+|+||.||+|++. +++    .||+|+++... ....+++.+|+.+++.++||||++++|+|..   ...++|+
T Consensus        11 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~~~v~   87 (316)
T cd05108          11 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLIT   87 (316)
T ss_pred             eeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCceeee
Confidence            3578999999999999854 344    48999987542 3445778899999999999999999999953   3578999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+++|+|.+++....    ..+++..+++++.||+.||+||| +.+|+||||||+||+++ ++..+||+|||+++....
T Consensus        88 e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH-~~~iiH~dlkp~Nill~-~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          88 QLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE-ERRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             ecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH-hcCeeccccchhheEec-CCCcEEEccccccccccC
Confidence            9999999999996532    35889999999999999999999 99999999999999998 578999999999987654


Q ss_pred             CCceee-eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          934 AGTIEQ-ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       934 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                      ...... ....++..|+|||++.+..+  +.++|||||||++|||++ |+.||+...       ..++.. ........ 
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~--~~~~Di~slGv~l~el~t~g~~p~~~~~-------~~~~~~-~~~~~~~~-  230 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEISS-ILEKGERL-  230 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCC--CchhhhHHHHHHHHHHHcCCCCCCCCCC-------HHHHHH-HHhCCCCC-
Confidence            332221 11234678999999987665  789999999999999998 999986431       112211 11111100 


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                       ..           .......+.+++.+|++ +|.+||++.+++..+..
T Consensus       231 -~~-----------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~  267 (316)
T cd05108         231 -PQ-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  267 (316)
T ss_pred             -CC-----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             00           01123457789999998 79999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.3e-35  Score=327.53  Aligned_cols=240  Identities=20%  Similarity=0.294  Sum_probs=187.0

Q ss_pred             CeeccccceEEEEEEE----cCCcEEEEEEcccchH----HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          782 EVLGRSSHGTSYRATL----ENGMFLTVKWLREGVA----KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      ++||+|+||.||+|+.    .+++.||+|+++....    .....+.+|++++++++||||+++++++.  ..+..++||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~lv~   79 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ--TGGKLYLIL   79 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe--cCCeEEEEE
Confidence            5799999999999985    3588999999875321    23356788999999999999999999885  556899999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+++++|.+++..     ...+.+..+..++.|++.||+||| +.+|+||||||+|||++ .++.+||+|||+++....
T Consensus        80 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          80 EYLSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLH-QQGIIYRDLKPENILLD-AQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             eCCCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEEC-CCCCEEEeeCcCCeeccc
Confidence            99999999999854     245788899999999999999999 99999999999999998 588999999999875433


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccc
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 1013 (1060)
                      ..... ....||+.|+|||++.+...  +.++|||||||++|||++|+.||....       .......... +..    
T Consensus       153 ~~~~~-~~~~gt~~y~aPE~~~~~~~--~~~~DiwslG~il~ell~G~~pf~~~~-------~~~~~~~~~~-~~~----  217 (323)
T cd05584         153 EGTVT-HTFCGTIEYMAPEILMRSGH--GKAVDWWSLGALMYDMLTGAPPFTAEN-------RKKTIDKILK-GKL----  217 (323)
T ss_pred             CCCcc-cccCCCccccChhhccCCCC--CCcceecccHHHHHHHhcCCCCCCCCC-------HHHHHHHHHc-CCC----
Confidence            22221 22368999999999987664  779999999999999999999997421       1122222111 110    


Q ss_pred             ccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHH
Q 001527         1014 DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYE 1055 (1060)
Q Consensus      1014 d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~ 1055 (1060)
                        .+ +       ......+.+++.+|++ +|++||     ++.++++
T Consensus       218 --~~-~-------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 --NL-P-------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --CC-C-------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence              00 0       1123456788889998 799999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-35  Score=316.34  Aligned_cols=246  Identities=26%  Similarity=0.414  Sum_probs=191.7

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .+.||+|+||.||+|..+++..+|+|++..... ....+.+|++++++++||||+++++++.  ..+..++||||+++++
T Consensus         9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~   85 (256)
T cd05059           9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCT--KQRPIFIVTEYMANGC   85 (256)
T ss_pred             hhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEc--CCCceEEEEecCCCCC
Confidence            578999999999999987778899999865422 3356888999999999999999999884  5567899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....    ..+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||.++...........
T Consensus        86 L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          86 LLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLE-SNGFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH-HCCcccccccHhhEEEC-CCCcEEECCcccceecccccccccC
Confidence            999996532    35899999999999999999999 99999999999999998 5789999999998865433222111


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||++.+..+  +.++|||||||++|||++ |+.||+.....    ....    ......     ....  
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~--~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~----~~~~~~-----~~~~--  222 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRF--SSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVVE----SVSAGY-----RLYR--  222 (256)
T ss_pred             CCCCCccccCHHHhccCCC--CchhhHHHHHHHHHHHhccCCCCCCCCCHH----HHHH----HHHcCC-----cCCC--
Confidence            1134457999999987665  779999999999999999 89998643211    1111    111110     0000  


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                            ......++.+++.+|+. +|++|||+.||++.|.
T Consensus       223 ------~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         223 ------PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             ------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence                  01234568889999998 7999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.2e-34  Score=314.52  Aligned_cols=254  Identities=20%  Similarity=0.263  Sum_probs=197.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG---VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.||+|.++..   .......+.+|++++++++||||+++++++.  ..+..++|+||+
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~   84 (267)
T cd08228           7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI--EDNELNIVLELA   84 (267)
T ss_pred             eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE--ECCeEEEEEEec
Confidence            578999999999999954 7899999987532   2344567889999999999999999999985  456889999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++.... .....+++.++..++.|++.||+||| +++++||||||+||+++ .++.++|+|||.+........
T Consensus        85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~~~nil~~-~~~~~~l~d~g~~~~~~~~~~  161 (267)
T cd08228          85 DAGDLSQMIKYFK-KQKRLIPERTVWKYFVQLCSAVEHMH-SRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             CCCcHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHh-hCCeeCCCCCHHHEEEc-CCCCEEECccccceeccchhH
Confidence            9999999886432 22345889999999999999999999 99999999999999998 578899999999887654322


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      .. ....|+..|+|||.+.+...  +.++||||||+++|||++|+.||....     ....++..... ...     .+.
T Consensus       162 ~~-~~~~~~~~~~aPE~~~~~~~--~~~~Di~slG~~l~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~-----~~~  227 (267)
T cd08228         162 AA-HSLVGTPYYMSPERIHENGY--NFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLFSLCQKIE-QCD-----YPP  227 (267)
T ss_pred             HH-hcCCCCccccChhhhccCCC--CchhhHHHHHHHHHHHhcCCCCCcccc-----ccHHHHHHHHh-cCC-----CCC
Confidence            11 12357889999999987654  779999999999999999999985421     12223322211 111     111


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      .       ........+.+++.+|++ +|++||++.||++.++++
T Consensus       228 ~-------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 L-------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             C-------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            1       011234567888889998 799999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.5e-35  Score=330.88  Aligned_cols=198  Identities=24%  Similarity=0.332  Sum_probs=162.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCC---CceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ---HEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~---~~~~lv~e  854 (1060)
                      .++||+|+||.||+|+.. +|+.||+|+++..  .......+.+|++++++++||||+++++++.....   ...++|||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e   84 (338)
T cd07859           5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE   84 (338)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence            578999999999999954 6899999998642  12334568899999999999999999998864322   34799999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+. ++|.+++..     ...+++..+..++.||+.||+||| +.||+||||||+|||++ .++.+||+|||+++.....
T Consensus        85 ~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          85 LME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIH-TANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFND  156 (338)
T ss_pred             cCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEEC-CCCcEEEccCccccccccc
Confidence            995 689998853     245899999999999999999999 99999999999999998 5889999999999865332


Q ss_pred             Cce--eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          935 GTI--EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       935 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ...  ......||..|+|||++.+....++.++|||||||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            211  1122368999999999876322347899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-34  Score=327.85  Aligned_cols=243  Identities=22%  Similarity=0.372  Sum_probs=187.0

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+.++.++ +||||+++++++.  .....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE--eCCEEEEEEeCC
Confidence            46999999999999965 68899999997542   23345677899988877 8999999999985  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|..++...     ..+++..+..|+.|++.||+||| +++|+||||||+||+++ .++.+||+|||+++.......
T Consensus        79 ~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~  151 (329)
T cd05618          79 NGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGD  151 (329)
T ss_pred             CCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCC
Confidence            999999988542     45899999999999999999999 99999999999999998 588999999999875432221


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC-CccChHHHHHHHHhcCCCCccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      . .....||..|+|||++.+..+  +.++|||||||++|||++|+.||+...... ......+++..........     
T Consensus       152 ~-~~~~~gt~~y~aPE~~~~~~~--~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-----  223 (329)
T cd05618         152 T-TSTFCGTPNYIAPEILRGEDY--GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-----  223 (329)
T ss_pred             c-cccccCCccccCHHHHcCCCC--CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC-----
Confidence            1 122368999999999987765  779999999999999999999997432221 1222334443333322110     


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGI 1050 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~ 1050 (1060)
                        .+       ......+.+++.+|++ +|.+||++
T Consensus       224 --~p-------~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 --IP-------RSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             --CC-------CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence              01       1223456778889998 79999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=296.39  Aligned_cols=245  Identities=21%  Similarity=0.273  Sum_probs=190.4

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .++||+|.|+.||++. ..+|+.+|+|++...  .....+++.+|+++-+.++|||||++.+.+  .+....|+|+|+|+
T Consensus        16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti--~~~~~~ylvFe~m~   93 (355)
T KOG0033|consen   16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI--QEESFHYLVFDLVT   93 (355)
T ss_pred             HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh--cccceeEEEEeccc
Confidence            4789999999999997 457999999987532  234568899999999999999999999988  46678899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeC--CCCCeEEcccccceeeccCC
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG--PDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~--~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      |++|..-+-.+     ..+++..+-.+++||++||.|+| .++|||||+||+|+++.+  ..--+||+|||+|.......
T Consensus        94 G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH-~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~  167 (355)
T KOG0033|consen   94 GGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH-SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE  167 (355)
T ss_pred             chHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH-hcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence            99998876443     34788889999999999999999 999999999999999953  23568999999999887322


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                        .....+||++|||||++...++  +..+|||+.||++|-++.|..||...+..       +. .+.+..+.+.  +++
T Consensus       168 --~~~G~~GtP~fmaPEvvrkdpy--~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rl-ye~I~~g~yd--~~~  233 (355)
T KOG0033|consen  168 --AWHGFAGTPGYLSPEVLKKDPY--SKPVDIWACGVILYILLVGYPPFWDEDQH-------RL-YEQIKAGAYD--YPS  233 (355)
T ss_pred             --ccccccCCCcccCHHHhhcCCC--CCcchhhhhhHHHHHHHhCCCCCCCccHH-------HH-HHHHhccccC--CCC
Confidence              2234589999999999998876  77999999999999999999999753211       11 1222222221  111


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                              +......+.-.+++.+|+. +|++|.|+.|.++
T Consensus       234 --------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  234 --------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             --------cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                    1122233344556667776 8999999998764

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.7e-34  Score=314.54  Aligned_cols=245  Identities=21%  Similarity=0.365  Sum_probs=190.4

Q ss_pred             eccccceEEEEEEEc---CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          784 LGRSSHGTSYRATLE---NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       784 iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      ||+|+||.||+|.+.   ++..||+|+++... ....+.+.+|++++++++||||+++++++.   ....++||||++++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~~~~~   79 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEMASGG   79 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEeCCCC
Confidence            899999999999864   35679999987653 234567999999999999999999999883   44689999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++....    ..+++.++.+++.|++.||+||| ++|++||||||+||+++ .+..+||+|||+++..........
T Consensus        80 ~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          80 PLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLE-GKNFVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH-hcCeeecccchheEEEc-CCCcEEeccCCccccccCCcccee
Confidence            9999996432    45899999999999999999999 89999999999999998 578999999999986543322111


Q ss_pred             --eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          940 --ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       940 --~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                        ....++..|+|||++.+..+  +.++|||||||++||+++ |+.||.....       .++.. .+..+...+     
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~-~~~~~~~~~-----  218 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKF--SSRSDVWSYGITMWEAFSYGQKPYKKMKG-------PEVMS-FIEQGKRLD-----  218 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCC--CchhhHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHH-HHHCCCCCC-----
Confidence              11233578999999877654  779999999999999996 9999875321       12221 111111100     


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                              .......++.+++.+||. +|++||++.+|.+.|+.+
T Consensus       219 --------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         219 --------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                    001234567788899998 799999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.8e-34  Score=313.35  Aligned_cols=255  Identities=22%  Similarity=0.345  Sum_probs=193.6

Q ss_pred             CCeeccccceEEEEEEEcC-Cc--EEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCC----CCceEE
Q 001527          781 AEVLGRSSHGTSYRATLEN-GM--FLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT----QHEKLI  851 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~~~l  851 (1060)
                      +++||+|+||.||+|+..+ +.  .||+|.++..  .....+.+.+|++++++++||||+++++++....    ....++
T Consensus         4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   83 (272)
T cd05075           4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV   83 (272)
T ss_pred             ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence            5789999999999999654 33  6899988653  2344577899999999999999999999875322    224689


Q ss_pred             EEEecCCCChHHHhhcCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          852 LSDYISPGSLASFLYDRP-GRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      +|||+++|+|.+++.... +.....+++..+..++.|++.||+||| +++|+||||||+||+++ +++.+||+|||+++.
T Consensus        84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~  161 (272)
T cd05075          84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS-SKSFIHRDLAARNCMLN-ENMNVCVADFGLSKK  161 (272)
T ss_pred             EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhheEEc-CCCCEEECCCCcccc
Confidence            999999999999874322 223345899999999999999999999 89999999999999998 588999999999987


Q ss_pred             eccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCC
Q 001527          931 MTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008 (1060)
Q Consensus       931 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 1008 (1060)
                      ........ .....++..|+|||+..+..+  +.++|||||||++|||++ |+.||.....       .+.. .....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~--~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~-~~~~~~~  231 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESLADRVY--TTKSDVWSFGVTMWEIATRGQTPYPGVEN-------SEIY-DYLRQGN  231 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHccCCCc--ChHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHH-HHHHcCC
Confidence            65433211 112245678999999987654  779999999999999999 8888864211       1111 1122211


Q ss_pred             CCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1009 GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1009 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ...     .        .......+.+++.+|++ +|++|||+.||++.|+.+
T Consensus       232 ~~~-----~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RLK-----Q--------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC-----C--------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            110     0        01233457889999998 799999999999999763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-34  Score=341.22  Aligned_cols=253  Identities=20%  Similarity=0.211  Sum_probs=195.6

Q ss_pred             ccCCCeeccccceEEEEEEE-cCCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCC------Cc
Q 001527          778 RAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ------HE  848 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~------~~  848 (1060)
                      |...++||+|+||+||+|+. .+|+.||||+++..  .......+.+|+..+..++|+||+++++.+.....      ..
T Consensus        34 Y~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~  113 (496)
T PTZ00283         34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLM  113 (496)
T ss_pred             EEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceE
Confidence            34467899999999999984 57999999998643  23445678899999999999999999877643221      13


Q ss_pred             eEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccc
Q 001527          849 KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLH  928 (1060)
Q Consensus       849 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a  928 (1060)
                      .++||||+++|+|.+++..+. .....+++..+..++.|++.||+||| +++|+||||||+|||++ .++.+||+|||++
T Consensus       114 i~lV~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH-~~~IiHrDLKP~NILl~-~~~~vkL~DFGls  190 (496)
T PTZ00283        114 IALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVH-SKHMIHRDIKSANILLC-SNGLVKLGDFGFS  190 (496)
T ss_pred             EEEEEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEe-CCCCEEEEecccC
Confidence            679999999999999997643 23457899999999999999999999 99999999999999998 5889999999999


Q ss_pred             eeeccCCce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC
Q 001527          929 RLMTQAGTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG 1007 (1060)
Q Consensus       929 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 1007 (1060)
                      +........ ......||+.|+|||++.+..+  +.++|||||||++|||++|+.||...       ...+.+...... 
T Consensus       191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~--s~k~DVwSlGvilyeLltG~~Pf~~~-------~~~~~~~~~~~~-  260 (496)
T PTZ00283        191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY--SKKADMFSLGVLLYELLTLKRPFDGE-------NMEEVMHKTLAG-  260 (496)
T ss_pred             eeccccccccccccccCCcceeCHHHhCCCCC--CcHHHHHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHhcC-
Confidence            875432211 1122368999999999987765  78999999999999999999998642       223333322211 


Q ss_pred             CCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1008 HGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1008 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      ..    ++         ........+.+++..|++ +|.+||++.++++.
T Consensus       261 ~~----~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        261 RY----DP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CC----CC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11    00         011233467788889998 79999999999864

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.8e-34  Score=315.43  Aligned_cols=247  Identities=27%  Similarity=0.412  Sum_probs=193.4

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .++||+|+||.||+|+..++..||+|+++.... ..+.+.+|++++++++||||+++++++.   ....++||||+++|+
T Consensus        11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e~~~~~~   86 (262)
T cd05071          11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYIVTEYMSKGS   86 (262)
T ss_pred             eeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC---CCCcEEEEEcCCCCc
Confidence            578999999999999987777899999975322 3457899999999999999999998873   345799999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....   ...+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||.++...........
T Consensus        87 L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~Nill~-~~~~~~L~dfg~~~~~~~~~~~~~~  161 (262)
T cd05071          87 LLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQ  161 (262)
T ss_pred             HHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHH-HCCccccccCcccEEEc-CCCcEEeccCCceeecccccccccc
Confidence            999996532   235789999999999999999999 99999999999999998 5888999999999876543322222


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||+..+..+  +.++|||||||++|||+| |+.||.....       .+.. .........         
T Consensus       162 ~~~~~~~y~~PE~~~~~~~--~~~~DvwslG~~l~ellt~g~~p~~~~~~-------~~~~-~~~~~~~~~---------  222 (262)
T cd05071         162 GAKFPIKWTAPEAALYGRF--TIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVL-DQVERGYRM---------  222 (262)
T ss_pred             CCcccceecCHhHhccCCC--CchhhHHHHHHHHHHHHcCCCCCCCCCCh-------HHHH-HHHhcCCCC---------
Confidence            2346678999999877664  789999999999999999 8888864211       1111 111111000         


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                          +...+....+.+++.+|++ +|++||+++++++.|+.
T Consensus       223 ----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         223 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             ----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence                0112344567899999998 79999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8e-35  Score=329.84  Aligned_cols=247  Identities=21%  Similarity=0.294  Sum_probs=188.2

Q ss_pred             CCeeccccceEEEEEEE----cCCcEEEEEEcccchH----HHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEE
Q 001527          781 AEVLGRSSHGTSYRATL----ENGMFLTVKWLREGVA----KQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLI  851 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~l  851 (1060)
                      .+.||+|+||.||+|+.    .+++.||+|+++....    ...+.+.+|+++++++ +||+|+++++++.  .....++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~~~~l   82 (332)
T cd05614           5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ--TEAKLHL   82 (332)
T ss_pred             EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe--cCCEEEE
Confidence            47899999999999975    3589999999875321    2345678899999999 5999999998884  5667899


Q ss_pred             EEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceee
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~  931 (1060)
                      ||||+++|+|.+++..+     ..+++.++..++.||+.||+||| +.||+||||||+|||++ .++.+||+|||+++..
T Consensus        83 v~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH-~~~ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~  155 (332)
T cd05614          83 ILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLH-KLGIVYRDIKLENILLD-SEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCHHHeEEC-CCCCEEEeeCcCCccc
Confidence            99999999999999543     35899999999999999999999 99999999999999998 5789999999999865


Q ss_pred             ccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          932 TQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                      ............||..|+|||++.+... ++.++|||||||++|||++|+.||.......    ....+.......    
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~----  226 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGG-HGKAVDWWSLGILIFELLTGASPFTLEGERN----TQSEVSRRILKC----  226 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCC-CCCccccccchhhhhhhhcCCCCCCCCCCCC----CHHHHHHHHhcC----
Confidence            4433322223469999999999976542 3779999999999999999999997432211    111121111111    


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHH
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYE 1055 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~ 1055 (1060)
                        ++...        ......+.+++.+|++ +|++||     +++|+++
T Consensus       227 --~~~~~--------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 --DPPFP--------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             --CCCCC--------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence              11111        1123456678889998 799999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=306.31  Aligned_cols=258  Identities=21%  Similarity=0.321  Sum_probs=188.6

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhc--CCCCceeeeeeEEeCCC--CCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFAN--IRHPNVVGLRGYYWGPT--QHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~~--~~~~~lv~e~~  856 (1060)
                      .+.||+|.||+||+|+|+ |+.||||++...   +++.+.+|.++++.  ++|+||+.+++.-.-..  -.+.|||++|.
T Consensus       216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH  291 (513)
T KOG2052|consen  216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH  291 (513)
T ss_pred             EEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence            478999999999999997 889999999753   34566777777765  49999999987654222  12589999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-------CCCcccCCCCCCCeEeeCCCCCeEEcccccce
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF-------DRAVPHGNLKATNILLDGPDLNARVADYCLHR  929 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-------~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~  929 (1060)
                      +.|||+|||..      ..++....++++..+|.||+|||.       .+.|+|||||+.|||+. +++.+.|+|+|+|.
T Consensus       292 e~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C~IADLGLAv  364 (513)
T KOG2052|consen  292 EHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAV  364 (513)
T ss_pred             cCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcEEEeeceeeE
Confidence            99999999954      458999999999999999999992       35799999999999998 68999999999998


Q ss_pred             eeccCCc---eeeeccCccccccchhcccCCCC----CCCCccchHHHHHHHHHHHhC----------CCCCCCCCCCCC
Q 001527          930 LMTQAGT---IEQILDAGVLGYRAPELAASKKP----HPSFKSDVYAFGVILLELLTG----------RCAGDVISGEGA  992 (1060)
Q Consensus       930 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~----~~s~~~DvwSlGvvl~elltG----------~~p~~~~~~~~~  992 (1060)
                      .......   ......+||.+|||||++...-.    ..-..+||||||.|+||+.-.          +.||...-+.+.
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            7665422   12234589999999999965321    111358999999999998763          356655433321


Q ss_pred             ccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527          993 GVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       993 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                        ...+. +..+-.++..-.++.++       ...+.+..+.+++..||. +|+.|-|+=.|-+.|.+
T Consensus       445 --s~eeM-rkVVCv~~~RP~ipnrW-------~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~  502 (513)
T KOG2052|consen  445 --SFEEM-RKVVCVQKLRPNIPNRW-------KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK  502 (513)
T ss_pred             --CHHHH-hcceeecccCCCCCccc-------ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence              11111 11111111111111111       223678899999999997 79999998777766643

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2e-34  Score=331.32  Aligned_cols=264  Identities=21%  Similarity=0.348  Sum_probs=198.2

Q ss_pred             CCCChhhhhccCCCeeccccceEEEEEEEc------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCC-CCceeeeeeE
Q 001527          769 LTLTPEELSRAPAEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIR-HPNVVGLRGY  840 (1060)
Q Consensus       769 ~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~  840 (1060)
                      +.+..+++.  ..+.||+|+||.||+|+++      .++.||+|+++... ....+.+.+|++++.++. |||||+++++
T Consensus        32 ~~~~~~~~~--~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          32 WEMPRDNLV--LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ceecHHHee--hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            344445443  3689999999999999864      34689999997543 233457889999999997 9999999999


Q ss_pred             EeCCCCCceEEEEEecCCCChHHHhhcCCC--------------------------------------------------
Q 001527          841 YWGPTQHEKLILSDYISPGSLASFLYDRPG--------------------------------------------------  870 (1060)
Q Consensus       841 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------  870 (1060)
                      |.  .....++||||+++|+|.++++....                                                  
T Consensus       110 ~~--~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         110 CT--KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             Ec--cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            85  45678999999999999999975321                                                  


Q ss_pred             -------------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCC
Q 001527          871 -------------------------------------------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLK  907 (1060)
Q Consensus       871 -------------------------------------------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlk  907 (1060)
                                                                 .....+++..+.+|+.|++.||+||| +++|+|||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrdlk  266 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA-SKNCVHRDLA  266 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh-cCCcCcccCC
Confidence                                                       01134778889999999999999999 9999999999


Q ss_pred             CCCeEeeCCCCCeEEcccccceeeccCCce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 001527          908 ATNILLDGPDLNARVADYCLHRLMTQAGTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGD  985 (1060)
Q Consensus       908 p~NILl~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~  985 (1060)
                      |+|||++ ++..+||+|||+++........ ......++..|+|||++.+..+  +.++|||||||++|||++ |+.||.
T Consensus       267 p~NiLl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~DvwslGvil~e~l~~g~~P~~  343 (401)
T cd05107         267 ARNVLIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY--TTLSDVWSFGILLWEIFTLGGTPYP  343 (401)
T ss_pred             cceEEEe-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC--CcHhHHHHHHHHHHHHHHcCCCCCC
Confidence            9999998 5789999999999865432211 1112246788999999987654  779999999999999998 899986


Q ss_pred             CCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527          986 VISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus       986 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ....       .+........+....  .    +       ......+.+++.+||. +|.+||+++||++.|+.+
T Consensus       344 ~~~~-------~~~~~~~~~~~~~~~--~----p-------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         344 ELPM-------NEQFYNAIKRGYRMA--K----P-------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             CCCc-------hHHHHHHHHcCCCCC--C----C-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            4321       111111122111100  0    0       1123467788889998 799999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5e-34  Score=310.97  Aligned_cols=244  Identities=23%  Similarity=0.374  Sum_probs=190.5

Q ss_pred             eeccccceEEEEEEEc---CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          783 VLGRSSHGTSYRATLE---NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       783 ~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .||+|+||.||+|.++   ++..+|+|+++...  ....+++.+|+.++++++||||+++++++.   .+..++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEecCC
Confidence            5899999999999753   57899999986432  334577899999999999999999999883   456789999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +|+|.+++...     ..+++..+.+++.|++.||+||| ++||+||||||+||+++ ++..+||+|||+++........
T Consensus        79 ~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          79 LGPLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLE-ETNFVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccchhhEEEc-CCCeEEECCCccccccCCCCCe
Confidence            99999999532     35899999999999999999999 99999999999999998 5788999999999876544322


Q ss_pred             ee--eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          938 EQ--ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       938 ~~--~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      ..  ....++..|+|||.+.....  +.++|||||||++|||++ |+.||.....       .++... +..+...+   
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~-i~~~~~~~---  218 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYYKF--SSKSDVWSFGVLMWEAFSYGQKPYKGMKG-------NEVTQM-IESGERME---  218 (257)
T ss_pred             eeecCCCCCCccccCHhHhccCCc--CchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHH-HHCCCCCC---
Confidence            11  11234578999999876654  779999999999999998 9999874321       122222 22221111   


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                        . +       ......+.+++.+|++ +|++||++.+|+++|++
T Consensus       219 --~-~-------~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         219 --C-P-------QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             --C-C-------CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence              0 0       1223457788899998 79999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-34  Score=321.92  Aligned_cols=262  Identities=20%  Similarity=0.249  Sum_probs=185.5

Q ss_pred             CCCeeccccceEEEEEEEc--CCcEEEEEEcccchH--HHHHHHHHHHHHHhcC---CCCceeeeeeEEeC---CCCCce
Q 001527          780 PAEVLGRSSHGTSYRATLE--NGMFLTVKWLREGVA--KQRKEFAKEAKKFANI---RHPNVVGLRGYYWG---PTQHEK  849 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~---~~~~~~  849 (1060)
                      ..+.||+|+||+||+|+..  +++.||+|+++....  .....+.+|+++++++   +||||++++++|..   ......
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~   84 (290)
T cd07862           5 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL   84 (290)
T ss_pred             eeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcE
Confidence            3578999999999999853  478899999864321  1223456677776665   69999999998852   234568


Q ss_pred             EEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccce
Q 001527          850 LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR  929 (1060)
Q Consensus       850 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~  929 (1060)
                      ++||||++ ++|.+++....   ...+++.++..++.|++.||+||| +.+|+||||||+|||++ +++.+||+|||+++
T Consensus        85 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH-~~~iiH~dlkp~Nil~~-~~~~~kl~Dfg~~~  158 (290)
T cd07862          85 TLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVT-SSGQIKLADFGLAR  158 (290)
T ss_pred             EEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEEc-CCCCEEEccccceE
Confidence            99999996 69999986532   235899999999999999999999 99999999999999998 57899999999998


Q ss_pred             eeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHh----
Q 001527          930 LMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA---- 1005 (1060)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~---- 1005 (1060)
                      .......  .....||..|+|||++.+..+  +.++|||||||++|||++|+.||......    +....+.....    
T Consensus       159 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~--~~~~DiwslG~il~el~~g~~~f~~~~~~----~~~~~i~~~~~~~~~  230 (290)
T cd07862         159 IYSFQMA--LTSVVVTLWYRAPEVLLQSSY--ATPVDLWSVGCIFAEMFRRKPLFRGSSDV----DQLGKILDVIGLPGE  230 (290)
T ss_pred             eccCCcc--cccccccccccChHHHhCCCC--CCccchHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHHHhCCCCh
Confidence            7654321  222368999999999977654  77999999999999999999998753211    11111111100    


Q ss_pred             cCCCCc--ccccccccccCC---hhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1006 EGHGSD--CFDAAVMPEMVN---PAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1006 ~~~~~~--~~d~~l~~~~~~---~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ..+..+  ............   ....+....+.+++.+|++ +|++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000000  000000000000   0001223456788999998 7999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.7e-34  Score=316.42  Aligned_cols=252  Identities=27%  Similarity=0.395  Sum_probs=196.1

Q ss_pred             CCeeccccceEEEEEEEc------CCcEEEEEEcccchHH-HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE------NGMFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|+..      +++.||+|+++..... ..+.+.+|++++++++||||+++++++.  .....++||
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~   87 (280)
T cd05049          10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT--EGDPPIMVF   87 (280)
T ss_pred             HhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe--cCCCeEEEE
Confidence            478999999999999863      3478999999765433 4578999999999999999999999985  457899999


Q ss_pred             EecCCCChHHHhhcCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcc
Q 001527          854 DYISPGSLASFLYDRP---------GRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVAD  924 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~---------~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~D  924 (1060)
                      ||+++++|.+++....         ......+++.++..++.|++.|++||| +.+++||||||+||+++ .++.+||+|
T Consensus        88 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~i~h~dlkp~nili~-~~~~~kl~d  165 (280)
T cd05049          88 EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA-SQHFVHRDLATRNCLVG-YDLVVKIGD  165 (280)
T ss_pred             ecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh-hCCeeccccccceEEEc-CCCeEEECC
Confidence            9999999999997542         122345889999999999999999999 99999999999999998 578999999


Q ss_pred             cccceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHH
Q 001527          925 YCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQL 1002 (1060)
Q Consensus       925 fg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 1002 (1060)
                      ||+++......... .....++..|+|||++.+..+  +.++|||||||++|||++ |+.||.....    ....+.+  
T Consensus       166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~il~e~~~~g~~p~~~~~~----~~~~~~~--  237 (280)
T cd05049         166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF--TTESDVWSFGVVLWEIFTYGKQPWYGLSN----EEVIECI--  237 (280)
T ss_pred             cccceecccCcceecCCCCcccceecChhhhccCCc--chhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHH--
Confidence            99987653322111 112245678999999987765  779999999999999998 9999864321    1122221  


Q ss_pred             HHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1003 KVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1003 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                        ..+.....             .......+.+++.+|++ +|++||++.||+++|++
T Consensus       238 --~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         238 --TQGRLLQR-------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             --HcCCcCCC-------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence              11111100             01233567888999998 79999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=338.24  Aligned_cols=246  Identities=18%  Similarity=0.233  Sum_probs=187.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||+||+|+.. +|+.||||+++...   ....+.+.+|+++++.++||||+++++++.  +....++||||+
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~lv~E~~   83 (364)
T cd05599           6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ--DENYLYLIMEYL   83 (364)
T ss_pred             EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCeEEEEECCC
Confidence            478999999999999965 68999999997542   223456789999999999999999999985  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++.++..|+.|++.||+||| +.+|+||||||+|||++ .++.+||+|||+++.......
T Consensus        84 ~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH-~~~ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          84 PGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIH-KLGYIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEEC-CCCCEEEeecccceecccccc
Confidence            999999999542     35899999999999999999999 99999999999999998 588999999999876432110


Q ss_pred             e-------------------------------------eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh
Q 001527          937 I-------------------------------------EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT  979 (1060)
Q Consensus       937 ~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt  979 (1060)
                      .                                     ......||+.|+|||++.+..+  +.++|||||||++|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlG~il~el~~  234 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY--NKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC--CCeeeeecchhHHHHhhc
Confidence            0                                     0011358999999999987765  789999999999999999


Q ss_pred             CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhccCCCCCCC---HHHHHH
Q 001527          980 GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPG---IKTIYE 1055 (1060)
Q Consensus       980 G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~~p~~RPs---~~evl~ 1055 (1060)
                      |+.||.....       .+..............  +    .     .......+.+++.+|+.+|.+|++   ++|+++
T Consensus       235 G~~Pf~~~~~-------~~~~~~i~~~~~~~~~--~----~-----~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDNP-------QETYRKIINWKETLQF--P----D-----EVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCCH-------HHHHHHHHcCCCccCC--C----C-----CCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhc
Confidence            9999974321       1111111110000000  0    0     001123455666778888888887   888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=337.96  Aligned_cols=247  Identities=21%  Similarity=0.275  Sum_probs=192.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||+||+|+.. +++.||+|+++....   ...+.+.+|+++++.++||||+++++++.  +....++||||+
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   83 (350)
T cd05573           6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ--DEEHLYLVMEYM   83 (350)
T ss_pred             EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee--cCCeEEEEEcCC
Confidence            478999999999999965 699999999975422   23467889999999999999999999884  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC-
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG-  935 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~-  935 (1060)
                      ++++|.+++...     ..+++..+..++.||+.||+||| ++||+||||||+||+++ .++.+||+|||+++...... 
T Consensus        84 ~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH-~~giiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          84 PGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVH-KLGFIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             CCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEEC-CCCCEEeecCCCCccCcccCc
Confidence            999999999643     45899999999999999999999 89999999999999998 58899999999998665433 


Q ss_pred             ---------------------------ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001527          936 ---------------------------TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVIS  988 (1060)
Q Consensus       936 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~  988 (1060)
                                                 ........||+.|+|||++.+..+  +.++|||||||++|||++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY--GLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC--CCceeeEecchhhhhhccCCCCCCCCC
Confidence                                       011122368999999999988754  789999999999999999999997532


Q ss_pred             CCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhccCCCCCCC-HHHHHHH
Q 001527          989 GEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPG-IKTIYED 1056 (1060)
Q Consensus       989 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~~p~~RPs-~~evl~~ 1056 (1060)
                             ...........  .....-+    .     .......+.+++..|+.+|.+||+ ++|+++.
T Consensus       235 -------~~~~~~~i~~~--~~~~~~p----~-----~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 -------LQETYNKIINW--KESLRFP----P-----DPPVSPEAIDLICRLLCDPEDRLGSFEEIKSH  285 (350)
T ss_pred             -------HHHHHHHHhcc--CCcccCC----C-----CCCCCHHHHHHHHHHccChhhcCCCHHHHhcC
Confidence                   11111111110  0000000    0     011234567788899999999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-34  Score=328.00  Aligned_cols=239  Identities=21%  Similarity=0.260  Sum_probs=186.9

Q ss_pred             CCeeccccceEEEEEEEcC--CcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLEN--GMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|+..+  +..||+|++....   ....+.+.+|+++++.++||||+++++++.  +....++||||
T Consensus        35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~lv~Ey  112 (340)
T PTZ00426         35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK--DESYLYLVLEF  112 (340)
T ss_pred             EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE--eCCEEEEEEeC
Confidence            4789999999999998543  3689999986432   223457889999999999999999999995  56689999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++|+|.+++...     ..+++..+..++.|++.||+||| +.||+||||||+|||++ .++.+||+|||+++......
T Consensus       113 ~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~~~~~  185 (340)
T PTZ00426        113 VIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQ-SLNIVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDTRT  185 (340)
T ss_pred             CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeEccCCCHHHEEEC-CCCCEEEecCCCCeecCCCc
Confidence            9999999999543     45899999999999999999999 99999999999999998 58899999999998764322


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                          ....||+.|+|||++.+..+  +.++|||||||++|||++|+.||.....       . .....+..+..  .   
T Consensus       186 ----~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~-~~~~~i~~~~~--~---  246 (340)
T PTZ00426        186 ----YTLCGTPEYIAPEILLNVGH--GKAADWWTLGIFIYEILVGCPPFYANEP-------L-LIYQKILEGII--Y---  246 (340)
T ss_pred             ----ceecCChhhcCHHHHhCCCC--CccccccchhhHHHHHhcCCCCCCCCCH-------H-HHHHHHhcCCC--C---
Confidence                12368999999999987654  7799999999999999999999974211       1 11111111110  0   


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHHH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYED 1056 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~~ 1056 (1060)
                        .+.       .....+.+++.+|++ +|.+|+     +++|+++.
T Consensus       247 --~p~-------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        247 --FPK-------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --CCC-------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              011       112345677889998 798884     88888753

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=302.08  Aligned_cols=245  Identities=24%  Similarity=0.323  Sum_probs=199.6

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      ..+++|+|+||.||+|.++ .|+.+|+|.+...  .+.+++.+|+.+|++++.|+||++||.|.  .....|+|||||.-
T Consensus        37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF--K~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF--KHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc--cCCceEeehhhcCC
Confidence            3578999999999999855 6999999998653  45688999999999999999999999885  45679999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      |+..+.++.+    ++++++.++..+.+..++||+||| ...-||||||..|||++ .++.+||+|||.|..+.......
T Consensus       113 GSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH-~~~KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTDTMAKR  186 (502)
T KOG0574|consen  113 GSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLH-DLKKIHRDIKAGNILLN-TDGIAKLADFGVAGQLTDTMAKR  186 (502)
T ss_pred             CcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHH-HHHHHHhhcccccEEEc-ccchhhhhhccccchhhhhHHhh
Confidence            9999999754    367999999999999999999999 77778999999999998 58899999999998776543333


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      . ...||+.|||||++..-.|  +.++||||+|++..||..|++||..+.+-.                   .+|-..-.
T Consensus       187 N-TVIGTPFWMAPEVI~EIGY--~~~ADIWSLGITaIEMAEG~PPYsDIHPMR-------------------AIFMIPT~  244 (502)
T KOG0574|consen  187 N-TVIGTPFWMAPEVIEEIGY--DTKADIWSLGITAIEMAEGRPPYSDIHPMR-------------------AIFMIPTK  244 (502)
T ss_pred             C-ccccCcccccHHHHHHhcc--chhhhHhhhcchhhhhhcCCCCcccccccc-------------------eeEeccCC
Confidence            2 3479999999999988766  779999999999999999999987643211                   11111111


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      +.......+.....+-+++..|+- .|++|-|+.++++.
T Consensus       245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            111122345677788999999996 69999999998764

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-35  Score=318.55  Aligned_cols=261  Identities=27%  Similarity=0.387  Sum_probs=207.4

Q ss_pred             CCCCCChhhhhccCCCeeccccceEEEEEEEcC-CcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCC
Q 001527          767 DTLTLTPEELSRAPAEVLGRSSHGTSYRATLEN-GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT  845 (1060)
Q Consensus       767 ~~~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  845 (1060)
                      |.+++...|+..  ..+||.|-||.||.|.|+. .-.||||.++++. ...++|.+|+.+|+.++|||+|+++|+|.  .
T Consensus       260 DkWEmeRtdItM--khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT--~  334 (1157)
T KOG4278|consen  260 DKWEMERTDITM--KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--H  334 (1157)
T ss_pred             chhhccchheee--eeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhc--c
Confidence            334444333332  5789999999999999874 6789999998763 45689999999999999999999999994  5


Q ss_pred             CCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccc
Q 001527          846 QHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY  925 (1060)
Q Consensus       846 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Df  925 (1060)
                      ....|||+|||..|+|.+||++..   ...++....+.++.||+.|++||. .+.+|||||...|.|+. ++..+|++||
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLE-kknFIHRDLAARNCLVg-EnhiVKvADF  409 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVG-ENHIVKVADF  409 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHH-Hhhhhhhhhhhhhcccc-ccceEEeecc
Confidence            557899999999999999998753   244677778899999999999999 99999999999999997 6889999999


Q ss_pred             ccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHH
Q 001527          926 CLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKV 1004 (1060)
Q Consensus       926 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 1004 (1060)
                      |+++++..+.........-...|.|||-+....+  +.|+|||+|||++||+.| |-.||..+       ++.+. ...+
T Consensus       410 GLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtF--SiKSDVWAFGVLLWEIATYGMsPYPGi-------dlSqV-Y~LL  479 (1157)
T KOG4278|consen  410 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTF--SIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQV-YGLL  479 (1157)
T ss_pred             chhhhhcCCceecccCccCcccccCccccccccc--ccchhhHHHHHHHHHHHhcCCCCCCCc-------cHHHH-HHHH
Confidence            9999987654433322233567999999988776  789999999999999988 88887643       33322 2233


Q ss_pred             hcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1005 AEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1005 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      .++...             ...+.+...+.+++.+||+ .|.+||++.|+-+.++.|
T Consensus       480 EkgyRM-------------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  480 EKGYRM-------------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             hccccc-------------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            332111             1123566789999999999 799999999999988753

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.1e-34  Score=313.22  Aligned_cols=248  Identities=26%  Similarity=0.402  Sum_probs=193.5

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .+.||+|+||.||+|...++..+|+|++.... ...+.+.+|++++++++|||++++++++.   ....++||||+++++
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e~~~~~~   86 (260)
T cd05069          11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPIYIVTEFMGKGS   86 (260)
T ss_pred             eeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCcEEEEEcCCCCC
Confidence            46899999999999998777789999987543 23467889999999999999999998873   456799999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....   ...+++..+..++.|++.||+||| +.||+||||||+||+++ +++.+||+|||.++...........
T Consensus        87 L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05069          87 LLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIE-RMNYIHRDLRAANILVG-DNLVCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             HHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccCcceEEEc-CCCeEEECCCccceEccCCcccccC
Confidence            999996532   245889999999999999999999 99999999999999998 5889999999999876443222222


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||+..+...  +.++|||||||++|||++ |+.||.....    ....++    ......     +    
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~--~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~----~~~~~~-----~----  222 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRF--TIKSDVWSFGILLTELVTKGRVPYPGMVN----REVLEQ----VERGYR-----M----  222 (260)
T ss_pred             CCccchhhCCHHHhccCCc--ChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH----HHcCCC-----C----
Confidence            2245678999999876654  789999999999999999 8999864211    111111    111100     0    


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                          +........+.+++.+|++ +|.+||++++|++.|++.
T Consensus       223 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         223 ----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             ----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                0011234567888889998 799999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.2e-34  Score=314.48  Aligned_cols=248  Identities=25%  Similarity=0.397  Sum_probs=195.6

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .++||+|+||.||+|...+++.||+|.+..... ..+++.+|++++++++||||+++++++.   ....++||||+++++
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e~~~~~~   86 (260)
T cd05067          11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYIITEYMENGS   86 (260)
T ss_pred             eeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEEEEcCCCCC
Confidence            578999999999999988899999999875432 3467889999999999999999999873   456899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....   ...+++.++..++.|++.||+||| +.+++||||||+||+++ +++.++|+|||.+............
T Consensus        87 L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH-~~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05067          87 LVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIE-RKNYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTARE  161 (260)
T ss_pred             HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHh-cCCeecccccHHhEEEc-CCCCEEEccCcceeecCCCCccccc
Confidence            999986532   346899999999999999999999 99999999999999998 5889999999999876533222222


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||++.+..+  +.++||||||+++||+++ |+.||.....       .+..... .......     .  
T Consensus       162 ~~~~~~~y~~pe~~~~~~~--~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~-~~~~~~~-----~--  224 (260)
T cd05067         162 GAKFPIKWTAPEAINYGTF--TIKSDVWSFGILLTEIVTYGRIPYPGMTN-------PEVIQNL-ERGYRMP-----R--  224 (260)
T ss_pred             CCcccccccCHHHhccCCc--CcccchHHHHHHHHHHHhCCCCCCCCCCh-------HHHHHHH-HcCCCCC-----C--
Confidence            2345678999999977654  779999999999999999 9999864321       1111111 1111000     0  


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                            ......++.+++.+|+. +|++||+++++++.|+..
T Consensus       225 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         225 ------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             ------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence                  01223468888999998 799999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.8e-34  Score=317.79  Aligned_cols=252  Identities=28%  Similarity=0.392  Sum_probs=193.2

Q ss_pred             CCeeccccceEEEEEEE-----cCCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATL-----ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+|+.     .++..||+|.++... ....+.+.+|++++++++||||+++++++.  .+...++|||
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e   87 (283)
T cd05090          10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT--QEQPVCMLFE   87 (283)
T ss_pred             eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe--cCCceEEEEE
Confidence            47899999999999984     256889999997433 334467889999999999999999999985  5567899999


Q ss_pred             ecCCCChHHHhhcCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEE
Q 001527          855 YISPGSLASFLYDRPG------------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARV  922 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl  922 (1060)
                      |+++++|.+++.....            .....+++.++..++.|++.||+||| +++|+||||||+||+++ ++..+||
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~nili~-~~~~~kl  165 (283)
T cd05090          88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS-SHFFVHKDLAARNILIG-EQLHVKI  165 (283)
T ss_pred             cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hcCeehhccccceEEEc-CCCcEEe
Confidence            9999999999854321            11235889999999999999999999 99999999999999998 5788999


Q ss_pred             cccccceeeccCCce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHH
Q 001527          923 ADYCLHRLMTQAGTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWM 1000 (1060)
Q Consensus       923 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~ 1000 (1060)
                      +|||+++........ ......++..|+|||++.+..+  +.++|||||||++|||++ |..||.....       .+. 
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~~~-  235 (283)
T cd05090         166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF--SSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------QEV-  235 (283)
T ss_pred             ccccccccccCCcceecccCCCccceecChHHhccCCC--CchhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHH-
Confidence            999999865433221 1122245678999999977654  789999999999999998 9989864211       111 


Q ss_pred             HHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1001 QLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1001 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ...........             ........+.+++.+|++ +|++||++.+|.++|++
T Consensus       236 ~~~~~~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         236 IEMVRKRQLLP-------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHcCCcCC-------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11122111110             001223457778889998 79999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.1e-35  Score=336.12  Aligned_cols=195  Identities=22%  Similarity=0.234  Sum_probs=163.6

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|++++++++||||+++++++.  +....++||||+
T Consensus         6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~~lv~E~~   83 (381)
T cd05626           6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLYFVMDYI   83 (381)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe--cCCEEEEEEecC
Confidence            478999999999999854 68999999997532   233467889999999999999999999985  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++..+..++.||+.||+||| ..||+||||||+|||++ .++.+||+|||+++.......
T Consensus        84 ~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH-~~givHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          84 PGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVH-KMGFIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCcHHHEEEC-CCCCEEEeeCcCCcccccccc
Confidence            999999999542     35889999999999999999999 99999999999999998 578999999999764311000


Q ss_pred             ----------------------------------------------eeeeccCccccccchhcccCCCCCCCCccchHHH
Q 001527          937 ----------------------------------------------IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAF  970 (1060)
Q Consensus       937 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSl  970 (1060)
                                                                    .......||+.|+|||++.+..+  +.++|||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~--~~~~DiwSl  234 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY--TQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC--CCccceeeh
Confidence                                                          00012369999999999987665  779999999


Q ss_pred             HHHHHHHHhCCCCCCC
Q 001527          971 GVILLELLTGRCAGDV  986 (1060)
Q Consensus       971 Gvvl~elltG~~p~~~  986 (1060)
                      ||++|||++|+.||..
T Consensus       235 G~il~elltG~~Pf~~  250 (381)
T cd05626         235 GVILFEMLVGQPPFLA  250 (381)
T ss_pred             hhHHHHHHhCCCCCcC
Confidence            9999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.2e-34  Score=311.62  Aligned_cols=247  Identities=24%  Similarity=0.391  Sum_probs=190.4

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      +.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++.  .....++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT--QKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCCeEEEEeeccCC
Confidence            46899999999999964 78999999886542 334567899999999999999999999985  456789999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++...    ...+++.++..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||.+...........
T Consensus        79 ~L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          79 DFLTFLRTE----GPRLKVKELIQMVENAAAGMEYLE-SKHCIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             cHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccchheEEEc-CCCcEEECccccCccccccccccc
Confidence            999999542    235889999999999999999999 99999999999999998 577899999999876443211110


Q ss_pred             -eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          940 -ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       940 -~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                       ....++..|+|||.+.+..+  +.++|||||||++|||++ |..||+.....        .............      
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~~~~~~~------  216 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRY--SSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIEQGVRLP------  216 (252)
T ss_pred             CCCCCCceeecCchhhcCCCC--ChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHHcCCCCC------
Confidence             11123457999999987764  779999999999999998 88888643211        1111111110000      


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                             ........+.+++.+|++ +|++|||+.||+++|+.
T Consensus       217 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         217 -------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             -------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence                   011224567888999998 79999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.1e-34  Score=311.52  Aligned_cols=244  Identities=27%  Similarity=0.416  Sum_probs=192.5

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .+.||+|+||.||+|... |..||+|.++...  ..+.+.+|+.++++++|+|++++++++.. .....++||||+++++
T Consensus        11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~e~~~~~~   86 (256)
T cd05082          11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTEYMAKGS   86 (256)
T ss_pred             eeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCCceEEEEECCCCCc
Confidence            578999999999999865 7789999987542  34678899999999999999999998753 4557899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....   ...+++..+..++.|++.||+||| ++||+||||||+||+++ +++.+||+|||+++.......    
T Consensus        87 L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~----  157 (256)
T cd05082          87 LVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE-ANNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQD----  157 (256)
T ss_pred             HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH-hCCEeccccchheEEEc-CCCcEEecCCccceeccccCC----
Confidence            999996543   235889999999999999999999 99999999999999998 588999999999876543221    


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||++.+..+  +.++|||||||++|||++ |+.||...       ...+..... ..+...+     .  
T Consensus       158 ~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~i~~~l~~~g~~p~~~~-------~~~~~~~~~-~~~~~~~-----~--  220 (256)
T cd05082         158 TGKLPVKWTAPEALREKKF--STKSDVWSFGILLWEIYSFGRVPYPRI-------PLKDVVPRV-EKGYKMD-----A--  220 (256)
T ss_pred             CCccceeecCHHHHccCCC--CchhhhHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHH-hcCCCCC-----C--
Confidence            1234668999999977654  779999999999999997 99998632       222222221 1111111     0  


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                            .......+.+++.+|++ +|++|||+.++++.|+.|
T Consensus       221 ------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         221 ------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                  01234567788899998 799999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.4e-35  Score=340.07  Aligned_cols=264  Identities=17%  Similarity=0.228  Sum_probs=186.0

Q ss_pred             ccCCCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCC------CCCceE
Q 001527          778 RAPAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGP------TQHEKL  850 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~~~~  850 (1060)
                      |...++||+|+||.||+|... +++.||||++....    ....+|+.++++++|||||++++++...      .....+
T Consensus        68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence            334688999999999999964 68999999886432    2345799999999999999999887532      112467


Q ss_pred             EEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          851 ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       851 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      +||||+++ ++.+++.... .....+++..+..++.||+.||+||| +.+|+||||||+|||++.++..+||+|||+++.
T Consensus       144 lvmE~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH-~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~  220 (440)
T PTZ00036        144 VVMEFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIH-SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN  220 (440)
T ss_pred             EEEecCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence            89999974 7877775432 23356899999999999999999999 999999999999999985456799999999987


Q ss_pred             eccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhc----
Q 001527          931 MTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAE---- 1006 (1060)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---- 1006 (1060)
                      ........  ...||+.|+|||++.+.. .++.++|||||||++|||++|++||......+   .+...++ ....    
T Consensus       221 ~~~~~~~~--~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~~i~~-~~~~p~~~  293 (440)
T PTZ00036        221 LLAGQRSV--SYICSRFYRAPELMLGAT-NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD---QLVRIIQ-VLGTPTED  293 (440)
T ss_pred             ccCCCCcc--cCCCCcCccCHHHhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHH-HhCCCCHH
Confidence            65433222  236899999999987653 24789999999999999999999997532111   1111111 0000    


Q ss_pred             ------CCCCcccccccccccC-ChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1007 ------GHGSDCFDAAVMPEMV-NPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1007 ------~~~~~~~d~~l~~~~~-~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                            ....++.-+....... ..........+.+++.+|++ +|.+|||+.|+++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                  0000000000000000 00001123567889999998 8999999999875

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.8e-34  Score=326.25  Aligned_cols=194  Identities=21%  Similarity=0.361  Sum_probs=164.6

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      ..+.||+|+||.||+|+.. ++..+|+|+++.. .....+.+.+|++++++++||||++++++|.  +.+..++||||++
T Consensus         9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~   86 (333)
T cd06650           9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMD   86 (333)
T ss_pred             eeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE--ECCEEEEEEecCC
Confidence            3578999999999999965 6889999988754 2334567899999999999999999999996  4668999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +|+|.+++...     ..+++..+..++.|++.||+|||...+|+||||||+||+++ +++.+||+|||++........ 
T Consensus        87 ~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~-  159 (333)
T cd06650          87 GGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-  159 (333)
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc-CCCCEEEeeCCcchhhhhhcc-
Confidence            99999999542     35889999999999999999999435899999999999998 577899999999876533211 


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                        ....|+..|+|||++.+..+  +.++|||||||++|||++|+.||..
T Consensus       160 --~~~~~~~~y~aPE~~~~~~~--~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         160 --NSFVGTRSYMSPERLQGTHY--SVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             --ccCCCCccccCHHHhcCCCC--CcHHHHHHHHHHHHHHHHCCCCCCC
Confidence              12368999999999987654  7799999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.9e-34  Score=312.93  Aligned_cols=247  Identities=20%  Similarity=0.293  Sum_probs=189.4

Q ss_pred             CCeeccccceEEEEEEEc-CCc----EEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGM----FLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .+.||+|+||+||+|.+. +++    .+++|.+..... ....++..|+..+++++||||+++++++.   ....++++|
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~---~~~~~~i~e   88 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP---GASLQLVTQ   88 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC---CCccEEEEE
Confidence            578999999999999864 444    478888764322 23467888999999999999999999883   345789999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++|+|.+++....    ..+++..+..|+.||+.||+||| +++++||||||+||+++ +++.+||+|||.++.....
T Consensus        89 ~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH-~~~iiH~dlkp~nili~-~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          89 LSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLE-EHRMVHRNLAARNILLK-SDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             eCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH-HCCEeccccCcceEEEc-CCCcEEEcCCccceeccCC
Confidence            999999999996532    45899999999999999999999 99999999999999998 5889999999999865433


Q ss_pred             Cce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          935 GTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       935 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ... ......++..|+|||++.+..+  +.++|||||||++||+++ |+.||.....    ....++    ...+...  
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~--~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~~----~~~~~~~--  230 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRY--THQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEVPDL----LEKGERL--  230 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCc--CchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH----HHCCCcC--
Confidence            221 1122346778999999987664  789999999999999998 9999864321    112222    2221111  


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ..+.           .....+.+++.+|+. +|.+|||+.|+++.|..
T Consensus       231 ~~~~-----------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~  267 (279)
T cd05111         231 AQPQ-----------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTR  267 (279)
T ss_pred             CCCC-----------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            1111           112346778889998 79999999999998865

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=302.47  Aligned_cols=259  Identities=24%  Similarity=0.371  Sum_probs=189.1

Q ss_pred             CeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhc--CCCCceeeeeeEEeCCC--CCceEEEEEecC
Q 001527          782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFAN--IRHPNVVGLRGYYWGPT--QHEKLILSDYIS  857 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~~--~~~~~lv~e~~~  857 (1060)
                      ++||+|+||.||+|.+. ++.||||++...   ..+.|++|-++++.  ++|+||++++++-...+  ..+++||+||.+
T Consensus       216 eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~  291 (534)
T KOG3653|consen  216 ELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP  291 (534)
T ss_pred             HHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence            68999999999999986 489999999753   45678888777765  58999999988764222  447899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------CCcccCCCCCCCeEeeCCCCCeEEcccccce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD--------RAVPHGNLKATNILLDGPDLNARVADYCLHR  929 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~--------~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~  929 (1060)
                      .|+|.+||..+      .++|....+|+..+++||+|||.+        ++|+|||||++||||. .|+.+.|+|||+|.
T Consensus       292 kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  292 KGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADFGLAL  364 (534)
T ss_pred             CCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeeccceeE
Confidence            99999999654      499999999999999999999942        5799999999999998 69999999999999


Q ss_pred             eeccCCceee-eccCccccccchhcccCCCCC----CCCccchHHHHHHHHHHHhCCCCCCC--------CCCCCC--cc
Q 001527          930 LMTQAGTIEQ-ILDAGVLGYRAPELAASKKPH----PSFKSDVYAFGVILLELLTGRCAGDV--------ISGEGA--GV  994 (1060)
Q Consensus       930 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~----~s~~~DvwSlGvvl~elltG~~p~~~--------~~~~~~--~~  994 (1060)
                      .+........ ...+||.+|||||++.+...-    .=.+.||||+|.|+|||++.-.-++.        .+.++-  ..
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            8875443322 235899999999999764321    01357999999999999995433321        111110  11


Q ss_pred             ChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527          995 DLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       995 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      .+.+.....++++....+.|.-..        ...+..+.+.+..||. ||+.|-|+.=|-+++..
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~W~~--------h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~  502 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDAWRK--------HAGMAVLCETIEECWDHDAEARLTAGCVEERMAE  502 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhhhhc--------CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence            222222223333222222221111        1345667788889997 89999999888877654

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.7e-34  Score=328.04  Aligned_cols=195  Identities=19%  Similarity=0.268  Sum_probs=164.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||+||+|+.. +++.||+|+++....   .....+.+|++++.+++||||+++++++.  +....++||||+
T Consensus         6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~--~~~~~~lv~E~~   83 (363)
T cd05628           6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ--DKLNLYLIMEFL   83 (363)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCeEEEEEcCC
Confidence            478999999999999854 689999999975422   23456888999999999999999999884  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++..     ...+++.++..++.|++.||+||| +.||+||||||+|||++ .++.+||+|||+++.......
T Consensus        84 ~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH-~~givHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          84 PGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIH-QLGFIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecCCCHHHeEEC-CCCCEEEeeccCccccccccc
Confidence            99999999954     245899999999999999999999 99999999999999998 578999999999875432110


Q ss_pred             e----------------------------------eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCC
Q 001527          937 I----------------------------------EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRC  982 (1060)
Q Consensus       937 ~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~  982 (1060)
                      .                                  ......||+.|+|||++.+..+  +.++|||||||++|||++|+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~--~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY--NKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC--CCchhhhhhHHHHHHHHhCCC
Confidence            0                                  0112369999999999987765  779999999999999999999


Q ss_pred             CCCC
Q 001527          983 AGDV  986 (1060)
Q Consensus       983 p~~~  986 (1060)
                      ||..
T Consensus       235 Pf~~  238 (363)
T cd05628         235 PFCS  238 (363)
T ss_pred             CCCC
Confidence            9974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.5e-34  Score=321.73  Aligned_cols=202  Identities=23%  Similarity=0.295  Sum_probs=162.8

Q ss_pred             CCeeccccceEEEEEEEc---CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE---NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      +++||+|+||+||+|+..   +++.||+|.++...  ....+.+|++++++++||||+++++++........++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999854   46889999986532  2245678999999999999999999987656667899999985


Q ss_pred             CCChHHHhhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEee---CCCCCeEEccccccee
Q 001527          858 PGSLASFLYDRPG----RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD---GPDLNARVADYCLHRL  930 (1060)
Q Consensus       858 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~---~~~~~~kl~Dfg~a~~  930 (1060)
                       ++|.+++.....    .....+++..+..++.||+.||+||| +.||+||||||+|||++   ...+.+||+|||+++.
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH-hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence             588888754321    12235899999999999999999999 99999999999999994   2356899999999987


Q ss_pred             eccCCce--eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          931 MTQAGTI--EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       931 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      .......  ......||+.|+|||++.+... ++.++||||+||++|||++|++||...
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCC-cCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            6543221  1122368999999999976542 478999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.1e-34  Score=327.53  Aligned_cols=241  Identities=20%  Similarity=0.295  Sum_probs=186.8

Q ss_pred             CeeccccceEEEEEEE-cCCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          782 EVLGRSSHGTSYRATL-ENGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      ++||+|+||.||+|+. .+|+.||+|+++...   ......+.+|+++++.++||||+++++++.  .....++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~--~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ--THDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE--cCCEEEEEEeCCC
Confidence            4699999999999985 478999999997542   223456778999999999999999998884  5668999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD-RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      +|+|.+++..     ...+++.++..++.||+.||+||| + .||+||||||+|||++ +++.+||+|||+++.......
T Consensus        79 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH-~~~~ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          79 GGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLH-SEKNVVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hcCCEEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCc
Confidence            9999998853     245899999999999999999999 6 7999999999999998 588999999999875432222


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      .. ....||+.|+|||++.+..+  +.++|||||||++|||++|+.||....       ..+....... ...      .
T Consensus       152 ~~-~~~~gt~~y~aPE~~~~~~~--~~~~DiwslG~il~el~tG~~Pf~~~~-------~~~~~~~i~~-~~~------~  214 (325)
T cd05594         152 TM-KTFCGTPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLPFYNQD-------HEKLFELILM-EEI------R  214 (325)
T ss_pred             cc-ccccCCcccCCHHHHccCCC--CCccccccccceeeeeccCCCCCCCCC-------HHHHHHHHhc-CCC------C
Confidence            11 12368999999999987765  779999999999999999999986421       1111111111 100      0


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~~ 1056 (1060)
                      . +.       .....+.+++.+|++ +|++|+     +++|+++.
T Consensus       215 ~-p~-------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         215 F-PR-------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             C-CC-------CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            0 01       123356677889998 799996     89988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.9e-35  Score=323.14  Aligned_cols=245  Identities=22%  Similarity=0.348  Sum_probs=194.0

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEccc----chHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLRE----GVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .++||+|+|-+||+|... +|..||=-.++.    ......++|..|+.+|+.|+|||||++|++|.+......-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            468999999999999854 577776432221    123445889999999999999999999999987777778899999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH-FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH-~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      +..|+|+.|+...     +.++......|++||++||.||| +.++|||||||.+||+|++..+.|||+|+|+|......
T Consensus       125 ~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  125 FTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999543     45888999999999999999999 56799999999999999988899999999999987655


Q ss_pred             CceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      ....   ..|||.|||||++.. .  |++.+||||||++++||+|+.+||....      +. ..+...+..+...+.+.
T Consensus       200 ~aks---vIGTPEFMAPEmYEE-~--YnE~VDVYaFGMCmLEMvT~eYPYsEC~------n~-AQIYKKV~SGiKP~sl~  266 (632)
T KOG0584|consen  200 HAKS---VIGTPEFMAPEMYEE-N--YNELVDVYAFGMCMLEMVTSEYPYSECT------NP-AQIYKKVTSGIKPAALS  266 (632)
T ss_pred             ccce---eccCccccChHHHhh-h--cchhhhhhhhhHHHHHHHhccCChhhhC------CH-HHHHHHHHcCCCHHHhh
Confidence            4332   479999999999973 3  4889999999999999999999986422      11 22233333333322222


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYE 1055 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~ 1055 (1060)
                      +-            ...++.+++.+|+....+|||+.|+++
T Consensus       267 kV------------~dPevr~fIekCl~~~~~R~sa~eLL~  295 (632)
T KOG0584|consen  267 KV------------KDPEVREFIEKCLATKSERLSAKELLK  295 (632)
T ss_pred             cc------------CCHHHHHHHHHHhcCchhccCHHHHhh
Confidence            11            123466778899998889999999986

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.6e-34  Score=327.15  Aligned_cols=249  Identities=18%  Similarity=0.231  Sum_probs=192.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||+||+|+.. +|+.||+|+++....   ...+.+.+|+++++.++||||+++++++.  +....++||||+
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   83 (330)
T cd05601           6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ--DKDNLYLVMEYQ   83 (330)
T ss_pred             EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe--cCCeEEEEECCC
Confidence            478999999999999854 689999999975432   24466889999999999999999998885  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++....    ..+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||++........
T Consensus        84 ~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH-~~~i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          84 PGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVH-QMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH-HCCeEcccCchHheEEC-CCCCEEeccCCCCeECCCCCc
Confidence            9999999996532    35899999999999999999999 99999999999999998 588999999999987655443


Q ss_pred             eeeeccCccccccchhcccCC----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          937 IEQILDAGVLGYRAPELAASK----KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      .......||+.|+|||++...    ...++.++|||||||++|||++|+.||....       .................
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~  230 (330)
T cd05601         158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-------SAKTYNNIMNFQRFLKF  230 (330)
T ss_pred             eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-------HHHHHHHHHcCCCccCC
Confidence            333334689999999998632    1124789999999999999999999996421       11122221111111100


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYE 1055 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~ 1055 (1060)
                            +.     .......+.+++..|+++|.+||+++++++
T Consensus       231 ------~~-----~~~~~~~~~~li~~ll~~p~~R~t~~~l~~  262 (330)
T cd05601         231 ------PE-----DPKVSSDFLDLIQSLLCGQKERLGYEGLCC  262 (330)
T ss_pred             ------CC-----CCCCCHHHHHHHHHHccChhhCCCHHHHhC
Confidence                  00     011234566677788889999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.5e-34  Score=323.49  Aligned_cols=235  Identities=22%  Similarity=0.303  Sum_probs=182.8

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||.||+|+.. +++.||+|+++....   ...+.+..|.+++..+ +||||+++++++.  ..+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ--TPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE--cCCEEEEEEcCC
Confidence            36999999999999965 689999999875421   2345677888888876 6999999999884  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++..+..++.|++.||+||| +++|+||||||+|||++ .++.+||+|||+++.......
T Consensus        79 ~~g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH-~~~ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~  151 (320)
T cd05590          79 NGGDLMFHIQKS-----RRFDEARARFYAAEITSALMFLH-DKGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGK  151 (320)
T ss_pred             CCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCC
Confidence            999999998542     35899999999999999999999 99999999999999998 578999999999876432222


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      . .....||+.|+|||++.+..+  +.++|||||||++|||++|+.||....       ..+...... ....   ..  
T Consensus       152 ~-~~~~~gt~~y~aPE~~~~~~~--~~~~DiwslG~il~el~~g~~Pf~~~~-------~~~~~~~i~-~~~~---~~--  215 (320)
T cd05590         152 T-TSTFCGTPDYIAPEILQEMLY--GPSVDWWAMGVLLYEMLCGHAPFEAEN-------EDDLFEAIL-NDEV---VY--  215 (320)
T ss_pred             c-ccccccCccccCHHHHcCCCC--CCccchhhhHHHHHHHhhCCCCCCCCC-------HHHHHHHHh-cCCC---CC--
Confidence            1 122368999999999987665  779999999999999999999997421       122222211 1110   00  


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGI 1050 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~ 1050 (1060)
                        +.       .....+.+++.+|++ +|.+||++
T Consensus       216 --~~-------~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 --PT-------WLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             --CC-------CCCHHHHHHHHHHcccCHHHCCCC
Confidence              11       123356778889998 79999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.4e-34  Score=317.08  Aligned_cols=246  Identities=20%  Similarity=0.279  Sum_probs=187.5

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          784 LGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       784 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      ||+|+||.||+++.. +|+.||+|++.....   ...+.+..|++++++++||||+++++++.  .+...++||||++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE--SKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe--cCCeEEEEEecCCCC
Confidence            699999999999854 699999999864322   12345567999999999999999998884  567899999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++....   ...+++..+..++.|++.||+||| +.||+||||||+||+++ ++..+||+|||++.........  
T Consensus        79 ~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~--  151 (277)
T cd05607          79 DLKYHIYNVG---ERGLEMERVIHYSAQITCGILHLH-SMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTI--  151 (277)
T ss_pred             CHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHH-HCCEEEccCChHhEEEc-CCCCEEEeeceeeeecCCCcee--
Confidence            9999886532   235889999999999999999999 99999999999999998 5889999999998876543222  


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ....|+..|+|||++.+..+  +.++||||+||++|||++|+.||......   ....+........ ..    .  ...
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~--~~~~DvwslGv~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~-~~----~--~~~  219 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEPY--SYPVDWFAMGCSIYEMVAGRTPFKDHKEK---VAKEELKRRTLED-EV----K--FEH  219 (277)
T ss_pred             eccCCCCCccCHHHHccCCC--CCchhHHHHHHHHHHHHhCCCCCCCCcch---hhHHHHHHHhhcc-cc----c--ccc
Confidence            22368999999999987764  78999999999999999999998643211   1111111111110 00    0  000


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHh
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDL 1057 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L 1057 (1060)
                             ......+.+++.+|++ +|++||+++|+++.+
T Consensus       220 -------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         220 -------QNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             -------ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence                   1123456788889998 799999997766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.1e-34  Score=320.70  Aligned_cols=196  Identities=24%  Similarity=0.360  Sum_probs=161.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++.  +....++||||++ 
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~-   86 (303)
T cd07869          10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH--TKETLTLVFEYVH-   86 (303)
T ss_pred             eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe--cCCeEEEEEECCC-
Confidence            478999999999999965 689999999875422 22345778999999999999999999985  5568999999995 


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++....    ..+++.++..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||+++........ 
T Consensus        87 ~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~-  159 (303)
T cd07869          87 TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIH-QRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHT-  159 (303)
T ss_pred             cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEC-CCCCEEECCCCcceeccCCCcc-
Confidence            68888885432    35888999999999999999999 99999999999999998 5789999999998754332211 


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      .....|++.|+|||++.+... ++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTE-YSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            122368899999999876442 477899999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.1e-34  Score=313.84  Aligned_cols=259  Identities=23%  Similarity=0.345  Sum_probs=196.2

Q ss_pred             CCCeeccccceEEEEEEE-----cCCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          780 PAEVLGRSSHGTSYRATL-----ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      ..+.||+|+||.||+|++     .++..||+|.++... ....+.+.+|++++++++||||+++++++........++||
T Consensus         8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   87 (284)
T cd05079           8 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM   87 (284)
T ss_pred             hceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEE
Confidence            457899999999999984     257899999987543 33456799999999999999999999998754456789999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+++++|.+++...    ...+++.++..++.|++.||+||| ++||+||||||+||+++ +++.+||+|||+++....
T Consensus        88 e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH-~~gi~H~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          88 EFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecccchheEEEc-CCCCEEECCCcccccccc
Confidence            999999999998543    235899999999999999999999 99999999999999998 578999999999986644


Q ss_pred             CCcee--eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC--------CCCccChHHHHHHH
Q 001527          934 AGTIE--QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISG--------EGAGVDLTDWMQLK 1003 (1060)
Q Consensus       934 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~--------~~~~~~l~~~~~~~ 1003 (1060)
                      .....  .....++..|+|||++.+..+  +.++|||||||++|||++++.|+.....        .........++. .
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~--~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  238 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKF--YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-V  238 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCC--CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-H
Confidence            32211  112346778999999877654  7799999999999999998876432110        000111111111 1


Q ss_pred             HhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1004 VAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1004 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      .......             +........+.+++.+|++ +|.+||+++||++.|++|
T Consensus       239 ~~~~~~~-------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKRL-------------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCccC-------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111100             0011234578889999998 799999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.6e-34  Score=318.67  Aligned_cols=254  Identities=25%  Similarity=0.389  Sum_probs=195.4

Q ss_pred             CCCeeccccceEEEEEEEc------CCcEEEEEEcccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEE
Q 001527          780 PAEVLGRSSHGTSYRATLE------NGMFLTVKWLREG-VAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLI  851 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~l  851 (1060)
                      ..+.||+|+||.||+|...      +...+|+|+++.. ......++.+|+++++++ +||||+++++++.  .....++
T Consensus        16 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~~~~~~l   93 (293)
T cd05053          16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT--QEGPLYV   93 (293)
T ss_pred             EeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc--CCCCeEE
Confidence            3578999999999999854      2368999998753 233456788999999999 8999999999985  5567899


Q ss_pred             EEEecCCCChHHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCe
Q 001527          852 LSDYISPGSLASFLYDRPG-----------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNA  920 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~  920 (1060)
                      +|||+++|+|.+++.....           .....+++..+++++.|++.||+||| +.+|+||||||+||+++ +++.+
T Consensus        94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivH~dlkp~Nil~~-~~~~~  171 (293)
T cd05053          94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA-SKKCIHRDLAARNVLVT-EDHVM  171 (293)
T ss_pred             EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-HCCccccccceeeEEEc-CCCeE
Confidence            9999999999999965321           22356899999999999999999999 99999999999999998 58899


Q ss_pred             EEcccccceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHH
Q 001527          921 RVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTD  998 (1060)
Q Consensus       921 kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~  998 (1060)
                      ||+|||.++......... .....++..|+|||++.+..+  +.++|||||||++||+++ |..||....       ..+
T Consensus       172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~il~el~~~g~~p~~~~~-------~~~  242 (293)
T cd05053         172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLLWEIFTLGGSPYPGIP-------VEE  242 (293)
T ss_pred             EeCccccccccccccceeccCCCCCCccccCHHHhccCCc--CcccceeehhhHHHHHhcCCCCCCCCCC-------HHH
Confidence            999999998765433221 111234678999999877654  789999999999999997 999986421       111


Q ss_pred             HHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527          999 WMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus       999 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ... ....+...+             ........+.+++.+|+. +|.+||||+||++.|+++
T Consensus       243 ~~~-~~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         243 LFK-LLKEGYRME-------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHH-HHHcCCcCC-------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            111 111111100             011234567889999998 799999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-33  Score=308.01  Aligned_cols=246  Identities=25%  Similarity=0.381  Sum_probs=192.5

Q ss_pred             CeeccccceEEEEEEEcC----CcEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLEN----GMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||.||+|.+..    +..+|+|.++.... ...+++.+|+++++++.||||+++++++.   ....++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEEEeC
Confidence            469999999999998532    37899999875543 34567899999999999999999999873   45689999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++..+..++.|++.||+||| ..+++||||||+||+++ .++.+||+|||.++.......
T Consensus        78 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          78 PLGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLE-SKHFVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHh-hcCeeccCcccceEEEc-CCCcEEeccccccceeecCCc
Confidence            999999999643     35899999999999999999999 99999999999999998 588999999999987654332


Q ss_pred             eeee--ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccc
Q 001527          937 IEQI--LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013 (1060)
Q Consensus       937 ~~~~--~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 1013 (1060)
                      ....  ...++..|+|||...+..+  +.++|||||||++|||++ |+.||....    ...+..++.    ......  
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~~~~~~g~~p~~~~~----~~~~~~~~~----~~~~~~--  218 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKF--SSKSDVWSYGVTLWEAFSYGAKPYGEMK----GAEVIAMLE----SGERLP--  218 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCC--CccchHHHHHHHHHHHHcCCCCCcccCC----HHHHHHHHH----cCCcCC--
Confidence            2111  1123567999999977664  779999999999999998 999986432    112222221    111110  


Q ss_pred             ccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1014 DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1014 d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                          .+       ......+.+++.+|+. +|.+||++.+|++.|+++
T Consensus       219 ----~~-------~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 ----RP-------EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ----CC-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                00       1233567889999998 799999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.6e-34  Score=321.53  Aligned_cols=239  Identities=23%  Similarity=0.321  Sum_probs=182.4

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||.||+|+.. +++.||+|+++....   ...+.+..|.+++... +||||+++++++.  .....++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ--TKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence            36999999999999965 588999999975422   2334556677777654 8999999999885  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++.++..++.|++.||+||| +++|+||||||+||+++ .++.+||+|||+++.......
T Consensus        79 ~gg~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH-~~~ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~  151 (316)
T cd05592          79 NGGDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLH-KKGIIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEG  151 (316)
T ss_pred             CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCEEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCC
Confidence            999999998542     35899999999999999999999 99999999999999998 578999999999986433222


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      . .....||+.|+|||++.+..+  +.++|||||||++|||++|+.||....       ..+...... ...      +.
T Consensus       152 ~-~~~~~gt~~y~aPE~~~~~~~--~~~~DvwslG~il~ell~G~~Pf~~~~-------~~~~~~~i~-~~~------~~  214 (316)
T cd05592         152 K-ASTFCGTPDYIAPEILKGQKY--NESVDWWSFGVLLYEMLIGQSPFHGED-------EDELFDSIL-NDR------PH  214 (316)
T ss_pred             c-cccccCCccccCHHHHcCCCC--CCcccchhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHH-cCC------CC
Confidence            1 222368999999999987765  779999999999999999999997421       111221111 110      00


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHH-HHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIK-TIY 1054 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~-evl 1054 (1060)
                       .+.       .....+.+++.+|++ +|.+||++. +++
T Consensus       215 -~~~-------~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         215 -FPR-------WISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             -CCC-------CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             011       122345677889998 799999875 453

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.4e-34  Score=323.98  Aligned_cols=240  Identities=23%  Similarity=0.304  Sum_probs=185.7

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.+++..+ +||||+++++++.  ..+..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~--~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ--TKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCeEEEEEeCC
Confidence            36999999999999965 58899999987542   22345677899998866 7999999999985  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|..++...     ..+++..+..++.|++.||+||| +.||+||||||+||+++ .++.+||+|||+++.......
T Consensus        79 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~  151 (321)
T cd05591          79 NGGDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLH-RHGVIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGV  151 (321)
T ss_pred             CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEEC-CCCCEEEeecccceecccCCc
Confidence            999999998542     35889999999999999999999 99999999999999998 588999999999876433222


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      . .....||+.|+|||++.+..+  +.++|||||||++|||++|+.||....       ..+........ .   ...  
T Consensus       152 ~-~~~~~gt~~y~aPE~~~~~~~--~~~~DvwslG~il~el~tg~~Pf~~~~-------~~~~~~~i~~~-~---~~~--  215 (321)
T cd05591         152 T-TTTFCGTPDYIAPEILQELEY--GPSVDWWALGVLMYEMMAGQPPFEADN-------EDDLFESILHD-D---VLY--  215 (321)
T ss_pred             c-ccccccCccccCHHHHcCCCC--CCccceechhHHHHHHhcCCCCCCCCC-------HHHHHHHHHcC-C---CCC--
Confidence            1 122368999999999987765  779999999999999999999997432       11222211111 1   000  


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-------CHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-------GIKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-------s~~evl~ 1055 (1060)
                        +.       .....+.+++..|++ +|++||       ++.++++
T Consensus       216 --p~-------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         216 --PV-------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             --CC-------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence              11       112456778889998 799999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-33  Score=311.65  Aligned_cols=252  Identities=21%  Similarity=0.320  Sum_probs=192.6

Q ss_pred             CCeeccccceEEEEEEEc------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|...      ++..||+|+++... .....++.+|+.++++++||||+++++++.  .....++||
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~~~lv~   88 (277)
T cd05062          11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QGQPTLVIM   88 (277)
T ss_pred             eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCeEEEE
Confidence            578999999999999753      35679999986432 334567889999999999999999999984  566889999


Q ss_pred             EecCCCChHHHhhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccc
Q 001527          854 DYISPGSLASFLYDRPGR-----KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLH  928 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a  928 (1060)
                      ||+++++|.+++......     ....+++.++..++.|++.||+||| +.+++||||||+||+++ +++.+||+|||++
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~vH~dlkp~Nil~~-~~~~~~l~dfg~~  166 (277)
T cd05062          89 ELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVA-EDFTVKIGDFGMT  166 (277)
T ss_pred             ecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCcchheEEEc-CCCCEEECCCCCc
Confidence            999999999999653211     1234688899999999999999999 89999999999999998 5889999999998


Q ss_pred             eeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhc
Q 001527          929 RLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAE 1006 (1060)
Q Consensus       929 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 1006 (1060)
                      +......... .....++..|+|||++.+..+  +.++|||||||++|||++ |..||....       ..+...... .
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~el~~~~~~p~~~~~-------~~~~~~~~~-~  236 (277)
T cd05062         167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVF--TTYSDVWSFGVVLWEIATLAEQPYQGMS-------NEQVLRFVM-E  236 (277)
T ss_pred             cccCCcceeecCCCCccCHhhcChhHhhcCCc--CchhHHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHHH-c
Confidence            7654332211 111245778999999987664  789999999999999999 788886421       112221111 1


Q ss_pred             CCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1007 GHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1007 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ......             .......+.+++.+|++ +|++|||+.|++++|++
T Consensus       237 ~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         237 GGLLDK-------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CCcCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            111110             01233467889999998 79999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=316.01  Aligned_cols=247  Identities=20%  Similarity=0.329  Sum_probs=202.5

Q ss_pred             CCeeccccceEEEEEEEcC-----CcEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLEN-----GMFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .++||.|-||.||+|.+.+     .-.||||..+.+ .....+.|..|+.+|++++|||||+++|+|.   ....|+|||
T Consensus       394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~---e~P~WivmE  470 (974)
T KOG4257|consen  394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV---EQPMWIVME  470 (974)
T ss_pred             HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee---ccceeEEEe
Confidence            5799999999999998643     345899999874 4456788999999999999999999999994   457899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      .++-|.|..|+..+.    ..++......+++||+.||+||| +...|||||...|||+.+ ...+|++|||+++.+...
T Consensus       471 L~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLe-SkrfVHRDIAaRNiLVsS-p~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  471 LAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLE-SKRFVHRDIAARNILVSS-PQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             cccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHH-hhchhhhhhhhhheeecC-cceeeecccchhhhcccc
Confidence            999999999997643    45889999999999999999999 999999999999999985 668999999999998877


Q ss_pred             CceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccc
Q 001527          935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 1013 (1060)
                      ..+......-...|||||.+.-..+  +.++|||-|||++||++. |..||......+-                    +
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrF--TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------------------I  602 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRF--TTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------------------I  602 (974)
T ss_pred             chhhccccccceeecCccccchhcc--cchhhHHHHHHHHHHHHHhcCCccccccccce--------------------E
Confidence            6655543344567999999987776  889999999999999876 9999986533211                    1


Q ss_pred             ccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1014 DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1014 d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      -. +-.....|.++.++..+..++.+||. +|.+||.++|+...|+.
T Consensus       603 ~~-iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  603 GH-IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             EE-ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence            00 00111223344667788999999999 89999999999988864

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.1e-34  Score=322.72  Aligned_cols=242  Identities=23%  Similarity=0.359  Sum_probs=186.3

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||.||+|+.. +++.||+|+++....   ...+.+.+|+.++.++ +||+|+++++++.  .....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ--TTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE--eCCEEEEEEeCC
Confidence            36999999999999964 689999999975432   2345688999999888 6999999999884  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++..     ...+++..+..++.||+.||+||| ++||+||||||+|||++ .++.+||+|||+++.......
T Consensus        79 ~~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~  151 (327)
T cd05617          79 NGGDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLH-ERGIIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGD  151 (327)
T ss_pred             CCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEe-CCCCEEEeccccceeccCCCC
Confidence            99999998853     245899999999999999999999 89999999999999998 578999999999875332222


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      . .....||+.|+|||++.+..+  +.++|||||||++|||++|+.||+...... .....++...........      
T Consensus       152 ~-~~~~~gt~~y~aPE~~~~~~~--~~~~DiwslGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~------  221 (327)
T cd05617         152 T-TSTFCGTPNYIAPEILRGEEY--GFSVDWWALGVLMFEMMAGRSPFDIITDNP-DMNTEDYLFQVILEKPIR------  221 (327)
T ss_pred             c-eecccCCcccCCHHHHCCCCC--CchheeehhHHHHHHHHhCCCCCCccCCCc-ccccHHHHHHHHHhCCCC------
Confidence            1 122368999999999987765  779999999999999999999997543221 122333333333221110      


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGI 1050 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~ 1050 (1060)
                       .+.       .....+.+++.+|++ +|.+||++
T Consensus       222 -~p~-------~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         222 -IPR-------FLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             -CCC-------CCCHHHHHHHHHHhccCHHHcCCC
Confidence             011       122345677889998 79999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.8e-34  Score=327.21  Aligned_cols=248  Identities=19%  Similarity=0.221  Sum_probs=188.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|+++++.++||||+++++++.  +....++||||+
T Consensus        48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~--~~~~~~lv~Ey~  125 (370)
T cd05596          48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ--DDKYLYMVMEYM  125 (370)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCEEEEEEcCC
Confidence            578999999999999965 68999999986432   223355788999999999999999998884  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...      .+++..+..++.|++.||+||| +.||+||||||+|||++ +++.+||+|||+++.......
T Consensus       126 ~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         126 PGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEc-CCCCEEEEeccceeeccCCCc
Confidence            999999998542      3788889999999999999999 99999999999999998 588999999999987654333


Q ss_pred             eeeeccCccccccchhcccCCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          937 IEQILDAGVLGYRAPELAASKK--PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      .......||+.|+|||++.+..  ..++.++|||||||++|||++|+.||....       .................  
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~--  268 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMDHKNSLTF--  268 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-------HHHHHHHHHcCCCcCCC--
Confidence            2222346999999999987542  124789999999999999999999997421       11111111111100000  


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhcc-CCCC--CCCHHHHHHH
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSE--RPGIKTIYED 1056 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~--RPs~~evl~~ 1056 (1060)
                          +.     .......+.+++..|++ +|.+  ||+++|+++.
T Consensus       269 ----~~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         269 ----PD-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ----CC-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                00     01223456677789998 4765  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.5e-35  Score=336.43  Aligned_cols=195  Identities=22%  Similarity=0.222  Sum_probs=163.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .++||+|+||+||+|+.. +++.||+|++....   ....+.+.+|++++++++|||||++++++.  +....++||||+
T Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~--~~~~~~lv~E~~   83 (382)
T cd05625           6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ--DKDNLYFVMDYI   83 (382)
T ss_pred             EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE--eCCEEEEEEeCC
Confidence            478999999999999854 68999999987542   223467889999999999999999999985  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC-
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG-  935 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~-  935 (1060)
                      ++|+|.+++...     ..+++..+..++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||+++...... 
T Consensus        84 ~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH-~~~ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          84 PGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVH-KMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEC-CCCCEEEeECCCCcccccccc
Confidence            999999998542     35888999999999999999999 99999999999999998 58899999999975321000 


Q ss_pred             ---------------------------------------------ceeeeccCccccccchhcccCCCCCCCCccchHHH
Q 001527          936 ---------------------------------------------TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAF  970 (1060)
Q Consensus       936 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSl  970 (1060)
                                                                   ........||+.|+|||++.+..+  +.++||||+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~--~~~~DiwSl  234 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY--TQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC--CCeeeEEec
Confidence                                                         000011368999999999987765  779999999


Q ss_pred             HHHHHHHHhCCCCCCC
Q 001527          971 GVILLELLTGRCAGDV  986 (1060)
Q Consensus       971 Gvvl~elltG~~p~~~  986 (1060)
                      ||++|||++|+.||..
T Consensus       235 Gvil~elltG~~Pf~~  250 (382)
T cd05625         235 GVILYEMLVGQPPFLA  250 (382)
T ss_pred             hHHHHHHHhCCCCCCC
Confidence            9999999999999974

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-33  Score=314.29  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=193.5

Q ss_pred             CCeeccccceEEEEEEEc------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|+..      ....+++|.+.... ....+++.+|++++++++||||+++++++.  ..+..++|+
T Consensus         5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~   82 (290)
T cd05045           5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS--QDGPLLLIV   82 (290)
T ss_pred             cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCCcEEEE
Confidence            578999999999999843      23579999887543 334567899999999999999999999984  556789999


Q ss_pred             EecCCCChHHHhhcCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEee
Q 001527          854 DYISPGSLASFLYDRPG-------------------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD  914 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~  914 (1060)
                      ||+.+++|.+++.....                   .....+++.+++.++.|++.||+||| +.+|+||||||+||+++
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~ivH~dikp~nill~  161 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA-EMKLVHRDLAARNVLVA  161 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH-HCCeehhhhhhheEEEc
Confidence            99999999999865321                   11245889999999999999999999 99999999999999998


Q ss_pred             CCCCCeEEcccccceeeccCCce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 001527          915 GPDLNARVADYCLHRLMTQAGTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGA  992 (1060)
Q Consensus       915 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~  992 (1060)
                       ++..+||+|||+++........ ......++..|+|||++.+..+  +.++||||||+++|||++ |+.||....    
T Consensus       162 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~--~~~~Di~slG~~l~el~t~g~~p~~~~~----  234 (290)
T cd05045         162 -EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIVTLGGNPYPGIA----  234 (290)
T ss_pred             -CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc--chHhHHHHHHHHHHHHHhcCCCCCCCCC----
Confidence             5789999999999865433221 1122245678999999877654  789999999999999998 999986421    


Q ss_pred             ccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527          993 GVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus       993 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                         ..++.. ........     .. +       ......+.+++..|++ +|.+||+++|+++.|+++
T Consensus       235 ---~~~~~~-~~~~~~~~-----~~-~-------~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         235 ---PERLFN-LLKTGYRM-----ER-P-------ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             ---HHHHHH-HHhCCCCC-----CC-C-------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence               112111 11111100     00 0       1233467788999998 799999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-34  Score=317.74  Aligned_cols=246  Identities=22%  Similarity=0.301  Sum_probs=189.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHH---HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAK---QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .++||+|+||+||++... +++.||+|++......   ....+.+|++++++++||||+++++++.  .++..++||||+
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~   82 (285)
T cd05605           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE--TKDALCLVLTLM   82 (285)
T ss_pred             EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec--CCCeEEEEEecc
Confidence            468999999999999954 6899999998653222   2345778999999999999999999884  556899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++....   ...+++.++..++.|++.||+||| +.+|+||||||+||+++ ++..++|+|||+++.......
T Consensus        83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          83 NGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLH-RERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             CCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCHHHEEEC-CCCCEEEeeCCCceecCCCCc
Confidence            9999999886432   245899999999999999999999 89999999999999998 578999999999987543322


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      .  ....|+..|+|||++.+..+  +.++||||+||++|||++|+.||......    ...+.+...+.....       
T Consensus       158 ~--~~~~~~~~y~aPE~~~~~~~--~~~~Diws~G~~l~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~-------  222 (285)
T cd05605         158 I--RGRVGTVGYMAPEVVKNERY--TFSPDWWGLGCLIYEMIEGKSPFRQRKEK----VKREEVERRVKEDQE-------  222 (285)
T ss_pred             c--ccccCCCCccCcHHhcCCCC--CccccchhHHHHHHHHHHCCCCCCCCchh----hHHHHHHHHhhhccc-------
Confidence            2  12368999999999987654  77999999999999999999999743211    111111111111100       


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~ 1055 (1060)
                         .    ........+.+++.+|++ +|.+||     +++++++
T Consensus       223 ---~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         223 ---E----YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ---c----cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence               0    011233456788889998 799999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-35  Score=335.60  Aligned_cols=195  Identities=18%  Similarity=0.242  Sum_probs=163.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++|||||++++++.  +....|+||||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~lv~E~~   83 (377)
T cd05629           6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ--DAQYLYLIMEFL   83 (377)
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCeeEEEEeCC
Confidence            478999999999999854 78999999986532   223467889999999999999999999985  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++..     ...+++..+..++.|++.||+||| +.||+||||||+|||++ .++.+||+|||+++.......
T Consensus        84 ~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH-~~givHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          84 PGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVH-KLGFIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEEC-CCCCEEEeecccccccccccc
Confidence            99999999954     245889999999999999999999 99999999999999998 588999999999864321100


Q ss_pred             e----------------------------------------------eeeccCccccccchhcccCCCCCCCCccchHHH
Q 001527          937 I----------------------------------------------EQILDAGVLGYRAPELAASKKPHPSFKSDVYAF  970 (1060)
Q Consensus       937 ~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSl  970 (1060)
                      .                                              ......||+.|+|||++.+..+  +.++|||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DiwSl  234 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY--GQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC--CCceeeEec
Confidence            0                                              0001358999999999987765  789999999


Q ss_pred             HHHHHHHHhCCCCCCC
Q 001527          971 GVILLELLTGRCAGDV  986 (1060)
Q Consensus       971 Gvvl~elltG~~p~~~  986 (1060)
                      ||++|||++|+.||..
T Consensus       235 Gvil~elltG~~Pf~~  250 (377)
T cd05629         235 GAIMFECLIGWPPFCS  250 (377)
T ss_pred             chhhhhhhcCCCCCCC
Confidence            9999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.8e-34  Score=345.17  Aligned_cols=250  Identities=19%  Similarity=0.269  Sum_probs=192.0

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||+||+|+.. ++..||+|++...  .......+..|+.++++++|||||+++++|........|+||||++
T Consensus        18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~   97 (1021)
T PTZ00266         18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD   97 (1021)
T ss_pred             EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence            478999999999999964 6788999988643  2334567899999999999999999999987666677899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCcccCCCCCCCeEeeCC--------------
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD-------RAVPHGNLKATNILLDGP--------------  916 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-------~~ivHrDlkp~NILl~~~--------------  916 (1060)
                      +|+|.+++.... .....+++..++.|+.||+.||+||| .       .+||||||||+||||+..              
T Consensus        98 gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLH-s~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~  175 (1021)
T PTZ00266         98 AGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCH-NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL  175 (1021)
T ss_pred             CCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHH-hcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence            999999996533 22346999999999999999999999 5       459999999999999621              


Q ss_pred             --CCCeEEcccccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 001527          917 --DLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGV  994 (1060)
Q Consensus       917 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~  994 (1060)
                        ...+||+|||+++........  ....||+.|+|||++.+....++.++|||||||++|||++|+.||....      
T Consensus       176 ng~~iVKLsDFGlAr~l~~~s~~--~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~------  247 (1021)
T PTZ00266        176 NGRPIAKIGDFGLSKNIGIESMA--HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN------  247 (1021)
T ss_pred             CCCCceEEccCCccccccccccc--cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC------
Confidence              234899999999866433221  2236899999999987654345789999999999999999999996421      


Q ss_pred             ChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527          995 DLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus       995 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ....++.. +....       .+..       ......+.+++..|++ +|.+||++.|++.
T Consensus       248 ~~~qli~~-lk~~p-------~lpi-------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 NFSQLISE-LKRGP-------DLPI-------KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cHHHHHHH-HhcCC-------CCCc-------CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            22222222 11110       0000       0123457788889998 7999999999984

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6e-34  Score=319.60  Aligned_cols=239  Identities=23%  Similarity=0.342  Sum_probs=183.4

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      +.||+|+||+||+|+.. +++.||+|+++....   ...+.+..|..++... +||||+++++++.  +.+..++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ--TKENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE--eCCEEEEEEeCC
Confidence            36999999999999965 588999999976421   2334566788888764 9999999999985  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++.++..++.|++.||+||| +++|+||||||+||+++ +++.+||+|||+++.......
T Consensus        79 ~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH-~~~ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05619          79 NGGDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLH-SKGIVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDA  151 (316)
T ss_pred             CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCC
Confidence            999999999542     35889999999999999999999 99999999999999998 578999999999875432221


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      . .....||..|+|||++.+..+  +.++||||+||++|||++|+.||....       ..+..... ....      +.
T Consensus       152 ~-~~~~~gt~~y~aPE~~~~~~~--~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~i-~~~~------~~  214 (316)
T cd05619         152 K-TCTFCGTPDYIAPEILLGQKY--NTSVDWWSFGVLLYEMLIGQSPFHGHD-------EEELFQSI-RMDN------PC  214 (316)
T ss_pred             c-eeeecCCccccCHHHHcCCCC--CchhhhhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHH-HhCC------CC
Confidence            1 122368999999999987765  789999999999999999999997421       11211111 1110      00


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHH-HHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIK-TIY 1054 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~-evl 1054 (1060)
                       .+.       .....+.+++.+|++ +|.+||++. ++.
T Consensus       215 -~~~-------~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         215 -YPR-------WLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             -CCc-------cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence             011       122346677889998 799999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-33  Score=315.78  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=196.4

Q ss_pred             ccCCCeeccccceEEEEEEEc--------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCC
Q 001527          778 RAPAEVLGRSSHGTSYRATLE--------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQH  847 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  847 (1060)
                      +...+.||+|+||.||+|+..        ++..||+|.++... ....+.+.+|+++++.+ +||||+++++++.  ...
T Consensus        17 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~~~   94 (304)
T cd05101          17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDG   94 (304)
T ss_pred             eeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--cCC
Confidence            334689999999999999741        34579999987542 34456789999999999 8999999999985  456


Q ss_pred             ceEEEEEecCCCChHHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCC
Q 001527          848 EKLILSDYISPGSLASFLYDRPGR-----------KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP  916 (1060)
Q Consensus       848 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~  916 (1060)
                      ..++||||+++|+|.+++......           ....+++.++..++.||+.||+||| +.||+||||||+||+++ +
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH-~~givH~dlkp~Nili~-~  172 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA-SQKCIHRDLAARNVLVT-E  172 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH-HCCeeecccccceEEEc-C
Confidence            789999999999999999764311           1245789999999999999999999 99999999999999998 5


Q ss_pred             CCCeEEcccccceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 001527          917 DLNARVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGV  994 (1060)
Q Consensus       917 ~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~  994 (1060)
                      ++.+||+|||.++......... .....++..|+|||++.+..+  +.++||||||+++|||++ |..||...       
T Consensus       173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~el~~~g~~p~~~~-------  243 (304)
T cd05101         173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFTLGGSPYPGI-------  243 (304)
T ss_pred             CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC--CchhhHHHHHHHHHHHHcCCCCCcccC-------
Confidence            7899999999998765432221 112245678999999977654  789999999999999998 78887532       


Q ss_pred             ChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527          995 DLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus       995 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ...++.... ........             .......+.+++.+|++ +|.+||+|.||++.|+.|
T Consensus       244 ~~~~~~~~~-~~~~~~~~-------------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         244 PVEELFKLL-KEGHRMDK-------------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             CHHHHHHHH-HcCCcCCC-------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence            222333322 21111100             01234567788889998 799999999999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.4e-33  Score=309.57  Aligned_cols=255  Identities=20%  Similarity=0.264  Sum_probs=186.9

Q ss_pred             eeccccceEEEEEEEcCC---cEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          783 VLGRSSHGTSYRATLENG---MFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       783 ~iG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .||+|+||.||+|+..++   ..+++|.++... ....+.+.+|+++++.++||||+++++++.  .....++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV--EAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec--CCCccEEEEecCCC
Confidence            589999999999985433   346677665432 344578999999999999999999999985  45678999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC-ce
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG-TI  937 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~-~~  937 (1060)
                      |+|.++++.... .....++..+..++.||+.||+||| +.+|+||||||+|||++ .++.+||+|||++....... ..
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          80 GDLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMH-KHNFLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CcHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHH-HCCeeccCCccceEEEc-CCccEEecccccccccCcchhhh
Confidence            999999976432 1245677788899999999999999 99999999999999998 58899999999986432211 11


Q ss_pred             eeeccCccccccchhcccCCC-----CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          938 EQILDAGVLGYRAPELAASKK-----PHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~-----~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                      ......++..|+|||++....     ..++.++|||||||++|||++ |..||+...       ..+.......+ ....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-------~~~~~~~~~~~-~~~~  228 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-------DREVLNHVIKD-QQVK  228 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhh-cccc
Confidence            112235788999999985321     123678999999999999997 566775321       12222222222 2222


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHhh
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~L~ 1058 (1060)
                      ..++.+...        ....+.+++..|+.+|++||+++||++.|.
T Consensus       229 ~~~~~~~~~--------~~~~~~~l~~~c~~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         229 LFKPQLELP--------YSERWYEVLQFCWLSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCCCccCCC--------CcHHHHHHHHHHhhCcccCCCHHHHHHHhc
Confidence            333333221        223566677789989999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.1e-35  Score=337.21  Aligned_cols=247  Identities=19%  Similarity=0.187  Sum_probs=185.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|++++++++||||+++++++.  +.+..++||||+
T Consensus         6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~lv~E~~   83 (376)
T cd05598           6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLYFVMDYI   83 (376)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCEEEEEEeCC
Confidence            578999999999999954 689999999865322   23456889999999999999999999985  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC-
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG-  935 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~-  935 (1060)
                      ++|+|.+++...     ..+++..+..++.||+.||+||| +.||+||||||+|||++ .++.+||+|||+|....... 
T Consensus        84 ~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          84 PGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVH-KMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHEEEC-CCCCEEEEeCCCCcccccccc
Confidence            999999999542     45888999999999999999999 99999999999999998 58899999999975321000 


Q ss_pred             -----------------------------------------ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHH
Q 001527          936 -----------------------------------------TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVIL  974 (1060)
Q Consensus       936 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl  974 (1060)
                                                               ........||+.|+|||++.+..+  +.++|||||||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlGvil  234 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY--TQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC--Ccceeeeecccee
Confidence                                                     000012368999999999987765  7799999999999


Q ss_pred             HHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhccCCCCCC---CHH
Q 001527          975 LELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERP---GIK 1051 (1060)
Q Consensus       975 ~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~~p~~RP---s~~ 1051 (1060)
                      |||++|+.||.....       .++..... .... ....+.         .......+.+++.+|+.+|.+|+   ++.
T Consensus       235 yell~G~~Pf~~~~~-------~~~~~~i~-~~~~-~~~~~~---------~~~~s~~~~~li~~l~~~p~~R~~~~t~~  296 (376)
T cd05598         235 YEMLVGQPPFLADTP-------AETQLKVI-NWET-TLHIPS---------QAKLSREASDLILRLCCGAEDRLGKNGAD  296 (376)
T ss_pred             eehhhCCCCCCCCCH-------HHHHHHHh-ccCc-cccCCC---------CCCCCHHHHHHHHHHhcCHhhcCCCCCHH
Confidence            999999999975321       11111111 1000 000000         01122344555666667899999   888


Q ss_pred             HHHHH
Q 001527         1052 TIYED 1056 (1060)
Q Consensus      1052 evl~~ 1056 (1060)
                      |+++.
T Consensus       297 ell~h  301 (376)
T cd05598         297 EIKAH  301 (376)
T ss_pred             HHhCC
Confidence            88753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.2e-34  Score=313.58  Aligned_cols=255  Identities=22%  Similarity=0.321  Sum_probs=197.3

Q ss_pred             CCCeeccccceEEEEEEEcC-----CcEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          780 PAEVLGRSSHGTSYRATLEN-----GMFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      ..++||+|+||.||+|...+     +..|++|+++.. .....+.+.+|+.++++++||||+++++++.. .....++++
T Consensus        10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~~~~~   88 (280)
T cd05043          10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE-DGEPPFVLY   88 (280)
T ss_pred             EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCCCCEEEE
Confidence            35789999999999999765     788999998754 23445778899999999999999999998863 356789999


Q ss_pred             EecCCCChHHHhhcCCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          854 DYISPGSLASFLYDRPGR---KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      ||+++++|.+++......   ....+++.++..++.|++.||+||| +.+++||||||+||+++ ++..+||+|||+++.
T Consensus        89 ~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~di~p~nil~~-~~~~~kl~d~g~~~~  166 (280)
T cd05043          89 PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-KRGVIHKDIAARNCVID-EELQVKITDNALSRD  166 (280)
T ss_pred             EcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccCHhhEEEc-CCCcEEECCCCCccc
Confidence            999999999999654211   1256899999999999999999999 99999999999999998 578999999999986


Q ss_pred             eccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCC
Q 001527          931 MTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008 (1060)
Q Consensus       931 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 1008 (1060)
                      +....... .....++..|+|||++.+..+  +.++|||||||++||+++ |+.||....    ...+..++.    .+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~--~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~~----~~~  236 (280)
T cd05043         167 LFPMDYHCLGDNENRPVKWMALESLVNKEY--SSASDVWSFGVLLWELMTLGQTPYVEID----PFEMAAYLK----DGY  236 (280)
T ss_pred             ccCCceEEeCCCCCcchhccCHHHHhcCCC--CchhhHHHhHHHHHHHhcCCCCCcCcCC----HHHHHHHHH----cCC
Confidence            54332221 112245678999999977654  789999999999999999 999986421    111222211    110


Q ss_pred             CCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1009 GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1009 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      .     ...        .......+.+++.+|+. +|++|||+.||++.|+.+
T Consensus       237 ~-----~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         237 R-----LAQ--------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             C-----CCC--------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            0     000        01123467889999998 799999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.8e-34  Score=326.05  Aligned_cols=197  Identities=21%  Similarity=0.264  Sum_probs=166.3

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      ..++||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.  +....++||||
T Consensus        47 ~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--~~~~~~lv~Ey  124 (370)
T cd05621          47 VVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ--DDKYLYMVMEY  124 (370)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEEEEcC
Confidence            3578999999999999965 68899999986432   223456789999999999999999999985  56789999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++|+|.+++...      .+++.++..++.||+.||+||| +.+|+||||||+|||++ +++.+||+|||+++......
T Consensus       125 ~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH-~~~IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         125 MPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIH-SMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             CCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEEC-CCCCEEEEecccceecccCC
Confidence            9999999999532      3788999999999999999999 99999999999999998 58899999999998765433


Q ss_pred             ceeeeccCccccccchhcccCCC--CCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          936 TIEQILDAGVLGYRAPELAASKK--PHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ........||+.|+|||++.+..  ..++.++||||+||++|||++|+.||..
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~  249 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA  249 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence            32223347999999999997543  1247799999999999999999999974

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.8e-34  Score=321.33  Aligned_cols=239  Identities=23%  Similarity=0.336  Sum_probs=183.4

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||.||+|+.. +|+.||+|+++....   ...+.+..|.+++... +||||+++++++.  +.+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ--TKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE--eCCEEEEEECCC
Confidence            46999999999999965 689999999975422   2345567788888754 8999999999985  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++.++..++.|++.||+||| +.||+||||||+||+++ .++.+||+|||+++.......
T Consensus        79 ~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH-~~~ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05620          79 NGGDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLH-SKGIIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDN  151 (316)
T ss_pred             CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCC
Confidence            999999998542     45889999999999999999999 99999999999999998 578999999999875332221


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      . .....||..|+|||++.+..+  +.++||||+||++|||++|+.||....       ..+.... .....      +.
T Consensus       152 ~-~~~~~gt~~y~aPE~~~~~~~--~~~~DiwslGvil~el~~g~~Pf~~~~-------~~~~~~~-~~~~~------~~  214 (316)
T cd05620         152 R-ASTFCGTPDYIAPEILQGLKY--TFSVDWWSFGVLLYEMLIGQSPFHGDD-------EDELFES-IRVDT------PH  214 (316)
T ss_pred             c-eeccCCCcCccCHHHHcCCCC--CcccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHH-HHhCC------CC
Confidence            1 122368999999999987765  779999999999999999999996421       1111111 11110      00


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHH-HHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIK-TIY 1054 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~-evl 1054 (1060)
                      . +.       .....+.+++.+|++ +|.+||++. ++.
T Consensus       215 ~-~~-------~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         215 Y-PR-------WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             C-CC-------CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            0 11       122346678889998 799999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-34  Score=325.77  Aligned_cols=237  Identities=22%  Similarity=0.315  Sum_probs=185.2

Q ss_pred             CeeccccceEEEEEEE----cCCcEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          782 EVLGRSSHGTSYRATL----ENGMFLTVKWLREGVA--KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      +.||+|+||.||+++.    .+|+.||+|+++....  .....+..|++++++++||||+++++++.  +....|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ--TEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE--cCCEEEEEEcC
Confidence            5799999999999974    3589999999975432  23456778999999999999999999985  56689999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++|+|.+++..     ...+++.++..++.||+.||+||| +.+|+||||||+||+++ +++.+||+|||+++......
T Consensus        80 ~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          80 LRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             CCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCC
Confidence            999999999853     245899999999999999999999 99999999999999998 57899999999988654432


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      .. .....|++.|+|||++.+..+  +.++|||||||++|||++|+.||....       ..+....... ... .    
T Consensus       153 ~~-~~~~~g~~~y~aPE~~~~~~~--~~~~DiwslG~il~el~tg~~p~~~~~-------~~~~~~~i~~-~~~-~----  216 (318)
T cd05582         153 KK-AYSFCGTVEYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGSLPFQGKD-------RKETMTMILK-AKL-G----  216 (318)
T ss_pred             Cc-eecccCChhhcCHHHHcCCCC--CCccceeccceEeeeeccCCCCCCCCC-------HHHHHHHHHc-CCC-C----
Confidence            22 222368999999999987665  779999999999999999999987421       1111111111 110 0    


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKT 1052 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~e 1052 (1060)
                        .+.       .....+.+++.+|++ +|.+||++.+
T Consensus       217 --~p~-------~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 --MPQ-------FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --CCC-------CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              011       123456678889998 7999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-33  Score=309.93  Aligned_cols=254  Identities=19%  Similarity=0.284  Sum_probs=198.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG---VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|... +|+.||+|.++..   .....+.+.+|++++++++|+||+++++++.  ..+..++||||+
T Consensus         7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   84 (267)
T cd08224           7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI--ENNELNIVLELA   84 (267)
T ss_pred             eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee--cCCeEEEEEecC
Confidence            578999999999999976 7999999988632   2234567899999999999999999999985  456789999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++.... .....+++.++..++.|++.||+||| +.||+||||||+||+++ +++.++|+|||+++.......
T Consensus        85 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          85 DAGDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMH-SKRIMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             CCCCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHH-hCCEecCCcChhhEEEC-CCCcEEEeccceeeeccCCCc
Confidence            9999999986532 23356899999999999999999999 99999999999999998 578999999999886544322


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      .. ....++..|+|||++.+..+  +.++|||||||++|+|++|+.||....     ....++...... +....     
T Consensus       162 ~~-~~~~~~~~y~apE~~~~~~~--~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~-~~~~~-----  227 (267)
T cd08224         162 AA-HSLVGTPYYMSPERIHENGY--NFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKKIEK-CDYPP-----  227 (267)
T ss_pred             cc-ceecCCccccCHHHhccCCC--CchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHhhhhc-CCCCC-----
Confidence            11 12357889999999987654  779999999999999999999985421     222222221111 11100     


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      .       ........+.+++.+|+. +|.+||++.+|+++|+.+
T Consensus       228 ~-------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         228 L-------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             C-------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            0       011334467788899998 799999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-34  Score=312.45  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=194.8

Q ss_pred             CCeeccccceEEEEEEEc-C---CcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCC----CceE
Q 001527          781 AEVLGRSSHGTSYRATLE-N---GMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ----HEKL  850 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----~~~~  850 (1060)
                      .+.||+|+||.||+|... +   +..||+|+++..  .....+.+.+|++.+++++||||+++++++.....    ...+
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05035           4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM   83 (273)
T ss_pred             ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence            578999999999999864 2   378999998743  23345678999999999999999999998863222    2478


Q ss_pred             EEEEecCCCChHHHhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccce
Q 001527          851 ILSDYISPGSLASFLYDRPG-RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR  929 (1060)
Q Consensus       851 lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~  929 (1060)
                      +||||+++|+|..++..... .....+++.++..++.|++.||+||| +.+|+||||||+||+++ ++..+||+|||.++
T Consensus        84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH-~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~  161 (273)
T cd05035          84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS-NRNFIHRDLAARNCMLR-EDMTVCVADFGLSK  161 (273)
T ss_pred             EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH-hCCeeccccchheEEEC-CCCeEEECCcccee
Confidence            99999999999999865431 22346899999999999999999999 89999999999999998 57899999999998


Q ss_pred             eeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcC
Q 001527          930 LMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEG 1007 (1060)
Q Consensus       930 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 1007 (1060)
                      ......... .....++..|+|||++.+..+  +.++|||||||++|||++ |..||.....       .+...... .+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~--~~~~Dv~SlG~il~el~~~g~~p~~~~~~-------~~~~~~~~-~~  231 (273)
T cd05035         162 KIYSGDYYRQGRIAKMPVKWIAIESLADRVY--TSKSDVWAFGVTMWEIATRGQTPYPGVEN-------HEIYDYLR-HG  231 (273)
T ss_pred             eccccccccccccccCCccccCHhhcccCCC--CcccchHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH-cC
Confidence            765433221 111235678999999876654  789999999999999999 8888864321       12221111 11


Q ss_pred             CCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1008 HGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1008 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ....     .        .......+.+++.+|++ +|.+||++.||++.|+.+
T Consensus       232 ~~~~-----~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 NRLK-----Q--------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCC-----C--------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1110     0        11234568888999998 799999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.2e-33  Score=310.07  Aligned_cols=254  Identities=21%  Similarity=0.301  Sum_probs=196.9

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREG---VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+. .+++.+|||.+...   .....+++.+|+++++.++||||+++++++.  ..+..+++|||+
T Consensus         7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~v~e~~   84 (267)
T cd08229           7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI--EDNELNIVLELA   84 (267)
T ss_pred             hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE--eCCeEEEEEEec
Confidence            46799999999999995 57999999987642   2234467889999999999999999999985  456889999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++.... .....+++.++..++.|++.||+||| +.|++|+||||+||+++ .++.++++|||++........
T Consensus        85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd08229          85 DAGDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             CCCCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEc-CCCCEEECcchhhhccccCCc
Confidence            9999999986432 22356899999999999999999999 99999999999999998 578999999999876644322


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      .. ....|+..|+|||++.+...  +.++||||||+++|||++|..||.....     ...++..... .     ...+.
T Consensus       162 ~~-~~~~~~~~~~ape~~~~~~~--~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~-~-----~~~~~  227 (267)
T cd08229         162 AA-HSLVGTPYYMSPERIHENGY--NFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIE-Q-----CDYPP  227 (267)
T ss_pred             cc-ccccCCcCccCHHHhcCCCc--cchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhhh-c-----CCCCC
Confidence            21 12358889999999977664  7799999999999999999999864211     1112211111 1     00111


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ..       .......+.+++.+|++ +|.+||||.+|+++++++
T Consensus       228 ~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         228 LP-------SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CC-------cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            10       11234567788889998 799999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-33  Score=304.82  Aligned_cols=244  Identities=31%  Similarity=0.482  Sum_probs=195.2

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .+.||+|+||.||+|... |+.||+|.++.... ..+++.+|+.++++++|+||+++++++.  +....++||||+++++
T Consensus        11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~~~~   86 (256)
T cd05039          11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL--QGNPLYIVTEYMAKGS   86 (256)
T ss_pred             eeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc--CCCCeEEEEEecCCCc
Confidence            578999999999999865 78899999986544 5678999999999999999999999985  4678899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....   ...+++.++..++.|++.||.||| +.+++||||||+||+++ +++.+||+|||.++.......    
T Consensus        87 L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~~~~~----  157 (256)
T cd05039          87 LVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLE-EKNFVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQD----  157 (256)
T ss_pred             HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH-hCCccchhcccceEEEe-CCCCEEEcccccccccccccc----
Confidence            999996532   235899999999999999999999 99999999999999998 588999999999987643222    


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||++.+..+  +.++||||||+++||+++ |+.||....       .. .+............       
T Consensus       158 ~~~~~~~~~ape~~~~~~~--~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~-~~~~~~~~~~~~~~-------  220 (256)
T cd05039         158 SGKLPVKWTAPEALREKKF--STKSDVWSFGILLWEIYSFGRVPYPRIP-------LK-DVVPHVEKGYRMEA-------  220 (256)
T ss_pred             cCCCcccccCchhhcCCcC--CcHHHHHHHHHHHHHHHhcCCCCCCCCC-------HH-HHHHHHhcCCCCCC-------
Confidence            1235668999999976654  779999999999999997 999986431       11 11122221111100       


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                            .......+.+++.+|+. +|++||+++|++++|++|
T Consensus       221 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         221 ------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ------ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                  01224567888999998 799999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.2e-33  Score=305.95  Aligned_cols=247  Identities=26%  Similarity=0.364  Sum_probs=194.2

Q ss_pred             CeeccccceEEEEEEEcC--C--cEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLEN--G--MFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|++|.||+|.+.+  +  ..||+|.++.... ...+.+.+|++++++++||||+++++++.+   ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence            468999999999998643  3  3699999987655 566789999999999999999999999853   6789999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++.....   ..+++..++.++.|++.||+||| +.+++||||||+||+++ .++.+||+|||+++.......
T Consensus        78 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          78 PLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE-SKRFIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH-hCCccccccCcccEEEe-cCCEEEecccccccccccccc
Confidence            99999999976431   46899999999999999999999 99999999999999998 578999999999987654322


Q ss_pred             ee--eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccc
Q 001527          937 IE--QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013 (1060)
Q Consensus       937 ~~--~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 1013 (1060)
                      ..  .....++..|+|||++.+..+  +.++|||||||++|||++ |+.||+...       ..+............   
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~--~~~~Di~slG~~l~el~t~g~~p~~~~~-------~~~~~~~~~~~~~~~---  220 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTF--SHASDVWMFGVTLWEMFTYGEEPWAGLS-------GSQILKKIDKEGERL---  220 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCc--CchhhhHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCcC---
Confidence            11  112356788999999887664  779999999999999998 999986431       112222111111000   


Q ss_pred             ccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527         1014 DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1014 d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                         ..+       ......+.+++.+|++ +|++||++.||++.|.
T Consensus       221 ---~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ---ERP-------EACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ---CCC-------ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence               000       1233567888999998 7999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.5e-34  Score=319.91  Aligned_cols=240  Identities=24%  Similarity=0.327  Sum_probs=186.9

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||+||+|+.. +++.||+|+++...   ....+.+..|.++++.+ +||||+++++++.  ..+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~--~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ--TKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence            36999999999999965 58899999997542   22345677899999888 7999999999985  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|..++...     ..+++.++..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||+++.......
T Consensus        79 ~~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~  151 (318)
T cd05570          79 NGGDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLH-ERGIIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGV  151 (318)
T ss_pred             CCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCeEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCC
Confidence            999999988542     35899999999999999999999 99999999999999998 588999999999875332222


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      .. ....|+..|+|||++.+..+  +.++|||||||++|||++|+.||....       ..+...... ....      .
T Consensus       152 ~~-~~~~g~~~y~aPE~~~~~~~--~~~~DiwslGvil~~l~~G~~pf~~~~-------~~~~~~~i~-~~~~------~  214 (318)
T cd05570         152 TT-STFCGTPDYIAPEILSYQPY--GPAVDWWALGVLLYEMLAGQSPFEGDD-------EDELFQSIL-EDEV------R  214 (318)
T ss_pred             cc-cceecCccccCHHHhcCCCC--CcchhhhhHHHHHHHHhhCCCCCCCCC-------HHHHHHHHH-cCCC------C
Confidence            11 12358999999999987765  779999999999999999999996421       112221111 1111      0


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCH-----HHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGI-----KTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~-----~evl~ 1055 (1060)
                       .+.       .....+.+++.+|++ +|.+||++     .++++
T Consensus       215 -~~~-------~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 -YPR-------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -CCC-------cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence             011       123456788889998 79999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-33  Score=311.43  Aligned_cols=252  Identities=25%  Similarity=0.330  Sum_probs=193.5

Q ss_pred             CCeeccccceEEEEEEEc------CCcEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE------NGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|+..      +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.  .....++++
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~~~~~~~~   87 (283)
T cd05091          10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT--KEQPLSMIF   87 (283)
T ss_pred             HHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCCceEEEE
Confidence            467999999999999853      357899999975432 33467889999999999999999999985  456789999


Q ss_pred             EecCCCChHHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEE
Q 001527          854 DYISPGSLASFLYDRPG-----------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARV  922 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl  922 (1060)
                      ||+++++|.+++.....           .....+++..+.+++.|++.||+||| ++||+||||||+||+++ ++..+||
T Consensus        88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH-~~gi~H~dlkp~Nil~~-~~~~~kl  165 (283)
T cd05091          88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS-SHHVVHKDLATRNVLVF-DKLNVKI  165 (283)
T ss_pred             EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-HcCccccccchhheEec-CCCceEe
Confidence            99999999999853211           11245889999999999999999999 99999999999999998 5788999


Q ss_pred             cccccceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHH
Q 001527          923 ADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWM 1000 (1060)
Q Consensus       923 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~ 1000 (1060)
                      +|||+++......... .....+++.|+|||++.+..+  +.++|||||||++|||++ |..||....       ..++.
T Consensus       166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~~~~  236 (283)
T cd05091         166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF--SIDSDIWSYGVVLWEVFSYGLQPYCGYS-------NQDVI  236 (283)
T ss_pred             cccccccccccchheeeccCccCCccccCHHHHhcCCC--CcchhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHH
Confidence            9999988654332211 122245778999999977664  779999999999999998 888876421       12232


Q ss_pred             HHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1001 QLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1001 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      .... ......             ...+....+.+++..|++ +|.+||+++||++.|+.
T Consensus       237 ~~i~-~~~~~~-------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIR-NRQVLP-------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHH-cCCcCC-------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            2222 111110             011234557788999998 79999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.1e-34  Score=309.66  Aligned_cols=240  Identities=24%  Similarity=0.355  Sum_probs=183.2

Q ss_pred             CeeccccceEEEEEEEcC-------------CcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCc
Q 001527          782 EVLGRSSHGTSYRATLEN-------------GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHE  848 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  848 (1060)
                      +.||+|+||.||+|++.+             ...|++|.+........+.+.+|+.++++++||||+++++++.  ....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~--~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV--RDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCC
Confidence            468999999999998532             2358999887655555567889999999999999999999985  4557


Q ss_pred             eEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCC-------CeE
Q 001527          849 KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDL-------NAR  921 (1060)
Q Consensus       849 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~-------~~k  921 (1060)
                      .++||||+++|+|..++...    ...+++..+.+++.||+.||+||| +++|+||||||+|||++. ++       .+|
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~-~~~~~~~~~~~~  152 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLE-DKDLVHGNVCTKNILLAR-EGIDGECGPFIK  152 (262)
T ss_pred             CEEEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhh-hCCeECCCCCcccEEEec-CCccCCCCceeE
Confidence            89999999999999988543    245899999999999999999999 999999999999999973 33       289


Q ss_pred             EcccccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHH-hCCCCCCCCCCCCCccChHHHH
Q 001527          922 VADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELL-TGRCAGDVISGEGAGVDLTDWM 1000 (1060)
Q Consensus       922 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ell-tG~~p~~~~~~~~~~~~l~~~~ 1000 (1060)
                      ++|||.+.......     ...++..|+|||++.... .++.++|||||||++|||+ +|+.|+....       ..+..
T Consensus       153 l~d~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~~l~el~~~~~~p~~~~~-------~~~~~  219 (262)
T cd05077         153 LSDPGIPITVLSRQ-----ECVERIPWIAPECVEDSK-NLSIAADKWSFGTTLWEICYNGEIPLKDKT-------LAEKE  219 (262)
T ss_pred             eCCCCCCccccCcc-----cccccccccChhhhcCCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCcc-------hhHHH
Confidence            99999987553321     125788999999886433 2477999999999999997 5888875321       11111


Q ss_pred             HHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527         1001 QLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1001 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                      . .. .... .     .    ..    .....+.+++.+|++ +|.+||+++||++.+.
T Consensus       220 ~-~~-~~~~-~-----~----~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         220 R-FY-EGQC-M-----L----VT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             H-HH-hcCc-c-----C----CC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1 01 1100 0     0    00    123457788899998 7999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.9e-34  Score=318.87  Aligned_cols=250  Identities=25%  Similarity=0.385  Sum_probs=189.5

Q ss_pred             CCeeccccceEEEEEEEc-CCc--EEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NGM--FLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|+.+ ++.  .+|+|.++... ....+.+.+|++++.++ +||||+++++++.  ..+..++||||
T Consensus        12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~--~~~~~~lv~e~   89 (303)
T cd05088          12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEY   89 (303)
T ss_pred             eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC--CCCCceEEEEe
Confidence            478999999999999964 454  46788776432 33456788999999999 8999999999984  56679999999


Q ss_pred             cCCCChHHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcc
Q 001527          856 ISPGSLASFLYDRPG-----------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVAD  924 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~D  924 (1060)
                      +++++|.++++....           .....+++.+++.++.|++.||+||| ++||+||||||+|||++ +++.+||+|
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~gi~H~dlkp~Nili~-~~~~~kl~d  167 (303)
T cd05088          90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVG-ENYVAKIAD  167 (303)
T ss_pred             CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH-hCCccccccchheEEec-CCCcEEeCc
Confidence            999999999965421           12246899999999999999999999 99999999999999998 578999999


Q ss_pred             cccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHH
Q 001527          925 YCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLK 1003 (1060)
Q Consensus       925 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 1003 (1060)
                      ||+++......  ......++..|+|||++.+..+  +.++|||||||++|||+| |..||.....       .+.....
T Consensus       168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~~  236 (303)
T cd05088         168 FGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVY--TTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYEKL  236 (303)
T ss_pred             cccCcccchhh--hcccCCCcccccCHHHHhccCC--cccccchhhhhHHHHHHhcCCCCcccCCh-------HHHHHHH
Confidence            99986432111  1111234667999999876654  779999999999999998 9999864321       1222111


Q ss_pred             HhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1004 VAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1004 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                       ......+     .        .......+.+++.+|++ +|.+||++++++.+|+.
T Consensus       237 -~~~~~~~-----~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         237 -PQGYRLE-----K--------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             -hcCCcCC-----C--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence             1110000     0        00123457788999998 79999999999998865

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.8e-34  Score=320.34  Aligned_cols=240  Identities=23%  Similarity=0.315  Sum_probs=183.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHH---hcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKF---ANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .++||+|+||.||+|+.. +++.||||+++...   ....+.+.+|++++   ++++||||+++++++.  .....|+||
T Consensus         4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~--~~~~~~lv~   81 (324)
T cd05589           4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ--TEDHVCFVM   81 (324)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE--cCCEEEEEE
Confidence            468999999999999864 68999999997542   12234566676655   5678999999999985  567899999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+++++|..++..      ..+++.++..++.||+.||+||| +.||+||||||+||+++ +++.+||+|||+++....
T Consensus        82 E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH-~~~ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          82 EYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLH-ENKIVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             cCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH-hCCeEecCCCHHHeEEC-CCCcEEeCcccCCccCCC
Confidence            99999999988843      34899999999999999999999 99999999999999998 578999999999875432


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccc
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 1013 (1060)
                      .... .....|++.|+|||++.+..+  +.++|||||||++|||++|+.||....       ..+........ ..    
T Consensus       154 ~~~~-~~~~~g~~~y~aPE~~~~~~~--~~~~DiwslG~il~el~~G~~pf~~~~-------~~~~~~~i~~~-~~----  218 (324)
T cd05589         154 FGDR-TSTFCGTPEFLAPEVLTETSY--TRAVDWWGLGVLIYEMLVGESPFPGDD-------EEEVFDSIVND-EV----  218 (324)
T ss_pred             CCCc-ccccccCccccCHhHhcCCCC--CcccchhhHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhC-CC----
Confidence            2221 122368999999999987765  779999999999999999999986421       11222221111 10    


Q ss_pred             ccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHH
Q 001527         1014 DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYE 1055 (1060)
Q Consensus      1014 d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~ 1055 (1060)
                        . .+.       .....+.+++.+|++ +|.+||     ++.++++
T Consensus       219 --~-~p~-------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 --R-YPR-------FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             --C-CCC-------CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence              0 011       123456778889998 799999     4566554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=4.5e-37  Score=334.62  Aligned_cols=366  Identities=24%  Similarity=0.351  Sum_probs=261.7

Q ss_pred             CCCCcEEECcCCccc-ccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEE
Q 001527           93 LSMLVKLSMSNNSIS-GVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSL  171 (1060)
Q Consensus        93 l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  171 (1060)
                      |+.++-.|+++|.++ +..|.....+++++.|.|...++. .+|..++.|.+|++|.+++|++. .+-..++.|+.|+.+
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv   83 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV   83 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence            567788999999999 579999999999999999999998 89999999999999999999998 456778999999999


Q ss_pred             EccCCCCCC-CCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCcCCccCchhhhccCCCCeecccCCcc
Q 001527          172 DLSHNSFSG-SLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMF  250 (1060)
Q Consensus       172 ~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l  250 (1060)
                      ++.+|++.. -+|..+..|..|..||||+|++. ..|..+...+++-+|+||+|+|..++...|.+|+.|-.||||+|+ 
T Consensus        84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~Nr-  161 (1255)
T KOG0444|consen   84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNR-  161 (1255)
T ss_pred             hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccch-
Confidence            999999864 37788889999999999999995 688889999999999999999988777777777663333333333 


Q ss_pred             ccCCCcCcCCCccccccEEEccCCcccccCCCCccccCCCCCCEEEccCCccccC-CCCccCCCCccEEEccCCcCcccC
Q 001527          251 VGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGE-LPGFNFVYELQVLKLSNNRFSGFI  329 (1060)
Q Consensus       251 ~~~~~~~~l~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~p~~~~l~~L~~L~Ls~N~l~~~~  329 (1060)
                                               +....   .....+.+|++|+|++|.+... +..+-.+++|              
T Consensus       162 -------------------------Le~LP---PQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL--------------  199 (1255)
T KOG0444|consen  162 -------------------------LEMLP---PQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSL--------------  199 (1255)
T ss_pred             -------------------------hhhcC---HHHHHHhhhhhhhcCCChhhHHHHhcCccchhh--------------
Confidence                                     32211   1223334444455555444311 0011122223              


Q ss_pred             CcchhccCCCCCCeEECCCCccccccCcccccCCcEEEccCCcCcccCCCCCCCCCEEEccCCccccccccccCCCccCE
Q 001527          330 PNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEY  409 (1060)
Q Consensus       330 p~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~Ls~N~l~~~~~~~~~~~~L~~  409 (1060)
                                                        +.|.+++.+-+                   +...++.+-.+.+|..
T Consensus       200 ----------------------------------~vLhms~TqRT-------------------l~N~Ptsld~l~NL~d  226 (1255)
T KOG0444|consen  200 ----------------------------------SVLHMSNTQRT-------------------LDNIPTSLDDLHNLRD  226 (1255)
T ss_pred             ----------------------------------hhhhcccccch-------------------hhcCCCchhhhhhhhh
Confidence                                              33333332211                   1112223333456666


Q ss_pred             EEcccCeecccCCCCCcccCCCCeEEccCCcCccccchhccccCCCcEEecCCccccCccccccccCCCcceEEccCccc
Q 001527          410 LDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLL  489 (1060)
Q Consensus       410 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  489 (1060)
                      +|||.|.+. .+|+.+.++.+|+.|+||+|+|+ .+........+|++|+||.|+++ .+|..++.++.|+.|++.+|++
T Consensus       227 vDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL  303 (1255)
T KOG0444|consen  227 VDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKL  303 (1255)
T ss_pred             ccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcc
Confidence            667777666 67777777777777777777776 44445555667777777777776 4777777777777777777776


Q ss_pred             cc-cCCCCCCCCCCCcEEEccCCccccccCccccCCCCCcEEECCCCccccccCccccCCCCCCeEeccCCccc
Q 001527          490 TG-VLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFT  562 (1060)
Q Consensus       490 ~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~  562 (1060)
                      +- -+|..++.|.+|+++..++|.|. ..|+.++.+..|+.|.|+.|+|- ++|+.+.-|+.|+.|||..|.-.
T Consensus       304 ~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL  375 (1255)
T KOG0444|consen  304 TFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL  375 (1255)
T ss_pred             cccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence            53 35677777888888888888776 77888888888888888888886 67888888888888888887644

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-33  Score=309.44  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=189.8

Q ss_pred             CeeccccceEEEEEEEc-CCc--EEEEEEcccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGM--FLTVKWLREG-VAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||.||+|+.. ++.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++.  .....++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe--cCCCceEEEEeC
Confidence            46899999999999965 343  5788888753 234456788999999999 8999999999985  456789999999


Q ss_pred             CCCChHHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccc
Q 001527          857 SPGSLASFLYDRPG-----------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY  925 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Df  925 (1060)
                      ++|+|.+++.....           .....+++.++..++.|++.||+||| +.|++||||||+||+++ ++..+|++||
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH-~~~i~H~dikp~nili~-~~~~~kl~df  156 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVG-ENYVAKIADF  156 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccccceEEEc-CCCeEEECCC
Confidence            99999999975431           11235889999999999999999999 89999999999999998 5889999999


Q ss_pred             ccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHH
Q 001527          926 CLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKV 1004 (1060)
Q Consensus       926 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~ 1004 (1060)
                      |++.......  .......+..|+|||++....+  +.++|||||||++|||++ |+.||....       ..+......
T Consensus       157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~--~~~~Di~slG~il~el~~~g~~pf~~~~-------~~~~~~~~~  225 (270)
T cd05047         157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVY--TTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYEKLP  225 (270)
T ss_pred             CCccccchhh--hccCCCCccccCChHHHccCCC--CchhhHHHHHHHHHHHHcCCCCCccccC-------HHHHHHHHh
Confidence            9986332111  1111234567999999876654  779999999999999997 999986421       122222211


Q ss_pred             hcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1005 AEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1005 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      . ....+     .        .......+.+++.+|++ +|.+|||+.|++++|+.|
T Consensus       226 ~-~~~~~-----~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         226 Q-GYRLE-----K--------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             C-CCCCC-----C--------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            1 11100     0        01123457789999998 799999999999999764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.3e-33  Score=306.81  Aligned_cols=249  Identities=26%  Similarity=0.376  Sum_probs=188.0

Q ss_pred             CeeccccceEEEEEEEc----CCcEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE----NGMFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      +.||+|+||.||+|...    ++..||+|++... .....+.+.+|+.+++.++||||+++++++.. .....++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP-SEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec-CCCCcEEEEecC
Confidence            46899999999999853    2467999998543 23445788899999999999999999998753 344678999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      .+|+|.+++....    ...++..+..++.|++.||+||| +.+++||||||+||+++ +++.+||+|||+++.......
T Consensus        80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          80 KHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLA-SKKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH-hCCccccccCcceEEEc-CCCcEEECCccccccccCCcc
Confidence            9999999996432    34678888999999999999999 89999999999999998 578999999999976543221


Q ss_pred             ee---eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          937 IE---QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTG-RCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       937 ~~---~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ..   .....++..|+|||++.+..+  +.++|||||||++|||++| ..||...       ...+....... +...  
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~el~~~~~~~~~~~-------~~~~~~~~~~~-~~~~--  221 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKF--TTKSDVWSFGVLLWELMTRGAPPYPDV-------DSFDITVYLLQ-GRRL--  221 (262)
T ss_pred             eeecccccCcCCccccChhHhccCcc--chHHHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHHhc-CCCC--
Confidence            11   112245678999999877654  7899999999999999995 4555432       11222222111 1000  


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                          ..+       ......+.+++..|++ +|++||++.||+++|+++
T Consensus       222 ----~~~-------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         222 ----LQP-------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             ----CCC-------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                001       1123467889999998 799999999999999763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=316.76  Aligned_cols=245  Identities=19%  Similarity=0.277  Sum_probs=196.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHH---HHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAK---QRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .+.||+|.||.||+++.. +|+.+|+|++.+....   ..+.+.+|+++|+++. |||||.++++|.  +....++|||+
T Consensus        40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e--~~~~~~lvmEL  117 (382)
T KOG0032|consen   40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE--DPDSVYLVMEL  117 (382)
T ss_pred             hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE--cCCeEEEEEEe
Confidence            478999999999999966 5999999999765443   3468899999999998 999999999995  56689999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCC---CCCeEEcccccceeec
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP---DLNARVADYCLHRLMT  932 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~---~~~~kl~Dfg~a~~~~  932 (1060)
                      +.||.|.+.+...      .+++.++..++.|++.|++||| +.||+|||+||+|+|+...   +..+|++|||++....
T Consensus       118 ~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH-~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~  190 (382)
T KOG0032|consen  118 CEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH-SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK  190 (382)
T ss_pred             cCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence            9999999999654      2999999999999999999999 9999999999999999643   2479999999999887


Q ss_pred             cCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          933 QAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ...  .....+||+.|+|||++....+  +..+||||+||++|.|++|..||.......      ...  .+..+.. + 
T Consensus       191 ~~~--~~~~~~Gtp~y~APEvl~~~~y--~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~------~~~--~i~~~~~-~-  256 (382)
T KOG0032|consen  191 PGE--RLHTIVGTPEYVAPEVLGGRPY--GDEVDVWSIGVILYILLSGVPPFWGETEFE------IFL--AILRGDF-D-  256 (382)
T ss_pred             CCc--eEeeecCCccccCchhhcCCCC--CcccchhHHHHHHHHHhhCCCCCcCCChhH------HHH--HHHcCCC-C-
Confidence            722  2233489999999999987765  779999999999999999999997643211      111  2222222 1 


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      +        ..+..........+++..|+. +|.+|+|+.++++.
T Consensus       257 f--------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  257 F--------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             C--------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            1        112222344556667778887 89999999999863

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2e-33  Score=313.17  Aligned_cols=259  Identities=23%  Similarity=0.337  Sum_probs=194.4

Q ss_pred             CCeeccccceEEEEEEEcC-----------------CcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 001527          781 AEVLGRSSHGTSYRATLEN-----------------GMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYW  842 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  842 (1060)
                      .+.||+|+||.||+|+..+                 +..||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05051          10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT   89 (296)
T ss_pred             cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            5789999999999998542                 2468999987543 345678899999999999999999999985


Q ss_pred             CCCCCceEEEEEecCCCChHHHhhcCCCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCC
Q 001527          843 GPTQHEKLILSDYISPGSLASFLYDRPGRK------GPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP  916 (1060)
Q Consensus       843 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~  916 (1060)
                        .....++||||+++++|.+++.......      ...+++..++.++.|++.||+||| +.+|+||||||+||+++ +
T Consensus        90 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH-~~~i~H~dlkp~Nili~-~  165 (296)
T cd05051          90 --VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE-SLNFVHRDLATRNCLVG-K  165 (296)
T ss_pred             --cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH-HcCccccccchhceeec-C
Confidence              4568899999999999999997644221      236899999999999999999999 99999999999999998 5


Q ss_pred             CCCeEEcccccceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCCCCCc
Q 001527          917 DLNARVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT--GRCAGDVISGEGAG  993 (1060)
Q Consensus       917 ~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt--G~~p~~~~~~~~~~  993 (1060)
                      ++.+||+|||.++......... .....++..|+|||++.+..+  +.++|||||||++|||++  |..||....    .
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~~l~el~~~~~~~p~~~~~----~  239 (296)
T cd05051         166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF--TTKSDVWAFGVTLWEILTLCREQPYEHLT----D  239 (296)
T ss_pred             CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC--CccchhhhhHHHHHHHHhcCCCCCCCCcC----h
Confidence            7899999999988654332211 122246778999999887654  789999999999999998  667775421    1


Q ss_pred             cChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527          994 VDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       994 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ......+..............          ........+.+++.+|++ +|.+|||+.||++.|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLP----------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHHHHHhccccccccccCC----------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            112222211111111100000          001223568889999998 79999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-33  Score=311.10  Aligned_cols=240  Identities=22%  Similarity=0.351  Sum_probs=183.1

Q ss_pred             eeccccceEEEEEEEcC-------------------------CcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeee
Q 001527          783 VLGRSSHGTSYRATLEN-------------------------GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGL  837 (1060)
Q Consensus       783 ~iG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  837 (1060)
                      .||+|+||.||+|.+..                         ...||+|++..........+.+|++++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997421                         24589999876544455678899999999999999999


Q ss_pred             eeEEeCCCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCC-
Q 001527          838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP-  916 (1060)
Q Consensus       838 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~-  916 (1060)
                      ++++.  .....++||||+++|+|..++...    ...+++..+..++.||++||+||| +++|+||||||+||+++.. 
T Consensus        82 ~~~~~--~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          82 HGVCV--RGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLE-DKNLVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEE--eCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH-cCCccCCCCCcccEEEeccC
Confidence            99996  456789999999999999998542    245889999999999999999999 9999999999999999732 


Q ss_pred             -----CCCeEEcccccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHH-HhCCCCCCCCCCC
Q 001527          917 -----DLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLEL-LTGRCAGDVISGE  990 (1060)
Q Consensus       917 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~el-ltG~~p~~~~~~~  990 (1060)
                           ...+|++|||.+.......     ...++..|+|||.+.+.. .++.++|||||||++||+ ++|+.||......
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  228 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGN-SLSTAADKWSFGTTLLEICFDGEVPLKERTPS  228 (274)
T ss_pred             cccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCC-CCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence                 1248999999876433221     125778899999887643 247899999999999998 5799998643211


Q ss_pred             CCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527          991 GAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus       991 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                          ....+.    ....       .. +.       .....+.+++.+|++ +|++||+|++|++.|+
T Consensus       229 ----~~~~~~----~~~~-------~~-~~-------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 ----EKERFY----EKKH-------RL-PE-------PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ----HHHHHH----Hhcc-------CC-CC-------CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                111111    1100       00 00       112357788899998 7999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6e-34  Score=323.65  Aligned_cols=256  Identities=25%  Similarity=0.384  Sum_probs=192.3

Q ss_pred             CCCeeccccceEEEEEEE------cCCcEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEE
Q 001527          780 PAEVLGRSSHGTSYRATL------ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLI  851 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~l  851 (1060)
                      ..+.||+|+||.||+|..      .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.. .+...++
T Consensus        11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~~~~~l   89 (343)
T cd05103          11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-PGGPLMV   89 (343)
T ss_pred             ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec-CCCceEE
Confidence            368899999999999973      357899999997543 23446788999999999 68999999998853 3456789


Q ss_pred             EEEecCCCChHHHhhcCCCC------------------------------------------------------------
Q 001527          852 LSDYISPGSLASFLYDRPGR------------------------------------------------------------  871 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~------------------------------------------------------------  871 (1060)
                      ||||+++|+|.++++.....                                                            
T Consensus        90 v~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (343)
T cd05103          90 IVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQE  169 (343)
T ss_pred             EEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhh
Confidence            99999999999998653210                                                            


Q ss_pred             --CCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce-eeeccCccccc
Q 001527          872 --KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI-EQILDAGVLGY  948 (1060)
Q Consensus       872 --~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y  948 (1060)
                        ....+++.++.+++.|++.||+||| +++|+||||||+||+++ ++..+||+|||+++........ ......++..|
T Consensus       170 ~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y  247 (343)
T cd05103         170 DLYKKVLTLEDLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  247 (343)
T ss_pred             hhhhccCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCccCeEEEc-CCCcEEEEecccccccccCcchhhcCCCCCCcce
Confidence              0124788899999999999999999 99999999999999998 5789999999998865332211 11112356779


Q ss_pred             cchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChhHH
Q 001527          949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAE 1027 (1060)
Q Consensus       949 ~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 1027 (1060)
                      +|||++.+..+  +.++|||||||++|||++ |..||......      .. .......+....      .+.       
T Consensus       248 ~aPE~~~~~~~--~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~-~~~~~~~~~~~~------~~~-------  305 (343)
T cd05103         248 MAPETIFDRVY--TIQSDVWSFGVLLWEIFSLGASPYPGVKID------EE-FCRRLKEGTRMR------APD-------  305 (343)
T ss_pred             ECcHHhcCCCC--CchhhHHHHHHHHHHHHHCCCCCCCCcccc------HH-HHHHHhccCCCC------CCC-------
Confidence            99999877654  789999999999999997 99998643211      11 111122211110      011       


Q ss_pred             HHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1028 KGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1028 ~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      .....+.+++..|++ +|++|||+.||++.|+.+
T Consensus       306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            112357888999998 799999999999999753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.9e-33  Score=314.89  Aligned_cols=256  Identities=26%  Similarity=0.386  Sum_probs=194.6

Q ss_pred             ccCCCeeccccceEEEEEEEc--------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCC
Q 001527          778 RAPAEVLGRSSHGTSYRATLE--------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQH  847 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  847 (1060)
                      +...+.||+|+||.||+|+..        +...+|+|.++... ....+++.+|+++++++ +||||+++++++.  ..+
T Consensus        20 ~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--~~~   97 (307)
T cd05098          20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--QDG   97 (307)
T ss_pred             eEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--cCC
Confidence            344689999999999999742        23579999997542 33456788999999999 7999999999985  456


Q ss_pred             ceEEEEEecCCCChHHHhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCC
Q 001527          848 EKLILSDYISPGSLASFLYDRPGR-----------KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP  916 (1060)
Q Consensus       848 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~  916 (1060)
                      ..++||||+++|+|.+++......           ....+++.++.+++.|++.||+||| +.|++||||||+||+++ +
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~gi~H~dlkp~Nill~-~  175 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVT-E  175 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH-HCCcccccccHHheEEc-C
Confidence            789999999999999999764321           1235899999999999999999999 99999999999999998 5


Q ss_pred             CCCeEEcccccceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 001527          917 DLNARVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGV  994 (1060)
Q Consensus       917 ~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~  994 (1060)
                      ++.+||+|||.++......... .....++..|+|||++.+..+  +.++|||||||++|||++ |+.||...       
T Consensus       176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~DvwslG~~l~el~~~g~~p~~~~-------  246 (307)
T cd05098         176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGV-------  246 (307)
T ss_pred             CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC--CcHHHHHHHHHHHHHHHcCCCCCCCcC-------
Confidence            7899999999987654322111 111134568999999987654  789999999999999998 88887532       


Q ss_pred             ChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527          995 DLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus       995 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ...+.... .......+             ........+.+++.+|++ +|.+||+|.||++.|+.|
T Consensus       247 ~~~~~~~~-~~~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         247 PVEELFKL-LKEGHRMD-------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             CHHHHHHH-HHcCCCCC-------------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            12222222 22111110             011234567788899998 799999999999999753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.1e-33  Score=310.46  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=194.1

Q ss_pred             CCeeccccceEEEEEEEc-CC---cEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NG---MFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|+.. ++   ..+|+|.++.. .....+.+.+|++++++++||||+++++++.  ..+..++||||
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~   87 (268)
T cd05063          10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT--KFKPAMIITEY   87 (268)
T ss_pred             eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc--cCCCcEEEEEc
Confidence            578999999999999864 33   37999998754 2344577899999999999999999999984  55678999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++++|.+++....    ..+++.++..++.|++.|++||| +.+++||||||+||+++ ++..+|++|||++.......
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          88 MENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLS-DMNYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhhEEEc-CCCcEEECCCccceeccccc
Confidence            99999999996432    45899999999999999999999 99999999999999998 58899999999998665432


Q ss_pred             ceeee--ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          936 TIEQI--LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       936 ~~~~~--~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      .....  ....+..|+|||++....+  +.++|||||||++|||++ |+.||....       ..++..........   
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~Dv~slG~il~ell~~g~~p~~~~~-------~~~~~~~i~~~~~~---  229 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKF--TSASDVWSFGIVMWEVMSFGERPYWDMS-------NHEVMKAINDGFRL---  229 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCc--ChHhHHHHHHHHHHHHHhCCCCCCCcCC-------HHHHHHHHhcCCCC---
Confidence            22111  1123457999999977654  789999999999999997 999986432       12222222111000   


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                                 +...+....+.+++.+|++ +|.+||++.+|++.|+++
T Consensus       230 -----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 -----------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                       0011234567899999998 799999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.4e-34  Score=327.43  Aligned_cols=199  Identities=21%  Similarity=0.330  Sum_probs=163.8

Q ss_pred             CCCeeccccceEEEEEEE-cCCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCC---CCceEEEE
Q 001527          780 PAEVLGRSSHGTSYRATL-ENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT---QHEKLILS  853 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---~~~~~lv~  853 (1060)
                      ..+.||+|+||.||+|+. .+|+.||+|++...  .....+.+.+|+++++.++||||+++++++....   ....++||
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence            357899999999999995 47999999998643  2234567889999999999999999999985322   12689999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+. ++|.+++..     ...+++..+..++.||+.||+||| +.+|+||||||+|||++ +++.+||+|||+++....
T Consensus        84 e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          84 ELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLH-SAGILHRDIKPGNLLVN-SNCVLKICDFGLARVEEP  155 (372)
T ss_pred             eccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChHHEEEC-CCCCEEeccccceeeccc
Confidence            9996 588888743     346899999999999999999999 99999999999999998 588999999999986544


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      ..........++..|+|||++.+... ++.++||||+||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~  208 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRH-YTSAVDIWSVGCIFAELLGRRILFQAQ  208 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCC-CCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence            33222222357889999999977542 477999999999999999999999753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.4e-34  Score=310.79  Aligned_cols=251  Identities=20%  Similarity=0.233  Sum_probs=191.3

Q ss_pred             CCCeeccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          780 PAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      ..+.||+|+||.||+|+. .+++.||+|+++.......+.+.+|+.++++++||||+++++++.  .....++||||+++
T Consensus        13 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~--~~~~~~iv~e~~~~   90 (267)
T cd06646          13 LIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL--SREKLWICMEYCGG   90 (267)
T ss_pred             hhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE--eCCEEEEEEeCCCC
Confidence            357899999999999995 578999999987554444567889999999999999999999985  45688999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.++++..     ..+++.++..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||+++........ 
T Consensus        91 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~-  162 (267)
T cd06646          91 GSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLH-SKGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAK-  162 (267)
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEC-CCCCEEECcCccceeecccccc-
Confidence            9999998532     35899999999999999999999 89999999999999998 5778999999999876432221 


Q ss_pred             eeccCccccccchhcccCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          939 QILDAGVLGYRAPELAASK-KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      .....|+..|+|||.+... ...++.++|||||||++|||++|+.||.........   ..+     ...   ....+..
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~---~~~-----~~~---~~~~~~~  231 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FLM-----SKS---NFQPPKL  231 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh---eee-----ecC---CCCCCCC
Confidence            1123578899999988532 122477999999999999999999998643211100   000     000   0000111


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHh
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDL 1057 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L 1057 (1060)
                      ..      .......+.+++.+|+. +|++||++++|++.+
T Consensus       232 ~~------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 KD------KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             cc------ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00      01233567788899998 799999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.4e-33  Score=304.26  Aligned_cols=245  Identities=21%  Similarity=0.341  Sum_probs=194.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|++|.||+|+.. +++.|++|.+...  .....+.+.+|++++++++||||+++++++.  .....++||||++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~   82 (256)
T cd08529           5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL--DKGKLNIVMEYAE   82 (256)
T ss_pred             eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec--cCCEEEEEEEeCC
Confidence            468999999999999965 6899999998642  2345678899999999999999999999985  4568999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +++|.++++...   ...+++.++..++.|++.||.||| +.||+||||||+||+++ +++.+||+|||+++........
T Consensus        83 ~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH-~~~i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          83 NGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLH-SKKILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEEe-CCCCEEEcccccceeccCccch
Confidence            999999997642   346899999999999999999999 99999999999999998 5789999999998876543322


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      . ....|+..|+|||+..+...  +.++|||||||++|||++|+.||....       ..+.... ...+....      
T Consensus       158 ~-~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~-~~~~~~~~------  220 (256)
T cd08529         158 A-NTIVGTPYYLSPELCEDKPY--NEKSDVWALGVVLYECCTGKHPFDANN-------QGALILK-IIRGVFPP------  220 (256)
T ss_pred             h-hccccCccccCHHHhcCCCC--CCccchHHHHHHHHHHHhCCCCCCCCC-------HHHHHHH-HHcCCCCC------
Confidence            2 12357889999999987764  779999999999999999999986432       1111111 11111110      


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                             ........+.+++.+|++ +|++||++.|+++.
T Consensus       221 -------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         221 -------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -------CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                   011234567888999998 79999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.7e-34  Score=321.97  Aligned_cols=236  Identities=24%  Similarity=0.306  Sum_probs=180.6

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHH-HHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAK-KFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||+||+|+.. +|+.||+|++.....   ...+++..|.. +++.++||||+++++++.  ..+..++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~--~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE--eCCEEEEEEcCC
Confidence            36999999999999965 799999999875322   22334555554 567899999999999885  566889999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++..     ...+++..+..++.||+.||+||| +.||+||||||+|||++ +++.+||+|||+++.......
T Consensus        79 ~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH-~~givH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~  151 (323)
T cd05575          79 NGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLH-SLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSK  151 (323)
T ss_pred             CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCC
Confidence            99999999854     245889999999999999999999 99999999999999998 588999999999875432221


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      . .....||+.|+|||++.+..+  +.++|||||||++|||++|+.||...       +..+........ ..      .
T Consensus       152 ~-~~~~~gt~~y~aPE~~~~~~~--~~~~DvwslG~il~ell~g~~pf~~~-------~~~~~~~~i~~~-~~------~  214 (323)
T cd05575         152 T-TSTFCGTPEYLAPEVLRKQPY--DRTVDWWCLGAVLYEMLYGLPPFYSR-------DTAEMYDNILNK-PL------R  214 (323)
T ss_pred             c-cccccCChhhcChhhhcCCCC--CccccccccchhhhhhhcCCCCCCCC-------CHHHHHHHHHcC-CC------C
Confidence            1 122368999999999987765  77999999999999999999998642       122222222111 10      0


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIK 1051 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~ 1051 (1060)
                      +.+        .....+.+++.+|++ +|.+||++.
T Consensus       215 ~~~--------~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 LKP--------NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCC--------CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            111        123456778889998 799999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.3e-33  Score=309.95  Aligned_cols=252  Identities=25%  Similarity=0.361  Sum_probs=195.1

Q ss_pred             CCeeccccceEEEEEEEc------CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE------NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .++||+|+||.||+|...      ++..+|+|.++.......+.+.+|++++++++||||+++++++.  .....++|||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e   87 (280)
T cd05092          10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT--EGRPLLMVFE   87 (280)
T ss_pred             ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe--cCCceEEEEe
Confidence            578999999999999742      46789999988766666778999999999999999999999985  4567899999


Q ss_pred             ecCCCChHHHhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcc
Q 001527          855 YISPGSLASFLYDRPG----------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVAD  924 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~D  924 (1060)
                      |+++++|.+++.....          .....+++.+++.++.|++.|++||| +.+|+||||||+||+++ ++..+||+|
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~~i~H~dlkp~nil~~-~~~~~kL~d  165 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA-SLHFVHRDLATRNCLVG-QGLVVKIGD  165 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH-HCCeecccccHhhEEEc-CCCCEEECC
Confidence            9999999999975421          11135889999999999999999999 99999999999999998 588999999


Q ss_pred             cccceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHH
Q 001527          925 YCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQL 1002 (1060)
Q Consensus       925 fg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 1002 (1060)
                      ||+++......... .....+++.|+|||++.+..+  +.++|||||||++|||++ |+.||.....       .+....
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~  236 (280)
T cd05092         166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF--TTESDIWSFGVVLWEIFTYGKQPWYQLSN-------TEAIEC  236 (280)
T ss_pred             CCceeEcCCCceeecCCCccccccccCHHHhccCCc--CchhhHHHHHHHHHHHHcCCCCCCccCCH-------HHHHHH
Confidence            99997654322211 111235678999999987764  789999999999999998 8999864321       111111


Q ss_pred             HHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1003 KVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1003 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      .. .+....  .+           ......+.+++.+|++ +|.+||++.||++.|++
T Consensus       237 ~~-~~~~~~--~~-----------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         237 IT-QGRELE--RP-----------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HH-cCccCC--CC-----------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            11 111100  00           1123457788899998 79999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.3e-33  Score=308.42  Aligned_cols=248  Identities=25%  Similarity=0.410  Sum_probs=194.9

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .+.||+|+||.||+|...++..+|+|.++... ...+.+.+|++++++++|+||+++++++.  . ...+++|||+++++
T Consensus        11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~-~~~~~v~e~~~~~~   86 (260)
T cd05073          11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT--K-EPIYIITEFMAKGS   86 (260)
T ss_pred             EeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEc--C-CCeEEEEEeCCCCc
Confidence            57899999999999998778889999987542 34567889999999999999999999884  2 56899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....   ...+++.+++.++.|++.||+||| ..|++||||||+||+++ .++.+||+|||.+............
T Consensus        87 L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~  161 (260)
T cd05073          87 LLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANILVS-ASLVCKIADFGLARVIEDNEYTARE  161 (260)
T ss_pred             HHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHH-hCCccccccCcceEEEc-CCCcEEECCCcceeeccCCCccccc
Confidence            999996532   345889999999999999999999 89999999999999998 5889999999999865443222222


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||++.....  +.++|||||||++|++++ |+.||.....    ..+..+    ...+....        
T Consensus       162 ~~~~~~~y~~PE~~~~~~~--~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~----~~~~~~~~--------  223 (260)
T cd05073         162 GAKFPIKWTAPEAINFGSF--TIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRA----LERGYRMP--------  223 (260)
T ss_pred             CCcccccccCHhHhccCCc--CccccchHHHHHHHHHHhcCCCCCCCCCH----HHHHHH----HhCCCCCC--------
Confidence            2245678999999977654  779999999999999999 8999864211    111111    11111110        


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                           ........+.+++.+|++ +|++||++.++.+.|+.+
T Consensus       224 -----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         224 -----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             -----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence                 011234567888899998 799999999999999763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.1e-34  Score=322.76  Aligned_cols=239  Identities=23%  Similarity=0.303  Sum_probs=181.5

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHH-HHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAK-KFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||+||+|+.. +|+.||+|++.....   ...+.+..|.. +++.++||||+++++++.  ..+..++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~--~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe--cCCEEEEEEcCC
Confidence            36999999999999854 799999999875422   23345555655 467799999999998885  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|..++..     ...+++.++..++.||+.||+||| +.||+||||||+|||++ +++.+||+|||+++.......
T Consensus        79 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH-~~givH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~  151 (325)
T cd05604          79 NGGELFFHLQR-----ERSFPEPRARFYAAEIASALGYLH-SINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSD  151 (325)
T ss_pred             CCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCC
Confidence            99999998853     345899999999999999999999 99999999999999998 588999999999875332211


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                       ......||..|+|||++.+..+  +.++|||||||++|||++|+.||....       ..+........ ..      .
T Consensus       152 -~~~~~~gt~~y~aPE~~~~~~~--~~~~DvwslG~il~el~~G~~pf~~~~-------~~~~~~~~~~~-~~------~  214 (325)
T cd05604         152 -TTTTFCGTPEYLAPEVIRKQPY--DNTVDWWCLGAVLYEMLYGLPPFYCRD-------VAEMYDNILHK-PL------V  214 (325)
T ss_pred             -CcccccCChhhCCHHHHcCCCC--CCcCccccccceehhhhcCCCCCCCCC-------HHHHHHHHHcC-Cc------c
Confidence             1122368999999999987765  779999999999999999999986421       12222222111 00      0


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIY 1054 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl 1054 (1060)
                      ..+        .....+.+++.+|++ +|.+||++++.+
T Consensus       215 ~~~--------~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         215 LRP--------GASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCC--------CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            001        123346677889997 799999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-33  Score=310.97  Aligned_cols=248  Identities=21%  Similarity=0.345  Sum_probs=192.5

Q ss_pred             CCeeccccceEEEEEEEcC----CcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLEN----GMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .++||+|+||.||+|...+    ...||+|...... ....+.+.+|++++++++||||+++++++.   ....++||||
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~---~~~~~lv~e~   87 (270)
T cd05056          11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT---ENPVWIVMEL   87 (270)
T ss_pred             eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc---CCCcEEEEEc
Confidence            5789999999999998643    3578999887654 445678999999999999999999999884   3457899999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++|+|.+++....    ..+++.++..++.|++.||+||| +.+++||||||+||+++ .+..+|++|||+++......
T Consensus        88 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH-~~~~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          88 APLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE-SKRFVHRDIAARNVLVS-SPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             CCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccChheEEEe-cCCCeEEccCceeeeccccc
Confidence            99999999996432    35899999999999999999999 99999999999999998 57799999999998765443


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      ........++..|+|||.+....+  +.++|||||||++||+++ |+.||......    ....+    ...+....   
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~----~~~~~~~~---  228 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRF--TSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGR----IENGERLP---  228 (270)
T ss_pred             ceecCCCCccccccChhhhccCCC--CchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHH----HHcCCcCC---
Confidence            322222234568999999876654  789999999999999986 99998753211    11111    11111100   


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                        . +       ......+.+++.+|+. +|.+|||+.|+++.|+++
T Consensus       229 --~-~-------~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         229 --M-P-------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             --C-C-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              0 0       1223467778889998 799999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.2e-33  Score=312.12  Aligned_cols=247  Identities=24%  Similarity=0.385  Sum_probs=191.2

Q ss_pred             CCeeccccceEEEEEEEc-CCc----EEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGM----FLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .++||+|+||+||+|++. +++    .||+|+++.. .....+.+.+|+.+++.+.||||+++++++.   ....++++|
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~---~~~~~l~~~   88 (279)
T cd05109          12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL---TSTVQLVTQ   88 (279)
T ss_pred             eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEc---CCCcEEEEE
Confidence            578999999999999853 454    4899998753 3344567889999999999999999999985   345789999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++|+|.+++....    ..+++.+++.++.|++.||+||| +++|+||||||+||+++ ++..+||+|||+++.....
T Consensus        89 ~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH-~~~iiH~dlkp~Nil~~-~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          89 LMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLE-EVRLVHRDLAARNVLVK-SPNHVKITDFGLARLLDID  162 (279)
T ss_pred             cCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccccceEEEc-CCCcEEECCCCceeecccc
Confidence            999999999996532    35899999999999999999999 99999999999999997 5778999999999876543


Q ss_pred             Cceee-eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          935 GTIEQ-ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       935 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ..... ....++..|+|||...+..+  +.++|||||||++|||++ |+.||+....    ..+..++.    ...... 
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~----~~~~~~-  231 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRF--THQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLE----KGERLP-  231 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCC--CchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH----CCCcCC-
Confidence            22211 11234678999999977654  789999999999999998 8999864321    11222221    111100 


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                                  ........+.+++.+|++ +|++||++.|+++.|+.
T Consensus       232 ------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~  267 (279)
T cd05109         232 ------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR  267 (279)
T ss_pred             ------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                        001233467788999998 79999999999998865

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-33  Score=312.53  Aligned_cols=260  Identities=25%  Similarity=0.347  Sum_probs=192.0

Q ss_pred             CCCeeccccceEEEEEEEcC---------------CcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeC
Q 001527          780 PAEVLGRSSHGTSYRATLEN---------------GMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWG  843 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  843 (1060)
                      ..+.||+|+||.||+|+..+               ...||+|+++... ......+.+|++++++++||||+++++++. 
T Consensus         9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-   87 (295)
T cd05097           9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV-   87 (295)
T ss_pred             ehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEc-
Confidence            35789999999999997532               2358999987542 334567999999999999999999999995 


Q ss_pred             CCCCceEEEEEecCCCChHHHhhcCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCC
Q 001527          844 PTQHEKLILSDYISPGSLASFLYDRPG-------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP  916 (1060)
Q Consensus       844 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~  916 (1060)
                       .....++||||+++++|.+++.....       .....+++.++..++.|++.||+||| +.+++||||||+||+++ +
T Consensus        88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~Nill~-~  164 (295)
T cd05097          88 -SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA-SLNFVHRDLATRNCLVG-N  164 (295)
T ss_pred             -CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH-hcCeeccccChhhEEEc-C
Confidence             56678999999999999999965321       11134789999999999999999999 99999999999999998 5


Q ss_pred             CCCeEEcccccceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCCCCCc
Q 001527          917 DLNARVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT--GRCAGDVISGEGAG  993 (1060)
Q Consensus       917 ~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt--G~~p~~~~~~~~~~  993 (1060)
                      ++.+||+|||++.......... .....++..|+|||+..+..+  +.++|||||||++|||++  |..||......   
T Consensus       165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~---  239 (295)
T cd05097         165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF--TTASDVWAFGVTLWEMFTLCKEQPYSLLSDE---  239 (295)
T ss_pred             CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc--CchhhHHHHHHHHHHHHHcCCCCCCcccChH---
Confidence            7899999999997654332211 111235678999999887664  789999999999999998  56676643211   


Q ss_pred             cChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527          994 VDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       994 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                       ....................   .       .......+.+++.+|++ +|.+||+|++|++.|+.
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~---~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 -QVIENTGEFFRNQGRQIYLS---Q-------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             -HHHHHHHHhhhhccccccCC---C-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence             11111111111100000000   0       01123578899999998 79999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.6e-34  Score=321.62  Aligned_cols=240  Identities=23%  Similarity=0.267  Sum_probs=180.9

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHH-HHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEA-KKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      +.||+|+||+||+|+.. +++.||+|++.....   .....+..|. .+++.++||||+++++++.  ..+..++||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~--~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE--cCCeEEEEEeCC
Confidence            36999999999999965 678999999875321   2223444444 4567889999999999885  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+.+.++..++.||+.||+||| +.||+||||||+|||++ +++.+||+|||+++.......
T Consensus        79 ~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH-~~giiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~  151 (325)
T cd05602          79 NGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH-SLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNG  151 (325)
T ss_pred             CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCC
Confidence            999999999542     35788889999999999999999 99999999999999998 578999999999875432221


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      . .....||+.|+|||++.+..+  +.++||||+||++|||++|+.||....       ..+........ ..      .
T Consensus       152 ~-~~~~~gt~~y~aPE~~~~~~~--~~~~DiwslG~il~el~~g~~pf~~~~-------~~~~~~~i~~~-~~------~  214 (325)
T cd05602         152 T-TSTFCGTPEYLAPEVLHKQPY--DRTVDWWCLGAVLYEMLYGLPPFYSRN-------TAEMYDNILNK-PL------Q  214 (325)
T ss_pred             C-cccccCCccccCHHHHcCCCC--CCccccccccHHHHHHhcCCCCCCCCC-------HHHHHHHHHhC-Cc------C
Confidence            1 122368999999999987765  779999999999999999999986421       12222222111 00      0


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ..        ......+.+++.+|++ +|.+||++.+.+.
T Consensus       215 ~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         215 LK--------PNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CC--------CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            00        1223456677779998 7999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.6e-33  Score=309.07  Aligned_cols=248  Identities=20%  Similarity=0.286  Sum_probs=191.6

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      ..||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++||||+++++++.  .++..++|+||+++++
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~   91 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS--ENGFFKIFMEQVPGGS   91 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec--cCCEEEEEEecCCCCC
Confidence            57999999999999954 68889999987665666778999999999999999999999985  5678999999999999


Q ss_pred             hHHHhhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          861 LASFLYDRPGRKGPPL--TWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l--~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      |.+++....    ..+  ++..+..++.||+.||+||| +.+|+||||||+||+++.++..+||+|||.+......... 
T Consensus        92 L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-  165 (268)
T cd06624          92 LSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLH-DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-  165 (268)
T ss_pred             HHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-
Confidence            999996532    224  78888999999999999999 9999999999999999754678999999998765432221 


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      .....|+..|+|||++.+....++.++||||||+++|+|++|+.||......    ....|......       ..+.+ 
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~----~~~~~~~~~~~-------~~~~~-  233 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP----QAAMFKVGMFK-------IHPEI-  233 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh----hhhHhhhhhhc-------cCCCC-
Confidence            1123578999999998765544578999999999999999999998642111    11111110000       00001 


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                             .......+.+++.+|++ +|.+|||+.||++.
T Consensus       234 -------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         234 -------PESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             -------CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                   11223456778889998 79999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-33  Score=313.52  Aligned_cols=250  Identities=28%  Similarity=0.397  Sum_probs=189.5

Q ss_pred             CCeeccccceEEEEEEEc-CC--cEEEEEEcccc-hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NG--MFLTVKWLREG-VAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .++||+|+||.||+|... ++  ..+++|.++.. .....+.+.+|++++.++ +||||+++++++.  .....++||||
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~~~~~~lv~e~   84 (297)
T cd05089           7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE--NRGYLYIAIEY   84 (297)
T ss_pred             eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc--cCCcceEEEEe
Confidence            478999999999999865 34  34788888743 233456789999999999 7999999999984  45678999999


Q ss_pred             cCCCChHHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcc
Q 001527          856 ISPGSLASFLYDRPG-----------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVAD  924 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~D  924 (1060)
                      +++++|.+++.....           .....+++.++..|+.|++.||+||| ++||+||||||+||+++ ++..+||+|
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH-~~~ivH~dlkp~Nill~-~~~~~kl~d  162 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS-EKQFIHRDLAARNVLVG-ENLASKIAD  162 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCcCCcceEEEC-CCCeEEECC
Confidence            999999999965321           11235889999999999999999999 99999999999999998 578999999


Q ss_pred             cccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHH
Q 001527          925 YCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLK 1003 (1060)
Q Consensus       925 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~ 1003 (1060)
                      ||++.......  .......+..|+|||+..+..+  +.++|||||||++|||++ |+.||....       ..++....
T Consensus       163 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~--~~~~DvwSlG~il~el~t~g~~pf~~~~-------~~~~~~~~  231 (297)
T cd05089         163 FGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVY--TTKSDVWSFGVLLWEIVSLGGTPYCGMT-------CAELYEKL  231 (297)
T ss_pred             cCCCcccccee--ccCCCCcCccccCchhhccCCC--CchhhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHH
Confidence            99986432211  1111123567999999877654  779999999999999997 999986432       12222221


Q ss_pred             HhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1004 VAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1004 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      .. +..     +.. +       ......+.+++.+|++ +|.+||++++|+++|+.
T Consensus       232 ~~-~~~-----~~~-~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  274 (297)
T cd05089         232 PQ-GYR-----MEK-P-------RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR  274 (297)
T ss_pred             hc-CCC-----CCC-C-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            11 100     000 0       1223457788999998 79999999999999875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.5e-33  Score=314.74  Aligned_cols=252  Identities=24%  Similarity=0.350  Sum_probs=194.0

Q ss_pred             cCCCeeccccceEEEEEEEc------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceE
Q 001527          779 APAEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKL  850 (1060)
Q Consensus       779 ~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~  850 (1060)
                      ...+.||+|+||.||+|+..      .+..||+|+++... ....+.+.+|+++++++ +||||+++++++.  ..+..+
T Consensus        38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~~~~  115 (302)
T cd05055          38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT--IGGPIL  115 (302)
T ss_pred             EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe--cCCceE
Confidence            34689999999999999741      35689999987542 33456789999999999 7999999999985  456789


Q ss_pred             EEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          851 ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       851 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      +||||+++|+|.++++...   ...+++.++..++.|++.||+||| +.+|+||||||+||+++ ++..+|++|||+++.
T Consensus       116 lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH-~~~ivH~dlkp~Nil~~-~~~~~~l~dfg~~~~  190 (302)
T cd05055         116 VITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNVLLT-HGKIVKICDFGLARD  190 (302)
T ss_pred             EEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH-HCCeehhhhccceEEEc-CCCeEEECCCccccc
Confidence            9999999999999996532   234899999999999999999999 99999999999999998 578999999999986


Q ss_pred             eccCCce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCC
Q 001527          931 MTQAGTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008 (1060)
Q Consensus       931 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 1008 (1060)
                      ....... ......++..|+|||++.+..+  +.++||||+||++|||++ |+.||......       +-.......+.
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~DiwslGvil~el~t~g~~p~~~~~~~-------~~~~~~~~~~~  261 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVY--TFESDVWSYGILLWEIFSLGSNPYPGMPVD-------SKFYKLIKEGY  261 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCC--CcHhHHHHHHHHHHHHHhCCCCCcCCCCch-------HHHHHHHHcCC
Confidence            5443221 1111245678999999987764  789999999999999998 99998643211       11111111111


Q ss_pred             CCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1009 GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1009 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ...      .+       ......+.+++.+|+. +|++|||+.||++.|++
T Consensus       262 ~~~------~~-------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         262 RMA------QP-------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             cCC------CC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            000      00       1123467889999998 79999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-33  Score=313.89  Aligned_cols=259  Identities=23%  Similarity=0.335  Sum_probs=192.7

Q ss_pred             CCeeccccceEEEEEEEc-----------------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-----------------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYW  842 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  842 (1060)
                      .+.||+|+||.||+|+..                 ++..||+|+++... ....+++.+|++++++++||||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05095          10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI   89 (296)
T ss_pred             eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            578999999999998632                 24579999997542 334578999999999999999999999985


Q ss_pred             CCCCCceEEEEEecCCCChHHHhhcCCCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCC
Q 001527          843 GPTQHEKLILSDYISPGSLASFLYDRPGR------KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP  916 (1060)
Q Consensus       843 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~  916 (1060)
                        ..+..++||||+++++|.+++......      ....+++.++..++.|++.||+||| +.||+||||||+||+++ +
T Consensus        90 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dlkp~Nili~-~  165 (296)
T cd05095          90 --TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS-SLNFVHRDLATRNCLVG-K  165 (296)
T ss_pred             --cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH-HCCeecccCChheEEEc-C
Confidence              456789999999999999999764311      1235788999999999999999999 99999999999999998 5


Q ss_pred             CCCeEEcccccceeeccCCceee-eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCCCCCc
Q 001527          917 DLNARVADYCLHRLMTQAGTIEQ-ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT--GRCAGDVISGEGAG  993 (1060)
Q Consensus       917 ~~~~kl~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt--G~~p~~~~~~~~~~  993 (1060)
                      ++.+||+|||+++.......... ....++..|+|||+..+..+  +.++|||||||++|||++  |..||......   
T Consensus       166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~--~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~---  240 (296)
T cd05095         166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF--TTASDVWAFGVTLWEILTLCKEQPYSQLSDE---  240 (296)
T ss_pred             CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc--cchhhhhHHHHHHHHHHHhCCCCCccccChH---
Confidence            88999999999986544322111 11234678999998877654  789999999999999998  67787643221   


Q ss_pred             cChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527          994 VDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       994 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                       ................ ...+         ........+.+++.+|++ +|.+||++.||++.|++
T Consensus       241 -~~~~~~~~~~~~~~~~-~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 -QVIENTGEFFRDQGRQ-VYLP---------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             -HHHHHHHHHHhhcccc-ccCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence             1111111111111000 0000         011233567889999998 79999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.6e-33  Score=315.62  Aligned_cols=202  Identities=23%  Similarity=0.297  Sum_probs=162.1

Q ss_pred             CCeeccccceEEEEEEEc---CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE---NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      +.+||+|+||+||+|+..   ++..||+|.++...  ....+.+|++++++++||||+++++++........++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999865   45789999987542  2345778999999999999999999987666677899999986


Q ss_pred             CCChHHHhhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEee---CCCCCeEEccccccee
Q 001527          858 PGSLASFLYDRPG----RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD---GPDLNARVADYCLHRL  930 (1060)
Q Consensus       858 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~---~~~~~~kl~Dfg~a~~  930 (1060)
                       ++|.+++.....    .....+++..+..++.||+.||+||| +.+|+||||||+||++.   .+++.+||+|||+++.
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH-hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence             578887753211    12245889999999999999999999 99999999999999993   2456899999999987


Q ss_pred             eccCCce--eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          931 MTQAGTI--EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       931 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      .......  ......||..|+|||++.+... ++.++|||||||++|||+||+.||...
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCc-cCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            6543221  1122367899999999876442 478999999999999999999999743

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-33  Score=308.34  Aligned_cols=248  Identities=27%  Similarity=0.409  Sum_probs=194.5

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .++||+|+||.||+|..++++.||+|.+.... ...+++.+|++++++++||||+++++++.  .....++||||+++++
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~~   87 (261)
T cd05034          11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS--EEEPIYIVTEYMSKGS   87 (261)
T ss_pred             eeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee--cCCceEEEEeccCCCC
Confidence            57899999999999998888899999987543 23467899999999999999999999884  4567899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....   ...+++.++..++.|++.|++||| +.+++||||||+||+++ ++..+|++|||.++...........
T Consensus        88 L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh-~~~i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~  162 (261)
T cd05034          88 LLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE-SRNYIHRDLAARNILVG-ENLVCKIADFGLARLIEDDEYTARE  162 (261)
T ss_pred             HHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcchheEEEc-CCCCEEECccccceeccchhhhhhh
Confidence            999996543   245899999999999999999999 99999999999999998 5789999999998876542221111


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++..|+|||.+.+...  +.++||||+||++||+++ |+.||....       ..+...........          
T Consensus       163 ~~~~~~~y~~PE~~~~~~~--~~~~Di~slG~il~~l~t~g~~p~~~~~-------~~~~~~~~~~~~~~----------  223 (261)
T cd05034         163 GAKFPIKWTAPEAANYGRF--TIKSDVWSFGILLTEIVTYGRVPYPGMT-------NREVLEQVERGYRM----------  223 (261)
T ss_pred             ccCCCccccCHHHhccCCc--CchhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHcCCCC----------
Confidence            1234568999999987654  779999999999999998 999985421       11111111111000          


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                          +........+.+++.+|++ +|++||+++++++.|+.
T Consensus       224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 ----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                0001123467888999998 79999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-33  Score=307.70  Aligned_cols=252  Identities=25%  Similarity=0.367  Sum_probs=194.7

Q ss_pred             CCeeccccceEEEEEEEc------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.  .....++||
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~~v~   88 (277)
T cd05032          11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--TGQPTLVVM   88 (277)
T ss_pred             EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc--CCCCcEEEE
Confidence            578999999999999864      24789999987543 344567889999999999999999999985  457789999


Q ss_pred             EecCCCChHHHhhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccc
Q 001527          854 DYISPGSLASFLYDRPGR-----KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLH  928 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a  928 (1060)
                      ||+++|+|.+++......     ....+++..+..++.|++.||.||| +.+|+||||||+||+++ +++.+||+|||++
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~di~p~nill~-~~~~~kl~dfg~~  166 (277)
T cd05032          89 ELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA-AKKFVHRDLAARNCMVA-EDLTVKIGDFGMT  166 (277)
T ss_pred             ecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccChheEEEc-CCCCEEECCcccc
Confidence            999999999999654321     1235789999999999999999999 99999999999999998 5889999999998


Q ss_pred             eeeccCCce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhc
Q 001527          929 RLMTQAGTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAE 1006 (1060)
Q Consensus       929 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 1006 (1060)
                      +........ ......++..|+|||.+.+...  +.++|||||||++||+++ |+.||.....    .....+.    ..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~~~----~~  236 (277)
T cd05032         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVF--TTKSDVWSFGVVLWEMATLAEQPYQGLSN----EEVLKFV----ID  236 (277)
T ss_pred             hhhccCcccccCCCCCccccccCHHHHhcCCC--CcccchHHHHHHHHHhhccCCCCCccCCH----HHHHHHH----hc
Confidence            765443221 1122346788999999876654  779999999999999998 9999864221    1111211    11


Q ss_pred             CCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1007 GHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1007 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ......      +       ......+.+++.+|++ +|.+|||+.|+++.|++
T Consensus       237 ~~~~~~------~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         237 GGHLDL------P-------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CCCCCC------C-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            111110      0       1124567889999998 79999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.4e-33  Score=323.19  Aligned_cols=248  Identities=20%  Similarity=0.229  Sum_probs=188.6

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.  +....++||||+
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--~~~~~~lv~Ey~  125 (371)
T cd05622          48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ--DDRYLYMVMEYM  125 (371)
T ss_pred             EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--cCCEEEEEEcCC
Confidence            578999999999999965 68999999986432   223456789999999999999999999885  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...      .+++..+..++.||+.||+||| +++|+||||||+|||++ .++.+||+|||+++.......
T Consensus       126 ~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         126 PGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH-HCCEEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCcCCc
Confidence            999999998542      3788889999999999999999 99999999999999998 588999999999987654433


Q ss_pred             eeeeccCccccccchhcccCCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          937 IEQILDAGVLGYRAPELAASKK--PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      .......||+.|+|||++.+..  ..++.++|||||||++|||++|+.||....       .................  
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~--  268 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-------LVGTYSKIMNHKNSLTF--  268 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCcccC--
Confidence            3323347999999999987543  124789999999999999999999997421       11112221111111110  


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhccCCC---CCCCHHHHHHH
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIRSVS---ERPGIKTIYED 1056 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~~p~---~RPs~~evl~~ 1056 (1060)
                               +........+.+++..|+.+|.   .||+++|+++.
T Consensus       269 ---------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         269 ---------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             ---------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence                     0011233456667778887543   37899998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1e-33  Score=315.12  Aligned_cols=247  Identities=20%  Similarity=0.311  Sum_probs=192.6

Q ss_pred             ccCCCeeccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          778 RAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      +...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++.  .....++||||+
T Consensus        22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~--~~~~~~lv~e~~   99 (296)
T cd06654          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVMEYL   99 (296)
T ss_pred             eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE--eCCEEEEeeccc
Confidence            33457899999999999985 468999999987655555677889999999999999999999985  456899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++..      ..+++.++..++.|++.||+||| ..||+||||||+||+++ +++.+||+|||.+........
T Consensus       100 ~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH-~~gi~H~dLkp~Nill~-~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654         100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             CCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEc-CCCCEEECccccchhcccccc
Confidence            99999999853      24789999999999999999999 99999999999999998 588999999999876543322


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      . .....|++.|+|||.+.+...  +.++|||||||++|+|++|+.||.....      ...+.. ..... ..     .
T Consensus       172 ~-~~~~~~~~~y~aPE~~~~~~~--~~~~Dv~s~Gvil~~l~~g~~pf~~~~~------~~~~~~-~~~~~-~~-----~  235 (296)
T cd06654         172 K-RSTMVGTPYWMAPEVVTRKAY--GPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYL-IATNG-TP-----E  235 (296)
T ss_pred             c-cCcccCCccccCHHHHcCCCC--CccchHHHHHHHHHHHHhCCCCCCCCCH------HHhHHH-HhcCC-CC-----C
Confidence            1 122368889999999987654  7799999999999999999999964321      111111 11110 00     0


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      +      +........+.+++.+|+. +|++||++.||++.
T Consensus       236 ~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         236 L------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             C------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0      0011233456788889998 79999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-33  Score=308.59  Aligned_cols=241  Identities=20%  Similarity=0.344  Sum_probs=184.1

Q ss_pred             CeeccccceEEEEEEEcC--------CcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          782 EVLGRSSHGTSYRATLEN--------GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      +.||+|+||.||+|....        ...||+|.+........+.+.+|+.++++++||||+++++++.  .+...++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV--CGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE--eCCCcEEEE
Confidence            469999999999998532        2348888887655555678889999999999999999999996  456789999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCC-------eEEcccc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLN-------ARVADYC  926 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~-------~kl~Dfg  926 (1060)
                      ||+++|+|.+++....    ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++..       +|++|||
T Consensus        79 e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH-~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          79 EYVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLE-DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             ecCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence            9999999999996532    35899999999999999999999 9999999999999999743322       6999999


Q ss_pred             cceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCC-CCCCCCCCCCCccChHHHHHHHHh
Q 001527          927 LHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR-CAGDVISGEGAGVDLTDWMQLKVA 1005 (1060)
Q Consensus       927 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~-~p~~~~~~~~~~~~l~~~~~~~~~ 1005 (1060)
                      .+.......     ...++..|+|||++.+... ++.++|||||||++|||++|. .|+....       ....... ..
T Consensus       154 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~~l~~l~~g~~~~~~~~~-------~~~~~~~-~~  219 (258)
T cd05078         154 ISITVLPKE-----ILLERIPWVPPECIENPQN-LSLAADKWSFGTTLWEIFSGGDKPLSALD-------SQKKLQF-YE  219 (258)
T ss_pred             cccccCCch-----hccccCCccCchhccCCCC-CCchhhHHHHHHHHHHHHcCCCCChhhcc-------HHHHHHH-HH
Confidence            886543321     1257889999999976432 477999999999999999995 5554321       1111111 11


Q ss_pred             cCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527         1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1006 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                      ..  ..     + +       .....++.+++.+|++ +|++|||++|+++.|+
T Consensus       220 ~~--~~-----~-~-------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 DR--HQ-----L-P-------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cc--cc-----C-C-------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            10  00     0 0       0123457888999998 7999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.6e-34  Score=320.58  Aligned_cols=236  Identities=23%  Similarity=0.304  Sum_probs=179.9

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHH-HHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAK-KFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|.. +++.++||||+++++++.  +.+..++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ--TAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCEEEEEEcCC
Confidence            46999999999999965 689999999875322   22344555554 678899999999998884  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|..++..     ...+++.++..++.||+.||+||| +.+|+||||||+||+++ .++.+||+|||+++.......
T Consensus        79 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH-~~~ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~  151 (321)
T cd05603          79 NGGELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLH-SLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEE  151 (321)
T ss_pred             CCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCC
Confidence            99999998853     245888999999999999999999 99999999999999998 578999999999875322221


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      . .....||+.|+|||++.+..+  +.++|||||||++|||++|+.||...       +.......... ...      .
T Consensus       152 ~-~~~~~gt~~y~aPE~~~~~~~--~~~~DiwslG~il~el~~g~~pf~~~-------~~~~~~~~i~~-~~~------~  214 (321)
T cd05603         152 T-TSTFCGTPEYLAPEVLRKEPY--DRTVDWWCLGAVLYEMLYGLPPFYSR-------DVSQMYDNILH-KPL------Q  214 (321)
T ss_pred             c-cccccCCcccCCHHHhcCCCC--CCcCcccccchhhhhhhcCCCCCCCC-------CHHHHHHHHhc-CCC------C
Confidence            1 122368999999999987665  77999999999999999999998642       12222221111 100      0


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIK 1051 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~ 1051 (1060)
                       .+       ......+.+++.+|++ +|.+||++.
T Consensus       215 -~~-------~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 -LP-------GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -CC-------CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             00       1223456778889998 799999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2e-33  Score=309.94  Aligned_cols=253  Identities=26%  Similarity=0.362  Sum_probs=192.0

Q ss_pred             CCeeccccceEEEEEEEc------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|.+.      .+..||+|.+.... ......+.+|+.++++++||||+++++++.  +....++||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~   88 (277)
T cd05036          11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF--ERLPRFILL   88 (277)
T ss_pred             eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCCcEEEE
Confidence            478999999999999864      36789999887443 334567899999999999999999999885  455789999


Q ss_pred             EecCCCChHHHhhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCC--CCCeEEcccccce
Q 001527          854 DYISPGSLASFLYDRPG--RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP--DLNARVADYCLHR  929 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~--~~~~kl~Dfg~a~  929 (1060)
                      ||+++++|.+++.....  .....+++.++.+++.||+.||+||| +++++||||||+||+++..  +..+||+|||+++
T Consensus        89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~  167 (277)
T cd05036          89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE-ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR  167 (277)
T ss_pred             ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccchheEEEeccCCCcceEeccCcccc
Confidence            99999999999976431  11235899999999999999999999 8999999999999999732  2469999999998


Q ss_pred             eeccCCceee-eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcC
Q 001527          930 LMTQAGTIEQ-ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEG 1007 (1060)
Q Consensus       930 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 1007 (1060)
                      .......... .....+..|+|||++.+..+  +.++|||||||++|||++ |+.||+....       .+.........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~DiwslG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~~  238 (277)
T cd05036         168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIF--TSKTDVWSFGVLLWEIFSLGYMPYPGRTN-------QEVMEFVTGGG  238 (277)
T ss_pred             ccCCccceecCCCCCccHhhCCHHHHhcCCc--CchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcCC
Confidence            7633222111 11123567999999987665  889999999999999997 9999874321       12222111111


Q ss_pred             CCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1008 HGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1008 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      .. +         .    .......+.+++.+|++ +|++||++.||++.|+.
T Consensus       239 ~~-~---------~----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         239 RL-D---------P----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             cC-C---------C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            10 0         0    01223567888999998 79999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.5e-33  Score=307.07  Aligned_cols=246  Identities=21%  Similarity=0.382  Sum_probs=192.5

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .+.||+|+||.||+|.+.++..+|+|+++.... ....+.+|++++++++||||+++++++.  .....++||||+++++
T Consensus         9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~~~~   85 (256)
T cd05112           9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCT--ERSPICLVFEFMEHGC   85 (256)
T ss_pred             EeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEc--cCCceEEEEEcCCCCc
Confidence            478999999999999987788999999875422 3457889999999999999999999984  5567899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++....    ..+++..+..++.|++.|++||| +.+++||||||+||+++ .+..+||+|||.++...........
T Consensus        86 L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH-~~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~  159 (256)
T cd05112          86 LSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLE-SSNVIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSST  159 (256)
T ss_pred             HHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH-HCCccccccccceEEEc-CCCeEEECCCcceeecccCcccccC
Confidence            999996432    35789999999999999999999 99999999999999998 5789999999998865433222111


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...++.+|+|||++.+..+  +.++||||||+++|||++ |+.||....       ..+..... ..+  .....+..  
T Consensus       160 ~~~~~~~~~aPe~~~~~~~--~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~-~~~--~~~~~~~~--  225 (256)
T cd05112         160 GTKFPVKWSSPEVFSFSKY--SSKSDVWSFGVLMWEVFSEGKTPYENRS-------NSEVVETI-NAG--FRLYKPRL--  225 (256)
T ss_pred             CCccchhhcCHhHhccCCc--ChHHHHHHHHHHHHHHHcCCCCCCCcCC-------HHHHHHHH-hCC--CCCCCCCC--
Confidence            2235678999999987654  779999999999999998 999986421       12222221 111  11111111  


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                               ....+.+++.+|++ +|++||+++||+++|.
T Consensus       226 ---------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 ---------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ---------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                     23567889999998 7999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.9e-33  Score=308.88  Aligned_cols=245  Identities=22%  Similarity=0.368  Sum_probs=189.2

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .++||+|+||.||+|+. .+++.||+|++... .....+.+.+|++++++++||||+++++++.  ..+..++||||+++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~   83 (279)
T cd06619           6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF--VENRISICTEFMDG   83 (279)
T ss_pred             eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE--ECCEEEEEEecCCC
Confidence            46899999999999985 47899999998654 2334567889999999999999999999995  45678999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|..+.         .+++..+..++.|++.||+||| +.||+|+||||+||+++ .++.+||+|||++........  
T Consensus        84 ~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~~--  150 (279)
T cd06619          84 GSLDVYR---------KIPEHVLGRIAVAVVKGLTYLW-SLKILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIA--  150 (279)
T ss_pred             CChHHhh---------cCCHHHHHHHHHHHHHHHHHHH-HCCEeeCCCCHHHEEEC-CCCCEEEeeCCcceecccccc--
Confidence            9997653         3678889999999999999999 99999999999999998 588999999999976543221  


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                       ....|+..|+|||++.+..+  +.++|||||||++|+|++|+.||..............+....... .     .+...
T Consensus       151 -~~~~~~~~y~aPE~~~~~~~--~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~  221 (279)
T cd06619         151 -KTYVGTNAYMAPERISGEQY--GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-D-----PPVLP  221 (279)
T ss_pred             -cCCCCChhhcCceeecCCCC--CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-C-----CCCCC
Confidence             12368999999999987664  789999999999999999999997543322211111222111111 0     01110


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .       ......+.+++.+|++ +|++||+++|+++.
T Consensus       222 ~-------~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 V-------GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             C-------CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0       1123457788889998 79999999999764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-33  Score=303.22  Aligned_cols=250  Identities=27%  Similarity=0.422  Sum_probs=196.7

Q ss_pred             CeeccccceEEEEEEEcC----CcEEEEEEcccchHH-HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLEN----GMFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||.||+|....    +..|++|+++..... ..+.+.+|++.+++++|+||+++++++.  .....++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT--EEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec--CCCceEEEEEec
Confidence            469999999999999653    889999999765433 3678899999999999999999999985  467899999999


Q ss_pred             CCCChHHHhhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeec
Q 001527          857 SPGSLASFLYDRPGR----KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT  932 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~  932 (1060)
                      ++++|.+++......    ....+++.++..++.|++.||+||| +++|+||||||+||+++ +++.+||+|||.+....
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~di~p~nili~-~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA-SKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVY  156 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH-cCCcccCccCcceEEEC-CCCcEEEcccccccccc
Confidence            999999999664211    1356899999999999999999999 89999999999999998 57899999999998766


Q ss_pred             cCCc-eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCC
Q 001527          933 QAGT-IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGS 1010 (1060)
Q Consensus       933 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 1010 (1060)
                      .... .......++..|+|||.+....+  +.++||||+||++|||++ |+.||....       ..+...... .....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~~~~~~-~~~~~  226 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIF--TSKSDVWSFGVLLWEIFTLGATPYPGLS-------NEEVLEYLR-KGYRL  226 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCc--chhhccHHHHHHHHHHHhcCCCCCCCCC-------HHHHHHHHH-cCCCC
Confidence            5431 11222357889999999987654  789999999999999999 699987531       112222111 11110


Q ss_pred             cccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527         1011 DCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1011 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                      .             .......++.+++.+|++ +|.+|||+.|+++.|+
T Consensus       227 ~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 P-------------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             C-------------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            0             011224567888999998 7999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5e-33  Score=312.50  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=192.8

Q ss_pred             CCCeeccccceEEEEEEEc--------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCce
Q 001527          780 PAEVLGRSSHGTSYRATLE--------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEK  849 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~  849 (1060)
                      ..+.||+|+||.||+|+..        ....+|+|.++... ......+.+|+++++++ +||||+++++++.  .....
T Consensus        16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~~~   93 (314)
T cd05099          16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--QEGPL   93 (314)
T ss_pred             eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--cCCce
Confidence            4689999999999999742        34679999987542 33456788999999999 6999999999985  45678


Q ss_pred             EEEEEecCCCChHHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCC
Q 001527          850 LILSDYISPGSLASFLYDRPG-----------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDL  918 (1060)
Q Consensus       850 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~  918 (1060)
                      ++||||+++|+|.+++.....           .....+++.++.+++.|++.||+||| ++||+||||||+||+++ +++
T Consensus        94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~gi~H~dlkp~Nill~-~~~  171 (314)
T cd05099          94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE-SRRCIHRDLAARNVLVT-EDN  171 (314)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH-HCCeeeccccceeEEEc-CCC
Confidence            999999999999999976431           12245899999999999999999999 99999999999999998 578


Q ss_pred             CeEEcccccceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccCh
Q 001527          919 NARVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDL  996 (1060)
Q Consensus       919 ~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l  996 (1060)
                      .+||+|||.++......... .....++..|+|||++.+..+  +.++|||||||++|||++ |+.||....       .
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~DiwslG~~l~el~~~g~~p~~~~~-------~  242 (314)
T cd05099         172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY--THQSDVWSFGILMWEIFTLGGSPYPGIP-------V  242 (314)
T ss_pred             cEEEccccccccccccccccccccCCCCccccCHHHHccCCc--CccchhhHHHHHHHHHHhCCCCCCCCCC-------H
Confidence            99999999998654322111 111134567999999987654  789999999999999999 888886421       1


Q ss_pred             HHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527          997 TDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       997 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      .+... ........+.             ......++.+++.+|++ +|++||++.|+++.|++
T Consensus       243 ~~~~~-~~~~~~~~~~-------------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~  292 (314)
T cd05099         243 EELFK-LLREGHRMDK-------------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK  292 (314)
T ss_pred             HHHHH-HHHcCCCCCC-------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            11111 1222111110             01223467788899998 79999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.4e-33  Score=318.26  Aligned_cols=236  Identities=23%  Similarity=0.311  Sum_probs=181.7

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCC-ceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHP-NVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|++++..++|+ +|+++++++.  ..+..|+||||
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~   82 (324)
T cd05587           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDRLYFVMEY   82 (324)
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE--cCCEEEEEEcC
Confidence            478999999999999865 57899999987542   23346678899999999764 5888888874  56689999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++|+|.+++...     ..+++.++..++.||+.||+||| ++||+||||||+|||++ +++.+||+|||+++......
T Consensus        83 ~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          83 VNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEEc-CCCCEEEeecCcceecCCCC
Confidence            9999999998542     35889999999999999999999 99999999999999998 57899999999987533222


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      .. .....||+.|+|||++.+..+  +.++||||+||++|||+||+.||.....       .+...... ....      
T Consensus       156 ~~-~~~~~gt~~y~aPE~~~~~~~--~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~-~~~~------  218 (324)
T cd05587         156 KT-TRTFCGTPDYIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQPPFDGEDE-------DELFQSIM-EHNV------  218 (324)
T ss_pred             Cc-eeeecCCccccChhhhcCCCC--CcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHH-cCCC------
Confidence            21 122368999999999987765  7799999999999999999999974311       11111111 1110      


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGI 1050 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~ 1050 (1060)
                      .. +       ......+.+++.+|++ +|.+||++
T Consensus       219 ~~-~-------~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 SY-P-------KSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CC-C-------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            00 0       1123456778889998 79999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3e-33  Score=309.70  Aligned_cols=258  Identities=22%  Similarity=0.352  Sum_probs=198.0

Q ss_pred             CCeeccccceEEEEEEEc-----CCcEEEEEEcccchHH-HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-----NGMFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+|++.     +++.||+|+++..... ..+.+.+|++++++++||||+++++++........++|||
T Consensus         9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   88 (284)
T cd05038           9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME   88 (284)
T ss_pred             heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence            378999999999999854     3789999999765433 4678999999999999999999999987555668899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++++|.+++....    ..+++.++..++.|++.||+||| +.|++||||||+||+++ .++.+||+|||.+......
T Consensus        89 ~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          89 YLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG-SQRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             cCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHhEEEc-CCCCEEEcccccccccccC
Confidence            999999999996532    25899999999999999999999 89999999999999998 5789999999999876533


Q ss_pred             Cceee--eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCc--------cChHHHHHHHH
Q 001527          935 GTIEQ--ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAG--------VDLTDWMQLKV 1004 (1060)
Q Consensus       935 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~--------~~l~~~~~~~~ 1004 (1060)
                      .....  ....++..|+|||...+...  +.++||||||+++|||++|+.|+.........        .....+.. ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~--~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  239 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRTSKF--SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE-LL  239 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHccCCC--CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH-HH
Confidence            22111  11234567999999977654  77999999999999999999997643211100        00111111 11


Q ss_pred             hcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1005 AEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1005 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      .....       .      +.......++.+++.+|++ +|.+||||.||+++|++|
T Consensus       240 ~~~~~-------~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         240 KEGER-------L------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HcCCc-------C------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11000       0      0011223568889999998 799999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.9e-33  Score=308.31  Aligned_cols=249  Identities=27%  Similarity=0.446  Sum_probs=193.2

Q ss_pred             CCeeccccceEEEEEEEc-C---CcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-N---GMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|+.. +   +..+|+|.++... ....+.+.+|+.++++++||||+++++++.  ..+..++||||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~   86 (267)
T cd05066           9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSKPVMIVTEY   86 (267)
T ss_pred             eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCccEEEEEc
Confidence            578999999999999853 2   3479999987542 334568899999999999999999999985  55678999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++++|.+++....    ..+++.++..|+.|++.||+||| +.+++||||||+||+++ .+..+|++|||.++......
T Consensus        87 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH-~~~i~h~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          87 MENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH-HCCEeehhhchhcEEEC-CCCeEEeCCCCccccccccc
Confidence            99999999996432    35899999999999999999999 99999999999999998 57899999999998765433


Q ss_pred             ceeee--ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          936 TIEQI--LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       936 ~~~~~--~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      .....  ...++..|+|||++.+..+  +.++|||||||++||+++ |+.||......    ....++    .+...   
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~--~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----~~~~~~----~~~~~---  227 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKF--TSASDVWSYGIVMWEVMSYGERPYWEMSNQ----DVIKAI----EEGYR---  227 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCcc--CchhhhHHHHHHHHHHhcCCCCCcccCCHH----HHHHHH----hCCCc---
Confidence            22211  1123568999999987654  779999999999999886 99998643211    111111    11100   


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                        .        +........+.+++.+|++ +|.+||+|.+|++.|+++
T Consensus       228 --~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 --L--------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --C--------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence              0        0011234567788999998 799999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.6e-33  Score=307.64  Aligned_cols=249  Identities=26%  Similarity=0.457  Sum_probs=192.2

Q ss_pred             CCeeccccceEEEEEEEc-CC---cEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NG---MFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|+.. ++   ..||+|.++.. .....++|..|++++++++||||+++++++.  .....++||||
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~e~   86 (269)
T cd05065           9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSRPVMIITEF   86 (269)
T ss_pred             EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC--CCCceEEEEec
Confidence            578999999999999964 33   36999998754 3445678999999999999999999999984  56678999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++++|.+++....    ..+++.+++.++.|++.||+||| +.|++||||||+||+++ ++..+|++|||.++......
T Consensus        87 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH-~~g~~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          87 MENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLS-EMNYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             CCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccChheEEEc-CCCcEEECCCccccccccCc
Confidence            99999999996532    35899999999999999999999 99999999999999998 57899999999987654332


Q ss_pred             ceee-e-ccC--ccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCC
Q 001527          936 TIEQ-I-LDA--GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGS 1010 (1060)
Q Consensus       936 ~~~~-~-~~~--gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 1010 (1060)
                      .... . ...  .+..|+|||++.+..+  +.++|||||||++||+++ |+.||....    .....+++.    .... 
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~DvwslG~~l~e~l~~g~~p~~~~~----~~~~~~~i~----~~~~-  229 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF--TSASDVWSYGIVMWEVMSYGERPYWDMS----NQDVINAIE----QDYR-  229 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcc--cchhhhhhhHHHHHHHhcCCCCCCCCCC----HHHHHHHHH----cCCc-
Confidence            2111 1 111  2457999999987665  779999999999999886 999986432    112222221    1100 


Q ss_pred             cccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1011 DCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1011 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                          .        +...+....+.+++..|++ +|.+||++++|+.+|+++
T Consensus       230 ----~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 ----L--------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----C--------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                0        0011233456788889998 799999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.8e-33  Score=303.66  Aligned_cols=239  Identities=22%  Similarity=0.355  Sum_probs=185.5

Q ss_pred             CeeccccceEEEEEEEcC-C----------cEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceE
Q 001527          782 EVLGRSSHGTSYRATLEN-G----------MFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKL  850 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  850 (1060)
                      +.||+|+||.||+|...+ +          ..+++|.++..... ...+.+|++++++++||||+++++++..   ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR---DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec---CCcE
Confidence            468999999999999764 3          25788887654333 6788999999999999999999999863   5679


Q ss_pred             EEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCC-------CeEEc
Q 001527          851 ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDL-------NARVA  923 (1060)
Q Consensus       851 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~-------~~kl~  923 (1060)
                      +||||+++|+|.+++....    ..+++..+..++.||+.||+||| +++|+||||||+||+++. +.       .+||+
T Consensus        77 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dlkp~Nill~~-~~~~~~~~~~~kl~  150 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLE-DKKLVHGNVCGKNILVAR-YGLNEGYVPFIKLS  150 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh-hCCeecccCccceEEEec-CccccCCceeEEeC
Confidence            9999999999999996532    25899999999999999999999 999999999999999984 54       69999


Q ss_pred             ccccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHH
Q 001527          924 DYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQL 1002 (1060)
Q Consensus       924 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 1002 (1060)
                      |||++.......     ...++..|+|||++.+....++.++|||||||++|||++ |..||......       ++...
T Consensus       151 Dfg~a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-------~~~~~  218 (259)
T cd05037         151 DPGIPITVLSRE-----ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-------EKERF  218 (259)
T ss_pred             CCCccccccccc-----ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-------hHHHH
Confidence            999988654411     124677899999998763335889999999999999999 57777543211       11111


Q ss_pred             HHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527         1003 KVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1003 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                      ....         ...+.       .....+.+++.+|+. +|.+|||+.||++.|+
T Consensus       219 ~~~~---------~~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         219 YQDQ---------HRLPM-------PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HhcC---------CCCCC-------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1100         00000       011567889999998 7999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-33  Score=322.91  Aligned_cols=191  Identities=19%  Similarity=0.214  Sum_probs=159.3

Q ss_pred             ccCCCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          778 RAPAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      +...+.||+|+||.||+|+.. .++.||||....      ..+.+|++++++++|||||++++++.  .....++||||+
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~--~~~~~~lv~e~~  242 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRV--VGGLTCLVLPKY  242 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEE--ECCEEEEEEEcc
Confidence            444678999999999999965 588999996432      34568999999999999999999985  456789999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      . ++|.+++....    ..+++.+++.|+.|++.||+||| +.||+||||||+|||++ .++.+||+|||+++.......
T Consensus       243 ~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH-~~gIvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        243 R-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIH-GEGIIHRDIKTENVLVN-GPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             C-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH-HCCEEECcCCHHHEEEC-CCCCEEEcccCCceecccccc
Confidence            4 78999885432    36999999999999999999999 99999999999999998 578999999999986543322


Q ss_pred             e-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001527          937 I-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGD  985 (1060)
Q Consensus       937 ~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~  985 (1060)
                      . ......||..|+|||++.+..+  +.++|||||||++|||++|..|+.
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~--~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPY--TPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCC--CchHHHHHHHHHHHHHHHcCCCcc
Confidence            1 1122369999999999988765  789999999999999999887653

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-33  Score=303.71  Aligned_cols=247  Identities=24%  Similarity=0.399  Sum_probs=192.2

Q ss_pred             CeeccccceEEEEEEEcCCcEEEEEEcccchHH-HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      ++||+|+||.||+|...+++.||+|+++..... ..+.+.+|++++++++||||+++++++.  .....++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV--QKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe--cCCCeEEEEEcCCCCc
Confidence            468999999999999777999999998764333 5578999999999999999999999985  5567899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee-
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ-  939 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~-  939 (1060)
                      |.+++....    ..+++..+..++.|++.||+||| +++++||||||+||+++ .+..+||+|||.++.......... 
T Consensus        79 l~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH-~~~i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          79 LLTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLE-SKNCIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH-hCCEehhhcCcceEEEc-CCCcEEEeeccccccccCCcceecc
Confidence            999996432    35789999999999999999999 99999999999999998 578999999999886543221111 


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      ....++..|+|||++.+..+  +.++|||||||++|||+| |..||.....       ..... .......  ..     
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~--~~~~Di~slG~i~~~l~t~~~~p~~~~~~-------~~~~~-~~~~~~~--~~-----  215 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRY--TSESDVWSYGILLWETFSLGDTPYPGMSN-------QQTRE-RIESGYR--MP-----  215 (251)
T ss_pred             ccCcceeccCChHhhccCCC--CcchhHHHHHHHHHHHHhccCCCCccCCH-------HHHHH-HHhcCCC--CC-----
Confidence            11133567999999877654  789999999999999999 8888864321       11111 1111100  00     


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                            ........+.+++.+|+. +|.+||++.||++.|++
T Consensus       216 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         216 ------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             ------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence                  011234568889999998 79999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.5e-33  Score=314.71  Aligned_cols=200  Identities=21%  Similarity=0.270  Sum_probs=162.0

Q ss_pred             CCeeccc--cceEEEEEEE-cCCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRS--SHGTSYRATL-ENGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .++||+|  +|++||+++. .+|+.||+|+++...  ....+.+.+|+++++.++||||+++++++.  ..+..++||||
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~--~~~~~~lv~e~   80 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI--ADNELWVVTSF   80 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--ECCEEEEEEec
Confidence            3679999  6889999985 479999999997542  233456788999999999999999999995  45678999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++|+|.+++..+.   ...+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.++++||+.+.......
T Consensus        81 ~~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH-~~~iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          81 MAYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIH-HMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             cCCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCChhhEEEe-cCCcEEEcccchhhcccccc
Confidence            99999999996532   234899999999999999999999 99999999999999998 57799999998654332111


Q ss_pred             cee------eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          936 TIE------QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       936 ~~~------~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      ...      .....++..|+|||++.+....++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            100      1112467789999999764333578999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-33  Score=317.18  Aligned_cols=260  Identities=18%  Similarity=0.243  Sum_probs=187.0

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++.  ..+..++||||+++
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~   88 (309)
T cd07872          11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH--TDKSLTLVFEYLDK   88 (309)
T ss_pred             EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe--eCCeEEEEEeCCCC
Confidence            478999999999999865 688999999874322 22346778999999999999999999985  45678999999975


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                       +|.+++...    ...+++..+..++.|++.||+||| ++||+||||||+||+++ +++.+||+|||+++.........
T Consensus        89 -~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH-~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          89 -DLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCH-RRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             -CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEC-CCCCEEECccccceecCCCcccc
Confidence             888888543    235789999999999999999999 99999999999999998 57899999999987644322211


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC-----------
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG----------- 1007 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~----------- 1007 (1060)
                       ....++..|+|||++.+.. .++.++||||+||++|||+||+.||......+    ....+.......           
T Consensus       162 -~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~tg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         162 -SNEVVTLWYRPPDVLLGSS-EYSTQIDMWGVGCIFFEMASGRPLFPGSTVED----ELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             -ccccccccccCCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHhhhcch
Confidence             1235789999999987543 24779999999999999999999997532111    000000000000           


Q ss_pred             -CCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1008 -HGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1008 -~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                       .....-.+...+.............+.+++.+|++ +|.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             00000000000000000011223456788899998 8999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.6e-33  Score=339.50  Aligned_cols=253  Identities=22%  Similarity=0.244  Sum_probs=190.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .++||+|+||.||+|+.. +|+.||+|+++...   ....+++.+|++++++++||||+++++++.  +.+..++||||+
T Consensus         7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~--d~~~lyLVMEY~   84 (932)
T PRK13184          7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS--DGDPVYYTMPYI   84 (932)
T ss_pred             EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe--eCCEEEEEEEcC
Confidence            478999999999999965 68999999987532   234567899999999999999999999985  566889999999


Q ss_pred             CCCChHHHhhcCCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          857 SPGSLASFLYDRPG------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      ++|+|.+++.....      ......++.++++++.||++||+||| +.||+||||||+||+++ .++.+||+|||+++.
T Consensus        85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH-s~GIIHRDLKPeNILLd-~dg~vKLiDFGLAk~  162 (932)
T PRK13184         85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH-SKGVLHRDLKPDNILLG-LFGEVVILDWGAAIF  162 (932)
T ss_pred             CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH-HCCccccCCchheEEEc-CCCCEEEEecCccee
Confidence            99999999864211      11234677888999999999999999 89999999999999998 578999999999987


Q ss_pred             eccCCc-----------------eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 001527          931 MTQAGT-----------------IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAG  993 (1060)
Q Consensus       931 ~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~  993 (1060)
                      ......                 .......||+.|+|||++.+..+  +.++|||||||++|||+||+.||......   
T Consensus       163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~--S~kSDIWSLGVILyELLTG~~PF~~~~~~---  237 (932)
T PRK13184        163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA--SESTDIYALGVILYQMLTLSFPYRRKKGR---  237 (932)
T ss_pred             cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC--CcHhHHHHHHHHHHHHHHCCCCCCCcchh---
Confidence            621110                 00011358999999999987765  78999999999999999999998652111   


Q ss_pred             cChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-CHHHHHHHhh
Q 001527          994 VDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-GIKTIYEDLS 1058 (1060)
Q Consensus       994 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-s~~evl~~L~ 1058 (1060)
                       ....  .     .   ...++.-...     ..+....+.+++.+|++ +|++|| +++++++.|+
T Consensus       238 -ki~~--~-----~---~i~~P~~~~p-----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le  288 (932)
T PRK13184        238 -KISY--R-----D---VILSPIEVAP-----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE  288 (932)
T ss_pred             -hhhh--h-----h---hccChhhccc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             0100  0     0   0001100000     01233457788889998 799996 6677777665

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-33  Score=317.63  Aligned_cols=236  Identities=23%  Similarity=0.313  Sum_probs=182.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .++||+|+||.||+|+.. +++.||+|+++....   ...+.+..|.+++..+ +||+|+++++++.  +.+..++||||
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~   82 (323)
T cd05616           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ--TMDRLYFVMEY   82 (323)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe--cCCEEEEEEcC
Confidence            468999999999999865 578999999875432   2334567788888877 5899999998884  56689999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++|+|.+++...     ..+++.++..++.|++.||+||| +.||+||||||+|||++ +++.+||+|||+++......
T Consensus        83 ~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          83 VNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             CCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCEEecCCCHHHeEEC-CCCcEEEccCCCceecCCCC
Confidence            9999999998542     35889999999999999999999 99999999999999998 58899999999987543222


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      .. .....||+.|+|||++.+..+  +.++|||||||++|||++|+.||+...       ..+...... ....      
T Consensus       156 ~~-~~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlGvil~elltg~~Pf~~~~-------~~~~~~~i~-~~~~------  218 (323)
T cd05616         156 VT-TKTFCGTPDYIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQAPFEGED-------EDELFQSIM-EHNV------  218 (323)
T ss_pred             Cc-cccCCCChhhcCHHHhcCCCC--CCccchhchhHHHHHHHhCCCCCCCCC-------HHHHHHHHH-hCCC------
Confidence            21 122368999999999987765  789999999999999999999997421       111111111 1110      


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGI 1050 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~ 1050 (1060)
                      . .+       ......+.+++.+|++ +|.+|+++
T Consensus       219 ~-~p-------~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 A-YP-------KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             C-CC-------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence            0 00       1223456778889998 79999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=302.63  Aligned_cols=243  Identities=19%  Similarity=0.253  Sum_probs=199.2

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccchHH--HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAK--QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+-||+|.|+.|-+|+ .-+|+.||||++.+....  ....+.+|++.|+-++|||||++|.+.  ......|+|+|.-.
T Consensus        23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyLiLELGD  100 (864)
T KOG4717|consen   23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYLILELGD  100 (864)
T ss_pred             hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEEEEEecC
Confidence            3679999999999998 448999999999765332  346788999999999999999999887  46678999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +|+|++|+..+.    ..+.+.-+.+++.||+.|+.|+| +-.||||||||+||.+-.+-+-+||.|||++-.+.++...
T Consensus       101 ~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCH-qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL  175 (864)
T KOG4717|consen  101 GGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCH-QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL  175 (864)
T ss_pred             CchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHh-hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence            999999996543    44889999999999999999999 8999999999999998767788999999999887766554


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      .+.  +|+..|.|||++.|..|+ .+++||||+||++|.+++|+.||+...+.+.                ...+.|.. 
T Consensus       176 ~Ts--CGSLAYSAPEILLGDsYD-APAVDiWSLGVILyMLVCGq~PFqeANDSET----------------LTmImDCK-  235 (864)
T KOG4717|consen  176 TTS--CGSLAYSAPEILLGDSYD-APAVDIWSLGVILYMLVCGQPPFQEANDSET----------------LTMIMDCK-  235 (864)
T ss_pred             hcc--cchhhccCchhhhcCccC-CcchhhhHHHHHHHHHHhCCCccccccchhh----------------hhhhhccc-
Confidence            443  899999999999999875 5789999999999999999999985432211                11122221 


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                         |.  .+.....++.+++..|+. +|.+|.+.+||+.
T Consensus       236 ---Yt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 ---YT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ---cc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence               11  123456778888889986 8999999999874

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=306.52  Aligned_cols=245  Identities=19%  Similarity=0.289  Sum_probs=189.7

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccch-----HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGV-----AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .+.||+|++|.||+|.. .+++.||+|.++...     ....+.+.+|++++++++||||+++++++.  .....++|+|
T Consensus         7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e   84 (263)
T cd06625           7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR--DDETLSIFME   84 (263)
T ss_pred             cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc--cCCeEEEEEE
Confidence            57899999999999985 468999999886432     123457889999999999999999999995  4568999999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++++|.+++...     ..+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||.++.....
T Consensus        85 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          85 YMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLH-SNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             ECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEc-CCCCEEEeecccceecccc
Confidence            99999999998542     35888999999999999999999 99999999999999998 5789999999998765432


Q ss_pred             Cceee--eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          935 GTIEQ--ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       935 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      .....  ....|+..|+|||++.+...  +.++||||+|+++|||++|+.||.....      ...... ..... ..  
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~-~~~~~-~~--  225 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGY--GRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFK-IATQP-TN--  225 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCC--CchhhhHHHHHHHHHHHhCCCCccccch------HHHHHH-HhccC-CC--
Confidence            21111  12357889999999987764  7899999999999999999999864211      111111 11110 00  


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                        +.+        .......+.+++.+|+. +|.+|||+.|+++.
T Consensus       226 --~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 --PQL--------PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --CCC--------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              000        01223456778889998 79999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=312.20  Aligned_cols=241  Identities=22%  Similarity=0.354  Sum_probs=187.7

Q ss_pred             CeeccccceEEEEEE-EcCCcEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREG---VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      +.||.|+||.||-|+ .++.+.||||++.-.   ......++.+|++.|++++|||+|.+.|+|.  .....|+||||| 
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL--re~TaWLVMEYC-  108 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL--REHTAWLVMEYC-  108 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee--ccchHHHHHHHH-
Confidence            569999999999999 568899999998632   2334468899999999999999999999996  455789999999 


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      -|+-.+.+.-.    .+++.+.++..|+.+.+.||+||| +.+.||||||+.|||++ +.+.|||+|||.|..+.+... 
T Consensus       109 lGSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLH-S~~~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~~PAns-  181 (948)
T KOG0577|consen  109 LGSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH-SHNRIHRDIKAGNILLS-EPGLVKLADFGSASIMAPANS-  181 (948)
T ss_pred             hccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHH-HhhHHhhhccccceEec-CCCeeeeccccchhhcCchhc-
Confidence            45777777432    256899999999999999999999 99999999999999998 688999999999988776544 


Q ss_pred             eeeccCccccccchhcccCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          938 EQILDAGVLGYRAPELAASK-KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                          .+||+.|||||++... ...|+-|+||||+|++..|+...++|+..+..       .. +...+....     .|.
T Consensus       182 ----FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MS-ALYHIAQNe-----sPt  244 (948)
T KOG0577|consen  182 ----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MS-ALYHIAQNE-----SPT  244 (948)
T ss_pred             ----ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HH-HHHHHHhcC-----CCC
Confidence                3799999999998521 11247799999999999999999999654311       00 011111110     112


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhccC-CCCCCCHHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIRS-VSERPGIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~~-p~~RPs~~evl~~ 1056 (1060)
                      +.    .   .+....+.+++-.|++. |.+|||.++++..
T Consensus       245 Lq----s---~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  245 LQ----S---NEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CC----C---chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            21    1   24555667777799995 8999999998763

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.3e-33  Score=306.79  Aligned_cols=252  Identities=22%  Similarity=0.329  Sum_probs=191.6

Q ss_pred             CCeeccccceEEEEEEEc------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .++||+|+||.||+|...      .+..||+|.++... ......+.+|+.++++++||||+++++++.  .....++||
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~   88 (288)
T cd05061          11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS--KGQPTLVVM   88 (288)
T ss_pred             eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCcEEEE
Confidence            578999999999999753      25589999986443 233456889999999999999999999985  456789999


Q ss_pred             EecCCCChHHHhhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccc
Q 001527          854 DYISPGSLASFLYDRPGR-----KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLH  928 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a  928 (1060)
                      ||+++|+|.+++......     .....++..+.+++.|++.||+||| +++|+||||||+||+++ +++.+||+|||++
T Consensus        89 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dikp~nili~-~~~~~~L~Dfg~~  166 (288)
T cd05061          89 ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN-AKKFVHRDLAARNCMVA-HDFTVKIGDFGMT  166 (288)
T ss_pred             eCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcCCCCChheEEEc-CCCcEEECcCCcc
Confidence            999999999999653211     1244677889999999999999999 99999999999999998 5889999999998


Q ss_pred             eeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhc
Q 001527          929 RLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAE 1006 (1060)
Q Consensus       929 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~ 1006 (1060)
                      +......... .....++..|+|||.+.+..+  +.++|||||||++|||++ |+.||....       ..++...... 
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~--~~~~DvwslG~~l~el~~~~~~p~~~~~-------~~~~~~~~~~-  236 (288)
T cd05061         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVF--TTSSDMWSFGVVLWEITSLAEQPYQGLS-------NEQVLKFVMD-  236 (288)
T ss_pred             ccccccccccccCCCcccccccCHHHhccCCC--ChHhHHHHHHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHc-
Confidence            8654322211 111235678999999987664  779999999999999998 788886421       1222221111 


Q ss_pred             CCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1007 GHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1007 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      +....     .        .......+.+++.+|++ +|.+|||+.|+++.|++
T Consensus       237 ~~~~~-----~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  277 (288)
T cd05061         237 GGYLD-----Q--------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD  277 (288)
T ss_pred             CCCCC-----C--------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            11110     0        01223568888899998 79999999999998874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.7e-33  Score=311.68  Aligned_cols=193  Identities=22%  Similarity=0.358  Sum_probs=163.7

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+|+.. ++..+|+|.++... ....+++.+|++++++++||||+++++++.  ..+..++||||+++
T Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~ey~~~   83 (308)
T cd06615           6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY--SDGEISICMEHMDG   83 (308)
T ss_pred             EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCCEEEEEeeccCC
Confidence            478999999999999854 68889999986542 334467889999999999999999999995  56789999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++...     ..+++..+..++.|++.||.|||...+++||||||+||+++ +++.+||+|||++........  
T Consensus        84 ~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~--  155 (308)
T cd06615          84 GSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA--  155 (308)
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe-cCCcEEEccCCCccccccccc--
Confidence            9999999542     45889999999999999999999336999999999999998 578899999999876543221  


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                       ....|+..|+|||++.+..+  +.++|||||||++|||++|+.||..
T Consensus       156 -~~~~~~~~~~aPE~~~~~~~--~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         156 -NSFVGTRSYMSPERLQGTHY--TVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             -ccCCCCcCccChhHhcCCCC--CccchHHHHHHHHHHHHhCCCCCCC
Confidence             12368899999999877654  7799999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.8e-33  Score=306.29  Aligned_cols=253  Identities=26%  Similarity=0.394  Sum_probs=194.4

Q ss_pred             CCCeeccccceEEEEEEEc------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEE
Q 001527          780 PAEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv  852 (1060)
                      ..+.||+|+||.||+|...      ++..||+|+++... ....+++.+|++++++++||||+++++++.  .+...++|
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~--~~~~~~lv   86 (288)
T cd05050           9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA--VGKPMCLL   86 (288)
T ss_pred             ecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc--CCCccEEE
Confidence            3578999999999999853      46889999987543 334567999999999999999999999884  55678999


Q ss_pred             EEecCCCChHHHhhcCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeC
Q 001527          853 SDYISPGSLASFLYDRPG-----------------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG  915 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~  915 (1060)
                      |||+++|+|.+++.....                 .....+++.+++.++.|++.||+||| .++++||||||+||+++ 
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH-~~~i~H~dl~p~nil~~-  164 (288)
T cd05050          87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS-ERKFVHRDLATRNCLVG-  164 (288)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hCCeecccccHhheEec-
Confidence            999999999999975321                 11235788999999999999999999 99999999999999998 


Q ss_pred             CCCCeEEcccccceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 001527          916 PDLNARVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAG  993 (1060)
Q Consensus       916 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~  993 (1060)
                      +++.+||+|||.++......... .....++..|+|||.+.+..+  +.++|||||||++|||++ |..||....     
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~il~el~~~~~~p~~~~~-----  237 (288)
T cd05050         165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIFSYGMQPYYGMA-----  237 (288)
T ss_pred             CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC--CchhHHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence            58899999999987654322111 111234667999999877654  779999999999999998 888875421     


Q ss_pred             cChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527          994 VDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       994 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                        ..++... ...+....             ........+.+++.+|++ +|.+|||+.|+++.|++
T Consensus       238 --~~~~~~~-~~~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 --HEEVIYY-VRDGNVLS-------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             --HHHHHHH-HhcCCCCC-------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence              2223222 11211110             001234567889999998 79999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-33  Score=315.35  Aligned_cols=198  Identities=20%  Similarity=0.286  Sum_probs=165.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|+.++..++||||+++++++.  +....++||||+
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   83 (331)
T cd05597           6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ--DENNLYLVMDYY   83 (331)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe--cCCeEEEEEecC
Confidence            478999999999999965 68999999987432   223456889999999999999999999885  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...    ...+++.++..++.||+.||+||| +++|+||||||+|||++ .++.+||+|||++........
T Consensus        84 ~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          84 VGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVH-QLGYVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             CCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeEECCCCHHHEEEC-CCCCEEEEECCceeecCCCCC
Confidence            999999999542    235889999999999999999999 99999999999999998 588999999999877654433


Q ss_pred             eeeeccCccccccchhcccCC---CCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          937 IEQILDAGVLGYRAPELAASK---KPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      .......||+.|+|||++...   ...++.++||||+||++|||++|+.||..
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            322334689999999998632   12247799999999999999999999864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.7e-33  Score=304.90  Aligned_cols=245  Identities=22%  Similarity=0.308  Sum_probs=192.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|++++++++||||+++++++.  +....++||||+++
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~   82 (255)
T cd08219           5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE--ADGHLYIVMEYCDG   82 (255)
T ss_pred             EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--ECCEEEEEEeeCCC
Confidence            478999999999999854 6899999998643 2345577889999999999999999999985  56789999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++....   ...+++..+..++.|++.||.||| +++|+|+||||+||+++ +++.++++|||.+..........
T Consensus        83 ~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~  157 (255)
T cd08219          83 GDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIH-EKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYA  157 (255)
T ss_pred             CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCcceEEEC-CCCcEEEcccCcceeeccccccc
Confidence            99999986432   345789999999999999999999 99999999999999998 58899999999998765433222


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                       ....|+..|+|||++.+...  +.++||||||+++|+|++|+.||+...       ........ ..+.....      
T Consensus       158 -~~~~~~~~~~aPE~~~~~~~--~~~~Dv~slG~i~~~l~~g~~p~~~~~-------~~~~~~~~-~~~~~~~~------  220 (255)
T cd08219         158 -CTYVGTPYYVPPEIWENMPY--NNKSDIWSLGCILYELCTLKHPFQANS-------WKNLILKV-CQGSYKPL------  220 (255)
T ss_pred             -ccccCCccccCHHHHccCCc--CchhhhhhhchhheehhhccCCCCCCC-------HHHHHHHH-hcCCCCCC------
Confidence             12368889999999977654  779999999999999999999987421       11121111 11111100      


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      +       ......+.+++.+|++ +|++||++.||+.+
T Consensus       221 ~-------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 P-------SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             C-------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            0       1123356788889998 79999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-33  Score=323.20  Aligned_cols=195  Identities=19%  Similarity=0.273  Sum_probs=164.6

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|++++.+++||+|+++++++.  +....++||||+
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~~~lv~E~~   83 (360)
T cd05627           6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ--DKRNLYLIMEFL   83 (360)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEEEEeCC
Confidence            478999999999999865 68999999997532   223456888999999999999999999884  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++..+..++.|++.||+||| +.||+||||||+|||++ .++.+||+|||+++.......
T Consensus        84 ~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH-~~givHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          84 PGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIH-QLGFIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             CCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeEccCCCHHHEEEC-CCCCEEEeeccCCcccccccc
Confidence            999999999542     45899999999999999999999 99999999999999998 588999999999875432110


Q ss_pred             ----------------------------------eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCC
Q 001527          937 ----------------------------------IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRC  982 (1060)
Q Consensus       937 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~  982 (1060)
                                                        .......||+.|+|||++.+..+  +.++|||||||++|||++|+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~--~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY--NKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC--CCcceeccccceeeecccCCC
Confidence                                              00112368999999999987765  779999999999999999999


Q ss_pred             CCCC
Q 001527          983 AGDV  986 (1060)
Q Consensus       983 p~~~  986 (1060)
                      ||..
T Consensus       235 Pf~~  238 (360)
T cd05627         235 PFCS  238 (360)
T ss_pred             CCCC
Confidence            9974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-32  Score=312.40  Aligned_cols=256  Identities=27%  Similarity=0.388  Sum_probs=195.4

Q ss_pred             ccCCCeeccccceEEEEEEEc--------CCcEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCC
Q 001527          778 RAPAEVLGRSSHGTSYRATLE--------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQH  847 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~  847 (1060)
                      +...+.||+|+||.||+|+..        .+..||+|.++... ....+++.+|+++++++ +||||+++++++.  ...
T Consensus        14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~~~   91 (334)
T cd05100          14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDG   91 (334)
T ss_pred             eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--cCC
Confidence            344689999999999999742        12468999887532 33457889999999999 8999999999985  456


Q ss_pred             ceEEEEEecCCCChHHHhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCC
Q 001527          848 EKLILSDYISPGSLASFLYDRPG-----------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP  916 (1060)
Q Consensus       848 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~  916 (1060)
                      ..+++|||+++|+|.+++.....           .....+++.++..++.|++.||+||| ++||+||||||+||+++ +
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~givH~dlkp~Nill~-~  169 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA-SQKCIHRDLAARNVLVT-E  169 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH-HCCeeccccccceEEEc-C
Confidence            78999999999999999975421           12345889999999999999999999 99999999999999998 5


Q ss_pred             CCCeEEcccccceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 001527          917 DLNARVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGV  994 (1060)
Q Consensus       917 ~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~  994 (1060)
                      +..+||+|||+++......... .....++..|+|||++.+..+  +.++|||||||++|||++ |+.||...       
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~il~el~~~g~~p~~~~-------  240 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLLWEIFTLGGSPYPGI-------  240 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc--CchhhhHHHHHHHHHHHhcCCCCCCCC-------
Confidence            7899999999998654332211 111234567999999987665  779999999999999998 88888642       


Q ss_pred             ChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527          995 DLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus       995 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ...++..... .....+.             .......+.+++.+|++ +|.+||+|.|+++.|+.+
T Consensus       241 ~~~~~~~~~~-~~~~~~~-------------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         241 PVEELFKLLK-EGHRMDK-------------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             CHHHHHHHHH-cCCCCCC-------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            2233332222 1111110             01223467788999998 799999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.8e-33  Score=309.87  Aligned_cols=246  Identities=21%  Similarity=0.310  Sum_probs=192.0

Q ss_pred             ccCCCeeccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          778 RAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      +...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.  .....++||||+
T Consensus        21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~   98 (297)
T cd06656          21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVMEYL   98 (297)
T ss_pred             ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCEEEEeeccc
Confidence            34467899999999999995 579999999997655555677889999999999999999999995  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++..      ..+++.++..++.|++.||.||| +.+|+||||||+||+++ .++.+||+|||.+........
T Consensus        99 ~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH-~~~i~H~dL~p~Nili~-~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEC-CCCCEEECcCccceEccCCcc
Confidence            99999999854      24788999999999999999999 99999999999999998 588999999999876544322


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      .. ....+++.|+|||.+.+...  +.++|||||||++|++++|+.||........      . .. .....     .+.
T Consensus       171 ~~-~~~~~~~~y~aPE~~~~~~~--~~~~Di~slGvil~~l~tg~~pf~~~~~~~~------~-~~-~~~~~-----~~~  234 (297)
T cd06656         171 KR-STMVGTPYWMAPEVVTRKAY--GPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------L-YL-IATNG-----TPE  234 (297)
T ss_pred             Cc-CcccCCccccCHHHHcCCCC--CcHHHHHHHHHHHHHHHhCCCCCCCCCcchh------e-ee-eccCC-----CCC
Confidence            11 12357889999999987654  7799999999999999999999964321100      0 00 00000     000


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .      .........+.+++.+|++ +|++||+++||++
T Consensus       235 ~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 L------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             C------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0      0011223446678889998 7999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3e-33  Score=309.59  Aligned_cols=246  Identities=22%  Similarity=0.288  Sum_probs=188.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .++||+|+||.||+|... +++.||+|.+.....   ...+.+.+|+.++++++|++|+++++++.  +.+..++||||+
T Consensus         5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~e~~   82 (285)
T cd05630           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE--TKDALCLVLTLM   82 (285)
T ss_pred             eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe--cCCEEEEEEEec
Confidence            468999999999999855 689999999864321   22345778999999999999999999885  456899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++....   ...+++.++..++.|++.||.||| +.+|+||||||+||+++ +++.++|+|||++........
T Consensus        83 ~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH-~~~iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          83 NGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLH-QERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             CCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHEEEC-CCCCEEEeeccceeecCCCcc
Confidence            9999999986432   235899999999999999999999 99999999999999998 578899999999876543322


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      .  ....|+..|+|||++.+..+  +.++||||+||++|||++|+.||.......   ....+ ......  ..    ..
T Consensus       158 ~--~~~~g~~~y~aPE~~~~~~~--~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---~~~~~-~~~~~~--~~----~~  223 (285)
T cd05630         158 I--KGRVGTVGYMAPEVVKNERY--TFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEV-ERLVKE--VQ----EE  223 (285)
T ss_pred             c--cCCCCCccccChHHHcCCCC--CCccccHHHHHHHHHHHhCCCCCCCCCccc---hHHHH-Hhhhhh--hh----hh
Confidence            2  12368999999999987765  779999999999999999999997532110   00111 111000  00    00


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCC-----HHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPG-----IKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs-----~~evl~ 1055 (1060)
                      ..        ......+.+++..|++ +|++|||     ++|+++
T Consensus       224 ~~--------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         224 YS--------EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             cC--------ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            00        1122346778889998 7999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.8e-33  Score=309.86  Aligned_cols=246  Identities=21%  Similarity=0.295  Sum_probs=187.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .++||+|+||+||+|... +++.||+|.+.....   ...+.+.+|++++++++|+||+++++++.  .++..++||||+
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~e~~   82 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE--TKDALCLVLTIM   82 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe--cCCEEEEEEEec
Confidence            367999999999999864 689999999865422   22345778999999999999999998884  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++....   ...+++..+..++.|++.||.||| +.+|+||||||+||+++ ++..+||+|||++........
T Consensus        83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH-~~~iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          83 NGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLH-RENTVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             cCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCHHHEEEC-CCCCEEEecCCcceecCCCCc
Confidence            9999999886532   235899999999999999999999 99999999999999998 577899999999876543222


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      .  ....|+..|+|||++.+..+  +.++|||||||++|||++|+.||......    ...+-+........  ..+   
T Consensus       158 ~--~~~~g~~~~~aPE~~~~~~~--~~~~Di~slG~~l~~l~~g~~P~~~~~~~----~~~~~~~~~~~~~~--~~~---  224 (285)
T cd05632         158 I--RGRVGTVGYMAPEVLNNQRY--TLSPDYWGLGCLIYEMIEGQSPFRGRKEK----VKREEVDRRVLETE--EVY---  224 (285)
T ss_pred             c--cCCCCCcCccChHHhcCCCC--CcccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhhhccc--ccc---
Confidence            1  22368999999999987664  77999999999999999999999743211    01111111111110  000   


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCC-----HHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPG-----IKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs-----~~evl~ 1055 (1060)
                               .......+.+++..|++ +|++||+     ++|++.
T Consensus       225 ---------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         225 ---------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ---------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                     01223456778889998 7999999     566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.3e-32  Score=304.35  Aligned_cols=248  Identities=21%  Similarity=0.315  Sum_probs=190.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++.  .....++||||++++
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~~~~~~~v~e~~~~~   87 (282)
T cd06643          10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY--YENNLWILIEFCAGG   87 (282)
T ss_pred             HhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe--eCCEEEEEEEecCCC
Confidence            467999999999999965 58889999987665566678899999999999999999999985  456889999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|..++...    ..++++..+..++.|++.||+||| +.||+||||||+||+++ .++.+|++|||++......... .
T Consensus        88 ~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH-~~~i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~-~  160 (282)
T cd06643          88 AVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLH-ENKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQR-R  160 (282)
T ss_pred             cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCcccEEEc-cCCCEEEccccccccccccccc-c
Confidence            999988542    245899999999999999999999 99999999999999998 5789999999998765432211 1


Q ss_pred             eccCccccccchhcccCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          940 ILDAGVLGYRAPELAASK---KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      ....++..|+|||++...   ...++.++|||||||++|||++|+.||.....       .+.+....... ......+ 
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~-~~~~~~~-  231 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSE-PPTLAQP-  231 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-------HHHHHHHhhcC-CCCCCCc-
Confidence            223688999999998421   11246799999999999999999999864321       11111111110 0000000 


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                                ......+.+++.+|++ +|.+||++.++++.
T Consensus       232 ----------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         232 ----------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ----------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      1123457788889998 79999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-33  Score=322.83  Aligned_cols=193  Identities=22%  Similarity=0.261  Sum_probs=161.3

Q ss_pred             ccCCCeeccccceEEEEEEEc---CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          778 RAPAEVLGRSSHGTSYRATLE---NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      +...+.||+|+||.||+|...   .++.||+|.+...     +...+|++++++++|||||++++++.  .....++|||
T Consensus        94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~lv~e  166 (392)
T PHA03207         94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR--WKSTVCMVMP  166 (392)
T ss_pred             eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe--eCCEEEEEeh
Confidence            344578999999999999753   3678999988653     24568999999999999999999884  5568899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+. ++|.+++..     ...+++.+++.|+.||+.||+||| +.||+||||||+|||++ .++.+||+|||+++.....
T Consensus       167 ~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH-~~givHrDlkp~Nill~-~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        167 KYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLH-GRGIIHRDVKTENIFLD-EPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEc-CCCCEEEccCccccccCcc
Confidence            995 689998832     346899999999999999999999 99999999999999998 5789999999999765543


Q ss_pred             Cce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          935 GTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       935 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      ... ......||..|+|||++.+..+  +.++|||||||++|||++|+.||...
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPY--CAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCC--CchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            221 1223468999999999987765  77999999999999999999998654

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.4e-33  Score=319.51  Aligned_cols=192  Identities=17%  Similarity=0.220  Sum_probs=159.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCC----CCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT----QHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|... .++.||+|++...  .....+.+.+|+.+++.++||||+++++++....    ....++||
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  101 (355)
T cd07874          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  101 (355)
T ss_pred             EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence            478999999999999854 6899999998743  2234467788999999999999999999885322    23579999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+++ ++.+++..       .+++..+..++.|++.||+||| ++||+||||||+||+++ +++.+||+|||+++....
T Consensus       102 e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH-~~givHrDikp~Nill~-~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874         102 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGT  171 (355)
T ss_pred             hhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHHEEEC-CCCCEEEeeCcccccCCC
Confidence            99965 67777632       3788999999999999999999 99999999999999998 588999999999986543


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ....  ....||..|+|||++.+..+  +.++|||||||++|||++|+.||..
T Consensus       172 ~~~~--~~~~~t~~y~aPE~~~~~~~--~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         172 SFMM--TPYVVTRYYRAPEVILGMGY--KENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             cccc--CCccccCCccCHHHHcCCCC--CchhhHHHHHHHHHHHHhCCCCCCC
Confidence            3221  22368999999999987765  7799999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.5e-33  Score=311.18  Aligned_cols=261  Identities=20%  Similarity=0.258  Sum_probs=184.6

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH--HHHHHHHHHHHHHhcC---CCCceeeeeeEEeCC---CCCceEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA--KQRKEFAKEAKKFANI---RHPNVVGLRGYYWGP---TQHEKLI  851 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~---~~~~~~l  851 (1060)
                      .+.||+|+||+||+|+.. +++.||+|.++....  .....+.+|+++++++   +||||+++++++...   .....++
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l   84 (288)
T cd07863           5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL   84 (288)
T ss_pred             eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence            478999999999999865 689999999864321  1123455677777655   799999999988532   2345799


Q ss_pred             EEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceee
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~  931 (1060)
                      ||||++ ++|.+++....   ...+++.++..++.|++.||+||| +.||+||||||+||+++ +++.+||+|||+++..
T Consensus        85 v~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dikp~Nili~-~~~~~kl~dfg~~~~~  158 (288)
T cd07863          85 VFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENILVT-SGGQVKLADFGLARIY  158 (288)
T ss_pred             EEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEC-CCCCEEECccCccccc
Confidence            999997 58999886532   234899999999999999999999 99999999999999998 5789999999999866


Q ss_pred             ccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHH---hcCC
Q 001527          932 TQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKV---AEGH 1008 (1060)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~---~~~~ 1008 (1060)
                      ......  ....|+..|+|||++.+..+  +.++||||+||++|||++|++||......+   .+........   ...+
T Consensus       159 ~~~~~~--~~~~~~~~y~aPE~~~~~~~--~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~  231 (288)
T cd07863         159 SCQMAL--TPVVVTLWYRAPEVLLQSTY--ATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPEDDW  231 (288)
T ss_pred             cCcccC--CCccccccccCchHhhCCCC--CCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChhhC
Confidence            433221  12357899999999987664  789999999999999999999986432111   1111111000   0000


Q ss_pred             CC------cccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1009 GS------DCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1009 ~~------~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ..      ..+.+... ........+....+.+++.+|++ +|++|||+.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         232 PRDVTLPRGAFSPRGP-RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccccCCCCC-CchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00      00000000 00000111234556788999998 8999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.7e-33  Score=316.96  Aligned_cols=193  Identities=19%  Similarity=0.251  Sum_probs=159.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCC----CCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT----QHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|+.. +|+.||+|++...  .....+.+.+|+.+++.++||||+++++++....    ....++||
T Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  105 (359)
T cd07876          26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  105 (359)
T ss_pred             EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence            578999999999999854 6899999998643  2234567889999999999999999999885322    13579999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+++ ++.+.++.       .+++..+..++.|++.||+||| ++||+||||||+||+++ .++.+||+|||+++....
T Consensus       106 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH-~~~ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         106 ELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTACT  175 (359)
T ss_pred             eCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEC-CCCCEEEecCCCcccccc
Confidence            99965 67666632       3788899999999999999999 99999999999999998 588999999999976433


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      ....  ....||..|+|||++.+..+  +.++||||+||++|||++|+.||...
T Consensus       176 ~~~~--~~~~~t~~y~aPE~~~~~~~--~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         176 NFMM--TPYVVTRYYRAPEVILGMGY--KENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             CccC--CCCcccCCCCCchhccCCCC--CcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            2211  22368999999999987765  77999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9e-33  Score=327.00  Aligned_cols=195  Identities=20%  Similarity=0.287  Sum_probs=155.6

Q ss_pred             ccCCCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCC------CceeeeeeEEeCCCCCceE
Q 001527          778 RAPAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRH------PNVVGLRGYYWGPTQHEKL  850 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l~~~~~~~~~~~~~  850 (1060)
                      |...++||+|+||+||+|... +++.||||+++... ...+.+..|++++++++|      ++++++++++.. ...+.+
T Consensus       131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-~~~~~~  208 (467)
T PTZ00284        131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-ETGHMC  208 (467)
T ss_pred             EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc-CCceEE
Confidence            334578999999999999854 68899999996532 223455667777776654      458899988863 345789


Q ss_pred             EEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCcccCCCCCCCeEeeCCC------------
Q 001527          851 ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD-RAVPHGNLKATNILLDGPD------------  917 (1060)
Q Consensus       851 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~ivHrDlkp~NILl~~~~------------  917 (1060)
                      +|||++ +++|.+++...     ..+++.++..|+.||+.||+||| . .|||||||||+|||++.++            
T Consensus       209 iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH-~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFH-TELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             EEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-hcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            999988 77899988542     45899999999999999999999 6 6999999999999997422            


Q ss_pred             ---CCeEEcccccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          918 ---LNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       918 ---~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                         ..+||+|||.+......    .....||+.|+|||++.+..+  +.++|||||||++|||++|+.||+..
T Consensus       282 ~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~--~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGW--MYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             CCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCC--CcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence               25999999987643222    122478999999999988765  77999999999999999999999753

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-32  Score=301.24  Aligned_cols=246  Identities=20%  Similarity=0.284  Sum_probs=185.7

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccc-----hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREG-----VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      ..++||+|+||.||+|... ++..||+|+++..     .....+.+.+|++++++++||||+++++++........++++
T Consensus         6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~   85 (266)
T cd06651           6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM   85 (266)
T ss_pred             ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence            4678999999999999854 6899999988532     123346788999999999999999999988654456788999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+++++|.+++...     ..+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||+++....
T Consensus        86 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH-~~~i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          86 EYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLH-SNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEEC-CCCCEEEccCCCcccccc
Confidence            999999999999542     34889999999999999999999 99999999999999998 578999999999876543


Q ss_pred             CCc--eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          934 AGT--IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       934 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                      ...  .......++..|+|||++.+...  +.++|||||||++|||++|+.||....       ....+.......    
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~i~~el~~g~~pf~~~~-------~~~~~~~~~~~~----  225 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGY--GRKADVWSLGCTVVEMLTEKPPWAEYE-------AMAAIFKIATQP----  225 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCC--CchhhhHHHHHHHHHHHHCCCCccccc-------hHHHHHHHhcCC----
Confidence            211  11112357889999999987654  789999999999999999999987421       111111111111    


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                       ..+.+ +       ....+.+.+++ .|+. +|++||+|+||++
T Consensus       226 -~~~~~-~-------~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 -TNPQL-P-------SHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -CCCCC-c-------hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence             01111 0       11122334444 5665 8999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.8e-33  Score=304.11  Aligned_cols=247  Identities=19%  Similarity=0.255  Sum_probs=188.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc-----hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG-----VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .++||+|+||.||+|... +++.||+|.+...     .....+.+.+|++++++++||||+++++++.+......++|||
T Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (265)
T cd06652           7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME   86 (265)
T ss_pred             eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence            578999999999999864 6899999987532     1233467889999999999999999999886444556889999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++++|.+++...     ..+++..+.+++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||.++.....
T Consensus        87 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          87 HMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLH-SNMIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             ecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEec-CCCCEEECcCccccccccc
Confidence            99999999998542     34788899999999999999999 99999999999999998 5889999999998765432


Q ss_pred             Cce--eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          935 GTI--EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       935 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ...  ......|+..|+|||++.+...  +.++|||||||++|||++|+.||....      .... ........     
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~il~el~~g~~p~~~~~------~~~~-~~~~~~~~-----  225 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGY--GRKADIWSVGCTVVEMLTEKPPWAEFE------AMAA-IFKIATQP-----  225 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCC--CcchhHHHHHHHHHHHhhCCCCCCccc------hHHH-HHHHhcCC-----
Confidence            111  1112358889999999987654  789999999999999999999986421      1111 11111110     


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYED 1056 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~ 1056 (1060)
                      ..+.        ........+.+++.+|+.+|++||+++||++.
T Consensus       226 ~~~~--------~~~~~~~~~~~~i~~~l~~p~~Rp~~~~il~~  261 (265)
T cd06652         226 TNPV--------LPPHVSDHCRDFLKRIFVEAKLRPSADELLRH  261 (265)
T ss_pred             CCCC--------CchhhCHHHHHHHHHHhcChhhCCCHHHHhcC
Confidence            0010        11133456677778888899999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.4e-33  Score=305.82  Aligned_cols=250  Identities=30%  Similarity=0.430  Sum_probs=190.5

Q ss_pred             eeccccceEEEEEEEcC-------CcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          783 VLGRSSHGTSYRATLEN-------GMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       783 ~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .||+|+||.||+|+..+       ++.+|+|.+.... ......+.+|++++++++||||+++++++.  .....++|||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e   79 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL--LNEPQYIIME   79 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec--CCCCeEEEEe
Confidence            68999999999998642       3679999886543 234567889999999999999999999985  4567899999


Q ss_pred             ecCCCChHHHhhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCC-----CeEEccccc
Q 001527          855 YISPGSLASFLYDRPGR--KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDL-----NARVADYCL  927 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~-----~~kl~Dfg~  927 (1060)
                      |+++++|.+++......  ....+++.++..++.|++.||+||| +.+++|+||||+||+++. +.     .+|++|||+
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nil~~~-~~~~~~~~~~l~dfg~  157 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE-QMHFIHRDLAARNCLVSE-KGYDADRVVKIGDFGL  157 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH-hCCcccCCCChheEEEec-CCCCCCcceEECCccc
Confidence            99999999999754321  2345789999999999999999999 899999999999999984 54     799999999


Q ss_pred             ceeeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHh
Q 001527          928 HRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVA 1005 (1060)
Q Consensus       928 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~ 1005 (1060)
                      ++......... .....++..|+|||++.+...  +.++|||||||++|||++ |+.||....    .   .+.... ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~il~ellt~g~~p~~~~~----~---~~~~~~-~~  227 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF--TTQSDVWSFGVLMWEILTLGQQPYPALN----N---QEVLQH-VT  227 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCc--ccchhHHHHHHHHHHHHHcCCCCCcccC----H---HHHHHH-Hh
Confidence            87654322111 111245678999999987765  789999999999999998 999986421    1   111111 11


Q ss_pred             cCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1006 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      .+....             ........+.+++.+|++ +|.+||++++|++.|++
T Consensus       228 ~~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         228 AGGRLQ-------------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cCCccC-------------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            110000             011234567789999998 79999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.1e-33  Score=306.73  Aligned_cols=250  Identities=22%  Similarity=0.321  Sum_probs=194.0

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.  .....++||||+++
T Consensus        10 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~   87 (284)
T cd06620          10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL--NENNICMCMEFMDC   87 (284)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe--cCCEEEEEEecCCC
Confidence            468999999999999954 68999999886542 334578899999999999999999999996  45789999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++..     ...+++..+..++.|++.||.|||+..+++||||||+||+++ +++.++|+|||++........  
T Consensus        88 ~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~~~--  159 (284)
T cd06620          88 GSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN-SRGQIKLCDFGVSGELINSIA--  159 (284)
T ss_pred             CCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC-CCCcEEEccCCcccchhhhcc--
Confidence            999999854     235899999999999999999999447999999999999998 588999999999875433221  


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC----CccChHHHHHHHHhcCCCCcccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG----AGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~----~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                       ....|+..|+|||++.+...  +.++|||||||++|++++|+.||+......    ....+.++........      .
T Consensus       160 -~~~~~~~~~~aPE~~~~~~~--~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  230 (284)
T cd06620         160 -DTFVGTSTYMSPERIQGGKY--TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------P  230 (284)
T ss_pred             -CccccCcccCCHHHHccCCC--CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------C
Confidence             12368999999999876654  789999999999999999999998643321    1112223333222111      0


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      +.+.       ..+....+.+++.+|++ +|++|||++||+++
T Consensus       231 ~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         231 PRLP-------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CCCC-------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1110       01233467788889998 79999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.4e-33  Score=305.62  Aligned_cols=253  Identities=24%  Similarity=0.367  Sum_probs=193.2

Q ss_pred             CCeeccccceEEEEEEEc------CCcEEEEEEcccchHH-HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE------NGMFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|+..      +.+.|++|.+...... ..+.+.+|++++++++||||+++++++.  +....++||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~   87 (275)
T cd05046          10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR--EAEPHYMIL   87 (275)
T ss_pred             eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC--CCCcceEEE
Confidence            467999999999999854      3567999998654333 4577999999999999999999999984  556789999


Q ss_pred             EecCCCChHHHhhcCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccce
Q 001527          854 DYISPGSLASFLYDRPGRK----GPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR  929 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~  929 (1060)
                      ||+++|+|.+++.......    ...+++.++..++.|++.||+||| +.+|+||||||+||+++ .++.++++|||+++
T Consensus        88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH-~~~i~H~dlkp~Nili~-~~~~~~l~~~~~~~  165 (275)
T cd05046          88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS-NARFVHRDLAARNCLVS-SQREVKVSLLSLSK  165 (275)
T ss_pred             EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh-hcCcccCcCccceEEEe-CCCcEEEccccccc
Confidence            9999999999996543111    126899999999999999999999 99999999999999998 57899999999987


Q ss_pred             eeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCC
Q 001527          930 LMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008 (1060)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 1008 (1060)
                      ..............++..|+|||.+.+...  +.++||||||+++|+|++ |..||.....       .+.+.. ...+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~-~~~~~  235 (275)
T cd05046         166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDF--STKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNR-LQAGK  235 (275)
T ss_pred             ccCcccccccCCceeEEeecChhhhccCCC--CchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHH-HHcCC
Confidence            543322222222346778999999877654  779999999999999999 7888854321       111111 11111


Q ss_pred             CCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1009 GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1009 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ....     ..       ......+.+++.+|++ +|.+||++.|++++|++
T Consensus       236 ~~~~-----~~-------~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         236 LELP-----VP-------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             cCCC-----CC-------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            1100     00       1223467888999998 79999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-33  Score=303.60  Aligned_cols=252  Identities=15%  Similarity=0.210  Sum_probs=192.3

Q ss_pred             hhccCCCeeccccceEEEEEEEcCCcEEEEEEccc--chHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEE
Q 001527          776 LSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLRE--GVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       776 l~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv  852 (1060)
                      -.|...++||+||.+.||++...+.+.||+|++..  ...+....|.+|+..|.++ .|.+||++++|-.  .++..|+|
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv--~d~~lYmv  438 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV--TDGYLYMV  438 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec--cCceEEEE
Confidence            34445689999999999999988888888887653  3344567899999999999 5999999999986  46789999


Q ss_pred             EEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeec
Q 001527          853 SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT  932 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~  932 (1060)
                      |||= ..+|.++|..+..   ....| .++.+..|++.|+.++| ..||||.||||.|+|+-  .+.+||+|||.|..+.
T Consensus       439 mE~G-d~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH-~~gIVHSDLKPANFLlV--kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIH-QHGIVHSDLKPANFLLV--KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             eecc-cccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHH-HhceeecCCCcccEEEE--eeeEEeeeechhcccC
Confidence            9986 5699999976432   22334 78889999999999999 99999999999999996  5689999999999877


Q ss_pred             cCCce-eeeccCccccccchhcccCCCC---------CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHH
Q 001527          933 QAGTI-EQILDAGVLGYRAPELAASKKP---------HPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQL 1002 (1060)
Q Consensus       933 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~---------~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~ 1002 (1060)
                      .+.+. .....+||+.||+||.+.....         ..+.++||||+||++|+|+.|+.||...        ...|.+ 
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--------~n~~aK-  581 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--------INQIAK-  581 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--------HHHHHH-
Confidence            65432 2334589999999999864332         2578999999999999999999998742        112222 


Q ss_pred             HHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1003 KVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1003 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                            +..+.||...-++..  . ..-.++++++..|++ +|.+||++.|+++
T Consensus       582 ------l~aI~~P~~~Iefp~--~-~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  582 ------LHAITDPNHEIEFPD--I-PENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ------HHhhcCCCccccccC--C-CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                  222334322111110  0 011227888999998 8999999999986

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.9e-33  Score=313.41  Aligned_cols=236  Identities=23%  Similarity=0.304  Sum_probs=181.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .++||+|+||+||+|+.. +|+.||+|+++....   ...+.+..|.++++.+. |++|+++++++.  +.+..++||||
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~Ey   82 (323)
T cd05615           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ--TVDRLYFVMEY   82 (323)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe--cCCEEEEEEcC
Confidence            468999999999999854 689999999875422   23456778999998885 577888888874  45679999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++|+|.+++..     ...+++.++..|+.|++.||+||| ++||+||||||+|||++ +++.+||+|||+++......
T Consensus        83 ~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH-~~~ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          83 VNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLH-RRGIIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             CCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEEC-CCCCEEEeccccccccCCCC
Confidence            999999999854     245899999999999999999999 99999999999999998 58899999999987543322


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      .. .....||+.|+|||++.+..+  +.++||||+||++|||++|+.||....       .......... ...      
T Consensus       156 ~~-~~~~~gt~~y~aPE~~~~~~~--~~~~DiwslGvil~elltG~~pf~~~~-------~~~~~~~i~~-~~~------  218 (323)
T cd05615         156 VT-TRTFCGTPDYIAPEIIAYQPY--GKSVDWWAYGVLLYEMLAGQPPFDGED-------EDELFQSIME-HNV------  218 (323)
T ss_pred             cc-ccCccCCccccCHHHHcCCCC--CCccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHh-CCC------
Confidence            21 122368999999999987664  779999999999999999999997431       1111221111 110      


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGI 1050 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~ 1050 (1060)
                      .. +       ......+.+++.+|++ +|.+|++.
T Consensus       219 ~~-p-------~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 SY-P-------KSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CC-C-------ccCCHHHHHHHHHHcccCHhhCCCC
Confidence            00 0       1123456778889998 79999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-32  Score=303.07  Aligned_cols=248  Identities=19%  Similarity=0.326  Sum_probs=188.6

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCC----CCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPT----QHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~----~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +||||+++++++....    ....++|||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e   89 (272)
T cd06637          11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME   89 (272)
T ss_pred             HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence            467999999999999864 68999999986542 3346788999999998 7999999999986432    245799999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++++|.+++....   ...+++..+..++.|++.||+||| +++|+||||||+||+++ ++..+||+|||+++.....
T Consensus        90 ~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH-~~~ivh~dl~~~nili~-~~~~~~l~Dfg~~~~~~~~  164 (272)
T cd06637          90 FCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLH-QHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRT  164 (272)
T ss_pred             cCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCHHHEEEC-CCCCEEEccCCCceecccc
Confidence            999999999996532   245899999999999999999999 89999999999999998 5789999999998865432


Q ss_pred             CceeeeccCccccccchhcccCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          935 GTIEQILDAGVLGYRAPELAASK---KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                      ... .....|+..|+|||++.+.   ...++.++|||||||++|||++|+.||+....      ...+..  .....   
T Consensus       165 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~------~~~~~~--~~~~~---  232 (272)
T cd06637         165 VGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFL--IPRNP---  232 (272)
T ss_pred             ccc-CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH------HHHHHH--HhcCC---
Confidence            221 1223688999999998632   12347799999999999999999999864321      111111  11110   


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                        .+....       ......+.+++.+|+. +|.+|||+.||++
T Consensus       233 --~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         233 --APRLKS-------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --CCCCCC-------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              111111       1223457788889998 7999999999986

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1e-32  Score=302.64  Aligned_cols=249  Identities=20%  Similarity=0.257  Sum_probs=189.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++++.  ..+..++||||++++
T Consensus        14 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~--~~~~~~lv~e~~~~~   91 (267)
T cd06645          14 IQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL--RRDKLWICMEFCGGG   91 (267)
T ss_pred             HHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE--eCCEEEEEEeccCCC
Confidence            467999999999999854 68999999987654455567889999999999999999999885  567889999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++...     ..+++.++..++.|++.||.||| +.||+||||||+||+++ .++.+||+|||.+........ ..
T Consensus        92 ~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~-~~  163 (267)
T cd06645          92 SLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLH-SKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIA-KR  163 (267)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEC-CCCCEEECcceeeeEccCccc-cc
Confidence            999998542     45899999999999999999999 89999999999999998 578899999999876543221 11


Q ss_pred             eccCccccccchhcccCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          940 ILDAGVLGYRAPELAASK-KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      ....|+..|+|||++... ...++.++||||+||++|||++|+.||.......       .+.. .......   .+...
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-------~~~~-~~~~~~~---~~~~~  232 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-------ALFL-MTKSNFQ---PPKLK  232 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-------hHHh-hhccCCC---CCccc
Confidence            223689999999997421 1124779999999999999999999985432110       0000 0000000   00010


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      ..      ......+.+++.+|++ +|++||++++|++.
T Consensus       233 ~~------~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         233 DK------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cc------CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            00      0122356788889998 79999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2e-32  Score=298.41  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=192.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|++|.||++... +++.||+|++....  ....+.+.+|++++++++|||++++++.+.. .....++||||++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~e~~~   83 (257)
T cd08223           5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVMGFCE   83 (257)
T ss_pred             EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEecccC
Confidence            578999999999999954 57899999986432  3345678899999999999999999988742 3445789999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +++|.+++....   ...+++.++..++.|++.|++||| +.||+||||||+||+++ +++.++|+|||++.........
T Consensus        84 ~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH-~~~i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          84 GGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLH-EKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCchhEEEe-cCCcEEEecccceEEecccCCc
Confidence            999999997532   345899999999999999999999 99999999999999998 5889999999999876543222


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      . ....+++.|+|||+..+..+  +.++||||+||+++||++|+.||+..       +...+...... +....      
T Consensus       159 ~-~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~il~~l~~g~~~~~~~-------~~~~~~~~~~~-~~~~~------  221 (257)
T cd08223         159 A-STLIGTPYYMSPELFSNKPY--NYKSDVWALGCCVYEMATLKHAFNAK-------DMNSLVYRIIE-GKLPP------  221 (257)
T ss_pred             c-ccccCCcCccChhHhcCCCC--CchhhhHHHHHHHHHHHcCCCCCCCC-------CHHHHHHHHHh-cCCCC------
Confidence            1 22357889999999987765  77999999999999999999998642       22233222221 11110      


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                             ........+.+++.+|++ +|.+||++.|+++.
T Consensus       222 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         222 -------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -------CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                   011234567888999998 79999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-32  Score=299.97  Aligned_cols=243  Identities=23%  Similarity=0.337  Sum_probs=192.0

Q ss_pred             CCeeccccceEEEEEEEcC-CcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRATLEN-GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|+||.||+|...+ ++.+++|.++....  .+++.+|++++++++||||+++++++.  .....++++||++++
T Consensus         8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~l~~e~~~~~   83 (256)
T cd06612           8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF--KNTDLWIVMEYCGAG   83 (256)
T ss_pred             hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee--cCCcEEEEEecCCCC
Confidence            5789999999999999764 89999999875432  678999999999999999999999985  457899999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++...    ...+++..+..++.|++.||.||| +.+|+||||+|+||+++ +++.+||+|||++......... .
T Consensus        84 ~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh-~~~i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~~~~~-~  156 (256)
T cd06612          84 SVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLH-SNKKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAK-R  156 (256)
T ss_pred             cHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEEC-CCCcEEEcccccchhcccCccc-c
Confidence            999998543    246899999999999999999999 99999999999999998 5789999999999876544321 1


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ....++..|+|||++.+...  +.++|||||||++|+|++|+.||.......      ....  ......     +... 
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~--~~~~Di~s~G~il~~l~~g~~p~~~~~~~~------~~~~--~~~~~~-----~~~~-  220 (256)
T cd06612         157 NTVIGTPFWMAPEVIQEIGY--NNKADIWSLGITAIEMAEGKPPYSDIHPMR------AIFM--IPNKPP-----PTLS-  220 (256)
T ss_pred             ccccCCccccCHHHHhcCCC--CchhhHHHHHHHHHHHHhCCCCCCCcchhh------hhhh--hccCCC-----CCCC-
Confidence            22357889999999987754  789999999999999999999987532211      0000  000000     0000 


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                           ........+.+++.+|++ +|.+|||++||++
T Consensus       221 -----~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 -----DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -----chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence                 011223457788889998 7999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.8e-33  Score=317.14  Aligned_cols=192  Identities=19%  Similarity=0.247  Sum_probs=159.7

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCC----CCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGP----TQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----~~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|... .++.||||++....  ....+.+.+|+.+++.++||||+++++++...    .....++||
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~  108 (364)
T cd07875          29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM  108 (364)
T ss_pred             EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence            578999999999999854 68899999986532  23446778999999999999999999987532    123579999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+++ ++.+++..       .+++.++..++.|++.||+||| ++||+||||||+||+++ .++.+||+|||+++....
T Consensus       109 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         109 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGT  178 (364)
T ss_pred             eCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHh-hCCeecCCCCHHHEEEC-CCCcEEEEeCCCccccCC
Confidence            99964 77777732       3788999999999999999999 99999999999999998 588999999999986543


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ....  ....||..|+|||++.+..+  +.++|||||||++|||++|+.||..
T Consensus       179 ~~~~--~~~~~t~~y~aPE~~~~~~~--~~~~DiwSlG~il~ell~g~~pf~~  227 (364)
T cd07875         179 SFMM--TPYVVTRYYRAPEVILGMGY--KENVDIWSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             CCcc--cCCcccCCcCCHHHHhCCCC--CchhhHHhHHHHHHHHHhCCCCCCC
Confidence            3221  22368999999999987765  7799999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-33  Score=275.75  Aligned_cols=258  Identities=21%  Similarity=0.343  Sum_probs=194.9

Q ss_pred             CCCChhhhhccCCCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCC
Q 001527          769 LTLTPEELSRAPAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPT  845 (1060)
Q Consensus       769 ~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  845 (1060)
                      ...+..|+..  ...||.|+.|.||+++++ .|..+|||.++... ....+++...++++.+- ..|+||+.+|||.  .
T Consensus        87 ~~~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi--~  162 (391)
T KOG0983|consen   87 YQADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI--T  162 (391)
T ss_pred             cccChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe--e
Confidence            3445555554  467999999999999966 58999999997643 44557788888887766 4899999999997  4


Q ss_pred             CCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccc
Q 001527          846 QHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY  925 (1060)
Q Consensus       846 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Df  925 (1060)
                      ....++.||.|.. -++..+..-    .+++++.-.-++...+++||.||...++|+|||+||+|||+| +.+.+|+|||
T Consensus       163 n~dV~IcMelMs~-C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD-e~GniKlCDF  236 (391)
T KOG0983|consen  163 NTDVFICMELMST-CAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD-ERGNIKLCDF  236 (391)
T ss_pred             CchHHHHHHHHHH-HHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc-cCCCEEeecc
Confidence            5568899999843 455555432    356888888899999999999999788999999999999999 6889999999


Q ss_pred             ccceeeccCCceeeeccCccccccchhcccCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHH
Q 001527          926 CLHRLMTQAGTIEQILDAGVLGYRAPELAASK-KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKV 1004 (1060)
Q Consensus       926 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~ 1004 (1060)
                      |.+..+.+.......  +|.+.|||||.+.-. ...|+.++||||||+.++|+.||+.||.....+   .+.   +....
T Consensus       237 GIsGrlvdSkAhtrs--AGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---Fe~---ltkvl  308 (391)
T KOG0983|consen  237 GISGRLVDSKAHTRS--AGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---FEV---LTKVL  308 (391)
T ss_pred             cccceeecccccccc--cCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---HHH---HHHHH
Confidence            999887766554433  799999999999754 445688999999999999999999999753211   111   11111


Q ss_pred             hcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1005 AEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1005 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .+.      -|.+.+..      .....+.+++..|++ |+.+||...++++.
T Consensus       309 n~e------PP~L~~~~------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  309 NEE------PPLLPGHM------GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             hcC------CCCCCccc------CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            111      12222211      234567788889997 79999999998763

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.1e-33  Score=313.74  Aligned_cols=198  Identities=20%  Similarity=0.269  Sum_probs=166.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||+||+++.. +++.||+|++....   ....+.+.+|+.++..++|++|+++++++.  +.+..|+||||+
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~--~~~~~~lv~Ey~   83 (331)
T cd05624           6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ--DENYLYLVMDYY   83 (331)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEEEEeCC
Confidence            478999999999999965 68899999986532   223455788999999999999999999885  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...    ...+++..+..++.|++.||+||| +++|+||||||+||+++ .++.+||+|||+++.......
T Consensus        84 ~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH-~~~iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          84 VGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIH-QLHYVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             CCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCchHHEEEc-CCCCEEEEeccceeeccCCCc
Confidence            999999999653    235889999999999999999999 99999999999999998 578999999999987655443


Q ss_pred             eeeeccCccccccchhcccCCC---CCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          937 IEQILDAGVLGYRAPELAASKK---PHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~---~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      .......||+.|+|||++.+..   ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            3333346999999999987521   1237799999999999999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.1e-33  Score=313.72  Aligned_cols=196  Identities=23%  Similarity=0.293  Sum_probs=165.9

Q ss_pred             hccCCCeeccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcCC-C-----CceeeeeeEEeCCCCCce
Q 001527          777 SRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR-H-----PNVVGLRGYYWGPTQHEK  849 (1060)
Q Consensus       777 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~l~~~~~~~~~~~~  849 (1060)
                      .|...++||+|+||.|-+|.. .+++.||||+++... ....+-..|+.+|..++ |     -|+|++++||.  ..++.
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~--fr~Hl  263 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY--FRNHL  263 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc--cccce
Confidence            345568999999999999984 579999999998763 34456678999999996 4     48999999996  67899


Q ss_pred             EEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEee-CCCCCeEEcccccc
Q 001527          850 LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD-GPDLNARVADYCLH  928 (1060)
Q Consensus       850 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~-~~~~~~kl~Dfg~a  928 (1060)
                      |||+|.+ ..+|.+++..+.   ...++...++.|+.||+.||.+|| +.+|||+||||+|||+. .....+||+|||.+
T Consensus       264 ciVfELL-~~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~-~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLH-ELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeehhh-hhhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCChhheeeccCCcCceeEEecccc
Confidence            9999999 559999997754   345999999999999999999999 99999999999999994 23457999999999


Q ss_pred             eeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          929 RLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ........  +  ..-+..|+|||++.|.++  +.+.||||||||++||++|.+-|..
T Consensus       339 c~~~q~vy--t--YiQSRfYRAPEVILGlpY--~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  339 CFESQRVY--T--YIQSRFYRAPEVILGLPY--DTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             cccCCcce--e--eeeccccccchhhccCCC--CCccceeehhhhHHhHhcCccccCC
Confidence            87655433  1  256789999999999987  8899999999999999999776654

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-33  Score=316.68  Aligned_cols=188  Identities=24%  Similarity=0.325  Sum_probs=156.4

Q ss_pred             ccCCCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          778 RAPAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      |...+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++.  .....++||||+
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~  139 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV--SGAITCMVLPHY  139 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE--eCCeeEEEEEcc
Confidence            445678999999999999965 5788999986543      2346999999999999999999985  456789999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      . ++|.+++...    ...+++.++..|+.||+.||+||| +++|+||||||+|||++ .+..+||+|||.++.......
T Consensus       140 ~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~  212 (357)
T PHA03209        140 S-SDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLH-AQRIIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPA  212 (357)
T ss_pred             C-CcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEC-CCCCEEEecCccccccccCcc
Confidence            4 6899888543    246899999999999999999999 99999999999999998 578899999999875432222


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCC
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAG  984 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~  984 (1060)
                      .  ....||..|+|||++.+..+  +.++|||||||++|||+++..|+
T Consensus       213 ~--~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        213 F--LGLAGTVETNAPEVLARDKY--NSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             c--ccccccccccCCeecCCCCC--CchhhHHHHHHHHHHHHHcCCcc
Confidence            1  12368999999999987765  78999999999999999866554

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.4e-33  Score=309.88  Aligned_cols=244  Identities=20%  Similarity=0.308  Sum_probs=191.3

Q ss_pred             CCCeeccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          780 PAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      ..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|++++++++||||+++++++.  .....++|+||+++
T Consensus        23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~  100 (296)
T cd06655          23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL--VGDELFVVMEYLAG  100 (296)
T ss_pred             EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe--cCceEEEEEEecCC
Confidence            357899999999999984 578999999987554445677889999999999999999999985  46689999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++..      ..+++.++..++.|++.||+||| +.|++||||||+||+++ +++.+||+|||++..........
T Consensus       101 ~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH-~~~i~H~dL~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~  172 (296)
T cd06655         101 GSLTDVVTE------TCMDEAQIAAVCRECLQALEFLH-ANQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKR  172 (296)
T ss_pred             CcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEC-CCCCEEEccCccchhcccccccC
Confidence            999999853      24899999999999999999999 99999999999999998 58899999999987654332211


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                       ....++..|+|||.+.+...  +.++|||||||++|+|++|+.||.....       .+........ .......    
T Consensus       173 -~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slGvil~~lltg~~pf~~~~~-------~~~~~~~~~~-~~~~~~~----  237 (296)
T cd06655         173 -STMVGTPYWMAPEVVTRKAY--GPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATN-GTPELQN----  237 (296)
T ss_pred             -CCcCCCccccCcchhcCCCC--CchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhc-CCcccCC----
Confidence             12358889999999987654  7799999999999999999999865321       1111111111 1100000    


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                             .......+.+++.+|+. +|.+||++.+|++
T Consensus       238 -------~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         238 -------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -------cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                   01223456678889998 7999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.3e-33  Score=291.29  Aligned_cols=198  Identities=23%  Similarity=0.292  Sum_probs=167.6

Q ss_pred             CCeeccccceEEEEEEEcC-CcEEEEEEcccchHH---HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLEN-GMFLTVKWLREGVAK---QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|.-|+||+|+.++ +..+|+|++.+....   ...+.+.|.+||+.++||.++.+|+.|  +..+..|+|||||
T Consensus        82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~~cl~meyC  159 (459)
T KOG0610|consen   82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKYSCLVMEYC  159 (459)
T ss_pred             HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee--eccceeEEEEecC
Confidence            3679999999999999764 699999999876433   335677899999999999999999999  4677899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC-
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG-  935 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~-  935 (1060)
                      +||+|....+.+.   +..+++..++.++.+|+-||+||| ..|||.|||||+||||. +++++.|+||.++....... 
T Consensus       160 pGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLH-mlGivYRDLKPENILvr-edGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  160 PGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLH-MLGIVYRDLKPENILVR-EDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             CCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHH-hhceeeccCCcceeEEe-cCCcEEeeeccccccCCCCCe
Confidence            9999999987644   456999999999999999999999 99999999999999998 69999999999865321100 


Q ss_pred             --------------------------------c----------------------eeeeccCccccccchhcccCCCCCC
Q 001527          936 --------------------------------T----------------------IEQILDAGVLGYRAPELAASKKPHP  961 (1060)
Q Consensus       936 --------------------------------~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~  961 (1060)
                                                      .                      ......+||-.|.|||++.|..-  
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH--  312 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH--  312 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC--
Confidence                                            0                      00011368999999999999876  


Q ss_pred             CCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          962 SFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       962 s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      +.++|+|+|||++|||+.|+.||...
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~  338 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGS  338 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCC
Confidence            77999999999999999999999764

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.4e-32  Score=299.27  Aligned_cols=246  Identities=22%  Similarity=0.351  Sum_probs=190.1

Q ss_pred             CCCeeccccceEEEEEEEcCCcEEEEEEcccch------HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          780 PAEVLGRSSHGTSYRATLENGMFLTVKWLREGV------AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      ..+.||+|+||+||+|...+++.+|+|.++...      ....+.+.+|++++++++|+||+++++++.  +....++||
T Consensus         4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~   81 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL--DDNTISIFM   81 (265)
T ss_pred             ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee--cCCeEEEEE
Confidence            357899999999999998889999999886321      223456889999999999999999999995  457899999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+++++|.+++...     .++++..+..++.|++.||+||| +.+|+|+||||+||+++ +++.+||+|||.+.....
T Consensus        82 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          82 EFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLH-NNCVVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             ecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcCHHhEEEC-CCCeEEeccchhhHhhhh
Confidence            999999999999542     35789999999999999999999 99999999999999998 588999999999876432


Q ss_pred             CC-----ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCC
Q 001527          934 AG-----TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008 (1060)
Q Consensus       934 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 1008 (1060)
                      ..     ........|+..|+|||++.+..+  +.++|||||||++|||++|+.||.....      .............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~--~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~~  226 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGY--GRKSDIWSIGCTVFEMATGKPPLASMDR------LAAMFYIGAHRGL  226 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCC--cchhhHHHHHHHHHHHHhCCCccccCCh------HHHHHHhhhccCC
Confidence            11     111112358889999999987664  7799999999999999999999964311      1111111110000


Q ss_pred             CCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1009 GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1009 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                           .+.+.        ......+.+++.+|++ +|.+||++.|+++
T Consensus       227 -----~~~~~--------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 -----MPRLP--------DSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -----CCCCC--------CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 11111        1233456788889997 7999999999975

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.6e-33  Score=310.93  Aligned_cols=260  Identities=19%  Similarity=0.264  Sum_probs=187.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++.  .....++||||++ 
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~--~~~~~~lv~e~~~-   87 (301)
T cd07873          11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH--TEKSLTLVFEYLD-   87 (301)
T ss_pred             eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe--cCCeEEEEEeccc-
Confidence            478999999999999865 68899999986432 223346778999999999999999999985  5668999999997 


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++...    ...+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||++..........
T Consensus        88 ~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH-~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          88 KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCH-RRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCHHHEEEC-CCCcEEECcCcchhccCCCCCcc
Confidence            5999988643    235889999999999999999999 99999999999999998 57899999999987644322111


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhc---CCCCcccc-
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAE---GHGSDCFD- 1014 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d- 1014 (1060)
                       ....++..|+|||++.+.. .++.++|||||||++|||++|+.||......    .....+......   .......+ 
T Consensus       162 -~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         162 -SNEVVTLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE----EQLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             -cccceeecccCcHHHhCCC-CCccHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCChhhchhhhcc
Confidence             1225688999999987644 2477999999999999999999998743211    111111110000   00000000 


Q ss_pred             --------cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1015 --------AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1015 --------~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                              +.................+.+++.+|++ +|.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                    0000000000011223456788999998 7999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.3e-33  Score=304.60  Aligned_cols=242  Identities=20%  Similarity=0.325  Sum_probs=190.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++||||+++++++.  .....++||||+++
T Consensus         9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~   86 (277)
T cd06642           9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL--KGTKLWIIMEYLGG   86 (277)
T ss_pred             HHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc--cCCceEEEEEccCC
Confidence            357999999999999854 68899999987432 334567899999999999999999999985  56679999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++..      ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++ +++.+|++|||++..........
T Consensus        87 ~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH-~~~ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          87 GSALDLLKP------GPLEETYIATILREILKGLDYLH-SERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             CcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh-cCCeeccCCChheEEEe-CCCCEEEccccccccccCcchhh
Confidence            999999843      34889999999999999999999 89999999999999998 58899999999987655432211


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                       ....|+..|+|||++.+..+  +.++|||||||++|||++|+.|+......    .   +.. ......     .+.+ 
T Consensus       159 -~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~il~el~tg~~p~~~~~~~----~---~~~-~~~~~~-----~~~~-  221 (277)
T cd06642         159 -NTFVGTPFWMAPEVIKQSAY--DFKADIWSLGITAIELAKGEPPNSDLHPM----R---VLF-LIPKNS-----PPTL-  221 (277)
T ss_pred             -hcccCcccccCHHHhCcCCC--chhhhHHHHHHHHHHHHhCCCCCcccchh----h---HHh-hhhcCC-----CCCC-
Confidence             12357889999999987654  77999999999999999999998643211    1   111 111110     1111 


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                             .......+.+++.+|++ +|.+||+|.||++.
T Consensus       222 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 -------EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             -------CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                   11234567788899998 79999999999874

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.4e-32  Score=297.28  Aligned_cols=242  Identities=28%  Similarity=0.432  Sum_probs=189.1

Q ss_pred             CCCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          780 PAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      ..+.||+|+||.||++.. +++.||+|.++...  ..+.+.+|+.++++++||||+++++++.   .+..++||||++++
T Consensus        10 ~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~---~~~~~~v~e~~~~~   83 (254)
T cd05083          10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL---HNGLYIVMELMSKG   83 (254)
T ss_pred             eeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEc---CCCcEEEEECCCCC
Confidence            357899999999999975 57889999987542  3467889999999999999999999984   23479999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++....   ...+++.++..++.|++.||.||| +.|++||||||+||+++ .++.+||+|||.++.......   
T Consensus        84 ~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH-~~~~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~~~~~---  155 (254)
T cd05083          84 NLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLE-SKKLVHRDLAARNILVS-EDGVAKVSDFGLARVGSMGVD---  155 (254)
T ss_pred             CHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccCcceEEEc-CCCcEEECCCccceeccccCC---
Confidence            9999996532   235889999999999999999999 99999999999999998 578999999999876432211   


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                       ....+..|+|||++.+..+  +.++|||||||++|||++ |+.||....       ..++... ...+...   ++   
T Consensus       156 -~~~~~~~y~~pe~~~~~~~--~~~~Dv~slG~~l~el~~~g~~p~~~~~-------~~~~~~~-~~~~~~~---~~---  218 (254)
T cd05083         156 -NSKLPVKWTAPEALKHKKF--SSKSDVWSYGVLLWEVFSYGRAPYPKMS-------LKEVKEC-VEKGYRM---EP---  218 (254)
T ss_pred             -CCCCCceecCHHHhccCCc--CchhhHHHHHHHHHHHHhCCCCCCccCC-------HHHHHHH-HhCCCCC---CC---
Confidence             1134567999999877654  779999999999999998 999986431       2222221 1111110   00   


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                             .......+.+++.+|++ +|.+||++++|++.|+.
T Consensus       219 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 -------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                   01234567788899998 79999999999999864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-32  Score=311.92  Aligned_cols=198  Identities=20%  Similarity=0.278  Sum_probs=165.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .++||+|+||+||+++.. +++.||+|++.+..   ....+.+.+|+.++..++||+|+++++++.  +....++||||+
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~ey~   83 (332)
T cd05623           6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ--DENNLYLVMDYY   83 (332)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCEEEEEEecc
Confidence            478999999999999965 57889999986432   123345888999999999999999999885  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++...    ...+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||+++.......
T Consensus        84 ~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH-~~~iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          84 VGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVH-QLHYVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             CCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEEC-CCCCEEEeecchheecccCCc
Confidence            999999999643    235899999999999999999999 99999999999999998 588999999999976544433


Q ss_pred             eeeeccCccccccchhcccCC---CCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          937 IEQILDAGVLGYRAPELAASK---KPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      .......||+.|+|||++...   ...++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence            333334799999999998631   11247799999999999999999999974

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=311.13  Aligned_cols=254  Identities=25%  Similarity=0.412  Sum_probs=200.6

Q ss_pred             CChhhhhccCCCeeccccceEEEEEEEc--CC--cEEEEEEcccchHH-HHHHHHHHHHHHhcCCCCceeeeeeEEeCCC
Q 001527          771 LTPEELSRAPAEVLGRSSHGTSYRATLE--NG--MFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYWGPT  845 (1060)
Q Consensus       771 ~~~~~l~~~~~~~iG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  845 (1060)
                      +..+++..  .|+||+|.||.|++|.|.  +|  ..||||.++.+... ...+|.+|+.+|.+|+|||++++||+..+  
T Consensus       107 Ipee~i~l--~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--  182 (1039)
T KOG0199|consen  107 IPEEQIKL--YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--  182 (1039)
T ss_pred             ccHHHHHH--HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--
Confidence            44444443  578999999999999976  34  46899999876544 56899999999999999999999999963  


Q ss_pred             CCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccc
Q 001527          846 QHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY  925 (1060)
Q Consensus       846 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Df  925 (1060)
                       ....+|||.++.|+|.+.|+..   ....+-......++.|||.|+.||. .++.|||||-..|+|+.. ...+||+||
T Consensus       183 -qp~mMV~ELaplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLe-skrlvHRDLAARNlllas-prtVKI~DF  256 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLE-SKRLVHRDLAARNLLLAS-PRTVKICDF  256 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhhhheecc-cceeeeecc
Confidence             4567999999999999999872   2356888889999999999999999 999999999999999974 668999999


Q ss_pred             ccceeeccCCceeeec--cCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHH
Q 001527          926 CLHRLMTQAGTIEQIL--DAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQL 1002 (1060)
Q Consensus       926 g~a~~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~ 1002 (1060)
                      |+.+.+.....+....  ..-.+.|+|||.+...++  +.++|||+|||++|||+| |..||-...+    ..+.+-   
T Consensus       257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kF--ShaSDvWmyGVTiWEMFtyGEePW~G~~g----~qIL~~---  327 (1039)
T KOG0199|consen  257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKF--SHASDVWMYGVTIWEMFTYGEEPWVGCRG----IQILKN---  327 (1039)
T ss_pred             cceeccCCCCcceEecCCCcCcccccCHhHhccccc--cccchhhhhhhhHHhhhccCCCCCCCCCH----HHHHHh---
Confidence            9999887665443221  223567999999999887  789999999999999999 7889875422    111111   


Q ss_pred             HHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHh
Q 001527         1003 KVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDL 1057 (1060)
Q Consensus      1003 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L 1057 (1060)
                       +.++        +..     +..+.+.+.+.+++..||. .|++|||+..|++.+
T Consensus       328 -iD~~--------erL-----pRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  328 -IDAG--------ERL-----PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             -cccc--------ccC-----CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence             1111        111     1223567889999999998 799999999997543

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2e-32  Score=305.92  Aligned_cols=247  Identities=25%  Similarity=0.392  Sum_probs=188.9

Q ss_pred             CCeeccccceEEEEEEEc-CCc----EEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGM----FLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+|+.. +|.    .||+|.+.... .....++.+|+.++++++||||+++++++..   ...++++|
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~~~v~e   88 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTIQLVTQ   88 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCceeeeh
Confidence            578999999999999853 454    57889887543 2334578899999999999999999999852   34679999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++|+|.+++....    ..+++..+..++.|++.||+||| +++|+||||||+||+++ ++..+||+|||+++.....
T Consensus        89 ~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          89 LMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLE-ERRLVHRDLAARNVLVK-SPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             hcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHh-hcCeeccccccceeeec-CCCceEEccccccccccCc
Confidence            999999999986432    35889999999999999999999 99999999999999998 5778999999999876433


Q ss_pred             Cce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          935 GTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       935 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ... ......++..|+|||++.+..+  +.++|||||||++|||++ |+.||....    .....+++    ..+...  
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~DiwslG~~l~el~t~g~~p~~~~~----~~~~~~~~----~~~~~~--  230 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKF--THQSDVWSYGVTIWELMTFGGKPYDGIP----TREIPDLL----EKGERL--  230 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCC--ChHHHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHH----HCCCCC--
Confidence            221 1112245678999999977664  789999999999999997 899986421    11122222    111100  


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ..+           ......+.+++..|+. +|++||+++|+++.|+.
T Consensus       231 ~~~-----------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~  267 (303)
T cd05110         231 PQP-----------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR  267 (303)
T ss_pred             CCC-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            000           1123457788899997 79999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.7e-33  Score=305.70  Aligned_cols=248  Identities=26%  Similarity=0.418  Sum_probs=190.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHH--HHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQR--KEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||+||+|+.. +++.||+|++........  ....+|+.++++++||||+++++++.  .....++||||++
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~~v~~~~~   81 (260)
T PF00069_consen    4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ--DDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE--ESSEEEEEEEEET
T ss_pred             eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc--ccccccccccccc
Confidence            478999999999999966 577999999986544332  23456999999999999999999996  4678899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +++|.+++..     ...+++.++..++.|+++||+||| +.+|+||||||+||+++ +++.++|+|||.+....... .
T Consensus        82 ~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh-~~~i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~-~  153 (260)
T PF00069_consen   82 GGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLH-SKGIVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENN-E  153 (260)
T ss_dssp             TEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHH-HTTEEESSBSGGGEEES-TTSEEEESSGTTTEESTSTT-S
T ss_pred             cccccccccc-----cccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccccccccc-c
Confidence            9999999962     245899999999999999999999 89999999999999999 68899999999998642222 2


Q ss_pred             eeeccCccccccchhccc-CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          938 EQILDAGVLGYRAPELAA-SKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~-~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      ......++..|+|||++. +...  +.++||||+|+++|+|++|+.||....    ..+...........    . ....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~--~~~~Di~slG~il~~l~~~~~p~~~~~----~~~~~~~~~~~~~~----~-~~~~  222 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKY--TRKSDIWSLGIILYELLTGKLPFEESN----SDDQLEIIEKILKR----P-LPSS  222 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSB--STHHHHHHHHHHHHHHHHSSSSSTTSS----HHHHHHHHHHHHHT----H-HHHH
T ss_pred             ccccccccccccccccccccccc--ccccccccccccccccccccccccccc----chhhhhhhhhcccc----c-cccc
Confidence            223347899999999988 4444  789999999999999999999987531    00111111111110    0 0000


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ..      ........+.+++..|++ +|.+||+++|+++
T Consensus       223 ~~------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  223 SQ------QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TT------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cc------ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00      001113678889999998 7999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.5e-32  Score=295.41  Aligned_cols=246  Identities=20%  Similarity=0.321  Sum_probs=194.4

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .++||+|+||.||.++. .+++.+++|.+...  .....+++.+|++++++++|+||+++++++.  +....++||||++
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~~~e~~~   82 (256)
T cd08221           5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM--DDNTLLIEMEYAN   82 (256)
T ss_pred             eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe--cCCeEEEEEEecC
Confidence            57899999999999984 46899999987643  2344567889999999999999999999995  4568899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +++|.+++....   ...+++.++..++.|++.||+||| +.+++||||||+||+++ ++..+||+|||.+.........
T Consensus        83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~~~~~  157 (256)
T cd08221          83 GGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIH-KAGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSM  157 (256)
T ss_pred             CCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCChHhEEEe-CCCCEEECcCcceEEccccccc
Confidence            999999996542   346899999999999999999999 89999999999999998 5789999999999876544321


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                       .....|+..|+|||+..+...  +.++||||||+++|||++|+.||+..       ...+....... +.....     
T Consensus       158 -~~~~~~~~~y~ape~~~~~~~--~~~~Dv~slG~i~~~l~~g~~~~~~~-------~~~~~~~~~~~-~~~~~~-----  221 (256)
T cd08221         158 -AETVVGTPYYMSPELCQGVKY--NFKSDIWALGCVLYELLTLKRTFDAT-------NPLNLVVKIVQ-GNYTPV-----  221 (256)
T ss_pred             -ccccCCCccccCHhhcCCCCC--CCcchhHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHc-CCCCCC-----
Confidence             122368899999999987654  77999999999999999999998642       12222222221 111100     


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHh
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDL 1057 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L 1057 (1060)
                              .......+.+++.+|++ +|.+||+++|+++.+
T Consensus       222 --------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 --------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             --------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                    01234457788889997 799999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.1e-32  Score=301.14  Aligned_cols=247  Identities=19%  Similarity=0.289  Sum_probs=190.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .++||+|+||.||+|+.. +++.||+|.+........+.+.+|++++++++||||+++++++.  .....++||||++++
T Consensus        17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~   94 (292)
T cd06644          17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY--WDGKLWIMIEFCPGG   94 (292)
T ss_pred             hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE--eCCeEEEEEecCCCC
Confidence            467999999999999965 58999999998766666778999999999999999999999885  456899999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|..++...    ...+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||.+.......... 
T Consensus        95 ~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~-  167 (292)
T cd06644          95 AVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLH-SMKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRR-  167 (292)
T ss_pred             cHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh-cCCeeecCCCcceEEEc-CCCCEEEccCccceecccccccc-
Confidence            999887543    235899999999999999999999 89999999999999998 57899999999987543322111 


Q ss_pred             eccCccccccchhcccCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          940 ILDAGVLGYRAPELAASK---KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      ....++..|+|||++.+.   ...++.++|||||||++|||++|+.||.....       ........ ....     +.
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~-~~~~-----~~  234 (292)
T cd06644         168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKIA-KSEP-----PT  234 (292)
T ss_pred             ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHHh-cCCC-----cc
Confidence            123578899999998532   12236789999999999999999999864211       11111111 1110     00


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ..      ........+.+++.+|++ +|++||+++||++
T Consensus       235 ~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         235 LS------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CC------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00      011223457788899998 7999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-33  Score=316.77  Aligned_cols=240  Identities=20%  Similarity=0.232  Sum_probs=178.8

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEcccchHH---HHHHHHHHHHHHhcC---CCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          784 LGRSSHGTSYRATLE-NGMFLTVKWLREGVAK---QRKEFAKEAKKFANI---RHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       784 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ||+|+||+||+|+.. +++.||+|++......   ....+..|..++.+.   +||||+++++++.  .....++||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~--~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ--TDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe--cCCeEEEEEcCC
Confidence            699999999999865 6899999998643221   223455677777665   6999999999884  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++|+|.+++..     ...+++..+..++.||+.||+||| +++|+||||||+|||++ .++.+||+|||+++.......
T Consensus        79 ~~g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH-~~~ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~  151 (330)
T cd05586          79 SGGELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLH-KYDIVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNK  151 (330)
T ss_pred             CCChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCC
Confidence            99999999853     245899999999999999999999 99999999999999998 578999999999875432222


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      . .....||..|+|||++.+... ++.++||||+||++|||++|+.||...       +..+.... +..+..      .
T Consensus       152 ~-~~~~~gt~~y~aPE~~~~~~~-~~~~~DvwslGvil~elltG~~Pf~~~-------~~~~~~~~-i~~~~~------~  215 (330)
T cd05586         152 T-TNTFCGTTEYLAPEVLLDEKG-YTKHVDFWSLGVLVFEMCCGWSPFYAE-------DTQQMYRN-IAFGKV------R  215 (330)
T ss_pred             C-ccCccCCccccCHHHHcCCCC-CCCccceeccccEEEEeccCCCCCCCC-------CHHHHHHH-HHcCCC------C
Confidence            1 122368999999999876542 478999999999999999999998642       11122221 111111      0


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCC----HHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPG----IKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs----~~evl~ 1055 (1060)
                      +...       .....+.+++.+|++ +|.+||+    +.|+++
T Consensus       216 ~~~~-------~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         216 FPKN-------VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCCc-------cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0000       122345677889998 7999984    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.2e-32  Score=301.93  Aligned_cols=252  Identities=19%  Similarity=0.291  Sum_probs=189.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeC---CCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWG---PTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~---~~~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|+.. +++.+|+|+++... .....+.+|+.+++++ +||||+++++++..   ..+...++||||
T Consensus        23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~  101 (286)
T cd06638          23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLEL  101 (286)
T ss_pred             eeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence            478999999999999864 68899999886532 2345678899999999 69999999998853   234568999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++++|.++++... .....+++..+..++.|++.||.||| +.+|+||||||+||+++ +++.+||+|||+++......
T Consensus       102 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~  178 (286)
T cd06638         102 CNGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLH-VNKTIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTR  178 (286)
T ss_pred             cCCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHH-hCCccccCCCHHhEEEC-CCCCEEEccCCceeecccCC
Confidence            99999999886432 22356889999999999999999999 99999999999999998 57789999999988764432


Q ss_pred             ceeeeccCccccccchhcccCCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          936 TIEQILDAGVLGYRAPELAASKK---PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ... ....|+..|+|||++....   ..++.++||||+||++|||++|+.||......      ..+..  .........
T Consensus       179 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~------~~~~~--~~~~~~~~~  249 (286)
T cd06638         179 LRR-NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM------RALFK--IPRNPPPTL  249 (286)
T ss_pred             Ccc-ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh------HHHhh--ccccCCCcc
Confidence            221 2236899999999985321   12477999999999999999999998643211      11110  000000011


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .++.           .....+.+++.+|++ +|++|||+.||++.
T Consensus       250 ~~~~-----------~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         250 HQPE-----------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cCCC-----------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            1110           122457788889998 79999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.3e-32  Score=299.58  Aligned_cols=257  Identities=23%  Similarity=0.296  Sum_probs=195.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||.|++|.||+|... +++.+|+|++..... ....++.+|++++++++||||++++++|........++||||+++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   85 (287)
T cd06621           6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG   85 (287)
T ss_pred             EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence            368999999999999964 689999999875422 345678999999999999999999999976566678999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++.... .....+++..+..++.|++.||+||| +.+++|+||+|+||+++ ++..++|+|||++......... 
T Consensus        86 ~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~lH-~~~i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~-  161 (287)
T cd06621          86 GSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLH-SRKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAG-  161 (287)
T ss_pred             CCHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEe-cCCeEEEeeccccccccccccc-
Confidence            99999875432 22356889999999999999999999 99999999999999998 5778999999998765432221 


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                        ...++..|+|||.+.+..+  +.++||||+||++|||++|+.||+.....  .....+....... ...... .... 
T Consensus       162 --~~~~~~~y~~pE~~~~~~~--~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~-~~~~~~-~~~~-  232 (287)
T cd06621         162 --TFTGTSFYMAPERIQGKPY--SITSDVWSLGLTLLEVAQNRFPFPPEGEP--PLGPIELLSYIVN-MPNPEL-KDEP-  232 (287)
T ss_pred             --cccCCccccCHHHhcCCCC--CchhhHHHHHHHHHHHHhCCCCCCcccCC--CCChHHHHHHHhc-CCchhh-ccCC-
Confidence              2257888999999987654  77999999999999999999999754321  0111222211111 111110 0000 


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                           +........+.+++.+|++ +|.+|||+.||++
T Consensus       233 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         233 -----GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -----CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence                 0001234567889999998 7999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-32  Score=302.96  Aligned_cols=247  Identities=24%  Similarity=0.381  Sum_probs=191.6

Q ss_pred             CCeeccccceEEEEEEEc-CCc----EEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGM----FLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+|... +|.    .+|+|..+... ......+.+|++++++++||||+++++++..   ...++|||
T Consensus        12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e   88 (279)
T cd05057          12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQVQLITQ   88 (279)
T ss_pred             cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---CceEEEEe
Confidence            578999999999999854 333    58999887553 3345678899999999999999999999963   67899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++|+|.+++....    ..+++..+..++.|++.||+||| +++|+||||||+||+++ ++..+||+|||.++.....
T Consensus        89 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH-~~~i~H~di~p~nil~~-~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          89 LMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLE-EKRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             cCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH-hCCEEecccCcceEEEc-CCCeEEECCCcccccccCc
Confidence            999999999996532    34899999999999999999999 89999999999999998 5778999999999876533


Q ss_pred             Cceee-eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          935 GTIEQ-ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       935 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ..... ....++..|+|||.+....+  +.++|||||||++||+++ |+.||+...       ..++..... .+...  
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~--~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~~~~~~~~-~~~~~--  230 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIY--THKSDVWSYGVTVWELMTFGAKPYEGIP-------AVEIPDLLE-KGERL--  230 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCc--CchhhHHHHHHHHHHHhcCCCCCCCCCC-------HHHHHHHHh-CCCCC--
Confidence            22211 11123568999999876654  779999999999999998 999987532       222222221 11110  


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ..+           ......+.+++.+|+. +|.+||++.++++.|++
T Consensus       231 ~~~-----------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~  267 (279)
T cd05057         231 PQP-----------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSK  267 (279)
T ss_pred             CCC-----------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            000           1122356788889997 79999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-32  Score=313.10  Aligned_cols=192  Identities=22%  Similarity=0.309  Sum_probs=159.8

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceeeeeeEEeCC----CCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVA--KQRKEFAKEAKKFANIRHPNVVGLRGYYWGP----TQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----~~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|.. .+++.||||+++....  ...+.+.+|++++++++||||+++++++...    .....++++
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   99 (343)
T cd07878          20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT   99 (343)
T ss_pred             heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence            47899999999999985 4688999999875322  2345677899999999999999999887522    123578999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      |++ +++|.+++..      ..+++.++..++.||+.||+||| +.||+||||||+||+++ +++.+||+|||+++....
T Consensus       100 ~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878         100 NLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIH-SAGIIHRDLKPSNVAVN-EDCELRILDFGLARQADD  170 (343)
T ss_pred             ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH-HCCeecccCChhhEEEC-CCCCEEEcCCccceecCC
Confidence            988 7899888743      34899999999999999999999 99999999999999998 588999999999986543


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ..    ....||..|+|||++.+.. .++.++|||||||++|||++|+.||..
T Consensus       171 ~~----~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         171 EM----TGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             Cc----CCccccccccCchHhcCCc-cCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            22    1236899999999987643 247899999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.9e-32  Score=300.83  Aligned_cols=251  Identities=22%  Similarity=0.312  Sum_probs=192.2

Q ss_pred             CCeeccccceEEEEEEEcC--CcEEEEEEcccc----------hHHHHHHHHHHHHHHhc-CCCCceeeeeeEEeCCCCC
Q 001527          781 AEVLGRSSHGTSYRATLEN--GMFLTVKWLREG----------VAKQRKEFAKEAKKFAN-IRHPNVVGLRGYYWGPTQH  847 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~  847 (1060)
                      .+.||+|+||.||+|....  ++.+|+|.+...          ......++.+|+.++.+ ++||||+++++++.  ..+
T Consensus         5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~--~~~   82 (269)
T cd08528           5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL--END   82 (269)
T ss_pred             hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc--cCC
Confidence            4679999999999999654  788999987532          12234567788888865 79999999999985  567


Q ss_pred             ceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccc
Q 001527          848 EKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL  927 (1060)
Q Consensus       848 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~  927 (1060)
                      ..++||||+++++|.+++.... .....+++..+++++.|++.||.|||...+++||||||+||+++ .++.+||+|||.
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~-~~~~~~l~dfg~  160 (269)
T cd08528          83 RLYIVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGL  160 (269)
T ss_pred             eEEEEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC-CCCcEEEecccc
Confidence            8999999999999999885432 22346899999999999999999999447899999999999998 588999999999


Q ss_pred             ceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC
Q 001527          928 HRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG 1007 (1060)
Q Consensus       928 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 1007 (1060)
                      +.......  ......|+..|+|||++.+..+  +.++||||||+++|||++|+.||...       .......... ..
T Consensus       161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~--~~~~Dv~slG~ll~~l~~g~~p~~~~-------~~~~~~~~~~-~~  228 (269)
T cd08528         161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPY--GEKADVWAFGCILYQMCTLQPPFYST-------NMLSLATKIV-EA  228 (269)
T ss_pred             eeeccccc--ccccccCcccCcChhhhcCCCC--chHHHHHHHHHHHHHHHhCCCccccc-------CHHHHHHHHh-hc
Confidence            98755433  2223368899999999987654  77999999999999999999998642       1122222111 11


Q ss_pred             CCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1008 HGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1008 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ...    +.. .       ......+.+++.+|++ +|.+||++.||.++++.
T Consensus       229 ~~~----~~~-~-------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         229 VYE----PLP-E-------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             cCC----cCC-c-------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            111    000 0       0123457788889998 79999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-32  Score=300.05  Aligned_cols=248  Identities=23%  Similarity=0.341  Sum_probs=191.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||.|+||.||+|+.. +++.||+|+++.......+.+.+|++++++++||||+++++++.  .....++||||++++
T Consensus        10 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~   87 (280)
T cd06611          10 IGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF--YENKLWILIEFCDGG   87 (280)
T ss_pred             HHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe--cCCeEEEEeeccCCC
Confidence            467999999999999964 68999999998666666678999999999999999999999985  566889999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++...    ...+++.++..++.|++.||.||| +.+|+||||||+||+++ .++.+||+|||.+.......... 
T Consensus        88 ~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~-  160 (280)
T cd06611          88 ALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLH-SHKVIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKR-  160 (280)
T ss_pred             cHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEEC-CCCCEEEccCccchhhccccccc-
Confidence            999998643    245899999999999999999999 99999999999999998 58899999999887654322211 


Q ss_pred             eccCccccccchhcccCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          940 ILDAGVLGYRAPELAASK---KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      ....++..|+|||++...   ...++.++|||||||++|||++|+.||.....       .+..... .....     +.
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-------~~~~~~~-~~~~~-----~~  227 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-------MRVLLKI-LKSEP-----PT  227 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-------HHHHHHH-hcCCC-----CC
Confidence            123588999999998532   11236789999999999999999999864321       1111111 11110     00


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      +..      .......+.+++..|++ +|.+||++.+|++.
T Consensus       228 ~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         228 LDQ------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             cCC------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            000      01223456778889998 79999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.3e-32  Score=299.26  Aligned_cols=242  Identities=19%  Similarity=0.304  Sum_probs=191.6

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||.|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.  +....++||||+++
T Consensus         9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~   86 (277)
T cd06640           9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KGTKLWIIMEYLGG   86 (277)
T ss_pred             hhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCEEEEEEecCCC
Confidence            467999999999999965 68999999987542 344577899999999999999999999985  46689999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++..      .++++.++..++.|++.||+||| +.+++|+||+|+||+++ +++.++++|||++......... 
T Consensus        87 ~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh-~~~ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~-  157 (277)
T cd06640          87 GSALDLLRA------GPFDEFQIATMLKEILKGLDYLH-SEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIK-  157 (277)
T ss_pred             CcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH-hCCccCcCCChhhEEEc-CCCCEEEcccccceeccCCccc-
Confidence            999999853      24788999999999999999999 99999999999999998 5789999999999766443221 


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      .....++..|+|||++.+...  +.++|||||||++|||++|+.||......       .... .......         
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~--~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~-~~~~~~~---------  218 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAY--DSKADIWSLGITAIELAKGEPPNSDMHPM-------RVLF-LIPKNNP---------  218 (277)
T ss_pred             cccccCcccccCHhHhccCCC--ccHHHHHHHHHHHHHHHHCCCCCCCcChH-------hHhh-hhhcCCC---------
Confidence            122357889999999987654  78999999999999999999998643211       1110 0110000         


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                          ..........+.+++.+|++ +|++||++.|++..
T Consensus       219 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 ----PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ----CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                01112345667889999998 79999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-33  Score=281.33  Aligned_cols=248  Identities=21%  Similarity=0.298  Sum_probs=192.6

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCC--CCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGP--TQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~~~~lv~e~~  856 (1060)
                      .++||-|-.|.|-.+.. ++|+.+|+|++...     ...++|++.--.. .|||||.++++|...  ...-..+|||+|
T Consensus        67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m  141 (400)
T KOG0604|consen   67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM  141 (400)
T ss_pred             hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence            47899999999999985 47999999998653     3445788776555 699999999998532  233467899999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeC--CCCCeEEcccccceeeccC
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG--PDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~--~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      +||.|+..+.++.   ...+++.++-.|+.||+.|+.||| +.+|.||||||+|+|..+  .+..+||+|||+|+.-...
T Consensus       142 eGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH-~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~  217 (400)
T KOG0604|consen  142 EGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLH-SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP  217 (400)
T ss_pred             cchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHH-hcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence            9999999998754   457999999999999999999999 999999999999999953  4567899999999976654


Q ss_pred             CceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      ....+  .+.|+.|.|||++...++  +..+|+||+||++|-|+.|.+||....+    ..+.--++..++.+.+     
T Consensus       218 ~~L~T--Pc~TPyYvaPevlg~eKy--dkscdmwSlgVimYIlLCGyPPFYS~hg----~aispgMk~rI~~gqy-----  284 (400)
T KOG0604|consen  218 GDLMT--PCFTPYYVAPEVLGPEKY--DKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKRRIRTGQY-----  284 (400)
T ss_pred             ccccC--CcccccccCHHHhCchhc--CCCCCccchhHHHHHhhcCCCcccccCC----ccCChhHHhHhhccCc-----
Confidence            43333  378999999999988875  7789999999999999999999986543    2333333444444333     


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                           ++..+......+...+++...++ +|.+|-|++|+++
T Consensus       285 -----~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  285 -----EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             -----cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence                 12333444445555566665566 7999999999875

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.9e-32  Score=298.10  Aligned_cols=249  Identities=20%  Similarity=0.345  Sum_probs=190.8

Q ss_pred             CCCeeccccceEEEEEEE-cCCcEEEEEEcccch------HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEE
Q 001527          780 PAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGV------AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv  852 (1060)
                      ..+.||+|+||.||+|.. .+++.||+|+++...      ....+.+.+|++++++++||||+++++++.  +.+..++|
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~~v   81 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC--EDSHFNLF   81 (268)
T ss_pred             ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec--cCCeEEEE
Confidence            357899999999999985 578999999986432      123467889999999999999999999984  56788999


Q ss_pred             EEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeec
Q 001527          853 SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT  932 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~  932 (1060)
                      |||+++++|.+++...     .++++..+..++.|++.||+||| +.|++||||||+||+++.++..+||+|||.+....
T Consensus        82 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH-~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          82 VEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH-ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            9999999999999542     35889999999999999999999 89999999999999998544569999999988765


Q ss_pred             cCCcee---eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCC
Q 001527          933 QAGTIE---QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHG 1009 (1060)
Q Consensus       933 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 1009 (1060)
                      ......   .....|+..|+|||++.+..+  +.++||||+|+++|+|++|+.||......    .............. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~--~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~-  228 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQY--GRSCDVWSVGCVIIEMATAKPPWNAEKHS----NHLALIFKIASATT-  228 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCC--CcccchHHHHHHHHHHHhCCCCCCCCCCc----chHHHHHHHhccCC-
Confidence            432111   112357889999999877654  78999999999999999999998642211    11111111110000 


Q ss_pred             CcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1010 SDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1010 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                          .+        .........+.+++.+|+. +|++||++.|+++
T Consensus       229 ----~~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 ----AP--------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ----CC--------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                00        0111234567788889997 7999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=286.82  Aligned_cols=264  Identities=20%  Similarity=0.288  Sum_probs=197.1

Q ss_pred             CCCChhhhhccCCCeeccccceEEEEEEEc-CCcEEEEEEcccchH-HHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCC
Q 001527          769 LTLTPEELSRAPAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA-KQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPT  845 (1060)
Q Consensus       769 ~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  845 (1060)
                      .+|+.++++.  ...||+|+||+|++-.++ .|+..|||+++.... ...+++..|.+...+- +.||||+++|.+.  .
T Consensus        59 ~~F~~~~Lqd--lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F--~  134 (361)
T KOG1006|consen   59 HTFTSDNLQD--LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF--S  134 (361)
T ss_pred             cccccchHHH--HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh--c
Confidence            4566666654  467999999999999855 799999999986544 5667888898876555 7999999999986  4


Q ss_pred             CCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccc
Q 001527          846 QHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY  925 (1060)
Q Consensus       846 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Df  925 (1060)
                      .+..|+.||.|. .|++.+...........+++.-.-+|+...+.||.||.....|||||+||+|||+| ..+.+|||||
T Consensus       135 EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld-r~G~vKLCDF  212 (361)
T KOG1006|consen  135 EGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD-RHGDVKLCDF  212 (361)
T ss_pred             CCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe-cCCCEeeecc
Confidence            567999999994 57666543222223356888888899999999999999778999999999999999 5889999999


Q ss_pred             ccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHh
Q 001527          926 CLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA 1005 (1060)
Q Consensus       926 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 1005 (1060)
                      |.+..+...-.  .+..+|...|||||.+.....+++.++||||+|+++||+.||+.|+....      .+-+.+...+.
T Consensus       213 GIcGqLv~SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------svfeql~~Vv~  284 (361)
T KOG1006|consen  213 GICGQLVDSIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------SVFEQLCQVVI  284 (361)
T ss_pred             cchHhHHHHHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------HHHHHHHHHHc
Confidence            99987654432  23347999999999998666567889999999999999999999986431      12222222222


Q ss_pred             cCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1006 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .. .     |.+....   ........|..++-.|+. +..+||...++.+
T Consensus       285 gd-p-----p~l~~~~---~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  285 GD-P-----PILLFDK---ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             CC-C-----CeecCcc---cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            11 1     1111111   111234567788889997 6789999998764

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-32  Score=298.40  Aligned_cols=247  Identities=27%  Similarity=0.431  Sum_probs=193.1

Q ss_pred             CCeeccccceEEEEEEEcC-----CcEEEEEEcccchHH-HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLEN-----GMFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+|+..+     +..||+|+++..... ..+.+..|++.+++++||||+++++++.  +....+++||
T Consensus         4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~i~e   81 (258)
T smart00219        4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT--EEEPLMIVME   81 (258)
T ss_pred             cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc--CCCeeEEEEe
Confidence            4689999999999999653     488999999765433 5678999999999999999999999985  4468999999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++++|.+++.....   ..+++.++..++.|++.||+||| +.+++||||||+||+++ +++.++|+|||.++.....
T Consensus        82 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh-~~~~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       82 YMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE-SKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             ccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHh-cCCeeecccccceEEEc-cCCeEEEcccCCceecccc
Confidence            9999999999965321   12899999999999999999999 99999999999999998 5779999999999876654


Q ss_pred             CceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCccc
Q 001527          935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 1013 (1060)
                      .........++..|+|||...+..+  +.++||||+|++++||++ |+.||...       ...+....... ...... 
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~--~~~~Di~slG~i~~~l~~~g~~p~~~~-------~~~~~~~~~~~-~~~~~~-  225 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKF--TSKSDVWSFGVLLWEIFTLGESPYPGM-------SNEEVLEYLKK-GYRLPK-  225 (258)
T ss_pred             cccccccCCCcccccChHHhccCCC--CcchhHHHHHHHHHHHHhCCCCCCCCC-------CHHHHHHHHhc-CCCCCC-
Confidence            3322212246789999999866554  789999999999999998 78887642       12222222111 111100 


Q ss_pred             ccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHh
Q 001527         1014 DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDL 1057 (1060)
Q Consensus      1014 d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L 1057 (1060)
                                  ......++.+++.+|+. +|.+|||+.|+++.|
T Consensus       226 ------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 ------------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ------------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                        01134567788889998 799999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.6e-32  Score=296.22  Aligned_cols=245  Identities=22%  Similarity=0.340  Sum_probs=192.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+++.. +|+.||+|++...  .....+++.+|++++++++||||+++++++.  ..+..++||||++
T Consensus         5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~   82 (256)
T cd08218           5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE--ENGNLYIVMDYCE   82 (256)
T ss_pred             EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec--CCCeEEEEEecCC
Confidence            578999999999999854 6899999998643  2334567899999999999999999999984  5678999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +++|.+++....   ...+++.++..++.|++.||+||| +.+++|+||+|+||+++ .+..++++|||.+.........
T Consensus        83 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          83 GGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEc-CCCCEEEeeccceeecCcchhh
Confidence            999999986532   235789999999999999999999 89999999999999998 5789999999999865443221


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      . ....|+..|+|||+..+...  +.++|||||||++++|++|+.||...       +..+.+...... ....      
T Consensus       158 ~-~~~~~~~~~~~pe~~~~~~~--~~~~Dv~slG~i~~~l~~g~~~~~~~-------~~~~~~~~~~~~-~~~~------  220 (256)
T cd08218         158 A-RTCIGTPYYLSPEICENRPY--NNKSDIWALGCVLYEMCTLKHAFEAG-------NMKNLVLKIIRG-SYPP------  220 (256)
T ss_pred             h-hhccCCccccCHHHhCCCCC--CCccchhHHHHHHHHHHcCCCCccCC-------CHHHHHHHHhcC-CCCC------
Confidence            1 12257889999999987664  77999999999999999999998632       222333222211 1100      


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                             ........+.+++.+|++ +|.+||++.||++.
T Consensus       221 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         221 -------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             -------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                   011234567888889998 79999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.2e-32  Score=299.41  Aligned_cols=250  Identities=20%  Similarity=0.291  Sum_probs=195.9

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||.|+||.||+|.. .+++.||+|+++..  .....+.+.+|++++++++||||+++++++....+...+++|||++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~   84 (265)
T cd08217           5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCE   84 (265)
T ss_pred             eeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhcc
Confidence            46799999999999985 46899999998643  2344567889999999999999999999887555667899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh----cCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH----FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH----~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      +++|.+++.... ....++++.+++.++.|++.||+|||    ++.+++||||||+||+++ +++.+|++|||++.....
T Consensus        85 ~~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~-~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          85 GGDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             CCCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe-cCCCEEEecccccccccC
Confidence            999999996543 23456899999999999999999999    246899999999999998 578999999999987655


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccc
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 1013 (1060)
                      ..... ....++..|+|||++.+...  +.++||||||+++|+|++|+.||....       ..++.. ....+...   
T Consensus       163 ~~~~~-~~~~~~~~~~~pE~~~~~~~--~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~-~~~~~~~~---  228 (265)
T cd08217         163 DSSFA-KTYVGTPYYMSPEQLNHMSY--DEKSDIWSLGCLIYELCALSPPFTARN-------QLQLAS-KIKEGKFR---  228 (265)
T ss_pred             Ccccc-cccccCCCccChhhhcCCCC--CchhHHHHHHHHHHHHHHCCCcccCcC-------HHHHHH-HHhcCCCC---
Confidence            43211 12368899999999987664  779999999999999999999987532       112211 11111111   


Q ss_pred             ccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1014 DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1014 d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                        .        ........+.+++.+|++ +|.+||+++||+++
T Consensus       229 --~--------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 --R--------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --C--------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              0        011234567888999998 79999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.7e-32  Score=298.35  Aligned_cols=255  Identities=23%  Similarity=0.389  Sum_probs=192.3

Q ss_pred             CCeeccccceEEEEEEEc----CCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCC----ceE
Q 001527          781 AEVLGRSSHGTSYRATLE----NGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQH----EKL  850 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~----~~~  850 (1060)
                      .++||+|+||.||+|.+.    +++.||+|+++..  .....+++.+|++++++++||||+++++++......    ..+
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05074           4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM   83 (273)
T ss_pred             hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence            468999999999999853    3689999998753  233456788999999999999999999988633221    247


Q ss_pred             EEEEecCCCChHHHhhcCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccce
Q 001527          851 ILSDYISPGSLASFLYDRP-GRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR  929 (1060)
Q Consensus       851 lv~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~  929 (1060)
                      +++||+++|+|.+++.... ......+++..+.+++.|++.||+||| +.+|+||||||+||+++ ++..+|++|||.++
T Consensus        84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~nili~-~~~~~kl~dfg~~~  161 (273)
T cd05074          84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS-SKNFIHRDLAARNCMLN-ENMTVCVADFGLSK  161 (273)
T ss_pred             EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccchhhEEEc-CCCCEEECcccccc
Confidence            8899999999999875432 122235889999999999999999999 99999999999999998 58899999999988


Q ss_pred             eeccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcC
Q 001527          930 LMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEG 1007 (1060)
Q Consensus       930 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 1007 (1060)
                      ......... .....++..|++||.+.....  +.++|||||||++|||++ |+.||.....    ..+..+.   ....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~--~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~---~~~~  232 (273)
T cd05074         162 KIYSGDYYRQGCASKLPVKWLALESLADNVY--TTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYL---IKGN  232 (273)
T ss_pred             cccCCcceecCCCccCchhhcCHhHHhcCcc--chhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHH---HcCC
Confidence            654332211 112235678999999877654  779999999999999999 8888764211    1111111   1111


Q ss_pred             CCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1008 HGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1008 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ...      . +       ......+.+++.+|++ +|.+||++.||++.|++|
T Consensus       233 ~~~------~-~-------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 RLK------Q-P-------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cCC------C-C-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            000      0 0       1234578889999998 799999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.8e-32  Score=298.12  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=190.7

Q ss_pred             CCCeeccccceEEEEEEE-cCCcEEEEEEcccchH----------HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCc
Q 001527          780 PAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVA----------KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHE  848 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  848 (1060)
                      ..+.||+|+||.||+|.. .+|+.||+|.++....          ...+.+.+|++++++++||||+++++++.  ....
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~   82 (272)
T cd06629           5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--TEEY   82 (272)
T ss_pred             ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec--cCCc
Confidence            467899999999999985 4689999998753211          12346788999999999999999999984  5678


Q ss_pred             eEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccc
Q 001527          849 KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLH  928 (1060)
Q Consensus       849 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a  928 (1060)
                      .++||||+++++|.+++...     ..+++..+..++.|++.||.||| +.+++||||||+||+++ +++.+|++|||.+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~~~nil~~-~~~~~~l~d~~~~  155 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLH-SKGILHRDLKADNLLVD-ADGICKISDFGIS  155 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh-hCCeeecCCChhhEEEc-CCCeEEEeecccc
Confidence            89999999999999999543     45899999999999999999999 89999999999999998 5889999999998


Q ss_pred             eeeccCCce-eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC
Q 001527          929 RLMTQAGTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG 1007 (1060)
Q Consensus       929 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 1007 (1060)
                      +........ ......|+..|+|||.+......++.++||||||+++||+++|+.||....      ....+.. ... .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~------~~~~~~~-~~~-~  227 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE------AIAAMFK-LGN-K  227 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc------hHHHHHH-hhc-c
Confidence            765432111 112235788999999987655335789999999999999999999986321      1111111 111 1


Q ss_pred             CCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1008 HGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1008 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .....+.+...        ......+.+++.+|++ +|.+||+++||++.
T Consensus       228 ~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         228 RSAPPIPPDVS--------MNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ccCCcCCcccc--------ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11111111111        1234567778889998 79999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.8e-32  Score=295.98  Aligned_cols=246  Identities=21%  Similarity=0.338  Sum_probs=192.6

Q ss_pred             CCCeeccccceEEEEEEE-cCCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          780 PAEVLGRSSHGTSYRATL-ENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ..+.||+|+||.||+|.. .+++.+|+|.+...  .....+.+.+|++++++++||||+++++++.  .....++||||+
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   81 (256)
T cd08220           4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL--EDKALMIVMEYA   81 (256)
T ss_pred             EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe--cCCEEEEEEecC
Confidence            357899999999999985 46899999998643  2234567889999999999999999999884  566889999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++....   ...+++..+.+++.|++.||+||| +++|+||||||+||+++.++..+|++|||.+........
T Consensus        82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          82 PGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVH-TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             CCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            9999999996532   345899999999999999999999 999999999999999985566789999999987654332


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      ..  ...|+..|+|||.+.+...  +.++||||||+++|+|++|+.||+...       ....+...... .....    
T Consensus       158 ~~--~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~~l~~l~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~----  221 (256)
T cd08220         158 AY--TVVGTPCYISPELCEGKPY--NQKSDIWALGCVLYELASLKRAFEAAN-------LPALVLKIMSG-TFAPI----  221 (256)
T ss_pred             cc--ccccCCcccCchhccCCCC--CcccchHHHHHHHHHHHhCCCCcccCc-------hHHHHHHHHhc-CCCCC----
Confidence            21  2357889999999987654  779999999999999999999986421       11222211111 11110    


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                               .......+.+++..|++ +|.+|||+.|+++.
T Consensus       222 ---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         222 ---------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ---------CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                     01223457788889998 79999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.9e-32  Score=302.02  Aligned_cols=197  Identities=23%  Similarity=0.343  Sum_probs=163.0

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++...  ....+.+.+|++++++++||||+++++++.  ++...++||||++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~   82 (285)
T cd07861           5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM--QESRLYLIFEFLS   82 (285)
T ss_pred             eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe--eCCeEEEEEecCC
Confidence            468999999999999965 68999999986432  122457889999999999999999999985  4668899999997


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                       ++|.+++....  ....+++.++..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||++.........
T Consensus        83 -~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          83 -MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCH-SRRVLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRV  157 (285)
T ss_pred             -CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCHHHEEEc-CCCcEEECcccceeecCCCccc
Confidence             68998886532  2356899999999999999999999 99999999999999998 5889999999998765432211


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                       .....+++.|+|||++.+... ++.++|||||||++|||+||+.||..
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         158 -YTHEVVTLWYRAPEVLLGSPR-YSTPVDIWSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             -ccCCcccccccChHHhcCCCC-cCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             122357889999999876542 37799999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.4e-33  Score=303.22  Aligned_cols=243  Identities=20%  Similarity=0.350  Sum_probs=188.0

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---------HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---------KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKL  850 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  850 (1060)
                      ...||+|+||.||+|... +++.||+|.+.....         ...+.+.+|++++++++||||+++++++.  .....+
T Consensus         5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~   82 (267)
T cd06628           5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL--DADHLN   82 (267)
T ss_pred             cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCccE
Confidence            468999999999999854 688999998854311         12356889999999999999999999985  456889


Q ss_pred             EEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          851 ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       851 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      +||||+++++|.+++...     ..+++..+..++.|++.||+||| +.+++||||||+||+++ +++.+||+|||.++.
T Consensus        83 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH-~~~ivH~di~p~nil~~-~~~~~~l~dfg~~~~  155 (267)
T cd06628          83 IFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLH-NRGIIHRDIKGANILVD-NKGGIKISDFGISKK  155 (267)
T ss_pred             EEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHH-hcCcccccCCHHHEEEc-CCCCEEecccCCCcc
Confidence            999999999999999542     45889999999999999999999 89999999999999998 588999999999987


Q ss_pred             eccCCce-----eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHh
Q 001527          931 MTQAGTI-----EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA 1005 (1060)
Q Consensus       931 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 1005 (1060)
                      .......     ......|+..|+|||.+.+...  +.++||||+||++|+|++|+.||.....      ... +.. ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~--~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~-~~~-~~  225 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSY--TRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQA-IFK-IG  225 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCC--CchhhhHHHHHHHHHHhhCCCCCCCccH------HHH-HHH-Hh
Confidence            6532111     1111247889999999987654  7799999999999999999999874211      111 110 11


Q ss_pred             cCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1006 ~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ..     ..+..        .......+.+++.+|++ +|.+||++.||++
T Consensus       226 ~~-----~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 EN-----ASPEI--------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             cc-----CCCcC--------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            10     01111        01233566778889998 7999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.3e-32  Score=294.60  Aligned_cols=243  Identities=23%  Similarity=0.341  Sum_probs=190.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-----HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-----AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+|... +++.|++|.+....     ....+.+.+|++++++++||||+++++++.  .....++|||
T Consensus         5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e   82 (258)
T cd06632           5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER--EEDNLYIFLE   82 (258)
T ss_pred             cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe--cCCeEEEEEE
Confidence            478999999999999966 78999999886432     234567899999999999999999999984  5568899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++++|.+++...     ..+++..+..++.|++.||+||| +.||+|+||||+||+++ +++.+||+|||.+......
T Consensus        83 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          83 LVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLH-DRNTVHRDIKGANILVD-TNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             ecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEC-CCCCEEEccCccceecccc
Confidence            99999999999542     35889999999999999999999 99999999999999998 5889999999998875443


Q ss_pred             CceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      ..  .....|+..|+|||.+.... .++.++|+|||||++|+|++|+.||....       ..+.............   
T Consensus       156 ~~--~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~---  222 (258)
T cd06632         156 SF--AKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQLE-------GVAAVFKIGRSKELPP---  222 (258)
T ss_pred             cc--ccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccCc-------HHHHHHHHHhcccCCC---
Confidence            31  12236888999999987655 24789999999999999999999986432       1111111111011100   


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                        . +       ......+.+++.+|++ +|.+||++.|++.
T Consensus       223 --~-~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 --I-P-------DHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --c-C-------CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence              0 0       1123456678889998 7999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-33  Score=281.10  Aligned_cols=211  Identities=21%  Similarity=0.362  Sum_probs=177.5

Q ss_pred             ChhhhhccCCCeeccccceEEEEEE-EcCCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCce
Q 001527          772 TPEELSRAPAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEK  849 (1060)
Q Consensus       772 ~~~~l~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~  849 (1060)
                      +.+|+..-+.+++|+|+|+.|-.+. +.+|..||||++.+.....+.+..+|++++.+. .|+||+++++||.  +....
T Consensus        74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE--dd~~F  151 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE--DDTRF  151 (463)
T ss_pred             hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc--ccceE
Confidence            3567777778999999999999998 789999999999888777788999999999999 5999999999994  66789


Q ss_pred             EEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCC--CCeEEccccc
Q 001527          850 LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPD--LNARVADYCL  927 (1060)
Q Consensus       850 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~--~~~kl~Dfg~  927 (1060)
                      |+|||-|.||+|..+++.+     ..+++.++.++.++|+.||.||| .+||.|||+||+|||-...+  .-+||+||.+
T Consensus       152 YLVfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH-~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  152 YLVFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLH-TKGIAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             EEEEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHh-hcCcccccCCccceeecCCCCcCceeeecccc
Confidence            9999999999999999654     45999999999999999999999 99999999999999986433  3489999987


Q ss_pred             ceeeccCC------ceeeeccCccccccchhccc---CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001527          928 HRLMTQAG------TIEQILDAGVLGYRAPELAA---SKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGE  990 (1060)
Q Consensus       928 a~~~~~~~------~~~~~~~~gt~~y~aPE~~~---~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~  990 (1060)
                      ..-+....      +......+|+..|||||+..   +....|+.++|.||+|||+|-|+.|.+||...-++
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~  297 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA  297 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence            75443221      22223357899999999863   44445688999999999999999999999876544

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.8e-32  Score=302.84  Aligned_cols=244  Identities=19%  Similarity=0.278  Sum_probs=189.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      ...||+|+||.||++... ++..||+|.+........+.+.+|+.++++++||||+++++++.  .++..++||||++++
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~~~~~~lv~e~~~~~  104 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL--VGDELWVVMEFLEGG  104 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee--cCCeEEEEEeCCCCC
Confidence            356999999999999854 68999999987655556677899999999999999999999985  567889999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++..      ..+++.++..++.||+.||+||| +.+|+||||||+||+++ +++.+||+|||++.......... 
T Consensus       105 ~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~~~~~-  175 (292)
T cd06658         105 ALTDIVTH------TRMNEEQIATVCLSVLRALSYLH-NQGVIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKR-  175 (292)
T ss_pred             cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEc-CCCCEEEccCcchhhcccccccC-
Confidence            99998843      24889999999999999999999 99999999999999998 57899999999987654322211 


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ....|+..|+|||+..+..+  +.++|||||||++|||++|+.||.....       .+-+.. ....     +.+....
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~-~~~~-----~~~~~~~  240 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPY--GTEVDIWSLGIMVIEMIDGEPPYFNEPP-------LQAMRR-IRDN-----LPPRVKD  240 (292)
T ss_pred             ceeecCccccCHHHHccCCC--CchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH-HHhc-----CCCcccc
Confidence            12358899999999977654  7799999999999999999999864211       111111 1110     1111111


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .      ......+.+++..|+. +|.+|||++|+++.
T Consensus       241 ~------~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 S------HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             c------cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0      0122346677778997 79999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-32  Score=295.91  Aligned_cols=249  Identities=22%  Similarity=0.301  Sum_probs=192.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|+||.||+|... +++.+++|++........+.+.+|++++++++||||+++++++.  .....+++|||++++
T Consensus         8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~l~~e~~~~~   85 (262)
T cd06613           8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL--RRDKLWIVMEYCGGG   85 (262)
T ss_pred             EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE--eCCEEEEEEeCCCCC
Confidence            478999999999999864 67899999998655556678999999999999999999999885  566899999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++....    ..+++.++..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||.+.......... 
T Consensus        86 ~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~-  158 (262)
T cd06613          86 SLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLH-ETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKR-  158 (262)
T ss_pred             cHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCChhhEEEC-CCCCEEECccccchhhhhhhhcc-
Confidence            9999986431    45899999999999999999999 89999999999999998 58899999999987655432111 


Q ss_pred             eccCccccccchhcccCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          940 ILDAGVLGYRAPELAASK-KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      ....++..|+|||.+.+. ...++.++|||||||++|||++|+.||......       +-.. ........   .+.+.
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-------~~~~-~~~~~~~~---~~~~~  227 (262)
T cd06613         159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-------RALF-LISKSNFP---PPKLK  227 (262)
T ss_pred             ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHH-HHHhccCC---Ccccc
Confidence            123578899999998765 112377999999999999999999998743211       0011 01111000   00000


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                            ........+.+++.+|+. +|.+|||+.||+.
T Consensus       228 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         228 ------DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ------chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  112334567889999998 7999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.3e-32  Score=305.06  Aligned_cols=261  Identities=20%  Similarity=0.274  Sum_probs=190.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++.  .....++||||++
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~v~e~~~   83 (286)
T cd07847           6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR--RKRKLHLVFEYCD   83 (286)
T ss_pred             eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe--eCCEEEEEEeccC
Confidence            467999999999999976 68999999886432  123356789999999999999999999985  5667899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      ++++..++..     ...+++.++..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||++.........
T Consensus        84 ~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH-~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          84 HTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCH-KHNCIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             ccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCChhhEEEc-CCCcEEECccccceecCCCccc
Confidence            9988887632     235899999999999999999999 89999999999999998 5789999999999876543321


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC--CCCccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG--HGSDCFDA 1015 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~d~ 1015 (1060)
                       .....++..|+|||++.+... ++.++|||||||++|||++|+.||......+    ............  ...+.++.
T Consensus       157 -~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07847         157 -YTDYVATRWYRAPELLVGDTQ-YGPPVDVWAIGCVFAELLTGQPLWPGKSDVD----QLYLIRKTLGDLIPRHQQIFST  230 (286)
T ss_pred             -ccCcccccccCCHHHHhCCCC-cCchhhhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChHHhhhccc
Confidence             112257889999999876432 3779999999999999999999997432211    111111100000  00000000


Q ss_pred             ------cccccc--CC---hhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1016 ------AVMPEM--VN---PAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1016 ------~l~~~~--~~---~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                            ...+..  ..   .........+.+++.+|++ +|++||++.|++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                  000000  00   0011234567889999998 79999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.8e-33  Score=308.48  Aligned_cols=258  Identities=21%  Similarity=0.315  Sum_probs=190.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA--KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .++||+|+||.||+|... +++.||+|++.....  ...+.+.+|++++++++||||+++++++.  .+...++||||++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~   83 (286)
T cd07846           6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR--RKKRLYLVFEFVD   83 (286)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc--cCCeEEEEEecCC
Confidence            478999999999999975 589999999864322  23467889999999999999999999984  5678999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      ++++.++...     ...+++.++..++.||+.||+||| +.+|+||||+|+||+++ +++.+||+|||++.........
T Consensus        84 ~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          84 HTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCH-SHNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             ccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCCccc
Confidence            9999887743     234899999999999999999999 89999999999999998 5889999999998875443321


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCC--------
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHG-------- 1009 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~-------- 1009 (1060)
                       .....++..|+|||++.+... ++.++|||||||++|||++|+.||.....      ...+.......+..        
T Consensus       157 -~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~el~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         157 -YTDYVATRWYRAPELLVGDTK-YGRAVDIWAVGCLVTEMLTGEPLFPGDSD------IDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             -cCcccceeeccCcHHhccccc-cCchHhHHHHHHHHHHHHcCCCCCCCCch------HHHHHHHHHHhCCCchhhHHHh
Confidence             112357889999999876442 47799999999999999999999864221      11111111000000        


Q ss_pred             --CcccccccccccCC-----hhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1010 --SDCFDAAVMPEMVN-----PAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1010 --~~~~d~~l~~~~~~-----~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                        ...++....+....     .........+.+++.+|++ +|++||+++||++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence              00000000000000     0011234568889999998 7999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.6e-32  Score=302.66  Aligned_cols=262  Identities=21%  Similarity=0.260  Sum_probs=192.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.  .+...++||||+ 
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~~v~e~~-   81 (286)
T cd07832           5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP--HGSGFVLVMEYM-   81 (286)
T ss_pred             EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe--cCCeeEEEeccc-
Confidence            468999999999999964 68999999987543  233567899999999999999999999985  467889999999 


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +++|.+++....    ..+++.++..++.||+.||+||| +.+|+|+||||+||+++ +++.++|+|||.+.........
T Consensus        82 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          82 PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMH-ANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCcCHHHEEEc-CCCcEEEeeeeecccccCCCCC
Confidence            999999986432    45899999999999999999999 99999999999999998 5789999999999876544322


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCC---------
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGH--------- 1008 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~--------- 1008 (1060)
                      ......|+..|+|||++.+... ++.++||||+||++|||++|++||.....    .....++........         
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARK-YDPGVDLWAVGCIFAELLNGSPLFPGEND----IEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             ccccccCcccccCceeeecccc-CCchhHHHHHHHHHHHHHcCCcCcCCCCH----HHHHHHHHHHcCCCChHHHhhccC
Confidence            2223368899999999876542 37799999999999999999877754211    111111111110000         


Q ss_pred             ---CCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1009 ---GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1009 ---~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                         ...+..+............+....+.+++.+|++ +|.+||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0000000000000000011234677889999998 79999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-32  Score=302.68  Aligned_cols=250  Identities=18%  Similarity=0.333  Sum_probs=190.7

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc-hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++||||+++++++.  .....++||||+++
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~   83 (286)
T cd06622           6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF--IEGAVYMCMEYMDA   83 (286)
T ss_pred             hhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee--cCCeEEEEEeecCC
Confidence            478999999999999965 7899999988653 2334567889999999999999999999885  46789999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++....  ....+++..+..++.|++.||.|||.+.+|+||||||+||+++ .++.+||+|||.+........  
T Consensus        84 ~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~--  158 (286)
T cd06622          84 GSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVASLA--  158 (286)
T ss_pred             CCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC-CCCCEEEeecCCcccccCCcc--
Confidence            99999986431  1246899999999999999999999446999999999999998 588999999999876543221  


Q ss_pred             eeccCccccccchhcccCCCC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          939 QILDAGVLGYRAPELAASKKP----HPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~----~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                       ....++..|+|||++.+...    .++.++|||||||++|||++|+.||.....    ......... .......    
T Consensus       159 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~-~~~~~~~----  228 (286)
T cd06622         159 -KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----ANIFAQLSA-IVDGDPP----  228 (286)
T ss_pred             -ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hhHHHHHHH-HhhcCCC----
Confidence             12257889999999865432    237799999999999999999999864211    111111111 1111111    


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                       .+        .......+.+++.+|++ +|++||+++|+++.
T Consensus       229 -~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         229 -TL--------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -CC--------CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence             01        11234556788889998 79999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4e-32  Score=302.33  Aligned_cols=243  Identities=20%  Similarity=0.273  Sum_probs=189.2

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      ..||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++.  .++..++||||+++++
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~iv~e~~~~~~  104 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL--VGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee--eCCeEEEEEecCCCCC
Confidence            46999999999999854 68999999987554445567889999999999999999999885  4678999999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++..      ..+++.++..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||++......... ..
T Consensus       105 L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~~~-~~  175 (297)
T cd06659         105 LTDIVSQ------TRLNEEQIATVCESVLQALCYLH-SQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPK-RK  175 (297)
T ss_pred             HHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHeEEc-cCCcEEEeechhHhhccccccc-cc
Confidence            9998743      34889999999999999999999 99999999999999998 5889999999998755433221 12


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPE 1020 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 1020 (1060)
                      ...|+..|+|||++.+..+  +.++|||||||++|||++|+.||.....       .+.... .......     .... 
T Consensus       176 ~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~-~~~~~~~-----~~~~-  239 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPY--GTEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKR-LRDSPPP-----KLKN-  239 (297)
T ss_pred             ceecCccccCHHHHccCCC--CchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH-HhccCCC-----Cccc-
Confidence            2368899999999987654  7799999999999999999999864211       111111 1111100     0000 


Q ss_pred             cCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1021 MVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1021 ~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                           .......+.+++..|++ +|.+||+++||++.
T Consensus       240 -----~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         240 -----AHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             -----cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                 01122346678889998 79999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=304.75  Aligned_cols=256  Identities=21%  Similarity=0.339  Sum_probs=194.9

Q ss_pred             ChhhhhccCCCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceE
Q 001527          772 TPEELSRAPAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKL  850 (1060)
Q Consensus       772 ~~~~l~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  850 (1060)
                      .++|..... ..||.|+||.||+|..+ .+-..|.|++........++|.-|++||..++||+||++++.|+  ..+..|
T Consensus        29 nP~d~WeIi-GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy--~enkLw  105 (1187)
T KOG0579|consen   29 NPRDHWEII-GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY--FENKLW  105 (1187)
T ss_pred             CHHHHHHHH-hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh--ccCceE
Confidence            344444332 34799999999999865 45666778887766777889999999999999999999998876  356799


Q ss_pred             EEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          851 ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       851 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      ++.|||.||-++..+.+-    +..+.+.++.-+++|++.||.||| +..|||||||+.|||++ -++.++|+|||.+..
T Consensus       106 iliEFC~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LH-s~~iIHRDLKAGNiL~T-ldGdirLADFGVSAK  179 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLH-SQNIIHRDLKAGNILLT-LDGDIRLADFGVSAK  179 (1187)
T ss_pred             EEEeecCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHh-hcchhhhhccccceEEE-ecCcEeeeccccccc
Confidence            999999999999887653    356999999999999999999999 99999999999999998 588999999998765


Q ss_pred             eccCCceeeeccCccccccchhcccCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC
Q 001527          931 MTQAGTIEQILDAGVLGYRAPELAASK---KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG 1007 (1060)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 1007 (1060)
                      ....... .....||++|||||+..-.   ...|+.++||||||+++.||..+.+|-+..       +....+ ..+...
T Consensus       180 n~~t~qk-RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-------npMRVl-lKiaKS  250 (1187)
T KOG0579|consen  180 NKSTRQK-RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-------NPMRVL-LKIAKS  250 (1187)
T ss_pred             chhHHhh-hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-------chHHHH-HHHhhc
Confidence            4332211 2234799999999997521   122467999999999999999999996532       111111 122222


Q ss_pred             CCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1008 HGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1008 ~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      ....+..|           ......+.++...|+. +|..||++.++++.
T Consensus       251 ePPTLlqP-----------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  251 EPPTLLQP-----------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             CCCcccCc-----------chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            22222222           2445567788889997 79999999999863

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=338.36  Aligned_cols=440  Identities=30%  Similarity=0.342  Sum_probs=348.5

Q ss_pred             CCCCCcEEECcCCcccccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEE
Q 001527           92 NLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSL  171 (1060)
Q Consensus        92 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  171 (1060)
                      .--+|+.|||++|++. ..|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|.|..|.+. ..|.++..+.+|+.|
T Consensus        43 ~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~L  119 (1081)
T KOG0618|consen   43 KRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYL  119 (1081)
T ss_pred             heeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhccccc
Confidence            3344999999999997 68889999999999999999999 77899999999999999999997 779999999999999


Q ss_pred             EccCCCCCCCCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCcCCccCchhhhccCCCCeecccCCccc
Q 001527          172 DLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFV  251 (1060)
Q Consensus       172 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~  251 (1060)
                      +++.|++. .+|..+..++.+..+..++|......+.    .. ++.++|..|.+.+.++.....++.  .|+|.+|.+.
T Consensus       120 dlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~----~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~  191 (1081)
T KOG0618|consen  120 DLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQ----TS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME  191 (1081)
T ss_pred             ccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhcc----cc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh
Confidence            99999998 7889999999999999999932222222    22 888899999998888888777777  7899999886


Q ss_pred             cCCCcCcCCCccccccEEEccCCcccccCCCCccccCCCCCCEEEccCCccccCCCCccCCCCccEEEccCCcCcccCCc
Q 001527          252 GSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPN  331 (1060)
Q Consensus       252 ~~~~~~~l~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~  331 (1060)
                       .....-    ...|+.|....|++.....      .-++|+.|+.++|.++...+.+ .-.+|+++++++|++++ +| 
T Consensus       192 -~~dls~----~~~l~~l~c~rn~ls~l~~------~g~~l~~L~a~~n~l~~~~~~p-~p~nl~~~dis~n~l~~-lp-  257 (1081)
T KOG0618|consen  192 -VLDLSN----LANLEVLHCERNQLSELEI------SGPSLTALYADHNPLTTLDVHP-VPLNLQYLDISHNNLSN-LP-  257 (1081)
T ss_pred             -hhhhhh----ccchhhhhhhhcccceEEe------cCcchheeeeccCcceeecccc-ccccceeeecchhhhhc-ch-
Confidence             222221    2347888888888875332      2367889999999888444333 34678999999999984 56 


Q ss_pred             chhccCCCCCCeEECCCCccccccCcccc-cCCcEEEccCCcCcccCCC--CCCCCCEEEccCCccccccccccCC--Cc
Q 001527          332 DLLKGDSLLLTDLDLSANNLSGSVSMILS-TNLHMLNLSSNGLTGELPL--LTGSCAVLDLSNNQFEGNLSRILKW--GN  406 (1060)
Q Consensus       332 ~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~-~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~Ls~N~l~~~~~~~~~~--~~  406 (1060)
                      ++...+.. |+.++..+|+|.......+. ++|+.|.+.+|.+.-..|.  .+.+++.|||..|++...+..++..  ..
T Consensus       258 ~wi~~~~n-le~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~  336 (1081)
T KOG0618|consen  258 EWIGACAN-LEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNAS  336 (1081)
T ss_pred             HHHHhccc-ceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHH
Confidence            46665554 89999999998544333333 7899999999988754433  2456778999999998877766554  45


Q ss_pred             cCEEEcccCeecccCCCCCcccCCCCeEEccCCcCccccchhccccCCCcEEecCCccccCccccccccCCCcceEEccC
Q 001527          407 IEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLAD  486 (1060)
Q Consensus       407 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  486 (1060)
                      |..|+.+.|++....-..=..+..|+.|+|.+|.|+...-+.+.+...|++|+|++|+|.......+.++..|++|+||+
T Consensus       337 l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSG  416 (1081)
T KOG0618|consen  337 LNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSG  416 (1081)
T ss_pred             HHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhccc
Confidence            78888888888733322233456799999999999988777889999999999999999854446688999999999999


Q ss_pred             ccccccCCCCCCCCCCCcEEEccCCccccccCccccCCCCCcEEECCCCcccc-ccCccccCCCCCCeEeccCCcc
Q 001527          487 NLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISG-SLPTSMANMTSLSSLVISQNHF  561 (1060)
Q Consensus       487 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l  561 (1060)
                      |+|+ .+|.++..+..|++|...+|+|. ..| ++..+++|+.+|||.|+|+. .+|..... ++|++|||++|.-
T Consensus       417 NkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  417 NKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTR  488 (1081)
T ss_pred             chhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcc
Confidence            9999 45688899999999999999998 677 89999999999999999974 34443333 8999999999974

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-32  Score=304.42  Aligned_cols=204  Identities=23%  Similarity=0.278  Sum_probs=165.9

Q ss_pred             CCeeccccceEEEEEEEc---CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE---NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .++||+|+||.||+|...   +++.||+|.+....   ....+.+.+|++++++++||||+++++++........++|||
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   84 (316)
T cd07842           5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD   84 (316)
T ss_pred             EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence            467999999999999964   47999999997632   223456788999999999999999999997654578999999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCC----CCCeEEccccccee
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP----DLNARVADYCLHRL  930 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~----~~~~kl~Dfg~a~~  930 (1060)
                      |+++ ++.+++..........+++..+..|+.|++.||+||| +.+|+||||||+||+++ .    ++.+||+|||+++.
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~h~dlkp~Nil~~-~~~~~~~~~kl~Dfg~~~~  161 (316)
T cd07842          85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH-SNWVLHRDLKPANILVM-GEGPERGVVKIGDLGLARL  161 (316)
T ss_pred             CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH-hCCEeeCCCCHHHEEEc-CCCCccceEEECCCccccc
Confidence            9964 7777775443333347899999999999999999999 99999999999999998 5    67899999999987


Q ss_pred             eccCCc--eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001527          931 MTQAGT--IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVIS  988 (1060)
Q Consensus       931 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~  988 (1060)
                      ......  .......++..|+|||++.+... ++.++|||||||++|||++|+.||....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         162 FNAPLKPLADLDPVVVTIWYRAPELLLGARH-YTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             cCCCcccccccCCccccccccCHHHHhCCCC-CCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            644322  11122357889999998876442 3779999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-32  Score=297.44  Aligned_cols=243  Identities=21%  Similarity=0.306  Sum_probs=191.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||.|+||.||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.  +....++|+||+++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~   83 (274)
T cd06609           6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL--KGSKLWIIMEYCGG   83 (274)
T ss_pred             hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE--ECCeEEEEEEeeCC
Confidence            467999999999999965 68999999987543 334567889999999999999999999985  45688999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++...      ++++.++..++.|++.|+.||| +.+++||||+|+||+++ +++.++|+|||.++........ 
T Consensus        84 ~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~-  154 (274)
T cd06609          84 GSCLDLLKPG------KLDETYIAFILREVLLGLEYLH-EEGKIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSK-  154 (274)
T ss_pred             CcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEC-CCCCEEEcccccceeecccccc-
Confidence            9999999542      5899999999999999999999 99999999999999998 5889999999999877644221 


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      .....++..|+|||++.+..+  +.++|||||||++|||++|+.||.....       ..... .........     +.
T Consensus       155 ~~~~~~~~~y~~PE~~~~~~~--~~~sDv~slG~il~~l~tg~~p~~~~~~-------~~~~~-~~~~~~~~~-----~~  219 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQSGY--DEKADIWSLGITAIELAKGEPPLSDLHP-------MRVLF-LIPKNNPPS-----LE  219 (274)
T ss_pred             cccccCCccccChhhhccCCC--CchhhHHHHHHHHHHHHhCCCCcccCch-------HHHHH-HhhhcCCCC-----Cc
Confidence            122367889999999987764  8899999999999999999999864321       11111 111111111     10


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      ..       .....+.+++.+|+. +|++|||++++++.
T Consensus       220 ~~-------~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         220 GN-------KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             cc-------ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            00       023456778889997 79999999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4e-32  Score=301.89  Aligned_cols=245  Identities=22%  Similarity=0.324  Sum_probs=190.8

Q ss_pred             CCCeeccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          780 PAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      ..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++||||+++++++.  ..+..++|+||+++
T Consensus        23 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~~  100 (293)
T cd06647          23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL--VGDELWVVMEYLAG  100 (293)
T ss_pred             eeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee--eCCcEEEEEecCCC
Confidence            357899999999999985 468899999987554445577889999999999999999999985  45678999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++...      .+++.++..++.|++.||+||| +.|++||||||+||+++ +++.+||+|||++..........
T Consensus       101 ~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH-~~gi~H~dL~p~Nili~-~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647         101 GSLTDVVTET------CMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             CcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH-hCCEeeccCCHHHEEEc-CCCCEEEccCcceeccccccccc
Confidence            9999998542      3788999999999999999999 99999999999999998 57899999999887654432221


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                       ....|+..|+|||++.+...  +.++|||||||++|++++|+.||........       +......+ .     +.. 
T Consensus       173 -~~~~~~~~y~~PE~~~~~~~--~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-------~~~~~~~~-~-----~~~-  235 (293)
T cd06647         173 -STMVGTPYWMAPEVVTRKAY--GPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIATNG-T-----PEL-  235 (293)
T ss_pred             -ccccCChhhcCchhhccCCC--CchhhHHHHHHHHHHHHhCCCCCCCCChhhh-------eeehhcCC-C-----CCC-
Confidence             12358889999999877654  7799999999999999999999975322110       00000000 0     000 


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                           +........+.+++.+|+. +|.+||++.|++.+
T Consensus       236 -----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         236 -----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0011223456778889998 79999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4e-32  Score=301.87  Aligned_cols=251  Identities=21%  Similarity=0.302  Sum_probs=189.6

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCC---CCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPT---QHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~---~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++++ +||||+++++++...+   ....++||||
T Consensus        27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey  105 (291)
T cd06639          27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL  105 (291)
T ss_pred             EEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence            46899999999999996 468999999986532 2345678899999999 8999999999986432   2468999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++++|.++++... .....+++..++.++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||.++......
T Consensus       106 ~~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~  182 (291)
T cd06639         106 CNGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLH-NNRIIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTR  182 (291)
T ss_pred             CCCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEEc-CCCCEEEeecccchhccccc
Confidence            99999999886432 22346899999999999999999999 99999999999999998 57889999999988654322


Q ss_pred             ceeeeccCccccccchhcccCCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          936 TIEQILDAGVLGYRAPELAASKK---PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ... ....|+..|+|||++....   ..++.++|||||||++|||++|+.||......   ..+.+     .........
T Consensus       183 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~~~~-----~~~~~~~~~  253 (291)
T cd06639         183 LRR-NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KTLFK-----IPRNPPPTL  253 (291)
T ss_pred             ccc-cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HHHHH-----HhcCCCCCC
Confidence            211 1236888999999986432   12377999999999999999999998643211   01111     111111111


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .+           ..+....+.+++.+|++ +|++||++.|+++
T Consensus       254 ~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         254 LH-----------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             Cc-----------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11           01223457888999998 7999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6e-32  Score=299.02  Aligned_cols=260  Identities=15%  Similarity=0.184  Sum_probs=188.7

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++... ........+|+.+++++. ||||+++++++.+...+..++||||++
T Consensus         4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~   83 (282)
T cd07831           4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD   83 (282)
T ss_pred             EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence            467999999999999854 68999999987532 122234457899999885 999999999997554478899999996


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                       +++.+++....    ..+++.++..++.|++.||+||| +.+|+||||||+||+++ + +.+||+|||.++........
T Consensus        84 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dl~p~ni~l~-~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          84 -MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMH-RNGIFHRDIKPENILIK-D-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             -ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH-HCCceecccCHHHEEEc-C-CCeEEEecccccccccCCCc
Confidence             58888885432    45899999999999999999999 99999999999999998 4 89999999999876443322


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHh-----------c
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA-----------E 1006 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~-----------~ 1006 (1060)
                      .  ...++..|+|||++..... ++.++||||+||++|||++|+.||.....    .+...+......           .
T Consensus       156 ~--~~~~~~~y~aPE~~~~~~~-~~~~~Di~slGv~l~el~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         156 T--EYISTRWYRAPECLLTDGY-YGPKMDIWAVGCVFFEILSLFPLFPGTNE----LDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             C--CCCCCcccCChhHhhcCCC-CCcchhHHHHHHHHHHHHcCCcCCCCCCH----HHHHHHHHHHcCCCCHHHHHhhcc
Confidence            1  1257889999998755432 37799999999999999999999965321    111222211110           0


Q ss_pred             CCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1007 GHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1007 ~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ........+...+....+........+.+++.+|++ +|++||+++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000010011111111111112345678899999998 7999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.98  E-value=2.3e-32  Score=304.98  Aligned_cols=261  Identities=21%  Similarity=0.287  Sum_probs=189.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHH-----HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAK-----QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+|... +++.||+|+++.....     ....+..|++++++++||||+++++++.  +....++|||
T Consensus         5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e   82 (298)
T cd07841           5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG--HKSNINLVFE   82 (298)
T ss_pred             eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee--cCCEEEEEEc
Confidence            467999999999999965 6899999999754322     3456778999999999999999999995  4668899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+ +++|.+++....    ..+++..+..++.||++||+||| +.||+||||||+||+++ .++.+||+|||+++.....
T Consensus        83 ~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          83 FM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLH-SNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             cc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCChhhEEEc-CCCCEEEccceeeeeccCC
Confidence            99 899999995432    36899999999999999999999 99999999999999998 5889999999999876543


Q ss_pred             CceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhc--------
Q 001527          935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAE-------- 1006 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~-------- 1006 (1060)
                      .... ....++..|+|||.+.+... ++.++|||||||++|||++|..||......+   .+..... ....        
T Consensus       156 ~~~~-~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~  229 (298)
T cd07841         156 NRKM-THQVVTRWYRAPELLFGARH-YGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFE-ALGTPTEENWPG  229 (298)
T ss_pred             Cccc-cccccceeeeCHHHHhCCCC-CCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHH-HcCCCchhhhhh
Confidence            2211 12246788999999865432 4779999999999999999987776422110   0101000 0000        


Q ss_pred             -CCCCccccccccccc-CChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1007 -GHGSDCFDAAVMPEM-VNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1007 -~~~~~~~d~~l~~~~-~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                       ............... ...........+.+++.+|++ +|.+|||++||++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             000000000000000 000111234567889999998 79999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.98  E-value=4.8e-32  Score=299.78  Aligned_cols=248  Identities=18%  Similarity=0.310  Sum_probs=188.1

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCC----CCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGP----TQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~----~~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+|+. .+++.+|+|++.... ....++..|+.+++++ +||||+++++++...    .....+++||
T Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e   99 (282)
T cd06636          21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME   99 (282)
T ss_pred             heeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence            46899999999999996 468999999986542 3346788899999998 799999999998532    2457899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++|+|.+++....   ...+++..+..++.|++.||+||| +.+|+||||||+||+++ +++.++|+|||++......
T Consensus       100 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH-~~~ivH~dl~~~nili~-~~~~~~l~dfg~~~~~~~~  174 (282)
T cd06636         100 FCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLH-AHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRT  174 (282)
T ss_pred             eCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEC-CCCCEEEeeCcchhhhhcc
Confidence            999999999996543   245788889999999999999999 99999999999999998 5888999999998765432


Q ss_pred             CceeeeccCccccccchhcccCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          935 GTIEQILDAGVLGYRAPELAASK---KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                      ... .....|+..|+|||.+...   ...++.++|||||||++|||++|+.||.......      ...  .....    
T Consensus       175 ~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------~~~--~~~~~----  241 (282)
T cd06636         175 VGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR------ALF--LIPRN----  241 (282)
T ss_pred             ccC-CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh------hhh--hHhhC----
Confidence            211 1123688999999997531   1234779999999999999999999986432110      000  00000    


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                       ..+....       ......+.+++.+|++ +|.+||++.|+++
T Consensus       242 -~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         242 -PPPKLKS-------KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -CCCCCcc-------cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence             0011111       1233567888999998 7999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=7.1e-34  Score=335.53  Aligned_cols=246  Identities=26%  Similarity=0.376  Sum_probs=191.8

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      +..||.|.||.||-|. .++|+..|+|.++-..  ....+...+|..++..++|||+|+++|+-.  +.+..+|.||||+
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv--HRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV--HREKVYIFMEYCE 1317 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee--cHHHHHHHHHHhc
Confidence            5689999999999998 6789999999886432  334467889999999999999999999875  5678899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC-c
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG-T  936 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~-~  936 (1060)
                      +|+|.+.+..     +...++.....+..|++.|++||| +.|||||||||.||+++ .++.+|++|||.|..+.... +
T Consensus      1318 ~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH-~~gIVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1318 GGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLH-EHGIVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             cCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHH-hcCceecCCCccceeee-cCCcEEeecccceeEecCchhc
Confidence            9999999943     334677777788999999999999 99999999999999999 57799999999999876542 1


Q ss_pred             e--eeeccCccccccchhcccCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHH-HHHhcCCCCcc
Q 001527          937 I--EQILDAGVLGYRAPELAASKK-PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQ-LKVAEGHGSDC 1012 (1060)
Q Consensus       937 ~--~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~-~~~~~~~~~~~ 1012 (1060)
                      .  .-....||+.|||||++.+.. .+..-++||||+|||+.||+||++||...+.        +|.- ..+..++...+
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--------e~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--------EWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--------hhHHHhHHhccCCCCC
Confidence            1  112247999999999997654 2224589999999999999999999986432        2432 22333322221


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                                   ++....+=.+++..|++ ||.+|.++.|+++.
T Consensus      1463 -------------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1463 -------------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -------------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                         11222333456669997 89999999998864

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=7.4e-33  Score=310.65  Aligned_cols=202  Identities=25%  Similarity=0.366  Sum_probs=169.8

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCC----CCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT----QHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+++ -.+|+.||||.++... ....+...+|+++|++++|||||++++.-....    .....+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            4689999999999999 4579999999998643 345677889999999999999999988764333    456789999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEee-CC--CCCeEEcccccceee
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD-GP--DLNARVADYCLHRLM  931 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~-~~--~~~~kl~Dfg~a~~~  931 (1060)
                      ||.+|||+..+.+..  ....+++.+.+.+..+++.||.||| ++|||||||||.||++- +.  ...-||+|||.|+..
T Consensus        98 yC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~Lr-En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLR-ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             ecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            999999999996543  3456999999999999999999999 99999999999999983 22  234699999999998


Q ss_pred             ccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001527          932 TQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVIS  988 (1060)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~  988 (1060)
                      +++....  ...||..|.+||++...++ ++..+|.|||||++||.+||..||....
T Consensus       175 ~d~s~~~--S~vGT~~YLhPel~E~q~~-y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  175 DDNSLFT--SLVGTEEYLHPELYERQKK-YTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             CCCCeee--eecCchhhcChHHHhhccC-cCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            8766433  3489999999999986332 4778999999999999999999997643

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.98  E-value=1.2e-31  Score=293.47  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=192.3

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA--KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ..+.||+|+||.||+|... +++.||+|.++....  ...+.+.+|++++++++|+||+++++++.  .....++|+||+
T Consensus         4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~lv~e~~   81 (264)
T cd06626           4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV--HREKVYIFMEYC   81 (264)
T ss_pred             eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe--cCCEEEEEEecC
Confidence            3578999999999999864 689999999875433  35678999999999999999999999874  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++...     ..+++..+..|+.|++.||+||| +.+|+||||||+||+++ +++.+||+|||.+........
T Consensus        82 ~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh-~~~i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          82 SGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLH-SHGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEC-CCCCEEEcccccccccCCCCC
Confidence            999999999542     34788999999999999999999 99999999999999998 588999999999887654332


Q ss_pred             eeee---ccCccccccchhcccCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHH-HhcCCCCc
Q 001527          937 IEQI---LDAGVLGYRAPELAASKK-PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLK-VAEGHGSD 1011 (1060)
Q Consensus       937 ~~~~---~~~gt~~y~aPE~~~~~~-~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~-~~~~~~~~ 1011 (1060)
                      ....   ...++..|+|||++.+.. ..++.++||||||+++||+++|+.||.....        .|.... .....   
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~---  223 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--------EFQIMFHVGAGH---  223 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--------hHHHHHHHhcCC---
Confidence            2111   235788999999997655 2247899999999999999999999974321        111111 11110   


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                        .+.+      +........+.+++.+|++ +|.+||++.|++.
T Consensus       224 --~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 --KPPI------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --CCCC------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              1111      0011123456678889998 7999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.98  E-value=9.4e-35  Score=316.63  Aligned_cols=392  Identities=26%  Similarity=0.317  Sum_probs=270.2

Q ss_pred             eEEEecCCCCccccC-ccccc-CCCCCcEEECcCCcccccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeec
Q 001527           72 AGVVLDNLGLSAAAD-LSVFS-NLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSL  149 (1060)
Q Consensus        72 ~~~~l~~~~~~~~~~-~~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  149 (1060)
                      -|-.+|.+++..+|+ .+... .+++++-|.|...++. .+|+.++.|.+|++|.+++|++. .+-..+..|+.|+.+++
T Consensus         8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~   85 (1255)
T KOG0444|consen    8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV   85 (1255)
T ss_pred             eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence            355667788877754 34333 8999999999999998 78999999999999999999998 66788999999999999


Q ss_pred             cccccCc-ccCCcccCCCcccEEEccCCCCCCCCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCcCCc
Q 001527          150 AGNNFSG-LIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDG  228 (1060)
Q Consensus       150 s~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  228 (1060)
                      .+|++.. -+|..+-.|..|+.||||+|+++ ..|..+..-+++-.|+||+|+|..++-.-|-+|+.|-.||||+|++..
T Consensus        86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~  164 (1255)
T KOG0444|consen   86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEM  164 (1255)
T ss_pred             hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhh
Confidence            9999964 47888889999999999999999 789999999999999999999976555667799999999999999986


Q ss_pred             cCchhhhccCCCCeecccCCccccCCCcCcCCCccccccEEEccCCcccccCCCCccccCCCCCCEEEccCCcc--ccCC
Q 001527          229 HLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQL--TGEL  306 (1060)
Q Consensus       229 ~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~l~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l--~~~~  306 (1060)
                      .+| ....|..|+.|+|++|.+.                          ....  ..+..+++|++|.+++.+=  ...+
T Consensus       165 LPP-Q~RRL~~LqtL~Ls~NPL~--------------------------hfQL--rQLPsmtsL~vLhms~TqRTl~N~P  215 (1255)
T KOG0444|consen  165 LPP-QIRRLSMLQTLKLSNNPLN--------------------------HFQL--RQLPSMTSLSVLHMSNTQRTLDNIP  215 (1255)
T ss_pred             cCH-HHHHHhhhhhhhcCCChhh--------------------------HHHH--hcCccchhhhhhhcccccchhhcCC
Confidence            655 5677777677777776552                          1111  2344567788888888763  2344


Q ss_pred             CCccCCCCccEEEccCCcCcccCCcchhccCCCCCCeEECCCCccccccCcccccCCcEEEccCCcCcccCCCCCCCCCE
Q 001527          307 PGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAV  386 (1060)
Q Consensus       307 p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~  386 (1060)
                      +++..+.+|..+|||.|.+. .+|+..+.                        ..+|+.|+||+|+|+            
T Consensus       216 tsld~l~NL~dvDlS~N~Lp-~vPecly~------------------------l~~LrrLNLS~N~it------------  258 (1255)
T KOG0444|consen  216 TSLDDLHNLRDVDLSENNLP-IVPECLYK------------------------LRNLRRLNLSGNKIT------------  258 (1255)
T ss_pred             CchhhhhhhhhccccccCCC-cchHHHhh------------------------hhhhheeccCcCcee------------
Confidence            46777777777777777765 44442211                        023444444444443            


Q ss_pred             EEccCCccccccccccCCCccCEEEcccCeecccCCCCCcccCCCCeEEccCCcCccccchhccccCCCcEEecCCcccc
Q 001527          387 LDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLD  466 (1060)
Q Consensus       387 L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  466 (1060)
                                                       .+.-......+|+.|+||.|+++ .+|.+++.+++|+.|.+.+|+++
T Consensus       259 ---------------------------------eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~  304 (1255)
T KOG0444|consen  259 ---------------------------------ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT  304 (1255)
T ss_pred             ---------------------------------eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc
Confidence                                             22222333334444444444444 45555555555555555555543


Q ss_pred             C-ccccccccCCCcceEEccCccccccCCCCCCCCCCCcEEEccCCccccccCccccCCCCCcEEECCCCccccccCccc
Q 001527          467 G-PFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSM  545 (1060)
Q Consensus       467 ~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~  545 (1060)
                      . -+|+.++.+.+|+.+..++|.+. ..|..++.+..|+.|.|++|+|. .+|+.+.-|+.|+.|||..|.=--..|..-
T Consensus       305 FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~  382 (1255)
T KOG0444|consen  305 FEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPN  382 (1255)
T ss_pred             ccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCCcc
Confidence            2 25666666666666666666665 56667777777888888888877 678888888888888888776542233222


Q ss_pred             cCCCCCCeEeccCC-----cccCCCCCC
Q 001527          546 ANMTSLSSLVISQN-----HFTGPLPNN  568 (1060)
Q Consensus       546 ~~l~~L~~L~ls~N-----~l~g~ip~~  568 (1060)
                      ..-++|+.-++..-     +|.|..|..
T Consensus       383 da~~~lefYNIDFSLq~QlrlAG~~pas  410 (1255)
T KOG0444|consen  383 DARKKLEFYNIDFSLQHQLRLAGQMPAS  410 (1255)
T ss_pred             hhhhcceeeecceehhhHHhhccCCccc
Confidence            22245554433321     345666654

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.98  E-value=2.5e-32  Score=302.44  Aligned_cols=262  Identities=17%  Similarity=0.165  Sum_probs=186.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA--KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|+.. +|+.||+|+++....  .....+.+|++++++++||||+++++++.  +....++|+||++
T Consensus         5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~   82 (284)
T cd07839           5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH--SDKKLTLVFEYCD   82 (284)
T ss_pred             EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc--cCCceEEEEecCC
Confidence            467999999999999965 689999999864321  22356778999999999999999999985  5668899999996


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                       ++|.+++...    ...+++..+..++.||++||+||| ..+|+||||||+||+++ .++.+||+|||+++........
T Consensus        83 -~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH-~~~i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~  155 (284)
T cd07839          83 -QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCH-SHNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRC  155 (284)
T ss_pred             -CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEEc-CCCcEEECccchhhccCCCCCC
Confidence             5888887543    245899999999999999999999 99999999999999998 5789999999998865432221


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCC------CCc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGH------GSD 1011 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~------~~~ 1011 (1060)
                      . ....++..|+|||++.+... ++.++|||||||++|||+||+.|+......   ....+.+........      ..+
T Consensus       156 ~-~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         156 Y-SAEVVTLWYRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             c-CCCccccCCcChHHHhCCcc-cCcHHHHHHHHHHHHHHHhcCCCCcCCCCH---HHHHHHHHHHhCCCChHHhHHhhh
Confidence            1 12357889999999876542 377999999999999999999986432111   001111100000000      000


Q ss_pred             ccccccccccC-----ChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1012 CFDAAVMPEMV-----NPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1012 ~~d~~l~~~~~-----~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      ..+........     .+........+.+++.+|++ +|.+|||++|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            00000000000     00111234566788899998 79999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.98  E-value=6.4e-32  Score=294.40  Aligned_cols=246  Identities=21%  Similarity=0.326  Sum_probs=192.1

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|... +|..+|+|.+....  ....+.+.+|++++++++||||+++++++.  .....++|+||++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~   82 (257)
T cd08225           5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ--ENGRLFIVMEYCD   82 (257)
T ss_pred             EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec--cCCeEEEEEecCC
Confidence            468999999999999965 68899999986432  134467889999999999999999999884  5678999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +++|.+++....   ...+++..+..++.|++.||+||| +.+++|+||||+||+++.++..+|++|||.+.........
T Consensus        83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (257)
T cd08225          83 GGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIH-DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL  158 (257)
T ss_pred             CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence            999999996532   235799999999999999999999 8999999999999999854456799999998766543222


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      . ....|+..|+|||+..+...  +.++|||||||++|||++|+.||...       ...+++...... .....     
T Consensus       159 ~-~~~~~~~~~~ape~~~~~~~--~~~~Dv~slG~il~~l~~g~~p~~~~-------~~~~~~~~~~~~-~~~~~-----  222 (257)
T cd08225         159 A-YTCVGTPYYLSPEICQNRPY--NNKTDIWSLGCVLYELCTLKHPFEGN-------NLHQLVLKICQG-YFAPI-----  222 (257)
T ss_pred             c-cccCCCccccCHHHHcCCCC--CchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHHHHhcc-cCCCC-----
Confidence            1 22358889999999877654  78999999999999999999998642       223333322221 11100     


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                              .......+.+++.+|+. +|++|||++||++.
T Consensus       223 --------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         223 --------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             --------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                    01223457788889998 79999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=9.4e-32  Score=296.65  Aligned_cols=244  Identities=21%  Similarity=0.329  Sum_probs=190.4

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccc-hHHHHHHHHHHHHHHhcCC---CCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREG-VAKQRKEFAKEAKKFANIR---HPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|.. .+++.||+|.++.. .....+++.+|++++++++   |||++++++++.  .+...++||||
T Consensus         6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~--~~~~~~lv~e~   83 (277)
T cd06917           6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL--KGPRLWIIMEY   83 (277)
T ss_pred             hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee--eCCEEEEEEec
Confidence            46799999999999995 47899999998653 2334567889999999996   999999999985  46678999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++++|.+++..      ..+++..+..++.|++.||.||| +.||+||||+|+||+++ +++.++|+|||.+.......
T Consensus        84 ~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh-~~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          84 AEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIH-KVGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             CCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcCHHHEEEc-CCCCEEEccCCceeecCCCc
Confidence            999999999843      25899999999999999999999 99999999999999998 58899999999998765443


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      ... ....|+..|+|||++.+.. .++.++|||||||++|+|++|+.||.....       ..+.. .....     ..+
T Consensus       156 ~~~-~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~~~~-~~~~~-----~~~  220 (277)
T cd06917         156 SKR-STFVGTPYWMAPEVITEGK-YYDTKADIWSLGITIYEMATGNPPYSDVDA-------FRAMM-LIPKS-----KPP  220 (277)
T ss_pred             ccc-ccccCCcceeCHHHhccCC-ccccchhHHHHHHHHHHHHhCCCCCCCCCh-------hhhhh-ccccC-----CCC
Confidence            222 2236888999999987543 247799999999999999999999864321       11111 00000     011


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .+...       .....+.+++.+|++ +|++||++.|+++.
T Consensus       221 ~~~~~-------~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         221 RLEDN-------GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCcc-------cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            11111       134567888899998 79999999999763

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.4e-31  Score=291.14  Aligned_cols=248  Identities=19%  Similarity=0.262  Sum_probs=190.1

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccc-----hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREG-----VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      ..+.||+|+||.||+|+.. +++.||+|++...     .....+.+.+|++++++++||||+++++++.+......++|+
T Consensus         6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (264)
T cd06653           6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV   85 (264)
T ss_pred             eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence            3578999999999999854 6899999987422     123446788999999999999999999998655556788999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+++++|.+++...     ..+++..+..++.|++.||.||| +.+|+||||||+||+++ +++.++|+|||.++....
T Consensus        86 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH-~~~i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          86 EYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLH-SNMIVHRDIKGANILRD-SAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEc-CCCCEEECcccccccccc
Confidence            999999999998542     34789999999999999999999 99999999999999998 578999999999986533


Q ss_pred             CCc--eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          934 AGT--IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       934 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                      ...  .......++..|+|||++.+...  +.++|||||||++||+++|+.||....      .. .-+....... .. 
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~il~~l~~g~~p~~~~~------~~-~~~~~~~~~~-~~-  227 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGY--GRKADVWSVACTVVEMLTEKPPWAEYE------AM-AAIFKIATQP-TK-  227 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCC--CccccHHHHHHHHHHHHhCCCCCCccC------HH-HHHHHHHcCC-CC-
Confidence            111  11112358889999999987654  779999999999999999999986421      11 1111111110 00 


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYED 1056 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~~p~~RPs~~evl~~ 1056 (1060)
                         +.+        .......+.+++.+|+.+|..||++.+++..
T Consensus       228 ---~~~--------p~~~~~~~~~~i~~~l~~~~~r~~~~~~~~~  261 (264)
T cd06653         228 ---PML--------PDGVSDACRDFLKQIFVEEKRRPTAEFLLRH  261 (264)
T ss_pred             ---CCC--------CcccCHHHHHHHHHHhcCcccCccHHHHhcC
Confidence               001        1123355777888999988999999988753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.98  E-value=4e-32  Score=297.48  Aligned_cols=248  Identities=25%  Similarity=0.362  Sum_probs=194.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++.  .....++|+||+++
T Consensus         6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~   83 (265)
T cd06605           6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY--NNGDISICMEYMDG   83 (265)
T ss_pred             HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee--cCCEEEEEEEecCC
Confidence            467999999999999965 68999999987543 344567889999999999999999999985  45789999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD-RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      ++|.+++....    ..+++..+..++.|++.||+||| + .+++||||||+||+++ +++.+||+|||.+.........
T Consensus        84 ~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH-~~~~i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          84 GSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLH-EKHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             CcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHc-CCCCeecCCCCHHHEEEC-CCCCEEEeecccchhhHHHHhh
Confidence            99999996532    46889999999999999999999 7 9999999999999998 5889999999998765433222


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      .   ..++..|+|||++.+..+  +.++||||||+++|+|++|+.||......  .....+.++...... .     +.+
T Consensus       158 ~---~~~~~~y~~PE~~~~~~~--~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~-~-----~~~  224 (265)
T cd06605         158 T---FVGTSSYMAPERIQGNDY--SVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEP-P-----PRL  224 (265)
T ss_pred             c---ccCChhccCHHHHcCCCC--CchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCC-C-----CCC
Confidence            1   368889999999987754  78999999999999999999998753211  112233332222111 0     000


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      ..       ......+.+++.+|+. +|.+|||+.|++..
T Consensus       225 ~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         225 PS-------GKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             Ch-------hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            00       0134557788889998 79999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=9.6e-32  Score=298.40  Aligned_cols=254  Identities=23%  Similarity=0.296  Sum_probs=186.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++.  .....+++|||+.
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~--~~~~~~~~~e~~~   86 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF--REGDCWICMELMD   86 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe--cCCcEEEEEeccc
Confidence            467999999999999854 68999999986432 234567889999999996 999999999885  4567899999985


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                       +++.++...........+++..+..++.|++.||+|||+..+|+||||||+||+++ .++.+||+|||+++........
T Consensus        87 -~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~  164 (288)
T cd06616          87 -ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAK  164 (288)
T ss_pred             -CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc-cCCcEEEeecchhHHhccCCcc
Confidence             46555432111122356899999999999999999999446999999999999998 5778999999998765433222


Q ss_pred             eeeccCccccccchhcccCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          938 EQILDAGVLGYRAPELAASKK-PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                        ....|+..|+|||++.+.. ..++.++|||||||++|||++|+.||....      ...+.+...... .     .+.
T Consensus       165 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~-~-----~~~  230 (288)
T cd06616         165 --TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKG-D-----PPI  230 (288)
T ss_pred             --ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCC-C-----CCc
Confidence              1225888999999987652 124789999999999999999999986421      111111111110 0     111


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      +....    .......+.+++.+|++ +|++|||++||++.
T Consensus       231 ~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         231 LSNSE----EREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCcC----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11110    01234567888899998 79999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.98  E-value=2.6e-31  Score=294.11  Aligned_cols=243  Identities=18%  Similarity=0.250  Sum_probs=191.4

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|++|.||+|.. .+++.+++|+++.......+.+.+|+.++++++||||+++++++.  ..+..++|+||++++
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~--~~~~~~~v~e~~~~~  101 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL--VGDELWVVMEFLEGG  101 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE--cCCeEEEEEeccCCC
Confidence            46899999999999985 478999999987554555667889999999999999999999885  567889999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++..      ..+++.++..++.|++.||+||| +.+|+||||||+||+++ +++.++|+|||.+......... .
T Consensus       102 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~~~~~-~  172 (285)
T cd06648         102 ALTDIVTH------TRMNEEQIATVCLAVLKALSFLH-AQGVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPR-R  172 (285)
T ss_pred             CHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCChhhEEEc-CCCcEEEcccccchhhccCCcc-c
Confidence            99999854      34889999999999999999999 99999999999999998 5889999999988755432221 1


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ....|+..|+|||...+..+  +.++|||||||++|||++|+.||...       +........... ..     +....
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slGv~l~ell~g~~p~~~~-------~~~~~~~~~~~~-~~-----~~~~~  237 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPY--GTEVDIWSLGIMVIEMVDGEPPYFNE-------PPLQAMKRIRDN-LP-----PKLKN  237 (285)
T ss_pred             ccccCCccccCHHHhcCCCC--CCcccHHHHHHHHHHHHhCCCCCcCC-------CHHHHHHHHHhc-CC-----CCCcc
Confidence            22358899999999977654  77999999999999999999998642       112222221111 10     01100


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                            .......+.+++.+|++ +|.+||++.|+++
T Consensus       238 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 ------LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ------cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence                  01123467888899998 7999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.98  E-value=1.9e-32  Score=303.97  Aligned_cols=258  Identities=19%  Similarity=0.238  Sum_probs=190.1

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|... +++.||+|+++...  ....+.+.+|++++++++||||+++++++.  .++..++||||++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~e~~~   83 (288)
T cd07833           6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR--RKGRLYLVFEYVE   83 (288)
T ss_pred             EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE--ECCEEEEEEecCC
Confidence            578999999999999965 58899999986532  223467899999999999999999999995  4667999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      ++.+..+...     ...+++.++..++.||+.||+||| ..+++||||||+||+++ +++.+||+|||.+.........
T Consensus        84 ~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          84 RTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCH-SHNIIHRDIKPENILVS-ESGVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             CCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEEC-CCCCEEEEeeecccccCCCccc
Confidence            8777665532     234899999999999999999999 89999999999999998 5889999999998876554321


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHh------------
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA------------ 1005 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~------------ 1005 (1060)
                      ......++..|+|||++.+.. .++.++||||||+++|+|++|+.||......    +..........            
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~-~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDT-NYGKPVDVWAIGCIMAELLDGEPLFPGDSDI----DQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             cccCcccccCCcCCchhcCCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCHHHhhhccc
Confidence            222236788999999998763 2478999999999999999999998643111    00000000000            


Q ss_pred             cCCCC-----cccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1006 EGHGS-----DCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1006 ~~~~~-----~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .....     +..++.....   .........+.+++.+|+. +|.+||++++|++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLER---RYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CccccccccCCCCCcHHHHH---hcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00000     0000000000   0001125678899999998 7999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.98  E-value=8.4e-32  Score=299.31  Aligned_cols=195  Identities=24%  Similarity=0.348  Sum_probs=160.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHH-HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+|+.. +++.||+|.+...... ....+.+|++++++++||||+++++++.  +....++||||+++
T Consensus        10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~   87 (291)
T cd07844          10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH--TKKTLTLVFEYLDT   87 (291)
T ss_pred             EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe--cCCeEEEEEecCCC
Confidence            478999999999999965 6899999998653221 2345678999999999999999999985  56789999999974


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                       +|.+++....    ..+++..+..++.|++.||.||| +.+|+||||||+||+++ .++.+||+|||.++.........
T Consensus        88 -~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH-~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          88 -DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCH-QRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             -CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH-hCCeecccCCHHHEEEc-CCCCEEECccccccccCCCCccc
Confidence             9999986532    35889999999999999999999 99999999999999998 57899999999987543221111


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                       ....++..|+|||++.+... ++.++||||+||++|||++|+.||..
T Consensus       161 -~~~~~~~~~~aPE~~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~  206 (291)
T cd07844         161 -SNEVVTLWYRPPDVLLGSTE-YSTSLDMWGVGCIFYEMATGRPLFPG  206 (291)
T ss_pred             -cccccccccCCcHHhhcCcc-cCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence             11246788999999875432 37799999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1e-31  Score=295.92  Aligned_cols=251  Identities=21%  Similarity=0.326  Sum_probs=191.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCC----CCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPT----QHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~----~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+|... +++.+++|++..... ..+.+.+|+++++++ +||||+++++++....    ....++|||
T Consensus        11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e   89 (275)
T cd06608          11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME   89 (275)
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence            578999999999999965 678999999876533 346789999999999 7999999999996432    445899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++++|.+++.... .....+++..+..++.|++.||.||| +.+++||||+|+||+++ +++.+||+|||.+......
T Consensus        90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH-~~~i~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~  166 (275)
T cd06608          90 LCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLH-ENKVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDST  166 (275)
T ss_pred             cCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCHHHEEEc-cCCeEEECCCccceecccc
Confidence            999999999986532 12356899999999999999999999 99999999999999998 5789999999998765433


Q ss_pred             CceeeeccCccccccchhcccCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          935 GTIEQILDAGVLGYRAPELAASK---KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                      .... ....|+..|+|||++...   ...++.++|||||||++|+|++|+.||.....      .... .. ......  
T Consensus       167 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~-~~-~~~~~~--  235 (275)
T cd06608         167 LGRR-NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP------MRAL-FK-IPRNPP--  235 (275)
T ss_pred             hhhh-cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch------HHHH-HH-hhccCC--
Confidence            2221 223688999999988542   22347789999999999999999999864211      1111 11 111101  


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                         +.+.      ........+.+++.+|+. +|.+|||+.||++
T Consensus       236 ---~~~~------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         236 ---PTLK------SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ---CCCC------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence               0110      011234567788889998 8999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.98  E-value=3.1e-31  Score=292.45  Aligned_cols=242  Identities=21%  Similarity=0.332  Sum_probs=189.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.  .+...++||||+++
T Consensus         9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~   86 (277)
T cd06641           9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDTKLWIIMEYLGG   86 (277)
T ss_pred             heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE--eCCeEEEEEEeCCC
Confidence            467999999999999854 68999999986432 334567889999999999999999999985  56678999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++..      ..+++..+..++.|++.|+.||| +.+++|+||||+||+++ .++.++++|||++......... 
T Consensus        87 ~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~-  157 (277)
T cd06641          87 GSALDLLEP------GPLDETQIATILREILKGLDYLH-SEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIK-  157 (277)
T ss_pred             CcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHc-cCCeecCCCCHHhEEEC-CCCCEEEeecccceecccchhh-
Confidence            999999853      34889999999999999999999 99999999999999998 5789999999998765443221 


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      .....++..|+|||++.+...  +.++|||||||++|+|++|+.||.....       ..+... .......     .+ 
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~--~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~~-~~~~~~~-----~~-  221 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAY--DSKADIWSLGITAIELAKGEPPHSELHP-------MKVLFL-IPKNNPP-----TL-  221 (277)
T ss_pred             hccccCCccccChhhhccCCC--CchhhHHHHHHHHHHHHcCCCCCCccch-------HHHHHH-HhcCCCC-----CC-
Confidence            112357889999999977654  7799999999999999999999864211       111111 1111110     01 


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                             .......+.+++.+|++ +|.+||++.|+++.
T Consensus       222 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 -------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -------CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                   01233457788889997 79999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.98  E-value=2.4e-31  Score=297.55  Aligned_cols=248  Identities=19%  Similarity=0.202  Sum_probs=187.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.||+|.+.....   ...+.+.+|+++++.++||||+++++++.  .+...++||||+
T Consensus         6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   83 (305)
T cd05609           6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE--TKRHLCMVMEYV   83 (305)
T ss_pred             eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe--cCCEEEEEEecC
Confidence            478999999999999965 588999999875432   23457889999999999999999999884  566889999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++...     ..+++..+..++.|++.||+||| +.+++||||||+||+++ +++.+|++|||+++.......
T Consensus        84 ~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          84 EGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLH-NYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCchHHEEEC-CCCCEEEeeCCCccccCcCcc
Confidence            999999999542     35899999999999999999999 89999999999999998 588999999999874211100


Q ss_pred             --------------eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHH
Q 001527          937 --------------IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQL 1002 (1060)
Q Consensus       937 --------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~ 1002 (1060)
                                    .......++..|+|||++.+...  +.++|||||||++|||++|+.||...       ...++...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~vl~el~~g~~pf~~~-------~~~~~~~~  227 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY--GKPVDWWAMGIILYEFLVGCVPFFGD-------TPEELFGQ  227 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCC--CchhhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHH
Confidence                          00011246788999999877654  78999999999999999999998632       11222222


Q ss_pred             HHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527         1003 KVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1003 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                      .....    ...+...        ......+.+++.+|++ +|++||++.++.+.|+
T Consensus       228 ~~~~~----~~~~~~~--------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         228 VISDD----IEWPEGD--------EALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHhcc----cCCCCcc--------ccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            22111    0011100        0123456788889998 7999999655555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.98  E-value=9.7e-32  Score=297.71  Aligned_cols=196  Identities=23%  Similarity=0.349  Sum_probs=162.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA--KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|++|.||+|+.. +++.||+|+++....  ...+.+.+|++++++++||||+++++++.  +....++||||+.
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~   82 (284)
T cd07860           5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLVFEFLH   82 (284)
T ss_pred             eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc--cCCcEEEEeeccc
Confidence            467999999999999865 689999999864322  22357889999999999999999999984  5668999999995


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                       ++|.+++....   ...+++.++..++.|++.||+||| ..+++||||||+||+++ +++.+||+|||.++........
T Consensus        83 -~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh-~~~i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~~~~  156 (284)
T cd07860          83 -QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRT  156 (284)
T ss_pred             -cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEC-CCCCEEEeeccchhhcccCccc
Confidence             68999886532   345899999999999999999999 99999999999999998 5889999999998765432211


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                       .....++..|+|||++.+... ++.++|||||||++|||+||+.||..
T Consensus       157 -~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         157 -YTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             -cccccccccccCCeEEecCCC-CCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             112256889999998876542 37789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.98  E-value=2.9e-31  Score=290.37  Aligned_cols=246  Identities=22%  Similarity=0.368  Sum_probs=195.0

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|++|.||+|+.. +++.|++|++..... ...+.+.+|++.+.+++||||+++++++.  .....++||||+++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~   83 (264)
T cd06623           6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY--KEGEISIVLEYMDG   83 (264)
T ss_pred             eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--cCCeEEEEEEecCC
Confidence            478999999999999966 599999999876543 44678999999999999999999999985  55789999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD-RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      ++|.+++...     ..+++..+..++.|+++|++||| + .+++||||+|+||+++ +++.++|+|||.+.........
T Consensus        84 ~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh-~~~~~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          84 GSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLH-TKRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh-ccCCCccCCCCHHHEEEC-CCCCEEEccCccceecccCCCc
Confidence            9999999543     45899999999999999999999 8 9999999999999998 5889999999999876543332


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      . ....++..|+|||.+.+...  +.++||||||+++|+|++|+.||.....    ....+......... .     +..
T Consensus       157 ~-~~~~~~~~y~~pE~~~~~~~--~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~-~-----~~~  223 (264)
T cd06623         157 C-NTFVGTVTYMSPERIQGESY--SYAADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAICDGP-P-----PSL  223 (264)
T ss_pred             c-cceeecccccCHhhhCCCCC--CchhhHHHHHHHHHHHHhCCCCCccccc----cCHHHHHHHHhcCC-C-----CCC
Confidence            2 12257889999999887754  7799999999999999999999875432    11112121111110 0     111


Q ss_pred             ccccCChhHHH-HHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1018 MPEMVNPAAEK-GMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1018 ~~~~~~~~~~~-~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                              ... ....+.+++.+|++ +|.+||++.|+++.
T Consensus       224 --------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 --------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             --------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                    011 34567888889998 69999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=4.4e-32  Score=300.82  Aligned_cols=241  Identities=21%  Similarity=0.310  Sum_probs=191.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      ...||+|.|+.|..|+.. ++..||+|.+.+..  ....+.+.+|+++|+.++|||||+++.+..  .....|+||||+.
T Consensus        61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~--t~~~lylV~eya~  138 (596)
T KOG0586|consen   61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE--TEATLYLVMEYAS  138 (596)
T ss_pred             eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee--ecceeEEEEEecc
Confidence            468999999999999954 79999999997653  233455889999999999999999999984  5778999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +|.+++|+...     ....+..+..++.|+.+|++||| +++|||||||++|||++ .++.+||+|||++.++......
T Consensus       139 ~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH-~k~ivHrdLk~eNilL~-~~mnikIaDfgfS~~~~~~~~l  211 (596)
T KOG0586|consen  139 GGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCH-SKNIVHRDLKAENILLD-ENMNIKIADFGFSTFFDYGLML  211 (596)
T ss_pred             CchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHh-hcceeccccchhhcccc-cccceeeeccccceeecccccc
Confidence            99999999643     34666888999999999999999 99999999999999999 5889999999999988755443


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      .+  .+|++.|.|||++.+.++ ..+++|+||+|+++|-|+.|..||+...       +.+             .-++.+
T Consensus       212 qt--~cgsppyAaPEl~~g~~y-~gpe~D~Wslgvvly~LV~GsLPFDG~~-------lk~-------------Lr~rvl  268 (596)
T KOG0586|consen  212 QT--FCGSPPYAAPELFNGKKY-DGPEVDIWSLGVVLYALVEGSLPFDGQN-------LKE-------------LRPRVL  268 (596)
T ss_pred             cc--cCCCCCccChHhhcCccc-CCcceehhhhhhhheeeeecccccCCcc-------ccc-------------ccchhe
Confidence            33  389999999999999886 4889999999999999999999998521       111             111112


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .+.+.-+  ......+-+++.+.+- +|.+|++++++.+
T Consensus       269 ~gk~rIp--~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  269 RGKYRIP--FYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eeeeccc--ceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            2222111  1122345555666655 7999999988865

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=1.4e-31  Score=302.69  Aligned_cols=198  Identities=26%  Similarity=0.311  Sum_probs=160.0

Q ss_pred             eeccc--cceEEEEEEEc-CCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          783 VLGRS--SHGTSYRATLE-NGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       783 ~iG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .||+|  +||+||+|+.. +|+.||+|++...  .....+.+.+|+.+++.++||||+++++++.  .+...++||||+.
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~--~~~~~~~v~e~~~   82 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT--TGSWLWVISPFMA   82 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe--cCCceEEEEeccc
Confidence            46666  99999999964 7999999998643  2334577889999999999999999999995  4667899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      ++++.+++....   ...+++..+..++.|++.||+||| +++|+||||||+||+++ .++.+|++||+.+.........
T Consensus        83 ~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH-~~~ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          83 YGSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLH-QNGYIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             CCCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCcc
Confidence            999999986542   234889999999999999999999 99999999999999998 5789999999865433221111


Q ss_pred             e------eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          938 E------QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       938 ~------~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      .      .....++..|+|||++.+....++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            0      0111346679999999775444578999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=2e-31  Score=292.24  Aligned_cols=252  Identities=24%  Similarity=0.317  Sum_probs=193.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++||||+++++.+.  .....++||||+++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~e~~~~   83 (267)
T cd06610           6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV--VGDELWLVMPYLSG   83 (267)
T ss_pred             eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe--eCCEEEEEEeccCC
Confidence            578999999999999954 68899999986432 235578899999999999999999999885  56788999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce-
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI-  937 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~-  937 (1060)
                      ++|.+++.....  ...+++..+..++.|++.||+||| +.||+||||||+||+++ ++..+||+|||++......... 
T Consensus        84 ~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh-~~~i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          84 GSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLH-SNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             CcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHhEEEc-CCCCEEEcccchHHHhccCcccc
Confidence            999999965321  245899999999999999999999 99999999999999998 5788999999998766543322 


Q ss_pred             --eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          938 --EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       938 --~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                        ......|+..|+|||++.... .++.++|||||||++|||++|+.||.......   ...+.    ....      .+
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~----~~~~------~~  225 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVH-GYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLT----LQND------PP  225 (267)
T ss_pred             ccccccccCChhhcChHHHcccc-CcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHH----hcCC------CC
Confidence              112235888999999987662 24789999999999999999999987532211   11111    1110      00


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ......   ........+.+++..|++ +|++||+++||++
T Consensus       226 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGA---DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCcc---ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            010000   011334567888889998 7999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=9.3e-32  Score=299.27  Aligned_cols=198  Identities=24%  Similarity=0.300  Sum_probs=164.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHH--HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAK--QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|+.. +++.+|+|.++.....  ....+.+|++++++++||||+++++++.+.+....++||||++
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~   89 (293)
T cd07843          10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE   89 (293)
T ss_pred             hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence            478999999999999975 6899999998744322  2345678999999999999999999987655578999999997


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                       ++|.+++....    ..+++.++..++.||+.||+||| +.+++||||||+||+++ +++.+||+|||.++........
T Consensus        90 -~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH-~~~i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          90 -HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLH-DNWILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             -cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCHHHEEEC-CCCcEEEeecCceeeccCCccc
Confidence             59999886432    35899999999999999999999 99999999999999998 5789999999999876543221


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      . ....++..|+|||++.+... .+.++||||+|+++|||++|+.||...
T Consensus       163 ~-~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~~f~~~  210 (293)
T cd07843         163 Y-TQLVVTLWYRAPELLLGAKE-YSTAIDMWSVGCIFAELLTKKPLFPGK  210 (293)
T ss_pred             c-ccccccccccCchhhcCCcc-ccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            1 12257889999999876542 377999999999999999999998753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-31  Score=301.57  Aligned_cols=246  Identities=21%  Similarity=0.276  Sum_probs=189.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|... +++.||+|.+.....   ...+.+.+|++++++++||||+++++++.  .....++||||+
T Consensus         6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~   83 (316)
T cd05574           6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ--TETYLCLVMDYC   83 (316)
T ss_pred             eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee--cCCEEEEEEEec
Confidence            468999999999999965 589999999875432   24567889999999999999999999984  566889999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      .+++|.+++....   ...+++..+..++.|++.||+||| +.|++||||||+||+++ .++.++|+|||++........
T Consensus        84 ~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          84 PGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLH-LLGIVYRDLKPENILLH-ESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             CCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHH-HCCeeccCCChHHeEEc-CCCCEEEeecchhhccccccc
Confidence            9999999986432   346899999999999999999999 99999999999999998 578999999999875432211


Q ss_pred             ee----------------------------eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001527          937 IE----------------------------QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVIS  988 (1060)
Q Consensus       937 ~~----------------------------~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~  988 (1060)
                      ..                            .....|+..|+|||++.+...  +.++||||||+++|+|++|+.||....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH--GSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC--CchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            00                            011257889999999987664  779999999999999999999986432


Q ss_pred             CCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCC----HHHHHH
Q 001527          989 GEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPG----IKTIYE 1055 (1060)
Q Consensus       989 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs----~~evl~ 1055 (1060)
                      ..      ..+.. .... ..      ..      +........+.+++.+|++ +|++||+    ++|+++
T Consensus       237 ~~------~~~~~-~~~~-~~------~~------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RD------ETFSN-ILKK-EV------TF------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hH------HHHHH-HhcC-Cc------cC------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            11      11111 1110 00      00      0011134567888889997 7999999    666664

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=1.8e-31  Score=297.36  Aligned_cols=265  Identities=20%  Similarity=0.224  Sum_probs=188.1

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH--HHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCC---CceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA--KQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQ---HEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~---~~~~lv~  853 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++....  ...+.+.+|++++++++ ||||+++++++.....   ...++||
T Consensus         6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~   85 (295)
T cd07837           6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF   85 (295)
T ss_pred             eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence            578999999999999965 689999998764322  12356888999999995 6999999998863221   1379999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+++ +|.+++..........+++.++..++.||+.||+||| ..+|+||||||+||+++.+++.+||+|||.++....
T Consensus        86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~  163 (295)
T cd07837          86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH-KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI  163 (295)
T ss_pred             eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChHHEEEecCCCeEEEeecccceecCC
Confidence            99985 8999886644332456899999999999999999999 999999999999999984478999999999886543


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCC-Ccc
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHG-SDC 1012 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~ 1012 (1060)
                      ..... ....+++.|+|||++.+... ++.++|||||||++|||++|+.||.....      ...........+.. .+.
T Consensus       164 ~~~~~-~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         164 PVKSY-THEIVTLWYRAPEVLLGSTH-YSTPVDIWSVGCIFAEMSRKQPLFPGDSE------LQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             Ccccc-CCcccccCCCChHHhhCCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHHHhCCCChhh
Confidence            22111 11246788999998865432 47899999999999999999999864211      11111110000000 000


Q ss_pred             c-------c----cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1013 F-------D----AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1013 ~-------d----~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .       +    +...+.............+.+++.+|+. +|.+||+++|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0       0    0000000000011234567889999998 7999999999975

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-32  Score=289.38  Aligned_cols=195  Identities=24%  Similarity=0.375  Sum_probs=170.1

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHH---HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAK---QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      -++||+|+||.||-++.+ +|+.+|+|.+.+...+   ......+|-.++.++..|.||.+--.|  ++.+..++|+..|
T Consensus       190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd~LClVLtlM  267 (591)
T KOG0986|consen  190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF--ETKDALCLVLTLM  267 (591)
T ss_pred             eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCCceEEEEEee
Confidence            479999999999999855 7999999988654322   234467899999999999999986555  5788999999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      .||+|.-+|+...   .+.+++..++.++.+|+.||+||| ..+||.||+||+|||+| +.++++|+|.|+|..+.....
T Consensus       268 NGGDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH-~~~iVYRDLKPeNILLD-d~GhvRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  268 NGGDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLH-RRRIVYRDLKPENILLD-DHGHVRISDLGLAVEIPEGKP  342 (591)
T ss_pred             cCCceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHH-hcceeeccCChhheeec-cCCCeEeeccceEEecCCCCc
Confidence            9999999997653   256999999999999999999999 99999999999999999 689999999999998877665


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ...  ++||.+|||||++....|  +...|.||+||++|||+.|+.||..
T Consensus       343 ~~~--rvGT~GYMAPEvl~ne~Y--~~s~Dwf~lGCllYemi~G~sPFr~  388 (591)
T KOG0986|consen  343 IRG--RVGTVGYMAPEVLQNEVY--DFSPDWFSLGCLLYEMIAGHSPFRQ  388 (591)
T ss_pred             ccc--ccCcccccCHHHHcCCcc--cCCccHHHHHhHHHHHHcccCchhh
Confidence            443  389999999999998885  7799999999999999999999964

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=2.2e-31  Score=295.97  Aligned_cols=196  Identities=24%  Similarity=0.343  Sum_probs=159.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHH-HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+|... +++.||+|+++..... ....+.+|++++++++|+||+++++++.  .+...++||||+. 
T Consensus        10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~e~~~-   86 (291)
T cd07870          10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH--TKETLTFVFEYMH-   86 (291)
T ss_pred             EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe--cCCeEEEEEeccc-
Confidence            468999999999999854 6899999998654222 2346778999999999999999999985  4567899999995 


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      +++.+++....    ..+++.++..++.|++.||+||| ..+|+||||||+||+++ .++.+||+|||+++.........
T Consensus        87 ~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          87 TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIH-GQHILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHHEEEc-CCCcEEEeccccccccCCCCCCC
Confidence            68877775432    34788889999999999999999 89999999999999998 57899999999987643322111


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                       ....++..|+|||++.+... ++.++|||||||++|||++|+.||+..
T Consensus       161 -~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~~l~~g~~~f~~~  207 (291)
T cd07870         161 -SSEVVTLWYRPPDVLLGATD-YSSALDIWGAGCIFIEMLQGQPAFPGV  207 (291)
T ss_pred             -CCccccccccCCceeecCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence             12257889999999875432 367899999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=307.99  Aligned_cols=248  Identities=24%  Similarity=0.393  Sum_probs=197.3

Q ss_pred             CCCeeccccceEEEEEEE-cCC----cEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          780 PAEVLGRSSHGTSYRATL-ENG----MFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      ..++||+|+||+||+|.| .+|    .+||+|++.... .+..+++..|+-+|.+++|||+++++|+|..   ....||+
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~---s~~qlvt  776 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML---STLQLVT  776 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc---chHHHHH
Confidence            368999999999999984 444    568999886543 3456789999999999999999999999953   3478999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      +|++.|+|.+|++.++    ..+.....+.|..|||+||.||| ++.+|||||-.+|||+.. -..+|+.|||+++....
T Consensus       777 q~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe-~qrlVHrdLaaRNVLVks-P~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLE-EQRLVHRDLAARNVLVKS-PNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHH-hcchhhhhhhhhheeecC-CCeEEEEecchhhccCc
Confidence            9999999999998765    34788899999999999999999 999999999999999984 56899999999998876


Q ss_pred             CCceeee-ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          934 AGTIEQI-LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       934 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                      ....... ...-.+.|||=|.+....+  +.++|||||||++||++| |..|++.++.++    +.+.    ++.+..  
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~--thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----I~dl----le~geR--  918 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKY--THQSDVWSFGVTIWELMTFGAKPYDGIPAEE----IPDL----LEKGER--  918 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCC--CchhhhhhhhhhHHHHHhcCCCccCCCCHHH----hhHH----Hhcccc--
Confidence            6543332 2233567999999988876  789999999999999998 999988654331    2222    222111  


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      +           +.++-....+..++.+||. |+..||+++++...+.+
T Consensus       919 L-----------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  919 L-----------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             C-----------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            1           1112445667888999998 67889999999988764

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=3.1e-31  Score=293.49  Aligned_cols=248  Identities=25%  Similarity=0.392  Sum_probs=183.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHH-HhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKK-FANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|+.. +|+.||+|+++... .....++..|+.. ++..+||||+++++++.  .....++||||++
T Consensus         6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~--~~~~~~lv~e~~~   83 (283)
T cd06617           6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF--REGDVWICMEVMD   83 (283)
T ss_pred             EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe--cCCcEEEEhhhhc
Confidence            468999999999999965 69999999987542 2233455566665 56678999999999985  4567999999996


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR-AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~-~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                       |+|.+++..... ....+++..+..++.||+.||+||| ++ +++||||||+||+++ ++..+||+|||.++.......
T Consensus        84 -~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH-~~~~i~h~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~  159 (283)
T cd06617          84 -TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLH-SKLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVA  159 (283)
T ss_pred             -ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHh-hcCCeecCCCCHHHEEEC-CCCCEEEeecccccccccccc
Confidence             689888865432 2356899999999999999999999 65 999999999999998 578999999999886543221


Q ss_pred             eeeeccCccccccchhcccCCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          937 IEQILDAGVLGYRAPELAASKK--PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      .  ....|+..|+|||++.+..  ..++.++|||||||++|||++|+.||.....     .. +........ .     .
T Consensus       160 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~-~~~~~~~~~-~-----~  225 (283)
T cd06617         160 K--TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PF-QQLKQVVEE-P-----S  225 (283)
T ss_pred             c--ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CH-HHHHHHHhc-C-----C
Confidence            1  2235788999999886521  1237799999999999999999999864211     11 111111111 0     0


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      +....       ......+.+++.+|+. +|++||++.||++
T Consensus       226 ~~~~~-------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 PQLPA-------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCc-------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11100       0123457788889998 7999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=4.5e-31  Score=296.91  Aligned_cols=263  Identities=17%  Similarity=0.181  Sum_probs=185.2

Q ss_pred             eeccccceEEEEEEEcCCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          783 VLGRSSHGTSYRATLENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       783 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .+|.|+++.||++.. +++.||+|+++..  .....+.+.+|++++++++||||+++++++.  ..+..+++|||+++|+
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~--~~~~~~~~~e~~~~~~   85 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI--VDSELYVVSPLMAYGS   85 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee--cCCeEEEEEeccCCCC
Confidence            344445555555443 6899999998754  3345578999999999999999999999985  4567899999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce---
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI---  937 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~---  937 (1060)
                      |.+++....   ...+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+|++|||.+.........   
T Consensus        86 l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH-~~~ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          86 CEDLLKTHF---PEGLPELAIAFILKDVLNALDYIH-SKGFIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             HHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCcceEEEe-cCCceEEecCccceeeccccccccc
Confidence            999997543   234889999999999999999999 99999999999999998 5789999999988765432211   


Q ss_pred             ---eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHH----hcC---
Q 001527          938 ---EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKV----AEG--- 1007 (1060)
Q Consensus       938 ---~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~----~~~--- 1007 (1060)
                         ......++..|+|||++......++.++|||||||++|||++|+.||.......   ...+......    ...   
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccCccccccCchh
Confidence               111224677899999987653345789999999999999999999997532110   0111000000    000   


Q ss_pred             ----CCCc----ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1008 ----HGSD----CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1008 ----~~~~----~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                          ....    ..++........+........+.+++.+|++ +|++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                0000    0011110001111122334567889999998 89999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=6.1e-32  Score=320.71  Aligned_cols=198  Identities=17%  Similarity=0.239  Sum_probs=152.7

Q ss_pred             ccCCCeeccccceEEEEEEEcC--CcEEEEE------------------EcccchHHHHHHHHHHHHHHhcCCCCceeee
Q 001527          778 RAPAEVLGRSSHGTSYRATLEN--GMFLTVK------------------WLREGVAKQRKEFAKEAKKFANIRHPNVVGL  837 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  837 (1060)
                      |...+.||+|+||+||+|..+.  +..+++|                  .++. .......+.+|++++++++|||||++
T Consensus       150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            3345789999999999987542  2222222                  1111 12234568899999999999999999


Q ss_pred             eeEEeCCCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCC
Q 001527          838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPD  917 (1060)
Q Consensus       838 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~  917 (1060)
                      ++++.  ..+..|+|+|++. +++.+++..............++..|+.||+.||+||| ++|||||||||+|||++ .+
T Consensus       229 ~~~~~--~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH-~~gIiHrDLKP~NILl~-~~  303 (501)
T PHA03210        229 EEILR--SEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH-DKKLIHRDIKLENIFLN-CD  303 (501)
T ss_pred             eEEEE--ECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEC-CC
Confidence            99995  4567899999984 57888775432222223446677889999999999999 99999999999999998 57


Q ss_pred             CCeEEcccccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCC
Q 001527          918 LNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCA  983 (1060)
Q Consensus       918 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p  983 (1060)
                      +.+||+|||+++.+............||..|+|||++.+..+  +.++|||||||++|||++|..+
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY--CEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC--CcHHHHHHHHHHHHHHHHCCCC
Confidence            899999999998765443332233469999999999988765  7899999999999999998864

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=2e-31  Score=294.03  Aligned_cols=243  Identities=22%  Similarity=0.286  Sum_probs=184.6

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          784 LGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       784 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      ||+|+||+||+|... +|+.||+|.+.....   ...+.+.+|++++++++||||+++++++.  ..+..++||||++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE--TKDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe--cCCeEEEEEecCCCC
Confidence            689999999999854 689999999864321   23445678999999999999999998884  556889999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++....   ...+++.++..++.|++.||.||| +.|++||||||+||+++ +++.+||+|||.+.........  
T Consensus        79 ~L~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~--  151 (277)
T cd05577          79 DLKYHIYNVG---EPGFPEARAIFYAAQIICGLEHLH-QRRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKI--  151 (277)
T ss_pred             cHHHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCcc--
Confidence            9999996543   135899999999999999999999 99999999999999998 5789999999998765432211  


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ....++..|+|||++.+..+  +.++||||+||++|+|++|+.||........   . +.+....    ...   +.-. 
T Consensus       152 ~~~~~~~~y~~PE~~~~~~~--~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-~~~~~~~----~~~---~~~~-  217 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEVY--DFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---K-EELKRRT----LEM---AVEY-  217 (277)
T ss_pred             ccccCCCCcCCHHHhcCCCC--CchhhhHHHHHHHHHHhhCCCCCCCCccccc---H-HHHHhcc----ccc---cccC-
Confidence            22357889999999887664  7799999999999999999999865322110   0 1111000    000   0000 


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHH
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYE 1055 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~ 1055 (1060)
                            .......+.+++.+|++ +|.+||     ++.++++
T Consensus       218 ------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         218 ------PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ------CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence                  01223456788889997 799999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=3.2e-31  Score=292.37  Aligned_cols=242  Identities=21%  Similarity=0.270  Sum_probs=179.2

Q ss_pred             eeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHH---hcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          783 VLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKF---ANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       783 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      +||+|+||.||+|... +++.+|+|.+.....   .....+.+|..++   ...+||||+.+++++.  ..+..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH--TPDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe--cCCeEEEEEec
Confidence            4899999999999964 689999998864321   1223344454433   3447999999998885  45678999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++++|.+++...     ..+++.++..|+.|++.||+||| +.+|+||||||+||+++ +++.+|++|||++.......
T Consensus        79 ~~~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH-~~~ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          79 MNGGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMH-NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCcCCCCCCHHHEEEC-CCCCEEEccCCcceeccccC
Confidence            9999999998542     45899999999999999999999 99999999999999998 57899999999987554322


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      .   ....|+..|+|||.+.+.. .++.++||||+||++|||++|+.||......    .. .........      ...
T Consensus       152 ~---~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~-~~~~~~~~~------~~~  216 (279)
T cd05633         152 P---HASVGTHGYMAPEVLQKGT-AYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DK-HEIDRMTLT------VNV  216 (279)
T ss_pred             c---cCcCCCcCccCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcCCCCCc----CH-HHHHHHhhc------CCc
Confidence            2   1236899999999986433 2377999999999999999999999753221    11 111111110      011


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHHH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYED 1056 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~~ 1056 (1060)
                      .+.        ......+.+++.+|+. +|.+||     +++|+++.
T Consensus       217 ~~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 ELP--------DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCc--------cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            110        1223456677889998 799999     69998874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=2.4e-31  Score=303.81  Aligned_cols=193  Identities=19%  Similarity=0.251  Sum_probs=160.1

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCC----CCceEEE
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT----QHEKLIL  852 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~~~lv  852 (1060)
                      ..+.||+|+||.||+|+.. +++.||+|++...  .....+.+.+|++++++++||||+++++++....    ....++|
T Consensus        20 ~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv   99 (353)
T cd07850          20 NLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV   99 (353)
T ss_pred             EEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEE
Confidence            3578999999999999954 7899999998642  2234456778999999999999999999885322    2357999


Q ss_pred             EEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeec
Q 001527          853 SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT  932 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~  932 (1060)
                      |||+. ++|.+++..       .+++.++..++.|++.||+||| ..||+||||||+||+++ .++.+||+|||.++...
T Consensus       100 ~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH-~~gi~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850         100 MELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAG  169 (353)
T ss_pred             EeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEEC-CCCCEEEccCccceeCC
Confidence            99995 588888742       2788999999999999999999 89999999999999998 57899999999998764


Q ss_pred             cCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          933 QAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ....  .....++..|+|||++.+..+  +.++|||||||++|+|++|+.||..
T Consensus       170 ~~~~--~~~~~~~~~y~aPE~~~~~~~--~~~~DvwslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         170 TSFM--MTPYVVTRYYRAPEVILGMGY--KENVDIWSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             CCCC--CCCCcccccccCHHHHhCCCC--CCchhhHhHHHHHHHHHHCCCCCCC
Confidence            4322  112357889999999987765  7899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=1.1e-30  Score=283.45  Aligned_cols=244  Identities=23%  Similarity=0.396  Sum_probs=194.1

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|++|.||+|... +++.+++|++........+.+.+|++.+++++||+|+++++++.  .....++++||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l~~e~~~~~   82 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL--KKDELWIVMEFCSGG   82 (253)
T ss_pred             eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe--cCCeEEEEEecCCCC
Confidence            478999999999999975 68999999998765556678999999999999999999999985  456789999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++....    ..+++..+..++.|++.||+||| ..+++||||+|+||+++ +++.++|+|||.+........  .
T Consensus        83 ~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh-~~~i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~--~  154 (253)
T cd05122          83 SLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLH-SNGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKA--R  154 (253)
T ss_pred             cHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhh-cCCEecCCCCHHHEEEc-cCCeEEEeecccccccccccc--c
Confidence            9999986532    46899999999999999999999 89999999999999998 588999999999987655432  1


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ....++..|+|||++.+...  +.++||||||+++|+|++|+.||....       .......... .......+.    
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~--~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~-~~~~~~~~~----  220 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPY--DYKADIWSLGITAIELAEGKPPYSELP-------PMKALFKIAT-NGPPGLRNP----  220 (253)
T ss_pred             cceecCCcccCHHHHcCCCC--CccccHHHHHHHHHHHHhCCCCCCCCc-------hHHHHHHHHh-cCCCCcCcc----
Confidence            22368889999999987654  789999999999999999999986431       1111111111 111111000    


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                             ......+.+++.+|++ +|.+|||+.|+++
T Consensus       221 -------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 -------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -------cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   0113467788889998 7999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=3.4e-31  Score=294.12  Aligned_cols=238  Identities=24%  Similarity=0.323  Sum_probs=187.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|... +++.||+|+++...   ....+.+.+|++++++++||||+++++++.  .+...++||||+
T Consensus         6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~   83 (290)
T cd05580           6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ--DDSNLYLVMEYV   83 (290)
T ss_pred             EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCeEEEEEecC
Confidence            478999999999999965 68999999986532   233467889999999999999999999985  566889999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++...     ..+++..+..++.|++.||+||| +.||+||||||+||+++ +++.+||+|||+++.....  
T Consensus        84 ~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH-~~~i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          84 PGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLH-SLDIVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             CCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC--
Confidence            999999999543     46899999999999999999999 89999999999999998 5789999999999876543  


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                        .....|++.|+|||.+.+...  +.++||||||+++|+|++|+.||....       ..+ .......+..      .
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~-~~~~~~~~~~------~  216 (290)
T cd05580         155 --TYTLCGTPEYLAPEIILSKGY--GKAVDWWALGILIYEMLAGYPPFFDDN-------PIQ-IYEKILEGKV------R  216 (290)
T ss_pred             --CCCCCCCccccChhhhcCCCC--CccccHHHHHHHHHHHHhCCCCCCCCC-------HHH-HHHHHhcCCc------c
Confidence              122368899999999877654  779999999999999999999986422       111 1111111110      0


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~ 1055 (1060)
                      + +       ......+.+++.+|+. +|.+||     +++|+++
T Consensus       217 ~-~-------~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         217 F-P-------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             C-C-------ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            0 0       1123456678889998 799998     7777653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=1e-31  Score=293.98  Aligned_cols=243  Identities=22%  Similarity=0.299  Sum_probs=188.3

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          784 LGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       784 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      ||+|+||.||+|+.. +|+.+++|++.....   ...+.+.+|++++++++||||+++++.+.  .+...++||||++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ--GKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee--cCcEEEEEEecCCCC
Confidence            689999999999976 499999999875433   34567889999999999999999998884  567889999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce--
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI--  937 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~--  937 (1060)
                      +|.+++...     ..+++..+..++.|++.||+||| +.+++||||+|+||+++ ++..+||+|||++.........  
T Consensus        79 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH-~~~i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          79 DLASLLENV-----GSLDEDVARIYIAEIVLALEYLH-SNGIIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HcCeecCCCCHHHeEEc-CCCCEEEEecccchhcccCccccc
Confidence            999999642     25899999999999999999999 99999999999999998 5889999999998765433211  


Q ss_pred             -----eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          938 -----EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       938 -----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                           ......++..|+|||...+...  +.++||||||+++||+++|+.||....       ..+....... +..   
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~--~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~-~~~---  218 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVILGQGH--SKTVDWWSLGCILYEFLVGIPPFHGET-------PEEIFQNILN-GKI---  218 (265)
T ss_pred             ccccccccCcccCccccCHHHhcCCCC--CcchhhHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhc-CCc---
Confidence                 1122357889999999977664  779999999999999999999986432       1122221111 111   


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHh
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDL 1057 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L 1057 (1060)
                       .        .+........+.+++.+|++ +|.+|||+.+|.+.|
T Consensus       219 -~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         219 -E--------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             -C--------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence             0        00000124567788889998 799999995555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=5.4e-31  Score=288.03  Aligned_cols=241  Identities=23%  Similarity=0.290  Sum_probs=188.8

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          784 LGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       784 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      ||.|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.  ++...++||||++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK--DKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE--cCCccEEEEecCCCC
Confidence            699999999999965 58999999986432   234467899999999999999999999885  566889999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++...     ..+++.++..++.|++.||+||| +++++|+||||+||+++ .++.+||+|||.++.......  .
T Consensus        79 ~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH-~~~~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~--~  149 (262)
T cd05572          79 ELWTILRDR-----GLFDEYTARFYIACVVLAFEYLH-NRGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQK--T  149 (262)
T ss_pred             cHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccc--c
Confidence            999999543     34889999999999999999999 89999999999999998 578999999999987654321  1


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ....++..|+|||.+.+..+  +.++|+||+|+++|+|++|+.||.....     +..+............         
T Consensus       150 ~~~~~~~~~~~PE~~~~~~~--~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~---------  213 (262)
T cd05572         150 WTFCGTPEYVAPEIILNKGY--DFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGKL---------  213 (262)
T ss_pred             ccccCCcCccChhHhcCCCC--CChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCCC---------
Confidence            22367889999999876654  7799999999999999999999875321     1222222222100000         


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCC-----HHHHHH
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPG-----IKTIYE 1055 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs-----~~evl~ 1055 (1060)
                      ..    .......+.+++.+|++ +|++||+     ++|+++
T Consensus       214 ~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         214 EF----PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CC----CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            00    01124567888889998 7999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=2.3e-31  Score=295.69  Aligned_cols=248  Identities=20%  Similarity=0.260  Sum_probs=188.0

Q ss_pred             CCeeccccceEEEEEEE----cCCcEEEEEEcccchH----HHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEE
Q 001527          781 AEVLGRSSHGTSYRATL----ENGMFLTVKWLREGVA----KQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLI  851 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~l  851 (1060)
                      .+.||+|+||.||+|+.    .+|+.||+|+++....    ...+.+.+|+++++++ +||||+++++++.  .....++
T Consensus         5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~~~~l   82 (290)
T cd05613           5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TDTKLHL   82 (290)
T ss_pred             eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee--cCCeEEE
Confidence            46899999999999985    3689999999875322    2346688899999999 5999999998884  4567899


Q ss_pred             EEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceee
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~  931 (1060)
                      ||||+++++|.+++...     ..+++..+..++.|++.||+||| +.+++||||||+||+++ +++.+||+|||+++..
T Consensus        83 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH-~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~  155 (290)
T cd05613          83 ILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLH-KLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeEEC-CCCCEEEeeCccceec
Confidence            99999999999999542     35889999999999999999999 99999999999999998 5789999999999875


Q ss_pred             ccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          932 TQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                      ............|+..|+|||++.+....++.++||||||+++|+|++|+.||.....   .....++........    
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~~~~~~----  228 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE---KNSQAEISRRILKSE----  228 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc---cccHHHHHHHhhccC----
Confidence            4433222223358899999999876443347799999999999999999999864211   112222222111110    


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHH
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYE 1055 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~ 1055 (1060)
                         +..        .......+.+++.+|++ +|++||     +++++++
T Consensus       229 ---~~~--------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 ---PPY--------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---CCC--------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence               000        01223456788889998 799997     6676654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-31  Score=297.48  Aligned_cols=264  Identities=20%  Similarity=0.249  Sum_probs=192.1

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|+.. +++.+|+|+++...  ....+.+.+|++++++++|||++++++++........++||||++
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   83 (287)
T cd07840           4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD   83 (287)
T ss_pred             eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence            468999999999999965 58999999997652  233457889999999999999999999996433478999999997


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      + +|.+++...    ...+++.++..++.|++.||+||| ..+++|+||||+||+++ +++.+||+|||.+.........
T Consensus        84 ~-~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH-~~~~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          84 H-DLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLH-SNGILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             c-cHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCcHHHeEEc-CCCCEEEccccceeeccCCCcc
Confidence            4 898888543    146899999999999999999999 89999999999999998 5889999999999876554322


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC---CCC---c
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG---HGS---D 1011 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---~~~---~ 1011 (1060)
                      ......++..|+|||.+.+.. .++.++||||||+++|||++|+.||+.....    .....+.......   ...   +
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~-~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIFQGSTEL----EQLEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             cccccccccccCCceeeEccc-cCChHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCchhhcccccc
Confidence            222335678899999876543 2478999999999999999999998743211    1111111110000   000   0


Q ss_pred             c-cccccccccC-C----hhHHH-HHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1012 C-FDAAVMPEMV-N----PAAEK-GMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1012 ~-~d~~l~~~~~-~----~~~~~-~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      . .......... .    ..... ....+.+++.+|+. +|.+||+++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            0 0000000000 0    00011 24578899999998 79999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=9e-31  Score=293.28  Aligned_cols=242  Identities=21%  Similarity=0.325  Sum_probs=185.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG---VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.||+|++...   .....+++.+|++++++++||||+++++++.  +.+..++||||+
T Consensus        20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~   97 (307)
T cd06607          20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL--REHTAWLVMEYC   97 (307)
T ss_pred             heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE--eCCeEEEEHHhh
Confidence            478999999999999864 6899999988632   2234467889999999999999999999996  456789999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      + |++.+++....    ..+++.++..++.|++.||.||| +.+|+||||+|+||+++ +++.+||+|||++....... 
T Consensus        98 ~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH-~~~i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~~~~~~-  169 (307)
T cd06607          98 L-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLH-SHERIHRDIKAGNILLT-EPGTVKLADFGSASLVSPAN-  169 (307)
T ss_pred             C-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcccEEEC-CCCCEEEeecCcceecCCCC-
Confidence            6 57777774322    35899999999999999999999 99999999999999998 57899999999987654322 


Q ss_pred             eeeeccCccccccchhcccCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          937 IEQILDAGVLGYRAPELAASK-KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                          ...++..|+|||++.+. ...++.++||||||+++|||++|+.||....       ....... ......     +
T Consensus       170 ----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~-------~~~~~~~-~~~~~~-----~  232 (307)
T cd06607         170 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYH-IAQNDS-----P  232 (307)
T ss_pred             ----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc-------HHHHHHH-HhcCCC-----C
Confidence                12578899999988521 1224779999999999999999999986421       1111111 111100     0


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      ...       .......+.+++.+|++ +|++||++.+|+..
T Consensus       233 ~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         233 TLS-------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCC-------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            110       11234567888899998 79999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=1.6e-31  Score=297.49  Aligned_cols=260  Identities=18%  Similarity=0.241  Sum_probs=186.0

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA--KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|++|.||+|+.. +|+.||+|+++....  ...+.+.+|++++++++||||+++++++.  .....++||||++
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~   84 (294)
T PLN00009          7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKRLYLVFEYLD   84 (294)
T ss_pred             EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe--cCCeEEEEEeccc
Confidence            468999999999999965 689999999864321  23356889999999999999999999995  5678999999995


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                       +++.+++....   ...+++..+..++.||+.||+||| +++|+||||||+||+++.++..+||+|||++.........
T Consensus        85 -~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH-~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         85 -LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCH-SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             -ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence             58888875432   234678888999999999999999 8999999999999999855667999999999765432111


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHh-cCCCCccc---
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA-EGHGSDCF--- 1013 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~--- 1013 (1060)
                       .....++..|+|||++.+... ++.++||||+||++|+|+||+.||......      ......... .....+..   
T Consensus       160 -~~~~~~~~~y~~PE~~~~~~~-~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        160 -FTHEVVTLWYRAPEILLGSRH-YSTPVDIWSVGCIFAEMVNQKPLFPGDSEI------DELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             -cccCceeecccCHHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCChhhcccc
Confidence             112256889999999866432 477999999999999999999998643211      111110000 00000000   


Q ss_pred             ----cc-ccccccCCh----hHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1014 ----DA-AVMPEMVNP----AAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1014 ----d~-~l~~~~~~~----~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                          +- ...+.....    ........+.+++.+|++ +|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                00 000000000    001223457788999998 7999999999986

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=2.3e-31  Score=290.24  Aligned_cols=243  Identities=19%  Similarity=0.290  Sum_probs=191.7

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||.|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.  ++...++|+||+
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~   82 (258)
T cd05578           5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLVVDLL   82 (258)
T ss_pred             EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEEEEeCC
Confidence            478999999999999965 68999999987532   234578899999999999999999999884  567899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++...     .++++.++..|+.|+++||.||| ..+++|+||||+||+++ +++.++|+|||.+........
T Consensus        83 ~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          83 LGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLH-SKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             CCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeEEc-CCCCEEEeecccccccCCCcc
Confidence            999999999542     46899999999999999999999 99999999999999998 588999999999886544322


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      .  ....|+..|+|||++.+...  +.++||||+|+++|+|++|+.||......     ..++.......  ...     
T Consensus       156 ~--~~~~~~~~y~~PE~~~~~~~--~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--~~~-----  219 (258)
T cd05578         156 T--TSTSGTPGYMAPEVLCRQGY--SVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQET--ADV-----  219 (258)
T ss_pred             c--cccCCChhhcCHHHHcccCC--CCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhcc--ccc-----
Confidence            1  22368889999999987664  78999999999999999999998754321     12222221111  000     


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCH--HHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGI--KTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~--~evl~ 1055 (1060)
                      .       ........+.+++.+|++ +|.+||++  +|+++
T Consensus       220 ~-------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         220 L-------YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             c-------CcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            0       011223567788889998 79999999  77653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=3.8e-31  Score=292.80  Aligned_cols=262  Identities=19%  Similarity=0.234  Sum_probs=188.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||.|++|.||+|... +|+.||+|++....  ....+.+.+|++++++++|||++++++++.  ++...++||||++
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~--~~~~~~iv~e~~~   81 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH--SENKLYLVFEFLD   81 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec--cCCeEEEEEeccC
Confidence            468999999999999864 79999999986432  122356888999999999999999999985  5678999999995


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                       ++|.+++....   ...+++..+..++.|+++||+||| +.+++||||+|+||+++ +++.+||+|||.++........
T Consensus        82 -~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH-~~~~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          82 -LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCH-SHRVLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             -cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCHHHEEEc-CCCcEEEeecccccccCCCccc
Confidence             69999986533   135899999999999999999999 89999999999999998 5889999999999765432211


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC--------CC
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG--------HG 1009 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~--------~~ 1009 (1060)
                      . ....++..|+|||++.+... ++.++|||||||++|||++|+.||......   ....+..+......        ..
T Consensus       156 ~-~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         156 Y-THEVVTLWYRAPEILLGSRQ-YSTPVDIWSIGCIFAEMVNRRPLFPGDSEI---DQLFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             c-CccccccCCCCCceeecCcc-cCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHHhhhhhhc
Confidence            1 12246889999998866432 377999999999999999999998643211   01111111000000        00


Q ss_pred             Ccccc--cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1010 SDCFD--AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1010 ~~~~d--~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .+...  +.................+.+++.+|++ +|++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00000  0000000000011223567889999998 7999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=3e-31  Score=293.80  Aligned_cols=262  Identities=18%  Similarity=0.252  Sum_probs=188.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||.|++|.||+|+.. +|+.||+|+++.... ...+.+.+|++++++++||||+++++++.  ..+..++||||+++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~   82 (284)
T cd07836           5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH--TENKLMLVFEYMDK   82 (284)
T ss_pred             eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe--eCCcEEEEEecCCc
Confidence            478999999999999965 689999999875432 23456778999999999999999999995  45678999999975


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                       +|.+++....  ....+++.++..++.|++.||+||| +.+++||||||+||+++ +++.+|++|||.++.........
T Consensus        83 -~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          83 -DLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCH-ENRVLHRDLKPQNLLIN-KRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             -cHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEEC-CCCcEEEeecchhhhhcCCcccc
Confidence             8999886543  1346899999999999999999999 99999999999999998 57899999999997654322111


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC---------CC
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG---------HG 1009 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---------~~ 1009 (1060)
                       ....++..|+|||++.+... ++.++|||||||++|||++|+.||......+.   ...... .....         ..
T Consensus       158 -~~~~~~~~y~~PE~~~~~~~-~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~  231 (284)
T cd07836         158 -SNEVVTLWYRAPDVLLGSRT-YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFR-IMGTPTESTWPGISQL  231 (284)
T ss_pred             -ccccccccccChHHhcCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHH-HhCCCChhhHHHHhcC
Confidence             12257889999999876542 47799999999999999999999875322110   000000 00000         00


Q ss_pred             Ccccc--cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1010 SDCFD--AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1010 ~~~~d--~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .....  +.................+.+++..|++ +|.+||+++||++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000  0000000000011223456788889998 8999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=1.3e-31  Score=300.48  Aligned_cols=263  Identities=24%  Similarity=0.273  Sum_probs=188.1

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHH--HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAK--QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|... +|+.||+|+++.....  ....+.+|++++++++||||+++++++.+...+..++||||+.
T Consensus        12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (309)
T cd07845          12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE   91 (309)
T ss_pred             eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence            468999999999999964 6999999998643221  1234668999999999999999999997655567899999996


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                       ++|.+++....    ..+++.++..++.|++.||+||| +.|++||||||+||+++ +++.+||+|||.++........
T Consensus        92 -~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~-~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          92 -QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLH-ENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             -CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEC-CCCCEEECccceeeecCCccCC
Confidence             58988885432    45899999999999999999999 99999999999999998 5789999999999876543211


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC---CCCcccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG---HGSDCFD 1014 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d 1014 (1060)
                      . ....++..|+|||.+.+... ++.++||||+||++|||++|+.||......    ....-+.......   .....-+
T Consensus       165 ~-~~~~~~~~y~aPE~~~~~~~-~~~~~DvwslG~il~el~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         165 M-TPKVVTLWYRAPELLLGCTT-YTTAIDMWAVGCILAELLAHKPLLPGKSEI----EQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             C-CcccccccccChhhhcCCCC-cCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCChhhchhhhc
Confidence            1 11245788999999876442 477999999999999999999998743211    1111111100000   0000000


Q ss_pred             -----c-ccccccCC---hhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1015 -----A-AVMPEMVN---PAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1015 -----~-~l~~~~~~---~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                           . ........   .........+.+++.+|++ +|.+|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                 0 00000000   0001124456788999998 79999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=9.2e-31  Score=290.53  Aligned_cols=242  Identities=19%  Similarity=0.271  Sum_probs=188.3

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCC
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .+||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++.  ..+..++||||+++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~  103 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE--eCCEEEEEEecCCCCc
Confidence            57999999999999864 78999999986554555677899999999999999999999985  5678999999999999


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      |.+++..      ..+++..+..++.|++.||+||| +.|++||||||+||+++ +++.++|+|||++......... ..
T Consensus       104 L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH-~~givH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~-~~  174 (292)
T cd06657         104 LTDIVTH------TRMNEEQIAAVCLAVLKALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPR-RK  174 (292)
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEC-CCCCEEEcccccceeccccccc-cc
Confidence            9998743      24789999999999999999999 89999999999999998 5788999999998765433221 12


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPE 1020 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 1020 (1060)
                      ...|+..|+|||++.+..+  +.++||||+||++|||++|+.||....       ..+.+... ....     .+.+.. 
T Consensus       175 ~~~~~~~y~~pE~~~~~~~--~~~~Dv~slGvil~el~tg~~p~~~~~-------~~~~~~~~-~~~~-----~~~~~~-  238 (292)
T cd06657         175 SLVGTPYWMAPELISRLPY--GPEVDIWSLGIMVIEMVDGEPPYFNEP-------PLKAMKMI-RDNL-----PPKLKN-  238 (292)
T ss_pred             ccccCccccCHHHhcCCCC--CchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHH-HhhC-----CcccCC-
Confidence            2358899999999876654  779999999999999999999986421       11111111 1100     000000 


Q ss_pred             cCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1021 MVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1021 ~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                           .......+.+++.+|++ +|.+||++.||++
T Consensus       239 -----~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         239 -----LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             -----cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence                 01122345677889998 7999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=3.1e-31  Score=288.74  Aligned_cols=244  Identities=23%  Similarity=0.370  Sum_probs=193.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+++.. +++.+|+|.+....  ......+.+|++++++++||||+++++++.  .....++||||++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~   82 (256)
T cd08530           5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL--DGNKLCIVMEYAP   82 (256)
T ss_pred             eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc--cCCEEEEEehhcC
Confidence            478999999999999854 78899999987532  234567789999999999999999999885  4578999999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +++|.+++.... .....+++..+..++.|++.||+||| +.|++||||||+||+++ ++..+|++|||+++....... 
T Consensus        83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh-~~~i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~-  158 (256)
T cd08530          83 FGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALH-EQKILHRDLKSANILLV-ANDLVKIGDLGISKVLKKNMA-  158 (256)
T ss_pred             CCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCcceEEEe-cCCcEEEeeccchhhhccCCc-
Confidence            999999986643 22356899999999999999999999 99999999999999998 478899999999987655421 


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                        ....++..|+|||.+.+..+  +.++|+||+|+++|||++|+.||....       ..+... .........      
T Consensus       159 --~~~~~~~~~~~Pe~~~~~~~--~~~~D~~slG~~~~~l~~g~~p~~~~~-------~~~~~~-~~~~~~~~~------  220 (256)
T cd08530         159 --KTQIGTPHYMAPEVWKGRPY--SYKSDIWSLGCLLYEMATFAPPFEARS-------MQDLRY-KVQRGKYPP------  220 (256)
T ss_pred             --ccccCCccccCHHHHCCCCC--CchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHH-HHhcCCCCC------
Confidence              12357889999999987664  779999999999999999999986432       111111 111111111      


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                             ........+.+++.+|++ +|++||++.|+++
T Consensus       221 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         221 -------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                   111344568889999998 7999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=3.2e-31  Score=294.14  Aligned_cols=251  Identities=20%  Similarity=0.264  Sum_probs=190.5

Q ss_pred             CCeeccccceEEEEEEE----cCCcEEEEEEcccchH----HHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEE
Q 001527          781 AEVLGRSSHGTSYRATL----ENGMFLTVKWLREGVA----KQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLI  851 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~l  851 (1060)
                      .+.||+|+||.||+|+.    .+++.||||+++....    ...+.+.+|++++.++ +||||+++++.+.  .+...++
T Consensus         5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~~~~l   82 (288)
T cd05583           5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDTKLHL   82 (288)
T ss_pred             EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCCEEEE
Confidence            46899999999999974    2578899999875321    2345688999999999 5999999998884  5667899


Q ss_pred             EEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceee
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~  931 (1060)
                      ||||+++|+|.+++..     ...+++..+..++.|+++||+||| +.+++||||||+||+++ .+..++|+|||+++..
T Consensus        83 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH-~~~~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~  155 (288)
T cd05583          83 ILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLH-QLGIIYRDIKLENILLD-SEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEEC-CCCCEEEEECcccccc
Confidence            9999999999999853     235889999999999999999999 89999999999999998 5788999999998865


Q ss_pred             ccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCc
Q 001527          932 TQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                      ............|+..|+|||...+....++.++||||||+++|||++|+.||......   ....+.........    
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~----  228 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ---NSQSEISRRILKSK----  228 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc---chHHHHHHHHHccC----
Confidence            44333222233588999999998766533477999999999999999999998632111   11122222111110    


Q ss_pred             ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                         +..        .......+.+++.+|++ +|++|||+.++.+.|+
T Consensus       229 ---~~~--------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         229 ---PPF--------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             ---CCC--------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence               000        01122456778889998 7999999988877664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=1e-30  Score=289.82  Aligned_cols=245  Identities=22%  Similarity=0.332  Sum_probs=191.7

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|+||.||+|... +++.|++|+++.... ..+.+.+|++.+++++|+||+++++++.  .....++|+||++++
T Consensus        24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~  100 (286)
T cd06614          24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL--VGDELWVVMEYMDGG  100 (286)
T ss_pred             hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE--ECCEEEEEEeccCCC
Confidence            367999999999999976 689999999976544 5567889999999999999999999986  457899999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++....    ..+++.++..++.|++.||+||| ..||+|+||||+||+++ .++.+||+|||.+......... .
T Consensus       101 ~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH-~~gi~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~-~  173 (286)
T cd06614         101 SLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH-SQNVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSK-R  173 (286)
T ss_pred             cHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCChhhEEEc-CCCCEEECccchhhhhccchhh-h
Confidence            9999997542    36899999999999999999999 89999999999999998 5889999999988755432211 1


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ....++..|+|||++.+...  +.++|||||||++|+|++|+.||.....       ...... ..........+     
T Consensus       174 ~~~~~~~~y~~PE~~~~~~~--~~~~Dv~slGvil~~l~~g~~p~~~~~~-------~~~~~~-~~~~~~~~~~~-----  238 (286)
T cd06614         174 NSVVGTPYWMAPEVIKRKDY--GPKVDIWSLGIMCIEMAEGEPPYLREPP-------LRALFL-ITTKGIPPLKN-----  238 (286)
T ss_pred             ccccCCcccCCHhHhcCCCC--CCccccHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH-HHhcCCCCCcc-----
Confidence            12257889999999887654  7899999999999999999999864211       111111 11111111000     


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                            .......+.+++.+|++ +|.+||++.||++.
T Consensus       239 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         239 ------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             ------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                  11133467788889998 79999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=1.4e-30  Score=283.84  Aligned_cols=248  Identities=23%  Similarity=0.354  Sum_probs=194.7

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA--KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|++|.||+|... +++.|++|+++....  ...+.+.+|++.+++++||||+++++++........++|+||++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   84 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS   84 (260)
T ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence            478999999999999976 789999999875532  45678899999999999999999999986433367899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +++|.+++...     ..+++.++..++.|++.||+||| +.+++|+||+|+||+++ +++.+||+|||.+.........
T Consensus        85 ~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh-~~~~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          85 GGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLH-SNGIVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEc-CCCCEEEcccccEEeccccccc
Confidence            99999999643     26899999999999999999999 89999999999999998 5789999999999876654321


Q ss_pred             -eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          938 -EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       938 -~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                       ......++..|+|||...+...  +.++||||||+++|+|++|+.||....      +....+...........     
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~--~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~-----  224 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEY--GRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGEPPE-----  224 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCC--CchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCCCcC-----
Confidence             1122368889999999987764  789999999999999999999987532      11111111110000000     


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                              ........+.+++.+|++ +|.+||++.|+++.
T Consensus       225 --------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         225 --------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             --------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                    011224567788889998 79999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=6.6e-31  Score=295.60  Aligned_cols=243  Identities=21%  Similarity=0.308  Sum_probs=185.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG---VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. ++..||+|++...   .....+.+.+|++++++++|||++++++++.  +....++||||+
T Consensus        30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~  107 (317)
T cd06635          30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL--REHTAWLVMEYC  107 (317)
T ss_pred             hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--eCCeEEEEEeCC
Confidence            467999999999999954 6899999998632   2233467889999999999999999999985  456789999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      + |++.+++...    ..++++.++..++.|++.||.||| ..+|+||||+|+||+++ .++.+||+|||++....... 
T Consensus       108 ~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH-~~~i~H~dL~p~Nil~~-~~~~~kl~dfg~~~~~~~~~-  179 (317)
T cd06635         108 L-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH-SHNMIHRDIKAGNILLT-EPGQVKLADFGSASIASPAN-  179 (317)
T ss_pred             C-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcccEEEC-CCCCEEEecCCCccccCCcc-
Confidence            6 5788877533    245899999999999999999999 99999999999999998 57899999999987543321 


Q ss_pred             eeeeccCccccccchhcccCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          937 IEQILDAGVLGYRAPELAASK-KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                          ...|+..|+|||++... ....+.++|||||||++|||++|+.||....       ..............      
T Consensus       180 ----~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~~~------  242 (317)
T cd06635         180 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESP------  242 (317)
T ss_pred             ----cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHhccCC------
Confidence                22578899999997421 1124779999999999999999999986421       11111111111100      


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHh
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDL 1057 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L 1057 (1060)
                      ...       .......+.+++.+|++ +|.+||++.||++..
T Consensus       243 ~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         243 TLQ-------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             CCC-------CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            000       11233457788889998 799999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=4.7e-31  Score=293.29  Aligned_cols=254  Identities=16%  Similarity=0.182  Sum_probs=175.7

Q ss_pred             cCCCeeccccceEEEEEEEcC----CcEEEEEEcccchHH---H--------HHHHHHHHHHHhcCCCCceeeeeeEEeC
Q 001527          779 APAEVLGRSSHGTSYRATLEN----GMFLTVKWLREGVAK---Q--------RKEFAKEAKKFANIRHPNVVGLRGYYWG  843 (1060)
Q Consensus       779 ~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~---~--------~~~~~~E~~~l~~l~hpnIv~l~~~~~~  843 (1060)
                      ...++||+|+||.||+|+..+    +..+|+|+.......   .        ......+...+..+.|++|+++++++..
T Consensus        15 ~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   94 (294)
T PHA02882         15 KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSF   94 (294)
T ss_pred             EEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeE
Confidence            346789999999999999654    456677754321110   0        1122334455677899999999987643


Q ss_pred             CCC--CceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeE
Q 001527          844 PTQ--HEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR  921 (1060)
Q Consensus       844 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~k  921 (1060)
                      ...  ...++++|++. .++.+.+...     ...++..+..|+.|++.||+||| +.+|+||||||+|||++ +++.+|
T Consensus        95 ~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH-~~~iiHrDiKp~Nill~-~~~~~~  166 (294)
T PHA02882         95 KRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIH-EHGISHGDIKPENIMVD-GNNRGY  166 (294)
T ss_pred             ecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEc-CCCcEE
Confidence            222  23467788774 4666666321     23577888999999999999999 99999999999999998 578999


Q ss_pred             EcccccceeeccCCce------eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccC
Q 001527          922 VADYCLHRLMTQAGTI------EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVD  995 (1060)
Q Consensus       922 l~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~  995 (1060)
                      |+|||+++........      ......||+.|+|||+..+..+  +.++|||||||++|||++|+.||...........
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~--~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV--TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC--CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            9999999876432211      1122369999999999987765  8899999999999999999999976422111000


Q ss_pred             --hHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527          996 --LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus       996 --l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                        ..++..... .+.        ..       .....+.+.+++..|++ +|++||++.++++.++
T Consensus       245 ~~~~~~~~~~~-~~~--------~~-------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        245 AAKCDFIKRLH-EGK--------IK-------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HhHHHHHHHhh-hhh--------hc-------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence              011111111 100        00       01223567788889998 7999999999998763

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-31  Score=292.41  Aligned_cols=264  Identities=22%  Similarity=0.306  Sum_probs=190.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH-HHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA-KQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||+||+|+.. +++.||+|++..... .......+|+..+++++ ||||+++++++.  .....++||||+ 
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~--~~~~~~lv~e~~-   80 (283)
T cd07830           4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR--ENDELYFVFEYM-   80 (283)
T ss_pred             heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh--cCCcEEEEEecC-
Confidence            468999999999999975 588999999865422 22334567999999999 999999999985  467899999999 


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +|+|.+++....   ...+++.++..++.|++.||.||| +++++|+||||+||+++ +++.++|+|||.+.........
T Consensus        81 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh-~~~i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          81 EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIH-KHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEEc-CCCCEEEeecccceeccCCCCc
Confidence            889999886532   246899999999999999999999 89999999999999998 5889999999999876543322


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCcc---------ChHHHHHHHHhcCC
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGV---------DLTDWMQLKVAEGH 1008 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~---------~l~~~~~~~~~~~~ 1008 (1060)
                      .  ...++..|+|||++.+... ++.++||||||++++||++|+.||......+...         .-..|.........
T Consensus       156 ~--~~~~~~~~~aPE~~~~~~~-~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         156 T--DYVSTRWYRAPEILLRSTS-YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             C--CCCCcccccCceeeecCcC-cCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence            1  2357889999998865432 4789999999999999999999986532211000         00011111111000


Q ss_pred             CCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1009 GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1009 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      ....+ +.................+.+++.+|++ +|++|||++|++..
T Consensus       233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRF-PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccc-cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000 0000000000011123568899999998 79999999999863

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=2.9e-31  Score=301.15  Aligned_cols=262  Identities=18%  Similarity=0.233  Sum_probs=186.6

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCC---CCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT---QHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|+.++++++||||+++++++....   ....++|+||
T Consensus        10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~   89 (336)
T cd07849          10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL   89 (336)
T ss_pred             EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence            57899999999999985 478999999986422 233466788999999999999999999875322   2357999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      ++ +++.+++..      ..+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||+++......
T Consensus        90 ~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH-~~~ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          90 ME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIH-SANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             cc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEEC-CCCCEEECcccceeeccccc
Confidence            96 488887743      35899999999999999999999 99999999999999998 58899999999988654322


Q ss_pred             cee--eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCC---C
Q 001527          936 TIE--QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHG---S 1010 (1060)
Q Consensus       936 ~~~--~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~---~ 1010 (1060)
                      ...  .....|+..|+|||.+.+.. .++.++||||+||++|+|++|+.||.....    .....++.........   .
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslGvil~el~~G~~~f~~~~~----~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSK-GYTKAIDIWSVGCILAEMLSNRPLFPGKDY----LHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHcCCCCHHHHH
Confidence            211  11235789999999876533 237799999999999999999999864211    0111111111100000   0


Q ss_pred             cccccc-------cccccCCh---hHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1011 DCFDAA-------VMPEMVNP---AAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1011 ~~~d~~-------l~~~~~~~---~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .+.+..       .......+   ........+.+++.+|++ +|.+|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000       00000000   011224567899999998 79999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=2.8e-31  Score=301.50  Aligned_cols=262  Identities=19%  Similarity=0.246  Sum_probs=189.0

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc--hHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG--VAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++++ +||||+++++++...+....++||||+
T Consensus        12 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~   91 (337)
T cd07852          12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM   91 (337)
T ss_pred             hHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence            478999999999999965 6889999988542  223345677899999999 999999999998655556789999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      + ++|.+++...      .+++..+..++.||+.||+||| +.||+||||||+||+++ +++.+||+|||.++.......
T Consensus        92 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH-~~~i~H~dl~p~nill~-~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          92 E-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIH-SGNVIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             c-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEc-CCCcEEEeeccchhccccccc
Confidence            7 5999988532      5789999999999999999999 99999999999999998 588999999999986543321


Q ss_pred             e----eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHH--------
Q 001527          937 I----EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKV-------- 1004 (1060)
Q Consensus       937 ~----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~-------- 1004 (1060)
                      .    ......|+..|+|||++.+... .+.++|||||||++|||++|+.||......+    ....+....        
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~sDi~slG~~l~el~tg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLGKPLFPGTSTLN----QLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             cccCcchhcccccccccCceeeecccc-ccccchHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHH
Confidence            1    1122357889999998865432 3779999999999999999999986432111    000000000        


Q ss_pred             ---hcCCCCcccccccccccC--ChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1005 ---AEGHGSDCFDAAVMPEMV--NPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1005 ---~~~~~~~~~d~~l~~~~~--~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                         ......+.++........  ..........+.+++.+|++ +|.+|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence               000000001000000000  00011134567889999998 79999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.2e-32  Score=314.76  Aligned_cols=197  Identities=21%  Similarity=0.268  Sum_probs=173.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .++||+|+||.|..++.+ +++.||+|++.+..   ......|..|-++|..-+.+-||.++-.|  ++..+.|+|||||
T Consensus        80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF--QD~~~LYlVMdY~  157 (1317)
T KOG0612|consen   80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF--QDERYLYLVMDYM  157 (1317)
T ss_pred             HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh--cCccceEEEEecc
Confidence            579999999999999965 68999999997632   23456799999999999999999998666  5788999999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      +||+|-..+..     ..++++..++.++..|+-||.-|| +.|+|||||||+|||+| ..+++||+|||.|-.+..++.
T Consensus       158 pGGDlltLlSk-----~~~~pE~~ArFY~aEiVlAldslH-~mgyVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  158 PGGDLLTLLSK-----FDRLPEDWARFYTAEIVLALDSLH-SMGYVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             cCchHHHHHhh-----cCCChHHHHHHHHHHHHHHHHHHH-hccceeccCCcceeEec-ccCcEeeccchhHHhcCCCCc
Confidence            99999999943     236899999999999999999999 99999999999999999 689999999999999998888


Q ss_pred             eeeeccCccccccchhcccCCC---CCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          937 IEQILDAGVLGYRAPELAASKK---PHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~---~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ......+|||.|.+||++....   ..|+..+|.||+||++|||+.|..||..
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            8777789999999999996321   3358899999999999999999999974

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=1.4e-31  Score=315.01  Aligned_cols=247  Identities=21%  Similarity=0.315  Sum_probs=178.3

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccch-HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCC--------------
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT--------------  845 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--------------  845 (1060)
                      ++||+||||.||+++.+ ||+.||||++.-.. ......+.+|++.+++++|||||+|+..|....              
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~  564 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE  564 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence            57999999999999955 89999999997553 333467889999999999999999986553110              


Q ss_pred             --------------------------------------------------------------C-----------------
Q 001527          846 --------------------------------------------------------------Q-----------------  846 (1060)
Q Consensus       846 --------------------------------------------------------------~-----------------  846 (1060)
                                                                                    +                 
T Consensus       565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~  644 (1351)
T KOG1035|consen  565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD  644 (1351)
T ss_pred             hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence                                                                          0                 


Q ss_pred             ------------------------CceEEEEEecCCCChHHHhhcCCCCCCCCC-CHHHHHHHHHHHHHHHHHHhcCCCc
Q 001527          847 ------------------------HEKLILSDYISPGSLASFLYDRPGRKGPPL-TWAQRLKIAVDVARGLNYLHFDRAV  901 (1060)
Q Consensus       847 ------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l-~~~~~~~i~~qia~gL~~LH~~~~i  901 (1060)
                                              ...||=||||+..++.+++++..     .. .....++++++|++||+|+| +.||
T Consensus       645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-----~~~~~d~~wrLFreIlEGLaYIH-~~gi  718 (1351)
T KOG1035|consen  645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-----FNSQRDEAWRLFREILEGLAYIH-DQGI  718 (1351)
T ss_pred             chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-----cchhhHHHHHHHHHHHHHHHHHH-hCce
Confidence                                    12467899999988888886542     11 45678899999999999999 9999


Q ss_pred             ccCCCCCCCeEeeCCCCCeEEcccccceeec----c-------------CCceeeeccCccccccchhcccCCC-CCCCC
Q 001527          902 PHGNLKATNILLDGPDLNARVADYCLHRLMT----Q-------------AGTIEQILDAGVLGYRAPELAASKK-PHPSF  963 (1060)
Q Consensus       902 vHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~----~-------------~~~~~~~~~~gt~~y~aPE~~~~~~-~~~s~  963 (1060)
                      |||||||.||++| ++..+||+|||+|....    .             ......+..+||.-|+|||++.+.. ..|+.
T Consensus       719 IHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~  797 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS  797 (1351)
T ss_pred             eeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence            9999999999999 57899999999998721    0             0111223457999999999998665 14588


Q ss_pred             ccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-
Q 001527          964 KSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR- 1042 (1060)
Q Consensus       964 ~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~- 1042 (1060)
                      |+|+||+|||++||+.   ||...      .+-..-+ ..++.+....-  +.+        ....+..=.+++.++++ 
T Consensus       798 KiDmYSLGIVlFEM~y---PF~Ts------MERa~iL-~~LR~g~iP~~--~~f--------~~~~~~~e~slI~~Ll~h  857 (1351)
T KOG1035|consen  798 KIDMYSLGIVLFEMLY---PFGTS------MERASIL-TNLRKGSIPEP--ADF--------FDPEHPEEASLIRWLLSH  857 (1351)
T ss_pred             hhhhHHHHHHHHHHhc---cCCch------HHHHHHH-HhcccCCCCCC--ccc--------ccccchHHHHHHHHHhcC
Confidence            9999999999999986   55431      1111111 12222222211  000        11223333556667777 


Q ss_pred             CCCCCCCHHHHHH
Q 001527         1043 SVSERPGIKTIYE 1055 (1060)
Q Consensus      1043 ~p~~RPs~~evl~ 1055 (1060)
                      +|.+||||.|++.
T Consensus       858 dP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  858 DPSKRPTATELLN  870 (1351)
T ss_pred             CCccCCCHHHHhh
Confidence            8999999999985

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-30  Score=284.75  Aligned_cols=242  Identities=19%  Similarity=0.234  Sum_probs=181.6

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHH-hcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKF-ANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      +.||+|+||.||+|+.. +|+.||+|+++....   .....+..|..++ ...+||||+++++++.  ..+..++||||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ--SKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE--cCCeEEEEEecc
Confidence            46899999999999864 689999999875432   1223344555544 4558999999999985  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      ++++|.+++...     ..+++..+..++.|++.||.||| +.+++||||+|+||+++ ++..+||+|||+++.....  
T Consensus        80 ~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH-~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~--  150 (260)
T cd05611          80 NGGDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLH-QRGIIHRDIKPENLLID-QTGHLKLTDFGLSRNGLEN--  150 (260)
T ss_pred             CCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEEC-CCCcEEEeecccceecccc--
Confidence            999999999542     35889999999999999999999 89999999999999998 5789999999998764331  


Q ss_pred             eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccc
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                         ....++..|+|||.+.+..  ++.++||||||+++|||++|+.||....       .......... ....  ..+.
T Consensus       151 ---~~~~~~~~y~~pe~~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~-~~~~--~~~~  215 (260)
T cd05611         151 ---KKFVGTPDYLAPETILGVG--DDKMSDWWSLGCVIFEFLFGYPPFHAET-------PDAVFDNILS-RRIN--WPEE  215 (260)
T ss_pred             ---ccCCCCcCccChhhhcCCC--CcchhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHh-cccC--CCCc
Confidence               1225788999999998765  3789999999999999999999986421       1111111111 1100  0000


Q ss_pred             cccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHh
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDL 1057 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L 1057 (1060)
                              ........+.+++.+|++ +|++||++.++.+.|
T Consensus       216 --------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         216 --------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             --------ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence                    011234567888889998 799999886555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=1.5e-30  Score=283.58  Aligned_cols=246  Identities=22%  Similarity=0.369  Sum_probs=195.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++|||++++++.+.  .....++|+||++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~--~~~~~~lv~e~~~   82 (258)
T cd08215           5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE--EKGKLCIVMEYAD   82 (258)
T ss_pred             EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe--cCCEEEEEEEecC
Confidence            468999999999999965 68999999987543  245677889999999999999999999885  4578899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +++|.+++.... .....+++.++..++.|++.||+||| +.|++|+||+|+||+++ ++..++|+|||.+.........
T Consensus        83 ~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          83 GGDLSQKIKKQK-KEGKPFPEEQILDWFVQLCLALKYLH-SRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             CCcHHHHHHHhh-ccCCCcCHHHHHHHHHHHHHHHHHHH-hCCEecccCChHHeEEc-CCCcEEECCccceeecccCcce
Confidence            999999997643 12356999999999999999999999 89999999999999998 5789999999999876554322


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                       .....|++.|+|||...+...  +.++||||+|+++++|++|+.||+...       ..+........ ....     +
T Consensus       160 -~~~~~~~~~y~~pe~~~~~~~--~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~~~~-~~~~-----~  223 (258)
T cd08215         160 -AKTVVGTPYYLSPELCQNKPY--NYKSDIWSLGCVLYELCTLKHPFEGEN-------LLELALKILKG-QYPP-----I  223 (258)
T ss_pred             -ecceeeeecccChhHhccCCC--CccccHHHHHHHHHHHHcCCCCCCCCc-------HHHHHHHHhcC-CCCC-----C
Confidence             222368889999999877664  779999999999999999999986431       22222222211 1110     0


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                              .......+.+++.+|+. +|++||++.|+++
T Consensus       224 --------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 --------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    01233567788889998 7999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=8.5e-31  Score=288.92  Aligned_cols=242  Identities=20%  Similarity=0.271  Sum_probs=179.5

Q ss_pred             eeccccceEEEEEEE-cCCcEEEEEEcccchH---HHHHHHHHHH---HHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVA---KQRKEFAKEA---KKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       783 ~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      +||+|+||.||+|.. .+++.||+|.+.....   .....+..|.   +.++...||+|+++++++.  ..+..++||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee--cCCEEEEEEec
Confidence            489999999999985 4689999999864321   1122233443   3445568999999998885  45688999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++|+|.+++..     ...+++.++..|+.|++.||+||| +.+|+||||||+||+++ .++.+||+|||++.......
T Consensus        79 ~~g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~~  151 (278)
T cd05606          79 MNGGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKK  151 (278)
T ss_pred             CCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCEEcCCCCHHHEEEC-CCCCEEEccCcCccccCccC
Confidence            999999998843     246999999999999999999999 89999999999999998 57899999999987554322


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      .   ....|+..|+|||++.+... ++.++||||+||++|||++|+.||.......    ... .......      .++
T Consensus       152 ~---~~~~~~~~y~aPE~~~~~~~-~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~----~~~-~~~~~~~------~~~  216 (278)
T cd05606         152 P---HASVGTHGYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHE-IDRMTLT------MAV  216 (278)
T ss_pred             C---cCcCCCcCCcCcHHhcCCCC-CCcccchHhHHHHHHHHHhCCCCCCCCCccc----hHH-HHHHhhc------cCC
Confidence            2   12368999999999875432 4779999999999999999999997532211    111 1111110      011


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCC-----CHHHHHHH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYED 1056 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP-----s~~evl~~ 1056 (1060)
                      .+.        ......+.+++.+|+. +|.+||     ++.|+++.
T Consensus       217 ~~~--------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         217 ELP--------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCC--------CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            111        1123467778889997 699999     99998863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=5.3e-31  Score=294.58  Aligned_cols=263  Identities=19%  Similarity=0.212  Sum_probs=187.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCC--------CCce
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA--KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT--------QHEK  849 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--------~~~~  849 (1060)
                      .+.||+|+||.||+|+.. +|+.||+|+++....  .....+.+|++++++++||||+++++++....        ....
T Consensus        12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   91 (302)
T cd07864          12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF   91 (302)
T ss_pred             eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence            578999999999999975 689999999865322  22356778999999999999999999986432        2378


Q ss_pred             EEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccce
Q 001527          850 LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR  929 (1060)
Q Consensus       850 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~  929 (1060)
                      ++|+||+++ ++.+.+...    ...+++.++..++.|++.||+||| +.+|+||||||+||+++ +++.+||+|||.+.
T Consensus        92 ~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH-~~~i~H~dl~p~nili~-~~~~~kl~dfg~~~  164 (302)
T cd07864          92 YLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCH-KKNFLHRDIKCSNILLN-NKGQIKLADFGLAR  164 (302)
T ss_pred             EEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEC-CCCcEEeCcccccc
Confidence            999999975 777777542    245899999999999999999999 99999999999999998 58899999999998


Q ss_pred             eeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCC-
Q 001527          930 LMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGH- 1008 (1060)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~- 1008 (1060)
                      ..............++..|+|||.+.+... .+.++|||||||++|||++|+.||.....    ......+........ 
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~Di~slG~~~~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~  239 (302)
T cd07864         165 LYNSEESRPYTNKVITLWYRPPELLLGEER-YGPAIDVWSCGCILGELFTKKPIFQANQE----LAQLELISRLCGSPCP  239 (302)
T ss_pred             cccCCcccccccceeccCccChHHhcCCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCCh
Confidence            765433221122245778999998865432 37799999999999999999999874211    111111111111100 


Q ss_pred             --CCccc--------cccc-ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1009 --GSDCF--------DAAV-MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1009 --~~~~~--------d~~l-~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                        ..++.        ++.. ...............+.+++..|++ +|.+||++++|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              00000        0000 0000000001124567889999998 7999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=312.51  Aligned_cols=264  Identities=25%  Similarity=0.374  Sum_probs=205.5

Q ss_pred             CCCCChhhhhccCCCeeccccceEEEEEEEc--------CCcEEEEEEcccchH-HHHHHHHHHHHHHhcC-CCCceeee
Q 001527          768 TLTLTPEELSRAPAEVLGRSSHGTSYRATLE--------NGMFLTVKWLREGVA-KQRKEFAKEAKKFANI-RHPNVVGL  837 (1060)
Q Consensus       768 ~~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l  837 (1060)
                      .+++..+.+..  .+.+|+|.||.||+|...        ....||||.++.... .+.+.+..|+++|+.+ +||||+.+
T Consensus       290 ~~e~~~~~l~~--~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  290 KWEIPRENLKL--GKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ceeechhhccc--cceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhh
Confidence            45666666633  459999999999999843        146799999986533 4567899999999999 69999999


Q ss_pred             eeEEeCCCCCceEEEEEecCCCChHHHhhcCC---------CCCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCcccCCC
Q 001527          838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRP---------GRKGP--PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNL  906 (1060)
Q Consensus       838 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDl  906 (1060)
                      +|+|.  ..+..++|+||++.|+|.++++..+         .....  .++..+.+.++.|||.|++||+ +.++|||||
T Consensus       368 lG~~t--~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~-~~~~vHRDL  444 (609)
T KOG0200|consen  368 LGACT--QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA-SVPCVHRDL  444 (609)
T ss_pred             eeeec--cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh-hCCccchhh
Confidence            99995  4678999999999999999998765         11112  3889999999999999999999 999999999


Q ss_pred             CCCCeEeeCCCCCeEEcccccceeeccCCceeeeccCc--cccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCC
Q 001527          907 KATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCA  983 (1060)
Q Consensus       907 kp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p  983 (1060)
                      -.+|||+. ++..+||+|||+|+..............|  ...|||||.+....+  +.|+|||||||++||++| |..|
T Consensus       445 AaRNVLi~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f--t~kSDVWSfGI~L~EifsLG~~P  521 (609)
T KOG0200|consen  445 AARNVLIT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF--TSKSDVWSFGILLWEIFTLGGTP  521 (609)
T ss_pred             hhhhEEec-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc--cccchhhHHHHHHHHHhhCCCCC
Confidence            99999998 58899999999999766655544332233  345999999998655  889999999999999999 8888


Q ss_pred             CCCCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527          984 GDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       984 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      |.....   ..++.+    .++++...+             .+..+..++.+++..||+ +|++||++.|+++.++.
T Consensus       522 Yp~~~~---~~~l~~----~l~~G~r~~-------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  522 YPGIPP---TEELLE----FLKEGNRME-------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             CCCCCc---HHHHHH----HHhcCCCCC-------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            864211   112222    333332221             112345678899999998 79999999999998864

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=7.9e-31  Score=297.31  Aligned_cols=264  Identities=20%  Similarity=0.272  Sum_probs=189.6

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCC--CCCceEEEEE
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGP--TQHEKLILSD  854 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~~~lv~e  854 (1060)
                      ..+.||+|+||.||+|+.. +|+.||+|++....  ....+.+.+|+.++++++||||+++++++...  .....++|||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e   88 (334)
T cd07855           9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD   88 (334)
T ss_pred             eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEe
Confidence            3578999999999999854 69999999986532  22346677899999999999999999987532  3346899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+. ++|.+++..     ...+++..+..++.||+.||+||| .++|+||||||+||+++ +++.+||+|||+++.....
T Consensus        89 ~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          89 LME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIH-SANVIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             hhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEc-CCCcEEecccccceeeccc
Confidence            995 689998843     245899999999999999999999 89999999999999998 5889999999999866433


Q ss_pred             Ccee---eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhc-----
Q 001527          935 GTIE---QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAE----- 1006 (1060)
Q Consensus       935 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~----- 1006 (1060)
                      ....   .....|+..|+|||++.+... ++.++|||||||++|||++|+.||......    .....+......     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~~Di~slG~~l~el~~g~~pf~~~~~~----~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGRRQLFPGKNYV----HQLKLILSVLGSPSEEV  235 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcc-cccccchHHHHHHHHHHHcCCCccCCCChH----HHHHHHHHHhCCChhHh
Confidence            2211   112368889999999865432 478999999999999999999999653211    111111110000     


Q ss_pred             ------CCCCcccccccccccC--ChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1007 ------GHGSDCFDAAVMPEMV--NPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1007 ------~~~~~~~d~~l~~~~~--~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                            ....+..+..-.....  ..........+.+++.+|++ +|.+||+++|++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                  0000000000000000  00011234668889999998 79999999998863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=9.4e-31  Score=290.25  Aligned_cols=261  Identities=22%  Similarity=0.305  Sum_probs=186.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH--HHHHHHHHHHHHHhcC---CCCceeeeeeEEeCCCC---CceEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA--KQRKEFAKEAKKFANI---RHPNVVGLRGYYWGPTQ---HEKLI  851 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~---~~~~l  851 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++....  .....+.+|+++++++   +||||+++++++...+.   ...++
T Consensus         4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   83 (287)
T cd07838           4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL   83 (287)
T ss_pred             EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence            468999999999999976 489999999974321  2234566788777665   69999999999964322   13899


Q ss_pred             EEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceee
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~  931 (1060)
                      +|||+. ++|.+++....   ...+++.++..++.|++.||+||| +.+++|+||||+||+++ +++.+||+|||.+...
T Consensus        84 ~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH-~~~i~h~~l~~~nili~-~~~~~~l~dfg~~~~~  157 (287)
T cd07838          84 VFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLH-SHRIVHRDLKPQNILVT-SDGQVKIADFGLARIY  157 (287)
T ss_pred             Eehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCChhhEEEc-cCCCEEEeccCcceec
Confidence            999996 58999886532   235899999999999999999999 89999999999999998 5789999999999876


Q ss_pred             ccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC---C
Q 001527          932 TQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG---H 1008 (1060)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---~ 1008 (1060)
                      .......  ...++..|+|||++.+...  +.++|||||||++|||++|+.||......   ..+..+........   +
T Consensus       158 ~~~~~~~--~~~~~~~~~~PE~~~~~~~--~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  230 (287)
T cd07838         158 SFEMALT--SVVVTLWYRAPEVLLQSSY--ATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQLDKIFDVIGLPSEEEW  230 (287)
T ss_pred             cCCcccc--cccccccccChHHhccCCC--CCcchhhhHHHHHHHHHhCCCcccCCChH---HHHHHHHHHcCCCChHhc
Confidence            5433221  1247889999999987664  77999999999999999999998743211   11111111100000   0


Q ss_pred             CCc------ccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1009 GSD------CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1009 ~~~------~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ...      .+.... .........+....+.+++.+|++ +|.+||+++|++.
T Consensus       231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         231 PRNVSLPRSSFPSYT-PRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCCcccchhhccccc-ccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000      000000 000011112334667889999998 7999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=2.3e-30  Score=288.39  Aligned_cols=249  Identities=22%  Similarity=0.362  Sum_probs=185.1

Q ss_pred             CCCeeccccceEEEEEEEcC-CcEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          780 PAEVLGRSSHGTSYRATLEN-GMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      ..+.||+|+||.||+|...+ ++.||||+++... ......+..|++++.+. .||||+++++++.  +....++||||+
T Consensus        19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~e~~   96 (296)
T cd06618          19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI--TDSDVFICMELM   96 (296)
T ss_pred             eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee--cCCeEEEEeecc
Confidence            35799999999999999764 8999999987542 23345666788777666 4999999999995  566899999998


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      + +++.+++...    ...+++..+..++.|++.||+|||...+|+||||+|+||+++ +++.+||+|||.+........
T Consensus        97 ~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~-~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          97 S-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             C-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc-CCCCEEECccccchhccCCCc
Confidence            5 5777776442    236899999999999999999999336999999999999998 588999999999876544322


Q ss_pred             eeeeccCccccccchhcccCCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          937 IEQILDAGVLGYRAPELAASKK--PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      ..  ...++..|+|||++.+..  ..++.++||||||+++|||++|+.||......      .+......... ...   
T Consensus       171 ~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-~~~---  238 (296)
T cd06618         171 KT--RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEE-PPS---  238 (296)
T ss_pred             cc--CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCC-CCC---
Confidence            21  225788999999987553  22477999999999999999999998642110      11111111111 000   


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                        . +.     .......+.+++.+|++ +|.+||++.++++.
T Consensus       239 --~-~~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 --L-PP-----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             --C-CC-----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              0 00     00223467888899998 79999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=8.9e-31  Score=297.68  Aligned_cols=197  Identities=24%  Similarity=0.308  Sum_probs=160.4

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCC------------C
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ------------H  847 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~------------~  847 (1060)
                      .+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++.....            .
T Consensus        10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~   89 (342)
T cd07854          10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN   89 (342)
T ss_pred             EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence            578999999999999864 689999999876544556778899999999999999999987643221            3


Q ss_pred             ceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccc
Q 001527          848 EKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL  927 (1060)
Q Consensus       848 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~  927 (1060)
                      ..++||||++ ++|.+++..      ..+++..+..++.||+.||+||| +.||+||||||+||+++.++..+|++|||.
T Consensus        90 ~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH-~~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          90 SVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIH-SANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             eEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence            4689999997 589888843      24889999999999999999999 999999999999999975567899999999


Q ss_pred             ceeeccCCcee--eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          928 HRLMTQAGTIE--QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       928 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ++.........  .....++..|+|||.+.+.. .++.++|||||||++|||++|+.||..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwSlGvil~el~~g~~pf~~  221 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN-NYTKAIDMWAAGCIFAEMLTGKPLFAG  221 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCcc-ccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            97654321111  11225788999999875533 247799999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=4.2e-31  Score=299.88  Aligned_cols=261  Identities=21%  Similarity=0.230  Sum_probs=187.0

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHHH--------------HHHHHHHHHHHhcCCCCceeeeeeEEeCCC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQ--------------RKEFAKEAKKFANIRHPNVVGLRGYYWGPT  845 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  845 (1060)
                      .+.||+|+||+||+|+.. +++.||+|+++......              ...+.+|++++++++||||+++++++.  .
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~   91 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV--E   91 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe--c
Confidence            467999999999999954 68999999986432211              124778999999999999999999985  5


Q ss_pred             CCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccc
Q 001527          846 QHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY  925 (1060)
Q Consensus       846 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Df  925 (1060)
                      .+..++||||+. |+|.+++..     ...+++.....++.|++.||+||| +.||+||||||+||+++ .++.+||+||
T Consensus        92 ~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH-~~~i~H~dl~~~nill~-~~~~~kl~df  163 (335)
T PTZ00024         92 GDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLH-KWYFMHRDLSPANIFIN-SKGICKIADF  163 (335)
T ss_pred             CCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeecccccHHHeEEC-CCCCEEECCc
Confidence            668899999996 699999853     245889999999999999999999 99999999999999998 5789999999


Q ss_pred             ccceeeccCC-------------ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCC
Q 001527          926 CLHRLMTQAG-------------TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGA  992 (1060)
Q Consensus       926 g~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~  992 (1060)
                      |.++......             ........++..|+|||++.+... ++.++||||+||++|||++|+.||......  
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~--  240 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLTGKPLFPGENEI--  240 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence            9998654111             011111246788999999876542 477999999999999999999998753211  


Q ss_pred             ccChHHHHHHHHhcCC---CCcccc-----cccc--cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527          993 GVDLTDWMQLKVAEGH---GSDCFD-----AAVM--PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus       993 ~~~l~~~~~~~~~~~~---~~~~~d-----~~l~--~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                        .....+........   ..+..+     +...  +.............+.+++..|++ +|++||+++|++..
T Consensus       241 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        241 --DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             --HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence              11111111111100   000000     0000  000000001223567789999998 79999999999863

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=2.9e-31  Score=301.08  Aligned_cols=262  Identities=18%  Similarity=0.231  Sum_probs=187.5

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCC---CceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ---HEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~---~~~~lv~e  854 (1060)
                      .+.||+|+||+||+|+. .+++.||+|.++..  .......+.+|+.++++++||||+++++++.....   ...++|||
T Consensus        10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e   89 (337)
T cd07858          10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE   89 (337)
T ss_pred             EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence            46899999999999985 46899999998643  22234567789999999999999999998853221   35799999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+. ++|.+++..     ...+++..+..++.|++.||.||| +++++||||||+||+++ .++.+||+|||+++.....
T Consensus        90 ~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH-~~~i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          90 LMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIH-SANVLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             CCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEc-CCCCEEECcCccccccCCC
Confidence            995 689988843     346899999999999999999999 99999999999999998 5789999999999876443


Q ss_pred             CceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhc--------
Q 001527          935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAE-------- 1006 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~-------- 1006 (1060)
                      ... .....++..|+|||.+..... ++.++|||||||++|+|++|+.||......    ............        
T Consensus       162 ~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         162 GDF-MTEYVVTRWYRAPELLLNCSE-YTTAIDVWSVGCIFAELLGRKPLFPGKDYV----HQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             ccc-ccccccccCccChHHHhcCCC-CCCcccHHHHHHHHHHHHcCCCCCCCCChH----HHHHHHHHHhCCCChHHhhh
Confidence            211 112357889999998865332 478999999999999999999998643110    000000000000        


Q ss_pred             ---CCCCccccc--ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1007 ---GHGSDCFDA--AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1007 ---~~~~~~~d~--~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                         ......++.  .................+.+++.+|++ +|++|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence               000000000  000000000011234567889999998 79999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=9.9e-31  Score=289.44  Aligned_cols=260  Identities=18%  Similarity=0.218  Sum_probs=191.0

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA--KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|++|.||+|... +++.+++|+++....  ...+.+.+|++++++++||||+++++++.  .+...++|+||++
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~   81 (283)
T cd05118           4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR--HKGDLYLVFEFMD   81 (283)
T ss_pred             ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc--cCCCEEEEEeccC
Confidence            467999999999999864 789999999875432  24567889999999999999999999985  5578999999997


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      + ++.+++....    ..+++.++..++.|++.||+||| +.+|+|+||||+||+++ +++.+||+|||.+........ 
T Consensus        82 ~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          82 T-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCH-SHGILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             C-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHH-HCCeeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCcc-
Confidence            5 8888885432    46899999999999999999999 99999999999999998 578999999999987655431 


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcC---CCCcccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG---HGSDCFD 1014 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d 1014 (1060)
                      ......++..|+|||.+.+.. .++.++||||+|+++|+|++|+.||......    +....+.......   ......+
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~-~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDK-GYSTPVDIWSVGCIFAELLSRRPLFPGKSEI----DQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             cccCccCcccccCcHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCchHhcccchh
Confidence            111235788899999987652 2488999999999999999999998643211    0100000000000   0000000


Q ss_pred             ---------cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1015 ---------AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1015 ---------~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                               +.................+.+++..|++ +|.+||++.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                     0000000001112345678899999998 7999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.1e-30  Score=279.46  Aligned_cols=242  Identities=24%  Similarity=0.382  Sum_probs=191.8

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA--KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|++|.||+|+.. +++.|++|.+.....  ...+.+.+|++++++++|||++++++++.  +....++||||++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~   82 (254)
T cd06627           5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE--TSDSLYIILEYAE   82 (254)
T ss_pred             eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE--eCCEEEEEEecCC
Confidence            578999999999999865 688999999976543  45578999999999999999999999985  4578899999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +++|.+++...     ..+++..+..++.|++.||.||| +.||+||||||+||+++ .++.+||+|||.+.........
T Consensus        83 ~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          83 NGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH-EQGVIHRDIKAANILTT-KDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCHHHEEEC-CCCCEEEeccccceecCCCccc
Confidence            99999998543     46899999999999999999999 99999999999999998 5789999999999876554332


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                       .....++..|+|||...+..  ++.++||||+|+++|+|++|+.||....      ........ . .....     ..
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~--~~~~~Dv~~lG~~l~~l~~g~~p~~~~~------~~~~~~~~-~-~~~~~-----~~  219 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSG--ASTASDIWSLGCTVIELLTGNPPYYDLN------PMAALFRI-V-QDDHP-----PL  219 (254)
T ss_pred             -ccccccchhhcCHhhhcCCC--CCcchhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHH-h-ccCCC-----CC
Confidence             12236788999999987765  4789999999999999999999986432      11111111 1 11000     00


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                              .......+.+++.+|+. +|++||++.|++.
T Consensus       220 --------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 --------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                    01223456788889998 7999999999975

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=3e-30  Score=282.67  Aligned_cols=233  Identities=21%  Similarity=0.256  Sum_probs=176.3

Q ss_pred             eccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEecCCCCh
Q 001527          784 LGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYISPGSL  861 (1060)
Q Consensus       784 iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gsL  861 (1060)
                      +|+|+||.||+++. .+++.+|+|.+.......     .|+.....+ +||||+++++++.  ..+..++||||+++++|
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~--~~~~~~iv~e~~~~~~L   96 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVT--TLKGHVLIMDYIKDGDL   96 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEe--cCCeeEEEEEcCCCCcH
Confidence            69999999999985 468899999986532111     122222222 7999999999985  45689999999999999


Q ss_pred             HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCC-CeEEcccccceeeccCCceeee
Q 001527          862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDL-NARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       862 ~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~  940 (1060)
                      .+++...     ..+++.++..++.|+++||+||| +.|++||||||+||+++. +. .++|+|||.++.......    
T Consensus        97 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~~-~~~~~~l~dfg~~~~~~~~~~----  165 (267)
T PHA03390         97 FDLLKKE-----GKLSEAEVKKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDR-AKDRIYLCDYGLCKIIGTPSC----  165 (267)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEEeC-CCCeEEEecCccceecCCCcc----
Confidence            9999543     36899999999999999999999 999999999999999984 55 899999999876543321    


Q ss_pred             ccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccc
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPE 1020 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 1020 (1060)
                       ..++..|+|||++.+..+  +.++||||+||++|||++|+.||.....  .......|.... .  ....         
T Consensus       166 -~~~~~~y~aPE~~~~~~~--~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~-~--~~~~---------  228 (267)
T PHA03390        166 -YDGTLDYFSPEKIKGHNY--DVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLESLLKRQ-Q--KKLP---------  228 (267)
T ss_pred             -CCCCCcccChhhhcCCCC--CchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHHHHHHhh-c--ccCC---------
Confidence             257899999999987665  7799999999999999999999974322  122233333221 0  0000         


Q ss_pred             cCChhHHHHHHHHHHHHHHhcc-CCCCCCC-HHHHHH
Q 001527         1021 MVNPAAEKGMKEVLGIALRCIR-SVSERPG-IKTIYE 1055 (1060)
Q Consensus      1021 ~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs-~~evl~ 1055 (1060)
                          ........+.+++.+|++ +|.+||+ ++|+++
T Consensus       229 ----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        229 ----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ----cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                001233456778889998 7999996 698875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=6.8e-31  Score=273.29  Aligned_cols=253  Identities=22%  Similarity=0.268  Sum_probs=196.7

Q ss_pred             CCeeccccceEEEEEEEcC------CcEEEEEEcccchH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLEN------GMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      ..++-+|.||.||+|.|++      .+.|.||.++.... -+...+..|.-.+..+.|||+.++.+++.. +....+.+|
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie-~~~~P~V~y  367 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE-DYATPFVLY  367 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee-ccCcceEEE
Confidence            4567899999999997543      45677787775533 345678899999999999999999999974 566789999


Q ss_pred             EecCCCChHHHhhcCCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          854 DYISPGSLASFLYDRPG---RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      .++.-|+|..++...++   +..+.++..+...++.|++.|++||| ..+|||.||..+|.+|| +..++||+|=.+++.
T Consensus       368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh-~~~ViHkDiAaRNCvId-d~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH-NHGVIHKDIAARNCVID-DQLQVKLTDSALSRD  445 (563)
T ss_pred             eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH-hcCcccchhhhhcceeh-hheeEEeccchhccc
Confidence            99999999999973322   23356788889999999999999999 99999999999999999 689999999999987


Q ss_pred             eccCCcee-eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHHHHHHHhcCC
Q 001527          931 MTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008 (1060)
Q Consensus       931 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 1008 (1060)
                      ..+....- .........||+||.+....+  +.++|||||||++|||+| |+.|+..+++       .+... .++++.
T Consensus       446 LFP~DYhcLGDnEnRPvkWMslEal~n~~y--ssasDvWsfGVllWELmtlg~~PyaeIDP-------fEm~~-ylkdGy  515 (563)
T KOG1024|consen  446 LFPGDYHCLGDNENRPVKWMSLEALQNSHY--SSASDVWSFGVLLWELMTLGKLPYAEIDP-------FEMEH-YLKDGY  515 (563)
T ss_pred             cCcccccccCCCCCCcccccCHHHHhhhhh--cchhhhHHHHHHHHHHHhcCCCCccccCH-------HHHHH-HHhccc
Confidence            65543321 111234678999999998876  889999999999999998 9999865432       22221 222221


Q ss_pred             CCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1009 GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1009 ~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      .       +.      .+-.++.++..++..||+ .|++||+++|++..|.+
T Consensus       516 R-------la------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  516 R-------LA------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             e-------ec------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            1       11      112466788899999998 79999999999998864

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=2.6e-31  Score=268.89  Aligned_cols=204  Identities=25%  Similarity=0.310  Sum_probs=167.3

Q ss_pred             cCCCeeccccceEEEEEEEc---C--CcEEEEEEcccchHH--HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEE
Q 001527          779 APAEVLGRSSHGTSYRATLE---N--GMFLTVKWLREGVAK--QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLI  851 (1060)
Q Consensus       779 ~~~~~iG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~l  851 (1060)
                      .....||+|.||.||+|.-.   +  ...+|+|+++.....  -.....+|+..++.++||||+.+..++.. .+...++
T Consensus        27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~-~d~~v~l  105 (438)
T KOG0666|consen   27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS-HDKKVWL  105 (438)
T ss_pred             hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc-cCceEEE
Confidence            34567999999999999633   2  237999999754221  12456789999999999999999998874 3668999


Q ss_pred             EEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCC---CCCeEEcccccc
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP---DLNARVADYCLH  928 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~---~~~~kl~Dfg~a  928 (1060)
                      ++||.+. +|.+.++-++......++...+..|+.||+.|+.||| ++=|+||||||.|||+.++   .+++||+|||++
T Consensus       106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH-~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla  183 (438)
T KOG0666|consen  106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH-SNWVLHRDLKPANILVMGDGPERGRVKIADLGLA  183 (438)
T ss_pred             Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh-hhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence            9999976 8999998776666678999999999999999999999 9999999999999999742   289999999999


Q ss_pred             eeeccCCce--eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          929 RLMTQAGTI--EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       929 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      +.+...-..  .....+-|.+|+|||.+.|.. +|+.+.||||.||++.||+|-++-|..
T Consensus       184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~-hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGAR-HYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             HHhhccccccccCCceEEEEEecChHHhcccc-cccchhhhHHHHHHHHHHHccCccccc
Confidence            987654322  122235689999999999877 479999999999999999998877754

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=3.1e-30  Score=281.72  Aligned_cols=245  Identities=23%  Similarity=0.314  Sum_probs=185.0

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch-----HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-----AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+++.. .+..+++|+++...     .....++..|+.++++++||||+++++++.  +....++|||
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e   82 (260)
T cd08222           5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL--ERDAFCIITE   82 (260)
T ss_pred             eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh--cCCceEEEEE
Confidence            578999999999999854 34556666655321     123345778999999999999999999985  4567899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |+++++|.+++.... .....+++.+++.++.|++.||.||| +.|++|+||||+||+++  +..+||+|||.++.....
T Consensus        83 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~h~~l~~~nili~--~~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          83 YCEGRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             eCCCCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHH-HcCccccCCChhheEee--cCCEeecccCceeecCCC
Confidence            999999999986532 23356899999999999999999999 99999999999999997  346999999998876443


Q ss_pred             CceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      .... ....|+..|+|||...+..+  +.++||||||+++|+|++|+.||...       .......... .+..     
T Consensus       159 ~~~~-~~~~~~~~~~~pe~~~~~~~--~~~~Dv~slG~~~~~l~~~~~~~~~~-------~~~~~~~~~~-~~~~-----  222 (260)
T cd08222         159 CDLA-TTFTGTPYYMSPEALKHQGY--DSKSDIWSLGCILYEMCCLAHAFEGQ-------NFLSVVLRIV-EGPT-----  222 (260)
T ss_pred             cccc-cCCCCCcCccCHHHHccCCC--CchhhHHHHHHHHHHHHhCCCCCCCc-------cHHHHHHHHH-cCCC-----
Confidence            2221 12357889999999876654  67999999999999999999998632       1122221111 1111     


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      +..        .......+.+++.+|++ +|++||++.|+++
T Consensus       223 ~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 PSL--------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCC--------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            111        11234567788889998 7999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=7.1e-30  Score=285.98  Aligned_cols=242  Identities=21%  Similarity=0.321  Sum_probs=184.5

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG---VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.+|+|.+...   .....+++.+|++++++++|||++++++++.  .....++||||+
T Consensus        20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~   97 (308)
T cd06634          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHTAWLVMEYC   97 (308)
T ss_pred             HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE--cCCeeEEEEEcc
Confidence            467999999999999954 6889999988532   2234457889999999999999999999986  456789999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      . |++.+++...    ...+++.++..++.|++.|+.||| +.+++||||||+||+++ +++.+||+|||++....... 
T Consensus        98 ~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH-~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~-  169 (308)
T cd06634          98 L-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN-  169 (308)
T ss_pred             C-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHhEEEC-CCCcEEECCcccceeecCcc-
Confidence            6 6888877532    235889999999999999999999 99999999999999998 57899999999987654322 


Q ss_pred             eeeeccCccccccchhcccCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccc
Q 001527          937 IEQILDAGVLGYRAPELAASK-KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                          ...++..|+|||++.+. ...++.++|||||||++|||++|+.||.....       .+....... ...     +
T Consensus       170 ----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~-~~~-----~  232 (308)
T cd06634         170 ----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQ-NES-----P  232 (308)
T ss_pred             ----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------HHHHHHHhh-cCC-----C
Confidence                22578899999997531 11237799999999999999999999754211       111111111 111     0


Q ss_pred             ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      ...       .......+.+++.+|++ +|.+||++.+|++.
T Consensus       233 ~~~-------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         233 ALQ-------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             CcC-------cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            000       01233557788889998 79999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.8e-30  Score=294.07  Aligned_cols=260  Identities=21%  Similarity=0.251  Sum_probs=191.6

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCC---CCceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT---QHEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---~~~~~lv~e  854 (1060)
                      .+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|++++++++||||+++++++....   ....++|||
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e   84 (330)
T cd07834           5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE   84 (330)
T ss_pred             eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence            578999999999999965 58999999987543  334567899999999999999999999986322   236899999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |++ ++|.+++...     ..+++..+..++.|++.||+||| +.||+||||||+||+++ +++.++|+|||.+......
T Consensus        85 ~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH-~~gi~H~dlkp~nili~-~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          85 LME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLH-SANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             chh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEc-CCCCEEEcccCceEeeccc
Confidence            997 5899988532     36899999999999999999999 99999999999999998 5789999999999876554


Q ss_pred             Cc--eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCC----
Q 001527          935 GT--IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGH---- 1008 (1060)
Q Consensus       935 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~---- 1008 (1060)
                      ..  .......++..|+|||++.+.. .++.++||||+|+++|+|++|+.||......       +..........    
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~~~~  228 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSSS-RYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-------DQLNLIVEVLGTPSE  228 (330)
T ss_pred             ccccccccccccccCcCCceeeeccc-CCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-------HHHHHHHHhcCCCCh
Confidence            31  1112235788999999998763 3488999999999999999999998753211       11111111000    


Q ss_pred             ----------CCccccc--ccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1009 ----------GSDCFDA--AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1009 ----------~~~~~d~--~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                                ..+.+..  .................+.+++.+|++ +|.+||+++++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                      0000000  000000000011234567889999998 79999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=1e-29  Score=285.25  Aligned_cols=243  Identities=22%  Similarity=0.320  Sum_probs=183.9

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccc---hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREG---VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      ..+.||+|+||+||+|+.. +++.|++|++...   .....+.+.+|++++++++|||++++++++.  +....++||||
T Consensus        25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~  102 (313)
T cd06633          25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL--KEHTAWLVMEY  102 (313)
T ss_pred             cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE--eCCEEEEEEec
Confidence            3567999999999999854 6899999998642   2233457889999999999999999999985  45678999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +. |++.+++...    ..++++.++..++.|++.|++||| +.||+||||||+||+++ +++.+||+|||++.......
T Consensus       103 ~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH-~~gi~H~dl~p~nili~-~~~~~kL~dfg~~~~~~~~~  175 (313)
T cd06633         103 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH-SHNMIHRDIKAGNILLT-EPGQVKLADFGSASKSSPAN  175 (313)
T ss_pred             CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCChhhEEEC-CCCCEEEeecCCCcccCCCC
Confidence            95 5788877542    245899999999999999999999 99999999999999998 57899999999886532221


Q ss_pred             ceeeeccCccccccchhcccCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccc
Q 001527          936 TIEQILDAGVLGYRAPELAASK-KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                           ...|+..|+|||++... ...++.++|||||||++|||++|+.||....       ....+....... ..    
T Consensus       176 -----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-------~~~~~~~~~~~~-~~----  238 (313)
T cd06633         176 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQND-SP----  238 (313)
T ss_pred             -----CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhcC-CC----
Confidence                 23688899999998531 1224779999999999999999999986431       111111111111 10    


Q ss_pred             cccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                       ....       ......+.+++.+|++ +|.+||++.+++..
T Consensus       239 -~~~~-------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         239 -TLQS-------NEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -CCCc-------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0000       0122346778889998 79999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.8e-31  Score=266.75  Aligned_cols=202  Identities=24%  Similarity=0.345  Sum_probs=170.1

Q ss_pred             CChhhhhccCCCeeccccceEEEEEEE-cCCcEEEEEEcccchHHH---HHHHHHHHHHHhcCCCCceeeeeeEEeCCCC
Q 001527          771 LTPEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQ---RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ  846 (1060)
Q Consensus       771 ~~~~~l~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  846 (1060)
                      ++.++..+  .+++|+|.||.|-+++- .+|+.+|+|++++...-.   ...-..|-++|+..+||.+..+.-.|  +..
T Consensus       165 vTm~dFdf--LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Qt~  240 (516)
T KOG0690|consen  165 VTMEDFDF--LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF--QTQ  240 (516)
T ss_pred             eccchhhH--HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh--ccC
Confidence            44455544  47899999999999984 479999999998764333   34556799999999999999886555  577


Q ss_pred             CceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccc
Q 001527          847 HEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYC  926 (1060)
Q Consensus       847 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg  926 (1060)
                      +..|+||||+.||.|.-++..     ...+++...+.+-..|+.||.||| +++||.||+|.+|.|+| +++++||+|||
T Consensus       241 drlCFVMeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLH-s~~ivYRDlKLENLlLD-kDGHIKitDFG  313 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLH-SRNIVYRDLKLENLLLD-KDGHIKITDFG  313 (516)
T ss_pred             ceEEEEEEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhh-hCCeeeeechhhhheec-cCCceEeeecc
Confidence            899999999999999998843     356888888999999999999999 89999999999999999 69999999999


Q ss_pred             cceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          927 LHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       927 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      +++.--..+.... ..+||+.|.|||++....+  ..++|.|.+|||+|||++|+.||..
T Consensus       314 LCKE~I~~g~t~k-TFCGTPEYLAPEVleDnDY--graVDWWG~GVVMYEMmCGRLPFyn  370 (516)
T KOG0690|consen  314 LCKEEIKYGDTTK-TFCGTPEYLAPEVLEDNDY--GRAVDWWGVGVVMYEMMCGRLPFYN  370 (516)
T ss_pred             cchhcccccceec-cccCChhhcCchhhccccc--cceeehhhhhHHHHHHHhccCcccc
Confidence            9986443333322 3489999999999988765  7799999999999999999999874

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=3.1e-30  Score=289.58  Aligned_cols=198  Identities=21%  Similarity=0.276  Sum_probs=159.0

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchH--HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCC------CCceEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA--KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT------QHEKLI  851 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~~~~l  851 (1060)
                      .+.||+|+||.||+|+.. +++.||+|++.....  .....+.+|++++++++||||+++++++....      ....++
T Consensus        17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l   96 (310)
T cd07865          17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL   96 (310)
T ss_pred             EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence            478999999999999965 689999998864321  12345668999999999999999999986422      234699


Q ss_pred             EEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceee
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~  931 (1060)
                      ||||+. +++.+++...    ...+++.++..++.|++.||+||| +.+++||||||+||+++ .++.+||+|||.+...
T Consensus        97 v~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~  169 (310)
T cd07865          97 VFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIH-RNKILHRDMKAANILIT-KDGILKLADFGLARAF  169 (310)
T ss_pred             EEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEC-CCCcEEECcCCCcccc
Confidence            999996 5888887542    235899999999999999999999 89999999999999998 5789999999999865


Q ss_pred             ccCCce---eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          932 TQAGTI---EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       932 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ......   ......++..|+|||++.+... ++.++||||||+++|||++|+.||..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di~slG~~l~el~t~~~~~~~  226 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERD-YGPPIDMWGAGCIMAEMWTRSPIMQG  226 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCCcc-cCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            432211   1112357788999999876442 36799999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=285.40  Aligned_cols=195  Identities=23%  Similarity=0.368  Sum_probs=165.3

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+++|.|-||+||-|.. ++|+.||||++.+..  .+...++++|+.+|++++||.||.+...|  ++.+..++|||-+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEKl~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEKLH  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehhhc
Confidence            57999999999999985 479999999996542  23457899999999999999999998777  57788999999995


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeC--CCCCeEEcccccceeeccCC
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG--PDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~--~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      | +..+++..   ...+++++.....++.||+.||.||| .++|||+||||+|||+.+  +--++||||||+|+.+.+..
T Consensus       647 G-DMLEMILS---sEkgRL~er~TkFlvtQIL~ALr~LH-~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  647 G-DMLEMILS---SEKGRLPERITKFLVTQILVALRYLH-FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             c-hHHHHHHH---hhcccchHHHHHHHHHHHHHHHHHhh-hcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            5 55555533   23356899888999999999999999 999999999999999953  22579999999999988765


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ....  .+||+.|.|||+++.+.+  ...-|+||.||++|--++|..||..
T Consensus       722 FRrs--VVGTPAYLaPEVLrnkGy--NrSLDMWSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  722 FRRS--VVGTPAYLAPEVLRNKGY--NRSLDMWSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             hhhh--hcCCccccCHHHHhhccc--cccccceeeeEEEEEEecccccCCC
Confidence            4443  389999999999998876  7788999999999999999999963

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=7.9e-30  Score=289.88  Aligned_cols=192  Identities=22%  Similarity=0.318  Sum_probs=158.6

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCC----CceEEEE
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ----HEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----~~~~lv~  853 (1060)
                      .+.||+|+||.||+|.. .+++.||||+++...  ....+.+.+|++++++++||||+++++++.....    ...++||
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~   99 (343)
T cd07880          20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM   99 (343)
T ss_pred             EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence            46899999999999984 479999999985432  2234568899999999999999999998853221    2468999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+ +++|.+++..      ..+++..+..++.|++.||+||| +.||+||||||+||+++ +++.+|++|||++.....
T Consensus       100 e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH-~~gi~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880         100 PFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIH-AAGIIHRDLKPGNLAVN-EDCELKILDFGLARQTDS  170 (343)
T ss_pred             ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEc-CCCCEEEeeccccccccc
Confidence            999 7799988843      34899999999999999999999 99999999999999998 578999999999886543


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ...    ...++..|+|||.+.+.. .++.++||||+||++|++++|+.||..
T Consensus       171 ~~~----~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~  218 (343)
T cd07880         171 EMT----GYVVTRWYRAPEVILNWM-HYTQTVDIWSVGCIMAEMLTGKPLFKG  218 (343)
T ss_pred             Ccc----ccccCCcccCHHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            221    225788999999987533 247899999999999999999999874

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=5.5e-30  Score=289.09  Aligned_cols=259  Identities=18%  Similarity=0.249  Sum_probs=185.7

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++.. .....++|+||+ 
T Consensus        15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~~lv~e~~-   92 (328)
T cd07856          15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS-PLEDIYFVTELL-   92 (328)
T ss_pred             EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec-CCCcEEEEeehh-
Confidence            578999999999999854 79999999875421  2234678899999999999999999998863 345788999998 


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      +++|.+++..      .++++..+..++.|+++||+||| +.+|+||||||+||+++ +++.+||+|||.+........ 
T Consensus        93 ~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH-~~~iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~~~~~-  163 (328)
T cd07856          93 GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVH-SAGVVHRDLKPSNILIN-ENCDLKICDFGLARIQDPQMT-  163 (328)
T ss_pred             ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEeEC-CCCCEEeCccccccccCCCcC-
Confidence            5689988843      24788888999999999999999 99999999999999998 578999999999875433211 


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCc--------cChHHHHHHHHhcCCC
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAG--------VDLTDWMQLKVAEGHG 1009 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~--------~~l~~~~~~~~~~~~~ 1009 (1060)
                         ...++..|+|||++.+.. .++.++|||||||++|||++|+.||.........        ....+|....... ..
T Consensus       164 ---~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  238 (328)
T cd07856         164 ---GYVSTRYYRAPEIMLTWQ-KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE-NT  238 (328)
T ss_pred             ---CCcccccccCceeeeccC-CcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch-hh
Confidence               125688899999876533 2478999999999999999999998643211000        0011111110000 00


Q ss_pred             CcccccccccccCChh---HHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1010 SDCFDAAVMPEMVNPA---AEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1010 ~~~~d~~l~~~~~~~~---~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .+.+.. .......+.   .......+.+++.+|++ +|++||++.|++..
T Consensus       239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         239 LRFVQS-LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHhh-ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000 000000000   01223577888999998 79999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=4.4e-30  Score=288.48  Aligned_cols=260  Identities=22%  Similarity=0.247  Sum_probs=184.7

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHH--HHHHHHHHHHHHhcCCCCceeeeeeEEeCCC------CCceEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAK--QRKEFAKEAKKFANIRHPNVVGLRGYYWGPT------QHEKLI  851 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~~~~l  851 (1060)
                      .++||+|+||.||+|+.. +++.||+|++......  ....+.+|++++++++||||+++++++....      ....++
T Consensus        13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l   92 (311)
T cd07866          13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM   92 (311)
T ss_pred             EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence            468999999999999965 6899999988643221  2345678999999999999999999876432      235799


Q ss_pred             EEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceee
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~  931 (1060)
                      ||||+.+ ++.+.+...    ...+++.++..++.|+++||+||| +.||+||||||+||+++ +++.+||+|||+++..
T Consensus        93 v~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH-~~~i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~  165 (311)
T cd07866          93 VTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLH-ENHILHRDIKAANILID-NQGILKIADFGLARPY  165 (311)
T ss_pred             EEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEC-CCCCEEECcCccchhc
Confidence            9999964 777777542    246899999999999999999999 99999999999999998 5889999999999865


Q ss_pred             ccCCcee----------eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHH
Q 001527          932 TQAGTIE----------QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQ 1001 (1060)
Q Consensus       932 ~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~ 1001 (1060)
                      .......          .....+++.|+|||++.+.. .++.++|||||||++|||++|+.||......       ....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-------~~~~  237 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER-RYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-------DQLH  237 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCC-ccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-------HHHH
Confidence            4322111          11124678899999886543 2477999999999999999999998643211       1111


Q ss_pred             HHHhcC------------CCCcccccccccccCCh---hHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1002 LKVAEG------------HGSDCFDAAVMPEMVNP---AAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1002 ~~~~~~------------~~~~~~d~~l~~~~~~~---~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ......            ......+..........   ........+.+++.+|++ +|.+|||+.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            100000            00000000000000000   001222567889999998 7999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=7.2e-30  Score=282.35  Aligned_cols=259  Identities=24%  Similarity=0.309  Sum_probs=189.6

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++...  ....+.+..|++++++++||||+++++++.  +....++||||++
T Consensus         4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~~v~e~~~   81 (282)
T cd07829           4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH--TERKLYLVFEYCD   81 (282)
T ss_pred             ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh--cCCceEEEecCcC
Confidence            467999999999999965 59999999987643  223467788999999999999999999985  4578999999997


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                       ++|.+++....    ..+++.++..++.|++.||+||| +.+|+||||+|+||+++ +++.+||+|||.++........
T Consensus        82 -~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          82 -MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCH-SHRILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             -cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChheEEEc-CCCCEEEecCCcccccCCCccc
Confidence             59999996532    35899999999999999999999 89999999999999998 5789999999999876543221


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHh-----------c
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA-----------E 1006 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~-----------~ 1006 (1060)
                      . ....++..|+|||++.+.. .++.++|||||||++||+++|+.||.....    ......+.....           .
T Consensus       155 ~-~~~~~~~~~~aPE~~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         155 Y-THEVVTLWYRAPEILLGSK-HYSTAVDIWSVGCIFAEMITGKPLFPGDSE----IDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             c-CccccCcCcCChHHhcCCc-CCCccccHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHHHhCCCcHHHHHhhcc
Confidence            1 1224577899999987662 247899999999999999999999864221    011111110000           0


Q ss_pred             CC-CCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1007 GH-GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1007 ~~-~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .. ....+ +.................+.+++.+|+. +|.+||++.||+.
T Consensus       229 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         229 LPDYKPTF-PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccc-cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00 00000 0000000000011224568899999998 7999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=7.6e-30  Score=281.81  Aligned_cols=242  Identities=20%  Similarity=0.284  Sum_probs=188.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++ ||||+++++++.  .....++||||
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~lv~e~   83 (280)
T cd05581           6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ--DEENLYFVLEY   83 (280)
T ss_pred             eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--CCceEEEEEcC
Confidence            468999999999999965 79999999986531   233467889999999998 999999999884  56688999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +++++|.+++...     ..+++.++..|+.|++.||+||| +.+++|+||||+||+++ .++.++++|||++.......
T Consensus        84 ~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh-~~~~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          84 APNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLH-SKGIIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEEC-CCCCEEecCCccccccCCcc
Confidence            9999999999543     36999999999999999999999 99999999999999998 57899999999988654432


Q ss_pred             c-------------------eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccCh
Q 001527          936 T-------------------IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDL  996 (1060)
Q Consensus       936 ~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l  996 (1060)
                      .                   .......++..|+|||...+...  +.++||||||++++++++|+.||.....      .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~--~~~~Di~slG~~l~~l~~g~~p~~~~~~------~  228 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA--GKSSDLWALGCIIYQMLTGKPPFRGSNE------Y  228 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC--ChhhhHHHHHHHHHHHHhCCCCCCCccH------H
Confidence            1                   11112357889999999877654  7799999999999999999999874321      0


Q ss_pred             HHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCH----HHHHH
Q 001527          997 TDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGI----KTIYE 1055 (1060)
Q Consensus       997 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~----~evl~ 1055 (1060)
                       .-.+...... .      ..        .....+.+.+++.+|++ +|.+||++    +|+++
T Consensus       229 -~~~~~~~~~~-~------~~--------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 -LTFQKILKLE-Y------SF--------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -HHHHHHHhcC-C------CC--------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence             1111111100 0      00        01223557788889998 79999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-30  Score=248.51  Aligned_cols=210  Identities=25%  Similarity=0.377  Sum_probs=168.5

Q ss_pred             CCCChhhhhccCCCeeccccceEEEEEEE-cCCcEEEEEEcccch-HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCC
Q 001527          769 LTLTPEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPT  845 (1060)
Q Consensus       769 ~~~~~~~l~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~  845 (1060)
                      +++..+++.  ..+.||+|+||.|-+-++ .+|+..|+|+++... .+..++...|+++..+. .+|.+|.++|.+.  .
T Consensus        41 ~eV~ad~L~--~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~--r  116 (282)
T KOG0984|consen   41 FEVPADDLV--GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF--R  116 (282)
T ss_pred             cccchhhhh--hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh--c
Confidence            344444443  356799999999988874 589999999997543 33456777888876554 7999999999875  4


Q ss_pred             CCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccc
Q 001527          846 QHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY  925 (1060)
Q Consensus       846 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Df  925 (1060)
                      ....|+.||.|. -||+.+-.+.. +.+..+++.-.-+||..|.+||.|||....|||||+||+|||++ .++++|+|||
T Consensus       117 egdvwIcME~M~-tSldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn-~~GqVKiCDF  193 (282)
T KOG0984|consen  117 EGDVWICMELMD-TSLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN-YDGQVKICDF  193 (282)
T ss_pred             cccEEEeHHHhh-hhHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc-cCCcEEEccc
Confidence            567999999995 48887765543 45677999999999999999999999777999999999999999 5889999999


Q ss_pred             ccceeeccCCceeeeccCccccccchhcccCC--CCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          926 CLHRLMTQAGTIEQILDAGVLGYRAPELAASK--KPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       926 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      |.+..+.+.-..  +...|...|||||.+...  ...|+.|+||||+|+.+.||.++++||+..
T Consensus       194 GIsG~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  194 GISGYLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             ccceeehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            999877654322  234789999999998643  224588999999999999999999998753

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=8.6e-30  Score=289.60  Aligned_cols=192  Identities=22%  Similarity=0.307  Sum_probs=156.5

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCC----CCceEEE
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT----QHEKLIL  852 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~~~lv  852 (1060)
                      ..+.||+|+||.||+|+.. +|+.||+|+++...  ......+.+|++++++++||||+++++++....    ....++|
T Consensus        19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   98 (342)
T cd07879          19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV   98 (342)
T ss_pred             EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence            3578999999999999954 68999999986432  222356789999999999999999999885321    2356899


Q ss_pred             EEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeec
Q 001527          853 SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT  932 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~  932 (1060)
                      +||+. .++.++..       ..+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.+||+|||+++...
T Consensus        99 ~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH-~~~i~H~dlkp~NIll~-~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          99 MPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIH-SAGIIHRDLKPGNLAVN-EDCELKILDFGLARHAD  168 (342)
T ss_pred             ecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEC-CCCCEEEeeCCCCcCCC
Confidence            99996 47777651       24889999999999999999999 99999999999999998 58899999999987643


Q ss_pred             cCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          933 QAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ....    ...++..|+|||++.+... ++.++|||||||++|||++|+.||..
T Consensus       169 ~~~~----~~~~~~~y~aPE~~~~~~~-~~~~~Dv~slGvil~el~~g~~pf~~  217 (342)
T cd07879         169 AEMT----GYVVTRWYRAPEVILNWMH-YNQTVDIWSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             CCCC----CceeeecccChhhhcCccc-cCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            3211    2256888999999876432 47799999999999999999999974

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=1e-29  Score=287.92  Aligned_cols=197  Identities=23%  Similarity=0.271  Sum_probs=158.2

Q ss_pred             CCeeccccceEEEEEEEc-C--CcEEEEEEcccch--HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeC--CCCCceEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-N--GMFLTVKWLREGV--AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWG--PTQHEKLIL  852 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~~~~~~lv  852 (1060)
                      .+.||+|+||.||+|+.. +  +..||+|++....  ....+.+.+|+++++++ .||||+++++++..  ......+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~   84 (332)
T cd07857           5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY   84 (332)
T ss_pred             EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence            468999999999999964 4  7899999986432  22345678899999999 59999999987642  223457888


Q ss_pred             EEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeec
Q 001527          853 SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT  932 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~  932 (1060)
                      +||+. ++|.+++..     ...+++.++..++.||+.||+||| ..||+||||||+||+++ +++.+||+|||.++...
T Consensus        85 ~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH-~~givH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          85 EELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIH-SANVLHRDLKPGNLLVN-ADCELKICDFGLARGFS  156 (332)
T ss_pred             Eeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHeEEc-CCCCEEeCcCCCceecc
Confidence            89885 689998843     345899999999999999999999 99999999999999998 57899999999998654


Q ss_pred             cCCce---eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          933 QAGTI---EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       933 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      .....   ......|+..|+|||+..+.. .++.++||||+||++|+|++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~~Di~slGv~l~~l~~g~~pf~~  212 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLSFQ-SYTKAIDVWSVGCILAELLGRKPVFKG  212 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence            32211   111235889999999886533 247899999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.6e-29  Score=287.61  Aligned_cols=192  Identities=23%  Similarity=0.333  Sum_probs=157.5

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCC----CCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGP----TQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----~~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|.. .+++.||+|+++...  ....+.+.+|++++++++||||+++++++...    .....++++
T Consensus        22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  101 (345)
T cd07877          22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  101 (345)
T ss_pred             EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence            46899999999999985 478999999987532  22346678899999999999999999988522    123467888


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      +++ +++|.+++..      ..+++..+..++.|+++||+||| +.+|+||||||+||+++ +++.+||+|||+++....
T Consensus       102 ~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIll~-~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877         102 HLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVN-EDCELKILDFGLARHTDD  172 (345)
T ss_pred             hhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChHHEEEc-CCCCEEEecccccccccc
Confidence            876 7899888743      24899999999999999999999 99999999999999998 578999999999876433


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ..    ....++..|+|||.+.+.. .++.++|||||||++|||++|+.||..
T Consensus       173 ~~----~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         173 EM----TGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             cc----cccccCCCccCHHHHhCcc-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            21    1235788999999986633 247799999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-29  Score=273.66  Aligned_cols=238  Identities=24%  Similarity=0.311  Sum_probs=186.2

Q ss_pred             eccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          784 LGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       784 iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      ||+|+||.||++... +++.+|+|+++....   ...+.+..|++++++++||||+++++.+.  .+...++||||++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCCC
Confidence            699999999999965 589999999875432   24567889999999999999999998884  567899999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+++...     ..+++.++..++.|++.||.||| +.+++|+||||+||+++ +++.++|+|||.+........ ..
T Consensus        79 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh-~~~~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~-~~  150 (250)
T cd05123          79 ELFSHLSKE-----GRFSEERARFYAAEIVLALEYLH-SLGIIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGS-RT  150 (250)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcceEEEc-CCCcEEEeecCcceecccCCC-cc
Confidence            999999543     35899999999999999999999 89999999999999998 578999999999887654321 12


Q ss_pred             eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccc
Q 001527          940 ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ....++..|+|||...+...  +.++|+||||+++||+++|+.||.....       ......... ...      . .+
T Consensus       151 ~~~~~~~~~~~Pe~~~~~~~--~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~------~-~~  213 (250)
T cd05123         151 NTFCGTPEYLAPEVLLGKGY--GKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILK-DPL------R-FP  213 (250)
T ss_pred             cCCcCCccccChHHhCCCCC--CchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhc-CCC------C-CC
Confidence            22367889999999987654  7799999999999999999999864311       122221111 000      0 00


Q ss_pred             ccCChhHHHHHHHHHHHHHHhcc-CCCCCCCH---HHHHH
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGI---KTIYE 1055 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~---~evl~ 1055 (1060)
                             ......+.+++.+|+. +|++||++   +++.+
T Consensus       214 -------~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         214 -------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             -------CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence                   1123456778889998 79999999   55543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-30  Score=239.99  Aligned_cols=194  Identities=22%  Similarity=0.305  Sum_probs=161.7

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccchHH--HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAK--QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      -|+||+|.||+||+|+ +++++.||+|+++-....  ......+|+-+++.++|.|||++++...  .....-+|+||| 
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh--sdkkltlvfe~c-   83 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKLTLVFEFC-   83 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc--cCceeEEeHHHh-
Confidence            3689999999999999 557999999998754221  2345678999999999999999999884  566788999999 


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCce
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~  937 (1060)
                      ..+|..|...-    ++.++.+.++.++.|+++||.|+| ++.+.|||+||.|.||+ .+++.|++|||+++.+......
T Consensus        84 dqdlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fch-shnvlhrdlkpqnllin-~ngelkladfglarafgipvrc  157 (292)
T KOG0662|consen   84 DQDLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCH-SHNVLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             hHHHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhh-hhhhhhccCCcceEEec-cCCcEEecccchhhhcCCceEe
Confidence            56898888543    356899999999999999999999 99999999999999998 6899999999999987654332


Q ss_pred             eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGD  985 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt-G~~p~~  985 (1060)
                      .. ..+-|.+|++|.++.+.+. |+...|+||.||++.|+.. |++-|.
T Consensus       158 ys-aevvtlwyrppdvlfgakl-y~tsidmwsagcifaelanagrplfp  204 (292)
T KOG0662|consen  158 YS-AEVVTLWYRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_pred             ee-ceeeeeeccCcceeeeeeh-hccchHhhhcchHHHHHhhcCCCCCC
Confidence            22 2256899999999998876 5889999999999999987 554454

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=289.62  Aligned_cols=249  Identities=18%  Similarity=0.303  Sum_probs=197.7

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeC---CCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWG---PTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~---~~~~~~~lv~e~  855 (1060)
                      .++||.|.+|.||+++ .++++.+|+|++.... ...++++.|.++++.. .|||++.++|+|.-   ..+++.||||||
T Consensus        24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf  102 (953)
T KOG0587|consen   24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF  102 (953)
T ss_pred             EEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence            3789999999999999 6689999999987653 3346788899999888 69999999999973   245689999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      |.+||..+++....   +..+.|..+..|++.++.|+.||| ...++|||||-.|||++ .++.+|++|||.+...+...
T Consensus       103 C~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH-~nkviHRDikG~NiLLT-~e~~VKLvDFGvSaQldsT~  177 (953)
T KOG0587|consen  103 CGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLH-NNKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDSTV  177 (953)
T ss_pred             cCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHh-hcceeeecccCceEEEe-ccCcEEEeeeeeeeeeeccc
Confidence            99999999997754   567999999999999999999999 99999999999999999 58899999999998776543


Q ss_pred             ceeeeccCccccccchhcccCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcc
Q 001527          936 TIEQILDAGVLGYRAPELAASK---KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ... ....||+.|||||++.-.   .+.++.++|+||+|++..||.-|.+|+.++.+.          +.+..   ...-
T Consensus       178 grR-nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----------raLF~---IpRN  243 (953)
T KOG0587|consen  178 GRR-NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----------RALFL---IPRN  243 (953)
T ss_pred             ccc-cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh----------hhhcc---CCCC
Confidence            322 234799999999998632   334567899999999999999999997654321          10110   0000


Q ss_pred             cccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .-|.+      .......+++.+++..|+. +-++||++.++++
T Consensus       244 PPPkL------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  244 PPPKL------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCccc------cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            11111      1235678899999999997 6789999998875

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.4e-29  Score=287.95  Aligned_cols=254  Identities=19%  Similarity=0.263  Sum_probs=185.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCC----CceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ----HEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----~~~~lv~  853 (1060)
                      .+.||+|+||.||+|+.. +++.||+|++...  .....+.+.+|+.++++++||||+++++++...+.    ...++|+
T Consensus        20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~   99 (343)
T cd07851          20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT   99 (343)
T ss_pred             EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence            478999999999999965 6889999998643  22334667789999999999999999987753221    2489999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ||+ +++|.+++..      ..+++.++..++.|++.||+||| +.||+||||||+||+++ +++.+||+|||.+.....
T Consensus       100 e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH-~~gi~H~dlkp~Nill~-~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851         100 HLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIH-SAGIIHRDLKPSNIAVN-EDCELKILDFGLARHTDD  170 (343)
T ss_pred             ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEEC-CCCCEEEccccccccccc
Confidence            998 6799998853      35899999999999999999999 99999999999999998 588999999999986543


Q ss_pred             CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhc-CCCCc-
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAE-GHGSD- 1011 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~-~~~~~- 1011 (1060)
                      ..    ....++..|+|||.+.+.. .++.++|||||||++||+++|+.||.....       .+.+...... +...+ 
T Consensus       171 ~~----~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslGv~l~elltg~~pf~~~~~-------~~~~~~i~~~~~~~~~~  238 (343)
T cd07851         171 EM----TGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGKTLFPGSDH-------IDQLKRIMNLVGTPDEE  238 (343)
T ss_pred             cc----cCCcccccccCHHHHhCCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhcCCCCHH
Confidence            31    1225788999999986543 347899999999999999999999864211       1111111100 00000 


Q ss_pred             ------------ccccc-ccccc-CChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1012 ------------CFDAA-VMPEM-VNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1012 ------------~~d~~-l~~~~-~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                                  ..... ..... ...........+.+++.+|+. +|.+|||+.||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                        00000 00000 000001124578899999998 7999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.1e-30  Score=259.18  Aligned_cols=216  Identities=22%  Similarity=0.389  Sum_probs=180.3

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      ..+||+|+|+.|..+++. +.+.+|+|++++..   ..+..-.+.|-.+..+. +||.+|.++.+|  ++....++|.||
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf--qtesrlffviey  332 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--QTESRLFFVIEY  332 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--cccceEEEEEEE
Confidence            479999999999999954 68999999998642   22344566787777776 799999999888  467789999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      ++||+|--++..     ...++++.++.+...|+-||.||| ++|||.||+|.+|||+|+ .+++|++|+|+++.--..+
T Consensus       333 v~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh-~rgiiyrdlkldnvllda-eghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  333 VNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLH-ERGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             ecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHh-hcCeeeeeccccceEEcc-CCceeecccchhhcCCCCC
Confidence            999999777633     345999999999999999999999 999999999999999995 7899999999998654444


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCC
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 1008 (1060)
                      ... ...+||+.|.|||++++..|  .+.+|.|++||+++||+.|+.||+....+....+..++.-+.+-+.+
T Consensus       406 d~t-stfcgtpnyiapeilrgeey--gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq  475 (593)
T KOG0695|consen  406 DTT-STFCGTPNYIAPEILRGEEY--GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ  475 (593)
T ss_pred             ccc-ccccCCCcccchhhhccccc--CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence            333 23489999999999999987  77999999999999999999999987666666777788776665543

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=4.7e-29  Score=305.15  Aligned_cols=140  Identities=21%  Similarity=0.323  Sum_probs=122.7

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++...   ......+.+|+++++.++||||+++++++.  .....|+||||+
T Consensus         9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~lVmEy~   86 (669)
T cd05610           9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ--SANNVYLVMEYL   86 (669)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE--ECCEEEEEEeCC
Confidence            478999999999999965 68999999987532   233467889999999999999999998874  566899999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccce
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR  929 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~  929 (1060)
                      ++++|.+++...     ..+++..++.|+.||+.||+||| .++||||||||+|||++ .++.+||+|||+++
T Consensus        87 ~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH-~~gIiHrDLKP~NILl~-~~g~vkL~DFGls~  152 (669)
T cd05610          87 IGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLH-RHGIIHRDLKPDNMLIS-NEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence            999999999542     35888999999999999999999 89999999999999998 57899999999886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.4e-30  Score=269.57  Aligned_cols=199  Identities=24%  Similarity=0.337  Sum_probs=164.9

Q ss_pred             CeeccccceEEEEEE-EcCCcEEEEEEcccchH-------HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVA-------KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .+||+|||+.||+|. +...++||||+-.....       ...+...+|.++-+.+.||.||++|+||.- +.+..|-|+
T Consensus       469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl-DtdsFCTVL  547 (775)
T KOG1151|consen  469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL-DTDSFCTVL  547 (775)
T ss_pred             HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee-ccccceeee
Confidence            579999999999998 56789999998643211       123456789999999999999999999963 556789999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCcccCCCCCCCeEeeC--CCCCeEEccccccee
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH-FDRAVPHGNLKATNILLDG--PDLNARVADYCLHRL  930 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH-~~~~ivHrDlkp~NILl~~--~~~~~kl~Dfg~a~~  930 (1060)
                      |||+|.+|+-||..     ...+++.+++.|+.||+.||.||. -..+|||-||||.|||+..  ..+.+||+|||+++.
T Consensus       548 EYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  548 EYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             eecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            99999999999954     356899999999999999999999 3468999999999999942  246799999999999


Q ss_pred             eccCCc------eeeeccCccccccchhcccCC--CCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          931 MTQAGT------IEQILDAGVLGYRAPELAASK--KPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       931 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~--~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ++.+..      ..+...+||.+|.+||.+.-.  +...+.|+||||.||++|..+.|+.||..
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH  686 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence            875432      223345899999999998644  44458899999999999999999999964

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=283.80  Aligned_cols=233  Identities=23%  Similarity=0.294  Sum_probs=179.2

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      ...+|.|+|+.|-++.. .+++..+||++.+.    ..+-.+|+.++... .||||+++.+.+  .++.+.|+|||++.+
T Consensus       327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~--~~~~~~~~v~e~l~g  400 (612)
T KOG0603|consen  327 REELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVY--EDGKEIYLVMELLDG  400 (612)
T ss_pred             ccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeeccee--cCCceeeeeehhccc
Confidence            34599999999999984 57899999999765    23445678777666 799999999999  467789999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      +-+.+.+...+     ... .++..|+.+|+.|+.||| ++||||||+||+|||+++..++++|+|||.++.....    
T Consensus       401 ~ell~ri~~~~-----~~~-~e~~~w~~~lv~Av~~LH-~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----  469 (612)
T KOG0603|consen  401 GELLRRIRSKP-----EFC-SEASQWAAELVSAVDYLH-EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----  469 (612)
T ss_pred             cHHHHHHHhcc-----hhH-HHHHHHHHHHHHHHHHHH-hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence            98887774322     233 777889999999999999 8999999999999999535778999999999877655    


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      ....+-|..|.|||+.....+  ++++||||||+++|+|++|+.||..-..+   .    -+...+..+...        
T Consensus       470 ~~tp~~t~~y~APEvl~~~~y--t~acD~WSLGvlLy~ML~G~tp~~~~P~~---~----ei~~~i~~~~~s--------  532 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEY--TEACDWWSLGVLLYEMLTGRTLFAAHPAG---I----EIHTRIQMPKFS--------  532 (612)
T ss_pred             hcccchhhcccChhhhccCCC--CcchhhHHHHHHHHHHHhCCCccccCCch---H----HHHHhhcCCccc--------
Confidence            112256889999999996654  89999999999999999999998753221   1    111122211111        


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                              ........+++.+|++ +|.+||+|.|+..
T Consensus       533 --------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 --------ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                    1223344556668898 8999999999864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=1.9e-29  Score=271.05  Aligned_cols=218  Identities=20%  Similarity=0.225  Sum_probs=168.2

Q ss_pred             ccceEEEEEEE-cCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCChHHHh
Q 001527          787 SSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFL  865 (1060)
Q Consensus       787 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  865 (1060)
                      |.||.||+|+. .+++.||+|+++...     .+.+|...+....||||+++++++.  .....++||||+++|+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV--SEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee--cCCeEEEEEecCCCCCHHHHH
Confidence            88999999995 478999999987642     2334555566667999999999985  467899999999999999998


Q ss_pred             hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeeeccCcc
Q 001527          866 YDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV  945 (1060)
Q Consensus       866 ~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt  945 (1060)
                      ...     ..+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.++++|||.+........    ...++
T Consensus        77 ~~~-----~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~~~----~~~~~  145 (237)
T cd05576          77 SKF-----LNIPEECVKRWAAEMVVALDALH-REGIVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDSCD----GEAVE  145 (237)
T ss_pred             HHh-----cCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEEc-CCCCEEEecccchhccccccc----cCCcC
Confidence            543     34899999999999999999999 99999999999999998 577899999998766543221    12456


Q ss_pred             ccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChh
Q 001527          946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPA 1025 (1060)
Q Consensus       946 ~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1025 (1060)
                      ..|+|||...+..+  +.++||||+||++|||++|+.|++.....        +     ..  ..   ...+ +.     
T Consensus       146 ~~y~aPE~~~~~~~--~~~~DvwslG~il~el~~g~~~~~~~~~~--------~-----~~--~~---~~~~-~~-----  199 (237)
T cd05576         146 NMYCAPEVGGISEE--TEACDWWSLGAILFELLTGKTLVECHPSG--------I-----NT--HT---TLNI-PE-----  199 (237)
T ss_pred             ccccCCcccCCCCC--CchhhHHHHHHHHHHHHHCcchhhcCchh--------c-----cc--cc---ccCC-cc-----
Confidence            78999999876654  77999999999999999999886532110        0     00  00   0000 01     


Q ss_pred             HHHHHHHHHHHHHHhcc-CCCCCCCH
Q 001527         1026 AEKGMKEVLGIALRCIR-SVSERPGI 1050 (1060)
Q Consensus      1026 ~~~~~~~l~~l~~~C~~-~p~~RPs~ 1050 (1060)
                        .....+.+++.+|++ +|++||++
T Consensus       200 --~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         200 --WVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             --cCCHHHHHHHHHHccCCHHHhcCC
Confidence              123456778889998 79999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.3e-29  Score=277.49  Aligned_cols=210  Identities=20%  Similarity=0.262  Sum_probs=173.3

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccchHH---HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAK---QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+-||-|+||+|.+++ .++...||.|.+++...-   +....+.|.+||...+.+-||++|-.|  ++++..|+||||+
T Consensus       634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF--QDkdnLYFVMdYI  711 (1034)
T KOG0608|consen  634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF--QDKDNLYFVMDYI  711 (1034)
T ss_pred             EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe--ccCCceEEEEecc
Confidence            4579999999999998 566788999999765432   345678899999999999999997666  6788999999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeec--c-
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT--Q-  933 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~--~-  933 (1060)
                      +||++-.+|..     .+.+.+.-++.++.++.+|+++.| ..|+|||||||+||||| .++++||+|||+|.-+.  . 
T Consensus       712 PGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVH-kmGFIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  712 PGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVH-KMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             CCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHH-hccceecccCccceEEc-cCCceeeeeccccccceeccc
Confidence            99999998854     356888889999999999999999 99999999999999999 68999999999986321  1 


Q ss_pred             -----CCceee---------------------------------eccCccccccchhcccCCCCCCCCccchHHHHHHHH
Q 001527          934 -----AGTIEQ---------------------------------ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILL  975 (1060)
Q Consensus       934 -----~~~~~~---------------------------------~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~  975 (1060)
                           .+.+..                                 ...+||+.|+|||++....+  +.-+|.||.|||+|
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~--~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY--TQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc--cccchhhHhhHHHH
Confidence                 000000                                 01259999999999988765  88999999999999


Q ss_pred             HHHhCCCCCCCCCCCCCccChHHHHH
Q 001527          976 ELLTGRCAGDVISGEGAGVDLTDWMQ 1001 (1060)
Q Consensus       976 elltG~~p~~~~~~~~~~~~l~~~~~ 1001 (1060)
                      ||+.|+.||......+....+..|..
T Consensus       863 em~~g~~pf~~~tp~~tq~kv~nw~~  888 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQYKVINWRN  888 (1034)
T ss_pred             HHhhCCCCccCCCCCcceeeeeehhh
Confidence            99999999987766666666777754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=4.1e-29  Score=297.63  Aligned_cols=264  Identities=16%  Similarity=0.125  Sum_probs=164.6

Q ss_pred             CCCeeccccceEEEEEEEc-C----CcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEe----CCCCCceE
Q 001527          780 PAEVLGRSSHGTSYRATLE-N----GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYW----GPTQHEKL  850 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~~~~~~~~  850 (1060)
                      ..+.||+|+||.||+|+.. +    +..||+|++......  +....|  .++...+.+++.+...+.    .......+
T Consensus       136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (566)
T PLN03225        136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW  211 (566)
T ss_pred             EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence            3578999999999999965 4    789999988643211  111111  112222233333222211    13556789


Q ss_pred             EEEEecCCCChHHHhhcCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeC
Q 001527          851 ILSDYISPGSLASFLYDRPGR---------------KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG  915 (1060)
Q Consensus       851 lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~  915 (1060)
                      +||||+++++|.+++......               .........+..|+.|++.||+||| +++|+||||||+|||++.
T Consensus       212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH-~~gIiHRDLKP~NILl~~  290 (566)
T PLN03225        212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH-STGIVHRDVKPQNIIFSE  290 (566)
T ss_pred             EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH-HCCEEeCcCCHHHEEEeC
Confidence            999999999999998653200               0011223456689999999999999 999999999999999985


Q ss_pred             CCCCeEEcccccceeeccCCceeeeccCccccccchhcccCCCC--------------------CCCCccchHHHHHHHH
Q 001527          916 PDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP--------------------HPSFKSDVYAFGVILL  975 (1060)
Q Consensus       916 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------~~s~~~DvwSlGvvl~  975 (1060)
                      +++.+||+|||+++..............+++.|+|||.+.....                    .++.++|||||||++|
T Consensus       291 ~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~  370 (566)
T PLN03225        291 GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL  370 (566)
T ss_pred             CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHH
Confidence            46789999999998665433332233468999999997643221                    1234679999999999


Q ss_pred             HHHhCCCCCCCCCC------CCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCC
Q 001527          976 ELLTGRCAGDVISG------EGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP 1048 (1060)
Q Consensus       976 elltG~~p~~~~~~------~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RP 1048 (1060)
                      ||+++..|++....      ...+.+...|.......      ..+.+...+  ...........+++.+|++ +|.+||
T Consensus       371 el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~--~~~d~~~~~~~dLi~~mL~~dP~kR~  442 (566)
T PLN03225        371 QMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGF--EVLDLDGGAGWELLKSMMRFKGRQRI  442 (566)
T ss_pred             HHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhh--hhccccchHHHHHHHHHccCCcccCC
Confidence            99998776542100      00111223332211100      000000000  0000011234478889998 899999


Q ss_pred             CHHHHHHH
Q 001527         1049 GIKTIYED 1056 (1060)
Q Consensus      1049 s~~evl~~ 1056 (1060)
                      |++|+++.
T Consensus       443 ta~e~L~H  450 (566)
T PLN03225        443 SAKAALAH  450 (566)
T ss_pred             CHHHHhCC
Confidence            99999863

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=9.2e-29  Score=286.41  Aligned_cols=205  Identities=18%  Similarity=0.202  Sum_probs=151.3

Q ss_pred             CCCeeccccceEEEEEEE-----------------cCCcEEEEEEcccchHHHHHH--------------HHHHHHHHhc
Q 001527          780 PAEVLGRSSHGTSYRATL-----------------ENGMFLTVKWLREGVAKQRKE--------------FAKEAKKFAN  828 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~~~l~~  828 (1060)
                      ..++||+|+||+||+|..                 .+++.||||+++.......++              ...|+.++.+
T Consensus       149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~  228 (507)
T PLN03224        149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK  228 (507)
T ss_pred             EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence            358999999999999963                 245789999987543322233              3347777777


Q ss_pred             CCCCce-----eeeeeEEeCC------CCCceEEEEEecCCCChHHHhhcCCCC-------------------CCCCCCH
Q 001527          829 IRHPNV-----VGLRGYYWGP------TQHEKLILSDYISPGSLASFLYDRPGR-------------------KGPPLTW  878 (1060)
Q Consensus       829 l~hpnI-----v~l~~~~~~~------~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~  878 (1060)
                      ++|.++     +++++||...      .....++||||+++++|.++++...+.                   ....+++
T Consensus       229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~  308 (507)
T PLN03224        229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI  308 (507)
T ss_pred             hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence            766554     6778877531      235689999999999999999753211                   1123567


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeeeccCccccccchhcccCCC
Q 001527          879 AQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK  958 (1060)
Q Consensus       879 ~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  958 (1060)
                      ..+..++.|++.||.||| ..+|+||||||+||+++ .+..+||+|||+++..............+++.|+|||.+....
T Consensus       309 ~~~~~i~~ql~~aL~~lH-~~~ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~  386 (507)
T PLN03224        309 NVIKGVMRQVLTGLRKLH-RIGIVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQ  386 (507)
T ss_pred             HHHHHHHHHHHHHHHHHH-HCCeecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCC
Confidence            889999999999999999 89999999999999998 5789999999999765433222222224578999999885432


Q ss_pred             C--------------------CCCCccchHHHHHHHHHHHhCCC-CCCC
Q 001527          959 P--------------------HPSFKSDVYAFGVILLELLTGRC-AGDV  986 (1060)
Q Consensus       959 ~--------------------~~s~~~DvwSlGvvl~elltG~~-p~~~  986 (1060)
                      .                    ....+.||||+||++|||++|.. |+..
T Consensus       387 ~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        387 SCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             CCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            1                    11235799999999999999875 6643

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=8.3e-30  Score=247.29  Aligned_cols=191  Identities=18%  Similarity=0.317  Sum_probs=167.4

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+++|+|.|++||.|. ..+.+.++||+++.-   ..+.+.+|+++|+.++ ||||+++++...++......+|+||+.+
T Consensus        43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n  119 (338)
T KOG0668|consen   43 VRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN  119 (338)
T ss_pred             HHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence            4689999999999998 567899999999853   4567889999999997 9999999999988888888999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      .+.....        +.++..+++.++.+++.||.|+| +.||+|||+||.||+||.+....+|+|+|+|.+..+.....
T Consensus       120 ~Dfk~ly--------~tl~d~dIryY~~elLkALdyCH-S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn  190 (338)
T KOG0668|consen  120 TDFKQLY--------PTLTDYDIRYYIYELLKALDYCH-SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  190 (338)
T ss_pred             ccHHHHh--------hhhchhhHHHHHHHHHHHHhHHH-hcCcccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence            8877765        34788889999999999999999 99999999999999999878889999999999887765543


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                        .++.+..|.-||.+...+. ++..-|+|||||++..|+..+.||-.
T Consensus       191 --VRVASRyfKGPELLVdy~~-YDYSLD~WS~GcmlA~miFrkepFFh  235 (338)
T KOG0668|consen  191 --VRVASRYFKGPELLVDYQM-YDYSLDMWSLGCMLASMIFRKEPFFH  235 (338)
T ss_pred             --eeeehhhcCCchheeechh-ccccHHHHHHHHHHHHHHhccCcccC
Confidence              3367788999999987664 47789999999999999999999864

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.1e-30  Score=267.24  Aligned_cols=195  Identities=25%  Similarity=0.338  Sum_probs=164.2

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccchHH---HHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAK---QRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      ..+||+|+||.|.+|..+ +.+.+|||++++...-   +.+--..|-++|.-- +-|.+++++.+|  ++.+..|+||||
T Consensus       354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRLyFVMEy  431 (683)
T KOG0696|consen  354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRLYFVMEY  431 (683)
T ss_pred             EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhheeeEEEE
Confidence            468999999999999855 5788999999876432   233345677777766 678999999888  577889999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      +.||+|--++.+     -+.+.+..+..+|.+||-||-||| ++|||.||||.+|||+|+ ++++||+|||+++.---.+
T Consensus       432 vnGGDLMyhiQQ-----~GkFKEp~AvFYAaEiaigLFFLh-~kgIiYRDLKLDNvmLd~-eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  432 VNGGDLMYHIQQ-----VGKFKEPVAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDS-EGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             ecCchhhhHHHH-----hcccCCchhhhhhHHHHHHhhhhh-cCCeeeeeccccceEecc-CCceEeeecccccccccCC
Confidence            999999888854     345788889999999999999999 999999999999999995 8899999999998644333


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      .... ..+||+.|+|||++..++|  +..+|.|||||++|||+.|++||+..
T Consensus       505 ~TTk-TFCGTPdYiAPEIi~YqPY--gksvDWWa~GVLLyEmlaGQpPFdGe  553 (683)
T KOG0696|consen  505 VTTK-TFCGTPDYIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQPPFDGE  553 (683)
T ss_pred             ccee-eecCCCcccccceEEeccc--ccchhHHHHHHHHHHHHcCCCCCCCC
Confidence            3322 2489999999999998876  77899999999999999999999864

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.4e-30  Score=256.00  Aligned_cols=197  Identities=22%  Similarity=0.303  Sum_probs=159.1

Q ss_pred             CeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeC------CCCCceEEE
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWG------PTQHEKLIL  852 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~~~~~lv  852 (1060)
                      .+||+|.||+||+|+.+ +|+.||+|++--..  ...-....+|+++|..++|+|++.++..|..      ......|+|
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            57999999999999955 57888988653211  1112345689999999999999999988852      123347999


Q ss_pred             EEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeec
Q 001527          853 SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT  932 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~  932 (1060)
                      |++|+. +|...+.+.    ...++..++.+++.++..||.|+| ...|+|||+||.||||+ .++.+||+|||+++.+.
T Consensus       103 f~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iH-r~kilHRDmKaaNvLIt-~dgilklADFGlar~fs  175 (376)
T KOG0669|consen  103 FDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIH-RNKILHRDMKAANVLIT-KDGILKLADFGLARAFS  175 (376)
T ss_pred             HHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHH-HhhHHhhcccHhhEEEc-CCceEEeecccccccee
Confidence            999976 888888543    356999999999999999999999 99999999999999999 58899999999998765


Q ss_pred             cCCce---eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          933 QAGTI---EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       933 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      .....   ..+.++-|.+|++||.+.|... ++++.|||..||++.||+||.+-+..
T Consensus       176 ~~~n~~kprytnrvvTLwYrppEllLG~r~-yg~~iDiWgAgCimaeMwtrspimqg  231 (376)
T KOG0669|consen  176 TSKNVVKPRYTNRVVTLWYRPPELLLGDRE-YGPPIDIWGAGCIMAEMWTRSPIMQG  231 (376)
T ss_pred             cccccCCCCcccceeeeecCCHHHhhcccc-cCCcchhHhHHHHHHHHHccCccccC
Confidence            43321   1223456899999999998774 58899999999999999999877654

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=271.96  Aligned_cols=202  Identities=22%  Similarity=0.282  Sum_probs=173.4

Q ss_pred             CChhhhhccCCCeeccccceEEEEEEEcCC-cEEEEEEcccch---HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCC
Q 001527          771 LTPEELSRAPAEVLGRSSHGTSYRATLENG-MFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ  846 (1060)
Q Consensus       771 ~~~~~l~~~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  846 (1060)
                      +..++++.  ..-+|-|+||.|-++..... ..+|+|++++..   ..+.+.+..|-.+|.+.+.|.||++|..|.  +.
T Consensus       417 v~l~dl~~--iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr--d~  492 (732)
T KOG0614|consen  417 VKLSDLKR--IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR--DS  492 (732)
T ss_pred             cchhhhhh--hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc--cc
Confidence            33444443  34689999999999986643 348999987642   345677889999999999999999999884  56


Q ss_pred             CceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccc
Q 001527          847 HEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYC  926 (1060)
Q Consensus       847 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg  926 (1060)
                      ...|++||-|-||.+...++++     +.++..+...++..+.+|++||| ++|||.|||||+|.++| .++-+||.|||
T Consensus       493 kyvYmLmEaClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH-~k~iIYRDLKPENllLd-~~Gy~KLVDFG  565 (732)
T KOG0614|consen  493 KYVYMLMEACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLH-RKGIIYRDLKPENLLLD-NRGYLKLVDFG  565 (732)
T ss_pred             hhhhhhHHhhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHH-hcCceeccCChhheeec-cCCceEEeehh
Confidence            7889999999999999999654     46899999999999999999999 99999999999999999 58889999999


Q ss_pred             cceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          927 LHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       927 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      +|+.+.......+.  +||+.|.|||++..+..  +.++|.||+|+++||+++|++||...
T Consensus       566 FAKki~~g~KTwTF--cGTpEYVAPEIILnKGH--D~avDyWaLGIli~ELL~G~pPFs~~  622 (732)
T KOG0614|consen  566 FAKKIGSGRKTWTF--CGTPEYVAPEIILNKGH--DRAVDYWALGILIYELLTGSPPFSGV  622 (732)
T ss_pred             hHHHhccCCceeee--cCCcccccchhhhccCc--chhhHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999887766554  89999999999988875  77999999999999999999999764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=286.23  Aligned_cols=244  Identities=22%  Similarity=0.308  Sum_probs=179.1

Q ss_pred             CCCeeccccceE-EEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          780 PAEVLGRSSHGT-SYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       780 ~~~~iG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      ..+++|.|+.|+ ||+|.++ |+.||||++-..   ......+|+..++.- +|||||+++  |.+.+....|++.|.| 
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyy--c~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYY--CSEQDRQFLYIALELC-  585 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEE--eeccCCceEEEEehHh-
Confidence            356789999984 8999985 789999998543   234567899999988 699999995  5557788899999999 


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeC----CCCCeEEcccccceeecc
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG----PDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~----~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ..+|.+++... +...........+.+..|+++||+||| +.+||||||||.||||+.    ...+++|+|||+++.+..
T Consensus       586 ~~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLH-sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  586 ACSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLH-SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             hhhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHH-hcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            56999999763 111111121445788999999999999 899999999999999974    236899999999998876


Q ss_pred             CCce--eeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCCCCccChHHHHHHHHhcCCCC
Q 001527          934 AGTI--EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTG-RCAGDVISGEGAGVDLTDWMQLKVAEGHGS 1010 (1060)
Q Consensus       934 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 1010 (1060)
                      +...  ......||-+|+|||++.....  +.++||||+|||+|+.++| .+||......+.  ++       +... . 
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~--~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NI-------l~~~-~-  730 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLREDRK--TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NI-------LTGN-Y-  730 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhcccc--CcccchhhcCceEEEEecCCccCCCchHHhhh--hh-------hcCc-c-
Confidence            5432  2234579999999999988765  6689999999999999886 999975322211  00       0000 0 


Q ss_pred             cccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1011 DCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1011 ~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      ..+  .+.+.     . ++  .-.+++.+++. +|..||+|.+|+.
T Consensus       731 ~L~--~L~~~-----~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  731 TLV--HLEPL-----P-DC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cee--eeccC-----c-hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            000  01110     0 11  44566778888 7999999999974

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-29  Score=262.32  Aligned_cols=258  Identities=18%  Similarity=0.244  Sum_probs=190.1

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCC-C-C----ceeeeeeEEeCCCCCceEEE
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIR-H-P----NVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-p----nIv~l~~~~~~~~~~~~~lv  852 (1060)
                      ....+|+|.||.|-.+..+ .+..||+|+++.- ....+...-|+++++++. + |    -+|++.+||  +..++.|+|
T Consensus        93 i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--dyrghiCiv  169 (415)
T KOG0671|consen   93 IVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--DYRGHICIV  169 (415)
T ss_pred             hhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--hccCceEEE
Confidence            3568999999999999854 4799999999854 444566778999999993 2 2    378888888  567899999


Q ss_pred             EEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeC-----------------
Q 001527          853 SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG-----------------  915 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~-----------------  915 (1060)
                      +|.+ |-|+.+++...   ...+++..+++.|++|++++++||| +.+++|-||||+|||+..                 
T Consensus       170 fell-G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh-~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r  244 (415)
T KOG0671|consen  170 FELL-GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLH-DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR  244 (415)
T ss_pred             Eecc-ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHH-hcceeecCCChheEEEeccceEEEeccCCccceec
Confidence            9998 67999999653   3467999999999999999999999 999999999999999832                 


Q ss_pred             --CCCCeEEcccccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 001527          916 --PDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAG  993 (1060)
Q Consensus       916 --~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~  993 (1060)
                        +...+|++|||.|.+..+....    .+.|..|+|||++.+-++  +.++||||+||++.|+.||..-|..-..    
T Consensus       245 ~~ks~~I~vIDFGsAtf~~e~hs~----iVsTRHYRAPEViLgLGw--S~pCDvWSiGCIL~ElytG~~LFqtHen----  314 (415)
T KOG0671|consen  245 PLKSTAIKVIDFGSATFDHEHHST----IVSTRHYRAPEVILGLGW--SQPCDVWSIGCILVELYTGETLFQTHEN----  314 (415)
T ss_pred             cCCCcceEEEecCCcceeccCcce----eeeccccCCchheeccCc--CCccCceeeeeEEEEeeccceecccCCc----
Confidence              1346899999999886554422    367899999999999887  8899999999999999999988764221    


Q ss_pred             cChHHHHHHHHhc-----------------CCC-----------CcccccccccccCChhHHHHHHHHHHHHHHhcc-CC
Q 001527          994 VDLTDWMQLKVAE-----------------GHG-----------SDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SV 1044 (1060)
Q Consensus       994 ~~l~~~~~~~~~~-----------------~~~-----------~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p 1044 (1060)
                      .+-...++.....                 ++.           ..++++-............+..++.+++..++. ||
T Consensus       315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            1111122111110                 000           000000000000001123456678999999998 99


Q ss_pred             CCCCCHHHHHH
Q 001527         1045 SERPGIKTIYE 1055 (1060)
Q Consensus      1045 ~~RPs~~evl~ 1055 (1060)
                      .+|+|+.|.++
T Consensus       395 ~~RiTl~EAL~  405 (415)
T KOG0671|consen  395 ARRITLREALS  405 (415)
T ss_pred             cccccHHHHhc
Confidence            99999999875

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.95  E-value=1.2e-27  Score=257.79  Aligned_cols=237  Identities=26%  Similarity=0.364  Sum_probs=186.0

Q ss_pred             cceEEEEEEEc-CCcEEEEEEcccchHHH-HHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCChHHHh
Q 001527          788 SHGTSYRATLE-NGMFLTVKWLREGVAKQ-RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFL  865 (1060)
Q Consensus       788 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  865 (1060)
                      +||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+||+++++++.  .....++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE--DEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee--eCCEEEEEEeCCCCCCHHHHH
Confidence            58999999976 58999999997654433 678999999999999999999999985  456889999999999999998


Q ss_pred             hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeeeccCcc
Q 001527          866 YDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV  945 (1060)
Q Consensus       866 ~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt  945 (1060)
                      ....     .+++.++..++.+++.|+.||| ..+++|+||+|+||+++ +++.++++|||.+........  .....++
T Consensus        79 ~~~~-----~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  149 (244)
T smart00220       79 KKRG-----RLSEDEARFYARQILSALEYLH-SNGIIHRDLKPENILLD-EDGHVKLADFGLARQLDPGGL--LTTFVGT  149 (244)
T ss_pred             Hhcc-----CCCHHHHHHHHHHHHHHHHHHH-HcCeecCCcCHHHeEEC-CCCcEEEccccceeeeccccc--cccccCC
Confidence            5432     2889999999999999999999 89999999999999998 578999999999987665431  1223678


Q ss_pred             ccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChh
Q 001527          946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPA 1025 (1060)
Q Consensus       946 ~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 1025 (1060)
                      ..|+|||...+...  +.++||||+|++++++++|+.||+...      +....... ........    .       +.
T Consensus       150 ~~~~~pE~~~~~~~--~~~~Di~slG~~l~~l~~~~~p~~~~~------~~~~~~~~-~~~~~~~~----~-------~~  209 (244)
T smart00220      150 PEYMAPEVLLGKGY--GKAVDVWSLGVILYELLTGKPPFPGDD------QLLELFKK-IGKPKPPF----P-------PP  209 (244)
T ss_pred             cCCCCHHHHccCCC--CchhhHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHH-HhccCCCC----c-------cc
Confidence            89999999986654  679999999999999999999986421      11122211 11111100    0       00


Q ss_pred             HHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1026 AEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1026 ~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .......+.+++.+|+. +|.+||++.++++
T Consensus       210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            00034567889999998 7999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-26  Score=249.32  Aligned_cols=131  Identities=22%  Similarity=0.291  Sum_probs=111.6

Q ss_pred             ccCCCeeccccceEEEEEE-EcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCC-----C---CceeeeeeEEe--CCCC
Q 001527          778 RAPAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR-----H---PNVVGLRGYYW--GPTQ  846 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~l~~~~~--~~~~  846 (1060)
                      |...++||-|.|++||+|. .++.+.||+|+.+.. ....+....||++|++++     |   .+||+++++|.  ++.+
T Consensus        80 Y~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG  158 (590)
T KOG1290|consen   80 YHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG  158 (590)
T ss_pred             EEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC
Confidence            4456899999999999998 457899999999864 344566778999999984     2   47999999996  5677


Q ss_pred             CceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEe
Q 001527          847 HEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILL  913 (1060)
Q Consensus       847 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl  913 (1060)
                      .++|+|+|++ |.+|..+|....   .+-++...+.+|++||+.||.|||...||||-||||+|||+
T Consensus       159 ~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  159 QHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             cEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            8999999999 779999986532   34588999999999999999999988999999999999998

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-27  Score=260.78  Aligned_cols=194  Identities=18%  Similarity=0.251  Sum_probs=163.4

Q ss_pred             cCCCeeccccceEEEEEEEc-CCcEEEEEEcccchHHH--------HHHHHHHHHHHhcCC---CCceeeeeeEEeCCCC
Q 001527          779 APAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQ--------RKEFAKEAKKFANIR---HPNVVGLRGYYWGPTQ  846 (1060)
Q Consensus       779 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~  846 (1060)
                      .+-+.+|.|+||.|+.|.++ +...|++|.+.+...-.        .-..-.|+++|..++   |+||++++++|  ++.
T Consensus       564 ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF--Edd  641 (772)
T KOG1152|consen  564 TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF--EDD  641 (772)
T ss_pred             eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee--ecC
Confidence            34578999999999999965 57789999887543211        112457999999997   99999999999  467


Q ss_pred             CceEEEEEec-CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccc
Q 001527          847 HEKLILSDYI-SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY  925 (1060)
Q Consensus       847 ~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Df  925 (1060)
                      +.+|++||-. ++.+|++++.-     .+.+++.++..|++||+.|++||| +.||||||||-+||.+++ ++.+||+||
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh-~~~ivhrdikdenvivd~-~g~~klidf  714 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLH-DQGIVHRDIKDENVIVDS-NGFVKLIDF  714 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhcccccc-ccCceecccccccEEEec-CCeEEEeec
Confidence            7899999976 46699999943     356999999999999999999999 999999999999999995 788999999


Q ss_pred             ccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001527          926 CLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGD  985 (1060)
Q Consensus       926 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~  985 (1060)
                      |.+.....+....   .+||..|.|||++.|.+| ....-|||++|+++|.++....||.
T Consensus       715 gsaa~~ksgpfd~---f~gtv~~aapevl~g~~y-~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSGPFDV---FVGTVDYAAPEVLGGEKY-LGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCCCcce---eeeeccccchhhhCCCcc-CCCcchhhhhhheeeEEEeccCCCc
Confidence            9998766554332   379999999999999886 4778899999999999999888874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1e-28  Score=245.18  Aligned_cols=197  Identities=22%  Similarity=0.338  Sum_probs=163.5

Q ss_pred             CCeeccccceEEEEEEE-cCCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCC---CceEEEEE
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ---HEKLILSD  854 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~---~~~~lv~e  854 (1060)
                      .+-||-|+||.||.++. ++|+.||.|++....  -...+.+.+|++++..++|.|++..++...-+..   .+.|+++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            56799999999999984 589999999986432  2345788899999999999999999887642222   24678889


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      .| ..+|.+.+-     ...+++...+.-+.+||++||.||| +.+|.||||||.|.|++ .+...||||||+++..+.+
T Consensus       138 Lm-QSDLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLH-sA~ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  138 LM-QSDLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLH-TANILHRDIKPGNLLVN-SNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HH-Hhhhhheec-----cCCCCCcchhhhhHHHHHhhhHHHh-hcchhhccCCCccEEec-cCceEEecccccccccchh
Confidence            88 458888773     3457888899999999999999999 99999999999999999 5889999999999987665


Q ss_pred             CceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      .....+..+-|..|+|||+++|.. .|+.+.||||.||++.|++..+.-|..
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaR-hYs~AvDiWSVGCIFaELLgRrILFQA  260 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGAR-RYTGAVDIWSVGCIFAELLQRKILFQA  260 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcch-hhcCccceehhhHHHHHHHhhhhhhhc
Confidence            544444445688999999999877 468899999999999999998887764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.93  E-value=3.9e-25  Score=232.39  Aligned_cols=212  Identities=31%  Similarity=0.490  Sum_probs=176.2

Q ss_pred             eccccceEEEEEEEcC-CcEEEEEEcccchHH-HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCCh
Q 001527          784 LGRSSHGTSYRATLEN-GMFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL  861 (1060)
Q Consensus       784 iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gsL  861 (1060)
                      ||+|++|.||+++..+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++.  .....++++||+++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE--DENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee--cCCeEEEEEecCCCCcH
Confidence            6899999999999754 899999999765332 3567899999999999999999999985  44688999999999999


Q ss_pred             HHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeeec
Q 001527          862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL  941 (1060)
Q Consensus       862 ~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  941 (1060)
                      .+++....    ..+++..+..++.+++++++||| ..+++|+||+|.||+++..+..++|+|||.+........ ....
T Consensus        79 ~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh-~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~  152 (215)
T cd00180          79 KDLLKENE----GKLSEDEILRILLQILEGLEYLH-SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT  152 (215)
T ss_pred             HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence            99996432    35889999999999999999999 889999999999999983267899999999987654431 1112


Q ss_pred             cCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccccccc
Q 001527          942 DAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEM 1021 (1060)
Q Consensus       942 ~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 1021 (1060)
                      ..+...|++||...... .++.++|+|++|++++++                                            
T Consensus       153 ~~~~~~~~~pe~~~~~~-~~~~~~D~~~lg~~~~~l--------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKG-YYSEKSDIWSLGVILYEL--------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccC-CCCchhhhHHHHHHHHHH--------------------------------------------
Confidence            35778899999987751 237799999999999999                                            


Q ss_pred             CChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHh
Q 001527         1022 VNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDL 1057 (1060)
Q Consensus      1022 ~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L 1057 (1060)
                               ..+.+++..|++ +|.+||++.++++.+
T Consensus       188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                     345667889997 799999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=6e-28  Score=252.55  Aligned_cols=396  Identities=26%  Similarity=0.280  Sum_probs=267.2

Q ss_pred             CCcEEECcCCcccccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccc-cccCcccCCcccCCCcccEEEc
Q 001527           95 MLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAG-NNFSGLIPDSVSGLVSIQSLDL  173 (1060)
Q Consensus        95 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L  173 (1060)
                      .-.+++|..|+|+.+.|++|+.+++|++||||+|+|+.+-|.+|.+|.+|..|-+.+ |+|+.+..+.|++|.+|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            347899999999999999999999999999999999999999999999998888877 9999888889999999999999


Q ss_pred             cCCCCCCCCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCc------------CCccCchhhhccCCCC
Q 001527          174 SHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNK------------LDGHLDGEFFLLTNAS  241 (1060)
Q Consensus       174 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~------------l~~~~~~~~~~l~~L~  241 (1060)
                      .-|++.-.....|..|++|..|.|-.|.+..+...+|..+..++.+.+..|.            +....|-.++...-..
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~  227 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS  227 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence            9999998888999999999999999999975555699999999999999998            3334445555555555


Q ss_pred             eecccCCccccCCCcCcCCCccccccEE--EccCCcccccCCCCccccCCCCCCEEEccCCccccCCC-CccCCCCccEE
Q 001527          242 HIDFSGNMFVGSSSQKFLPGLSQSVQYL--NLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVL  318 (1060)
Q Consensus       242 ~L~ls~N~l~~~~~~~~l~~~~~~L~~L--~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L  318 (1060)
                      -..+.++++..+...+|...    ++.+  .++.+.....+-+...|..+++|+.|+|++|+|+++.+ +|....+++.|
T Consensus       228 p~rl~~~Ri~q~~a~kf~c~----~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL  303 (498)
T KOG4237|consen  228 PYRLYYKRINQEDARKFLCS----LESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQEL  303 (498)
T ss_pred             hHHHHHHHhcccchhhhhhh----HHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhh
Confidence            55566666655555555332    1211  22222222222333568889999999999999998877 78899999999


Q ss_pred             EccCCcCcccCCcchhccCCCCCCeEECCCCccccccCcccc--cCCcEEEccCCcCcccCCCCCCCCCEE----EccCC
Q 001527          319 KLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPLLTGSCAVL----DLSNN  392 (1060)
Q Consensus       319 ~Ls~N~l~~~~p~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~--~~L~~L~Ls~N~l~~~~p~~~~~l~~L----~Ls~N  392 (1060)
                      .|..|+|. .+.+.+|.+... |+.|+|++|+|+...|..|-  ..|.+|+|-.|.+--       +|...    -|..+
T Consensus       304 ~L~~N~l~-~v~~~~f~~ls~-L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C-------nC~l~wl~~Wlr~~  374 (498)
T KOG4237|consen  304 YLTRNKLE-FVSSGMFQGLSG-LKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC-------NCRLAWLGEWLRKK  374 (498)
T ss_pred             hcCcchHH-HHHHHhhhcccc-ceeeeecCCeeEEEecccccccceeeeeehccCcccC-------ccchHHHHHHHhhC
Confidence            99999997 445556666665 88999999999887776665  578888888886531       11000    01111


Q ss_pred             ccccccccccCCCccCEEEcccCeecc---cCCCCCc---------ccCCCCe-EEccCCcCccccchhccccCCCcEEe
Q 001527          393 QFEGNLSRILKWGNIEYLDLSRNHLTG---SIPEETP---------QFLRLNH-LNLSHNSLSSSLPKVIIQYQKLRVLD  459 (1060)
Q Consensus       393 ~l~~~~~~~~~~~~L~~L~Ls~N~l~~---~~p~~~~---------~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~  459 (1060)
                      .-.|. |.-..-..++.++++++.+..   ..|++.+         .++-+.. ..-|++.+. .+|..+.  ..-..|+
T Consensus       375 ~~~~~-~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~tely  450 (498)
T KOG4237|consen  375 SVVGN-PRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELY  450 (498)
T ss_pred             CCCCC-CCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHh
Confidence            11111 111111223333333332221   1111111         1112222 223333333 3443322  1344566


Q ss_pred             cCCccccCccccccccCCCcceEEccCccccccCCCCCCCCCCCcEEEccCC
Q 001527          460 LSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHN  511 (1060)
Q Consensus       460 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  511 (1060)
                      +.+|.++. +|..  .+.+| .+++++|+++......|.++++|.+|-||.|
T Consensus       451 l~gn~~~~-vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  451 LDGNAITS-VPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             cccchhcc-cCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            66666653 4444  44555 6677777776666666777777777777765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=5.7e-27  Score=259.81  Aligned_cols=248  Identities=21%  Similarity=0.288  Sum_probs=191.6

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      ...+|.|.||.||+|+ .+.++..|+|+++-....+.+-.++|+-+++..+|||||.++|.|.  ..+..|++||||.+|
T Consensus        20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl--r~dklwicMEycggg   97 (829)
T KOG0576|consen   20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL--RRDKLWICMEYCGGG   97 (829)
T ss_pred             eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh--hhcCcEEEEEecCCC
Confidence            3579999999999999 5579999999999776667778889999999999999999999984  566789999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~  939 (1060)
                      +|.+.-+-     ..++++.++..+++...+|++||| +.|-+|||||-.||+++ +.+.+|++|||.+..+...-... 
T Consensus        98 slQdiy~~-----TgplselqiayvcRetl~gl~ylh-s~gk~hRdiKGanillt-d~gDvklaDfgvsaqitati~Kr-  169 (829)
T KOG0576|consen   98 SLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLH-SQGKIHRDIKGANILLT-DEGDVKLADFGVSAQITATIAKR-  169 (829)
T ss_pred             cccceeee-----cccchhHHHHHHHhhhhccchhhh-cCCcccccccccceeec-ccCceeecccCchhhhhhhhhhh-
Confidence            99987643     357999999999999999999999 99988999999999998 68899999999987655432222 


Q ss_pred             eccCccccccchhccc-CCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          940 ILDAGVLGYRAPELAA-SKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~-~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      ....||+.|||||+.. +....|..++|||+.|+...|+-.-++|.....+      +.  +...    .....++|.-.
T Consensus       170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr--~l~L----mTkS~~qpp~l  237 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MR--ALFL----MTKSGFQPPTL  237 (829)
T ss_pred             hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HH--HHHH----hhccCCCCCcc
Confidence            2247999999999974 3334458899999999999999887777332110      00  0111    11223343322


Q ss_pred             cccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .+.     ......+.+++..|+. .|.+||+++.++.
T Consensus       238 kDk-----~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 KDK-----TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cCC-----ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            221     1344567778888886 6999999987764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=7e-26  Score=225.66  Aligned_cols=194  Identities=21%  Similarity=0.309  Sum_probs=156.7

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEecC
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~~  857 (1060)
                      ..+.+|+|.||.+-+++++ ..+.+++|.+... ....++|.+|...--.+ .|.||+.-|+... ++.+.+++++||++
T Consensus        28 I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~qE~aP  105 (378)
T KOG1345|consen   28 INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFVQEFAP  105 (378)
T ss_pred             HHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEeeccCc
Confidence            3578999999999999976 5788999988754 34567899998876666 5899999887654 45667889999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEe-eCCCCCeEEcccccceeeccCCc
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILL-DGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl-~~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      .|+|.+-+...      .+.+....+++.|+++|+.|+| +..+||||||.+|||| +.+..++|+||||..+..+..-.
T Consensus       106 ~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMH-sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~  178 (378)
T KOG1345|consen  106 RGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMH-SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK  178 (378)
T ss_pred             cchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhh-ccchhhcccccceEEEecCCccEEEeeecccccccCceeh
Confidence            99999988542      3778888999999999999999 9999999999999998 44557899999999876443221


Q ss_pred             eeeeccCccccccchhcccC---CCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          937 IEQILDAGVLGYRAPELAAS---KKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~---~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      .    ...+..|.|||....   ..+...+.+|||.||++++.++||..||..
T Consensus       179 ~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk  227 (378)
T KOG1345|consen  179 Y----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK  227 (378)
T ss_pred             h----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence            1    134567999998753   333446678999999999999999999984

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=7.1e-25  Score=233.38  Aligned_cols=197  Identities=28%  Similarity=0.391  Sum_probs=164.8

Q ss_pred             CCeeccccceEEEEEEEcC-CcEEEEEEcccchHH-HHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRATLEN-GMFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++.  .....++++||+++
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~e~~~~   81 (225)
T smart00221        4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE--DPEPLYLVMEYCEG   81 (225)
T ss_pred             eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee--cCCceEEEEeccCC
Confidence            4679999999999999764 899999999865444 5678999999999999999999999985  45678999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      ++|.+++....    ..+++..+..++.+++.++.||| ..+++|+|++|+||+++ ++..++|+|||.+..........
T Consensus        82 ~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       82 GDLFDYLRKKG----GKLSEEEARFYLRQILEALEYLH-SLGIVHRDLKPENILLG-MDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEc-CCCCEEEeeCceeeEecCccccc
Confidence            99999996532    11789999999999999999999 88999999999999998 47899999999998776543111


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      .....++..|++||... ....++.++|||+||++++||++|+.||+.
T Consensus       156 ~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            12235778899999984 222346699999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=9.5e-26  Score=242.74  Aligned_cols=196  Identities=18%  Similarity=0.186  Sum_probs=161.9

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCC------CCceeeeeeEEeCCCCCceEEE
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIR------HPNVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~l~~~~~~~~~~~~~lv  852 (1060)
                      .....|+|-|++|.+|... -|+.||||+++.... -.+.=.+|+++|++|.      --|+++++..|.  ..++.|+|
T Consensus       436 V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~--hknHLClV  512 (752)
T KOG0670|consen  436 VQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK--HKNHLCLV  512 (752)
T ss_pred             EEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh--hcceeEEE
Confidence            3456799999999999855 488999999987633 2345568999999995      357888888774  67899999


Q ss_pred             EEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeec
Q 001527          853 SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT  932 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~  932 (1060)
                      +|-+ .-+|.++|....  ....|....+..++.|+.-||.+|. .+||+|.||||+|||++.....+||||||.|....
T Consensus       513 FE~L-slNLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK-~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~  588 (752)
T KOG0670|consen  513 FEPL-SLNLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLK-KCGVLHADIKPDNILVNESKNILKLCDFGSASFAS  588 (752)
T ss_pred             ehhh-hchHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHH-hcCeeecccCccceEeccCcceeeeccCccccccc
Confidence            9988 458999996653  2345788899999999999999999 99999999999999998767789999999998876


Q ss_pred             cCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          933 QAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                      .......   .-+..|.|||++.|..|  +...|+||.||++||+.||+..|...
T Consensus       589 eneitPY---LVSRFYRaPEIiLG~~y--d~~iD~WSvgctLYElYtGkIlFpG~  638 (752)
T KOG0670|consen  589 ENEITPY---LVSRFYRAPEIILGLPY--DYPIDTWSVGCTLYELYTGKILFPGR  638 (752)
T ss_pred             cccccHH---HHHHhccCcceeecCcc--cCCccceeeceeeEEeeccceecCCC
Confidence            6543322   24568999999999987  55899999999999999999888653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=1.7e-25  Score=228.93  Aligned_cols=193  Identities=20%  Similarity=0.246  Sum_probs=154.5

Q ss_pred             cCCCeeccccceEEEEEEEc-CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCC----CCCceEE
Q 001527          779 APAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGP----TQHEKLI  851 (1060)
Q Consensus       779 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----~~~~~~l  851 (1060)
                      .....+|.|.- .|..|... .++.||+|++....  ....++..+|...+..+.|+||++++.+|.-.    ...+.|+
T Consensus        20 ~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~   98 (369)
T KOG0665|consen   20 VNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYL   98 (369)
T ss_pred             eeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHH
Confidence            33456788877 55555432 58899999875331  22346677899999999999999999988521    1235799


Q ss_pred             EEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceee
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~  931 (1060)
                      ||||| ..+|.+.++.       .++-.+...|.+|+++|++||| +.||+||||||+||++. .+..+||.|||+|+..
T Consensus        99 v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lh-s~~IihRdLkPsnivv~-~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   99 VMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLH-SAGIIHRDLKPSNIVVN-SDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHH-hcceeecccCcccceec-chhheeeccchhhccc
Confidence            99999 5699998862       3677889999999999999999 99999999999999998 5889999999999875


Q ss_pred             ccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          932 TQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ...  ...+....|..|.|||++.+.++  .+.+||||.||++.||++|+.-|..
T Consensus       169 ~~~--~~mtpyVvtRyyrapevil~~~~--ke~vdiwSvGci~gEli~~~Vlf~g  219 (369)
T KOG0665|consen  169 DTD--FMMTPYVVTRYYRAPEVILGMGY--KENVDIWSVGCIMGELILGTVLFPG  219 (369)
T ss_pred             Ccc--cccCchhheeeccCchheeccCC--cccchhhhhhhHHHHHhhceEEecC
Confidence            544  22233467889999999998875  7799999999999999999987763

>PLN03210 Resistant to P

Probab=99.91  E-value=3e-23  Score=268.43  Aligned_cols=127  Identities=21%  Similarity=0.237  Sum_probs=90.2

Q ss_pred             cCCCCeEEccCCcCccccchhccccCCCcEEecCCccccCccccccccCCCcceEEccCccccccCCCCCCCCCCCcEEE
Q 001527          428 FLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLD  507 (1060)
Q Consensus       428 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  507 (1060)
                      .++|+.|+|++|...+.+|..+.++++|+.|++++|..-+.+|..+ ++++|+.|+|++|..-..+|..   .++|+.|+
T Consensus       777 ~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~  852 (1153)
T PLN03210        777 SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLN  852 (1153)
T ss_pred             cccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeE
Confidence            3456666666666555666666667777777776654434455544 5677777777776544444432   35788889


Q ss_pred             ccCCccccccCccccCCCCCcEEECCC-CccccccCccccCCCCCCeEeccCCc
Q 001527          508 LSHNRLNGYFPDRLGSLTGLKVLCLAG-NNISGSLPTSMANMTSLSSLVISQNH  560 (1060)
Q Consensus       508 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L~~L~ls~N~  560 (1060)
                      |++|.++ .+|.+++.+++|+.|+|++ |+|. .+|..+..+++|+.|+++++.
T Consensus       853 Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        853 LSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            9998887 5788888899999999988 5555 588888888999999988874

syringae 6; Provisional

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=1.1e-24  Score=231.83  Aligned_cols=195  Identities=21%  Similarity=0.307  Sum_probs=161.9

Q ss_pred             CCCeeccccceEEEEEEEc----CCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEE
Q 001527          780 PAEVLGRSSHGTSYRATLE----NGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      ..++||+|.|++||+|...    ..+.||+|.+....  ....+.+|+++|..+ -+.||+++.+++  ...+...+|+|
T Consensus        40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~--rnnd~v~ivlp  115 (418)
T KOG1167|consen   40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCF--RNNDQVAIVLP  115 (418)
T ss_pred             hhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhh--ccCCeeEEEec
Confidence            4689999999999999843    47899999987543  235688999999999 589999999988  46778999999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      |++.....++...        ++..++..+++.+..||+|+| ..|||||||||+|+|.+.....-.|.|||+|......
T Consensus       116 ~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h-~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  116 YFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLH-KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             ccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhh-ccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            9999999998843        778899999999999999999 9999999999999999877778899999998721100


Q ss_pred             ------------------C----------------c---------eeeeccCccccccchhcccCCCCCCCCccchHHHH
Q 001527          935 ------------------G----------------T---------IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFG  971 (1060)
Q Consensus       935 ------------------~----------------~---------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlG  971 (1060)
                                        +                .         .....++||++|+|||++...+. .+.++||||.|
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~-QttaiDiws~G  265 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR-QTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC-cCCccceeecc
Confidence                              0                0         00112469999999999988764 37899999999


Q ss_pred             HHHHHHHhCCCCCCCCC
Q 001527          972 VILLELLTGRCAGDVIS  988 (1060)
Q Consensus       972 vvl~elltG~~p~~~~~  988 (1060)
                      |+++-++++++||-...
T Consensus       266 VI~Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAK  282 (418)
T ss_pred             ceeehhhccccccccCc
Confidence            99999999999986543

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.90  E-value=4.4e-26  Score=238.66  Aligned_cols=288  Identities=24%  Similarity=0.229  Sum_probs=198.0

Q ss_pred             CCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEEEccC-CCCCCCCCccccCCCCccEEEe
Q 001527          119 SLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSH-NSFSGSLPPALTRLNNLVYLNL  197 (1060)
Q Consensus       119 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L  197 (1060)
                      .-++++|..|+|+.+.|.+|+.+++|+.||||+|+|+.+-|++|.+|.+|..|-+.+ |+|+......|++|..|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            457899999999988899999999999999999999999999999999998877766 9999877788999999999999


Q ss_pred             ecCcccccCCcccccCCCCCEEEccCCcCCccCchhhhccCCCCeecccCCccccCCCcCcCCCccccccEEEccCCccc
Q 001527          198 SSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLT  277 (1060)
Q Consensus       198 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~l~~~~~~L~~L~Ls~N~l~  277 (1060)
                      .-|++.-+..++|..+++|..|.|.+|.+..+....|..+.+++.+.+..|.+.......|+...        +..|.  
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~--------~a~~~--  217 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADD--------LAMNP--  217 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhH--------Hhhch--
Confidence            99999988899999999999999999999988888999999999999999998877766554321        11111  


Q ss_pred             ccCCCCccccCCCCCCEEEccCCccccCCC-CccCC-CCccEEEccCCcCcccCCcchhccCCCCCCeEECCCCcccccc
Q 001527          278 GSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFV-YELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSV  355 (1060)
Q Consensus       278 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L~Ls~N~l~~~~  355 (1060)
                            .+++.+....-..|.++++..+.+ .|... ..+..=..+.....+.-|...|..                   
T Consensus       218 ------ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~-------------------  272 (498)
T KOG4237|consen  218 ------IETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKK-------------------  272 (498)
T ss_pred             ------hhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhh-------------------
Confidence                  223333333334444444442222 11110 011000011111111222211111                   


Q ss_pred             CcccccCCcEEEccCCcCcccCCCCCCCCCEEEccCCccccccccccCCCccCEEEcccCeecccCCCCCcccCCCCeEE
Q 001527          356 SMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLN  435 (1060)
Q Consensus       356 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  435 (1060)
                          .++|+.|+|++|+|++.-+.++                    -+...++.|.|..|+|...-...|.++..|+.|+
T Consensus       273 ----L~~L~~lnlsnN~i~~i~~~aF--------------------e~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~  328 (498)
T KOG4237|consen  273 ----LPNLRKLNLSNNKITRIEDGAF--------------------EGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLS  328 (498)
T ss_pred             ----cccceEeccCCCccchhhhhhh--------------------cchhhhhhhhcCcchHHHHHHHhhhccccceeee
Confidence                1345555555555543322221                    1235666777777777655555667777777777


Q ss_pred             ccCCcCccccchhccccCCCcEEecCCccc
Q 001527          436 LSHNSLSSSLPKVIIQYQKLRVLDLSFNHL  465 (1060)
Q Consensus       436 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  465 (1060)
                      |.+|+|+..-|..|..+.+|.+|+|-.|.+
T Consensus       329 L~~N~it~~~~~aF~~~~~l~~l~l~~Np~  358 (498)
T KOG4237|consen  329 LYDNQITTVAPGAFQTLFSLSTLNLLSNPF  358 (498)
T ss_pred             ecCCeeEEEecccccccceeeeeehccCcc
Confidence            777777777777777777777777777765

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=2.7e-23  Score=248.54  Aligned_cols=66  Identities=29%  Similarity=0.343  Sum_probs=48.6

Q ss_pred             CccCEEEcccCeecccCCCCCcccCCCCeEEccCCcCccccchhccccCCCcEEecCCccccCcccccccc
Q 001527          405 GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLN  475 (1060)
Q Consensus       405 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  475 (1060)
                      ++|+.|++++|+|+ .+|...   .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..+..+..
T Consensus       402 s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~  467 (788)
T PRK15387        402 SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE  467 (788)
T ss_pred             cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence            45667777777776 356432   35777888888887 67888888888888888888888877766543

>PLN03210 Resistant to P

Probab=99.90  E-value=2.2e-22  Score=260.37  Aligned_cols=126  Identities=22%  Similarity=0.252  Sum_probs=99.7

Q ss_pred             CccCEEEcccCeecccCCCCCcccCCCCeEEccCCcCccccchhccccCCCcEEecCCccccCccccccccCCCcceEEc
Q 001527          405 GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHL  484 (1060)
Q Consensus       405 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  484 (1060)
                      ++|+.|+|++|...+.+|..+.++++|+.|+|++|..-+.+|..+ ++++|+.|++++|..-..+|..   ..+|+.|+|
T Consensus       778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L  853 (1153)
T PLN03210        778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL  853 (1153)
T ss_pred             ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence            567788888887777788888888889999988876545677665 6888999999887654445543   357889999


Q ss_pred             cCccccccCCCCCCCCCCCcEEEccC-CccccccCccccCCCCCcEEECCCCc
Q 001527          485 ADNLLTGVLDFSPPSVSNLQVLDLSH-NRLNGYFPDRLGSLTGLKVLCLAGNN  536 (1060)
Q Consensus       485 ~~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~  536 (1060)
                      ++|.++ .+|..+..+++|+.|+|++ |+|+ .+|..+..+++|+.|++++|.
T Consensus       854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            999988 4677888899999999988 5665 588888899999999988774

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=4.7e-23  Score=246.47  Aligned_cols=123  Identities=28%  Similarity=0.264  Sum_probs=88.8

Q ss_pred             CCcEEEccCCcCcccCCCCCCCCCEEEccCCccccccccccCCCccCEEEcccCeecccCCCCCcccCCCCeEEccCCcC
Q 001527          362 NLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSL  441 (1060)
Q Consensus       362 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  441 (1060)
                      +|+.|+|++|+|++ +|....+++.|++++|+++..+ ..  ..+|+.|++++|+|+ .+|..   ..+|+.|++++|+|
T Consensus       343 ~Lq~LdLS~N~Ls~-LP~lp~~L~~L~Ls~N~L~~LP-~l--~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~L  414 (788)
T PRK15387        343 GLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLP-AL--PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRL  414 (788)
T ss_pred             ccceEecCCCccCC-CCCCCcccceehhhccccccCc-cc--ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcC
Confidence            44555555555543 3333445555566666665432 22  257889999999998 46654   35799999999999


Q ss_pred             ccccchhccccCCCcEEecCCccccCccccccccCCCcceEEccCccccccCCCCC
Q 001527          442 SSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSP  497 (1060)
Q Consensus       442 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  497 (1060)
                      ++ +|...   .+|+.|++++|+|+ .+|..+.++++|+.|+|++|.|++..+..+
T Consensus       415 ss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        415 TS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             CC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence            95 67543   46889999999998 589999999999999999999998766554

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.89  E-value=1.5e-23  Score=263.51  Aligned_cols=198  Identities=16%  Similarity=0.186  Sum_probs=136.1

Q ss_pred             cCCC-CceeeeeeEEeC-----CCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCc
Q 001527          828 NIRH-PNVVGLRGYYWG-----PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV  901 (1060)
Q Consensus       828 ~l~h-pnIv~l~~~~~~-----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~i  901 (1060)
                      .++| +||++++++|..     ......+.++||+ +++|.+++...    ...+++.+++.|+.||++||+||| ++||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH-~~gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAH-SQGI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHH-hCCe
Confidence            3455 578888887621     1123456778887 66999999642    245899999999999999999999 9999


Q ss_pred             ccCCCCCCCeEeeC------------------CCCCeEEcccccceeeccCC---------------ceeeeccCccccc
Q 001527          902 PHGNLKATNILLDG------------------PDLNARVADYCLHRLMTQAG---------------TIEQILDAGVLGY  948 (1060)
Q Consensus       902 vHrDlkp~NILl~~------------------~~~~~kl~Dfg~a~~~~~~~---------------~~~~~~~~gt~~y  948 (1060)
                      +||||||+||||+.                  .+..+|++|||+++......               ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999952                  24567777888776432100               0001113578899


Q ss_pred             cchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHH
Q 001527          949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEK 1028 (1060)
Q Consensus       949 ~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 1028 (1060)
                      ||||++.+..+  +.++|||||||++|||++|..|+...         ...+..... .    ...+.         ...
T Consensus       182 ~APE~~~~~~~--~~~sDVwSlGviL~ELl~~~~~~~~~---------~~~~~~~~~-~----~~~~~---------~~~  236 (793)
T PLN00181        182 TSPEEDNGSSS--NCASDVYRLGVLLFELFCPVSSREEK---------SRTMSSLRH-R----VLPPQ---------ILL  236 (793)
T ss_pred             EChhhhccCCC--CchhhhhhHHHHHHHHhhCCCchhhH---------HHHHHHHHH-h----hcChh---------hhh
Confidence            99999988765  78999999999999999998886421         011111110 0    01110         011


Q ss_pred             HHHHHHHHHHHhcc-CCCCCCCHHHHHHH
Q 001527         1029 GMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1029 ~~~~l~~l~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .......++.+|++ +|.+||+|.||++.
T Consensus       237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        237 NWPKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             cCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence            12334577788998 79999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=3.2e-22  Score=204.28  Aligned_cols=164  Identities=21%  Similarity=0.199  Sum_probs=119.9

Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      |+|.+++..+    +..+++.+++.|+.||+.||+||| +.+      ||+||+++ +++.+|+  ||.++......   
T Consensus         1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH-~~~------kp~Nil~~-~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELH-RQA------KSGNILLT-WDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-hcC------CcccEeEc-Cccceee--ccceEeecccc---
Confidence            6899999643    245999999999999999999999 655      99999998 5788998  99998765432   


Q ss_pred             eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                         ..||+.|+|||++.+..+  +.++|||||||++|||+||+.||.....      ...............   ++...
T Consensus        64 ---~~g~~~y~aPE~~~~~~~--~~~~DiwSlG~il~elltg~~p~~~~~~------~~~~~~~~~~~~~~~---~~~~~  129 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSY--TEKADIYSLGITLYEALDYELPYNEERE------LSAILEILLNGMPAD---DPRDR  129 (176)
T ss_pred             ---CCCcccccChHHhcCCCC--cchhhHHHHHHHHHHHHhCCCCccccch------hcHHHHHHHHHhccC---Ccccc
Confidence               158899999999988765  7799999999999999999999864321      111111111111000   00000


Q ss_pred             cccCChhHHHHH--HHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527         1019 PEMVNPAAEKGM--KEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus      1019 ~~~~~~~~~~~~--~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                           +......  ..+.+++.+|+. +|.+||++.|+++.+.
T Consensus       130 -----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      130 -----SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             -----ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence                 0111222  268899999998 7999999999998864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=3.8e-22  Score=221.79  Aligned_cols=158  Identities=20%  Similarity=0.176  Sum_probs=121.9

Q ss_pred             CCeeccccceEEEEEEEc--CCcEEEEEEcccc-----hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          781 AEVLGRSSHGTSYRATLE--NGMFLTVKWLREG-----VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .++||+|+||+||+|+..  +++.||||++...     .....+.+.+|++++++++|+||++.+..+     +..++||
T Consensus        23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-----~~~~LVm   97 (365)
T PRK09188         23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-----GKDGLVR   97 (365)
T ss_pred             ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----CCcEEEE
Confidence            578999999999999864  5788899986532     122356799999999999999998533221     3579999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCC-CCCCeEeeCCCCCeEEcccccceeec
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNL-KATNILLDGPDLNARVADYCLHRLMT  932 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDl-kp~NILl~~~~~~~kl~Dfg~a~~~~  932 (1060)
                      ||++|++|.. ..    .    ..   ...++.|+++||+||| ++||+|||| ||+|||++ .++.+||+|||+|+...
T Consensus        98 E~~~G~~L~~-~~----~----~~---~~~~~~~i~~aL~~lH-~~gIiHrDL~KP~NILv~-~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         98 GWTEGVPLHL-AR----P----HG---DPAWFRSAHRALRDLH-RAGITHNDLAKPQNWLMG-PDGEAAVIDFQLASVFR  163 (365)
T ss_pred             EccCCCCHHH-hC----c----cc---hHHHHHHHHHHHHHHH-HCCCeeCCCCCcceEEEc-CCCCEEEEECccceecc
Confidence            9999999963 21    0    01   1467899999999999 999999999 99999997 57789999999999775


Q ss_pred             cCCceee-------eccCccccccchhcccCC
Q 001527          933 QAGTIEQ-------ILDAGVLGYRAPELAASK  957 (1060)
Q Consensus       933 ~~~~~~~-------~~~~gt~~y~aPE~~~~~  957 (1060)
                      .......       ....+++.|+|||++...
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            5432111       123578889999998644

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2e-22  Score=200.57  Aligned_cols=246  Identities=22%  Similarity=0.337  Sum_probs=181.9

Q ss_pred             CeeccccceEEEEEEEcCCcEEEEEEcccc--hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          782 EVLGRSSHGTSYRATLENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+|.+...|+.|+|+++ |..+++|+++..  .....++|..|.-.++-+.||||..++|.|.  ......++..||+.|
T Consensus       196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn--sppnlv~isq~mp~g  272 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN--SPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc--CCCCceEeeeeccch
Confidence            46788889999999997 455677877543  2334478999999999999999999999994  556789999999999


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCcee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD-RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~  938 (1060)
                      +|+..+++..   ....+..++.+++.++|+|++|||+- +-|..--+.+..|++| ++..++|+-- -+++...     
T Consensus       273 slynvlhe~t---~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid-edltarisma-d~kfsfq-----  342 (448)
T KOG0195|consen  273 SLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMA-DTKFSFQ-----  342 (448)
T ss_pred             HHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecc-cceeeee-----
Confidence            9999998743   45678889999999999999999943 3344557899999999 6888876421 1121111     


Q ss_pred             eeccCccccccchhcccCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCCCccccccc
Q 001527          939 QILDAGVLGYRAPELAASKKPHP-SFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~-s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      .......+.||+||.++..+.+. -.++|+|||++++||+.|...||...++-+.+..+      .+      +-+.+.+
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------al------eglrv~i  410 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------AL------EGLRVHI  410 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh------hh------ccccccC
Confidence            11124578899999998776533 24689999999999999999999876544332111      01      1111111


Q ss_pred             ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhcC
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                           +   +.....+.+++.-|.. ||.+||.++.|+-.|+++
T Consensus       411 -----p---pgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  411 -----P---PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             -----C---CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                 1   1344567778888997 799999999999888764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.4e-20  Score=210.82  Aligned_cols=202  Identities=17%  Similarity=0.214  Sum_probs=158.7

Q ss_pred             cCCCeeccccceEEEEEEEcCC--cEEEEEEcccchHHHHHHHHHHHHHHhcCCC----CceeeeeeEEeCCCCCceEEE
Q 001527          779 APAEVLGRSSHGTSYRATLENG--MFLTVKWLREGVAKQRKEFAKEAKKFANIRH----PNVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       779 ~~~~~iG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~l~~~~~~~~~~~~~lv  852 (1060)
                      ...+.||+|+||.||.|...+.  ..+|+|.-..........+..|+.++..+..    +++..+++... ......++|
T Consensus        21 ~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~iV   99 (322)
T KOG1164|consen   21 KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNFIV   99 (322)
T ss_pred             EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeEEE
Confidence            3467899999999999996543  5788888765422222267788888888863    58888877763 355678999


Q ss_pred             EEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCC----CCeEEcccccc
Q 001527          853 SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPD----LNARVADYCLH  928 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~----~~~kl~Dfg~a  928 (1060)
                      |+.+ |.+|.++.....   ...++..++.+|+.|++.+|+++| +.|++||||||+|+++....    ..+.+.|||++
T Consensus       100 M~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH-~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen  100 MSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLH-SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             Eecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHH-hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            9988 889999775443   356999999999999999999999 99999999999999997432    46999999999


Q ss_pred             e--eeccCCc----ee---eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001527          929 R--LMTQAGT----IE---QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVIS  988 (1060)
Q Consensus       929 ~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~  988 (1060)
                      +  .......    ..   .....||..|+++.+..+...  +.+.|+||++.++.|+..|..||....
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~--~r~DDles~~Y~l~el~~g~LPW~~~~  241 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ--GRRDDLESLFYMLLELLKGSLPWEALE  241 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc--CCchhhhhHHHHHHHHhcCCCCCcccc
Confidence            8  3222111    01   122359999999999988876  789999999999999999999996543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.5e-21  Score=229.61  Aligned_cols=252  Identities=21%  Similarity=0.205  Sum_probs=182.3

Q ss_pred             CCCeeccccceEEEEEEE-cCCcEEEEEEcc----cc-hH-HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEE
Q 001527          780 PAEVLGRSSHGTSYRATL-ENGMFLTVKWLR----EG-VA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~~~----~~-~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv  852 (1060)
                      ..+++|.|++|.|+.+.. .....++.|.++    .. .. .....+..|+.+-..++|||++..+..+..  .....-+
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--~~~~~~~  399 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--IDGILQS  399 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh--cccchhh
Confidence            357899999998887763 334445555433    11 11 112236678888899999999888777642  3333444


Q ss_pred             EEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeec
Q 001527          853 SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT  932 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~  932 (1060)
                      ||||++ +|...+...     ..+...++..++.|+..|++|+| ..||.|||+|++|++++ .++.+||+|||.+....
T Consensus       400 mE~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h-~~GiahrdlK~enll~~-~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLH-SMGLAHRDLKLENLLVT-ENGILKIIDFGAASVFR  471 (601)
T ss_pred             hhcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHH-hcCceeccCccccEEEe-cCCceEEeecCcceeec
Confidence            999999 999999542     35888899999999999999999 99999999999999998 58899999999988665


Q ss_pred             cCCc---eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCC
Q 001527          933 QAGT---IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHG 1009 (1060)
Q Consensus       933 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 1009 (1060)
                      .+..   .......|+..|+|||++.+..++ ....||||.|+++..|.+|+.||.....++...      ...    ..
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~yd-pr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~----~~  540 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYD-PRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTN----NY  540 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccC-cchhhhhhccceEEEEecCCCccccccccccch------hhh----cc
Confidence            4433   233445799999999999998875 457899999999999999999998654433211      000    00


Q ss_pred             CcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1010 SDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1010 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                         .+..-..............+...++.++++ +|.+|.|+++|++
T Consensus       541 ---~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  541 ---SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ---ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence               000001111222344556667777778888 7999999999986

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.83  E-value=5.7e-21  Score=230.62  Aligned_cols=246  Identities=26%  Similarity=0.406  Sum_probs=125.8

Q ss_pred             cccEEEccCCcccccCCCCccccCCCCCCEEEccCCccccCCCCccCCCCccEEEccCCcCcccCCcchhccCCCCCCeE
Q 001527          265 SVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDL  344 (1060)
Q Consensus       265 ~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~L~~L  344 (1060)
                      +...|+++++.++.. |  ..+  .++|+.|+|++|+|+..++.+.  .+|+.|++++|+|+. +|..+.    ..|+.|
T Consensus       179 ~~~~L~L~~~~LtsL-P--~~I--p~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~Lts-LP~~l~----~~L~~L  246 (754)
T PRK15370        179 NKTELRLKILGLTTI-P--ACI--PEQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLTS-IPATLP----DTIQEM  246 (754)
T ss_pred             CceEEEeCCCCcCcC-C--ccc--ccCCcEEEecCCCCCcCChhhc--cCCCEEECCCCcccc-CChhhh----ccccEE
Confidence            467788888887753 3  122  2467888888888875544432  467777777777763 454221    135666


Q ss_pred             ECCCCccccccCcccccCCcEEEccCCcCcccCCCCCCCCCEEEccCCccccccccccCCCccCEEEcccCeecccCCCC
Q 001527          345 DLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEE  424 (1060)
Q Consensus       345 ~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~  424 (1060)
                      +|++|++. .+|..+..+|+.|+|++|+|+. +|..+                    .  .+|++|++++|+|+ .+|..
T Consensus       247 ~Ls~N~L~-~LP~~l~s~L~~L~Ls~N~L~~-LP~~l--------------------~--~sL~~L~Ls~N~Lt-~LP~~  301 (754)
T PRK15370        247 ELSINRIT-ELPERLPSALQSLDLFHNKISC-LPENL--------------------P--EELRYLSVYDNSIR-TLPAH  301 (754)
T ss_pred             ECcCCccC-cCChhHhCCCCEEECcCCccCc-ccccc--------------------C--CCCcEEECCCCccc-cCccc
Confidence            66666655 2333333455555555555542 22211                    0  24555555555554 23433


Q ss_pred             CcccCCCCeEEccCCcCccccchhccccCCCcEEecCCccccCccccccccCCCcceEEccCccccccCCCCCCCCCCCc
Q 001527          425 TPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQ  504 (1060)
Q Consensus       425 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  504 (1060)
                      +.  .+|+.|++++|+++. +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|+|++|+|+. +|..+.  ++|+
T Consensus       302 lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L~  370 (754)
T PRK15370        302 LP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--PTIT  370 (754)
T ss_pred             ch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--CCcC
Confidence            32  245555555555552 333221  345555555555543 333332  355555555555552 333221  3555


Q ss_pred             EEEccCCccccccCccccCCCCCcEEECCCCccccccCccc----cCCCCCCeEeccCCccc
Q 001527          505 VLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSM----ANMTSLSSLVISQNHFT  562 (1060)
Q Consensus       505 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~----~~l~~L~~L~ls~N~l~  562 (1060)
                      .|+|++|+|+ .+|..+.  .+|+.|++++|+|+ .+|.++    +.++.+..|+|.+|+|+
T Consensus       371 ~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        371 TLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             EEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            5666666655 3444433  24555666666655 344433    22345555566666554

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.82  E-value=1.6e-20  Score=226.72  Aligned_cols=119  Identities=19%  Similarity=0.246  Sum_probs=57.7

Q ss_pred             CCCeEEccCCcCccccchhccccCCCcEEecCCccccCccccccccCCCcceEEccCccccccCCCC----CCCCCCCcE
Q 001527          430 RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFS----PPSVSNLQV  505 (1060)
Q Consensus       430 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~  505 (1060)
                      +|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+. +|..+.  ..|+.|++++|+|++ +|..    ...++++..
T Consensus       347 sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~  419 (754)
T PRK15370        347 ELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN-LPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTR  419 (754)
T ss_pred             cccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccE
Confidence            4445555555444 2333332  345555555555542 333322  235555555555552 2222    233466777


Q ss_pred             EEccCCccccccCccccCCCCCcEEECCCCcccc-ccCccccCCCCCCeEeccCCccc
Q 001527          506 LDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISG-SLPTSMANMTSLSSLVISQNHFT  562 (1060)
Q Consensus       506 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~~~~l~~L~~L~ls~N~l~  562 (1060)
                      |+|.+|.|+.      ..+.+|+.| ++.+.+.| .++.+++.+.+++....-.+.+.
T Consensus       420 L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~  470 (754)
T PRK15370        420 IIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQ  470 (754)
T ss_pred             EEeeCCCccH------HHHHHHHHh-hhcccccCCcccccccccccccccchHHHHHh
Confidence            7777777762      344455555 44555554 33445555555554444444443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=3.3e-20  Score=190.00  Aligned_cols=141  Identities=16%  Similarity=0.199  Sum_probs=108.8

Q ss_pred             CeeccccceEEEEEEEcCCcEEEEEEcccchHH--H------------------------HHHHHHHHHHHhcCCCCcee
Q 001527          782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAK--Q------------------------RKEFAKEAKKFANIRHPNVV  835 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~hpnIv  835 (1060)
                      +.||+|+||.||+|...+|+.||||+++.....  .                        ......|++.+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            579999999999999878999999999754211  0                        11223599999999887764


Q ss_pred             eeeeEEeCCCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeC
Q 001527          836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG  915 (1060)
Q Consensus       836 ~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~  915 (1060)
                      ....+..    ...++||||++++++......     ...+++.++..++.|++.+|.|+|++.||+||||||+|||++ 
T Consensus        83 ~p~~~~~----~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-  152 (190)
T cd05147          83 CPEPILL----KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCcEEEe----cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence            4433321    123899999998877654321     235889999999999999999993388999999999999998 


Q ss_pred             CCCCeEEcccccceeecc
Q 001527          916 PDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       916 ~~~~~kl~Dfg~a~~~~~  933 (1060)
                       +..++|+|||+|.....
T Consensus       153 -~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         153 -DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             -CCcEEEEEccccccCCC
Confidence             35799999999875433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.82  E-value=7.1e-19  Score=199.16  Aligned_cols=258  Identities=24%  Similarity=0.361  Sum_probs=185.3

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHH---HHHHHHHHHHHHhcCCCC-ceeeeeeEEeCCCCCceEEEEEec
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAK---QRKEFAKEAKKFANIRHP-NVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +|+++.+++.  .....+++++|+
T Consensus         5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~~~~   80 (384)
T COG0515           5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ--DEGSLYLVMEYV   80 (384)
T ss_pred             EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe--cCCEEEEEEecC
Confidence            467999999999999976  78899998754332   367899999999999988 7999999984  444579999999


Q ss_pred             CCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCC-CeEEcccccceeeccCC
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDL-NARVADYCLHRLMTQAG  935 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~-~~kl~Dfg~a~~~~~~~  935 (1060)
                      .++++.+++......  ..+.......++.|++.++.|+| ..+++|||+||+||+++. .. .++++|||.++......
T Consensus        81 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H-~~~~~hrd~kp~nil~~~-~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          81 DGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH-SKGIIHRDIKPENILLDR-DGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeeecC-CCCeEEEeccCcceecCCCC
Confidence            999999777543211  36889999999999999999999 999999999999999984 44 79999999998655433


Q ss_pred             ce-----eeeccCccccccchhcccCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCCccChHHHHHHHHhcCCC
Q 001527          936 TI-----EQILDAGVLGYRAPELAASKK-PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHG 1009 (1060)
Q Consensus       936 ~~-----~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~ 1009 (1060)
                      ..     ......|+..|+|||...+.. ..++...|+||+|++++++++|..||......    ...............
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCC
Confidence            21     123347999999999998741 22477999999999999999999997643221    001111111111111


Q ss_pred             CcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHH
Q 001527         1010 SDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1010 ~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      . ...........    ......+.+++..|+. +|..|.++.+...
T Consensus       233 ~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         233 P-SLASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             c-ccccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            0 00000000000    1223456677778877 6899998877654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=1.3e-19  Score=186.20  Aligned_cols=201  Identities=15%  Similarity=0.269  Sum_probs=163.4

Q ss_pred             ccCCCeeccccceEEEEEE-EcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEEEEEe
Q 001527          778 RAPAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       778 ~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      +..+++||+|+||+.+.|+ +-+++.||||.=..  .....++..|.+.++.|. .+.|..+  ||+++.+.+-.+|+|.
T Consensus        30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~v--YYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQV--YYFGQEGKYNILVIDL  105 (449)
T ss_pred             ceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCce--eeeccccchhhhhhhh
Confidence            3457899999999999998 66899999997432  223456778888888884 6888887  4555788888999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeC----CCCCeEEcccccceee
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG----PDLNARVADYCLHRLM  931 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~----~~~~~kl~Dfg~a~~~  931 (1060)
                      + |.||++...-.    +..++..++..||.|++.-++|+| ++..|.|||||+|+||..    +...+.++|||+|+.+
T Consensus       106 L-GPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH-~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVH-EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHH-hcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 77888876322    346999999999999999999999 999999999999999942    2346899999999988


Q ss_pred             ccCCceee------eccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 001527          932 TQAGTIEQ------ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGE  990 (1060)
Q Consensus       932 ~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~~  990 (1060)
                      .+..+...      ....||.+||+--...+...  +.+.|+-|+|-|+...+-|..||.....+
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ--SRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ--SRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchh--hhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            66554322      22469999999999888876  88999999999999999999999876543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=8.9e-20  Score=179.36  Aligned_cols=197  Identities=17%  Similarity=0.225  Sum_probs=156.6

Q ss_pred             CCeeccccceEEEEEE-EcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCC-CceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRH-PNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .+.||.|+||.+|.|. ..+|+.||+|+=....  ...++..|.++.+.++| ..|..+..|.  .++..-.+|||.+ |
T Consensus        20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ynvlVMdLL-G   94 (341)
T KOG1163|consen   20 VRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYNVLVMDLL-G   94 (341)
T ss_pred             EEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhc--cccccceeeeecc-C
Confidence            4789999999999998 6789999999865432  23467789999999875 5566665555  5677889999998 7


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEee--CCCCCeEEcccccceeeccCCc
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD--GPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~--~~~~~~kl~Dfg~a~~~~~~~~  936 (1060)
                      .||++...-.    ...++..+++-.+-|++.-++|+| .++.|||||||+|+|+.  .....+.++|||+|+.+.+..+
T Consensus        95 PsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH-~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t  169 (341)
T KOG1163|consen   95 PSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVH-LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT  169 (341)
T ss_pred             ccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHH-hhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence            8998877432    245899999999999999999999 99999999999999984  2234688999999997754332


Q ss_pred             ee------eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001527          937 IE------QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISG  989 (1060)
Q Consensus       937 ~~------~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~  989 (1060)
                      ..      ...-.||.+|.+--...+...  +.+.|+-|+|.|+...--|..||.....
T Consensus       170 ~~HIpyre~r~ltGTaRYASinAh~g~eq--SRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  170 RQHIPYREDRNLTGTARYASINAHLGIEQ--SRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             cccCccccCCccceeeeehhhhhhhhhhh--hhhhhhhhhcceeeeeecCCCcccccch
Confidence            21      122369999999888776654  7789999999999999999999987644

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=3.6e-19  Score=179.08  Aligned_cols=184  Identities=16%  Similarity=0.062  Sum_probs=137.7

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHH----HHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAK----QRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      ...|++|+||+||.+.. .+..++.+.+......    ....+.+|+++|+++. |++|++++++.      ..+++|||
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvmey   79 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDRSY   79 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEEee
Confidence            46899999999997765 6788887777654331    1235889999999995 58899998752      46999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCC-CCCCeEeeCCCCCeEEcccccceeeccC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNL-KATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDl-kp~NILl~~~~~~~kl~Dfg~a~~~~~~  934 (1060)
                      ++|.+|.+.+..            ....++.|++.+|+++| +.||+|||| ||+|||++ +++.++|+|||++......
T Consensus        80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH-~~GIvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLH-RCGVAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh------------hhHHHHHHHHHHHHHHH-HCcCccCCCCCcceEEEc-CCCCEEEEECCCceecCCc
Confidence            999998754310            11357889999999999 999999999 79999998 5778999999999865543


Q ss_pred             Cce----e--------eeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 001527          935 GTI----E--------QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGD  985 (1060)
Q Consensus       935 ~~~----~--------~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~  985 (1060)
                      ...    .        ......++.|++|+...-.....-.+.+.++-|+-+|.++||+.|.-
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            321    0        01124677888888654332111246788999999999999998853

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=7.3e-20  Score=188.71  Aligned_cols=168  Identities=14%  Similarity=0.203  Sum_probs=127.0

Q ss_pred             CCCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHH---------HHHHHHHHHhcCCCCceeeeeeEEeCCC-----
Q 001527          780 PAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRK---------EFAKEAKKFANIRHPNVVGLRGYYWGPT-----  845 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----  845 (1060)
                      ..+++|.|+||.||.+.. ++..+|+|.+++......+         .+.+|++.+.+++||+|..+.+++....     
T Consensus        35 ~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~  113 (232)
T PRK10359         35 TIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLR  113 (232)
T ss_pred             EEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccc
Confidence            457999999999999766 5778999999754322222         2689999999999999999998875332     


Q ss_pred             -CCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcc
Q 001527          846 -QHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVAD  924 (1060)
Q Consensus       846 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~D  924 (1060)
                       ....++||||++|.+|.++..         ++.    ....+++.++..+| ..|++|||+||+||+++ +++ ++++|
T Consensus       114 ~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH-~~gi~H~Dikp~Nili~-~~g-i~liD  177 (232)
T PRK10359        114 YAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH-QHGMVSGDPHKGNFIVS-KNG-LRIID  177 (232)
T ss_pred             ccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH-HcCCccCCCChHHEEEe-CCC-EEEEE
Confidence             235789999999999988741         222    24569999999999 99999999999999998 466 99999


Q ss_pred             cccceeeccCCceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh
Q 001527          925 YCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT  979 (1060)
Q Consensus       925 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt  979 (1060)
                      ||..+........             ..+.....+  ..++|+|+||+.+.....
T Consensus       178 fg~~~~~~e~~a~-------------d~~vler~y--~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        178 LSGKRCTAQRKAK-------------DRIDLERHY--GIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             CCCcccccchhhH-------------HHHHHHhHh--cccccccceeEeehHHHH
Confidence            9987755322111             113333333  468999999999876543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.78  E-value=9.2e-19  Score=180.32  Aligned_cols=140  Identities=17%  Similarity=0.197  Sum_probs=110.9

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHH--------------------------HHHHHHHHHHHHhcCCCCce
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAK--------------------------QRKEFAKEAKKFANIRHPNV  834 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~hpnI  834 (1060)
                      .+.||+|+||.||+|+..+|+.||||+++.....                          ....+..|.+.+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3679999999999999778999999998754210                          01234679999999999988


Q ss_pred             eeeeeEEeCCCCCceEEEEEecCCCChHHH-hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCcccCCCCCCCeE
Q 001527          835 VGLRGYYWGPTQHEKLILSDYISPGSLASF-LYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD-RAVPHGNLKATNIL  912 (1060)
Q Consensus       835 v~l~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~ivHrDlkp~NIL  912 (1060)
                      .....+...    ..++||||++++++... +.+      ..++..++..++.|++.++.|+| . .||+||||||+||+
T Consensus        82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH-~~~givHrDlkP~NIl  150 (190)
T cd05145          82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLY-QEAGLVHGDLSEYNIL  150 (190)
T ss_pred             CCceEEEec----CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHH-HhCCEecCCCChhhEE
Confidence            655444421    24899999998865443 321      34778889999999999999999 6 99999999999999


Q ss_pred             eeCCCCCeEEcccccceeecc
Q 001527          913 LDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       913 l~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ++  ++.++|+|||+++....
T Consensus       151 l~--~~~~~liDFG~a~~~~~  169 (190)
T cd05145         151 YH--DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EE--CCCEEEEEcccceecCC
Confidence            97  56899999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.76  E-value=2.4e-18  Score=194.14  Aligned_cols=216  Identities=25%  Similarity=0.350  Sum_probs=159.1

Q ss_pred             HhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCC
Q 001527          826 FANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGN  905 (1060)
Q Consensus       826 l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrD  905 (1060)
                      |+.+.|.|+.+++|.+.+  +...+.|.+||..|+|.+.+...    ...++|.-...++++|+.||+|||.+..-.|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCcceeeee
Confidence            467899999999999974  47889999999999999999653    356899999999999999999999544448999


Q ss_pred             CCCCCeEeeCCCCCeEEcccccceeeccC-CceeeeccCccccccchhcccCCCCC-----CCCccchHHHHHHHHHHHh
Q 001527          906 LKATNILLDGPDLNARVADYCLHRLMTQA-GTIEQILDAGVLGYRAPELAASKKPH-----PSFKSDVYAFGVILLELLT  979 (1060)
Q Consensus       906 lkp~NILl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-----~s~~~DvwSlGvvl~ellt  979 (1060)
                      ++++|.++| ..+.+|++|||+....... .........-..-|.|||.+.+....     .+.++||||||++++|+++
T Consensus        75 l~s~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   75 LKSSNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             eccccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            999999999 5999999999998876431 11111111234569999999874211     2678999999999999999


Q ss_pred             CCCCCCCCCCCCCccChHHHHHHHHhcCCCCcccccccccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhh
Q 001527          980 GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus       980 G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                      .+.||+..........+..++.    . .....+.|.+...      .+....++.++.+||. +|.+||++++|-..++
T Consensus       154 r~~~~~~~~~~~~~~eii~~~~----~-~~~~~~rP~i~~~------~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~  222 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDPDEIILRVK----K-GGSNPFRPSIELL------NELPPELLLLVARCWEEIPEKRPSIEQIRSKLL  222 (484)
T ss_pred             ccCccccccccCChHHHHHHHH----h-cCCCCcCcchhhh------hhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence            9999986443322222333322    1 1222233333211      1233368889999998 6999999999988776


Q ss_pred             c
Q 001527         1059 S 1059 (1060)
Q Consensus      1059 ~ 1059 (1060)
                      .
T Consensus       223 ~  223 (484)
T KOG1023|consen  223 T  223 (484)
T ss_pred             h
Confidence            4

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.76  E-value=6.4e-21  Score=177.67  Aligned_cols=187  Identities=30%  Similarity=0.462  Sum_probs=151.5

Q ss_pred             cccccCCCccCEEEcccCeecccCCCCCcccCCCCeEEccCCcCccccchhccccCCCcEEecCCccccCccccccccCC
Q 001527          398 LSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSS  477 (1060)
Q Consensus       398 ~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  477 (1060)
                      ++..+.+++++.|.||+|+++ .+|..+..+.+|+.|++++|+|. .+|..++.+++|+.|+++-|++. ..|..|+.++
T Consensus        26 ~~gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p  102 (264)
T KOG0617|consen   26 LPGLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFP  102 (264)
T ss_pred             cccccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCc
Confidence            445566678888888999888 78888888889999999999988 68888888999999999888886 6788888889


Q ss_pred             CcceEEccCccccc-cCCCCCCCCCCCcEEEccCCccccccCccccCCCCCcEEECCCCccccccCccccCCCCCCeEec
Q 001527          478 TLQELHLADNLLTG-VLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVI  556 (1060)
Q Consensus       478 ~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~l  556 (1060)
                      .|+.|||.+|.+.. ..|..|..++.|+.|+|+.|.+. .+|..+++|++|+.|.+..|.+- ++|..++.+++|+.|.+
T Consensus       103 ~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhi  180 (264)
T KOG0617|consen  103 ALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHI  180 (264)
T ss_pred             hhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhc
Confidence            99999998888864 57777888888999999999997 78889999999999999999987 78999999999999999


Q ss_pred             cCCcccCCCCCCCc-----cCCceeeCcCCcCccccCcc
Q 001527          557 SQNHFTGPLPNNLP-----NSLETFNVSYNDFSGAVPEN  590 (1060)
Q Consensus       557 s~N~l~g~ip~~~~-----~~l~~l~ls~N~l~g~~p~~  590 (1060)
                      .+|+|+ .+|..+.     .+-+.+.+.+|.+-.+|.+.
T Consensus       181 qgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIaeQ  218 (264)
T KOG0617|consen  181 QGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPIAEQ  218 (264)
T ss_pred             ccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChHHHH
Confidence            999998 5555531     12244556666665555443

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=6e-18  Score=174.59  Aligned_cols=138  Identities=19%  Similarity=0.187  Sum_probs=105.2

Q ss_pred             CCCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcC-----CCCceeeeeeEEeCCCC-Cc-eEEE
Q 001527          780 PAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-----RHPNVVGLRGYYWGPTQ-HE-KLIL  852 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~~-~~-~~lv  852 (1060)
                      ..++||+|+||.||. .-+++.. +||++........+.+.+|+++++++     .||||++++|++....+ .. ..+|
T Consensus         6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            357899999999996 3334444 68888754444567799999999999     57999999999974332 23 3378


Q ss_pred             EEe--cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCcccCCCCCCCeEeeC---CCCCeEEcccc
Q 001527          853 SDY--ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGL-NYLHFDRAVPHGNLKATNILLDG---PDLNARVADYC  926 (1060)
Q Consensus       853 ~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL-~~LH~~~~ivHrDlkp~NILl~~---~~~~~kl~Dfg  926 (1060)
                      +||  +++|+|.+++.+.      .+++.  ..++.|++.++ +||| +.+||||||||+|||++.   .+..++|+||+
T Consensus        84 ~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh-~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLL-DNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            999  5579999999432      25544  35678888888 9999 999999999999999963   23479999954


Q ss_pred             cc
Q 001527          927 LH  928 (1060)
Q Consensus       927 ~a  928 (1060)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.74  E-value=9.9e-19  Score=204.80  Aligned_cols=246  Identities=20%  Similarity=0.256  Sum_probs=166.1

Q ss_pred             CCCeeccccceEEEEEEEcCCcEEEEEEcccch-HHHHHHH---HHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          780 PAEVLGRSSHGTSYRATLENGMFLTVKWLREGV-AKQRKEF---AKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~---~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      ..+.+|++.|=.|.+|+.++|. |+||++-+.. .-..+.|   .+|++ ...++|||.+++.-+-  ......|+|-+|
T Consensus        27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAAylvRqy  102 (1431)
T KOG1240|consen   27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAAYLVRQY  102 (1431)
T ss_pred             eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHHHHHHHH
Confidence            3578999999999999998887 8889885433 2222333   34444 5556999999986553  345567888888


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceee--cc
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM--TQ  933 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~--~~  933 (1060)
                      +.. +|+|.+..     ++-+...+.+-|+.|++.||.-+| ..||+|||||.+||||+. =.-+.|+||..-+..  .+
T Consensus       103 vkh-nLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH-~~gVcHGDIKsENILiTS-WNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  103 VKH-NLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCH-KLGVCHGDIKSENILITS-WNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             Hhh-hhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHH-HcCccccccccceEEEee-echhhhhcccccCCccCCC
Confidence            854 88888843     345778888999999999999999 999999999999999984 345889999766532  22


Q ss_pred             CCceeee----ccCccccccchhcccCCC--------C-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCCccChHHH
Q 001527          934 AGTIEQI----LDAGVLGYRAPELAASKK--------P-HPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDW  999 (1060)
Q Consensus       934 ~~~~~~~----~~~gt~~y~aPE~~~~~~--------~-~~s~~~DvwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~  999 (1060)
                      +......    ....-..|.|||.+....        . ..+++.||||+|||+.|+++ |++||+..          +.
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----------QL  244 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----------QL  244 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----------HH
Confidence            2211111    011223599999885421        1 12568899999999999988 68887631          11


Q ss_pred             HHHHHhcCCCCccccccc-ccccCChhHHHHHHHHHHHHHHhcc-CCCCCCCHHHHHHHhhc
Q 001527         1000 MQLKVAEGHGSDCFDAAV-MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1000 ~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~~~~~l~~l~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ..  ++.+.   ..|+.. ....       +-..+.++++.|++ +|.+|-++++.++.-+.
T Consensus       245 ~a--Yr~~~---~~~~e~~Le~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  245 LA--YRSGN---ADDPEQLLEKI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             Hh--HhccC---ccCHHHHHHhC-------cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            11  11110   111110 0000       01134566777777 89999999999987543

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.73  E-value=1.1e-19  Score=169.39  Aligned_cols=161  Identities=29%  Similarity=0.473  Sum_probs=144.8

Q ss_pred             ccccCCCCCcEEECcCCcccccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCc
Q 001527           88 SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVS  167 (1060)
Q Consensus        88 ~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  167 (1060)
                      +...++++.+.|.||+|+++ .+|..+..|.+|+.|++++|+|. .+|.+++.|++|+.|+++-|++. ..|..|+.++.
T Consensus        27 ~gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~  103 (264)
T KOG0617|consen   27 PGLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPA  103 (264)
T ss_pred             ccccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCch
Confidence            33447788899999999999 67778999999999999999999 88999999999999999999997 78999999999


Q ss_pred             ccEEEccCCCCCC-CCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCcCCccCchhhhccCCCCeeccc
Q 001527          168 IQSLDLSHNSFSG-SLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFS  246 (1060)
Q Consensus       168 L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls  246 (1060)
                      |++|||.+|++.. .+|..|..++.|+.|+|+.|.+. .+|..++.+++|+.|.+.+|.+- .+|..++.++.|++|.+.
T Consensus       104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq  181 (264)
T KOG0617|consen  104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ  181 (264)
T ss_pred             hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence            9999999999975 58999999999999999999995 78889999999999999999997 468899999998888777


Q ss_pred             CCccccC
Q 001527          247 GNMFVGS  253 (1060)
Q Consensus       247 ~N~l~~~  253 (1060)
                      +|+++-.
T Consensus       182 gnrl~vl  188 (264)
T KOG0617|consen  182 GNRLTVL  188 (264)
T ss_pred             cceeeec
Confidence            7776543

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.71  E-value=8.9e-19  Score=197.44  Aligned_cols=106  Identities=24%  Similarity=0.295  Sum_probs=54.7

Q ss_pred             EEECcCCccc-ccCCCCcCCCCCCcEEEcCCCccccc----CccccccccccCeeeccccccCc------ccCCcccCCC
Q 001527           98 KLSMSNNSIS-GVIPDNIGDFKSLEFLDVSDNLFSSS----LPSGIGKLESLQNLSLAGNNFSG------LIPDSVSGLV  166 (1060)
Q Consensus        98 ~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~  166 (1060)
                      .|+|.+++++ ...+..|..+.+|++|+|+++.++..    ++..+...++|++|+++++.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            3566666665 33444455566667777776666432    34445555566666666665542      1223344455


Q ss_pred             cccEEEccCCCCCCCCCccccCCCC---ccEEEeecCccc
Q 001527          167 SIQSLDLSHNSFSGSLPPALTRLNN---LVYLNLSSNGFS  203 (1060)
Q Consensus       167 ~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~  203 (1060)
                      +|+.|+|++|.+....+..+..+.+   |++|++++|+++
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~  121 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG  121 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccc
Confidence            5555555555554433333333333   555555554443

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.70  E-value=2.2e-18  Score=193.52  Aligned_cols=186  Identities=24%  Similarity=0.342  Sum_probs=154.2

Q ss_pred             eeccccceEEEEEE----EcCCcEEEEEEcccchHH--HHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEEEEEe
Q 001527          783 VLGRSSHGTSYRAT----LENGMFLTVKWLREGVAK--QRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       783 ~iG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      ++|+|+||.|+.++    .+.|..+|+|+.++....  .+.....|..++..++ ||.+|+++-.+  +.....+++++|
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee--ccccchhHhhhh
Confidence            36999999999875    335788999988754322  1225567888898886 99999997666  467788999999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      ..+|++...+..     ...+++.....+...++-|++++| +.+|+|||+|++||+++ .++++|+.|||.++..-...
T Consensus        79 ~rgg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh-~l~iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   79 LRGGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLH-KLGIAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             cccchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcc-hhHHHHhcccccceeec-ccCccccCCchhhhHhHhhh
Confidence            999999988843     345778888888999999999999 99999999999999999 58899999999998765443


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      ..     +||..|||||+..+.    ..++|.||||++++||+||..||..
T Consensus       152 ~~-----cgt~eymApEI~~gh----~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  152 IA-----CGTYEYRAPEIINGH----LSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hc-----ccchhhhhhHhhhcc----CCcccchhhhhhHHHHhhCCCCCch
Confidence            32     799999999999833    5589999999999999999999865

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.69  E-value=1.4e-18  Score=195.86  Aligned_cols=58  Identities=26%  Similarity=0.281  Sum_probs=32.9

Q ss_pred             EEEcCCCccc-ccCccccccccccCeeeccccccCcc----cCCcccCCCcccEEEccCCCCC
Q 001527          122 FLDVSDNLFS-SSLPSGIGKLESLQNLSLAGNNFSGL----IPDSVSGLVSIQSLDLSHNSFS  179 (1060)
Q Consensus       122 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  179 (1060)
                      .|+|+.+.++ ...+..|..+.+|+.|+|+++.++..    ++..+...++|++|++++|.+.
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~   64 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETG   64 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccC
Confidence            4566666666 33444556666677777777666432    3334445555666666655554

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.69  E-value=1e-16  Score=170.38  Aligned_cols=199  Identities=22%  Similarity=0.333  Sum_probs=128.9

Q ss_pred             CCeeccccceEEEEEEEc-CCcEEEEEEcccc---hHHHHHHHHHHHHHHhcCCC-----------CceeeeeeEEe---
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG---VAKQRKEFAKEAKKFANIRH-----------PNVVGLRGYYW---  842 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-----------pnIv~l~~~~~---  842 (1060)
                      ++.||.|+++.||.++.. +++.+|+|++...   .....+++.+|.-....+.+           .-++++ +...   
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~i~~   95 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLRIPG   95 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEEETT
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEEEcC
Confidence            578999999999999976 5999999998532   22345667777665555432           112221 2111   


Q ss_pred             ------C-CCCC-----ceEEEEEecCCCChHHHhh---cCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCC
Q 001527          843 ------G-PTQH-----EKLILSDYISPGSLASFLY---DRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLK  907 (1060)
Q Consensus       843 ------~-~~~~-----~~~lv~e~~~~gsL~~~l~---~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlk  907 (1060)
                            . ....     ..+++|+-+ -+||.+++.   ... .....+....+..+..|+++.+++|| ..|+||+|||
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~-~~~~~l~~~arl~lT~Q~I~lvA~Lh-~~GlVHgdi~  172 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA-QTHSPLAFAARLSLTVQMIRLVANLH-SYGLVHGDIK  172 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT-TTSHHHHHHHHHHHHHHHHHHHHHHH-HTTEEEST-S
T ss_pred             CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc-cccchhHHHHHHHHHHHHHHHHHHHh-hcceEecccc
Confidence                  0 0011     235677777 568888753   222 11223455667888899999999999 9999999999


Q ss_pred             CCCeEeeCCCCCeEEcccccceeeccCCceeeeccCccccccchhcccCC------CCCCCCccchHHHHHHHHHHHhCC
Q 001527          908 ATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASK------KPHPSFKSDVYAFGVILLELLTGR  981 (1060)
Q Consensus       908 p~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~~DvwSlGvvl~elltG~  981 (1060)
                      |+|++++ +++.++|+||+.....+.....    ...+..|.+||.....      ...++.+.|.|++|+++|.|.+|+
T Consensus       173 ~~nfll~-~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  173 PENFLLD-QDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             GGGEEE--TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             eeeEEEc-CCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            9999999 5899999999877654432211    2345789999987542      223477899999999999999999


Q ss_pred             CCCCCCC
Q 001527          982 CAGDVIS  988 (1060)
Q Consensus       982 ~p~~~~~  988 (1060)
                      .||+...
T Consensus       248 lPf~~~~  254 (288)
T PF14531_consen  248 LPFGLSS  254 (288)
T ss_dssp             -STCCCG
T ss_pred             CCCCCCC
Confidence            9998643

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=2.5e-16  Score=165.71  Aligned_cols=148  Identities=22%  Similarity=0.305  Sum_probs=111.8

Q ss_pred             CCCceeeeeeEEeCC-------------------------CCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHH
Q 001527          830 RHPNVVGLRGYYWGP-------------------------TQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKI  884 (1060)
Q Consensus       830 ~hpnIv~l~~~~~~~-------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i  884 (1060)
                      +|||||++.++|.++                         ++...|+||..+ ..+|++|+-.+      ..+...+.-|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~------~~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR------HRSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC------CCchHHHHHH
Confidence            599999999888532                         233578999888 45999999543      3566777888


Q ss_pred             HHHHHHHHHHHhcCCCcccCCCCCCCeEeeC-CC--CCeEEcccccceeeccCC-----ceeeeccCccccccchhcccC
Q 001527          885 AVDVARGLNYLHFDRAVPHGNLKATNILLDG-PD--LNARVADYCLHRLMTQAG-----TIEQILDAGVLGYRAPELAAS  956 (1060)
Q Consensus       885 ~~qia~gL~~LH~~~~ivHrDlkp~NILl~~-~~--~~~kl~Dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~  956 (1060)
                      ..|+++|+.||| .+||.|||+|++|||+.- +|  -...++|||++-..+..+     ........|...-||||+...
T Consensus       347 laQlLEav~hL~-~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  347 LAQLLEAVTHLH-KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHH-HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            999999999999 999999999999999942 22  346799999886443311     111122357778999999875


Q ss_pred             CCC-----CCCCccchHHHHHHHHHHHhCCCCCCC
Q 001527          957 KKP-----HPSFKSDVYAFGVILLELLTGRCAGDV  986 (1060)
Q Consensus       957 ~~~-----~~s~~~DvwSlGvvl~elltG~~p~~~  986 (1060)
                      .+.     . -.|+|.|+.|.+.||+++...||..
T Consensus       426 ~PGp~avvn-y~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  426 VPGPNAVVN-YEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             CCCCceeec-cchhhhhhhhhhHHHHhccCCcccc
Confidence            431     1 2389999999999999999999875

>smart00090 RIO RIO-like kinase

Probab=99.68  E-value=1e-16  Score=170.00  Aligned_cols=139  Identities=17%  Similarity=0.200  Sum_probs=107.0

Q ss_pred             CCCeeccccceEEEEEE--EcCCcEEEEEEcccchHH------------------------HHHHHHHHHHHHhcCCCC-
Q 001527          780 PAEVLGRSSHGTSYRAT--LENGMFLTVKWLREGVAK------------------------QRKEFAKEAKKFANIRHP-  832 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~hp-  832 (1060)
                      ..+.||+|+||.||+|+  ..+|+.||+|+++.....                        ....+..|++.+.++.+. 
T Consensus        32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~  111 (237)
T smart00090       32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG  111 (237)
T ss_pred             hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence            35789999999999998  568999999998743210                        113467899999999753 


Q ss_pred             -ceeeeeeEEeCCCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-cccCCCCCCC
Q 001527          833 -NVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA-VPHGNLKATN  910 (1060)
Q Consensus       833 -nIv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~-ivHrDlkp~N  910 (1060)
                       .+.+++++      ...++||||++++++..+...     ...+...+...++.|++.+++||| ..| |+||||||+|
T Consensus       112 i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH-~~g~iiH~Dikp~N  179 (237)
T smart00090      112 VPVPKPIAW------RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLY-KEGELVHGDLSEYN  179 (237)
T ss_pred             CCCCeeeEe------cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHH-hcCCEEeCCCChhh
Confidence             33444432      134899999999888765422     123556677899999999999999 889 9999999999


Q ss_pred             eEeeCCCCCeEEcccccceeec
Q 001527          911 ILLDGPDLNARVADYCLHRLMT  932 (1060)
Q Consensus       911 ILl~~~~~~~kl~Dfg~a~~~~  932 (1060)
                      |+++  ++.++++|||.+....
T Consensus       180 Ili~--~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH--DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE--CCCEEEEEChhhhccC
Confidence            9998  5689999999887543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=1.2e-16  Score=192.57  Aligned_cols=194  Identities=16%  Similarity=0.208  Sum_probs=148.6

Q ss_pred             hccCCCeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCC---CCceeeeeeEEeCCCCCceEEEE
Q 001527          777 SRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR---HPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       777 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      .+...+.||+|+||.||+|...+|+.||+|+=+.....   +|.--.+++.+|+   -+-|..+...+.  -.+..++|+
T Consensus       699 ~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~--~~~~S~lv~  773 (974)
T KOG1166|consen  699 KFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHV--FQNASVLVS  773 (974)
T ss_pred             eEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHc--cCCcceeee
Confidence            34446789999999999999888999999997654332   2222233344444   133444444333  244678999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEee------CCCCCeEEccccc
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD------GPDLNARVADYCL  927 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~------~~~~~~kl~Dfg~  927 (1060)
                      ||.+.|+|.+++.     ..+.++|.-++.++.|+++-+++|| ..+|||+||||+|.||.      .+...++|+|||.
T Consensus       774 ey~~~Gtlld~~N-----~~~~m~e~lv~~~~~qml~ive~lH-~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  774 EYSPYGTLLDLIN-----TNKVMDEYLVMFFSCQMLRIVEHLH-AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eccccccHHHhhc-----cCCCCCchhhhHHHHHHHHHHHHHH-hcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            9999999999994     4456899999999999999999999 99999999999999993      2345689999999


Q ss_pred             ceeeccCCc-eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCC
Q 001527          928 HRLMTQAGT-IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCA  983 (1060)
Q Consensus       928 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p  983 (1060)
                      +.-+.--.. ..-...++|-.+-.+|+..|+.+  +..+|.|.++.+++-|+.|++-
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpW--tYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPW--TYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcCCCC--chhhhhHHHHHHHHHHHHHHHH
Confidence            875542211 12223478889999999999998  6699999999999999999864

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.64  E-value=1.2e-15  Score=160.82  Aligned_cols=134  Identities=19%  Similarity=0.364  Sum_probs=110.1

Q ss_pred             CeeccccceEEEEEEEcCCcEEEEEEcccchH--------HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVA--------KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      +.||+|++|.||+|.. +|..+++|+......        .....+.+|++++..++|++|+....++.  .....++||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~--~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV--DPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE--eCCCCEEEE
Confidence            4689999999999987 577888997653211        12346788999999999999887776664  345678999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      ||++|++|.+++...        .+ ++..++.+++.+|.++| ..+++|||++|+||+++  +..++++|||.++.
T Consensus        79 e~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH-~~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLH-SAGIIHGDLTTSNMILS--GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHH-hCCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence            999999999998432        12 78899999999999999 99999999999999998  56799999998765

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.64  E-value=8.4e-16  Score=159.77  Aligned_cols=136  Identities=17%  Similarity=0.188  Sum_probs=105.8

Q ss_pred             cCCCeeccccceEEEEEEEcCCcEEEEEEcccchH----------------------HHHHHHHHHHHHHhcCCCCc--e
Q 001527          779 APAEVLGRSSHGTSYRATLENGMFLTVKWLREGVA----------------------KQRKEFAKEAKKFANIRHPN--V  834 (1060)
Q Consensus       779 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~hpn--I  834 (1060)
                      ...+.||+|+||.||+|..++|+.||||+++....                      .....+..|+.++.++.|++  +
T Consensus        18 ~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v   97 (198)
T cd05144          18 SLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPV   97 (198)
T ss_pred             hcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCC
Confidence            34578999999999999988899999998654220                      01123677899999998774  4


Q ss_pred             eeeeeEEeCCCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEee
Q 001527          835 VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD  914 (1060)
Q Consensus       835 v~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~  914 (1060)
                      ++.++.      ...++||||+++++|.+....           .....++.+++.++.++| ..||+||||||+||+++
T Consensus        98 ~~~~~~------~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh-~~gi~H~Dl~p~Nill~  159 (198)
T cd05144          98 PKPIDW------NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY-KHGIIHGDLSEFNILVD  159 (198)
T ss_pred             Cceeec------CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH-HCCCCcCCCCcccEEEc
Confidence            444332      245899999999998765420           234678899999999999 89999999999999998


Q ss_pred             CCCCCeEEcccccceeecc
Q 001527          915 GPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       915 ~~~~~~kl~Dfg~a~~~~~  933 (1060)
                       +++.++|+|||.+.....
T Consensus       160 -~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         160 -DDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             -CCCcEEEEECCccccCCC
Confidence             588999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.63  E-value=1.6e-15  Score=158.03  Aligned_cols=130  Identities=19%  Similarity=0.289  Sum_probs=103.5

Q ss_pred             eeccccceEEEEEEEcCCcEEEEEEcccch--------HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEE
Q 001527          783 VLGRSSHGTSYRATLENGMFLTVKWLREGV--------AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       783 ~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e  854 (1060)
                      .||+|+||.||+|.+ +|..|++|+.....        ....+++.+|++++..++|+++.....++.  .....++|||
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~--~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV--DPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE--ECCCCEEEEE
Confidence            489999999999985 56789999854321        112356788999999999887655444443  2345689999


Q ss_pred             ecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      |++|++|.+++....            ..++.+++.+|.+|| ..|++|||++|.||+++  +..++++|||.++.
T Consensus        78 ~~~g~~l~~~~~~~~------------~~~~~~i~~~l~~lH-~~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGN------------DELLREIGRLVGKLH-KAGIVHGDLTTSNIIVR--DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcH------------HHHHHHHHHHHHHHH-HCCeecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence            999999999874311            078999999999999 99999999999999998  56899999998875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.63  E-value=1.9e-15  Score=181.26  Aligned_cols=134  Identities=19%  Similarity=0.268  Sum_probs=106.9

Q ss_pred             CCCeeccccceEEEEEEEcCCcEEEEEEcccc-------hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEE
Q 001527          780 PAEVLGRSSHGTSYRATLENGMFLTVKWLREG-------VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv  852 (1060)
                      ..+.||+|+||+||+|.+.+...++.++..+.       .....+.+.+|++++++++|++++....++.  .....++|
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~--~~~~~~lv  414 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV--DPEEKTIV  414 (535)
T ss_pred             ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE--eCCCCEEE
Confidence            35789999999999998765443333322211       0112356889999999999999988776665  34467899


Q ss_pred             EEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceee
Q 001527          853 SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~  931 (1060)
                      |||+++++|.+++.             .+..++.|++.+|.||| +.+|+|||+||+|||++  +..++|+|||+++..
T Consensus       415 ~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH-~~giiHrDlkp~NILl~--~~~~~liDFGla~~~  477 (535)
T PRK09605        415 MEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH-KAGIVHGDLTTSNFIVR--DDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH-hCCCccCCCChHHEEEE--CCcEEEEeCcccccC
Confidence            99999999999883             35679999999999999 99999999999999995  568999999998763

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.61  E-value=2.9e-16  Score=173.29  Aligned_cols=123  Identities=27%  Similarity=0.399  Sum_probs=104.8

Q ss_pred             ceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccc
Q 001527          848 EKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL  927 (1060)
Q Consensus       848 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~  927 (1060)
                      ..|+.|++|+..+|.+|+..++  .....++.....++.|++.|+.|    ++.+|||+||.||... .+.++||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~-~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFS-DDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh----ccchhhhccccccccc-cchhhhhhhhhh
Confidence            4789999999999999997543  33457788899999999999999    7899999999999997 566899999999


Q ss_pred             ceeeccCC-----ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHh
Q 001527          928 HRLMTQAG-----TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT  979 (1060)
Q Consensus       928 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~ellt  979 (1060)
                      ........     ....+...||..||+||.+.+..+  +.|+||||+|++++|+++
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y--~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY--SEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhh--hhhcchhhHHHHHHHHHH
Confidence            88766554     222334479999999999999876  889999999999999988

>PLN03150 hypothetical protein; Provisional

Probab=99.57  E-value=7.9e-15  Score=177.42  Aligned_cols=159  Identities=27%  Similarity=0.460  Sum_probs=124.0

Q ss_pred             CChHHHHHHHHHHHhccCCCCCccCCCCCCCCCCCCCCCCccceEEecCCCeeEEEecCCCCccccCcccccCCCCCcEE
Q 001527           20 LPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKL   99 (1060)
Q Consensus        20 ~~~~~~~aLl~~k~~~~~~~~~~~l~sW~~~~~~~~~~~c~w~gv~C~~~~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L   99 (1060)
                      ....|.+||++||+++. +| .  ..+|+.+  .|....|.|.||.|+.....                   ....++.|
T Consensus       369 t~~~~~~aL~~~k~~~~-~~-~--~~~W~g~--~C~p~~~~w~Gv~C~~~~~~-------------------~~~~v~~L  423 (623)
T PLN03150        369 TLLEEVSALQTLKSSLG-LP-L--RFGWNGD--PCVPQQHPWSGADCQFDSTK-------------------GKWFIDGL  423 (623)
T ss_pred             cCchHHHHHHHHHHhcC-Cc-c--cCCCCCC--CCCCcccccccceeeccCCC-------------------CceEEEEE
Confidence            45567999999999986 44 1  2479731  11112247999999632110                   01135788


Q ss_pred             ECcCCcccccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEEEccCCCCC
Q 001527          100 SMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFS  179 (1060)
Q Consensus       100 ~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  179 (1060)
                      +|++|.++|.+|..|+.+++|++|+|++|++.|.+|..|+.+++|+.|+|++|++++.+|..+++|++|++|+|++|+++
T Consensus       424 ~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~  503 (623)
T PLN03150        424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS  503 (623)
T ss_pred             ECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCccccCC-CCccEEEeecCccc
Q 001527          180 GSLPPALTRL-NNLVYLNLSSNGFS  203 (1060)
Q Consensus       180 ~~~p~~~~~l-~~L~~L~Ls~N~l~  203 (1060)
                      +.+|..+..+ .++..+++++|...
T Consensus       504 g~iP~~l~~~~~~~~~l~~~~N~~l  528 (623)
T PLN03150        504 GRVPAALGGRLLHRASFNFTDNAGL  528 (623)
T ss_pred             ccCChHHhhccccCceEEecCCccc
Confidence            8888887764 46677788777643

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=4e-14  Score=150.58  Aligned_cols=139  Identities=24%  Similarity=0.273  Sum_probs=106.0

Q ss_pred             cCCCeec-cccceEEEEEEEcCCcEEEEEEcccch-------------HHHHHHHHHHHHHHhcCCCCce--eeeeeEEe
Q 001527          779 APAEVLG-RSSHGTSYRATLENGMFLTVKWLREGV-------------AKQRKEFAKEAKKFANIRHPNV--VGLRGYYW  842 (1060)
Q Consensus       779 ~~~~~iG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpnI--v~l~~~~~  842 (1060)
                      ..+.+|| .|+.|+||.+... +..++||++....             ......+.+|++++.+++|++|  ++.+++..
T Consensus        34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~  112 (239)
T PRK01723         34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV  112 (239)
T ss_pred             hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence            3467898 8999999999875 6778999885321             1223567889999999998775  66776654


Q ss_pred             CCCCC--ceEEEEEecCC-CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCC
Q 001527          843 GPTQH--EKLILSDYISP-GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLN  919 (1060)
Q Consensus       843 ~~~~~--~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~  919 (1060)
                      .....  ..++||||+++ .+|.+++...      +++..    .+.+++.++.+|| +.||+||||||.|||++ .+..
T Consensus       113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH-~~GI~HrDlkp~NILv~-~~~~  180 (239)
T PRK01723        113 VRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFH-DAGVYHADLNAHNILLD-PDGK  180 (239)
T ss_pred             eecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHH-HCCCCCCCCCchhEEEc-CCCC
Confidence            22221  23599999997 6999988431      24443    3678999999999 99999999999999998 4668


Q ss_pred             eEEccccccee
Q 001527          920 ARVADYCLHRL  930 (1060)
Q Consensus       920 ~kl~Dfg~a~~  930 (1060)
                      ++|+|||.+..
T Consensus       181 v~LIDfg~~~~  191 (239)
T PRK01723        181 FWLIDFDRGEL  191 (239)
T ss_pred             EEEEECCCccc
Confidence            99999998875

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.54  E-value=1.9e-14  Score=148.33  Aligned_cols=137  Identities=20%  Similarity=0.248  Sum_probs=97.6

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHH--HHHH----------------------HHHHHHHHhcCCCCc--e
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAK--QRKE----------------------FAKEAKKFANIRHPN--V  834 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~hpn--I  834 (1060)
                      .+.||+|+||+||+|...+++.||||+++.....  ....                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            3579999999999999878999999998653211  1111                      135666666664432  3


Q ss_pred             eeeeeEEeCCCCCceEEEEEecCCCChHHH-hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCcccCCCCCCCeE
Q 001527          835 VGLRGYYWGPTQHEKLILSDYISPGSLASF-LYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD-RAVPHGNLKATNIL  912 (1060)
Q Consensus       835 v~l~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~ivHrDlkp~NIL  912 (1060)
                      .+.+++      ...++||||++++++... +.+..      .. .+...++.+++.++.++| . .+|+||||||+||+
T Consensus        82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh-~~~~ivH~Dl~p~Nil  147 (187)
T cd05119          82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLY-REAGLVHGDLSEYNIL  147 (187)
T ss_pred             CceEec------CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHh-hccCcCcCCCChhhEE
Confidence            444332      235899999998554321 21100      11 567889999999999999 6 99999999999999


Q ss_pred             eeCCCCCeEEcccccceeecc
Q 001527          913 LDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       913 l~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      ++  ++.++++|||.+.....
T Consensus       148 i~--~~~~~liDfg~a~~~~~  166 (187)
T cd05119         148 VD--DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EE--CCcEEEEECcccccccC
Confidence            98  66899999999875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PLN03150 hypothetical protein; Provisional

Probab=99.52  E-value=3.7e-14  Score=171.67  Aligned_cols=92  Identities=35%  Similarity=0.551  Sum_probs=74.9

Q ss_pred             CcceEEccCccccccCCCCCCCCCCCcEEEccCCccccccCccccCCCCCcEEECCCCccccccCccccCCCCCCeEecc
Q 001527          478 TLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVIS  557 (1060)
Q Consensus       478 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~L~ls  557 (1060)
                      .++.|+|++|.++|.+|..+..+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            36777888888888888878888888888888888888888888888888888888888888888888888888888888


Q ss_pred             CCcccCCCCCCC
Q 001527          558 QNHFTGPLPNNL  569 (1060)
Q Consensus       558 ~N~l~g~ip~~~  569 (1060)
                      +|+|+|.+|..+
T Consensus       499 ~N~l~g~iP~~l  510 (623)
T PLN03150        499 GNSLSGRVPAAL  510 (623)
T ss_pred             CCcccccCChHH
Confidence            888888888764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.50  E-value=3.4e-14  Score=167.45  Aligned_cols=160  Identities=21%  Similarity=0.289  Sum_probs=112.6

Q ss_pred             CCCeeccccceEEEEEEEc-CCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          780 PAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      ..+.|..|+||.||.++++ ..+.+|+|+-++..      +.+-  ++.....|.+|                       
T Consensus        87 ~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv-----------------------  135 (1205)
T KOG0606|consen   87 TIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV-----------------------  135 (1205)
T ss_pred             eeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee-----------------------
Confidence            4578999999999999866 47788885543321      1110  22222333333                       


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCc--
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT--  936 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~--  936 (1060)
                      |+-...+.     ..++++..        ++.+++||| ..||+|||+||+|.+|+ .-+++|+.|||+.+..-....  
T Consensus       136 gDc~tllk-----~~g~lPvd--------mvla~Eylh-~ygivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 GDCATLLK-----NIGPLPVD--------MVLAVEYLH-SYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             chhhhhcc-----cCCCCcch--------hhHHhHhhc-cCCeecCCCCCCcceee-ecccccccchhhhhhhhhhccch
Confidence            33333332     11233332        278999999 99999999999999998 478999999999875321110  


Q ss_pred             ------------eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 001527          937 ------------IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI  987 (1060)
Q Consensus       937 ------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~  987 (1060)
                                  ......+||+.|+|||++..+.|  ...+|+|++|+++||.+.|..||+..
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy--gkpvdwwamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY--GKPVDWWAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhcc--CCCccHHHHHHHHHHHheeeeeccCC
Confidence                        00112479999999999998876  77999999999999999999999864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.50  E-value=5.5e-14  Score=139.34  Aligned_cols=130  Identities=17%  Similarity=0.140  Sum_probs=107.8

Q ss_pred             CeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCC--CceeeeeeEEeCCCCCceEEEEEecCCC
Q 001527          782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRH--PNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      +.||+|.++.||+++..+ ..+++|..+....  ...+.+|+.+++.++|  ++++++++++.  ..+..+++|||++++
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~--~~~~~~~v~e~~~g~   78 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGE--SDGWSYLLMEWIEGE   78 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcC--CCCccEEEEEecCCe
Confidence            579999999999999755 7899999876533  4678899999999976  58888887763  446789999999887


Q ss_pred             ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---CCcccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD---RAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~---~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      .+..+            +......++.+++++++++| .   .+++|+|+||+||+++ +...++++|||.++.
T Consensus        79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh-~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV------------SEEEKEDIAEQLAELLAKLH-QLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC------------CHHHHHHHHHHHHHHHHHHh-CCCceEEEecCCCcceEEEE-CCcEEEEEecccccC
Confidence            66433            45667788999999999999 5   4799999999999998 467899999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.40  E-value=1.2e-12  Score=151.47  Aligned_cols=143  Identities=23%  Similarity=0.292  Sum_probs=102.4

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEEEcccchHHHH----------------------------------------HHHH
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQR----------------------------------------KEFA  820 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  820 (1060)
                      .+.||.|++|.||+|++++|+.||||+.+.+.....                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            467999999999999999999999999875421110                                        0245


Q ss_pred             HHHHHHhcCC----CCceeeeeeEEeCCCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHH-HHHHH
Q 001527          821 KEAKKFANIR----HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR-GLNYL  895 (1060)
Q Consensus       821 ~E~~~l~~l~----hpnIv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~-gL~~L  895 (1060)
                      +|++.+.+++    |.+-+.+-.++. ......++||||++|++|.++......    ..   .+.+++.+++. .+..+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~-~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYW-DRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQV  273 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEeh-hhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHH
Confidence            5666666552    333333333332 123457999999999999887643210    12   24567777766 47888


Q ss_pred             hcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          896 HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       896 H~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      | ..|++|+|+||.||+++ +++.++++|||++..+..
T Consensus       274 ~-~~g~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 L-RDGFFHADLHPGNIFVL-KDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             H-hCCceeCCCCcccEEEC-CCCcEEEEeCCCeeECCH
Confidence            9 89999999999999997 578999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=6.9e-14  Score=166.53  Aligned_cols=200  Identities=23%  Similarity=0.265  Sum_probs=156.7

Q ss_pred             CeeccccceEEEEEEEc--CCcEEEEEEcccch--HHHHHHHHHHHHHHhcCC-CCceeeeeeEEeCCCCCceEEEEEec
Q 001527          782 EVLGRSSHGTSYRATLE--NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~lv~e~~  856 (1060)
                      +-||+|+|+.|-.+...  ....+|+|.+....  ....+....|..+-..+. |+|++.+++..  ...+..+++++|.
T Consensus        26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~~~~~~~s  103 (601)
T KOG0590|consen   26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSYLLSLSYS  103 (601)
T ss_pred             ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc--CCCcccccccCcc
Confidence            45899999999888743  35566777665432  223345566888888886 99999999987  4677889999999


Q ss_pred             CCCChHHHhh-cCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCC-CeEEcccccceeecc-
Q 001527          857 SPGSLASFLY-DRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDL-NARVADYCLHRLMTQ-  933 (1060)
Q Consensus       857 ~~gsL~~~l~-~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~-~~kl~Dfg~a~~~~~-  933 (1060)
                      .++++.+-+. ..    ....+......++.|+..|+.|+|...++.|||+||+|.+++. .. ..|++|||+|..+.. 
T Consensus       104 ~g~~~f~~i~~~~----~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~-s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  104 DGGSLFSKISHPD----STGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE-SGSALKIADFGLATAYRNK  178 (601)
T ss_pred             cccccccccccCC----ccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc-CCCcccCCCchhhcccccc
Confidence            9999998873 22    1134556677899999999999997789999999999999984 66 899999999987766 


Q ss_pred             CC-ceeeeccCc-cccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 001527          934 AG-TIEQILDAG-VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISG  989 (1060)
Q Consensus       934 ~~-~~~~~~~~g-t~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~~  989 (1060)
                      .+ .......+| ++.|+|||...+..+ .....|+||.|+++.-+++|..|++....
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~-~~~~~d~~S~g~~l~~~~~g~~p~~~~~~  235 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAY-RGPSVDVWSLGIVLSAMLTGELPWDFPSR  235 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhh-cCCCcccccccccccccccCCCCcccccc
Confidence            33 233344578 999999999988543 36689999999999999999999886543

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.38  E-value=1.2e-14  Score=160.08  Aligned_cols=169  Identities=30%  Similarity=0.376  Sum_probs=143.4

Q ss_pred             EEEccCCccccccccccCCCccCEEEcccCeecccCCCCCcccCCCCeEEccCCcCccccchhccccCCCcEEecCCccc
Q 001527          386 VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL  465 (1060)
Q Consensus       386 ~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  465 (1060)
                      ..||+.|+|...+.....+..|+.+.|..|.|. .+|..++++..|++|||+.|+++ .+|..++.|+ |+.|-+++|++
T Consensus        79 ~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl  155 (722)
T KOG0532|consen   79 FADLSRNRFSELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKL  155 (722)
T ss_pred             hhhccccccccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCcc
Confidence            567777777766666666678888889999988 88899999999999999999998 7888888887 89999999998


Q ss_pred             cCccccccccCCCcceEEccCccccccCCCCCCCCCCCcEEEccCCccccccCccccCCCCCcEEECCCCccccccCccc
Q 001527          466 DGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSM  545 (1060)
Q Consensus       466 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~  545 (1060)
                      + .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .+|++++.|+ |..||+|.|+++ .||-.|
T Consensus       156 ~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~f  230 (722)
T KOG0532|consen  156 T-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDF  230 (722)
T ss_pred             c-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhh
Confidence            7 57888888888999999999988 45667888899999999999998 6788888654 888999999998 799999


Q ss_pred             cCCCCCCeEeccCCccc
Q 001527          546 ANMTSLSSLVISQNHFT  562 (1060)
Q Consensus       546 ~~l~~L~~L~ls~N~l~  562 (1060)
                      .+|+.|++|-|.+|+|.
T Consensus       231 r~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  231 RKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             hhhhhheeeeeccCCCC
Confidence            99999999999999997

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=6.4e-12  Score=142.27  Aligned_cols=224  Identities=19%  Similarity=0.156  Sum_probs=166.8

Q ss_pred             ccCCCcccccceeeccCCCCCChhhhhccCCCeecc--ccceEEEEEEE---cCCcEEEEEEcccchH--HHHHHHHHHH
Q 001527          751 DVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGR--SSHGTSYRATL---ENGMFLTVKWLREGVA--KQRKEFAKEA  823 (1060)
Q Consensus       751 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~iG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~  823 (1060)
                      +...++...++....+.....+.++......+-+|.  |.+|.||.+..   +++..+|+|+-+....  .....-.+|+
T Consensus        89 ~~~~~~~~~~~s~~~~~S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~  168 (524)
T KOG0601|consen   89 DSDGPGCESLSSPIYGASPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREF  168 (524)
T ss_pred             cCCCCccccccccccCCCCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchh
Confidence            333343344444555555566666666666788999  99999999986   4688999998543222  2333445677


Q ss_pred             HHHhcC-CCCceeeeeeEEeCCCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcC
Q 001527          824 KKFANI-RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR----GLNYLHFD  898 (1060)
Q Consensus       824 ~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~----gL~~LH~~  898 (1060)
                      ...+++ .|++.|+.+..+  ...+..++-+|++ +.++.++.+...    ..++....+.+..+...    ||.++| .
T Consensus       169 ~s~~~i~~~~~~v~~~~~~--e~~~~lfiqtE~~-~~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~h-s  240 (524)
T KOG0601|consen  169 LSHHKIDSHENPVRDSPAW--EGSGILFIQTELC-GESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLH-S  240 (524)
T ss_pred             hcccccCccccccccCccc--ccCCcceeeeccc-cchhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccC-C
Confidence            777777 499999987777  3566788888888 578888886543    33666777777778877    999999 9


Q ss_pred             CCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceee----eccCccccccchhcccCCCCCCCCccchHHHHHHH
Q 001527          899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ----ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVIL  974 (1060)
Q Consensus       899 ~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl  974 (1060)
                      .+++|-|+||.||+...+....+++|||....+........    ....|...|++||...+..   +.+.|||++|.|+
T Consensus       241 ~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~---~~~~di~sl~ev~  317 (524)
T KOG0601|consen  241 NNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA---TFASDIFSLGEVI  317 (524)
T ss_pred             CcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc---chHhhhcchhhhh
Confidence            99999999999999984327899999999988766542211    1125777899999998764   7799999999999


Q ss_pred             HHHHhCCCCCC
Q 001527          975 LELLTGRCAGD  985 (1060)
Q Consensus       975 ~elltG~~p~~  985 (1060)
                      .+..+|.++..
T Consensus       318 l~~~l~~~~~~  328 (524)
T KOG0601|consen  318 LEAILGSHLPS  328 (524)
T ss_pred             HhhHhhccccc
Confidence            99999887754

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.28  E-value=3.1e-13  Score=149.10  Aligned_cols=194  Identities=30%  Similarity=0.383  Sum_probs=130.0

Q ss_pred             EEECcCCcccccC-CCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEEEccCC
Q 001527           98 KLSMSNNSISGVI-PDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHN  176 (1060)
Q Consensus        98 ~L~Ls~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  176 (1060)
                      .|.|++-+++... +.+=..|+.-...||+.|++. .+|..+..+..|+.|.|.+|.+. .+|..+.+|..|++|||+.|
T Consensus        54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N  131 (722)
T KOG0532|consen   54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN  131 (722)
T ss_pred             ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence            3445555554221 112234555567788888887 77777777778888888888886 66777888888888888888


Q ss_pred             CCCCCCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCcCCccCchhhhccCCCCeecccCCccccCCCc
Q 001527          177 SFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQ  256 (1060)
Q Consensus       177 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~  256 (1060)
                      +++ .+|..+..|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.+.. +|..+.++.+|+.|.+..|++...+. 
T Consensus       132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~s-lpsql~~l~slr~l~vrRn~l~~lp~-  206 (722)
T KOG0532|consen  132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQS-LPSQLGYLTSLRDLNVRRNHLEDLPE-  206 (722)
T ss_pred             hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhh-chHHhhhHHHHHHHHHhhhhhhhCCH-
Confidence            887 6677776665 788888888884 677777777788888888888864 45567777777777776666643322 


Q ss_pred             CcCCCccccccEEEccCCcccccCCCCccccCCCCCCEEEccCCccccCCCCccCCCCccEEEccCCcCcc
Q 001527          257 KFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSG  327 (1060)
Q Consensus       257 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~  327 (1060)
                                                  ++..| .|..||+|.|++..++-.|..++.|++|-|.+|.+..
T Consensus       207 ----------------------------El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  207 ----------------------------ELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             ----------------------------HHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCCC
Confidence                                        12211 3566666666666444466667777777777777664

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.26  E-value=4.3e-12  Score=147.29  Aligned_cols=176  Identities=35%  Similarity=0.484  Sum_probs=104.8

Q ss_pred             EEEccCCccccccccccCCC-ccCEEEcccCeecccCCCCCcccCCCCeEEccCCcCccccchhccccCCCcEEecCCcc
Q 001527          386 VLDLSNNQFEGNLSRILKWG-NIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNH  464 (1060)
Q Consensus       386 ~L~Ls~N~l~~~~~~~~~~~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  464 (1060)
                      .|++.+|.++...+...... +|+.|++++|++. .+|..+..++.|+.|++++|+++ .+|.....++.|+.|++++|+
T Consensus       120 ~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~  197 (394)
T COG4886         120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK  197 (394)
T ss_pred             EEecCCcccccCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCc
Confidence            34444444443333333332 6666666666666 55556666667777777777766 455554466666777777777


Q ss_pred             ccCccccccccCCCcceEEccCccccccCCCCCCCCCCCcEEEccCCccccccCccccCCCCCcEEECCCCccccccCcc
Q 001527          465 LDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTS  544 (1060)
Q Consensus       465 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~  544 (1060)
                      +. .+|.....+..|++|++++|.+. ..+..+..+.++..|.+++|++. .+|..++.+++|++|++++|.++ .++. 
T Consensus       198 i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-  272 (394)
T COG4886         198 IS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-  272 (394)
T ss_pred             cc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-
Confidence            65 34444444455666666666432 23344556666666666666665 33666666666777777777776 3444 


Q ss_pred             ccCCCCCCeEeccCCcccCCCCCC
Q 001527          545 MANMTSLSSLVISQNHFTGPLPNN  568 (1060)
Q Consensus       545 ~~~l~~L~~L~ls~N~l~g~ip~~  568 (1060)
                      ++.+.+|+.|++++|.++..+|..
T Consensus       273 ~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         273 LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             ccccCccCEEeccCccccccchhh
Confidence            666677777777777766555543

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.25  E-value=5.6e-12  Score=146.34  Aligned_cols=198  Identities=33%  Similarity=0.467  Sum_probs=165.6

Q ss_pred             EEEccCCccccccccccCCCccCEEEcccCeecccCCCCCcccC-CCCeEEccCCcCccccchhccccCCCcEEecCCcc
Q 001527          386 VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNH  464 (1060)
Q Consensus       386 ~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  464 (1060)
                      .++++.|.+...+......+.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+
T Consensus        97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~  174 (394)
T COG4886          97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND  174 (394)
T ss_pred             eeeccccccccCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence            466666766666666666689999999999999 7787777775 9999999999999 677789999999999999999


Q ss_pred             ccCccccccccCCCcceEEccCccccccCCCCCCCCCCCcEEEccCCccccccCccccCCCCCcEEECCCCccccccCcc
Q 001527          465 LDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTS  544 (1060)
Q Consensus       465 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~  544 (1060)
                      ++. +|...+.++.|+.|++++|+++. +|........|++|++++|++. .++..+.++.++..|.+++|++. .+|..
T Consensus       175 l~~-l~~~~~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~  250 (394)
T COG4886         175 LSD-LPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES  250 (394)
T ss_pred             hhh-hhhhhhhhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccch
Confidence            984 66666688999999999999995 4544455677999999999654 57888999999999999999998 45889


Q ss_pred             ccCCCCCCeEeccCCcccCCCCCC-CccCCceeeCcCCcCccccCcc
Q 001527          545 MANMTSLSSLVISQNHFTGPLPNN-LPNSLETFNVSYNDFSGAVPEN  590 (1060)
Q Consensus       545 ~~~l~~L~~L~ls~N~l~g~ip~~-~~~~l~~l~ls~N~l~g~~p~~  590 (1060)
                      ++.+++|+.|++++|+++ .++.. -...++.|++++|.+....|..
T Consensus       251 ~~~l~~l~~L~~s~n~i~-~i~~~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         251 IGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             hccccccceecccccccc-ccccccccCccCEEeccCccccccchhh
Confidence            999999999999999998 44432 1158999999999998887765

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=1e-11  Score=128.59  Aligned_cols=158  Identities=22%  Similarity=0.387  Sum_probs=116.2

Q ss_pred             HHHHHHhcCCCCceeeeeeEEeCC---CCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-
Q 001527          821 KEAKKFANIRHPNVVGLRGYYWGP---TQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH-  896 (1060)
Q Consensus       821 ~E~~~l~~l~hpnIv~l~~~~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH-  896 (1060)
                      .-+..+-++.|-|||+++.|+.+.   +.....++.|||..|++.++|++.. +....+......+|+.||..||.||| 
T Consensus       116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs  194 (458)
T KOG1266|consen  116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHS  194 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhc
Confidence            344556677899999999998532   3345788999999999999997754 33456788888999999999999999 


Q ss_pred             cCCCcccCCCCCCCeEeeCCCCCeEEcccccceeecc---CCceeeeccCccccccchhcccCCCCCCCCccchHHHHHH
Q 001527          897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVI  973 (1060)
Q Consensus       897 ~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvv  973 (1060)
                      .++.|+|+++..+-|++. .++-+|+.----......   ..........+-++|.|||+-.....  +.++|||+||+.
T Consensus       195 ~~PpiihgnlTc~tifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~--~~a~dIy~fgmc  271 (458)
T KOG1266|consen  195 CDPPIIHGNLTCDTIFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT--TGASDIYKFGMC  271 (458)
T ss_pred             cCCccccCCcchhheeec-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc--ccchhhhhhhHH
Confidence            457899999999999998 576677643211111110   01111222356789999998765554  668999999999


Q ss_pred             HHHHHhCCC
Q 001527          974 LLELLTGRC  982 (1060)
Q Consensus       974 l~elltG~~  982 (1060)
                      ..||..|..
T Consensus       272 AlemailEi  280 (458)
T KOG1266|consen  272 ALEMAILEI  280 (458)
T ss_pred             HHHHHHhee
Confidence            999988764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.18  E-value=6.2e-11  Score=138.34  Aligned_cols=142  Identities=17%  Similarity=0.203  Sum_probs=92.4

Q ss_pred             CeeccccceEEEEEEEcC-CcEEEEEEcccchHHH----------------------------------HH------HHH
Q 001527          782 EVLGRSSHGTSYRATLEN-GMFLTVKWLREGVAKQ----------------------------------RK------EFA  820 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~------~~~  820 (1060)
                      +.||+|++|.||+|++++ |+.||||+.+++....                                  .+      ++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999887 9999999997552110                                  01      244


Q ss_pred             HHHHHHhcCC----CCceeeeeeEEeCCCCCceEEEEEecCCCChHHHhhc-CCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 001527          821 KEAKKFANIR----HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYD-RPGRKGPPLTWAQRLKIAVDVARGLNYL  895 (1060)
Q Consensus       821 ~E~~~l~~l~----hpnIv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~l~~~~~~~i~~qia~gL~~L  895 (1060)
                      +|+..+.+++    +...+.+-.++++ -....++||||++|+.+.++-.- ..+.....+....+..++.|+       
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d-~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------  276 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWD-YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------  276 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecc-cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------
Confidence            4555555542    4444444344431 23467899999999999874211 111100112223333333343       


Q ss_pred             hcCCCcccCCCCCCCeEeeCCCC----CeEEcccccceeecc
Q 001527          896 HFDRAVPHGNLKATNILLDGPDL----NARVADYCLHRLMTQ  933 (1060)
Q Consensus       896 H~~~~ivHrDlkp~NILl~~~~~----~~kl~Dfg~a~~~~~  933 (1060)
                      + ..|++|+|+||.||+++ .++    +++++|||++..+..
T Consensus       277 f-~~GffHaDpHPGNIlv~-~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 F-RDGFFHADMHPGNIFVS-YDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H-hCCeeeCCCChHHeEEe-cCCCCCCeEEEEecceEEECCH
Confidence            4 57999999999999998 455    899999999987654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.18  E-value=6e-11  Score=120.14  Aligned_cols=127  Identities=17%  Similarity=0.169  Sum_probs=94.1

Q ss_pred             CeeccccceEEEEEEEcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCcee-eeeeEEeCCCCCceEEEEEecCCCC
Q 001527          782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVV-GLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      +.++.|.++.||+++.. +..|++|+...... ....+.+|+++++.+.+..++ +++++.    ....++||||++|.+
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~----~~~~~lv~e~i~G~~   77 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD----PETGVLITEFIEGSE   77 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe----CCCCeEEEEecCCCc
Confidence            56889999999999875 77899999865432 223467899999988655544 444433    223589999999987


Q ss_pred             hHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-----cccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA-----VPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~-----ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      +.+.-             .....++.+++++|+.|| ..+     ++|+|++|.||+++  +..++++|||.+..
T Consensus        78 l~~~~-------------~~~~~~~~~l~~~l~~LH-~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTED-------------FSDPENLEKIAKLLKKLH-SSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc-------------ccCHHHHHHHHHHHHHHh-CCCCCCceeecCCCCcCcEEEE--CCeEEEEecccccC
Confidence            75430             011345789999999999 666     49999999999998  44799999998653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.17  E-value=2.3e-10  Score=115.96  Aligned_cols=137  Identities=14%  Similarity=0.137  Sum_probs=98.4

Q ss_pred             CeeccccceEEEEEEEcC-------CcEEEEEEcccch------H----------------HHHHHHH----HHHHHHhc
Q 001527          782 EVLGRSSHGTSYRATLEN-------GMFLTVKWLREGV------A----------------KQRKEFA----KEAKKFAN  828 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------~----------------~~~~~~~----~E~~~l~~  828 (1060)
                      .+||.|.=+.||.|.-.+       +..+|||+.+...      .                ...+.+.    +|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999998543       4799999875211      0                0122233    89999998


Q ss_pred             CCC--CceeeeeeEEeCCCCCceEEEEEecCCCChHH-HhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCcccC
Q 001527          829 IRH--PNVVGLRGYYWGPTQHEKLILSDYISPGSLAS-FLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL-HFDRAVPHG  904 (1060)
Q Consensus       829 l~h--pnIv~l~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~L-H~~~~ivHr  904 (1060)
                      +..  -++.+.+++      ...++||||+.+..+.. .+.+      ..++..+...+..+++.+|.++ | ..||||+
T Consensus        83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H-~~glVHG  149 (197)
T cd05146          83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYK-ECNLVHA  149 (197)
T ss_pred             HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHH-hCCeecC
Confidence            842  455566543      24689999997654322 2211      2245566778889999999999 6 8999999


Q ss_pred             CCCCCCeEeeCCCCCeEEcccccceeecc
Q 001527          905 NLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       905 Dlkp~NILl~~~~~~~kl~Dfg~a~~~~~  933 (1060)
                      |+++.||+++  ++.++++|||.+....+
T Consensus       150 DLs~~NIL~~--~~~v~iIDF~qav~~~h  176 (197)
T cd05146         150 DLSEYNMLWH--DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CCCHHHEEEE--CCcEEEEECCCceeCCC
Confidence            9999999997  45799999998876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.13  E-value=3.1e-10  Score=129.56  Aligned_cols=168  Identities=14%  Similarity=0.215  Sum_probs=126.7

Q ss_pred             EcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCCCChHHHhhcCCCCCCCCC
Q 001527          797 LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPL  876 (1060)
Q Consensus       797 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l  876 (1060)
                      ..++.+|.|+..+...........+-++-|+.+|||||+++++.+.  .....|+|+|-+.  .|..++.+        +
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e--~~~~~ylvTErV~--Pl~~~lk~--------l  101 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE--EEGTLYLVTERVR--PLETVLKE--------L  101 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc--ccCceEEEeeccc--cHHHHHHH--------h
Confidence            4578888888877554433455677888999999999999999884  5568999999985  57777743        3


Q ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCCceeeeccCccccccchhcccC
Q 001527          877 TWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS  956 (1060)
Q Consensus       877 ~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~  956 (1060)
                      ....+.-.+.||+.||.|||.+++++|++|.-+-|+++ ..+++||++|.++........... ...---.|..|+.+..
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~-~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAK-SLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccc-cchhhhcccChhhcCc
Confidence            45667778899999999999789999999999999999 688999999988765443322110 0011224677776643


Q ss_pred             CCCCCCCccchHHHHHHHHHHHhCCC
Q 001527          957 KKPHPSFKSDVYAFGVILLELLTGRC  982 (1060)
Q Consensus       957 ~~~~~s~~~DvwSlGvvl~elltG~~  982 (1060)
                      ..    ...|.|-|||+++|++.|..
T Consensus       180 s~----~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  180 SE----WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             cc----cchhhhhHHHHHHHHhCccc
Confidence            32    25699999999999999943

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.13  E-value=4.4e-11  Score=118.67  Aligned_cols=125  Identities=28%  Similarity=0.390  Sum_probs=34.8

Q ss_pred             CCCCCcEEEcCCCcccccCccccc-cccccCeeeccccccCcccCCcccCCCcccEEEccCCCCCCCCCccc-cCCCCcc
Q 001527          116 DFKSLEFLDVSDNLFSSSLPSGIG-KLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPAL-TRLNNLV  193 (1060)
Q Consensus       116 ~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~  193 (1060)
                      +...+++|+|++|+|+. +. .++ .+.+|+.|||++|.|+..  +.+..+++|++|+|++|+|+. +...+ ..+++|+
T Consensus        17 n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~   91 (175)
T PF14580_consen   17 NPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ   91 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred             ccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence            33344555555555542 21 233 344555555555555432  134455555555555555553 22222 3455566


Q ss_pred             EEEeecCcccccCC-cccccCCCCCEEEccCCcCCccCc---hhhhccCCCCeecc
Q 001527          194 YLNLSSNGFSKRIP-RGFELILGLQVLDFHGNKLDGHLD---GEFFLLTNASHIDF  245 (1060)
Q Consensus       194 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~l  245 (1060)
                      .|+|++|+|...-. ..+..+++|+.|+|.+|.+.....   -.+..+++|+.||-
T Consensus        92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            66666665543211 334556666666666666654322   24566677666654

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.12  E-value=3.6e-11  Score=119.32  Aligned_cols=129  Identities=29%  Similarity=0.402  Sum_probs=54.3

Q ss_pred             cccCCCCCcEEECcCCcccccCCCCcC-CCCCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcc-cCCC
Q 001527           89 VFSNLSMLVKLSMSNNSISGVIPDNIG-DFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSV-SGLV  166 (1060)
Q Consensus        89 ~~~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~  166 (1060)
                      .+.+...+++|+|++|+|+.+ . .++ .+.+|+.|||++|.|+.. + .|..|++|++|+|++|+|+.. +..+ ..++
T Consensus        14 ~~~n~~~~~~L~L~~n~I~~I-e-~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp   88 (175)
T PF14580_consen   14 QYNNPVKLRELNLRGNQISTI-E-NLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISSI-SEGLDKNLP   88 (175)
T ss_dssp             ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-T
T ss_pred             ccccccccccccccccccccc-c-chhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCcc-ccchHHhCC
Confidence            344667899999999999953 3 465 689999999999999954 3 588899999999999999965 3334 4689


Q ss_pred             cccEEEccCCCCCCCCC-ccccCCCCccEEEeecCcccccCC---cccccCCCCCEEEcc
Q 001527          167 SIQSLDLSHNSFSGSLP-PALTRLNNLVYLNLSSNGFSKRIP---RGFELILGLQVLDFH  222 (1060)
Q Consensus       167 ~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls  222 (1060)
                      +|++|+|++|+|...-. ..+..+++|+.|+|.+|.+....-   ..+..+++|+.||-.
T Consensus        89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen   89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred             cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence            99999999999985422 467889999999999999975421   246789999998854

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.04  E-value=1.9e-11  Score=124.68  Aligned_cols=134  Identities=24%  Similarity=0.331  Sum_probs=78.8

Q ss_pred             CCCCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEEEccCCCCCCCCCccccCCCCccEE
Q 001527          116 DFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYL  195 (1060)
Q Consensus       116 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  195 (1060)
                      .-..|++||||+|.|+ .+..+..-++.++.|++|+|.|...  +.+..|.+|+.||||+|.++ .+..+-..|.|.+.|
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL  357 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence            3345666666666666 4455555566666666666666532  22566666666666666666 444555566666666


Q ss_pred             EeecCcccccCCcccccCCCCCEEEccCCcCCccCc-hhhhccCCCCeecccCCccccCCC
Q 001527          196 NLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLD-GEFFLLTNASHIDFSGNMFVGSSS  255 (1060)
Q Consensus       196 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~~~  255 (1060)
                      .|+.|.|...  ..++.+-+|..||+++|+|..... ..+++|+-|+++.|.+|.+.++..
T Consensus       358 ~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  358 KLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             ehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            6666666422  345555666666666666654322 245666666666666666655443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.02  E-value=4e-11  Score=139.27  Aligned_cols=243  Identities=29%  Similarity=0.304  Sum_probs=110.9

Q ss_pred             CCCCcEEECcCCcccccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEEE
Q 001527           93 LSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLD  172 (1060)
Q Consensus        93 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  172 (1060)
                      +..++.+++..|.|.. +-..+..+++|+.|++.+|+|..+ ...+..+++|++|+|++|+|+.+.  .+..++.|+.|+
T Consensus        71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~  146 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN  146 (414)
T ss_pred             hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence            3444555555555553 223345555555555555555532 222445555555555555555332  234444455555


Q ss_pred             ccCCCCCCCCCccccCCCCccEEEeecCcccccCC-cccccCCCCCEEEccCCcCCccCchhhhccCCCCeecccCCccc
Q 001527          173 LSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIP-RGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFV  251 (1060)
Q Consensus       173 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~  251 (1060)
                      +++|.|+..  ..+..+.+|+.+++++|++....+ . ...+.+|+.+++.+|.+..+  ..+..+..+..         
T Consensus       147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~---------  212 (414)
T KOG0531|consen  147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVL---------  212 (414)
T ss_pred             eccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHH---------
Confidence            555555421  223335555555555555543322 1 24444555555555554422  12222222223         


Q ss_pred             cCCCcCcCCCccccccEEEccCCcccccCCCCccccCCCC--CCEEEccCCccccCCCCccCCCCccEEEccCCcCcccC
Q 001527          252 GSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFEN--LKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFI  329 (1060)
Q Consensus       252 ~~~~~~~l~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~l~~--L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~  329 (1060)
                                       +++..|.++..    ..+..+..  |+.+++++|++......+..+..+..|++.+|++...-
T Consensus       213 -----------------~~l~~n~i~~~----~~l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~~  271 (414)
T KOG0531|consen  213 -----------------LSLLDNKISKL----EGLNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNLE  271 (414)
T ss_pred             -----------------hhcccccceec----cCcccchhHHHHHHhcccCccccccccccccccccccchhhccccccc
Confidence                             34444444321    11122222  55566666655533234444555556666666554321


Q ss_pred             CcchhccCCCCCCeEECCCCccccccC------cccccCCcEEEccCCcCcccCC
Q 001527          330 PNDLLKGDSLLLTDLDLSANNLSGSVS------MILSTNLHMLNLSSNGLTGELP  378 (1060)
Q Consensus       330 p~~~~~~~~~~L~~L~Ls~N~l~~~~~------~~~~~~L~~L~Ls~N~l~~~~p  378 (1060)
                      ..    .....+..+.+..|.+.....      ..-...++.+.+..|.+....+
T Consensus       272 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  272 GL----ERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             cc----cccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            11    011124444555555442111      1112567777777777665443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.02  E-value=3.6e-11  Score=139.63  Aligned_cols=263  Identities=29%  Similarity=0.285  Sum_probs=166.4

Q ss_pred             CCCcEEECcCCcccccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEEEc
Q 001527           94 SMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDL  173 (1060)
Q Consensus        94 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  173 (1060)
                      +.++.++...+.+.+.--. ...+..++.+++..|.+.. +-..+..+++|+.|+|..|+|... ...+..+++|++|+|
T Consensus        49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~l  125 (414)
T KOG0531|consen   49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDL  125 (414)
T ss_pred             chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheec
Confidence            3455566665554421111 1456777777788888874 344577788888888888888744 333677888888888


Q ss_pred             cCCCCCCCCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCcCCccCchhhhccCCCCeecccCCccccC
Q 001527          174 SHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGS  253 (1060)
Q Consensus       174 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~  253 (1060)
                      ++|+|+...  .+..++.|+.|++++|.|+..  ..|..+.+|+.+++++|++..+.+.....+.+++.++         
T Consensus       126 s~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~---------  192 (414)
T KOG0531|consen  126 SFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELD---------  192 (414)
T ss_pred             ccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHh---------
Confidence            888887542  355666688888888888542  4455677788888888887765441034555544444         


Q ss_pred             CCcCcCCCccccccEEEccCCcccccCCCCccccCCCCCCEEEccCCccccCCCCccCCC--CccEEEccCCcCcccCCc
Q 001527          254 SSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVY--ELQVLKLSNNRFSGFIPN  331 (1060)
Q Consensus       254 ~~~~~l~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~l~--~L~~L~Ls~N~l~~~~p~  331 (1060)
                                       +..|.+...    ..+..+..+..+++..|.++..-+ +..+.  .|+.+++++|++... +.
T Consensus       193 -----------------l~~n~i~~i----~~~~~~~~l~~~~l~~n~i~~~~~-l~~~~~~~L~~l~l~~n~i~~~-~~  249 (414)
T KOG0531|consen  193 -----------------LGGNSIREI----EGLDLLKKLVLLSLLDNKISKLEG-LNELVMLHLRELYLSGNRISRS-PE  249 (414)
T ss_pred             -----------------ccCCchhcc----cchHHHHHHHHhhcccccceeccC-cccchhHHHHHHhcccCccccc-cc
Confidence                             444444321    334445566677999999875443 22233  389999999999842 11


Q ss_pred             chhccCCCCCCeEECCCCccccccCcccccCCcEEEccCCcCcccC-------CCCCCCCCEEEccCCccccc
Q 001527          332 DLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGEL-------PLLTGSCAVLDLSNNQFEGN  397 (1060)
Q Consensus       332 ~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~-------p~~~~~l~~L~Ls~N~l~~~  397 (1060)
                       ..... ..+..|++.+|.+...........+..+.+..|.+....       -.....+....+..|.....
T Consensus       250 -~~~~~-~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (414)
T KOG0531|consen  250 -GLENL-KNLPVLDLSSNRISNLEGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKI  320 (414)
T ss_pred             -ccccc-ccccccchhhccccccccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccc
Confidence             11112 238899999999987766666677788888888776321       11122344566666666543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.01  E-value=2.8e-11  Score=123.39  Aligned_cols=137  Identities=24%  Similarity=0.273  Sum_probs=96.9

Q ss_pred             cccccccccCeeeccccccCcccCCcccCCCcccEEEccCCCCCCCCCccccCCCCccEEEeecCcccccCCcccccCCC
Q 001527          136 SGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILG  215 (1060)
Q Consensus       136 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  215 (1060)
                      ..+..-..|++||||+|.|+ .+..++.-++.++.|++|+|.|+.. . .+..|++|+.||||+|.++. +.+.-..+.+
T Consensus       278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v-~-nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGN  353 (490)
T KOG1259|consen  278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV-Q-NLAELPQLQLLDLSGNLLAE-CVGWHLKLGN  353 (490)
T ss_pred             EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee-h-hhhhcccceEeecccchhHh-hhhhHhhhcC
Confidence            34444567888888888887 4566777778888888888888733 2 37788888888888888864 3444456778


Q ss_pred             CCEEEccCCcCCccCchhhhccCCCCeecccCCccccCCCcCcCCCccccccEEEccCCccccc
Q 001527          216 LQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGS  279 (1060)
Q Consensus       216 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~l~~~~~~L~~L~Ls~N~l~~~  279 (1060)
                      ++.|.|++|.|...  ..+..|.+|..||+++|++.....-..+..+ +.|+.+.|.+|.+.+.
T Consensus       354 IKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~L-PCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  354 IKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNL-PCLETLRLTGNPLAGS  414 (490)
T ss_pred             EeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccc-cHHHHHhhcCCCcccc
Confidence            88888888888643  3456677788888888888655443333333 3488888888888753

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.00  E-value=3.4e-09  Score=102.94  Aligned_cols=131  Identities=22%  Similarity=0.282  Sum_probs=94.0

Q ss_pred             CeeccccceEEEEEEEcCCcEEEEEE-cccch-------HHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEE
Q 001527          782 EVLGRSSHGTSYRATLENGMFLTVKW-LREGV-------AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~  853 (1060)
                      ..+++|+-+.+|.+.+.+.. +++|. +++.-       .-..++..+|++++.+++--.|...+=|..  +.....++|
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cCCCCEEEE
Confidence            35789999999999875444 55554 32211       112346778999998885333322222332  355678999


Q ss_pred             EecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      ||++|..|.+++...            +..++..+-.-+.-|| ..||||+||.++||++.  +..+.++|||++..
T Consensus        79 e~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH-~~givHGDLTtsNiIl~--~~~i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA------------RPDLLREVGRLVGKLH-KAGIVHGDLTTSNIILS--GGRIYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc------------chHHHHHHHHHHHHHH-hcCeecCCCccceEEEe--CCcEEEEECCcccc
Confidence            999999999898432            2456777778888899 99999999999999997  33599999999874

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.00  E-value=6.5e-11  Score=127.48  Aligned_cols=187  Identities=21%  Similarity=0.226  Sum_probs=103.8

Q ss_pred             CCCCCCcEEEcCCCcccccCc--cccccccccCeeeccccccCccc--CCcccCCCcccEEEccCCCCCCCCCcc-ccCC
Q 001527          115 GDFKSLEFLDVSDNLFSSSLP--SGIGKLESLQNLSLAGNNFSGLI--PDSVSGLVSIQSLDLSHNSFSGSLPPA-LTRL  189 (1060)
Q Consensus       115 ~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l  189 (1060)
                      .++++|++.-|.+.... ..+  .....|++++.||||+|-|....  -.....|++|+.|+|+.|++....... -..+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            35667777777777665 222  34566777777777777665422  223456777777777777775322221 1245


Q ss_pred             CCccEEEeecCccccc-CCcccccCCCCCEEEccCCcCCccCchhhhccCCCCeecccCCccccCCCcCcCCCccccccE
Q 001527          190 NNLVYLNLSSNGFSKR-IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQY  268 (1060)
Q Consensus       190 ~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~l~~~~~~L~~  268 (1060)
                      +.|+.|.|+.|.|+.. +-......++|+.|+|..|.....-......+..|+.|||++|.+.......-. +..+.|..
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~-~~l~~L~~  275 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKV-GTLPGLNQ  275 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccccccccccc-ccccchhh
Confidence            6777777777777521 223334566777777777754444444555566666666666666443321111 11223555


Q ss_pred             EEccCCcccccCCCCc----cccCCCCCCEEEccCCccc
Q 001527          269 LNLSLNQLTGSLVNGG----ELQLFENLKVLDLSYNQLT  303 (1060)
Q Consensus       269 L~Ls~N~l~~~~~~~~----~l~~l~~L~~L~Ls~N~l~  303 (1060)
                      |+++.+.++.....+.    -...+++|++|+++.|+|.
T Consensus       276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             hhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            5555555554322111    1234556666666666654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.95  E-value=6.8e-09  Score=100.04  Aligned_cols=143  Identities=19%  Similarity=0.262  Sum_probs=99.2

Q ss_pred             CCeeccccceEEEEEEEcCCcEEEEE-Ecccc-------hHHHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEE
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVK-WLREG-------VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~~~~~vavK-~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv  852 (1060)
                      .+++-+|+-+.|+++.+. |+...|| ++.+.       ..-..++..+|++.+.+++--.|.--.=++.  +...-.++
T Consensus        12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~--D~~~~~i~   88 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI--DTYGGQIY   88 (229)
T ss_pred             ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE--ecCCCeEE
Confidence            367889999999999986 5555555 33221       1123467788999999886333322222443  33455799


Q ss_pred             EEecCC-CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCC--eEEcccccce
Q 001527          853 SDYISP-GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLN--ARVADYCLHR  929 (1060)
Q Consensus       853 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~--~kl~Dfg~a~  929 (1060)
                      |||++| .++.+++......   ..........+.+|-+.+.-|| ..+|||+||..+||++..++.+  +.++|||++.
T Consensus        89 ME~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH-~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLH-DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EEeccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhh-hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            999976 4788888654321   1222223678889999999999 9999999999999999654444  4899999976


Q ss_pred             e
Q 001527          930 L  930 (1060)
Q Consensus       930 ~  930 (1060)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.95  E-value=1.3e-10  Score=125.16  Aligned_cols=210  Identities=24%  Similarity=0.268  Sum_probs=148.9

Q ss_pred             CCCCCcEEECcCCcccccCC--CCcCCCCCCcEEEcCCCcccccCc--cccccccccCeeeccccccCcccCC-cccCCC
Q 001527           92 NLSMLVKLSMSNNSISGVIP--DNIGDFKSLEFLDVSDNLFSSSLP--SGIGKLESLQNLSLAGNNFSGLIPD-SVSGLV  166 (1060)
Q Consensus        92 ~l~~L~~L~Ls~n~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~  166 (1060)
                      ++.+|++..|.+....- .+  +....|++++.||||+|-|..-.|  .-...|++|+.|+|+.|++...... .-..++
T Consensus       119 n~kkL~~IsLdn~~V~~-~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVED-AGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hHHhhhheeecCccccc-cchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            68889999999988763 23  467789999999999999885432  3467899999999999999743222 123578


Q ss_pred             cccEEEccCCCCCCC-CCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCcCCccCc-hhhhccCCCCeec
Q 001527          167 SIQSLDLSHNSFSGS-LPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLD-GEFFLLTNASHID  244 (1060)
Q Consensus       167 ~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~  244 (1060)
                      .|+.|.|+.|.|+.. +-.....+++|+.|+|..|..-.........+..|+.|||++|++-.... .....++.|+.|+
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln  277 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN  277 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence            899999999999843 23345678999999999996434455566678899999999999875542 2456788888888


Q ss_pred             ccCCccccCCCcCcC----CCccccccEEEccCCcccccCCCCccccCCCCCCEEEccCCccc
Q 001527          245 FSGNMFVGSSSQKFL----PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLT  303 (1060)
Q Consensus       245 ls~N~l~~~~~~~~l----~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~  303 (1060)
                      ++.+.+..+.....-    -....+|++|+++.|+|... ..-..+..+++|+.|....|.|+
T Consensus       278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w-~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDW-RSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             ccccCcchhcCCCccchhhhcccccceeeecccCccccc-cccchhhccchhhhhhccccccc
Confidence            888877654332210    01335799999999999642 21233444555555555555554

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.94  E-value=3.5e-09  Score=112.37  Aligned_cols=143  Identities=20%  Similarity=0.228  Sum_probs=106.5

Q ss_pred             CeeccccceEEEEEEEcCCcEEEEEEcccchH-HHHHHHHHHHHHHhcCCC--CceeeeeeEEeCCC-CCceEEEEEecC
Q 001527          782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRH--PNVVGLRGYYWGPT-QHEKLILSDYIS  857 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~-~~~~~lv~e~~~  857 (1060)
                      +.||.|.++.||+++..+|+.+++|+...... .....+.+|+++++.+++  ..+.+++.+..... .+..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987778999999865422 134578899999999975  34566666653211 125689999999


Q ss_pred             CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF----------------------------------------  897 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~----------------------------------------  897 (1060)
                      |.++.+.+..      ..++..++..++.+++++|.+||.                                        
T Consensus        84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            9888775521      236777888888888888888882                                        


Q ss_pred             ---------------CCCcccCCCCCCCeEeeCC-CCCeEEccccccee
Q 001527          898 ---------------DRAVPHGNLKATNILLDGP-DLNARVADYCLHRL  930 (1060)
Q Consensus       898 ---------------~~~ivHrDlkp~NILl~~~-~~~~kl~Dfg~a~~  930 (1060)
                                     ...++|+|++|.||+++.+ +..+.++||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           1235899999999999842 45678999987764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=1.3e-08  Score=103.05  Aligned_cols=126  Identities=21%  Similarity=0.280  Sum_probs=83.1

Q ss_pred             EEEEEEEcCCcEEEEEEcccchH--------------------------HHHHHHHHHHHHHhcCCCC--ceeeeeeEEe
Q 001527          791 TSYRATLENGMFLTVKWLREGVA--------------------------KQRKEFAKEAKKFANIRHP--NVVGLRGYYW  842 (1060)
Q Consensus       791 ~Vy~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~  842 (1060)
                      .||.|...+|..+|+|+.+....                          .......+|++.|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999988999999999752210                          1123567899999999754  566666543 


Q ss_pred             CCCCCceEEEEEecC--CCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCcccCCCCCCCeEeeCCCCC
Q 001527          843 GPTQHEKLILSDYIS--PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL-HFDRAVPHGNLKATNILLDGPDLN  919 (1060)
Q Consensus       843 ~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~L-H~~~~ivHrDlkp~NILl~~~~~~  919 (1060)
                           ..++||||++  |..+..+. +..      ++......++.+++..+..+ | ..||+|+|+.+.||+++ ++ .
T Consensus        80 -----~~~ivME~I~~~G~~~~~l~-~~~------~~~~~~~~~~~~il~~~~~~~~-~~givHGDLs~~NIlv~-~~-~  144 (188)
T PF01163_consen   80 -----RNVIVMEYIGEDGVPLPRLK-DVD------LSPEEPKELLEEILEEIIKMLH-KAGIVHGDLSEYNILVD-DG-K  144 (188)
T ss_dssp             -----TTEEEEE--EETTEEGGCHH-HCG------GGGSTHHHHHHHHHHHHHHHHH-CTTEEESS-STTSEEEE-TT-C
T ss_pred             -----CCEEEEEecCCCccchhhHH-hcc------ccchhHHHHHHHHHHHHHHHHH-hcCceecCCChhhEEee-cc-e
Confidence                 3479999998  54444433 211      12344567788888866664 6 99999999999999998 34 8


Q ss_pred             eEEcccccceeec
Q 001527          920 ARVADYCLHRLMT  932 (1060)
Q Consensus       920 ~kl~Dfg~a~~~~  932 (1060)
                      +.++|||.+....
T Consensus       145 ~~iIDf~qav~~~  157 (188)
T PF01163_consen  145 VYIIDFGQAVDSS  157 (188)
T ss_dssp             EEE--GTTEEETT
T ss_pred             EEEEecCcceecC
Confidence            9999999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.86  E-value=4.3e-08  Score=105.41  Aligned_cols=146  Identities=17%  Similarity=0.171  Sum_probs=102.3

Q ss_pred             CCCeeccccceEEEEEEEcCCcEEEEEEcccchHH-HH----------HHHHHHHHHHhcCCCCc--eeeeeeEEeCC--
Q 001527          780 PAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAK-QR----------KEFAKEAKKFANIRHPN--VVGLRGYYWGP--  844 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~--  844 (1060)
                      ..+++-......|++..+ +|+.|.||+....... ..          ..+.+|.+.+.++....  +++.++|....  
T Consensus        26 ~~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~  104 (268)
T PRK15123         26 QGEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN  104 (268)
T ss_pred             CCcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC
Confidence            345566555566778776 5778999977543211 11          13778998888874222  23334444211  


Q ss_pred             -CCCceEEEEEecCCC-ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeC------C
Q 001527          845 -TQHEKLILSDYISPG-SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG------P  916 (1060)
Q Consensus       845 -~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~------~  916 (1060)
                       .....++|||++++. +|.+++.+..   ..+.+...+..++.+++..+.-|| ..||+|+|++++|||++.      +
T Consensus       105 ~~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH-~~Gi~HgDL~~~NiLl~~~~~~~~~  180 (268)
T PRK15123        105 PATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMH-AAGINHRDCYICHFLLHLPFPGREE  180 (268)
T ss_pred             CccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHH-HCcCccCCCChhhEEEeccccCCCC
Confidence             133578999999886 8999885321   123556778899999999999999 999999999999999973      2


Q ss_pred             CCCeEEccccccee
Q 001527          917 DLNARVADYCLHRL  930 (1060)
Q Consensus       917 ~~~~kl~Dfg~a~~  930 (1060)
                      +..+.++||+.++.
T Consensus       181 ~~~~~LIDl~r~~~  194 (268)
T PRK15123        181 DLKLSVIDLHRAQI  194 (268)
T ss_pred             CceEEEEECCcccc
Confidence            46899999998754

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.86  E-value=1.8e-09  Score=88.14  Aligned_cols=59  Identities=36%  Similarity=0.565  Sum_probs=31.7

Q ss_pred             CCcEEECcCCcccccCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccccc
Q 001527           95 MLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNN  153 (1060)
Q Consensus        95 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  153 (1060)
                      +|++|+|++|+|+.+.++.|.++++|++|+|++|.++...|.+|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            45555555555555444555555555555555555554444455555555555555554

...

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.86  E-value=8.7e-08  Score=103.25  Aligned_cols=266  Identities=16%  Similarity=0.199  Sum_probs=157.3

Q ss_pred             CCCeeccccceEEEEEE-EcCCcEEEEEEcccchHHHHHHHHHHHHHHhcC-CCCceeeee----eEEeCCCCCc-eEEE
Q 001527          780 PAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLR----GYYWGPTQHE-KLIL  852 (1060)
Q Consensus       780 ~~~~iG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~----~~~~~~~~~~-~~lv  852 (1060)
                      .+.-+|+|+-+.+|..- ..|   .+.|++.........+   -++.|... .||-+-.-+    ...++.++.. ..++
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchhhc---hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            35679999999999653 222   2446665433222222   22333333 566443311    1112233333 5678


Q ss_pred             EEecCCC-ChHHHhhcC-CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEccccccee
Q 001527          853 SDYISPG-SLASFLYDR-PGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       853 ~e~~~~g-sL~~~l~~~-~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~  930 (1060)
                      |..+++. -...+.... +.+..+...|.-.++.++.+|.+.+-|| ..|.+-+|+.++|+|+. ++..+.|.|=..-..
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH-~~Gh~vGDVn~~~~lVs-d~~~V~LVdsDsfqi  166 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH-EHGHVVGDVNQNSFLVS-DDSKVVLVDSDSFQI  166 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH-hcCCcccccCccceeee-cCceEEEEcccceee
Confidence            8887765 233333221 2234466889999999999999999999 99999999999999997 688899887544333


Q ss_pred             eccCCceeeeccCccccccchhccc-CC--CCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCCCCccChHHHHHHHHhc
Q 001527          931 MTQAGTIEQILDAGVLGYRAPELAA-SK--KPHPSFKSDVYAFGVILLELLTG-RCAGDVISGEGAGVDLTDWMQLKVAE 1006 (1060)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~--~~~~s~~~DvwSlGvvl~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~ 1006 (1060)
                      ...  .......+|...|.+||.-. +.  ....+...|-|.+||++++++.| ++||..+..........+   ..+..
T Consensus       167 ~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~  241 (637)
T COG4248         167 NAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAH  241 (637)
T ss_pred             ccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhc
Confidence            222  22233447899999999865 11  11225678999999999999886 999987653322111111   11122


Q ss_pred             CCCCccccc--ccccccCChhHHHHHHHHHHHHHHhccCC---CCCCCHHHHHHHhh
Q 001527         1007 GHGSDCFDA--AVMPEMVNPAAEKGMKEVLGIALRCIRSV---SERPGIKTIYEDLS 1058 (1060)
Q Consensus      1007 ~~~~~~~d~--~l~~~~~~~~~~~~~~~l~~l~~~C~~~p---~~RPs~~evl~~L~ 1058 (1060)
                      +.+...-|.  ...+.......+-....+..+..+|..++   .-|||++..+..|.
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~  298 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD  298 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence            222111111  11111111112223334555666888754   47999998887764

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.84  E-value=2.5e-09  Score=87.28  Aligned_cols=61  Identities=36%  Similarity=0.594  Sum_probs=40.1

Q ss_pred             CCCcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEEEccCCCC
Q 001527          118 KSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF  178 (1060)
Q Consensus       118 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  178 (1060)
                      ++|++|+|++|+|+...+..|.++++|++|+|++|+++...|.+|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3566677777766655555666666666666666666666666666666666666666654

...

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.81  E-value=3.9e-10  Score=118.57  Aligned_cols=233  Identities=21%  Similarity=0.225  Sum_probs=123.0

Q ss_pred             CCCCCcEEECcCCcccc----cCCCCcCCCCCCcEEEcCCC---cccccCcc-------ccccccccCeeeccccccCcc
Q 001527           92 NLSMLVKLSMSNNSISG----VIPDNIGDFKSLEFLDVSDN---LFSSSLPS-------GIGKLESLQNLSLAGNNFSGL  157 (1060)
Q Consensus        92 ~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~Ls~N---~l~~~~p~-------~~~~l~~L~~L~Ls~N~l~~~  157 (1060)
                      .+..+++|+||+|.|..    .+...+.+.++|+.-++|+=   ++...+|.       ++-..++|++||||.|-|.-.
T Consensus        28 ~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~  107 (382)
T KOG1909|consen   28 PMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK  107 (382)
T ss_pred             ccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence            45566777777777642    24445566667777777652   23333343       334455777777777766532


Q ss_pred             cCC----cccCCCcccEEEccCCCCCCCC-------------CccccCCCCccEEEeecCcccc----cCCcccccCCCC
Q 001527          158 IPD----SVSGLVSIQSLDLSHNSFSGSL-------------PPALTRLNNLVYLNLSSNGFSK----RIPRGFELILGL  216 (1060)
Q Consensus       158 ~p~----~~~~l~~L~~L~Ls~N~l~~~~-------------p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L  216 (1060)
                      -+.    -+..++.|++|+|.+|.+.-.-             ..-.+.-++|+.+..++|++..    .+...|...+.|
T Consensus       108 g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~l  187 (382)
T KOG1909|consen  108 GIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTL  187 (382)
T ss_pred             chHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcccc
Confidence            222    2345667777777777665211             1112334567777777777742    123456666777


Q ss_pred             CEEEccCCcCCcc----CchhhhccCCCCeecccCCccccCCCc---CcCCCccccccEEEccCCcccccCCC--Cccc-
Q 001527          217 QVLDFHGNKLDGH----LDGEFFLLTNASHIDFSGNMFVGSSSQ---KFLPGLSQSVQYLNLSLNQLTGSLVN--GGEL-  286 (1060)
Q Consensus       217 ~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~~~~---~~l~~~~~~L~~L~Ls~N~l~~~~~~--~~~l-  286 (1060)
                      +.+.++.|.|...    ....|..+++|++|||.+|.|+.....   ..++.+. +|+.|+++++.+...-..  ...+ 
T Consensus       188 eevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~-~L~El~l~dcll~~~Ga~a~~~al~  266 (382)
T KOG1909|consen  188 EEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWP-HLRELNLGDCLLENEGAIAFVDALK  266 (382)
T ss_pred             ceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccc-hheeecccccccccccHHHHHHHHh
Confidence            7777777776521    223566777777777777766533221   1222222 355555555555421100  0000 


Q ss_pred             cCCCCCCEEEccCCccccCC----C-CccCCCCccEEEccCCcC
Q 001527          287 QLFENLKVLDLSYNQLTGEL----P-GFNFVYELQVLKLSNNRF  325 (1060)
Q Consensus       287 ~~l~~L~~L~Ls~N~l~~~~----p-~~~~l~~L~~L~Ls~N~l  325 (1060)
                      ...++|++|.|.+|.|+..-    . .....+.|..|+|++|++
T Consensus       267 ~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  267 ESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             ccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            12455666666666654211    0 123345555555555555

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.79  E-value=3.2e-09  Score=131.38  Aligned_cols=135  Identities=28%  Similarity=0.354  Sum_probs=106.7

Q ss_pred             ccccCCCCCcEEECcCCcccccCCCCcCCCCCCcEEEcCCCc--ccccCccccccccccCeeeccccccCcccCCcccCC
Q 001527           88 SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNL--FSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGL  165 (1060)
Q Consensus        88 ~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  165 (1060)
                      +...+....+...+.+|++. .++.... .+.|+.|-+..|.  +....+..|..++.|++|||++|.=-+.+|..+++|
T Consensus       517 ~~~~~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~L  594 (889)
T KOG4658|consen  517 PQVKSWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGEL  594 (889)
T ss_pred             ccccchhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhh
Confidence            33446677888888888887 3444433 3378888888886  554444557889999999999887777889999999


Q ss_pred             CcccEEEccCCCCCCCCCccccCCCCccEEEeecCcccccCCcccccCCCCCEEEccCCc
Q 001527          166 VSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNK  225 (1060)
Q Consensus       166 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  225 (1060)
                      .+|++|+|++..++ .+|..+++|.+|.+||+..+.-...+|.....|.+|++|.|..-.
T Consensus       595 i~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  595 VHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             hhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            99999999999988 788899999999999999887666677777888999998887765

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.77  E-value=3e-09  Score=120.85  Aligned_cols=190  Identities=17%  Similarity=0.223  Sum_probs=138.2

Q ss_pred             CCeeccccceEEEEEEEc--CCcEEEEEEcccchHHHHHH--HHHHHHHHhcC-CCCceeeeeeEEeCCCCCceEEEEEe
Q 001527          781 AEVLGRSSHGTSYRATLE--NGMFLTVKWLREGVAKQRKE--FAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~iG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~lv~e~  855 (1060)
                      ...||.|.|+.||....+  ++..|++|.+.+.......+  -..|+.+...+ .|.+++++...|.  .....|+--||
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--~~r~~~ip~e~  347 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--QLRQGYIPLEF  347 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc--ccccccCchhh
Confidence            457999999999998744  68889999887654433222  23466666555 5888888776663  34456788999


Q ss_pred             cCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      |+++++...+.     ....+++..++++..|++.|+.++| ++.++|+|+||+||++..+++..++.|||.+..+.-..
T Consensus       348 ~~~~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~-s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~  421 (524)
T KOG0601|consen  348 CEGGSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIH-SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS  421 (524)
T ss_pred             hcCcchhhhhH-----HHHhcCcchhhhhHHHHHhcccccc-chhhhcccccccceeeccchhhhhccccccccccceec
Confidence            99998877662     2234778888999999999999999 99999999999999997434788999999886422211


Q ss_pred             ceeeeccCcccccc-chhcccCCCCCCCCccchHHHHHHHHHHHhCCCC
Q 001527          936 TIEQILDAGVLGYR-APELAASKKPHPSFKSDVYAFGVILLELLTGRCA  983 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~-aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p  983 (1060)
                      .    .....-+++ .+|++..... +-.++|+||||.-+.|.++|..-
T Consensus       422 ~----~~~~~~r~~p~~~~~~e~~~-~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  422 G----VFHHIDRLYPIAEILLEDYP-HLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             c----cccccccccccchhhccccc-cccccccccccccccccccCccc
Confidence            1    112333444 3555554433 35699999999999999998753

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.73  E-value=1.5e-09  Score=114.14  Aligned_cols=235  Identities=24%  Similarity=0.262  Sum_probs=138.7

Q ss_pred             CcCCCCCCcEEEcCCCccccc----CccccccccccCeeeccccc---cCcccCC-------cccCCCcccEEEccCCCC
Q 001527          113 NIGDFKSLEFLDVSDNLFSSS----LPSGIGKLESLQNLSLAGNN---FSGLIPD-------SVSGLVSIQSLDLSHNSF  178 (1060)
Q Consensus       113 ~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~---l~~~~p~-------~~~~l~~L~~L~Ls~N~l  178 (1060)
                      ....+..++.|+||+|.|...    +...+.+.++|+.-++|.--   +...+|.       .+.+.++|++||||+|-|
T Consensus        25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~  104 (382)
T KOG1909|consen   25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF  104 (382)
T ss_pred             HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence            456778999999999999744    44567778889999888532   2223333       355667899999999998


Q ss_pred             CCCCCc----cccCCCCccEEEeecCcccccCCcc-------------cccCCCCCEEEccCCcCCccCch----hhhcc
Q 001527          179 SGSLPP----ALTRLNNLVYLNLSSNGFSKRIPRG-------------FELILGLQVLDFHGNKLDGHLDG----EFFLL  237 (1060)
Q Consensus       179 ~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~-------------~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l  237 (1060)
                      ....+.    .+..+..|++|+|.+|.+...--..             ...-+.|+++..++|++..-...    .|...
T Consensus       105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~  184 (382)
T KOG1909|consen  105 GPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSH  184 (382)
T ss_pred             CccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhc
Confidence            754444    3456788999999999884211111             22334455555555555432221    22222


Q ss_pred             CCCCeecccCCccccCCCcCcCCCccccccEEEccCCcccccCC--CCccccCCCCCCEEEccCCccccCC-----CCcc
Q 001527          238 TNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLV--NGGELQLFENLKVLDLSYNQLTGEL-----PGFN  310 (1060)
Q Consensus       238 ~~L~~L~ls~N~l~~~~~~~~l~~~~~~L~~L~Ls~N~l~~~~~--~~~~l~~l~~L~~L~Ls~N~l~~~~-----p~~~  310 (1060)
                      +                          .|+.+.++.|.|...-.  -...+..+++|+.|||.+|-++..-     ..+.
T Consensus       185 ~--------------------------~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~  238 (382)
T KOG1909|consen  185 P--------------------------TLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALS  238 (382)
T ss_pred             c--------------------------ccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhc
Confidence            2                          36666666666642111  0134667888888888888886422     1466


Q ss_pred             CCCCccEEEccCCcCcccCCcchh---ccCCCCCCeEECCCCcccccc------CcccccCCcEEEccCCcC
Q 001527          311 FVYELQVLKLSNNRFSGFIPNDLL---KGDSLLLTDLDLSANNLSGSV------SMILSTNLHMLNLSSNGL  373 (1060)
Q Consensus       311 ~l~~L~~L~Ls~N~l~~~~p~~~~---~~~~~~L~~L~Ls~N~l~~~~------~~~~~~~L~~L~Ls~N~l  373 (1060)
                      .+++|+.|+++.+.++..-...+.   ......|+.|.|.+|.++..-      +..-.+.|..|+|++|.+
T Consensus       239 s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  239 SWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             ccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            677888888888877632111111   111223666666666665211      011124566666666665

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.73  E-value=8.2e-08  Score=106.35  Aligned_cols=171  Identities=19%  Similarity=0.283  Sum_probs=127.8

Q ss_pred             eEEEEEE-EcCCcEEEEEEcccchHHHHHHHHHHHHHHhcCCCCceeeeeeEEeC--CCCCceEEEEEecCC-CChHHHh
Q 001527          790 GTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWG--PTQHEKLILSDYISP-GSLASFL  865 (1060)
Q Consensus       790 g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~~~lv~e~~~~-gsL~~~l  865 (1060)
                      .+.|++. ..||..|++|++.............-+++++++.|+|||++.+++..  -.+...++||+|.++ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            5789998 45899999999943322222334466889999999999999988852  133457899999986 4777755


Q ss_pred             hcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccCC
Q 001527          866 YDRPG----------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       866 ~~~~~----------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~~  935 (1060)
                      .....          ..+...++...+.++.|+..||.++| +.|..-+-|.|.+|++++ +.+++|+..|.......+.
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH-ssGLAck~L~~~kIlv~G-~~RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH-SSGLACKTLDLKKILVTG-KMRIRISGCGIMDVLQEDP  447 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH-hcCceeecccHhHeEeeC-cceEEEecccceeeecCCC
Confidence            43221          12345778999999999999999999 899999999999999995 6689998888776655443


Q ss_pred             ceeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCC
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRC  982 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~  982 (1060)
                      .               |-+.+     -.+-|.=.||.+++.|.||..
T Consensus       448 ~---------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  448 T---------------EPLES-----QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             C---------------cchhH-----HhhhhHHHHHHHHHHHhhccc
Confidence            1               11111     225688899999999999954

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.59  E-value=4.7e-08  Score=72.90  Aligned_cols=42  Identities=55%  Similarity=0.984  Sum_probs=29.9

Q ss_pred             hHHHHHHHHHHHhccCCCCCccCCCCCCCCCCCCCCCCccceEEec
Q 001527           22 SQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCN   67 (1060)
Q Consensus        22 ~~~~~aLl~~k~~~~~~~~~~~l~sW~~~~~~~~~~~c~w~gv~C~   67 (1060)
                      ..|++||++||+++..+| ...+.+|+.+.   +.+||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~-~~~l~~W~~~~---~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDP-SGVLSSWNPSS---DSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC--CCCTT--TT-----S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhccccc-CcccccCCCcC---CCCCeeeccEEeC
Confidence            367999999999999766 67899999621   3799999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.56  E-value=2.9e-08  Score=123.00  Aligned_cols=130  Identities=22%  Similarity=0.328  Sum_probs=103.6

Q ss_pred             CCCCCcEEEcCCCcccccCccccccccccCeeeccccc--cCcccCCcccCCCcccEEEccCCCCCCCCCccccCCCCcc
Q 001527          116 DFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNN--FSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLV  193 (1060)
Q Consensus       116 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  193 (1060)
                      +....+...+-+|.+. .++....+ ++|++|-+..|.  +.......|..++.|++|||++|.=-+.+|..++.|-+|+
T Consensus       521 ~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr  598 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR  598 (889)
T ss_pred             chhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence            4467788888888887 44444433 379999999986  5545555688899999999999876678999999999999


Q ss_pred             EEEeecCcccccCCcccccCCCCCEEEccCCcCCccCchhhhccCCCCeecccCC
Q 001527          194 YLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGN  248 (1060)
Q Consensus       194 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N  248 (1060)
                      +|+|++..++ .+|..+++|..|.+|++..+.-...+|.....|.+|++|.+..-
T Consensus       599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRS  652 (889)
T ss_pred             cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeecc
Confidence            9999999996 68899999999999999988876677777877888777666433

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.55  E-value=3.5e-07  Score=94.54  Aligned_cols=136  Identities=20%  Similarity=0.223  Sum_probs=98.6

Q ss_pred             hhccCCCeeccccceEEEEEEEcCCcEEEEEEcccchH----------------------HHHHHHHHHHHHHhcCCCC-
Q 001527          776 LSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVA----------------------KQRKEFAKEAKKFANIRHP-  832 (1060)
Q Consensus       776 l~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~hp-  832 (1060)
                      ...+.++.||-|.-+.||.|..++|..+|||.=+.+..                      ..+...++|.++|.++.-. 
T Consensus        91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             hHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            34456789999999999999999999999997542211                      1123466899999999644 


Q ss_pred             -ceeeeeeEEeCCCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCe
Q 001527          833 -NVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNI  911 (1060)
Q Consensus       833 -nIv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NI  911 (1060)
                       .|.+.+++      +...+||||++|--|...-          ++....-.|+..|++-+...- ..||||+|+.+-||
T Consensus       171 ~~VP~P~~~------nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~-~~GiVHGDlSefNI  233 (304)
T COG0478         171 VKVPKPIAW------NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY-RRGIVHGDLSEFNI  233 (304)
T ss_pred             CCCCCcccc------ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH-HcCccccCCchheE
Confidence             67776654      3468999999885554321          223344455566666665555 68999999999999


Q ss_pred             EeeCCCCCeEEcccccce
Q 001527          912 LLDGPDLNARVADYCLHR  929 (1060)
Q Consensus       912 Ll~~~~~~~kl~Dfg~a~  929 (1060)
                      +++ +++.+.++||=-+.
T Consensus       234 lV~-~dg~~~vIDwPQ~v  250 (304)
T COG0478         234 LVT-EDGDIVVIDWPQAV  250 (304)
T ss_pred             EEe-cCCCEEEEeCcccc
Confidence            998 58899999995443

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.51  E-value=4.5e-09  Score=119.47  Aligned_cols=104  Identities=31%  Similarity=0.375  Sum_probs=52.0

Q ss_pred             cCeeeccccccCcccCCcccCCCcccEEEccCCCCCCCCCccccCCCCccEEEeecCcccccCCc-ccccCCCCCEEEcc
Q 001527          144 LQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPR-GFELILGLQVLDFH  222 (1060)
Q Consensus       144 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls  222 (1060)
                      |.+.+.++|.+. ....++.-++.|+.|||++|+++...  .+..|++|++|||++|.+.. +|. ...++ .|+.|.|+
T Consensus       166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc-~L~~L~lr  240 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRH-VPQLSMVGC-KLQLLNLR  240 (1096)
T ss_pred             HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhcc-ccccchhhh-hheeeeec
Confidence            444445555554 33444555555666666666665321  45555666666666666542 232 11222 25666666


Q ss_pred             CCcCCccCchhhhccCCCCeecccCCccccCC
Q 001527          223 GNKLDGHLDGEFFLLTNASHIDFSGNMFVGSS  254 (1060)
Q Consensus       223 ~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~  254 (1060)
                      +|.++..  ..+.+|.+|+.||++.|-|.+-.
T Consensus       241 nN~l~tL--~gie~LksL~~LDlsyNll~~hs  270 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHS  270 (1096)
T ss_pred             ccHHHhh--hhHHhhhhhhccchhHhhhhcch
Confidence            6655433  12445555555555555554433

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.47  E-value=1.6e-06  Score=90.33  Aligned_cols=109  Identities=21%  Similarity=0.258  Sum_probs=80.0

Q ss_pred             HHHHHHHHHHhcCCC--CceeeeeeEEeCCC--CCceEEEEEecCCC-ChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 001527          817 KEFAKEAKKFANIRH--PNVVGLRGYYWGPT--QHEKLILSDYISPG-SLASFLYDRPGRKGPPLTWAQRLKIAVDVARG  891 (1060)
Q Consensus       817 ~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~--~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~qia~g  891 (1060)
                      ....+|.+.+.++..  =.+.+.+++.....  ....++|+|++++. +|.+++....     ..+......++.+++..
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALARL  130 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHHH
Confidence            456778887777742  22344444443211  13458999999884 8999985422     25666788999999999


Q ss_pred             HHHHhcCCCcccCCCCCCCeEeeCCC--CCeEEcccccceee
Q 001527          892 LNYLHFDRAVPHGNLKATNILLDGPD--LNARVADYCLHRLM  931 (1060)
Q Consensus       892 L~~LH~~~~ivHrDlkp~NILl~~~~--~~~kl~Dfg~a~~~  931 (1060)
                      ++-|| ..||+|+|+++.|||++.++  ..+.++||+-++..
T Consensus       131 i~~lH-~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  131 IAKLH-DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHH-HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999 99999999999999998432  37899999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.46  E-value=2.1e-06  Score=87.23  Aligned_cols=140  Identities=15%  Similarity=0.114  Sum_probs=101.5

Q ss_pred             ccccceEEEEEEEcCCcEEEEEEcccch------HHHHHHHHHHHHHHhcCCC--CceeeeeeEEe---CCCCCceEEEE
Q 001527          785 GRSSHGTSYRATLENGMFLTVKWLREGV------AKQRKEFAKEAKKFANIRH--PNVVGLRGYYW---GPTQHEKLILS  853 (1060)
Q Consensus       785 G~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~---~~~~~~~~lv~  853 (1060)
                      |+||-+-|++..+++ +.+-+|+-....      +.....|.+|+..+.++..  -.+.+.. ++.   ......-+||+
T Consensus        27 ~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            789999999988764 468888764211      2245789999999988842  2244444 331   12233468999


Q ss_pred             EecCC-CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCC-CCCeEEccccccee
Q 001527          854 DYISP-GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP-DLNARVADYCLHRL  930 (1060)
Q Consensus       854 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~-~~~~kl~Dfg~a~~  930 (1060)
                      |-+++ .+|.+++.+..   -.+.+...+..+..+++..++-|| ..|+.|+|+-+.||+++.+ +..++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH-~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMH-SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98864 58999985432   234677888899999999999999 9999999999999999732 23499999986653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.46  E-value=4e-08  Score=117.21  Aligned_cols=196  Identities=19%  Similarity=0.216  Sum_probs=134.5

Q ss_pred             eeccccceEEEEEEEc-CCcEEEEEEcccchH---HHHHHHHHHHHHHhcCCCCceeeeeeEEeCCCCCceEEEEEecCC
Q 001527          783 VLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       783 ~iG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~lv~e~~~~  858 (1060)
                      -+-+|+++.++.++-. .|...+.|.......   .+.+....+-.+.-..+||.++...--+  ......++|++|..+
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~L~~~~~~~  888 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLPLVGHYLNG  888 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCCCcchhhHHhcc
Confidence            4667888888877633 344444444432211   1122233343444444567777653332  345678999999999


Q ss_pred             CChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeCCCCCeEEcccccceeeccC----
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA----  934 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~~~~~~kl~Dfg~a~~~~~~----  934 (1060)
                      ++|...++...     ..+..........+..+++||| ...+.|||++|.|.++. .++..++.|||......-.    
T Consensus       889 ~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~-s~~r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  889 GDLPSKLHNSG-----CLSAEPARSPILERVQSLESLH-SSLRKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             CCchhhhhcCC-----CcccccccchhHHHHhhhhccc-cchhhcccccccchhhc-ccCCcccCccccccccccccCcC
Confidence            99999996543     3455555667778889999999 77789999999999997 6889999999843321100    


Q ss_pred             -----------------C------c---eeeeccCccccccchhcccCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 001527          935 -----------------G------T---IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVIS  988 (1060)
Q Consensus       935 -----------------~------~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwSlGvvl~elltG~~p~~~~~  988 (1060)
                                       .      .   .......||+.|.|||...+...  ...+|+|+.|++++|.++|..||....
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h--gs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH--GSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC--CCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence                             0      0   00112368999999999988875  558999999999999999999998654


Q ss_pred             C
Q 001527          989 G  989 (1060)
Q Consensus       989 ~  989 (1060)
                      .
T Consensus      1040 p 1040 (1205)
T KOG0606|consen 1040 P 1040 (1205)
T ss_pred             h
Confidence            3

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.40  E-value=4.1e-09  Score=119.80  Aligned_cols=128  Identities=26%  Similarity=0.334  Sum_probs=75.7

Q ss_pred             CcEEEcCCCcccccCccccccccccCeeeccccccCcccCCcccCCCcccEEEccCCCCCCCCCccccCCCCccEEEeec
Q 001527          120 LEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSS  199 (1060)
Q Consensus       120 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  199 (1060)
                      |..-+.++|++. .+..++.-++.|+.|||++|++...  +.+..|++|++|||++|.+....--...++. |+.|.|++
T Consensus       166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrn  241 (1096)
T KOG1859|consen  166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRN  241 (1096)
T ss_pred             HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecc
Confidence            555566666665 4555566666666666666666533  2556666666666666666632222233333 66677777


Q ss_pred             CcccccCCcccccCCCCCEEEccCCcCCccCc-hhhhccCCCCeecccCCccccC
Q 001527          200 NGFSKRIPRGFELILGLQVLDFHGNKLDGHLD-GEFFLLTNASHIDFSGNMFVGS  253 (1060)
Q Consensus       200 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~~~  253 (1060)
                      |.++..  ..+.+|.+|+.|||+.|-|.+.-. ..++.|..|+.|+|.+|.+.+.
T Consensus       242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            766432  345666677777777776655332 2345566777777777777543

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.38  E-value=3.3e-08  Score=101.56  Aligned_cols=104  Identities=27%  Similarity=0.331  Sum_probs=67.4

Q ss_pred             EecCCCCccccCccccc-CCCCCcEEECcCCcccc--cCCCCcCCCCCCcEEEcCCCcccccCccccccccccCeeeccc
Q 001527           75 VLDNLGLSAAADLSVFS-NLSMLVKLSMSNNSISG--VIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAG  151 (1060)
Q Consensus        75 ~l~~~~~~~~~~~~~~~-~l~~L~~L~Ls~n~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  151 (1060)
                      .+......-.|+...|. ..++++.|||.+|+|+.  .+-.-+.+|+.|++|+|+.|.+...|...=..+.+|++|-|.+
T Consensus        51 vln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNg  130 (418)
T KOG2982|consen   51 VLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNG  130 (418)
T ss_pred             eecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcC
Confidence            33333333445555555 67888888898888873  3444566788888888888888754432213566788888877


Q ss_pred             cccCcc-cCCcccCCCcccEEEccCCCC
Q 001527          152 NNFSGL-IPDSVSGLVSIQSLDLSHNSF  178 (1060)
Q Consensus       152 N~l~~~-~p~~~~~l~~L~~L~Ls~N~l  178 (1060)
                      ..+.-. ....+..++.+++|++|.|.+
T Consensus       131 T~L~w~~~~s~l~~lP~vtelHmS~N~~  158 (418)
T KOG2982|consen  131 TGLSWTQSTSSLDDLPKVTELHMSDNSL  158 (418)
T ss_pred             CCCChhhhhhhhhcchhhhhhhhccchh
Confidence            776532 223456677777777777743

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.31  E-value=2.8e-08  Score=90.68  Aligned_cols=135  Identities=20%  Similarity=0.252  Sum_probs=83.2

Q ss_pred             CcEEecCCccccCccccc---cccCCCcceEEccCccccccCCCCCCCCCCCcEEEccCCccccccCccccCCCCCcEEE
Q 001527          455 LRVLDLSFNHLDGPFLTN---LLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLC  531 (1060)
Q Consensus       455 L~~L~Ls~N~l~~~~~~~---~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  531 (1060)
                      +..+||+++++. .+++.   +.....|+..+|++|.+....+..-...+.++.|+|++|.|+ .+|.++..++.|+.|+
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN  106 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence            344555555543 12222   233344555566666666443333334456778888888887 5777788888888888


Q ss_pred             CCCCccccccCccccCCCCCCeEeccCCcccCCCCCCC--ccCCceeeCcCCcCccccCccccC
Q 001527          532 LAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNL--PNSLETFNVSYNDFSGAVPENLRK  593 (1060)
Q Consensus       532 Ls~N~l~g~ip~~~~~l~~L~~L~ls~N~l~g~ip~~~--~~~l~~l~ls~N~l~g~~p~~~~~  593 (1060)
                      ++.|.|. ..|..+..|.+|-.||..+|... +||..+  +......++.++.+.+.-|..++.
T Consensus       107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa  168 (177)
T KOG4579|consen  107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQA  168 (177)
T ss_pred             cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccccc
Confidence            8888887 67777777888888888888775 555442  123334455566666655554443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.30  E-value=7.6e-06  Score=84.05  Aligned_cols=139  Identities=19%  Similarity=0.256  Sum_probs=96.5

Q ss_pred             CeeccccceEEEEEEEcCCcEEEEEEcccchHHH-------------------H-----HHHHHHHHHHhcCC--CCcee
Q 001527          782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQ-------------------R-----KEFAKEAKKFANIR--HPNVV  835 (1060)
Q Consensus       782 ~~iG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~-----~~~~~E~~~l~~l~--hpnIv  835 (1060)
                      ..|..|.-+.||+|.-.++..+|||+++......                   .     .-..+|+..|+++.  +=.+.
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            3677888889999998889999999986332110                   0     11346777777773  44455


Q ss_pred             eeeeEEeCCCCCceEEEEEecCCCChHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCcccCCCCCCCeEeeC
Q 001527          836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG  915 (1060)
Q Consensus       836 ~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ivHrDlkp~NILl~~  915 (1060)
                      +-+++.      .-.|||||+....     ...+.-...++...+...+..++++.+.-|-...++||+||+.=|||+. 
T Consensus       134 ~Pi~~~------~nVLvMEfIg~~g-----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-  201 (268)
T COG1718         134 EPIAFR------NNVLVMEFIGDDG-----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-  201 (268)
T ss_pred             Cceeec------CCeEEEEeccCCC-----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence            555544      3579999996431     0111111122333467788889999998888459999999999999997 


Q ss_pred             CCCCeEEcccccceeecc
Q 001527          916 PDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       916 ~~~~~kl~Dfg~a~~~~~  933 (1060)
                       ++.+.++|||-|....+
T Consensus       202 -~~~p~iID~~QaV~~~h  218 (268)
T COG1718         202 -DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             -CCeEEEEECccccccCC
Confidence             56899999998776543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1060
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		5e-34
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		9e-12
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-33
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-11
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-27
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-27
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-20
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-17
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-06
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-15
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-14
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-13
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-07
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-07
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-07
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-07
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-07
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-07
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-07
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-07
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-07
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		8e-07
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-07
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		8e-07
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-07
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-07
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-07
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-07
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-06
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-06
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-06
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-06
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-06
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-06
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-06
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-06
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-06
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-06
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-06
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-06
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-06
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-06
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-06
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-06
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-06
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-06
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-06
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-06
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-06
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-06
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-06
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-06
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-06
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-06
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-06
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-05
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-05
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-05
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-05
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-05
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-05
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-05
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-05
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-05
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-04
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-04
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-04
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		1e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-04
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-04
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-04
4g8a_A	635	Crystal Structure Of Human Tlr4 Polymorphic Variant		2e-04
4g8a_A	635	Crystal Structure Of Human Tlr4 Polymorphic Variant		3e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-04
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-04
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		2e-04
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		5e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-04
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-04
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-04
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-04
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-04
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-04
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-04
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		3e-04
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		8e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-04
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		3e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-04
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-04
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-04
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-04
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-04
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		5e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-04
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		6e-04
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-04
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-04
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-04
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		6e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-04
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-04
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-04
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-04
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-04
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		8e-04
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-04
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-04
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-04
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-04
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-04
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-04
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-04
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  143 bits (360), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 154/514 (29%), Positives = 232/514 (45%), Gaps = 52/514 (10%)
Query: 92  NLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAG 151
           + S L  L +S N +SG     I     L+ L++S N F   +P     L+SLQ LSLA 
Sbjct: 218 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAE 275
Query: 152 NNFSGLIPDSVSGLV-SIQSLDLSHNSFSGSLPPALTRXXXXXXXXXXXXGFSKRIPRGF 210
           N F+G IPD +SG   ++  LDLS N F G++PP                 FS  +P   
Sbjct: 276 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 335
Query: 211 ELIL-GLQVLDFHGNKLDGHLDGEFFLLTNASH----IDFSGNMFVGSSSQKFLPGLSQ- 264
            L + GL+VLD   N+  G L      LTN S     +D S N F G      LP L Q 
Sbjct: 336 LLKMRGLKVLDLSFNEFSGELPES---LTNLSASLLTLDLSSNNFSG----PILPNLCQN 388
Query: 265 ---SVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKL 320
              ++Q L L  N  TG +     L     L  L LS+N L+G +P     + +L+ LKL
Sbjct: 389 PKNTLQELYLQNNGFTGKIP--PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 446
Query: 321 SNNRFSGFIPXXXXXXXXXXXXXXXXXXXXXXGSVSMILSTNLHMLNLSSNGLTGELPLL 380
             N   G IP                          +   TNL+ ++LS+N LTGE+P  
Sbjct: 447 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 506
Query: 381 TG---SCAVLDLSNNQFEGNL-SRILKWGNIEYLDLSRNHLTGSIPEE--------TPQF 428
            G   + A+L LSNN F GN+ + +    ++ +LDL+ N   G+IP             F
Sbjct: 507 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF 566
Query: 429 L---RXXXXXXXXXXXXXXXPKVIIQYQKLRVLDLSFNHLDGPFLTNLL----------- 474
           +   R                  ++++Q +R   L  N L      N+            
Sbjct: 567 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQL--NRLSTRNPCNITSRVYGGHTSPT 624
Query: 475 --NSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCL 532
             N+ ++  L ++ N+L+G +     S+  L +L+L HN ++G  PD +G L GL +L L
Sbjct: 625 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL 684
Query: 533 AGNNISGSLPTSMANMTSLSSLVISQNHFTGPLP 566
           + N + G +P +M+ +T L+ + +S N+ +GP+P
Sbjct: 685 SSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 718

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 141/314 (44%), Gaps = 41/314 (13%)
Query: 297 LSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPXXXXXXXXXXXXXXXXXXXXXX--GS 354
           LS + + G + GF     L  L LS N  SG +                         G 
Sbjct: 81  LSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK 140
Query: 355 VSMILSTN-LHMLNLSSNGLTGELPL---LTGSCAVLD---LSNNQFEGNLSRILKWGNI 407
           VS  L  N L +L+LS+N ++G   +   L+  C  L    +S N+  G++  + +  N+
Sbjct: 141 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNL 199
Query: 408 EYLDLSRNHLTGSIPEETPQFLRXXXXXXXXXXXXXXXPKVIIQYQKLRVLDLSFNHLDG 467
           E+LD+S N+ +  IP                          +     L+ LD+S N L G
Sbjct: 200 EFLDVSSNNFSTGIP-------------------------FLGDCSALQHLDISGNKLSG 234
Query: 468 PFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRL-GSLTG 526
            F   +   + L+ L+++ N   G +   P  + +LQ L L+ N+  G  PD L G+   
Sbjct: 235 DFSRAISTCTELKLLNISSNQFVGPI--PPLPLKSLQYLSLAENKFTGEIPDFLSGACDT 292
Query: 527 LKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNL---PNSLETFNVSYNDF 583
           L  L L+GN+  G++P    + + L SL +S N+F+G LP +       L+  ++S+N+F
Sbjct: 293 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 352
Query: 584 SGAVPENLRKFPSS 597
           SG +PE+L    +S
Sbjct: 353 SGELPESLTNLSAS 366

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  142 bits (358), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 154/514 (29%), Positives = 232/514 (45%), Gaps = 52/514 (10%)
Query: 92  NLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAG 151
           + S L  L +S N +SG     I     L+ L++S N F   +P     L+SLQ LSLA 
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAE 278
Query: 152 NNFSGLIPDSVSGLV-SIQSLDLSHNSFSGSLPPALTRXXXXXXXXXXXXGFSKRIPRGF 210
           N F+G IPD +SG   ++  LDLS N F G++PP                 FS  +P   
Sbjct: 279 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338
Query: 211 ELIL-GLQVLDFHGNKLDGHLDGEFFLLTNASH----IDFSGNMFVGSSSQKFLPGLSQ- 264
            L + GL+VLD   N+  G L      LTN S     +D S N F G      LP L Q 
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPES---LTNLSASLLTLDLSSNNFSG----PILPNLCQN 391
Query: 265 ---SVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKL 320
              ++Q L L  N  TG +     L     L  L LS+N L+G +P     + +L+ LKL
Sbjct: 392 PKNTLQELYLQNNGFTGKIP--PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKL 449
Query: 321 SNNRFSGFIPXXXXXXXXXXXXXXXXXXXXXXGSVSMILSTNLHMLNLSSNGLTGELPLL 380
             N   G IP                          +   TNL+ ++LS+N LTGE+P  
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
Query: 381 TG---SCAVLDLSNNQFEGNL-SRILKWGNIEYLDLSRNHLTGSIPEE--------TPQF 428
            G   + A+L LSNN F GN+ + +    ++ +LDL+ N   G+IP             F
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANF 569
Query: 429 L---RXXXXXXXXXXXXXXXPKVIIQYQKLRVLDLSFNHLDGPFLTNLL----------- 474
           +   R                  ++++Q +R   L  N L      N+            
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQL--NRLSTRNPCNITSRVYGGHTSPT 627
Query: 475 --NSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCL 532
             N+ ++  L ++ N+L+G +     S+  L +L+L HN ++G  PD +G L GL +L L
Sbjct: 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL 687
Query: 533 AGNNISGSLPTSMANMTSLSSLVISQNHFTGPLP 566
           + N + G +P +M+ +T L+ + +S N+ +GP+P
Sbjct: 688 SSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 141/314 (44%), Gaps = 41/314 (13%)
Query: 297 LSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPXXXXXXXXXXXXXXXXXXXXXX--GS 354
           LS + + G + GF     L  L LS N  SG +                         G 
Sbjct: 84  LSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK 143
Query: 355 VSMILSTN-LHMLNLSSNGLTGELPL---LTGSCAVLD---LSNNQFEGNLSRILKWGNI 407
           VS  L  N L +L+LS+N ++G   +   L+  C  L    +S N+  G++  + +  N+
Sbjct: 144 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNL 202
Query: 408 EYLDLSRNHLTGSIPEETPQFLRXXXXXXXXXXXXXXXPKVIIQYQKLRVLDLSFNHLDG 467
           E+LD+S N+ +  IP                          +     L+ LD+S N L G
Sbjct: 203 EFLDVSSNNFSTGIP-------------------------FLGDCSALQHLDISGNKLSG 237
Query: 468 PFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRL-GSLTG 526
            F   +   + L+ L+++ N   G +   P  + +LQ L L+ N+  G  PD L G+   
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPI--PPLPLKSLQYLSLAENKFTGEIPDFLSGACDT 295
Query: 527 LKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNL---PNSLETFNVSYNDF 583
           L  L L+GN+  G++P    + + L SL +S N+F+G LP +       L+  ++S+N+F
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355
Query: 584 SGAVPENLRKFPSS 597
           SG +PE+L    +S
Sbjct: 356 SGELPESLTNLSAS 369

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  122 bits (306), Expect = 1e-27,   Method: Composition-based stats.
 Identities = 91/276 (32%), Positives = 147/276 (53%), Gaps = 15/276 (5%)
Query: 783  VLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIR-HPNVVGLRGYY 841
            +LGR   G  Y+  L +G  + VK L+E   +             ++  H N++ LRG+ 
Sbjct: 45   ILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 842  WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL--HFDR 899
              PT  E+L++  Y++ GS+AS L +RP  + PPL W +R +IA+  ARGL YL  H D 
Sbjct: 105  MTPT--ERLLVYPYMANGSVASCLRERPESQ-PPLDWPKRQRIALGSARGLAYLHDHCDP 161
Query: 900  AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
             + H ++KA NILLD  +  A V D+ L +LM            G +G+ APE  ++ K 
Sbjct: 162  KIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGK- 219
Query: 960  HPSFKSDVYAFGVILLELLTGRCAGDVIS-GEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018
              S K+DV+ +GV+LLEL+TG+ A D+        V L DW++  + E       +A V 
Sbjct: 220  -SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK----LEALVD 274
Query: 1019 PEMVNPAAEKGMKEVLGIALRCIRSVS-ERPGIKTI 1053
             ++     ++ +++++ +AL C +S   ERP +  +
Sbjct: 275  VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 310

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  122 bits (306), Expect = 1e-27,   Method: Composition-based stats.
 Identities = 91/276 (32%), Positives = 147/276 (53%), Gaps = 15/276 (5%)
Query: 783  VLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIR-HPNVVGLRGYY 841
            +LGR   G  Y+  L +G  + VK L+E   +             ++  H N++ LRG+ 
Sbjct: 37   ILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 842  WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL--HFDR 899
              PT  E+L++  Y++ GS+AS L +RP  + PPL W +R +IA+  ARGL YL  H D 
Sbjct: 97   MTPT--ERLLVYPYMANGSVASCLRERPESQ-PPLDWPKRQRIALGSARGLAYLHDHCDP 153
Query: 900  AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
             + H ++KA NILLD  +  A V D+ L +LM            G +G+ APE  ++ K 
Sbjct: 154  KIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGK- 211
Query: 960  HPSFKSDVYAFGVILLELLTGRCAGDVIS-GEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018
              S K+DV+ +GV+LLEL+TG+ A D+        V L DW++  + E       +A V 
Sbjct: 212  -SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK----LEALVD 266
Query: 1019 PEMVNPAAEKGMKEVLGIALRCIRSVS-ERPGIKTI 1053
             ++     ++ +++++ +AL C +S   ERP +  +
Sbjct: 267  VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 132/272 (48%), Gaps = 18/272 (6%)
Query: 783  VLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYW 842
            ++G    G  Y+  L +G  + +K      ++               RHP++V L G+  
Sbjct: 46   LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF-- 103
Query: 843  GPTQHEKLILSDYISPGSLASFLY--DRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
               ++E +++  Y+  G+L   LY  D P      ++W QRL+I +  ARGL+YLH  RA
Sbjct: 104  CDERNEMILIYKYMENGNLKRHLYGSDLPTM---SMSWEQRLEICIGAARGLHYLH-TRA 159
Query: 901  VPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKP 959
            + H ++K+ NILLD  +   ++ D+ + +  T+ G      +  G LGY  PE     K 
Sbjct: 160  IIHRDVKSINILLD-ENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFI--KG 216
Query: 960  HPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019
              + KSDVY+FGV+L E+L  R A  V S     V+L +W      E H +   +  V P
Sbjct: 217  RLTEKSDVYSFGVVLFEVLCARSA-IVQSLPREMVNLAEW----AVESHNNGQLEQIVDP 271
Query: 1020 EMVNPAAEKGMKEVLGIALRCIRSVSE-RPGI 1050
             + +    + +++    A++C+   SE RP +
Sbjct: 272  NLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 18/272 (6%)
Query: 783  VLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYW 842
            ++G    G  Y+  L +G  + +K      ++               RHP++V L G+  
Sbjct: 46   LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF-- 103
Query: 843  GPTQHEKLILSDYISPGSLASFLY--DRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
               ++E +++  Y+  G+L   LY  D P      ++W QRL+I +  ARGL+YLH  RA
Sbjct: 104  CDERNEMILIYKYMENGNLKRHLYGSDLPTM---SMSWEQRLEICIGAARGLHYLH-TRA 159
Query: 901  VPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKP 959
            + H ++K+ NILLD  +   ++ D+ + +  T+        +  G LGY  PE     K 
Sbjct: 160  IIHRDVKSINILLD-ENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFI--KG 216
Query: 960  HPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019
              + KSDVY+FGV+L E+L  R A  V S     V+L +W      E H +   +  V P
Sbjct: 217  RLTEKSDVYSFGVVLFEVLCARSA-IVQSLPREMVNLAEW----AVESHNNGQLEQIVDP 271
Query: 1020 EMVNPAAEKGMKEVLGIALRCIRSVSE-RPGI 1050
             + +    + +++    A++C+   SE RP +
Sbjct: 272  NLADKIRPESLRKFGDTAVKCLALSSEDRPSM 303

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 92/311 (29%), Positives = 139/311 (44%), Gaps = 34/311 (10%)
Query: 23  QDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLS 82
           QD  ALL+ KK + N  T   L+SW   +   D C  +W G++C+  +     ++NL LS
Sbjct: 6   QDKQALLQIKKDLGNPTT---LSSWLPTT---DCCNRTWLGVLCDT-DTQTYRVNNLDLS 58
Query: 83  AAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSD-NLFSSSLPSGIGKL 141
                               N      IP ++ +   L FL +   N     +P  I KL
Sbjct: 59  GL------------------NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL 100
Query: 142 ESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRXXXXXXXXXXXXG 201
             L  L +   N SG IPD +S + ++ +LD S+N+ SG+LPP+++              
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 202 FSKRIPRGFELILGL-QVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP 260
            S  IP  +     L   +    N+L G +   F  L N + +D S NM  G +S  F  
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLF-- 217
Query: 261 GLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLK 319
           G  ++ Q ++L+ N L   L   G++ L +NL  LDL  N++ G LP G   +  L  L 
Sbjct: 218 GSDKNTQKIHLAKNSLAFDL---GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274
Query: 320 LSNNRFSGFIP 330
           +S N   G IP
Sbjct: 275 VSFNNLCGEIP 285

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 39/230 (16%)
Query: 405 GNIEYLDL----SRNHLTGSIPEETPQFLRXXXXXXXXXXXXXXXPKVIIQYQKLRVLDL 460
            N+ YL+       N+L G IP    +  +               P  + Q + L  LD 
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132
Query: 461 SFNHLDG---PFLTNLLN----------------------SSTLQELHLADNLLTGVLDF 495
           S+N L G   P +++L N                      S     + ++ N LTG +  
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI-- 190
Query: 496 SPPSVSNLQV--LDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSS 553
            PP+ +NL +  +DLS N L G      GS    + + LA N+++  L   +    +L+ 
Sbjct: 191 -PPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNG 248
Query: 554 LVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPE--NLRKFPSSSF 599
           L +  N   G LP  L     L + NVS+N+  G +P+  NL++F  S++
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/205 (38%), Positives = 108/205 (52%), Gaps = 20/205 (9%)
Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREG--VAKQRXXXXXXXXXXXNIRHPNVVGLRG 839
           E +G  S GT +RA   +G  + VK L E    A++             +RHPN+V   G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
                TQ   L I+++Y+S GSL   L+    R+   L   +RL +A DVA+G+NYLH +
Sbjct: 102 ---AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ--LDERRRLSMAYDVAKGMNYLH-N 155
Query: 899 RAVP--HGNLKATNILLDGPDLNARVADYCLHRLMTQAGT-IEQILDAGVLGYRAPELAA 955
           R  P  H NLK+ N+L+D      +V D+ L RL  +A T +     AG   + APE+  
Sbjct: 156 RNPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVL- 211
Query: 956 SKKPHPS-FKSDVYAFGVILLELLT 979
             +  PS  KSDVY+FGVIL EL T
Sbjct: 212 --RDEPSNEKSDVYSFGVILWELAT 234

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/204 (36%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREG--VAKQRXXXXXXXXXXXNIRHPNVVGLRG 839
           E +G  S GT +RA   +G  + VK L E    A++             +RHPN+V   G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
                TQ   L I+++Y+S GSL   L+    R+   L   +RL +A DVA+G+NYLH +
Sbjct: 102 ---AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ--LDERRRLSMAYDVAKGMNYLH-N 155
Query: 899 RAVP--HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
           R  P  H +LK+ N+L+D      +V D+ L RL   +  +     AG   + APE+   
Sbjct: 156 RNPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSRL-KASXFLXSKXAAGTPEWMAPEVL-- 211
Query: 957 KKPHPS-FKSDVYAFGVILLELLT 979
            +  PS  KSDVY+FGVIL EL T
Sbjct: 212 -RDEPSNEKSDVYSFGVILWELAT 234

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/158 (36%), Positives = 84/158 (53%), Gaps = 12/158 (7%)
Query: 830 RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
           +H N+V L G+       +  ++  Y+  GSL   L    G   PPL+W  R KIA   A
Sbjct: 88  QHENLVELLGF--SSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAA 143
Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ-AGTIEQILDAGVLGY 948
            G+N+LH +  + H ++K+ NILLD     A+++D+ L R   + A T+      G   Y
Sbjct: 144 NGINFLHENHHI-HRDIKSANILLDEA-FTAKISDFGLARASEKFAQTVMXXRIVGTTAY 201
Query: 949 RAPE-LAASKKPHPSFKSDVYAFGVILLELLTGRCAGD 985
            APE L     P    KSD+Y+FGV+LLE++TG  A D
Sbjct: 202 MAPEALRGEITP----KSDIYSFGVVLLEIITGLPAVD 235

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/158 (36%), Positives = 84/158 (53%), Gaps = 12/158 (7%)
Query: 830 RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
           +H N+V L G+       +  ++  Y+  GSL   L    G   PPL+W  R KIA   A
Sbjct: 88  QHENLVELLGF--SSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAA 143
Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ-AGTIEQILDAGVLGY 948
            G+N+LH +  + H ++K+ NILLD     A+++D+ L R   + A T+      G   Y
Sbjct: 144 NGINFLHENHHI-HRDIKSANILLDEA-FTAKISDFGLARASEKFAQTVMXSRIVGTTAY 201
Query: 949 RAPE-LAASKKPHPSFKSDVYAFGVILLELLTGRCAGD 985
            APE L     P    KSD+Y+FGV+LLE++TG  A D
Sbjct: 202 MAPEALRGEITP----KSDIYSFGVVLLEIITGLPAVD 235

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 83/158 (52%), Gaps = 12/158 (7%)
Query: 830 RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
           +H N+V L G+       +  ++  Y+  GSL   L    G   PPL+W  R KIA   A
Sbjct: 82  QHENLVELLGF--SSDGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAA 137
Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ-AGTIEQILDAGVLGY 948
            G+N+LH +  + H ++K+ NILLD     A+++D+ L R   + A  +      G   Y
Sbjct: 138 NGINFLHENHHI-HRDIKSANILLDEA-FTAKISDFGLARASEKFAQXVMXXRIVGTTAY 195
Query: 949 RAPE-LAASKKPHPSFKSDVYAFGVILLELLTGRCAGD 985
            APE L     P    KSD+Y+FGV+LLE++TG  A D
Sbjct: 196 MAPEALRGEITP----KSDIYSFGVVLLEIITGLPAVD 229

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/159 (37%), Positives = 83/159 (52%), Gaps = 14/159 (8%)
Query: 830 RHPNVVGLRGYYWGPTQHEKLILSDYISP-GSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           +H N+V L G+    +  + L L     P GSL   L    G   PPL+W  R KIA   
Sbjct: 79  QHENLVELLGF---SSDGDDLCLVYVYXPNGSLLDRLSCLDGT--PPLSWHXRCKIAQGA 133
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ-AGTIEQILDAGVLG 947
           A G+N+LH +  + H ++K+ NILLD     A+++D+ L R   + A  +      G   
Sbjct: 134 ANGINFLHENHHI-HRDIKSANILLDEA-FTAKISDFGLARASEKFAQXVXXSRIVGTTA 191
Query: 948 YRAPE-LAASKKPHPSFKSDVYAFGVILLELLTGRCAGD 985
           Y APE L     P    KSD+Y+FGV+LLE++TG  A D
Sbjct: 192 YXAPEALRGEITP----KSDIYSFGVVLLEIITGLPAVD 226

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 111/235 (47%), Gaps = 30/235 (12%)
Query: 830  RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
            RH N++   GY    T+ +  I++ +    SL   L+    +        + + IA   A
Sbjct: 66   RHVNILLFMGY---STKPQLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTA 118
Query: 890  RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVL 946
            RG++YLH  +++ H +LK+ NI L   D   ++ D+ L  + ++   +   EQ+  +G +
Sbjct: 119  RGMDYLH-AKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQL--SGSI 174
Query: 947  GYRAPELAASKKPHP-SFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA 1005
             + APE+   +  +P SF+SDVYAFG++L EL+TG+     I+     +++         
Sbjct: 175  LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV-------- 226
Query: 1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI 1060
             G GS   D +     V     K MK ++   L+  R   ERP    I  ++  +
Sbjct: 227  -GRGSLSPDLS----KVRSNCPKRMKRLMAECLKKKR--DERPSFPRILAEIEEL 274

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 86/169 (50%), Gaps = 23/169 (13%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           N+ HPN+V L G    P +    ++ +++  G L   L D    K  P+ W+ +L++ +D
Sbjct: 79  NLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLD 130
Query: 888 VARGLNYLH-FDRAVPHGNLKATNILLDGPDLN----ARVADYCLHRLMTQAGTIEQILD 942
           +A G+ Y+   +  + H +L++ NI L   D N    A+VAD+ L +    + +      
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVS------ 184
Query: 943 AGVLG---YRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVIS 988
            G+LG   + APE   +++   + K+D Y+F +IL  +LTG    D  S
Sbjct: 185 -GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 88/171 (51%), Gaps = 27/171 (15%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           N+ HPN+V L G    P +    ++ +++  G L   L D    K  P+ W+ +L++ +D
Sbjct: 79  NLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLD 130
Query: 888 VARGLNYLH-FDRAVPHGNLKATNILLDGPDLN----ARVADYCLHRLMTQAGTIEQILD 942
           +A G+ Y+   +  + H +L++ NI L   D N    A+VAD+         GT +Q + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF---------GTSQQSVH 181
Query: 943 --AGVLG---YRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVIS 988
             +G+LG   + APE   +++   + K+D Y+F +IL  +LTG    D  S
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           +G  S GT Y+      + + +  +     +Q              RH N++   GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY--- 77
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            T+ +  I++ +    SL   L+    +        + + IA   A+G++YLH  +++ H
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH-AKSIIH 132
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVLGYRAPELAASKKPH 960
            +LK+ NI L   DL  ++ D+ L  + ++   +   EQ+  +G + + APE+   +  +
Sbjct: 133 RDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRMQDKN 189
Query: 961 P-SFKSDVYAFGVILLELLTGR 981
           P SF+SDVYAFG++L EL+TG+
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 86/169 (50%), Gaps = 23/169 (13%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           N+ HPN+V L G    P +    ++ +++  G L   L D    K  P+ W+ +L++ +D
Sbjct: 79  NLNHPNIVKLYGLMHNPPR----MVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLD 130
Query: 888 VARGLNYLH-FDRAVPHGNLKATNILLDGPDLN----ARVADYCLHRLMTQAGTIEQILD 942
           +A G+ Y+   +  + H +L++ NI L   D N    A+VAD+ L +    + +      
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS------ 184
Query: 943 AGVLG---YRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVIS 988
            G+LG   + APE   +++   + K+D Y+F +IL  +LTG    D  S
Sbjct: 185 -GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           +G  S GT Y+      + + +  +     +Q              RH N++   GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY--- 72
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            T+ +  I++ +    SL   L+    +        + + IA   A+G++YLH  +++ H
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH-AKSIIH 127
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVLGYRAPELAASKKPH 960
            +LK+ NI L   DL  ++ D+ L  + ++   +   EQ+  +G + + APE+   +  +
Sbjct: 128 RDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRMQDKN 184
Query: 961 P-SFKSDVYAFGVILLELLTGR 981
           P SF+SDVYAFG++L EL+TG+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           +G  S GT Y+      + + +  +     +Q              RH N++   GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY--- 77
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            T+ +  I++ +    SL   L+    +        + + IA   A+G++YLH  +++ H
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH-AKSIIH 132
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVLGYRAPELAASKKPH 960
            +LK+ NI L   DL  ++ D+ L  + ++   +   EQ+  +G + + APE+   +  +
Sbjct: 133 RDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRMQDKN 189
Query: 961 P-SFKSDVYAFGVILLELLTGR 981
           P SF+SDVYAFG++L EL+TG+
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQ 211

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 15/202 (7%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           +G  S GT Y+      + + +  +     +Q              RH N++   GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
           P   +  I++ +    SL   L+    +        + + IA   A+G++YLH  +++ H
Sbjct: 76  P---QLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH-AKSIIH 127
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVLGYRAPELAASKKPH 960
            +LK+ NI L   DL  ++ D+ L  + ++   +   EQ+  +G + + APE+   +  +
Sbjct: 128 RDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRMQDKN 184
Query: 961 P-SFKSDVYAFGVILLELLTGR 981
           P SF+SDVYAFG++L EL+TG+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           +G  S GT Y+      + + +  +     +Q              RH N++   GY   
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY--- 74
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            T+ +  I++ +    SL   L+    +        + + IA   A+G++YLH  +++ H
Sbjct: 75  STKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH-AKSIIH 129
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVLGYRAPELAASKKPH 960
            +LK+ NI L   DL  ++ D+ L  + ++   +   EQ+  +G + + APE+   +  +
Sbjct: 130 RDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRMQDKN 186
Query: 961 P-SFKSDVYAFGVILLELLTGR 981
           P SF+SDVYAFG++L EL+TG+
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQ 208

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 30/235 (12%)
Query: 830  RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
            RH N++   GY    T+ +  I++ +    SL   L+    +        + + IA   A
Sbjct: 78   RHVNILLFMGY---STKPQLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTA 130
Query: 890  RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVL 946
            RG++YLH  +++ H +LK+ NI L   D   ++ D+ L    ++   +   EQ+  +G +
Sbjct: 131  RGMDYLH-AKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQL--SGSI 186
Query: 947  GYRAPELAASKKPHP-SFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA 1005
             + APE+   +  +P SF+SDVYAFG++L EL+TG+     I+     +++         
Sbjct: 187  LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV-------- 238
Query: 1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI 1060
             G GS   D +     V     K MK ++   L+  R   ERP    I  ++  +
Sbjct: 239  -GRGSLSPDLS----KVRSNCPKRMKRLMAECLKKKR--DERPSFPRILAEIEEL 286

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 30/235 (12%)
Query: 830  RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
            RH N++   GY   P   +  I++ +    SL   L+    +        + + IA   A
Sbjct: 78   RHVNILLFMGYSTAP---QLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTA 130
Query: 890  RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVL 946
            RG++YLH  +++ H +LK+ NI L   D   ++ D+ L    ++   +   EQ+  +G +
Sbjct: 131  RGMDYLH-AKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQL--SGSI 186
Query: 947  GYRAPELAASKKPHP-SFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA 1005
             + APE+   +  +P SF+SDVYAFG++L EL+TG+     I+     +++         
Sbjct: 187  LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV-------- 238
Query: 1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI 1060
             G GS   D +     V     K MK ++   L+  R   ERP    I  ++  +
Sbjct: 239  -GRGSLSPDLS----KVRSNCPKRMKRLMAECLKKKR--DERPSFPRILAEIEEL 286

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 86/156 (55%), Gaps = 15/156 (9%)
Query: 830 RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
           RH N++   GY    T+ +  I++ +    SL   L+    +        + + IA   A
Sbjct: 89  RHVNILLFMGY---STKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTA 141
Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVL 946
           +G++YLH  +++ H +LK+ NI L   DL  ++ D+ L  + ++   +   EQ+  +G +
Sbjct: 142 QGMDYLH-AKSIIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSI 197
Query: 947 GYRAPELAASKKPHP-SFKSDVYAFGVILLELLTGR 981
            + APE+   +  +P SF+SDVYAFG++L EL+TG+
Sbjct: 198 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYY 841
           + +G  S GT Y+      + + +  +     +Q              RH N++   GY 
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 100
Query: 842 WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
              T+ +  I++ +    SL   L+    +        + + IA   A+G++YLH  +++
Sbjct: 101 --STKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH-AKSI 153
Query: 902 PHGNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVLGYRAPELAASKK 958
            H +LK+ NI L   DL  ++ D+ L  + ++   +   EQ+  +G + + APE+   + 
Sbjct: 154 IHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL--SGSILWMAPEVIRMQD 210
Query: 959 PHP-SFKSDVYAFGVILLELLTGR 981
            +P SF+SDVYAFG++L EL+TG+
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 15/202 (7%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           +G  S GT Y+      + + +  +     +Q              RH N++   GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY--- 72
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            T+ +  I++ +    SL   L+    +        + + IA   A+G++YLH  +++ H
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH-AKSIIH 127
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVLGYRAPELAASKKPH 960
            +LK+ NI L   DL  ++ D+ L    ++   +   EQ+  +G + + APE+   +  +
Sbjct: 128 RDLKSNNIFLH-EDLTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWMAPEVIRMQDKN 184
Query: 961 P-SFKSDVYAFGVILLELLTGR 981
           P SF+SDVYAFG++L EL+TG+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLR----EGVAKQRXXXXXXXXXXXNIRHPNVVGL 837
           E++G    G  YRA    G  + VK  R    E +++              ++HPN++ L
Sbjct: 13  EIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP---LTWAQRLKIAVDVARGLNY 894
           RG      +    ++ ++   G L   L    G++ PP   + WA      V +ARG+NY
Sbjct: 72  RGV--CLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWA------VQIARGMNY 120
Query: 895 LHFDRAVP--HGNLKATNILL----DGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           LH +  VP  H +LK++NIL+    +  DL+ ++       L  +     ++  AG   +
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW 180
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            APE+   +    S  SDV+++GV+L ELLTG 
Sbjct: 181 MAPEVI--RASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYY 841
           + +G  S GT Y+      + + +  +     +Q              RH N++   GY 
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 100
Query: 842 WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
              T+ +  I++ +    SL   L+    +        + + IA   A+G++YLH  +++
Sbjct: 101 --STKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH-AKSI 153
Query: 902 PHGNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVLGYRAPELAASKK 958
            H +LK+ NI L   DL  ++ D+ L    ++   +   EQ+  +G + + APE+   + 
Sbjct: 154 IHRDLKSNNIFLH-EDLTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWMAPEVIRMQD 210
Query: 959 PHP-SFKSDVYAFGVILLELLTGR 981
            +P SF+SDVYAFG++L EL+TG+
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYY 841
           + +G  S GT Y+      + + +  +     +Q              RH N++   GY 
Sbjct: 34  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 92
Query: 842 WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
              T+ +  I++ +    SL   L+    +        + + IA   A+G++YLH  +++
Sbjct: 93  --STKPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH-AKSI 145
Query: 902 PHGNLKATNILLDGPDLNARVADYCLHRLMTQ---AGTIEQILDAGVLGYRAPELAASKK 958
            H +LK+ NI L   DL  ++ D+ L    ++   +   EQ+  +G + + APE+   + 
Sbjct: 146 IHRDLKSNNIFLH-EDLTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWMAPEVIRMQD 202
Query: 959 PHP-SFKSDVYAFGVILLELLTGR 981
            +P SF+SDVYAFG++L EL+TG+
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           +G  S GT Y+      + + +  + +   +Q              RH N++   GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM-- 101
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            T+    I++ +    SL   L+ +  +        Q + IA   A+G++YLH  + + H
Sbjct: 102 -TKDNLAIVTQWCEGSSLYKHLHVQETK----FQMFQLIDIARQTAQGMDYLH-AKNIIH 155
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD-AGVLGYRAPELAASKKPHP- 961
            ++K+ NI L    L  ++ D+ L  + ++    +Q+    G + + APE+   +  +P 
Sbjct: 156 RDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 962 SFKSDVYAFGVILLELLTG 980
           SF+SDVY++G++L EL+TG
Sbjct: 215 SFQSDVYSYGIVLYELMTG 233

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 IRH  +V L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KIRHEKLVQL---YAV 81
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 137
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 138 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 194
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 71
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 127
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 128 RDLRAANILV-GENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF--TI 184
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 185 KSDVWSFGILLTELTTKGR 203

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 330
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 386
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 387 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 443
Query: 964 KSDVYAFGVILLELLT 979
           KSDV++FG++L EL T
Sbjct: 444 KSDVWSFGILLTELTT 459

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 74
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 75  VSEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 130
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 131 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 187
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 188 KSDVWSFGILLTELTTKGR 206

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 247
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 303
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 304 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 360
Query: 964 KSDVYAFGVILLELLT 979
           KSDV++FG++L EL T
Sbjct: 361 KSDVWSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 247
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 303
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 304 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 360
Query: 964 KSDVYAFGVILLELLT 979
           KSDV++FG++L EL T
Sbjct: 361 KSDVWSFGILLTELTT 376

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 70
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 71  VSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 126
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 127 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 183
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 184 KSDVWSFGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 72
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 73  VSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 128
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 129 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 185
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 186 KSDVWSFGILLTELTTKGR 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 81
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 137
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 138 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 194
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            +RH  +V L   Y   ++    I+++Y+S GSL  FL    G  G  L   Q + +A  
Sbjct: 236 KLRHEKLVQL---YAVVSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQ 289
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
           +A G+ Y+     V H +L+A NIL+ G +L  +VAD+ L RL+       +      + 
Sbjct: 290 IASGMAYVERMNYV-HRDLRAANILV-GENLVCKVADFGLGRLIEDNEYTARQGAKFPIK 347
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           + APE A   +   + KSDV++FG++L EL T
Sbjct: 348 WTAPEAALYGRF--TIKSDVWSFGILLTELTT 377

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 247
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+ +Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 303
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 304 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 360
Query: 964 KSDVYAFGVILLELLT 979
           KSDV++FG++L EL T
Sbjct: 361 KSDVWSFGILLTELTT 376

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 81
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+ +Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 82  VSEEPIYIVCEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 137
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 138 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 194
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 81
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+ +Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 137
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 138 RDLRAANILV-GENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF--TI 194
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 81
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 137
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 138 RDLAAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 194
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 81
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+ +Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 137
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 138 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 194
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 81
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y+S G L  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 82  VSEEPIYIVTEYMSKGCLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 137
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 138 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 194
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 78
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y++ GSL  FL    G  G  L   Q + ++  +A G+ Y+     V H
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFL---KGETGKYLRLPQLVDMSAQIASGMAYVERMNYV-H 134
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 135 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 191
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 192 KSDVWSFGILLTELTTKGR 210

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 65  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 118
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H +L+A NIL+    L+ ++AD+ L RL+  A    +      + +
Sbjct: 119 AEGMAFIE-ERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDAEXTAREGAKFPIKW 176
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 177 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 78
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y++ GSL  FL    G  G  L   Q + ++  +A G+ Y+     V H
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFL---KGETGKYLRLPQLVDMSAQIASGMAYVERMNYV-H 134
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 135 RDLRAANILV-GENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRF--TI 191
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 192 KSDVWSFGILLTELTTKGR 210

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 61  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 114
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H NL+A NIL+    L+ ++AD+ L RL+       +      + +
Sbjct: 115 AEGMAFIE-ERNYIHRNLRAANILVSD-TLSCKIADFGLARLIEDNEYTAREGAKFPIKW 172
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 173 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 204

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 15/184 (8%)
Query: 801 MFLTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPG 859
           +F+ +K L+ G   KQR              HPNV+ L G     T    +I+++++  G
Sbjct: 62  IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST--PVMIITEFMENG 119
Query: 860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLN 919
           SL SFL    G+     T  Q + +   +A G+ YL  D    H +L A NIL++  +L 
Sbjct: 120 SLDSFLRQNDGQ----FTVIQLVGMLRGIAAGMKYLA-DMNYVHRDLAARNILVNS-NLV 173
Query: 920 ARVADYCLHRLM---TQAGTIEQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILL 975
            +V+D+ L R +   T   T    L   + + + APE    +K   +  SDV+++G+++ 
Sbjct: 174 CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA--SDVWSYGIVMW 231
Query: 976 ELLT 979
           E+++
Sbjct: 232 EVMS 235

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG+   G  +  T      + +K L+ G                 +RH  +V L   Y  
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMK-KLRHEKLVQL---YAV 81
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+ +Y+S G L  FL    G  G  L   Q + +A  +A G+ Y+     V H
Sbjct: 82  VSEEPIYIVMEYMSKGCLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV-H 137
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+ G +L  +VAD+ L RL+       +      + + APE A   +   + 
Sbjct: 138 RDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TI 194
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL T GR
Sbjct: 195 KSDVWSFGILLTELTTKGR 213

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 27/220 (12%)
Query: 781 AEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRG 839
            EVLG+   G + + T  E G  + +K L     + +            + HPNV+   G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
             +   + ++L  +++YI  G+L   +     +      W+QR+  A D+A G+ YLH  
Sbjct: 75  VLY---KDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASGMAYLH-S 126
Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA----------GVLG- 947
             + H +L + N L+   + N  VAD+ L RLM    T  + L +           V+G 
Sbjct: 127 MNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 948 --YRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGD 985
             + APE+   +      K DV++FG++L E++ GR   D
Sbjct: 186 PYWMAPEMINGRSYDE--KVDVFSFGIVLCEII-GRVNAD 222

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG    G  +  T      + +K L+ G                 ++H  +V L   Y  
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMK-KLKHDKLVQL---YAV 72
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            ++    I+++Y++ GSL  FL D  GR    L     + +A  VA G+ Y+     + H
Sbjct: 73  VSEEPIYIVTEYMNKGSLLDFLKDGEGRA---LKLPNLVDMAAQVAAGMAYIERMNYI-H 128
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L++ NIL+ G  L  ++AD+ L RL+       +      + + APE A   +   + 
Sbjct: 129 RDLRSANILV-GNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF--TI 185
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L EL+T GR
Sbjct: 186 KSDVWSFGILLTELVTKGR 204

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 60  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVV--TKCKPVMIITEYMENGSL 117
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            +FL    GR     T  Q + +   +  G+ YL  D +  H +L A NIL++  +L  +
Sbjct: 118 DAFLRKNDGR----FTVIQLVGMLRGIGSGMKYLS-DMSAVHRDLAARNILVNS-NLVCK 171
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ + R++            G +  R  APE  A +K   +  SDV+++G+++ E+++
Sbjct: 172 VSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA--SDVWSYGIVMWEVMS 229

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 89/184 (48%), Gaps = 15/184 (8%)
Query: 801 MFLTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPG 859
           +F+ +K L+ G   KQR              HPNV+ L G     T    +I+++++  G
Sbjct: 36  IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST--PVMIITEFMENG 93
Query: 860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLN 919
           SL SFL    G+     T  Q + +   +A G+ YL  D    H  L A NIL++  +L 
Sbjct: 94  SLDSFLRQNDGQ----FTVIQLVGMLRGIAAGMKYLA-DMNYVHRALAARNILVNS-NLV 147
Query: 920 ARVADYCLHRLM---TQAGTIEQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILL 975
            +V+D+ L R +   T   T    L   + + + APE    +K   +  SDV+++G+++ 
Sbjct: 148 CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA--SDVWSYGIVMW 205
Query: 976 ELLT 979
           E+++
Sbjct: 206 EVMS 209

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 65  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 118
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H +L+A NIL+    L+ ++AD+ L RL+       +      + +
Sbjct: 119 AEGMAFIE-ERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 177 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 73  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 126
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H +L+A NIL+    L+ ++AD+ L RL+       +      + +
Sbjct: 127 AEGMAFIE-ERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEXTAREGAKFPIKW 184
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 185 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 216

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 71  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 124
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H +L+A NIL+    L+ ++AD+ L RL+       +      + +
Sbjct: 125 AEGMAFIE-ERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEXTAREGAKFPIKW 182
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 183 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 66  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 119
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H +L+A NIL+    L+ ++AD+ L RL+       +      + +
Sbjct: 120 AEGMAFIE-ERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEXTAREGAKFPIKW 177
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 178 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 209

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 67  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 120
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H +L+A NIL+    L+ ++AD+ L RL+       +      + +
Sbjct: 121 AEGMAFIE-ERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEXTAREGAKFPIKW 178
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 179 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 210

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 65  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 118
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H +L+A NIL+    L+ ++AD+ L RL+       +      + +
Sbjct: 119 AEGMAFIE-ERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 177 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 74  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 127
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H +L+A NIL+    L+ ++AD+ L RL+       +      + +
Sbjct: 128 AEGMAFIE-ERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEXTAREGAKFPIKW 185
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 186 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 217

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 39  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVV--TKCKPVMIITEYMENGSL 96
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            +FL    GR     T  Q + +   +  G+ YL  D +  H +L A NIL++  +L  +
Sbjct: 97  DAFLRKNDGR----FTVIQLVGMLRGIGSGMKYLS-DMSYVHRDLAARNILVNS-NLVCK 150
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ + R++            G +  R  APE  A +K   +  SDV+++G+++ E+++
Sbjct: 151 VSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA--SDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 45  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVV--TKCKPVMIITEYMENGSL 102
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            +FL    GR     T  Q + +   +  G+ YL  D +  H +L A NIL++  +L  +
Sbjct: 103 DAFLRKNDGR----FTVIQLVGMLRGIGSGMKYLS-DMSYVHRDLAARNILVNS-NLVCK 156
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ + R++            G +  R  APE  A +K   +  SDV+++G+++ E+++
Sbjct: 157 VSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA--SDVWSYGIVMWEVMS 214

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 71  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 124
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H +L+A NIL+    L+ ++AD+ L RL+       +      + +
Sbjct: 125 AEGMAFIE-ERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEYTAREGAKFPIKW 182
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 183 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 75  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 128
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H +L+A NIL+    L+ ++AD+ L RL+       +      + +
Sbjct: 129 AEGMAFIE-ERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEYTAREGAKFPIKW 186
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 187 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 65  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 118
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H +L+A NIL+    L+ ++AD+ L RL+       +      + +
Sbjct: 119 AEGMAFIE-ERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 177 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 60  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 113
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H +L+A NIL+    L+ ++AD+ L RL+       +      + +
Sbjct: 114 AEGMAFIE-ERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEYTAREGAKFPIKW 171
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 172 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 203

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 11/154 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           ++H  +V L   Y   TQ    I+++Y+  GSL  FL    G K   LT  + L +A  +
Sbjct: 70  LQHQRLVRL---YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQI 123
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A G+ ++  +R   H +L+A NIL+    L+ ++AD+ L RL+       +      + +
Sbjct: 124 AEGMAFIE-ERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEYTAREGAKFPIKW 181
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT-GR 981
            APE  A      + KSDV++FG++L E++T GR
Sbjct: 182 TAPE--AINYGTFTIKSDVWSFGILLTEIVTHGR 213

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   +QR              HPN++ L G          +I+++Y+  GSL
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV--TRGRLAMIVTEYMENGSL 137
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            +FL    G+     T  Q + +   V  G+ YL  D    H +L A N+L+D  +L  +
Sbjct: 138 DTFLRTHDGQ----FTIMQLVGMLRGVGAGMRYLS-DLGYVHRDLAARNVLVDS-NLVCK 191
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELL 978
           V+D+ L R++            G +  R  APE  A +    S  SDV++FGV++ E+L
Sbjct: 192 VSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTF--SSASDVWSFGVVMWEVL 248

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   +QR              HPN++ L G          +I+++Y+  GSL
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV--TRGRLAMIVTEYMENGSL 137
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            +FL    G+     T  Q + +   V  G+ YL  D    H +L A N+L+D  +L  +
Sbjct: 138 DTFLRTHDGQ----FTIMQLVGMLRGVGAGMRYLS-DLGYVHRDLAARNVLVDS-NLVCK 191
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELL 978
           V+D+ L R++            G +  R  APE  A +    S  SDV++FGV++ E+L
Sbjct: 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF--SSASDVWSFGVVMWEVL 248

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSL 133
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL     +     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 134 DSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-DMGFVHRDLAARNILINS-NLVCK 187
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  +PE  A +K   +  SDV+++G++L E+++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA--SDVWSYGIVLWEVMS 245

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 52/181 (28%), Positives = 92/181 (50%), Gaps = 19/181 (10%)
Query: 829  IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
            + HP +V   G      ++   I+++YIS G L ++L  R   KG  L  +Q L++  DV
Sbjct: 60   LSHPKLVKFYGVC--SKEYPIYIVTEYISNGCLLNYL--RSHGKG--LEPSQLLEMCYDV 113
Query: 889  ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
              G+ +L   + + H +L A N L+D  DL  +V+D+ + R +     +  +     + +
Sbjct: 114  CEGMAFLESHQFI-HRDLAARNCLVD-RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKW 171
Query: 949  RAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEG 1007
             APE+    K   S KSDV+AFG+++ E+ + G+   D+ +           + LKV++G
Sbjct: 172  SAPEVFHYFKY--SSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--------VVLKVSQG 221
Query: 1008 H 1008
            H
Sbjct: 222  H 222

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSL 133
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL     +     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 134 DSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINS-NLVCK 187
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  +PE  A +K   +  SDV+++G++L E+++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA--SDVWSYGIVLWEVMS 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 64  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSL 121
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL     +     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 122 DSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINS-NLVCK 175
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  +PE  A +K   +  SDV+++G++L E+++
Sbjct: 176 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA--SDVWSYGIVLWEVMS 233

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           N+ H N+V  +G       +   ++ +++  GSL  +L   P  K   +   Q+LK AV 
Sbjct: 67  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNK-INLKQQLKYAVQ 122
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM---TQAGTIEQILDAG 944
           + +G++YL   R   H +L A N+L++  +   ++ D+ L + +    +  T++   D+ 
Sbjct: 123 ICKGMDYLG-SRQYVHRDLAARNVLVES-EHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 180
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           V  Y APE     K +    SDV++FGV L ELLT
Sbjct: 181 VFWY-APECLMQSKFY--IASDVWSFGVTLHELLT 212

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 53  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVV--TKSKPVMIVTEYMENGSL 110
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            +FL    G+     T  Q + +   ++ G+ YL  D    H +L A NIL++  +L  +
Sbjct: 111 DTFLKKNDGQ----FTVIQLVGMLRGISAGMKYLS-DMGYVHRDLAARNILINS-NLVCK 164
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  APE  A +K   +  SDV+++G+++ E+++
Sbjct: 165 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSA--SDVWSYGIVMWEVVS 222

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSL 133
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL     +     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 134 DSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINS-NLVCK 187
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  +PE  A +K   +  SDV+++G++L E+++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA--SDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSL 133
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL     +     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 134 DSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINS-NLVCK 187
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  +PE  A +K   +  SDV+++G++L E+++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA--SDVWSYGIVLWEVMS 245

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           N+ H N+V  +G       +   ++ +++  GSL  +L   P  K   +   Q+LK AV 
Sbjct: 79  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNK-INLKQQLKYAVQ 134
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM---TQAGTIEQILDAG 944
           + +G++YL   R   H +L A N+L++  +   ++ D+ L + +    +  T++   D+ 
Sbjct: 135 ICKGMDYLG-SRQYVHRDLAARNVLVES-EHQVKIGDFGLTKAIETDKEXXTVKDDRDSP 192
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           V  Y APE     K +    SDV++FGV L ELLT
Sbjct: 193 VFWY-APECLMQSKFY--IASDVWSFGVTLHELLT 224

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSL 133
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL     +     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 134 DSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINS-NLVCK 187
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  +PE  A +K   +  SDV+++G++L E+++
Sbjct: 188 VSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA--SDVWSYGIVLWEVMS 245

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSL 104
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL     +     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 105 DSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINS-NLVCK 158
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  +PE  A +K   +  SDV+++G++L E+++
Sbjct: 159 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA--SDVWSYGIVLWEVMS 216

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFL--YDRPGRKGPPLTWAQRLKIAV 886
           + HPN+V L  +    T+    ++ +Y S G +  +L  + R   K     + Q      
Sbjct: 71  LNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ------ 122
Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVL 946
            +   + Y H  R V H +LKA N+LLD  D+N ++AD+      T  G ++     G  
Sbjct: 123 -IVSAVQYCHQKRIV-HRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGKLDAF--CGAP 177
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            Y APEL   KK +   + DV++ GVIL  L++G
Sbjct: 178 PYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSG 210

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSL 133
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL     +     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 134 DSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINS-NLVCK 187
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  +PE  A +K   +  SDV+++G++L E+++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA--SDVWSYGIVLWEVMS 245

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSL 133
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL     +     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 134 DSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINS-NLVCK 187
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  +PE  A +K   +  SDV+++G++L E+++
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA--SDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++Y+  GSL
Sbjct: 74  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEYMENGSL 131
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL     +     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 132 DSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINS-NLVCK 185
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  +PE  A +K   +  SDV+++G++L E+++
Sbjct: 186 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA--SDVWSYGIVLWEVMS 243

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFL--YDRPGRKGPPLTWAQRLKIAV 886
           + HPN+V L  +    T+    ++ +Y S G +  +L  + R   K     + Q      
Sbjct: 68  LNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ------ 119
Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVL 946
            +   + Y H  R V H +LKA N+LLD  D+N ++AD+      T  G ++     G  
Sbjct: 120 -IVSAVQYCHQKRIV-HRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGKLDTF--CGSP 174
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            Y APEL   KK +   + DV++ GVIL  L++G
Sbjct: 175 PYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSG 207

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 10/153 (6%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           + HPNV+ L G    P     ++L  Y+  G L  F+  R  ++ P  T    +   + V
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLP-YMCHGDLLQFI--RSPQRNP--TVKDLISFGLQV 133
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR--LMTQAGTIEQILDAGVL 946
           ARG+ YL   + V H +L A N +LD      +VAD+ L R  L  +  +++Q   A  L
Sbjct: 134 ARGMEYLAEQKFV-HRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHAR-L 190
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
             +   L + +    + KSDV++FGV+L ELLT
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 76/152 (50%), Gaps = 9/152 (5%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            I+HPN+V L G      +    I++++++ G+L  +L +   ++   +     L +A  
Sbjct: 272 EIKHPNLVQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV---LLYMATQ 326
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
           ++  + YL     + H NL A N L+ G +   +VAD+ L RLMT             + 
Sbjct: 327 ISSAMEYLEKKNFI-HRNLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           + APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 385 WTAPESLAYNKF--SIKSDVWAFGVLLWEIAT 414

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 16/170 (9%)
Query: 813 AKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRK 872
           +K+R           N++HPN+V  R  +         I+ DY   G L   +     +K
Sbjct: 64  SKEREESRREVAVLANMKHPNIVQYRESF--EENGSLYIVMDYCEGGDLFKRI---NAQK 118
Query: 873 GPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT 932
           G      Q L   V +   L ++H DR + H ++K+ NI L   D   ++ D+ + R++ 
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLT-KDGTVQLGDFGIARVLN 176
Query: 933 QAGTIEQILDAGVLG---YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
              T+E  L    +G   Y +PE+  + KP+ + KSD++A G +L EL T
Sbjct: 177 --STVE--LARACIGTPYYLSPEICEN-KPYNN-KSDIWALGCVLYELCT 220

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 68  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 123
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H NL   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 124 ICKGMEYLGTKRYI-HRNLATRNILVENEN-RVKIGDFGLTKVLPQDKEYYKVKEPGESP 181
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 182 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 213

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 10/182 (5%)
Query: 800 GMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPG 859
           G  + VK L+     Q+            +    +V  RG  +GP + E  ++ +Y+  G
Sbjct: 36  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSG 95
Query: 860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLN 919
            L  FL     R    L  ++ L  +  + +G+ YL   R V H +L A NIL++  + +
Sbjct: 96  CLRDFLQRHRAR----LDASRLLLYSSQICKGMEYLGSRRCV-HRDLAARNILVES-EAH 149
Query: 920 ARVADYCLHRLMTQAGTIEQILDAGV--LGYRAPELAASKKPHPSFKSDVYAFGVILLEL 977
            ++AD+ L +L+        + + G   + + APE  +      S +SDV++FGV+L EL
Sbjct: 150 VKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF--SRQSDVWSFGVVLYEL 207
Query: 978 LT 979
            T
Sbjct: 208 FT 209

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 782 EVLGRSSHGTSYRATLENG-----MFLTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVV 835
           +V+G    G  Y+  L+       + + +K L+ G   KQR              H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
            L G          +I+++Y+  G+L  FL ++ G      +  Q + +   +A G+ YL
Sbjct: 110 RLEGVI--SKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYL 163
Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APEL 953
                V H +L A NIL++  +L  +V+D+ L R++            G +  R  APE 
Sbjct: 164 ANMNYV-HRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            + +K   +  SDV++FG+++ E++T
Sbjct: 222 ISYRKFTSA--SDVWSFGIVMWEVMT 245

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   +     L +A  +
Sbjct: 312 IKHPNLVQLLGV--CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV---LLYMATQI 366
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL     + H NL A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 367 SSAMEYLEKKNFI-HRNLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 424
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 425 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 453

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 120
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 121 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 178
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 179 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 126
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 127 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 184
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 185 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 125
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 126 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 184 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 122
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 123 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 181 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 122
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 123 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 180
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 181 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 153
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 154 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 211
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 212 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 243

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 121
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 122 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 179
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 180 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 211

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 127
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 128 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 185
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 186 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 129
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 130 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 187
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 188 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 128
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 129 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 186
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 187 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 218

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 140
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 141 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 199 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 140
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 141 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 198
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 199 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 230

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 12/152 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           + HPN+V L  +    T+    ++ +Y S G +  +L    GR       A+  +I   V
Sbjct: 71  LNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFRQIVSAV 127
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
                Y H  + + H +LKA N+LLDG D+N ++AD+      T    ++     G   Y
Sbjct: 128 ----QYCH-QKYIVHRDLKAENLLLDG-DMNIKIADFGFSNEFTVGNKLDTF--CGSPPY 179
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            APEL   KK +   + DV++ GVIL  L++G
Sbjct: 180 AAPELFQGKK-YDGPEVDVWSLGVILYTLVSG 210

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER----IDHIKLLQYTSQ 125
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 126 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 184 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 215

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 10/182 (5%)
Query: 800 GMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPG 859
           G  + VK L+     Q+            +    +V  RG  +GP +    ++ +Y+  G
Sbjct: 52  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLN 919
            L  FL     R    L  ++ L  +  + +G+ YL   R V H +L A NIL++  + +
Sbjct: 112 CLRDFLQRHRAR----LDASRLLLYSSQICKGMEYLGSRRCV-HRDLAARNILVES-EAH 165
Query: 920 ARVADYCLHRLMTQAGTIEQILDAGV--LGYRAPELAASKKPHPSFKSDVYAFGVILLEL 977
            ++AD+ L +L+        + + G   + + APE  +      S +SDV++FGV+L EL
Sbjct: 166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF--SRQSDVWSFGVVLYEL 223
Query: 978 LT 979
            T
Sbjct: 224 FT 225

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 84/180 (46%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++ +  GSL
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEXMENGSL 133
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL     +     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 134 DSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-DMGAVHRDLAARNILINS-NLVCK 187
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  +PE  A +K   +  SDV+++G++L E+++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA--SDVWSYGIVLWEVMS 245

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/155 (25%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQ 122
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 123 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 181 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 10/182 (5%)
Query: 800 GMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPG 859
           G  + VK L+     Q+            +    +V  RG  +GP +    ++ +Y+  G
Sbjct: 40  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 99
Query: 860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLN 919
            L  FL     R    L  ++ L  +  + +G+ YL   R V H +L A NIL++  + +
Sbjct: 100 CLRDFLQRHRAR----LDASRLLLYSSQICKGMEYLGSRRCV-HRDLAARNILVES-EAH 153
Query: 920 ARVADYCLHRLMTQAGTIEQILDAGV--LGYRAPELAASKKPHPSFKSDVYAFGVILLEL 977
            ++AD+ L +L+        + + G   + + APE  +      S +SDV++FGV+L EL
Sbjct: 154 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF--SRQSDVWSFGVVLYEL 211
Query: 978 LT 979
            T
Sbjct: 212 FT 213

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 82/160 (51%), Gaps = 28/160 (17%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEK---LILSDYISPGSLASFLYDRPGRK---GPPLTWAQR 881
            +RH N+V L G        EK    I+++Y++ GSL  +L  R GR    G  L     
Sbjct: 70  QLRHSNLVQLLGV----IVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCL----- 119
Query: 882 LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL 941
           LK ++DV   + YL  +  V H +L A N+L+   D  A+V+D+ L    T+  +  Q  
Sbjct: 120 LKFSLDVCEAMEYLEGNNFV-HRDLAARNVLV-SEDNVAKVSDFGL----TKEASSTQ-- 171
Query: 942 DAGVL--GYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           D G L   + APE    KK   S KSDV++FG++L E+ +
Sbjct: 172 DTGKLPVKWTAPEALREKKF--STKSDVWSFGILLWEIYS 209

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 82/160 (51%), Gaps = 28/160 (17%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEK---LILSDYISPGSLASFLYDRPGRK---GPPLTWAQR 881
            +RH N+V L G        EK    I+++Y++ GSL  +L  R GR    G  L     
Sbjct: 55  QLRHSNLVQLLGV----IVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCL----- 104
Query: 882 LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL 941
           LK ++DV   + YL  +  V H +L A N+L+   D  A+V+D+ L    T+  +  Q  
Sbjct: 105 LKFSLDVCEAMEYLEGNNFV-HRDLAARNVLV-SEDNVAKVSDFGL----TKEASSTQ-- 156
Query: 942 DAGVL--GYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           D G L   + APE    KK   S KSDV++FG++L E+ +
Sbjct: 157 DTGKLPVKWTAPEALREKKF--STKSDVWSFGILLWEIYS 194

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 10/182 (5%)
Query: 800 GMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPG 859
           G  + VK L+     Q+            +    +V  RG  +GP +    ++ +Y+  G
Sbjct: 39  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 98
Query: 860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLN 919
            L  FL     R    L  ++ L  +  + +G+ YL   R V H +L A NIL++  + +
Sbjct: 99  CLRDFLQRHRAR----LDASRLLLYSSQICKGMEYLGSRRCV-HRDLAARNILVES-EAH 152
Query: 920 ARVADYCLHRLMTQAGTIEQILDAGV--LGYRAPELAASKKPHPSFKSDVYAFGVILLEL 977
            ++AD+ L +L+        + + G   + + APE  +      S +SDV++FGV+L EL
Sbjct: 153 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF--SRQSDVWSFGVVLYEL 210
Query: 978 LT 979
            T
Sbjct: 211 FT 212

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 50/199 (25%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG    G  + AT      + VK ++ G +               ++H  +V L      
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVV-- 79
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            T+    I++++++ GSL  FL    G K P     + +  +  +A G+ ++   R   H
Sbjct: 80  -TKEPIYIITEFMAKGSLLDFLKSDEGSKQP---LPKLIDFSAQIAEGMAFIE-QRNYIH 134
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+    L  ++AD+ L R++       +      + + APE  A      + 
Sbjct: 135 RDLRAANILVSA-SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE--AINFGSFTI 191
Query: 964 KSDVYAFGVILLELLT-GR 981
           KSDV++FG++L+E++T GR
Sbjct: 192 KSDVWSFGILLMEIVTYGR 210

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 775 ELSRAPAEVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXN 828
           EL R   +VLG  + GT Y+   +  G    + + +K L E    K             +
Sbjct: 16  ELKRV--KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 73
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           + HP++V L G    PT     +++  +  G L  ++++     G  L     L   V +
Sbjct: 74  MDHPHLVRLLGVCLSPTIQ---LVTQLMPHGCLLEYVHEHKDNIGSQLL----LNWCVQI 126
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A+G+ YL  +R + H +L A N+L+  P+ + ++ D+ L RL+ +    E   D G +  
Sbjct: 127 AKGMMYLE-ERRLVHRDLAARNVLVKSPN-HVKITDFGLARLL-EGDEKEYNADGGKMPI 183
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +   L        + +SDV+++GV + EL+T
Sbjct: 184 KWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVA-------KQRXXXXXXXXXXXNIRHPNV 834
           EV+GR + G   +A          KW  + VA        +R            + HPN+
Sbjct: 15  EVVGRGAFGVVCKA----------KWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNI 64
Query: 835 VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
           V L G    P      ++ +Y   GSL + L+       P  T A  +   +  ++G+ Y
Sbjct: 65  VKLYGACLNPV----CLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAY 118
Query: 895 LHF--DRAVPHGNLKATNILLDGPDLNARVADY---C-LHRLMTQAGTIEQILDAGVLGY 948
           LH    +A+ H +LK  N+LL       ++ D+   C +   MT         + G   +
Sbjct: 119 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN--------NKGSAAW 170
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISG 989
            APE+      + S K DV+++G+IL E++T R   D I G
Sbjct: 171 MAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGG 209

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 39/221 (17%)
Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVA-------KQRXXXXXXXXXXXNIRHPNV 834
           EV+GR + G   +A          KW  + VA        +R            + HPN+
Sbjct: 14  EVVGRGAFGVVCKA----------KWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNI 63
Query: 835 VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
           V L G    P      ++ +Y   GSL + L+       P  T A  +   +  ++G+ Y
Sbjct: 64  VKLYGACLNPV----CLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 895 LHF--DRAVPHGNLKATNILLDGPDLNARVADY---C-LHRLMTQAGTIEQILDAGVLGY 948
           LH    +A+ H +LK  N+LL       ++ D+   C +   MT         + G   +
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN--------NKGSAAW 169
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISG 989
            APE+      + S K DV+++G+IL E++T R   D I G
Sbjct: 170 MAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGG 208

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 775 ELSRAPAEVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXN 828
           EL R   +VLG  + GT Y+   +  G    + + +K L E    K             +
Sbjct: 39  ELKRV--KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 96
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           + HP++V L G    PT     +++  +  G L  ++++     G  L     L   V +
Sbjct: 97  MDHPHLVRLLGVCLSPTIQ---LVTQLMPHGCLLEYVHEHKDNIGSQLL----LNWCVQI 149
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           A+G+ YL  +R + H +L A N+L+  P+ + ++ D+ L RL+ +    E   D G +  
Sbjct: 150 AKGMMYLE-ERRLVHRDLAARNVLVKSPN-HVKITDFGLARLL-EGDEKEYNADGGKMPI 206
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +   L        + +SDV+++GV + EL+T
Sbjct: 207 KWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 84/180 (46%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++ +  GSL
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEXMENGSL 104
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL     +     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 105 DSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINS-NLVCK 158
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  +PE  A +K   +  SDV+++G++L E+++
Sbjct: 159 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA--SDVWSYGIVLWEVMS 216

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 52/184 (28%), Positives = 82/184 (44%), Gaps = 15/184 (8%)
Query: 800 GMFLTVKWLREGVAKQ-RXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISP 858
           G  + VK L+EG   Q R            + H ++V  +G      +    ++ +Y+  
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDL 918
           GSL  +L          +  AQ L  A  +  G+ YLH    + H  L A N+LLD   L
Sbjct: 97  GSLRDYLPRHC------VGLAQLLLFAQQICEGMAYLHAQHYI-HRALAARNVLLDNDRL 149
Query: 919 NARVADYCLHRLMTQAGTIEQILDAG---VLGYRAPELAASKKPHPSFKSDVYAFGVILL 975
             ++ D+ L + + +     ++ + G   V  Y APE     K +  + SDV++FGV L 
Sbjct: 150 -VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECKFY--YASDVWSFGVTLY 205
Query: 976 ELLT 979
           ELLT
Sbjct: 206 ELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 52/184 (28%), Positives = 82/184 (44%), Gaps = 15/184 (8%)
Query: 800 GMFLTVKWLREGVAKQ-RXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISP 858
           G  + VK L+EG   Q R            + H ++V  +G      +    ++ +Y+  
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 97
Query: 859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDL 918
           GSL  +L          +  AQ L  A  +  G+ YLH    + H  L A N+LLD   L
Sbjct: 98  GSLRDYLPRHC------VGLAQLLLFAQQICEGMAYLHAQHYI-HRALAARNVLLDNDRL 150
Query: 919 NARVADYCLHRLMTQAGTIEQILDAG---VLGYRAPELAASKKPHPSFKSDVYAFGVILL 975
             ++ D+ L + + +     ++ + G   V  Y APE     K +  + SDV++FGV L 
Sbjct: 151 -VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECKFY--YASDVWSFGVTLY 206
Query: 976 ELLT 979
           ELLT
Sbjct: 207 ELLT 210

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 84/180 (46%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPN++ L G          +I+++ +  GSL
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV--TKSKPVMIVTEXMENGSL 133
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            SFL     +     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 134 DSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINS-NLVCK 187
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  +PE  A +K   +  SDV+++G++L E+++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA--SDVWSYGIVLWEVMS 245

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG    G  + AT      + VK ++ G +               ++H  +V L      
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVV-- 252
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            T+    I++++++ GSL  FL    G K P     + +  +  +A G+ ++   R   H
Sbjct: 253 -TKEPIYIITEFMAKGSLLDFLKSDEGSKQP---LPKLIDFSAQIAEGMAFIE-QRNYIH 307
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+    L  ++AD+ L R++       +      + + APE  A      + 
Sbjct: 308 RDLRAANILVSA-SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE--AINFGSFTI 364
Query: 964 KSDVYAFGVILLELLT 979
           KSDV++FG++L+E++T
Sbjct: 365 KSDVWSFGILLMEIVT 380

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 38/155 (24%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +++H N+V  +G  +   +    ++ +++  GSL  +L     R    +   + L+    
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER----IDHIKLLQYTSQ 125
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG--- 944
           + +G+ YL   R + H +L   NIL++  +   ++ D+ L +++ Q     ++ + G   
Sbjct: 126 ICKGMEYLGTKRYI-HRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  Y    L  SK    S  SDV++FGV+L EL T
Sbjct: 184 IFWYAPESLTESKF---SVASDVWSFGVVLYELFT 215

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 82/160 (51%), Gaps = 28/160 (17%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEK---LILSDYISPGSLASFLYDRPGRK---GPPLTWAQR 881
            +RH N+V L G        EK    I+++Y++ GSL  +L  R GR    G  L     
Sbjct: 242 QLRHSNLVQLLGV----IVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCL----- 291
Query: 882 LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL 941
           LK ++DV   + YL  +  V H +L A N+L+   D  A+V+D+ L    T+  +  Q  
Sbjct: 292 LKFSLDVCEAMEYLEGNNFV-HRDLAARNVLV-SEDNVAKVSDFGL----TKEASSTQ-- 343
Query: 942 DAGVL--GYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           D G L   + APE    KK   S KSDV++FG++L E+ +
Sbjct: 344 DTGKLPVKWTAPEALREKKF--STKSDVWSFGILLWEIYS 381

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFL--YDRPGRKGPPLTWAQRLKIAVDV 888
           HPN+V L  +    T+    ++ +Y S G +  +L  + R   K     + Q       +
Sbjct: 72  HPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-------I 122
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
              + Y H  + + H +LKA N+LLD  D+N ++AD+      T    +++    G   Y
Sbjct: 123 VSAVQYCH-QKFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDEF--CGSPPY 178
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            APEL   KK +   + DV++ GVIL  L++G
Sbjct: 179 AAPELFQGKK-YDGPEVDVWSLGVILYTLVSG 209

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   ++    L +A  +
Sbjct: 64  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQI 118
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 119 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 176
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 177 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 205

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 12/167 (7%)
Query: 815 QRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGP 874
           QR           ++ H +VVG  G++         ++ +     SL      R     P
Sbjct: 82  QREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEP 139
Query: 875 PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
              +  R      +  G  YLH +R + H +LK  N+ L+  DL  ++ D+ L   +   
Sbjct: 140 EARYYLR-----QIVLGCQYLHRNRVI-HRDLKLGNLFLNE-DLEVKIGDFGLATKVEYD 192
Query: 935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           G  +++L  G   Y APE+  SKK H SF+ DV++ G I+  LL G+
Sbjct: 193 GERKKVL-CGTPNYIAPEVL-SKKGH-SFEVDVWSIGCIMYTLLVGK 236

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 14/152 (9%)
Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           H +++  +G      +    ++ +Y+  GSL  +L   P      +  AQ L  A  +  
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHS---IGLAQLLLFAQQICE 128
Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG---VLG 947
           G+ YLH    + H NL A N+LLD   L  ++ D+ L + + +     ++ + G   V  
Sbjct: 129 GMAYLHAQHYI-HRNLAARNVLLDNDRL-VKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 186
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           Y APE     K +  + SDV++FGV L ELLT
Sbjct: 187 Y-APECLKEYKFY--YASDVWSFGVTLYELLT 215

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 12/167 (7%)
Query: 815 QRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGP 874
           QR           ++ H +VVG  G++         ++ +     SL      R     P
Sbjct: 84  QREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEP 141
Query: 875 PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
              +  R      +  G  YLH +R + H +LK  N+ L+  DL  ++ D+ L   +   
Sbjct: 142 EARYYLR-----QIVLGCQYLHRNRVI-HRDLKLGNLFLNE-DLEVKIGDFGLATKVEYD 194
Query: 935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           G  +++L  G   Y APE+  SKK H SF+ DV++ G I+  LL G+
Sbjct: 195 GERKKVL-CGTPNYIAPEVL-SKKGH-SFEVDVWSIGCIMYTLLVGK 238

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   ++    L +A  +
Sbjct: 66  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQI 120
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 121 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 179 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 207

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 14/152 (9%)
Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           H +++  +G      +    ++ +Y+  GSL  +L   P      +  AQ L  A  +  
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHS---IGLAQLLLFAQQICE 128
Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG---VLG 947
           G+ YLH    + H NL A N+LLD   L  ++ D+ L + + +     ++ + G   V  
Sbjct: 129 GMAYLHSQHYI-HRNLAARNVLLDNDRL-VKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 186
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           Y APE     K +  + SDV++FGV L ELLT
Sbjct: 187 Y-APECLKEYKFY--YASDVWSFGVTLYELLT 215

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   ++    L +A  +
Sbjct: 66  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQI 120
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 121 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 179 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   ++    L +A  +
Sbjct: 71  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQI 125
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 126 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 184 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 212

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 83/160 (51%), Gaps = 28/160 (17%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEK---LILSDYISPGSLASFLYDRPGRK---GPPLTWAQR 881
            +RH N+V L G        EK    I+++Y++ GSL  +L  R GR    G  L     
Sbjct: 61  QLRHSNLVQLLGV----IVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCL----- 110
Query: 882 LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL 941
           LK ++DV   + YL  +  V H +L A N+L+   D  A+V+D+ L    T+  +  Q  
Sbjct: 111 LKFSLDVCEAMEYLEGNNFV-HRDLAARNVLV-SEDNVAKVSDFGL----TKEASSTQ-- 162
Query: 942 DAGVL--GYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           D G L   + APE  A ++   S KSDV++FG++L E+ +
Sbjct: 163 DTGKLPVKWTAPE--ALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           HP +VGL   +   T+     + +Y++ G L   ++    ++  P   A+     + +A 
Sbjct: 112 HPFLVGLHSCF--QTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA- 165
Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRA 950
            LNYLH +R + + +LK  N+LLD  + + ++ DY + +   + G        G   Y A
Sbjct: 166 -LNYLH-ERGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTF-CGTPNYIA 221
Query: 951 PELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI 987
           PE+   +     F  D +A GV++ E++ GR   D++
Sbjct: 222 PEILRGEDY--GFSVDWWALGVLMFEMMAGRSPFDIV 256

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 28/152 (18%)
Query: 851 ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD---------RAV 901
           +++ +   GSL+ FL      K   ++W +   IA  +ARGL YLH D          A+
Sbjct: 99  LITAFHEKGSLSDFL------KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI 152
Query: 902 PHGNLKATNILLDGPDLNARVADYCLHRLMTQAG-----TIEQILDAGVLGYRAPEL--- 953
            H ++K+ N+LL   +L A +AD+ L  L  +AG     T  Q+   G   Y APE+   
Sbjct: 153 SHRDIKSKNVLLKN-NLTACIADFGL-ALKFEAGKSAGDTHGQV---GTRRYMAPEVLEG 207
Query: 954 AASKKPHPSFKSDVYAFGVILLELLTGRCAGD 985
           A + +     + D+YA G++L EL +   A D
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   +     L +A  +
Sbjct: 71  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQI 125
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 126 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 183
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 184 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 212

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 7/102 (6%)
Query: 883 KIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD 942
           KI +   + LN+L  +  + H ++K +NILLD    N ++ D+ +   +    +I +  D
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGISGQLVD--SIAKTRD 185
Query: 943 AGVLGYRAPEL---AASKKPHPSFKSDVYAFGVILLELLTGR 981
           AG   Y APE    +AS++ +   +SDV++ G+ L EL TGR
Sbjct: 186 AGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGR 226

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   ++    L +A  +
Sbjct: 64  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQI 118
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 119 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKW 176
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 177 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 205

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 22/149 (14%)
Query: 848 EKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD--------- 898
           E  +++ +   GSL  +L      KG  +TW +   +A  ++RGL+YLH D         
Sbjct: 87  ELWLITAFHDKGSLTDYL------KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGH 140
Query: 899 -RAVPHGNLKATNILLDGPDLNARVADYCLH-RLMTQAGTIEQILDAGVLGYRAPEL--- 953
             ++ H + K+ N+LL   DL A +AD+ L  R        +     G   Y APE+   
Sbjct: 141 KPSIAHRDFKSKNVLLKS-DLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEG 199
Query: 954 AASKKPHPSFKSDVYAFGVILLELLTGRC 982
           A + +     + D+YA G++L EL++ RC
Sbjct: 200 AINFQRDAFLRIDMYAMGLVLWELVS-RC 227

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           + HPN+V L  +    T+    ++ +Y S G +  +L    GR       A+  +I   V
Sbjct: 70  LNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFRQIVSAV 126
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
                Y H  + + H +LKA N+LLD  D+N ++AD+      T    ++     G   Y
Sbjct: 127 ----QYCH-QKFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDAF--CGAPPY 178
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            APEL   KK +   + DV++ GVIL  L++G
Sbjct: 179 AAPELFQGKK-YDGPEVDVWSLGVILYTLVSG 209

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   +     L +A  +
Sbjct: 71  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQI 125
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 126 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 184 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   +     L +A  +
Sbjct: 79  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQI 133
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 134 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 191
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 192 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 220

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   +     L +A  +
Sbjct: 71  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQI 125
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 126 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 184 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   +     L +A  +
Sbjct: 66  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQI 120
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 121 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 179 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   +     L +A  +
Sbjct: 70  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQI 124
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 125 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 183 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   +     L +A  +
Sbjct: 66  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQI 120
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 121 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 179 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   +     L +A  +
Sbjct: 68  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQI 122
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 123 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 180
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 181 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   +     L +A  +
Sbjct: 68  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQI 122
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 123 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 180
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 181 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFL--YDRPGRKGPPLTWAQRLKIAV 886
           + HPN+V L  +    T+    ++ +Y S G +  +L  + R   K     + Q      
Sbjct: 70  LNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------ 121
Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVL 946
            +   + Y H  + + H +LKA N+LLD  D+N ++AD+      T    ++     G  
Sbjct: 122 -IVSAVQYCH-QKFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDTF--CGSP 176
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            Y APEL   KK +   + DV++ GVIL  L++G
Sbjct: 177 PYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           HP +VGL   +   T+     + +Y++ G L   ++    ++  P   A+     + +A 
Sbjct: 80  HPFLVGLHSCF--QTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA- 133
Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRA 950
            LNYLH +R + + +LK  N+LLD  + + ++ DY + +   + G        G   Y A
Sbjct: 134 -LNYLH-ERGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSXF-CGTPNYIA 189
Query: 951 PELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI 987
           PE+   +     F  D +A GV++ E++ GR   D++
Sbjct: 190 PEILRGEDY--GFSVDWWALGVLMFEMMAGRSPFDIV 224

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           HP +VGL   +   T+     + +Y++ G L   ++    ++  P   A+     + +A 
Sbjct: 65  HPFLVGLHSCF--QTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA- 118
Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRA 950
            LNYLH +R + + +LK  N+LLD  + + ++ DY + +   + G        G   Y A
Sbjct: 119 -LNYLH-ERGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSXF-CGTPNYIA 174
Query: 951 PELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI 987
           PE+   +     F  D +A GV++ E++ GR   D++
Sbjct: 175 PEILRGEDY--GFSVDWWALGVLMFEMMAGRSPFDIV 209

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 19/218 (8%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG    G  +     N   + VK L+ G    +            ++H  +V L   Y  
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMK-TLQHDKLVRL---YAV 76
Query: 844 PTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP 902
            T+ E + I+++Y++ GSL  FL    G K   +   + +  +  +A G+ Y+     + 
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGK---VLLPKLIDFSAQIAEGMAYIERKNYI- 132
Query: 903 HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPS 962
           H +L+A N+L+    L  ++AD+ L R++       +      + + APE  A      +
Sbjct: 133 HRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE--AINFGCFT 189
Query: 963 FKSDVYAFGVILLELLT-------GRCAGDVISGEGAG 993
            KSDV++FG++L E++T       GR   DV++    G
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQG 227

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFL--YDRPGRKGPPLTWAQRLKIAV 886
           + HPN+V L  +    T+    ++ +Y S G +  +L  + R   K     + Q      
Sbjct: 70  LNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ------ 121
Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVL 946
            +   + Y H  + + H +LKA N+LLD  D+N ++AD+      T    ++     G  
Sbjct: 122 -IVSAVQYCH-QKFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDTF--CGSP 176
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            Y APEL   KK +   + DV++ GVIL  L++G
Sbjct: 177 PYAAPELFQGKK-YDGPEVDVWSLGVILYTLVSG 209

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I+++Y+  G+L  +L +    +   +T    L +A  +
Sbjct: 85  IKHPNLVQLLGVC--TLEPPFYIVTEYMPYGNLLDYLRECNREE---VTAVVLLYMATQI 139
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 140 SSAMEYLE-KKNFIHRDLAARNCLV-GENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKW 197
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A      S KSDV+AFGV+L E+ T
Sbjct: 198 TAPESLAYNTF--SIKSDVWAFGVLLWEIAT 226

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFL--YDRPGRKGPPLTWAQRLKIAVDV 888
           HPN+V L  +    T+    ++ +Y S G +  +L  + R   K     + Q       +
Sbjct: 72  HPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ-------I 122
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
              + Y H  + + H +LKA N+LLD  D+N ++AD+      T    ++     G   Y
Sbjct: 123 VSAVQYCH-QKFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDTF--CGSPPY 178
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            APEL   KK +   + DV++ GVIL  L++G
Sbjct: 179 AAPELFQGKK-YDGPEVDVWSLGVILYTLVSG 209

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           HP +VGL   +   T+     + +Y++ G L   ++    ++  P   A+     + +A 
Sbjct: 69  HPFLVGLHSCF--QTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA- 122
Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRA 950
            LNYLH +R + + +LK  N+LLD  + + ++ DY + +   + G        G   Y A
Sbjct: 123 -LNYLH-ERGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSXF-CGTPNYIA 178
Query: 951 PELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVI 987
           PE+   +     F  D +A GV++ E++ GR   D++
Sbjct: 179 PEILRGEDY--GFSVDWWALGVLMFEMMAGRSPFDIV 213

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I+ ++++ G+L  +L +   ++   ++    L +A  +
Sbjct: 64  IKHPNLVQLLGVC--TREPPFYIIIEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQI 118
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 119 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 176
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 177 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 205

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 12/167 (7%)
Query: 815 QRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGP 874
           QR           ++ H +VVG  G++         ++ +     SL      R     P
Sbjct: 58  QREKMSMEISIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEP 115
Query: 875 PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
              +  R      +  G  YLH +R + H +LK  N+ L+  DL  ++ D+ L   +   
Sbjct: 116 EARYYLR-----QIVLGCQYLHRNRVI-HRDLKLGNLFLN-EDLEVKIGDFGLATKVEYD 168
Query: 935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           G  +++L  G   Y APE+  SKK H SF+ DV++ G I+  LL G+
Sbjct: 169 GERKKVL-CGTPNYIAPEVL-SKKGH-SFEVDVWSIGCIMYTLLVGK 212

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 12/167 (7%)
Query: 815 QRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGP 874
           QR           ++ H +VVG  G++         ++ +     SL      R     P
Sbjct: 60  QREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEP 117
Query: 875 PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
              +  R      +  G  YLH +R + H +LK  N+ L+  DL  ++ D+ L   +   
Sbjct: 118 EARYYLR-----QIVLGCQYLHRNRVI-HRDLKLGNLFLNE-DLEVKIGDFGLATKVEYD 170
Query: 935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           G  ++ L  G   Y APE+  SKK H SF+ DV++ G I+  LL G+
Sbjct: 171 GERKKTL-CGTPNYIAPEVL-SKKGH-SFEVDVWSIGCIMYTLLVGK 214

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           + HPN+V L  +    T+    ++ +Y S G +  +L    GR       A+  +I   V
Sbjct: 70  LNHPNIVKL--FEVIETEKTLYLVXEYASGGEVFDYLVAH-GRXKEKEARAKFRQIVSAV 126
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
                Y H  + + H +LKA N+LLD  D N ++AD+      T    ++     G   Y
Sbjct: 127 ----QYCH-QKFIVHRDLKAENLLLDA-DXNIKIADFGFSNEFTFGNKLDAF--CGAPPY 178
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            APEL   KK +   + DV++ GVIL  L++G
Sbjct: 179 AAPELFQGKK-YDGPEVDVWSLGVILYTLVSG 209

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 12/167 (7%)
Query: 815 QRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGP 874
           QR           ++ H +VVG  G++         ++ +     SL      R     P
Sbjct: 64  QREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEP 121
Query: 875 PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
              +  R      +  G  YLH +R + H +LK  N+ L+  DL  ++ D+ L   +   
Sbjct: 122 EARYYLR-----QIVLGCQYLHRNRVI-HRDLKLGNLFLNE-DLEVKIGDFGLATKVEYD 174
Query: 935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           G  ++ L  G   Y APE+  SKK H SF+ DV++ G I+  LL G+
Sbjct: 175 GERKKTL-CGTPNYIAPEVL-SKKGH-SFEVDVWSIGCIMYTLLVGK 218

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   +     L +A  +
Sbjct: 67  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQI 121
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 122 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW 179
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 180 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I++++++ G+L  +L +   ++   +     L +A  +
Sbjct: 68  IKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQI 122
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 123 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW 180
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 181 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 209

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 12/167 (7%)
Query: 815 QRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGP 874
           QR           ++ H +VVG  G++         ++ +     SL      R     P
Sbjct: 60  QREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEP 117
Query: 875 PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
              +  R      +  G  YLH +R + H +LK  N+ L+  DL  ++ D+ L   +   
Sbjct: 118 EARYYLR-----QIVLGCQYLHRNRVI-HRDLKLGNLFLNE-DLEVKIGDFGLATKVEYD 170
Query: 935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           G  ++ L  G   Y APE+  SKK H SF+ DV++ G I+  LL G+
Sbjct: 171 GERKKTL-CGTPNYIAPEVL-SKKGH-SFEVDVWSIGCIMYTLLVGK 214

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 31/166 (18%)
Query: 831 HPNVVGL------RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--------- 875
           HPN++ L      RGY +        +  +Y   G+L  FL      +  P         
Sbjct: 82  HPNIINLLGACEHRGYLY--------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 133
Query: 876 --LTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ 933
             L+  Q L  A DVARG++YL   + + H NL A NIL+ G +  A++AD+ L R   Q
Sbjct: 134 STLSSQQLLHFAADVARGMDYLSQKQFI-HRNLAARNILV-GENYVAKIADFGLSR--GQ 189
Query: 934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
              +++ +  G L  R   + +      +  SDV+++GV+L E+++
Sbjct: 190 EVYVKKTM--GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ YL 
Sbjct: 114 LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKYLA 168
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-LGYRAPELAA 955
             + V H +L A N +LD      +VAD+ L R M            G  L  +   L +
Sbjct: 169 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 956 SKKPHPSFKSDVYAFGVILLELLT 979
            +    + KSDV++FGV+L EL+T
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 108/248 (43%), Gaps = 47/248 (18%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQR------- 881
            +H N++ L G     TQ   L ++ +Y S G+L  +L     R+ P L ++         
Sbjct: 133  KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYL---QARRPPGLEYSYNPSHNPEE 186
Query: 882  -------LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
                   +  A  VARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +   
Sbjct: 187  QLSSKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNV-MKIADFGLARDIHHI 244
Query: 935  GTIEQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAG 993
               ++  +  + + + APE    +    + +SDV++FGV+L E+ T      +      G
Sbjct: 245  DYYKKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT------LGGSPYPG 296
Query: 994  VDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKT 1052
            V + +  +L + EGH  D                    E+  +   C  +V S+RP  K 
Sbjct: 297  VPVEELFKL-LKEGHRMD-------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQ 342
Query: 1053 IYEDLSSI 1060
            + EDL  I
Sbjct: 343  LVEDLDRI 350

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I+ ++++ G+L  +L +   ++   ++    L +A  +
Sbjct: 66  IKHPNLVQLLGVC--TREPPFYIIIEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQI 120
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 121 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 179 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I+ ++++ G+L  +L +   ++   ++    L +A  +
Sbjct: 66  IKHPNLVQLLGVC--TREPPFYIIIEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQI 120
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 121 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 179 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 207

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 48/180 (26%), Positives = 84/180 (46%), Gaps = 13/180 (7%)
Query: 803 LTVKWLREG-VAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSL 861
           + +K L+ G   KQR              HPNVV L G          +I+ +++  G+L
Sbjct: 74  VAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVV--TRGKPVMIVIEFMENGAL 131
Query: 862 ASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR 921
            +FL    G+     T  Q + +   +A G+ YL  D    H +L A NIL++  +L  +
Sbjct: 132 DAFLRKHDGQ----FTVIQLVGMLRGIAAGMRYLA-DMGYVHRDLAARNILVNS-NLVCK 185
Query: 922 VADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           V+D+ L R++            G +  R  APE    +K   +  SDV+++G+++ E+++
Sbjct: 186 VSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSA--SDVWSYGIVMWEVMS 243

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I+ ++++ G+L  +L +   ++   +     L +A  +
Sbjct: 67  IKHPNLVQLLGVC--TREPPFYIIIEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQI 121
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 122 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 179
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 180 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 208

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 831 HPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYD---RPGRKGPPLTWAQRLKIAV 886
           HPN+V    YY      ++L ++   +S GS+   +     +   K   L  +    I  
Sbjct: 67  HPNIVS---YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 123
Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ----ILD 942
           +V  GL YLH +  + H ++KA NILL G D + ++AD+ +   +   G I +       
Sbjct: 124 EVLEGLEYLHKNGQI-HRDVKAGNILL-GEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 943 AGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            G   + APE+    + +  FK+D+++FG+  +EL TG
Sbjct: 182 VGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATG 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 14/158 (8%)
Query: 831 HPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYD---RPGRKGPPLTWAQRLKIAV 886
           HPN+V    YY      ++L ++   +S GS+   +     +   K   L  +    I  
Sbjct: 72  HPNIVS---YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ----ILD 942
           +V  GL YLH +  + H ++KA NILL G D + ++AD+ +   +   G I +       
Sbjct: 129 EVLEGLEYLHKNGQI-HRDVKAGNILL-GEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 943 AGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            G   + APE+    + +  FK+D+++FG+  +EL TG
Sbjct: 187 VGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATG 223

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ YL 
Sbjct: 95  LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKYLA 149
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-LGYRAPELAA 955
             + V H +L A N +LD      +VAD+ L R M            G  L  +   L +
Sbjct: 150 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 956 SKKPHPSFKSDVYAFGVILLELLT 979
            +    + KSDV++FGV+L EL+T
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ YL 
Sbjct: 115 LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKYLA 169
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-LGYRAPELAA 955
             + V H +L A N +LD      +VAD+ L R M            G  L  +   L +
Sbjct: 170 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 956 SKKPHPSFKSDVYAFGVILLELLT 979
            +    + KSDV++FGV+L EL+T
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L G      +    I+ ++++ G+L  +L +   ++   +     L +A  +
Sbjct: 71  IKHPNLVQLLGVC--TREPPFYIIIEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQI 125
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           +  + YL   +   H +L A N L+ G +   +VAD+ L RLMT             + +
Sbjct: 126 SSAMEYLE-KKNFIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            APE  A  K   S KSDV+AFGV+L E+ T
Sbjct: 184 TAPESLAYNKF--SIKSDVWAFGVLLWEIAT 212

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 21/196 (10%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHPNVVGLRGYYWG 843
           LG    G  + AT      + VK ++ G +               ++H  +V L      
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVV-- 246
Query: 844 PTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPH 903
            T+    I++++++ GSL  FL    G K P     + +  +  +A G+ ++   R   H
Sbjct: 247 -TKEPIYIITEFMAKGSLLDFLKSDEGSKQP---LPKLIDFSAQIAEGMAFIE-QRNYIH 301
Query: 904 GNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
            +L+A NIL+    L  ++AD+ L R+  +            + + APE  A      + 
Sbjct: 302 RDLRAANILVSA-SLVCKIADFGLARVGAKFP----------IKWTAPE--AINFGSFTI 348
Query: 964 KSDVYAFGVILLELLT 979
           KSDV++FG++L+E++T
Sbjct: 349 KSDVWSFGILLMEIVT 364

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ YL 
Sbjct: 96  LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKYLA 150
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-LGYRAPELAA 955
             + V H +L A N +LD      +VAD+ L R M            G  L  +   L +
Sbjct: 151 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 956 SKKPHPSFKSDVYAFGVILLELLT 979
            +    + KSDV++FGV+L EL+T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ YL 
Sbjct: 94  LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKYLA 148
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-LGYRAPELAA 955
             + V H +L A N +LD      +VAD+ L R M            G  L  +   L +
Sbjct: 149 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 956 SKKPHPSFKSDVYAFGVILLELLT 979
            +    + KSDV++FGV+L EL+T
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 12/152 (7%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           + HPN+V L  +    T+    ++ +Y S G +  +L      K        R      +
Sbjct: 63  LNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-----QI 115
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
              + Y H  + + H +LKA N+LLD  D+N ++AD+      T    ++     G   Y
Sbjct: 116 VSAVQYCH-QKFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDTF--CGSPPY 171
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            APEL   KK +   + DV++ GVIL  L++G
Sbjct: 172 AAPELFQGKK-YDGPEVDVWSLGVILYTLVSG 202

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 28/197 (14%)
Query: 798 ENGMFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSD-- 854
           + G  + +K  R+ ++ K R            + HPNVV  R     P   +KL  +D  
Sbjct: 37  DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV---PDGLQKLAPNDLP 93
Query: 855 -----YISPGSLASFLYDRPG----RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGN 905
                Y   G L  +L         ++GP  T      +  D++  L YLH +R + H +
Sbjct: 94  LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT------LLSDISSALRYLHENRII-HRD 146
Query: 906 LKATNILLD-GPD-LNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
           LK  NI+L  GP  L  ++ D    + + Q     + +  G L Y APEL   KK   + 
Sbjct: 147 LKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLAPELLEQKK--YTV 202
Query: 964 KSDVYAFGVILLELLTG 980
             D ++FG +  E +TG
Sbjct: 203 TVDYWSFGTLAFECITG 219

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ YL 
Sbjct: 88  LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKYLA 142
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-LGYRAPELAA 955
             + V H +L A N +LD      +VAD+ L R M            G  L  +   L +
Sbjct: 143 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 956 SKKPHPSFKSDVYAFGVILLELLT 979
            +    + KSDV++FGV+L EL+T
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 38/130 (29%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 851 ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATN 910
           I+ +Y+  GS    L  +PG    PL       I  ++ +GL+YLH +R + H ++KA N
Sbjct: 94  IIMEYLGGGSALDLL--KPG----PLEETYIATILREILKGLDYLHSERKI-HRDIKAAN 146
Query: 911 ILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAF 970
           +LL     + ++AD+ +   +T    I++    G   + APE+   K+    FK+D+++ 
Sbjct: 147 VLLSEQG-DVKLADFGVAGQLTDT-QIKRNXFVGTPFWMAPEVI--KQSAYDFKADIWSL 202
Query: 971 GVILLELLTG 980
           G+  +EL  G
Sbjct: 203 GITAIELAKG 212

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ YL 
Sbjct: 93  LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKYLA 147
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-LGYRAPELAA 955
             + V H +L A N +LD      +VAD+ L R M            G  L  +   L +
Sbjct: 148 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 956 SKKPHPSFKSDVYAFGVILLELLT 979
            +    + KSDV++FGV+L EL+T
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 28/197 (14%)
Query: 798 ENGMFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQHEKLILSD-- 854
           + G  + +K  R+ ++ K R            + HPNVV  R     P   +KL  +D  
Sbjct: 38  DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV---PDGLQKLAPNDLP 94
Query: 855 -----YISPGSLASFLYDRPG----RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGN 905
                Y   G L  +L         ++GP  T      +  D++  L YLH +R + H +
Sbjct: 95  LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT------LLSDISSALRYLHENRII-HRD 147
Query: 906 LKATNILLD-GPD-LNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSF 963
           LK  NI+L  GP  L  ++ D    + + Q     + +  G L Y APEL   KK   + 
Sbjct: 148 LKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLAPELLEQKK--YTV 203
Query: 964 KSDVYAFGVILLELLTG 980
             D ++FG +  E +TG
Sbjct: 204 TVDYWSFGTLAFECITG 220

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 42/132 (31%), Positives = 66/132 (50%), Gaps = 14/132 (10%)
Query: 851 ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATN 910
           ++ +Y+  GSL  +L   P      +  AQ L  A  +  G+ YLH    + H +L A N
Sbjct: 112 LVMEYVPLGSLRDYL---PRHS---IGLAQLLLFAQQICEGMAYLHAQHYI-HRDLAARN 164
Query: 911 ILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG---VLGYRAPELAASKKPHPSFKSDV 967
           +LLD   L  ++ D+ L + + +     ++ + G   V  Y APE     K +  + SDV
Sbjct: 165 VLLDNDRL-VKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLKEYKFY--YASDV 220
Query: 968 YAFGVILLELLT 979
           ++FGV L ELLT
Sbjct: 221 WSFGVTLYELLT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ YL 
Sbjct: 95  LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKYLA 149
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-LGYRAPELAA 955
             + V H +L A N +LD      +VAD+ L R M            G  L  +   L +
Sbjct: 150 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 956 SKKPHPSFKSDVYAFGVILLELLT 979
            +    + KSDV++FGV+L EL+T
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 108/245 (44%), Gaps = 41/245 (16%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +            L+
Sbjct: 92   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLS 148
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
                +  A  VARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 149  SKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNV-MKIADFGLARDIHHIDXX 206
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDL 996
            ++  +  + + + APE    +    + +SDV++FGV+L E+ T      +      GV +
Sbjct: 207  KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT------LGGSPYPGVPV 258
Query: 997  TDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIYE 1055
             +  +L + EGH  D                    E+  +   C  +V S+RP  K + E
Sbjct: 259  EELFKL-LKEGHRMD-------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 304
Query: 1056 DLSSI 1060
            DL  I
Sbjct: 305  DLDRI 309

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ YL 
Sbjct: 96  LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKYLA 150
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-LGYRAPELAA 955
             + V H +L A N +LD      +VAD+ L R M            G  L  +   L +
Sbjct: 151 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 956 SKKPHPSFKSDVYAFGVILLELLT 979
            +    + KSDV++FGV+L EL+T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 13/204 (6%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ YL 
Sbjct: 91  LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKYLA 145
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-LGYRAPELAA 955
             + V H +L A N +LD      +VAD+ L R M            G  L  +   L +
Sbjct: 146 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 956 SKKPHPSFKSDVYAFGVILLELLT 979
            +    + KSDV++FGV+L EL+T
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 40/152 (26%), Positives = 78/152 (51%), Gaps = 14/152 (9%)
Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           HPNV+ + G    P      +++ ++  GSL + L++        +  +Q +K A+D+AR
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV---VDQSQAVKFALDMAR 122
Query: 891 GLNYLH-FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR 949
           G+ +LH  +  +P   L + ++++D  D+ AR++   +       G +          + 
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMY------APAWV 175
Query: 950 APELAASKKPHPSFK--SDVYAFGVILLELLT 979
           APE A  KKP  + +  +D+++F V+L EL+T
Sbjct: 176 APE-ALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           +RHP+++ L      PT    +++    + G L  ++ ++       +T  +  +    +
Sbjct: 66  LRHPHIIKLYDVITTPTD---IVMVIEYAGGELFDYIVEKK-----RMTEDEGRRFFQQI 117
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
              + Y H  + V H +LK  N+LLD  +LN ++AD+ L  +MT    ++     G   Y
Sbjct: 118 ICAIEYCHRHKIV-HRDLKPENLLLDD-NLNVKIADFGLSNIMTDGNFLKT--SCGSPNY 173
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGD 985
            APE+  + K +   + DV++ G++L  +L GR   D
Sbjct: 174 AAPEV-INGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 108/248 (43%), Gaps = 47/248 (18%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQR------- 881
            +H N++ L G     TQ   L ++ +Y S G+L  +L     R+ P L ++         
Sbjct: 84   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYL---QARRPPGLEYSYNPSHNPEE 137
Query: 882  -------LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
                   +  A  VARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +   
Sbjct: 138  QLSSKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNV-MKIADFGLARDIHHI 195
Query: 935  GTIEQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAG 993
               ++  +  + + + APE    +    + +SDV++FGV+L E+ T      +      G
Sbjct: 196  DYYKKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT------LGGSPYPG 247
Query: 994  VDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKT 1052
            V + +  +L + EGH  D                    E+  +   C  +V S+RP  K 
Sbjct: 248  VPVEELFKL-LKEGHRMD-------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQ 293
Query: 1053 IYEDLSSI 1060
            + EDL  I
Sbjct: 294  LVEDLDRI 301

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 62/246 (25%), Positives = 111/246 (45%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +            +T
Sbjct: 99   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     +ARG+ YL   + + H +L A N+L+   ++  R+AD+ L R +      
Sbjct: 156  FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNV-MRIADFGLARDINNIDYY 213
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV++ E+ T       + G    G+ 
Sbjct: 214  KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT-------LGGSPYPGIP 264
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  PA      E+  +   C  +V S+RP  K + 
Sbjct: 265  VEELFKL-LKEGH-----------RMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 311  EDLDRI 316

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 60/114 (52%), Gaps = 7/114 (6%)
Query: 871 RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL 930
            +GP L    RL     + RGL Y+H    V H +LK  N+ ++  DL  ++ D+ L R+
Sbjct: 113 EQGPLLEEHARL-FMYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 931 MTQAGTIEQILDAGVLG--YRAPELAASKKPHPSFKS-DVYAFGVILLELLTGR 981
           M    + +  L  G++   YR+P L  S  P+   K+ D++A G I  E+LTG+
Sbjct: 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLS--PNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 784 LGRSSHGTSYRATLENGMFLTVKWL----REGVAKQRXXXXXXXXXXXNIRHPNVVGLRG 839
           +GR S  T Y+  L+    + V W     R+    +R            ++HPN+V    
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 840 YYWGPTQHEKLIL--SDYISPGSLASFLYDRPGRKGPPL-TWAQRLKIAVDVARGLNYLH 896
            +    + +K I+  ++  + G+L ++L      K   L +W ++      + +GL +LH
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGLQFLH 146
Query: 897 FDRAVP--HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELA 954
             R  P  H +LK  NI + GP  + ++ D  L  L  +A   + ++  G   + APE  
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVI--GTPEFXAPEXY 202
Query: 955 ASKKPHPSFKSDVYAFGVILLELLT 979
             K        DVYAFG   LE  T
Sbjct: 203 EEKYDE---SVDVYAFGXCXLEXAT 224

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 31/166 (18%)
Query: 831 HPNVVGL------RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--------- 875
           HPN++ L      RGY +        +  +Y   G+L  FL      +  P         
Sbjct: 75  HPNIINLLGACEHRGYLY--------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 126
Query: 876 --LTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ 933
             L+  Q L  A DVARG++YL   + + H +L A NIL+ G +  A++AD+ L R   Q
Sbjct: 127 STLSSQQLLHFAADVARGMDYLSQKQFI-HRDLAARNILV-GENYVAKIADFGLSR--GQ 182
Query: 934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
              +++ +  G L  R   + +      +  SDV+++GV+L E+++
Sbjct: 183 EVYVKKTM--GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 31/166 (18%)
Query: 831 HPNVVGL------RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--------- 875
           HPN++ L      RGY +        +  +Y   G+L  FL      +  P         
Sbjct: 85  HPNIINLLGACEHRGYLY--------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 876 --LTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ 933
             L+  Q L  A DVARG++YL   + + H +L A NIL+ G +  A++AD+ L R   Q
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFI-HRDLAARNILV-GENYVAKIADFGLSR--GQ 192
Query: 934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
              +++ +  G L  R   + +      +  SDV+++GV+L E+++
Sbjct: 193 EVYVKKTM--GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 774 EELSRAPAEV------LGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRXXXXXXXXXX 826
           + L++ P EV      LG  S+G+ Y+A   E G  + +K +   V              
Sbjct: 21  DSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIM 78
Query: 827 XNIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV 886
                P+VV   G Y+  T  +  I+ +Y   GS++  +  R       LT  +   I  
Sbjct: 79  QQCDSPHVVKYYGSYFKNT--DLWIVMEYCGAGSVSDIIRLR----NKTLTEDEIATILQ 132
Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVL 946
              +GL YLHF R + H ++KA NILL+  + +A++AD+ +   +T        +  G  
Sbjct: 133 STLKGLEYLHFMRKI-HRDIKAGNILLN-TEGHAKLADFGVAGQLTDXMAKRNXV-IGTP 189
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            + APE+   ++   +  +D+++ G+  +E+  G+
Sbjct: 190 FWMAPEVI--QEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 12/154 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++ +P+VVG  G++         ++ +     SL      R     P   +  R  I   
Sbjct: 98  SLDNPHVVGFHGFF--EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI--- 152
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
             +G+ YLH +R + H +LK  N+ L+  D++ ++ D+ L   +   G  ++ L  G   
Sbjct: 153 --QGVQYLHNNRVI-HRDLKLGNLFLND-DMDVKIGDFGLATKIEFDGERKKTL-CGTPN 207
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           Y APE+   KK H SF+ D+++ G IL  LL G+
Sbjct: 208 YIAPEVLC-KKGH-SFEVDIWSLGCILYTLLVGK 239

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 110/245 (44%), Gaps = 41/245 (16%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +            +T
Sbjct: 145  KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     +ARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 202  FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNV-MKIADFGLARDINNIDYY 259
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDL 996
            ++  +  + + + APE    +    + +SDV++FGV++ E+ T      +      G+ +
Sbjct: 260  KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT------LGGSPYPGIPV 311
Query: 997  TDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIYE 1055
             +  +L + EGH  D            PA      E+  +   C  +V S+RP  K + E
Sbjct: 312  EELFKL-LKEGHRMD-----------KPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVE 357
Query: 1056 DLSSI 1060
            DL  I
Sbjct: 358  DLDRI 362

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 72/160 (45%), Gaps = 10/160 (6%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGR--KGP-PLTWAQRLKI 884
            ++HPNV+ L+  +      +  +L DY          + R  +  K P  L       +
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 885 AVDVARGLNYLHFDRAVPHGNLKATNILL--DGPDL-NARVADYCLHRLMTQAGTIEQIL 941
              +  G++YLH +  V H +LK  NIL+  +GP+    ++AD    RL          L
Sbjct: 134 LYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 942 DAGVL--GYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           D  V+   YRAPEL    + H +   D++A G I  ELLT
Sbjct: 193 DPVVVTFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLT 231

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ +L 
Sbjct: 155 LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKFLA 209
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM--TQAGTIEQILDAGV-LGYRAPEL 953
             + V H +L A N +LD      +VAD+ L R M   +  ++     A + + + A E 
Sbjct: 210 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
             ++K   + KSDV++FGV+L EL+T
Sbjct: 268 LQTQKF--TTKSDVWSFGVLLWELMT 291

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 47/155 (30%), Positives = 83/155 (53%), Gaps = 22/155 (14%)
Query: 831 HPNVVGL-RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
           HPN+V L   +Y+   ++   IL ++ + G++ + + +       PLT +Q   +     
Sbjct: 93  HPNIVKLLDAFYY---ENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTL 145
Query: 890 RGLNYLHFDRAVPHGNLKATNIL--LDGPDLNARVADYCLHRLMTQAGTIEQILDA--GV 945
             LNYLH D  + H +LKA NIL  LDG   + ++AD+ +    T+  TI++  D+  G 
Sbjct: 146 DALNYLH-DNKIIHRDLKAGNILFTLDG---DIKLADFGVSAKNTR--TIQR-RDSFIGT 198
Query: 946 LGYRAPE--LAASKKPHP-SFKSDVYAFGVILLEL 977
             + APE  +  + K  P  +K+DV++ G+ L+E+
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ +L 
Sbjct: 97  LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKFLA 151
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM--TQAGTIEQILDAGV-LGYRAPEL 953
             + V H +L A N +LD      +VAD+ L R M   +  ++     A + + + A E 
Sbjct: 152 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
             ++K   + KSDV++FGV+L EL+T
Sbjct: 210 LQTQKF--TTKSDVWSFGVLLWELMT 233

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 12/154 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++ +P+VVG  G++         ++ +     SL      R     P   +  R  I   
Sbjct: 98  SLDNPHVVGFHGFF--EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI--- 152
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
             +G+ YLH +R + H +LK  N+ L+  D++ ++ D+ L   +   G  ++ L  G   
Sbjct: 153 --QGVQYLHNNRVI-HRDLKLGNLFLND-DMDVKIGDFGLATKIEFDGERKKXL-CGTPN 207
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           Y APE+   KK H SF+ D+++ G IL  LL G+
Sbjct: 208 YIAPEVLC-KKGH-SFEVDIWSLGCILYTLLVGK 239

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ +L 
Sbjct: 97  LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKFLA 151
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM--TQAGTIEQILDAGV-LGYRAPEL 953
             + V H +L A N +LD      +VAD+ L R M   +  ++     A + + + A E 
Sbjct: 152 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
             ++K   + KSDV++FGV+L EL+T
Sbjct: 210 LQTQKF--TTKSDVWSFGVLLWELMT 233

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 61/246 (24%), Positives = 111/246 (45%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRKGP---------PLT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +            +T
Sbjct: 99   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMT 155
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     +ARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 156  FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNV-MKIADFGLARDINNIDXX 213
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV++ E+ T       + G    G+ 
Sbjct: 214  KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT-------LGGSPYPGIP 264
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  PA      E+  +   C  +V S+RP  K + 
Sbjct: 265  VEELFKL-LKEGH-----------RMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 311  EDLDRI 316

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 25/175 (14%)
Query: 832  PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
            P +VG  G ++  +  E  I  +++  GSL   L  + GR    +      K+++ V +G
Sbjct: 83   PYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL-KKAGRIPEQILG----KVSIAVIKG 135
Query: 892  LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA------GV 945
            L YL     + H ++K +NIL++      ++ D+         G   Q++D+      G 
Sbjct: 136  LTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDF---------GVSGQLIDSMANSFVGT 185
Query: 946  LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWM 1000
              Y +PE    +  H S +SD+++ G+ L+E+  GR      SG  A  +L D++
Sbjct: 186  RSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYI 238

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ +L 
Sbjct: 101 LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKFLA 155
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM--TQAGTIEQILDAGV-LGYRAPEL 953
             + V H +L A N +LD      +VAD+ L R M   +  ++     A + + + A E 
Sbjct: 156 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
             ++K   + KSDV++FGV+L EL+T
Sbjct: 214 LQTQKF--TTKSDVWSFGVLLWELMT 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ +L 
Sbjct: 96  LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKFLA 150
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM--TQAGTIEQILDAGV-LGYRAPEL 953
             + V H +L A N +LD      +VAD+ L R M   +  ++     A + + + A E 
Sbjct: 151 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
             ++K   + KSDV++FGV+L EL+T
Sbjct: 209 LQTQKF--TTKSDVWSFGVLLWELMT 232

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 61/246 (24%), Positives = 111/246 (45%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +            +T
Sbjct: 99   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     +ARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 156  FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNV-MKIADFGLARDINNIDXX 213
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV++ E+ T       + G    G+ 
Sbjct: 214  KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT-------LGGSPYPGIP 264
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  PA      E+  +   C  +V S+RP  K + 
Sbjct: 265  VEELFKL-LKEGH-----------RMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 311  EDLDRI 316

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ +L 
Sbjct: 96  LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKFLA 150
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM--TQAGTIEQILDAGV-LGYRAPEL 953
             + V H +L A N +LD      +VAD+ L R M   +  ++     A + + + A E 
Sbjct: 151 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
             ++K   + KSDV++FGV+L EL+T
Sbjct: 209 LQTQKF--TTKSDVWSFGVLLWELMT 232

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 61/246 (24%), Positives = 111/246 (45%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +            +T
Sbjct: 86   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 142
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     +ARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 143  FKDLVSCTYQLARGMEYLASQKCI-HRDLTARNVLVTENNV-MKIADFGLARDINNIDYY 200
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV++ E+ T       + G    G+ 
Sbjct: 201  KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT-------LGGSPYPGIP 251
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  PA      E+  +   C  +V S+RP  K + 
Sbjct: 252  VEELFKL-LKEGH-----------RMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLV 297
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 298  EDLDRI 303

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 61/246 (24%), Positives = 111/246 (45%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +            +T
Sbjct: 91   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 147
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     +ARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 148  FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNV-MKIADFGLARDINNIDYY 205
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV++ E+ T       + G    G+ 
Sbjct: 206  KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT-------LGGSPYPGIP 256
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  PA      E+  +   C  +V S+RP  K + 
Sbjct: 257  VEELFKL-LKEGH-----------RMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLV 302
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 303  EDLDRI 308

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 61/246 (24%), Positives = 111/246 (45%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +            +T
Sbjct: 88   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 144
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     +ARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 145  FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNV-MKIADFGLARDINNIDYY 202
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV++ E+ T       + G    G+ 
Sbjct: 203  KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT-------LGGSPYPGIP 253
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  PA      E+  +   C  +V S+RP  K + 
Sbjct: 254  VEELFKL-LKEGH-----------RMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLV 299
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 300  EDLDRI 305

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 12/154 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++ +P+VVG  G++         ++ +     SL      R     P   +  R  I   
Sbjct: 82  SLDNPHVVGFHGFF--EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI--- 136
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
             +G+ YLH +R + H +LK  N+ L+  D++ ++ D+ L   +   G  ++ L  G   
Sbjct: 137 --QGVQYLHNNRVI-HRDLKLGNLFLND-DMDVKIGDFGLATKIEFDGERKKDL-CGTPN 191
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           Y APE+   KK H SF+ D+++ G IL  LL G+
Sbjct: 192 YIAPEVLC-KKGH-SFEVDIWSLGCILYTLLVGK 223

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 61/246 (24%), Positives = 111/246 (45%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +            +T
Sbjct: 99   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     +ARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 156  FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNV-MKIADFGLARDINNIDYY 213
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV++ E+ T       + G    G+ 
Sbjct: 214  KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT-------LGGSPYPGIP 264
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  PA      E+  +   C  +V S+RP  K + 
Sbjct: 265  VEELFKL-LKEGH-----------RMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 311  EDLDRI 316

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 25/219 (11%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVA-KQRXXXXXXXXXXXNIR 830
           P+E+S    +V+G  S G  Y+A L ++G  + +K + +G A K R            + 
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-----ELQIMRKLD 71
Query: 831 HPNVVGLRGYYWGPTQHE-----KLILSDYISPGSL--ASFLYDRPGRKGPPLTWAQRLK 883
           H N+V LR +++   + +      L+L DY+ P ++   +  Y R  ++  P+ + +   
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVL-DYV-PATVYRVARHYSR-AKQTLPVIYVKLY- 127
Query: 884 IAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILD 942
               + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I  
Sbjct: 128 -MYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 943 AGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 186 R---YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 220

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 782 EVLGRSSHGTSYRATLENG----MFLTVKWL-REGVAKQRXXXXXXXXXXXNIRHPNVVG 836
           EV+GR   G  Y  TL +     +   VK L R     +            +  HPNV+ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     ++   L++  Y+  G L +F+  R     P  T    +   + VA+G+ +L 
Sbjct: 94  LLGICLR-SEGSPLVVLPYMKHGDLRNFI--RNETHNP--TVKDLIGFGLQVAKGMKFLA 148
Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM--TQAGTIEQILDAGV-LGYRAPEL 953
             + V H +L A N +LD      +VAD+ L R M   +  ++     A + + + A E 
Sbjct: 149 SKKFV-HRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
             ++K   + KSDV++FGV+L EL+T
Sbjct: 207 LQTQKF--TTKSDVWSFGVLLWELMT 230

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 65/246 (26%), Positives = 112/246 (45%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---GPP------LT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +    P       L+
Sbjct: 77   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLS 133
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
                +  A  VARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 134  SKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 191
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV+L E+ T       + G    GV 
Sbjct: 192  KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT-------LGGSPYPGVP 242
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  P+      E+  +   C  +V S+RP  K + 
Sbjct: 243  VEELFKL-LKEGH-----------RMDKPS--NCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 289  EDLDRI 294

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 12/154 (7%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++ +P+VVG  G++         ++ +     SL      R     P   +  R  I   
Sbjct: 98  SLDNPHVVGFHGFF--EDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI--- 152
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
             +G+ YLH +R + H +LK  N+ L+  D++ ++ D+ L   +   G  ++ L  G   
Sbjct: 153 --QGVQYLHNNRVI-HRDLKLGNLFLND-DMDVKIGDFGLATKIEFDGERKKDL-CGTPN 207
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           Y APE+   KK H SF+ D+++ G IL  LL G+
Sbjct: 208 YIAPEVLC-KKGH-SFEVDIWSLGCILYTLLVGK 239

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 832 PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
           P +VG  G ++  +  E  I  +++  GSL   L  +  ++ P        K+++ V RG
Sbjct: 74  PYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL--KEAKRIPEEILG---KVSIAVLRG 126
Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA------GV 945
           L YL     + H ++K +NIL++      ++ D+         G   Q++D+      G 
Sbjct: 127 LAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDF---------GVSGQLIDSMANSFVGT 176
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             Y APE       H S +SD+++ G+ L+EL  GR
Sbjct: 177 RSYMAPERLQGT--HYSVQSDIWSMGLSLVELAVGR 210

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 64/246 (26%), Positives = 110/246 (44%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---GPP------LT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +    P       L+
Sbjct: 85   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 141
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
                +  A  VARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 142  SKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 199
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV+L E+ T       + G    GV 
Sbjct: 200  KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT-------LGGSPYPGVP 250
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH  D                    E+  +   C  +V S+RP  K + 
Sbjct: 251  VEELFKL-LKEGHRMD-------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 296
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 297  EDLDRI 302

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVA-KQRXXXXXXXXXXXNIR 830
           P+E+S    +V+G  S G  Y+A L ++G  + +K + +G A K R            + 
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-----ELQIMRKLD 71
Query: 831 HPNVVGLRGYYWGPTQHE-----KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIA 885
           H N+V LR +++   + +      L+L DY+         +    ++  P+ + +     
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLY--M 128
Query: 886 VDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAG 944
             + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I    
Sbjct: 129 YQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR- 186
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
              YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 187 --YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVA-KQRXXXXXXXXXXXNIR 830
           P+E+S    +V+G  S G  Y+A L ++G  + +K + +G A K R            + 
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-----ELQIMRKLD 71
Query: 831 HPNVVGLRGYYWGPTQHE-----KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIA 885
           H N+V LR +++   + +      L+L DY+         +    ++  P+ + +     
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLY--M 128
Query: 886 VDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAG 944
             + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I    
Sbjct: 129 YQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR- 186
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
              YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 187 --YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 220

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 61/246 (24%), Positives = 111/246 (45%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +            +T
Sbjct: 99   KHKNIITLLG---ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     +ARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 156  FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNV-MKIADFGLARDINNIDYY 213
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV++ E+ T       + G    G+ 
Sbjct: 214  KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT-------LGGSPYPGIP 264
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  PA      E+  +   C  +V S+RP  K + 
Sbjct: 265  VEELFKL-LKEGH-----------RMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 311  EDLDRI 316

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 22/155 (14%)
Query: 831 HPNVVGL-RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
           HPN+V L   +Y+   ++   IL ++ + G++ + + +       PLT +Q   +     
Sbjct: 93  HPNIVKLLDAFYY---ENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTL 145
Query: 890 RGLNYLHFDRAVPHGNLKATNIL--LDGPDLNARVADYCLHRLMTQAGTIEQILDA--GV 945
             LNYLH D  + H +LKA NIL  LDG   + ++AD+ +    T+     Q  D+  G 
Sbjct: 146 DALNYLH-DNKIIHRDLKAGNILFTLDG---DIKLADFGVSAKNTRX---IQRRDSFIGT 198
Query: 946 LGYRAPE--LAASKKPHP-SFKSDVYAFGVILLEL 977
             + APE  +  + K  P  +K+DV++ G+ L+E+
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           +RHP+++ L  Y    ++ E +++ +Y +   L  ++  R       ++  +  +    +
Sbjct: 71  LRHPHIIKL--YDVIKSKDEIIMVIEY-AGNELFDYIVQRD-----KMSEQEARRFFQQI 122
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
              + Y H  + V H +LK  N+LLD   LN ++AD+ L  +MT    ++     G   Y
Sbjct: 123 ISAVEYCHRHKIV-HRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKT--SCGSPNY 178
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGD 985
            APE+  S K +   + DV++ GVIL  +L  R   D
Sbjct: 179 AAPEV-ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 18/153 (11%)
Query: 831 HPNVVGL-RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
           HPN+V L   +Y+   ++   IL ++ + G++ + + +       PLT +Q   +     
Sbjct: 93  HPNIVKLLDAFYY---ENNLWILIEFCAGGAVDAVMLELE----RPLTESQIQVVCKQTL 145
Query: 890 RGLNYLHFDRAVPHGNLKATNIL--LDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
             LNYLH D  + H +LKA NIL  LDG   + ++AD+ +    T+          G   
Sbjct: 146 DALNYLH-DNKIIHRDLKAGNILFTLDG---DIKLADFGVSAKNTRXIQRRDXF-IGTPY 200
Query: 948 YRAPE--LAASKKPHP-SFKSDVYAFGVILLEL 977
           + APE  +  + K  P  +K+DV++ G+ L+E+
Sbjct: 201 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 61/246 (24%), Positives = 110/246 (44%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +            +T
Sbjct: 99   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     +ARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 156  FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNV-MKIADFGLARDINNIDYY 213
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            +   +  + + + APE    +    + +SDV++FGV++ E+ T       + G    G+ 
Sbjct: 214  KNTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT-------LGGSPYPGIP 264
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  PA      E+  +   C  +V S+RP  K + 
Sbjct: 265  VEELFKL-LKEGH-----------RMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 311  EDLDRI 316

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 64/246 (26%), Positives = 110/246 (44%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---GPP------LT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +    P       L+
Sbjct: 92   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 148
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
                +  A  VARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 149  SKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 206
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV+L E+ T       + G    GV 
Sbjct: 207  KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT-------LGGSPYPGVP 257
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH  D                    E+  +   C  +V S+RP  K + 
Sbjct: 258  VEELFKL-LKEGHRMD-------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 303
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 304  EDLDRI 309

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 64/246 (26%), Positives = 110/246 (44%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---GPP------LT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +    P       L+
Sbjct: 92   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLS 148
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
                +  A  VARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 149  SKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 206
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV+L E+ T       + G    GV 
Sbjct: 207  KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT-------LGGSPYPGVP 257
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH  D                    E+  +   C  +V S+RP  K + 
Sbjct: 258  VEELFKL-LKEGHRMD-------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 303
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 304  EDLDRI 309

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 64/246 (26%), Positives = 110/246 (44%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---GPP------LT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +    P       L+
Sbjct: 81   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 137
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
                +  A  VARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 138  SKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 195
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV+L E+ T       + G    GV 
Sbjct: 196  KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT-------LGGSPYPGVP 246
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH  D                    E+  +   C  +V S+RP  K + 
Sbjct: 247  VEELFKL-LKEGHRMD-------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 292
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 293  EDLDRI 298

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 64/246 (26%), Positives = 110/246 (44%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---GPP------LT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +    P       L+
Sbjct: 92   KHKNIINLLG---ACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLS 148
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
                +  A  VARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 149  SKDLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVTEDNV-MKIADFGLARDIHHIDYY 206
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV+L E+ T       + G    GV 
Sbjct: 207  KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT-------LGGSPYPGVP 257
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH  D                    E+  +   C  +V S+RP  K + 
Sbjct: 258  VEELFKL-LKEGHRMD-------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 303
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 304  EDLDRI 309

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 10/156 (6%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            + HPNVV L      P +    ++ + ++ G +       P  K  PL+  Q      D
Sbjct: 92  KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----PTLK--PLSEDQARFYFQD 145
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
           + +G+ YLH+ + + H ++K +N+L+ G D + ++AD+ +      +  +      G   
Sbjct: 146 LIKGIEYLHYQKII-HRDIKPSNLLV-GEDGHIKIADFGVSNEFKGSDALLSNT-VGTPA 202
Query: 948 YRAPE-LAASKKPHPSFKSDVYAFGVILLELLTGRC 982
           + APE L+ ++K       DV+A GV L   + G+C
Sbjct: 203 FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           +RHP+++ L  Y    ++ E +++ +Y +   L  ++  R       ++  +  +    +
Sbjct: 70  LRHPHIIKL--YDVIKSKDEIIMVIEY-AGNELFDYIVQRD-----KMSEQEARRFFQQI 121
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
              + Y H  + V H +LK  N+LLD   LN ++AD+ L  +MT    ++     G   Y
Sbjct: 122 ISAVEYCHRHKIV-HRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKT--SCGSPNY 177
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGD 985
            APE+  S K +   + DV++ GVIL  +L  R   D
Sbjct: 178 AAPEV-ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 61/246 (24%), Positives = 111/246 (45%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++ +Y S G+L  +L  R  PG +            +T
Sbjct: 99   KHKNIIHLLG---ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     +ARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 156  FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNV-MKIADFGLARDINNIDYY 213
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV++ E+ T       + G    G+ 
Sbjct: 214  KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT-------LGGSPYPGIP 264
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  PA      E+  +   C  +V S+RP  K + 
Sbjct: 265  VEELFKL-LKEGH-----------RMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 311  EDLDRI 316

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L   Y     H  LI+   +S G     L+DR   KG   T     ++   V
Sbjct: 73  IKHPNIVALDDIY-ESGGHLYLIMQ-LVSGGE----LFDRIVEKG-FYTERDASRLIFQV 125
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR--VADYCLHRLMTQAGTIEQILDAGVL 946
              + YLH D  + H +LK  N+L    D +++  ++D+ L + M   G++      G  
Sbjct: 126 LDAVKYLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTA-CGTP 182
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           GY APE+ A +KP+ S   D ++ GVI   LL G
Sbjct: 183 GYVAPEVLA-QKPY-SKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L   Y     H  LI+   +S G     L+DR   KG   T     ++   V
Sbjct: 73  IKHPNIVALDDIY-ESGGHLYLIMQ-LVSGGE----LFDRIVEKG-FYTERDASRLIFQV 125
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR--VADYCLHRLMTQAGTIEQILDAGVL 946
              + YLH D  + H +LK  N+L    D +++  ++D+ L + M   G++      G  
Sbjct: 126 LDAVKYLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTA-CGTP 182
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           GY APE+ A +KP+ S   D ++ GVI   LL G
Sbjct: 183 GYVAPEVLA-QKPY-SKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L   Y     H  LI+   +S G     L+DR   KG   T     ++   V
Sbjct: 73  IKHPNIVALDDIY-ESGGHLYLIMQ-LVSGGE----LFDRIVEKG-FYTERDASRLIFQV 125
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR--VADYCLHRLMTQAGTIEQILDAGVL 946
              + YLH D  + H +LK  N+L    D +++  ++D+ L + M   G++      G  
Sbjct: 126 LDAVKYLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTA-CGTP 182
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           GY APE+ A +KP+ S   D ++ GVI   LL G
Sbjct: 183 GYVAPEVLA-QKPY-SKAVDCWSIGVIAYILLCG 214

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           I+HPN+V L   Y     H  LI+   +S G     L+DR   KG   T     ++   V
Sbjct: 73  IKHPNIVALDDIY-ESGGHLYLIMQ-LVSGGE----LFDRIVEKG-FYTERDASRLIFQV 125
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR--VADYCLHRLMTQAGTIEQILDAGVL 946
              + YLH D  + H +LK  N+L    D +++  ++D+ L + M   G++      G  
Sbjct: 126 LDAVKYLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-MEDPGSVLSTA-CGTP 182
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           GY APE+ A +KP+ S   D ++ GVI   LL G
Sbjct: 183 GYVAPEVLA-QKPY-SKAVDCWSIGVIAYILLCG 214

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 84
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +  +    + DY+         +    ++  P+ + +       
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 142
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 143 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR--- 198
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 199 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 232

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 27/97 (27%), Positives = 54/97 (55%), Gaps = 5/97 (5%)
Query: 883 KIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD 942
           KIAV + + L +LH   +V H ++K +N+L++      ++ D+ +   +    ++ + +D
Sbjct: 157 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYLVD--SVAKTID 213
Query: 943 AGVLGYRAPELAASK--KPHPSFKSDVYAFGVILLEL 977
           AG   Y APE    +  +   S KSD+++ G+ ++EL
Sbjct: 214 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 72
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + + ++    + DY+         +    ++  P+ + +       
Sbjct: 73  CNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 130
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 131 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR--- 186
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 187 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 220

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 850 LILSDYISPGSLASFLY-------DRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP 902
           L++ + ++ G L S+L        + PGR  PP T  + +++A ++A G+ YL+  + V 
Sbjct: 97  LVVMELMAHGDLKSYLRSLRPEAENNPGR--PPPTLQEMIQMAAEIADGMAYLNAKKFV- 153
Query: 903 HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPH 960
           H NL A N ++   D   ++ D+ + R + +     +    G+L  R  APE  + K   
Sbjct: 154 HRNLAARNCMV-AHDFTVKIGDFGMTRDIYETDYYRK-GGKGLLPVRWMAPE--SLKDGV 209
Query: 961 PSFKSDVYAFGVILLEL 977
            +  SD+++FGV+L E+
Sbjct: 210 FTTSSDMWSFGVVLWEI 226

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 850 LILSDYISPGSLASFLY-------DRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP 902
           L++ + ++ G L S+L        + PGR  PP T  + +++A ++A G+ YL+  + V 
Sbjct: 96  LVVMELMAHGDLKSYLRSLRPEAENNPGR--PPPTLQEMIQMAAEIADGMAYLNAKKFV- 152
Query: 903 HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPH 960
           H NL A N ++   D   ++ D+ + R + +     +    G+L  R  APE  + K   
Sbjct: 153 HRNLAARNCMV-AHDFTVKIGDFGMTRDIYETDYYRKG-GKGLLPVRWMAPE--SLKDGV 208
Query: 961 PSFKSDVYAFGVILLEL 977
            +  SD+++FGV+L E+
Sbjct: 209 FTTSSDMWSFGVVLWEI 225

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 21  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 76
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +  +    + DY+         +    ++  P+ + +       
Sbjct: 77  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 134
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 135 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR--- 190
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 191 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 224

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 9/99 (9%)
Query: 885 AVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY--CLHRLMTQAGTIEQILD 942
           A ++  GL +LH  + + + +LK  NILLD  D + ++AD+  C   ++  A T E    
Sbjct: 125 AAEIILGLQFLH-SKGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNEF--- 179
Query: 943 AGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            G   Y APE+   +K + S   D ++FGV+L E+L G+
Sbjct: 180 CGTPDYIAPEILLGQKYNHSV--DWWSFGVLLYEMLIGQ 216

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           +RHP+++ L  Y    ++ E +++ +Y +   L  ++  R       ++  +  +    +
Sbjct: 65  LRHPHIIKL--YDVIKSKDEIIMVIEY-AGNELFDYIVQRDK-----MSEQEARRFFQQI 116
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
              + Y H  + V H +LK  N+LLD   LN ++AD+ L  +MT    ++     G   Y
Sbjct: 117 ISAVEYCHRHKIV-HRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKT--SCGSPNY 172
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGD 985
            APE+  S K +   + DV++ GVIL  +L  R   D
Sbjct: 173 AAPEV-ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 36  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 91
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +  +    + DY+         +    ++  P+ + +       
Sbjct: 92  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 149
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 150 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR--- 205
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 206 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 239

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 115/276 (41%), Gaps = 45/276 (16%)
Query: 85  ADLSVFSNLSMLVKLSMSNNSISGVIP--------------------DNIGDFKSLEFLD 124
            D++   NL+ LV + M+NN I+ + P                    D + +  +L  L+
Sbjct: 76  TDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 135
Query: 125 VSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP 184
           +S N  S    S +  L SLQ LS + N  + L P  ++ L +++ LD+S N  S     
Sbjct: 136 LSSNTISD--ISALSGLTSLQQLSFSSNQVTDLKP--LANLTTLERLDISSNKVSD--IS 189
Query: 185 ALTRXXXXXXXXXXXXGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHID 244
            L +              S   P G  ++  L  L  +GN+L     G    LTN + +D
Sbjct: 190 VLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDI--GTLASLTNLTDLD 245
Query: 245 FSGNMFVGSSSQKFLPGLSQ----SVQYLNLS----LNQLTGSLVNGGELQL------FE 290
            + N     +    L  L++    + Q  N+S    L  LT   +N  +L+        +
Sbjct: 246 LANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 305
Query: 291 NLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFS 326
           NL  L L +N ++   P  + + +LQ L  SNN+ S
Sbjct: 306 NLTYLTLYFNNISDISP-VSSLTKLQRLFFSNNKVS 340

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 25  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 80
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +  +    + DY+         +    ++  P+ + +       
Sbjct: 81  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 138
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 139 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR--- 194
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 195 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 228

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 61/246 (24%), Positives = 110/246 (44%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++  Y S G+L  +L  R  PG +            +T
Sbjct: 99   KHKNIINLLG---ACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     +ARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 156  FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNV-MKIADFGLARDINNIDYY 213
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV++ E+ T       + G    G+ 
Sbjct: 214  KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT-------LGGSPYPGIP 264
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  PA      E+  +   C  +V S+RP  K + 
Sbjct: 265  VEELFKL-LKEGH-----------RMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 311  EDLDRI 316

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 828 NIRHPNVVGLRGYYWGPTQH---EKLILSDYISPGSLASFL-YDR--PGRKGPPLTWAQR 881
           +  HPNV+ L G     +     + +++  ++  G L ++L Y R   G K  PL     
Sbjct: 92  DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL--QTL 149
Query: 882 LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL 941
           LK  VD+A G+ YL  +R   H +L A N +L   D+   VAD+ L + +       Q  
Sbjct: 150 LKFMVDIALGMEYLS-NRNFLHRDLAARNCMLRD-DMTVCVADFGLSKKIYSGDYYRQGR 207
Query: 942 DAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
            A + + + A E  A +    + KSDV+AFGV + E+ T
Sbjct: 208 IAKMPVKWIAIESLADRVY--TSKSDVWAFGVTMWEIAT 244

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 84
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +  +    + DY+         +    ++  P+ + +       
Sbjct: 85  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 142
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 143 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR--- 198
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 199 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 232

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 45  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 100
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +  +    + DY+         +    ++  P+ + +       
Sbjct: 101 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 158
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 159 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 214
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 215 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 248

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 22  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 77
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +  +    + DY+         +    ++  P+ + +       
Sbjct: 78  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 135
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 136 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 191
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 192 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 225

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 66/135 (48%), Gaps = 6/135 (4%)
Query: 849 KLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLNYLHFDRAVPHGNL 906
           + IL + ++ G L SFL +   R   P  L     L +A D+A G  YL  +  + H ++
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFI-HRDI 207
Query: 907 KATNILLD--GPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFK 964
            A N LL   GP   A++ D+ + R + +AG   +   A +     P  A  +    S K
Sbjct: 208 AARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTS-K 266
Query: 965 SDVYAFGVILLELLT 979
           +D ++FGV+L E+ +
Sbjct: 267 TDTWSFGVLLWEIFS 281

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 33/110 (30%), Positives = 59/110 (53%), Gaps = 10/110 (9%)
Query: 875 PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
           P+T  + +++  D  + LN+ H    + H ++K  NIL+   +   +V D+ + R +  +
Sbjct: 112 PMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANILISATNA-VKVVDFGIARAIADS 169
Query: 935 G-TIEQILDAGVLG---YRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           G ++ Q   A V+G   Y +PE A  +      +SDVY+ G +L E+LTG
Sbjct: 170 GNSVXQT--AAVIGTAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 66/135 (48%), Gaps = 6/135 (4%)
Query: 849 KLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLNYLHFDRAVPHGNL 906
           + IL + ++ G L SFL +   R   P  L     L +A D+A G  YL  +  + H ++
Sbjct: 126 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFI-HRDI 184
Query: 907 KATNILLD--GPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFK 964
            A N LL   GP   A++ D+ + R + +AG   +   A +     P  A  +    S K
Sbjct: 185 AARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTS-K 243
Query: 965 SDVYAFGVILLELLT 979
           +D ++FGV+L E+ +
Sbjct: 244 TDTWSFGVLLWEIFS 258

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRATL----EN-GMFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+       EN  + + +K LRE  + K              +  P V 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L   + +  GR G    L W  +      +A+G++
Sbjct: 83  RLLGICLTSTVQ---LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMS 133
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL   R V H +L A N+L+  P+ + ++ D+ L RL+    T E   D G +  +   L
Sbjct: 134 YLEDVRLV-HRDLAARNVLVKSPN-HVKITDFGLARLLDIDET-EYHADGGKVPIKWMAL 190
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +  +   + +SDV+++GV + EL+T
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 61/246 (24%), Positives = 110/246 (44%), Gaps = 43/246 (17%)
Query: 830  RHPNVVGLRGYYWGPTQHEKL-ILSDYISPGSLASFLYDR--PGRK---------GPPLT 877
            +H N++ L G     TQ   L ++  Y S G+L  +L  R  PG +            +T
Sbjct: 99   KHKNIINLLG---ACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 878  WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
            +   +     +ARG+ YL   + + H +L A N+L+   ++  ++AD+ L R +      
Sbjct: 156  FKDLVSCTYQLARGMEYLASQKCI-HRDLAARNVLVTENNV-MKIADFGLARDINNIDYY 213
Query: 938  EQILDAGV-LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG-AGVD 995
            ++  +  + + + APE    +    + +SDV++FGV++ E+ T       + G    G+ 
Sbjct: 214  KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT-------LGGSPYPGIP 264
Query: 996  LTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIY 1054
            + +  +L + EGH            M  PA      E+  +   C  +V S+RP  K + 
Sbjct: 265  VEELFKL-LKEGH-----------RMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLV 310
Query: 1055 EDLSSI 1060
            EDL  I
Sbjct: 311  EDLDRI 316

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 30  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 85
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +  +    + DY+         +    ++  P+ + +       
Sbjct: 86  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 143
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 144 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 199
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 200 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 233

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 106
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +  +    + DY+         +    ++  P+ + +       
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 164
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 165 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR--- 220
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 221 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 254

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 850 LILSDYISPGSLASFLY-------DRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP 902
           L++ + ++ G L S+L        + PGR  PP T  + +++A ++A G+ YL+  + V 
Sbjct: 93  LVVMELMAHGDLKSYLRSLRPEAENNPGR--PPPTLQEMIQMAAEIADGMAYLNAKKFV- 149
Query: 903 HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPH 960
           H +L A N ++   D   ++ D+ + R + +     +    G+L  R  APE  + K   
Sbjct: 150 HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKG-GKGLLPVRWMAPE--SLKDGV 205
Query: 961 PSFKSDVYAFGVILLEL 977
            +  SD+++FGV+L E+
Sbjct: 206 FTTSSDMWSFGVVLWEI 222

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 41/142 (28%), Positives = 71/142 (50%), Gaps = 12/142 (8%)
Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
           YY    +  KL I+ +Y+  GS    L   PG    PL   Q   I  ++ +GL+YLH +
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALDLL--EPG----PLDETQIATILREILKGLDYLHSE 123
Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK 958
           + + H ++KA N+LL       ++AD+ +   +T    I++    G   + APE+   K+
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDT-QIKRNXFVGTPFWMAPEVI--KQ 178
Query: 959 PHPSFKSDVYAFGVILLELLTG 980
                K+D+++ G+  +EL  G
Sbjct: 179 SAYDSKADIWSLGITAIELARG 200

>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 61/126 (48%), Gaps = 7/126 (5%)
Query: 60  SWNGIVCNGGNVAGV-VLDNL-----GLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDN 113
           S+NG++    N  G+  L++L      L   ++ SVF +L  L+ L +S+          
Sbjct: 405 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 464
Query: 114 IGDFKSLEFLDVSDNLFSSS-LPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLD 172
                SLE L ++ N F  + LP    +L +L  L L+      L P + + L S+Q L+
Sbjct: 465 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524
Query: 173 LSHNSF 178
           +SHN+F
Sbjct: 525 MSHNNF 530

>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 73/171 (42%), Gaps = 29/171 (16%)
Query: 455 LRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSP-PSVSNLQVLDLSHNRL 513
           L+ LDLSFN +     +N L    L+ L    + L  + +FS   S+ NL  LD+SH   
Sbjct: 399 LKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 457
Query: 514 NGYFPDRLGSLTGLKVLCLAGNNISGSL-------------------------PTSMANM 548
              F      L+ L+VL +AGN+   +                          PT+  ++
Sbjct: 458 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 517
Query: 549 TSLSSLVISQNHFTG--PLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSS 597
           +SL  L +S N+F      P    NSL+  + S N    +  + L+ FPSS
Sbjct: 518 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 568

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 96  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 151
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +  +    + DY+         +    ++  P+ + +       
Sbjct: 152 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 209
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 210 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 265
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 266 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 299

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 41/142 (28%), Positives = 71/142 (50%), Gaps = 12/142 (8%)
Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
           YY    +  KL I+ +Y+  GS    L   PG    PL   Q   I  ++ +GL+YLH +
Sbjct: 70  YYGSYLKDTKLWIIMEYLGGGSALDLL--EPG----PLDETQIATILREILKGLDYLHSE 123
Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK 958
           + + H ++KA N+LL       ++AD+ +   +T    I++    G   + APE+   K+
Sbjct: 124 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDT-QIKRNTFVGTPFWMAPEVI--KQ 178
Query: 959 PHPSFKSDVYAFGVILLELLTG 980
                K+D+++ G+  +EL  G
Sbjct: 179 SAYDSKADIWSLGITAIELARG 200

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 850 LILSDYISPGSLASFLY-------DRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP 902
           L++ + ++ G L S+L        + PGR  PP T  + +++A ++A G+ YL+  + V 
Sbjct: 96  LVVMELMAHGDLKSYLRSLRPEAENNPGR--PPPTLQEMIQMAAEIADGMAYLNAKKFV- 152
Query: 903 HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPH 960
           H +L A N ++   D   ++ D+ + R + +     +    G+L  R  APE  + K   
Sbjct: 153 HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRK-GGKGLLPVRWMAPE--SLKDGV 208
Query: 961 PSFKSDVYAFGVILLEL 977
            +  SD+++FGV+L E+
Sbjct: 209 FTTSSDMWSFGVVLWEI 225

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 66/148 (44%), Gaps = 21/148 (14%)
Query: 52  IDFDGCPS--------------SWNGIVCNGGNVAGV-VLDNL-----GLSAAADLSVFS 91
           + F GC S              S+NG++    N  G+  L++L      L   ++ SVF 
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 92  NLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSS-LPSGIGKLESLQNLSLA 150
           +L  L+ L +S+               SLE L ++ N F  + LP    +L +L  L L+
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 151 GNNFSGLIPDSVSGLVSIQSLDLSHNSF 178
                 L P + + L S+Q L++SHN+F
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNF 506

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 73/171 (42%), Gaps = 29/171 (16%)
Query: 455 LRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSP-PSVSNLQVLDLSHNRL 513
           L+ LDLSFN +     +N L    L+ L    + L  + +FS   S+ NL  LD+SH   
Sbjct: 375 LKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 514 NGYFPDRLGSLTGLKVLCLAGNNISGSL-------------------------PTSMANM 548
              F      L+ L+VL +AGN+   +                          PT+  ++
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
Query: 549 TSLSSLVISQNHFTG--PLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSS 597
           +SL  L +S N+F      P    NSL+  + S N    +  + L+ FPSS
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 544

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 58/105 (55%), Gaps = 11/105 (10%)
Query: 880 QRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY--CLHRLMTQAGTI 937
           Q +  A +++ GL +LH  R + + +LK  N++LD  + + ++AD+  C   +M    T 
Sbjct: 121 QAVFYAAEISIGLFFLH-KRGIIYRDLKLDNVMLDS-EGHIKIADFGMCKEHMMDGVTTR 178
Query: 938 EQILDAGVLGYRAPELAASKKPHPSFKS-DVYAFGVILLELLTGR 981
           E     G   Y APE+ A +   P  KS D +A+GV+L E+L G+
Sbjct: 179 EF---CGTPDYIAPEIIAYQ---PYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 850 LILSDYISPGSLASFLY-------DRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP 902
           L++ + ++ G L S+L        + PGR  PP T  + +++A ++A G+ YL+  + V 
Sbjct: 96  LVVMELMAHGDLKSYLRSLRPEAENNPGR--PPPTLQEMIQMAAEIADGMAYLNAKKFV- 152
Query: 903 HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPH 960
           H +L A N ++   D   ++ D+ + R + +     +    G+L  R  APE  + K   
Sbjct: 153 HRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRK-GGKGLLPVRWMAPE--SLKDGV 208
Query: 961 PSFKSDVYAFGVILLEL 977
            +  SD+++FGV+L E+
Sbjct: 209 FTTSSDMWSFGVVLWEI 225

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 72
Query: 832 PNVVGLRGYYWGPTQHE-----KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV 886
            N+V LR +++   + +      L+L DY+         +    ++  P+ + +      
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLY--MY 129
Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGV 945
            + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I     
Sbjct: 130 QLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-- 186
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 187 -YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 220

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 17/158 (10%)
Query: 829 IRHPNVVGL--RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV 886
           + HP +V +   G    P      I+ +Y+   +L   ++        P+T  + +++  
Sbjct: 86  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIA 140
Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG-TIEQILDAGV 945
           D  + LN+ H    + H ++K  NI++   +   +V D+ + R +  +G ++ Q   A V
Sbjct: 141 DACQALNFSH-QNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQT--AAV 196
Query: 946 LG---YRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           +G   Y +PE A  +      +SDVY+ G +L E+LTG
Sbjct: 197 IGTAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 106
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +  +    + DY+         +    ++  P+ + +       
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 164
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 165 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 220
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 221 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 254

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 55  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 110
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +  +    + DY+         +    ++  P+ + +       
Sbjct: 111 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 168
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 169 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 224
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 225 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 258

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 22/187 (11%)
Query: 799 NGMFLTVKWLREGVA---KQRXXXXXXXXXXXNIRHPNVVGLRGYYWGPTQ--HEKLILS 853
           NG +  +K L++ +    KQ             + HP ++ +    WG  Q   +  ++ 
Sbjct: 30  NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM----WGTFQDAQQIFMIM 85
Query: 854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILL 913
           DYI  G L S L        P   +      A +V   L YLH  + + + +LK  NILL
Sbjct: 86  DYIEGGELFSLLRKSQRFPNPVAKF-----YAAEVCLALEYLH-SKDIIYRDLKPENILL 139
Query: 914 DGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVI 973
           D  + + ++ D+   + +            G   Y APE+ ++K  + S   D ++FG++
Sbjct: 140 D-KNGHIKITDFGFAKYVPDV----TYXLCGTPDYIAPEVVSTKPYNKSI--DWWSFGIL 192
Query: 974 LLELLTG 980
           + E+L G
Sbjct: 193 IYEMLAG 199

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 850 LILSDYISPGSLASFLY-------DRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP 902
           L++ + ++ G L S+L        + PGR  PP T  + +++A ++A G+ YL+  + V 
Sbjct: 96  LVVMELMAHGDLKSYLRSLRPEAENNPGR--PPPTLQEMIQMAAEIADGMAYLNAKKFV- 152
Query: 903 HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPH 960
           H +L A N ++   D   ++ D+ + R + +     +    G+L  R  APE  + K   
Sbjct: 153 HRDLAARNCMV-AHDFTVKIGDFGMTRDIYETAYYRKG-GKGLLPVRWMAPE--SLKDGV 208
Query: 961 PSFKSDVYAFGVILLEL 977
            +  SD+++FGV+L E+
Sbjct: 209 FTTSSDMWSFGVVLWEI 225

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 41/142 (28%), Positives = 71/142 (50%), Gaps = 12/142 (8%)
Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
           YY    +  KL I+ +Y+  GS    L   PG    PL   Q   I  ++ +GL+YLH +
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLL--EPG----PLDETQIATILREILKGLDYLHSE 138
Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK 958
           + + H ++KA N+LL       ++AD+ +   +T    I++    G   + APE+   K+
Sbjct: 139 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDT-QIKRNXFVGTPFWMAPEVI--KQ 193
Query: 959 PHPSFKSDVYAFGVILLELLTG 980
                K+D+++ G+  +EL  G
Sbjct: 194 SAYDSKADIWSLGITAIELARG 215

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 53  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 108
Query: 832 PNVVGLRGYYWGPTQHEKLI----LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +  +    + DY+         +    ++  P+ + +       
Sbjct: 109 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQ 166
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVL 946
           + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I      
Sbjct: 167 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 222
Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 223 YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 256

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 18  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 73
Query: 832 PNVVGLRGYYWGPTQHE-----KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV 886
            N+V LR +++   + +      L+L DY+         +    ++  P+ + +      
Sbjct: 74  CNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLY--MY 130
Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGV 945
            + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I     
Sbjct: 131 QLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-- 187
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 188 -YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 72
Query: 832 PNVVGLRGYYWGPTQHE-----KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV 886
            N+V LR +++   + +      L+L DY+         +    ++  P+ + +      
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLY--MY 129
Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGV 945
            + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I     
Sbjct: 130 QLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-- 186
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 187 -YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 220

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 5/107 (4%)
Query: 874 PPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ 933
           PPL+ A++L IA  VA G+ YL  +R   H +L   N L+ G ++  ++AD+ L R +  
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCLV-GENMVVKIADFGLSRNIYS 226
Query: 934 AGTIEQI-LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           A   +    DA  + +  PE     +   + +SDV+A+GV+L E+ +
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIFS 271

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 41/142 (28%), Positives = 71/142 (50%), Gaps = 12/142 (8%)
Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
           YY    +  KL I+ +Y+  GS    L   PG    PL   Q   I  ++ +GL+YLH +
Sbjct: 90  YYGSYLKDTKLWIIMEYLGGGSALDLL--EPG----PLDETQIATILREILKGLDYLHSE 143
Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK 958
           + + H ++KA N+LL       ++AD+ +   +T    I++    G   + APE+   K+
Sbjct: 144 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDT-QIKRNTFVGTPFWMAPEVI--KQ 198
Query: 959 PHPSFKSDVYAFGVILLELLTG 980
                K+D+++ G+  +EL  G
Sbjct: 199 SAYDSKADIWSLGITAIELARG 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K     V + +            + H
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDH 72
Query: 832 PNVVGLRGYYWGPTQHE-----KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV 886
            N+V LR +++   + +      L+L DY+         +    ++  P+ + +      
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSRAKQTLPVIYVKLY--MY 129
Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGV 945
            + R L Y+H    + H ++K  N+LLD      ++ D+    +L+     +  I     
Sbjct: 130 QLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-- 186
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             YRAPEL      + S   DV++ G +L ELL G+
Sbjct: 187 -YYRAPELIFGATDYTS-SIDVWSAGCVLAELLLGQ 220

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 3/98 (3%)
Query: 882 LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL 941
           L   V +A+G+NYL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   
Sbjct: 154 LNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHA 210
Query: 942 DAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           + G +  +   L +      + +SDV+++GV + EL+T
Sbjct: 211 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 21/166 (12%)
Query: 34  GIKNDPTGFVLNSWNEESIDFDGCPS--------------SWNGIVCNGGNVAGV-VLDN 78
           G+ +  T     S +   + F GC S              S+NG++    N  G+  L++
Sbjct: 46  GVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEH 105
Query: 79  L-----GLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSS 133
           L      L   ++ SVF +L  L+ L +S+               SLE L ++ N F  +
Sbjct: 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165
Query: 134 -LPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF 178
            LP    +L +L  L L+      L P + + L S+Q L++SHN+F
Sbjct: 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 211

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 73/171 (42%), Gaps = 29/171 (16%)
Query: 455 LRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSP-PSVSNLQVLDLSHNRL 513
           L+ LDLSFN +     +N L    L+ L    + L  + +FS   S+ NL  LD+SH   
Sbjct: 80  LKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 514 NGYFPDRLGSLTGLKVLCLAGNNISGSL-------------------------PTSMANM 548
              F      L+ L+VL +AGN+   +                          PT+  ++
Sbjct: 139 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 198
Query: 549 TSLSSLVISQNHFTG--PLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSS 597
           +SL  L +S N+F      P    NSL+  + S N    +  + L+ FPSS
Sbjct: 199 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 249

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A+G+N
Sbjct: 81  RLLGICLTSTVQ---LITQLMPFGXLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 131
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 132 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 188
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 27/97 (27%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 883 KIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD 942
           KIAV + + L +LH   +V H ++K +N+L++      ++ D+ +   +     + + +D
Sbjct: 113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYLVD--DVAKDID 169
Query: 943 AGVLGYRAPELAASK--KPHPSFKSDVYAFGVILLEL 977
           AG   Y APE    +  +   S KSD+++ G+ ++EL
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 108/266 (40%), Gaps = 39/266 (14%)
Query: 85  ADLSVFSNLSMLVKLSMSNNSISGVIP--------------------DNIGDFKSLEFLD 124
            D++   NL+ LV + M+NN I+ + P                    D + +  +L  L+
Sbjct: 76  TDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 135
Query: 125 VSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP 184
           +S N  S    S +  L SLQ LS + N  + L P  ++ L +++ LD+S N  S     
Sbjct: 136 LSSNTISD--ISALSGLTSLQQLSFSSNQVTDLKP--LANLTTLERLDISSNKVSD--IS 189
Query: 185 ALTRXXXXXXXXXXXXGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHID 244
            L +              S   P G  ++  L  L  +GN+L     G    LTN + +D
Sbjct: 190 VLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDI--GTLASLTNLTDLD 245
Query: 245 FSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTG 304
            + N     S+   L GL++  + L L  NQ++    N   L     L  L+L+ NQL  
Sbjct: 246 LANNQI---SNLAPLSGLTKLTE-LKLGANQIS----NISPLAGLTALTNLELNENQLED 297
Query: 305 ELPGFNFVYELQVLKLSNNRFSGFIP 330
             P  N    L  L L  N  S   P
Sbjct: 298 ISPISNL-KNLTYLTLYFNNISDISP 322

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A+G+N
Sbjct: 83  RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 133
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 134 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 190
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A+G+N
Sbjct: 106 RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 156
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 157 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 213
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 214 ESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A+G+N
Sbjct: 87  RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 137
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 138 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 194
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 195 ESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A+G+N
Sbjct: 91  RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 141
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 142 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 198
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 199 ESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A+G+N
Sbjct: 84  RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 134
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 135 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 191
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A+G+N
Sbjct: 88  RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 138
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 139 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 195
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A+G+N
Sbjct: 81  RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 131
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 132 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 188
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A+G+N
Sbjct: 75  RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 125
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 126 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 182
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A+G+N
Sbjct: 81  RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 131
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 132 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 188
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A+G+N
Sbjct: 84  RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 134
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 135 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 191
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A+G+N
Sbjct: 84  RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 134
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 135 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 191
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 850 LILSDYISPGSLASFLY-------DRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP 902
           L++ + ++ G L S+L        + PGR  PP T  + +++A ++A G+ YL+  + V 
Sbjct: 95  LVVMELMAHGDLKSYLRSLRPEAENNPGR--PPPTLQEMIQMAAEIADGMAYLNAKKFV- 151
Query: 903 HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPH 960
           H +L A N ++   D   ++ D+ + R + +     +    G+L  R  APE  + K   
Sbjct: 152 HRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYYRKG-GKGLLPVRWMAPE--SLKDGV 207
Query: 961 PSFKSDVYAFGVILLEL 977
            +  SD+++FGV+L E+
Sbjct: 208 FTTSSDMWSFGVVLWEI 224

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 10/110 (9%)
Query: 875 PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
           P+T  + +++  D  + LN+ H    + H ++K  NI++   +   +V D+ + R +  +
Sbjct: 112 PMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADS 169
Query: 935 G-TIEQILDAGVLG---YRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           G ++ Q   A V+G   Y +PE A  +      +SDVY+ G +L E+LTG
Sbjct: 170 GNSVTQT--AAVIGTAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 10/110 (9%)
Query: 875 PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
           P+T  + +++  D  + LN+ H    + H ++K  NI++   +   +V D+ + R +  +
Sbjct: 112 PMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADS 169
Query: 935 G-TIEQILDAGVLG---YRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           G ++ Q   A V+G   Y +PE A  +      +SDVY+ G +L E+LTG
Sbjct: 170 GNSVTQT--AAVIGTAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 10/110 (9%)
Query: 875 PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
           P+T  + +++  D  + LN+ H    + H ++K  NI++   +   +V D+ + R +  +
Sbjct: 112 PMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADS 169
Query: 935 G-TIEQILDAGVLG---YRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           G ++ Q   A V+G   Y +PE A  +      +SDVY+ G +L E+LTG
Sbjct: 170 GNSVTQT--AAVIGTAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           +RHP+++ L  Y    ++ E +++ +Y +   L  ++  R       ++  +  +    +
Sbjct: 61  LRHPHIIKL--YDVIKSKDEIIMVIEY-AGNELFDYIVQRD-----KMSEQEARRFFQQI 112
Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGY 948
              + Y H  + V H +LK  N+LLD   LN ++AD+ L  +MT    ++     G   Y
Sbjct: 113 ISAVEYCHRHKIV-HRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKT--SCGSPNY 168
Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGD 985
            APE+  S K +   + DV++ GVIL  +L  R   D
Sbjct: 169 AAPEV-ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 10/110 (9%)
Query: 875 PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
           P+T  + +++  D  + LN+ H    + H ++K  NI++   +   +V D+ + R +  +
Sbjct: 112 PMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADS 169
Query: 935 G-TIEQILDAGVLG---YRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           G ++ Q   A V+G   Y +PE A  +      +SDVY+ G +L E+LTG
Sbjct: 170 GNSVTQT--AAVIGTAQYLSPEQA--RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 72/137 (52%), Gaps = 16/137 (11%)
Query: 850 LILSDYISPGSLASFLY-------DRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVP 902
           L++ + ++ G L S+L        + PGR  PP T  + +++A ++A G+ YL+  + V 
Sbjct: 96  LVVMELMAHGDLKSYLRSLRPEAENNPGR--PPPTLQEMIQMAAEIADGMAYLNAKKFV- 152
Query: 903 HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPH 960
           H +L A N ++   D   ++ D+ + R + +     +    G+L  R  APE  + K   
Sbjct: 153 HRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYYRK-GGKGLLPVRWMAPE--SLKDGV 208
Query: 961 PSFKSDVYAFGVILLEL 977
            +  SD+++FGV+L E+
Sbjct: 209 FTTSSDMWSFGVVLWEI 225

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 40/156 (25%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQR--LKIAV 886
           + HPN++ L+  +  PT  E  ++ + ++ G     L+DR   KG    +++R       
Sbjct: 105 LSHPNIIKLKEIFETPT--EISLVLELVTGGE----LFDRIVEKG---YYSERDAADAVK 155
Query: 887 DVARGLNYLHFDRAVPHGNLKATNILL--DGPDLNARVADYCLHRLMTQAGTIEQILDAG 944
            +   + YLH +  + H +LK  N+L     PD   ++AD+ L +++     ++ +   G
Sbjct: 156 QILEAVAYLH-ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV--CG 212
Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
             GY APE+       P  + D+++ G+I   LL G
Sbjct: 213 TPGYCAPEILRGCAYGP--EVDMWSVGIITYILLCG 246

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 832 PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
           P +VG  G ++  +  E  I  +++  GSL   L  + GR    +      K+++ V +G
Sbjct: 91  PYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL-KKAGRIPEQILG----KVSIAVIKG 143
Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA------GV 945
           L YL     + H ++K +NIL++      ++ D+         G   Q++D+      G 
Sbjct: 144 LTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDF---------GVSGQLIDSMANSFVGT 193
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             Y +PE       H S +SD+++ G+ L+E+  GR
Sbjct: 194 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 832 PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
           P +VG  G ++  +  E  I  +++  GSL   L  + GR    +      K+++ V +G
Sbjct: 64  PYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL-KKAGRIPEQILG----KVSIAVIKG 116
Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA------GV 945
           L YL     + H ++K +NIL++      ++ D+         G   Q++D+      G 
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDF---------GVSGQLIDSMANSFVGT 166
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             Y +PE       H S +SD+++ G+ L+E+  GR
Sbjct: 167 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 832 PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
           P +VG  G ++  +  E  I  +++  GSL   L  + GR    +      K+++ V +G
Sbjct: 64  PYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL-KKAGRIPEQILG----KVSIAVIKG 116
Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA------GV 945
           L YL     + H ++K +NIL++      ++ D+         G   Q++D+      G 
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDF---------GVSGQLIDSMANSFVGT 166
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             Y +PE       H S +SD+++ G+ L+E+  GR
Sbjct: 167 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           N+ H  +V L G      Q    I+++Y++ G L ++L +   R        Q L++  D
Sbjct: 75  NLSHEKLVQLYGVC--TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKD 128
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
           V   + YL   +   H +L A N L++   +  +V+D+ L R +        +     + 
Sbjct: 129 VCEAMEYLE-SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEETSSVGSKFPVR 186
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  PE+    K   S KSD++AFGV++ E+ +
Sbjct: 187 WSPPEVLMYSKF--SSKSDIWAFGVLMWEIYS 216

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 3/97 (3%)
Query: 89  VFSNLSMLVKLSMSNNSIS-GVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNL 147
           +F+ LS L  L M+ NS     +PD   + ++L FLD+S        P+    L SLQ L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 148 SLAGNNFSGLIPDSV-SGLVSIQSLDLSHNSFSGSLP 183
           ++A N     +PD +   L S+Q + L  N +  S P
Sbjct: 500 NMASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 832 PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
           P +VG  G ++  +  E  I  +++  GSL   L  + GR    +      K+++ V +G
Sbjct: 64  PYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL-KKAGRIPEQILG----KVSIAVIKG 116
Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA------GV 945
           L YL     + H ++K +NIL++      ++ D+         G   Q++D+      G 
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDF---------GVSGQLIDSMANSFVGT 166
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             Y +PE       H S +SD+++ G+ L+E+  GR
Sbjct: 167 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 832 PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
           P +VG  G ++  +  E  I  +++  GSL   L  + GR    +      K+++ V +G
Sbjct: 64  PYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL-KKAGRIPEQILG----KVSIAVIKG 116
Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA------GV 945
           L YL     + H ++K +NIL++      ++ D+         G   Q++D+      G 
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDF---------GVSGQLIDSMANSFVGT 166
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             Y +PE       H S +SD+++ G+ L+E+  GR
Sbjct: 167 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 832 PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
           P +VG  G ++  +  E  I  +++  GSL   L  + GR    +      K+++ V +G
Sbjct: 126 PYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL-KKAGRIPEQILG----KVSIAVIKG 178
Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA------GV 945
           L YL     + H ++K +NIL++      ++ D+         G   Q++D+      G 
Sbjct: 179 LTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDF---------GVSGQLIDSMANSFVGT 228
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             Y +PE       H S +SD+++ G+ L+E+  GR
Sbjct: 229 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 262

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 774 EELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRXXXXXXXXXXXNIRHP 832
            E++    +V+G  S G  ++A L E+      K L++   K R            ++HP
Sbjct: 38  REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRI-----VKHP 92
Query: 833 NVVGLRGYYW--GPTQHE---KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           NVV L+ +++  G  + E    L+L         AS  Y +  +  P L     +     
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM---YQ 149
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
           + R L Y+H    + H ++K  N+LLD P    ++ D+   +++  AG    +       
Sbjct: 150 LLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGE-PNVSXICSRY 206
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           YRAPEL      + +   D+++ G ++ EL+ G+
Sbjct: 207 YRAPELIFGATNYTT-NIDIWSTGCVMAELMQGQ 239

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 43/163 (26%), Positives = 69/163 (42%), Gaps = 29/163 (17%)
Query: 848 EKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL--------HFDR 899
           E L++ +Y   GSL  +L            W    ++A  V RGL YL        H+  
Sbjct: 86  EYLLVMEYYPNGSLXKYLSLHTS------DWVSSCRLAHSVTRGLAYLHTELPRGDHYKP 139
Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE-------QILDAGVLGYRAPE 952
           A+ H +L + N+L+   D    ++D+ L   +T    +         I + G + Y APE
Sbjct: 140 AISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE 198
Query: 953 LAAS----KKPHPSFKS-DVYAFGVILLELLTGRCAGDVISGE 990
           +       +    + K  D+YA G+I  E+   RC  D+  GE
Sbjct: 199 VLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCT-DLFPGE 239

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           N+ H  +V L G      Q    I+++Y++ G L ++L +   R        Q L++  D
Sbjct: 66  NLSHEKLVQLYGVC--TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKD 119
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
           V   + YL   +   H +L A N L++   +  +V+D+ L R +        +     + 
Sbjct: 120 VCEAMEYLE-SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVR 177
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  PE+    K   S KSD++AFGV++ E+ +
Sbjct: 178 WSPPEVLMYSKF--SSKSDIWAFGVLMWEIYS 207

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           N+ H  +V L G      Q    I+++Y++ G L ++L +   R        Q L++  D
Sbjct: 59  NLSHEKLVQLYGVC--TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKD 112
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
           V   + YL   +   H +L A N L++   +  +V+D+ L R +        +     + 
Sbjct: 113 VCEAMEYLE-SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVR 170
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  PE+    K   S KSD++AFGV++ E+ +
Sbjct: 171 WSPPEVLMYSKF--SSKSDIWAFGVLMWEIYS 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           N+ H  +V L G      Q    I+++Y++ G L ++L +   R        Q L++  D
Sbjct: 60  NLSHEKLVQLYGVC--TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKD 113
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
           V   + YL   +   H +L A N L++   +  +V+D+ L R +        +     + 
Sbjct: 114 VCEAMEYLE-SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVR 171
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  PE+    K   S KSD++AFGV++ E+ +
Sbjct: 172 WSPPEVLMYSKF--SSKSDIWAFGVLMWEIYS 201

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           N+ H  +V L G      Q    I+++Y++ G L ++L +   R        Q L++  D
Sbjct: 75  NLSHEKLVQLYGVC--TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKD 128
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
           V   + YL   +   H +L A N L++   +  +V+D+ L R +        +     + 
Sbjct: 129 VCEAMEYLE-SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  PE+    K   S KSD++AFGV++ E+ +
Sbjct: 187 WSPPEVLMYSKF--SSKSDIWAFGVLMWEIYS 216

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           N+ H  +V L G      Q    I+++Y++ G L ++L +   R        Q L++  D
Sbjct: 55  NLSHEKLVQLYGVC--TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKD 108
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
           V   + YL   +   H +L A N L++   +  +V+D+ L R +        +     + 
Sbjct: 109 VCEAMEYLE-SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVR 166
Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           +  PE+    K   S KSD++AFGV++ E+ +
Sbjct: 167 WSPPEVLMYSKF--SSKSDIWAFGVLMWEIYS 196

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 25/156 (16%)
Query: 832 PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
           P +VG  G ++  +  E  I  +++  GSL   L  + GR    +      K+++ V +G
Sbjct: 67  PYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL-KKAGRIPEQILG----KVSIAVIKG 119
Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD------AGV 945
           L YL     + H ++K +NIL++      ++ D+         G   Q++D       G 
Sbjct: 120 LTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDF---------GVSGQLIDEMANEFVGT 169
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             Y +PE       H S +SD+++ G+ L+E+  GR
Sbjct: 170 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 18/156 (11%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++ H ++V L G   G +     +++ Y+  GSL   +    G  GP L     L   V 
Sbjct: 71  SLDHAHIVRLLGLCPGSSLQ---LVTQYLPLGSLLDHVRQHRGALGPQLL----LNWGVQ 123
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV-- 945
           +A+G+ YL  +  + H NL A N+LL  P    +VAD+ +  L+      +Q+L +    
Sbjct: 124 IAKGMYYLE-EHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDD--KQLLYSEAKT 179
Query: 946 -LGYRAPE-LAASKKPHPSFKSDVYAFGVILLELLT 979
            + + A E +   K  H   +SDV+++GV + EL+T
Sbjct: 180 PIKWMALESIHFGKYTH---QSDVWSYGVTVWELMT 212

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T    + L  +   G L  ++ +     G    L W       V +A+G+N
Sbjct: 82  RLLGICLTSTVQLIMQLMPF---GXLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 132
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 133 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 189
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 849 KLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLNYLHFDRAVPHGNL 906
           + IL + ++ G L SFL +   R   P  L     L +A D+A G  YL  +  + H ++
Sbjct: 123 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFI-HRDI 181
Query: 907 KATNILLD--GPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFK 964
            A N LL   GP   A++ D+ + R + +A    +   A +     P  A  +    S K
Sbjct: 182 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTS-K 240
Query: 965 SDVYAFGVILLELLT 979
           +D ++FGV+L E+ +
Sbjct: 241 TDTWSFGVLLWEIFS 255

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T    + L  +   G L  ++ +     G    L W       V +A+G+N
Sbjct: 83  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 133
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 134 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 190
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T    + L  +   G L  ++ +     G    L W       V +A+G+N
Sbjct: 84  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 134
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 135 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 191
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T    + L  +   G L  ++ +     G    L W       V +A+G+N
Sbjct: 85  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 135
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 136 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 192
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T    + L  +   G L  ++ +     G    L W       V +A+G+N
Sbjct: 82  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 132
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 133 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 189
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T    + L  +   G L  ++ +     G    L W       V +A+G+N
Sbjct: 81  RLLGICLTSTVQLIMQLMPF---GCLLDYVREHKDNIGSQYLLNWC------VQIAKGMN 131
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 132 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 188
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 782 EVLGRSSHGTSYRAT-LENG----MFLTVKWLREGVA-KQRXXXXXXXXXXXNIRHPNVV 835
           +VLG  + GT Y+   +  G    + + +K LRE  + K             ++ +P+V 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLN 893
            L G     T     +++  +  G L  ++ +     G    L W       V +A G+N
Sbjct: 78  RLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAEGMN 128
Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           YL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   + G +  +   L
Sbjct: 129 YLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMAL 185
Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            +      + +SDV+++GV + EL+T
Sbjct: 186 ESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 832 PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
           P +VG  G ++  +  E  I  +++  GSL   L  + GR    +      K+++ V +G
Sbjct: 64  PYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL-KKAGRIPEQILG----KVSIAVIKG 116
Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA------GV 945
           L YL     + H ++K +NIL++      ++ D+         G   Q++D+      G 
Sbjct: 117 LTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDF---------GVSGQLIDSMANSFVGT 166
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             Y +PE       H S +SD+++ G+ L+E+  GR
Sbjct: 167 RSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 885 AVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY--CLHRLMTQAGTIEQILD 942
           A ++  GL +LH  + + + +LK  NILLD  D + ++AD+  C   ++  A T      
Sbjct: 124 AAEIILGLQFLH-SKGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNXF--- 178
Query: 943 AGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            G   Y APE+   +K + S   D ++FGV+L E+L G+
Sbjct: 179 CGTPDYIAPEILLGQKYNHSV--DWWSFGVLLYEMLIGQ 215

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 849 KLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLNYLHFDRAVPHGNL 906
           + IL + ++ G L SFL +   R   P  L     L +A D+A G  YL  +  + H ++
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFI-HRDI 166
Query: 907 KATNILLD--GPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFK 964
            A N LL   GP   A++ D+ + R + +A    +   A +     P  A  +    S K
Sbjct: 167 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTS-K 225
Query: 965 SDVYAFGVILLELLT 979
           +D ++FGV+L E+ +
Sbjct: 226 TDTWSFGVLLWEIFS 240

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++RHPN++ L GY+   T+   LIL +Y   G++      R  +K       +      +
Sbjct: 63  HLRHPNILRLYGYFHDATR-VYLIL-EYAPLGTVY-----RELQKLSKFDEQRTATYITE 115
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY--CLHRLMTQAGTIEQILDAGV 945
           +A  L+Y H  R + H ++K  N+LL G     ++AD+   +H   ++  T+      G 
Sbjct: 116 LANALSYCHSKRVI-HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTL-----CGT 168
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L Y  PE+   +  H   K D+++ GV+  E L G+
Sbjct: 169 LDYLPPEMIEGRM-HDE-KVDLWSLGVLCYEFLVGK 202

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++RHPN++ L GY+   T+   LIL +Y   G++      R  +K       +      +
Sbjct: 61  HLRHPNILRLYGYFHDATR-VYLIL-EYAPLGTVY-----RELQKLSKFDEQRTATYITE 113
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY--CLHRLMTQAGTIEQILDAGV 945
           +A  L+Y H  R + H ++K  N+LL G     ++AD+   +H   ++  T+      G 
Sbjct: 114 LANALSYCHSKRVI-HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTL-----CGT 166
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L Y  PE+   +  H   K D+++ GV+  E L G+
Sbjct: 167 LDYLPPEMIEGRM-HDE-KVDLWSLGVLCYEFLVGK 200

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++RHPN++ L GY+   T+   LIL +Y   G++      R  +K       +      +
Sbjct: 67  HLRHPNILRLYGYFHDATR-VYLIL-EYAPLGTVY-----RELQKLSKFDEQRTATYITE 119
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY--CLHRLMTQAGTIEQILDAGV 945
           +A  L+Y H  R + H ++K  N+LL G     ++AD+   +H   ++  T+      G 
Sbjct: 120 LANALSYCHSKRVI-HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTL-----CGT 172
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L Y  PE+   +  H   K D+++ GV+  E L G+
Sbjct: 173 LDYLPPEMIEGRM-HDE-KVDLWSLGVLCYEFLVGK 206

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 8/99 (8%)
Query: 884 IAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNA--RVADYCLHRLMTQAGTIEQIL 941
           I   V  G+ YLH    + H +LK  N+LL+  + +A  ++ D+ L  +      +++ L
Sbjct: 141 IIKQVLSGVTYLH-KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199
Query: 942 DAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
             G   Y APE+   K      K DV++ GVIL  LL G
Sbjct: 200 --GTAYYIAPEVLRKKYDE---KCDVWSIGVILFILLAG 233

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 18/156 (11%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++RHPN++ L GY+   T+   LIL +Y   G++      R  +K       +      +
Sbjct: 67  HLRHPNILRLYGYFHDATR-VYLIL-EYAPLGTVY-----RELQKLSKFDEQRTATYITE 119
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY--CLHRLMTQAGTIEQILDAGV 945
           +A  L+Y H  R + H ++K  N+LL G     ++AD+   +H   ++  T+      G 
Sbjct: 120 LANALSYCHSKRVI-HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTL-----CGT 172
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L Y  PE+   +  H   K D+++ GV+  E L G+
Sbjct: 173 LDYLPPEMIEGRM-HDE-KVDLWSLGVLCYEFLVGK 206

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 108/266 (40%), Gaps = 39/266 (14%)
Query: 85  ADLSVFSNLSMLVKLSMSNNSISGVIP--------------------DNIGDFKSLEFLD 124
            D++   NL+ LV + M+NN I+ + P                    D + +  +L  L+
Sbjct: 76  TDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 135
Query: 125 VSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP 184
           +S N  S    S +  L SLQ L+ + N  + L P  ++ L +++ LD+S N  S     
Sbjct: 136 LSSNTISD--ISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD--IS 189
Query: 185 ALTRXXXXXXXXXXXXGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHID 244
            L +              S   P G  ++  L  L  +GN+L     G    LTN + +D
Sbjct: 190 VLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDI--GTLASLTNLTDLD 245
Query: 245 FSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTG 304
            + N     S+   L GL++  + L L  NQ++    N   L     L  L+L+ NQL  
Sbjct: 246 LANNQI---SNLAPLSGLTKLTE-LKLGANQIS----NISPLAGLTALTNLELNENQLED 297
Query: 305 ELPGFNFVYELQVLKLSNNRFSGFIP 330
             P  N    L  L L  N  S   P
Sbjct: 298 ISPISNL-KNLTYLTLYFNNISDISP 322

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 18/156 (11%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++RHPN++ L GY+   T+    ++ +Y   G++      R  +K       +      +
Sbjct: 69  HLRHPNILRLYGYFHDATR--VYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITE 121
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY--CLHRLMTQAGTIEQILDAGV 945
           +A  L+Y H  R + H ++K  N+LL G     ++AD+   +H   ++  T+      G 
Sbjct: 122 LANALSYCHSKRVI-HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTL-----CGT 174
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L Y  PE+   +  H   K D+++ GV+  E L G+
Sbjct: 175 LDYLPPEMIEGRM-HDE-KVDLWSLGVLCYEFLVGK 208

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 18/156 (11%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++RHPN++ L GY+   T+    ++ +Y   G++      R  +K       +      +
Sbjct: 65  HLRHPNILRLYGYFHDATR--VYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITE 117
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY--CLHRLMTQAGTIEQILDAGV 945
           +A  L+Y H  R + H ++K  N+LL G     ++AD+   +H   ++  T+      G 
Sbjct: 118 LANALSYCHSKRVI-HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRDTL-----CGT 170
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L Y  PE+   +  H   K D+++ GV+  E L G+
Sbjct: 171 LDYLPPEMIEGRM-HDE-KVDLWSLGVLCYEFLVGK 204

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 31/163 (19%)
Query: 828 NIRHPNVVGL------RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQR 881
            + HPN++ L      +GY++        ++ +  + G L   +  R        +    
Sbjct: 106 QLDHPNIMKLYEFFEDKGYFY--------LVGEVYTGGELFDEIISRK-----RFSEVDA 152
Query: 882 LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP--DLNARVADYCLHRLMTQAGTIEQ 939
            +I   V  G+ Y+H ++ V H +LK  N+LL+    D N R+ D+ L      +  ++ 
Sbjct: 153 ARIIRQVLSGITYMHKNKIV-HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 211
Query: 940 ILDAGVLGYRAPELAASKKPHPSF--KSDVYAFGVILLELLTG 980
            +  G   Y APE+      H ++  K DV++ GVIL  LL+G
Sbjct: 212 KI--GTAYYIAPEVL-----HGTYDEKCDVWSTGVILYILLSG 247

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 18/156 (11%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++RHPN++ L GY+   T+    ++ +Y   G++      R  +K       +      +
Sbjct: 90  HLRHPNILRLYGYFHDATR--VYLILEYAPLGTVY-----RELQKLSKFDEQRTATYITE 142
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY--CLHRLMTQAGTIEQILDAGV 945
           +A  L+Y H  R + H ++K  N+LL G     ++AD+   +H   ++  T+      G 
Sbjct: 143 LANALSYCHSKRVI-HRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTL-----CGT 195
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L Y  PE+   +  H   K D+++ GV+  E L G+
Sbjct: 196 LDYLPPEMIEGRM-HDE-KVDLWSLGVLCYEFLVGK 229

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 3/98 (3%)
Query: 882 LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL 941
           L   V +A+G+NYL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   
Sbjct: 127 LNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHA 183
Query: 942 DAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           + G +  +   L +      + +SDV+++GV + EL+T
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 3/98 (3%)
Query: 882 LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL 941
           L   V +A+G+NYL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   
Sbjct: 127 LNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHA 183
Query: 942 DAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           + G +  +   L +      + +SDV+++GV + EL+T
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 30/98 (30%), Positives = 54/98 (55%), Gaps = 3/98 (3%)
Query: 882 LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL 941
           L   V +A+G+NYL  DR + H +L A N+L+  P  + ++ D+ L +L+  A   E   
Sbjct: 120 LNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG-AEEKEYHA 176
Query: 942 DAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
           + G +  +   L +      + +SDV+++GV + EL+T
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 6/135 (4%)
Query: 849 KLILSDYISPGSLASFLYDRPGRKGPP--LTWAQRLKIAVDVARGLNYLHFDRAVPHGNL 906
           + IL + ++ G L SFL +   R   P  L     L +A D+A G  YL  +  + H ++
Sbjct: 123 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFI-HRDI 181
Query: 907 KATNILLD--GPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFK 964
            A N LL   GP   A++ D+ + R + +A    +   A +     P  A  +    S K
Sbjct: 182 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTS-K 240
Query: 965 SDVYAFGVILLELLT 979
           +D ++FGV+L E+ +
Sbjct: 241 TDTWSFGVLLWEIFS 255

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 31/163 (19%)
Query: 828 NIRHPNVVGL------RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQR 881
            + HPN++ L      +GY++        ++ +  + G L   +  R        +    
Sbjct: 105 QLDHPNIMKLYEFFEDKGYFY--------LVGEVYTGGELFDEIISRK-----RFSEVDA 151
Query: 882 LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP--DLNARVADYCLHRLMTQAGTIEQ 939
            +I   V  G+ Y+H ++ V H +LK  N+LL+    D N R+ D+ L      +  ++ 
Sbjct: 152 ARIIRQVLSGITYMHKNKIV-HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 210
Query: 940 ILDAGVLGYRAPELAASKKPHPSF--KSDVYAFGVILLELLTG 980
            +  G   Y APE+      H ++  K DV++ GVIL  LL+G
Sbjct: 211 KI--GTAYYIAPEVL-----HGTYDEKCDVWSTGVILYILLSG 246

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 6/102 (5%)
Query: 883 KIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD 942
           K+ V + + L YL     V H ++K +NILLD      ++ D+ +   +      ++   
Sbjct: 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRLVDDKAKDR--S 184
Query: 943 AGVLGYRAPEL---AASKKPHPSFKSDVYAFGVILLELLTGR 981
           AG   Y APE        KP    ++DV++ G+ L+EL TG+
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 18/155 (11%)
Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++RHPN++ L GY+   T+   LIL +Y   G++      R  +K       +      +
Sbjct: 68  HLRHPNILRLYGYFHDATR-VYLIL-EYAPLGTVY-----RELQKLSRFDEQRTATYITE 120
Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY--CLHRLMTQAGTIEQILDAGV 945
           +A  L+Y H  R + H ++K  N+LL G +   ++AD+   +H   ++  T+      G 
Sbjct: 121 LANALSYCHSKRVI-HRDIKPENLLL-GSNGELKIADFGWSVHAPSSRRTTL-----CGT 173
Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           L Y  PE+   +  H   K D+++ GV+  E L G
Sbjct: 174 LDYLPPEMIEGRM-HDE-KVDLWSLGVLCYEFLVG 206

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1060
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-115
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-110
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-102
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-80
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-59
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-92
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-88
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-84
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-64
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-64
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-43
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-90
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-84
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-57
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-44
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-29
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-79
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-74
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-42
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-25
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-76
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-76
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-75
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-59
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-35
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-76
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-64
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-57
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-71
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-58
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-57
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-53
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-38
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-64
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-53
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-50
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	6e-28
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-18
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-63
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-40
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-38
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-63
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-45
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-29
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-23
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-18
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-57
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-53
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-51
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-41
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-24
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-57
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-47
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-21
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-55
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-53
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-39
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-36
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-36
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-49
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-47
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-35
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-31
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-18
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-47
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-45
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-38
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-34
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-17
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-42
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-39
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-42
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-39
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-34
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-32
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-11
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-41
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-40
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-38
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-34
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	8e-27
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-21
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-12
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-39
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-39
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-29
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-27
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-08
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-39
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-38
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-33
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-21
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-38
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-31
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-25
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-23
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-22
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-38
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-32
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-07
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-37
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-37
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-37
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-37
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-36
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-30
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-25
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-23
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-35
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-34
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-28
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-35
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-34
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-33
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-19
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-10
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-32
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-32
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-31
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-31
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-26
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-25
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-23
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-22
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-17
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-30
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-28
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-30
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-30
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-24
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-19
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-18
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-12
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-26
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-25
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-25
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-20
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-23
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-25
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-23
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-06
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-06
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-17
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-21
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-21
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-20
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-20
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-12
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-20
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-20
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-20
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-19
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-19
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-19
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-07
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-19
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-19
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-19
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-19
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-19
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-18
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-18
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-18
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-16
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-09
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-18
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-18
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-18
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-18
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-18
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-11
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-12
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-09
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-17
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-17
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-17
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-17
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-17
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-10
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-04
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-11
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-16
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-16
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-10
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-16
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-16
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-16
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-16
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-16
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-13
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-12
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-15
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-15
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-15
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-15
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-15
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-15
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-15
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-14
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-14
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-14
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-14
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-11
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	8e-10
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	8e-04
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-14
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-14
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-14
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-13
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-13
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-13
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-13
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	8e-04
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-13
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-13
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-13
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-07
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	9e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-06
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-12
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-06
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-05
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-12
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-12
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-11
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-11
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-11
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-10
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-04
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-11
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-11
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-11
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-11
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-11
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-10
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-10
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-10
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-10
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-10
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-09
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-09
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-09
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-09
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-09
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-09
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-09
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-04
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-04
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-09
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-09
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-09
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-09
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-09
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-09
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-08
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-08
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-08
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-08
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-08
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-08
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-08
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-08
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-08
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-08
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	8e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-04
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-08
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-04
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-07
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-07
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-07
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-07
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-07
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-07
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-07
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	7e-06
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-07
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-07
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-07
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-07
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-07
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-07
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-07
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-07
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	9e-04
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-07
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-06
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-06
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-06
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-06
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	7e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	9e-05
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	1e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	9e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-05
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-05
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	8e-04
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-05
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-05
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	9e-05
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	1e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-04
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-04
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-04
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-04
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-04
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-04
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-04
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-04
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-04
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-04
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-04
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-04
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  374 bits (962), Expect = e-115
 Identities = 167/602 (27%), Positives = 265/602 (44%), Gaps = 82/602 (13%)

Query: 13  FLSSVGQLPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVA 72
           F +S  Q   ++I  L+ FK  + +     +L  W+      + C  +++G+ C    V 
Sbjct: 2   FQASPSQSLYREIHQLISFKDVLPDKN---LLPDWSSNK---NPC--TFDGVTCRDDKVT 53

Query: 73  GVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSS 132
            + L +  L                      N     +  ++     LE L +S++  + 
Sbjct: 54  SIDLSSKPL----------------------NVGFSAVSSSLLSLTGLESLFLSNSHING 91

Query: 133 SLPSGIGKLESLQNLSLAGNNFSGLIPD--SVSGLVSIQSLDLSHNSFSGSLP-PALTRL 189
           S+        SL +L L+ N+ SG +    S+     ++ L++S N+           +L
Sbjct: 92  SVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKL 150

Query: 190 NNLVYLNLSSNGFSKRIPRGFELILG---LQVLDFHGNKLDGHLDGEFFLLTNASHIDFS 246
           N+L  L+LS+N  S     G+ L  G   L+ L   GNK+ G +  +     N   +D S
Sbjct: 151 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVS 208

Query: 247 GNMFVGSSSQKFLPGLSQ--SVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTG 304
            N F        +P L    ++Q+L++S N+L+G       +     LK+L++S NQ  G
Sbjct: 209 SNNFSTG-----IPFLGDCSALQHLDISGNKLSGDFSR--AISTCTELKLLNISSNQFVG 261

Query: 305 ELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TN 362
            +P       LQ L L+ N+F+G IP+ L  G    LT LDLS N+  G+V       + 
Sbjct: 262 PIPPLPLK-SLQYLSLAENKFTGEIPDFLS-GACDTLTGLDLSGNHFYGAVPPFFGSCSL 319

Query: 363 LHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIP 422
           L  L LSSN  +GELP                   +  +LK   ++ LDLS N  +G +P
Sbjct: 320 LESLALSSNNFSGELP-------------------MDTLLKMRGLKVLDLSFNEFSGELP 360

Query: 423 EETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQK--LRVLDLSFNHLDGPFLTNLLNSSTL 479
           E        L  L+LS N+ S  +   + Q  K  L+ L L  N   G     L N S L
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSEL 420

Query: 480 QELHLADNLLTGVLDFSPPSV---SNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNN 536
             LHL+ N L+G +   P S+   S L+ L L  N L G  P  L  +  L+ L L  N+
Sbjct: 421 VSLHLSFNYLSGTI---PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477

Query: 537 ISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLRKF 594
           ++G +P+ ++N T+L+ + +S N  TG +P  +    +L    +S N FSG +P  L   
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537

Query: 595 PS 596
            S
Sbjct: 538 RS 539

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  359 bits (924), Expect = e-110
 Identities = 149/520 (28%), Positives = 229/520 (44%), Gaps = 29/520 (5%)

Query: 87  LSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQN 146
             +      L  L++S N ISG +   +    +LEFLDVS N FS+ +P  +G   +LQ+
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQH 227

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRI 206
           L ++GN  SG    ++S    ++ L++S N F G +PP    L +L YL+L+ N F+  I
Sbjct: 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEI 285

Query: 207 PRGFELILG-LQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
           P         L  LD  GN   G +   F   +    +  S N F G      L  +   
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR-G 344

Query: 266 VQYLNLSLNQLTGSLVNGGEL-QLFENLKVLDLSYNQLTGELP---GFNFVYELQVLKLS 321
           ++ L+LS N+ +G L     L  L  +L  LDLS N  +G +      N    LQ L L 
Sbjct: 345 LKVLDLSFNEFSGELPE--SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402

Query: 322 NNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSV--SMILSTNLHMLNLSSNGLTGELPL 379
           NN F+G IP  L   +   L  L LS N LSG++  S+   + L  L L  N L GE+P 
Sbjct: 403 NNGFTGKIPPTL--SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460

Query: 380 LTGSCA---VLDLSNNQFEGNLSR-ILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLN 435
                     L L  N   G +   +    N+ ++ LS N LTG IP+   +   L  L 
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520

Query: 436 LSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDF 495
           LS+NS S ++P  +   + L  LDL+ N  +G     +   S      +A N + G    
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYV 576

Query: 496 SPPSVSNLQVLDLSHN--RLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSS 553
              +    +    + N     G   ++L  L+      +      G    +  N  S+  
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636

Query: 554 LVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENL 591
           L +S N  +G +P  + +   L   N+ +ND SG++P+ +
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  338 bits (868), Expect = e-102
 Identities = 136/506 (26%), Positives = 226/506 (44%), Gaps = 32/506 (6%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNLS 148
            S  + L  L++S+N   G IP      KSL++L +++N F+  +P  + G  ++L  L 
Sbjct: 243 ISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLD 300

Query: 149 LAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIP 207
           L+GN+F G +P        ++SL LS N+FSG LP   L ++  L  L+LS N FS  +P
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360

Query: 208 RGF-ELILGLQVLDFHGNKLDGHLDGEFF--LLTNASHIDFSGNMFVGSSSQKFLPGLSQ 264
                L   L  LD   N   G +              +    N F G            
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL--SNCS 418

Query: 265 SVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNN 323
            +  L+LS N L+G++ +   L     L+ L L  N L GE+P    +V  L+ L L  N
Sbjct: 419 ELVSLHLSFNYLSGTIPS--SLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476

Query: 324 RFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPLLT 381
             +G IP+ L   +   L  + LS N L+G +   +    NL +L LS+N  +G +P   
Sbjct: 477 DLTGEIPSGL--SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534

Query: 382 GSCA---VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSH 438
           G C     LDL+ N F G +   +         ++ N + G               + + 
Sbjct: 535 GDCRSLIWLDLNTNLFNGTIPAAM--FKQS-GKIAANFIAGKRYVYIKNDGMKKECHGAG 591

Query: 439 N--SLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFS 496
           N         + + +       +++     G       N+ ++  L ++ N+L+G +   
Sbjct: 592 NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI--- 648

Query: 497 PPSVSN---LQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSS 553
           P  + +   L +L+L HN ++G  PD +G L GL +L L+ N + G +P +M+ +T L+ 
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708

Query: 554 LVISQNHFTGPLPNNLPNSLETFNVS 579
           + +S N+ +GP+P       ETF  +
Sbjct: 709 IDLSNNNLSGPIPEM--GQFETFPPA 732

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  278 bits (714), Expect = 1e-80
 Identities = 108/393 (27%), Positives = 167/393 (42%), Gaps = 22/393 (5%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFK-SLEFLDVSDNLFSSSLPSGIGK--LESL 144
                +  L  L +S N  SG +P+++ +   SL  LD+S N FS  +   + +    +L
Sbjct: 337 DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396

Query: 145 QNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSK 204
           Q L L  N F+G IP ++S    + SL LS N  SG++P +L  L+ L  L L  N    
Sbjct: 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG 456

Query: 205 RIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP---G 261
            IP+    +  L+ L    N L G +       TN + I  S N   G      +P   G
Sbjct: 457 EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE-----IPKWIG 511

Query: 262 LSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLS 321
             +++  L LS N  +G++    EL    +L  LDL+ N   G +P        Q  K++
Sbjct: 512 RLENLAILKLSNNSFSGNI--PAELGDCRSLIWLDLNTNLFNGTIPA---AMFKQSGKIA 566

Query: 322 NNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPL 379
            N  +G     +             +     G  S  L+  +  +  N++S    G    
Sbjct: 567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626

Query: 380 LTGSC---AVLDLSNNQFEGNL-SRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLN 435
              +      LD+S N   G +   I     +  L+L  N ++GSIP+E      LN L+
Sbjct: 627 TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILD 686

Query: 436 LSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGP 468
           LS N L   +P+ +     L  +DLS N+L GP
Sbjct: 687 LSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGP 719

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  216 bits (552), Expect = 6e-59
 Identities = 87/312 (27%), Positives = 141/312 (45%), Gaps = 16/312 (5%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSL 149
             +LS L  L +  N + G IP  +   K+LE L +  N  +  +PSG+    +L  +SL
Sbjct: 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL 497

Query: 150 AGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRG 209
           + N  +G IP  +  L ++  L LS+NSFSG++P  L    +L++L+L++N F+  IP  
Sbjct: 498 SNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557

Query: 210 FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYL 269
               +  Q      N + G                 +GN+      +        +    
Sbjct: 558 ----MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPC 613

Query: 270 NLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYELQVLKLSNNRFSG 327
           N++     G            ++  LD+SYN L+G +P    +  Y L +L L +N  SG
Sbjct: 614 NITSRVYGGHTSP--TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPY-LFILNLGHNDISG 670

Query: 328 FIPNDLLKGDSLLLTDLDLSANNLSGSV--SMILSTNLHMLNLSSNGLTGELPLLTGSCA 385
            IP+++  GD   L  LDLS+N L G +  +M   T L  ++LS+N L+G +P   G   
Sbjct: 671 SIPDEV--GDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP-EMGQFE 727

Query: 386 VLDLSNNQFEGN 397
               +   F  N
Sbjct: 728 TFPPAK--FLNN 737

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 87.7 bits (218), Expect = 1e-17
 Identities = 30/133 (22%), Positives = 50/133 (37%), Gaps = 11/133 (8%)

Query: 475 NSSTLQELHLADNLLTGVLDFSPPSVSN---LQVLDLSHNRLNGYFPDRLGSLTGLKVLC 531
               +  + L+   L         S+ +   L+ L LS++ +NG           L  L 
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLD 106

Query: 532 LAGNNISGSLPT--SMANMTSLSSLVISQNHFTGPLP----NNLPNSLETFNVSYNDFSG 585
           L+ N++SG + T  S+ + + L  L +S N    P        L + LE  ++S N  SG
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNS-LEVLDLSANSISG 165

Query: 586 AVPENLRKFPSSS 598
           A            
Sbjct: 166 ANVVGWVLSDGCG 178

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 51.4 bits (124), Expect = 1e-06
 Identities = 23/102 (22%), Positives = 41/102 (40%), Gaps = 4/102 (3%)

Query: 522 GSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPN-NLPNSLETFNVSY 580
             +T + +     N    ++ +S+ ++T L SL +S +H  G +       SL + ++S 
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSR 109

Query: 581 NDFSGAVPE--NLRKFPS-SSFYPGNSKLSFPGGAPGSGNFP 619
           N  SG V    +L            ++ L FPG   G     
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLN 151

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  307 bits (789), Expect = 5e-92
 Identities = 112/543 (20%), Positives = 198/543 (36%), Gaps = 34/543 (6%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNL 147
           + F+  S L  L +  N+IS + P+       L+ L++  N  S           +L  L
Sbjct: 43  ANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTEL 102

Query: 148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIP 207
            L  N+   +  +      ++ +LDLSHN  S +      +L NL  L LS+N       
Sbjct: 103 HLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162

Query: 208 RGFELI--LGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQ- 264
              ++     L+ L+   N++     G F  +     +  +      S ++K    L+  
Sbjct: 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANT 222

Query: 265 SVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNN 323
           S++ L+LS +QL+ +         + NL +LDLSYN L       F ++ +L+   L  N
Sbjct: 223 SIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN 282

Query: 324 RFSGFIPNDLLKGDSLL-------LTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLT 374
                  + L    ++         T   +S  +L             L  LN+  N + 
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342

Query: 375 GELPLLTGSCA---VLDLSNNQFE-----GNLSRILKWGNIEYLDLSRNHLTGSIPEETP 426
           G    +         L LSN+              L    +  L+L++N ++    +   
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402

Query: 427 QFLRLNHLNLSHNSLSSSLP-KVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLA 485
               L  L+L  N +   L  +     + +  + LS+N        +     +LQ L L 
Sbjct: 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLR 462

Query: 486 DNLLTGVLDFSPP--SVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNIS----- 538
              L  V     P   + NL +LDLS+N +     D L  L  L++L L  NN++     
Sbjct: 463 RVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKH 522

Query: 539 ---GSLPTSMANMTSLSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLRK 593
              G     +  ++ L  L +  N F         +   L+  ++  N+ +         
Sbjct: 523 ANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN 582

Query: 594 FPS 596
             S
Sbjct: 583 QVS 585

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  296 bits (761), Expect = 4e-88
 Identities = 124/552 (22%), Positives = 204/552 (36%), Gaps = 52/552 (9%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNL 147
             F+  + L +L + +NSI  +  +     K+L  LD+S N  SS+      +LE+LQ L
Sbjct: 91  KTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQEL 150

Query: 148 SLAGNNFSGLIPD--SVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            L+ N    L  +   +    S++ L+LS N      P     +  L  L L++      
Sbjct: 151 LLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPS 210

Query: 206 IPRGFELILG---LQVLDFHGNKLDGHLDGEFFLL--TNASHIDFSGNMFVGSSSQKFLP 260
           +     L L    ++ L    ++L    +  F  L  TN + +D S N      +  F  
Sbjct: 211 LTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF-- 268

Query: 261 GLSQSVQYLNLSLNQLTG-------SLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFV 312
                ++Y  L  N +          L N   L L  +     +S   L       F ++
Sbjct: 269 AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328

Query: 313 YELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLS------GSVSMILSTNLHML 366
             L+ L + +N   G   N      +L    L LS +  S       +   +  + LH+L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINL--KYLSLSNSFTSLRTLTNETFVSLAHSPLHIL 386

Query: 367 NLSSNGLTG-------ELPLLTGSCAVLDLSNNQFEGNLSR--ILKWGNIEYLDLSRNHL 417
           NL+ N ++         L  L     VLDL  N+    L+        NI  + LS N  
Sbjct: 387 NLTKNKISKIESDAFSWLGHLE----VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKY 442

Query: 418 TGSIPEETPQFLRLNHLNLSHNSLSS--SLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLN 475
                        L  L L   +L +  S P      + L +LDLS N++       L  
Sbjct: 443 LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502

Query: 476 SSTLQELHLADNLLTGVLDFSPPSV--------SNLQVLDLSHNRLNGYFPDRLGSLTGL 527
              L+ L L  N L  +   + P          S+L +L+L  N  +    +    L  L
Sbjct: 503 LEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562

Query: 528 KVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNL---PNSLETFNVSYNDFS 584
           K++ L  NN++    +   N  SL SL + +N  T            +L   ++ +N F 
Sbjct: 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622

Query: 585 GAVPENLRKFPS 596
               E++  F +
Sbjct: 623 C-TCESIAWFVN 633

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  286 bits (733), Expect = 4e-84
 Identities = 107/532 (20%), Positives = 190/532 (35%), Gaps = 33/532 (6%)

Query: 96  LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFS 155
                 S+  ++  +PD++    ++  L+++ N       +   +   L +L +  N  S
Sbjct: 6   HEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62

Query: 156 GLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILG 215
            L P+    L  ++ L+L HN  S           NL  L+L SN   K     F     
Sbjct: 63  KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122

Query: 216 LQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQ 275
           L  LD   N L     G    L N   +  S N      S++     + S++ L LS NQ
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182

Query: 276 LTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVY----ELQVLKLSNNRFSGFIPN 331
           +     + G       L  L L+  QL   L     +      ++ L LSN++ S     
Sbjct: 183 IKE--FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 332 DLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPLLTGSCA---V 386
             L      LT LDLS NNL+   +   +    L    L  N +                
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300

Query: 387 LDLSNNQFEGNLSR----------ILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNL 436
           L+L  +  + ++S                 +E+L++  N + G         + L +L+L
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360

Query: 437 SHNSLS-SSLPKVI---IQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGV 492
           S++  S  +L       + +  L +L+L+ N +             L+ L L  N +   
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420

Query: 493 LDFSPPS-VSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISG--SLPTSMANMT 549
           L       + N+  + LS+N+      +    +  L+ L L    +    S P+    + 
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480

Query: 550 SLSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLRKFPSSSF 599
           +L+ L +S N+      + L     LE  ++ +N+ +          P    
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFL 532

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  229 bits (585), Expect = 6e-64
 Identities = 100/460 (21%), Positives = 162/460 (35%), Gaps = 37/460 (8%)

Query: 166 VSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNK 225
           VS +  D SH   +  +P  L    N+  LNL+ N   +     F     L  LD   N 
Sbjct: 4   VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 226 LDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGE 285
           +          L     ++   N     S + F      ++  L+L  N +    +    
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF--AFCTNLTELHLMSNSIQK--IKNNP 116

Query: 286 LQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDL 344
               +NL  LDLS+N L+    G    +  LQ L LSNN+       +L    +  L  L
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176

Query: 345 DLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPLLTGSCA------VLDLSNNQFEG 396
           +LS+N +             L  L L++  L   L               L LSN+Q   
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236

Query: 397 NLSRI---LKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQ 453
             +     LKW N+  LDLS N+L     +      +L +  L +N++       +    
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296

Query: 454 KLRVLDLSFNHLDGPFLTNLLNS---------STLQELHLADNLLTGVLDFSPPSVSNLQ 504
            +R L+L  +          L             L+ L++ DN + G+       + NL+
Sbjct: 297 NVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK 356

Query: 505 VLDLSHNRLNGYFPDRLG----SLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNH 560
            L LS++  +            + + L +L L  N IS     + + +  L  L +  N 
Sbjct: 357 YLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNE 416

Query: 561 FTGPLPN----NLPNSLETFNVSYNDFSGAVPENLRKFPS 596
               L       L N +    +SYN +      +    PS
Sbjct: 417 IGQELTGQEWRGLEN-IFEIYLSYNKYLQLTRNSFALVPS 455

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  228 bits (584), Expect = 8e-64
 Identities = 105/535 (19%), Positives = 181/535 (33%), Gaps = 88/535 (16%)

Query: 78  NLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFK--SLEFLDVSDNLFSSSLP 135
            LG S    L +    + +  LS+SN+ +S          K  +L  LD+S N  +    
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265

Query: 136 SGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYL 195
                L  L+   L  NN   L   S+ GL +++ L+L                 +    
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR---------------SFTKQ 310

Query: 196 NLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSS- 254
           ++S     K     F+ +  L+ L+   N + G     F  L N  ++  S +     + 
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370

Query: 255 -SQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVY 313
            ++ F+      +  LNL+ N+++   +         +L+VLDL  N++  EL G  +  
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISK--IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428

Query: 314 --ELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSN 371
              +  + LS N++     N                   +          +L  L L   
Sbjct: 429 LENIFEIYLSYNKYLQLTRNSF---------------ALV---------PSLQRLMLRRV 464

Query: 372 GLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRL 431
            L             +D S + F   L       N+  LDLS N++     +      +L
Sbjct: 465 ALKN-----------VDSSPSPF-QPLR------NLTILDLSNNNIANINDDMLEGLEKL 506

Query: 432 NHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTG 491
             L+L HN+L+                 L  +   G  +  L   S L  L+L  N    
Sbjct: 507 EILDLQHNNLAR----------------LWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550

Query: 492 VLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMA-NMTS 550
           +       +  L+++DL  N LN        +   LK L L  N I+            +
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610

Query: 551 LSSLVISQNHFTGPLPN--NLPNSLETFNVSYNDFSGAV----PENLRKFPSSSF 599
           L+ L +  N F     +     N +   + +  + S       P +   FP   F
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLF 665

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  169 bits (429), Expect = 1e-43
 Identities = 70/325 (21%), Positives = 125/325 (38%), Gaps = 20/325 (6%)

Query: 291 NLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANN 350
           + +V D S+ +LT ++P       + VL L++N+       +        LT LD+  N 
Sbjct: 5   SHEVADCSHLKLT-QVPDDLPTN-ITVLNLTHNQLRRLPAANF--TRYSQLTSLDVGFNT 60

Query: 351 LSGSVSMILS--TNLHMLNLSSNGLTGELPLLTGSCA---VLDLSNNQFEGNLSRILKW- 404
           +S     +      L +LNL  N L+         C     L L +N  +   +      
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 405 GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVI--IQYQKLRVLDLSF 462
            N+  LDLS N L+ +      Q   L  L LS+N + +   + +       L+ L+LS 
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 463 NHLDGPFLTNLLNSSTLQELHLADNLLTGVLD---FSPPSVSNLQVLDLSHNRLNGYFPD 519
           N +             L  L L +  L   L        + ++++ L LS+++L+     
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240

Query: 520 RLGSL--TGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPN--SLET 575
               L  T L +L L+ NN++     S A +  L    +  N+      ++L    ++  
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300

Query: 576 FNVSYNDFSGAVPEN-LRKFPSSSF 599
            N+  +    ++    L K    SF
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSF 325

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  301 bits (772), Expect = 2e-90
 Identities = 117/535 (21%), Positives = 197/535 (36%), Gaps = 30/535 (5%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNL 147
             + +LS L  L ++ N I  +         SL+ L   +   +S     IG L++L+ L
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129

Query: 148 SLAGNNFSGL-IPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNL----VYLNLSSNGF 202
           ++A N      +P+  S L +++ LDLS N         L  L+ +    + L+LS N  
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189

Query: 203 SKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFL-LTNASHIDFSGNMFVGSSSQKFLPG 261
           +   P  F+  + L  L    N    ++       L            F    + +    
Sbjct: 190 NFIQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248

Query: 262 LS----QSVQYLNLSLNQLTGSLVNG-GELQLFENLKVLDLSYNQLTGELPGFNFVYELQ 316
            +     ++      L  L   L +         N+    L    +   +  F++ +  Q
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQ 307

Query: 317 VLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT-- 374
            L+L N +F  F    L       L  L  ++N    + S +   +L  L+LS NGL+  
Sbjct: 308 HLELVNCKFGQFPTLKLKS-----LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFK 362

Query: 375 GELPLLTGSCA---VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLR- 430
           G              LDLS N      S  L    +E+LD   ++L           LR 
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422

Query: 431 LNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLL-NSSTLQELHLADNLL 489
           L +L++SH     +   +      L VL ++ N     FL ++      L  L L+   L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482

Query: 490 TGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANM- 548
             +   +  S+S+LQVL++SHN            L  L+VL  + N+I  S    + +  
Sbjct: 483 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542

Query: 549 TSLSSLVISQNHFTGPLPN----NLPNSLETFNVSYNDFSGAVPENLRKFPSSSF 599
           +SL+ L ++QN F     +              V       A P + +  P  S 
Sbjct: 543 SSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 597

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  285 bits (731), Expect = 1e-84
 Identities = 110/530 (20%), Positives = 198/530 (37%), Gaps = 26/530 (4%)

Query: 88  SVFSNLSM-LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQN 146
            +  NL      L +S N +  +   +   F  L+ LD+S     +        L  L  
Sbjct: 21  KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSK-R 205
           L L GN    L   + SGL S+Q L     + +      +  L  L  LN++ N     +
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTN----ASHIDFSGNMFVGSSSQKFLPG 261
           +P  F  +  L+ LD   NK+      +  +L         +D S N         F   
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF--- 197

Query: 262 LSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTG----ELPGFNFVYELQV 317
               +  L L  N  + +++      L   L+V  L   +       E    + +  L  
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGL-AGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256

Query: 318 LKLSNNRFS--GFIPNDLLKGDSLL--LTDLDLSANNLSGSVSMILSTNLHMLNLSSNGL 373
           L +   R +   +  +D++   + L  ++   L +  +        +     L L +   
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316

Query: 374 TGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLT--GSIPEETPQFLRL 431
                L   S   L  ++N+     S  +   ++E+LDLSRN L+  G   +       L
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFS-EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375

Query: 432 NHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLL-NSSTLQELHLADNLLT 490
            +L+LS N +  ++    +  ++L  LD   ++L      ++  +   L  L ++     
Sbjct: 376 KYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434

Query: 491 GVLDFSPPSVSNLQVLDLSHNRLNGYF-PDRLGSLTGLKVLCLAGNNISGSLPTSMANMT 549
              +     +S+L+VL ++ N     F PD    L  L  L L+   +    PT+  +++
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494

Query: 550 SLSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLRKFPSS 597
           SL  L +S N+F            SL+  + S N    +  + L+ FPSS
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 544

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  206 bits (527), Expect = 8e-57
 Identities = 85/467 (18%), Positives = 161/467 (34%), Gaps = 56/467 (11%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFS---SSLPSGIGKLESL 144
             FSNL+ L  L +S+N I  +   ++     +  L++S +L     + +  G  K   L
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202

Query: 145 QNLSLAGNNFSG-LIPDSVSGLVSIQSLDLSHNSFSGS---LPPALTRLNNLVYLNLSSN 200
             L+L  N  S  ++   + GL  ++   L    F           + L  L  L +   
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262

Query: 201 GFSK------RIPRGFELILGLQVLDFHGNKLDGHLDGEFFL------------------ 236
             +        I   F  +  +         ++   D  +                    
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL 322

Query: 237 -LTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVL 295
            L +   + F+ N    + S+  LP L    ++L+LS N L+             +LK L
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEVDLPSL----EFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378

Query: 296 DLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSV 355
           DLS+N +      F  + +L+ L   ++         +      L+  LD+S  +   + 
Sbjct: 379 DLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY-LDISHTHTRVAF 437

Query: 356 SMILS--TNLHMLNLSSNGLTGELP--LLTGSCA--VLDLSNNQFEGNLSRILK-WGNIE 408
           + I +  ++L +L ++ N         + T       LDLS  Q E           +++
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497

Query: 409 YLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQ-YQKLRVLDLSFNHLDG 467
            L++S N+              L  L+ S N + +S  + +      L  L+L+ N    
Sbjct: 498 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

Query: 468 -----PFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLS 509
                 FL  + +   L    +    +      +P     + VL L+
Sbjct: 558 TCEHQSFLQWIKDQRQLL---VEVERMECA---TPSDKQGMPVLSLN 598

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  169 bits (430), Expect = 3e-44
 Identities = 80/311 (25%), Positives = 122/311 (39%), Gaps = 20/311 (6%)

Query: 76  LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLP 135
           L  L       + +F+ L+ +   S+ + +I  V           + L++ +  F     
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPT 321

Query: 136 SGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHN--SFSGSLPPALTRLNNLV 193
             +  L+ L   S  G N    +      L S++ LDLS N  SF G    +     +L 
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEV-----DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376

Query: 194 YLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFL-LTNASHIDFSGNMFVG 252
           YL+LS NG    +   F  +  L+ LDF  + L    +   FL L N  ++D S      
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435

Query: 253 SSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNF 311
           + +  F  GLS S++ L ++ N    +           NL  LDLS  QL    P  FN 
Sbjct: 436 AFNGIF-NGLS-SLEVLKMAGNSFQENF-LPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492

Query: 312 VYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS---TNLHMLNL 368
           +  LQVL +S+N F               L  LD S N++  S    L    ++L  LNL
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPY--KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550

Query: 369 SSNGLTGELPL 379
           + N        
Sbjct: 551 TQNDFACTCEH 561

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  149 bits (377), Expect = 2e-37
 Identities = 58/351 (16%), Positives = 105/351 (29%), Gaps = 53/351 (15%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVL 318
             L  S + L+LS N L    +       F  L+VLDLS  ++     G +  +  L  L
Sbjct: 24  DNLPFSTKNLDLSFNPLRH--LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL 81

Query: 319 KLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGE 376
            L+ N                 L  L     NL+   +  +     L  LN++ N +   
Sbjct: 82  ILTGNPIQSLALGAF--SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS- 138

Query: 377 LPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQF----LRLN 432
                           ++  NL+      N+E+LDLS N +      +        L   
Sbjct: 139 ------------FKLPEYFSNLT------NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180

Query: 433 HLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNS-STLQELHLADNLLTG 491
            L+LS N ++  +     +  +L  L L  N      +   +   + L+   L       
Sbjct: 181 SLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239

Query: 492 ---VLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANM 548
              +  F   ++  L  L +   RL                     +     +      +
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYL------------------DYYLDDIIDLFNCL 281

Query: 549 TSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSF 599
           T++SS  +           +     +   +    F       L+     +F
Sbjct: 282 TNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF 332

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  122 bits (308), Expect = 6e-29
 Identities = 40/163 (24%), Positives = 66/163 (40%), Gaps = 2/163 (1%)

Query: 76  LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLP 135
             +  L   ++ SVF +L  L+ L +S+               SLE L ++ N F  +  
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

Query: 136 SGI-GKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVY 194
             I  +L +L  L L+      L P + + L S+Q L++SHN+F          LN+L  
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 522

Query: 195 LNLSSNGFSKRIPRGFELILG-LQVLDFHGNKLDGHLDGEFFL 236
           L+ S N       +  +     L  L+   N      + + FL
Sbjct: 523 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 565

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  269 bits (690), Expect = 7e-79
 Identities = 99/490 (20%), Positives = 170/490 (34%), Gaps = 24/490 (4%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSL 149
           +  L  L  L ++ N I    P +     SLE L   +   +S     IG+L +L+ L++
Sbjct: 76  WHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135

Query: 150 AGNNFSGL-IPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNL----VYLNLSSNGFSK 204
           A N      +P   S L ++  +DLS+N         L  L       + L++S N    
Sbjct: 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF 195

Query: 205 RIPRGFELILGLQVLDFHGNKLDGHLDGEFFL-LTNASHIDFSGNMFVGSSSQKFLPGLS 263
              + F+  + L  L   GN    ++       L            F    + +      
Sbjct: 196 IQDQAFQG-IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254

Query: 264 ----QSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLK 319
                 V      L        +  +     N+  + L+   +   L      ++ Q L 
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLS 313

Query: 320 LSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELP- 378
           +   +   F   DL       L  L L+ N  S S   +   +L  L+LS N L+     
Sbjct: 314 IIRCQLKQFPTLDLPF-----LKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCC 368

Query: 379 ----LLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLR-LNH 433
               L T S   LDLS N      +  +    +++LD   + L           L  L +
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428

Query: 434 LNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNS-STLQELHLADNLLTGV 492
           L++S+ +       + +    L  L ++ N      L+N+  + + L  L L+   L  +
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488

Query: 493 LDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLS 552
                 ++  LQ+L++SHN L          L  L  L  + N I  S         SL+
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLA 548

Query: 553 SLVISQNHFT 562
              ++ N   
Sbjct: 549 FFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  257 bits (658), Expect = 2e-74
 Identities = 96/521 (18%), Positives = 179/521 (34%), Gaps = 27/521 (5%)

Query: 96  LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFS 155
              + +S N +  +   +  +F  L++LD+S     +        L  L NL L GN   
Sbjct: 34  TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93

Query: 156 GLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSK-RIPRGFELIL 214
              P S SGL S+++L       +      + +L  L  LN++ N     ++P  F  + 
Sbjct: 94  SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153

Query: 215 GLQVLDFHGNKLDGHLDGEFFLLTNAS----HIDFSGNMFVGSSSQKFLPGLSQSVQYLN 270
            L  +D   N +      +   L         +D S N       Q F       +  L 
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF---QGIKLHELT 210

Query: 271 LSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTG-------ELPGFNFVYELQVLKLSNN 323
           L  N  + +++      L   L V  L   +          E      + ++ + +    
Sbjct: 211 LRGNFNSSNIMKTCLQNL-AGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269

Query: 324 RFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGS 383
             + F  + +       ++ + L+  ++     +        L++    L     L    
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPF 329

Query: 384 CAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL---RLNHLNLSHNS 440
              L L+ N+   +    +   ++ YLDLSRN L+      +   L    L HL+LS N 
Sbjct: 330 LKSLTLTMNKGSISFK-KVALPSLSYLDLSRNALS-FSGCCSYSDLGTNSLRHLDLSFNG 387

Query: 441 LSSSLPKVIIQYQKLRVLDLSFNHLDG-PFLTNLLNSSTLQELHLADNLLTGVLDFSPPS 499
               +    +  ++L+ LD   + L      +  L+   L  L ++        D     
Sbjct: 388 A-IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG 446

Query: 500 VSNLQVLDLSHNRLNGYFPDR-LGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQ 558
           +++L  L ++ N            + T L  L L+   +          +  L  L +S 
Sbjct: 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH 506

Query: 559 NHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLRKFPSS 597
           N+      ++     SL T + S+N         L+ FP S
Sbjct: 507 NNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKS 546

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  164 bits (417), Expect = 2e-42
 Identities = 67/377 (17%), Positives = 124/377 (32%), Gaps = 31/377 (8%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDN-IGDFKSLEFLDVSDNLFSSSL------PSGI 138
               F  +  L +L++  N  S  I    + +   L    +    F          PS +
Sbjct: 197 QDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255

Query: 139 GKLESLQ--NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLN 196
             L  +      L   N           L ++ ++ L+  S        + +      L+
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLS 313

Query: 197 LSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQ 256
           +      +           L+ L    NK    +  +   L + S++D S N    S   
Sbjct: 314 IIRCQLKQFPTLDLP---FLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCC 368

Query: 257 KFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYE 314
            +    + S+++L+LS N      +        E L+ LD  ++ L        F  + +
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAI---IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425

Query: 315 LQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSV---SMILSTNLHMLNLSSN 371
           L  L +S            L   SL    L ++ N+   +        +TNL  L+LS  
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSL--NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483

Query: 372 GLTGELPLLTGSCA---VLDLSNNQFEGNLSRILK-WGNIEYLDLSRNHLTGSIPEETPQ 427
            L      +  +     +L++S+N      S       ++  LD S N +  S       
Sbjct: 484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543

Query: 428 FLRLNHLNLSHNSLSSS 444
              L   NL++NS++  
Sbjct: 544 PKSLAFFNLTNNSVACI 560

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  109 bits (274), Expect = 9e-25
 Identities = 29/153 (18%), Positives = 51/153 (33%), Gaps = 1/153 (0%)

Query: 76  LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLP 135
             +  L    + S F +L  L+ L +S  +             SL  L ++ N F  +  
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465

Query: 136 SGI-GKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVY 194
           S +     +L  L L+      +       L  +Q L++SHN+          +L +L  
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525

Query: 195 LNLSSNGFSKRIPRGFELILGLQVLDFHGNKLD 227
           L+ S N               L   +   N + 
Sbjct: 526 LDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  107 bits (269), Expect = 4e-24
 Identities = 50/276 (18%), Positives = 90/276 (32%), Gaps = 27/276 (9%)

Query: 338 SLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGN 397
            +           LS  V   + ++   ++LS N L               L +  F  N
Sbjct: 10  VVPNITYQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKI-------------LKSYSF-SN 54

Query: 398 LSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRV 457
            S       +++LDLSR  +     +       L++L L+ N + S  P        L  
Sbjct: 55  FS------ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLEN 108

Query: 458 LDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGV-LDFSPPSVSNLQVLDLSHNRLNGY 516
           L      L       +    TL++L++A N +    L     +++NL  +DLS+N +   
Sbjct: 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168

Query: 517 FPDRLGSLTGLK----VLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNS 572
             + L  L         L ++ N I   +         L  L +  N  +  +      +
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQN 227

Query: 573 LETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSF 608
           L   +V          E   +    S   G   ++ 
Sbjct: 228 LAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  263 bits (674), Expect = 1e-76
 Identities = 110/493 (22%), Positives = 184/493 (37%), Gaps = 25/493 (5%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLS 148
            F +   L  L ++ N +  +    +   K+L+ L       SS     +   ++L++L 
Sbjct: 76  TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135

Query: 149 LAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNL--VYLNLSSNGFSKRI 206
           L  N+ S +          ++ LD  +N+        ++ L     + LNL+ N     I
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN-DIAGI 194

Query: 207 PRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNAS--HIDFSGNMFVGSSSQKFLPGLSQ 264
             G       Q L+F G +    +       T  S     F        S   F      
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM 254

Query: 265 SVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNR 324
           SV+ +NL  +      ++      F  L+ LDL+   L+    G   +  L+ L LS N+
Sbjct: 255 SVESINLQKHYFFN--ISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANK 312

Query: 325 FSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMIL---STNLHMLNLSSNGLTGELPLLT 381
           F           +   LT L +  N     +         NL  L+LS + +        
Sbjct: 313 FENLCQISA--SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET-SDCCN 369

Query: 382 GSCA------VLDLSNNQFEGNLSRILK-WGNIEYLDLSRNHLTGSIPEETPQFL-RLNH 433
                      L+LS N+     +   K    +E LDL+   L     +   Q L  L  
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429

Query: 434 LNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL---DGPFLTNLLNSSTLQELHLADNLLT 490
           LNLSH+ L  S  ++      L+ L+L  NH    +     +L     L+ L L+   L+
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489

Query: 491 GVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTS 550
            +   +  S+  +  +DLSHNRL     + L  L G+  L LA N+IS  LP+ +  ++ 
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQ 548

Query: 551 LSSLVISQNHFTG 563
             ++ + QN    
Sbjct: 549 QRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  262 bits (671), Expect = 3e-76
 Identities = 103/517 (19%), Positives = 188/517 (36%), Gaps = 25/517 (4%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNL 147
           + FS L  L  L ++   I  +  D       L+ L ++ N       + +   ++L++L
Sbjct: 51  TTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHL 110

Query: 148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIP 207
                  S +    +    +++SL L  N  S    P       L  L+  +N       
Sbjct: 111 FFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK 170

Query: 208 RGFELILGLQV--LDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
                +       L+ +GN +   ++   F       ++F G   +    +       QS
Sbjct: 171 EDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNR 324
           +                  E     +++ ++L  +         F+    LQ L L+   
Sbjct: 230 LWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH 289

Query: 325 FSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPLLT- 381
            S  +P+ L+   +  L  L LSAN       +  S   +L  L++  N    EL     
Sbjct: 290 LSE-LPSGLVGLST--LKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346

Query: 382 ---GSCAVLDLSNNQFEGNLSRILKWGN---IEYLDLSRNHLTGSIPEETPQFL-RLNHL 434
               +   LDLS++  E +    L+  N   ++ L+LS N    S+  E  +   +L  L
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL-SLKTEAFKECPQLELL 405

Query: 435 NLSHNSLSSSLPKVIIQY-QKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVL 493
           +L+   L     +   Q    L+VL+LS + LD            LQ L+L  N      
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGN 465

Query: 494 DFSPPS---VSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTS 550
                S   +  L++L LS   L+        SL  +  + L+ N ++ S   +++++  
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525

Query: 551 LSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSG 585
           +  L ++ NH +  LP+ LP      T N+  N    
Sbjct: 526 I-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  258 bits (662), Expect = 6e-75
 Identities = 96/519 (18%), Positives = 174/519 (33%), Gaps = 31/519 (5%)

Query: 99  LSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLI 158
            +  N  ++  IP  +    S E L+ S N+  +   +   +L +L  L L       + 
Sbjct: 17  YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 159 PDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQV 218
            D+      + +L L+ N        AL+    L +L     G S            L+ 
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 219 LDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTG 278
           L    N +      + F       +DF  N     S +        +   LNL+ N + G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193

Query: 279 SLVNGGELQLFENLKVLDLSYNQLTGELP---GFNFVYELQVLKLSNNRFSGFIPNDLLK 335
                 +       + L+    Q    +      + +  L +    +       P     
Sbjct: 194 IEPGAFDSA---VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250

Query: 336 GDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLT------GELPLLTGSCAVL 387
              + +  ++L  +      S      + L  L+L++  L+        L  L      L
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLK----KL 306

Query: 388 DLSNNQFEGNLSRILKW-GNIEYLDLSRNHLTGSIPEETPQFLR-LNHLNLSHNSLSSS- 444
            LS N+FE           ++ +L +  N     +     + L  L  L+LSH+ + +S 
Sbjct: 307 VLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSD 366

Query: 445 -LPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPS-VSN 502
                +     L+ L+LS+N               L+ L LA   L      SP   +  
Sbjct: 367 CCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHL 426

Query: 503 LQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISG---SLPTSMANMTSLSSLVISQN 559
           L+VL+LSH+ L+         L  L+ L L GN+          S+  +  L  LV+S  
Sbjct: 427 LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486

Query: 560 HFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLRKFPS 596
             +    +   +   +   ++S+N  + +  E L     
Sbjct: 487 DLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  215 bits (549), Expect = 1e-59
 Identities = 94/442 (21%), Positives = 169/442 (38%), Gaps = 29/442 (6%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIG--KLES 143
           D+S     + L  L+++ N I+G I     D    + L+         +  G+    ++S
Sbjct: 172 DMSSLQQATNL-SLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229

Query: 144 LQNLSLAGNNFSGLIPDSVSGL--VSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNG 201
           L   +    +   + P    GL  +S++S++L  + F           + L  L+L++  
Sbjct: 230 LWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATH 289

Query: 202 FSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPG 261
            S  +P G   +  L+ L    NK +           + +H+   GN          L  
Sbjct: 290 LS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348

Query: 262 LSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKL 320
           L  +++ L+LS + +  S     +L+   +L+ L+LSYN+        F    +L++L L
Sbjct: 349 LE-NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407

Query: 321 SNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELP 378
           +  R          +    LL  L+LS + L  S   +      L  LNL  N       
Sbjct: 408 AFTRLKVKDAQSPFQN-LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466

Query: 379 LLTGSCA------VLDLSNNQFEGNLSRILKW-GNIEYLDLSRNHLTGSIPEETPQFLRL 431
             T S        +L LS                 + ++DLS N LT S   E    L+ 
Sbjct: 467 QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-SSSIEALSHLKG 525

Query: 432 NHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDG----PFLTNLLNSSTLQELHLADN 487
            +LNL+ N +S  LP ++    + R ++L  N LD      +       +  +     D 
Sbjct: 526 IYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDTEDT 585

Query: 488 LLTGVLDFSPPSVSNLQVLDLS 509
           L       +PP +  +++ D++
Sbjct: 586 LCE-----NPPLLRGVRLSDVT 602

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  142 bits (359), Expect = 3e-35
 Identities = 53/335 (15%), Positives = 98/335 (29%), Gaps = 42/335 (12%)

Query: 293 KVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLS 352
           K  +     L  E+PG       + L+ S N               + LT LDL+   + 
Sbjct: 15  KTYNCENLGLN-EIPG-TLPNSTECLEFSFNVLPTIQNTTF--SRLINLTFLDLTRCQIY 70

Query: 353 GSVSMILS--TNLHMLNLSSNGLTGELPLLTGSCA---VLDLSNNQFEGNLSRILKW-GN 406
                       L  L L++N L                L              L     
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 407 IEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLS------------------------ 442
           +E L L  NH++     +     +L  L+  +N++                         
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190

Query: 443 -SSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSS--TLQELHLADNLLTGVLDFSPPS 499
            + +          + L+             L NS+  +L      D     +       
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250

Query: 500 VSNLQV--LDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVIS 557
           +  + V  ++L  +       +     +GL+ L L   ++S  LP+ +  +++L  LV+S
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309

Query: 558 QNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPEN 590
            N F      +  N  SL   ++  N     +   
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG 344

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 90.5 bits (225), Expect = 1e-18
 Identities = 36/187 (19%), Positives = 58/187 (31%), Gaps = 11/187 (5%)

Query: 418 TGSIPEETPQFLRLNHLNLSHNSLSS---SLPKVIIQYQKLRVLDLSFNHLDGPFLTNLL 474
           T S  ++  +       N  +  L+    +LP           L+ SFN L     T   
Sbjct: 1   TTSSDQKCIEKEVNKTYNCENLGLNEIPGTLPN------STECLEFSFNVLPTIQNTTFS 54

Query: 475 NSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAG 534
               L  L L    +  + + +  S   L  L L+ N L       L     LK L    
Sbjct: 55  RLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQ 114

Query: 535 NNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLR 592
             IS      + N  +L SL +  NH +            L+  +   N       E++ 
Sbjct: 115 TGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMS 174

Query: 593 KFPSSSF 599
               ++ 
Sbjct: 175 SLQQATN 181

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  263 bits (674), Expect = 2e-76
 Identities = 90/557 (16%), Positives = 186/557 (33%), Gaps = 70/557 (12%)

Query: 104 NSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSG----LIP 159
            +  GV  ++ G    +  L +     S  +P  IG+L  L+ L+L  +          P
Sbjct: 70  GAQPGVSLNSNG---RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126

Query: 160 DSVSGLVSIQSLDLSHNSFSGSLPPALTRLN--NLVYLNLSSNGFSKRIPRGFELILGLQ 217
             +S  +S +        +  +      R +  +L+   ++S+   K I +   + L   
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186

Query: 218 VLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLS-------------- 263
            +    N +   +      LT         + FV  +  +     +              
Sbjct: 187 QIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKW 245

Query: 264 ---QSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTG---------ELPGFNF 311
              + +  + +        L     L+    +++++++ N+             L     
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPT--FLKALPEMQLINVACNRGISGEQLKDDWQALADAPV 303

Query: 312 VYELQVLKLSNNRF-SGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS-TNLHMLNLS 369
             ++Q++ +  N   +  +   L K     L  L+   N L G +    S   L  LNL+
Sbjct: 304 GEKIQIIYIGYNNLKTFPVETSLQKMKK--LGMLECLYNQLEGKLPAFGSEIKLASLNLA 361

Query: 370 SNGLTGELPLLTGSCA---VLDLSNNQFEG--NLSRILKWGNIEYLDLSRNHLTG----- 419
            N +T       G       L  ++N+ +   N+        +  +D S N +       
Sbjct: 362 YNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421

Query: 420 --SIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDG-------PFL 470
              +     + + ++ +NLS+N +S    ++      L  ++L  N L            
Sbjct: 422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481

Query: 471 TNLLNSSTLQELHLADNLLTGVLD-FSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKV 529
            N  N+  L  + L  N LT + D F   ++  L  +DLS+N  +  FP +  + + LK 
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKG 540

Query: 530 L------CLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDF 583
                     GN      P  +    SL+ L I  N     +   +  ++   ++  N  
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPNISVLDIKDNPN 599

Query: 584 SGAVPENLRKFPSSSFY 600
                  +  +  +  Y
Sbjct: 600 ISIDLSYVCPYIEAGMY 616

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  229 bits (587), Expect = 1e-64
 Identities = 76/521 (14%), Positives = 165/521 (31%), Gaps = 64/521 (12%)

Query: 124 DVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSG--- 180
           +   +++ +     +     +  LSL G   SG +PD++  L  ++ L L  +       
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122

Query: 181 -SLPPALTRLNNLVYLNLSSNGFSKRIPR--GFELILGLQVLDFHGNKLDGHLDGEFFLL 237
              P  ++   +          + K        E    L     + +     +     + 
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182

Query: 238 TNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDL 297
              + I    N     S    +  L+  ++   +  +             + E  +  + 
Sbjct: 183 LKDTQIGQLSNNITFVSKA--VMRLT-KLRQFYMGNSPFVAEN-------ICEAWENENS 232

Query: 298 SYNQLTGELP-GFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVS 356
            Y Q        ++ + +L  +++ N      +P  L       +  ++++ N       
Sbjct: 233 EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL--KALPEMQLINVACNRGISGEQ 290

Query: 357 MILS----------TNLHMLNLSSNGL-TGELPLLTGSCA---VLDLSNNQFEGNLSRIL 402
           +               + ++ +  N L T  +           +L+   NQ EG L    
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFG 350

Query: 403 KWGNIEYLDLSRNHLTGSIPEETPQFLR-LNHLNLSHNSLSSSLPKV--IIQYQKLRVLD 459
               +  L+L+ N +T  IP     F   + +L+ +HN L   +P +        +  +D
Sbjct: 351 SEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAID 408

Query: 460 LSFNHLDG-------PFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNR 512
            S+N +         P          +  ++L++N ++        + S L  ++L  N 
Sbjct: 409 FSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNM 468

Query: 513 LNG-------YFPDRLGSLTGLKVLCLAGNNISGSLPTSMA--NMTSLSSLVISQNHFTG 563
           L            +   +   L  + L  N ++  L        +  L  + +S N F+ 
Sbjct: 469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK 527

Query: 564 PLPNNLPN--SLETF------NVSYNDFSGAVPENLRKFPS 596
             P    N  +L+ F      +   N      PE +   PS
Sbjct: 528 -FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  208 bits (531), Expect = 4e-57
 Identities = 77/401 (19%), Positives = 132/401 (32%), Gaps = 40/401 (9%)

Query: 76  LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSS--- 132
            +        DL  + NL  L  + + N      +P  +     ++ ++V+ N   S   
Sbjct: 232 SEYAQQYKTEDLK-WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290

Query: 133 -----SLPSGIGKLESLQNLSLAGNNFSGL-IPDSVSGLVSIQSLDLSHNSFSGSLPPAL 186
                   +     E +Q + +  NN     +  S+  +  +  L+  +N   G   PA 
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAF 349

Query: 187 TRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFL-LTNASHIDF 245
                L  LNL+ N  ++           ++ L F  NKL    +      ++  S IDF
Sbjct: 350 GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDF 409

Query: 246 SGNMFVGSSSQKFLP-----GLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYN 300
           S N       + F P         +V  +NLS NQ++              L  ++L  N
Sbjct: 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFP--KELFSTGSPLSSINLMGN 467

Query: 301 QLTG--------ELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLS 352
            LT         E   F   Y L  + L  N+ +  + +D        L  +DLS N+ S
Sbjct: 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFS 526

Query: 353 G-SVSMILSTNL------HMLNLSSNGLTGELPLLTGSC---AVLDLSNNQFEGNLSRIL 402
                 + S+ L      +  +   N    E P     C     L + +N       +I 
Sbjct: 527 KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKIT 586

Query: 403 KWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSS 443
              NI  LD+  N            ++      L ++    
Sbjct: 587 P--NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQD 625

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  255 bits (652), Expect = 2e-71
 Identities = 101/603 (16%), Positives = 193/603 (32%), Gaps = 78/603 (12%)

Query: 23  QDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGI--VCNGGNVAGVVLDNLG 80
           +D  AL    + +           +   +I+      +WN    +   G+  GV LDN G
Sbjct: 269 KDYKALKAIWEALDGKN-----WRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNG 323

Query: 81  LSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGK 140
                          +  LS++     G +PD IG    L+ L    +  + S      +
Sbjct: 324 --------------RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369

Query: 141 LESLQNLSLAGNNFSGLI-PDSVSGLVSIQSLDLSHNSFS-----GSLPPALTRLNNLVY 194
             +        +          +     +   DL  ++ +       +            
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ 429

Query: 195 LNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSS 254
           +   +N  +  I +  + +  LQ++ F  +          +   N+ +     N      
Sbjct: 430 IGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE---EL 485

Query: 255 SQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTG---------E 305
           S   L  L      + L        L     L     L+ L+++ N+             
Sbjct: 486 SWSNLKDL----TDVELYNCPNMTQL--PDFLYDLPELQSLNIACNRGISAAQLKADWTR 539

Query: 306 LPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLH 364
           L    +   ++Q+  +  N    F  +  L    + L  LD   N +    +   +  L 
Sbjct: 540 LADDEDTGPKIQIFYMGYNNLEEFPASASL-QKMVKLGLLDCVHNKVRHLEAFGTNVKLT 598

Query: 365 MLNLSSNGLTGELPLLTGSCA----VLDLSNNQFEG--NLSRILKWGNIEYLDLSRNHLT 418
            L L  N +  E+P    +       L  S+N+ +   N+        +  +D S N + 
Sbjct: 599 DLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG 657

Query: 419 GSIPEETP------QFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLD------ 466
            S            + +  + + LS+N +     ++      +  + LS N +       
Sbjct: 658 -SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS 716

Query: 467 -GPFLTNLLNSSTLQELHLADNLLTGV-LDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSL 524
             P   N  N+  L  + L  N LT +  DF   ++  L  +D+S+N  +  FP +  + 
Sbjct: 717 LKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNS 775

Query: 525 TGLKVLCL------AGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNV 578
           + LK   +       GN I    PT +    SL  L I  N     +   L   L   ++
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTPQLYILDI 834

Query: 579 SYN 581
           + N
Sbjct: 835 ADN 837

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  216 bits (551), Expect = 2e-58
 Identities = 82/554 (14%), Positives = 174/554 (31%), Gaps = 71/554 (12%)

Query: 93  LSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGN 152
            ++   L   N        +N     +  F +   +++       +     +  LSLAG 
Sbjct: 275 KAIWEALDGKNWRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTGLSLAGF 333

Query: 153 NFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFEL 212
              G +PD++  L  ++ L    +S + S                  +       + F  
Sbjct: 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLD 393

Query: 213 IL-GLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQ-KFLP---GLSQSVQ 267
               L + D   + ++ +   E   +   S I          +++  F+         +Q
Sbjct: 394 YDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQ 451

Query: 268 YLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFS 326
            +  + +  T          +  + +  +  Y +        ++ + +L  ++L N    
Sbjct: 452 IIYFANSPFTY-------DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM 504

Query: 327 GFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS-----------TNLHMLNLSSNGLT- 374
             +P+ L   D   L  L+++ N    +  +                + +  +  N L  
Sbjct: 505 TQLPDFL--YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE 562

Query: 375 -------GELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQ 427
                   ++  L     +LD  +N+   +L        +  L L  N +   IPE+   
Sbjct: 563 FPASASLQKMVKLG----LLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCA 616

Query: 428 FLR-LNHLNLSHNSLSSSLPKV--IIQYQKLRVLDLSFNHLDG-----PFLTNLLNSSTL 479
           F   +  L  SHN L   +P +        +  +D S+N +           +       
Sbjct: 617 FTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINA 675

Query: 480 QELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRL-------NGYFPDRLGSLTGLKVLCL 532
             + L+ N +         + S +  + LS+N +                +   L  + L
Sbjct: 676 STVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDL 735

Query: 533 AGNNISGSLPTSMA--NMTSLSSLVISQNHFTGPLPNNLPN--SLETFNVSY------ND 582
             N ++ SL        +  LS++ +S N F+   P    N   L+ F + +      N 
Sbjct: 736 RFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNR 793

Query: 583 FSGAVPENLRKFPS 596
                P  +   PS
Sbjct: 794 ILRQWPTGITTCPS 807

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  213 bits (543), Expect = 2e-57
 Identities = 74/438 (16%), Positives = 138/438 (31%), Gaps = 60/438 (13%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSL 149
              L+ L  +  +N+  +             E  +        +       L+ L ++ L
Sbjct: 444 IQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKDLTDVEL 498

Query: 150 AGNNFSGLIPDSVSGLVSIQSLDLSHNSFSG---------SLPPALTRLNNLVYLNLSSN 200
                   +PD +  L  +QSL+++ N              L         +    +  N
Sbjct: 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYN 558

Query: 201 GFSKRIPRGFEL--ILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKF 258
                 P    L  ++ L +LD   NK+  HL+  F      + +    N          
Sbjct: 559 NLE-EFPASASLQKMVKLGLLDCVHNKV-RHLE-AFGTNVKLTDLKLDYNQIEEIPEDFC 615

Query: 259 LPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYE---- 314
               +  V+ L  S N+L   + N    +    +  +D SYN++  E    +   +    
Sbjct: 616 --AFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672

Query: 315 --LQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS---------TNL 363
                + LS N    F       G  +  + + LS N ++      L            L
Sbjct: 673 INASTVTLSYNEIQKFPTELFATGSPI--STIILSNNLMTSIPENSLKPKDGNYKNTYLL 730

Query: 364 HMLNLSSNGLT--------GELPLLTGSCAVLDLSNNQFE------GNLSRILKWGNIEY 409
             ++L  N LT          LP L+     +D+S N F        N S++  +G    
Sbjct: 731 TTIDLRFNKLTSLSDDFRATTLPYLS----NMDVSYNCFSSFPTQPLNSSQLKAFGIRHQ 786

Query: 410 LDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPF 469
            D   N +    P        L  L +  N +   + + +    +L +LD++ N      
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTP--QLYILDIADNPNISID 843

Query: 470 LTNLLNSSTLQELHLADN 487
           +T++          L  +
Sbjct: 844 VTSVCPYIEAGMYVLLYD 861

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  200 bits (511), Expect = 2e-53
 Identities = 66/413 (15%), Positives = 137/413 (33%), Gaps = 43/413 (10%)

Query: 87  LSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQN 146
            +  +        +            +  + K L  +++ +    + LP  +  L  LQ+
Sbjct: 460 FTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519

Query: 147 LSLAGNNFSGL---------IPDSVSGLVSIQSLDLSHNSFSGSLPP--ALTRLNNLVYL 195
           L++A N              + D       IQ   + +N+     P   +L ++  L  L
Sbjct: 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLL 578

Query: 196 NLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNA-SHIDFSGNMFVGSS 254
           +   N         F   + L  L    N+++  +  +F   T+    + FS N      
Sbjct: 579 DCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIP 635

Query: 255 SQKFLPGLSQSVQYLNLSLNQLTG---SLVNGGELQLFENLKVLDLSYNQLTGELPG-FN 310
           +      +   +  ++ S N++     ++    +     N   + LSYN++       F 
Sbjct: 636 NIFNAKSV-YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFA 694

Query: 311 FVYELQVLKLSNNRFSGFIPNDLLKGDSLL-----LTDLDLSANNLSG---SVSMILSTN 362
               +  + LSNN  +    N L   D        LT +DL  N L+             
Sbjct: 695 TGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPY 754

Query: 363 LHMLNLSSNGLTGELPLLTGSCAVL---------DLSNNQFEGNL-SRILKWGNIEYLDL 412
           L  +++S N  +   P    + + L         D   N+      + I    ++  L +
Sbjct: 755 LSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQI 813

Query: 413 SRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL 465
             N +   + E+     +L  L+++ N   S     +  Y +  +  L ++  
Sbjct: 814 GSNDIR-KVDEKLTP--QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  154 bits (391), Expect = 1e-38
 Identities = 66/505 (13%), Positives = 149/505 (29%), Gaps = 103/505 (20%)

Query: 104 NSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVS 163
              +  I D        E LD  +  + S   +      +  N +   + +       + 
Sbjct: 262 KETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLD 320

Query: 164 GLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHG 223
               +  L L+     G +P A+ +L  L  L+  ++  +       +  L   + +   
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380

Query: 224 NKLDGHLDGEFF-LLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVN 282
           +++  H    F       +  D   +    +   K +   S+    ++L   Q+      
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR----ISLKDTQI------ 430

Query: 283 GGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLT 342
                            N++T        + +LQ++  +N+ F+           ++   
Sbjct: 431 -------------GNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI-------AVDWE 470

Query: 343 DLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSR 400
           D +        +  +  S   +L  + L +     +LP             +    +L  
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLP-------------DFL-YDLP- 515

Query: 401 ILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDL 460
                 ++ L+++ N    +                   +  + L        K+++  +
Sbjct: 516 -----ELQSLNIACNRGISAAQL---------------KADWTRLADDEDTGPKIQIFYM 555

Query: 461 SFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDR 520
            +N+L          S++LQ++                    L +LD  HN++     + 
Sbjct: 556 GYNNL-----EEFPASASLQKM------------------VKLGLLDCVHNKVR--HLEA 590

Query: 521 LGSLTGLKVLCLAGNNISGSLPTSM-ANMTSLSSLVISQNHFTGPLPN-----NLPNSLE 574
            G+   L  L L  N I   +P    A    +  L  S N     +PN     ++   + 
Sbjct: 591 FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYV-MG 647

Query: 575 TFNVSYNDFSGAVPENLRKFPSSSF 599
           + + SYN                  
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKG 672

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  217 bits (556), Expect = 8e-64
 Identities = 83/312 (26%), Positives = 138/312 (44%), Gaps = 23/312 (7%)

Query: 22  SQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVC----NGGNVAGVVLD 77
            QD  ALL+ KK + N      L+SW   +   D C  +W G++C        V  + L 
Sbjct: 5   PQDKQALLQIKKDLGNPT---TLSSWLPTT---DCCNRTWLGVLCDTDTQTYRVNNLDLS 58

Query: 78  NLGLSAAADLSV-FSNLSMLVKLSMSN-NSISGVIPDNIGDFKSLEFLDVSDNLFSSSLP 135
            L L     +    +NL  L  L +   N++ G IP  I     L +L ++    S ++P
Sbjct: 59  GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118

Query: 136 SGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLV-Y 194
             + ++++L  L  + N  SG +P S+S L ++  +    N  SG++P +    + L   
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178

Query: 195 LNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSS 254
           + +S N  + +IP  F   L L  +D   N L+G     F    N   I  + N      
Sbjct: 179 MTISRNRLTGKIPPTFAN-LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD- 236

Query: 255 SQKFLP--GLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFV 312
               L   GLS+++  L+L  N++ G+L     L   + L  L++S+N L GE+P    +
Sbjct: 237 ----LGKVGLSKNLNGLDLRNNRIYGTLPQ--GLTQLKFLHSLNVSFNNLCGEIPQGGNL 290

Query: 313 YELQVLKLSNNR 324
               V   +NN+
Sbjct: 291 QRFDVSAYANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  188 bits (481), Expect = 2e-53
 Identities = 76/300 (25%), Positives = 128/300 (42%), Gaps = 39/300 (13%)

Query: 320 LSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS----TNLHMLNLSS-NGLT 374
             N  + G + +      +  + +LDLS  NL     +  S      L+ L +   N L 
Sbjct: 33  CCNRTWLGVLCDTD--TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 375 GELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHL 434
           G +P                   L+       + YL ++  +++G+IP+   Q   L  L
Sbjct: 91  GPIP--------------PAIAKLT------QLHYLYITHTNVSGAIPDFLSQIKTLVTL 130

Query: 435 NLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTL-QELHLADNLLTGVL 493
           + S+N+LS +LP  I     L  +    N + G    +  + S L   + ++ N LTG +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190

Query: 494 DFSPPSVSN--LQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSL 551
              PP+ +N  L  +DLS N L G      GS    + + LA N+++  L   +    +L
Sbjct: 191 ---PPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNL 246

Query: 552 SSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPE--NLRKFPSSSFYPGNSKLS 607
           + L +  N   G LP  L     L + NVS+N+  G +P+  NL++F  S++   N  L 
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYA-NNKCLC 305

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  178 bits (454), Expect = 6e-50
 Identities = 73/342 (21%), Positives = 127/342 (37%), Gaps = 64/342 (18%)

Query: 133 SLPSGIGKLESLQN----LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGS--LPPAL 186
            +   +G   +L +           + G++ D+ +    + +LDLS  +      +P +L
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 187 TRLNNLVYLNLSS-NGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDF 245
             L  L +L +   N     IP     +  L  L      + G +      +     +DF
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 246 SGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGE 305
           S N   G+     LP           S++ L              NL  +    N+++G 
Sbjct: 133 SYNALSGT-----LP----------PSISSLP-------------NLVGITFDGNRISGA 164

Query: 306 LPG--FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--T 361
           +P    +F      + +S NR +G IP       +L L  +DLS N L G  S++     
Sbjct: 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTF---ANLNLAFVDLSRNMLEGDASVLFGSDK 221

Query: 362 NLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSI 421
           N   ++L+ N L  +L  +               G         N+  LDL  N + G++
Sbjct: 222 NTQKIHLAKNSLAFDLGKV---------------GLSK------NLNGLDLRNNRIYGTL 260

Query: 422 PEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFN 463
           P+   Q   L+ LN+S N+L   +P+     Q+  V   + N
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  114 bits (288), Expect = 6e-28
 Identities = 43/189 (22%), Positives = 78/189 (41%), Gaps = 32/189 (16%)

Query: 410 LDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPF 469
            D       G + +   Q  R+N+L+LS  +L    P             +         
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP-------------IP------SS 71

Query: 470 LTNLLNSSTLQELHLAD-NLLTGVLDFSPPSV---SNLQVLDLSHNRLNGYFPDRLGSLT 525
           L NL     L  L++   N L G +   PP++   + L  L ++H  ++G  PD L  + 
Sbjct: 72  LANL---PYLNFLYIGGINNLVGPI---PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125

Query: 526 GLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPN---NLPNSLETFNVSYND 582
            L  L  + N +SG+LP S++++ +L  +    N  +G +P+   +      +  +S N 
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185

Query: 583 FSGAVPENL 591
            +G +P   
Sbjct: 186 LTGKIPPTF 194

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 85.3 bits (212), Expect = 5e-18
 Identities = 38/126 (30%), Positives = 59/126 (46%), Gaps = 5/126 (3%)

Query: 476 SSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNG--YFPDRLGSLTGLKVLCLA 533
           SS L      +    GVL  +      +  LDLS   L      P  L +L  L  L + 
Sbjct: 25  SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIG 84

Query: 534 G-NNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPEN 590
           G NN+ G +P ++A +T L  L I+  + +G +P+ L    +L T + SYN  SG +P +
Sbjct: 85  GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144

Query: 591 LRKFPS 596
           +   P+
Sbjct: 145 ISSLPN 150

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  229 bits (586), Expect = 4e-63
 Identities = 123/646 (19%), Positives = 228/646 (35%), Gaps = 86/646 (13%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQN 146
            V   L+   +L +S N I  V   +    + L+ L++       ++       L +L+ 
Sbjct: 18  QVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRI 77

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP--ALTRLNNLVYLNLSSNGFSK 204
           L L  +    L PD+  GL  +  L L     S ++        L  L  L+LS N    
Sbjct: 78  LDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS 137

Query: 205 -RIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNAS--HIDFSGNMFVGSSSQKFLPG 261
             +   F  +  L+ +DF  N++    + E   L   +      + N      S  +   
Sbjct: 138 LYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197

Query: 262 LSQ----SVQYLNLSLNQLTG----------SLVNGGELQLFENLKVLDLSYNQLTGELP 307
           ++      ++ L++S N  T           S      L L  ++      ++ +  +  
Sbjct: 198 MNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPD 256

Query: 308 GFNFV----YELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--T 361
              F       ++ L LS+      + + + +    L   L+L+ N ++           
Sbjct: 257 QNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKV-LNLAYNKINKIADEAFYGLD 314

Query: 362 NLHMLNLSSNGLT-------GELPLLTGSCAVLDLSNNQFEGNLSRILKW-GNIEYLDLS 413
           NL +LNLS N L          LP +      +DL  N       +  K+   ++ LDL 
Sbjct: 315 NLQVLNLSYNLLGELYSSNFYGLPKVA----YIDLQKNHIAIIQDQTFKFLEKLQTLDLR 370

Query: 414 RNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLD-GPFLTN 472
            N LT            +  + LS N L  +LPK+ +    + + +    +LD   FL  
Sbjct: 371 DNALT-----TIHFIPSIPDIFLSGNKL-VTLPKINLTANLIHLSENRLENLDILYFLLR 424

Query: 473 LLNSSTLQELHLADNLLTGVL-DFSPPSVSNLQVLDLSHNRLNGYF-----PDRLGSLTG 526
           + +   LQ L L  N  +    D +P    +L+ L L  N L   +      D    L+ 
Sbjct: 425 VPH---LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481

Query: 527 LKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGA 586
           L+VL L  N ++   P   +++T+L  L ++ N  T    N+LP +LE  ++S N     
Sbjct: 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAP 541

Query: 587 VPENLRKFPSSSF---------------------------YPGNSKLSFPGGAPGSG--N 617
            P+                                      P +    +P    G    +
Sbjct: 542 NPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFS 601

Query: 618 FPAENSNGKPISTIVKVIIIVSCVIALIILILLAIFIHYVRISRRM 663
              E  + + +   +K  + + C + L + ++  + +   R    +
Sbjct: 602 LSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFCFI 647

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  159 bits (405), Expect = 3e-40
 Identities = 81/446 (18%), Positives = 155/446 (34%), Gaps = 86/446 (19%)

Query: 148 SLAGNNFSGL--IPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            +A   F  L  +P     L + + L LS N        +   L  L  L L S      
Sbjct: 7   RIAFYRFCNLTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63

Query: 206 IPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQ 264
           I +  F  +  L++LD   +K+   L  + F                     + L  L  
Sbjct: 64  IDKEAFRNLPNLRILDLGSSKIY-FLHPDAF---------------------QGLFHL-- 99

Query: 265 SVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLT--GELPGFNFVYELQVLKLSN 322
               L L    L+ +++  G  +  + L  LDLS NQ+      P F  +  L+ +  S+
Sbjct: 100 --FELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS 157

Query: 323 NRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTG 382
           N+      ++L       L+   L+AN+L   VS+                         
Sbjct: 158 NQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWG---------------------- 195

Query: 383 SCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLS 442
                               +   +E LD+S N  T            ++      N++S
Sbjct: 196 --------------KCMNPFRNMVLEILDVSGNGWT------------VDITGNFSNAIS 229

Query: 443 SSLPKVIIQYQKLRVLDLSFNHLDGPFLTNL--LNSSTLQELHLADNLLTGVLDFSPPSV 500
            S    +I    +      F+++  P       L  S+++ L L+   +  +      ++
Sbjct: 230 KSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL 289

Query: 501 SNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNH 560
            +L+VL+L++N++N    +    L  L+VL L+ N +     ++   +  ++ + + +NH
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349

Query: 561 FTGPLPNNLPN--SLETFNVSYNDFS 584
                         L+T ++  N  +
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  153 bits (388), Expect = 3e-38
 Identities = 84/432 (19%), Positives = 146/432 (33%), Gaps = 68/432 (15%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFK--SLEFLDVSDNLFSSSLPSGIGKLES 143
                     ++      ++I     +        S+  LD+S     S        L+ 
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291

Query: 144 LQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFS 203
           L+ L+LA N  + +  ++  GL ++Q L+LS+N            L  + Y++L  N  +
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351

Query: 204 KRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLS 263
               + F+ +  LQ LD   N L          + +   I  SGN          LP ++
Sbjct: 352 IIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKL------VTLPKIN 400

Query: 264 QSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVY--ELQVLKLS 321
            +   ++LS N+L  +L     L    +L++L L+ N+ +             L+ L L 
Sbjct: 401 LTANLIHLSENRLE-NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG 459

Query: 322 NNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLT 381
            N        +L      +   L                ++L +L L+ N L        
Sbjct: 460 ENMLQLAWETELCWD---VFEGL----------------SHLQVLYLNHNYLN------- 493

Query: 382 GSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSL 441
                  L    F            +  L L+ N LT  +         L  L++S N L
Sbjct: 494 ------SLPPGVFSHL-------TALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQL 538

Query: 442 SSSLPKVIIQYQKLRVLDLSFNHL----DGPFLTNLLNSSTLQELHLADNLLTGVLDFSP 497
            +  P V      L VLD++ N      +     N LN + +       +    +    P
Sbjct: 539 LAPNPDVF---VSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPAD----IYCVYP 591

Query: 498 PSVSNLQVLDLS 509
            S S + +  LS
Sbjct: 592 DSFSGVSLFSLS 603

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  223 bits (571), Expect = 5e-63
 Identities = 101/525 (19%), Positives = 178/525 (33%), Gaps = 50/525 (9%)

Query: 102 SNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDS 161
              +    IPDN+    S + LD+S N               LQ L L+      +   +
Sbjct: 15  MELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71

Query: 162 VSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDF 221
              L  + +L L+ N        A + L++L  L       +         +  L+ L+ 
Sbjct: 72  YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131

Query: 222 HGNKL-DGHLDGEFFLLTNASHIDFSGNMFVGSSSQKF--LPGLSQSVQYLNLSLNQLTG 278
             N +    L   F  LTN  H+D S N            L  +      L+LSLN +  
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191

Query: 279 SLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYELQVLKLSNNRFSGF-----IPN 331
             +  G  +    L  L L  N  +  +       +  L+V +L    F           
Sbjct: 192 --IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248

Query: 332 DLLKG-DSLLLTDLDLSANNLSGSVSMILS-------------------------TNLHM 365
             L+G  +L + +  L+  +      + L                               
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH 308

Query: 366 LNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLT--GSIPE 423
           L L +        L   S   L  ++N+  GN    +   ++E+LDLSRN L+  G   +
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKG-GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ 367

Query: 424 ETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDG-PFLTNLLNSSTLQEL 482
                  L +L+LS N +  ++    +  ++L  LD   ++L      +  L+   L  L
Sbjct: 368 SDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426

Query: 483 HLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDR-LGSLTGLKVLCLAGNNISGSL 541
            ++        +     +S+L+VL ++ N     F       L  L  L L+   +    
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486

Query: 542 PTSMANMTSLSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFS 584
           PT+  +++SL  L ++ N              SL+   +  N + 
Sbjct: 487 PTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  170 bits (432), Expect = 8e-45
 Identities = 95/444 (21%), Positives = 152/444 (34%), Gaps = 58/444 (13%)

Query: 81  LSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFS---SSLPSG 137
           + +      FSNL+ L  L +S+N I  +   ++     +  L++S +L     + +  G
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195

Query: 138 IGKLESLQNLSLAGNNFSGLIPDSV-SGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLN 196
             K   L  L+L  N  S  +  +   GL  ++   L    F            NL   +
Sbjct: 196 AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE--------GNLEKFD 247

Query: 197 LSSNGFSKRIPRGFELILGLQVLDFHGNKLDG---HLDGEFFLLTNASHIDFSGNMFVGS 253
            S+           E +  L + +F    LD     +   F  LTN S            
Sbjct: 248 KSA----------LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV 297

Query: 254 SSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVY 313
               +  G  Q ++ +N    Q              ++LK L  + N+          + 
Sbjct: 298 KDFSYNFGW-QHLELVNCKFGQFPT--------LKLKSLKRLTFTSNKGG-NAFSEVDLP 347

Query: 314 ELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS-TNLHMLNLSSNG 372
            L+ L LS N  S           +  L  LDLS N +    S  L    L  L+   + 
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 407

Query: 373 LTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL-RL 431
           L               +S      +L       N+ YLD+S  H            L  L
Sbjct: 408 LK-------------QMSEFSVFLSLR------NLIYLDISHTHTR-VAFNGIFNGLSSL 447

Query: 432 NHLNLSHNSLSSSLPKVIIQY-QKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLT 490
             L ++ NS   +    I    + L  LDLS   L+    T   + S+LQ L++A N L 
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507

Query: 491 GVLDFSPPSVSNLQVLDLSHNRLN 514
            V D     +++LQ + L  N  +
Sbjct: 508 SVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  122 bits (307), Expect = 7e-29
 Identities = 59/323 (18%), Positives = 101/323 (31%), Gaps = 37/323 (11%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSD--NLFSSSLPSGIGKLES 143
           D S    L  L         +   + D I  F  L  +      ++    +         
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY-NFG 305

Query: 144 LQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFS 203
            Q+L L    F          L S++ L  + N    +   +   L +L +L+LS NG S
Sbjct: 306 WQHLELVNCKFGQFPTLK---LKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLS 360

Query: 204 K--RIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPG 261
                 +       L+ LD   N +   +   F  L    H+DF  +     S       
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419

Query: 262 LSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYELQVLK 319
           L  ++ YL++S           G      +L+VL ++ N          F  +  L  L 
Sbjct: 420 LR-NLIYLDISHTHTRV--AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476

Query: 320 LSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPL 379
           LS  +    +        S L   L++++N L               ++        L  
Sbjct: 477 LSQCQLE-QLSPTAFNSLSSL-QVLNMASNQLK--------------SVPDGIFDR-LTS 519

Query: 380 LTGSCAVLDLSNNQFEGNLSRIL 402
           L      + L  N ++ +  RI 
Sbjct: 520 LQ----KIWLHTNPWDCSCPRID 538

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  104 bits (260), Expect = 4e-23
 Identities = 53/249 (21%), Positives = 87/249 (34%), Gaps = 9/249 (3%)

Query: 367 NLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKW-GNIEYLDLSRNHLTGSIPEET 425
                        L  S   LDLS N      S        ++ LDLSR  +  +I +  
Sbjct: 13  QCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA 71

Query: 426 PQFLR-LNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHL 484
            Q L  L+ L L+ N + S           L+ L     +L       + +  TL+EL++
Sbjct: 72  YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131

Query: 485 ADNLLTGV-LDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLC----LAGNNISG 539
           A NL+    L     +++NL+ LDLS N++   +   L  L  + +L     L+ N ++ 
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190

Query: 540 SLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSF 599
            +         L  L +  N  +  +       L    V          E   +    S 
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 600 YPGNSKLSF 608
             G   L+ 
Sbjct: 251 LEGLCNLTI 259

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 87.8 bits (218), Expect = 5e-18
 Identities = 33/127 (25%), Positives = 56/127 (44%), Gaps = 3/127 (2%)

Query: 76  LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLP 135
             +  L   ++ SVF +L  L+ L +S+               SLE L ++ N F  +  
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

Query: 136 SGI-GKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLV 193
             I  +L +L  L L+      L P + + L S+Q L+++ N    S+P     RL +L 
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQ 521

Query: 194 YLNLSSN 200
            + L +N
Sbjct: 522 KIWLHTN 528

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  206 bits (527), Expect = 2e-57
 Identities = 102/508 (20%), Positives = 193/508 (37%), Gaps = 51/508 (10%)

Query: 88  SVFSNL-SMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQN 146
           S+ S L + +  L +S N I+ +   ++    +L+ L +  +  ++        L SL++
Sbjct: 19  SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEH 78

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSG-SLPPALTRLNNLVYLNLSSNGFSKR 205
           L L+ N+ S L       L S++ L+L  N +    +      L NL  L + +      
Sbjct: 79  LDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSE 138

Query: 206 IPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQ 264
           I R  F  +  L  L+     L  +       + +  H+    +    +   +    +  
Sbjct: 139 IRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES--AFLLEIFADILS 196

Query: 265 SVQYLNLSLNQLTG---------SLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYEL 315
           SV+YL L    L            + +  +   F    + D S+N+L   L     + E+
Sbjct: 197 SVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV 256

Query: 316 QVLKLSNNRFSGFIPN------DLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLN 367
           +    + N    F P+      +L K +++ +  L +    L   +S + S    +  + 
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316

Query: 368 LSSNGLTG-------ELPLLTGSCAVLDLSNNQFE----GNLSRILKWGNIEYLDLSRNH 416
           + ++ +          L  L      LDLS N        N +    W +++ L LS+NH
Sbjct: 317 VENSKVFLVPCSFSQHLKSLE----FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH 372

Query: 417 LTGSIPEETPQFL---RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNL 473
           L  S+ +     L    L  L++S N+    +P      +K+R L+LS   +        
Sbjct: 373 LR-SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRVVKTCIP 430

Query: 474 LNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLA 533
               TL+ L +++N L          +  LQ L +S N+L    PD       L V+ ++
Sbjct: 431 ---QTLEVLDVSNNNLDSF----SLFLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKIS 481

Query: 534 GNNISGSLPTSMANMTSLSSLVISQNHF 561
            N +          +TSL  + +  N +
Sbjct: 482 RNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  194 bits (494), Expect = 5e-53
 Identities = 104/513 (20%), Positives = 179/513 (34%), Gaps = 39/513 (7%)

Query: 99  LSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLI 158
               + S +  IP  +    +++ LD+S N  +      +    +LQ L L  +  + + 
Sbjct: 10  CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66

Query: 159 PDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELILGL 216
            D+   L S++ LDLS N  S SL       L++L YLNL  N +        F  +  L
Sbjct: 67  GDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125

Query: 217 QVLDFHGNKLDGHLDGEFFL-LTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQ 275
           Q L     +    +    F  LT+ + ++          SQ       + + +L L L++
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS--IRDIHHLTLHLSE 183

Query: 276 LTGSLVNGGELQLFENLKVLDLSYNQLTG-ELPGFNFVYELQVLKLSNNRFSGFIPNDLL 334
                +      +  +++ L+L    L   +            +K    R S        
Sbjct: 184 SA--FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241

Query: 335 KGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLL-TGSCAVLDLSNNQ 393
           +   LL   L+LS               L   N S + +  EL  + T +   L +    
Sbjct: 242 ELLKLLRYILELSEVEFDD----CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFY 297

Query: 394 FEGNLSRILKW-GNIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPK---V 448
              +LS +      ++ + +  + +   +P    Q L  L  L+LS N +     K    
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356

Query: 449 IIQYQKLRVLDLSFNHL-----DGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNL 503
              +  L+ L LS NHL      G  L  L N   L  L ++ N     +  S      +
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN---LTSLDISRNTFH-PMPDSCQWPEKM 412

Query: 504 QVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTG 563
           + L+LS   +             L+VL ++ NN+  S       +  L  L IS+N    
Sbjct: 413 RFLNLSSTGIRVVKT---CIPQTLEVLDVSNNNLD-SFS---LFLPRLQELYISRNKLKT 465

Query: 564 PLPNNLPNSLETFNVSYNDFSGAVPENLRKFPS 596
               +L   L    +S N           +  S
Sbjct: 466 LPDASLFPVLLVMKISRNQLKSVPDGIFDRLTS 498

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  190 bits (484), Expect = 1e-51
 Identities = 86/456 (18%), Positives = 173/456 (37%), Gaps = 42/456 (9%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSS-SLPSGIGKLESLQN 146
             F +L  L  L +S+N +S +     G   SL++L++  N + +  + S    L +LQ 
Sbjct: 68  DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127

Query: 147 LSLAGNNFSGLIPDSV-SGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
           L +        I     +GL S+  L++   S       +L  + ++ +L L  +  +  
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGN--MFVGSSSQKFLPGLS 263
           +    +++  ++ L+     L         +   +S +         +   S   L  L 
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247

Query: 264 Q------SVQYLNLSLNQLT-------GSLVNGGELQLFENLKVLDLSYNQLTGELPG-F 309
           +       V++ + +LN L          +   G+++    ++ L +    L  +L   +
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV-TIRRLHIPQFYLFYDLSTVY 306

Query: 310 NFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSG-----SVSMILSTNLH 364
           + + +++ + + N++    +P    +    L   LDLS N +       S       +L 
Sbjct: 307 SLLEKVKRITVENSKVF-LVPCSFSQHLKSLEF-LDLSENLMVEEYLKNSACKGAWPSLQ 364

Query: 365 MLNLSSNGLTGELPLLTGSCA------VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLT 418
            L LS N L   +               LD+S N F            + +L+LS   + 
Sbjct: 365 TLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR 423

Query: 419 GSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSST 478
             +    PQ   L  L++S+N+L S      +   +L+ L +S N L    L +      
Sbjct: 424 -VVKTCIPQ--TLEVLDVSNNNLDS----FSLFLPRLQELYISRNKLK--TLPDASLFPV 474

Query: 479 LQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLN 514
           L  + ++ N L  V D     +++LQ + L  N  +
Sbjct: 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  160 bits (406), Expect = 1e-41
 Identities = 85/424 (20%), Positives = 156/424 (36%), Gaps = 40/424 (9%)

Query: 88  SVFSNLSMLVKLSMS-NNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQN 146
           S+F NL+ L  L +    + S +   +     SL  L++      +     +  +  + +
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN------ 200
           L+L  +  + L+      L S++ L+L   + +      L        +   +       
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236

Query: 201 -GFSKRIPRGFELILGLQVLDFHGNKLDGHL-----------DGEFFLLTNASHIDFSGN 248
                 + +    IL L  ++F    L+G             +           +     
Sbjct: 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296

Query: 249 MFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG 308
                 S  +   L + V+ + +  +++   LV     Q  ++L+ LDLS N +  E   
Sbjct: 297 YLFYDLSTVY--SLLEKVKRITVENSKVF--LVPCSFSQHLKSLEFLDLSENLMVEEYLK 352

Query: 309 ----FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLL-LTDLDLSANNLSG-SVSMILSTN 362
                     LQ L LS N     +        +L  LT LD+S N       S      
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEK 411

Query: 363 LHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIP 422
           +  LNLSS G+      +  +  VLD+SNN  + + S  L    ++ L +SRN L  ++P
Sbjct: 412 MRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD-SFSLFLP--RLQELYISRNKLK-TLP 467

Query: 423 EETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLD-----GPFLTNLLNSS 477
           + +  F  L  + +S N L S    +  +   L+ + L  N  D       +L+  LN +
Sbjct: 468 DAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKN 526

Query: 478 TLQE 481
           + +E
Sbjct: 527 SQKE 530

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  107 bits (270), Expect = 2e-24
 Identities = 49/250 (19%), Positives = 89/250 (35%), Gaps = 5/250 (2%)

Query: 363 LHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEG-NLSRILKWGNIEYLDLSRNHLTGSI 421
             + +  S   T     LT +   LDLS N+        +    N++ L L  + +  +I
Sbjct: 7   SGVCDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TI 65

Query: 422 PEETPQFLR-LNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDG-PFLTNLLNSSTL 479
             +    L  L HL+LS N LSS           L+ L+L  N        +   N + L
Sbjct: 66  EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125

Query: 480 QELHLAD-NLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNIS 538
           Q L + +    + +       +++L  L++    L  Y    L S+  +  L L  +  +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185

Query: 539 GSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSS 598
             L      ++S+  L +   +      + LP    +  +    F G+V  +        
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245

Query: 599 FYPGNSKLSF 608
                 +LS 
Sbjct: 246 LLRYILELSE 255

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  204 bits (521), Expect = 2e-57
 Identities = 99/514 (19%), Positives = 194/514 (37%), Gaps = 73/514 (14%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
            +   + L+  +K  +   +++  +     D   +  L        S    G+  L +L 
Sbjct: 16  QIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLT 71

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            ++ + N  + + P  +  L  +  + +++N  +      L  L NL  L L +N  +  
Sbjct: 72  QINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDI 127

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
            P   + +  L  L+   N +              S I     +               S
Sbjct: 128 DP--LKNLTNLNRLELSSNTI--------------SDISALSGL--------------TS 157

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRF 325
           +Q L+   NQ+T        L     L+ LD+S N+++ ++     +  L+ L  +NN+ 
Sbjct: 158 LQQLSFG-NQVTDLK----PLANLTTLERLDISSNKVS-DISVLAKLTNLESLIATNNQI 211

Query: 326 SGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPL--LTGS 383
           S   P  +L      L +L L+ N L    ++   TNL  L+L++N ++   PL  LT  
Sbjct: 212 SDITPLGILTN----LDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLT-K 266

Query: 384 CAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSS 443
              L L  NQ   N+S +     +  L+L+ N L    P        L +L L  N++S 
Sbjct: 267 LTELKLGANQIS-NISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323

Query: 444 SLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNL 503
             P  +    KL+ L    N +    +++L N + +  L    N ++ +   +  +++ +
Sbjct: 324 ISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA--NLTRI 377

Query: 504 QVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTG 563
             L L+         +   +++    +      +    P ++++  S +   I+ N    
Sbjct: 378 TQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWN---- 431

Query: 564 PLPNNLPNSLETFN------VSYNDFSGAVPENL 591
            LP+       TF+           FSG V + L
Sbjct: 432 -LPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  176 bits (448), Expect = 1e-47
 Identities = 97/452 (21%), Positives = 168/452 (37%), Gaps = 57/452 (12%)

Query: 143 SLQNLSLAGNN-FSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNG 201
            L + ++  +   + +  D+   L       L   + + ++    T L+ +  L     G
Sbjct: 2   PLGSATITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57

Query: 202 FSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPG 261
                  G E +  L  ++F  N+L          LT    I  + N     +    L  
Sbjct: 58  IKS--IDGVEYLNNLTQINFSNNQLTDI--TPLKNLTKLVDILMNNNQIADITPLANLTN 113

Query: 262 LSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLS 321
           L      L L  NQ+T        L+   NL  L+LS N ++  +   + +  LQ L   
Sbjct: 114 L----TGLTLFNNQITDID----PLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFG 164

Query: 322 NNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLT 381
           N   +   P   L      L  LD+S+N +S    +   TNL  L  ++N ++   PL  
Sbjct: 165 NQ-VTDLKPLANLTT----LERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL-- 217

Query: 382 GSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSL 441
                         G L+      N++ L L+ N L             L  L+L++N +
Sbjct: 218 --------------GILT------NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 255

Query: 442 SSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVS 501
           S+  P  +    KL  L L  N +    ++ L   + L  L L +N L  +   S  ++ 
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISPIS--NLK 309

Query: 502 NLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHF 561
           NL  L L  N ++   P  + SLT L+ L    N +S    +S+AN+T+++ L    N  
Sbjct: 310 NLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQI 365

Query: 562 TGPLPNNLPNSLETFNVSYNDFSGAVPENLRK 593
           +   P      +    ++   ++ A       
Sbjct: 366 SDLTPLANLTRITQLGLNDQAWTNAPVNYKAN 397

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 98.5 bits (246), Expect = 1e-21
 Identities = 44/213 (20%), Positives = 84/213 (39%), Gaps = 18/213 (8%)

Query: 385 AVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSS 444
           +     +      +             L + ++T ++ +      ++  L      + S 
Sbjct: 5   SATITQDTPIN-QIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS- 60

Query: 445 LPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQ 504
               +     L  ++ S N L    +T L N + L ++ + +N +  +   +  +++NL 
Sbjct: 61  -IDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITPLA--NLTNLT 115

Query: 505 VLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGP 564
            L L +N++    P  L +LT L  L L+ N IS    ++++ +TSL  L    N  T  
Sbjct: 116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDL 170

Query: 565 LP-NNLPNSLETFNVSYNDFSGAVPENLRKFPS 596
            P  NL   LE  ++S N  S      L K  +
Sbjct: 171 KPLANLTT-LERLDISSNKVSD--ISVLAKLTN 200

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  193 bits (492), Expect = 7e-55
 Identities = 95/295 (32%), Positives = 152/295 (51%), Gaps = 32/295 (10%)

Query: 770  TLTPEELSRA-----PAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRK-EFAKEA 823
              +  EL  A        +LGR   G  Y+  L +G  + VK L+E   +  + +F  E 
Sbjct: 19   RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 824  KKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLK 883
            +  +   H N++ LRG+   PT+  +L++  Y++ GS+AS L +RP  + PPL W +R +
Sbjct: 79   EMISMAVHRNLLRLRGFCMTPTE--RLLVYPYMANGSVASCLRERPESQ-PPLDWPKRQR 135

Query: 884  IAVDVARGLNYLHFDRAVP---HGNLKATNILLDGPDLNARVADYCLHRLMTQAGT---- 936
            IA+  ARGL YLH D   P   H ++KA NILLD  +  A V D+ L +LM    T    
Sbjct: 136  IALGSARGLAYLH-DHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMDYKDTHVTT 193

Query: 937  -IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGA-GV 994
             +      G +G+ APE  ++     S K+DV+ +GV+LLEL+TG+ A D+        V
Sbjct: 194  AV-----RGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 995  DLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP 1048
             L DW++  + E       D     ++     ++ +++++ +AL C + S  ERP
Sbjct: 247  MLLDWVKGLLKEKKLEALVD----VDLQGNYKDEEVEQLIQVALLCTQSSPMERP 297

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  191 bits (487), Expect = 7e-53
 Identities = 117/499 (23%), Positives = 180/499 (36%), Gaps = 82/499 (16%)

Query: 92  NLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKL---------- 141
           + + L +    +++++  +P    + KS      + + +  + P G G+           
Sbjct: 9   SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67

Query: 142 ---ESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLS 198
                   L L     S L P+    L   +SL  S NS +  LP     L +L+  N +
Sbjct: 68  CLDRQAHELELNNLGLSSL-PELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNN 122

Query: 199 SNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKF 258
               S       +L   L+ L    N+L+  L  E    +    ID   N        K 
Sbjct: 123 LKALS-------DLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSL------KK 167

Query: 259 LPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVL 318
           LP L  S++++    NQL   L     L     L  +    N L  +LP  +    L+ +
Sbjct: 168 LPDLPPSLEFIAAGNNQLE-ELPELQNLP---FLTAIYADNNSLK-KLP--DLPLSLESI 220

Query: 319 KLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELP 378
              NN          L      LT +    N L     +    +L  LN+  N LT +LP
Sbjct: 221 VAGNNILEELPELQNLPF----LTTIYADNNLLKTLPDLP--PSLEALNVRDNYLT-DLP 273

Query: 379 LLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSH 438
            L  S   LD+S N F   LS +    N+ YL+ S N +  S+ +  P    L  LN+S+
Sbjct: 274 ELPQSLTFLDVSENIFS-GLSELP--PNLYYLNASSNEIR-SLCDLPPS---LEELNVSN 326

Query: 439 NSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGV------ 492
           N L   LP +     +L  L  SFNHL    +  L     L++LH+  N L         
Sbjct: 327 NKL-IELPALP---PRLERLIASFNHLA--EVPELP--QNLKQLHVEYNPLREFPDIPES 378

Query: 493 ---------LDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPT 543
                    L   P    NL+ L +  N L   FPD   S+  L++       +      
Sbjct: 379 VEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDLRMN---SERVVDPYEF 434

Query: 544 SMANMTSLSSLVISQNHFT 562
           +      L   V   +H  
Sbjct: 435 AHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  152 bits (386), Expect = 1e-39
 Identities = 85/402 (21%), Positives = 152/402 (37%), Gaps = 59/402 (14%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSL 149
             +L  L+  + +  ++S + P        LE+L VS+N     LP  +     L+ + +
Sbjct: 110 PQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQL-EKLPE-LQNSSFLKIIDV 160

Query: 150 AGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRG 209
             N+   L         S++ +   +N     LP  L  L  L  +   +N     + + 
Sbjct: 161 DNNSLKKLP----DLPPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNN----SLKKL 210

Query: 210 FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYL 269
            +L L L+ +    N L+  L  E   L   + I    N+       K LP L  S++ L
Sbjct: 211 PDLPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLL------KTLPDLPPSLEAL 262

Query: 270 NLSLNQLTGSLVNGGEL-QLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGF 328
           N+  N LT       +L +L ++L  LD+S N  +  L        L  L  S+N     
Sbjct: 263 NVRDNYLT-------DLPELPQSLTFLDVSENIFS-GLS--ELPPNLYYLNASSNEIRS- 311

Query: 329 IPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLD 388
           + +         L +L++S N L    ++     L  L  S N L  E+P L  +   L 
Sbjct: 312 LCDLPPS-----LEELNVSNNKLIELPALP--PRLERLIASFNHLA-EVPELPQNLKQLH 363

Query: 389 LSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKV 448
           +  N        I    ++E L ++ +HL   +PE       L  L++  N L    P +
Sbjct: 364 VEYNPLR-EFPDIP--ESVEDLRMN-SHLA-EVPEL---PQNLKQLHVETNPL-REFPDI 414

Query: 449 IIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLT 490
               + +  L ++   +  P+      +  L++     +   
Sbjct: 415 P---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  141 bits (358), Expect = 5e-36
 Identities = 83/395 (21%), Positives = 137/395 (34%), Gaps = 69/395 (17%)

Query: 207 PRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSV 266
           PR       LQ    H + L   +  E   + + +    + + +  ++          +V
Sbjct: 5   PRNVSNTF-LQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 267 QYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFS 326
             L   L++                   L+L+   L+  LP       L+ L  S N  +
Sbjct: 63  SRLRDCLDR---------------QAHELELNNLGLS-SLP--ELPPHLESLVASCNSLT 104

Query: 327 GFIPNDL--LKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT-----GELPL 379
             +P     LK     L   + +   LS      L   L  L +S+N L           
Sbjct: 105 -ELPELPQSLKS----LLVDNNNLKALSD-----LPPLLEYLGVSNNQLEKLPELQNSSF 154

Query: 380 LTGSCAVLDLSNNQFEGNLSRILKW-GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSH 438
           L     ++D+ NN     L ++     ++E++    N L   +PE       L  +   +
Sbjct: 155 LK----IIDVDNNS----LKKLPDLPPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADN 204

Query: 439 NSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPP 498
           NSL   LP +      L  +    N L+   L  L N   L  ++  +NLL  +    P 
Sbjct: 205 NSLKK-LPDLP---LSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTL----PD 254

Query: 499 SVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQ 558
              +L+ L++  N L    P+   SLT L V     + +S   P       +L  L  S 
Sbjct: 255 LPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASS 306

Query: 559 NHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRK 593
           N     L +  P+ LE  NVS N     +P    +
Sbjct: 307 NEIRS-LCDLPPS-LEELNVSNNKLI-ELPALPPR 338

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  141 bits (358), Expect = 6e-36
 Identities = 81/381 (21%), Positives = 136/381 (35%), Gaps = 74/381 (19%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
            L    N S L  + + NNS+   +PD      SLEF+   +N     LP  +  L  L 
Sbjct: 145 KLPELQNSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQL-EELPE-LQNLPFLT 198

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            +    N+   L        +S++S+   +N       P L  L  L  +   +N     
Sbjct: 199 AIYADNNSLKKLPD----LPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-T 251

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
           +P   +L   L+ L+   N L                                LP L QS
Sbjct: 252 LP---DLPPSLEALNVRDNYL------------------------------TDLPELPQS 278

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRF 325
           + +L++S N  +  L       L  NL  L+ S N++   L        L+ L +SNN+ 
Sbjct: 279 LTFLDVSENIFS-GLSE-----LPPNLYYLNASSNEIR-SLCD--LPPSLEELNVSNNKL 329

Query: 326 SGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCA 385
              +P    +     L  L  S N+L+  V  +   NL  L++  N L  E P +  S  
Sbjct: 330 I-ELPALPPR-----LERLIASFNHLA-EVPELP-QNLKQLHVEYNPLR-EFPDIPESVE 380

Query: 386 VLDLSNNQFEGNLSRILKW-GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSS 444
            L +++     +L+ + +   N++ L +  N L    P+       +  L ++   +   
Sbjct: 381 DLRMNS-----HLAEVPELPQNLKQLHVETNPLR-EFPDIPES---VEDLRMNSERVVDP 431

Query: 445 LPKVIIQYQKLRVLDLSFNHL 465
                    KL       +H 
Sbjct: 432 YEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 77.7 bits (192), Expect = 5e-15
 Identities = 30/188 (15%), Positives = 52/188 (27%), Gaps = 28/188 (14%)

Query: 421 IPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQ 480
           I         L       ++L + +P      +       +++  +            + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 481 ELHLADNLLTG--VLDFS-------PPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLC 531
              L D L      L+ +       P    +L+ L  S N L    P+   SL  L V  
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDN 120

Query: 532 LAGNNISGSLPT---------------SMANMTSLSSLVISQNHFTGPLPNNLPNSLETF 576
                +S   P                 + N + L  + +  N     LP+  P+ LE  
Sbjct: 121 NNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDLPPS-LEFI 178

Query: 577 NVSYNDFS 584
               N   
Sbjct: 179 AAGNNQLE 186

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  178 bits (453), Expect = 1e-49
 Identities = 81/316 (25%), Positives = 140/316 (44%), Gaps = 29/316 (9%)

Query: 754  SPDRLVGELHFLDDTLTLTPEELSRA-----PAEVLGRSSHGTSYRATLENGMFLTVKWL 808
              D L        ++  +   +L  A        ++G    G  Y+  L +G  + +K  
Sbjct: 12   INDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR 71

Query: 809  REGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS-DYISPGSLASFLYD 867
                ++  +EF  E +  +  RHP++V L G+     +  ++IL   Y+  G+L   LY 
Sbjct: 72   TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD---ERNEMILIYKYMENGNLKRHLYG 128

Query: 868  RPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL 927
                    ++W QRL+I +  ARGL+YLH  RA+ H ++K+ NILLD  +   ++ D+ +
Sbjct: 129  S-DLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINILLDE-NFVPKITDFGI 185

Query: 928  HRLMTQAG-----TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRC 982
             +  T+       T+      G LGY  PE         + KSDVY+FGV+L E+L  R 
Sbjct: 186  SKKGTELDQTHLSTVV----KGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARS 239

Query: 983  AGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR 1042
            A          V+L +W       G      +  V P + +    + +++    A++C+ 
Sbjct: 240  AIVQSLPREM-VNLAEWAVESHNNGQ----LEQIVDPNLADKIRPESLRKFGDTAVKCLA 294

Query: 1043 -SVSERPGIKTIYEDL 1057
             S  +RP +  +   L
Sbjct: 295  LSSEDRPSMGDVLWKL 310

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  176 bits (447), Expect = 2e-47
 Identities = 66/498 (13%), Positives = 146/498 (29%), Gaps = 78/498 (15%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLS 148
           +  N +      ++++S+   +        +++ LD+S N  S    + +     L+ L+
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 149 LAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPR 208
           L+ N     +   +  L ++++LDL++N         L    ++  L+ ++N  S+    
Sbjct: 65  LSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCS 117

Query: 209 GFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQY 268
             +   G + +    NK+    D +    +                           VQY
Sbjct: 118 RGQ---GKKNIYLANNKITMLRDLDEGCRSR--------------------------VQY 148

Query: 269 LNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGF 328
           L+L LN++  ++         + L+ L+L YN +  ++ G     +L+ L LS+N+    
Sbjct: 149 LDLKLNEID-TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNK---- 202

Query: 329 IPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT------GELPLLTG 382
                       L  +     +            +  ++L +N L            L  
Sbjct: 203 ------------LAFMGPEFQSA---------AGVTWISLRNNKLVLIEKALRFSQNLE- 240

Query: 383 SCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLS 442
                DL  N F     R     N     +++  +     +   +       +       
Sbjct: 241 ---HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297

Query: 443 SSLPKVIIQYQKLRVLDLSFNHLDGPFLTNL----LNSSTLQELHLADNLLTGVLDFSPP 498
                   +   L+  + +     G     L     N +  +E+         V+D    
Sbjct: 298 DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTL 357

Query: 499 SVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQ 558
                  L+     L+    +   +   L             L  +    + L  L    
Sbjct: 358 RKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIV 416

Query: 559 NHFTGPLPNNLPNSLETF 576
             +               
Sbjct: 417 KRYEEMYVEQQSVQNNAI 434

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  140 bits (355), Expect = 2e-35
 Identities = 62/454 (13%), Positives = 133/454 (29%), Gaps = 37/454 (8%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNL 147
           +  +  + L  L++S+N +   +   +    +L  LD+++N         +    S++ L
Sbjct: 52  ADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-----LLVGPSIETL 104

Query: 148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIP 207
             A NN S +      G    +++ L++N  +          + + YL+L  N       
Sbjct: 105 HAANNNISRVSCSRGQGK---KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161

Query: 208 RGFELILG-LQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSV 266
                    L+ L+   N +   + G+         +D S N    +         +  V
Sbjct: 162 AELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKL--AFMGPEFQSAA-GV 216

Query: 267 QYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFS 326
            +++L  N+L   +     L+  +NL+  DL  N          F    +V  ++     
Sbjct: 217 TWISLRNNKLV-LI--EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273

Query: 327 GFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAV 386
                +  +     L             +    +  L  L    + L             
Sbjct: 274 KLTGQNEEECTVPTLGHYG---AYCCEDLPAPFADRLIALKRKEHAL------------- 317

Query: 387 LDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLP 446
           L    ++ E              +D  +      I + T +      L     +L   + 
Sbjct: 318 LSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377

Query: 447 KVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVL 506
                + +L                    S       +        ++      + ++  
Sbjct: 378 NGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDW 437

Query: 507 DLSHNRLNGYFPD--RLGSLTGLKVLCLAGNNIS 538
           D+  ++      +  RL  L G   L LA  N +
Sbjct: 438 DMYQHKETQLAEENARLKKLNGEADLALASANAT 471

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  126 bits (319), Expect = 8e-31
 Identities = 56/414 (13%), Positives = 126/414 (30%), Gaps = 26/414 (6%)

Query: 87  LSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQN 146
           +        +  L  +NN+IS V        +  + + +++N  +       G    +Q 
Sbjct: 92  VQELLVGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQY 148

Query: 147 LSLAGNNFSGL-IPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
           L L  N    +   +  +   +++ L+L +N     +   +     L  L+LSSN  +  
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-F 205

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
           +   F+   G+  +    NKL   ++       N  H D  GN F   + + F     + 
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTG-ELPGFNFVYELQVLKLSNNR 324
                ++   +    + G   +      +             P  + +  L+  + +   
Sbjct: 265 ---QTVAKQTVKK--LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLS 319

Query: 325 FSGFIPNDLLKGDSLL--LTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPLL 380
             G     L           ++D         +  +         L      L  ++   
Sbjct: 320 GQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNG 379

Query: 381 TGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNS 440
                    ++ + +G L + +    +++    ++ L                     N+
Sbjct: 380 RR-------AHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNN 432

Query: 441 LSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLL-NSSTLQELHLADNLLTGVL 493
                     +  +L   +     L+G     L   ++TLQEL + +  L   L
Sbjct: 433 AIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLASQL 486

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 88.8 bits (220), Expect = 2e-18
 Identities = 39/189 (20%), Positives = 73/189 (38%), Gaps = 20/189 (10%)

Query: 420 SIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTL 479
           +I E      R     ++ +SL  +L  +      ++ LDLS N L      +L   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 480 QELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISG 539
           + L+L+ N+L   LD    S+S L+ LDL++N +       L     ++ L  A NNIS 
Sbjct: 61  ELLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 540 SLPTSMANMTSLSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLRKFPSS 597
            +  S        ++ ++ N  T     +      ++  ++  N         +     +
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN--------EIDTVNFA 162

Query: 598 SFYPGNSKL 606
                +  L
Sbjct: 163 ELAASSDTL 171

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  170 bits (434), Expect = 2e-47
 Identities = 80/302 (26%), Positives = 129/302 (42%), Gaps = 41/302 (13%)

Query: 774  EELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQ----RKEFAKEAKKFANI 829
            E         +G    G  Y+  + N   + VK L   V       +++F +E K  A  
Sbjct: 29   ERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC 87

Query: 830  RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
            +H N+V L G+       +  ++  Y+  GSL   L    G   PPL+W  R KIA   A
Sbjct: 88   QHENLVELLGFSS--DGDDLCLVYVYMPNGSLLDRLSCLDGT--PPLSWHMRCKIAQGAA 143

Query: 890  RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ----------AGTIEQ 939
             G+N+LH +    H ++K+ NILLD     A+++D+ L R   +           GT   
Sbjct: 144  NGINFLH-ENHHIHRDIKSANILLDE-AFTAKISDFGLARASEKFAQTVMTSRIVGTT-- 199

Query: 940  ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDW 999
                    Y APE         + KSD+Y+FGV+LLE++TG  A D          L D 
Sbjct: 200  -------AYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREP---QLLLDI 246

Query: 1000 MQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058
             +    E       +  +  +M + A    ++ +  +A +C+    ++RP IK + + L 
Sbjct: 247  KEEIEDEEKT---IEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

Query: 1059 SI 1060
             +
Sbjct: 303  EM 304

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  171 bits (435), Expect = 5e-47
 Identities = 70/385 (18%), Positives = 141/385 (36%), Gaps = 58/385 (15%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
            +   ++L+  ++  +   S++ V+     + +S+  L V+    +S    GI  L +L+
Sbjct: 14  QIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLE 69

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            L+L GN  + + P  +S LV + +L +  N  +     AL  L NL  L L+ +  S  
Sbjct: 70  YLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDI 125

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
            P     +  +  L+   N     L      +T                           
Sbjct: 126 SP--LANLTKMYSLNLGANHNLSDLS-PLSNMTG-------------------------- 156

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRF 325
           + YL ++ +++         +    +L  L L+YNQ+   +     +  L       N+ 
Sbjct: 157 LNYLTVTESKVKDV----TPIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQI 211

Query: 326 SGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT-----GELPLL 380
           +   P   +      L  L +  N ++    +   + L  L + +N ++      +L  L
Sbjct: 212 TDITPVANMTR----LNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDINAVKDLTKL 267

Query: 381 TGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNS 440
                +L++ +NQ   ++S +     +  L L+ N L     E       L  L LS N 
Sbjct: 268 K----MLNVGSNQIS-DISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322

Query: 441 LSSSLPKVIIQYQKLRVLDLSFNHL 465
           ++   P  +    K+   D +   +
Sbjct: 323 ITDIRP--LASLSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  166 bits (424), Expect = 1e-45
 Identities = 74/395 (18%), Positives = 137/395 (34%), Gaps = 50/395 (12%)

Query: 144 LQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFS 203
              L+      + + PD+   L       L   S +         L ++  L ++    +
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 204 KRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLS 263
             I  G E +  L+ L+ +GN++          L   +++    N     S+ + L  L 
Sbjct: 58  S-IQ-GIEYLTNLEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNKITDISALQNLTNL- 112

Query: 264 QSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNN 323
              + L L+ + ++        L     +  L+L  N    +L   + +  L  L ++ +
Sbjct: 113 ---RELYLNEDNISDIS----PLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTES 165

Query: 324 RFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGS 383
           +     P   L      L  L L+ N +     +   T+LH      N +T   P+    
Sbjct: 166 KVKDVTPIANLTD----LYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDITPV---- 217

Query: 384 CAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSS 443
                        N++       +  L +  N +T   P       +L  L +  N +S 
Sbjct: 218 ------------ANMT------RLNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQISD 257

Query: 444 SLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNL 503
                +    KL++L++  N +    ++ L N S L  L L +N L          ++NL
Sbjct: 258 --INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313

Query: 504 QVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNIS 538
             L LS N +    P  L SL+ +     A   I 
Sbjct: 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  155 bits (393), Expect = 2e-41
 Identities = 67/343 (19%), Positives = 141/343 (41%), Gaps = 34/343 (9%)

Query: 259 LPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVL 318
              L++      L    +T  +      +  E++  L ++  ++   + G  ++  L+ L
Sbjct: 18  DADLAE-GIRAVLQKASVTDVV----TQEELESITKLVVAGEKVA-SIQGIEYLTNLEYL 71

Query: 319 KLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT---- 374
            L+ N+ +   P   L      LT+L +  N ++   ++   TNL  L L+ + ++    
Sbjct: 72  NLNGNQITDISPLSNLVK----LTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP 127

Query: 375 -GELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNH 433
              L  +      L+L  N    +LS +     + YL ++ + +    P        L  
Sbjct: 128 LANLTKMY----SLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPIA--NLTDLYS 181

Query: 434 LNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVL 493
           L+L++N +    P  +     L       N +    +T + N + L  L + +N +T + 
Sbjct: 182 LSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLS 237

Query: 494 DFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSS 553
             +  ++S L  L++  N+++    + +  LT LK+L +  N IS    + + N++ L+S
Sbjct: 238 PLA--NLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNS 291

Query: 554 LVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVP-ENLRK 593
           L ++ N         +    +L T  +S N  +   P  +L K
Sbjct: 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSK 334

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  146 bits (371), Expect = 2e-38
 Identities = 59/339 (17%), Positives = 124/339 (36%), Gaps = 35/339 (10%)

Query: 264 QSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNN 323
            ++  L   +NQ+                    L    +T  +     +  +  L ++  
Sbjct: 3   ATLATLPAPINQIF-------PDADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGE 54

Query: 324 RFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT-----GELP 378
           + +     + L      L  L+L+ N ++    +     L  L + +N +T       L 
Sbjct: 55  KVASIQGIEYLTN----LEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITDISALQNLT 110

Query: 379 LLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSH 438
            L      L L+ +     +S +     +  L+L  NH   S          LN+L ++ 
Sbjct: 111 NLR----ELYLNEDNISD-ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTE 164

Query: 439 NSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPP 498
           + +    P  I     L  L L++N ++   ++ L + ++L       N +T +   +  
Sbjct: 165 SKVKDVTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITPVA-- 218

Query: 499 SVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQ 558
           +++ L  L + +N++    P  L +L+ L  L +  N IS     ++ ++T L  L +  
Sbjct: 219 NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGS 274

Query: 559 NHFTGPLP-NNLPNSLETFNVSYNDFSGAVPENLRKFPS 596
           N  +     NNL   L +  ++ N       E +    +
Sbjct: 275 NQISDISVLNNLSQ-LNSLFLNNNQLGNEDMEVIGGLTN 312

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  133 bits (336), Expect = 5e-34
 Identities = 52/289 (17%), Positives = 113/289 (39%), Gaps = 44/289 (15%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
           D+S   NL+ L +L ++ ++IS + P  + +   +  L++  N   S   S +  +  L 
Sbjct: 102 DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLN 158

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            L++  +    + P  ++ L  + SL L++N         L  L +L Y     N  +  
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDI 214

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
            P     +  L  L    NK+              + +    N+                
Sbjct: 215 TP--VANMTRLNSLKIGNNKI--------------TDLSPLANL--------------SQ 244

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRF 325
           + +L +  NQ++        ++    LK+L++  NQ++ ++   N + +L  L L+NN+ 
Sbjct: 245 LTWLEIGTNQISDI----NAVKDLTKLKMLNVGSNQIS-DISVLNNLSQLNSLFLNNNQL 299

Query: 326 SGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT 374
                  +    +  LT L LS N+++    +   + +   + ++  + 
Sbjct: 300 GNEDMEVIGGLTN--LTTLFLSQNHITDIRPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 84.9 bits (211), Expect = 1e-17
 Identities = 32/119 (26%), Positives = 52/119 (43%), Gaps = 6/119 (5%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
           DLS  +NLS L  L +  N IS +  + + D   L+ L+V  N  S    S +  L  L 
Sbjct: 235 DLSPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLN 290

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSK 204
           +L L  N       + + GL ++ +L LS N  +      L  L+ +   + ++    K
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI--RPLASLSKMDSADFANQVIKK 347

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 50.2 bits (121), Expect = 2e-06
 Identities = 16/103 (15%), Positives = 33/103 (32%), Gaps = 6/103 (5%)

Query: 479 LQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNIS 538
              L      +  +  F    ++      L    +          L  +  L +AG  ++
Sbjct: 2   AATLATLPAPINQI--FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 539 GSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYN 581
            S+   +  +T+L  L ++ N  T   P +    L    +  N
Sbjct: 58  -SIQ-GIEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTN 98

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 44.1 bits (105), Expect = 2e-04
 Identities = 17/92 (18%), Positives = 31/92 (33%), Gaps = 5/92 (5%)

Query: 503 LQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFT 562
              L      +N  FP     L       L   +++  +      + S++ LV++     
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 563 GPLPNNLPNSLETFNVSYNDFSGAVP-ENLRK 593
                    +LE  N++ N  +   P  NL K
Sbjct: 58  SIQGIEYLTNLEYLNLNGNQITDISPLSNLVK 89

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  164 bits (417), Expect = 1e-42
 Identities = 96/532 (18%), Positives = 180/532 (33%), Gaps = 67/532 (12%)

Query: 76  LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLP 135
           +D               L+    ++  N+++  +    +  F+ +E L+++D      + 
Sbjct: 34  IDMQTQDVYFGFE-DITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-ID 91

Query: 136 SGI-GKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLV 193
           +       ++Q L +  N    L P     +  +  L L  N  S SLP         L 
Sbjct: 92  TYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLT 150

Query: 194 YLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVG 252
            L++S+N    RI    F+    LQ L    N+L  H+D    L+ +  H + S N+   
Sbjct: 151 TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-- 204

Query: 253 SSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFV 312
                 L     +V+ L+ S N +   +       +   L +L L +N LT +       
Sbjct: 205 ----STLAIPI-AVEELDASHNSIN-VV----RGPVNVELTILKLQHNNLT-DTAWLLNY 253

Query: 313 YELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSS 370
             L  + LS N     I           L  L +S N L  ++++       L +L+LS 
Sbjct: 254 PGLVEVDLSYNELE-KIMYHPFVKMQ-RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSH 310

Query: 371 NGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLR 430
           N L               +  NQ + +         +E L L  N +  ++   T     
Sbjct: 311 NHLL-------------HVERNQPQFD--------RLENLYLDHNSIV-TLKLST--HHT 346

Query: 431 LNHLNLSHNSLS-SSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQE-------L 482
           L +L LSHN    +SL  +     +  V D   +      L + L      +        
Sbjct: 347 LKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQ 406

Query: 483 HLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLP 542
           ++A   +   +  +    S    ++   +  +         L G + L    N +     
Sbjct: 407 YIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELR---- 462

Query: 543 TSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKF 594
              A +  L++  I Q      L   +  +L  + +  +  + +     + F
Sbjct: 463 ---AEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVF 511

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  155 bits (393), Expect = 1e-39
 Identities = 81/421 (19%), Positives = 142/421 (33%), Gaps = 53/421 (12%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLN 190
             + S +       ++ +               L + + +   +++    LP   L    
Sbjct: 17  KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFR 75

Query: 191 NLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNM 249
            +  LNL+       I    F     +Q L    N +  +L    F              
Sbjct: 76  QVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVF-------------- 119

Query: 250 FVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG- 308
                  + +P L      L L  N L+   +  G       L  L +S N L   +   
Sbjct: 120 -------QNVPLL----TVLVLERNDLS--SLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 165

Query: 309 -FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLN 367
            F     LQ L+LS+NR +  +   L+      L   ++S N LS   ++ +   +  L+
Sbjct: 166 TFQATTSLQNLQLSSNRLT-HVDLSLIPS----LFHANVSYNLLS---TLAIPIAVEELD 217

Query: 368 LSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQ 427
            S N +      +     +L L +N    + + +L +  +  +DLS N L   I      
Sbjct: 218 ASHNSINVVRGPVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFV 275

Query: 428 FL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLAD 486
            + RL  L +S+N L  +L         L+VLDLS NHL      N      L+ L+L  
Sbjct: 276 KMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDH 333

Query: 487 NLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMA 546
           N +         +   L+ L LSHN  +            +    +   +    +   + 
Sbjct: 334 NSIV---TLKLSTHHTLKNLTLSHNDWD--CNSLRALFRNVARPAVDDADQHCKIDYQLE 388

Query: 547 N 547
           +
Sbjct: 389 H 389

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 77.3 bits (190), Expect = 1e-14
 Identities = 36/204 (17%), Positives = 64/204 (31%), Gaps = 25/204 (12%)

Query: 405 GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNH 464
           G   Y    R      I            +++   +         I     +++    + 
Sbjct: 3   GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST 62

Query: 465 L----DGPF--LTNL------------------LNSSTLQELHLADNLLTGVLDFSPPSV 500
           +             +                    + T+Q+L++  N +  +      +V
Sbjct: 63  MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 122

Query: 501 SNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNH 560
             L VL L  N L+        +   L  L ++ NN+      +    TSL +L +S N 
Sbjct: 123 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182

Query: 561 FTGPLPNNLPNSLETFNVSYNDFS 584
            T  +  +L  SL   NVSYN  S
Sbjct: 183 LTH-VDLSLIPSLFHANVSYNLLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 65.7 bits (160), Expect = 5e-11
 Identities = 23/173 (13%), Positives = 58/173 (33%), Gaps = 12/173 (6%)

Query: 430 RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLL 489
           +  +           +   +        + +     D  F    +  +  + +   ++ +
Sbjct: 4   QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63

Query: 490 TGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMT 549
             +      S   +++L+L+  ++             ++ L +  N I    P    N+ 
Sbjct: 64  RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 123

Query: 550 SLSSLVISQNHFT---GPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSF 599
            L+ LV+ +N  +     + +N P  L T ++S N        NL +    +F
Sbjct: 124 LLTVLVLERNDLSSLPRGIFHNTPK-LTTLSMSNN--------NLERIEDDTF 167

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  158 bits (402), Expect = 2e-42
 Identities = 80/426 (18%), Positives = 141/426 (33%), Gaps = 53/426 (12%)

Query: 127 DNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-A 185
                  + S +       ++ +               L + + +   +++    LP   
Sbjct: 6   RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL 64

Query: 186 LTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHID 244
           L     +  LNL+       I    F     +Q L    N +                  
Sbjct: 65  LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR----------------Y 107

Query: 245 FSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTG 304
              ++F        +P L      L L  N L+   +  G       L  L +S N L  
Sbjct: 108 LPPHVFQN------VPLL----TVLVLERNDLS--SLPRGIFHNTPKLTTLSMSNNNLE- 154

Query: 305 ELPG--FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTN 362
            +    F     LQ L+LS+NR +  +   L+      L   ++S N LS   ++ +   
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLTH-VDLSLIPS----LFHANVSYNLLS---TLAIPIA 206

Query: 363 LHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIP 422
           +  L+ S N +      +     +L L +N    + + +L +  +  +DLS N L   I 
Sbjct: 207 VEELDASHNSINVVRGPVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KIM 264

Query: 423 EETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQE 481
                 + RL  L +S+N L  +L         L+VLDLS NHL      N      L+ 
Sbjct: 265 YHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLEN 322

Query: 482 LHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSL 541
           L+L  N +         +   L+ L LSHN  +            +    +   +    +
Sbjct: 323 LYLDHNSIV---TLKLSTHHTLKNLTLSHNDWD--CNSLRALFRNVARPAVDDADQHCKI 377

Query: 542 PTSMAN 547
              + +
Sbjct: 378 DYQLEH 383

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  156 bits (397), Expect = 1e-41
 Identities = 86/407 (21%), Positives = 146/407 (35%), Gaps = 61/407 (14%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSL 149
                +   + +   +             + + +   ++       + +     ++ L+L
Sbjct: 17  LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 76

Query: 150 AGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPR 208
                  +   + +   +IQ L +  N+    LPP     +  L  L L  N  S  +PR
Sbjct: 77  NDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPR 134

Query: 209 G-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQ 267
           G F     L  L    N L+  ++ + F                     +    L    Q
Sbjct: 135 GIFHNTPKLTTLSMSNNNLE-RIEDDTF---------------------QATTSL----Q 168

Query: 268 YLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSG 327
            L LS N+LT  +    +L L  +L   ++SYN L+  L        ++ L  S+N  + 
Sbjct: 169 NLQLSSNRLT-HV----DLSLIPSLFHANVSYNLLS-TLAIPIA---VEELDASHNSIN- 218

Query: 328 FIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT-------GELPLL 380
            +   +       LT L L  NNL+ +  ++    L  ++LS N L         ++  L
Sbjct: 219 VVRGPVNVE----LTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 274

Query: 381 TGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNS 440
                 L +SNN+             ++ LDLS NHL   +    PQF RL +L L HNS
Sbjct: 275 E----RLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS 329

Query: 441 LSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADN 487
           +  +L      +  L+ L LS N  D   L  L     +    + D 
Sbjct: 330 I-VTLKLST--HHTLKNLTLSHNDWDCNSLRALF--RNVARPAVDDA 371

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  148 bits (376), Expect = 7e-39
 Identities = 76/354 (21%), Positives = 143/354 (40%), Gaps = 39/354 (11%)

Query: 242 HIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQ 301
           HID              L       + +    + +    +    L  F  +++L+L+  Q
Sbjct: 27  HIDMQTQDVYFGFEDITLNNQ----KIVTFKNSTMRK--LPAALLDSFRQVELLNLNDLQ 80

Query: 302 LTGELPGFNFVY--ELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMIL 359
           +  E+  + F Y   +Q L +  N    ++P  + +   LL T L L  N+LS     I 
Sbjct: 81  IE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLL-TVLVLERNDLSSLPRGIF 137

Query: 360 S--TNLHMLNLSSNGLT-------GELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYL 410
                L  L++S+N L             L      L LS+N+       ++   ++ + 
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQ----NLQLSSNRLTHVDLSLIP--SLFHA 191

Query: 411 DLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFL 470
           ++S N L+ ++         +  L+ SHNS++  +   +    +L +L L  N+L     
Sbjct: 192 NVSYNLLS-TLAIPI----AVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTD--T 241

Query: 471 TNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVL 530
             LLN   L E+ L+ N L  ++      +  L+ L +S+NRL          +  LKVL
Sbjct: 242 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300

Query: 531 CLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFS 584
            L+ N++   +  +      L +L +  N     L  +  ++L+   +S+ND+ 
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  135 bits (341), Expect = 3e-34
 Identities = 68/342 (19%), Positives = 121/342 (35%), Gaps = 46/342 (13%)

Query: 262 LSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYELQVLK 319
           L     + ++ ++  T  +  G E     N K++    + +  +LP    +   ++++L 
Sbjct: 17  LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLN 75

Query: 320 LSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGEL 377
           L++ +    I          +   L +  N +      +      L +L L  N L+   
Sbjct: 76  LNDLQIE-EIDTYAFAYAHTI-QKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS--- 130

Query: 378 PLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLR-LNHLNL 436
                      L    F            +  L +S N+L   I ++T Q    L +L L
Sbjct: 131 ----------SLPRGIFHNT-------PKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQL 172

Query: 437 SHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFS 496
           S N L+     +I     L   ++S+N L     + L     ++EL  + N +  V    
Sbjct: 173 SSNRLTHVDLSLI---PSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVV---R 221

Query: 497 PPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVI 556
            P    L +L L HN L       L +  GL  + L+ N +   +      M  L  L I
Sbjct: 222 GPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 279

Query: 557 SQNHFTG--PLPNNLPNSLETFNVSYNDFSGAVPENLRKFPS 596
           S N           +P  L+  ++S+N     V  N  +F  
Sbjct: 280 SNNRLVALNLYGQPIPT-LKVLDLSHNHLL-HVERNQPQFDR 319

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  128 bits (324), Expect = 5e-32
 Identities = 79/360 (21%), Positives = 130/360 (36%), Gaps = 95/360 (26%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQN 146
             F+    + KL M  N+I  + P    +   L  L +  N   SSLP GI      L  
Sbjct: 87  YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTT 145

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRI 206
           LS++ NN   +  D+     S+Q+L LS N  +  +  +L  + +L + N+S N  S   
Sbjct: 146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLST-- 200

Query: 207 PRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSV 266
                + + ++ LD   N +              + +                  ++  +
Sbjct: 201 ---LAIPIAVEELDASHNSI--------------NVVR---------------GPVNVEL 228

Query: 267 QYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYELQVLKLSNNR 324
             L L  N LT +      L  +  L  +DLSYN+L  ++    F  +  L+ L +SNNR
Sbjct: 229 TILKLQHNNLTDT----AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNR 283

Query: 325 FSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSC 384
                           L  L+L    +           L +L+LS N L           
Sbjct: 284 ----------------LVALNLYGQPI---------PTLKVLDLSHNHLL---------- 308

Query: 385 AVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSS 444
               +  NQ + +         +E L L  N +  ++   T     L +L LSHN    +
Sbjct: 309 ---HVERNQPQFD--------RLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCN 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 76.2 bits (188), Expect = 1e-14
 Identities = 27/118 (22%), Positives = 52/118 (44%), Gaps = 5/118 (4%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
           D +   N   LV++ +S N +  ++       + LE L +S+N    +L      + +L+
Sbjct: 240 DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLK 298

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFS 203
            L L+ N+    +  +      +++L L HNS   +L  +    + L  L LS N + 
Sbjct: 299 VLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 67.0 bits (164), Expect = 1e-11
 Identities = 25/170 (14%), Positives = 60/170 (35%), Gaps = 16/170 (9%)

Query: 433 HLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGV 492
                +  + S+L    +       + +     D  F    +  +  + +   ++ +  +
Sbjct: 5   PRQPEYKCIDSNLQYDCV----FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 60

Query: 493 LDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLS 552
                 S   +++L+L+  ++             ++ L +  N I    P    N+  L+
Sbjct: 61  PAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 120

Query: 553 SLVISQNHFT---GPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSF 599
            LV+ +N  +     + +N P  L T ++S N        NL +    +F
Sbjct: 121 VLVLERNDLSSLPRGIFHNTPK-LTTLSMSNN--------NLERIEDDTF 161

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  152 bits (386), Expect = 2e-41
 Identities = 45/204 (22%), Positives = 93/204 (45%), Gaps = 15/204 (7%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRG 839
             L  +  G  ++     G  + VK L+      ++ ++F +E  +     HPNV+ + G
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH-FD 898
               P      +++ ++  GSL + L++        +  +Q +K A+D+ARG+ +LH  +
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFALDMARGMAFLHTLE 131

Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPE-LAASK 957
             +P   L + ++++D  D+ AR++   +       G +          + APE L    
Sbjct: 132 PLIPRHALNSRSVMIDE-DMTARISMADVKFSFQSPGRM------YAPAWVAPEALQKKP 184

Query: 958 KPHPSFKSDVYAFGVILLELLTGR 981
           +      +D+++F V+L EL+T  
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  157 bits (398), Expect = 1e-40
 Identities = 95/506 (18%), Positives = 184/506 (36%), Gaps = 51/506 (10%)

Query: 99  LSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLI 158
           +  S N +  V P ++   +    L++S N  S    S I  L  L+ L ++ N    L 
Sbjct: 5   VDRSKNGLIHV-PKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 159 PDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRG--FELILGL 216
                    ++ LDLSHN     +        NL +L+LS N F   +P    F  +  L
Sbjct: 62  ISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAF-DALPICKEFGNMSQL 117

Query: 217 QVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQL 276
           + L      L+         L  +  +   G  +      + L   +    ++    N+ 
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKE 177

Query: 277 TGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKG 336
              +++           V +L  + +   L      Y L +L                K 
Sbjct: 178 FHFILD------VSVKTVANLELSNIKCVLEDNKCSYFLSIL---------AKLQTNPKL 222

Query: 337 DSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCA--------VLD 388
            +L L +++ + N+    + ++  T +   ++S+  L G+L       +        +  
Sbjct: 223 SNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQ 282

Query: 389 LSNNQFEGNLSRILKW-GNIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLP 446
           + ++ F    S I +   N+   + + +     +    P  +    HL+ S+N L+ ++ 
Sbjct: 283 VVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR-MVHMLCPSKISPFLHLDFSNNLLTDTVF 341

Query: 447 KVIIQYQKLRVLDLSFNHL----DGPFLTNLLNSSTLQELHLADNLLTGVLDFSP-PSVS 501
           +      +L  L L  N L        +T  + S  LQ+L ++ N ++            
Sbjct: 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKS--LQQLDISQNSVSYDEKKGDCSWTK 399

Query: 502 NLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHF 561
           +L  L++S N L       L     +KVL L  N I  S+P  +  + +L  L ++ N  
Sbjct: 400 SLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456

Query: 562 TGPLPN----NLPNSLETFNVSYNDF 583
              +P+     L  SL+   +  N +
Sbjct: 457 KS-VPDGIFDRLT-SLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  148 bits (376), Expect = 6e-38
 Identities = 106/500 (21%), Positives = 183/500 (36%), Gaps = 59/500 (11%)

Query: 88  SVFSNLSMLVK-LSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQ 145
            V  +LS     L++S N IS +   +I     L  L +S N     L   +    + L+
Sbjct: 14  HVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRI-QYLDISVFKFNQELE 72

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPA--LTRLNNLVYLNLSSNGFS 203
            L L+ N    +        V+++ LDLS N+F  +LP       ++ L +L LS+    
Sbjct: 73  YLDLSHNKLVKISCHP---TVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLE 128

Query: 204 KRIPRGFELILGLQVLDFHGNKLDGHLDGEFF--LLTNASHIDFSGNM---FVGSSSQKF 258
           K        +   +VL   G       D E      T + HI F  N    F+   S K 
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188

Query: 259 LPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGE----LPGFNFVYE 314
           +  L  S     L  N+ +  L    +LQ    L  L L+  + T      +    +   
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248

Query: 315 LQVLKLSNNRFSGFIPNDLLKGDSLLLTDL---DLSANNLSGSVSMILS--TNLHMLNLS 369
           +    +SN +  G +           L  L    + ++      S I    +N+++ N +
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308

Query: 370 SNGLTGELPLLTGSCA---VLDLSNNQFEGNLSRIL-KWGNIEYLDLSRNHLTGSIPEET 425
            +G      L     +    LD SNN     +         +E L L  N L   + +  
Sbjct: 309 VSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIA 367

Query: 426 PQFLRLN---HLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQEL 482
               ++     L++S NS+S    K               +              +L  L
Sbjct: 368 EMTTQMKSLQQLDISQNSVSYDEKKGD------------CSWT-----------KSLLSL 404

Query: 483 HLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLP 542
           +++ N+LT  +    P    ++VLDL  N++    P ++  L  L+ L +A N +  S+P
Sbjct: 405 NMSSNILTDTIFRCLP--PRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVP 460

Query: 543 TSM-ANMTSLSSLVISQNHF 561
             +   +TSL  + +  N +
Sbjct: 461 DGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  136 bits (344), Expect = 9e-34
 Identities = 86/481 (17%), Positives = 167/481 (34%), Gaps = 45/481 (9%)

Query: 122 FLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGS 181
            +D S N     +P  + +      L+++ N  S L    +  L  ++ L +SHN     
Sbjct: 4   LVDRSKNGLIH-VPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-Y 59

Query: 182 LPP-ALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDG-HLDGEFFLLTN 239
           L          L YL+LS N   K I       + L+ LD   N  D   +  EF  ++ 
Sbjct: 60  LDISVFKFNQELEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQ 116

Query: 240 ASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSY 299
              +  S            LP    ++  + L L +  G   +   LQ   +     L  
Sbjct: 117 LKFLGLSTTHL---EKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQ---DFNTESLHI 170

Query: 300 NQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMIL 359
              T +   F+F+ ++ V  ++N   S           S  L+ L     N       + 
Sbjct: 171 VFPTNKE--FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN-----PKLS 223

Query: 360 STNLHMLNLSSNGLTGELPLLTGSCAV-LDLSNNQFEGNLSRILKWGNIEYLDLSRNHLT 418
           +  L+ +  + N     L L+  +      +SN + +G         +    D S   L 
Sbjct: 224 NLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQ-------LDFRDFDYSGTSLK 276

Query: 419 GSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSST 478
                       L+   +  +        +   +  + + + + +      +      S 
Sbjct: 277 -----------ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325

Query: 479 LQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLN--GYFPDRLGSLTGLKVLCLAGNN 536
              L  ++NLLT  +  +   ++ L+ L L  N+L       +    +  L+ L ++ N+
Sbjct: 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS 385

Query: 537 ISGSLPTSM-ANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFP 595
           +S        +   SL SL +S N  T  +   LP  ++  ++  N    ++P+ + K  
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLE 444

Query: 596 S 596
           +
Sbjct: 445 A 445

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  115 bits (289), Expect = 8e-27
 Identities = 76/443 (17%), Positives = 145/443 (32%), Gaps = 68/443 (15%)

Query: 76  LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLP 135
           L      A      F N+S L  L +S   +       I      + L V    +     
Sbjct: 97  LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED 156

Query: 136 SGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYL 195
                 E LQ+ +                  S+  +  ++  F   L  ++  + NL   
Sbjct: 157 -----PEGLQDFN----------------TESLHIVFPTNKEFHFILDVSVKTVANLELS 195

Query: 196 NLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSS 255
           N+       +               +  + L              ++I+ + N F+    
Sbjct: 196 NIKCVLEDNK-------------CSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ 242

Query: 256 QKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVL---DLSYNQLTGELPG-FNF 311
             +      +V Y ++S  +L G L          +LK L    +  +         +  
Sbjct: 243 LVWHT----TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEI 298

Query: 312 VYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLS 369
              + +   + +  +  +        S     LD S N L+ +V       T L  L L 
Sbjct: 299 FSNMNIKNFTVSG-TRMVHMLCPSKIS-PFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356

Query: 370 SNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL 429
            N L  EL  +                      +  +++ LD+S+N ++    +    + 
Sbjct: 357 MNQLK-ELSKIAEM-----------------TTQMKSLQQLDISQNSVSYDEKKGDCSWT 398

Query: 430 -RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNL 488
             L  LN+S N L+ ++ + +    +++VLDL  N +       ++    LQEL++A N 
Sbjct: 399 KSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQ 455

Query: 489 LTGVLDFSPPSVSNLQVLDLSHN 511
           L  V D     +++LQ + L  N
Sbjct: 456 LKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 97.6 bits (243), Expect = 3e-21
 Identities = 45/250 (18%), Positives = 93/250 (37%), Gaps = 18/250 (7%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDF-----KSLEFLDVSDNLFSSSLPSGIGK 140
            +      + +   S+SN  + G +     D+     K+L    V  ++F          
Sbjct: 239 RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEI 298

Query: 141 LESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN 200
             ++   +   +    +     S +     LD S+N  + ++      L  L  L L  N
Sbjct: 299 FSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358

Query: 201 GFSK--RIPRGFELILGLQVLDFHGNKLDGHL-DGEFFLLTNASHIDFSGNMFVGSSSQK 257
              +  +I      +  LQ LD   N +      G+     +   ++ S N+   +  + 
Sbjct: 359 QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418

Query: 258 FLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYEL 315
             P +    + L+L  N++    +    ++L E L+ L+++ NQL   +P   F+ +  L
Sbjct: 419 LPPRI----KVLDLHSNKIKS--IPKQVVKL-EALQELNVASNQLK-SVPDGIFDRLTSL 470

Query: 316 QVLKLSNNRF 325
           Q + L  N +
Sbjct: 471 QKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 70.3 bits (172), Expect = 1e-12
 Identities = 43/209 (20%), Positives = 69/209 (33%), Gaps = 9/209 (4%)

Query: 406 NIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL 465
               L++S+N+++     +     +L  L +SHN +      V    Q+L  LDLS N L
Sbjct: 22  KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81

Query: 466 DGPFLTNLLNSSTLQELHLADNLLTGVLDFSP-PSVSNLQVLDLSHNRLNGYFPDRLGSL 524
                   +N   L+ L L+ N    +       ++S L+ L LS   L       +  L
Sbjct: 82  VKISCHPTVN---LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138

Query: 525 TGLKVLCLAGNNIS-----GSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVS 579
              KVL + G           L         +      + HF   +      +LE  N+ 
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198

Query: 580 YNDFSGAVPENLRKFPSSSFYPGNSKLSF 608
                      L         P  S L+ 
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTL 227

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  150 bits (382), Expect = 2e-40
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 17/202 (8%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
           EV+GR + G   +A       + +K +      +RK F  E ++ + + HPN+V L G  
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 842 WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
             P      ++ +Y   GSL + L+       P  T A  +   +  ++G+ YLH  +  
Sbjct: 71  LNPV----CLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124

Query: 902 P--HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
              H +LK  N+LL       ++ D+     +    T       G   + APE+      
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN----KGSAAWMAPEVFEGS-- 178

Query: 960 HPSFKSDVYAFGVILLELLTGR 981
           + S K DV+++G+IL E++T R
Sbjct: 179 NYSEKCDVFSWGIILWEVITRR 200

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  147 bits (372), Expect = 2e-39
 Identities = 52/214 (24%), Positives = 104/214 (48%), Gaps = 25/214 (11%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREG-------VAKQRKEFAKEAKKFANIRHPN 833
           + +G+   G  ++   +++   + +K L  G       + ++ +EF +E    +N+ HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 834 VVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLN 893
           +V L G    P      ++ +++  G L   L D+      P+ W+ +L++ +D+A G+ 
Sbjct: 85  IVKLYGLMHNP----PRMVMEFVPCGDLYHRLLDKAH----PIKWSVKLRLMLDIALGIE 136

Query: 894 YLH-FDRAVPHGNLKATNILLDGPDLN----ARVADYCLHRLMTQAGTIEQILDAGVLGY 948
           Y+   +  + H +L++ NI L   D N    A+VAD+ L +    + +       G   +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL----LGNFQW 192

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGRC 982
            APE   +++   + K+D Y+F +IL  +LTG  
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  153 bits (389), Expect = 6e-39
 Identities = 80/359 (22%), Positives = 125/359 (34%), Gaps = 50/359 (13%)

Query: 236 LLTNASHIDFSGNMFVGSSSQKFLP-GLSQSVQYLNLSLNQLTGSLVNGGEL-QLFENLK 293
           L    + ++   +          LP  L   +  L +  N LT        L  L   L+
Sbjct: 38  LNNGNAVLNVGESGL------TTLPDCLPAHITTLVIPDNNLT-------SLPALPPELR 84

Query: 294 VLDLSYNQLTGELP-GFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLS 352
            L++S NQLT  LP     + EL +                       L  L +  N L+
Sbjct: 85  TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG---------LCKLWIFGNQLT 134

Query: 353 GSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDL 412
               +     L  L++S N L   LP L      L   NNQ   +L  +     ++ L +
Sbjct: 135 SLPVLP--PGLQELSVSDNQLA-SLPALPSELCKLWAYNNQLT-SLPMLP--SGLQELSV 188

Query: 413 SRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTN 472
           S N L  S+P        L  L   +N L+S LP +      L+ L +S N L    L  
Sbjct: 189 SDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPALP---SGLKELIVSGNRLTS--LPV 238

Query: 473 LLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCL 532
           L +   L+EL ++ N LT +    P   S L  L +  N+L    P+ L  L+    + L
Sbjct: 239 LPSE--LKELMVSGNRLTSL----PMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291

Query: 533 AGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENL 591
            GN +S           + +               + P      +++  D+     E  
Sbjct: 292 EGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGE 349

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  141 bits (357), Expect = 5e-35
 Identities = 81/401 (20%), Positives = 130/401 (32%), Gaps = 85/401 (21%)

Query: 96  LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFS 155
              L++  + ++  +PD +     +  L + DN   +SLP+   +   L+ L ++GN  +
Sbjct: 42  NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNL-TSLPALPPE---LRTLEVSGNQLT 94

Query: 156 GLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILG 215
            L P    GL+ +                       L  L +  N  +  +P    L  G
Sbjct: 95  SL-PVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLP---VLPPG 142

Query: 216 LQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQ 275
           LQ L    N+L                                LP L   +  L    NQ
Sbjct: 143 LQELSVSDNQLAS------------------------------LPALPSELCKLWAYNNQ 172

Query: 276 LTGSLVNGGEL-QLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLL 334
           LT        L  L   L+ L +S NQL   LP      EL  L   NNR +  +P    
Sbjct: 173 LT-------SLPMLPSGLQELSVSDNQLA-SLP--TLPSELYKLWAYNNRLT-SLPALPS 221

Query: 335 KGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQF 394
                 L +L +S N L+    +   + L  L +S N LT  LP+L      L +  NQ 
Sbjct: 222 G-----LKELIVSGNRLTSLPVLP--SELKELMVSGNRLT-SLPMLPSGLLSLSVYRNQL 273

Query: 395 E------GNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKV 448
                   +LS      +   ++L  N L+     +  +   +         +       
Sbjct: 274 TRLPESLIHLS------SETTVNLEGNPLS-ERTLQALR--EITSAPGYSGPIIRFDMAG 324

Query: 449 IIQYQKLRVLDLS-FNHLDGPFLTNLLNSSTLQELHLADNL 488
               ++ R L L+  + L          +         DN 
Sbjct: 325 ASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNA 365

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  123 bits (309), Expect = 5e-29
 Identities = 64/238 (26%), Positives = 99/238 (41%), Gaps = 33/238 (13%)

Query: 359 LSTNLHMLNLSSNGLTGELPL-LTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHL 417
           L+    +LN+  +GLT  LP  L      L + +N    +L  +     +  L++S N L
Sbjct: 38  LNNGNAVLNVGESGLT-TLPDCLPAHITTLVIPDNNLT-SLPALP--PELRTLEVSGNQL 93

Query: 418 TGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSS 477
           T S+P   P  L L+  +     L +           L  L +  N L    L  L    
Sbjct: 94  T-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT--SLPVLPPG- 142

Query: 478 TLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNI 537
            LQEL ++DN L  +    P   S L  L   +N+L    P      +GL+ L ++ N +
Sbjct: 143 -LQELSVSDNQLASL----PALPSELCKLWAYNNQLT-SLPM---LPSGLQELSVSDNQL 193

Query: 538 SGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSG--AVPENLRK 593
           + SLPT  + +  L       N  T  LP  LP+ L+   VS N  +    +P  L++
Sbjct: 194 A-SLPTLPSELYKLW---AYNNRLT-SLP-ALPSGLKELIVSGNRLTSLPVLPSELKE 245

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  118 bits (298), Expect = 1e-27
 Identities = 89/447 (19%), Positives = 144/447 (32%), Gaps = 80/447 (17%)

Query: 91  SNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLA 150
           +    L  L +S N ++  +P        L           +           L  L + 
Sbjct: 78  ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIF 129

Query: 151 GNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGF 210
           GN  + L P    GL   Q L +S N  + SLP   +    L  L   +N  +  +P   
Sbjct: 130 GNQLTSL-PVLPPGL---QELSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLP--- 177

Query: 211 ELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLN 270
            L  GLQ L    N+L   L      L     +    N          LP L   ++ L 
Sbjct: 178 MLPSGLQELSVSDNQL-ASLPTLPSELYK---LWAYNNRL------TSLPALPSGLKELI 227

Query: 271 LSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIP 330
           +S N+LT SL       L   LK L +S N+LT  LP       L  L +  N+ +  +P
Sbjct: 228 VSGNRLT-SLPV-----LPSELKELMVSGNRLT-SLP--MLPSGLLSLSVYRNQLT-RLP 277

Query: 331 NDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT---GELPLLTGSCAVL 387
             L+   S   T ++L  N LS   ++     +      S  +                L
Sbjct: 278 ESLIHLSS--ETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL 334

Query: 388 DLSNNQF-----EGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLS 442
            L+   +     EG  +   +W      D +               L L+ L+ + N + 
Sbjct: 335 HLAAADWLVPAREGEPAPADRWHMFGQEDNADAF-----------SLFLDRLSETENFIK 383

Query: 443 SSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQE--LHLADNLLTGVLDFSPPSV 500
            +  K        ++            L  L     L+     +A    +   D     +
Sbjct: 384 DAGFKA-------QISSW---------LAQLAEDEALRANTFAMATEATSSCEDRVTFFL 427

Query: 501 SNLQVLDLSHNRLNGYFPDRLGSLTGL 527
             ++ + L HN   G + + L +L   
Sbjct: 428 HQMKNVQLVHNAEKGQYDNDLAALVAT 454

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 57.2 bits (138), Expect = 2e-08
 Identities = 28/146 (19%), Positives = 45/146 (30%), Gaps = 12/146 (8%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNL 147
           S+    S L +L +S N ++  +P        L  L V  N  +  LP  +  L S   +
Sbjct: 235 SLPVLPSELKELMVSGNRLTS-LPMLPS---GLLSLSVYRNQLTR-LPESLIHLSSETTV 289

Query: 148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFS---GSLPPALTRLNNLVYLNLSSNGFSK 204
           +L GN  S     ++  + S          F     S P     L+      L      +
Sbjct: 290 NLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGE 349

Query: 205 RIPRG----FELILGLQVLDFHGNKL 226
             P      F             ++L
Sbjct: 350 PAPADRWHMFGQEDNADAFSLFLDRL 375

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  146 bits (371), Expect = 7e-39
 Identities = 71/327 (21%), Positives = 120/327 (36%), Gaps = 41/327 (12%)

Query: 761  ELHFLDDTLTLTPEELSRAP-----AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQ 815
              H     + L  E L          EV  R   G  ++A L    ++ VK       KQ
Sbjct: 4    HHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ-DKQ 61

Query: 816  RKEFAKEAKKFANIRHPNVVGLRGYYWGPT--QHEKLILSDYISPGSLASFLYDRPGRKG 873
              +   E      ++H N++   G     T    +  +++ +   GSL+ FL      K 
Sbjct: 62   SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL------KA 115

Query: 874  PPLTWAQRLKIAVDVARGLNYLHFDR---------AVPHGNLKATNILLDGPDLNARVAD 924
              ++W +   IA  +ARGL YLH D          A+ H ++K+ N+LL   +L A +AD
Sbjct: 116  NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIAD 174

Query: 925  YCLHRLMTQAGT-IEQILDAGVLGYRAPELA--ASKKPHPSF-KSDVYAFGVILLELLTG 980
            + L        +  +     G   Y APE+   A      +F + D+YA G++L EL + 
Sbjct: 175  FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234

Query: 981  RCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPA------AEKGMKEVL 1034
              A D    E   +   +     + +    +     V+ +   P          GM  + 
Sbjct: 235  CTAADGPVDEYM-LPFEEE----IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC 289

Query: 1035 GIALRCIR-SVSERPGIKTIYEDLSSI 1060
                 C       R     + E ++ +
Sbjct: 290  ETIEECWDHDAEARLSAGCVGERITQM 316

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  149 bits (377), Expect = 2e-38
 Identities = 100/535 (18%), Positives = 168/535 (31%), Gaps = 103/535 (19%)

Query: 91  SNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLA 150
            N +  V  +    +   +   +     +L  LD  ++  +    +GI KL  L  L   
Sbjct: 18  DNFASEVAAAFEMQATDTI---SEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICT 72

Query: 151 GNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGF 210
            NN + L    +S   ++  L    N  + +L   +T L  L YLN  +N  +K +    
Sbjct: 73  SNNITTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTK-LD--V 123

Query: 211 ELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLN 270
                L  L+   N L              + ID S N                 +  L+
Sbjct: 124 SQNPLLTYLNCARNTL--------------TEIDVSHN---------------TQLTELD 154

Query: 271 LSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIP 330
             LN+    L    ++     L  LD S+N++T EL        L  L    N  +    
Sbjct: 155 CHLNKKITKL----DVTPQTQLTTLDCSFNKIT-ELDVSQNK-LLNRLNCDTNNITKLDL 208

Query: 331 NDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLS 390
           N  ++     LT LD S+N L+  + +   T L   + S N LT            LD+S
Sbjct: 209 NQNIQ-----LTFLDCSSNKLT-EIDVTPLTQLTYFDCSVNPLT-----------ELDVS 251

Query: 391 NNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVII 450
                           +  L   +  L   I        +L +           L   + 
Sbjct: 252 TLS------------KLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VT 294

Query: 451 QYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSH 510
              +L +LD     +    L+       L  L+L +  LT  LD S    + L+ L   +
Sbjct: 295 HNTQLYLLDCQAAGITELDLSQNPK---LVYLYLNNTELT-ELDVS--HNTKLKSLSCVN 348

Query: 511 NRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLV------ISQNHFTGP 564
             +  +    +G +  L     A      ++P       SL+  V         N     
Sbjct: 349 AHIQDF--SSVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIE 405

Query: 565 LPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFPGGAPGSGNFP 619
             +       T  +++ + S   P       + +F   N  +      P     P
Sbjct: 406 PGDGGVYDQATNTITWENLSTDNPA-----VTYTFTSENGAIVGTVTTPFEAPQP 455

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  132 bits (334), Expect = 8e-33
 Identities = 84/468 (17%), Positives = 154/468 (32%), Gaps = 97/468 (20%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
           D++    L+ L KL  ++N+I+ +   ++    +L +L    N   ++L   +  L  L 
Sbjct: 56  DMTGIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKL-TNLD--VTPLTKLT 109

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            L+   N  + L    VS    +  L+ + N+ +  +   ++    L  L+   N    +
Sbjct: 110 YLNCDTNKLTKL---DVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITK 163

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
           +         L  LD   NK+              + +D S N               + 
Sbjct: 164 LD--VTPQTQLTTLDCSFNKI--------------TELDVSQN---------------KL 192

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRF 325
           +  LN   N +T  L    +L     L  LD S N+LT E+       +L     S N  
Sbjct: 193 LNRLNCDTNNIT-KL----DLNQNIQLTFLDCSSNKLT-EIDVTPLT-QLTYFDCSVNPL 245

Query: 326 SGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCA 385
           +    + L K     LT L     +L   + +  +T L            E         
Sbjct: 246 TELDVSTLSK-----LTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKIKE--------- 290

Query: 386 VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSL 445
            LD+++N              +  LD     +T  +     Q  +L +L L++  L + L
Sbjct: 291 -LDVTHNT------------QLYLLDCQAAGIT-ELDLS--QNPKLVYLYLNNTEL-TEL 333

Query: 446 PKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQV 505
              +    KL+ L     H+     +++     L     A+                +  
Sbjct: 334 D--VSHNTKLKSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQTI-----------TMPK 378

Query: 506 LDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSS 553
             L++N L       L    G  +    G+       T+     +LS+
Sbjct: 379 ETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLST 426

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 97.8 bits (244), Expect = 2e-21
 Identities = 49/313 (15%), Positives = 94/313 (30%), Gaps = 55/313 (17%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSL 149
            S   +L +L+   N+I+ +   ++     L FLD S N  +  +   +  L  L     
Sbjct: 187 VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDC 240

Query: 150 AGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRG 209
           + N  + L    VS L  + +L          +   LT    L+Y         K +   
Sbjct: 241 SVNPLTEL---DVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD-- 292

Query: 210 FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYL 269
                 L +LD     +              + +D S N                 + YL
Sbjct: 293 VTHNTQLYLLDCQAAGI--------------TELDLSQN---------------PKLVYL 323

Query: 270 NLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFI 329
            L+  +LT  L    ++     LK L      +  +      +  L     +  +     
Sbjct: 324 YLNNTELT-EL----DVSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTITMP 377

Query: 330 PNDLLKGD---SLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAV 386
              L       ++    LD   N ++         +     ++   L+ + P +T +   
Sbjct: 378 KETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTF-- 435

Query: 387 LDLSNNQFEGNLS 399
               N    G ++
Sbjct: 436 -TSENGAIVGTVT 447

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  144 bits (366), Expect = 3e-38
 Identities = 59/383 (15%), Positives = 128/383 (33%), Gaps = 78/383 (20%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLS 148
           +  N +      ++++S+   +        +++ LD+S N  S    + +     L+ L+
Sbjct: 5   IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64

Query: 149 LAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPR 208
           L+ N     +   +  L ++++LDL++N         L    ++  L+ ++N  S+    
Sbjct: 65  LSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCS 117

Query: 209 GFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQY 268
             +   G + +    NK+    D +    +                           VQY
Sbjct: 118 RGQ---GKKNIYLANNKITMLRDLDEGCRSR--------------------------VQY 148

Query: 269 LNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGF 328
           L+L LN++  ++         + L+ L+L YN +  ++ G     +L+ L LS+N+    
Sbjct: 149 LDLKLNEID-TVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNK---- 202

Query: 329 IPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT------GELPLLTG 382
                       L  +     +            +  ++L +N L            L  
Sbjct: 203 ------------LAFMGPEFQSA---------AGVTWISLRNNKLVLIEKALRFSQNLE- 240

Query: 383 SCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLS 442
                DL  N F     R     N     +++  +   +  +  +   +  L        
Sbjct: 241 ---HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCC 296

Query: 443 SSLPKVIIQYQKLRVLDLSFNHL 465
             LP         R++ L  +H 
Sbjct: 297 EDLPAPFA----DRLIALGHHHH 315

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  136 bits (345), Expect = 2e-35
 Identities = 55/361 (15%), Positives = 123/361 (34%), Gaps = 48/361 (13%)

Query: 181 SLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNA 240
           ++       N      ++ +   + +    +    ++ LD  GN L      +    T  
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 241 SHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYN 300
             ++ S N+   +   + L  L    + L+L+ N +        EL +  +++ L  + N
Sbjct: 61  ELLNLSSNVLYETLDLESLSTL----RTLDLNNNYVQ-------ELLVGPSIETLHAANN 109

Query: 301 QLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS 360
            ++  +         + + L+NN+ +     D   G    +  LDL  N +         
Sbjct: 110 NIS-RVSCSRGQ-GKKNIYLANNKITMLRDLDE--GCRSRVQYLDLKLNEID-------- 157

Query: 361 TNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGS 420
                  ++   L      L      L+L  N    ++   + +  ++ LDLS N L   
Sbjct: 158 ------TVNFAELAASSDTLE----HLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-F 205

Query: 421 IPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQ 480
           +  E      +  ++L +N L   + K +   Q L   DL  N           +  TL+
Sbjct: 206 MGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNG---------FHCGTLR 255

Query: 481 ELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRL---NGYFPDRLGSLTGLKVLCLAGNNI 537
           +    +  +  V   +   ++     + +   L     Y  + L +    +++ L  ++ 
Sbjct: 256 DFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHH 315

Query: 538 S 538
            
Sbjct: 316 H 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  125 bits (315), Expect = 2e-31
 Identities = 57/309 (18%), Positives = 110/309 (35%), Gaps = 66/309 (21%)

Query: 290 ENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSA 348
              K+  ++ + L   L       + ++ L LS N  S     DL     L    L+LS+
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL--ELLNLSS 67

Query: 349 NNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIE 408
           N L  ++ +   + L  L+L++N +  EL +                          +IE
Sbjct: 68  NVLYETLDLESLSTLRTLDLNNNYVQ-ELLVGP------------------------SIE 102

Query: 409 YLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDG- 467
            L  + N+++  +     Q  +  ++ L++N ++           +++ LDL  N +D  
Sbjct: 103 TLHAANNNIS-RVSCSRGQGKK--NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159

Query: 468 PFLTNLLNSSTLQELHLADNLLTGVLDFSPPSV--SNLQVLDLSHNRLNGYFPDRLGSLT 525
            F     +S TL+ L+L  N +  V       V  + L+ LDLS N+L            
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIYDV----KGQVVFAKLKTLDLSSNKLA----------- 204

Query: 526 GLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDF 583
                          +     +   ++ + +  N     +   L    +LE F++  N F
Sbjct: 205 --------------FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249

Query: 584 SGAVPENLR 592
                 +  
Sbjct: 250 HCGTLRDFF 258

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  106 bits (267), Expect = 3e-25
 Identities = 49/310 (15%), Positives = 100/310 (32%), Gaps = 47/310 (15%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNL 147
           +  +  + L  L++S+N +   +   +    +L  LD+++N         +    S++ L
Sbjct: 52  ADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-----LLVGPSIETL 104

Query: 148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSK-RI 206
             A NN S +      G    +++ L++N  +          + + YL+L  N       
Sbjct: 105 HAANNNISRVSCSRGQGK---KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161

Query: 207 PRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSV 266
                    L+ L+   N +   + G+                                +
Sbjct: 162 AELAASSDTLEHLNLQYNFIY-DVKGQVVF---------------------------AKL 193

Query: 267 QYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNNRF 325
           + L+LS N+L   +  G E Q    +  + L  N+L   +     F   L+   L  N F
Sbjct: 194 KTLDLSSNKLA-FM--GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249

Query: 326 SGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCA 385
                 D    +  + T    +   L+G         +  L         +LP       
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE--EECTVPTLGHYGAYCCEDLPAPFAD-R 306

Query: 386 VLDLSNNQFE 395
           ++ L ++   
Sbjct: 307 LIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  100 bits (250), Expect = 6e-23
 Identities = 37/198 (18%), Positives = 70/198 (35%), Gaps = 23/198 (11%)

Query: 406 NIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL 465
             +   ++ + L  ++         +  L+LS N LS      +  + KL +L+LS N L
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 466 DGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLT 525
                 +L + STL+ L L +N +  +         +++ L  ++N ++           
Sbjct: 71  YE--TLDLESLSTLRTLDLNNNYVQEL-----LVGPSIETLHAANNNIS-RVS--CSRGQ 120

Query: 526 GLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFT----GPLPNNLPNSLETFNVSYN 581
           G K + LA N I+          + +  L +  N         L  +    LE  N+ YN
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT-LEHLNLQYN 179

Query: 582 DFSGAVPENLRKFPSSSF 599
                    +        
Sbjct: 180 --------FIYDVKGQVV 189

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 47/260 (18%), Positives = 81/260 (31%), Gaps = 41/260 (15%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
           +     +LS L  L ++NN +       +    S+E L  ++N   S +       +  +
Sbjct: 72  ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSR--GQGKK 123

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSG-SLPPALTRLNNLVYLNLSSNGFSK 204
           N+ LA N  + L          +Q LDL  N     +        + L +LNL  N    
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183

Query: 205 RIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQ 264
            +         L+ LD   NKL   +  EF                              
Sbjct: 184 -VKGQVVFA-KLKTLDLSSNKLA-FMGPEFQSAAG------------------------- 215

Query: 265 SVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNR 324
            V +++L  N+L   +     L+  +NL+  DL  N          F    +V  ++   
Sbjct: 216 -VTWISLRNNKLV-LI--EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271

Query: 325 FSGFIPNDLLKGDSLLLTDL 344
                  +  +     L   
Sbjct: 272 VKKLTGQNEEECTVPTLGHY 291

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 27/128 (21%), Positives = 53/128 (41%), Gaps = 17/128 (13%)

Query: 474 LNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLA 533
            N +  +   + D+ L   L     S  N++ LDLS N L+      L   T L++L L+
Sbjct: 7   QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 534 GNNISGSLPTSMANMTSLSSLVISQNHFT--GPLPNNLPNSLETFNVSYNDFSGAVPENL 591
            N +       + ++++L +L ++ N+       P+     +ET + + N        N+
Sbjct: 67  SNVLY-ETL-DLESLSTLRTLDLNNNYVQELLVGPS-----IETLHAANN--------NI 111

Query: 592 RKFPSSSF 599
            +   S  
Sbjct: 112 SRVSCSRG 119

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 2/89 (2%)

Query: 497 PPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVI 556
             + +  ++  ++ + L         S   +K L L+GN +S      +A  T L  L +
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 557 SQNHFTGPLP-NNLPNSLETFNVSYNDFS 584
           S N     L   +L   L T +++ N   
Sbjct: 66  SSNVLYETLDLESLST-LRTLDLNNNYVQ 93

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  147 bits (372), Expect = 9e-38
 Identities = 84/435 (19%), Positives = 140/435 (32%), Gaps = 76/435 (17%)

Query: 119 SLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSV-SGLVSIQSLDLSHNS 177
            + ++D+S N  +    +   +L+ LQ L +       +I ++   GL S+  L L +N 
Sbjct: 31  HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 178 FSGSLPP-ALTRLNNLVYLNLSSNGF-SKRIPRG-FELILGLQVLDFHGNKLDG-HLDGE 233
           F   L   A   L NL  L L+        +    F+ +  L++L    N +        
Sbjct: 91  FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 234 FFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLK 293
           F  +     +D + N       +  L    +    L LS   L                 
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL----------------- 192

Query: 294 VLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLS 352
             D++   L  E  G       +  L LS N F   +        +              
Sbjct: 193 -QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG------------- 238

Query: 353 GSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDL 412
                   T +  L LS++   G      G     D  N  F+G     L+   ++  DL
Sbjct: 239 --------TKIQSLILSNSYNMGS---SFGHTNFKDPDNFTFKG-----LEASGVKTCDL 282

Query: 413 SRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL----DG 467
           S++ +  ++ +        L  L L+ N ++            L  L+LS N L      
Sbjct: 283 SKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSR 341

Query: 468 PF--LTNLLNSSTLQELHLADNLLTGVLDFSPPSV----SNLQVLDLSHNRLNGYFPDRL 521
            F  L        L+ L L+ N +  +             NL+ L L  N+L        
Sbjct: 342 MFENLDK------LEVLDLSYNHIRAL----GDQSFLGLPNLKELALDTNQLKSVPDGIF 391

Query: 522 GSLTGLKVLCLAGNN 536
             LT L+ + L  N 
Sbjct: 392 DRLTSLQKIWLHTNP 406

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  129 bits (327), Expect = 6e-32
 Identities = 88/425 (20%), Positives = 150/425 (35%), Gaps = 82/425 (19%)

Query: 166 VSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHG 223
             +  +DLS NS +  L   + +RL +L +L +        I    F  +  L +L    
Sbjct: 30  AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88

Query: 224 NKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNG 283
           N+      G F  L N                          ++ L L+   L G++++G
Sbjct: 89  NQFLQLETGAFNGLAN--------------------------LEVLTLTQCNLDGAVLSG 122

Query: 284 GELQLFENLKVLDLSYNQLTGELPG--FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLL 341
              +   +L++L L  N +    P   F  +    VL L+ N+       DLL       
Sbjct: 123 NFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHF 182

Query: 342 TDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRI 401
           T L LS+  L          +++   L         P    S   LDLS N F+ ++++ 
Sbjct: 183 TLLRLSSITL---------QDMNEYWLGW--EKCGNPFKNTSITTLDLSGNGFKESMAKR 231

Query: 402 LKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLS 461
                             +I     Q L L++     +S   +  K           D  
Sbjct: 232 F---------------FDAIAGTKIQSLILSNSYNMGSSFGHTNFK-----------DPD 265

Query: 462 FNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRL 521
                G      L +S ++   L+ + +  +L       ++L+ L L+ N +N    +  
Sbjct: 266 NFTFKG------LEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAF 319

Query: 522 GSLTGLKVLCLAGNNISGSLPTSM-ANMTSLSSLVISQNHFTGPLPN----NLPNSLETF 576
             LT L  L L+ N +  S+ + M  N+  L  L +S NH    L +     LPN L+  
Sbjct: 320 WGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPN-LKEL 376

Query: 577 NVSYN 581
            +  N
Sbjct: 377 ALDTN 381

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 53.2 bits (128), Expect = 3e-07
 Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 2/91 (2%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNL 147
            F  L+ L+KL++S N +  +      +   LE LD+S N   + L       L +L+ L
Sbjct: 318 AFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKEL 376

Query: 148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF 178
           +L  N    +       L S+Q + L  N +
Sbjct: 377 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  143 bits (362), Expect = 1e-37
 Identities = 73/203 (35%), Positives = 106/203 (52%), Gaps = 12/203 (5%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           E +G  S GT +RA   +G  + VK L E    A++  EF +E      +RHPN+V   G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH-FD 898
               P      I+++Y+S GSL   L+    R+   L   +RL +A DVA+G+NYLH  +
Sbjct: 102 AVTQPPNL--SIVTEYLSRGSLYRLLHKSGARE--QLDERRRLSMAYDVAKGMNYLHNRN 157

Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK 958
             + H NLK+ N+L+D      +V D+ L RL      +     AG   + APE+   + 
Sbjct: 158 PPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKAS-TFLSSKSAAGTPEWMAPEVLRDE- 214

Query: 959 PHPSFKSDVYAFGVILLELLTGR 981
              + KSDVY+FGVIL EL T +
Sbjct: 215 -PSNEKSDVYSFGVILWELATLQ 236

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  139 bits (353), Expect = 6e-37
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 41/220 (18%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREG----VAKQRKEFAKEAKKFANIRHPNVVGL 837
           E++G    G  YRA    G  + VK  R      +++  +   +EAK FA ++HPN++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 838 RGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           RG      +   L ++ ++   G L   L       G  +     +  AV +ARG+NYLH
Sbjct: 72  RGVC---LKEPNLCLVMEFARGGPLNRVL------SGKRIPPDILVNWAVQIARGMNYLH 122

Query: 897 FDRAVP--HGNLKATNILLDGP-------DLNARVADYCLHRL------MTQAGTIEQIL 941
            +  VP  H +LK++NIL+          +   ++ D+ L R       M+ AG      
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA--- 179

Query: 942 DAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                 + APE+  +     S  SDV+++GV+L ELLTG 
Sbjct: 180 ------WMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGE 211

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  139 bits (353), Expect = 7e-37
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 15/205 (7%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRG 839
           + +G  S GT Y+      +   VK L       +Q + F  E       RH N++   G
Sbjct: 30  QRIGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
           Y    T  +  I++ +    SL   L+             + + IA   ARG++YLH  +
Sbjct: 88  YS---TAPQLAIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLH-AK 139

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL-DAGVLGYRAPELAASKK 958
           ++ H +LK+ NI L   D   ++ D+ L    ++     Q    +G + + APE+   + 
Sbjct: 140 SIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 959 PHP-SFKSDVYAFGVILLELLTGRC 982
            +P SF+SDVYAFG++L EL+TG+ 
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQL 223

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  144 bits (365), Expect = 3e-36
 Identities = 108/497 (21%), Positives = 184/497 (37%), Gaps = 55/497 (11%)

Query: 88  SVFSNLSMLVK-LSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQ 145
            V  +L    K LS+S NSIS +   +I     L  L +S N    SL   +    + L+
Sbjct: 45  HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLE 103

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPA--LTRLNNLVYLNLSSNGFS 203
            L ++ N    +   S   + S++ LDLS N F   LP       L  L +L LS+  F 
Sbjct: 104 YLDVSHNRLQNI---SCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR 159

Query: 204 KRIPRGF-ELILGLQVLDFHGNKLDGHLDGEFFLL-TNASHIDFSGNMFVGSSSQKFLPG 261
           +        L L   +LD     + G       +  T   H+ F  N          +  
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNA 219

Query: 262 LSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTG------ELPGFNFVYEL 315
           L   +Q  N+ LN      +     +L     +L+++   +        +L  F +   +
Sbjct: 220 L-GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278

Query: 316 QVLKLSNNRFSGFIPNDLLKGDSLLLTDL---DLSANNLSGSVSMILS--TNLHMLNLSS 370
           + L + N   +  I  +        L  L    +       S   + S    +++  LS 
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338

Query: 371 NGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLR 430
           +       +   S +                    +  +L+ ++N  T S+ +      R
Sbjct: 339 SDTPFIHMVCPPSPS--------------------SFTFLNFTQNVFTDSVFQGCSTLKR 378

Query: 431 LNHLNLSHNSLSSSLPKV---IIQYQKLRVLDLSFNHL-DGPFLTNLLNSSTLQELHLAD 486
           L  L L  N L  +  KV         L  LD+S N L    +      + ++  L+L+ 
Sbjct: 379 LQTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSS 437

Query: 487 NLLT-GVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSM 545
           N+LT  V    PP    ++VLDL +NR+    P  +  L  L+ L +A N +  S+P  +
Sbjct: 438 NMLTGSVFRCLPP---KVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK-SVPDGV 492

Query: 546 -ANMTSLSSLVISQNHF 561
              +TSL  + +  N +
Sbjct: 493 FDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  125 bits (315), Expect = 5e-30
 Identities = 83/445 (18%), Positives = 163/445 (36%), Gaps = 38/445 (8%)

Query: 167 SIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGN 224
             ++L LS NS S  L    ++ L+ L  L LS N     +    F     L+ LD   N
Sbjct: 53  RTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHN 110

Query: 225 KLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGG 284
           +L  ++      + +  H+D S N F      K    L+  + +L LS  +    L    
Sbjct: 111 RL-QNI--SCCPMASLRHLDLSFNDFDVLPVCKEFGNLT-KLTFLGLSAAKFR-QLDLLP 165

Query: 285 ELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKL---SNNRFSGFIPNDLLKGDSLLL 341
              L  +  +LDL    + G       +    VL L    N+ FS  +   +     L L
Sbjct: 166 VAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL 225

Query: 342 TDLDLSANNLSG--SVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLS 399
           +++ L+  N     +    L+    +LN++   +                        L 
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSV---------------KLF 270

Query: 400 RILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNH-----LNLSHNSLSSSLPKVIIQYQK 454
           +      +EYL++    +T  I  E   +           ++ +     S   +   + +
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330

Query: 455 LRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLN 514
           + +  LS +      +    + S+   L+   N+ T  +     ++  LQ L L  N L 
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390

Query: 515 --GYFPDRLGSLTGLKVLCLAGNNI-SGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPN 571
                     +++ L+ L ++ N++ S +   + A   S+  L +S N  TG +   LP 
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP 450

Query: 572 SLETFNVSYNDFSGAVPENLRKFPS 596
            ++  ++  N    ++P+++    +
Sbjct: 451 KVKVLDLHNNRIM-SIPKDVTHLQA 474

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  109 bits (273), Expect = 8e-25
 Identities = 72/386 (18%), Positives = 130/386 (33%), Gaps = 28/386 (7%)

Query: 76  LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLP 135
           L             F NL+ L  L +S      +   ++     L    +  +L S  + 
Sbjct: 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184

Query: 136 SG------IGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQ--SLDLSHNSFSGSLPPALT 187
            G      I     L  +    + FS  +  SV+ L  +Q  ++ L+  +    +     
Sbjct: 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSE 244

Query: 188 RLNNLVYLNLS---SNGFSKRIPRGFELILGLQV--LDFHGNKLDGHLDGEFFLLTNASH 242
                  LN++        K   + F+      V  L+ +   +   +D E F  +  + 
Sbjct: 245 LTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL 304

Query: 243 IDFSGNMFVGSSSQKFLPGLSQS---VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSY 299
                              L      +    LS++     +          +   L+ + 
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP-FIHMVCPPSP-SSFTFLNFTQ 362

Query: 300 NQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMI 358
           N  T  +    + +  LQ L L  N    F    L+  +   L  LD+S N+L+      
Sbjct: 363 NVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDR 422

Query: 359 L---STNLHMLNLSSNGLT-GELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSR 414
               + ++ +LNLSSN LT      L     VLDL NN+       +     ++ L+++ 
Sbjct: 423 TCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVAS 482

Query: 415 NHLTGSIPEETPQFL-RLNHLNLSHN 439
           N L  S+P+     L  L ++ L  N
Sbjct: 483 NQLK-SVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  103 bits (259), Expect = 5e-23
 Identities = 60/332 (18%), Positives = 118/332 (35%), Gaps = 40/332 (12%)

Query: 28  LLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADL 87
           L   +  +  +  G +  S  + + +      ++   +  G  +  V L ++  +    +
Sbjct: 208 LFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSV 267

Query: 88  SVFSNL--SMLVKLSMSNNSISGVIPDNIGDF-----KSLEFLDVSDNLFSSSLPSGIGK 140
            +F       +  L++ N +I+  I      +     KSL    V + +F  S  +    
Sbjct: 268 KLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSV 327

Query: 141 LESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN 200
              +    L+ ++   +         S   L+ + N F+ S+    + L  L  L L  N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387

Query: 201 GFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP 260
           G  K   +   +   +  L+     L+      +                          
Sbjct: 388 GL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTC---------------------- 424

Query: 261 GLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLK 319
             ++S+  LNLS N LTGS+       L   +KVLDL  N++   +P     +  LQ L 
Sbjct: 425 AWAESILVLNLSSNMLTGSVFRC----LPPKVKVLDLHNNRIM-SIPKDVTHLQALQELN 479

Query: 320 LSNNRFSGFIPNDLLKGDSLL-LTDLDLSANN 350
           +++N+    +P+ +   D L  L  + L  N 
Sbjct: 480 VASNQLK-SVPDGVF--DRLTSLQYIWLHDNP 508

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  140 bits (355), Expect = 2e-35
 Identities = 87/447 (19%), Positives = 148/447 (33%), Gaps = 71/447 (15%)

Query: 102 SNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDS 161
                   +P+ I        LD+  N   +           L+ L L  N  S + P +
Sbjct: 19  HRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA 75

Query: 162 VSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVL 219
            + L ++++L L  N     +P    T L+NL  L++S N     +    F+ +  L+ L
Sbjct: 76  FNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSL 133

Query: 220 DFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGS 279
           +   N L               +I  S   F G      L  L    + L L    LT  
Sbjct: 134 EVGDNDL--------------VYI--SHRAFSG------LNSL----EQLTLEKCNLT-- 165

Query: 280 LVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYELQVLKLSNNRFSGFIPNDLLKGD 337
            +    L     L VL L +  +   +    F  +Y L+VL++S+  +   +  + L G 
Sbjct: 166 SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG- 223

Query: 338 SLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFE 395
            L LT L ++  NL+    + +     L  LNLS N ++              +  +   
Sbjct: 224 -LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-------------TIEGSMLH 269

Query: 396 GNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQK 454
                      ++ + L    L   +     + L  L  LN+S N L++    V      
Sbjct: 270 EL-------LRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGN 321

Query: 455 LRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLN 514
           L  L L  N    P   +       +     +         +P  V   +  D     L 
Sbjct: 322 LETLILDSN----PLACDCRLLWVFRRRWRLNFNRQQPTCATPEFVQGKEFKDFPDVLLP 377

Query: 515 GYF---PDRLGSLTGLKVLCLAGNNIS 538
            YF     R+      +V    G+ + 
Sbjct: 378 NYFTCRRARIRDRKAQQVFVDEGHTVQ 404

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  136 bits (343), Expect = 6e-34
 Identities = 65/290 (22%), Positives = 122/290 (42%), Gaps = 15/290 (5%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQN 146
             F++   L +L ++ N +S V P    +  +L  L +  N     +P G+   L +L  
Sbjct: 50  DEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLSNLTK 108

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKR 205
           L ++ N    L+      L +++SL++  N     +   A + LN+L  L L     +  
Sbjct: 109 LDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-S 166

Query: 206 IPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQ 264
           IP      + GL VL      ++   D  F  L     ++ S   ++ + +   L GL  
Sbjct: 167 IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL-- 224

Query: 265 SVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNN 323
           ++  L+++   LT   V    ++    L+ L+LSYN ++       + +  LQ ++L   
Sbjct: 225 NLTSLSITHCNLTA--VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282

Query: 324 RFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSN 371
           + +  +     +G +  L  L++S N L+     +     NL  L L SN
Sbjct: 283 QLA-VVEPYAFRGLN-YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  133 bits (337), Expect = 3e-33
 Identities = 70/353 (19%), Positives = 115/353 (32%), Gaps = 59/353 (16%)

Query: 96  LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFS 155
              L +  N I  +  D    F  LE L++++N+ S+  P     L +L+ L L  N   
Sbjct: 34  TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93

Query: 156 GLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELI 213
            +     +GL ++  LD+S N     L       L NL  L +  N     I    F  +
Sbjct: 94  LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGL 151

Query: 214 LGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSL 273
             L+ L      L              + I               L GL      L L  
Sbjct: 152 NSLEQLTLEKCNL--------------TSIPT--EALSH------LHGL----IVLRLRH 185

Query: 274 NQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVY-ELQVLKLSNNRFSGFIPND 332
             +    +     +    LKVL++S+      +         L  L +++   +  +P  
Sbjct: 186 LNINA--IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYL 242

Query: 333 LLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPLLTGSCAVLDLS 390
            ++     L  L+LS N +S     +L     L  + L    L               + 
Sbjct: 243 AVRHLV-YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-------------VVE 288

Query: 391 NNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLS 442
              F G          +  L++S N LT ++ E     +  L  L L  N L+
Sbjct: 289 PYAFRGL-------NYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  119 bits (300), Expect = 2e-28
 Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 9/241 (3%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNL 147
           VF+ LS L KL +S N I  ++     D  +L+ L+V DN     +       L SL+ L
Sbjct: 99  VFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL-VYISHRAFSGLNSLEQL 157

Query: 148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIP 207
           +L   N + +  +++S L  +  L L H + +     +  RL  L  L +S   +   + 
Sbjct: 158 TLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT 217

Query: 208 RGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQ 267
                 L L  L      L          L     ++ S N             L + +Q
Sbjct: 218 PNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLH-ELLR-LQ 275

Query: 268 YLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYELQVLKLSNNRF 325
            + L   QL    V     +    L+VL++S NQLT  L    F+ V  L+ L L +N  
Sbjct: 276 EIQLVGGQLAV--VEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332

Query: 326 S 326
           +
Sbjct: 333 A 333

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  136 bits (345), Expect = 2e-35
 Identities = 57/255 (22%), Positives = 92/255 (36%), Gaps = 32/255 (12%)

Query: 743 TAENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMF 802
              NL+ L  RS  R   +         +  E+L     E++G+   G  Y         
Sbjct: 2   PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIG--ELIGKGRFGQVYHGRWHG--- 56

Query: 803 LTV--KWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKL-ILSDYIS 857
             V  + +        Q K F +E   +   RH NVV   G          L I++    
Sbjct: 57  -EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC---MSPPHLAIITSLCK 112

Query: 858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPD 917
             +L S + D        L   +  +IA ++ +G+ YLH  + + H +LK+ N+  D  +
Sbjct: 113 GRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLH-AKGILHKDLKSKNVFYD--N 165

Query: 918 LNARVADYCLHRLMTQAGTIEQ----ILDAGVLGYRAPELAASKKPHP-------SFKSD 966
               + D+ L  +        +     +  G L + APE+     P         S  SD
Sbjct: 166 GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSD 225

Query: 967 VYAFGVILLELLTGR 981
           V+A G I  EL    
Sbjct: 226 VFALGTIWYELHARE 240

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  133 bits (337), Expect = 1e-34
 Identities = 71/297 (23%), Positives = 119/297 (40%), Gaps = 50/297 (16%)

Query: 782  EVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
            EVLG+   G + + T  E G  + +K L     + ++ F KE K    + HPNV+   G 
Sbjct: 16   EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 841  YWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
                 + ++L  +++YI  G+L   +            W+QR+  A D+A G+ YLH   
Sbjct: 76   L---YKDKRLNFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDIASGMAYLH-SM 127

Query: 900  AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR---------- 949
             + H +L + N L+   + N  VAD+ L RLM    T  + L +     R          
Sbjct: 128  NIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 950  ---APELAASKKPHPSF--KSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKV 1004
               APE+   +     +  K DV++FG++L E++    A              D++   +
Sbjct: 187  YWMAPEMINGRS----YDEKVDVFSFGIVLCEIIGRVNADP------------DYLPRTM 230

Query: 1005 AEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSV-SERPGIKTIYEDLSSI 1060
              G     F     P    P+          I +RC      +RP    +   L ++
Sbjct: 231  DFGLNVRGFLDRYCPPNCPPS-------FFPITVRCCDLDPEKRPSFVKLEHWLETL 280

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  136 bits (344), Expect = 1e-33
 Identities = 65/310 (20%), Positives = 118/310 (38%), Gaps = 37/310 (11%)

Query: 295 LDLSYNQLTGELPG-FNFVYELQVLKLSN---NRFSGFIPNDLLKGDSLLLTDLDLSANN 350
            +  YN ++G     F+   + +   L     N     +   L+       ++L L+  N
Sbjct: 15  QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ----FSELQLNRLN 70

Query: 351 LSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYL 410
           LS S+   L   + +L ++ N L   LP L  S   LD  +N+    L  +    ++++L
Sbjct: 71  LS-SLPDNLPPQITVLEITQNALI-SLPELPASLEYLDACDNRLS-TLPELP--ASLKHL 125

Query: 411 DLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFL 470
           D+  N LT  +PE       L ++N  +N L+  LP++      L VL +  N L   FL
Sbjct: 126 DVDNNQLT-MLPELPAL---LEYINADNNQLTM-LPELP---TSLEVLSVRNNQLT--FL 175

Query: 471 TNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQ-------VLDLSHNRLNGYFPDRLGS 523
             L  S  L+ L ++ NLL  +    P                    NR+  + P+ + S
Sbjct: 176 PELPES--LEALDVSTNLLESL----PAVPVRNHHSEETEIFFRCRENRIT-HIPENILS 228

Query: 524 LTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDF 583
           L     + L  N +S  +  S++  T+       + +F+              +     F
Sbjct: 229 LDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWF 288

Query: 584 SGAVPENLRK 593
                 ++ +
Sbjct: 289 PENKQSDVSQ 298

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  114 bits (286), Expect = 2e-26
 Identities = 85/429 (19%), Positives = 144/429 (33%), Gaps = 65/429 (15%)

Query: 123 LDVSDNLFSSSLP-------SGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSH 175
             +S N F +++        S   K E         N    L+ + +  +     L L+ 
Sbjct: 11  FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNR 68

Query: 176 NSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFF 235
            + S SLP  L     +  L ++ N     +P   EL   L+ LD   N+L   L     
Sbjct: 69  LNLS-SLPDNL--PPQITVLEITQNALIS-LP---ELPASLEYLDACDNRLS-TLPEL-- 118

Query: 236 LLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVL 295
              +  H+D   N          LP L   ++Y+N   NQLT  L      +L  +L+VL
Sbjct: 119 -PASLKHLDVDNNQL------TMLPELPALLEYINADNNQLT-ML-----PELPTSLEVL 165

Query: 296 DLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSL--LLTDLDLSANNLSG 353
            +  NQLT  LP       L+ L +S N     +P   ++               N ++ 
Sbjct: 166 SVRNNQLT-FLP--ELPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRITH 221

Query: 354 -SVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDL 412
              +++       + L  N      PL +     L     Q + +  RI    +    + 
Sbjct: 222 IPENILSLDPTCTIILEDN------PLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNT 275

Query: 413 SRNHL----TGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGP 468
               L    T   PE     +        H   +++          L  L  + +  +  
Sbjct: 276 LHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTF------SAFLDRLSDTVSARNTS 329

Query: 469 --------FLTNLLNSSTLQE--LHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFP 518
                   +L  L  S+ L++    +A +      D    + +NL+   L H    G F 
Sbjct: 330 GFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFD 389

Query: 519 DRLGSLTGL 527
           +  G+L  L
Sbjct: 390 NDTGALLSL 398

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 90.8 bits (225), Expect = 6e-19
 Identities = 58/352 (16%), Positives = 116/352 (32%), Gaps = 54/352 (15%)

Query: 96  LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFS 155
           +  L ++ N++   +P+      SLE+LD  DN   S+LP       SL++L +  N  +
Sbjct: 82  ITVLEITQNALI-SLPELPA---SLEYLDACDNRL-STLPELPA---SLKHLDVDNNQLT 133

Query: 156 GLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILG 215
            L P+  + L   + ++  +N  +  LP   T   +L  L++ +N  +  +P   EL   
Sbjct: 134 ML-PELPALL---EYINADNNQLT-MLPELPT---SLEVLSVRNNQLT-FLP---ELPES 181

Query: 216 LQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQ 275
           L+ LD   N L+  L        +                        ++  +     N+
Sbjct: 182 LEALDVSTNLLE-SLPAVPVRNHH----------------------SEETEIFFRCRENR 218

Query: 276 LTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLK 335
           +T  +     +   +    + L  N L+      +   +         R   +      +
Sbjct: 219 IT-HIPE--NILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPRI--YFSMSDGQ 272

Query: 336 GDSLLLTDLDLSANNLSGSVSMILSTNLHML--NLSSNGLTGELPLLTGSCAVLDLSNNQ 393
            ++L     D        +    +S   H       +N  +  L  L+ + +  + S   
Sbjct: 273 QNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTS--G 330

Query: 394 FEGNLSRILKW-GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSS 444
           F   ++  L+       L      +     E     + L   NL    L   
Sbjct: 331 FREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQ 382

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 63.8 bits (155), Expect = 2e-10
 Identities = 27/122 (22%), Positives = 49/122 (40%), Gaps = 10/122 (8%)

Query: 91  SNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQN---- 146
              + L  LS+ NN ++  +P+      SLE LDVS NL  S LP+   +    +     
Sbjct: 157 ELPTSLEVLSVRNNQLT-FLPELPE---SLEALDVSTNLLES-LPAVPVRNHHSEETEIF 211

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRI 206
                N  + + P+++  L    ++ L  N  S  +  +L++       +     FS   
Sbjct: 212 FRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSD 270

Query: 207 PR 208
            +
Sbjct: 271 GQ 272

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  127 bits (322), Expect = 3e-32
 Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 30/227 (13%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKF--ANIRHPNVVGLRG 839
           E +G+   G  +R     G  + VK       ++ + + +EA+ +    +RH N++G   
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103

Query: 840 YYWGPTQHEK--LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
                        ++SDY   GSL  +L          +T    +K+A+  A GL +LH 
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 898 DR-------AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG--- 947
           +        A+ H +LK+ NIL+   +    +AD  L      A     I     +G   
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 948 YRAPEL---AASKKPHPSF-KSDVYAFGVILLELLTGRCAGDVISGE 990
           Y APE+   + + K   SF ++D+YA G++  E+   RC+   I  +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHED 262

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  125 bits (317), Expect = 6e-32
 Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 29/224 (12%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAK--KFANIRHPNVVGLRG 839
           E +G+  +G  +R +   G  + VK       +  K + +E +      +RH N++G   
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 840 Y-YWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
                     +L +++ Y   GSL  +L      +   L     L+I + +A GL +LH 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 898 DR-------AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG--- 947
           +        A+ H +LK+ NIL+   +    +AD  L  + +Q+     + +   +G   
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 948 YRAPEL---AASKKPHPSF-KSDVYAFGVILLELLTGRCAGDVI 987
           Y APE+           S+ + D++AFG++L E+     +  ++
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  125 bits (316), Expect = 1e-31
 Identities = 61/338 (18%), Positives = 103/338 (30%), Gaps = 51/338 (15%)

Query: 263 SQSVQYLNLS-LNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLS 321
           S   + L       L     +   L  ++     D +           N     Q+   +
Sbjct: 11  SSGRENLYFQGSTALR-PYHD--VLSQWQRHYNADRNRWHSAWRQANSN---NPQIETRT 64

Query: 322 NNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGELPL 379
                    + L          L+L +  L           ++L  + + + GL  ELP 
Sbjct: 65  GRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPD 121

Query: 380 LTGSCA---VLDLSNNQFE------GNLSRILKWGNIEYLDLSRNHLTGSIPEE------ 424
                A    L L+ N          +L+       +  L +        +PE       
Sbjct: 122 TMQQFAGLETLTLARNPLRALPASIASLN------RLRELSIRACPELTELPEPLASTDA 175

Query: 425 ---TPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDG--PFLTNLLNSSTL 479
                  + L  L L    + S LP  I   Q L+ L +  + L    P + +L     L
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSALGPAIHHLPK---L 231

Query: 480 QELHLAD-NLLTGVLDFSPPSV---SNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGN 535
           +EL L     L       PP     + L+ L L         P  +  LT L+ L L G 
Sbjct: 232 EELDLRGCTALRNY----PPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287

Query: 536 NISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSL 573
                LP+ +A + +   +++   H    L  + P + 
Sbjct: 288 VNLSRLPSLIAQLPANCIILVP-PHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  124 bits (314), Expect = 3e-31
 Identities = 49/302 (16%), Positives = 96/302 (31%), Gaps = 33/302 (10%)

Query: 315 LQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT 374
            + L    +       + L +       D +        +     S N  +   +   L 
Sbjct: 14  RENLYFQGSTALRPYHDVLSQWQRHYNADRNR----WHSAWRQANSNNPQIETRTGRALK 69

Query: 375 GELPLLTGSCA-----VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL 429
                L           L+L +        +  +  +++++ +    L   +P+   QF 
Sbjct: 70  -ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127

Query: 430 RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLS-FNHL--------DGPFLTNLLNSSTLQ 480
            L  L L+ N L + LP  I    +LR L +     L                     LQ
Sbjct: 128 GLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186

Query: 481 ELHLADNLLTGVLDFSPPSV---SNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNI 537
            L L    +  +    P S+    NL+ L + ++ L+      +  L  L+ L L G   
Sbjct: 187 SLRLEWTGIRSL----PASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTA 241

Query: 538 SGSLPTSMANMTSLSSLVIS-QNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLRKF 594
             + P        L  L++   ++    LP ++     LE  ++        +P  + + 
Sbjct: 242 LRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300

Query: 595 PS 596
           P+
Sbjct: 301 PA 302

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  108 bits (273), Expect = 8e-26
 Identities = 59/406 (14%), Positives = 98/406 (24%), Gaps = 96/406 (23%)

Query: 108 GVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVS 167
           G    +       E L    +         + + +   N      + +    +      +
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNN 57

Query: 168 IQSLDLSHNSFSGSLPPALTRLN--NLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNK 225
            Q    +  +   +    L        V L L S     + P     +  LQ +      
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAG 115

Query: 226 LDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGE 285
           L                                LP           ++ Q          
Sbjct: 116 L------------------------------MELPD----------TMQQFA-------- 127

Query: 286 LQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDL 344
                 L+ L L+ N L   LP     +  L+ L +        +P  L           
Sbjct: 128 -----GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPL----------- 170

Query: 345 DLSANNLSGSVSMILSTNLHMLNLSSNGLT------GELPLLTGSCAVLDLSNNQFEGNL 398
                +   S       NL  L L   G+         L  L      L + N+      
Sbjct: 171 ----ASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLK----SLKIRNSPLSALG 222

Query: 399 SRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVL 458
             I     +E LDL       + P        L  L L   S   +LP  I +  +L  L
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282

Query: 459 DLSFNHLDGPFLTNLLNS----STLQELHLADNLLTGVLDFSPPSV 500
           DL         L+ L +          + +  +L   +    P + 
Sbjct: 283 DLRGC----VNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  105 bits (265), Expect = 7e-25
 Identities = 64/408 (15%), Positives = 104/408 (25%), Gaps = 94/408 (23%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNN 191
            S           +NL   G+       D +S      + D +    +          NN
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57

Query: 192 LVYLNLSSNGFSKRIPRGFELI--LGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNM 249
                 +     K      E     G   L+     L      + F L++          
Sbjct: 58  PQIETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSH---------- 105

Query: 250 FVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-G 308
                           +Q++ +    L   L +   +Q F  L+ L L+ N L   LP  
Sbjct: 106 ----------------LQHMTIDAAGLM-ELPD--TMQQFAGLETLTLARNPLR-ALPAS 145

Query: 309 FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNL 368
              +  L+ L +        +P  L                +   S       NL  L L
Sbjct: 146 IASLNRLRELSIRACPELTELPEPL---------------ASTDASGEHQGLVNLQSLRL 190

Query: 369 SSNGLT------GELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIP 422
              G+         L  L      L + N+        I     +E LDL       + P
Sbjct: 191 EWTGIRSLPASIANLQNLK----SLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYP 246

Query: 423 EETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQEL 482
                   L  L L   S   +LP  I +  +L  LDL         L+ L         
Sbjct: 247 PIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC----VNLSRL--------- 293

Query: 483 HLADNLLTGVLDFSPPSVSNL---QVLDLSHNRLNGYFPDRLGSLTGL 527
                         P  ++ L    ++ +  +        R  +    
Sbjct: 294 --------------PSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  100 bits (250), Expect = 6e-23
 Identities = 30/145 (20%), Positives = 52/145 (35%), Gaps = 2/145 (1%)

Query: 87  LSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQN 146
                 L  L  L +    I   +P +I + ++L+ L + ++  S+ L   I  L  L+ 
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEE 233

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRI 206
           L L G       P    G   ++ L L   S   +LP  + RL  L  L+L       R+
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293

Query: 207 PRGFELILGLQVLDFHGNKLDGHLD 231
           P     +    ++    +       
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 98.9 bits (247), Expect = 2e-22
 Identities = 43/226 (19%), Positives = 80/226 (35%), Gaps = 23/226 (10%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSL 149
              LS L  +++    +   +PD +  F  LE L ++ N    +LP+ I  L  L+ LS+
Sbjct: 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSI 157

Query: 150 AGNNFSGLIPDSV---------SGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN 200
                   +P+ +          GLV++QSL L       SLP ++  L NL  L + ++
Sbjct: 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216

Query: 201 GFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP 260
                +      +  L+ LD  G     +    F        +          S+   LP
Sbjct: 217 PL-SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC-----SNLLTLP 270

Query: 261 ---GLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLT 303
                   ++ L+L        L +   +       ++ +  +   
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPS--LIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 93.9 bits (234), Expect = 9e-21
 Identities = 40/206 (19%), Positives = 75/206 (36%), Gaps = 22/206 (10%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGK--------- 140
               + L  L+++ N +   +P +I     L  L +      + LP  +           
Sbjct: 123 MQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181

Query: 141 LESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN 200
           L +LQ+L L       L P S++ L +++SL + ++  S +L PA+  L  L  L+L   
Sbjct: 182 LVNLQSLRLEWTGIRSL-PASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGC 239

Query: 201 GFSKRIPRGFELILGLQVLD-FHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFL 259
              +  P  F     L+ L     + L   L  +   LT    +D  G + +       L
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNL-LTLPLDIHRLTQLEKLDLRGCVNLSR-----L 293

Query: 260 P---GLSQSVQYLNLSLNQLTGSLVN 282
           P       +   + +  +       +
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 84.6 bits (210), Expect = 1e-17
 Identities = 34/179 (18%), Positives = 63/179 (35%), Gaps = 10/179 (5%)

Query: 431 LNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLT 490
             +L    ++       V+ Q+Q+    D +  H          NS+  Q        L 
Sbjct: 14  RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK 69

Query: 491 GVLD-FSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMT 549
              D     +      L+L    L   FPD+   L+ L+ + +    +   LP +M    
Sbjct: 70  ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127

Query: 550 SLSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPENLRKFPSSSFYPGNSKL 606
            L +L +++N     LP ++ +   L   ++        +PE L    +S  + G   L
Sbjct: 128 GLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  125 bits (315), Expect = 2e-31
 Identities = 50/224 (22%), Positives = 91/224 (40%), Gaps = 29/224 (12%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAK--KFANIRHPNVVGLRG 839
           + +G+  +G  +      G  + VK        +   + +E +  +   +RH N++G   
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 840 YYWGPTQHEK--LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
                T       +++DY   GSL  +L      K   L     LK+A     GL +LH 
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 898 DR-------AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG--- 947
           +        A+ H +LK+ NIL+   +    +AD  L            I     +G   
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211

Query: 948 YRAPEL---AASKKPHPSF-KSDVYAFGVILLELLTGRCAGDVI 987
           Y  PE+   + ++    S+  +D+Y+FG+IL E+     +G ++
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  123 bits (311), Expect = 7e-31
 Identities = 60/301 (19%), Positives = 120/301 (39%), Gaps = 44/301 (14%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVL 318
             L      L+L  N++T   +  G+ +  +NL  L L  N+++   PG F  + +L+ L
Sbjct: 48  KDLPPDTALLDLQNNKITE--IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL 105

Query: 319 KLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGE 376
            LS N+    +P  + K     L +L +  N ++     + +    + ++ L +N L   
Sbjct: 106 YLSKNQLKE-LPEKMPKT----LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 160

Query: 377 ---------LPLLTGSCAVLDLSNNQFEGNLSRILKW--GNIEYLDLSRNHLTGSIPEET 425
                    +  L+     + +++     N++ I +    ++  L L  N +T  +   +
Sbjct: 161 GIENGAFQGMKKLS----YIRIADT----NITTIPQGLPPSLTELHLDGNKIT-KVDAAS 211

Query: 426 PQFLR-LNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDG--PFLTNLLNSSTLQEL 482
            + L  L  L LS NS+S+     +     LR L L+ N L      L +      +Q +
Sbjct: 212 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY---IQVV 268

Query: 483 HLADNLLTGV--LDFSPPSV----SNLQVLDLSHNRLNGYF--PDRLGSLTGLKVLCLAG 534
           +L +N ++ +   DF PP      ++   + L  N +  +   P     +     + L  
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328

Query: 535 N 535
            
Sbjct: 329 Y 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  122 bits (308), Expect = 2e-30
 Identities = 68/341 (19%), Positives = 115/341 (33%), Gaps = 63/341 (18%)

Query: 119 SLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF 178
            L  +  SD      +P  +        L L  N  + +       L ++ +L L +N  
Sbjct: 32  HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 179 SGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLL 237
           S  + P A   L  L  L LS N   + +P    +   LQ L  H N++           
Sbjct: 89  S-KISPGAFAPLVKLERLYLSKNQLKE-LPEK--MPKTLQELRVHENEI----------- 133

Query: 238 TNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDL 297
                     ++F G      L  +      + L  N L  S +  G  Q  + L  + +
Sbjct: 134 -----TKVRKSVFNG------LNQM----IVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178

Query: 298 SYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLL--LTDLDLSANNLSGSV 355
           +   +T  +P       L  L L  N+ +  +    LKG   L  L  L LS N++S   
Sbjct: 179 ADTNIT-TIPQGLPP-SLTELHLDGNKIT-KVDAASLKG---LNNLAKLGLSFNSISAVD 232

Query: 356 SMILS--TNLHMLNLSSNGLT------GELPLLTGSCAVLDLSNNQFE-------GNLSR 400
           +  L+   +L  L+L++N L        +   +     V+ L NN               
Sbjct: 233 NGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ----VVYLHNNNISAIGSNDFCPPGY 288

Query: 401 ILKWGNIEYLDLSRNHLT-GSIPEETPQFLR-LNHLNLSHN 439
             K  +   + L  N +    I   T + +     + L + 
Sbjct: 289 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  117 bits (294), Expect = 1e-28
 Identities = 68/297 (22%), Positives = 106/297 (35%), Gaps = 50/297 (16%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNL 147
             F NL  L  L + NN IS + P        LE L +S N     LP  +   ++LQ L
Sbjct: 70  GDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKM--PKTLQEL 126

Query: 148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF-SGSLPP-ALTRLNNLVYLNLSSNGFSKR 205
            +  N  + +     +GL  +  ++L  N   S  +   A   +  L Y+ ++    +  
Sbjct: 127 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT- 185

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
           IP+G  L   L  L   GNK           +T        G           L  L   
Sbjct: 186 IPQG--LPPSLTELHLDGNK-----------ITKVDAASLKG-----------LNNL--- 218

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNNR 324
              L LS N ++   V+ G L    +L+ L L+ N+L  ++P G      +QV+ L NN 
Sbjct: 219 -AKLGLSFNSISA--VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN 274

Query: 325 FSGFIPNDLLKGDSLL----LTDLDLSANNLSGSVSMILS------TNLHMLNLSSN 371
            S    ND             + + L +N +      I             + L + 
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPV--QYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  110 bits (277), Expect = 2e-26
 Identities = 63/306 (20%), Positives = 112/306 (36%), Gaps = 49/306 (16%)

Query: 291 NLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANN 350
           +L+V+  S   L  ++P  +   +  +L L NN+ +  I +   K    L   L L  N 
Sbjct: 32  HLRVVQCSDLGLE-KVPK-DLPPDTALLDLQNNKITE-IKDGDFKNLKNL-HTLILINNK 87

Query: 351 LSGSVSMILS--TNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIE 408
           +S       +    L  L LS N L              +L     +           ++
Sbjct: 88  ISKISPGAFAPLVKLERLYLSKNQLK-------------ELPEKMPK----------TLQ 124

Query: 409 YLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSL--PKVIIQYQKLRVLDLSFNHL 465
            L +  N +T  + +     L ++  + L  N L SS          +KL  + ++  ++
Sbjct: 125 ELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183

Query: 466 DGPFLTNLLNS--STLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGS 523
                T +      +L ELHL  N +T V   S   ++NL  L LS N ++      L +
Sbjct: 184 -----TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238

Query: 524 LTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNH--------FTGPLPNNLPNSLET 575
              L+ L L  N +   +P  +A+   +  + +  N+        F  P  N    S   
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 297

Query: 576 FNVSYN 581
            ++  N
Sbjct: 298 VSLFSN 303

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 90.8 bits (226), Expect = 1e-19
 Identities = 42/200 (21%), Positives = 75/200 (37%), Gaps = 25/200 (12%)

Query: 406 NIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL 465
           ++  +  S   L   +P++ P       L+L +N ++          + L  L L  N +
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPPDTA--LLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 466 ----DGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRL 521
                G F   L+    L+ L+L+ N L  + +  P     LQ L +  N +        
Sbjct: 89  SKISPGAF-APLVK---LERLYLSKNQLKELPEKMPK---TLQELRVHENEITKVRKSVF 141

Query: 522 GSLTGLKVLCLAGNNISGSL--PTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVS 579
             L  + V+ L  N +  S     +   M  LS + I+  + T  +P  LP SL   ++ 
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLPPSLTELHLD 200

Query: 580 YNDFSGAVPENLRKFPSSSF 599
            N         + K  ++S 
Sbjct: 201 GN--------KITKVDAASL 212

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  122 bits (308), Expect = 2e-30
 Identities = 52/234 (22%), Positives = 88/234 (37%), Gaps = 37/234 (15%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAK--KFANIRHPNVVGLRG 839
           E++GR  +G  Y+ +L +   + VK         R+ F  E    +   + H N+     
Sbjct: 19  ELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIV 74

Query: 840 YYWGPT---QHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
                T   + E L++ +Y   GSL  +L            W    ++A  V RGL YLH
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLH 128

Query: 897 FD--------RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD------ 942
            +         A+ H +L + N+L+   D    ++D+ L   +T    +    +      
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187

Query: 943 -AGVLGYRAPELA-----ASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGE 990
             G + Y APE+               + D+YA G+I  E+   RC        
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTDLFPGES 240

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  119 bits (301), Expect = 9e-30
 Identities = 72/250 (28%), Positives = 103/250 (41%), Gaps = 21/250 (8%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHN--SFSGSLPPALTRL 189
           +S+P+GI    S   L L  N    L       L  +  L LS N  SF G    +    
Sbjct: 20  TSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77

Query: 190 NNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFL-LTNASHIDFSGN 248
            +L YL+LS NG    +   F  +  L+ LDF  + L    +   FL L N  ++D S  
Sbjct: 78  TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136

Query: 249 MFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG 308
                +      GLS S++ L ++ N    + +         NL  LDLS  QL  +L  
Sbjct: 137 HTR-VAFNGIFNGLS-SLEVLKMAGNSFQENFLPDI-FTELRNLTFLDLSQCQLE-QLSP 192

Query: 309 --FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLL--LTDLDLSANNLS---GSVSMILST 361
             FN +  LQVL +S+N F   +     K    L  L  LD S N++            +
Sbjct: 193 TAFNSLSSLQVLNMSHNNFF-SLDTFPYKC---LNSLQVLDYSLNHIMTSKKQELQHFPS 248

Query: 362 NLHMLNLSSN 371
           +L  LNL+ N
Sbjct: 249 SLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  116 bits (293), Expect = 1e-28
 Identities = 68/258 (26%), Positives = 107/258 (41%), Gaps = 21/258 (8%)

Query: 342 TDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT-------GELPLLTGSCAVLDLSNNQF 394
           T++  ++  L+ SV   + ++   L L SN L         +L  LT     L LS+N  
Sbjct: 10  TEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLT----KLSLSSNGL 64

Query: 395 E-GNLSRILKWG--NIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQ 451
                     +G  +++YLDLS N +  ++        +L HL+  H++L       +  
Sbjct: 65  SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123

Query: 452 Y-QKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADN-LLTGVLDFSPPSVSNLQVLDLS 509
             + L  LD+S  H    F       S+L+ L +A N      L      + NL  LDLS
Sbjct: 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183

Query: 510 HNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPN-- 567
             +L    P    SL+ L+VL ++ NN           + SL  L  S NH         
Sbjct: 184 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 243

Query: 568 -NLPNSLETFNVSYNDFS 584
            + P+SL   N++ NDF+
Sbjct: 244 QHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  105 bits (265), Expect = 4e-25
 Identities = 65/301 (21%), Positives = 105/301 (34%), Gaps = 62/301 (20%)

Query: 195 LNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSS 254
           +  +S G +  +P G  +      L+   NKL     G F  LT                
Sbjct: 12  IRCNSKGLT-SVPTG--IPSSATRLELESNKLQSLPHGVFDKLTQ--------------- 53

Query: 255 SQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYE 314
                      +  L+LS N L+             +LK LDLS+N +      F  + +
Sbjct: 54  -----------LTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ 102

Query: 315 LQVLKLSNNRFSGFIPNDLLKGDSLL--LTDLDLSANNLSGSVSMILS--TNLHMLNLSS 370
           L+ L   ++         +      L  L  LD+S  +   + + I +  ++L +L ++ 
Sbjct: 103 LEHLDFQHSNLKQMSEFSVFLS---LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 159

Query: 371 NGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL- 429
           N                    + F   L       N+ +LDLS+  L   +       L 
Sbjct: 160 NSFQENFL------------PDIFTE-LR------NLTFLDLSQCQLE-QLSPTAFNSLS 199

Query: 430 RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL---DGPFLTNLLNSSTLQELHLAD 486
            L  LN+SHN+  S           L+VLD S NH+       L +  +S  L  L+L  
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS--LAFLNLTQ 257

Query: 487 N 487
           N
Sbjct: 258 N 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  104 bits (261), Expect = 2e-24
 Identities = 65/290 (22%), Positives = 107/290 (36%), Gaps = 71/290 (24%)

Query: 288 LFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDL 346
           +  +   L+L  N+L     G F+ + +L  L LS+N                 L+    
Sbjct: 26  IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG----------------LSFKGC 69

Query: 347 SANNLSGSVSMILSTNLHMLNLSSNGLTG------ELPLLTGSCAVLDLSNNQFEGNLSR 400
            + +  G+      T+L  L+LS NG+         L  L      LD  ++     L +
Sbjct: 70  CSQSDFGT------TSLKYLDLSFNGVITMSSNFLGLEQLE----HLDFQHSN----LKQ 115

Query: 401 ILKWG------NIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQY- 452
           + ++       N+ YLD+S  H            L  L  L ++ NS   +    I    
Sbjct: 116 MSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 174

Query: 453 QKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNR 512
           + L  LDLS   L+                 L+      +        S+LQVL++SHN 
Sbjct: 175 RNLTFLDLSQCQLE----------------QLSPTAFNSL--------SSLQVLNMSHNN 210

Query: 513 LNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANM-TSLSSLVISQNHF 561
                      L  L+VL  + N+I  S    + +  +SL+ L ++QN F
Sbjct: 211 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  103 bits (260), Expect = 2e-24
 Identities = 55/263 (20%), Positives = 93/263 (35%), Gaps = 37/263 (14%)

Query: 96  LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSS-SLPSGI-GKLESLQNLSLAGNN 153
             +L + +N +  +          L  L +S N  S     S       SL+ L L+ N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 154 FSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP--ALTRLNNLVYLNLSSNGFSKRIPRG-F 210
               +  +  GL  ++ LD  H++    +        L NL+YL++S          G F
Sbjct: 90  VIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIF 146

Query: 211 ELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLN 270
             +  L+VL   GN    +   + F                       L  L     +L+
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIF---------------------TELRNL----TFLD 181

Query: 271 LSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFI 329
           LS  QL    ++        +L+VL++S+N         +  +  LQVL  S N      
Sbjct: 182 LSQCQLEQ--LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TS 238

Query: 330 PNDLLKGDSLLLTDLDLSANNLS 352
               L+     L  L+L+ N+ +
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 87.4 bits (217), Expect = 8e-19
 Identities = 40/156 (25%), Positives = 63/156 (40%), Gaps = 6/156 (3%)

Query: 76  LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLP 135
             +  L   ++ SVF +L  L+ L +S+               SLE L ++ N F  +  
Sbjct: 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167

Query: 136 SGI-GKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLV 193
             I  +L +L  L L+      L P + + L S+Q L++SHN+F  SL       LN+L 
Sbjct: 168 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQ 226

Query: 194 YLNLSSNGFSKRIPRG--FELILGLQVLDFHGNKLD 227
            L+ S N       +         L  L+   N   
Sbjct: 227 VLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  118 bits (297), Expect = 5e-29
 Identities = 77/328 (23%), Positives = 118/328 (35%), Gaps = 38/328 (11%)

Query: 119 SLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF 178
            L  +  SD    + +P  I        L L  N+ S L  D   GL  + +L L +N  
Sbjct: 34  HLRVVQCSDLGLKA-VPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 179 SGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLT 238
           S     A + L  L  L +S N     IP    L   L  L  H N++     G F  L 
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLV-EIPPN--LPSSLVELRIHDNRIRKVPKGVFSGLR 147

Query: 239 NASHIDFSGNMFVGSS-SQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDL 297
           N + I+  GN    S        GL   + YL +S  +LTG   +     L E L  L L
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGL--KLNYLRISEAKLTGIPKD-----LPETLNELHL 200

Query: 298 SYNQLTGELPGFNFV--YELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSV 355
            +N++   +   + +   +L  L L +N+    I N  L      L +L L  N LS  V
Sbjct: 201 DHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLP-TLRELHLDNNKLS-RV 256

Query: 356 SMILS--TNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLS 413
              L     L ++ L +N +T              +  N F   +   +K      + L 
Sbjct: 257 PAGLPDLKLLQVVYLHTNNIT-------------KVGVNDFCP-VGFGVKRAYYNGISLF 302

Query: 414 RNHLT-GSIPEETPQFLR-LNHLNLSHN 439
            N +    +   T + +     +   + 
Sbjct: 303 NNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  114 bits (287), Expect = 1e-27
 Identities = 58/293 (19%), Positives = 104/293 (35%), Gaps = 29/293 (9%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVL 318
             +S     L+L  N ++   +   + +  ++L  L L  N+++      F+ + +LQ L
Sbjct: 50  KEISPDTTLLDLQNNDISE--LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKL 107

Query: 319 KLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLTGE 376
            +S N     IP +L       L +L +  N +      + S   N++ + +  N L   
Sbjct: 108 YISKNHLVE-IPPNLPSS----LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE-N 161

Query: 377 LPLLTGSCA-----VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLR- 430
                G+        L +S  +  G    + +   +  L L  N +  +I  E       
Sbjct: 162 SGFEPGAFDGLKLNYLRISEAKLTGIPKDLPE--TLNELHLDHNKIQ-AIELEDLLRYSK 218

Query: 431 LNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLT 490
           L  L L HN +       +     LR L L  N L       L +   LQ ++L  N +T
Sbjct: 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT 277

Query: 491 GV--LDFSPPSV----SNLQVLDLSHNRLNGYF--PDRLGSLTGLKVLCLAGN 535
            V   DF P       +    + L +N +  +   P     +T    +     
Sbjct: 278 KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  112 bits (283), Expect = 4e-27
 Identities = 66/303 (21%), Positives = 104/303 (34%), Gaps = 44/303 (14%)

Query: 291 NLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANN 350
           +L+V+  S   L   +P      +  +L L NN  S  +  D  KG   L   L L  N 
Sbjct: 34  HLRVVQCSDLGLK-AVPK-EISPDTTLLDLQNNDISE-LRKDDFKGLQHL-YALVLVNNK 89

Query: 351 LSGSVSMILS--TNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIE 408
           +S       S    L  L +S N L              ++  N             ++ 
Sbjct: 90  ISKIHEKAFSPLRKLQKLYISKNHLV-------------EIPPNLPS----------SLV 126

Query: 409 YLDLSRNHLTGSIPEETPQFLR-LNHLNLSHNSL-SSSLPKVIIQYQKLRVLDLSFNHLD 466
            L +  N +   +P+     LR +N + +  N L +S          KL  L +S   L 
Sbjct: 127 ELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185

Query: 467 GPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTG 526
           G    +L    TL ELHL  N +  +        S L  L L HN++       L  L  
Sbjct: 186 G-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPT 242

Query: 527 LKVLCLAGNNISGSLPTSMANMTSLSSLVISQNH--------FTGPLPNNLPNSLETFNV 578
           L+ L L  N +S  +P  + ++  L  + +  N+        F               ++
Sbjct: 243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISL 301

Query: 579 SYN 581
             N
Sbjct: 302 FNN 304

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 39/199 (19%), Positives = 75/199 (37%), Gaps = 24/199 (12%)

Query: 406 NIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL 465
           ++  +  S   L  ++P+E         L+L +N +S          Q L  L L  N +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISPDTT--LLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 466 ----DGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRL 521
               +  F + L     LQ+L+++ N L  +    P    +L  L +  NR+        
Sbjct: 91  SKIHEKAF-SPLRK---LQKLYISKNHLVEIPPNLPS---SLVELRIHDNRIRKVPKGVF 143

Query: 522 GSLTGLKVLCLAGNNI-SGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSY 580
             L  +  + + GN + +        +   L+ L IS+   TG +P +LP +L   ++ +
Sbjct: 144 SGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDLPETLNELHLDH 202

Query: 581 NDFSGAVPENLRKFPSSSF 599
           N         ++       
Sbjct: 203 N--------KIQAIELEDL 213

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  110 bits (277), Expect = 3e-26
 Identities = 65/292 (22%), Positives = 117/292 (40%), Gaps = 42/292 (14%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYELQV 317
            GL+++V+ L+LS N++T   ++  +LQ   NL+ L L+ N +   +    F+ +  L+ 
Sbjct: 48  SGLTEAVKSLDLSNNRITY--ISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEH 104

Query: 318 LKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLS----GSVSMILSTNLHMLNLSSNGL 373
           L LS N  S  + +   K  S L T L+L  N        S+   L T L +L + +   
Sbjct: 105 LDLSYNYLS-NLSSSWFKPLSSL-TFLNLLGNPYKTLGETSLFSHL-TKLQILRVGNMDT 161

Query: 374 TGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL-RLN 432
             ++                F G L+       +E L++  + L  S   ++ + +  ++
Sbjct: 162 FTKIQ------------RKDFAG-LT------FLEELEIDASDLQ-SYEPKSLKSIQNVS 201

Query: 433 HLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLT--------NLLNSSTLQELHL 484
           HL L        L   +     +  L+L    LD    +        +L+   T + + +
Sbjct: 202 HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261

Query: 485 ADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNN 536
            D  L  V+      +S L  L+ S N+L          LT L+ + L  N 
Sbjct: 262 TDESLFQVMKLLNQ-ISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNP 312

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  105 bits (264), Expect = 1e-24
 Identities = 59/276 (21%), Positives = 108/276 (39%), Gaps = 19/276 (6%)

Query: 88  SVFSNLSM-LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQ 145
           S+ S L+  +  L +SNN I+ +   ++    +L+ L ++ N   +++       L SL+
Sbjct: 45  SIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLE 103

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP--ALTRLNNLVYLNLSSNGFS 203
           +L L+ N  S L       L S+  L+L  N +  +L      + L  L  L + +    
Sbjct: 104 HLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTF 162

Query: 204 KRIPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGL 262
            +I R  F  +  L+ L+   + L  +       + N SH+       +    + F+   
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVT 221

Query: 263 SQSVQYLNLSLNQLTG----SLVNG--GELQLFENLKVLDLSYNQLTGELPGFNFVYELQ 316
           S SV+ L L    L       L  G    L      + + ++   L   +   N +  L 
Sbjct: 222 S-SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLL 280

Query: 317 VLKLSNNRFSGFIPNDLLKGDSLL-LTDLDLSANNL 351
            L+ S N+    +P+ +   D L  L  + L  N  
Sbjct: 281 ELEFSRNQLKS-VPDGIF--DRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  103 bits (258), Expect = 9e-24
 Identities = 63/300 (21%), Positives = 110/300 (36%), Gaps = 51/300 (17%)

Query: 110 IPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQ 169
           IP  +   ++++ LD+S+N  +    S + +  +LQ L L  N  + +  DS S L S++
Sbjct: 46  IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE 103

Query: 170 SLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHG-NKLD 227
            LDLS+N  S +L       L++L +LNL  N +                  F    KL 
Sbjct: 104 HLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSL----------FSHLTKLQ 152

Query: 228 GHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQ 287
               G     T     DF+G           L  L    + L +  + L         L+
Sbjct: 153 ILRVGNMDTFTKIQRKDFAG-----------LTFL----EELEIDASDLQS--YEPKSLK 195

Query: 288 LFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDS------LL 340
             +N+  L L   Q    L    +    ++ L+L +     F  ++L  G++        
Sbjct: 196 SIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255

Query: 341 LTDLDLSANNLSGSVSMILS-TNLHMLNLSSNGLTG-------ELPLLTGSCAVLDLSNN 392
             ++ ++  +L   + ++   + L  L  S N L          L  L      + L  N
Sbjct: 256 FRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQ----KIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 90.9 bits (226), Expect = 1e-19
 Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 19/216 (8%)

Query: 367 NLSSNGLTGELPL-LTGSCAVLDLSNNQF----EGNLSRILKWGNIEYLDLSRNHLTGSI 421
             SS  L   +P  LT +   LDLSNN+       +L R     N++ L L+ N +  +I
Sbjct: 37  KGSSGSLN-SIPSGLTEAVKSLDLSNNRITYISNSDLQRC---VNLQALVLTSNGIN-TI 91

Query: 422 PEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL----DGPFLTNLLNS 476
            E++   L  L HL+LS+N LS+           L  L+L  N      +    ++L   
Sbjct: 92  EEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTK- 150

Query: 477 STLQELHLADN-LLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGN 535
             LQ L + +    T +       ++ L+ L++  + L  Y P  L S+  +  L L   
Sbjct: 151 --LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208

Query: 536 NISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPN 571
                L   +   +S+  L +          + L  
Sbjct: 209 QHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  108 bits (272), Expect = 5e-26
 Identities = 65/304 (21%), Positives = 102/304 (33%), Gaps = 37/304 (12%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLK 319
           P  S +   L  +  +L G   +   L    + +     +  +   L        L+ L 
Sbjct: 22  PDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSL-------SLKRLT 74

Query: 320 LSNNRFSGFIPNDLLKGDSLL-LTDLDLSANNLSG----SVSMILSTNLHMLNLSSNGLT 374
           +   R    I    L+   +  L +L L    ++G     +      +L++LNL +    
Sbjct: 75  VRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134

Query: 375 GEL-------PLLTGSCAVLDLSNNQFEG---NLSRILKWGNIEYLDLSRNHLTGSIPEE 424
                       L     VL ++            R+     +  LDLS N   G     
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP--ALSTLDLSDNPELGERGLI 192

Query: 425 T----PQFLRLNHLNLSHN---SLSSSLPKVIIQYQKLRVLDLSFNHLDG-PFLTNLLNS 476
           +     +F  L  L L +    + S     +     +L+ LDLS N L       +    
Sbjct: 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252

Query: 477 STLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNN 536
           S L  L+L+   L  V    P     L VLDLS+NRL+   P     L  +  L L GN 
Sbjct: 253 SQLNSLNLSFTGLKQVPKGLPA---KLSVLDLSYNRLDR-NPS-PDELPQVGNLSLKGNP 307

Query: 537 ISGS 540
              S
Sbjct: 308 FLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  108 bits (270), Expect = 1e-25
 Identities = 63/326 (19%), Positives = 98/326 (30%), Gaps = 40/326 (12%)

Query: 153 NFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFEL 212
           NFS   PD  S    + + D+       SL   L R++           F+  I      
Sbjct: 16  NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDT----EADLGQFTDIIKS---- 67

Query: 213 ILGLQVLDFHGNKLDGHLDGEFFLLTNASHI---DFSGNMFVGSSSQKFLPGLSQSVQYL 269
            L L+ L     ++   +      +   S +           G++    L      +  L
Sbjct: 68  -LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126

Query: 270 NLSLNQLTGSLVNGGELQ--LFENLKVLDLSYNQLTG-ELPGFNFVYELQVLKLSNNRFS 326
           NL             ELQ  L   LKVL ++                 L  L LS+N   
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186

Query: 327 G--FIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSC 384
           G   + + L       L  L L    +               +   + L      L    
Sbjct: 187 GERGLISALCPLKFPTLQVLALRNAGME------------TPSGVCSALAAARVQLQ--- 231

Query: 385 AVLDLSNNQFEGNLSRILKWG--NIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLS 442
             LDLS+N                +  L+LS   L   +P+  P   +L+ L+LS+N L 
Sbjct: 232 -GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRL- 286

Query: 443 SSLPKVIIQYQKLRVLDLSFNHLDGP 468
              P    +  ++  L L  N     
Sbjct: 287 DRNPS-PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  106 bits (265), Expect = 4e-25
 Identities = 51/267 (19%), Positives = 83/267 (31%), Gaps = 46/267 (17%)

Query: 76  LDNLGLSAAA--DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDF--KSLEFLDVSDN--- 128
           +    + +           +S L +L++ N  ++G  P  + +     L  L++ +    
Sbjct: 75  VRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134

Query: 129 -LFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALT 187
              +            L+ LS+A  +      + V    ++ +LDLS N   G       
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194

Query: 188 ----RLNNLVYLNLSSNGF---SKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNA 240
               +   L  L L + G    S          + LQ LD   N L              
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP-- 252

Query: 241 SHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYN 300
                                    +  LNLS   L   +  G    L   L VLDLSYN
Sbjct: 253 -----------------------SQLNSLNLSFTGLK-QVPKG----LPAKLSVLDLSYN 284

Query: 301 QLTGELPGFNFVYELQVLKLSNNRFSG 327
           +L    P  + + ++  L L  N F  
Sbjct: 285 RLD-RNPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 94.6 bits (235), Expect = 4e-21
 Identities = 60/296 (20%), Positives = 100/296 (33%), Gaps = 33/296 (11%)

Query: 324 RFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGS 383
            FS   P+     + L   D++L     S    ++   +          +   L L    
Sbjct: 16  NFSDPKPDWSSAFNCLGAADVELYGGGRSLE-YLLKRVDTEADLGQFTDIIKSLSLKR-- 72

Query: 384 CAVLDLSNNQF----EGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQF--LRLNHLNLS 437
              L +   +          R+L    ++ L L    +TG+ P    +     LN LNL 
Sbjct: 73  ---LTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129

Query: 438 HNSLSSSLPKVIIQYQK----LRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVL 493
           + S ++    +    Q     L+VL ++  H        +     L  L L+DN   G  
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189

Query: 494 DFS----PPSVSNLQVLDLSHNRLN---GYFPDRLGSLTGLKVLCLAGNNISGSLPTSM- 545
                  P     LQVL L +  +    G       +   L+ L L+ N++  +      
Sbjct: 190 GLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249

Query: 546 ANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSGAVPENLRKFPSSSFYP 601
              + L+SL +S       +P  LP  L   ++SYN         L + PS    P
Sbjct: 250 DWPSQLNSLNLSFTGLKQ-VPKGLPAKLSVLDLSYN--------RLDRNPSPDELP 296

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 91.5 bits (227), Expect = 5e-20
 Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 14/177 (7%)

Query: 85  ADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI----GK 140
           A+L  +     L  LS++         + +  F +L  LD+SDN               K
Sbjct: 141 AELQQWLKPG-LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199

Query: 141 LESLQNLSLAGNNF---SGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLN 196
             +LQ L+L        SG+     +  V +Q LDLSHNS   +    +    + L  LN
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259

Query: 197 LSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGS 253
           LS  G  + +P+G  L   L VLD   N+LD +   +   L    ++   GN F+ S
Sbjct: 260 LSFTGLKQ-VPKG--LPAKLSVLDLSYNRLDRNPSPDE--LPQVGNLSLKGNPFLDS 311

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  106 bits (266), Expect = 2e-25
 Identities = 47/206 (22%), Positives = 90/206 (43%), Gaps = 17/206 (8%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVK--WLREGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
             +GR S  T Y+    E  + +       R+    +R+ F +EA+    ++HPN+V   
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 839 GYYWGPTQHEKL--ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
             +    + +K   ++++ ++ G+L ++L     ++   +           + +GL +LH
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLH 146

Query: 897 F-DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAA 955
                + H +LK  NI + GP  + ++ D  L  L   +     I   G   + APE+  
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---GTPEFMAPEMY- 202

Query: 956 SKKPHPSFKSDVYAFGVILLELLTGR 981
             +       DVYAFG+ +LE+ T  
Sbjct: 203 --EEKYDESVDVYAFGMCMLEMATSE 226

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  108 bits (271), Expect = 6e-25
 Identities = 59/277 (21%), Positives = 102/277 (36%), Gaps = 54/277 (19%)

Query: 288 LFENLKVLDLSYNQLTGELPGFNFVY--ELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLD 345
           +  N ++L+L  NQ+   +   +F +   L++L+LS N     I      G         
Sbjct: 62  ISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNG--------- 110

Query: 346 LSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWG 405
                           NL+ L L  N LT              + N  F           
Sbjct: 111 --------------LANLNTLELFDNRLT-------------TIPNGAFVYL-------S 136

Query: 406 NIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQY-QKLRVLDLSFN 463
            ++ L L  N +  SIP      +  L  L+L      S + +   +    LR L+L+  
Sbjct: 137 KLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC 195

Query: 464 HLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGS 523
           +L    + NL     L EL L+ N L+ +   S   + +LQ L +  +++     +   +
Sbjct: 196 NLR--EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN 253

Query: 524 LTGLKVLCLAGNNISGSLPTSM-ANMTSLSSLVISQN 559
           L  L  + LA NN++  LP  +   +  L  + +  N
Sbjct: 254 LQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  104 bits (260), Expect = 2e-23
 Identities = 56/254 (22%), Positives = 105/254 (41%), Gaps = 17/254 (6%)

Query: 102 SNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDS 161
              ++   +PD I    +   L++ +N       +    L  L+ L L+ N+   +   +
Sbjct: 51  VRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGA 107

Query: 162 VSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVL 219
            +GL ++ +L+L  N  + ++P  A   L+ L  L L +N     IP   F  I  L+ L
Sbjct: 108 FNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRL 165

Query: 220 D-FHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTG 278
           D     +L    +G F  L+N  +++ +        +   L  L      L+LS N L+ 
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKL----DELDLSGNHLSA 221

Query: 279 SLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGD 337
             +  G  Q   +L+ L +  +Q+       F+ +  L  + L++N  +  +P+DL    
Sbjct: 222 --IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPL 278

Query: 338 SLLLTDLDLSANNL 351
             L   + L  N  
Sbjct: 279 HHLER-IHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  103 bits (258), Expect = 2e-23
 Identities = 54/233 (23%), Positives = 94/233 (40%), Gaps = 14/233 (6%)

Query: 96  LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNLSLAGNNF 154
              L++  N I  +  ++    + LE L +S N    ++  G    L +L  L L  N  
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRL 124

Query: 155 SGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FEL 212
           + +   +   L  ++ L L +N    S+P  A  R+ +L  L+L        I  G FE 
Sbjct: 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183

Query: 213 ILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLS 272
           +  L+ L+     L          L     +D SGN         F  GL   +Q L + 
Sbjct: 184 LSNLRYLNLAMCNL--REIPNLTPLIKLDELDLSGNHLSAIRPGSF-QGLM-HLQKLWMI 239

Query: 273 LNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYELQVLKLSNN 323
            +Q+    +        ++L  ++L++N LT  LP   F  ++ L+ + L +N
Sbjct: 240 QSQIQV--IERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 92.5 bits (230), Expect = 9e-20
 Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 35/217 (16%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNL 147
            F+ L+ L  L + +N ++ +          L+ L + +N   S +PS    ++ SL+ L
Sbjct: 107 AFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRL 165

Query: 148 SLAGNN-FSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRI 206
            L      S +   +  GL +++ L+L+  +      P LT L  L  L+LS N  S  I
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLS-AI 222

Query: 207 PRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
             G F+ ++ LQ L    +++                     N F        L  L   
Sbjct: 223 RPGSFQGLMHLQKLWMIQSQIQ----------------VIERNAFDN------LQSL--- 257

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQL 302
              +NL+ N LT   +         +L+ + L +N  
Sbjct: 258 -VEINLAHNNLTL--LPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 91.3 bits (227), Expect = 2e-19
 Identities = 62/243 (25%), Positives = 106/243 (43%), Gaps = 21/243 (8%)

Query: 360 STNLHMLNLSSNGLTGELPL-LTGSCAVLDLSNNQFEGNLSRILKW-GNIEYLDLSRNHL 417
           S     +      L  E+P  ++ +  +L+L  NQ +       K   ++E L LSRNH+
Sbjct: 42  SNQFSKVICVRKNLR-EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 418 TGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL----DGPFLTN 472
             +I       L  LN L L  N L++      +   KL+ L L  N +       F   
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAF-NR 158

Query: 473 LLNSSTLQELHLAD-NLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLC 531
           + +   L+ L L +   L+ + + +   +SNL+ L+L+   L    P+ L  L  L  L 
Sbjct: 159 IPS---LRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELD 213

Query: 532 LAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPN---NLPNSLETFNVSYNDFSGAVP 588
           L+GN++S   P S   +  L  L + Q+       N   NL + L   N+++N+ +  +P
Sbjct: 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQS-LVEINLAHNNLT-LLP 271

Query: 589 ENL 591
            +L
Sbjct: 272 HDL 274

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 77.9 bits (192), Expect = 5e-15
 Identities = 31/139 (22%), Positives = 60/139 (43%), Gaps = 5/139 (3%)

Query: 88  SVFSNLSMLVKLSMS-NNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQN 146
             F+ +  L +L +     +S +         +L +L+++       +P+ +  L  L  
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDE 211

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKR 205
           L L+GN+ S + P S  GL+ +Q L +  +     +   A   L +LV +NL+ N  +  
Sbjct: 212 LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLL 270

Query: 206 IPRGFELILGLQVLDFHGN 224
               F  +  L+ +  H N
Sbjct: 271 PHDLFTPLHHLERIHLHHN 289

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score =  108 bits (272), Expect = 7e-25
 Identities = 89/430 (20%), Positives = 141/430 (32%), Gaps = 80/430 (18%)

Query: 191 NLVYLNLSSNGFS-KRIPRGFELILGLQVLDFHGNKLD----GHLDGEFFLLTNASHIDF 245
           ++  L++     S  R      L+   QV+      L       +     +    + ++ 
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 246 SGNMFVGSSSQKFLPGL---SQSVQYLNLSLNQLT--GSLVNGGELQLFENLKVLDLSYN 300
             N          L GL   S  +Q L+L    LT  G  V    L+    L+ L LS N
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123

Query: 301 QLTGELPGFNFVYE--------LQVLKLSNNRFSGFIPNDLLKGDSLL----LTDLDLSA 348
            L     G   + E        L+ L+L     S      L     L       +L +S 
Sbjct: 124 LLGDA--GLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL--ASVLRAKPDFKELTVSN 179

Query: 349 NNLSGSVSMILS-------TNLHMLNLSSNGLTGELPLLTGSCAVLD--LSNNQFEGNLS 399
           N+++ +   +L          L  L L S G+T +      +C  L   +++        
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSD------NCRDLCGIVASKA------ 227

Query: 400 RILKWGNIEYLDLSRNHLTGS-----IPEETPQFLRLNHLNLSHNSLS----SSLPKVII 450
                 ++  L L  N L         P       RL  L +    ++      L +V+ 
Sbjct: 228 ------SLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281

Query: 451 QYQKLRVLDLSFNHLDGP---FLTNLL--NSSTLQELHLADNLLT--GVLDFSP--PSVS 501
             + L+ L L+ N L       L   L      L+ L +     T      FS       
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR 341

Query: 502 NLQVLDLSHNRLNG----YFPDRLGS-LTGLKVLCLAGNNIS----GSLPTSMANMTSLS 552
            L  L +S+NRL           LG   + L+VL LA  ++S     SL  ++    SL 
Sbjct: 342 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401

Query: 553 SLVISQNHFT 562
            L +S N   
Sbjct: 402 ELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score =  101 bits (255), Expect = 8e-23
 Identities = 94/505 (18%), Positives = 155/505 (30%), Gaps = 115/505 (22%)

Query: 118 KSLEFLDVSDNLFS-SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHN 176
             ++ LD+     S +     +  L+  Q + L     +         + S     L  N
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT---EARCKDISSA----LRVN 55

Query: 177 SFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELIL--------GLQVLDFHGNKLD- 227
                          L  LNL SN        G   +L         +Q L      L  
Sbjct: 56  P-------------ALAELNLRSNELG---DVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 99

Query: 228 ---GHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQ---SVQYLNLSLNQLT--GS 279
              G L      L     +  S N+   +  Q    GL      ++ L L    L+    
Sbjct: 100 AGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC 159

Query: 280 LVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYE--------LQVLKLSNNRFSGFIPN 331
                 L+   + K L +S N +     G   + +        L+ LKL +   +     
Sbjct: 160 EPLASVLRAKPDFKELTVSNNDINEA--GVRVLCQGLKDSPCQLEALKLESCGVTSDNCR 217

Query: 332 DLLKG--DSLLLTDLDLSANNLSGSVSMILS-------TNLHMLNLSSNGLTGELPLLTG 382
           DL         L +L L +N L       L        + L  L +   G+T +      
Sbjct: 218 DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAK------ 271

Query: 383 SCAVL--DLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL---------RL 431
            C  L   L   +            +++ L L+ N L     +E  + L         +L
Sbjct: 272 GCGDLCRVLRAKE------------SLKELSLAGNELG----DEGARLLCETLLEPGCQL 315

Query: 432 NHLNLSHNSLSS----SLPKVIIQYQKLRVLDLSFNHLDGPFLTNL-----LNSSTLQEL 482
             L +   S ++        V+ Q + L  L +S N L+   +  L        S L+ L
Sbjct: 316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375

Query: 483 HLADNLLT--GVLDFSPPSVSN--LQVLDLSHNRLNG----YFPDRLGSL-TGLKVLCLA 533
            LAD  ++       +   ++N  L+ LDLS+N L         + +      L+ L L 
Sbjct: 376 WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLY 435

Query: 534 GNNIS----GSLPTSMANMTSLSSL 554
               S      L     +  SL  +
Sbjct: 436 DIYWSEEMEDRLQALEKDKPSLRVI 460

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 88.9 bits (221), Expect = 1e-18
 Identities = 81/467 (17%), Positives = 143/467 (30%), Gaps = 119/467 (25%)

Query: 78  NLGLSAAADL-SVFSNLSMLVKLSMSNNSISGVIPDNIGDF-----KSLEFLDVSDNLFS 131
            L  +   D+ S       L +L++ +N +  V    +          ++ L + +   +
Sbjct: 39  GLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 98

Query: 132 ----SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLV--------SIQSLDLSHNSFS 179
                 L S +  L +LQ L L+ N         +  L          ++ L L + S S
Sbjct: 99  GAGCGVLSSTLRTLPTLQELHLSDNLLG---DAGLQLLCEGLLDPQCRLEKLQLEYCSLS 155

Query: 180 ----GSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELI--------LGLQVLDFHGNKLD 227
                 L   L    +   L +S+N  +     G  ++          L+ L      + 
Sbjct: 156 AASCEPLASVLRAKPDFKELTVSNNDIN---EAGVRVLCQGLKDSPCQLEALKLESCGVT 212

Query: 228 ----GHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGL---SQSVQYLNLSLNQLT--- 277
                 L G      +   +    N        +  PGL   S  ++ L +    +T   
Sbjct: 213 SDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKG 272

Query: 278 -GSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKG 336
            G L     L+  E+LK L L+ N+L  E              L           + L  
Sbjct: 273 CGDLCRV--LRAKESLKELSLAGNELGDE----------GARLLC----------ETLLE 310

Query: 337 DSLLLTDLDLSANNLSGSVSMILS------TNLHMLNLSSNGLTGELPLLTGSCAVLDLS 390
               L  L + + + + +     S        L  L +S+N L        G        
Sbjct: 311 PGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA-----GVRE----- 360

Query: 391 NNQFEGNLSRILKWGN--IEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKV 448
                  L + L      +  L L+   ++                + S +SL+++L   
Sbjct: 361 -------LCQGLGQPGSVLRVLWLADCDVS----------------DSSCSSLAATLLA- 396

Query: 449 IIQYQKLRVLDLSFNHLDGPFLTNLL-----NSSTLQELHLADNLLT 490
                 LR LDLS N L    +  L+         L++L L D   +
Sbjct: 397 ---NHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 87.3 bits (217), Expect = 5e-18
 Identities = 72/350 (20%), Positives = 119/350 (34%), Gaps = 77/350 (22%)

Query: 290 ENLKVLDLSYNQLTGE-----LPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLL---- 340
            +++ LD+   +L+       LP      + QV++L +   +           S L    
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQ---QCQVVRLDDCGLT---EARCKDISSALRVNP 56

Query: 341 -LTDLDLSANNLSGSVSMIL-------STNLHMLNLSSNGLTGELPLLTGSCAVL--DLS 390
            L +L+L +N L       +       S  +  L+L +  LTG        C VL   L 
Sbjct: 57  ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA------GCGVLSSTLR 110

Query: 391 NNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLR-----LNHLNLSHNSLSS-- 443
                           ++ L LS N L  +  +   + L      L  L L + SLS+  
Sbjct: 111 TLP------------TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS 158

Query: 444 --SLPKVIIQYQKLRVLDLSFNHLDGPFLTNLL-----NSSTLQELHLADNLLT--GVLD 494
              L  V+      + L +S N ++   +  L      +   L+ L L    +T     D
Sbjct: 159 CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRD 218

Query: 495 FSP--PSVSNLQVLDLSHNRL-----NGYFPDRLGSLTGLKVLCLAGNNIS----GSLPT 543
                 S ++L+ L L  N+L         P  L   + L+ L +    I+    G L  
Sbjct: 219 LCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR 278

Query: 544 SMANMTSLSSLVISQNHFTGP----LPNNLPN---SLETFNVSYNDFSGA 586
            +    SL  L ++ N         L   L      LE+  V    F+ A
Sbjct: 279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAA 328

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 80.8 bits (200), Expect = 6e-16
 Identities = 51/272 (18%), Positives = 91/272 (33%), Gaps = 45/272 (16%)

Query: 359 LSTNLHMLNLSSNGLTGE-----LPLLTGSCAVLDLSNNQF--EG--NLSRILK-WGNIE 408
           +S ++  L++    L+       LPLL   C V+ L +         ++S  L+    + 
Sbjct: 1   MSLDIQSLDIQCEELSDARWAELLPLLQ-QCQVVRLDDCGLTEARCKDISSALRVNPALA 59

Query: 409 YLDLSRNHLTGSIPEETPQFLR-----LNHLNLSHNSLS----SSLPKVIIQYQKLRVLD 459
            L+L  N L         Q L+     +  L+L +  L+      L   +     L+ L 
Sbjct: 60  ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119

Query: 460 LSFNHLDGPFLTNLL-----NSSTLQELHLADNLLT--GVLDFSP--PSVSNLQVLDLSH 510
           LS N L    L  L          L++L L    L+       +    +  + + L +S+
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179

Query: 511 NRLNG----YFPDRLGSLT-GLKVLCLAGNNIS----GSLPTSMANMTSLSSLVISQNHF 561
           N +N          L      L+ L L    ++      L   +A+  SL  L +  N  
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239

Query: 562 T-------GPLPNNLPNSLETFNVSYNDFSGA 586
                    P   +  + L T  +     +  
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAK 271

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 49.6 bits (119), Expect = 5e-06
 Identities = 52/259 (20%), Positives = 88/259 (33%), Gaps = 57/259 (22%)

Query: 78  NLGLSAAADL-SVFSNLSMLVKLSMSNNSI--SGVI---PDNIGDFKSLEFLDVSDNLFS 131
            +      DL  + ++ + L +L++ +N +   G+    P  +     L  L + +   +
Sbjct: 210 GVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGIT 269

Query: 132 ----SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLV--------SIQSLDLSHNSFS 179
                 L   +   ESL+ LSLAGN       +    L          ++SL +   SF+
Sbjct: 270 AKGCGDLCRVLRAKESLKELSLAGNELG---DEGARLLCETLLEPGCQLESLWVKSCSFT 326

Query: 180 G----SLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFF 235
                     L +   L+ L +S+N        G   +   Q L   G+ L         
Sbjct: 327 AACCSHFSSVLAQNRFLLELQISNNRLE---DAGVRELC--QGLGQPGSVL--------- 372

Query: 236 LLTNASHIDFSGNMFVGSSSQKFLPGLS--QSVQYLNLSLNQLTGSLVNGGELQLFE--- 290
                  +  +      SS       L    S++ L+LS N L     + G LQL E   
Sbjct: 373 -----RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG----DAGILQLVESVR 423

Query: 291 ----NLKVLDLSYNQLTGE 305
                L+ L L     + E
Sbjct: 424 QPGCLLEQLVLYDIYWSEE 442

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  107 bits (270), Expect = 8e-25
 Identities = 57/276 (20%), Positives = 97/276 (35%), Gaps = 33/276 (11%)

Query: 289 FENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSA 348
                 +  +   L+ E+P        + L L  N     I  D  +    L   L L  
Sbjct: 53  SNQFSKVVCTRRGLS-EVPQ-GIPSNTRYLNLMENNIQ-MIQADTFRHLHHL-EVLQLGR 108

Query: 349 NNLSGSVSMILS--TNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGN 406
           N++        +   +L+ L L  N LT              + +  FE           
Sbjct: 109 NSIRQIEVGAFNGLASLNTLELFDNWLT-------------VIPSGAFEYL-------SK 148

Query: 407 IEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSH-NSLSSSLPKVIIQYQKLRVLDLSFNH 464
           +  L L  N +  SIP      +  L  L+L     L             L+ L+L   +
Sbjct: 149 LRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207

Query: 465 LDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSL 524
           +    + NL     L+EL ++ N    +   S   +S+L+ L + +++++    +    L
Sbjct: 208 I--KDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGL 265

Query: 525 TGLKVLCLAGNNISGSLPTSM-ANMTSLSSLVISQN 559
             L  L LA NN+S SLP  +   +  L  L +  N
Sbjct: 266 ASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  104 bits (261), Expect = 1e-23
 Identities = 58/279 (20%), Positives = 106/279 (37%), Gaps = 44/279 (15%)

Query: 314 ELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSN 371
           +   +  +    S  +P  +          L+L  NN+    +       +L +L L  N
Sbjct: 55  QFSKVVCTRRGLS-EVPQGIPSN----TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109

Query: 372 GLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL-R 430
            +               +    F G L+      ++  L+L  N LT  IP    ++L +
Sbjct: 110 SIR-------------QIEVGAFNG-LA------SLNTLELFDNWLT-VIPSGAFEYLSK 148

Query: 431 LNHLNLSHNSLSSSLPKVIIQYQKLRVLDLS-FNHL----DGPFLTNLLNSSTLQELHLA 485
           L  L L +N + S       +   L  LDL     L    +G F   L N   L+ L+L 
Sbjct: 149 LRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAF-EGLFN---LKYLNLG 204

Query: 486 DNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSM 545
              +  + + +P  +  L+ L++S N      P     L+ LK L +  + +S     + 
Sbjct: 205 MCNIKDMPNLTP--LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAF 262

Query: 546 ANMTSLSSLVISQNHFTGPLPNNL---PNSLETFNVSYN 581
             + SL  L ++ N+ +  LP++L      L   ++ +N
Sbjct: 263 DGLASLVELNLAHNNLSS-LPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  103 bits (259), Expect = 2e-23
 Identities = 67/276 (24%), Positives = 108/276 (39%), Gaps = 26/276 (9%)

Query: 55  DGCPSSWNGIVCN-GGNVAGVVLDNLGLSAAADLSVFSNLSM-LVKLSMSNNSISGVIPD 112
             CPS     VC+     + VV    GLS      V   +      L++  N+I  +  D
Sbjct: 44  QNCPS-----VCSCSNQFSKVVCTRRGLS-----EVPQGIPSNTRYLNLMENNIQMIQAD 93

Query: 113 NIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSL 171
                  LE L +  N     +  G    L SL  L L  N  + +   +   L  ++ L
Sbjct: 94  TFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLREL 152

Query: 172 DLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLDGH 229
            L +N    S+P  A  R+ +L+ L+L      + I  G FE +  L+ L+     +   
Sbjct: 153 WLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI--K 209

Query: 230 LDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLF 289
                  L     ++ SGN F       F  GLS S++ L +  +Q++   +        
Sbjct: 210 DMPNLTPLVGLEELEMSGNHFPEIRPGSF-HGLS-SLKKLWVMNSQVSL--IERNAFDGL 265

Query: 290 ENLKVLDLSYNQLTGELPG--FNFVYELQVLKLSNN 323
            +L  L+L++N L+  LP   F  +  L  L L +N
Sbjct: 266 ASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 60.9 bits (148), Expect = 1e-09
 Identities = 29/93 (31%), Positives = 42/93 (45%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
           D+   + L  L +L MS N    + P +     SL+ L V ++  S    +    L SL 
Sbjct: 210 DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLV 269

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF 178
            L+LA NN S L  D  + L  +  L L HN +
Sbjct: 270 ELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 50.1 bits (120), Expect = 3e-06
 Identities = 26/114 (22%), Positives = 44/114 (38%), Gaps = 11/114 (9%)

Query: 476 SSTLQELHLADNLLTGVLDFSPPSV-SNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAG 534
           S+   ++      L+ V    P  + SN + L+L  N +     D    L  L+VL L  
Sbjct: 53  SNQFSKVVCTRRGLSEV----PQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGR 108

Query: 535 NNISGSLPTSMANMTSLSSLVISQNHFTGPLPN----NLPNSLETFNVSYNDFS 584
           N+I      +   + SL++L +  N  T  +P+     L   L    +  N   
Sbjct: 109 NSIRQIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSK-LRELWLRNNPIE 160

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 99.8 bits (249), Expect = 6e-23
 Identities = 48/286 (16%), Positives = 104/286 (36%), Gaps = 48/286 (16%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
            +     L+  +K++   ++++  +     D   +  L       ++    G+  L +L 
Sbjct: 11  VIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLI 66

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            L L  N  + L P  +  L  I  L+LS N    ++   +  L ++  L+L+S   +  
Sbjct: 67  GLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDV 122

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
            P     +  LQVL    N++              ++I     +               +
Sbjct: 123 TP--LAGLSNLQVLYLDLNQI--------------TNISPLAGL--------------TN 152

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRF 325
           +QYL++   Q++    +   L     L  L    N+++ ++     +  L  + L NN+ 
Sbjct: 153 LQYLSIGNAQVS----DLTPLANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQI 207

Query: 326 SGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSN 371
           S   P          L  + L+   ++ +  +  + NL + N+   
Sbjct: 208 SDVSPLANTSN----LFIVTLTNQTIT-NQPVFYNNNLVVPNVVKG 248

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 54/246 (21%), Positives = 100/246 (40%), Gaps = 23/246 (9%)

Query: 341 LTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT-----GELPLLTGSCAVLDLSNNQFE 395
              +    +N++ +V+      +  L+    G+T       L  L      L+L +NQ  
Sbjct: 21  AIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEGVQYLNNLI----GLELKDNQIT 76

Query: 396 GNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKL 455
            +L+ +     I  L+LS N L         Q ++   L+L+   ++   P  +     L
Sbjct: 77  -DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIK--TLDLTSTQITDVTP--LAGLSNL 131

Query: 456 RVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNG 515
           +VL L  N +    ++ L   + LQ L + +  ++ +   +  ++S L  L    N+++ 
Sbjct: 132 QVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKADDNKISD 187

Query: 516 YFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLET 575
             P  L SL  L  + L  N IS   P  +AN ++L  + ++    T   P    N+L  
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN-QPVFYNNNLVV 242

Query: 576 FNVSYN 581
            NV   
Sbjct: 243 PNVVKG 248

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 61/313 (19%), Positives = 116/313 (37%), Gaps = 48/313 (15%)

Query: 237 LTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLD 296
           L NA  I    +    + +Q  L G+      L+     +T ++     +Q   NL  L+
Sbjct: 18  LANAIKIAAGKSNVTDTVTQADLDGI----TTLSAFGTGVT-TIEG---VQYLNNLIGLE 69

Query: 297 LSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVS 356
           L  NQ+T +L     + ++  L+LS N          L+     +  LDL++  ++    
Sbjct: 70  LKDNQIT-DLAPLKNLTKITELELSGNPLKNVSAIAGLQS----IKTLDLTSTQITDVTP 124

Query: 357 MILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNH 416
           +   +NL +L L  N +T                      N+S +    N++YL +    
Sbjct: 125 LAGLSNLQVLYLDLNQIT----------------------NISPLAGLTNLQYLSIGNAQ 162

Query: 417 LTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNS 476
           ++   P       +L  L    N +S   P  +     L  + L  N +    ++ L N+
Sbjct: 163 VSDLTPLA--NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD--VSPLANT 216

Query: 477 STLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNN 536
           S L  + L +  +T   +      +NL V ++              S  G      A  N
Sbjct: 217 SNLFIVTLTNQTIT---NQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGT----YASPN 269

Query: 537 ISGSLPTSMANMT 549
           ++ +L + + N++
Sbjct: 270 LTWNLTSFINNVS 282

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 51/267 (19%), Positives = 102/267 (38%), Gaps = 45/267 (16%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
            +     L+ L+ L + +N I+ +    + +   +  L++S N   +   S I  L+S++
Sbjct: 55  TIEGVQYLNNLIGLELKDNQITDL--APLKNLTKITELELSGNPLKN--VSAIAGLQSIK 110

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            L L     + + P  ++GL ++Q L L  N  + ++ P L  L NL YL++ +   S  
Sbjct: 111 TLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD- 165

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
           +      +  L  L    NK+              S I    ++               +
Sbjct: 166 LT-PLANLSKLTTLKADDNKI--------------SDISPLASL--------------PN 196

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRF 325
           +  ++L  NQ++    +   L    NL ++ L+   +T +   +N    L V  +     
Sbjct: 197 LIEVHLKNNQIS----DVSPLANTSNLFIVTLTNQTITNQPVFYN--NNLVVPNVVKGPS 250

Query: 326 SGFIPNDLLKGDSLLLTDLDLSANNLS 352
              I    +  D+      +L+ N  S
Sbjct: 251 GAPIAPATI-SDNGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 44/242 (18%), Positives = 88/242 (36%), Gaps = 18/242 (7%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
           DL+   NL+ + +L +S N +  V    I   +S++ LD++    +    + +  L +LQ
Sbjct: 77  DLAPLKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQ 132

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            L L  N  + + P  ++GL ++Q L + +   S  L P L  L+ L  L    N  S  
Sbjct: 133 VLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISD- 187

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
           I      +  L  +    N++           +N   +  +             P    +
Sbjct: 188 IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN------QPVFYNN 238

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRF 325
              +   +   +G+ +    +         +L++N  +          +    K +   F
Sbjct: 239 NLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPF 298

Query: 326 SG 327
           SG
Sbjct: 299 SG 300

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 56/218 (25%), Positives = 87/218 (39%), Gaps = 12/218 (5%)

Query: 110 IPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQ 169
           +P  I    + + + +  N  S    +      +L  L L  N  + +   + +GL  ++
Sbjct: 26  VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 170 SLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLD 227
            LDLS N+   S+ P     L  L  L+L   G    +  G F  +  LQ L    N L 
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142

Query: 228 GHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQ 287
              D  F  L N +H+   GN       + F  GL  S+  L L  N++    V+    +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFR-GLH-SLDRLLLHQNRVAH--VHPHAFR 198

Query: 288 LFENLKVLDLSYNQLTGELPG--FNFVYELQVLKLSNN 323
               L  L L  N L+  LP      +  LQ L+L++N
Sbjct: 199 DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 97.0 bits (242), Expect = 4e-22
 Identities = 59/246 (23%), Positives = 86/246 (34%), Gaps = 40/246 (16%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLN 190
            ++P GI    + Q + L GN  S +   S     ++  L L  N  +  +   A T L 
Sbjct: 24  QAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLA 80

Query: 191 NLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNM 249
            L  L+LS N   + +    F  +  L  L      L                +     +
Sbjct: 81  LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL--------------QEL--GPGL 124

Query: 250 FVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGF 309
           F G      L  L    QYL L  N L    +     +   NL  L L  N+++  +P  
Sbjct: 125 FRG------LAAL----QYLYLQDNALQ--ALPDDTFRDLGNLTHLFLHGNRIS-SVPER 171

Query: 310 NFVY--ELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHM 365
            F     L  L L  NR +  +     +     L  L L ANNLS   +  L+    L  
Sbjct: 172 AFRGLHSLDRLLLHQNRVA-HVHPHAFRDLG-RLMTLYLFANNLSALPTEALAPLRALQY 229

Query: 366 LNLSSN 371
           L L+ N
Sbjct: 230 LRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 96.2 bits (240), Expect = 7e-22
 Identities = 61/234 (26%), Positives = 91/234 (38%), Gaps = 32/234 (13%)

Query: 344 LDLSANNLSGSVSMILSTNLHMLNLSSNGLT-------GELPLLTGSCAVLDLSNNQFEG 396
                  L  +V + +      + L  N ++            LT    +L L +N    
Sbjct: 16  TSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLT----ILWLHSNV--- 67

Query: 397 NLSRILKW-----GNIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVII 450
            L+RI          +E LDLS N    S+   T   L RL+ L+L    L    P +  
Sbjct: 68  -LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR 126

Query: 451 QYQKLRVLDLSFNHL----DGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVL 506
               L+ L L  N L    D  F  +L N   L  L L  N ++ V + +   + +L  L
Sbjct: 127 GLAALQYLYLQDNALQALPDDTF-RDLGN---LTHLFLHGNRISSVPERAFRGLHSLDRL 182

Query: 507 DLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTS-MANMTSLSSLVISQN 559
            L  NR+    P     L  L  L L  NN+S +LPT  +A + +L  L ++ N
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 38/164 (23%), Positives = 61/164 (37%), Gaps = 7/164 (4%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNI-GDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQN 146
            F+ L++L +L +S+N+    +          L  L +        L  G+   L +LQ 
Sbjct: 75  AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQY 133

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKR 205
           L L  N    L  D+   L ++  L L  N  S S+P  A   L++L  L L  N  +  
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-H 191

Query: 206 IPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGN 248
           +    F  +  L  L    N L          L    ++  + N
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 52/206 (25%), Positives = 74/206 (35%), Gaps = 25/206 (12%)

Query: 406 NIEYLDLSRNHLTGSIPEETPQFLR-LNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNH 464
             + + L  N ++  +P  + +  R L  L L  N L+            L  LDLS N 
Sbjct: 33  ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 465 LDGPFLTNL-----LNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPD 519
                L ++          L  LHL    L  +       ++ LQ L L  N L     D
Sbjct: 92  Q----LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 520 RLGSLTGLKVLCLAGNNISGSLPTSM-ANMTSLSSLVISQNHFTGPLPN---NLPNSLET 575
               L  L  L L GN IS S+P      + SL  L++ QN      P+   +L   L T
Sbjct: 148 TFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR-LMT 205

Query: 576 FNVSYNDFSGAVPENLRKFPSSSFYP 601
             +  N        NL   P+ +  P
Sbjct: 206 LYLFAN--------NLSALPTEALAP 223

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  102 bits (256), Expect = 1e-22
 Identities = 57/318 (17%), Positives = 112/318 (35%), Gaps = 34/318 (10%)

Query: 292 LKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNL 351
           +         +  ++   +   E     L     +  +  + L      +  +  + +++
Sbjct: 1   MGETITVSTPIK-QIFPDDAFAETIKDNLKKKSVTDAVTQNELNS----IDQIIANNSDI 55

Query: 352 SGSVSMILS-TNLHMLNLSSNGLT-----GELPLLTGSCAVLDLSNNQFEGNLSRILKWG 405
             SV  I    N+  L L+ N LT       L  L      L L  N+ + +LS +    
Sbjct: 56  K-SVQGIQYLPNVTKLFLNGNKLTDIKPLTNLKNLG----WLFLDENKIK-DLSSLKDLK 109

Query: 406 NIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL 465
            ++ L L  N ++  I        +L  L L +N ++     V+ +  KL  L L  N +
Sbjct: 110 KLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 165

Query: 466 DGPFLTNLLNSSTLQELHLADNLLTGVLDFSP-PSVSNLQVLDLSHNRLNGYFPDRLGSL 524
               +  L   + LQ L+L+ N ++   D      + NL VL+L          +   +L
Sbjct: 166 SD--IVPLAGLTKLQNLYLSKNHIS---DLRALAGLKNLDVLELFSQECLNKPINHQSNL 220

Query: 525 TGLKVLCLAGNNISGSL--PTSMANMTSLSSLVISQNHFTGPLPNN-LPNSLETFNVSYN 581
                +     N  GSL  P  +++        +  +        + +     T   +  
Sbjct: 221 VVPNTV----KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276

Query: 582 DFSGAVPENLRKFPSSSF 599
            F G V + L++  + S+
Sbjct: 277 RFHGRVTQPLKEVYTVSY 294

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 99.8 bits (248), Expect = 1e-21
 Identities = 51/286 (17%), Positives = 102/286 (35%), Gaps = 45/286 (15%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
            +      +  +K ++   S++  +     +  S++ +  +++   S    GI  L ++ 
Sbjct: 13  QIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVT 68

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            L L GN  + + P  ++ L ++  L L  N     L   L  L  L  L+L  NG S  
Sbjct: 69  KLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISD- 123

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
           I  G   +  L+ L    NK+              + I     +                
Sbjct: 124 IN-GLVHLPQLESLYLGNNKI--------------TDITVLSRL--------------TK 154

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRF 325
           +  L+L  NQ++  +V    L     L+ L LS N ++ +L     +  L VL+L +   
Sbjct: 155 LDTLSLEDNQIS-DIVP---LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQEC 209

Query: 326 SGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSN 371
                N     + ++   +  +  +L     +    +    N+  +
Sbjct: 210 LNKPINHQS--NLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWH 253

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 92.9 bits (230), Expect = 2e-19
 Identities = 47/283 (16%), Positives = 93/283 (32%), Gaps = 51/283 (18%)

Query: 237 LTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLD 296
                  +        + +Q  L  +      +  + + +  S+     +Q   N+  L 
Sbjct: 20  FAETIKDNLKKKSVTDAVTQNELNSI----DQIIANNSDIK-SVQG---IQYLPNVTKLF 71

Query: 297 LSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVS 356
           L+ N+LT ++     +  L  L L  N+                + DL     +L     
Sbjct: 72  LNGNKLT-DIKPLTNLKNLGWLFLDENK----------------IKDLS----SLKD--- 107

Query: 357 MILSTNLHMLNLSSNGLT-----GELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLD 411
                 L  L+L  NG++       LP L      L L NN+   +++ + +   ++ L 
Sbjct: 108 ---LKKLKSLSLEHNGISDINGLVHLPQLE----SLYLGNNKIT-DITVLSRLTKLDTLS 159

Query: 412 LSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLT 471
           L  N ++  I        +L +L LS N +S      +   + L VL+L         + 
Sbjct: 160 LEDNQIS-DIVPLA-GLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPIN 215

Query: 472 NLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLN 514
           +  N      +   D  L      S     + +  ++  +   
Sbjct: 216 HQSNLVVPNTVKNTDGSLVTPEIISDD--GDYEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 85.9 bits (212), Expect = 2e-17
 Identities = 48/300 (16%), Positives = 97/300 (32%), Gaps = 47/300 (15%)

Query: 74  VVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSS 133
            + DNL   +  D    + L+ + ++  +N+ I  V    I    ++  L ++ N  +  
Sbjct: 23  TIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDI 80

Query: 134 LPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLV 193
               +  L++L  L L  N    L    +  L  ++SL L HN  S  +   L  L  L 
Sbjct: 81  --KPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLE 134

Query: 194 YLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGS 253
            L L +N  +         +  L  L    N++              S I     +    
Sbjct: 135 SLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI--------------SDIVPLAGL---- 174

Query: 254 SSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFV 312
                       +Q L LS N ++    +   L   +NL VL+L   +   +     + +
Sbjct: 175 ----------TKLQNLYLSKNHIS----DLRALAGLKNLDVLELFSQECLNKPINHQSNL 220

Query: 313 YELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNG 372
                +K ++      +    +  D       ++  +    +  +       +    +  
Sbjct: 221 VVPNTVKNTDGS----LVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 96.3 bits (240), Expect = 1e-21
 Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 13/211 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           + LG            L +G F  +K +     + R+E  +EA       HPN++ L  Y
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 841 YW--GPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
                  +HE  +L  +   G+L + +      KG  LT  Q L + + + RGL  +H  
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIH-A 152

Query: 899 RAVPHGNLKATNILLDGPDL-------NARVADYCLHRLMTQAGTIEQILDAGVLGYRAP 951
           +   H +LK TNILL            +   A   +          +       + YRAP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 952 ELAASKKPHP-SFKSDVYAFGVILLELLTGR 981
           EL + +       ++DV++ G +L  ++ G 
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 96.2 bits (240), Expect = 3e-21
 Identities = 46/179 (25%), Positives = 77/179 (43%), Gaps = 16/179 (8%)

Query: 805 VKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHE-KLILSDYISPGSLA 862
           VK  RE +    + +F +EA+      HPN+V L G     TQ +   I+ + +  G   
Sbjct: 144 VKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC---TQKQPIYIVMELVQGGDFL 200

Query: 863 SFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARV 922
           +FL       G  L     L++  D A G+ YL     + H +L A N L+       ++
Sbjct: 201 TFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKCCI-HRDLAARNCLV-TEKNVLKI 254

Query: 923 ADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           +D+ + R     G          +  +  APE     +   S +SDV++FG++L E  +
Sbjct: 255 SDFGMSREEAD-GVYAASGGLRQVPVKWTAPEALNYGR--YSSESDVWSFGILLWETFS 310

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 95.6 bits (238), Expect = 1e-20
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 15/200 (7%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
             LG+   G  +  T      + +K L+ G     + F +EA+    +RH  +V L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 842 WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
              ++    I+++Y+S GSL  FL       G  L   Q + +A  +A G+ Y+     V
Sbjct: 249 ---SEEPIYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMNYV 302

Query: 902 PHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKP 959
            H +L+A NIL+ G +L  +VAD+ L RL+                 +  APE A   + 
Sbjct: 303 -HRDLRAANILV-GENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRF 358

Query: 960 HPSFKSDVYAFGVILLELLT 979
             + KSDV++FG++L EL T
Sbjct: 359 --TIKSDVWSFGILLTELTT 376

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 20/206 (9%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
           E LG    G  +         + VK L++G +     F  EA     ++H  +V L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 842 WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
              TQ    I+++Y+  GSL  FL       G  LT  + L +A  +A G+ ++     +
Sbjct: 78  ---TQEPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEERNYI 131

Query: 902 PHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKP 959
            H +L+A NIL+    L+ ++AD+ L RL+       +  +      +  APE       
Sbjct: 132 -HRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAR--EGAKFPIKWTAPEAINYGT- 186

Query: 960 HPSF--KSDVYAFGVILLELLT-GRC 982
              F  KSDV++FG++L E++T GR 
Sbjct: 187 ---FTIKSDVWSFGILLTEIVTHGRI 209

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 93.4 bits (232), Expect = 2e-20
 Identities = 47/235 (20%), Positives = 80/235 (34%), Gaps = 15/235 (6%)

Query: 96  LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNLSLAGNNF 154
            ++L      +  +       F  LE +++S N     + + +   L  L  + +   N 
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91

Query: 155 SGLIPDSV-SGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FE 211
              I       L ++Q L +S+      LP          V L++  N     I R  F 
Sbjct: 92  LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150

Query: 212 -LILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLN 270
            L     +L  + N +   +    F  T    ++ S N  +         G S     L+
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS-GPVILD 208

Query: 271 LSLNQLTGSLVNGGELQLFENLKVLD-LSYNQLTGELPGFNFVYELQVLKLSNNR 324
           +S  ++  SL + G     ENLK L   S   L  +LP    +  L    L+   
Sbjct: 209 ISRTRIH-SLPSYG----LENLKKLRARSTYNLK-KLPTLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 83.7 bits (207), Expect = 3e-17
 Identities = 41/257 (15%), Positives = 82/257 (31%), Gaps = 29/257 (11%)

Query: 342 TDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT-------GELPLLTGSCAVLDLSNNQF 394
                  + ++  +   L  N   L      L             L      +++S N  
Sbjct: 12  RVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLE----KIEISQNDV 66

Query: 395 EGNLSRILKWG--NIEYLDLSR-NHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVII 450
              +   +      +  + + + N+L   I  E  Q L  L +L +S+  +        I
Sbjct: 67  LEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 125

Query: 451 QYQKLRVLDLSFN-HL----DGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQV 505
              +  +LD+  N ++       F   L  S     L L  N +  + + +       ++
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSF-VGL--SFESVILWLNKNGIQEIHNSAFNGTQLDEL 182

Query: 506 LDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPT-SMANMTSLSSLVISQNHFTGP 564
               +N L     D     +G  +L ++   I  SLP+  + N+  L +           
Sbjct: 183 NLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLPT 241

Query: 565 LPNNLPNSLETFNVSYN 581
           L   L   L   +++Y 
Sbjct: 242 L-EKLVA-LMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 82.2 bits (203), Expect = 1e-16
 Identities = 47/266 (17%), Positives = 89/266 (33%), Gaps = 47/266 (17%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYELQV 317
             L ++   L   L +L    +  G    F +L+ +++S N +   +    F+ + +L  
Sbjct: 26  SDLPRNAIELRFVLTKLRV--IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHE 83

Query: 318 LKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSG--SVSMILSTNLHMLNLSSNGLTG 375
           +++       +I  +  +    L   L +S   +     V  I S    +L++  N    
Sbjct: 84  IRIEKANNLLYINPEAFQNLPNL-QYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 142

Query: 376 ELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLN 435
            +              N F G LS          L L++N +   I        +L+ LN
Sbjct: 143 TIE------------RNSFVG-LSFESVI-----LWLNKNGIQ-EIHNSAFNGTQLDELN 183

Query: 436 LSH-NSLSSSLPKVIIQYQKLRVLDLSFNHL----DGPF--LTNL--LNSSTLQELHLAD 486
           LS  N+L      V        +LD+S   +          L  L   ++  L++L   +
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTLE 243

Query: 487 NLLTGVLDFSPPSVSNLQVLDLSHNR 512
            L              L    L++  
Sbjct: 244 KL------------VALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.0 bits (200), Expect = 2e-16
 Identities = 56/384 (14%), Positives = 101/384 (26%), Gaps = 91/384 (23%)

Query: 143 SLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNG 201
           S +      +  +  IP  +    +   L          +   A +   +L  + +S N 
Sbjct: 10  SNRVFLCQESKVTE-IPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQND 65

Query: 202 FSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPG 261
             + I              F               L     I                  
Sbjct: 66  VLEVIEADV----------FSN-------------LPKLHEIRIEKA------------- 89

Query: 262 LSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVY--ELQVLK 319
                       N L   +       L  NL+ L +S   +   LP  + ++  +  +L 
Sbjct: 90  ------------NNLL-YINPEAFQNL-PNLQYLLISNTGIK-HLPDVHKIHSLQKVLLD 134

Query: 320 LSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSM---ILSTNLHMLNLSSNGLTGE 376
           + +N     I  +   G S     L L+ N +   +       +    +    +N L   
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-- 191

Query: 377 LPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNL 436
                      +L N+ F G             LD+SR  +  S+P        L  L  
Sbjct: 192 -----------ELPNDVFHG-------ASGPVILDISRTRIH-SLPSYG--LENLKKLRA 230

Query: 437 SHNSLSSSLPKVIIQYQKLRVLDLSFN-HLDGPFLTNLLNSSTLQELHLADNLLTGVLDF 495
                   LP  + +   L    L++  H       N      + ELH   N      + 
Sbjct: 231 RSTYNLKKLP-TLEKLVALMEASLTYPSHCCA--FANWR--RQISELHPICNKSILRQEV 285

Query: 496 SPPSVSNLQVLDLSHNRLNGYFPD 519
              + +  Q   L+ +  + Y   
Sbjct: 286 DYMTQARGQRSSLAEDNESSYSRG 309

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 39/204 (19%), Positives = 62/204 (30%), Gaps = 11/204 (5%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDF-KSLEFLDVSDNLFSSSLPSGI--GKLESLQ 145
            F NL  L  L +SN  I   +PD           LD+ DN+   ++      G      
Sbjct: 99  AFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESV 157

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            L L  N    +   + +G    +     +N+            +  V L++S       
Sbjct: 158 ILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFL----LTNASHIDFSGNM---FVGSSSQKF 258
              G E +  L+    +  K    L+    L    LT  SH     N             
Sbjct: 218 PSYGLENLKKLRARSTYNLKKLPTLEKLVALMEASLTYPSHCCAFANWRRQISELHPICN 277

Query: 259 LPGLSQSVQYLNLSLNQLTGSLVN 282
              L Q V Y+  +  Q +    +
Sbjct: 278 KSILRQEVDYMTQARGQRSSLAED 301

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 94.4 bits (235), Expect = 2e-20
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
           + LG    G  + AT      + VK ++ G +   + F  EA     ++H  +V L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 842 WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
              T+    I++++++ GSL  FL      +G      + +  +  +A G+ ++     +
Sbjct: 253 ---TKEPIYIITEFMAKGSLLDFLKS---DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 306

Query: 902 PHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKP 959
            H +L+A NIL+    L  ++AD+ L R++          +      +  APE       
Sbjct: 307 -HRDLRAANILV-SASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGS- 361

Query: 960 HPSFKSDVYAFGVILLELLT-GRC 982
             + KSDV++FG++L+E++T GR 
Sbjct: 362 -FTIKSDVWSFGILLMEIVTYGRI 384

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 91.7 bits (228), Expect = 4e-20
 Identities = 48/205 (23%), Positives = 94/205 (45%), Gaps = 15/205 (7%)

Query: 782 EVLGRSSHGTSYRATLE-----NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVG 836
           + LG+ + G+      +      G  + VK L+    +  ++F +E +   +++H N+V 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
            +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    + +G+ YL 
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 162

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELA 954
             R + H +L   NIL+   +   ++ D+ L +++ Q     ++ + G       APE  
Sbjct: 163 TKRYI-HRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 955 ASKKPHPSFKSDVYAFGVILLELLT 979
              K   S  SDV++FGV+L EL T
Sbjct: 221 TESK--FSVASDVWSFGVVLYELFT 243

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 90.8 bits (226), Expect = 6e-20
 Identities = 48/205 (23%), Positives = 94/205 (45%), Gaps = 15/205 (7%)

Query: 782 EVLGRSSHGTSYRATLE-----NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVG 836
           + LG+ + G+      +      G  + VK L+    +  ++F +E +   +++H N+V 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
            +G  +   +    ++ +Y+  GSL  +L     R    +   + L+    + +G+ YL 
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 131

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELA 954
             R + H +L   NIL+   +   ++ D+ L +++ Q     ++ + G       APE  
Sbjct: 132 TKRYI-HRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189

Query: 955 ASKKPHPSFKSDVYAFGVILLELLT 979
              K   S  SDV++FGV+L EL T
Sbjct: 190 TESK--FSVASDVWSFGVVLYELFT 212

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 93.8 bits (233), Expect = 6e-20
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 15/200 (7%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
             LG+   G  +  T      + +K L+ G     + F +EA+    +RH  +V L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 842 WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
              ++    I+++Y+S GSL  FL       G  L   Q + +A  +A G+ Y+     V
Sbjct: 332 ---SEEPIYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVERMNYV 385

Query: 902 PHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKKP 959
            H +L+A NIL+ G +L  +VAD+ L RL+                 +  APE A   + 
Sbjct: 386 -HRDLRAANILV-GENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRF 441

Query: 960 HPSFKSDVYAFGVILLELLT 979
             + KSDV++FG++L EL T
Sbjct: 442 --TIKSDVWSFGILLTELTT 459

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 48/215 (22%), Positives = 81/215 (37%), Gaps = 28/215 (13%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLR 838
             +G  S+G   +     +G  L  K L  G     +++    E      ++HPN+V   
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
                 T     I+ +Y   G LAS +  +  ++   L     L++   +   L   H  
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 899 RAVP----HGNLKATNILLDGPDLNARVADYCLHRLM--------TQAGTIEQILDAGVL 946
                   H +LK  N+ LDG   N ++ D+ L R++        T  GT          
Sbjct: 131 SDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTP--------- 180

Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            Y +PE       + + KSD+++ G +L EL    
Sbjct: 181 YYMSPEQMNR-MSY-NEKSDIWSLGCLLYELCALM 213

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 91.6 bits (227), Expect = 8e-20
 Identities = 37/292 (12%), Positives = 74/292 (25%), Gaps = 53/292 (18%)

Query: 737 ESGDSFTAENLARL-------------DVRSPDRLVGELHFLDDTLTLTPEELSRAPA-- 781
           E+GDSF  + L R              +  +    V    +  +  T     LS+     
Sbjct: 5   EAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKL 64

Query: 782 ---EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKE---FAKEAKKFANIRHPNV 834
              E L        +    +E      +K    G    R E     +     A +   + 
Sbjct: 65  KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124

Query: 835 VGLRGYY-------------------WGPTQHEKLILSDYI----SPGSLASF--LYDRP 869
              R                        P Q +  + +  +    +   L       D  
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV 184

Query: 870 GRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR 929
                         +   + R    L   + + HG+    N+ +  PD    + D     
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQ-SKGLVHGHFTPDNLFIM-PDGRLMLGDV---S 239

Query: 930 LMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            + + GT      +  + Y   E   +     +   + +  G+ +  +    
Sbjct: 240 ALWKVGTRGPAS-SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 43/212 (20%), Positives = 86/212 (40%), Gaps = 31/212 (14%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQ---RKEFAKEAKKFANIRHPNVVGL 837
           + LG     T Y A      + + +K +     ++    K F +E    + + H N+V +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
                        ++ +YI   +L+ ++         PL+    +     +  G+ + H 
Sbjct: 77  --IDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQILDGIKHAH- 128

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRL-----MTQAGTIEQILDAGVLG---YR 949
           D  + H ++K  NIL+D  +   ++ D+ + +      +TQ           VLG   Y 
Sbjct: 129 DMRIVHRDIKPQNILID-SNKTLKIFDFGIAKALSETSLTQTNH--------VLGTVQYF 179

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           +PE A  +       +D+Y+ G++L E+L G 
Sbjct: 180 SPEQAKGEATDE--CTDIYSIGIVLYEMLVGE 209

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 90.5 bits (225), Expect = 2e-19
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 27/210 (12%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVK--WLREGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
           + +G  S G +      E+G    +K   +    +K+R+E  +E    AN++HPN+V  R
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
             +         I+ DY   G L   +  +   KG      Q L   V +   L ++H D
Sbjct: 90  ESF--EENGSLYIVMDYCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVH-D 143

Query: 899 RAVPHGNLKATNILLDGP------DLN-ARVADYCLHRLMTQAGTIEQILDAGVLGYRAP 951
           R + H ++K+ NI L         D   ARV +  +       GT           Y +P
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY---------YLSP 194

Query: 952 ELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           E+  +K P+ + KSD++A G +L EL T +
Sbjct: 195 EICENK-PY-NNKSDIWALGCVLYELCTLK 222

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 49/221 (22%), Positives = 83/221 (37%), Gaps = 29/221 (13%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           + LGR   G  + A    +     +K +R       R++  +E K  A + HP +V    
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 840 YYWGPTQHEKL----------ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
            +      EKL          I        +L  ++  R   +      +  L I + +A
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE--RSVCLHIFLQIA 128

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG-- 947
             + +LH  + + H +LK +NI     D   +V D+ L   M Q    + +L        
Sbjct: 129 EAVEFLH-SKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186

Query: 948 ---------YRAPELAASKKPHPSFKSDVYAFGVILLELLT 979
                    Y +PE       + S K D+++ G+IL ELL 
Sbjct: 187 HTGQVGTKLYMSPEQI-HGNSY-SHKVDIFSLGLILFELLY 225

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 42/223 (18%)

Query: 782 EVLGRSSHGTSYRATL--ENGMFLTV--KWLREGVA--KQRKEFAKEAKKFANIRHPNVV 835
            +LG+   G+   A L  E+G F+ V  K L+  +      +EF +EA       HP+V 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 836 GLRG--YYWGPTQHEK--LILSDYISPGSLASFL-YDRPGRKGPPLTWAQRLKIAVDVAR 890
            L G              +++  ++  G L +FL   R G     L     ++  VD+A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR- 949
           G+ YL     + H +L A N +L   D+   VAD+ L R +                YR 
Sbjct: 149 GMEYLSSRNFI-HRDLAARNCML-AEDMTVCVADFGLSRKIYSGDY-----------YRQ 195

Query: 950 -----------APELAASKKPHPSF--KSDVYAFGVILLELLT 979
                      A E  A       +   SDV+AFGV + E++T
Sbjct: 196 GCASKLPVKWLALESLADNL----YTVHSDVWAFGVTMWEIMT 234

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 45/213 (21%), Positives = 85/213 (39%), Gaps = 30/213 (14%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREG---VAKQRKEFAKEAKKFANIRHPNVVGL 837
           + +GR      YRA  L +G+ + +K ++      AK R +  KE      + HPNV+  
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 838 RGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
              +    +  +L I+ +    G L+  +     ++   +      K  V +   L ++H
Sbjct: 98  YASF---IEDNELNIVLELADAGDLSRMI-KHFKKQKRLIPERTVWKYFVQLCSALEHMH 153

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM--------TQAGTIEQILDAGVLGY 948
             R V H ++K  N+ +       ++ D  L R          +  GT           Y
Sbjct: 154 -SRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY---------Y 202

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            +PE       + +FKSD+++ G +L E+   +
Sbjct: 203 MSPERIHEN-GY-NFKSDIWSLGCLLYEMAALQ 233

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 56/230 (24%), Positives = 84/230 (36%), Gaps = 31/230 (13%)

Query: 98  KLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNLSLAGNNFSG 156
            L +S N +  +   +   F  L+ LD+S     + +  G    L  L  L L GN    
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQS 90

Query: 157 LIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELIL 214
           L   + SGL S+Q L     + + SL    +  L  L  LN++ N          F  + 
Sbjct: 91  LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 215 GLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLN 274
            L+ LD   NK           + +    D              L  +      L+LSLN
Sbjct: 150 NLEHLDLSSNK-----------IQSIYCTDLRV-----------LHQMPLLNLSLDLSLN 187

Query: 275 QLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNN 323
            +   +  G   ++   LK L L  NQL     G F+ +  LQ + L  N
Sbjct: 188 PMN-FIQPGAFKEI--RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 53/250 (21%), Positives = 85/250 (34%), Gaps = 45/250 (18%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLN 190
             +P  +    S +NL L+ N    L   S      +Q LDLS      ++   A   L+
Sbjct: 20  YKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76

Query: 191 NLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNM 249
           +L  L L+ N     +  G F  +  LQ L      L    +     L            
Sbjct: 77  HLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL--------- 126

Query: 250 FVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG- 308
                            + LN++ N +  S           NL+ LDLS N++   +   
Sbjct: 127 -----------------KELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCT 167

Query: 309 -FNFVYELQV----LKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--T 361
               ++++ +    L LS N  + FI         + L +L L  N L      I    T
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF--KEIRLKELALDTNQLKSVPDGIFDRLT 224

Query: 362 NLHMLNLSSN 371
           +L  + L +N
Sbjct: 225 SLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 53/244 (21%), Positives = 91/244 (37%), Gaps = 52/244 (21%)

Query: 359 LSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLT 418
           L  +   L+LS N L               L +  F  +         ++ LDLSR  + 
Sbjct: 26  LPFSTKNLDLSFNPLR-------------HLGSYSF-FSFP------ELQVLDLSRCEIQ 65

Query: 419 GSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL----DGPFLTNL 473
            +I +   Q L  L+ L L+ N + S           L+ L     +L    + P   +L
Sbjct: 66  -TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI-GHL 123

Query: 474 LNSSTLQELHLADNLLT-----GVLDFSPPSVSNLQVLDLSHNRL----NGYFPDRLGSL 524
               TL+EL++A NL+              +++NL+ LDLS N++           L  +
Sbjct: 124 ---KTLKELNVAHNLIQSFKLPEYFS----NLTNLEHLDLSSNKIQSIYCTDL-RVLHQM 175

Query: 525 TGLKV-LCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLP----NNLPNSLETFNVS 579
             L + L L+ N ++  +         L  L +  N     +P    + L  SL+   + 
Sbjct: 176 PLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKS-VPDGIFDRLT-SLQKIWLH 232

Query: 580 YNDF 583
            N +
Sbjct: 233 TNPW 236

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 61/241 (25%), Positives = 87/241 (36%), Gaps = 49/241 (20%)

Query: 288 LFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSL-LLTDLD 345
           L  + K LDLS+N L       F    ELQVL LS       I +      SL  L+ L 
Sbjct: 26  LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAY--QSLSHLSTLI 82

Query: 346 LSANNLSGSVSMILS--TNLHMLNLSSNGLT-------GELPLLTGSCAVLDLSNNQFEG 396
           L+ N +        S  ++L  L      L        G L  L      L++++N    
Sbjct: 83  LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK----ELNVAHNL--- 135

Query: 397 NLSRILKWG------NIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVII 450
            +             N+E+LDLS N +  SI         L+ + L + SL         
Sbjct: 136 -IQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTD--LRVLHQMPLLNLSL--------- 182

Query: 451 QYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSH 510
                   DLS N ++            L+EL L  N L  V D     +++LQ + L  
Sbjct: 183 --------DLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 233

Query: 511 N 511
           N
Sbjct: 234 N 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 68.8 bits (169), Expect = 9e-13
 Identities = 42/167 (25%), Positives = 62/167 (37%), Gaps = 34/167 (20%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNL 147
            FS LS L KL     ++                         +SL +   G L++L+ L
Sbjct: 95  AFSGLSSLQKLVAVETNL-------------------------ASLENFPIGHLKTLKEL 129

Query: 148 SLAGNNFSGLIPDSV-SGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVY----LNLSSNG 201
           ++A N           S L +++ LDLS N    S+    L  L+ +      L+LS N 
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 202 FSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGN 248
               I  G    + L+ L    N+L    DG F  LT+   I    N
Sbjct: 189 M-NFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 45/194 (23%), Positives = 72/194 (37%), Gaps = 31/194 (15%)

Query: 420 SIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL----DGPF--LTNL 473
            IP+  P   +  +L+LS N L          + +L+VLDLS   +    DG +  L++ 
Sbjct: 21  KIPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH- 77

Query: 474 LNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLA 533
                L  L L  N +  +   +   +S+LQ L      L       +G L  LK L +A
Sbjct: 78  -----LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132

Query: 534 GNNISGSLPTSMA--NMTSLSSLVISQNHFTGPLPN------NLPNSLETFNVSYNDFSG 585
            N I  S        N+T+L  L +S N               +P    + ++S N    
Sbjct: 133 HNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN---- 187

Query: 586 AVPENLRKFPSSSF 599
                +      +F
Sbjct: 188 ----PMNFIQPGAF 197

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 51.1 bits (123), Expect = 7e-07
 Identities = 23/104 (22%), Positives = 44/104 (42%), Gaps = 3/104 (2%)

Query: 76  LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFS---S 132
           + +  + +      FSNL+ L  L +S+N I  +   ++     +  L++S +L     +
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 133 SLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHN 176
            +  G  K   L+ L+L  N    +       L S+Q + L  N
Sbjct: 191 FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 92.2 bits (229), Expect = 3e-19
 Identities = 43/206 (20%), Positives = 80/206 (38%), Gaps = 24/206 (11%)

Query: 782 EVLGRSSHGTSYRA--TLENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
             +     G  Y A     NG  + +K L   G A+ +     E +  A + HP++V + 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 839 GYYWGPTQHEKL---ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
            +     +H      I+ +Y+   SL              L  A+ +   +++   L+YL
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYL 198

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAA 955
           H    + + +LK  NI+L   +   ++ D      +   G +      G  G++APE+  
Sbjct: 199 H-SIGLVYNDLKPENIMLT-EE-QLKLIDLGAVSRINSFGYL-----YGTPGFQAPEIVR 250

Query: 956 SKKPHPSFKSDVYAFGVILLELLTGR 981
           +    P+  +D+Y  G  L  L    
Sbjct: 251 T---GPTVATDIYTVGRTLAALTLDL 273

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 28/214 (13%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           E++G    G  ++A    +G    +K     V    ++  +E K  A + H N+V   G 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIK----RVKYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 841 YWGPTQHEKL--------------ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV 886
           + G     +               I  ++   G+L  ++  R   +G  L     L++  
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFE 129

Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVL 946
            + +G++Y+H  + + + +LK +NI L       ++ D+ L   +   G   +    G L
Sbjct: 130 QITKGVDYIH-SKKLINRDLKPSNIFLVD-TKQVKIGDFGLVTSLKNDGKRTRS--KGTL 185

Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            Y +PE   S + +   + D+YA G+IL ELL  
Sbjct: 186 RYMSPEQI-SSQDY-GKEVDLYALGLILAELLHV 217

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 27/218 (12%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQ---RKEFAKEAKKFANIRHPNVVGL 837
            ++GR   G  Y A        + +K + E ++     R    +EA+    ++ P+VV +
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
             + +G    +  +    I+   LA+ L     R+  PL   + + I   +   L+  H 
Sbjct: 100 --HDFGEIDGQLYVDMRLINGVDLAAML-----RRQGPLAPPRAVAIVRQIGSALDAAH- 151

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRL-----MTQAGTIEQILDAGVLGYRAPE 952
                H ++K  NIL+   D  A + D+ +        +TQ G        G L Y APE
Sbjct: 152 AAGATHRDVKPENILVS-ADDFAYLVDFGIASATTDEKLTQLGNT-----VGTLYYMAPE 205

Query: 953 LAASKKPHPSFKSDVYAFGVILLELLTGRC--AGDVIS 988
             +        ++D+YA   +L E LTG     GD +S
Sbjct: 206 RFSESHATY--RADIYALTCVLYECLTGSPPYQGDQLS 241

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 40/296 (13%)

Query: 782  EVLGRSSHGTSYRATL-----ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVG 836
              LG+ + G+             G  + VK L+     Q+++F +E +    +    +V 
Sbjct: 29   SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 837  LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
             RG  +GP +    ++ +Y+  G L  FL     R    L  ++ L  +  + +G+ YL 
Sbjct: 89   YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYLG 144

Query: 897  FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELA 954
              R V H +L A NIL+   + + ++AD+ L +L+        + + G       APE  
Sbjct: 145  SRRCV-HRDLAARNILV-ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 955  ASKKPHPSFKSDVYAFGVILLELLT--------GRCAGDVISGEGAGVDLTDWMQLKVAE 1006
            +      S +SDV++FGV+L EL T              ++  E     L+  ++L + E
Sbjct: 203  SDNI--FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL-LEE 259

Query: 1007 GHGSDCFDAAVMPEMVN-PAAEKGMKEVLGIALRC-IRSVSERPGIKTIYEDLSSI 1060
            G          +P     PA      EV  +   C   S  +RP    +   L  +
Sbjct: 260  GQ--------RLPAPPACPA------EVHELMKLCWAPSPQDRPSFSALGPQLDML 301

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 91.0 bits (226), Expect = 5e-19
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 17/202 (8%)

Query: 782 EVLGRSSHGTSYRATLEN-GMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
             LG   +G  Y    +   + + VK L+E    + +EF KEA     I+HPN+V L G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 841 YWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
               T+     I++++++ G+L  +L +        ++    L +A  ++  + YL    
Sbjct: 285 C---TREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKN 338

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASK 957
            + H NL A N L+ G +   +VAD+ L RLMT  G             +  APE  A  
Sbjct: 339 FI-HRNLAARNCLV-GENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYN 394

Query: 958 KPHPSFKSDVYAFGVILLELLT 979
           K   S KSDV+AFGV+L E+ T
Sbjct: 395 KF--SIKSDVWAFGVLLWEIAT 414

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 88.1 bits (219), Expect = 6e-19
 Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 26/219 (11%)

Query: 771 LTPEELSRAPAEVLGRSSHGTSYRATLENGMFLT-----VKWLREGV-AKQRKEFAKEAK 824
           L   E  +   +VLG  + GT Y+               +K LRE    K  KE   EA 
Sbjct: 12  LKETEFKKI--KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69

Query: 825 KFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKI 884
             A++ +P+V  L G           +++  +  G L  ++ +        +     L  
Sbjct: 70  VMASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNW 122

Query: 885 AVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG 944
            V +A+G+NYL   R V H +L A N+L+  P    ++ D+ L +L+  A   E   + G
Sbjct: 123 CVQIAKGMNYLEDRRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLL-GAEEKEYHAEGG 179

Query: 945 VLGYR--APELAASKKPHPSF--KSDVYAFGVILLELLT 979
            +  +  A E    +     +  +SDV+++GV + EL+T
Sbjct: 180 KVPIKWMALESILHRI----YTHQSDVWSYGVTVWELMT 214

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 88.1 bits (219), Expect = 7e-19
 Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 25/214 (11%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT------VKWLREGV-AKQRKEFAKEAKKFANIRHPNV 834
             LG  + G  Y   +             VK L E    +   +F  EA   +   H N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 835 VGLRGYYWGPTQHE-KLILSDYISPGSLASFLYDR--PGRKGPPLTWAQRLKIAVDVARG 891
           V   G      Q   + IL + ++ G L SFL +      +   L     L +A D+A G
Sbjct: 96  VRCIGVS---LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 892 LNYLHFDRAVPHGNLKATNILLD--GPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR 949
             YL  +  + H ++ A N LL   GP   A++ D+ + R + +A    +     +L  +
Sbjct: 153 CQYLEENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK-GGCAMLPVK 210

Query: 950 --APELAASKKPHPSF--KSDVYAFGVILLELLT 979
              PE          F  K+D ++FGV+L E+ +
Sbjct: 211 WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFS 240

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 87.7 bits (218), Expect = 8e-19
 Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 41/222 (18%)

Query: 782 EVLGRSSHGTSYRATL--ENGMFLTV--KWLREGVA--KQRKEFAKEAKKFANIRHPNVV 835
           ++LG    G+     L  E+G  L V  K ++   +  ++ +EF  EA    +  HPNV+
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 836 GLRG--YYWGPTQHEK-LILSDYISPGSLASFL-YDRPGRKGPPLTWAQRLKIAVDVARG 891
            L G           K +++  ++  G L ++L Y R       +     LK  VD+A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR-- 949
           + YL     + H +L A N +L   D+   VAD+ L + +                YR  
Sbjct: 160 MEYLSNRNFL-HRDLAARNCML-RDDMTVCVADFGLSKKIYSGDY-----------YRQG 206

Query: 950 ----------APELAASKKPHPSF--KSDVYAFGVILLELLT 979
                     A E  A +     +  KSDV+AFGV + E+ T
Sbjct: 207 RIAKMPVKWIAIESLADRV----YTSKSDVWAFGVTMWEIAT 244

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 87.7 bits (218), Expect = 1e-18
 Identities = 62/262 (23%), Positives = 97/262 (37%), Gaps = 62/262 (23%)

Query: 760 GELHFLDDTLTLTPEELSRAPA-----------EVLGRSSHGTSYRATLENGMFLT---- 804
           G+   L   +   P+  S A               LG  + G  + A   N +       
Sbjct: 14  GKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKML 73

Query: 805 --VKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHE-KLILSDYISPGSL 861
             VK L+E     R++F +EA+    ++H ++V   G     T+    L++ +Y+  G L
Sbjct: 74  VAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC---TEGRPLLMVFEYMRHGDL 130

Query: 862 ASFL----------YDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNI 911
             FL                   PL   Q L +A  VA G+ YL     V H +L   N 
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFV-HRDLATRNC 189

Query: 912 LLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR------------APELAASKKP 959
           L+ G  L  ++ D+ + R +                YR             PE    +K 
Sbjct: 190 LV-GQGLVVKIGDFGMSRDIYSTDY-----------YRVGGRTMLPIRWMPPESILYRK- 236

Query: 960 HPSF--KSDVYAFGVILLELLT 979
              F  +SDV++FGV+L E+ T
Sbjct: 237 ---FTTESDVWSFGVVLWEIFT 255

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 62/297 (20%), Positives = 110/297 (37%), Gaps = 41/297 (13%)

Query: 782  EVLGRSSHGTSYRATLE-----NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVV 835
              LG    G       +      G  + VK L+         +  KE +   N+ H N+V
Sbjct: 27   RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 836  GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
              +G       +   ++ +++  GSL  +L     +    +   Q+LK AV + +G++YL
Sbjct: 87   KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYL 142

Query: 896  HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APEL 953
               + V H +L A N+L+   +   ++ D+ L + +        + D         APE 
Sbjct: 143  GSRQYV-HRDLAARNVLV-ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200

Query: 954  AASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGA-------GVDLTDWMQLKVA 1005
                K      SDV++FGV L ELLT        ++            + +T  +   + 
Sbjct: 201  LMQSK--FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT-LK 257

Query: 1006 EGHGSDCFDAAVMPEMVN-PAAEKGMKEVLGIALRC-IRSVSERPGIKTIYEDLSSI 1060
            EG          +P   N P       EV  +  +C     S R   + + E   ++
Sbjct: 258  EGK--------RLPCPPNCPD------EVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 21/203 (10%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
           + LG    G       +    + VK ++EG +    EF +EA+    + HP +V   G  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 842 WGPTQHE-KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
              ++     I+++YIS G L ++L       G  L  +Q L++  DV  G+ +L   + 
Sbjct: 73  ---SKEYPIYIVTEYISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLESHQF 125

Query: 901 VPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKK 958
           + H +L A N L+   DL  +V+D+ + R +                 +  APE+    K
Sbjct: 126 I-HRDLAARNCLV-DRDLCVKVSDFGMTRYVL--DDQYVSSVGTKFPVKWSAPEVFHYFK 181

Query: 959 PHPSF--KSDVYAFGVILLELLT 979
               +  KSDV+AFG+++ E+ +
Sbjct: 182 ----YSSKSDVWAFGILMWEVFS 200

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 23/208 (11%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT----VKWLREGV-AKQRKEFAKEAKKFANIRHPNVVG 836
           +++G    G      L           +K L+ G   +QR++F  EA       HPN++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 837 LRGYYWGPTQHE-KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
           L G     T+    +I+++Y+  GSL +FL    G+     T  Q + +   V  G+ YL
Sbjct: 115 LEGVV---TRGRLAMIVTEYMENGSLDTFLRTHDGQ----FTIMQLVGMLRGVGAGMRYL 167

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APEL 953
                V H +L A N+L+   +L  +V+D+ L R++            G +  R  APE 
Sbjct: 168 SDLGYV-HRDLAARNVLV-DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225

Query: 954 AASKKPHPSF--KSDVYAFGVILLELLT 979
            A +     F   SDV++FGV++ E+L 
Sbjct: 226 IAFRT----FSSASDVWSFGVVMWEVLA 249

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 24/209 (11%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT-----VKWLREGV-AKQRKEFAKEAKKFANIRHPNVV 835
           +V+G    G  Y+  L+           +K L+ G   KQR +F  EA       H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 836 GLRGYYWGPTQHE-KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
            L G     ++++  +I+++Y+  G+L  FL ++ G      +  Q + +   +A G+ Y
Sbjct: 110 RLEGVI---SKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKY 162

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APE 952
           L     V H +L A NIL+   +L  +V+D+ L R++            G +  R  APE
Sbjct: 163 LANMNYV-HRDLAARNILV-NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220

Query: 953 LAASKKPHPSF--KSDVYAFGVILLELLT 979
             + +K    F   SDV++FG+++ E++T
Sbjct: 221 AISYRK----FTSASDVWSFGIVMWEVMT 245

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 58/322 (18%), Positives = 105/322 (32%), Gaps = 64/322 (19%)

Query: 286 LQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLD 345
              F      +L    +T +    N +  +  +  +N+          L      +T L 
Sbjct: 20  DDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIKSVQGIQYLPN----VTKLF 74

Query: 346 LSANNLSGSVSMILS-TNLHMLNLSSNGLT-----GELPLLTGSCAVLDLSNNQFEGNLS 399
           L+ N L+  +  + +  NL  L L  N +       +L  L      L L +N    +++
Sbjct: 75  LNGNKLT-DIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLK----SLSLEHNGIS-DIN 128

Query: 400 RILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLD 459
            ++    +E L L  N +T  I              LS  +             KL  L 
Sbjct: 129 GLVHLPQLESLYLGNNKIT-DIT------------VLSRLT-------------KLDTLS 162

Query: 460 LSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPD 519
           L  N +    +  L   + LQ L+L+ N ++ +   +   + NL VL+L          +
Sbjct: 163 LEDNQISD--IVPLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPIN 218

Query: 520 RLGSLTGLKVLCLAGNNISGSL--PTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFN 577
              +L     +     N  GSL  P  +++        +  +     LP         F 
Sbjct: 219 HQSNLVVPNTV----KNTDGSLVTPEIISDDGDYEKPNVKWH-----LPEFTNEVSFIFY 269

Query: 578 VSYN------DFSGAVPENLRK 593
                      F G V + L++
Sbjct: 270 QPVTIGKAKARFHGRVTQPLKE 291

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 52/287 (18%), Positives = 100/287 (34%), Gaps = 23/287 (8%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
            +      +  +K ++   S++  +     +  S++ +  +++   S    GI  L ++ 
Sbjct: 16  QIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVT 71

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            L L GN  + + P  ++ L ++  L L  N     L   L  L  L  L+L  NG S  
Sbjct: 72  KLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISD- 126

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
           I  G   +  L+ L    NK+   +      LT    +    N          L  L   
Sbjct: 127 IN-GLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVPLAGLTKL--- 180

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNR 324
            Q L LS N ++    +   L   +NL VL+L   +   +     + +     +K ++  
Sbjct: 181 -QNLYLSKNHIS----DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 235

Query: 325 FSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSN 371
                P  +         ++       +  VS I    + +    + 
Sbjct: 236 LVT--PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 280

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 48/276 (17%), Positives = 93/276 (33%), Gaps = 54/276 (19%)

Query: 237 LTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLD 296
                  +        + +Q  L  +      +  + + +  S+     +Q   N+  L 
Sbjct: 23  FAETIKDNLKKKSVTDAVTQNELNSI----DQIIANNSDIK-SVQG---IQYLPNVTKLF 74

Query: 297 LSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVS 356
           L+ N+LT ++     +  L  L L  N+                + DL     +L     
Sbjct: 75  LNGNKLT-DIKPLANLKNLGWLFLDENK----------------VKDLS----SLKD--- 110

Query: 357 MILSTNLHMLNLSSNGLT-----GELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLD 411
                 L  L+L  NG++       LP L      L L NN+   +++ + +   ++ L 
Sbjct: 111 ---LKKLKSLSLEHNGISDINGLVHLPQLE----SLYLGNNKIT-DITVLSRLTKLDTLS 162

Query: 412 LSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLT 471
           L  N ++  I        +L +L LS N +S      +   + L VL+L         + 
Sbjct: 163 LEDNQIS-DIVPLA-GLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPIN 218

Query: 472 NLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLD 507
           +  N      +   D  L      +P  +S+    +
Sbjct: 219 HQSNLVVPNTVKNTDGSLV-----TPEIISDDGDYE 249

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 30/164 (18%), Positives = 57/164 (34%), Gaps = 8/164 (4%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
           D++   +L  L  L + NN I+ +    +     L+ L + DN  S      +  L  LQ
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQ 181

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
           NL L+ N+ S L   +++GL ++  L+L             + L     +  +       
Sbjct: 182 NLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHID--FSG 247
                +       + +H  +    +   F+           F G
Sbjct: 240 EIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHG 283

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 85.3 bits (212), Expect = 2e-18
 Identities = 45/203 (22%), Positives = 91/203 (44%), Gaps = 21/203 (10%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
           + +G    G  +     N   + +K +REG A   ++F +EA+    + HP +V L G  
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 842 WGPTQHE-KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
               +     ++++++  G L+ +L  + G           L + +DV  G+ YL     
Sbjct: 73  ---LEQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDVCEGMAYLEEACV 125

Query: 901 VPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKK 958
           + H +L A N L+ G +   +V+D+ + R +                 +  +PE+ +  +
Sbjct: 126 I-HRDLAARNCLV-GENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFSFSR 181

Query: 959 PHPSF--KSDVYAFGVILLELLT 979
               +  KSDV++FGV++ E+ +
Sbjct: 182 ----YSSKSDVWSFGVLMWEVFS 200

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 51/222 (22%), Positives = 92/222 (41%), Gaps = 22/222 (9%)

Query: 766 DDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLT---VKWLREGV-AKQRKEFAK 821
           D  L L  + L  A  E LG  + G+  +             +K L++G      +E  +
Sbjct: 1   DKKLFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 59

Query: 822 EAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQR 881
           EA+    + +P +V L G          +++ +    G L  FL  +       +  +  
Sbjct: 60  EAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNV 112

Query: 882 LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL 941
            ++   V+ G+ YL     V H +L A N+LL      A+++D+ L + +    +     
Sbjct: 113 AELLHQVSMGMKYLEEKNFV-HRDLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTAR 170

Query: 942 DAGVLGYR--APELAASKKPHPSF--KSDVYAFGVILLELLT 979
            AG    +  APE    +K    F  +SDV+++GV + E L+
Sbjct: 171 SAGKWPLKWYAPECINFRK----FSSRSDVWSYGVTMWEALS 208

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 38/218 (17%), Positives = 84/218 (38%), Gaps = 24/218 (11%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVA--KQRKEFAKEAKKFANI-RHPNVVGL 837
           E +G    G+ ++     +G    +K  ++ +A     +   +E    A + +H +VV  
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76

Query: 838 RGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
              +    + + + I ++Y + GSLA  +     R       A+   + + V RGL Y+H
Sbjct: 77  FSAW---AEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG--------- 947
              ++ H ++K +NI +    +    ++            + +I D G +          
Sbjct: 133 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191

Query: 948 ----YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
               + A E+      H   K+D++A  + ++      
Sbjct: 192 GDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAE 228

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 87.0 bits (216), Expect = 3e-18
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 19/206 (9%)

Query: 782 EVLGRSSHGTSYRATL----ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVG 836
           +V+G    G      L    +  + + +K L+ G   KQR++F  EA       HPN++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 837 LRGYYWGPTQHE-KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
           L G     T+ +  +I+++Y+  GSL SFL     +     T  Q + +   +A G+ YL
Sbjct: 111 LEGVV---TKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGMLRGIASGMKYL 163

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APEL 953
             D    H +L A NIL+   +L  +V+D+ L R++            G +  R  +PE 
Sbjct: 164 S-DMGYVHRDLAARNILI-NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEA 221

Query: 954 AASKKPHPSFKSDVYAFGVILLELLT 979
            A +K   +  SDV+++G++L E+++
Sbjct: 222 IAYRK--FTSASDVWSYGIVLWEVMS 245

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 21/203 (10%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
           + LG    G            + +K ++EG +    EF +EAK   N+ H  +V L G  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 842 WGPTQHE-KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
              T+     I+++Y++ G L ++L +            Q L++  DV   + YL   + 
Sbjct: 89  ---TKQRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLESKQF 141

Query: 901 VPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASKK 958
           + H +L A N L+       +V+D+ L R +                 R   PE+    K
Sbjct: 142 L-HRDLAARNCLV-NDQGVVKVSDFGLSRYVLDDEYTSS--VGSKFPVRWSPPEVLMYSK 197

Query: 959 PHPSF--KSDVYAFGVILLELLT 979
               F  KSD++AFGV++ E+ +
Sbjct: 198 ----FSSKSDIWAFGVLMWEIYS 216

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 85.5 bits (212), Expect = 5e-18
 Identities = 62/297 (20%), Positives = 108/297 (36%), Gaps = 43/297 (14%)

Query: 782  EVLGRSSHGTSYRATLEN-----GMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVV 835
              LG    G       +      G  + VK L+     + R  + +E      + H +++
Sbjct: 37   RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 836  GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
              +G           ++ +Y+  GSL  +L          +  AQ L  A  +  G+ YL
Sbjct: 97   KYKGCCEDAGAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYL 150

Query: 896  HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APEL 953
            H    + H +L A N+LL   D   ++ D+ L + + +     ++ + G       APE 
Sbjct: 151  HAQHYI-HRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208

Query: 954  AASKKPHPSFKSDVYAFGVILLELLT--------GRCAGDVISGEGAGVDLTDWMQLKVA 1005
                K    + SDV++FGV L ELLT             ++I      + +    +L + 
Sbjct: 209  LKEYK--FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL-LE 265

Query: 1006 EGHGSDCFDAAVMPEMVN-PAAEKGMKEVLGIALRC-IRSVSERPGIKTIYEDLSSI 1060
             G          +P     PA      EV  +   C     S RP  + +   L ++
Sbjct: 266  RGE--------RLPRPDKCPA------EVYHLMKNCWETEASFRPTFENLIPILKTV 308

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 86.3 bits (214), Expect = 5e-18
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 25/214 (11%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT------VKWLREGV-AKQRKEFAKEAKKFANIRHPNV 834
             LG  + G  Y   +             VK L E    +   +F  EA   +   H N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 835 VGLRGYYWGPTQHE-KLILSDYISPGSLASFLYDR--PGRKGPPLTWAQRLKIAVDVARG 891
           V   G      Q   + IL + ++ G L SFL +      +   L     L +A D+A G
Sbjct: 137 VRCIGVS---LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 892 LNYLHFDRAVPHGNLKATNILLD--GPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR 949
             YL  +  + H ++ A N LL   GP   A++ D+ + R + +AG   +     +L  +
Sbjct: 194 CQYLEENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK-GGCAMLPVK 251

Query: 950 --APELAASKKPHPSF--KSDVYAFGVILLELLT 979
              PE          F  K+D ++FGV+L E+ +
Sbjct: 252 WMPPEAFMEGI----FTSKTDTWSFGVLLWEIFS 281

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 86.3 bits (214), Expect = 5e-18
 Identities = 68/297 (22%), Positives = 112/297 (37%), Gaps = 44/297 (14%)

Query: 704 KKGSSSGILSPDEKAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELH 763
           +   ++GIL P     +    S  + S   +     ++   +    + +     L  EL 
Sbjct: 18  RASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSA-LNPELV 76

Query: 764 FLDDTLTLTPEELSRAPAEVLGRSSHGTSYRATL--ENGMFLTV--KWLREGV-AKQRKE 818
                + + P  L     EV+GR   G  Y  TL   +G  +    K L       +  +
Sbjct: 77  QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 136

Query: 819 FAKEAKKFANIRHPNVVGLRGYYWGPTQHEK--LILSDYISPGSLASFLYDRPGRKGPPL 876
           F  E     +  HPNV+ L G      + E   L++  Y+  G L +F+ +         
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGIC---LRSEGSPLVVLPYMKHGDLRNFIRNE----THNP 189

Query: 877 TWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT 936
           T    +   + VA+G+ +L   + V H +L A N +L       +VAD+ L R       
Sbjct: 190 TVKDLIGFGLQVAKGMKFLASKKFV-HRDLAARNCML-DEKFTVKVADFGLARD------ 241

Query: 937 IEQILDAGVLGYR------------APELAASKKPHPSF--KSDVYAFGVILLELLT 979
              + D                   A E   ++K    F  KSDV++FGV+L EL+T
Sbjct: 242 ---MYDKEFDSVHNKTGAKLPVKWMALESLQTQK----FTTKSDVWSFGVLLWELMT 291

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 85.0 bits (211), Expect = 5e-18
 Identities = 57/230 (24%), Positives = 92/230 (40%), Gaps = 52/230 (22%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT------VKWLREGVAKQRKEFAKEAKKFANIRHPNVV 835
             LG  + G  + A   N           VK L++     RK+F +EA+   N++H ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 836 GLRGYYWGPTQHE-KLILSDYISPGSLASFL-----------YDRPGRKGPPLTWAQRLK 883
              G        +  +++ +Y+  G L  FL             +P +    L  +Q L 
Sbjct: 81  KFYGVC---GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 884 IAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA 943
           IA  +A G+ YL     V H +L   N L+ G +L  ++ D+ + R +            
Sbjct: 138 IASQIASGMVYLASQHFV-HRDLATRNCLV-GANLLVKIGDFGMSRDVYSTDY------- 188

Query: 944 GVLGYR------------APELAASKKPHPSF--KSDVYAFGVILLELLT 979
               YR             PE    +K    F  +SDV++FGVIL E+ T
Sbjct: 189 ----YRVGGHTMLPIRWMPPESIMYRK----FTTESDVWSFGVILWEIFT 230

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 81.9 bits (203), Expect = 8e-18
 Identities = 30/158 (18%), Positives = 77/158 (48%), Gaps = 6/158 (3%)

Query: 70  NVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNL 129
                +   LG S+ A+++  + ++ L  ++++N +++ +    I    +++ L +++  
Sbjct: 21  TFKAYLNGLLGQSSTANIT-EAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIH 77

Query: 130 FSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRL 189
            ++   + I  L +L+ L + G + +     ++SGL S+  LD+SH++   S+   +  L
Sbjct: 78  ATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 190 NNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLD 227
             +  ++LS NG    I    + +  L+ L+   + + 
Sbjct: 136 PKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 31/154 (20%), Positives = 58/154 (37%), Gaps = 8/154 (5%)

Query: 387 LDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLP 446
           + L+N     +L+ I    NI+ L ++  H T   P        L  L +    ++S   
Sbjct: 49  ITLANINVT-DLTGIEYAHNIKDLTINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKI 105

Query: 447 KVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSP-PSVSNLQV 505
             +     L +LD+S +  D   LT +     +  + L+ N      D  P  ++  L+ 
Sbjct: 106 PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT--DIMPLKTLPELKS 163

Query: 506 LDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISG 539
           L++  + ++ Y    +     L  L      I G
Sbjct: 164 LNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.8 bits (187), Expect = 9e-16
 Identities = 34/186 (18%), Positives = 75/186 (40%), Gaps = 23/186 (12%)

Query: 267 QYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFS 326
            YLN  L Q + + +   ++    +L  + L+   +T +L G  + + ++ L ++N   +
Sbjct: 24  AYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHAT 79

Query: 327 GFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLT-------GEL 377
            + P   L      L  L +   +++      LS  T+L +L++S +            L
Sbjct: 80  NYNPISGLSN----LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 378 PLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLS 437
           P +      +DLS N    ++  +     ++ L++  + +      E   F +LN L   
Sbjct: 136 PKVN----SIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAF 189

Query: 438 HNSLSS 443
             ++  
Sbjct: 190 SQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 33/231 (14%), Positives = 79/231 (34%), Gaps = 40/231 (17%)

Query: 77  DNLGLSAAADLSVF--SNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSL 134
           +  GL A+ D      S     +   +  +S + +         SL ++ +++   +   
Sbjct: 4   EQTGLKASQDNVNIPDSTFKAYLNGLLGQSSTANITE---AQMNSLTYITLANINVTDL- 59

Query: 135 PSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVY 194
            +GI    ++++L++   + +   P                          ++ L+NL  
Sbjct: 60  -TGIEYAHNIKDLTINNIHATNYNP--------------------------ISGLSNLER 92

Query: 195 LNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSS 254
           L +     +         +  L +LD   +  D  +  +   L   + ID S N  +  +
Sbjct: 93  LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI--T 150

Query: 255 SQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGE 305
               L  L + ++ LN+  + +     +   ++ F  L  L      + G+
Sbjct: 151 DIMPLKTLPE-LKSLNIQFDGVH----DYRGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 70.4 bits (173), Expect = 7e-14
 Identities = 29/158 (18%), Positives = 65/158 (41%), Gaps = 10/158 (6%)

Query: 426 PQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLA 485
             F    +  L  +S ++       Q   L  + L+  ++    LT +  +  +++L + 
Sbjct: 20  STFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTD--LTGIEYAHNIKDLTIN 74

Query: 486 DNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSM 545
           +   T     S   +SNL+ L +    +       L  LT L +L ++ +    S+ T +
Sbjct: 75  NIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

Query: 546 ANMTSLSSLVISQNHFTGPLPN--NLPNSLETFNVSYN 581
             +  ++S+ +S N     +     LP  L++ N+ ++
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMPLKTLPE-LKSLNIQFD 169

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 27/213 (12%), Positives = 72/213 (33%), Gaps = 39/213 (18%)

Query: 141 LESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN 200
            ++  N  L  ++ + +   + + + S+  + L++ + +  L   +   +N+  L +++ 
Sbjct: 22  FKAYLNGLLGQSSTANI---TEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNI 76

Query: 201 GFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP 260
             +   P     +  L+ L   G  +          LT+                     
Sbjct: 77  HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTS--------------------- 113

Query: 261 GLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKL 320
                +  L++S +    S++    +     +  +DLSYN    ++     + EL+ L +
Sbjct: 114 -----LTLLDISHSAHDDSILTK--INTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNI 166

Query: 321 SNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSG 353
             +    +   +        L  L   +  + G
Sbjct: 167 QFDGVHDYRGIEDFPK----LNQLYAFSQTIGG 195

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 86.4 bits (214), Expect = 8e-18
 Identities = 45/240 (18%), Positives = 87/240 (36%), Gaps = 53/240 (22%)

Query: 766 DDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKK 825
           ++T  +   ++S  P +VLG  + GT     + +   + VK +         E    A +
Sbjct: 14  EETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-------PECFSFADR 66

Query: 826 FANI-----RHPNVVGLRGYYWGPTQHEKLILSDYIS----PGSLASFLYDRPGRKGPPL 876
              +      HPNV+                   YI+      +L     +   +K    
Sbjct: 67  EVQLLRESDEHPNVIRYFCTEKDRQFQ-------YIAIELCAATLQ----EYVEQKDFAH 115

Query: 877 TWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPD----LNARVAD-------- 924
              + + +      GL +LH    + H +LK  NIL+  P+    + A ++D        
Sbjct: 116 LGLEPITLLQQTTSGLAHLH-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174

Query: 925 ---YCLHRLMTQAGTIEQILDAGVLGYRAPE-LAASKKPHPSFKSDVYAFGVILLELLTG 980
              +   R     GT          G+ APE L+   K +P++  D+++ G +   +++ 
Sbjct: 175 VGRHSFSRRSGVPGTE---------GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 84.3 bits (209), Expect = 8e-18
 Identities = 33/189 (17%), Positives = 74/189 (39%), Gaps = 34/189 (17%)

Query: 805 VKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHE-KLILSDYISPGSLAS 863
           +K L +      + F + A   + + H ++V   G        +  +++ +++  GSL +
Sbjct: 45  LKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC---VCGDENILVQEFVKFGSLDT 101

Query: 864 FLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD-------GP 916
           +L          +    +L++A  +A  +++L  +  + HGN+ A NILL        G 
Sbjct: 102 YLKKN----KNCINILWKLEVAKQLAAAMHFLEENTLI-HGNVCAKNILLIREEDRKTGN 156

Query: 917 DLNARVADYCLHRLMTQAGTIEQILDAGVLGYR------APELAASKKPHPSFKSDVYAF 970
               +++D  +   +                 +       PE   + K   +  +D ++F
Sbjct: 157 PPFIKLSDPGISITVLPKD-----------ILQERIPWVPPECIENPKNL-NLATDKWSF 204

Query: 971 GVILLELLT 979
           G  L E+ +
Sbjct: 205 GTTLWEICS 213

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 51/223 (22%), Positives = 72/223 (32%), Gaps = 45/223 (20%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNN 191
           ++LP  +   +    L L+ N        ++     +  L+L     +         L  
Sbjct: 23  TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK--LQVDGTLPV 78

Query: 192 LVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFV 251
           L  L+LS N     +P   + +  L VLD   N+L     G    L              
Sbjct: 79  LGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE------------ 125

Query: 252 GSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFE---NLKVLDLSYNQLTGELPG 308
                         +Q L L  N+L  +L  G    L      L+ L L+ N LT ELP 
Sbjct: 126 --------------LQELYLKGNELK-TLPPG----LLTPTPKLEKLSLANNNLT-ELPA 165

Query: 309 --FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSAN 349
              N +  L  L L  N     IP       S LL    L  N
Sbjct: 166 GLLNGLENLDTLLLQENSLYT-IPKGFF--GSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 55/238 (23%), Positives = 87/238 (36%), Gaps = 42/238 (17%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSL 149
            S ++  ++++    +++  +P ++   K    L +S+NL  +   + +     L  L+L
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 150 AGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRG 209
                + L       L  + +LDLSHN    SLP     L  L  L++S N  +  +P G
Sbjct: 63  DRAELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLG 118

Query: 210 -FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQY 268
               +  LQ L   GN+L     G                                 ++ 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPK--------------------------LEK 152

Query: 269 LNLSLNQLTGSLVNGGELQLF---ENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNN 323
           L+L+ N LT  L  G    L    ENL  L L  N L     GF   + L    L  N
Sbjct: 153 LSLANNNLT-ELPAG----LLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 47/140 (33%), Positives = 63/140 (45%), Gaps = 6/140 (4%)

Query: 87  LSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQ 145
           L V   L +L  L +S+N +   +P       +L  LDVS N   +SLP G    L  LQ
Sbjct: 70  LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQ 127

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSK 204
            L L GN    L P  ++    ++ L L++N+ +  LP   L  L NL  L L  N    
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL-Y 185

Query: 205 RIPRGFELILGLQVLDFHGN 224
            IP+GF     L     HGN
Sbjct: 186 TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 43/163 (26%), Positives = 66/163 (40%), Gaps = 8/163 (4%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNL 147
           +     + L +L++    ++ +  D  G    L  LD+S N   S LP     L +L  L
Sbjct: 49  ATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVL 105

Query: 148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRI 206
            ++ N  + L   ++ GL  +Q L L  N    +LPP  LT    L  L+L++N  +  +
Sbjct: 106 DVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-EL 163

Query: 207 PRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGN 248
           P G    +  L  L    N L     G FF           GN
Sbjct: 164 PAGLLNGLENLDTLLLQENSLYTIPKG-FFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 16/182 (8%)

Query: 406 NIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL 465
           +   ++  + +LT ++P + P+      L+LS N L +     ++ Y +L  L+L    L
Sbjct: 11  SHLEVNCDKRNLT-ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

Query: 466 DG-PFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSL 524
                   L     L  L L+ N L   L     ++  L VLD+S NRL       L  L
Sbjct: 68  TKLQVDGTLPV---LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123

Query: 525 TGLKVLCLAGNNISGSLPTSM-ANMTSLSSLVISQNHFTGPLP----NNLPNSLETFNVS 579
             L+ L L GN +  +LP  +      L  L ++ N+ T  LP    N L N L+T  + 
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLEN-LDTLLLQ 180

Query: 580 YN 581
            N
Sbjct: 181 EN 182

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 58/261 (22%), Positives = 82/261 (31%), Gaps = 74/261 (28%)

Query: 189 LNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGN 248
           + + + +N      +  +P    L     +L    N L           T          
Sbjct: 9   VASHLEVNCDKRNLT-ALPPD--LPKDTTILHLSENLLYTFSLATLMPYTR--------- 56

Query: 249 MFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFE---NLKVLDLSYNQLTGE 305
                            +  LNL   +LT       +LQ+      L  LDLS+NQL   
Sbjct: 57  -----------------LTQLNLDRAELT-------KLQVDGTLPVLGTLDLSHNQLQ-S 91

Query: 306 LPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLL-LTDLDLSANNLSGSVSMILSTNL 363
           LP     +  L VL +S NR +  +P   L    L  L +L L  N L           L
Sbjct: 92  LPLLGQTLPALTVLDVSFNRLT-SLPLGAL--RGLGELQELYLKGNEL---------KTL 139

Query: 364 HMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRI-----LKWGNIEYLDLSRNHLT 418
                   GL    P L      L L+NN     L+ +         N++ L L  N L 
Sbjct: 140 ------PPGLLTPTPKLE----KLSLANNN----LTELPAGLLNGLENLDTLLLQENSLY 185

Query: 419 GSIPEETPQFLRLNHLNLSHN 439
            +IP+       L    L  N
Sbjct: 186 -TIPKGFFGSHLLPFAFLHGN 205

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 44/206 (21%), Positives = 82/206 (39%), Gaps = 23/206 (11%)

Query: 783 VLGRSSHGTSYRATLENGMFLT---VKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGL 837
            LG  + GT  +   +    +    VK L+        + E   EA     + +P +V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
            G          +++ +    G L  +L     ++   +     +++   V+ G+ YL  
Sbjct: 84  IGIC---EAESWMLVMEMAELGPLNKYL-----QQNRHVKDKNIIELVHQVSMGMKYLEE 135

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAA 955
              V H +L A N+LL      A+++D+ L + +       +    G    +  APE   
Sbjct: 136 SNFV-HRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193

Query: 956 SKKPHPSF--KSDVYAFGVILLELLT 979
             K    F  KSDV++FGV++ E  +
Sbjct: 194 YYK----FSSKSDVWSFGVLMWEAFS 215

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 25/212 (11%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQ---RKEFAKEAKKFANIRHPNVVGL 837
           E+LG       + A  L +   + VK LR  +A+       F +EA+  A + HP +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 838 RGYYWGPTQHEKLILS----DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLN 893
             Y  G  +     L     +Y+   +L   +         P+T  + +++  D  + LN
Sbjct: 78  --YDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQALN 130

Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG-TIEQILDAGVLG---YR 949
           + H    + H ++K  NI++       +V D+ + R +  +G ++ Q   A V+G   Y 
Sbjct: 131 FSH-QNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQ--TAAVIGTAQYL 186

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           +PE A         +SDVY+ G +L E+LTG 
Sbjct: 187 SPEQARGDSVDA--RSDVYSLGCVLYEVLTGE 216

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 22/217 (10%)

Query: 771 LTPEELSRAPAEVLGRSSHGTSYRATLENGMFLT-----VKWLREGV-AKQRKEFAKEAK 824
           L   E  +   +VLG  + GT Y+               +K LRE    K  KE   EA 
Sbjct: 12  LKETEFKKI--KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69

Query: 825 KFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKI 884
             A++ +P+V  L G           +++  +  G L  ++ +        +     L  
Sbjct: 70  VMASVDNPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNW 122

Query: 885 AVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAG 944
            V +A+G+NYL   R V H +L A N+L+  P    ++ D+ L +L+  A   E   + G
Sbjct: 123 CVQIAKGMNYLEDRRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLL-GAEEKEYHAEGG 179

Query: 945 VLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
            +  +  A E    +    + +SDV+++GV + EL+T
Sbjct: 180 KVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 214

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 24/207 (11%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT----VKWLREGV-AKQRKEFAKEAKKFANIRHPNVVG 836
             +G    G  ++    +         +K  +       R++F +EA       HP++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     T++   I+ +  + G L SFL  R       L  A  +  A  ++  L YL 
Sbjct: 81  LIGVI---TENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLE 133

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELA 954
             R V H ++ A N+L+   +   ++ D+ L R M  +   +     G L  +  APE  
Sbjct: 134 SKRFV-HRDIAARNVLV-SSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLPIKWMAPESI 189

Query: 955 ASKKPHPSF--KSDVYAFGVILLELLT 979
             ++    F   SDV+ FGV + E+L 
Sbjct: 190 NFRR----FTSASDVWMFGVCMWEILM 212

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 39/232 (16%), Positives = 77/232 (33%), Gaps = 30/232 (12%)

Query: 143 SLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNG 201
           S Q L L   +   +   + S L +I  + +S +     L   +   L+ + ++ + +  
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 202 FSKRIPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP 260
               I     + +  L+ L      L                  F     V S+   F+ 
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGL----------------KMFPDLTKVYSTDIFFI- 134

Query: 261 GLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVY-ELQVLK 319
                   L ++ N    S+       L      L L  N  T  + G+ F   +L  + 
Sbjct: 135 --------LEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVY 185

Query: 320 LSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSN 371
           L+ N++   I  D   G     + LD+S  +++ ++      +L  L   + 
Sbjct: 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 80.0 bits (198), Expect = 8e-17
 Identities = 32/211 (15%), Positives = 69/211 (32%), Gaps = 13/211 (6%)

Query: 96  LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNLSLAGNNF 154
              L +    +  +      +  ++  + VS ++    L S     L  + ++ +     
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92

Query: 155 SGLIPDSV-SGLVSIQSLDLSHNSFSGSLPP--ALTRLNNLVYLNLSSNGFSKRIPRG-F 210
              I       L  ++ L + +       P    +   +    L ++ N +   IP   F
Sbjct: 93  LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151

Query: 211 E-LILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYL 269
           + L      L  + N     + G  F  T    +  + N ++    +    G+      L
Sbjct: 152 QGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210

Query: 270 NLSLNQLTGSLVNGGELQLFENLKVLDLSYN 300
           ++S   +T +L + G     E+LK L     
Sbjct: 211 DVSQTSVT-ALPSKG----LEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 47/264 (17%), Positives = 80/264 (30%), Gaps = 38/264 (14%)

Query: 183 PPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASH 242
                  +      ++      RIP    L    Q L      L       F  L N S 
Sbjct: 4   SSPPCECHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISR 59

Query: 243 IDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFE---NLKVLDLSY 299
           I  S ++ +          LS  V ++ +   +    +         +    LK L +  
Sbjct: 60  IYVSIDVTLQQLESHSFYNLS-KVTHIEIRNTRNLTYIDPD----ALKELPLLKFLGIFN 114

Query: 300 NQLTGELPGFNFVYE---LQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSG-SV 355
             L    P    VY      +L++++N +   IP +  +G       L L  N  +    
Sbjct: 115 TGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQG 173

Query: 356 SMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRN 415
                T L  + L+ N        LT       +  + F G  S          LD+S+ 
Sbjct: 174 YAFNGTKLDAVYLNKN------KYLT------VIDKDAFGGVYS------GPSLLDVSQT 215

Query: 416 HLTGSIPEETPQFLRLNHLNLSHN 439
            +T ++P +      L  L   + 
Sbjct: 216 SVT-ALPSKG--LEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 26/142 (18%), Positives = 54/142 (38%), Gaps = 11/142 (7%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDN--IGDFKSLEFLDVSDNLFSSSLPSGI--GKLESL 144
               L +L  L + N  +  + PD   +        L+++DN + +S+P     G     
Sbjct: 100 ALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET 158

Query: 145 QNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRL-NNLVYLNLSSNGF 202
             L L  N F+ +   + +G   + ++ L+ N +   +   A   + +    L++S    
Sbjct: 159 LTLKLYNNGFTSVQGYAFNGT-KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV 217

Query: 203 SKRIPRGFELILGLQVLDFHGN 224
           +    +G E    L+ L     
Sbjct: 218 TALPSKGLE---HLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 56.2 bits (136), Expect = 9e-09
 Identities = 31/225 (13%), Positives = 65/225 (28%), Gaps = 50/225 (22%)

Query: 410 LDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL---- 465
             ++   +   IP   P       L L    L +           +  + +S +      
Sbjct: 16  FRVTCKDIQ-RIPSLPPS---TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQL 71

Query: 466 -DGPF--LTNLL-------------------NSSTLQELHLADNLLTGVLDFS-PPSVSN 502
               F  L+ +                        L+ L + +  L    D +   S   
Sbjct: 72  ESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDI 131

Query: 503 LQVLDLSHNRLNGYFPDRLGSLTGL----KVLCLAGNNISGSLPTSMANMTSLSSLVISQ 558
             +L+++ N      P    +  GL      L L  N  + S+     N T L ++ +++
Sbjct: 132 FFILEITDNPYMTSIPV--NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188

Query: 559 NHFTGPLPNN----LPNSLETFNVSYNDFSGAVPENLRKFPSSSF 599
           N +   +  +    + +     +VS          ++   PS   
Sbjct: 189 NKYLTVIDKDAFGGVYSGPSLLDVSQT--------SVTALPSKGL 225

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 86.5 bits (214), Expect = 2e-17
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 18/220 (8%)

Query: 766 DDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLT---VKWLREGV-AKQRKEFAK 821
           D  L L  + L  A  E LG  + G+  +             +K L++G      +E  +
Sbjct: 327 DKKLFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 385

Query: 822 EAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQR 881
           EA+    + +P +V L G          +++ +    G L  FL  +       +  +  
Sbjct: 386 EAQIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNV 438

Query: 882 LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQIL 941
            ++   V+ G+ YL     V H NL A N+LL      A+++D+ L + +    +     
Sbjct: 439 AELLHQVSMGMKYLEEKNFV-HRNLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTAR 496

Query: 942 DAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
            AG    +  APE    +K   S +SDV+++GV + E L+
Sbjct: 497 SAGKWPLKWYAPECINFRK--FSSRSDVWSYGVTMWEALS 534

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 24/209 (11%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTV--KWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
             LG   +G  Y         LTV  K L+E    + +EF KEA     I+HPN+V L G
Sbjct: 19  HKLGGGQYGEVYEGVW-KKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
                T+     I++++++ G+L  +L +        ++    L +A  ++  + YL   
Sbjct: 77  VC---TREPPFYIITEFMTYGNLLDYLRE---CNRQEVSAVVLLYMATQISSAMEYLEKK 130

Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAAS 956
             + H +L A N L+ G +   +VAD+ L RLMT  G             +  APE  A 
Sbjct: 131 NFI-HRDLAARNCLV-GENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAY 186

Query: 957 KKPHPSF--KSDVYAFGVILLELLT-GRC 982
            K    F  KSDV+AFGV+L E+ T G  
Sbjct: 187 NK----FSIKSDVWAFGVLLWEIATYGMS 211

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 22/229 (9%)

Query: 760 GELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLT----VKWLREGV--- 812
           GE      T  +  ++L     E LG  S G   R   +     T    VK L+  V   
Sbjct: 4   GEGPLQSLTCLIGEKDLRLL--EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ 61

Query: 813 AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRK 872
            +   +F +E     ++ H N++ L G           ++++    GSL   L    G  
Sbjct: 62  PEAMDDFIREVNAMHSLDHRNLIRLYGVV---LTPPMKMVTELAPLGSLLDRLRKHQGH- 117

Query: 873 GPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMT 932
                     + AV VA G+ YL   R + H +L A N+LL       ++ D+ L R + 
Sbjct: 118 ---FLLGTLSRYAVQVAEGMGYLESKRFI-HRDLAARNLLL-ATRDLVKIGDFGLMRALP 172

Query: 933 QAGTIEQILDAGVLGYR--APELAASKKPHPSFKSDVYAFGVILLELLT 979
           Q      + +   + +   APE   ++    S  SD + FGV L E+ T
Sbjct: 173 QNDDHYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFT 219

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 25/210 (11%)

Query: 782 EVLGRSSHGTSYRATL--ENGMFLTV--KWLREGV-AKQRKEFAKEAKKFANIRHPNVVG 836
           EV+GR   G  Y  TL   +G  +    K L       +  +F  E     +  HPNV+ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 837 LRGYYWGPTQHEK--LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
           L G      + E   L++  Y+  G L +F+ +         T    +   + VA+G+ Y
Sbjct: 91  LLGIC---LRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKY 143

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI-LDAGVLGYR--AP 951
           L   + V H +L A N +L       +VAD+ L R M               L  +  A 
Sbjct: 144 LASKKFV-HRDLAARNCML-DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201

Query: 952 ELAASKKPHPSF--KSDVYAFGVILLELLT 979
           E   ++K    F  KSDV++FGV+L EL+T
Sbjct: 202 ESLQTQK----FTTKSDVWSFGVLLWELMT 227

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 45/207 (21%), Positives = 87/207 (42%), Gaps = 19/207 (9%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
            VLG+ ++G  Y    L N + + +K + E  ++  +   +E     +++H N+V     
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83

Query: 841 YWGPTQHE-KL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
           Y G       + I  + +  GSL++ L  + G                 +  GL YLH D
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL--KDNEQTIGFYTKQILEGLKYLH-D 140

Query: 899 RAVPHGNLKATNILLDGPDLNARVADY----CLHRLMTQAGTIEQILDAGVLGYRAPELA 954
             + H ++K  N+L++      +++D+     L  +     T       G L Y APE+ 
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-----TGTLQYMAPEII 195

Query: 955 ASKKPHPSFKSDVYAFGVILLELLTGR 981
                     +D+++ G  ++E+ TG+
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGK 222

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 81.9 bits (203), Expect = 5e-17
 Identities = 56/210 (26%), Positives = 83/210 (39%), Gaps = 25/210 (11%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT----VKWLREGV-AKQRKEFAKEAKKFANIRHPNVVG 836
            V+G+   G  Y     +         +K L      +Q + F +E      + HPNV+ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 837 LRGYYWGPTQHE--KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
           L G        E    +L  Y+  G L  F+           T    +   + VARG+ Y
Sbjct: 87  LIGIM---LPPEGLPHVLLPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEY 139

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG-TIEQILDAGVLGYR--AP 951
           L   + V H +L A N +L       +VAD+ L R +        Q      L  +  A 
Sbjct: 140 LAEQKFV-HRDLAARNCML-DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 952 ELAASKKPHPSF--KSDVYAFGVILLELLT 979
           E   + +    F  KSDV++FGV+L ELLT
Sbjct: 198 ESLQTYR----FTTKSDVWSFGVLLWELLT 223

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 81.5 bits (202), Expect = 6e-17
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 28/208 (13%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
           + +G+   G         G  + VK ++       + F  EA     +RH N+V L G  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 842 WGPTQHEK--LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
               + +    I+++Y++ GSL  +L     R    L     LK ++DV   + YL  + 
Sbjct: 84  ---VEEKGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASK 957
            V H +L A N+L+   D  A+V+D+ L +  +           G L  +  APE    K
Sbjct: 138 FV-HRDLAARNVLV-SEDNVAKVSDFGLTKEASSTQD------TGKLPVKWTAPEALREK 189

Query: 958 KPHPSF--KSDVYAFGVILLELLT-GRC 982
           K    F  KSDV++FG++L E+ + GR 
Sbjct: 190 K----FSTKSDVWSFGILLWEIYSFGRV 213

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.4 bits (204), Expect = 6e-17
 Identities = 45/208 (21%), Positives = 80/208 (38%), Gaps = 24/208 (11%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT-----VKWLREGV-AKQRKEFAKEAKKFANIRHPNVV 835
           +VLG    GT ++               +K + +    +  +          ++ H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
            L G           +++ Y+  GSL   +    G     L     L   V +A+G+ YL
Sbjct: 79  RLLGL---CPGSSLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGVQIAKGMYYL 131

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APEL 953
                V H NL A N+LL       +VAD+ +  L+      + +        +  A E 
Sbjct: 132 EEHGMV-HRNLAARNVLL-KSPSQVQVADFGVADLL-PPDDKQLLYSEAKTPIKWMALES 188

Query: 954 AASKKPHPSF--KSDVYAFGVILLELLT 979
               K    +  +SDV+++GV + EL+T
Sbjct: 189 IHFGK----YTHQSDVWSYGVTVWELMT 212

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 82.6 bits (204), Expect = 6e-17
 Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 14/161 (8%)

Query: 406 NIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNH 464
               LDLS N+L+    E TP  L  L+ L LSHN L+    +  +    LR LDLS NH
Sbjct: 40  YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99

Query: 465 L----DGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRL----NGY 516
           L    +  F ++L     L+ L L +N +  V   +   ++ LQ L LS N++       
Sbjct: 100 LHTLDEFLF-SDLQA---LEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVEL 155

Query: 517 FPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVIS 557
             D    L  L +L L+ N +     T +  + +     + 
Sbjct: 156 IKD-GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 79.5 bits (196), Expect = 7e-16
 Identities = 35/146 (23%), Positives = 63/146 (43%), Gaps = 9/146 (6%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNL 147
             + L+ L  L +S+N ++ +  +      +L +LD+S N   + L   +   L++L+ L
Sbjct: 59  TPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVL 117

Query: 148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP----ALTRLNNLVYLNLSSNGFS 203
            L  N+   +  ++   +  +Q L LS N  S   P        +L  L+ L+LSSN   
Sbjct: 118 LLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176

Query: 204 KRIPRGFELI--LGLQVLDFHGNKLD 227
           K      + +       L  H N L+
Sbjct: 177 KLPLTDLQKLPAWVKNGLYLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.7 bits (181), Expect = 6e-14
 Identities = 42/211 (19%), Positives = 67/211 (31%), Gaps = 53/211 (25%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYELQV 317
             L      L+LS N L+  L          NL  L LS+N L   +    F  V  L+ 
Sbjct: 35  QSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRY 92

Query: 318 LKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGEL 377
           L LS+N     +   L                             L +L L +N +    
Sbjct: 93  LDLSSNHLH-TLDEFLFSD-----------------------LQALEVLLLYNNHIV--- 125

Query: 378 PLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEET----PQFLRLNH 433
                      +  N FE  ++       ++ L LS+N ++   P E      +  +L  
Sbjct: 126 ----------VVDRNAFED-MA------QLQKLYLSQNQIS-RFPVELIKDGNKLPKLML 167

Query: 434 LNLSHNSLSSSLPKVIIQYQKLRVLDLSFNH 464
           L+LS N L       + +        L  ++
Sbjct: 168 LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 50/205 (24%), Positives = 79/205 (38%), Gaps = 45/205 (21%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSV-SGLVSIQSLDLSHNSFSGSLPP-ALTRL 189
            ++P  +        L L+ NN S L  +   + L ++ SL LSHN  +  +   A   +
Sbjct: 31  PNVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 190 NNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGN 248
            NL YL+LSSN     +    F  +  L+VL  + N +       F  +           
Sbjct: 88  PNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQ--------- 137

Query: 249 MFVGSSSQKFLPGLSQSVQYLNLSLNQLT----GSLVNGGELQLFENLKVLDLSYNQLTG 304
                            +Q L LS NQ++      + +G +L     L +LDLS N+L  
Sbjct: 138 -----------------LQKLYLSQNQISRFPVELIKDGNKLP---KLMLLDLSSNKLK- 176

Query: 305 ELPGFNFV----YELQVLKLSNNRF 325
           +LP  +      +    L L NN  
Sbjct: 177 KLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 62.6 bits (152), Expect = 3e-10
 Identities = 45/173 (26%), Positives = 66/173 (38%), Gaps = 26/173 (15%)

Query: 238 TNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDL 297
           +  + +D S N      ++     L+  +  L LS N L    ++        NL+ LDL
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTN-LHSLLLSHNHLN--FISSEAFVPVPNLRYLDL 95

Query: 298 SYNQLTGELPGFNFVY--ELQVLKLSNNRFSGFIPNDLLKGDSLL--LTDLDLSANNLS- 352
           S N L   L  F F     L+VL L NN     +  +  +    +  L  L LS N +S 
Sbjct: 96  SSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFED---MAQLQKLYLSQNQISR 150

Query: 353 ---GSVSMILS-TNLHMLNLSSNGLT-------GELPLLTGSCAVLDLSNNQF 394
                +        L +L+LSSN L         +LP    +   L L NN  
Sbjct: 151 FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKN--GLYLHNNPL 201

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 82.3 bits (203), Expect = 1e-16
 Identities = 28/217 (12%), Positives = 67/217 (30%), Gaps = 22/217 (10%)

Query: 782 EVLGRSSHGTSYRAT------LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVV 835
            +LG  +    Y AT       +N     +K  +     +     +  ++         +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
                +    Q+  +++ +  S G+L + +          +     +  A+ +   +  +
Sbjct: 131 KFYSAH--LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 896 HFDRAVPHGNLKATNILLDGP----------DLNARVADYCLHRLMTQAGTIEQIL-DAG 944
           H D  + HG++K  N +L                  + D      M              
Sbjct: 189 H-DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247

Query: 945 VLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             G++  E+ +  KP   ++ D +     +  +L G 
Sbjct: 248 TSGFQCVEMLS-NKPWN-YQIDYFGVAATVYCMLFGT 282

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 49/263 (18%), Positives = 88/263 (33%), Gaps = 34/263 (12%)

Query: 341 LTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT-----GELPLLTGSCAVLDLSNNQFE 395
               +L   +++  VS    + +   N  ++ +           L      L LS+NQ  
Sbjct: 21  AVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQSLAGMQFFTNLK----ELHLSHNQIS 76

Query: 396 GNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKL 455
            +LS +     +E L ++RN L  ++         L+ L L +N L       +I  + L
Sbjct: 77  -DLSPLKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELRD--TDSLIHLKNL 130

Query: 456 RVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNG 515
            +L +  N L    +  L   S L+ L L  N +T     +   +  +  +DL+  +   
Sbjct: 131 EILSIRNNKLKS--IVMLGFLSKLEVLDLHGNEITNTGGLT--RLKKVNWIDLTGQKCVN 186

Query: 516 YFPDRLGSLTGL-KVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLP---- 570
                   L     V    G  IS   P  ++N  S     +        LP        
Sbjct: 187 EPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWE-----LPVYTDEVSY 238

Query: 571 --NSLETFNVSYNDFSGAVPENL 591
             +       +   F G V + +
Sbjct: 239 KFSEYINVGETEAIFDGTVTQPI 261

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 24/212 (11%)

Query: 237 LTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLD 296
           L NA   +          SQK L G+    Q  N   + +  SL     +Q F NLK L 
Sbjct: 18  LANAVKQNLGKQSVTDLVSQKELSGV----QNFNGDNSNIQ-SLAG---MQFFTNLKELH 69

Query: 297 LSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVS 356
           LS+NQ++ +L     + +L+ L ++ NR       +L    S  L+ L L  N L  + S
Sbjct: 70  LSHNQIS-DLSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRDTDS 123

Query: 357 MILSTNLHMLNLSSNGLT-----GELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLD 411
           +I   NL +L++ +N L      G L  L     VLDL  N+   N   + +   + ++D
Sbjct: 124 LIHLKNLEILSIRNNKLKSIVMLGFLSKLE----VLDLHGNEIT-NTGGLTRLKKVNWID 178

Query: 412 LSRNHLTGSIPEETPQFLRLNHLNLSHNSLSS 443
           L+         +  P+    N +        S
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWIS 210

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 41/223 (18%), Positives = 78/223 (34%), Gaps = 17/223 (7%)

Query: 286 LQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLD 345
                N    +L    +T +L     +  +Q     N+                 L +L 
Sbjct: 15  DPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQSLAGMQFFTN----LKELH 69

Query: 346 LSANNLSGSVSMILS-TNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKW 404
           LS N +S  +S +   T L  L+++ N L     + +   + L L NN+   +   ++  
Sbjct: 70  LSHNQIS-DLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELR-DTDSLIHL 127

Query: 405 GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNH 464
            N+E L +  N L  SI        +L  L+L  N ++++    + + +K+  +DL+   
Sbjct: 128 KNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQK 183

Query: 465 LDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLD 507
                +           +   D         SP  +SN     
Sbjct: 184 CVNEPVKYQPELYITNTVKDPDGRWI-----SPYYISNGGSYV 221

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 35/195 (17%), Positives = 73/195 (37%), Gaps = 18/195 (9%)

Query: 389 LSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKV 448
                    +       N    +L +  +T  + ++  +   + + N  ++++ S     
Sbjct: 4   QRPTPIN-QVFPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQS--LAG 58

Query: 449 IIQYQKLRVLDLSFNHL-DGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLD 507
           +  +  L+ L LS N + D   L +L     L+EL +  N L    + +    + L  L 
Sbjct: 59  MQFFTNLKELHLSHNQISDLSPLKDLTK---LEELSVNRNRLK---NLNGIPSACLSRLF 112

Query: 508 LSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLP- 566
           L +N L     D L  L  L++L +  N +  S+   +  ++ L  L +  N  T     
Sbjct: 113 LDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGGL 168

Query: 567 NNLPNSLETFNVSYN 581
             L   +   +++  
Sbjct: 169 TRLKK-VNWIDLTGQ 182

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 43/265 (16%), Positives = 89/265 (33%), Gaps = 57/265 (21%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
            +     L+  VK ++   S++ ++     +   ++  +  ++   S   +G+    +L+
Sbjct: 11  QVFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS--LAGMQFFTNLK 66

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            L L+ N  S L P  +  L  ++ L ++ N    +L         L  L L +N     
Sbjct: 67  ELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELRD- 120

Query: 206 IPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
                  +  L++L    NKL                I   G +                
Sbjct: 121 -TDSLIHLKNLEILSIRNNKL--------------KSIVMLGFL--------------SK 151

Query: 266 VQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRF 325
           ++ L+L  N++T    N G L   + +  +DL+  +   E      V     L ++N   
Sbjct: 152 LEVLDLHGNEIT----NTGGLTRLKKVNWIDLTGQKCVNEP-----VKYQPELYITNT-- 200

Query: 326 SGFIPNDLLKGDSLLLTDLDLSANN 350
                  +   D   ++   +S   
Sbjct: 201 -------VKDPDGRWISPYYISNGG 218

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 21/113 (18%), Positives = 41/113 (36%), Gaps = 8/113 (7%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
           D     +L  L  LS+ NN +  +    +G    LE LD+  N  ++    G+ +L+ + 
Sbjct: 120 DTDSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITN--TGGLTRLKKVN 175

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLS 198
            + L G      + + V     +   +   +   G         N   Y++  
Sbjct: 176 WIDLTGQK---CVNEPVKYQPELYITNTVKD-PDGRWISPYYISNGGSYVDGC 224

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 6/164 (3%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQN 146
             F  L+ L  L +++N +  +      + K+LE L V+DN    +LP G+  +L +L  
Sbjct: 55  KAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAE 113

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKR 205
           L L  N    L P     L  +  L L +N    SLP     +L +L  L L +N   KR
Sbjct: 114 LRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL-KR 171

Query: 206 IPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGN 248
           +P G F+ +  L+ L    N+L    +G F  L     +    N
Sbjct: 172 VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 55/217 (25%), Positives = 82/217 (37%), Gaps = 33/217 (15%)

Query: 360 STNLHMLNLSSNGLT---GELPLLTGSCAVLDLSNNQF---EGNLSRILKWGNIEYLDLS 413
           + N + ++ SS  LT     +P  T     LDL +N+           L    +  L L+
Sbjct: 15  NNNKNSVDCSSKKLTAIPSNIPADT---KKLDLQSNKLSSLPSKAFHRLT--KLRLLYLN 69

Query: 414 RNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL----DGP 468
            N L  ++P    + L  L  L ++ N L +    V  Q   L  L L  N L       
Sbjct: 70  DNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRV 128

Query: 469 F--LTNLLNSSTLQELHLADNLLT----GVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLG 522
           F  LT L        L L  N L     GV D     +++L+ L L +N+L         
Sbjct: 129 FDSLTKL------TYLSLGYNELQSLPKGVFD----KLTSLKELRLYNNQLKRVPEGAFD 178

Query: 523 SLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQN 559
            LT LK L L  N +      +  ++  L  L + +N
Sbjct: 179 KLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 56/217 (25%), Positives = 83/217 (38%), Gaps = 35/217 (16%)

Query: 110 IPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQ 169
           IP NI      + LD+  N  SS       +L  L+ L L  N    L       L +++
Sbjct: 31  IPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88

Query: 170 SLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLD 227
           +L ++ N    +LP     +L NL  L L  N     +P   F+ +  L  L    N+L 
Sbjct: 89  TLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ 146

Query: 228 GHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQ 287
               G F  LT+                          ++ L L  NQL   +  G   +
Sbjct: 147 SLPKGVFDKLTS--------------------------LKELRLYNNQLK-RVPEGAFDK 179

Query: 288 LFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNN 323
           L   LK L L  NQL     G F+ + +L++L+L  N
Sbjct: 180 L-TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 48/180 (26%), Positives = 77/180 (42%), Gaps = 8/180 (4%)

Query: 98  KLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNLSLAGNNFSG 156
           KL + +N +S +          L  L ++DN    +LP+GI  +L++L+ L +  N    
Sbjct: 41  KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQA 99

Query: 157 LIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELIL 214
           L       LV++  L L  N    SLPP     L  L YL+L  N   + +P+G F+ + 
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDKLT 157

Query: 215 GLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLN 274
            L+ L  + N+L    +G F  LT    +    N         F     + ++ L L  N
Sbjct: 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDS--LEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 8/143 (5%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDF-KSLEFLDVSDNLFSSSLPSGI-GKLESLQN 146
           +F  L  L  L +++N +   +P  + D   +L  L +  N   S LP  +   L  L  
Sbjct: 80  IFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTY 137

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKR 205
           LSL  N    L       L S++ L L +N     +P  A  +L  L  L L +N   KR
Sbjct: 138 LSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQL-KR 195

Query: 206 IPRG-FELILGLQVLDFHGNKLD 227
           +P G F+ +  L++L    N  D
Sbjct: 196 VPEGAFDSLEKLKMLQLQENPWD 218

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 57/180 (31%), Positives = 74/180 (41%), Gaps = 26/180 (14%)

Query: 405 GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNH 464
            N   +D S   LT +IP   P   +   L+L  N LSS   K   +  KLR+L L+ N 
Sbjct: 16  NNKNSVDCSSKKLT-AIPSNIPADTK--KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK 72

Query: 465 L----DGPF--LTNLLNSSTLQELHLADNLLTGVLDFSPPSV----SNLQVLDLSHNRLN 514
           L     G F  L N      L+ L + DN L  +    P  V     NL  L L  N+L 
Sbjct: 73  LQTLPAGIFKELKN------LETLWVTDNKLQAL----PIGVFDQLVNLAELRLDRNQLK 122

Query: 515 GYFPDRLGSLTGLKVLCLAGNNISGSLPTSM-ANMTSLSSLVISQNHFTGPLPNNLPNSL 573
              P    SLT L  L L  N +  SLP  +   +TSL  L +  N     +P    + L
Sbjct: 123 SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKL 180

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 57/232 (24%), Positives = 90/232 (38%), Gaps = 59/232 (25%)

Query: 288 LFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDL 346
           +  + K LDL  N+L+      F+ + +L++L L++N+    +P  +     L       
Sbjct: 35  IPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIF--KEL------- 84

Query: 347 SANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGN 406
                          NL  L ++ N L               L    F+  L       N
Sbjct: 85  --------------KNLETLWVTDNKLQ-------------ALPIGVFDQ-LV------N 110

Query: 407 IEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL 465
           +  L L RN L  S+P      L +L +L+L +N L S    V  +   L+ L L  N L
Sbjct: 111 LAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169

Query: 466 ----DGPF--LTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHN 511
               +G F  LT L      + L L +N L  V + +  S+  L++L L  N
Sbjct: 170 KRVPEGAFDKLTEL------KTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 46/212 (21%), Positives = 72/212 (33%), Gaps = 34/212 (16%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVA--KQRKEFAKEAKKFANI-RHPNVVGL 837
             LG  S+G  ++    E+G    VK         K R     E      + +HP  V L
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 838 RGYYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
              +    +   L + ++     SL           G  L  AQ      D    L +LH
Sbjct: 123 EQAW---EEGGILYLQTEL-CGPSLQQHCE----AWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM-------TQAGTIEQILDAGVLGYR 949
             + + H ++K  NI L  P    ++ D+ L   +        Q G            Y 
Sbjct: 175 -SQGLVHLDVKPANIFLG-PRGRCKLGDFGLLVELGTAGAGEVQEGDPR---------YM 223

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           APEL           +DV++ G+ +LE+    
Sbjct: 224 APELLQGS---YGTAADVFSLGLTILEVACNM 252

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 83.3 bits (205), Expect = 2e-16
 Identities = 59/297 (19%), Positives = 101/297 (34%), Gaps = 17/297 (5%)

Query: 242 HIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQ 301
             +   ++   +   +  P           SLN               ++ K   L  ++
Sbjct: 278 VDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDR 337

Query: 302 LTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILST 361
                       +L   +LS  + S  + ++L     L   + +     L+  + M    
Sbjct: 338 PECWCRDSATDEQLFRCELSVEK-STVLQSELESCKELQELEPENKWCLLTIILLM---R 393

Query: 362 NLHMLNLSSNGLTGELPLLT----GSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHL 417
            L  L      L     L       +  + DL +     N    +++ ++  L L+   L
Sbjct: 394 ALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453

Query: 418 TGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSS 477
           T  +     Q L + HL+LSHN L  +LP  +   + L VL  S N L+   +  + N  
Sbjct: 454 T--VLCHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALE--NVDGVANLP 508

Query: 478 TLQELHLADNLLTGVLDFSP-PSVSNLQVLDLSHNRL---NGYFPDRLGSLTGLKVL 530
            LQEL L +N L       P  S   L +L+L  N L    G        L  +  +
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.1 bits (176), Expect = 4e-13
 Identities = 45/251 (17%), Positives = 79/251 (31%), Gaps = 16/251 (6%)

Query: 318 LKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGEL 377
               N++        +  G       + L                L    LS    T   
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQ 365

Query: 378 PLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLS 437
             L     + +L        L+ IL    ++ L   +  L      +    +R  +L+  
Sbjct: 366 SELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL 425

Query: 438 HNSLSSSLPKVIIQYQKLRVLDLSFNHLDG-PFLTNLLNSSTLQELHLADNLLTGVLDFS 496
            +        + ++Y  +RVL L+   L     L  LL    +  L L+ N L  +    
Sbjct: 426 RSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLL---VTHLDLSHNRLRAL---- 478

Query: 497 PPSVS---NLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPT--SMANMTSL 551
           PP+++    L+VL  S N L       + +L  L+ L L  N +         + +   L
Sbjct: 479 PPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRL 535

Query: 552 SSLVISQNHFT 562
             L +  N   
Sbjct: 536 VLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.1 bits (176), Expect = 5e-13
 Identities = 51/260 (19%), Positives = 85/260 (32%), Gaps = 22/260 (8%)

Query: 120 LEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFS 179
           L    ++D L   +        +S +   L  +       DS +    +   +LS    S
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSAT-DEQLFRCELSVEK-S 361

Query: 180 GSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTN 239
             L   L     L  L   +            +IL ++ LD    + +           +
Sbjct: 362 TVLQSELESCKELQELEPENKWCLL------TIILLMRALDPLLYEKETLQYFSTLKAVD 415

Query: 240 ASHIDFSGNMF-VGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLS 298
                +  ++          L      V+ L+L+   LT  L +   L+    +  LDLS
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH---LEQLLLVTHLDLS 471

Query: 299 YNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMI 358
           +N+L    P    +  L+VL+ S+N          L      L +L L  N L    + I
Sbjct: 472 HNRLRALPPALAALRCLEVLQASDNALENVDGVANLP----RLQELLLCNNRLQ-QSAAI 526

Query: 359 LS----TNLHMLNLSSNGLT 374
                   L +LNL  N L 
Sbjct: 527 QPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 63.6 bits (154), Expect = 2e-10
 Identities = 24/104 (23%), Positives = 40/104 (38%), Gaps = 7/104 (6%)

Query: 74  VVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSS 133
           + L +  L+    L     L ++  L +S+N +   +P  +   + LE L  SDN   + 
Sbjct: 446 LHLAHKDLT---VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN- 500

Query: 134 LPSGIGKLESLQNLSLAGNNFSGL-IPDSVSGLVSIQSLDLSHN 176
              G+  L  LQ L L  N          +     +  L+L  N
Sbjct: 501 -VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 42/207 (20%), Positives = 77/207 (37%), Gaps = 24/207 (11%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT----VKWLREGV-AKQRKEFAKEAKKFANIRHPNVVG 836
            +LG    G  Y     N         VK  ++      +++F  EA    N+ HP++V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G      +    I+ +    G L  +L          L     +  ++ + + + YL 
Sbjct: 78  LIGII---EEEPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAYLE 130

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELA 954
               V H ++   NIL+       ++ D+ L R +      +       L  +  +PE  
Sbjct: 131 SINCV-HRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKA--SVTRLPIKWMSPESI 186

Query: 955 ASKKPHPSF--KSDVYAFGVILLELLT 979
             ++    F   SDV+ F V + E+L+
Sbjct: 187 NFRR----FTTASDVWMFAVCMWEILS 209

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 55/231 (23%), Positives = 91/231 (39%), Gaps = 58/231 (25%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT---VKWLREGV-AKQRKEFAKEA---KKFANIRHPNV 834
           +V+G  + G   +A ++         +K ++E       ++FA E     K     HPN+
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG--HHPNI 88

Query: 835 VGLRGYYWGPTQHEKL-ILSDYISPGSLASFL-----------YDRPGRKGPPLTWAQRL 882
           + L G          L +  +Y   G+L  FL           +         L+  Q L
Sbjct: 89  INLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 883 KIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD 942
             A DVARG++YL   + + H +L A NIL+ G +  A++AD+ L R             
Sbjct: 146 HFAADVARGMDYLSQKQFI-HRDLAARNILV-GENYVAKIADFGLSR------------G 191

Query: 943 AGVLGYR------------APELAASKKPHPSF--KSDVYAFGVILLELLT 979
             V  Y             A E          +   SDV+++GV+L E+++
Sbjct: 192 QEV--YVKKTMGRLPVRWMAIESLNYSV----YTTNSDVWSYGVLLWEIVS 236

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 58/234 (24%), Positives = 88/234 (37%), Gaps = 59/234 (25%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT------VKWLREGV-AKQRKEFAKEAKKFANIRHPNV 834
           E LG    G  Y+  L             +K L++      R+EF  EA   A ++HPNV
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 835 VGLRGYYWGPTQHE-KLILSDYISPGSLASFL-----------YDRPGRKGPPLTWAQRL 882
           V L G     T+ +   ++  Y S G L  FL            D        L     +
Sbjct: 75  VCLLGVV---TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 883 KIAVDVARGLNYL---HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ 939
            +   +A G+ YL   H    V H +L   N+L+    LN +++D  L R +  A     
Sbjct: 132 HLVAQIAAGMEYLSSHHV---V-HKDLATRNVLV-YDKLNVKISDLGLFREVYAADY--- 183

Query: 940 ILDAGVLGYR------------APELAASKKPHPSF--KSDVYAFGVILLELLT 979
                   Y+            APE     K    F   SD++++GV+L E+ +
Sbjct: 184 --------YKLLGNSLLPIRWMAPEAIMYGK----FSIDSDIWSYGVVLWEVFS 225

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 29/216 (13%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT------VKWLREGV-AKQRKEFAKEAKKFANIRHPNV 834
             LG+ S G  Y    +  +         +K + E    ++R EF  EA         +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 835 VGLRG--YYWGPTQHEKLILSDYISPGSLASFL-YDRP----GRKGPPLTWAQRLKIAVD 887
           V L G      PT    L++ + ++ G L S+L   RP         P + ++ +++A +
Sbjct: 91  VRLLGVVSQGQPT----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146

Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
           +A G+ YL+ ++ V H +L A N ++   D   ++ D+ + R +       +    G+L 
Sbjct: 147 IADGMAYLNANKFV-HRDLAARNCMV-AEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLP 203

Query: 948 YR--APELAASKKPHPSF--KSDVYAFGVILLELLT 979
            R  +PE          F   SDV++FGV+L E+ T
Sbjct: 204 VRWMSPESLKDGV----FTTYSDVWSFGVVLWEIAT 235

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 82.6 bits (204), Expect = 3e-16
 Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 20/205 (9%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT----VKWLREGV-AKQRKEFAKEAKKFANIRHPNVVG 836
             +G    G  ++    +         +K  +       R++F +EA       HP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           L G     T++   I+ +  + G L SFL  R       L  A  +  A  ++  L YL 
Sbjct: 456 LIGVI---TENPVWIIMELCTLGELRSFLQVRKFS----LDLASLILYAYQLSTALAYLE 508

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELA 954
             R V H ++ A N+L+   +   ++ D+ L R M  +   +     G L  +  APE  
Sbjct: 509 SKRFV-HRDIAARNVLV-SSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLPIKWMAPESI 564

Query: 955 ASKKPHPSFKSDVYAFGVILLELLT 979
             ++   +  SDV+ FGV + E+L 
Sbjct: 565 NFRR--FTSASDVWMFGVCMWEILM 587

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 81.6 bits (202), Expect = 3e-16
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 24/206 (11%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
           + +G+   G         G  + VK ++       + F  EA     +RH N+V L G  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 842 WGPTQHEKL--ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
               + +    I+++Y++ GSL  +L  R       L     LK ++DV   + YL    
Sbjct: 256 ---VEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLE-GN 308

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAASK 957
              H +L A N+L+   D  A+V+D+ L +            D G L  +  APE    K
Sbjct: 309 NFVHRDLAARNVLV-SEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREK 361

Query: 958 KPHPSFKSDVYAFGVILLELLT-GRC 982
           K   S KSDV++FG++L E+ + GR 
Sbjct: 362 K--FSTKSDVWSFGILLWEIYSFGRV 385

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 27/169 (15%), Positives = 63/169 (37%), Gaps = 31/169 (18%)

Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +I++   +   G          +I  +Y+   S+  F           L       I + 
Sbjct: 99  DIKNEYCLTCEGIITNYD-EVYIIY-EYMENDSILKFD-----EYFFVLDKNYTCFIPIQ 151

Query: 888 VAR--------GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL------HRLMTQ 933
           V +          +Y+H ++ + H ++K +NIL+D  +   +++D+         ++   
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK-NGRVKLSDFGESEYMVDKKIKGS 210

Query: 934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRC 982
            GT E         +  PE  +++  +   K D+++ G+ L  +     
Sbjct: 211 RGTYE---------FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 80.5 bits (199), Expect = 4e-16
 Identities = 63/321 (19%), Positives = 107/321 (33%), Gaps = 56/321 (17%)

Query: 265 SVQYLNLSLNQLT--GSLVNGGELQLFENLKVLDLSYNQLTGE-----LPGFNFVYELQV 317
           S++  +L L+ +T          L   +++K + LS N +  E             +L++
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 318 LKLSNNRFSGFIPNDLLKGDSLL---------LTDLDLSANNLSGSVSMILS------TN 362
            + S+  F+G + +++ +   LL         L  + LS N    +    L       T 
Sbjct: 65  AEFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123

Query: 363 LHMLNLSSNGLTGELPLLTGSCAVLD-LSNNQFEGNLSRILKWGNIEYLDLSRNHLTG-- 419
           L  L L +NGL  +         +   L                 +  +   RN L    
Sbjct: 124 LEHLYLHNNGLGPQ-----AGAKIARALQELAVNKKAKNAP---PLRSIICGRNRLENGS 175

Query: 420 --SIPEETPQFLRLNHLNLSHNSL-----SSSLPKVIIQYQKLRVLDLSFNHLD---GPF 469
                +       L+ + +  N +        L + +   Q+L+VLDL  N         
Sbjct: 176 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 235

Query: 470 LTNLL-NSSTLQELHLADNLLT--GVLDFS----PPSVSNLQVLDLSHNRLNG----YFP 518
           L   L +   L+EL L D LL+  G               LQ L L +N +         
Sbjct: 236 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 295

Query: 519 DRLGS-LTGLKVLCLAGNNIS 538
             +   +  L  L L GN  S
Sbjct: 296 TVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 73.2 bits (180), Expect = 1e-13
 Identities = 53/333 (15%), Positives = 101/333 (30%), Gaps = 67/333 (20%)

Query: 91  SNLSMLVKLSMSNNSISGV----IPDNIGDFKSLEFLDVSDNLFS----SSLPSGIGKLE 142
           +  S +   S+  ++I+      +   + +  S++ + +S N         L   I   +
Sbjct: 2   ARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60

Query: 143 SLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGF 202
            L+    +      +  +    L  +                AL +   L  + LS N F
Sbjct: 61  DLEIAEFSDIFTGRVKDEIPEALRLLLQ--------------ALLKCPKLHTVRLSDNAF 106

Query: 203 SKRIPRGFELILG----LQVLDFHGNKL-------------DGHLDGEFFLLTNASHIDF 245
                      L     L+ L  H N L             +  ++ +         I  
Sbjct: 107 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 166

Query: 246 SGNMFVGSSSQKFLPGLS--QSVQYLNLSLNQLT--GSLVNGGE-LQLFENLKVLDLSYN 300
             N     S +++       + +  + +  N +   G      E L   + LKVLDL  N
Sbjct: 167 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDN 226

Query: 301 QLTGE--------LPGFNFVYELQVLKLSNNRFSG----FIPNDLLKGDSLLLTDLDLSA 348
             T          L  +     L+ L L++   S      + +   K +++ L  L L  
Sbjct: 227 TFTHLGSSALAIALKSWP---NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 283

Query: 349 NNLSGSVSMILS-------TNLHMLNLSSNGLT 374
           N +       L         +L  L L+ N  +
Sbjct: 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 68.2 bits (167), Expect = 4e-12
 Identities = 50/283 (17%), Positives = 94/283 (33%), Gaps = 62/283 (21%)

Query: 363 LHMLNLSSNGLTGE-----LPLLTGSCAV--LDLSNNQF--EG--NLSRILK-WGNIEYL 410
           +   +L  + +T E       +L    +V  + LS N    E    LS  +    ++E  
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 411 DLSRNHLTGSIPEETPQFLR-----------LNHLNLSHNSLS----SSLPKVIIQYQKL 455
           + S    TG + +E P+ LR           L+ + LS N+        L   + ++  L
Sbjct: 66  EFSDIF-TGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 456 RVLDLSFNHL-------------DGPFLTNLLNSSTLQELHLADNLLT--GVLDFSP--P 498
             L L  N L             +        N+  L+ +    N L    + +++    
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184

Query: 499 SVSNLQVLDLSHNRLN-----GYFPDRLGSLTGLKVLCLAGNNISG----SLPTSMANMT 549
           S   L  + +  N +          + L     LKVL L  N  +     +L  ++ +  
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244

Query: 550 SLSSLVISQNHFTGP--------LPNNLPNSLETFNVSYNDFS 584
           +L  L ++    +                  L+T  + YN+  
Sbjct: 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 47/205 (22%), Positives = 82/205 (40%), Gaps = 52/205 (25%)

Query: 805 VKWLREGV-AKQRKEFAKEA---KKFANIRHPNVVGLRGYYWGPTQHEKL-ILSDYISPG 859
           VK L++    K   +   E    K     +H N++ L G     TQ   L ++ +Y S G
Sbjct: 72  VKMLKDDATEKDLSDLVSEMEMMKMIG--KHKNIINLLGAC---TQDGPLYVIVEYASKG 126

Query: 860 SLASFL-----------YDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKA 908
           +L  +L           YD        +T+   +     +ARG+ YL   + + H +L A
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI-HRDLAA 185

Query: 909 TNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR------------APELAAS 956
            N+L+   +   ++AD+ L R +                Y+            APE    
Sbjct: 186 RNVLV-TENNVMKIADFGLARDINNIDY-----------YKKTTNGRLPVKWMAPEALFD 233

Query: 957 KKPHPSF--KSDVYAFGVILLELLT 979
           +     +  +SDV++FGV++ E+ T
Sbjct: 234 RV----YTHQSDVWSFGVLMWEIFT 254

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 50/223 (22%), Positives = 81/223 (36%), Gaps = 29/223 (13%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR-HPNVVGLRG 839
            VL        Y A  + +G    +K L     ++ +   +E      +  HPN+V    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 840 YYW------GPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLN 893
                       Q E L+L++    G L  FL         PL+    LKI     R + 
Sbjct: 94  AASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKM--ESRGPLSCDTVLKIFYQTCRAVQ 150

Query: 894 YLHFDRAVP--HGNLKATNILLDGPDLNARVADYCLHRLMT----------QAGTIEQ-I 940
           ++H  +  P  H +LK  N+LL       ++ D+     ++          +   +E+ I
Sbjct: 151 HMH-RQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 941 LDAGVLGYRAPEL--AASKKPHPSFKSDVYAFGVILLELLTGR 981
                  YR PE+    S  P    K D++A G IL  L   +
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQ 250

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 49/235 (20%), Positives = 85/235 (36%), Gaps = 59/235 (25%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT------VKWLREGV-AKQRKEFAKEA---KKFANIRH 831
           + LGR + G    A               VK L+EG    + +    E           H
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG--HH 90

Query: 832 PNVVGLRGYYWGPTQHEK--LILSDYISPGSLASFL-----------YDRPGRKGPPLTW 878
            NVV L G     T+     +++ ++   G+L+++L                     LT 
Sbjct: 91  LNVVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 879 AQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE 938
              +  +  VA+G+ +L   + + H +L A NILL       ++ D+ L R + +     
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCI-HRDLAARNILL-SEKNVVKICDFGLARDIYKDPD-- 203

Query: 939 QILDAGVLGYR------------APELAASKKPHPSF--KSDVYAFGVILLELLT 979
                    Y             APE    +     +  +SDV++FGV+L E+ +
Sbjct: 204 ---------YVRKGDARLPLKWMAPETIFDRV----YTIQSDVWSFGVLLWEIFS 245

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 44/205 (21%), Positives = 71/205 (34%), Gaps = 50/205 (24%)

Query: 805 VKWLREGV-AKQRKEFAKEA---KKFANIRHPNVVGLRGYYWGPTQHEKL-ILSDYISPG 859
           VK L+      +R+    E           H N+V L G     T      ++++Y   G
Sbjct: 58  VKMLKPSAHLTEREALMSELKVLSYLG--NHMNIVNLLGAC---TIGGPTLVITEYCCYG 112

Query: 860 SLASFL-------------YDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNL 906
            L +FL                       L     L  +  VA+G+ +L     + H +L
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI-HRDL 171

Query: 907 KATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR------------APELA 954
            A NILL       ++ D+ L R +                Y             APE  
Sbjct: 172 AARNILL-THGRITKICDFGLARDIKNDSN-----------YVVKGNARLPVKWMAPESI 219

Query: 955 ASKKPHPSFKSDVYAFGVILLELLT 979
            +     +F+SDV+++G+ L EL +
Sbjct: 220 FNCVY--TFESDVWSYGIFLWELFS 242

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 38/211 (18%), Positives = 76/211 (36%), Gaps = 16/211 (7%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWL-REGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           ++LG+ +    +R    + G    +K        +      +E +    + H N+V L  
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
                T   K+++ ++   GSL + L +        L  ++ L +  DV  G+N+L  + 
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLR-EN 131

Query: 900 AVPHGNLKATNILLDG---PDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
            + H N+K  NI+           ++ D+   R +        +   G   Y  P++   
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDMYER 189

Query: 957 KKPHPSF------KSDVYAFGVILLELLTGR 981
                          D+++ GV      TG 
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 50/205 (24%), Positives = 81/205 (39%), Gaps = 52/205 (25%)

Query: 805 VKWLREGV-AKQRKEFAKEA---KKFANIRHPNVVGLRGYYWGPTQHEKL-ILSDYISPG 859
           VK L+     K   +   E    K     +H N++ L G     TQ   L ++ +Y S G
Sbjct: 106 VKMLKSDATEKDLSDLISEMEMMKMIG--KHKNIINLLGAC---TQDGPLYVIVEYASKG 160

Query: 860 SLASFL-----------YDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKA 908
           +L  +L           Y+        L+    +  A  VARG+ YL   + + H +L A
Sbjct: 161 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI-HRDLAA 219

Query: 909 TNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR------------APELAAS 956
            N+L+   D   ++AD+ L R +                Y+            APE    
Sbjct: 220 RNVLV-TEDNVMKIADFGLARDIHHIDY-----------YKKTTNGRLPVKWMAPEALFD 267

Query: 957 KKPHPSF--KSDVYAFGVILLELLT 979
           +     +  +SDV++FGV+L E+ T
Sbjct: 268 RI----YTHQSDVWSFGVLLWEIFT 288

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 43/224 (19%), Positives = 85/224 (37%), Gaps = 33/224 (14%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
            VLG+ + G   +A    +  +  +K +R    ++      E    A++ H  VV     
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAA 70

Query: 841 YWGPTQHEKL-----------ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
           +       K            I  +Y   G+L    YD    +       +  ++   + 
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYWRLFRQIL 126

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG-- 947
             L+Y+H  + + H +LK  NI +D    N ++ D+ L + + ++  I ++    + G  
Sbjct: 127 EALSYIH-SQGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 948 -----------YRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
                      Y A E+      H + K D+Y+ G+I  E++  
Sbjct: 185 DNLTSAIGTAMYVATEVL-DGTGHYNEKIDMYSLGIIFFEMIYP 227

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 77.8 bits (192), Expect = 3e-15
 Identities = 47/205 (22%), Positives = 82/205 (40%), Gaps = 52/205 (25%)

Query: 805 VKWLREGV-AKQRKEFAKEA---KKFANIRHPNVVGLRGYYWGPTQHEKL-ILSDYISPG 859
           VK L++    K   +   E    K     +H N++ L G     TQ   L ++ +Y S G
Sbjct: 118 VKMLKDDATEKDLSDLVSEMEMMKMIG--KHKNIINLLGAC---TQDGPLYVIVEYASKG 172

Query: 860 SLASFL-----------YDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKA 908
           +L  +L           YD        +T+   +     +ARG+ YL   + + H +L A
Sbjct: 173 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI-HRDLAA 231

Query: 909 TNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR------------APELAAS 956
            N+L+   +   ++AD+ L R +                Y+            APE    
Sbjct: 232 RNVLV-TENNVMKIADFGLARDINNIDY-----------YKKTTNGRLPVKWMAPEALFD 279

Query: 957 KKPHPSF--KSDVYAFGVILLELLT 979
           +     +  +SDV++FGV++ E+ T
Sbjct: 280 RV----YTHQSDVWSFGVLMWEIFT 300

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 78.2 bits (192), Expect = 3e-15
 Identities = 36/237 (15%), Positives = 65/237 (27%), Gaps = 43/237 (18%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR------EGVAKQRKEFAKEAKKFANIRHPNV 834
            VLG+        AT  E G    V              KQ KE     +    I++   
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 835 VGLRG-----------------YYWGPTQHEKLILSDYI-------SPGSLASFLYDRPG 870
             +                         + +  +LS +        +  +    L     
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH-S 202

Query: 871 RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL 930
                L    RL++ + V R L  LH    + H  L+  +I+LD       +  +     
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLH-HYGLVHTYLRPVDIVLD-QRGGVFLTGF---EH 257

Query: 931 MTQAGTIEQILDAGVLG---YRAPELAASKKPHP---SFKSDVYAFGVILLELLTGR 981
           + + G                 A  +    + HP   +F  D +  G+ +  +    
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 47/231 (20%), Positives = 86/231 (37%), Gaps = 54/231 (23%)

Query: 782 EVLGRSSHGTSYRATL------ENGMFLTVKWLREGV-AKQRKEFAKEA---KKFANIRH 831
           + LG  + G    AT       +  + + VK L+    A +++    E          +H
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG--QH 109

Query: 832 PNVVGLRG--YYWGPTQHEKLILSDYISPGSLASFL---------YDRPGRKGPPLTWAQ 880
            N+V L G   + GP     L++++Y   G L +FL                    +   
Sbjct: 110 ENIVNLLGACTHGGPV----LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 881 RLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI 940
            L  +  VA+G+ +L     + H ++ A N+LL      A++ D+ L R +         
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI-HRDVAARNVLL-TNGHVAKIGDFGLARDIMNDSN---- 219

Query: 941 LDAGVLGYR------------APELAASKKPHPSFKSDVYAFGVILLELLT 979
                  Y             APE         + +SDV+++G++L E+ +
Sbjct: 220 -------YIVKGNARLPVKWMAPESIFDCV--YTVQSDVWSYGILLWEIFS 261

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 77.7 bits (191), Expect = 3e-15
 Identities = 38/240 (15%), Positives = 68/240 (28%), Gaps = 48/240 (20%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR------EGVAKQRKEFAKEAKKFANIRHPNV 834
            VLG+        AT  E G    V              KQ KE     +    I++   
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 835 VGLRG-----------------YYWGPTQHEKLILSDYI-------SPGSLASFLYDRPG 870
             +                         + +  +LS +        +  +    L     
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH-S 197

Query: 871 RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL 930
                L    RL++ + V R L  LH    + H  L+  +I+LD       +  +     
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLH-HYGLVHTYLRPVDIVLD-QRGGVFLTGFEHLVR 255

Query: 931 MTQAGTIEQILDAGVLGYRAPELAASK---------KPHPSFKSDVYAFGVILLELLTGR 981
                       +   G+  PEL A +         +   +F  D +A G+++  +    
Sbjct: 256 DGARVVS-----SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 75.3 bits (186), Expect = 6e-15
 Identities = 38/164 (23%), Positives = 71/164 (43%), Gaps = 31/164 (18%)

Query: 828 NIRHPNVVGLRGYYWGPTQHEK--LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIA 885
            ++HP+++ L  Y+          L+L +    G +  +L +R        +  +     
Sbjct: 67  QLKHPSILELYNYFEDSN---YVYLVL-EMCHNGEMNRYLKNRVKP----FSENEARHFM 118

Query: 886 VDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTI 937
             +  G+ YLH    + H +L  +N+LL   ++N ++AD+ L         +  T  GT 
Sbjct: 119 HQIITGMLYLH-SHGILHRDLTLSNLLLTR-NMNIKIADFGLATQLKMPHEKHYTLCGT- 175

Query: 938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                     Y +PE+A ++  H   +SDV++ G +   LL GR
Sbjct: 176 --------PNYISPEIA-TRSAH-GLESDVWSLGCMFYTLLIGR 209

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 76.3 bits (188), Expect = 7e-15
 Identities = 49/206 (23%), Positives = 80/206 (38%), Gaps = 22/206 (10%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
             +GR S G  +R    + G    VK +R  V +       E    A +  P +V L G 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 118

Query: 841 YWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
                +   + I  + +  GSL   +     ++   L   + L        GL YLH  R
Sbjct: 119 V---REGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQALEGLEYLH-TR 169

Query: 900 AVPHGNLKATNILLDGPDLNARVADY-CLHRLMTQAGTIEQILDAGVLG---YRAPELAA 955
            + HG++KA N+LL      A + D+     L         +    + G   + APE+  
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV- 228

Query: 956 SKKPHPSFKSDVYAFGVILLELLTGR 981
             KP    K D+++   ++L +L G 
Sbjct: 229 MGKPC-DAKVDIWSSCCMMLHMLNGC 253

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 75.8 bits (187), Expect = 1e-14
 Identities = 58/240 (24%), Positives = 95/240 (39%), Gaps = 63/240 (26%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT------VKWLREGV-AKQRKEFAKEAKKFANIRHPNV 834
             +G  + G  ++A     +         VK L+E   A  + +F +EA   A   +PN+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 835 VGLRG--YYWGPTQHEKLILSDYISPGSLASFL-------------------YDRPGRKG 873
           V L G      P      +L +Y++ G L  FL                           
Sbjct: 113 VKLLGVCAVGKPM----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168

Query: 874 PPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ 933
           PPL+ A++L IA  VA G+ YL   + V H +L   N L+ G ++  ++AD+ L R +  
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFV-HRDLATRNCLV-GENMVVKIADFGLSRNIYS 226

Query: 934 AGTIEQILDAGVLGYR------------APELAASKKPHPSF--KSDVYAFGVILLELLT 979
           A             Y+             PE     +    +  +SDV+A+GV+L E+ +
Sbjct: 227 ADY-----------YKADGNDAIPIRWMPPESIFYNR----YTTESDVWAYGVVLWEIFS 271

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 25/204 (12%), Positives = 51/204 (25%), Gaps = 45/204 (22%)

Query: 782 EVLGRSSHGTSYRATLEN-GMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGL 837
              G       ++A        + + ++           +E      + + I  P V  +
Sbjct: 37  IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
                  T+   L+++++I  GSL       P     P      ++    +A   +  H 
Sbjct: 97  --LDVVHTRAGGLVVAEWIRGGSLQEVADTSP----SP---VGAIRAMQSLAAAADAAH- 146

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASK 957
              V       + + +   D +  +A                                  
Sbjct: 147 RAGVALSIDHPSRVRV-SIDGDVVLAY---------------------PATMPDANPQD- 183

Query: 958 KPHPSFKSDVYAFGVILLELLTGR 981
                   D+   G  L  LL  R
Sbjct: 184 --------DIRGIGASLYALLVNR 199

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 51/239 (21%), Positives = 87/239 (36%), Gaps = 61/239 (25%)

Query: 782 EVLGRSSHGTSYRATLENGMFLT------VKWLREGV-AKQRKEFAKEAKKFANIRHPNV 834
           + LG    G   +AT  +           VK L+E     + ++   E      + HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 835 VGLRGYYWGPTQHE-KLILSDYISPGSLASFL-------------------YDRPGRKGP 874
           + L G     +Q    L++ +Y   GSL  FL                            
Sbjct: 89  IKLYG---ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 875 PLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA 934
            LT    +  A  +++G+ YL   + V H +L A NIL+       +++D+ L R + + 
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLV-HRDLAARNILV-AEGRKMKISDFGLSRDVYEE 203

Query: 935 GTIEQILDAGVLGYR------------APELAASKKPHPSF--KSDVYAFGVILLELLT 979
            +           Y             A E          +  +SDV++FGV+L E++T
Sbjct: 204 DS-----------YVKRSQGRIPVKWMAIESLFDHI----YTTQSDVWSFGVLLWEIVT 247

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 44/216 (20%)

Query: 783 VLGRSSHGTSYRAT-LENGMFLTVKWL------REGVAKQRKEFAKEAKKFANIRHPNVV 835
            LG+   G  Y A   ++   L +K L      + GV  Q +   +E +  +++RHPN++
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNIL 72

Query: 836 GLRGYYWGPTQHEK----LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
            L GY+     H+     LIL +Y   G++   L     +K       +      ++A  
Sbjct: 73  RLYGYF-----HDATRVYLIL-EYAPLGTVYREL-----QKLSKFDEQRTATYITELANA 121

Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL------HRLMTQAGTIEQILDAGV 945
           L+Y H  + V H ++K  N+LL       ++AD+         R     GT++       
Sbjct: 122 LSYCH-SKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTDLCGTLD------- 172

Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             Y  PE+    + H   K D+++ GV+  E L G+
Sbjct: 173 --YLPPEMI-EGRMH-DEKVDLWSLGVLCYEFLVGK 204

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 74.9 bits (184), Expect = 3e-14
 Identities = 38/211 (18%), Positives = 76/211 (36%), Gaps = 16/211 (7%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWL-REGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           ++LG+ +    +R    + G    +K        +      +E +    + H N+V L  
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
                T   K+++ ++   GSL + L +        L  ++ L +  DV  G+N+L  + 
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLR-EN 131

Query: 900 AVPHGNLKATNILLDG---PDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
            + H N+K  NI+           ++ D+   R +        +   G   Y  P++   
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDMYER 189

Query: 957 KKPHPSF------KSDVYAFGVILLELLTGR 981
                          D+++ GV      TG 
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 74.3 bits (183), Expect = 4e-14
 Identities = 45/210 (21%), Positives = 76/210 (36%), Gaps = 55/210 (26%)

Query: 805 VKWLREGV-AKQRKEFAKEA---KKFANIRHPNVVGLRGYYWGPTQHEKL-ILSDYISPG 859
           VK L+E   + +R+    E     +     H N+V L G     T    + ++ +Y   G
Sbjct: 80  VKMLKEKADSSEREALMSELKMMTQLG--SHENIVNLLGAC---TLSGPIYLIFEYCCYG 134

Query: 860 SLASFL------------------YDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
            L ++L                            LT+   L  A  VA+G+ +L F   V
Sbjct: 135 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 194

Query: 902 PHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR------------ 949
            H +L A N+L+       ++ D+ L R +                Y             
Sbjct: 195 -HRDLAARNVLV-THGKVVKICDFGLARDIMSDSN-----------YVVRGNARLPVKWM 241

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLT 979
           APE         + KSDV+++G++L E+ +
Sbjct: 242 APESLFEGIY--TIKSDVWSYGILLWEIFS 269

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 74.4 bits (183), Expect = 4e-14
 Identities = 65/363 (17%), Positives = 115/363 (31%), Gaps = 73/363 (20%)

Query: 263 SQSVQYLNLSLNQLT--GSLVNGGELQ-LFENLKVLDLSYNQLTGE--------LPGFNF 311
              V  L+LSLN L    ++           ++  L+LS N L  +        L     
Sbjct: 21  PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP- 79

Query: 312 VYELQVLKLSNNRFSGFIPNDL---LKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNL 368
              +  L LS N  S    ++L   L      +T LDL  N+ S   S         L  
Sbjct: 80  -ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138

Query: 369 SSNGLTGELPLLTGSCAVLDLSNNQFEGN----LSRILKWGN--IEYLDLSRNHLT---- 418
           S   +T            L+L  N         L +IL      +  L+L  N+L     
Sbjct: 139 S---IT-----------SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC 184

Query: 419 ---GSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQY-----QKLRVLDLSFNHLDGPFL 470
                     P  +    L+LS N L       +          +  L+L  N L GP L
Sbjct: 185 AELAKFLASIPASVT--SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242

Query: 471 TNLL----NSSTLQELHLADNLLT-----GVLDFSP--PSVSNLQVLDLSHNRLNGYFPD 519
            NL     +   LQ ++L  +++               P++  + ++D +   ++     
Sbjct: 243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP---- 298

Query: 520 RLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVS 579
                +    +      +SG     + ++ +   +   ++        N+P+ L     +
Sbjct: 299 -----SHSIPISNLIRELSGKA--DVPSLLNQCLIFAQKHQTNIED-LNIPDELRESIQT 350

Query: 580 YND 582
              
Sbjct: 351 CKP 353

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 62/362 (17%), Positives = 104/362 (28%), Gaps = 93/362 (25%)

Query: 143 SLQNLSLAGNNFSGLIPDSVSGLV--------SIQSLDLSHNSFS----GSLPPALTRLN 190
            + +L L+ NN       S   L+        S+ SL+LS NS        L   L  + 
Sbjct: 23  GVTSLDLSLNNLY---SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79

Query: 191 -NLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNAS--HIDFSG 247
            N+  LNLS N  S +             L             +       +   +D   
Sbjct: 80  ANVTSLNLSGNFLSYK---------SSDEL------------VKTLAAIPFTITVLDLGW 118

Query: 248 NMFVGSSSQKFLPGLS---QSVQYLNLSLNQLT---GSLVNGGELQLFENLKVLDLSYNQ 301
           N F   SS +F    S    S+  LNL  N L       +      +  N+  L+L  N 
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178

Query: 302 LTGE--------LPGFNFVYELQVLKLSNNRF--SGFIP-NDLLKGDSLLLTDLDLSANN 350
           L  +        L        +  L LS N      +     +       +  L+L  N 
Sbjct: 179 LASKNCAELAKFLASIPAS--VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236

Query: 351 LSGSVSMILS------TNLHMLNLSSNGLTGELPLLTGSCA--------------VLDLS 390
           L G     L        +L  + L  + +      ++                  ++D +
Sbjct: 237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKN----MSKEQCKALGAAFPNIQKIILVDKN 292

Query: 391 NNQF--EG--NLSRILK--WGNIEYLDLSRNHLT-----GSIPEETPQFLRLNHLNLSHN 439
             +        +S +++   G  +   L    L       +  E+      L     +  
Sbjct: 293 GKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCK 352

Query: 440 SL 441
            L
Sbjct: 353 PL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 60.9 bits (148), Expect = 8e-10
 Identities = 61/378 (16%), Positives = 112/378 (29%), Gaps = 90/378 (23%)

Query: 78  NLGLSAAADL--SVFSNLSMLVKLSMSNNSISGVIPDNIGD-----FKSLEFLDVSDNLF 130
            L L   ++      S    +  L +S N++  +    +         S+  L++S N  
Sbjct: 4   KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSL 63

Query: 131 SSSLPSGIGKL-----ESLQNLSLAGNNFSGLIPDSVSGLV--------SIQSLDLSHNS 177
                  + ++      ++ +L+L+GN  S     S   LV        +I  LDL  N 
Sbjct: 64  GFKNSDELVQILAAIPANVTSLNLSGNFLS---YKSSDELVKTLAAIPFTITVLDLGWND 120

Query: 178 FSGS----LPPALTRLN-NLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDG 232
           FS         A + L  ++  LNL  N    +             L             
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK---------SSDEL------------I 159

Query: 233 EFFLLTNAS--HIDFSGNMFVGSSSQ---KFLPGLSQSVQYLNLSLNQLTGSLVNGGELQ 287
           +      A+   ++  GN     +     KFL  +  SV  L+LS N L          +
Sbjct: 160 QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLG----LKSYAE 215

Query: 288 LFE-------NLKVLDLSYNQLTGE-----LPGFNFVYELQVLKLSNNRFSGFIPNDLLK 335
           L         ++  L+L  N L G          + +  LQ + L  +            
Sbjct: 216 LAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKA 275

Query: 336 GDSLL-----LTDLDLSANNLSGSVSMILS-------TNLHMLNLSSNGLTGELPLLTGS 383
             +       +  +D +   +  S S+ +S           + +L +  L       T  
Sbjct: 276 LGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNI 335

Query: 384 CAV--------LDLSNNQ 393
             +           +   
Sbjct: 336 EDLNIPDELRESIQTCKP 353

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 46.6 bits (111), Expect = 3e-05
 Identities = 33/179 (18%), Positives = 65/179 (36%), Gaps = 27/179 (15%)

Query: 433 HLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLD---GPFLTNLL--NSSTLQELHLADN 487
           +  L+ +  S+ + +       +  LDLS N+L       L        +++  L+L+ N
Sbjct: 2   NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGN 61

Query: 488 LLT--GVLDFS---PPSVSNLQVLDLSHNRLNGYFPDRLGSL-----TGLKVLCLAGNNI 537
            L      +         +N+  L+LS N L+    D L          + VL L  N+ 
Sbjct: 62  SLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121

Query: 538 SGSLPTSMANM-----TSLSSLVISQNHFT-------GPLPNNLPNSLETFNVSYNDFS 584
           S    +           S++SL +  N            +   +P ++ + N+  N+ +
Sbjct: 122 SSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 42.0 bits (99), Expect = 8e-04
 Identities = 42/267 (15%), Positives = 84/267 (31%), Gaps = 45/267 (16%)

Query: 78  NLGLSAAADLSVF--SNLSMLVKLSMSNNSISGVIPDNIGDF-----KSLEFLDVSDNLF 130
            L   ++ +L     +    +  L +  N  S                S+  L++  N  
Sbjct: 91  FLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL 150

Query: 131 S----SSLPSGIGKL-ESLQNLSLAGNNFSGLIPDSVSGLV--------SIQSLDLSHNS 177
                  L   +  +  ++ +L+L GNN +     + + L         S+ SLDLS N 
Sbjct: 151 GIKSSDELIQILAAIPANVNSLNLRGNNLA---SKNCAELAKFLASIPASVTSLDLSANL 207

Query: 178 FSGS----LPPALTRLNN-LVYLNLSSNGFS----KRIPRGFELILGLQVLDFHGNKLDG 228
                   L    + + N +V LNL  N       + +    + +  LQ +    + +  
Sbjct: 208 LGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKN 267

Query: 229 HLDGEFFLLTNA-------SHIDFSGNMFVGSSSQKFLPGLSQ---SVQYLNLSLNQLTG 278
               +   L  A         +D +G     S S      + +        +L    L  
Sbjct: 268 MSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIF 327

Query: 279 SLVNG---GELQLFENLKVLDLSYNQL 302
           +  +     +L + + L+    +   L
Sbjct: 328 AQKHQTNIEDLNIPDELRESIQTCKPL 354

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 75.1 bits (184), Expect = 7e-14
 Identities = 53/208 (25%), Positives = 81/208 (38%), Gaps = 15/208 (7%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           E LG    G   R    + G  + +K  R E   K R+ +  E +    + HPNVV  R 
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 840 YYWGPTQ----HEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
              G  +       L+  +Y   G L  +L ++       L       +  D++  L YL
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYL-NQFENCCG-LKEGPIRTLLSDISSALRYL 137

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARV--ADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           H +  + H +LK  NI+L            D    + + Q     + +  G L Y APEL
Sbjct: 138 H-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLAPEL 194

Query: 954 AASKKPHPSFKSDVYAFGVILLELLTGR 981
              KK       D ++FG +  E +TG 
Sbjct: 195 LEQKKYTV--TVDYWSFGTLAFECITGF 220

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 73.2 bits (180), Expect = 7e-14
 Identities = 40/215 (18%), Positives = 78/215 (36%), Gaps = 27/215 (12%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKW--LREGVAKQRKEFAKEAKKFANIRHPN--VVGL 837
           + +G       ++   E      +K+  L E   +    +  E      ++  +  ++ L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
             Y    T     ++ +      L S+L     +K   +   +R     ++   ++ +H 
Sbjct: 75  YDYEI--TDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIH- 125

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD--AGVLGYRAPEL-- 953
              + H +LK  N L+   D   ++ D+ +   M Q  T   + D   G + Y  PE   
Sbjct: 126 QHGIVHSDLKPANFLIV--DGMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 954 -------AASKKPHPSFKSDVYAFGVILLELLTGR 981
                      K   S KSDV++ G IL  +  G+
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 71.9 bits (177), Expect = 9e-14
 Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 40/214 (18%)

Query: 783 VLGRSSHGTSYRA-TLENGMFLTVKWL------REGVAKQRKEFAKEAKKFANIRHPNVV 835
            LG+   G  Y A   +N   + +K L      +EGV  Q +   +E +  +++RHPN++
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR---REIEIQSHLRHPNIL 77

Query: 836 GLRGYYWGPTQHEK--LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLN 893
            +  Y+       +  L+L ++   G L   L     +K       +      ++A  L+
Sbjct: 78  RMYNYFHDRK---RIYLML-EFAPRGELYKEL-----QKHGRFDEQRSATFMEELADALH 128

Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCL------HRLMTQAGTIEQILDAGVLG 947
           Y H +R V H ++K  N+L+       ++AD+         R  T  GT++         
Sbjct: 129 YCH-ERKVIHRDIKPENLLMGY-KGELKIADFGWSVHAPSLRRRTMCGTLD--------- 177

Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           Y  PE+    K H   K D++  GV+  E L G 
Sbjct: 178 YLPPEMI-EGKTH-DEKVDLWCAGVLCYEFLVGM 209

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 40/215 (18%), Positives = 78/215 (36%), Gaps = 27/215 (12%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKW--LREGVAKQRKEFAKEAKKFANIRHPN--VVGL 837
           + +G       ++   E      +K+  L E   +    +  E      ++  +  ++ L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
             Y    T     ++ +      L S+L     +K   +   +R     ++   ++ +H 
Sbjct: 94  YDYEI--TDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIH- 144

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD--AGVLGYRAPEL-- 953
              + H +LK  N L+   D   ++ D+ +   M Q  T   + D   G + Y  PE   
Sbjct: 145 QHGIVHSDLKPANFLIV--DGMLKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 954 -------AASKKPHPSFKSDVYAFGVILLELLTGR 981
                      K   S KSDV++ G IL  +  G+
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 73.3 bits (180), Expect = 1e-13
 Identities = 40/215 (18%), Positives = 78/215 (36%), Gaps = 27/215 (12%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKW--LREGVAKQRKEFAKEAKKFANIRHPN--VVGL 837
           + +G       ++   E      +K+  L E   +    +  E      ++  +  ++ L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
             Y    T     ++ +      L S+L     +K   +   +R     ++   ++ +H 
Sbjct: 122 YDYEI--TDQYIYMVMEC-GNIDLNSWL-----KKKKSIDPWERKSYWKNMLEAVHTIH- 172

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD--AGVLGYRAPEL-- 953
              + H +LK  N L+   D   ++ D+ +   M Q  T   + D   G + Y  PE   
Sbjct: 173 QHGIVHSDLKPANFLIV--DGMLKLIDFGIANQM-QPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 954 -------AASKKPHPSFKSDVYAFGVILLELLTGR 981
                      K   S KSDV++ G IL  +  G+
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 14/157 (8%)

Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           + HPNVV L      P +    ++ + ++ G +     + P  K  PL+  Q      D+
Sbjct: 93  LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK--PLSEDQARFYFQDL 146

Query: 889 ARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD--AGVL 946
            +G+ YLH+ + + H ++K +N+L+   D + ++AD+ +      +   + +L    G  
Sbjct: 147 IKGIEYLHY-QKIIHRDIKPSNLLVGE-DGHIKIADFGVSNEFKGS---DALLSNTVGTP 201

Query: 947 GYRAPE-LAASKKPHPSFKSDVYAFGVILLELLTGRC 982
            + APE L+ ++K       DV+A GV L   + G+C
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 25/227 (11%)

Query: 766 DDTLTLTPEELSRAPAEVLGRSSHGTSYRAT-LENGMFLTVKWLR-EGVAKQRKEFAKEA 823
           +     T E+L       +GR ++G+  +     +G  + VK +R     K++K+   + 
Sbjct: 14  EQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71

Query: 824 K-KFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRL 882
                +   P +V   G  +   + +  I  + +S  S   F           +      
Sbjct: 72  DVVMRSSDCPYIVQFYGALF--REGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILG 128

Query: 883 KIAVDVARGLNYLHFDRAVPHGNLKATNILLD--GPDLNARVADY----CLHRLMTQAGT 936
           KI +   + LN+L  +  + H ++K +NILLD  G   N ++ D+     L   + +   
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSG---NIKLCDFGISGQLVDSIAKTRD 185

Query: 937 IEQILDAGVLGYRAPE-LAASKKPHP-SFKSDVYAFGVILLELLTGR 981
                  G   Y APE +  S        +SDV++ G+ L EL TGR
Sbjct: 186 A------GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 24/130 (18%), Positives = 51/130 (39%), Gaps = 6/130 (4%)

Query: 410 LDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPF 469
           + L+   +  +   +    +R   L+L    +   +  +     +   +D S N +    
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RK 56

Query: 470 LTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFP-DRLGSLTGLK 528
           L        L+ L + +N +  + +    ++ +L  L L++N L      D L SL  L 
Sbjct: 57  LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116

Query: 529 VLCLAGNNIS 538
            LC+  N ++
Sbjct: 117 YLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 61.2 bits (149), Expect = 7e-11
 Identities = 32/138 (23%), Positives = 54/138 (39%), Gaps = 11/138 (7%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGD-FKSLEFLDVSDNLFSSSLPSGIGKLESLQNLS 148
           ++N     +L +    I  +  +N+G      + +D SDN        G   L  L+ L 
Sbjct: 15  YTNAVRDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLL 70

Query: 149 LAGNNFSGLIPDSVSGLVSIQSLDLSHNSFS--GSLPPALTRLNNLVYLNLSSNGFSKRI 206
           +  N    +       L  +  L L++NS    G L P L  L +L YL +  N  + + 
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRNPVTNKK 129

Query: 207 ---PRGFELILGLQVLDF 221
                    +  ++VLDF
Sbjct: 130 HYRLYVIYKVPQVRVLDF 147

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 19/103 (18%), Positives = 39/103 (37%), Gaps = 5/103 (4%)

Query: 457 VLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGY 516
           ++ L+   ++        N+   +EL L    +  V++    ++     +D S N +   
Sbjct: 1   MVKLTAELIEQ--AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL 57

Query: 517 FPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQN 559
             D    L  LK L +  N I          +  L+ L+++ N
Sbjct: 58  --DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 26/131 (19%), Positives = 46/131 (35%), Gaps = 20/131 (15%)

Query: 344 LDLSANNLSGSVSMILSTNLHMLNLSSN------GLTGELPLLTGSCAVLDLSNNQFE-- 395
           + L+A  +  +     +     L+L          L   L         +D S+N+    
Sbjct: 2   VKLTAELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFD----AIDFSDNEIRKL 57

Query: 396 GNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLR-LNHLNLSHNSLSS--SLPKVIIQY 452
                 L+   ++ L ++ N +   I E   Q L  L  L L++NSL     L   +   
Sbjct: 58  DGFPL-LR--RLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDL-DPLASL 112

Query: 453 QKLRVLDLSFN 463
           + L  L +  N
Sbjct: 113 KSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 29/113 (25%), Positives = 52/113 (46%), Gaps = 9/113 (7%)

Query: 265 SVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNR 324
             + L+L   ++   + N G     +    +D S N++  +L GF  +  L+ L ++NNR
Sbjct: 20  RDRELDLRGYKIP-VIENLGAT--LDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNR 75

Query: 325 FSGFIPNDLLKGDSLLLTDLDLSANNLS--GSVSMILS-TNLHMLNLSSNGLT 374
               I   L +     LT+L L+ N+L   G +  + S  +L  L +  N +T
Sbjct: 76  ICR-IGEGLDQALP-DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 27/131 (20%), Positives = 50/131 (38%), Gaps = 11/131 (8%)

Query: 195 LNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSS 254
           + L++    +     +   +  + LD  G K+   ++     L     IDFS N      
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN---EIR 55

Query: 255 SQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLT--GELPGFNFV 312
                P L + ++ L ++ N++    +  G  Q   +L  L L+ N L   G+L     +
Sbjct: 56  KLDGFPLL-RRLKTLLVNNNRICR--IGEGLDQALPDLTELILTNNSLVELGDLDPLASL 112

Query: 313 YELQVLKLSNN 323
             L  L +  N
Sbjct: 113 KSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.6 bits (111), Expect = 7e-06
 Identities = 22/115 (19%), Positives = 39/115 (33%), Gaps = 6/115 (5%)

Query: 136 SGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYL 195
           +        + L L G     +I +  + L    ++D S N     L      L  L  L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69

Query: 196 NLSSNGFSKRIPRGFELILGLQVLDFHGNKLD--GHLDGEFFLLTNASHIDFSGN 248
            +++N   +      + +  L  L    N L   G LD     L + +++    N
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLD-PLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 17/69 (24%), Positives = 26/69 (37%), Gaps = 3/69 (4%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSS--SLPSGIGKLES 143
            L  F  L  L  L ++NN I  +          L  L +++N       L   +  L+S
Sbjct: 56  KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKS 114

Query: 144 LQNLSLAGN 152
           L  L +  N
Sbjct: 115 LTYLCILRN 123

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 70.8 bits (174), Expect = 4e-13
 Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 32/212 (15%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWL-REGVAK--QRKEFAKEAKKFANIRHPNVVGL 837
             LG+      +  +  +       K + +  + K  QR++ + E     ++ H +VVG 
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
            G++        ++L +     SL     +   R+   LT  +       +  G  YLH 
Sbjct: 107 HGFFEDND-FVFVVL-ELCRRRSL----LELHKRRKA-LTEPEARYYLRQIVLGCQYLH- 158

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTIEQILDAGVLGYR 949
              V H +LK  N+ L+  DL  ++ D+ L         R     GT           Y 
Sbjct: 159 RNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGT---------PNYI 208

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           APE+  SKK H SF+ DV++ G I+  LL G+
Sbjct: 209 APEVL-SKKGH-SFEVDVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 69.9 bits (172), Expect = 5e-13
 Identities = 57/232 (24%), Positives = 87/232 (37%), Gaps = 47/232 (20%)

Query: 777 SRAPAEVLGRSSHGTSYR--ATLENGMFLTVKWLR-----EGVA------------KQRK 817
           ++   EVL        Y     L  G F     +      E  A             QR+
Sbjct: 1   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60

Query: 818 EFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLT 877
           + + E     ++ H +VVG  G++        ++L +     SL     +   R+   LT
Sbjct: 61  KMSMEISIHRSLAHQHVVGFHGFFEDND-FVFVVL-ELCRRRSL----LELHKRRKA-LT 113

Query: 878 WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL--------HR 929
             +       +  G  YLH    V H +LK  N+ L+  DL  ++ D+ L         R
Sbjct: 114 EPEARYYLRQIVLGCQYLH-RNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGER 171

Query: 930 LMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                GT           Y APE+  SKK H SF+ DV++ G I+  LL G+
Sbjct: 172 KKVLCGT---------PNYIAPEVL-SKKGH-SFEVDVWSIGCIMYTLLVGK 212

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 72.2 bits (176), Expect = 6e-13
 Identities = 101/609 (16%), Positives = 181/609 (29%), Gaps = 176/609 (28%)

Query: 13  FLSSVGQLPSQDILALLE--FKKGIK----NDPTGFVLNSWNEESIDFDGCPSSWNG--- 63
           F +   Q   +DIL++ E  F          D    +L+   EE         + +G   
Sbjct: 9   FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK--EEIDHIIMSKDAVSGTLR 66

Query: 64  ---IVCNGGN------VAGVVLDNLGLSAAADLSVFSNLSMLVKLSMS-----NNSISGV 109
               + +         V  V+  N     +   +     SM+ ++ +       N     
Sbjct: 67  LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVF 126

Query: 110 IPDNIGDFK-------SLEFLDVSDNLFSSSLPSGIGK----LESLQNLSLAGNNFSGL- 157
              N+   +       +L  L  + N+    +  G GK    L+   +  +       + 
Sbjct: 127 AKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL-GSGKTWVALDVCLSYKVQCKMDFKIF 185

Query: 158 --------IPDSVSGLVSIQSL--DLSHNSFSGSLPPALTRLN-NLVYLNLSSNGFSKRI 206
                    P++V  L  +Q L   +  N  S S   +  +L  + +   L     SK  
Sbjct: 186 WLNLKNCNSPETV--LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243

Query: 207 PRGFELILGLQVLDFHGNKLD----GHLDGEFF------LLT--NASHIDF-SGNMFVGS 253
                    L VL       +       +   F      LLT       DF S       
Sbjct: 244 ENC------LLVLL------NVQNAKAWNA--FNLSCKILLTTRFKQVTDFLSAATTTHI 289

Query: 254 SSQKFLPGLSQS------VQYLNLSLNQLTGSLVNGGELQL-------------FENLK- 293
           S       L+        ++YL+     L   ++     +L             ++N K 
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKH 349

Query: 294 --------VLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLD 345
                   +++ S N L        F   L V   S +     IP  LL   SL+  D+ 
Sbjct: 350 VNCDKLTTIIESSLNVLEPAEYRKMF-DRLSVFPPSAH-----IPTILL---SLIWFDVI 400

Query: 346 LSANNLSGSVSMILSTNLH---MLNLSSNGLTGELPLLTGSCAVLDLS-NNQFEGNLSRI 401
                   S  M++   LH   ++       T  +P +      L+L    + E  L R 
Sbjct: 401 -------KSDVMVVVNKLHKYSLVEKQPKESTISIPSIY-----LELKVKLENEYALHRS 448

Query: 402 LKWGNIEYLDLSRN---------------------HLTGSIPEETPQFLRLNHLNLSHNS 440
           +    +++ ++ +                      HL      E     R+  L+     
Sbjct: 449 I----VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFR--- 501

Query: 441 LSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADN------LLTGVLD 494
                    ++ QK+R    ++N      + N L      + ++ DN      L+  +LD
Sbjct: 502 --------FLE-QKIRHDSTAWNASGS--ILNTLQQLKFYKPYICDNDPKYERLVNAILD 550

Query: 495 FSPPSVSNL 503
           F P    NL
Sbjct: 551 FLPKIEENL 559

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.9 bits (152), Expect = 4e-10
 Identities = 96/624 (15%), Positives = 181/624 (29%), Gaps = 186/624 (29%)

Query: 109 VIPDNIGDF-KSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSG------LIPDS 161
           ++      F  + +  DV D      +P  I   E + ++ ++ +  SG       +   
Sbjct: 21  ILSVFEDAFVDNFDCKDVQD------MPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSK 74

Query: 162 VSGLVSI---QSLDLSHNSFSGSLP-----PALTRLNNLVYLNLSSNG---FSKR-IPRG 209
              +V     + L +++      +      P++     +   +   N    F+K  + R 
Sbjct: 75  QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR- 133

Query: 210 FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGS----------SSQKFL 259
            +  L L+        L          L  A ++   G +  GS           S K  
Sbjct: 134 LQPYLKLR------QALLE--------LRPAKNVLIDG-VL-GSGKTWVALDVCLSYKVQ 177

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENL-KVLDLSYNQLTGELPGFNFVYELQVL 318
             +   + +LNL       ++     L++ + L   +D ++          N    +  +
Sbjct: 178 CKMDFKIFWLNLKNCNSPETV-----LEMLQKLLYQIDPNWTSR--SDHSSNIKLRIHSI 230

Query: 319 KLSNNRFSGFI-----PNDLLKGD---------------SLLLTDLDLS-ANNLSGSVSM 357
           +         +      N LL                   +LLT       + LS + + 
Sbjct: 231 Q---AELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT 287

Query: 358 ILSTNLHMLNLS---SNGL--------TGELP--LLTGSCAVLDLSNNQFEGNLSRILKW 404
            +S + H + L+      L          +LP  +LT +   L +        L+    W
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW 347

Query: 405 GNIEY------LDLSRNHLTGSIPEET-PQFLRLNHLNLSHNSLSSSLPK-VIIQYQKLR 456
            ++        ++ S N L    P E    F RL           S  P    I    L 
Sbjct: 348 KHVNCDKLTTIIESSLNVLE---PAEYRKMFDRL-----------SVFPPSAHIPTILLS 393

Query: 457 VL--DLSFNHLDGPFLTNLLNSSTLQELHLADNLLT--GV-LDFSPPSVSNLQVL----- 506
           ++  D+  +  D   + N L+  +L E    ++ ++   + L+     + N   L     
Sbjct: 394 LIWFDVIKS--DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK-LENEYALHRSIV 450

Query: 507 ------------DLSHNRLNGYF-------------PDRLGSLTGL---------KV--L 530
                       DL    L+ YF             P+R+     +         K+   
Sbjct: 451 DHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHD 510

Query: 531 CLAGNNISGSLPTSMANMTSLSSLVISQNHFT--GPLPNNLPNSLETFNVSYNDFSGAVP 588
             A N     L T       L  L   + +     P    L N++  F            
Sbjct: 511 STAWNASGSILNT-------LQQLKFYKPYICDNDPKYERLVNAILDFLPKIE------- 556

Query: 589 ENLRKFPSSSFYPGNSKLSFPGGA 612
           ENL     +        L     A
Sbjct: 557 ENLICSKYTDLL--RIALMAEDEA 578

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.7 bits (128), Expect = 4e-07
 Identities = 68/425 (16%), Positives = 139/425 (32%), Gaps = 86/425 (20%)

Query: 219 LDFHGNKLDGHLDGEFFLLTNASHI-DFSGNMFVGSSSQ-KFLPGLSQSVQYLNLSLNQL 276
             +    +    +  F    +   + D   ++   S  +   +     +V         L
Sbjct: 14  HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSIL--SKEEIDHIIMSKDAVSGTLR----L 67

Query: 277 TGSLVNGGE--LQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLL 334
             +L++  E  +Q F   +VL ++Y  L   +       E +   +    +      D L
Sbjct: 68  FWTLLSKQEEMVQKFVE-EVLRINYKFLMSPIK-----TEQRQPSMMTRMYIEQR--DRL 119

Query: 335 KGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSN------GLTGELPLLTG-SCAVL 387
             D+ +    ++S       +   L     +L L         G+ G     +G +   L
Sbjct: 120 YNDNQVFAKYNVS------RLQPYLKLRQALLELRPAKNVLIDGVLG-----SGKTWVAL 168

Query: 388 D-LSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLP 446
           D   + + +  +        I +L+L   +   ++ E   + L     N +  S  SS  
Sbjct: 169 DVCLSYKVQCKMD-----FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223

Query: 447 KVIIQYQKLRVLDLSFNHLDGPFLTNLL------NSSTLQELHLADN----LLT----GV 492
           K+ I   +  +  L  +    P+   LL      N+         +     LLT     V
Sbjct: 224 KLRIHSIQAELRRLLKSK---PYENCLLVLLNVQNAKAWNAF---NLSCKILLTTRFKQV 277

Query: 493 LDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLS 552
            DF   S +    + L H+ +    PD + SL  LK L    +     LP     + + +
Sbjct: 278 TDFL--SAATTTHISLDHHSM-TLTPDEVKSLL-LKYL----DCRPQDLPRE---VLTTN 326

Query: 553 SLVISQNHFTGPLPNNLPNSLETF-NVSYNDFSGAV--------PENLRK-FPSSSFYPG 602
              +S          +   + + + +V+ +  +  +        P   RK F   S +P 
Sbjct: 327 PRRLSI---IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPP 383

Query: 603 NSKLS 607
           ++ + 
Sbjct: 384 SAHIP 388

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 69.9 bits (171), Expect = 9e-13
 Identities = 52/238 (21%), Positives = 101/238 (42%), Gaps = 25/238 (10%)

Query: 750 LDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWL 808
           LD +   RL   L        L  ++  +     LG  + G  ++ +   +G+ +  K +
Sbjct: 9   LDEQQRKRLEAFLTQKQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGLVMARKLI 66

Query: 809 R-EGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYD 867
             E     R +  +E +       P +VG  G ++  +  E  I  +++  GSL   L  
Sbjct: 67  HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVL-- 122

Query: 868 RPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD--GPDLNARVADY 925
              +K   +      K+++ V +GL YL     + H ++K +NIL++  G     ++ D+
Sbjct: 123 ---KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG---EIKLCDF 176

Query: 926 --CLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                 + + A +       G   Y +PE    +  H S +SD+++ G+ L+E+  GR
Sbjct: 177 GVSGQLIDSMANSF-----VGTRSYMSPERL--QGTHYSVQSDIWSMGLSLVEMAVGR 227

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 37/142 (26%), Positives = 61/142 (42%), Gaps = 8/142 (5%)

Query: 110 IPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNLSLAGNNFSGLIPDSVSGLVSI 168
           IP N+   +++  + +  N     +P G     + L+ + L+ N  S L PD+  GL S+
Sbjct: 26  IPTNL--PETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82

Query: 169 QSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKL 226
            SL L  N  +  LP      L +L  L L++N     +    F+ +  L +L  + NKL
Sbjct: 83  NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKL 140

Query: 227 DGHLDGEFFLLTNASHIDFSGN 248
                G F  L     +  + N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 32/114 (28%), Positives = 51/114 (44%), Gaps = 4/114 (3%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNL 147
            FS    L ++ +SNN IS + PD     +SL  L +  N  +  LP  +   L SLQ L
Sbjct: 51  AFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLL 109

Query: 148 SLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSN 200
            L  N  + L  D+   L ++  L L  N    ++     + L  +  ++L+ N
Sbjct: 110 LLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 38/133 (28%), Positives = 59/133 (44%), Gaps = 6/133 (4%)

Query: 98  KLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNLSLAGNNFSG 156
           ++ +  N+I  + P     +K L  +D+S+N  S  L       L SL +L L GN  + 
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKITE 94

Query: 157 LIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELIL 214
           L      GL S+Q L L+ N  +  L   A   L+NL  L+L  N   + I +G F  + 
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL-QTIAKGTFSPLR 152

Query: 215 GLQVLDFHGNKLD 227
            +Q +    N   
Sbjct: 153 AIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 38/159 (23%), Positives = 67/159 (42%), Gaps = 23/159 (14%)

Query: 413 SRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL----DGP 468
               LT  IP   P+ +    + L  N++    P     Y+KLR +DLS N +       
Sbjct: 19  RGKGLT-EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA 75

Query: 469 F--LTNLLNSSTLQELHLADNLLT----GVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLG 522
           F  L +L        L L  N +T     + +     + +LQ+L L+ N++N    D   
Sbjct: 76  FQGLRSL------NSLVLYGNKITELPKSLFE----GLFSLQLLLLNANKINCLRVDAFQ 125

Query: 523 SLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHF 561
            L  L +L L  N +      + + + ++ ++ ++QN F
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 62.0 bits (151), Expect = 9e-11
 Identities = 32/137 (23%), Positives = 52/137 (37%), Gaps = 14/137 (10%)

Query: 406 NIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNH 464
            I  + L +N +   IP        +L  ++LS+N +S   P      + L  L L  N 
Sbjct: 33  TITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91

Query: 465 L----DGPF--LTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFP 518
           +       F  L +L      Q L L  N +  +   +   + NL +L L  N+L     
Sbjct: 92  ITELPKSLFEGLFSL------QLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145

Query: 519 DRLGSLTGLKVLCLAGN 535
                L  ++ + LA N
Sbjct: 146 GTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 37/171 (21%), Positives = 66/171 (38%), Gaps = 34/171 (19%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLN 190
           + +P+ +   E++  + L  N    + P + S    ++ +DLS+N  S  L P A   L 
Sbjct: 24  TEIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80

Query: 191 NLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNM 249
           +L  L L  N     +P+  FE +  LQ+L  + NK++      F  L N          
Sbjct: 81  SLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN---------- 129

Query: 250 FVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYN 300
                           +  L+L  N+L    +  G       ++ + L+ N
Sbjct: 130 ----------------LNLLSLYDNKLQT--IAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 35/145 (24%), Positives = 62/145 (42%), Gaps = 16/145 (11%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYELQV 317
             L +++  + L  N +    +  G    ++ L+ +DLS NQ++ EL    F  +  L  
Sbjct: 28  TNLPETITEIRLEQNTIKV--IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNS 84

Query: 318 LKLSNNRFSGFIPNDLLKGDSL-LLTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGLT 374
           L L  N+ +  +P  L   + L  L  L L+AN ++           NL++L+L  N L 
Sbjct: 85  LVLYGNKIT-ELPKSLF--EGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141

Query: 375 GELPLLT----GSCAVLDLSNNQFE 395
             +   T     +   + L+ N F 
Sbjct: 142 -TIAKGTFSPLRAIQTMHLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 26/94 (27%), Positives = 41/94 (43%), Gaps = 8/94 (8%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDFK---SLEFLDVSDNLFSSSLPSGI-GKLESL 144
            F  L  L  L +  N I+  +P     F+   SL+ L ++ N  +  L       L +L
Sbjct: 75  AFQGLRSLNSLVLYGNKIT-ELPK--SLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNL 130

Query: 145 QNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF 178
             LSL  N    +   + S L +IQ++ L+ N F
Sbjct: 131 NLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 39/201 (19%), Positives = 88/201 (43%), Gaps = 13/201 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           E LG  + G  +R      G     K++       +     E      + HP ++ L   
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           +    ++E +++ +++S G     L+DR   +   ++ A+ +        GL ++H + +
Sbjct: 117 F--EDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMH-EHS 169

Query: 901 VPHGNLKATNILLDGPDLNA-RVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
           + H ++K  NI+ +    ++ ++ D+ L   +     ++         + APE+   ++P
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEI-VDREP 226

Query: 960 HPSFKSDVYAFGVILLELLTG 980
              F +D++A GV+   LL+G
Sbjct: 227 V-GFYTDMWAIGVLGYVLLSG 246

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 69.2 bits (169), Expect = 2e-12
 Identities = 41/210 (19%), Positives = 75/210 (35%), Gaps = 24/210 (11%)

Query: 785 GRSSHGTSYRAT-LENGMFLTVKW--LREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
           G     T   A     G ++TV+   L     +       E        HPN+V  R  +
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 842 WGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV---DVARGLNYLHF 897
                  +L +++ +++ GS    +          +       IA     V + L+Y+H 
Sbjct: 96  ---IADNELWVVTSFMAYGSAKDLI--CTHFMDG-MNELA---IAYILQGVLKALDYIHH 146

Query: 898 DRAVPHGNLKATNILLDGPDLNARVAD----YCLHRLMTQAGTIEQILD--AGVLGYRAP 951
              V H ++KA++IL+   D    ++       +     +   +         VL + +P
Sbjct: 147 MGYV-HRSVKASHILISV-DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

Query: 952 ELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           E+          KSD+Y+ G+   EL  G 
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGH 234

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 34/127 (26%), Positives = 59/127 (46%), Gaps = 4/127 (3%)

Query: 76  LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLP 135
           L+N   +      +F  L  L K++ SNN I+ +          +  + ++ N   + + 
Sbjct: 39  LNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN-VQ 97

Query: 136 SGI-GKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLV 193
             +   LESL+ L L  N  + +  DS  GL S++ L L  N  + ++ P A   L++L 
Sbjct: 98  HKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLS 156

Query: 194 YLNLSSN 200
            LNL +N
Sbjct: 157 TLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 40/165 (24%), Positives = 64/165 (38%), Gaps = 40/165 (24%)

Query: 166 VSIQSLDLSHNSFSGSLPP--ALTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFH 222
                L L++N F+  L       +L  L  +N S+N  +  I  G FE   G+  +   
Sbjct: 32  QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLT 89

Query: 223 GNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVN 282
            N+L+                +    MF G      L  L    + L L  N++T  + N
Sbjct: 90  SNRLE----------------NVQHKMFKG------LESL----KTLMLRSNRIT-CVGN 122

Query: 283 GGELQLFE---NLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNN 323
                 F    ++++L L  NQ+T   PG F+ ++ L  L L  N
Sbjct: 123 D----SFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 59.3 bits (144), Expect = 8e-10
 Identities = 30/137 (21%), Positives = 51/137 (37%), Gaps = 26/137 (18%)

Query: 406 NIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNH 464
               L L+ N  T        + L +L  +N S+N ++            +  + L+ N 
Sbjct: 33  YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92

Query: 465 L----DGPF--LTNLLNSSTLQELHLADNLLT----GVLDFSPPSVSNLQVLDLSHNRL- 513
           L       F  L +      L+ L L  N +T             +S++++L L  N++ 
Sbjct: 93  LENVQHKMFKGLES------LKTLMLRSNRITCVGNDSFI----GLSSVRLLSLYDNQIT 142

Query: 514 ---NGYFPDRLGSLTGL 527
               G F D L SL+ L
Sbjct: 143 TVAPGAF-DTLHSLSTL 158

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 35/182 (19%), Positives = 61/182 (33%), Gaps = 48/182 (26%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVL 318
             + Q    L L+ N+ T  L   G  +    L+ ++ S N++T    G F     +  +
Sbjct: 28  EHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI 86

Query: 319 KLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELP 378
            L++NR    + + +     L                      +L  L L SN +T    
Sbjct: 87  LLTSNRLEN-VQHKMF--KGL---------------------ESLKTLMLRSNRIT---- 118

Query: 379 LLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLR-LNHLNLS 437
                     + N+ F           ++  L L  N +T ++       L  L+ LNL 
Sbjct: 119 ---------CVGNDSFI-------GLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLL 161

Query: 438 HN 439
            N
Sbjct: 162 AN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 23/113 (20%), Positives = 41/113 (36%), Gaps = 11/113 (9%)

Query: 456 RVLDLSFNHLDG-PFLTNLLNSSTLQELHLADNLLT----GVLDFSPPSVSNLQVLDLSH 510
             L L+ N                L++++ ++N +T    G  +      S +  + L+ 
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFE----GASGVNEILLTS 90

Query: 511 NRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSM-ANMTSLSSLVISQNHFT 562
           NRL          L  LK L L  N I+  +       ++S+  L +  N  T
Sbjct: 91  NRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 22/94 (23%), Positives = 43/94 (45%), Gaps = 8/94 (8%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDFK---SLEFLDVSDNLFSSSLPSGI-GKLESL 144
            F   S + ++ +++N +   +      FK   SL+ L +  N  +  + +     L S+
Sbjct: 76  AFEGASGVNEILLTSNRLEN-VQH--KMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSV 131

Query: 145 QNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF 178
           + LSL  N  + + P +   L S+ +L+L  N F
Sbjct: 132 RLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 33/154 (21%), Positives = 56/154 (36%), Gaps = 33/154 (21%)

Query: 342 TDLDLSANNLSGSVSMIL---STNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNL 398
            +L L+ N  +   +  +      L  +N S+N +T             D+    FEG  
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-------------DIEEGAFEG-A 80

Query: 399 SRILKWGNIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRV 457
           S       +  + L+ N L  ++  +  + L  L  L L  N ++       I    +R+
Sbjct: 81  S------GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRL 133

Query: 458 LDLSFNHL----DGPFLTNLLNSSTLQELHLADN 487
           L L  N +     G F   L +   L  L+L  N
Sbjct: 134 LSLYDNQITTVAPGAF-DTLHS---LSTLNLLAN 163

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 50/237 (21%), Positives = 87/237 (36%), Gaps = 30/237 (12%)

Query: 757 RLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRAT-LENGMFLTVKWLR-EGVAK 814
           +  G L            +L       +G  + G  ++    + G  + VK +R  G  +
Sbjct: 8   KQTGYLTIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE 65

Query: 815 QRKEFAKEAK-KFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKG 873
           + K    +      +   P +V   G +   T  +  I  + +   +          R  
Sbjct: 66  ENKRILMDLDVVLKSHDCPYIVQCFGTFI--TNTDVFIAMELMGTCAEKLKK-----RMQ 118

Query: 874 PPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD--GPDLNARVADY----CL 927
            P+      K+ V + + L YL     V H ++K +NILLD  G     ++ D+     L
Sbjct: 119 GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG---QIKLCDFGISGRL 175

Query: 928 HRLMTQAGTIEQILDAGVLGYRAPE---LAASKKPHPSFKSDVYAFGVILLELLTGR 981
                      +   AG   Y APE        KP    ++DV++ G+ L+EL TG+
Sbjct: 176 VD------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 47/233 (20%)

Query: 98  KLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGL 157
           K ++   S++  +  N  +  S++ +  +++   S +  GI  L +++ L+L GN    +
Sbjct: 23  KANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQ-GIQYLPNVRYLALGGNKLHDI 78

Query: 158 -IPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELIL 214
                   L ++  L L+ N    SLP     +L NL  L L  N     +P G F+ + 
Sbjct: 79  SALKE---LTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLT 133

Query: 215 GLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLN 274
            L  L+   N+L     G F  LTN                          +  L+LS N
Sbjct: 134 NLTYLNLAHNQLQSLPKGVFDKLTN--------------------------LTELDLSYN 167

Query: 275 QLTGSLVNGGELQLFE---NLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNN 323
           QL  SL  G    +F+    LK L L  NQL     G F+ +  LQ + L +N
Sbjct: 168 QLQ-SLPEG----VFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 60.8 bits (148), Expect = 5e-10
 Identities = 53/187 (28%), Positives = 73/187 (39%), Gaps = 37/187 (19%)

Query: 360 STNLHMLNLSSNGLTGELPLLTG--SCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHL 417
                  NL    +T +        S   +  +N+  + ++  I    N+ YL L  N L
Sbjct: 18  FAETIKANLKKKSVT-DAVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVRYLALGGNKL 75

Query: 418 TGSIPEETPQFLRLN---HLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL----DGPF- 469
                 +      L    +L L+ N L S    V  +   L+ L L  N L    DG F 
Sbjct: 76  H-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFD 130

Query: 470 -LTNLLNSSTLQELHLADNLLT----GVLDFSPPSVSNLQVLDLSHNRL----NGYFPDR 520
            LTN      L  L+LA N L     GV D     ++NL  LDLS+N+L     G F D+
Sbjct: 131 KLTN------LTYLNLAHNQLQSLPKGVFD----KLTNLTELDLSYNQLQSLPEGVF-DK 179

Query: 521 LGSLTGL 527
           L  L  L
Sbjct: 180 LTQLKDL 186

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 60.4 bits (147), Expect = 5e-10
 Identities = 49/196 (25%), Positives = 74/196 (37%), Gaps = 27/196 (13%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLK 319
                     NL    +T   V   EL    ++  +  + + +   + G  ++  ++ L 
Sbjct: 15  DDAFAETIKANLKKKSVT-DAVTQNELN---SIDQIIANNSDIK-SVQGIQYLPNVRYLA 69

Query: 320 LSNNRFSG---FIPNDLLKGDSLL-LTDLDLSANNLSGSVSMILS--TNLHMLNLSSNGL 373
           L  N+                 L  LT L L+ N L    + +    TNL  L L  N L
Sbjct: 70  LGGNKLHDISAL--------KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL 121

Query: 374 T----GELPLLTGSCAVLDLSNNQFEGNLSRIL-KWGNIEYLDLSRNHLTGSIPEETPQF 428
                G    LT +   L+L++NQ +     +  K  N+  LDLS N L  S+PE     
Sbjct: 122 QSLPDGVFDKLT-NLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDK 179

Query: 429 L-RLNHLNLSHNSLSS 443
           L +L  L L  N L S
Sbjct: 180 LTQLKDLRLYQNQLKS 195

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 8/142 (5%)

Query: 87  LSVFSNLSMLVKLSMSNNSISGVIPDNIGD-FKSLEFLDVSDNLFSSSLPSGI-GKLESL 144
           +S    L+ L  L ++ N +  + P+ + D   +L+ L + +N    SLP G+  KL +L
Sbjct: 78  ISALKELTNLTYLILTGNQLQSL-PNGVFDKLTNLKELVLVENQL-QSLPDGVFDKLTNL 135

Query: 145 QNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFS 203
             L+LA N    L       L ++  LDLS+N    SLP     +L  L  L L  N   
Sbjct: 136 TYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL- 193

Query: 204 KRIPRG-FELILGLQVLDFHGN 224
           K +P G F+ +  LQ +  H N
Sbjct: 194 KSVPDGVFDRLTSLQYIWLHDN 215

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 53/198 (26%), Positives = 78/198 (39%), Gaps = 41/198 (20%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLN 190
            S+PSGI      + L L     + L   +  GL  +  L+L +N    +L       L 
Sbjct: 27  DSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLT 83

Query: 191 NLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNM 249
            L  L L++N  +  +P G F+ +  L  L   GN+L     G F  LT           
Sbjct: 84  ELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTK---------- 132

Query: 250 FVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFE---NLKVLDLSYNQLTGEL 306
                           ++ L L+ NQL  S+  G     F+   NL+ L LS NQL    
Sbjct: 133 ----------------LKELRLNTNQLQ-SIPAG----AFDKLTNLQTLSLSTNQLQSVP 171

Query: 307 PG-FNFVYELQVLKLSNN 323
            G F+ + +LQ + L  N
Sbjct: 172 HGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 42/144 (29%), Positives = 67/144 (46%), Gaps = 8/144 (5%)

Query: 88  SVFSNLSMLVKLSMSNNSISGVIPDNIGD-FKSLEFLDVSDNLFSSSLPSGI-GKLESLQ 145
           + F  L+ L  L++  N +   +   + D    L  L +++N   +SLP G+   L  L 
Sbjct: 53  ATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL-ASLPLGVFDHLTQLD 110

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSK 204
            L L GN    L       L  ++ L L+ N    S+P  A  +L NL  L+LS+N   +
Sbjct: 111 KLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL-Q 168

Query: 205 RIPRG-FELILGLQVLDFHGNKLD 227
            +P G F+ +  LQ +   GN+ D
Sbjct: 169 SVPHGAFDRLGKLQTITLFGNQFD 192

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 46/168 (27%), Positives = 67/168 (39%), Gaps = 28/168 (16%)

Query: 408 EYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL-- 465
           E LDL    L            +L  LNL +N L +    V     +L  L L+ N L  
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 466 --DGPF--LTNLLNSSTLQELHLADNLLT----GVLDFSPPSVSNLQVLDLSHNRL---- 513
              G F  LT       L +L+L  N L     GV D     ++ L+ L L+ N+L    
Sbjct: 98  LPLGVFDHLTQ------LDKLYLGGNQLKSLPSGVFD----RLTKLKELRLNTNQLQSIP 147

Query: 514 NGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHF 561
            G F D+   LT L+ L L+ N +      +   +  L ++ +  N F
Sbjct: 148 AGAF-DK---LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 38/141 (26%), Positives = 57/141 (40%), Gaps = 6/141 (4%)

Query: 110 IPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQ 169
           +P  I      E LD+     ++   +    L  L  L+L  N    L       L  + 
Sbjct: 29  VPSGIPA--DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86

Query: 170 SLDLSHNSFSGSLPPAL-TRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLD 227
           +L L++N  + SLP  +   L  L  L L  N   K +P G F+ +  L+ L  + N+L 
Sbjct: 87  TLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ 144

Query: 228 GHLDGEFFLLTNASHIDFSGN 248
               G F  LTN   +  S N
Sbjct: 145 SIPAGAFDKLTNLQTLSLSTN 165

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 44/184 (23%), Positives = 62/184 (33%), Gaps = 39/184 (21%)

Query: 293 KVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNL 351
           + LDL    L       F  + +L  L L  N+    +   +   D L            
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVF--DDL------------ 82

Query: 352 SGSVSMILSTNLHMLNLSSNGLT-------GELPLLTGSCAVLDLSNNQFEGNLSRIL-K 403
                    T L  L L++N L          L  L      L L  NQ +   S +  +
Sbjct: 83  ---------TELGTLGLANNQLASLPLGVFDHLTQLD----KLYLGGNQLKSLPSGVFDR 129

Query: 404 WGNIEYLDLSRNHLTGSIPEETPQFLR-LNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSF 462
              ++ L L+ N L  SIP      L  L  L+LS N L S       +  KL+ + L  
Sbjct: 130 LTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188

Query: 463 NHLD 466
           N  D
Sbjct: 189 NQFD 192

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 67.4 bits (165), Expect = 7e-12
 Identities = 53/284 (18%), Positives = 106/284 (37%), Gaps = 17/284 (5%)

Query: 703 SKKGSSSGILSPDEKAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGEL 762
              G+ +      + +      S    +   WS             R    + D      
Sbjct: 12  VDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPA 71

Query: 763 HFLDDTLTLTPEELSR----APAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRK 817
            F    +T     ++     +  E+LG    G  ++      G+ L  K ++    K ++
Sbjct: 72  PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131

Query: 818 EFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLT 877
           E   E      + H N++ L   +   ++++ +++ +Y+  G     L+DR   +   LT
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAF--ESKNDIVLVMEYVDGGE----LFDRIIDESYNLT 185

Query: 878 WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNA-RVADYCLHRLMTQAGT 936
               +     +  G+ ++H    + H +LK  NIL    D    ++ D+ L R       
Sbjct: 186 ELDTILFMKQICEGIRHMH-QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244

Query: 937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           ++     G   + APE+  +     SF +D+++ GVI   LL+G
Sbjct: 245 LKVNF--GTPEFLAPEV-VNYDFV-SFPTDMWSVGVIAYMLLSG 284

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 66.8 bits (163), Expect = 8e-12
 Identities = 32/141 (22%), Positives = 54/141 (38%), Gaps = 17/141 (12%)

Query: 851 ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATN 910
           I        +L  ++  R   +         L I + +A  + +LH  + + H +LK +N
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVC--LHIFIQIAEAVEFLH-SKGLMHRDLKPSN 194

Query: 911 ILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG-----------YRAPELAASKKP 959
           I     D   +V D+ L   M Q    + +L                 Y +PE       
Sbjct: 195 IFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI-HGNN 252

Query: 960 HPSFKSDVYAFGVILLELLTG 980
           + S K D+++ G+IL ELL  
Sbjct: 253 Y-SHKVDIFSLGLILFELLYS 272

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 34/219 (15%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           EV+G  +      A        + +K +  E       E  KE +  +   HPN+V    
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80

Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFL---YDRPGRKGPPLTWAQRLKIAV---DVARGL 892
            +      ++L ++   +S GS+   +     +   K   L  +    IA    +V  GL
Sbjct: 81  SF---VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST---IATILREVLEGL 134

Query: 893 NYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--- 949
            YLH +  + H ++KA NILL   D + ++AD+ +      +  +    D      R   
Sbjct: 135 EYLHKNGQI-HRDVKAGNILLGE-DGSVQIADFGV------SAFLATGGDITRNKVRKTF 186

Query: 950 -------APELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                  APE+    + +  FK+D+++FG+  +EL TG 
Sbjct: 187 VGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGA 224

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 65.7 bits (161), Expect = 1e-11
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 18/221 (8%)

Query: 768 TLTLTPEELSRAPAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQ-RKEFAKEAK- 824
           ++ +  ++L       LGR ++G   +   + +G  + VK +R  V  Q +K    +   
Sbjct: 1   SMEVKADDLEPI--MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 58

Query: 825 KFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKI 884
               +  P  V   G  +   + +  I  + +   SL  F Y +   KG  +      KI
Sbjct: 59  SMRTVDCPFTVTFYGALF--REGDVWICMELMD-TSLDKF-YKQVIDKGQTIPEDILGKI 114

Query: 885 AVDVARGLNYLHFDRAVPHGNLKATNILLD--GPDLNARVADYCLHRLMTQAGTIEQILD 942
           AV + + L +LH   +V H ++K +N+L++  G     ++ D+ +   +     + + +D
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLINALG---QVKMCDFGISGYLVD--DVAKDID 169

Query: 943 AGVLGYRAPE-LAASKKPHP-SFKSDVYAFGVILLELLTGR 981
           AG   Y APE +         S KSD+++ G+ ++EL   R
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 67.4 bits (165), Expect = 1e-11
 Identities = 43/205 (20%), Positives = 81/205 (39%), Gaps = 18/205 (8%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWL--REGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
           + LG  ++G           +   +K +           +  +E      + HPN++ L 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
            ++    +    ++ +    G L    +D    +           I   V  G+ YLH  
Sbjct: 103 DFF--EDKRNYYLVMECYKGGEL----FDEIIHRMK-FNEVDAAVIIKQVLSGVTYLH-K 154

Query: 899 RAVPHGNLKATNILLDGPDLNA--RVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
             + H +LK  N+LL+  + +A  ++ D+ L  +      +++    G   Y APE+   
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER--LGTAYYIAPEVL-- 210

Query: 957 KKPHPSFKSDVYAFGVILLELLTGR 981
           +K +   K DV++ GVIL  LL G 
Sbjct: 211 RKKY-DEKCDVWSIGVILFILLAGY 234

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 41/143 (28%), Positives = 60/143 (41%), Gaps = 11/143 (7%)

Query: 110 IPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGL---IPDSVSGLV 166
           +P  I    + + L + DN  +   P     L +L+ L L  N    L   + DS   L 
Sbjct: 34  VPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS---LT 88

Query: 167 SIQSLDLSHNSFSGSLPPAL-TRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNK 225
            +  LDL  N  +  LP A+  RL +L  L +  N     +PRG E +  L  L    N+
Sbjct: 89  QLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQ 146

Query: 226 LDGHLDGEFFLLTNASHIDFSGN 248
           L     G F  L++ +H    GN
Sbjct: 147 LKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 40/131 (30%), Positives = 54/131 (41%), Gaps = 24/131 (18%)

Query: 408 EYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL-- 465
           + L L  N +T   P      + L  L L  N L +    V     +L VLDL  N L  
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102

Query: 466 --DGPF--LTNLLNSSTLQELHLADNLLTGVLDFSPPSV---SNLQVLDLSHNRL----N 514
                F  L +      L+EL +  N LT +    P  +   ++L  L L  N+L    +
Sbjct: 103 LPSAVFDRLVH------LKELFMCCNKLTEL----PRGIERLTHLTHLALDQNQLKSIPH 152

Query: 515 GYFPDRLGSLT 525
           G F DRL SLT
Sbjct: 153 GAF-DRLSSLT 162

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 44/163 (26%), Positives = 61/163 (37%), Gaps = 44/163 (26%)

Query: 194 YLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGS 253
            L L  N  +K  P  F+ ++ L+ L    N+L     G F  LT               
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ-------------- 89

Query: 254 SSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFE---NLKVLDLSYNQLTGELP-GF 309
                       +  L+L  NQLT  L +     +F+   +LK L +  N+LT ELP G 
Sbjct: 90  ------------LTVLDLGTNQLT-VLPSA----VFDRLVHLKELFMCCNKLT-ELPRGI 131

Query: 310 NFVYELQVLKLSNNRFSGFIPN---DLLKGDSLLLTDLDLSAN 349
             +  L  L L  N+    IP+   D L      LT   L  N
Sbjct: 132 ERLTHLTHLALDQNQLKS-IPHGAFDRLSS----LTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 40/152 (26%), Positives = 60/152 (39%), Gaps = 46/152 (30%)

Query: 293 KVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNL 351
           ++L L  NQ+T   PG F+ +  L+ L L +N+    +P  +   DSL            
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVF--DSL------------ 87

Query: 352 SGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLD 411
                    T L +L+L +N LT  LP      AV D              +  +++ L 
Sbjct: 88  ---------TQLTVLDLGTNQLT-VLPS-----AVFD--------------RLVHLKELF 118

Query: 412 LSRNHLTGSIPEETPQFLRLNHLNLSHNSLSS 443
           +  N LT  +P    +   L HL L  N L S
Sbjct: 119 MCCNKLT-ELPRGIERLTHLTHLALDQNQLKS 149

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 62.0 bits (151), Expect = 2e-11
 Identities = 27/110 (24%), Positives = 50/110 (45%), Gaps = 4/110 (3%)

Query: 431 LNHLNLSHNSLSS-SLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLL 489
           +  L L ++  +   L  +  ++++L  L      L    + NL   + L++L L+DN +
Sbjct: 19  VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS--IANLPKLNKLKKLELSDNRV 76

Query: 490 TGVLDFSPPSVSNLQVLDLSHNRLNGY-FPDRLGSLTGLKVLCLAGNNIS 538
           +G L+       NL  L+LS N++      + L  L  LK L L    ++
Sbjct: 77  SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 61.6 bits (150), Expect = 3e-11
 Identities = 34/135 (25%), Positives = 60/135 (44%), Gaps = 9/135 (6%)

Query: 92  NLSMLVKLSMSNNSIS-GVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLA 150
             S + +L + N+  + G +     +F+ LEFL   +   +S   + + KL  L+ L L+
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72

Query: 151 GNNFSGLIPDSVSGLVSIQSLDLSHNSFS--GSLPPALTRLNNLVYLNLSSNGFSKRI-- 206
            N  SG +        ++  L+LS N      ++ P L +L NL  L+L +   +     
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNCEVTNLNDY 131

Query: 207 -PRGFELILGLQVLD 220
               F+L+  L  LD
Sbjct: 132 RENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 58.5 bits (142), Expect = 3e-10
 Identities = 28/103 (27%), Positives = 47/103 (45%), Gaps = 3/103 (2%)

Query: 75  VLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSL 134
           VLDN   +      +      L  LS  N  ++ +   N+     L+ L++SDN  S  L
Sbjct: 23  VLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGL 80

Query: 135 PSGIGKLESLQNLSLAGNNFSGL-IPDSVSGLVSIQSLDLSHN 176
                K  +L +L+L+GN    L   + +  L +++SLDL + 
Sbjct: 81  EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 32/126 (25%), Positives = 50/126 (39%), Gaps = 6/126 (4%)

Query: 386 VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSL 445
           VLD S +          ++  +E+L      LT SI    P+  +L  L LS N +S  L
Sbjct: 23  VLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGL 80

Query: 446 PKVIIQYQKLRVLDLSFNHLDGP-FLTNLLNSSTLQELHLADNLLTGVLDFSPPSVS--- 501
             +  +   L  L+LS N +     +  L     L+ L L +  +T + D+         
Sbjct: 81  EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLP 140

Query: 502 NLQVLD 507
            L  LD
Sbjct: 141 QLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 32/115 (27%), Positives = 49/115 (42%), Gaps = 9/115 (7%)

Query: 264 QSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNN 323
             V+ L L  ++        G    FE L+ L      LT  +     + +L+ L+LS+N
Sbjct: 17  SDVKELVLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDN 74

Query: 324 RFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS----TNLHMLNLSSNGLT 374
           R SG +    L      LT L+LS N +   +S I       NL  L+L +  +T
Sbjct: 75  RVSGGLEV--LAEKCPNLTHLNLSGNKIK-DLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 23/89 (25%), Positives = 35/89 (39%), Gaps = 3/89 (3%)

Query: 475 NSSTLQELHLADNLLT-GVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLA 533
             S ++EL L ++    G L+        L+ L   +  L       L  L  LK L L+
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72

Query: 534 GNNISGSLPTSMANMTSLSSLVISQNHFT 562
            N +SG L        +L+ L +S N   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 33/154 (21%), Positives = 54/154 (35%), Gaps = 33/154 (21%)

Query: 314 ELQVLKLSNNRFSGFIPNDLLKGDSLL-LTDLDLSANNLSGSVSMILS-TNLHMLNLSSN 371
           +++ L L N+R +          D    L  L      L+ S++ +     L  L LS N
Sbjct: 18  DVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDN 74

Query: 372 GLTGELPLLTGSCA---VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQF 428
            ++G L +L   C     L+LS N       +I     IE L                + 
Sbjct: 75  RVSGGLEVLAEKCPNLTHLNLSGN-------KIKDLSTIEPLK---------------KL 112

Query: 429 LRLNHLNLSHNSLSSS---LPKVIIQYQKLRVLD 459
             L  L+L +  +++       V     +L  LD
Sbjct: 113 ENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.1 bits (102), Expect = 6e-05
 Identities = 20/89 (22%), Positives = 34/89 (38%), Gaps = 3/89 (3%)

Query: 140 KLESLQNLSLAGNNFS-GLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLS 198
               ++ L L  +  + G +         ++ L   +   + S+   L +LN L  L LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72

Query: 199 SNGFSKRIPRGFELILGLQVLDFHGNKLD 227
            N  S  +    E    L  L+  GNK+ 
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.0 bits (94), Expect = 8e-04
 Identities = 30/132 (22%), Positives = 55/132 (41%), Gaps = 13/132 (9%)

Query: 170 SLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGH 229
            LD S ++  G L         L +L+  + G +  I      +  L+ L+   N++ G 
Sbjct: 23  VLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLTS-IA-NLPKLNKLKKLELSDNRVSGG 79

Query: 230 LDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTG-----SLVNGG 284
           L+       N +H++ SGN     S+ + L  L ++++ L+L   ++T        V   
Sbjct: 80  LEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKL-ENLKSLDLFNCEVTNLNDYRENV--- 135

Query: 285 ELQLFENLKVLD 296
             +L   L  LD
Sbjct: 136 -FKLLPQLTYLD 146

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 37/149 (24%), Positives = 64/149 (42%), Gaps = 29/149 (19%)

Query: 397 NLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLS-----SSLPKVIIQ 451
            +        IE +D + + L               HL LS N++      S +      
Sbjct: 27  KVELHGMIPPIEKMDATLSTLKA-----------CKHLALSTNNIEKISSLSGMEN---- 71

Query: 452 YQKLRVLDLSFNHLDGPFLTNLLN-SSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSH 510
              LR+L L  N +    + NL   + TL+EL ++ N +  +       + NL+VL +S+
Sbjct: 72  ---LRILSLGRNLIKK--IENLDAVADTLEELWISYNQIASLSGIE--KLVNLRVLYMSN 124

Query: 511 NRLNGYFP-DRLGSLTGLKVLCLAGNNIS 538
           N++  +   D+L +L  L+ L LAGN + 
Sbjct: 125 NKITNWGEIDKLAALDKLEDLLLAGNPLY 153

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 26/112 (23%), Positives = 53/112 (47%), Gaps = 8/112 (7%)

Query: 91  SNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLA 150
           S L     L++S N+I  +   ++   ++L  L +  NL    + +     ++L+ L ++
Sbjct: 45  STLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLI-KKIENLDAVADTLEELWIS 101

Query: 151 GNNFSGLIPDSVSGLVSIQSLDLSHNSFS--GSLPPALTRLNNLVYLNLSSN 200
            N  + L    +  LV+++ L +S+N  +  G +   L  L+ L  L L+ N
Sbjct: 102 YNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDK-LAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 31/134 (23%), Positives = 57/134 (42%), Gaps = 11/134 (8%)

Query: 96  LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFS 155
            V+L      I   +   +   K+ + L +S N       S +  +E+L+ LSL  N   
Sbjct: 27  KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK 83

Query: 156 GLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILG 215
             I +  +   +++ L +S+N  + SL   + +L NL  L +S+N  +       + +  
Sbjct: 84  K-IENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN--WGEIDKLAA 138

Query: 216 ---LQVLDFHGNKL 226
              L+ L   GN L
Sbjct: 139 LDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 50.1 bits (120), Expect = 7e-07
 Identities = 37/201 (18%), Positives = 65/201 (32%), Gaps = 60/201 (29%)

Query: 269 LNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGF 328
           L+  +  +         L   +  K L LS N +  ++   + +  L++L L  N     
Sbjct: 30  LHGMIPPIEKMDAT---LSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKKI 85

Query: 329 IPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLD 388
              D +      L +L +S N ++            +  +        L  L     VL 
Sbjct: 86  ENLDAVAD---TLEELWISYNQIA-----------SLSGIEK------LVNLR----VLY 121

Query: 389 LSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSL--- 445
           +SNN+       I  WG I+ L                   +L  L L+ N L +     
Sbjct: 122 MSNNK-------ITNWGEIDKLA---------------ALDKLEDLLLAGNPLYNDYKEN 159

Query: 446 -------PKVIIQYQKLRVLD 459
                   +V+ +   L+ LD
Sbjct: 160 NATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 31/178 (17%), Positives = 60/178 (33%), Gaps = 45/178 (25%)

Query: 140 KLESLQNLSLAGNNFSGL--IPDSVSGLVSIQSLDLSHNSFS---GSLPPALTRLNNLVY 194
                + + L       +  +  ++S L + + L LS N+           L+ + NL  
Sbjct: 21  VATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRI 74

Query: 195 LNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSS 254
           L+L  N   K I     +   L+ L    N++                            
Sbjct: 75  LSLGRNLIKK-IENLDAVADTLEELWISYNQI---------------------------- 105

Query: 255 SQKFLPGLS--QSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFN 310
               L G+    +++ L +S N++T +     +L   + L+ L L+ N L  +    N
Sbjct: 106 --ASLSGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENN 160

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 31/117 (26%), Positives = 49/117 (41%), Gaps = 14/117 (11%)

Query: 91  SNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLA 150
           S +  L  LS+  N I   I +      +LE L +S N  +S   SGI KL +L+ L ++
Sbjct: 67  SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS--LSGIEKLVNLRVLYMS 123

Query: 151 GNNFSGLIP-DSVSGLVSIQSLDLSHNSFSGSLPPA----------LTRLNNLVYLN 196
            N  +     D ++ L  ++ L L+ N                   + RL NL  L+
Sbjct: 124 NNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 25/118 (21%), Positives = 44/118 (37%), Gaps = 18/118 (15%)

Query: 472 NLLNSSTLQ--ELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRL----NGYFPDRLGSLT 525
             + ++  +  ELH     +   +D +  ++   + L LS N +    +      L  + 
Sbjct: 18  KSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS------LSGME 70

Query: 526 GLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFT--GPLPNNLPNSLETFNVSYN 581
            L++L L  N I   +    A   +L  L IS N       +   L N L    +S N
Sbjct: 71  NLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSGI-EKLVN-LRVLYMSNN 125

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 21/97 (21%), Positives = 33/97 (34%), Gaps = 4/97 (4%)

Query: 133 SLPSGIGKLESLQNLSLAGNNFSGLIPD-SVSGLVSIQSLDLSHNSFSGSLPP-ALTRLN 190
                +   E+L  L +        +    + GL  +++L +  +     + P A     
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 191 NLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLD 227
            L  LNLS N     +       L LQ L   GN L 
Sbjct: 81  RLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 5e-07
 Identities = 23/94 (24%), Positives = 36/94 (38%), Gaps = 2/94 (2%)

Query: 470 LTNLLNSSTLQELHLADN-LLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLK 528
           L +L  +  L EL++ +   L  +       +  L+ L +  + L    PD       L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 529 VLCLAGNNISGSLPTSMANMTSLSSLVISQNHFT 562
            L L+ N +  SL        SL  LV+S N   
Sbjct: 84  RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.5 bits (120), Expect = 2e-06
 Identities = 25/92 (27%), Positives = 35/92 (38%), Gaps = 5/92 (5%)

Query: 286 LQLFENLKVLDLSYNQLTGELPGFNFVY--ELQVLKLSNNRFSGFIPNDLLKGDSLLLTD 343
           L   ENL  L +   Q    L   +     EL+ L +  +    F+  D        L+ 
Sbjct: 27  LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP-RLSR 84

Query: 344 LDLSANNLSG-SVSMILSTNLHMLNLSSNGLT 374
           L+LS N L   S   +   +L  L LS N L 
Sbjct: 85  LNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 23/104 (22%), Positives = 33/104 (31%), Gaps = 2/104 (1%)

Query: 76  LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDN-IGDFKSLEFLDVSDNLFSSSL 134
           L      A   L        L +L + N      +    +     L  L +  +      
Sbjct: 13  LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72

Query: 135 PSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF 178
           P        L  L+L+ N    L   +V GL S+Q L LS N  
Sbjct: 73  PDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 7e-06
 Identities = 27/107 (25%), Positives = 44/107 (41%), Gaps = 15/107 (14%)

Query: 369 SSNGLTGELPLLTGSCAV--LDLSNNQFEGNLSRILKWG------NIEYLDLSRNHLTGS 420
           + +G    L  L G+  +  L + N        + L+         +  L + ++ L   
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQ----QHLQHLELRDLRGLGELRNLTIVKSGLR-F 70

Query: 421 IPEETPQFL-RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLD 466
           +  +   F  RL+ LNLS N+L  SL    +Q   L+ L LS N L 
Sbjct: 71  VAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 27/147 (18%), Positives = 42/147 (28%), Gaps = 44/147 (29%)

Query: 295 LDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGS 354
           L  + +     L        L  L + N +    +    L+               L   
Sbjct: 13  LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLR--------------GL--- 55

Query: 355 VSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSR 414
                   L  L +  +GL               ++ + F            +  L+LS 
Sbjct: 56  ------GELRNLTIVKSGLR-------------FVAPDAFHFT-------PRLSRLNLSF 89

Query: 415 NHLTGSIPEETPQFLRLNHLNLSHNSL 441
           N L  S+  +T Q L L  L LS N L
Sbjct: 90  NALE-SLSWKTVQGLSLQELVLSGNPL 115

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 32/168 (19%), Positives = 59/168 (35%), Gaps = 35/168 (20%)

Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           +RH NV+ L    +   + +  ++ +Y   G     + D    K        R  +    
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK--------RFPV--CQ 110

Query: 889 AR--------GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI 940
           A         GL YLH  + + H ++K  N+LL       +++   +   +         
Sbjct: 111 AHGYFCQLIDGLEYLH-SQGIVHKDIKPGNLLLTT-GGTLKISALGVAEAL------HPF 162

Query: 941 LDAGVL-------GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                         ++ PE+A        FK D+++ GV L  + TG 
Sbjct: 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 61.7 bits (150), Expect = 5e-11
 Identities = 32/130 (24%), Positives = 57/130 (43%), Gaps = 5/130 (3%)

Query: 410 LDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPF 469
           +D+ R  +   +   TP  +R   L+   ++    +  +  ++  L  L L    L    
Sbjct: 8   MDMKRR-IHLELRNRTPAAVRELVLDNCKSNDGK-IEGLTAEFVNLEFLSLINVGLIS-- 63

Query: 470 LTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFP-DRLGSLTGLK 528
           ++NL     L++L L++N + G LD     + NL  L+LS N+L      + L  L  LK
Sbjct: 64  VSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLK 123

Query: 529 VLCLAGNNIS 538
            L L    ++
Sbjct: 124 SLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 27/103 (26%), Positives = 47/103 (45%), Gaps = 3/103 (2%)

Query: 75  VLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSL 134
           VLDN   +      + +    L  LS+ N  +  V   N+     L+ L++S+N     L
Sbjct: 30  VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGL 87

Query: 135 PSGIGKLESLQNLSLAGNNFSGL-IPDSVSGLVSIQSLDLSHN 176
                KL +L +L+L+GN    +   + +  L  ++SLDL + 
Sbjct: 88  DMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 31/115 (26%), Positives = 49/115 (42%), Gaps = 9/115 (7%)

Query: 264 QSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNN 323
            +V+ L L   +     + G     F NL+ L L    L   +     + +L+ L+LS N
Sbjct: 24  AAVRELVLDNCKSNDGKIEGL-TAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSEN 81

Query: 324 RFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS----TNLHMLNLSSNGLT 374
           R  G +  D+L      LT L+LS N L   +S +        L  L+L +  +T
Sbjct: 82  RIFGGL--DMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 6/107 (5%)

Query: 362 NLHMLNLSSNGLT-GELPLLTGSCA---VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHL 417
            +  L L +     G++  LT        L L N     ++S + K   ++ L+LS N +
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRI 83

Query: 418 TGSIPEETPQFLRLNHLNLSHNSLSS-SLPKVIIQYQKLRVLDLSFN 463
            G +     +   L HLNLS N L   S  + + + + L+ LDL   
Sbjct: 84  FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 28/153 (18%), Positives = 48/153 (31%), Gaps = 31/153 (20%)

Query: 314 ELQVLKLSNNRFSGFIPNDLLKGDSLL-LTDLDLSANNLSGSVSMILSTNLHMLNLSSNG 372
            ++ L L N + +             + L  L L    L    ++     L  L LS N 
Sbjct: 25  AVRELVLDNCKSN--DGKIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLELSENR 82

Query: 373 LTGELPLLTGSCA---VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL 429
           + G L +L         L+LS N+       +     +E L                +  
Sbjct: 83  IFGGLDMLAEKLPNLTHLNLSGNK-------LKDISTLEPLK---------------KLE 120

Query: 430 RLNHLNLSHNSLSSSL---PKVIIQYQKLRVLD 459
            L  L+L +  +++       V     +L  LD
Sbjct: 121 CLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 9e-05
 Identities = 22/88 (25%), Positives = 36/88 (40%), Gaps = 3/88 (3%)

Query: 141 LESLQNLSLAGNNFS-GLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSS 199
             +++ L L     + G I    +  V+++ L L +     S+   L +L  L  L LS 
Sbjct: 23  PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSE 80

Query: 200 NGFSKRIPRGFELILGLQVLDFHGNKLD 227
           N     +    E +  L  L+  GNKL 
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 23/90 (25%), Positives = 36/90 (40%), Gaps = 3/90 (3%)

Query: 474 LNSSTLQELHLADNLLT-GVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCL 532
              + ++EL L +     G ++       NL+ L L +  L       L  L  LK L L
Sbjct: 21  RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLEL 78

Query: 533 AGNNISGSLPTSMANMTSLSSLVISQNHFT 562
           + N I G L      + +L+ L +S N   
Sbjct: 79  SENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 64.8 bits (158), Expect = 6e-11
 Identities = 42/239 (17%), Positives = 76/239 (31%), Gaps = 64/239 (26%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKK-----FANIRHPNVVG 836
           ++LG  S GT        G  + VK +         +F   A         +  HPNV+ 
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNVIR 73

Query: 837 LRGYYWGPTQHEKLILSDYIS----PGSLASFL--YDRPGRKGPPLTWAQRLKIAVDVAR 890
                      ++ +   YI+      +L   +   +              + +   +A 
Sbjct: 74  YYCSE----TTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 891 GLNYLHFDRAVPHGNLKATNILLDGP------------DLNARVAD------------YC 926
           G+ +LH    + H +LK  NIL+               +L   ++D              
Sbjct: 127 GVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185

Query: 927 LHRLMTQAGTIEQILDAGVLGYRAPEL-----AASKKPHPSFKSDVYAFGVILLELLTG 980
              L   +GT          G+RAPEL         K   +   D+++ G +   +L+ 
Sbjct: 186 RTNLNNPSGT---------SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 65.1 bits (159), Expect = 6e-11
 Identities = 46/206 (22%), Positives = 84/206 (40%), Gaps = 19/206 (9%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWL---REGVAKQRKEFAKEAKKFANIRHPNVVGL 837
            VLG+ S G          G    VK +   +      ++   +E +    + HPN++ L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
             ++    +    ++ +  + G L    +D    +    +     +I   V  G+ Y+H 
Sbjct: 92  YEFF--EDKGYFYLVGEVYTGGEL----FDEIISRKR-FSEVDAARIIRQVLSGITYMH- 143

Query: 898 DRAVPHGNLKATNILLDGPDLNA--RVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAA 955
              + H +LK  N+LL+    +A  R+ D+ L      +  ++     G   Y APE+  
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTAYYIAPEVL- 200

Query: 956 SKKPHPSFKSDVYAFGVILLELLTGR 981
               +   K DV++ GVIL  LL+G 
Sbjct: 201 -HGTY-DEKCDVWSTGVILYILLSGC 224

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 64.9 bits (158), Expect = 9e-11
 Identities = 44/201 (21%), Positives = 93/201 (46%), Gaps = 13/201 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           E LG  + G  +R T    G     K++       ++   KE +  + +RHP +V L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           +     +E +++ +++S G     L+++   +   ++  + ++    V +GL ++H +  
Sbjct: 223 F--EDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-ENN 275

Query: 901 VPHGNLKATNILLDGPDLNA-RVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
             H +LK  NI+      N  ++ D+ L   +    +++     G   + APE+ A  KP
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEV-AEGKP 332

Query: 960 HPSFKSDVYAFGVILLELLTG 980
              + +D+++ GV+   LL+G
Sbjct: 333 V-GYYTDMWSVGVLSYILLSG 352

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 63.6 bits (155), Expect = 2e-10
 Identities = 46/205 (22%), Positives = 81/205 (39%), Gaps = 18/205 (8%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWL--REGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
            +LG+ S G   +           VK +       K      +E +    + HPN++ L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
                       I+ +  + G L    +D   ++    +     +I   V  G+ Y+H  
Sbjct: 88  EIL--EDSSSFYIVGELYTGGEL----FDEIIKRKR-FSEHDAARIIKQVFSGITYMH-K 139

Query: 899 RAVPHGNLKATNILLDGPDLNA--RVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
             + H +LK  NILL+  + +   ++ D+ L     Q   ++     G   Y APE+   
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVL-- 195

Query: 957 KKPHPSFKSDVYAFGVILLELLTGR 981
           +  +   K DV++ GVIL  LL+G 
Sbjct: 196 RGTY-DEKCDVWSAGVILYILLSGT 219

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 63.2 bits (154), Expect = 3e-10
 Identities = 42/216 (19%), Positives = 82/216 (37%), Gaps = 29/216 (13%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVK-------------WLREGVAKQRKEFAKEAKKFA 827
             LG  ++G               +K                + + K  +E   E     
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           ++ HPN++ L   +    +    +++++   G L    +++   +           I   
Sbjct: 102 SLDHPNIIKLFDVF--EDKKYFYLVTEFYEGGEL----FEQIINRHK-FDECDAANIMKQ 154

Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNA--RVADYCLHRLMTQAGTIEQILDAGV 945
           +  G+ YLH    + H ++K  NILL+  +     ++ D+ L    ++   +      G 
Sbjct: 155 ILSGICYLH-KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR--LGT 211

Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
             Y APE+   KK + + K DV++ GVI+  LL G 
Sbjct: 212 AYYIAPEVL--KKKY-NEKCDVWSCGVIMYILLCGY 244

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 61.1 bits (149), Expect = 4e-10
 Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 29/163 (17%)

Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           + H NVV   G+       + L L +Y S G L    +DR             +      
Sbjct: 62  LNHENVVKFYGHRREGN-IQYLFL-EYCSGGEL----FDRIEPDI-------GMP--EPD 106

Query: 889 AR--------GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI 940
           A+        G+ YLH    + H ++K  N+LLD    N +++D+ L  +       E++
Sbjct: 107 AQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDE-RDNLKISDFGLATVFRY-NNRERL 163

Query: 941 LDA--GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L+   G L Y APEL   ++   +   DV++ G++L  +L G 
Sbjct: 164 LNKMCGTLPYVAPELL-KRREFHAEPVDVWSCGIVLTAMLAGE 205

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 60.7 bits (148), Expect = 7e-10
 Identities = 53/208 (25%), Positives = 85/208 (40%), Gaps = 28/208 (13%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           EVLG  +    +       G    +K +++  A +      E      I+H N+V L   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           Y   +     ++   +S G L    +DR   +G   T      +   V   + YLH +  
Sbjct: 75  Y--ESTTHYYLVMQLVSGGEL----FDRILERGV-YTEKDASLVIQQVLSAVKYLH-ENG 126

Query: 901 VPHGNLKATNILLDGPDLNARV--ADYCL------HRLMTQAGTIEQILDAGVLGYRAPE 952
           + H +LK  N+L   P+ N+++   D+ L        + T  GT          GY APE
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGT---------PGYVAPE 177

Query: 953 LAASKKPHPSFKSDVYAFGVILLELLTG 980
           + A +KP+ S   D ++ GVI   LL G
Sbjct: 178 VLA-QKPY-SKAVDCWSIGVITYILLCG 203

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 59.9 bits (146), Expect = 9e-10
 Identities = 38/202 (18%), Positives = 77/202 (38%), Gaps = 16/202 (7%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
             +GR S G    A      +    K + +   +    F +E +   ++ HPN++ L   
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           +      +  ++ +  + G     L++R   K      +   +I  DV   + Y H    
Sbjct: 75  F--EDNTDIYLVMELCTGGE----LFERVVHKR-VFRESDAARIMKDVLSAVAYCH-KLN 126

Query: 901 VPHGNLKATNILLDGPDLNA--RVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK 958
           V H +LK  N L      ++  ++ D+ L         +      G   Y +P++   + 
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVL--EG 182

Query: 959 PHPSFKSDVYAFGVILLELLTG 980
            +   + D ++ GV++  LL G
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCG 203

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 33/210 (15%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           E +G+ S G  ++         + +K +  E    + ++  +E    +    P V    G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 840 -YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV---DVARGLNY 894
            Y        KL I+ +Y+  GS    L      +  PL   Q   IA    ++ +GL+Y
Sbjct: 88  SYLKD----TKLWIIMEYLGGGSALDLL------EPGPLDETQ---IATILREILKGLDY 134

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADY----CLHRLMTQAGTIEQILDAGVLGYRA 950
           LH ++ + H ++KA N+LL       ++AD+     L     +  T       G   + A
Sbjct: 135 LHSEKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTF-----VGTPFWMA 187

Query: 951 PELAASKKPHPSFKSDVYAFGVILLELLTG 980
           PE+   +  +   K+D+++ G+  +EL  G
Sbjct: 188 PEVIK-QSAY-DSKADIWSLGITAIELARG 215

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 49/164 (29%), Positives = 72/164 (43%), Gaps = 32/164 (19%)

Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           + HPN+V L       T+    ++ +Y S G +    +D     G       R+K     
Sbjct: 71  LNHPNIVKLFEVIE--TEKTLYLIMEYASGGEV----FDYLVAHG-------RMK--EKE 115

Query: 889 AR--------GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI 940
           AR         + Y H  + + H +LKA N+LLD  D+N ++AD+      T        
Sbjct: 116 ARSKFRQIVSAVQYCH-QKRIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTV----GGK 169

Query: 941 LDA--GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRC 982
           LDA  G   Y APEL   KK     + DV++ GVIL  L++G  
Sbjct: 170 LDAFCGAPPYAAPELFQGKKYDGP-EVDVWSLGVILYTLVSGSL 212

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 59.6 bits (145), Expect = 2e-09
 Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 29/163 (17%)

Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           + H NVV   G+       + L L +Y S G L    +DR             +      
Sbjct: 62  LNHENVVKFYGHRREGN-IQYLFL-EYCSGGEL----FDRIEPDI-------GMP--EPD 106

Query: 889 AR--------GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI 940
           A+        G+ YLH    + H ++K  N+LLD    N +++D+ L  +       E++
Sbjct: 107 AQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDE-RDNLKISDFGLATVFRY-NNRERL 163

Query: 941 LDA--GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L+   G L Y APEL   ++ H     DV++ G++L  +L G 
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAGE 205

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 46/204 (22%), Positives = 81/204 (39%), Gaps = 18/204 (8%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWL--REGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
            +LG+ S G   +           VK +       K      +E +    + HPN++ L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
                       I+ +  + G     L+D   ++    +     +I   V  G+ Y+H  
Sbjct: 88  EIL--EDSSSFYIVGELYTGGE----LFDEIIKRK-RFSEHDAARIIKQVFSGITYMH-K 139

Query: 899 RAVPHGNLKATNILLDGPDLNA--RVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
             + H +LK  NILL+  + +   ++ D+ L     Q   ++     G   Y APE+   
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVL-- 195

Query: 957 KKPHPSFKSDVYAFGVILLELLTG 980
           +  +   K DV++ GVIL  LL+G
Sbjct: 196 RGTY-DEKCDVWSAGVILYILLSG 218

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 37/215 (17%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRG- 839
             LG  + G  Y+A   E G     K +     ++ +++  E +  A   HP +V L G 
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84

Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV---DVARGLNYL 895
           YY       KL I+ ++   G++ + + +        LT  Q   I V    +   LN+L
Sbjct: 85  YYHD----GKLWIMIEFCPGGAVDAIMLELDR----GLTEPQ---IQVVCRQMLEALNFL 133

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADY--C--LHRLMTQAGTIEQILDAGVLG---Y 948
           H  R + H +LKA N+L+   + + R+AD+       + + +  +         +G   +
Sbjct: 134 HSKRII-HRDLKAGNVLMTL-EGDIRLADFGVSAKNLKTLQKRDS--------FIGTPYW 183

Query: 949 RAPELAASKKPHPS---FKSDVYAFGVILLELLTG 980
            APE+   +    +   +K+D+++ G+ L+E+   
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 32/163 (19%)

Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
            RHP+++ L  Y    T  +  ++ +Y+S G L    +D   + G       R++     
Sbjct: 68  FRHPHIIKL--YQVISTPTDFFMVMEYVSGGEL----FDYICKHG-------RVEE--ME 112

Query: 889 AR--------GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI 940
           AR         ++Y H    V H +LK  N+LLD   +NA++AD+ L  +M+        
Sbjct: 113 ARRLFQQILSAVDYCH-RHMVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGE----F 166

Query: 941 LDA--GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L    G   Y APE+ + +      + D+++ GVIL  LL G 
Sbjct: 167 LRTSCGSPNYAAPEVISGRLYAGP-EVDIWSCGVILYALLCGT 208

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 44/203 (21%), Positives = 83/203 (40%), Gaps = 13/203 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWL-REGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
             LG  + G  +      +G+   +K + ++      ++   E +   ++ HPN++ +  
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
            +     H   I+ +    G L   +     R    L+     ++   +   L Y H  +
Sbjct: 88  VF--EDYHNMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMNALAYFH-SQ 143

Query: 900 AVPHGNLKATNILLDGPDLNA--RVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASK 957
            V H +LK  NIL      ++  ++ D+ L  L            AG   Y APE+   K
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA--AGTALYMAPEVF--K 199

Query: 958 KPHPSFKSDVYAFGVILLELLTG 980
           +   +FK D+++ GV++  LLTG
Sbjct: 200 RDV-TFKCDIWSAGVVMYFLLTG 221

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 59.3 bits (144), Expect = 3e-09
 Identities = 46/202 (22%), Positives = 85/202 (42%), Gaps = 17/202 (8%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
             LGR +    YR           +K L++     +K    E      + HPN++ L+  
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           +   T  E  ++ + ++ G L    +DR   KG   +          +   + YLH +  
Sbjct: 117 F--ETPTEISLVLELVTGGEL----FDRIVEKGY-YSERDAADAVKQILEAVAYLH-ENG 168

Query: 901 VPHGNLKATNILLDGPDLNARV--ADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK 958
           + H +LK  N+L   P  +A +  AD+ L +++     ++ +   G  GY APE+     
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV--CGTPGYCAPEILR-GC 225

Query: 959 PHPSFKSDVYAFGVILLELLTG 980
            +   + D+++ G+I   LL G
Sbjct: 226 AY-GPEVDMWSVGIITYILLCG 246

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 42/141 (29%), Positives = 62/141 (43%), Gaps = 6/141 (4%)

Query: 110 IPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQ 169
           +P  I       +LD+  N   S       +L SL  L L GN    L     + L S+ 
Sbjct: 22  VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79

Query: 170 SLDLSHNSFSGSLPPAL-TRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLD 227
            L+LS N    SLP  +  +L  L  L L++N   + +P G F+ +  L+ L  + N+L 
Sbjct: 80  YLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLK 137

Query: 228 GHLDGEFFLLTNASHIDFSGN 248
              DG F  LT+  +I    N
Sbjct: 138 SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 44/132 (33%), Positives = 54/132 (40%), Gaps = 25/132 (18%)

Query: 408 EYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL-- 465
            YLDL  N L         +   L  L L  N L S    V  +   L  L+LS N L  
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90

Query: 466 --DGPF--LTNLLNSSTLQELHLADNLLT----GVLDFSPPSVSNLQVLDLSHNRL---- 513
             +G F  LT       L+EL L  N L     GV D     ++ L+ L L  N+L    
Sbjct: 91  LPNGVFDKLTQ------LKELALNTNQLQSLPDGVFD----KLTQLKDLRLYQNQLKSVP 140

Query: 514 NGYFPDRLGSLT 525
           +G F DRL SL 
Sbjct: 141 DGVF-DRLTSLQ 151

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 43/163 (26%), Positives = 59/163 (36%), Gaps = 37/163 (22%)

Query: 166 VSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGN 224
                LDL  NS           L +L  L L  N     +P G F  +  L  L+   N
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTN 86

Query: 225 KLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGG 284
           +L    +G F  LT                           ++ L L+ NQL  SL +G 
Sbjct: 87  QLQSLPNGVFDKLTQ--------------------------LKELALNTNQLQ-SLPDG- 118

Query: 285 ELQLFE---NLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNN 323
              +F+    LK L L  NQL     G F+ +  LQ + L +N
Sbjct: 119 ---VFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 44/153 (28%), Positives = 62/153 (40%), Gaps = 15/153 (9%)

Query: 367 NLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKW-GNIEYLDLSRNHLTGSIPEET 425
              S G T     +      LDL  N  +   + +     ++  L L  N L  S+P   
Sbjct: 13  ECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGV 71

Query: 426 PQFLR-LNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL----DGPF--LTNLLNSST 478
              L  L +LNLS N L S    V  +  +L+ L L+ N L    DG F  LT L     
Sbjct: 72  FNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQL----- 126

Query: 479 LQELHLADNLLTGVLDFSPPSVSNLQVLDLSHN 511
            ++L L  N L  V D     +++LQ + L  N
Sbjct: 127 -KDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 40/245 (16%), Positives = 73/245 (29%), Gaps = 48/245 (19%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVK-----WLREGVAKQRKEFAKEAKKFANIRHPNVV 835
             +G+ S+G    A   +      +K      +R+   K  +    E +    + HPN+ 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRL------------- 882
            L   Y    +    ++ +    G L   L                              
Sbjct: 92  RLYEVY--EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 883 ----------------------KIAVDVARGLNYLHFDRAVPHGNLKATNILLDGP-DLN 919
                                  I   +   L+YLH ++ + H ++K  N L        
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH-NQGICHRDIKPENFLFSTNKSFE 208

Query: 920 ARVADYCLHRLMTQAGTIEQILDAGVLG---YRAPELAASKKPHPSFKSDVYAFGVILLE 976
            ++ D+ L +   +    E        G   + APE+  +       K D ++ GV+L  
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 977 LLTGR 981
           LL G 
Sbjct: 269 LLMGA 273

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 56.5 bits (137), Expect = 3e-09
 Identities = 36/119 (30%), Positives = 49/119 (41%), Gaps = 6/119 (5%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPAL-TRLN 190
           +S+P+GI    S   L L  N    L       L  +  L LS N    SLP  +  +L 
Sbjct: 20  TSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLT 76

Query: 191 NLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGN 248
            L  L L  N   + +P G F+ +  L+ L    N+L    DG F  LT+   I    N
Sbjct: 77  KLTILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.4 bits (103), Expect = 8e-05
 Identities = 31/94 (32%), Positives = 44/94 (46%), Gaps = 7/94 (7%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVL 318
            G+  S   L L  N+L  SL +G   +L   L  L LS NQ+     G F+ + +L +L
Sbjct: 24  TGIPSSATRLELESNKLQ-SLPHGVFDKL-TQLTKLSLSQNQIQSLPDGVFDKLTKLTIL 81

Query: 319 KLSNNRFSGFIPNDLLKGDSL-LLTDLDLSANNL 351
            L  N+    +PN +   D L  L +L L  N L
Sbjct: 82  YLHENKLQS-LPNGVF--DKLTQLKELALDTNQL 112

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 36/126 (28%), Positives = 48/126 (38%), Gaps = 37/126 (29%)

Query: 408 EYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDG 467
             L+L  N L         +  +L  L+LS N +  SLP          V D        
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPD--------GVFDK------- 74

Query: 468 PFLTNLLNSSTLQELHLADNLLT----GVLDFSPPSVSNLQVLDLSHNRL----NGYFPD 519
             LT       L  L+L +N L     GV D     ++ L+ L L  N+L    +G F D
Sbjct: 75  --LTK------LTILYLHENKLQSLPNGVFD----KLTQLKELALDTNQLKSVPDGIF-D 121

Query: 520 RLGSLT 525
           RL SL 
Sbjct: 122 RLTSLQ 127

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 58.4 bits (142), Expect = 4e-09
 Identities = 37/202 (18%), Positives = 78/202 (38%), Gaps = 16/202 (7%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAK-EAKKFANIRHPNVVGLRG 839
           E LGR   G  +R     +      K+++  V    +   K E       RH N++ L  
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRNILHLHE 68

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
            +   +  E +++ ++IS       +++R       L   + +     V   L +LH   
Sbjct: 69  SF--ESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFLH-SH 121

Query: 900 AVPHGNLKATNILLDGPDLNA-RVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK 958
            + H +++  NI+      +  ++ ++   R +        +       Y APE+     
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEV-HQHD 178

Query: 959 PHPSFKSDVYAFGVILLELLTG 980
              S  +D+++ G ++  LL+G
Sbjct: 179 VV-STATDMWSLGTLVYVLLSG 199

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 54/267 (20%), Positives = 98/267 (36%), Gaps = 30/267 (11%)

Query: 724 ISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRAPAEV 783
                + H    P + + +    +  +        + +    +      PE+L       
Sbjct: 3   YYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSD-LRE 61

Query: 784 LGRSSHGTSYRAT-LENGMFLTVKWL---REGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           +G  S G  Y A  + N   + +K +    +   ++ ++  KE +    +RHPN +  RG
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 840 -YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV---DVARGLNY 894
            Y           ++ +Y   GS +  L         PL   +   IA       +GL Y
Sbjct: 122 CYLRE----HTAWLVMEYCL-GSASDLLEVHKK----PLQEVE---IAAVTHGALQGLAY 169

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELA 954
           LH    + H ++KA NILL       ++ D+    +M  A +       G   + APE+ 
Sbjct: 170 LHSHNMI-HRDVKAGNILLS-EPGLVKLGDFGSASIMAPANSF-----VGTPYWMAPEVI 222

Query: 955 ASKKPHP-SFKSDVYAFGVILLELLTG 980
            +        K DV++ G+  +EL   
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAER 249

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 46/211 (21%), Positives = 83/211 (39%), Gaps = 32/211 (15%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           +VLG   +G          G    +K L +   K R+E     +       P++V +   
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLYD-SPKARQEVDHHWQ---ASGGPHIVCILDV 90

Query: 841 YWGPTQHEK--LILSDYISPGSLASFLYDRPGRKGP-PLTWAQRLKIAVDVARGLNYLHF 897
           Y      ++  LI+ + +  G     L+ R   +G    T  +  +I  D+   + +LH 
Sbjct: 91  YENMHHGKRCLLIIMECMEGGE----LFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH- 145

Query: 898 DRAVPHGNLKATNILLDGPDLNA--RVADYCL------HRLMTQAGTIEQILDAGVLGYR 949
              + H ++K  N+L    + +A  ++ D+        + L T   T           Y 
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT---------PYYV 196

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLTG 980
           APE+   +K   S   D+++ GVI+  LL G
Sbjct: 197 APEVLGPEKYDKS--CDMWSLGVIMYILLCG 225

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 58.6 bits (142), Expect = 5e-09
 Identities = 31/156 (19%), Positives = 66/156 (42%), Gaps = 14/156 (8%)

Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            + HP ++ ++ ++     +  ++L + +  G     L+D+       L  A        
Sbjct: 196 KLNHPCIIKIKNFFDAEDYY--IVL-ELMEGGE----LFDKVVGNK-RLKEATCKLYFYQ 247

Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARV--ADYCLHRLMTQAGTIEQILDAGV 945
           +   + YLH +  + H +LK  N+LL   + +  +   D+   +++ +   +  +   G 
Sbjct: 248 MLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL--CGT 304

Query: 946 LGYRAPE-LAASKKPHPSFKSDVYAFGVILLELLTG 980
             Y APE L +      +   D ++ GVIL   L+G
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 57.8 bits (140), Expect = 7e-09
 Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 35/238 (14%)

Query: 753 RSPDRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRAT-LENGMFLTVKWLREG 811
             P R + +L   +D+LT  PEE+     E LG  S+G+ Y+A   E G  + +K +   
Sbjct: 9   NPPRRQLKKLD--EDSLTKQPEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-- 63

Query: 812 VAKQRKEFAKEAKKFANIRHPNVVGLRG-YYWGPTQHEKL-ILSDYISPGSLASFLYDRP 869
           V    +E  KE         P+VV   G Y+        L I+ +Y   GS++  +  R 
Sbjct: 64  VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN----TDLWIVMEYCGAGSVSDIIRLRN 119

Query: 870 GRKGPPLTWAQRLKIAV---DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY- 925
                 LT  +   IA       +GL YLHF R + H ++KA NILL+  + +A++AD+ 
Sbjct: 120 K----TLTEDE---IATILQSTLKGLEYLHFMRKI-HRDIKAGNILLNT-EGHAKLADFG 170

Query: 926 -C--LHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
               L   M +  T+      G   + APE+   +  + +  +D+++ G+  +E+  G
Sbjct: 171 VAGQLTDTMAKRNTV-----IGTPFWMAPEVIQ-EIGY-NCVADIWSLGITAIEMAEG 221

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.6 bits (139), Expect = 8e-09
 Identities = 33/144 (22%), Positives = 55/144 (38%), Gaps = 7/144 (4%)

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
           R      +Q             S               LT    +  +  VA+G+ +L  
Sbjct: 152 RLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 211

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYR--APELAA 955
            R   H +L A NILL       ++ D+ L R + +     +  D   L  +  APE   
Sbjct: 212 -RKCIHRDLAARNILL-SEKNVVKICDFGLARDIYKDPDYVRKGD-ARLPLKWMAPETIF 268

Query: 956 SKKPHPSFKSDVYAFGVILLELLT 979
            +    + +SDV++FGV+L E+ +
Sbjct: 269 DRVY--TIQSDVWSFGVLLWEIFS 290

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 31/166 (18%), Positives = 61/166 (36%), Gaps = 37/166 (22%)

Query: 829 IRHPNVVGL------RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRL 882
           + H N++ +      +G++        L++  + S   L    +    R    L      
Sbjct: 86  VEHANIIKVLDIFENQGFFQ-------LVMEKHGSGLDL----FAFIDRHPR-LDEPLAS 133

Query: 883 KIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL-------HRLMTQAG 935
            I   +   + YL   + + H ++K  NI++   D   ++ D+             T  G
Sbjct: 134 YIFRQLVSAVGYLR-LKDIIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGKLFYTFCG 191

Query: 936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           TIE         Y APE+     P+   + ++++ GV L  L+   
Sbjct: 192 TIE---------YCAPEV-LMGNPYRGPELEMWSLGVTLYTLVFEE 227

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 57.3 bits (139), Expect = 1e-08
 Identities = 41/226 (18%), Positives = 88/226 (38%), Gaps = 25/226 (11%)

Query: 769 LTLTPEELSR--APAEVLGRSSHGTSYRAT-LENGMFLTVKWL-REGVAKQRKEFAKEAK 824
           +++ P+ L      ++ LG  + G    A   +    + +K + +   A      A  A 
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60

Query: 825 KFAN-------IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLT 877
                      + HP ++ ++ ++     +  ++L + +  G     L+D+       L 
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDYY--IVL-ELMEGGE----LFDKVVGNK-RLK 112

Query: 878 WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARV--ADYCLHRLMTQAG 935
            A        +   + YLH +  + H +LK  N+LL   + +  +   D+   +++ +  
Sbjct: 113 EATCKLYFYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171

Query: 936 TIEQILDAGVLGYRAPE-LAASKKPHPSFKSDVYAFGVILLELLTG 980
            +  +   G   Y APE L +      +   D ++ GVIL   L+G
Sbjct: 172 LMRTL--CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 57.8 bits (140), Expect = 1e-08
 Identities = 59/277 (21%), Positives = 104/277 (37%), Gaps = 49/277 (17%)

Query: 720 VVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTPEELSRA 779
           V  G+     + + +   S    +      + +  P   V    F          E  + 
Sbjct: 106 VADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEF----------EYLK- 154

Query: 780 PAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFA---KEAKKFANIRHPNVV 835
              +LG+ + G          G +  +K L++ V   + E A    E +   N RHP + 
Sbjct: 155 ---LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211

Query: 836 GLRGYYWGPTQ-HEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLN 893
            L+  +    Q H++L    +Y + G L   L  R            R   A ++   L+
Sbjct: 212 ALKYSF----QTHDRLCFVMEYANGGELFFHLS-RERVFSEDRA---RFYGA-EIVSALD 262

Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTIEQILDAGV 945
           YLH ++ V + +LK  N++LD  D + ++ D+ L          + T  GT E       
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDGATMKTFCGTPE------- 314

Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRC 982
             Y APE+      +     D +  GV++ E++ GR 
Sbjct: 315 --YLAPEVLE-DNDY-GRAVDWWGLGVVMYEMMCGRL 347

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 57.5 bits (139), Expect = 2e-08
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 17/204 (8%)

Query: 783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFA---KEAKKFANIRHPNVVGLR 838
           VLG+   G      +   G     K L +   K+RK  A    E +    +    VV L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250

Query: 839 GYYWGPTQHEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
             Y      + L L    ++ G L   +Y   G+ G P   A     A ++  GL  LH 
Sbjct: 251 YAYETK---DALCLVLTLMNGGDLKFHIY-HMGQAGFPEARA-VFYAA-EICCGLEDLH- 303

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASK 957
              + + +LK  NILLD    + R++D  L   + +  TI+     G +GY APE+    
Sbjct: 304 RERIVYRDLKPENILLDD-HGHIRISDLGLAVHVPEGQTIKGR--VGTVGYMAPEVVK-N 359

Query: 958 KPHPSFKSDVYAFGVILLELLTGR 981
           + + +F  D +A G +L E++ G+
Sbjct: 360 ERY-TFSPDWWALGCLLYEMIAGQ 382

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 55.6 bits (135), Expect = 2e-08
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 17/204 (8%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWL--REGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
           E LG+ +     R      G+    K +  ++  A+  ++  +EA+    ++HPN+V L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
                 + H  L+  D ++ G     L++    +    + A        +   + Y H  
Sbjct: 72  DSIQEESFHY-LVF-DLVTGGE----LFEDIVARE-FYSEADASHCIQQILESIAYCH-S 123

Query: 899 RAVPHGNLKATNILLDGPDLNARV--ADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
             + H NLK  N+LL      A V  AD+ L   +  +        AG  GY +PE+   
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK- 180

Query: 957 KKPHPSFKSDVYAFGVILLELLTG 980
           K P+ S   D++A GVIL  LL G
Sbjct: 181 KDPY-SKPVDIWACGVILYILLVG 203

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 56.7 bits (137), Expect = 3e-08
 Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 32/163 (19%)

Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
            RHP+++ L  Y    T  +  ++ +Y+S G L    +D   + G       RL      
Sbjct: 73  FRHPHIIKL--YQVISTPSDIFMVMEYVSGGEL----FDYICKNG-------RLDE--KE 117

Query: 889 AR--------GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI 940
           +R        G++Y H    V H +LK  N+LLD   +NA++AD+ L  +M+        
Sbjct: 118 SRRLFQQILSGVDYCH-RHMVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGE----F 171

Query: 941 LDA--GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L    G   Y APE+  S + +   + D+++ GVIL  LL G 
Sbjct: 172 LRTSCGSPNYAAPEVI-SGRLYAGPEVDIWSSGVILYALLCGT 213

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 55.8 bits (135), Expect = 4e-08
 Identities = 44/165 (26%), Positives = 67/165 (40%), Gaps = 34/165 (20%)

Query: 829 IRHPNVVGLRGYYWGPTQHEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
           +RHPN+V  +     PT    L +  +Y S G L    Y+R    G       R     D
Sbjct: 73  LRHPNIVRFKEVILTPT---HLAIIMEYASGGEL----YERICNAG-------RFS--ED 116

Query: 888 VAR--------GLNYLHFDRAVPHGNLKATNILLDG-PDLNARVADYCLHRLMTQAGTIE 938
            AR        G++Y H    + H +LK  N LLDG P    ++ D+   +         
Sbjct: 117 EARFFFQQLLSGVSYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 172

Query: 939 QILDA--GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
               +  G   Y APE+   ++ +    +DV++ GV L  +L G 
Sbjct: 173 -QPKSTVGTPAYIAPEV-LLRQEYDGKIADVWSCGVTLYVMLVGA 215

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 55.4 bits (134), Expect = 4e-08
 Identities = 37/158 (23%), Positives = 62/158 (39%), Gaps = 23/158 (14%)

Query: 830 RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVA 889
            HP V+ L    W  TQ   +++ +   P      L+D    KGP L           V 
Sbjct: 96  GHPGVIRL--LDWFETQEGFMLVLERPLPAQD---LFDYITEKGP-LGEGPSRCFFGQVV 149

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM------TQAGTIEQILDA 943
             + + H  R V H ++K  NIL+D     A++ D+    L+         GT       
Sbjct: 150 AAIQHCH-SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV----- 203

Query: 944 GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
               Y  PE  +  + H    + V++ G++L +++ G 
Sbjct: 204 ----YSPPEWISRHQYHAL-PATVWSLGILLYDMVCGD 236

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 55.4 bits (134), Expect = 4e-08
 Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 22/209 (10%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR------EGVAKQRKEFAKEAKKFANIRHPNV 834
           E LG        +      G+    K+++            R+E  +E      + HPN+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 835 VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
           + L   Y   T    LIL + +S G     L+D   +K   L+  +       +  G+NY
Sbjct: 78  ITLHDVYENRTDVV-LIL-ELVSGGE----LFDFLAQKE-SLSEEEATSFIKQILDGVNY 130

Query: 895 LHFDRAVPHGNLKATNILL---DGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAP 951
           LH  + + H +LK  NI+L   + P  + ++ D+ L   +      + I   G   + AP
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI--FGTPEFVAP 187

Query: 952 ELAASKKPHPSFKSDVYAFGVILLELLTG 980
           E+  + +P    ++D+++ GVI   LL+G
Sbjct: 188 EI-VNYEPL-GLEADMWSIGVITYILLSG 214

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 55.4 bits (134), Expect = 4e-08
 Identities = 44/211 (20%), Positives = 82/211 (38%), Gaps = 34/211 (16%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           E +G  S+    R       M   VK + +      +E     +     +HPN++ L+  
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLR---YGQHPNIITLKDV 84

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           Y         ++++ +  G     L D+  R+    +  +   +   + + + YLH  + 
Sbjct: 85  Y--DDGKYVYVVTELMKGGE----LLDKILRQK-FFSEREASAVLFTITKTVEYLH-AQG 136

Query: 901 VPHGNLKATNILLDGPDLNA---RVADYCL--------HRLMTQAGTIEQILDAGVLGYR 949
           V H +LK +NIL      N    R+ D+            LMT   T           + 
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYT---------ANFV 187

Query: 950 APELAASKKPHPSFKSDVYAFGVILLELLTG 980
           APE+   ++ +     D+++ GV+L  +LTG
Sbjct: 188 APEVLE-RQGY-DAACDIWSLGVLLYTMLTG 216

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 55.0 bits (133), Expect = 5e-08
 Identities = 46/209 (22%), Positives = 89/209 (42%), Gaps = 22/209 (10%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR------EGVAKQRKEFAKEAKKFANIRHPNV 834
           E LG        +      G+    K+++            R+E  +E      + H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 835 VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
           + L   Y    + + +++ + +S G     L+D   +K   L+  +       +  G+NY
Sbjct: 78  ITLHDVY--ENRTDVVLILELVSGGE----LFDFLAQKE-SLSEEEATSFIKQILDGVNY 130

Query: 895 LHFDRAVPHGNLKATNILL---DGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAP 951
           LH  + + H +LK  NI+L   + P  + ++ D+ L   +      + I   G   + AP
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI--FGTPEFVAP 187

Query: 952 ELAASKKPHPSFKSDVYAFGVILLELLTG 980
           E+  + +P    ++D+++ GVI   LL+G
Sbjct: 188 EI-VNYEPL-GLEADMWSIGVITYILLSG 214

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 55.0 bits (133), Expect = 5e-08
 Identities = 44/215 (20%), Positives = 81/215 (37%), Gaps = 34/215 (15%)

Query: 778 RAPAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR-HPNVV 835
               + LG  S     +    ++     VK + +   +      KE         HPN+V
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIV 69

Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
            L   +    Q    ++ + ++ G     L++R  +K    +  +   I   +   ++++
Sbjct: 70  KLHEVF--HDQLHTFLVMELLNGGE----LFERIKKKK-HFSETEASYIMRKLVSAVSHM 122

Query: 896 HFDRAVPHGNLKATNILLDGPDLNA--RVADYCL--------HRLMTQAGTIEQILDAGV 945
           H D  V H +LK  N+L    + N   ++ D+            L T   T         
Sbjct: 123 H-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFT--------- 172

Query: 946 LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
           L Y APEL   +  +     D+++ GVIL  +L+G
Sbjct: 173 LHYAAPELLN-QNGY-DESCDLWSLGVILYTMLSG 205

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 55.3 bits (132), Expect = 6e-08
 Identities = 27/192 (14%), Positives = 61/192 (31%), Gaps = 19/192 (9%)

Query: 402 LKWGNIEYLDLSRNHLTGSIPEETPQFLR-LNHLNLSHNSLSSSLPKVIIQYQKLRVLDL 460
            +      +D     ++     +    L  +  LN      +++L         L+ L++
Sbjct: 141 FEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEI 200

Query: 461 SFNHLDGPFLTNLLNS--STLQELHLADNLLTGVLD---------FSPPSVSNLQVLDLS 509
               L    + ++L S    L++L L   +     D         FS     NL+ L + 
Sbjct: 201 ISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIV 260

Query: 510 HNRLNGYFPDRLGS---LTGLKVLCLAGNNISGS----LPTSMANMTSLSSLVISQNHFT 562
                    +       L  L+ + ++   ++      L   +  +  L  + +  N+ +
Sbjct: 261 DAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

Query: 563 GPLPNNLPNSLE 574
             +   L  SL 
Sbjct: 321 DEMKKELQKSLP 332

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.9 bits (123), Expect = 7e-07
 Identities = 22/136 (16%), Positives = 44/136 (32%), Gaps = 18/136 (13%)

Query: 315 LQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT 374
           L+ L++ +      +  D+L  D   L  L L               +  M         
Sbjct: 195 LKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVG------VEDYGFDGDMNVFRPLFSK 248

Query: 375 GELPLLTGSCAVLDLSNNQFEGNLSRILK----WGNIEYLDLSRNHLTGS----IPEETP 426
              P L      L + + + +  +  +         +E +D+S   LT      + +   
Sbjct: 249 DRFPNLK----WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVD 304

Query: 427 QFLRLNHLNLSHNSLS 442
           +   L  +N+ +N LS
Sbjct: 305 KIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.7 bits (107), Expect = 6e-05
 Identities = 29/156 (18%), Positives = 54/156 (34%), Gaps = 21/156 (13%)

Query: 258 FLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYN-----------QLTGEL 306
                  +++ L +    L  S+V         NL+ L L                    
Sbjct: 187 IGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246

Query: 307 PGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLL-LTDLDLSANNLSGS-VSMILS---- 360
               F   L+ L + +      +    L+ D L  L  +D+SA  L+     ++L     
Sbjct: 247 SKDRFP-NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDK 305

Query: 361 -TNLHMLNLSSNGLTGELP--LLTGSCAVLDLSNNQ 393
             +L  +N+  N L+ E+   L       +D+S++Q
Sbjct: 306 IKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.3 bits (106), Expect = 8e-05
 Identities = 28/161 (17%), Positives = 54/161 (33%), Gaps = 16/161 (9%)

Query: 160 DSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGF--------- 210
           D    L ++  L+      + +L        NL  L + S G    +             
Sbjct: 163 DLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLE 222

Query: 211 ELILGLQVLDFHGNKLDGHLDGEFFL--LTNASHIDFSGNMFVGSSSQKFL--PGLSQSV 266
           +L+L + V D+  +         F      N   +            + FL    L Q +
Sbjct: 223 KLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ-L 281

Query: 267 QYLNLSLNQLTGSLVNG--GELQLFENLKVLDLSYNQLTGE 305
           + +++S   LT          +   ++LK +++ YN L+ E
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.6 bits (104), Expect = 1e-04
 Identities = 28/192 (14%), Positives = 57/192 (29%), Gaps = 54/192 (28%)

Query: 338 SLLLTDLDLSANNLSG----SVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQ 393
            +L     L+   + G    S+      NL  L + S GL            V D+  + 
Sbjct: 166 PVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDS--------VVEDILGSD 217

Query: 394 FEGNLSRILKWGNIEYLDL---SRNHLTGSIPE------ETPQFLRLNHLNLSHNSLSSS 444
                       N+E L L     ++                +F  L  L +      + 
Sbjct: 218 LP----------NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNV 267

Query: 445 LPKVIIQYQ---KLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVS 501
           + ++ ++     +L  +D+S   L       LL+                        + 
Sbjct: 268 VVEMFLESDILPQLETMDISAGVLTDEGARLLLDHV--------------------DKIK 307

Query: 502 NLQVLDLSHNRL 513
           +L+ +++ +N L
Sbjct: 308 HLKFINMKYNYL 319

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 54.3 bits (131), Expect = 9e-08
 Identities = 45/215 (20%), Positives = 94/215 (43%), Gaps = 30/215 (13%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRG 839
           E++G  ++G  Y+   ++ G    +K + +    + +E  +E         H N+    G
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88

Query: 840 YY---WGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV---DVARGL 892
            +     P   ++L ++ ++   GS+   + +  G     L       IA    ++ RGL
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEW---IAYICREILRGL 142

Query: 893 NYLHFDRAVPHGNLKATNILLDGPDLNARVADY----CLHRLMTQAGTIEQILDAGVLGY 948
           ++LH  + + H ++K  N+LL   +   ++ D+     L R + +  T       G   +
Sbjct: 143 SHLHQHKVI-HRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTF-----IGTPYW 195

Query: 949 RAPELAASKKPHPS---FKSDVYAFGVILLELLTG 980
            APE+ A  +   +   FKSD+++ G+  +E+  G
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 54.2 bits (131), Expect = 9e-08
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 33/163 (20%)

Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDV 888
           +RHP+++ L  Y    T  + +++ +Y   G L    +D    K        R+    D 
Sbjct: 66  LRHPHIIKL--YDVITTPTDIVMVIEYAG-GEL----FDYIVEKK-------RMTE--DE 109

Query: 889 AR--------GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI 940
            R         + Y H    + H +LK  N+LLD  +LN ++AD+ L  +MT        
Sbjct: 110 GRRFFQQIICAIEYCH-RHKIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGN----F 163

Query: 941 LDA--GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L    G   Y APE+   K      + DV++ G++L  +L GR
Sbjct: 164 LKTSCGSPNYAAPEVINGKLYAGP-EVDVWSCGIVLYVMLVGR 205

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 5/107 (4%)

Query: 123 LDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSL 182
           L +  N F+  +P  +   + L  + L+ N  S L   S S +  + +L LS+N     +
Sbjct: 36  LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93

Query: 183 PP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKLD 227
           PP     L +L  L+L  N     +P G F  +  L  L    N L 
Sbjct: 94  PPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGANPLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 30/95 (31%), Positives = 45/95 (47%), Gaps = 8/95 (8%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVL 318
            G+ + V  L L  NQ T       EL  +++L ++DLS N+++      F+ + +L  L
Sbjct: 27  KGIPRDVTELYLDGNQFTLVP---KELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTL 83

Query: 319 KLSNNRFSGFIPNDLLKGDSL-LLTDLDLSANNLS 352
            LS NR    IP      D L  L  L L  N++S
Sbjct: 84  ILSYNRLRC-IPPRTF--DGLKSLRLLSLHGNDIS 115

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 40/144 (27%), Positives = 60/144 (41%), Gaps = 41/144 (28%)

Query: 421 IPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQ 480
           IP +         L L  N  +  +PK +  Y+ L ++DLS N +           STL 
Sbjct: 29  IPRDV------TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRI-----------STLS 70

Query: 481 ELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRL----NGYFPDRLGSLTGLKVLCLAGNN 536
                             +++ L  L LS+NRL       F D L SL    +L L GN+
Sbjct: 71  N---------QSFS----NMTQLLTLILSYNRLRCIPPRTF-DGLKSLR---LLSLHGND 113

Query: 537 ISGSLPT-SMANMTSLSSLVISQN 559
           IS  +P  +  ++++LS L I  N
Sbjct: 114 IS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 23/84 (27%), Positives = 33/84 (39%), Gaps = 6/84 (7%)

Query: 293 KVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLL-LTDLDLSANNL 351
             L L  NQ T      +    L ++ LSNNR S  + N      ++  L  L LS N L
Sbjct: 34  TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSF--SNMTQLLTLILSYNRL 90

Query: 352 SGSVSMILS--TNLHMLNLSSNGL 373
                       +L +L+L  N +
Sbjct: 91  RCIPPRTFDGLKSLRLLSLHGNDI 114

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 26/91 (28%), Positives = 41/91 (45%), Gaps = 6/91 (6%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGD-FKSLEFLDVSDNLFSSSLPSGI-GKLESLQN 146
             SN   L  + +SNN IS  + +        L  L +S N     +P      L+SL+ 
Sbjct: 49  ELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL-RCIPPRTFDGLKSLRL 106

Query: 147 LSLAGNNFSGLIPDSV-SGLVSIQSLDLSHN 176
           LSL GN+ S  +P+   + L ++  L +  N
Sbjct: 107 LSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 28/107 (26%), Positives = 49/107 (45%), Gaps = 10/107 (9%)

Query: 386 VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL-RLNHLNLSHNSLSSS 444
            L L  NQF      +  + ++  +DLS N ++ ++  ++   + +L  L LS+N L   
Sbjct: 35  ELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCI 93

Query: 445 LPKVIIQYQKLRVLDLSFNHL----DGPFLTNLLNSSTLQELHLADN 487
            P+     + LR+L L  N +    +G F  +L   S L  L +  N
Sbjct: 94  PPRTFDGLKSLRLLSLHGNDISVVPEGAF-NDL---SALSHLAIGAN 136

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 54.2 bits (131), Expect = 1e-07
 Identities = 44/207 (21%), Positives = 81/207 (39%), Gaps = 15/207 (7%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKW-----LREGVAKQRKEFAKEAKKFANIRHPNVV 835
           EV+G+       R    E G    VK               ++  +EA     ++HP++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
            L   Y   +     ++ +++    L   +  R    G   + A        +   L Y 
Sbjct: 90  ELLETY--SSDGMLYMVFEFMDGADLCFEIVKR-ADAGFVYSEAVASHYMRQILEALRYC 146

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARV--ADYCLHRLMTQAGTIEQILDAGVLGYRAPEL 953
           H D  + H ++K   +LL   + +A V    + +   + ++G +      G   + APE+
Sbjct: 147 H-DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPEV 204

Query: 954 AASKKPHPSFKSDVYAFGVILLELLTG 980
              ++P+     DV+  GVIL  LL+G
Sbjct: 205 VK-REPY-GKPVDVWGCGVILFILLSG 229

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 53.3 bits (129), Expect = 1e-07
 Identities = 46/209 (22%), Positives = 89/209 (42%), Gaps = 22/209 (10%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR------EGVAKQRKEFAKEAKKFANIRHPNV 834
           E LG        +      G     K+++            R+E  +E      IRHPN+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 835 VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
           + L   +    + + +++ + +S G     L+D    K   LT  +  +    +  G++Y
Sbjct: 71  ITLHDIF--ENKTDVVLILELVSGGE----LFDFLAEKE-SLTEDEATQFLKQILDGVHY 123

Query: 895 LHFDRAVPHGNLKATNILL---DGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAP 951
           LH  + + H +LK  NI+L   + P+   ++ D+ +   +      + I   G   + AP
Sbjct: 124 LH-SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI--FGTPEFVAP 180

Query: 952 ELAASKKPHPSFKSDVYAFGVILLELLTG 980
           E+    +P    ++D+++ GVI   LL+G
Sbjct: 181 EIVN-YEPL-GLEADMWSIGVITYILLSG 207

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 54.2 bits (131), Expect = 1e-07
 Identities = 43/219 (19%), Positives = 86/219 (39%), Gaps = 37/219 (16%)

Query: 782 EVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAK----EAKKFANIRHPNVVG 836
            + G+ + GT         GM + +K +      Q   F        +  A + HPN+V 
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKVI-----QDPRFRNRELQIMQDLAVLHHPNIVQ 83

Query: 837 LRGYYWGPTQHEK-----LILSDYISPGSLASFLYDRPGRKGPPLTWA-------QRLKI 884
           L+ Y++   + ++      ++ +Y+ P +L         R+              Q +  
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC-RNYYRRQVAPPPILIKVFLFQLI-- 139

Query: 885 AVDVARGLNYLHFDRA-VPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT-IEQILD 942
                R +  LH     V H ++K  N+L++  D   ++ D+   + ++ +   +  I  
Sbjct: 140 -----RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC- 193

Query: 943 AGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                YRAPEL    + H +   D+++ G I  E++ G 
Sbjct: 194 --SRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGE 229

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 46/212 (21%), Positives = 87/212 (41%), Gaps = 21/212 (9%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR-HPNVVGLRG 839
           +VLG  +H        L       VK + +     R    +E +     + H NV+ L  
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
           ++    +    ++ + +  GS+         ++       +   +  DVA  L++LH ++
Sbjct: 79  FF--EEEDRFYLVFEKMRGGSI----LSHIHKRRH-FNELEASVVVQDVASALDFLH-NK 130

Query: 900 AVPHGNLKATNILLDGPDLNA--RVADYCLHRLMTQAGTIEQILD------AGVLGYRAP 951
            + H +LK  NIL + P+  +  ++ D+ L   +   G    I         G   Y AP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 952 E-LAASKKPHPSF--KSDVYAFGVILLELLTG 980
           E + A  +    +  + D+++ GVIL  LL+G
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 54.5 bits (131), Expect = 1e-07
 Identities = 48/213 (22%), Positives = 81/213 (38%), Gaps = 34/213 (15%)

Query: 783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFA---KEAK---KFANIRHPNVV 835
           ++GR   G  Y     + G    +K L +   K ++       E       +    P +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255

Query: 836 GLRGYYWGPTQHEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
            +   +  P   +KL    D ++ G L   L  + G          R   A ++  GL +
Sbjct: 256 CMSYAFHTP---DKLSFILDLMNGGDLHYHLS-QHGVFSEADM---RFYAA-EIILGLEH 307

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCL------HRLMTQAGTIEQILDAGVLGY 948
           +H +R V + +LK  NILLD    + R++D  L       +     GT           Y
Sbjct: 308 MH-NRFVVYRDLKPANILLDE-HGHVRISDLGLACDFSKKKPHASVGTHG---------Y 356

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            APE+      +    +D ++ G +L +LL G 
Sbjct: 357 MAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGH 388

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 42/206 (20%), Positives = 96/206 (46%), Gaps = 26/206 (12%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRG- 839
           E +G+ + GT Y A  +  G  + ++ +      +++    E       ++PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
           Y  G    ++L ++ +Y++ GSL   +          +   Q   +  +  + L +LH +
Sbjct: 86  YLVG----DELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 899 RAVPHGNLKATNILLDGPDLNARVAD--YC--LHRLMTQAGTIEQILDAGVLGYRAPELA 954
           + + H ++K+ NILL   D + ++ D  +C  +    ++  T+      G   + APE+ 
Sbjct: 136 QVI-HRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTM-----VGTPYWMAPEV- 187

Query: 955 ASKKPHPSFKSDVYAFGVILLELLTG 980
            ++K +   K D+++ G++ +E++ G
Sbjct: 188 VTRKAY-GPKVDIWSLGIMAIEMIEG 212

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 36/185 (19%), Positives = 64/185 (34%), Gaps = 33/185 (17%)

Query: 406 NIEYLDLSRNHLTGS----------IPEETPQFLRLNHLNLSHNSLSSSLPKVIIQY-QK 454
           ++  L+L+   +T                      L+ +NL+   L  +  + ++    +
Sbjct: 73  SLRQLNLAGVRMTPVKCTVVAAVLGSGRHA-----LDEVNLASCQLDPAGLRTLLPVFLR 127

Query: 455 LRVLDLSFNHLDGP---FLTNLL--NSSTLQELHLADNLLT--GVLDFSP--PSVSNLQV 505
            R L L  N L       L +LL  +   +  L L++N LT  GV          +++  
Sbjct: 128 ARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTH 187

Query: 506 LDLSHNRLN----GYFPDRLGSLTGLKVLCLAGNNISGS----LPTSMANMTSLSSLVIS 557
           L L H  L          +L     L+ L +A N    +    L  +     SL  L + 
Sbjct: 188 LSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLY 247

Query: 558 QNHFT 562
            N  +
Sbjct: 248 FNELS 252

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 48.6 bits (116), Expect = 7e-06
 Identities = 63/396 (15%), Positives = 113/396 (28%), Gaps = 88/396 (22%)

Query: 134 LPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLV 193
           L   I  L++L+N          L    +     +  L   +   +     +   L++L 
Sbjct: 18  LGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRF--SAEVLSSLR 75

Query: 194 YLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGS 253
            LNL+    +   P    ++    VL    + LD               ++ +      +
Sbjct: 76  QLNLAGVRMT---PVKCTVVA--AVLGSGRHALD--------------EVNLASCQLDPA 116

Query: 254 SSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGEL---QLFEN---LKVLDLSYNQLTGELP 307
             +  LP      + L L LN L        +     L  +   +  L LS N LT    
Sbjct: 117 GLRTLLPVF-LRARKLGLQLNSLGPE---ACKDLRDLLLHDQCQITTLRLSNNPLTAA-- 170

Query: 308 GFNFVYE-------LQVLKLSNNRFSGFIPNDLLKGDSLL---------LTDLDLSANNL 351
           G   + E       +  L L +            +G  LL         L +L+++ N  
Sbjct: 171 GVAVLMEGLAGNTSVTHLSLLHTGLGD-------EGLELLAAQLDRNRQLQELNVAYNGA 223

Query: 352 SGSVSMILS------TNLHMLNLSSNGLTGE--------LPLLTGSC--AVLDLSNNQFE 395
             + ++ L+       +L +L+L  N L+ E             G     V         
Sbjct: 224 GDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283

Query: 396 GNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQY--- 452
              S IL           + +L         + L L   +L  +  ++  P    Q    
Sbjct: 284 EYWSVILS--------EVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRV 335

Query: 453 -QKLRVLDLSFNHLDGP----FLTNLLNSSTLQELH 483
             ++R L         P            +     H
Sbjct: 336 EGEVRALLEQLGSSGSPSGSWSHPQFEKGAGHHHHH 371

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 53.4 bits (129), Expect = 2e-07
 Identities = 46/209 (22%), Positives = 88/209 (42%), Gaps = 22/209 (10%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR------EGVAKQRKEFAKEAKKFANIRHPNV 834
           E LG        +      G+    K+++            R++  +E      I+HPNV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76

Query: 835 VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
           + L   Y    + + +++ + ++ G     L+D    K   LT  +  +    +  G+ Y
Sbjct: 77  ITLHEVY--ENKTDVILILELVAGGE----LFDFLAEKE-SLTEEEATEFLKQILNGVYY 129

Query: 895 LHFDRAVPHGNLKATNILL---DGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAP 951
           LH    + H +LK  NI+L   + P    ++ D+ L   +      + I   G   + AP
Sbjct: 130 LH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--FGTPEFVAP 186

Query: 952 ELAASKKPHPSFKSDVYAFGVILLELLTG 980
           E+  + +P    ++D+++ GVI   LL+G
Sbjct: 187 EI-VNYEPL-GLEADMWSIGVITYILLSG 213

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 29/161 (18%), Positives = 56/161 (34%), Gaps = 25/161 (15%)

Query: 829 IRH--PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV 886
           +      V+ L    W       +++ +   P      L+D    +G  L          
Sbjct: 103 VSSGFSGVIRL--LDWFERPDSFVLILERPEPVQD---LFDFITERGA-LQEELARSFFW 156

Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM------TQAGTIEQI 940
            V   + + H +  V H ++K  NIL+D      ++ D+    L+         GT    
Sbjct: 157 QVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV-- 213

Query: 941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                  Y  PE     + H    + V++ G++L +++ G 
Sbjct: 214 -------YSPPEWIRYHRYHGR-SAAVWSLGILLYDMVCGD 246

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 54.0 bits (130), Expect = 2e-07
 Identities = 54/223 (24%), Positives = 80/223 (35%), Gaps = 52/223 (23%)

Query: 783 VLGRSSHG----TSYRATLENGMFLTVKWLREGVAKQRKEFA---KEAKKFANIRHPNVV 835
           VLGR   G       +AT   G     K L +   K+RK +     E K  A +    +V
Sbjct: 192 VLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIV 248

Query: 836 GLRGYYWGPTQHEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR---- 890
            L   +        L L    ++ G +   +Y+                     A     
Sbjct: 249 SLAYAFETK---TDLCLVMTIMNGGDIRYHIYNVDEDNP---------GFQEPRAIFYTA 296

Query: 891 ----GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTIE 938
               GL +LH  R + + +LK  N+LLD  D N R++D  L         +    AGT  
Sbjct: 297 QIVSGLEHLH-QRNIIYRDLKPENVLLDD-DGNVRISDLGLAVELKAGQTKTKGYAGTPG 354

Query: 939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                    + APEL    + +  F  D +A GV L E++  R
Sbjct: 355 ---------FMAPELLL-GEEY-DFSVDYFALGVTLYEMIAAR 386

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 44/206 (21%), Positives = 93/206 (45%), Gaps = 26/206 (12%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRG- 839
             +G  S G    A    +G  + VK +     ++R+    E     + +H NVV +   
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110

Query: 840 YYWGPTQHEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
           Y  G    E+L +L +++  G+L   +          L   Q   +   V + L YLH  
Sbjct: 111 YLVG----EELWVLMEFLQGGALTDIV------SQVRLNEEQIATVCEAVLQALAYLHAQ 160

Query: 899 RAVPHGNLKATNILLDGPDLNARVAD--YC--LHRLMTQAGTIEQILDAGVLGYRAPELA 954
             + H ++K+ +ILL   D   +++D  +C  + + + +  ++      G   + APE+ 
Sbjct: 161 GVI-HRDIKSDSILLTL-DGRVKLSDFGFCAQISKDVPKRKSL-----VGTPYWMAPEV- 212

Query: 955 ASKKPHPSFKSDVYAFGVILLELLTG 980
            S+  + + + D+++ G++++E++ G
Sbjct: 213 ISRSLY-ATEVDIWSLGIMVIEMVDG 237

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 52.6 bits (127), Expect = 2e-07
 Identities = 49/222 (22%), Positives = 81/222 (36%), Gaps = 42/222 (18%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR---------- 830
           E+LGR       R           VK +             +  + A ++          
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           HPN++ L+  Y   T     ++ D +  G L    +D    K   L+  +  KI   +  
Sbjct: 83  HPNIIQLKDTY--ETNTFFFLVFDLMKKGEL----FDYLTEKVT-LSEKETRKIMRALLE 135

Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL-------HRLMTQAGTIEQILDA 943
            +  LH    + H +LK  NILLD  D+N ++ D+          +L    GT       
Sbjct: 136 VICALH-KLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGT------- 186

Query: 944 GVLGYRAPE-----LAASKKPHPSFKSDVYAFGVILLELLTG 980
               Y APE     +  +   +   + D+++ GVI+  LL G
Sbjct: 187 --PSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAG 225

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 17/204 (8%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWL--REGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
           E LG+ +     R      G+    K +  ++  A+  ++  +EA+    ++HPN+V L 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
                 + H  L+  D ++ G     L++    +    + A        +   + Y H  
Sbjct: 95  DSIQEESFHY-LVF-DLVTGGE----LFEDIVARE-FYSEADASHCIQQILESIAYCH-S 146

Query: 899 RAVPHGNLKATNILLDGPDLNARV--ADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
             + H NLK  N+LL      A V  AD+ L   +  +        AG  GY +PE+   
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF--AGTPGYLSPEVLK- 203

Query: 957 KKPHPSFKSDVYAFGVILLELLTG 980
           K P+ S   D++A GVIL  LL G
Sbjct: 204 KDPY-SKPVDIWACGVILYILLVG 226

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 52.3 bits (126), Expect = 4e-07
 Identities = 46/206 (22%), Positives = 80/206 (38%), Gaps = 18/206 (8%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWL--REGVAKQRKEFAKEAKKFANIRH-PNVVGL 837
           + LGR       +      G     K+L  R      R E   E       +  P V+ L
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDR-PGRKGPPLTWAQRLKIAVDVARGLNYLH 896
              Y   ++   LIL +Y + G +    +          ++    +++   +  G+ YLH
Sbjct: 95  HEVYENTSEI-ILIL-EYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148

Query: 897 FDRAVPHGNLKATNILLDGPDLNARV--ADYCLHRLMTQAGTIEQILDAGVLGYRAPELA 954
               + H +LK  NILL        +   D+ + R +  A  + +I+  G   Y APE+ 
Sbjct: 149 -QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAPEIL 205

Query: 955 ASKKPHPSFKSDVYAFGVILLELLTG 980
            +  P  +  +D++  G+I   LLT 
Sbjct: 206 -NYDPI-TTATDMWNIGIIAYMLLTH 229

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 52.8 bits (127), Expect = 4e-07
 Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 33/212 (15%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           +VLG   +G   +           +K L++   K R+E     +     + P++V +   
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRA---SQCPHIVRIVDV 123

Query: 841 YWGPTQHEK--LILSDYISPGSLASFLYDRPGRKGP-PLTWAQRLKIAVDVARGLNYLHF 897
           Y       K  LI+ + +  G     L+ R   +G    T  +  +I   +   + YLH 
Sbjct: 124 YENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 178

Query: 898 DRAVPHGNLKATNILLDGPDLNA--RVADYCL-------HRLMTQAGTIEQILDAGVLGY 948
              + H ++K  N+L      NA  ++ D+         + L T   T           Y
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT---------PYY 229

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTG 980
            APE+   +K   S   D+++ GVI+  LL G
Sbjct: 230 VAPEVLGPEKYDKS--CDMWSLGVIMYILLCG 259

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 52.7 bits (127), Expect = 4e-07
 Identities = 50/213 (23%), Positives = 82/213 (38%), Gaps = 34/213 (15%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWL--REGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
           E LG+ +     R   +  G       +  ++  A+  ++  +EA+    ++HPN+V L 
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
                  +    ++ D ++ G L    ++    +    + A        +   + + H  
Sbjct: 77  DSI--SEEGHHYLIFDLVTGGEL----FEDIVAREY-YSEADASHCIQQILEAVLHCH-Q 128

Query: 899 RAVPHGNLKATNILLDGPDLNARV--ADYCL--------HRLMTQAGTIEQILDAGVLGY 948
             V H NLK  N+LL      A V  AD+ L              AGT          GY
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT---------PGY 179

Query: 949 RAPE-LAASKKPHPSFKSDVYAFGVILLELLTG 980
            +PE L   K P+     D++A GVIL  LL G
Sbjct: 180 LSPEVLR--KDPY-GKPVDLWACGVILYILLVG 209

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 33/121 (27%), Positives = 48/121 (39%), Gaps = 7/121 (5%)

Query: 110 IPDNIGDFKSLEFLDVSDNLFSSSLPSGI-GKLESLQNLSLAGNNFSGLIPDSVSGLVSI 168
           IP +I        L ++DN        G+ G+L  L  L L  N  +G+ P++  G   I
Sbjct: 23  IPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 169 QSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNKL 226
           Q L L  N     +       L+ L  LNL  N     +  G FE +  L  L+   N  
Sbjct: 81  QELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASNPF 138

Query: 227 D 227
           +
Sbjct: 139 N 139

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 34/120 (28%), Positives = 50/120 (41%), Gaps = 16/120 (13%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVL 318
             +      L L+ N+L   + + G      +L  L+L  NQLTG  P  F     +Q L
Sbjct: 25  RDIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL 83

Query: 319 KLSNNRFSGFIPNDLLKGDSL-LLTDLDLSANNLSGSV------SMILSTNLHMLNLSSN 371
           +L  N+    I N +     L  L  L+L  N +S  V       +    +L  LNL+SN
Sbjct: 84  QLGENKIKE-ISNKMF--LGLHQLKTLNLYDNQIS-CVMPGSFEHL---NSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 28/127 (22%), Positives = 46/127 (36%), Gaps = 28/127 (22%)

Query: 76  LDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLP 135
           L++  L   +   +F  L  LVKL +  N +                         + + 
Sbjct: 36  LNDNELGRISSDGLFGRLPHLVKLELKRNQL-------------------------TGIE 70

Query: 136 SGI-GKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLV 193
                    +Q L L  N    +      GL  +++L+L  N  S  + P +   LN+L 
Sbjct: 71  PNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLT 129

Query: 194 YLNLSSN 200
            LNL+SN
Sbjct: 130 SLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 43.8 bits (104), Expect = 7e-05
 Identities = 25/123 (20%), Positives = 40/123 (32%), Gaps = 30/123 (24%)

Query: 408 EYLDLSRNHLTGSIPEETPQFLR-LNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLD 466
             L L+ N L     +     L  L  L L  N L+   P        ++ L L  N   
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK-- 89

Query: 467 GPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRL----NGYFPDRLG 522
                       ++E+         +       +  L+ L+L  N++     G F + L 
Sbjct: 90  ------------IKEIS------NKMFL----GLHQLKTLNLYDNQISCVMPGSF-EHLN 126

Query: 523 SLT 525
           SLT
Sbjct: 127 SLT 129

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 40.8 bits (96), Expect = 9e-04
 Identities = 20/83 (24%), Positives = 29/83 (34%), Gaps = 5/83 (6%)

Query: 169 QSLDLSHNSFSGSLPPA--LTRLNNLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGNK 225
             L L+ N     +       RL +LV L L  N  +  I    FE    +Q L    NK
Sbjct: 32  TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENK 89

Query: 226 LDGHLDGEFFLLTNASHIDFSGN 248
           +    +  F  L     ++   N
Sbjct: 90  IKEISNKMFLGLHQLKTLNLYDN 112

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 52.3 bits (125), Expect = 7e-07
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 35/213 (16%)

Query: 783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFA---KEAKKFANI-RHPNVVGL 837
           VLG+ S G    +          VK L++ V  Q  +      E +  A   + P +  L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 838 RGYYWGPTQHEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
             +    T  ++L    +Y++ G L  +   + GR   P         A ++A GL +L 
Sbjct: 408 --HSCFQTM-DRLYFVMEYVNGGDL-MYHIQQVGRFKEPHA---VFYAA-EIAIGLFFLQ 459

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTIEQILDAGVLGY 948
             + + + +LK  N++LD  + + ++AD+ +            T  GT +         Y
Sbjct: 460 -SKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTPD---------Y 508

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            APE+ A  +P+     D +AFGV+L E+L G+
Sbjct: 509 IAPEIIA-YQPY-GKSVDWWAFGVLLYEMLAGQ 539

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 51.1 bits (123), Expect = 8e-07
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 4/94 (4%)

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG-- 947
           RGL Y+H    V H +LK  N+ ++  DL  ++ D+ L R+M    + +  L  G++   
Sbjct: 131 RGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189

Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           YR+P L  S   + +   D++A G I  E+LTG+
Sbjct: 190 YRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 222

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 51.1 bits (123), Expect = 1e-06
 Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 36/214 (16%)

Query: 783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFA---KEAKKFANIRHPNVVGLR 838
           +LG+ + G          G +  +K LR+ V   + E A    E++   N RHP +  L+
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 839 GYYWGPTQ-HEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
             +    Q H++L    +Y + G L   L  R            R   A ++   L YLH
Sbjct: 72  YAF----QTHDRLCFVMEYANGGELFFHLS-RERVFTEERA---RFYGA-EIVSALEYLH 122

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTIEQILDAGVLGY 948
             R V + ++K  N++LD  D + ++ D+ L          + T  GT E         Y
Sbjct: 123 -SRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPE---------Y 171

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGRC 982
            APE+      +     D +  GV++ E++ GR 
Sbjct: 172 LAPEVLE-DNDY-GRAVDWWGLGVVMYEMMCGRL 203

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 44/162 (27%), Positives = 67/162 (41%), Gaps = 12/162 (7%)

Query: 829 IRHPNVVGLRGYYWGPTQHEKLILSDYIS---PGSLASFLYDRPGRKGPPLTWAQRLKIA 885
           ++HPNV+ L+  +      +  +L DY        +      +  +K   L       + 
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134

Query: 886 VDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNA---RVADYCLHRLMTQAGTIEQILD 942
             +  G++YLH    V H +LK  NIL+ G        ++AD    RL          LD
Sbjct: 135 YQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 943 AGV--LGYRAPE-LAASKKPHPSFKSDVYAFGVILLELLTGR 981
             V    YRAPE L  ++  H +   D++A G I  ELLT  
Sbjct: 194 PVVVTFWYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTSE 233

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 50.3 bits (121), Expect = 2e-06
 Identities = 49/223 (21%), Positives = 80/223 (35%), Gaps = 54/223 (24%)

Query: 783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFA---KEAKKFANIRHPNVVGLR 838
           +LG  S  T   A          +K L +    +  +     +E    + + HP  V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 839 GYYWGPTQ-HEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR------ 890
             +    Q  EKL     Y   G L  ++  + G                   R      
Sbjct: 97  FTF----QDDEKLYFGLSYAKNGELLKYIR-KIGS------------FDETCTRFYTAEI 139

Query: 891 --GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL----------HRLMTQAGTIE 938
              L YLH  + + H +LK  NILL+  D++ ++ D+             R  +  GT +
Sbjct: 140 VSALEYLH-GKGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                    Y +PEL  ++K      SD++A G I+ +L+ G 
Sbjct: 198 ---------YVSPELL-TEKSA-CKSSDLWALGCIIYQLVAGL 229

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 50.0 bits (120), Expect = 3e-06
 Identities = 48/197 (24%), Positives = 82/197 (41%), Gaps = 33/197 (16%)

Query: 798 ENGMFLTVKWLREGVAKQRKEFA---KEAKKFANIRHPNVVGLRGYYWGPTQ-HEKLIL- 852
           +      +K++ +    +R E     KE +    + HP +V L   +    Q  E + + 
Sbjct: 38  DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF----QDEEDMFMV 93

Query: 853 SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNIL 912
            D +  G L   L  +            +L I  ++   L+YL  ++ + H ++K  NIL
Sbjct: 94  VDLLLGGDLRYHLQ-QNVHFKEETV---KLFIC-ELVMALDYLQ-NQRIIHRDMKPDNIL 147

Query: 913 LDGPDLNARVADYCL-------HRLMTQAGTIEQILDAGVLGYRAPELAASKKPHP-SFK 964
           LD    +  + D+ +        ++ T AGT           Y APE+ +S+K    SF 
Sbjct: 148 LDE-HGHVHITDFNIAAMLPRETQITTMAGTKP---------YMAPEMFSSRKGAGYSFA 197

Query: 965 SDVYAFGVILLELLTGR 981
            D ++ GV   ELL GR
Sbjct: 198 VDWWSLGVTAYELLRGR 214

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 60/301 (19%), Positives = 107/301 (35%), Gaps = 55/301 (18%)

Query: 714 PDEKAAVVSGISPSKNSHLSWSPESGDSFTAENLARLDVRSPDRLVGELHFLDDTLTLTP 773
              +   +  ++  +      S     S +A  LA     +  +  G  +    ++    
Sbjct: 22  ARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPED 81

Query: 774 EELSRAPA----------EVLGRSSHGTSYRAT-LENGMFLTVK--------WLREGVAK 814
           E    A A          +V+GR       R      G    VK           E + +
Sbjct: 82  ELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEE 141

Query: 815 QRKEFAKEA---KKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGR 871
            R+   +E    ++ A   HP+++ L   Y   +     ++ D +  G L    +D    
Sbjct: 142 VREATRRETHILRQVAG--HPHIITLIDSY--ESSSFMFLVFDLMRKGEL----FDYLTE 193

Query: 872 KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL---- 927
           K   L+  +   I   +   +++LH    + H +LK  NILLD  ++  R++D+      
Sbjct: 194 KVA-LSEKETRSIMRSLLEAVSFLH-ANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHL 250

Query: 928 ---HRLMTQAGTIEQILDAGVLGYRAPE-----LAASKKPHPSFKSDVYAFGVILLELLT 979
               +L    GT          GY APE     +  +   +   + D++A GVIL  LL 
Sbjct: 251 EPGEKLRELCGT---------PGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLA 300

Query: 980 G 980
           G
Sbjct: 301 G 301

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 49.1 bits (117), Expect = 7e-06
 Identities = 57/325 (17%), Positives = 107/325 (32%), Gaps = 44/325 (13%)

Query: 265 SVQYLNLSLNQLTGSLVNGGE--LQLFENLKVLDLSYNQLTGELPGFNFVYE----LQVL 318
                NL  +   G +    E     +  L+ + L    +T +      + +     +VL
Sbjct: 78  HFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDD--CLELIAKSFKNFKVL 135

Query: 319 KLSN-NRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS------TNLHMLNLS-- 369
            LS+   FS      +       L +LDL  +++       LS      T+L  LN+S  
Sbjct: 136 VLSSCEGFSTDGLAAIAAT-CRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCL 194

Query: 370 SNGLTGE-LPLLTGSCA---VLDLSNN-------QFEGNLSRILKWGNIEYLDLSRNHLT 418
           ++ ++   L  L   C     L L+                ++ + G   Y    R  + 
Sbjct: 195 ASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVY 254

Query: 419 GSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLL-NSS 477
             +         L  L+   +++ + LP V     +L  L+LS+  +    L  LL    
Sbjct: 255 SGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCP 314

Query: 478 TLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNI 537
            LQ L + D +    L+    +  +L+ L +  +      P+   +  GL  +       
Sbjct: 315 KLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVS------ 368

Query: 538 SGSLPTSMANMTSLSSLVISQNHFT 562
                        L S++      T
Sbjct: 369 --------MGCPKLESVLYFCRQMT 385

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 45.3 bits (107), Expect = 9e-05
 Identities = 49/382 (12%), Positives = 110/382 (28%), Gaps = 47/382 (12%)

Query: 80  GLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDF----KSLEFLDVSD---NLFSS 132
           G S     ++ +    L +L +  + +  V    +  F     SL  L++S     +  S
Sbjct: 142 GFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFS 201

Query: 133 SLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLS------HNSFSGSLPPAL 186
           +L   + +  +L++L L        +   +     ++ L                L  AL
Sbjct: 202 ALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVAL 261

Query: 187 TRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHG-NKLDGHLDGEFFLLTNASHIDF 245
           +    L  L+   +     +P  + +   L  L+          L            +  
Sbjct: 262 SGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWV 321

Query: 246 SGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGE--------LQLFENLKVLDL 297
                +  +  + L    + ++ L +  ++      N                 L+ +  
Sbjct: 322 LDY--IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLY 379

Query: 298 SYNQLTGELPGFNFVYE----LQVLKLSNNRFSGFIPNDLLKGDSLL---------LTDL 344
              Q+T        +      +   +L            L   D            L  L
Sbjct: 380 FCRQMTNA--ALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRL 437

Query: 345 DLSANNLSGSVSMILS--TNLHMLNLSSNGLTGE-LPLLTGSC---AVLDLSNNQF--EG 396
            LS          I +    + ML+++  G +   +  +   C     L++ +  F  + 
Sbjct: 438 SLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKA 497

Query: 397 NLSRILKWGNIEYLDLSRNHLT 418
            L+   K   +  L +S   ++
Sbjct: 498 LLANASKLETMRSLWMSSCSVS 519

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 48.1 bits (115), Expect = 9e-06
 Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 37/215 (17%)

Query: 783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFA---KEAKKFANI-RHPNVVGL 837
           V+GR S+       L +      ++ +++ +    ++      E   F     HP +VGL
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118

Query: 838 RGYYWGPTQ-HEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
              +    Q   +L    +Y++ G L   +  R  +         R   A +++  LNYL
Sbjct: 119 HSCF----QTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHA---RFYSA-EISLALNYL 169

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTIEQILDAGVLG 947
           H +R + + +LK  N+LLD  + + ++ DY +            T  GT           
Sbjct: 170 H-ERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN--------- 218

Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLTGRC 982
           Y APE+    + +  F  D +A GV++ E++ GR 
Sbjct: 219 YIAPEILR-GEDY-GFSVDWWALGVLMFEMMAGRS 251

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 48.0 bits (115), Expect = 9e-06
 Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 37/215 (17%)

Query: 783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFA---KEAKKFANI-RHPNVVGL 837
           V+GR S+       L +      +K +++ +    ++      E   F     HP +VGL
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 838 RGYYWGPTQ-HEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
              +    Q   +L    +Y++ G L   +  R  +         R   A +++  LNYL
Sbjct: 76  HSCF----QTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHA---RFYSA-EISLALNYL 126

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTIEQILDAGVLG 947
           H +R + + +LK  N+LLD  + + ++ DY +            T  GT           
Sbjct: 127 H-ERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN--------- 175

Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLTGRC 982
           Y APE+    + +  F  D +A GV++ E++ GR 
Sbjct: 176 YIAPEILR-GEDY-GFSVDWWALGVLMFEMMAGRS 208

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 30/95 (31%), Positives = 44/95 (46%), Gaps = 6/95 (6%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLN 190
           +S+P+GI    + Q L L  N  + L P     L  +  LDL +N  +  LP     +L 
Sbjct: 22  ASVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLT 78

Query: 191 NLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGN 224
            L  L+L+ N   K IPRG F+ +  L  +    N
Sbjct: 79  QLTQLSLNDNQL-KSIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 40.3 bits (95), Expect = 9e-04
 Identities = 25/66 (37%), Positives = 34/66 (51%), Gaps = 5/66 (7%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG--FNFVYELQV 317
            G+  + Q L L  NQ+T  L  G   +L   L  LDL  NQLT  LP   F+ + +L  
Sbjct: 26  TGIPTTTQVLYLYDNQIT-KLEPGVFDRL-TQLTRLDLDNNQLT-VLPAGVFDKLTQLTQ 82

Query: 318 LKLSNN 323
           L L++N
Sbjct: 83  LSLNDN 88

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 33/182 (18%), Positives = 55/182 (30%), Gaps = 53/182 (29%)

Query: 860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPD-- 917
            L  ++     + G PL   ++  I   V +GL+YLH    + H ++K  NILL   +  
Sbjct: 130 HLLKWIIKSNYQ-GLPLPCVKK--IIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186

Query: 918 ----------------------------LNARVADYCLHRLMTQAGTIEQILDAGV---- 945
                                         A                  +I D G     
Sbjct: 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV 246

Query: 946 ----------LGYRAPE--LAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAG 993
                       YR+ E  + +      +  +D+++   +  EL TG    +  SGE   
Sbjct: 247 HKHFTEDIQTRQYRSLEVLIGSGY----NTPADIWSTACMAFELATGDYLFEPHSGEEYT 302

Query: 994 VD 995
            D
Sbjct: 303 RD 304

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 51/223 (22%), Positives = 89/223 (39%), Gaps = 49/223 (21%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAK----EAKKFANIRHPNVVG 836
             +G  ++G    A    N + + +K +      + + + +    E K     RH N++G
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIG 89

Query: 837 LRGYYWGPTQHE----------------KLILSDYISPGSLASFLYDRPGRKGPPLTWAQ 880
           +      PT  +                KL+ + ++S   +  FLY             Q
Sbjct: 90  INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY-------------Q 136

Query: 881 RLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI 940
            L       RGL Y+H    V H +LK +N+LL+    + ++ D+ L R+          
Sbjct: 137 IL-------RGLKYIH-SANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGF 187

Query: 941 LDAGVLG--YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L   V    YRAPE+  + K   +   D+++ G IL E+L+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSK-GYTKSIDIWSVGCILAEMLSNR 229

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 46.9 bits (112), Expect = 2e-05
 Identities = 51/211 (24%), Positives = 83/211 (39%), Gaps = 35/211 (16%)

Query: 783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFA---KEAKKFANIRHPNVVGLR 838
            LG  S G        E+G    +K L +    + K+      E +    +  P +V L 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 839 GYYWGPTQ-HEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
             +    + +  L ++ +Y++ G + S L  R GR   P     R   A  +     YLH
Sbjct: 108 FSF----KDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHA---RFYAA-QIVLTFEYLH 158

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCL-----HRLMTQAGTIEQILDAGVLGYRAP 951
               + + +LK  N+L+D      +V D+        R  T  GT E           AP
Sbjct: 159 -SLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVKGRTWTLCGTPE---------ALAP 207

Query: 952 ELAASKKPHPSFKS-DVYAFGVILLELLTGR 981
           E+  SK  +   K+ D +A GV++ E+  G 
Sbjct: 208 EIILSK-GYN--KAVDWWALGVLIYEMAAGY 235

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 6/95 (6%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLN 190
           +S+P+GI      Q L L  N  + L P     LV++Q L  + N  + ++P     +L 
Sbjct: 25  ASVPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLT 81

Query: 191 NLVYLNLSSNGFSKRIPRG-FELILGLQVLDFHGN 224
            L  L+L+ N   K IPRG F+ +  L  +  + N
Sbjct: 82  QLTQLDLNDNHL-KSIPRGAFDNLKSLTHIYLYNN 115

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 46.6 bits (111), Expect = 3e-05
 Identities = 51/227 (22%), Positives = 97/227 (42%), Gaps = 36/227 (15%)

Query: 770 TLTPEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVA----KQRKEFA-KEA 823
           T    E++    +V+G  S G  ++A L E+            VA     Q K F  +E 
Sbjct: 34  TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE----------VAIKKVLQDKRFKNREL 83

Query: 824 KKFANIRHPNVVGLRGYYWGPTQHEK-----LILSDYISPGSLASFLYDRPGRKGP-PLT 877
           +    ++HPNVV L+ +++     +      L+L +Y+ P ++          K   P+ 
Sbjct: 84  QIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL-EYV-PETVYRASRHYAKLKQTMPML 141

Query: 878 WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT- 936
             +       + R L Y+H    + H ++K  N+LLD P    ++ D+   +++      
Sbjct: 142 LIK--LYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198

Query: 937 IEQILDAGVLGYRAPE--LAASKKPHPSFKSDVYAFGVILLELLTGR 981
           +  I       YRAPE    A+   + +   D+++ G ++ EL+ G+
Sbjct: 199 VSYIC---SRYYRAPELIFGAT---NYTTNIDIWSTGCVMAELMQGQ 239

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 57/267 (21%), Positives = 97/267 (36%), Gaps = 31/267 (11%)

Query: 250 FVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGE--LP 307
             G +    + G   S   +     +             F  ++ +DLS + +       
Sbjct: 54  LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLHG 112

Query: 308 GFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSA-NNLS-GSVSMILS--TNL 363
             +   +LQ L L   R S  I N L K  +L    L+LS  +  S  ++  +LS  + L
Sbjct: 113 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNL--VRLNLSGCSGFSEFALQTLLSSCSRL 170

Query: 364 HMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLS--RNHLT-GS 420
             LNLS              C   D +    +  ++ + +   I  L+LS  R +L    
Sbjct: 171 DELNLSW-------------CF--DFTEKHVQVAVAHVSE--TITQLNLSGYRKNLQKSD 213

Query: 421 IPEETPQFLRLNHLNLSH-NSLSSSLPKVIIQYQKLRVLDLSF-NHLDGPFLTNLLNSST 478
           +     +   L HL+LS    L +   +   Q   L+ L LS    +    L  L    T
Sbjct: 214 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 273

Query: 479 LQELHLADNLLTGVLDFSPPSVSNLQV 505
           L+ L +   +  G L     ++ +LQ+
Sbjct: 274 LKTLQVFGIVPDGTLQLLKEALPHLQI 300

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 41.8 bits (98), Expect = 8e-04
 Identities = 39/224 (17%), Positives = 83/224 (37%), Gaps = 17/224 (7%)

Query: 60  SWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKS 119
            W  +  +      + L    L       + S    ++      + +   + ++   F+ 
Sbjct: 38  RWYRLASDESLWQTLDLTGKNLHPDVTGRLLSQG--VIAFRCPRSFMDQPLAEHFSPFRV 95

Query: 120 LEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF- 178
                 +  +  S+L   + +   LQNLSL G   S  I ++++   ++  L+LS  S  
Sbjct: 96  QHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF 155

Query: 179 -SGSLPPALTRLNNLVYLNLSSNGFSKRI-PRGFELILG-----LQVLDFHGNKL---DG 228
              +L   L+  + L  LNLS          +  ++ +      +  L+  G +      
Sbjct: 156 SEFALQTLLSSCSRLDELNLSWC---FDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS 212

Query: 229 HLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLS 272
            L        N  H+D S ++ + +   +    L+  +Q+L+LS
Sbjct: 213 DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY-LQHLSLS 255

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 45.7 bits (109), Expect = 5e-05
 Identities = 36/167 (21%), Positives = 61/167 (36%), Gaps = 29/167 (17%)

Query: 830 RHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLY--------DRPG---RKGPPLTW 878
           +H NVV L            +  +           +Y        D  G         T 
Sbjct: 74  KHENVVNLIE----------ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL 123

Query: 879 AQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ-AGTI 937
           ++  ++   +  GL Y+H    + H ++KA N+L+   D   ++AD+ L R  +    + 
Sbjct: 124 SEIKRVMQMLLNGLYYIH-RNKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQ 181

Query: 938 EQILDAGV--LGYRAPE-LAASKKPHPSFKSDVYAFGVILLELLTGR 981
                  V  L YR PE L   +   P    D++  G I+ E+ T  
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDYGPPI--DLWGAGCIMAEMWTRS 226

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 45.8 bits (109), Expect = 5e-05
 Identities = 23/94 (24%), Positives = 44/94 (46%), Gaps = 10/94 (10%)

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG-- 947
            G+ +LH    + H +LK +NI++   D   ++ D+ L R          ++   V+   
Sbjct: 138 CGIKHLH-SAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGT----SFMMTPYVVTRY 191

Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           YRAPE+        +   D+++ G I+ E++ G 
Sbjct: 192 YRAPEVILGMGYKENV--DIWSVGCIMGEMIKGG 223

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 45.3 bits (108), Expect = 8e-05
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 35/213 (16%)

Query: 783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFA---KEAKKFANI-RHPNVVGL 837
           VLG+ S G    +          VK L++ V  Q  +      E +  A   + P +  L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 838 RGYYWGPTQHEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
             +    T  ++L    +Y++ G L   +  + GR   P         A ++A GL +L 
Sbjct: 87  --HSCFQTM-DRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHA---VFYAA-EIAIGLFFLQ 138

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTIEQILDAGVLGY 948
             + + + +LK  N++LD  + + ++AD+ +            T  GT +         Y
Sbjct: 139 -SKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTPD---------Y 187

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            APE+ A  +P+     D +AFGV+L E+L G+
Sbjct: 188 IAPEIIA-YQPY-GKSVDWWAFGVLLYEMLAGQ 218

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 45.5 bits (108), Expect = 8e-05
 Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 51/232 (21%)

Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVA--KQRKEFAKEAKKFAN- 828
           P+E+S    +V+G  S G  Y+A L ++G         E VA  K  ++     K+F N 
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSG---------ELVAIKKVLQD-----KRFKNR 96

Query: 829 -------IRHPNVVGLRGYYWGPTQHEK-----LILSDYISPGSLASFLYDRPGRKGPPL 876
                  + H N+V LR +++   + +      L+L DY+ P ++          K    
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYV-PETVYRVARHYSRAK---- 150

Query: 877 TWAQRLKIAV------DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL 930
              Q L +         + R L Y+H    + H ++K  N+LLD      ++ D+   + 
Sbjct: 151 ---QTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206

Query: 931 MTQAGT-IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           + +    +  I       YRAPEL        +   DV++ G +L ELL G+
Sbjct: 207 LVRGEPNVSYIC---SRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 254

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 44.9 bits (107), Expect = 9e-05
 Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 35/214 (16%)

Query: 783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFA---KEAKKFA-NIRHPNVVGL 837
           +LG+ S G  + A   +   F  +K L++ V     +      E +  +    HP +  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 838 RGYYWGPTQHEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
             +    T+ E L    +Y++ G L   +     +             A ++  GL +LH
Sbjct: 84  --FCTFQTK-ENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRA---TFYAA-EIILGLQFLH 135

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTIEQILDAGVLGY 948
             + + + +LK  NILLD  D + ++AD+ +         +  T  GT +         Y
Sbjct: 136 -SKGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPD---------Y 184

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGRC 982
            APE+    + + +   D ++FGV+L E+L G+ 
Sbjct: 185 IAPEILL-GQKY-NHSVDWWSFGVLLYEMLIGQS 216

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 14/51 (27%), Positives = 23/51 (45%), Gaps = 2/51 (3%)

Query: 128 NLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF 178
            L  +SLP+          L L GNN + L P  +  L ++++  L  N +
Sbjct: 19  GLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 45.3 bits (107), Expect = 1e-04
 Identities = 53/418 (12%), Positives = 106/418 (25%), Gaps = 51/418 (12%)

Query: 167 SIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKL 226
           + + + ++   ++ +      R  NL  L L      K     F LI         G  +
Sbjct: 51  TREHVTMA-LCYTATPDRLSRRFPNLRSLKLKG----KPRAAMFNLIPENW-----GGYV 100

Query: 227 DGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGEL 286
              +      L     + F   +       +     +  ++ L L       +      +
Sbjct: 101 TPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIV 160

Query: 287 QLFENLKVLDLSYNQL-TGELPGFNFVYE----LQVLKLSNNRFSGFIPNDL--LKGDSL 339
                +K L +  +     +    + + +    L+VL      F+   P DL  +  +  
Sbjct: 161 THCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCR 220

Query: 340 LLTDLDLS-ANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCA------VLDLSNN 392
            L  + +     L        + NL      S      +P    +         L LS  
Sbjct: 221 SLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM 280

Query: 393 QFEGNLSRILKWGNIEYLDLSR-NHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQ 451
                         I  LDL      T        +   L  L   +      L  +   
Sbjct: 281 GPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQY 340

Query: 452 YQKLRVLDLSF--NHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLS 509
            ++L+ L +    +         L++   L    LA                 L+ + + 
Sbjct: 341 CKQLKRLRIERGADEQGMEDEEGLVSQRGLI--ALAQGC------------QELEYMAVY 386

Query: 510 HNRLN----GYFPDRLGSLTGLKVLCLAGNNISGSLPTSMA------NMTSLSSLVIS 557
            + +           L +L   +++ L        LP              L      
Sbjct: 387 VSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFY 444

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 44.5 bits (106), Expect = 1e-04
 Identities = 36/172 (20%), Positives = 64/172 (37%), Gaps = 35/172 (20%)

Query: 824 KKFANIRHPNVVGLRGYYWGPTQHEKLILS---DYISPGSLASFLYDRPGRKGPPLTWAQ 880
           ++     HPNVV L           ++ ++   +++    L ++L   P    P L    
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAP---PPGLPAET 121

Query: 881 RLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL-----------HR 929
              +     RGL++LH    + H +LK  NIL+       ++AD+ L             
Sbjct: 122 IKDLMRQFLRGLDFLH-ANCIVHRDLKPENILVTS-GGTVKLADFGLARIYSYQMALTPV 179

Query: 930 LMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           ++T             L YRAPE+            D+++ G I  E+   +
Sbjct: 180 VVT-------------LWYRAPEVLLQSTYATPV--DMWSVGCIFAEMFRRK 216

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 44.5 bits (106), Expect = 1e-04
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 35/213 (16%)

Query: 783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFA---KEAKKFANI-RHPNVVGL 837
           VLG+ S G    A + E G    VK L++ V  Q  +      E +  +    HP +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 838 RGYYWGPTQHEKLIL-SDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
             +    T  ++L    ++++ G L   +  +  R         R   A ++   L +LH
Sbjct: 90  --FCCFQTP-DRLFFVMEFVNGGDLMFHIQ-KSRRFDEARA---RFYAA-EIISALMFLH 141

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTIEQILDAGVLGY 948
            D+ + + +LK  N+LLD  + + ++AD+ +            T  GT +         Y
Sbjct: 142 -DKGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPD---------Y 190

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            APE+   +  +     D +A GV+L E+L G 
Sbjct: 191 IAPEILQ-EMLY-GPAVDWWAMGVLLYEMLCGH 221

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 47/226 (20%), Positives = 86/226 (38%), Gaps = 55/226 (24%)

Query: 780 PAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAK----EAKKFANIRHPNV 834
             + +G  ++G    A     G  + +K L      Q + FAK    E +   ++RH NV
Sbjct: 29  DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSELFAKRAYRELRLLKHMRHENV 86

Query: 835 VGLRGYYWGPTQHE-----------------KLILSDYISPGSLASFLYDRPGRKGPPLT 877
           +GL   +      +                 KL+  + +    +   +Y           
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY----------- 135

Query: 878 WAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI 937
             Q L       +GL Y+H    + H +LK  N+ ++  D   ++ D+ L R      T 
Sbjct: 136 --QML-------KGLRYIH-AAGIIHRDLKPGNLAVNE-DCELKILDFGLARQADSEMTG 184

Query: 938 EQILDAGVLG--YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
                  V+   YRAPE+  +     +   D+++ G I+ E++TG+
Sbjct: 185 Y------VVTRWYRAPEVILNWM-RYTQTVDIWSVGCIMAEMITGK 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 55/224 (24%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAK----EAKKFANIRHPNVVG 836
             +G  ++G+   A   + G+ + VK L      Q    AK    E +   +++H NV+G
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--PFQSIIHAKRTYRELRLLKHMKHENVIG 92

Query: 837 LRGYYWGPTQHE-----------------KLILSDYISPGSLASFLYDRPGRKGPPLTWA 879
           L   +      E                  ++    ++   +   +Y             
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY------------- 139

Query: 880 QRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ 939
           Q L       RGL Y+H    + H +LK +N+ ++  D   ++ D+ L R          
Sbjct: 140 QIL-------RGLKYIH-SADIIHRDLKPSNLAVNE-DCELKILDFGLAR------HTAD 184

Query: 940 ILDAGVLG--YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            +   V    YRAPE+  +   H +   D+++ G I+ ELLTGR
Sbjct: 185 EMTGYVATRWYRAPEIMLNWM-HYNQTVDIWSVGCIMAELLTGR 227

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 22/93 (23%), Positives = 42/93 (45%), Gaps = 8/93 (8%)

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR-LMTQAGTIEQILDAGVLGY 948
            G+ +LH    + H +LK +NI++   D   ++ D+ L R   T       +       Y
Sbjct: 175 CGIKHLH-SAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYV---VTRYY 229

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           RAPE+        +   D+++ G I+ E++  +
Sbjct: 230 RAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 260

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 44.1 bits (105), Expect = 2e-04
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 35/211 (16%)

Query: 783 VLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFA---KEAKKFANIRHPNVVGLR 838
            LG  S G  +      NG +  +K L++ +  + K+      E    + + HP ++ + 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72

Query: 839 GYYWGPTQ-HEKL-ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           G +    Q  +++ ++ DYI  G L S L  +  R   P+    +   A +V   L YLH
Sbjct: 73  GTF----QDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVA---KFYAA-EVCLALEYLH 123

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADY-----CLHRLMTQAGTIEQILDAGVLGYRAP 951
             + + + +LK  NILLD  + + ++ D+           T  GT +         Y AP
Sbjct: 124 -SKDIIYRDLKPENILLDK-NGHIKITDFGFAKYVPDVTYTLCGTPD---------YIAP 172

Query: 952 ELAASKKPHPSFKS-DVYAFGVILLELLTGR 981
           E+ ++K P+   KS D ++FG+++ E+L G 
Sbjct: 173 EVVSTK-PYN--KSIDWWSFGILIYEMLAGY 200

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 43.7 bits (104), Expect = 2e-04
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 38/215 (17%)

Query: 783 VLGRSSHGT----SYRATLENGMFLTVKWLREGVAKQRKEFAKEAKK--FANIRHPNVVG 836
           VLG+ S G        +  +      +K L++   K R     + ++     + HP +V 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 837 LRGYYWGPTQHEKL--ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
           L  +Y   T   KL  IL D++  G L + L  +            +  +A ++A  L++
Sbjct: 91  L--HYAFQT-EGKLYLIL-DFLRGGDLFTRLS-KEVMFTEEDV---KFYLA-ELALALDH 141

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCL--------HRLMTQAGTIEQILDAGVL 946
           LH    + + +LK  NILLD  + + ++ D+ L         +  +  GT+E        
Sbjct: 142 LH-SLGIIYRDLKPENILLDE-EGHIKLTDFGLSKESIDHEKKAYSFCGTVE-------- 191

Query: 947 GYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
            Y APE+  +++ H +  +D ++FGV++ E+LTG 
Sbjct: 192 -YMAPEVV-NRRGH-TQSADWWSFGVLMFEMLTGT 223

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 43.8 bits (104), Expect = 2e-04
 Identities = 36/172 (20%), Positives = 63/172 (36%), Gaps = 43/172 (25%)

Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILS-DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAV 886
            ++H N++ L+        + +L L  +Y     L  ++      K P ++         
Sbjct: 89  ELQHRNIIELKSVI---HHNHRLHLIFEYAE-NDLKKYM-----DKNPDVSMRVIKSFLY 139

Query: 887 DVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR----VADYCL------------HRL 930
            +  G+N+ H  R   H +LK  N+LL   D +      + D+ L            H +
Sbjct: 140 QLINGVNFCH-SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI 198

Query: 931 MTQAGTIEQILDAGVLGYRAPE-LAASKKPHPSFKSDVYAFGVILLELLTGR 981
           +T             L YR PE L  S+    S   D+++   I  E+L   
Sbjct: 199 IT-------------LWYRPPEILLGSRHYSTSV--DIWSIACIWAEMLMKT 235

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 43.3 bits (103), Expect = 3e-04
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 31/211 (14%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLR-----EGVAKQ--RKEFAKEAKKFANIRHPNV 834
           E +G  ++G  Y+A    G  + +K +R     EG+     R     E      + HPN+
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-----EISLLKELHHPNI 81

Query: 835 VGLRGYYWGPTQHEKLILS-DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLN 893
           V L            L L  +++    L   L +        L  +Q       + RG+ 
Sbjct: 82  VSLIDVI---HSERCLTLVFEFM-EKDLKKVLDENKT----GLQDSQIKIYLYQLLRGVA 133

Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV--LGYRAP 951
           + H    + H +LK  N+L++  D   ++AD+ L R     G   +     V  L YRAP
Sbjct: 134 HCH-QHRILHRDLKPQNLLIN-SDGALKLADFGLARAF---GIPVRSYTHEVVTLWYRAP 188

Query: 952 E-LAASKKPHPSFKSDVYAFGVILLELLTGR 981
           + L  SKK   S   D+++ G I  E++TG+
Sbjct: 189 DVLMGSKKYSTSV--DIWSIGCIFAEMITGK 217

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 43.3 bits (103), Expect = 3e-04
 Identities = 37/169 (21%), Positives = 67/169 (39%), Gaps = 36/169 (21%)

Query: 828 NIRHPNVVGLRGYYWGPTQHEKLILS-DYISPGSLASFLYDRPGRKGP-PLTWAQRLKIA 885
            ++H N+V L           KL L  +++    L  ++  R     P  L         
Sbjct: 59  ELKHENIVRLYDVI---HTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 886 VDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL------------HRLMTQ 933
             + +GL + H +  + H +LK  N+L++      ++ D+ L              ++T 
Sbjct: 115 WQLLQGLAFCH-ENKILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVT- 171

Query: 934 AGTIEQILDAGVLGYRAPE-LAASKKPHPSFKSDVYAFGVILLELLTGR 981
                       L YRAP+ L  S+    S   D+++ G IL E++TG+
Sbjct: 172 ------------LWYRAPDVLMGSRTYSTSI--DIWSCGCILAEMITGK 206

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 43.0 bits (102), Expect = 3e-04
 Identities = 39/163 (23%), Positives = 67/163 (41%), Gaps = 17/163 (10%)

Query: 824 KKFANIRHPNVVGLRGYYWGPTQHEKLILS---DYISPGSLASFLYDRPGRKGPPLTWAQ 880
           +      HPNVV L           +  L+   +++    L ++L   P    P +    
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTET 121

Query: 881 RLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI 940
              +   + RGL++LH    V H +LK  NIL+       ++AD+ L R+     + +  
Sbjct: 122 IKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTS-SGQIKLADFGLARIY----SFQMA 175

Query: 941 LDAGV--LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           L + V  L YRAPE+            D+++ G I  E+   +
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPV--DLWSVGCIFAEMFRRK 216

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 43.1 bits (102), Expect = 4e-04
 Identities = 50/223 (22%), Positives = 85/223 (38%), Gaps = 54/223 (24%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAK----EAKKFANIRHPNVVG 836
             +G  ++G+   A    +G  + +K L      Q + FAK    E     +++H NV+G
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSR--PFQSEIFAKRAYRELLLLKHMQHENVIG 87

Query: 837 LRGYYWGPTQHEKL----------------ILSDYISPGSLASFLYDRPGRKGPPLTWAQ 880
           L   +   +                     I+    S   +   +Y             Q
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY-------------Q 134

Query: 881 RLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI 940
            L       +GL Y+H    V H +LK  N+ ++  D   ++ D+ L R      T    
Sbjct: 135 ML-------KGLKYIH-SAGVVHRDLKPGNLAVNE-DCELKILDFGLARHADAEMTGY-- 183

Query: 941 LDAGVLG--YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
               V+   YRAPE+  S   H +   D+++ G I+ E+LTG+
Sbjct: 184 ----VVTRWYRAPEVILSWM-HYNQTVDIWSVGCIMAEMLTGK 221

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 43.0 bits (102), Expect = 4e-04
 Identities = 36/177 (20%), Positives = 66/177 (37%), Gaps = 48/177 (27%)

Query: 830 RHPNVVGLRGYYWGPTQHE----------------KLILSDYISPGSLASFLYDRPGRKG 873
           +H N++ +       +                   ++I +  +S   +  F+Y       
Sbjct: 67  KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY------- 119

Query: 874 PPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ 933
                 Q L       R +  LH    V H +LK +N+L++  + + +V D+ L R++ +
Sbjct: 120 ------QTL-------RAVKVLH-GSNVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDE 164

Query: 934 AGTIEQILDAGVLG---------YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           +            G         YRAPE+  +   + S   DV++ G IL EL   R
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY-SRAMDVWSCGCILAELFLRR 220

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 42.7 bits (101), Expect = 4e-04
 Identities = 40/203 (19%), Positives = 76/203 (37%), Gaps = 36/203 (17%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           +VLG   +G   +           +K L++   K R+E     +     + P++V +   
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRA---SQCPHIVRIVDV 79

Query: 841 Y--WGPTQHEKLILSDYISPGSLASFLYDRPGRKGP-PLTWAQRLKIAVDVARGLNYLHF 897
           Y      +   LI+ + +  G     L+ R   +G    T  +  +I   +   + YLH 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 134

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASK 957
              + H ++K  N+L      NA +                ++ D G     A E   + 
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAIL----------------KLTDFGF----AKET--TG 172

Query: 958 KPHPSFKSDVYAFGVILLELLTG 980
           + +     D+++ GVI+  LL G
Sbjct: 173 EKY-DKSCDMWSLGVIMYILLCG 194

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 42.6 bits (101), Expect = 5e-04
 Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 45/220 (20%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAK-----EAKKFANIRHPNVV 835
           + LG     T Y+A        + +K ++ G   + K+        E K    + HPN++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75

Query: 836 GLRGYYWGPTQHEKLILS-DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
           GL   +        + L  D++    L   + D        LT +      +   +GL Y
Sbjct: 76  GLLDAF---GHKSNISLVFDFM-ETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEY 127

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCL------------HRLMTQAGTIEQILD 942
           LH    + H +LK  N+LLD  +   ++AD+ L            H+++T          
Sbjct: 128 LH-QHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVT---------- 175

Query: 943 AGVLGYRAPE-LAASKKPHPSFKSDVYAFGVILLELLTGR 981
                YRAPE L  ++        D++A G IL ELL   
Sbjct: 176 ---RWYRAPELLFGARMYGVGV--DMWAVGCILAELLLRV 210

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 42.4 bits (100), Expect = 7e-04
 Identities = 20/93 (21%), Positives = 43/93 (46%), Gaps = 6/93 (6%)

Query: 890 RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT-IEQILDAGVLGY 948
           R + ++H    + H ++K  N+L++  D   ++ D+   + +  +   +  I       Y
Sbjct: 152 RAVGFIH-SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC---SRFY 207

Query: 949 RAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           RAPEL        +   D+++ G +  EL+ G+
Sbjct: 208 RAPELMLGAT-EYTPSIDLWSIGCVFGELILGK 239

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 41.7 bits (99), Expect = 8e-04
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 31/211 (14%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLR-----EGVAKQ--RKEFAKEAKKFANIRHPNV 834
           E +G  ++G  Y+A    G    +K +R     EG+     R     E      ++H N+
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-----EISILKELKHSNI 62

Query: 835 VGLRGYYWGPTQHEKLILS-DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLN 893
           V L          ++L+L  +++    L   L    G     L         + +  G+ 
Sbjct: 63  VKLYDVI---HTKKRLVLVFEHLD-QDLKKLLDVCEG----GLESVTAKSFLLQLLNGIA 114

Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV--LGYRAP 951
           Y H DR V H +LK  N+L++  +   ++AD+ L R     G   +     +  L YRAP
Sbjct: 115 YCH-DRRVLHRDLKPQNLLIN-REGELKIADFGLARAF---GIPVRKYTHEIVTLWYRAP 169

Query: 952 E-LAASKKPHPSFKSDVYAFGVILLELLTGR 981
           + L  SKK   +   D+++ G I  E++ G 
Sbjct: 170 DVLMGSKKYSTTI--DIWSVGCIFAEMVNGT 198

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 41.8 bits (99), Expect = 9e-04
 Identities = 48/221 (21%), Positives = 80/221 (36%), Gaps = 51/221 (23%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR----EGVAKQ--RKEFAKEAKKFANIRHPNV 834
           + LG  ++ T Y+         + +K +R    EG      R     E     +++H N+
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-----EVSLLKDLKHANI 62

Query: 835 VGLRGYYWGPTQHEKLILS-DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLN 893
           V L          + L L  +Y+    L  +L D        +           + RGL 
Sbjct: 63  VTLHDII---HTEKSLTLVFEYLD-KDLKQYLDDCGN----IINMHNVKLFLFQLLRGLA 114

Query: 894 YLHFDRAVPHGNLKATNILLDGPDLNARVADYCL------------HRLMTQAGTIEQIL 941
           Y H  + V H +LK  N+L++      ++AD+ L            + ++T         
Sbjct: 115 YCH-RQKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVT--------- 163

Query: 942 DAGVLGYRAPE-LAASKKPHPSFKSDVYAFGVILLELLTGR 981
               L YR P+ L  S         D++  G I  E+ TGR
Sbjct: 164 ----LWYRPPDILLGSTDYSTQI--DMWGVGCIFYEMATGR 198

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1060
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-45
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-39
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-38
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-38
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-36
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-36
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-36
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-36
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-35
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-34
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-34
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-34
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-34
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-32
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-32
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-32
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-32
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-32
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-32
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-31
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-31
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-30
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-30
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-30
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-29
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-29
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-29
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-29
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-28
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-27
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-27
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-27
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-25
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-13
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-27
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-27
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-27
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-27
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-26
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-26
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-26
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-26
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-26
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-25
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-05
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	0.003
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-25
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-25
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-24
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-24
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-23
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-23
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-23
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-22
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-22
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-08
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-21
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-20
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-20
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-20
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-20
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-13
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-18
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-16
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.003
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-09
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-08
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	3e-07
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	5e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	8e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	9e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	7e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	7e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	6e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	3e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 8e-45
 Identities = 64/282 (22%), Positives = 121/282 (42%), Gaps = 28/282 (9%)

Query: 782  EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
            + +G  S GT Y+      + + +  +     +Q + F  E       RH N++   GY 
Sbjct: 14   QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 842  WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
               T  +  I++ +    SL   L+    +        + + IA   A+G++YLH  +++
Sbjct: 74   ---TAPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHA-KSI 125

Query: 902  PHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD-AGVLGYRAPELAASKKPH 960
             H +LK+ NI L   DL  ++ D+ L  + ++     Q    +G + + APE+   +  +
Sbjct: 126  IHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184

Query: 961  P-SFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019
            P SF+SDVYAFG++L EL+TG+            ++  D +   V  G+         + 
Sbjct: 185  PYSFQSDVYAFGIVLYELMTGQLPYS-------NINNRDQIIFMVGRGY---------LS 228

Query: 1020 EMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
              ++       K +  +   C+ +   ERP    I   +  +
Sbjct: 229  PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 1e-39
 Identities = 66/280 (23%), Positives = 114/280 (40%), Gaps = 32/280 (11%)

Query: 782  EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
            E LG    G  +         + VK L++G +     F  EA     ++H  +V L    
Sbjct: 19   ERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 842  WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
               TQ    I+++Y+  GSL  FL       G  LT  + L +A  +A G+ ++  +R  
Sbjct: 78   ---TQEPIYIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIE-ERNY 130

Query: 902  PHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHP 961
             H +L+A NIL+    L+ ++AD+ L RL+       +      + + APE         
Sbjct: 131  IHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG--TF 187

Query: 962  SFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEM 1021
            + KSDV++FG++L E++T             G+   + +Q  +  G+            M
Sbjct: 188  TIKSDVWSFGILLTEIVTHGRIPY------PGMTNPEVIQ-NLERGY-----------RM 229

Query: 1022 VNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
            V P  +   +E+  +   C      +RP    +   L   
Sbjct: 230  VRP--DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 4e-38
 Identities = 61/299 (20%), Positives = 109/299 (36%), Gaps = 32/299 (10%)

Query: 782  EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
            E +G+   G  +R     G  + VK       ++      E  +   +RH N++G     
Sbjct: 9    ESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 842  W--GPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD- 898
                 T  +  ++SDY   GSL  +L          +T    +K+A+  A GL +LH + 
Sbjct: 67   NKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 899  ------RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG---YR 949
                   A+ H +LK+ NIL+   +    +AD  L      A     I     +G   Y 
Sbjct: 121  VGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 950  APELAAS----KKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEG---AGVDLTDWMQL 1002
            APE+       K      ++D+YA G++  E+      G +          +  +D    
Sbjct: 180  APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 1003 KVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
            ++ +          +     +  A + M +   I   C   + + R     I + LS +
Sbjct: 240  EMRKVVCEQKLRPNIPNRWQSCEALRVMAK---IMRECWYANGAARLTALRIKKTLSQL 295

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 8e-38
 Identities = 54/280 (19%), Positives = 104/280 (37%), Gaps = 32/280 (11%)

Query: 782  EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
            + +G    G  +     N   + +K +REG A   ++F +EA+    + HP +V L G  
Sbjct: 11   QEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 842  WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
                Q    ++ +++  G     L D    +         L + +DV  G+ YL  +  V
Sbjct: 70   L--EQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-EACV 122

Query: 902  PHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHP 961
             H +L A N L+   +   +V+D+ + R +              + + +PE+ +  +   
Sbjct: 123  IHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR--Y 179

Query: 962  SFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEM 1021
            S KSDV++FGV++ E+ +               +     ++      G   +   +    
Sbjct: 180  SSKSDVWSFGVLMWEVFSEGKIPY---------ENRSNSEVVEDISTGFRLYKPRLAST- 229

Query: 1022 VNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
                       V  I   C      +RP    +   L+ I
Sbjct: 230  ----------HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-36
 Identities = 62/282 (21%), Positives = 112/282 (39%), Gaps = 37/282 (13%)

Query: 782  EVLGRSSHGTSYRATL-ENGMFLTVKWL--REGVAKQRKEFAKEAKKFANIRHPNVVGLR 838
              +GR S  T Y+    E  + +    L  R+    +R+ F +EA+    ++HPN+V   
Sbjct: 15   IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 839  GYYWGPTQHEK--LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
              +    + +K  +++++ ++ G+L ++L     ++   +           + +GL +LH
Sbjct: 75   DSWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 897  FD-RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAA 955
                 + H +LK  NI + GP  + ++ D  L  L   +     I   G   + APE+  
Sbjct: 130  TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---GTPEFMAPEMYE 186

Query: 956  SKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015
             K        DVYAFG+ +LE+ T                    +  +V  G     FD 
Sbjct: 187  EK---YDESVDVYAFGMCMLEMATSEYPYS-------ECQNAAQIYRRVTSGVKPASFDK 236

Query: 1016 AVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYED 1056
              +PE+              I   CI ++  ER  IK +   
Sbjct: 237  VAIPEVKE------------IIEGCIRQNKDERYSIKDLLNH 266

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-36
 Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 36/280 (12%)

Query: 782  EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
            + +G+   G         G  + VK ++       + F  EA     +RH N+V L G  
Sbjct: 13   QTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 842  WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
                    ++  +Y++ GSL  +L     R    L     LK ++DV   + YL      
Sbjct: 70   VEEKGGLYIVT-EYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLE-GNNF 124

Query: 902  PHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHP 961
             H +L A N+L+   D  A+V+D+ L +  +      +      + + APE    KK   
Sbjct: 125  VHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKK--F 177

Query: 962  SFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEM 1021
            S KSDV++FG++L E+ +              + L D +  +V +G+  D       P+ 
Sbjct: 178  STKSDVWSFGILLWEIYSFGRVPY------PRIPLKDVVP-RVEKGYKMDA------PDG 224

Query: 1022 VNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
              PA  +       +   C     + RP    + E L  I
Sbjct: 225  CPPAVYE-------VMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 3e-36
 Identities = 66/280 (23%), Positives = 113/280 (40%), Gaps = 32/280 (11%)

Query: 782  EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
              LG+   G  +  T      + +K L+ G     + F +EA+    +RH  +V L    
Sbjct: 23   VKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81

Query: 842  WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
               ++    I+++Y+S GSL  FL    G  G  L   Q + +A  +A G+ Y+      
Sbjct: 82   ---SEEPIYIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN-Y 134

Query: 902  PHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHP 961
             H +L+A NIL+   +L  +VAD+ L RL+       +      + + APE A   +   
Sbjct: 135  VHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-- 191

Query: 962  SFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEM 1021
            + KSDV++FG++L EL T         G      + +   L              V    
Sbjct: 192  TIKSDVWSFGILLTELTTK--------GRVPYPGMVNREVLD------------QVERGY 231

Query: 1022 VNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
              P   +  + +  +  +C  +   ERP  + +   L   
Sbjct: 232  RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 7e-36
 Identities = 60/280 (21%), Positives = 110/280 (39%), Gaps = 32/280 (11%)

Query: 782  EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYY 841
            + LG    G            + +K ++EG +    EF +EAK   N+ H  +V L G  
Sbjct: 10   KELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 842  WGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAV 901
                Q    I+++Y++ G L ++L +   R        Q L++  DV   + YL   +  
Sbjct: 69   T--KQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESKQ-F 121

Query: 902  PHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHP 961
             H +L A N L++      +V+D+ L R +        +     + +  PE+    K   
Sbjct: 122  LHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK--F 178

Query: 962  SFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEM 1021
            S KSD++AFGV++ E+ +                 ++  +  +A+G           P +
Sbjct: 179  SSKSDIWAFGVLMWEIYSLGKMPY------ERFTNSETAE-HIAQGLRLYR------PHL 225

Query: 1022 VNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
             +        +V  I   C      ERP  K +  ++  +
Sbjct: 226  ASE-------KVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 7e-36
 Identities = 44/202 (21%), Positives = 89/202 (44%), Gaps = 15/202 (7%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
             LG  + G  ++ +   +G+ +  K +  E     R +  +E +       P +VG  G
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
            ++  +  E  I  +++  GSL   L     +K   +      K+++ V +GL YL    
Sbjct: 72  AFY--SDGEISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
            + H ++K +NIL++      ++ D+ +   +  +     +   G   Y +PE       
Sbjct: 125 KIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGT-- 178

Query: 960 HPSFKSDVYAFGVILLELLTGR 981
           H S +SD+++ G+ L+E+  GR
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGR 200

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-35
 Identities = 48/204 (23%), Positives = 91/204 (44%), Gaps = 13/204 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
             LG  + G  Y+A   E  +    K +     ++ +++  E    A+  HPN+V L   
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           ++   ++   IL ++ + G++ + + +       PLT +Q   +       LNYLH D  
Sbjct: 78  FY--YENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLH-DNK 130

Query: 901 VPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPH 960
           + H +LKA NIL    D + ++AD+ +    T+          G   + APE+   +   
Sbjct: 131 IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCETSK 188

Query: 961 P---SFKSDVYAFGVILLELLTGR 981
                +K+DV++ G+ L+E+    
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIE 212

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  132 bits (332), Expect = 1e-34
 Identities = 68/281 (24%), Positives = 120/281 (42%), Gaps = 32/281 (11%)

Query: 782  EVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
              LG   +G  Y     +  + + VK L+E    + +EF KEA     I+HPN+V L G 
Sbjct: 23   HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 841  YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
                 +    I++++++ G+L  +L +   +    ++    L +A  ++  + YL   + 
Sbjct: 82   CT--REPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLE-KKN 135

Query: 901  VPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPH 960
              H +L A N L+   +   +VAD+ L RLMT             + + APE  A     
Sbjct: 136  FIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--K 192

Query: 961  PSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPE 1020
             S KSDV+AFGV+L E+ T   +         G+DL+   +L              +  +
Sbjct: 193  FSIKSDVWAFGVLLWEIATYGMSPY------PGIDLSQVYEL--------------LEKD 232

Query: 1021 MVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
                  E   ++V  +   C   + S+RP    I++   ++
Sbjct: 233  YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-34
 Identities = 64/302 (21%), Positives = 122/302 (40%), Gaps = 41/302 (13%)

Query: 768  TLTLTPEELSRAPAEVLGRSSHGTSYRATLENG-----MFLTVKWLREGVA-KQRKEFAK 821
            T  + P  ++R   +V+G    G  Y+  L+       + + +K L+ G   KQR +F  
Sbjct: 1    TTEIHPSCVTRQ--KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG 58

Query: 822  EAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQR 881
            EA       H N++  R           +I+++Y+  G+L          K    +  Q 
Sbjct: 59   EAGIMGQFSHHNII--RLEGVISKYKPMMIITEYMENGAL----DKFLREKDGEFSVLQL 112

Query: 882  LKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM--TQAGTIEQ 939
            + +   +A G+ YL  +    H +L A NIL++  +L  +V+D+ L R++      T   
Sbjct: 113  VGMLRGIAAGMKYLA-NMNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTT 170

Query: 940  ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDW 999
                  + + APE  + +K      SDV++FG+++ E++T         GE    +L++ 
Sbjct: 171  SGGKIPIRWTAPEAISYRKFTS--ASDVWSFGIVMWEVMTY--------GERPYWELSNH 220

Query: 1000 MQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLS 1058
              +K            A+      P        +  + ++C  +  + RP    I   L 
Sbjct: 221  EVMK------------AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268

Query: 1059 SI 1060
             +
Sbjct: 269  KL 270

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-34
 Identities = 69/301 (22%), Positives = 114/301 (37%), Gaps = 38/301 (12%)

Query: 769  LTLTPEELSRAPAEVLGRSSHGTSYRATLEN----GMFLTVKWLREGV-AKQRKEFAKEA 823
            + + P  L     EV+GR   G  Y  TL +     +   VK L       +  +F  E 
Sbjct: 20   VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 79

Query: 824  KKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLK 883
                +  HPNV+ L G     ++   L++  Y+  G L +F+ +         T    + 
Sbjct: 80   IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIG 134

Query: 884  IAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA 943
              + VA+G+ +L   +   H +L A N +LD      +VAD+ L R M            
Sbjct: 135  FGLQVAKGMKFLASKK-FVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKT 192

Query: 944  GVLG---YRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWM 1000
            G      + A E   ++K     KSDV++FGV+L EL+T              V+  D  
Sbjct: 193  GAKLPVKWMALESLQTQKFTT--KSDVWSFGVLLWELMTRGAPPY------PDVNTFDIT 244

Query: 1001 QLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSS 1059
               + +G             ++ P  E     +  + L+C       RP    +   +S+
Sbjct: 245  V-YLLQGR-----------RLLQP--EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290

Query: 1060 I 1060
            I
Sbjct: 291  I 291

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (331), Expect = 3e-34
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 25/231 (10%)

Query: 756 DRLVGELHFLDDTLTLTPEELSRAPAEVLGRSSHGTSYRAT-LENGMFLTVKWLREGVA- 813
           D  V EL F DD     PE+L       +G  S G  Y A  + N   + +K +      
Sbjct: 1   DPDVAELFFKDD-----PEKLFS-DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ 54

Query: 814 --KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGR 871
             ++ ++  KE +    +RHPN +  RG Y    +H   ++ +Y    +           
Sbjct: 55  SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHTAWLVMEYCLGSASDLLE-----V 107

Query: 872 KGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM 931
              PL   +   +     +GL YLH    + H ++KA NILL       ++ D+    +M
Sbjct: 108 HKKPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM 165

Query: 932 TQAGTIEQILDAGVLGYRAPE-LAASKKPHPSFKSDVYAFGVILLELLTGR 981
             A +       G   + APE + A  +     K DV++ G+  +EL   +
Sbjct: 166 APANSF-----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (324), Expect = 2e-33
 Identities = 65/289 (22%), Positives = 118/289 (40%), Gaps = 40/289 (13%)

Query: 782  EVLGRSSHGTSYRATL----ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVG 836
            +V+G    G      L    +  +F+ +K L+ G   KQR++F  EA       HPNV+ 
Sbjct: 32   QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 91

Query: 837  LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
            L            +I+++++  GSL SFL    G+     T  Q + +   +A G+ YL 
Sbjct: 92   L--EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF----TVIQLVGMLRGIAAGMKYLA 145

Query: 897  FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE----QILDAGVLGYRAPE 952
                  H +L A NIL++  +L  +V+D+ L R +    +       +     + + APE
Sbjct: 146  DMN-YVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203

Query: 953  LAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012
                +K      SDV+++G+++ E+++         GE    D+T+   +          
Sbjct: 204  AIQYRKFTS--ASDVWSYGIVMWEVMSY--------GERPYWDMTNQDVIN--------- 244

Query: 1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
               A+  +   P        +  + L C  +  + RP    I   L  +
Sbjct: 245  ---AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  126 bits (318), Expect = 1e-32
 Identities = 68/307 (22%), Positives = 120/307 (39%), Gaps = 54/307 (17%)

Query: 782  EVLGRSSHGTSYRATL------ENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNV 834
              +G  + G  ++A        E    + VK L+ E  A  + +F +EA   A   +PN+
Sbjct: 19   RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 835  VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRK-------------------GPP 875
            V  +            +L +Y++ G L  FL                           PP
Sbjct: 79   V--KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136

Query: 876  LTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG 935
            L+ A++L IA  VA G+ YL   + V H +L   N L+   ++  ++AD+ L R +  A 
Sbjct: 137  LSCAEQLCIARQVAAGMAYLSERKFV-HRDLATRNCLVGE-NMVVKIADFGLSRNIYSAD 194

Query: 936  TIEQIL-DAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGV 994
              +    DA  + +  PE         + +SDV+A+GV+L E+ +             G+
Sbjct: 195  YYKADGNDAIPIRWMPPESI--FYNRYTTESDVWAYGVVLWEIFSYGLQPY------YGM 246

Query: 995  DLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTI 1053
               + +   V +G+   C      PE           E+  +   C  +  ++RP   +I
Sbjct: 247  AHEEVIY-YVRDGNILAC------PENCPL-------ELYNLMRLCWSKLPADRPSFCSI 292

Query: 1054 YEDLSSI 1060
            +  L  +
Sbjct: 293  HRILQRM 299

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 1e-32
 Identities = 47/207 (22%), Positives = 81/207 (39%), Gaps = 12/207 (5%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLR 838
             +G  S+G   +     +G  L  K L  G     +++    E      ++HPN+V   
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH-- 896
                 T     I+ +Y   G LAS +  +  ++   L     L++   +   L   H  
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALKECHRR 128

Query: 897 --FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELA 954
                 V H +LK  N+ LDG   N ++ D+ L R++    +  +    G   Y +PE  
Sbjct: 129 SDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQM 186

Query: 955 ASKKPHPSFKSDVYAFGVILLELLTGR 981
                  + KSD+++ G +L EL    
Sbjct: 187 NRMS--YNEKSDIWSLGCLLYELCALM 211

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-32
 Identities = 55/284 (19%), Positives = 111/284 (39%), Gaps = 38/284 (13%)

Query: 784  LGRSSHGTSYRATL---ENGMFLTVKWLREGVAK-QRKEFAKEAKKFANIRHPNVVGLRG 839
            LG  + G+  +      +  + + +K L++G  K   +E  +EA+    + +P +V L G
Sbjct: 17   LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 840  YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
                      +++ +    G L  FL  +       +  +   ++   V+ G+ YL   +
Sbjct: 77   VCQA---EALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEE-K 128

Query: 900  AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV--LGYRAPELAASK 957
               H +L A N+LL      A+++D+ L + +    +      AG   L + APE    +
Sbjct: 129  NFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187

Query: 958  KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017
            K     +SDV+++GV + E L+              +   + M   + +G   +C     
Sbjct: 188  KFSS--RSDVWSYGVTMWEALSYGQK------PYKKMKGPEVMA-FIEQGKRMEC----- 233

Query: 1018 MPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
             P    P       E+  +   C      +RP   T+ + + + 
Sbjct: 234  -PPECPP-------ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  127 bits (320), Expect = 2e-32
 Identities = 43/202 (21%), Positives = 90/202 (44%), Gaps = 13/202 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           E LG  + G  +R T    G     K++       ++   KE +  + +RHP +V L   
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           +     +E +++ +++S G L   + D   +    ++  + ++    V +GL ++H +  
Sbjct: 92  FE--DDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMH-ENN 144

Query: 901 VPHGNLKATNILLDGP-DLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
             H +LK  NI+         ++ D+ L   +    +++     G   + APE+A  K  
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKP- 201

Query: 960 HPSFKSDVYAFGVILLELLTGR 981
              + +D+++ GV+   LL+G 
Sbjct: 202 -VGYYTDMWSVGVLSYILLSGL 222

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 6e-32
 Identities = 58/286 (20%), Positives = 105/286 (36%), Gaps = 39/286 (13%)

Query: 782  EVLGRSSHGTSYRATL----ENGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVG 836
              +G    G  ++          + + +K  +   +   R++F +EA       HP++V 
Sbjct: 13   RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 837  LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
            L G     T++   I+ +  + G L SFL  R       L  A  +  A  ++  L YL 
Sbjct: 73   LIGVI---TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLE 125

Query: 897  FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
              +   H ++ A N+L+   D   ++ D+ L R M  +   +       + + APE    
Sbjct: 126  -SKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 957  KKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQL-KVAEGHGSDCFDA 1015
            ++      SDV+ FGV + E+L          G      + +   + ++  G        
Sbjct: 184  RRFTS--ASDVWMFGVCMWEILMH--------GVKPFQGVKNNDVIGRIENGERLP---- 229

Query: 1016 AVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
              MP    P           +  +C     S RP    +   LS+I
Sbjct: 230  --MPPNCPPTLYS-------LMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (311), Expect = 9e-32
 Identities = 41/201 (20%), Positives = 86/201 (42%), Gaps = 14/201 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           E +G+ + GT Y A  +  G  + ++ +      +++    E       ++PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           Y      E  ++ +Y++ GSL   + +            Q   +  +  + L +LH    
Sbjct: 86  YL--VGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEFLH-SNQ 136

Query: 901 VPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPH 960
           V H ++K+ NILL   D + ++ D+     +T   +    +  G   + APE+   K   
Sbjct: 137 VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRK--A 192

Query: 961 PSFKSDVYAFGVILLELLTGR 981
              K D+++ G++ +E++ G 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 4e-31
 Identities = 44/203 (21%), Positives = 80/203 (39%), Gaps = 13/203 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           + LG  ++G    A        + VK +  +      +   KE      + H NVV   G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
           +      + + +  +Y S G L   +          +      +    +  G+ YLH   
Sbjct: 71  HRREG--NIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLH-GI 122

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD-AGVLGYRAPELAASKK 958
            + H ++K  N+LLD    N +++D+ L  +         +    G L Y APEL   ++
Sbjct: 123 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 959 PHPSFKSDVYAFGVILLELLTGR 981
            H +   DV++ G++L  +L G 
Sbjct: 182 FH-AEPVDVWSCGIVLTAMLAGE 203

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 4e-31
 Identities = 54/287 (18%), Positives = 102/287 (35%), Gaps = 42/287 (14%)

Query: 783  VLGRSSHGTSYRATLEN---GMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGL 837
             LG  + GT  +   +       + VK L+        + E   EA     + +P +V +
Sbjct: 14   ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 838  RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
             G     +    +++ +    G L  +L      +   +     +++   V+ G+ YL  
Sbjct: 74   IGICEAES---WMLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLEE 125

Query: 898  DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV--LGYRAPELAA 955
                 H +L A N+LL      A+++D+ L + +       +    G   + + APE   
Sbjct: 126  -SNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 956  SKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014
              K     KSDV++FGV++ E  + G+     + G          +   + +G    C  
Sbjct: 184  YYKFSS--KSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGERMGC-- 231

Query: 1015 AAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
                P            E+  +   C    V  RPG   +   L + 
Sbjct: 232  ----PAGCPR-------EMYDLMNLCWTYDVENRPGFAAVELRLRNY 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 4e-30
 Identities = 64/296 (21%), Positives = 119/296 (40%), Gaps = 45/296 (15%)

Query: 782  EVLGRSSHGTSYRATLENG---MFLTVKWLREGVAKQ-RKEFAKEAKKFANI-RHPNVVG 836
            +V+G  + G   +A ++     M   +K ++E  +K   ++FA E +    +  HPN++ 
Sbjct: 16   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75

Query: 837  LRGYYWGPTQHEKLILSDYISPGSLASFLYDRP-----------GRKGPPLTWAQRLKIA 885
            L G           +  +Y   G+L  FL                     L+  Q L  A
Sbjct: 76   LLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133

Query: 886  VDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV 945
             DVARG++YL   +   H +L A NIL+   +  A++AD+ L R       +++ +    
Sbjct: 134  ADVARGMDYLS-QKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEV--YVKKTMGRLP 189

Query: 946  LGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA 1005
            + + A E         +  SDV+++GV+L E+++             G+   +  + K+ 
Sbjct: 190  VRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPY------CGMTCAELYE-KLP 240

Query: 1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
            +G+  +       P   +        EV  +  +C      ERP    I   L+ +
Sbjct: 241  QGYRLE------KPLNCDD-------EVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 6e-30
 Identities = 45/204 (22%), Positives = 84/204 (41%), Gaps = 18/204 (8%)

Query: 782 EVLGRSSHGTSYRATL-ENGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGL 837
             LG+   G  Y A   ++   L +K L +     A    +  +E +  +++RHPN++ L
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
            GY+         ++ +Y   G++   L     +K       +      ++A  L+Y H 
Sbjct: 72  YGYFH--DATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH- 123

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASK 957
            + V H ++K  N+LL       ++AD+        +         G L Y  PE+   +
Sbjct: 124 SKRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLC---GTLDYLPPEMIEGR 179

Query: 958 KPHPSFKSDVYAFGVILLELLTGR 981
                 K D+++ GV+  E L G+
Sbjct: 180 MH--DEKVDLWSLGVLCYEFLVGK 201

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 8e-30
 Identities = 63/302 (20%), Positives = 111/302 (36%), Gaps = 48/302 (15%)

Query: 782  EVLGRSSHGTSYRATL------ENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANI-RHPN 833
            + LG  + G    AT       +  M + VK L+      +R+    E K  + +  H N
Sbjct: 29   KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 834  VVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGR-------------KGPPLTWAQ 880
            +V L G          L++++Y   G L +FL  +                    L    
Sbjct: 89   IVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 881  RLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT-IEQ 939
             L  +  VA+G+ +L   +   H +L A NILL       ++ D+ L R +      + +
Sbjct: 147  LLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVK 204

Query: 940  ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDW 999
                  + + APE   +     +F+SDV+++G+ L EL +   +         G+ +   
Sbjct: 205  GNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPY------PGMPVDSK 256

Query: 1000 MQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLS 1058
                + EG             M++P  E    E+  I   C      +RP  K I + + 
Sbjct: 257  FYKMIKEG-----------FRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

Query: 1059 SI 1060
              
Sbjct: 304  KQ 305

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  119 bits (299), Expect = 1e-29
 Identities = 36/202 (17%), Positives = 83/202 (41%), Gaps = 13/202 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           E LG  + G  +R      G     K++       +     E      + HP ++ L   
Sbjct: 35  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           +    ++E +++ +++S G L   +      +   ++ A+ +        GL ++H + +
Sbjct: 95  FE--DKYEMVLILEFLSGGELFDRIA----AEDYKMSEAEVINYMRQACEGLKHMH-EHS 147

Query: 901 VPHGNLKATNILLDGP-DLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
           + H ++K  NI+ +     + ++ D+ L   +     ++         + APE+   +  
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREP- 204

Query: 960 HPSFKSDVYAFGVILLELLTGR 981
              F +D++A GV+   LL+G 
Sbjct: 205 -VGFYTDMWAIGVLGYVLLSGL 225

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 3e-29
 Identities = 61/286 (21%), Positives = 102/286 (35%), Gaps = 40/286 (13%)

Query: 782  EVLGRSSHGTSYRATLE----NGMFLTVKWLREGVAKQ---RKEFAKEAKKFANIRHPNV 834
            E LG  S G   R   +      + + VK L+  V  Q     +F +E     ++ H N+
Sbjct: 14   EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 835  VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
            + L G    P      ++++    GS    L DR  +           + AV VA G+ Y
Sbjct: 74   IRLYGVVLTPPMK---MVTELAPLGS----LLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 895  LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD--AGVLGYRAPE 952
            L   +   H +L A N+LL       ++ D+ L R + Q      + +       + APE
Sbjct: 127  LE-SKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 953  LAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012
               ++    S  SD + FGV L E+ T                     Q      +GS  
Sbjct: 185  SLKTR--TFSHASDTWMFGVTLWEMFTYG-------------------QEPWIGLNGSQI 223

Query: 1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDL 1057
                       P  E   +++  + ++C      +RP    + + L
Sbjct: 224  LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 6e-29
 Identities = 59/306 (19%), Positives = 109/306 (35%), Gaps = 53/306 (17%)

Query: 782  EVLGRSSHGTSYRATLEN------GMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPN 833
            +VLG  + G    AT          + + VK L+E   + +R+    E K    +  H N
Sbjct: 43   KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 834  VVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGR------------------KGPP 875
            +V L G           ++ +Y   G L ++L  +  +                      
Sbjct: 103  IVNLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 876  LTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR-LMTQA 934
            LT+   L  A  VA+G+ +L   ++  H +L A N+L+       ++ D+ L R +M+ +
Sbjct: 161  LTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLVTH-GKVVKICDFGLARDIMSDS 218

Query: 935  GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGV 994
              + +      + + APE         + KSDV+++G++L E+ +             G+
Sbjct: 219  NYVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILLWEIFSLGVNPY------PGI 270

Query: 995  DLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTI 1053
             +       +  G   D       P            E+  I   C      +RP    +
Sbjct: 271  PVDANFYKLIQNGFKMDQ------PFYATE-------EIYIIMQSCWAFDSRKRPSFPNL 317

Query: 1054 YEDLSS 1059
               L  
Sbjct: 318  TSFLGC 323

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 9e-29
 Identities = 64/299 (21%), Positives = 113/299 (37%), Gaps = 43/299 (14%)

Query: 782  EVLGRSSHGTSYRAT------LENGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNV 834
            + LGR + G    A             + VK L+EG    + +    E K   +I H   
Sbjct: 19   KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 835  VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGP-----------PLTWAQRLK 883
            V              +++ ++   G+L+++L  +     P            LT    + 
Sbjct: 79   VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 884  IAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA 943
             +  VA+G+ +L   R   H +L A NILL       ++ D+ L R + +     +  DA
Sbjct: 139  YSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 944  -GVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQL 1002
               L + APE    +    + +SDV++FGV+L E+ +   +         GV + +    
Sbjct: 197  RLPLKWMAPETIFDRV--YTIQSDVWSFGVLLWEIFSLGASPY------PGVKIDEEFCR 248

Query: 1003 KVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
            ++ EG           P+   P       E+    L C     S+RP    + E L ++
Sbjct: 249  RLKEGTRMRA------PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 3e-28
 Identities = 58/287 (20%), Positives = 108/287 (37%), Gaps = 39/287 (13%)

Query: 782  EVLGRSSHGTSYRATL-----ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVV 835
            +VLG  + GT Y+        +  + + +K LRE    K  KE   EA   A++ +P+V 
Sbjct: 15   KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 836  GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
             L G           +++  +  G     L D        +     L   V +A+G+NYL
Sbjct: 75   RLLGIC---LTSTVQLITQLMPFGC----LLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 896  HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA-GVLGYRAPELA 954
               R + H +L A N+L+     + ++ D+ L +L+               + + A E  
Sbjct: 128  ED-RRLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 955  ASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014
              +    + +SDV+++GV + EL+T                       K  +G  +    
Sbjct: 186  LHRI--YTHQSDVWSYGVTVWELMTFGS--------------------KPYDGIPASEIS 223

Query: 1015 AAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
            + +      P       +V  I ++C       RP  + +  + S +
Sbjct: 224  SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 1e-27
 Identities = 35/202 (17%), Positives = 75/202 (37%), Gaps = 14/202 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
           E LGR   G  +R     +      K+++      +    KE       RH N++ L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHES 69

Query: 841 YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
           +   +  E +++ ++IS   +   +          L   + +     V   L +LH    
Sbjct: 70  FE--SMEELVMIFEFISGLDIFERIN----TSAFELNEREIVSYVHQVCEALQFLH-SHN 122

Query: 901 VPHGNLKATNILLDGP-DLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
           + H +++  NI+         ++ ++   R +        +       Y APE+   +  
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVH--QHD 178

Query: 960 HPSFKSDVYAFGVILLELLTGR 981
             S  +D+++ G ++  LL+G 
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGI 200

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  110 bits (277), Expect = 3e-27
 Identities = 46/204 (22%), Positives = 80/204 (39%), Gaps = 16/204 (7%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
           +VLG  +      A        + +K +  + +  +      E      I+HPN+V L  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
            Y   +     ++   +S G L   +      +    T     ++   V   + YLH D 
Sbjct: 75  IYE--SGGHLYLIMQLVSGGELFDRI-----VEKGFYTERDASRLIFQVLDAVKYLH-DL 126

Query: 900 AVPHGNLKATNILLDGPDLNARV--ADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASK 957
            + H +LK  N+L    D ++++  +D+ L ++      +      G  GY APE+ A K
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVLAQK 184

Query: 958 KPHPSFKSDVYAFGVILLELLTGR 981
               S   D ++ GVI   LL G 
Sbjct: 185 --PYSKAVDCWSIGVIAYILLCGY 206

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  112 bits (281), Expect = 3e-27
 Identities = 69/397 (17%), Positives = 131/397 (32%), Gaps = 32/397 (8%)

Query: 91  SNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLA 150
           + L+  +K  +   +++  +     D   +  L        S    G+  L +L  ++ +
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 74

Query: 151 GNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGF 210
            N  + + P  +  L  +  + +++N  +   P A       + L  +       +    
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 211 ELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLN 270
            L      L+   N +                           ++   L  L  S   ++
Sbjct: 133 NL----NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188

Query: 271 LSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIP 330
                               NL+ L  + NQ++   P    +  L  L L+ N+      
Sbjct: 189 DISVL-----------AKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDIGT 236

Query: 331 NDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLS 390
              L      LTDLDL+ N +S    +   T L  L L +N ++   PL   +       
Sbjct: 237 LASLTN----LTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292

Query: 391 NNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVII 450
           N     ++S I    N+ YL L  N+++   P       +L  L  ++N +S      + 
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD--VSSLA 348

Query: 451 QYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADN 487
               +  L    N +    LT L N + + +L L D 
Sbjct: 349 NLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  105 bits (263), Expect = 8e-25
 Identities = 75/384 (19%), Positives = 136/384 (35%), Gaps = 34/384 (8%)

Query: 70  NVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNL 129
            +A  +   LG +   D    ++L  +  L      I  +  D +    +L  ++ S+N 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ 77

Query: 130 FSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQS------LDLSHNSFSGSLP 183
            +   P  +  L  L ++ +  N  + + P +    ++  +       D+       +L 
Sbjct: 78  LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135

Query: 184 PALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLD-------FHGNKLDGHLDGEFFL 236
                 N +  ++  S   S +       +  L+ L           +            
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195

Query: 237 LTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLD 296
           LTN   +  + N     +    L  L      L+L+ NQL       G L    NL  LD
Sbjct: 196 LTNLESLIATNNQISDITPLGILTNL----DELSLNGNQLKDI----GTLASLTNLTDLD 247

Query: 297 LSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVS 356
           L+ NQ++  L   + + +L  LKL  N+ S   P   L       T+L+L+ N L     
Sbjct: 248 LANNQISN-LAPLSGLTKLTELKLGANQISNISPLAGLTAL----TNLELNENQLEDISP 302

Query: 357 MILSTNLHMLNLSSNGLTGELPLLT-GSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRN 415
           +    NL  L L  N ++   P+ +      L  +NN+    +S +    NI +L    N
Sbjct: 303 ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHN 361

Query: 416 HLTGSIPEETPQFLRLNHLNLSHN 439
            ++   P       R+  L L+  
Sbjct: 362 QISDLTPLA--NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  100 bits (249), Expect = 4e-23
 Identities = 79/397 (19%), Positives = 139/397 (35%), Gaps = 36/397 (9%)

Query: 141 LESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN 200
           L       L   N +  +  S + L  + +L         S+   +  LNNL  +N S+N
Sbjct: 21  LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 76

Query: 201 GFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP 260
             +   P     +  L  L       +   D                N  +         
Sbjct: 77  QLTDITP-----LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 261 GLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKL 320
                ++  + +++ ++         QL           NQ+T   P  N     ++   
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSF--------GNQVTDLKPLANLTTLERLDIS 183

Query: 321 SNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTG--ELP 378
           SN      +   L   +S     L  + N +S    + + TNL  L+L+ N L     L 
Sbjct: 184 SNKVSDISVLAKLTNLES-----LIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLA 238

Query: 379 LLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSH 438
            LT +   LDL+NNQ    L+ +     +  L L  N ++   P            NL  
Sbjct: 239 SLT-NLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISNISPLAGLT----ALTNLEL 292

Query: 439 NSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPP 498
           N         I   + L  L L FN++    ++ + + + LQ L  A+N ++ V   +  
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSDVSSLA-- 348

Query: 499 SVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGN 535
           +++N+  L   HN+++   P  L +LT +  L L   
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 90.8 bits (224), Expect = 8e-20
 Identities = 73/383 (19%), Positives = 129/383 (33%), Gaps = 58/383 (15%)

Query: 237 LTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLD 296
           L               + SQ  L      V  L      +  S+     ++   NL  ++
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQTDL----DQVTTLQADRLGIK-SIDG---VEYLNNLTQIN 72

Query: 297 LSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVS 356
            S NQLT  +     + +L  + ++NN+ +   P   L   + L    +   +       
Sbjct: 73  FSNNQLTD-ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 357 MILSTNLHMLNL-----------------SSNGLTGELPLLTGSCAVLDLSNNQFEGNLS 399
             L+      N                    N +T   PL   +       ++    ++S
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 400 RILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLD 459
            + K  N+E L  + N ++   P      L    L+L+ N L       +     L  LD
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILTNLD--ELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 460 LSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSV------------------- 500
           L+ N +    L  L   + L EL L  N ++ +   +  +                    
Sbjct: 248 LANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305

Query: 501 -SNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQN 559
             NL  L L  N ++   P  + SLT L+ L  A N +S    +S+AN+T+++ L    N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361

Query: 560 HFTGPLP-NNLPNSLETFNVSYN 581
             +   P  NL   +    ++  
Sbjct: 362 QISDLTPLANLTR-ITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 81.2 bits (199), Expect = 9e-17
 Identities = 67/369 (18%), Positives = 127/369 (34%), Gaps = 59/369 (15%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLK 319
             L++ ++   L    +T ++         + +  L      +   + G  ++  L  + 
Sbjct: 19  TALAEKMK-TVLGKTNVTDTV----SQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQIN 72

Query: 320 LSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTG---- 375
            SNN+ +   P   L      L D+ ++ N ++    +   TNL  L L +N +T     
Sbjct: 73  FSNNQLTDITPLKNLTK----LVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128

Query: 376 --------------ELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSI 421
                          +  ++    +  L    F   ++ +    N+  L+          
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188

Query: 422 PEETPQFLRLNH-LNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQ 480
                  L     L  ++N +S   P  I     L  L L+ N L       L + + L 
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKDI--GTLASLTNLT 244

Query: 481 ELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFP--------------------DR 520
           +L LA+N ++ +   S   ++ L  L L  N+++   P                      
Sbjct: 245 DLDLANNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP 302

Query: 521 LGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLP-NNLPNSLETFNVS 579
           + +L  L  L L  NNIS   P  ++++T L  L  + N  +      NL N +   +  
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSLANLTN-INWLSAG 359

Query: 580 YNDFSGAVP 588
           +N  S   P
Sbjct: 360 HNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 70.4 bits (171), Expect = 3e-13
 Identities = 42/176 (23%), Positives = 66/176 (37%), Gaps = 29/176 (16%)

Query: 45  NSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNN 104
              N + +  +G      G + +  N+  + L N  +S   +L+  S L+ L +L +  N
Sbjct: 217 ILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQIS---NLAPLSGLTKLTELKLGAN 273

Query: 105 SISGVIP--------------------DNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESL 144
            IS + P                      I + K+L +L +  N  S   P  +  L  L
Sbjct: 274 QISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKL 331

Query: 145 QNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN 200
           Q L  A N  S     S++ L +I  L   HN  S   P  L  L  +  L L+  
Sbjct: 332 QRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 5e-27
 Identities = 54/293 (18%), Positives = 104/293 (35%), Gaps = 40/293 (13%)

Query: 782  EVLGRSSHGTSYRATL------ENGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNV 834
              LG+ S G  Y          E    + +K + E  + ++R EF  EA         +V
Sbjct: 26   RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 835  VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGR-----KGPPLTWAQRLKIAVDVA 889
            V  R           L++ + ++ G L S+L              P + ++ +++A ++A
Sbjct: 86   V--RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 890  RGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA-GVLGY 948
             G+ YL+      H +L A N ++   D   ++ D+ + R + +     +       + +
Sbjct: 144  DGMAYLN-ANKFVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201

Query: 949  RAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008
             +PE            SDV++FGV+L E+ T          E     L++   L+     
Sbjct: 202  MSPESLKDGVFTT--YSDVWSFGVVLWEIATL--------AEQPYQGLSNEQVLR----- 246

Query: 1009 GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLSSI 1060
                    VM   +    +     +  +   C   +   RP    I   +   
Sbjct: 247  -------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  109 bits (273), Expect = 6e-27
 Identities = 50/215 (23%), Positives = 82/215 (38%), Gaps = 26/215 (12%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR---------EGVAKQRKEFAKEAKKFANIR- 830
           E+LGR       R           VK +          E V + R+   KE      +  
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 831 HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVAR 890
           HPN++ L       T     ++ D +  G L  +L      +   L+  +  KI   +  
Sbjct: 69  HPNIIQL--KDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRKIMRALLE 121

Query: 891 GLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRA 950
            +  LH    + H +LK  NILLD  D+N ++ D+     +     + ++   G   Y A
Sbjct: 122 VICALH-KLNIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEKLREV--CGTPSYLA 177

Query: 951 PELAAS----KKPHPSFKSDVYAFGVILLELLTGR 981
           PE+         P    + D+++ GVI+  LL G 
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 6e-27
 Identities = 47/214 (21%), Positives = 93/214 (43%), Gaps = 15/214 (7%)

Query: 773 PEELSRAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRH 831
           P+E+S    +V+G  S G  Y+A L ++G  + +K +     + ++   +E +    + H
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDH 72

Query: 832 PNVVGLRGYYWGPTQHEKL----ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVD 887
            N+V LR +++   + +      ++ DY+         +    R    L           
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY--SRAKQTLPVIYVKLYMYQ 130

Query: 888 VARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG 947
           + R L Y+H    + H ++K  N+LLD      ++ D+   + + +       + +    
Sbjct: 131 LFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--Y 187

Query: 948 YRAPELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           YRAPEL      + +   DV++ G +L ELL G+
Sbjct: 188 YRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 220

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 7e-27
 Identities = 65/302 (21%), Positives = 112/302 (37%), Gaps = 49/302 (16%)

Query: 782  EVLGRSSHGTSYRATL--------ENGMFLTVKWLR-EGVAKQRKEFAKEAKKFANI-RH 831
            + LG  + G    A               + VK L+ +   K   +   E +    I +H
Sbjct: 19   KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 832  PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFL-----------YDRPGRKGPPLTWAQ 880
             N++               ++ +Y S G+L  +L           Y+        L+   
Sbjct: 79   KNII--NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 881  RLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ- 939
             +  A  VARG+ YL   +   H +L A N+L+   D   ++AD+ L R +      ++ 
Sbjct: 137  LVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHIDYYKKT 194

Query: 940  ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDW 999
                  + + APE    +    + +SDV++FGV+L E+ T   +         GV + + 
Sbjct: 195  TNGRLPVKWMAPEALFDRI--YTHQSDVWSFGVLLWEIFTLGGSPY------PGVPV-EE 245

Query: 1000 MQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCI-RSVSERPGIKTIYEDLS 1058
            +   + EGH  D       P            E+  +   C     S+RP  K + EDL 
Sbjct: 246  LFKLLKEGHRMD------KPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

Query: 1059 SI 1060
             I
Sbjct: 293  RI 294

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  108 bits (271), Expect = 2e-26
 Identities = 37/288 (12%), Positives = 83/288 (28%), Gaps = 33/288 (11%)

Query: 782  EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGY 840
              +G  S G  Y  T +  G  + +K     V  +  +   E+K +  ++    +    +
Sbjct: 13   RKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 841  YWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA 900
              G      +++ + + P      L D         +    L +A  +   + Y+H  + 
Sbjct: 71   C-GAEGDYNVMVMELLGPS-----LEDLFNFCSRKFSLKTVLLLADQMISRIEYIH-SKN 123

Query: 901  VPHGNLKATNIL--LDGPDLNARVADYCLHRLMTQAGTIEQILD------AGVLGYRAPE 952
              H ++K  N L  L        + D+ L +    A T + I         G   Y +  
Sbjct: 124  FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 953  LAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012
                 +     + D+ + G +L+    G      +             Q           
Sbjct: 184  THLGIEQSR--RDDLESLGYVLMYFNLGSLPWQGLKAA-------TKRQKYERISEKKMS 234

Query: 1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI 1060
                V+ +         +               ++P    + +   ++
Sbjct: 235  TPIEVLCKGYPSEFATYLNFCR------SLRFDDKPDYSYLRQLFRNL 276

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 3e-26
 Identities = 40/204 (19%), Positives = 73/204 (35%), Gaps = 15/204 (7%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRG 839
           +VLG   +G   +           +K     + +   +  +E +      + P++V +  
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVD 72

Query: 840 YYWGPTQHEK--LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
            Y       K  LI+ + +  G L S + DR  +     T  +  +I   +   + YLH 
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLH- 128

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASK 957
              + H ++K  N+L      NA +                         Y APE+   +
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188

Query: 958 KPHPSFKSDVYAFGVILLELLTGR 981
           K       D+++ GVI+  LL G 
Sbjct: 189 K--YDKSCDMWSLGVIMYILLCGY 210

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 4e-26
 Identities = 43/205 (20%), Positives = 77/205 (37%), Gaps = 16/205 (7%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGL 837
           ++LG  S  T   A  L       +K L +       +     +E    + + HP  V L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
              +      +      Y   G L  ++      K              ++   L YLH 
Sbjct: 74  YFTFQ--DDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLH- 125

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILD-AGVLGYRAPELAAS 956
            + + H +LK  NILL+  D++ ++ D+   ++++      +     G   Y +PEL   
Sbjct: 126 GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 957 KKPHPSFKSDVYAFGVILLELLTGR 981
           K       SD++A G I+ +L+ G 
Sbjct: 185 KSA--CKSSDLWALGCIIYQLVAGL 207

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  106 bits (266), Expect = 5e-26
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 17/208 (8%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGL 837
           E+LG       + A  L     + VK LR  +A        F +EA+  A + HP +V +
Sbjct: 13  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72

Query: 838 RGYYWGPTQHEKL--ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
                  T    L  I+ +Y+   +L   +         P+T  + +++  D  + LN+ 
Sbjct: 73  YDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQALNFS 127

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA--GVLGYRAPEL 953
           H    + H ++K  NI++   +   +V D+ + R +  +G       A  G   Y +PE 
Sbjct: 128 H-QNGIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 954 AASKKPHPSFKSDVYAFGVILLELLTGR 981
           A         +SDVY+ G +L E+LTG 
Sbjct: 186 ARGDSVDA--RSDVYSLGCVLYEVLTGE 211

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 8e-26
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 15/206 (7%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQ-RKEFAKEAKKFANIRHPNVVGLRG 839
             +G  ++G    A    N + + +K +     +   +   +E K     RH N++G+  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 840 YYWGPT--QHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
               PT  Q + + L  ++    L   L      K   L+          + RGL Y+H 
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLL------KTQHLSNDHICYFLYQILRGLKYIH- 126

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGV--LGYRAPELAA 955
              V H +LK +N+LL+    + ++ D+ L R+          L   V    YRAPE+  
Sbjct: 127 SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 956 SKKPHPSFKSDVYAFGVILLELLTGR 981
           + K + +   D+++ G IL E+L+ R
Sbjct: 186 NSKGY-TKSIDIWSVGCILAEMLSNR 210

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  105 bits (261), Expect = 3e-25
 Identities = 72/309 (23%), Positives = 125/309 (40%), Gaps = 17/309 (5%)

Query: 23  QDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPSSWNGIVCNGGNVAGVV----LDN 78
           QD  ALL+ KK + N      L+SW   +   D C  +W G++C+       V    L  
Sbjct: 6   QDKQALLQIKKDLGNPT---TLSSWLPTT---DCCNRTWLGVLCDTDTQTYRVNNLDLSG 59

Query: 79  LGLSAAADL-SVFSNLSMLVKLSMSNN-SISGVIPDNIGDFKSLEFLDVSDNLFSSSLPS 136
           L L     + S  +NL  L  L +    ++ G IP  I     L +L ++    S ++P 
Sbjct: 60  LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119

Query: 137 GIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLN 196
            + ++++L  L  + N  SG +P S+S L ++  +    N  SG++P +    + L    
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179

Query: 197 LSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQ 256
             S     R+            L F     +        L  +  +           +  
Sbjct: 180 TISR---NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236

Query: 257 KFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQ 316
               GLS+++  L+L  N++ G+L     L   + L  L++S+N L GE+P    +    
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQ--GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD 294

Query: 317 VLKLSNNRF 325
           V   +NN+ 
Sbjct: 295 VSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 72.5 bits (176), Expect = 4e-14
 Identities = 56/266 (21%), Positives = 88/266 (33%), Gaps = 11/266 (4%)

Query: 310 NFVYELQVLKLSNNRFSGF--IPNDLLKGDSLLLTDLDLSANNLSGSV-SMILSTNLHML 366
              Y +  L LS         IP+ L     L    +    N +     ++   T LH L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 367 NLSSNGLTGELPLLTGSCAVL----DLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIP 422
            ++   ++G +P        L       N         I    N+  +    N ++G+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 423 EETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQEL 482
           +    F +L        +  +           L  +DLS N L+G   + L  S    + 
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDA-SVLFGSDKNTQK 225

Query: 483 HLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLP 542
                              NL  LDL +NR+ G  P  L  L  L  L ++ NN+ G +P
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

Query: 543 TSMANMTSLSSLVISQNHFT--GPLP 566
               N+        + N      PLP
Sbjct: 286 -QGGNLQRFDVSAYANNKCLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 64.0 bits (154), Expect = 2e-11
 Identities = 57/266 (21%), Positives = 104/266 (39%), Gaps = 18/266 (6%)

Query: 360 STNLHMLNLSSNGLTGELPLLTG-------SCAVLDLSNNQFEGNLSRILKWGNIEYLDL 412
           +  ++ L+LS   L    P+ +        +   +   NN        I K   + YL +
Sbjct: 49  TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYI 108

Query: 413 SRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTN 472
           +  +++G+IP+   Q   L  L+ S+N+LS +LP  I     L  +    N + G    +
Sbjct: 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168

Query: 473 LLNSSTLQE-LHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLC 531
             + S L   + ++ N LTG +  +  +++   V    +                     
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN--TQKI 226

Query: 532 LAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPN--SLETFNVSYNDFSGAVPE 589
               N        +    +L+ L +  N   G LP  L     L + NVS+N+  G +P+
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

Query: 590 --NLRKFPSSSFYPGNSKLSFPGGAP 613
             NL++F  S++   N  L    G+P
Sbjct: 287 GGNLQRFDVSAYA-NNKCLC---GSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 58.2 bits (139), Expect = 2e-09
 Identities = 19/67 (28%), Positives = 32/67 (47%), Gaps = 1/67 (1%)

Query: 117 FKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHN 176
            K+L  LD+ +N    +LP G+ +L+ L +L+++ NN  G IP     L        ++N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301

Query: 177 SFSGSLP 183
                 P
Sbjct: 302 KCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 45.1 bits (105), Expect = 3e-05
 Identities = 14/49 (28%), Positives = 25/49 (51%), Gaps = 3/49 (6%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDN--LFSSSLPS 136
            + L  L  L++S N++ G IP   G+ +  +    ++N  L  S LP+
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 38.6 bits (88), Expect = 0.003
 Identities = 33/111 (29%), Positives = 53/111 (47%), Gaps = 5/111 (4%)

Query: 490 TGVLDFSPPSVSNLQVLDLSHNRLNGYF--PDRLGSLTGLKVLCLAGN-NISGSLPTSMA 546
            GVL  +      +  LDLS   L   +  P  L +L  L  L + G  N+ G +P ++A
Sbjct: 39  LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98

Query: 547 NMTSLSSLVISQNHFTGPLP--NNLPNSLETFNVSYNDFSGAVPENLRKFP 595
            +T L  L I+  + +G +P   +   +L T + SYN  SG +P ++   P
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  106 bits (265), Expect = 3e-25
 Identities = 45/208 (21%), Positives = 80/208 (38%), Gaps = 20/208 (9%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQR------KEFAKEAKKFANIRHPNV 834
            ++GR   G  Y     + G    +K L +   K +                +    P +
Sbjct: 10  RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69

Query: 835 VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
           V +   Y   T  +   + D ++ G L   L      +    + A     A ++  GL +
Sbjct: 70  VCM--SYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYAAEIILGLEH 122

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELA 954
           +H +R V + +LK  NILLD    + R++D  L    ++      +   G  GY APE+ 
Sbjct: 123 MH-NRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 177

Query: 955 ASKKPHPSFKSDVYAFGVILLELLTGRC 982
                +    +D ++ G +L +LL G  
Sbjct: 178 QKGVAY-DSSADWFSLGCMLFKLLRGHS 204

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 9e-25
 Identities = 46/203 (22%), Positives = 77/203 (37%), Gaps = 13/203 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQ--RKEFAKEAKKFANIRHPNVVGLR 838
           E +G  ++G  Y+A     G  + +K +R     +       +E      + HPN+V L 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
                     KL L        L  F+          +           + +GL + H  
Sbjct: 68  DVI---HTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCH-S 120

Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK 958
             V H +LK  N+L++  +   ++AD+ L R                L YRAPE+    K
Sbjct: 121 HRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHE-VVTLWYRAPEILLGCK 178

Query: 959 PHPSFKSDVYAFGVILLELLTGR 981
            + S   D+++ G I  E++T R
Sbjct: 179 YY-STAVDIWSLGCIFAEMVTRR 200

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 3e-24
 Identities = 32/209 (15%), Positives = 68/209 (32%), Gaps = 20/209 (9%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR------EGVAKQRKEFAKEAKKFANIR--HP 832
            +LG    G+ Y    + + + + +K +        G          E      +     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 833 NVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGL 892
            V+ L  ++  P     +++ +   P           G     L           V   +
Sbjct: 70  GVIRLLDWFERPDSF--VLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAV 123

Query: 893 NYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPE 952
            + H +  V H ++K  NIL+D      ++ D+    L+      +     G   Y  PE
Sbjct: 124 RHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPE 179

Query: 953 LAASKKPHPSFKSDVYAFGVILLELLTGR 981
                  +    + V++ G++L +++ G 
Sbjct: 180 WIRYH-RYHGRSAAVWSLGILLYDMVCGD 207

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 4e-24
 Identities = 40/203 (19%), Positives = 81/203 (39%), Gaps = 13/203 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQ--RKEFAKEAKKFANIRHPNVVGLR 838
           + +G  ++G    A     G  + +K L      +   K   +E +   ++RH NV+GL 
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
             +           +D+            +  +    L   +   +   + +GL Y+H  
Sbjct: 84  DVFT--PDETLDDFTDFYLVMPFMGTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIH-A 139

Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK 958
             + H +LK  N+ ++  D   ++ D+ L R      T           YRAPE+  +  
Sbjct: 140 AGIIHRDLKPGNLAVN-EDCELKILDFGLARQADSEMTG----YVVTRWYRAPEVILNWM 194

Query: 959 PHPSFKSDVYAFGVILLELLTGR 981
            + +   D+++ G I+ E++TG+
Sbjct: 195 RY-TQTVDIWSVGCIMAEMITGK 216

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 7e-24
 Identities = 47/209 (22%), Positives = 80/209 (38%), Gaps = 18/209 (8%)

Query: 782 EVLGRSSHGTSYRAT--LENGMFLTVKWLR-----EGVAKQRKEFAKEAKKFANIRHPNV 834
             +G  ++G  ++A      G F+ +K +R     EG+           +      HPNV
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 835 VGLRGYYWGPTQHE--KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGL 892
           V L             KL L        L ++L        P +       +   + RGL
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGL 129

Query: 893 NYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPE 952
           ++LH    V H +LK  NIL+       ++AD+ L R+ +    +  +     L YRAPE
Sbjct: 130 DFLH-SHRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSV--VVTLWYRAPE 185

Query: 953 LAASKKPHPSFKSDVYAFGVILLELLTGR 981
           +        +   D+++ G I  E+   +
Sbjct: 186 VLLQSSY--ATPVDLWSVGCIFAEMFRRK 212

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 2e-23
 Identities = 46/206 (22%), Positives = 77/206 (37%), Gaps = 17/206 (8%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLR-----EGVAKQRKEFAKEAKKFANIRHPNVV 835
           + LG     T Y+A        + +K ++     E      +   +E K    + HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 836 GLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
           GL        +    ++ D++                   LT +      +   +GL YL
Sbjct: 64  GL--LDAFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYL 116

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAA 955
           H    + H +LK  N+LLD  +   ++AD+ L +                  YRAPEL  
Sbjct: 117 H-QHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTH-QVVTRWYRAPELLF 173

Query: 956 SKKPHPSFKSDVYAFGVILLELLTGR 981
             + +     D++A G IL ELL   
Sbjct: 174 GARMY-GVGVDMWAVGCILAELLLRV 198

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.4 bits (247), Expect = 4e-23
 Identities = 45/205 (21%), Positives = 89/205 (43%), Gaps = 17/205 (8%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVA---KQRKEFAKEAKKFA-NIRHPNVVG 836
           ++LG+ S G  + A   +   F  +K L++ V       +    E +  +    HP +  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 837 LRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLH 896
           +   +   T+     + +Y++ G L   +     +       ++    A ++  GL +LH
Sbjct: 68  MFCTFQ--TKENLFFVMEYLNGGDLMYHI-----QSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAAS 956
             + + + +LK  NILLD  D + ++AD+ + +              G   Y APE+   
Sbjct: 121 -SKGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTF-CGTPDYIAPEILLG 177

Query: 957 KKPHPSFKSDVYAFGVILLELLTGR 981
           +K +     D ++FGV+L E+L G+
Sbjct: 178 QKYNH--SVDWWSFGVLLYEMLIGQ 200

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 98.7 bits (245), Expect = 4e-23
 Identities = 45/291 (15%), Positives = 87/291 (29%), Gaps = 37/291 (12%)

Query: 782  EVLGRSSHGTSYRAT-LENGMFLTVKWL-REGVAKQRKEFAKEAKKFANIRHPNVVGLRG 839
              +G  S G  +  T L N   + +K+  R   A Q ++  +  K  A       V    
Sbjct: 11   RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV---- 66

Query: 840  YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
            YY+G      +++ D + P        D     G   +       A  +   +  +H ++
Sbjct: 67   YYFGQEGLHNVLVIDLLGPSL-----EDLLDLCGRKFSVKTVAMAAKQMLARVQSIH-EK 120

Query: 900  AVPHGNLKATNILLDGP----DLNARVADYCLHRLMTQAGTIEQILD------AGVLGYR 949
            ++ + ++K  N L+  P         V D+ + +      T + I        +G   Y 
Sbjct: 121  SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 950  APELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHG 1009
            +      ++   S + D+ A G + +  L G            G+      Q     G  
Sbjct: 181  SINTHLGREQ--SRRDDLEALGHVFMYFLRGSLPWQ-------GLKAATNKQKYERIGEK 231

Query: 1010 SDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIRSVSERPGIKTIYEDLSSI 1060
                    +         K M            +    P    +    S +
Sbjct: 232  KQSTPLRELCAGFPEEFYKYMHYARN------LAFDATPDYDYLQGLFSKV 276

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 98.0 bits (243), Expect = 6e-23
 Identities = 42/202 (20%), Positives = 81/202 (40%), Gaps = 13/202 (6%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQ--RKEFAKEAKKFANIRHPNVVGLRG 839
           E +G  ++G  Y+A    G    +K +R     +       +E      ++H N+V L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
                T+   +++ +++                   L         + +  G+ Y H DR
Sbjct: 68  VIH--TKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCH-DR 119

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
            V H +LK  N+L++  +   ++AD+ L R        +   +   L YRAP++    K 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKK 177

Query: 960 HPSFKSDVYAFGVILLELLTGR 981
           + S   D+++ G I  E++ G 
Sbjct: 178 Y-STTIDIWSVGCIFAEMVNGT 198

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 97.2 bits (241), Expect = 2e-22
 Identities = 35/202 (17%), Positives = 77/202 (38%), Gaps = 17/202 (8%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR-HPNVVGLRG 839
             LGR  +   + A  + N   + VK L+     ++K+  +E K   N+R  PN++ L  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLAD 97

Query: 840 YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR 899
               P      ++ ++++                  LT         ++ + L+Y H   
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH-SM 148

Query: 900 AVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKP 959
            + H ++K  N+++D      R+ D+ L                    ++ PEL    + 
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--VASRYFKGPELLVDYQM 206

Query: 960 HPSFKSDVYAFGVILLELLTGR 981
           +  +  D+++ G +L  ++  +
Sbjct: 207 Y-DYSLDMWSLGCMLASMIFRK 227

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 3e-22
 Identities = 46/211 (21%), Positives = 88/211 (41%), Gaps = 22/211 (10%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQ------RKEFAKEAKKFANIRHPNV 834
           E LG        +      G+    K++++   K       R++  +E      I+HPNV
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75

Query: 835 VGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
           + L   Y    + + +++ + ++ G L  FL ++       LT  +  +    +  G+ Y
Sbjct: 76  ITLHEVYE--NKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYY 128

Query: 895 LHFDRAVPHGNLKATNILLD---GPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAP 951
           LH    + H +LK  NI+L     P    ++ D+ L   +      + I   G   + AP
Sbjct: 129 LH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--FGTPEFVAP 185

Query: 952 ELAASKKPHPSFKSDVYAFGVILLELLTGRC 982
           E+   +      ++D+++ GVI   LL+G  
Sbjct: 186 EIVNYE--PLGLEADMWSIGVITYILLSGAS 214

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 96.7 bits (240), Expect = 3e-22
 Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 19/204 (9%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGL 837
             LG  S G  +      NG +  +K L++ +    KQ +    E    + + HP ++ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
            G +      +  ++ DYI  G L S L                   A +V   L YLH 
Sbjct: 70  WGTFQ--DAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH- 121

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASK 957
            + + + +LK  NILLD  + + ++ D+   + +            G   Y APE+ ++K
Sbjct: 122 SKDIIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVTYTL----CGTPDYIAPEVVSTK 176

Query: 958 KPHPSFKSDVYAFGVILLELLTGR 981
               +   D ++FG+++ E+L G 
Sbjct: 177 P--YNKSIDWWSFGILIYEMLAGY 198

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 93.6 bits (231), Expect = 3e-21
 Identities = 52/304 (17%), Positives = 96/304 (31%), Gaps = 27/304 (8%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNN 191
             +P  +        L L  N  + +       L ++ +L L +N  S   P A   L  
Sbjct: 23  EKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80

Query: 192 LVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFV 251
           L  L LS N   +      ++   LQ L  H N++       F  L     ++   N   
Sbjct: 81  LERLYLSKNQLKELPE---KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 137

Query: 252 GSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FN 310
            S  +       + + Y+ ++   +T          L  +L  L L  N++T        
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNITTIPQG-----LPPSLTELHLDGNKITKVDAASLK 192

Query: 311 FVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSS 370
            +  L  L LS N  S      L     L    L+ +   +     +     + ++ L +
Sbjct: 193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN-NNKLVKVPGGLADHKYIQVVYLHN 251

Query: 371 NGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLT-GSIPEETPQFL 429
           N ++              + +N F        K  +   + L  N +    I   T + +
Sbjct: 252 NNISA-------------IGSNDFCP-PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297

Query: 430 RLNH 433
            +  
Sbjct: 298 YVRA 301

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 87.0 bits (214), Expect = 5e-19
 Identities = 52/280 (18%), Positives = 103/280 (36%), Gaps = 15/280 (5%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQVL 318
             L      L+L  N++T   +  G+ +  +NL  L L  N+++   PG F  + +L+ L
Sbjct: 27  KDLPPDTALLDLQNNKITE--IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL 84

Query: 319 KLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELP 378
            LS N+              L + + +++    S    +     + +          E  
Sbjct: 85  YLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 144

Query: 379 LLTG--SCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNL 436
              G    + + +++         +    ++  L L  N +T            L  L L
Sbjct: 145 AFQGMKKLSYIRIADTNITTIPQGLPP--SLTELHLDGNKITKVDAASLKGLNNLAKLGL 202

Query: 437 SHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGV--LD 494
           S NS+S+     +     LR L L+ N L       L +   +Q ++L +N ++ +   D
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 261

Query: 495 FSPPSV----SNLQVLDLSHNRLNGYFPDRLGSLTGLKVL 530
           F PP      ++   + L  N +  Y+  +  +   + V 
Sbjct: 262 FCPPGYNTKKASYSGVSLFSNPVQ-YWEIQPSTFRCVYVR 300

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 85.5 bits (210), Expect = 2e-18
 Identities = 56/284 (19%), Positives = 100/284 (35%), Gaps = 21/284 (7%)

Query: 110 IPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQ 169
           +P ++        LD+ +N  +         L++L  L L  N  S + P + + LV ++
Sbjct: 25  VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 170 SLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGH 229
            L LS N            L  L           K +  G   ++ ++ L  +  K  G 
Sbjct: 83  RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGI 141

Query: 230 LDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLF 289
            +G F  +   S+I  +              GL  S+  L+L  N++T   V+   L+  
Sbjct: 142 ENGAFQGMKKLSYIRIADTNI-----TTIPQGLPPSLTELHLDGNKITK--VDAASLKGL 194

Query: 290 ENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSAN 349
            NL  L LS+N ++    G         L+  +   +  +       D   +  + L  N
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANT--PHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN 252

Query: 350 NLS--------GSVSMILSTNLHMLNLSSNGLT-GELPLLTGSC 384
           N+S                 +   ++L SN +   E+   T  C
Sbjct: 253 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 296

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 83.2 bits (204), Expect = 8e-18
 Identities = 61/314 (19%), Positives = 115/314 (36%), Gaps = 35/314 (11%)

Query: 291 NLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANN 350
           +L+V+  S   L  ++P  +   +  +L L NN+ +     D    +   L  L L  N 
Sbjct: 11  HLRVVQCSDLGLE-KVPK-DLPPDTALLDLQNNKITEIKDGDF--KNLKNLHTLILINNK 66

Query: 351 LSGSVSMILS--TNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEG---NLSRILKWG 405
           +S       +    L  L LS N L      +  +   L +  N+      ++   L   
Sbjct: 67  ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126

Query: 406 NIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL 465
            +  L  +    +G          +L+++ ++  ++++    +      L  L L  N +
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELHLDGNKI 183

Query: 466 DGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLT 525
                 +L   + L +L L+ N ++ V + S  +  +L+ L L++N+L    P  L    
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 242

Query: 526 GLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVSYNDFSG 585
            ++V+ L  NNIS                 I  N F  P  N    S    ++  N    
Sbjct: 243 YIQVVYLHNNNISA----------------IGSNDFCPPGYNTKKASYSGVSLFSN---- 282

Query: 586 AVPENLRKFPSSSF 599
             P    +   S+F
Sbjct: 283 --PVQYWEIQPSTF 294

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 82.8 bits (203), Expect = 1e-17
 Identities = 52/263 (19%), Positives = 93/263 (35%), Gaps = 16/263 (6%)

Query: 96  LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFS 155
              L + NN I+ +   +  + K+L  L + +N  S   P     L  L+ L L+ N   
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 156 GLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSS--NGFSKRIPRGFELI 213
            L         ++Q L +  N  +         LN ++ + L +     S      F+ +
Sbjct: 93  ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149

Query: 214 LGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSL 273
             L  +      +     G   L  + + +   GN      +         ++  L LS 
Sbjct: 150 KKLSYIRIADTNITTIPQG---LPPSLTELHLDGNKITKVDAASLKG--LNNLAKLGLSF 204

Query: 274 NQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDL 333
           N ++   V+ G L    +L+ L L+ N+L     G      +QV+ L NN  S    ND 
Sbjct: 205 NSISA--VDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDF 262

Query: 334 ----LKGDSLLLTDLDLSANNLS 352
                       + + L +N + 
Sbjct: 263 CPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.4 bits (189), Expect = 9e-16
 Identities = 54/274 (19%), Positives = 87/274 (31%), Gaps = 18/274 (6%)

Query: 341 LTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCA---VLDLSNNQFEGN 397
           L  +  S   L   V   L  +  +L+L +N +T        +      L L NN+    
Sbjct: 12  LRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70

Query: 398 LSRIL-KWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLR 456
                     +E L LS+N L     +       L         +  S+   + Q   + 
Sbjct: 71  SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130

Query: 457 VLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGY 516
            L  +     G           L  + +AD  +T +    PP   +L  L L  N++   
Sbjct: 131 -LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPP---SLTELHLDGNKITKV 186

Query: 517 FPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHF-TGPLPNNLPNSLET 575
               L  L  L  L L+ N+IS     S+AN   L  L ++ N     P        ++ 
Sbjct: 187 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQV 246

Query: 576 FNVSYNDFSGAVPENLRKFPSSSFYPGNSKLSFP 609
             +  N        N+    S+ F P        
Sbjct: 247 VYLHNN--------NISAIGSNDFCPPGYNTKKA 272

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 54.3 bits (129), Expect = 3e-08
 Identities = 26/143 (18%), Positives = 46/143 (32%), Gaps = 3/143 (2%)

Query: 476 SSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGN 535
                 L L +N +T + D    ++ NL  L L +N+++   P     L  L+ L L+ N
Sbjct: 30  PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89

Query: 536 NISGSLPTSMANMTSLSSLVISQNHFTGPLPNNLPN-SLETFNVSYNDFSGAVPENLRKF 594
            +          +  L             + N L    +     +    SG      +  
Sbjct: 90  QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149

Query: 595 PSSSFY--PGNSKLSFPGGAPGS 615
              S+      +  + P G P S
Sbjct: 150 KKLSYIRIADTNITTIPQGLPPS 172

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.9 bits (230), Expect = 8e-21
 Identities = 46/204 (22%), Positives = 81/204 (39%), Gaps = 16/204 (7%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGL 837
           ++LG+ + G          G +  +K LR+ V     +      E++   N RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
              Y   T      + +Y + G L   L      +    T  +      ++   L YLH 
Sbjct: 71  --KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLH- 122

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASK 957
            R V + ++K  N++LD  D + ++ D+ L +     G   +    G   Y APE+    
Sbjct: 123 SRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTF-CGTPEYLAPEVLEDN 180

Query: 958 KPHPSFKSDVYAFGVILLELLTGR 981
                   D +  GV++ E++ GR
Sbjct: 181 --DYGRAVDWWGLGVVMYEMMCGR 202

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.2 bits (228), Expect = 1e-20
 Identities = 48/209 (22%), Positives = 88/209 (42%), Gaps = 18/209 (8%)

Query: 782 EVLGRSSHGTSYRATL----ENGMFLTVKWLREGV----AKQRKEFAKEAKKFANIRH-P 832
           +VLG  ++G  +        + G    +K L++      AK  +    E +   +IR  P
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 833 NVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGL 892
            +V L  +Y   T+ +  ++ DYI+ G L + L      +    T  +      ++   L
Sbjct: 90  FLVTL--HYAFQTETKLHLILDYINGGELFTHL-----SQRERFTEHEVQIYVGEIVLAL 142

Query: 893 NYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPE 952
            +LH    + + ++K  NILLD  + +  + D+ L +      T       G + Y AP+
Sbjct: 143 EHLH-KLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 953 LAASKKPHPSFKSDVYAFGVILLELLTGR 981
           +            D ++ GV++ ELLTG 
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 92.2 bits (228), Expect = 1e-20
 Identities = 41/204 (20%), Positives = 74/204 (36%), Gaps = 19/204 (9%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGL 837
           + LG  S G        E+G    +K L +      KQ +    E +    +  P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 838 RGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
              +         ++ +Y++ G + S L      +    +       A  +     YLH 
Sbjct: 107 --EFSFKDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYLH- 158

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASK 957
              + + +LK  N+L+D      +V D+   + +            G     APE+  SK
Sbjct: 159 SLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSK 213

Query: 958 KPHPSFKSDVYAFGVILLELLTGR 981
               +   D +A GV++ E+  G 
Sbjct: 214 --GYNKAVDWWALGVLIYEMAAGY 235

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.8 bits (224), Expect = 2e-20
 Identities = 37/203 (18%), Positives = 75/203 (36%), Gaps = 14/203 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQ--RKEFAKEAKKFANIRHPNVVGLR 838
           E +G  ++GT ++A   E    + +K +R     +       +E      ++H N+V  R
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV--R 65

Query: 839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFD 898
            +    +  +  ++ ++        F                       + +GL + H  
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-----PEIVKSFLFQLLKGLGFCHSR 120

Query: 899 RAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKK 958
             V H +LK  N+L++  +   ++A++ L R                L YR P++    K
Sbjct: 121 N-VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAK 177

Query: 959 PHPSFKSDVYAFGVILLELLTGR 981
            + S   D+++ G I  EL    
Sbjct: 178 LY-STSIDMWSAGCIFAELANAG 199

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 3e-20
 Identities = 42/207 (20%), Positives = 85/207 (41%), Gaps = 10/207 (4%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQ--RKEFAKEAKKFANIRHPNVVGLR 838
             +G+ + G  ++A   + G  + +K +     K+       +E K    ++H NVV L 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 839 GYYW-GPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF 897
                  + + +   S Y+        L           T ++  ++   +  GL Y+H 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135

Query: 898 DRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLG---YRAPELA 954
           ++ + H ++KA N+L+   D   ++AD+ L R  + A   +       +    YR PEL 
Sbjct: 136 NKIL-HRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193

Query: 955 ASKKPHPSFKSDVYAFGVILLELLTGR 981
             ++ +     D++  G I+ E+ T  
Sbjct: 194 LGERDY-GPPIDLWGAGCIMAEMWTRS 219

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 88.9 bits (219), Expect = 2e-19
 Identities = 31/211 (14%), Positives = 69/211 (32%), Gaps = 14/211 (6%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRG- 839
             LG     T + A  + N   + +K +R       +    E K    +   +       
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 840 --------YYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
                         +    +    +      + L      +   +      +I+  +  G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDA-GVLGYRA 950
           L+Y+H    + H ++K  N+L++  D    +    +  L       E   ++     YR+
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 951 PELAASKKPHPSFKSDVYAFGVILLELLTGR 981
           PE+           +D+++   ++ EL+TG 
Sbjct: 198 PEVLLGAPWGC--GADIWSTACLIFELITGD 226

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (214), Expect = 3e-19
 Identities = 62/299 (20%), Positives = 98/299 (32%), Gaps = 19/299 (6%)

Query: 57  CPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVK-LSMSNNSISGVIPDNIG 115
           CP      VC             GL      +V   +    + + +  N IS V   +  
Sbjct: 2   CPG---ACVCYNEPKVTTSCPQQGLQ-----AVPVGIPAASQRIFLHGNRISHVPAASFR 53

Query: 116 DFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLI-PDSVSGLVSIQSLDLS 174
             ++L  L +  N+ +    +    L  L+ L L+ N     + P +  GL  + +L L 
Sbjct: 54  ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113

Query: 175 HNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEF 234
                   P     L  L YL L  N         F  +  L  L  HGN++    +  F
Sbjct: 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173

Query: 235 FLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKV 294
             L +   +    N         F       +  L L  N L+   +    L     L+ 
Sbjct: 174 RGLHSLDRLLLHQNRVAHVHPHAFRD--LGRLMTLYLFANNLSA--LPTEALAPLRALQY 229

Query: 295 LDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSG 353
           L L+ N    +         LQ  + S++     +P   L G  L      L+AN+L G
Sbjct: 230 LRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQR-LAGRDL----KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.5 bits (207), Expect = 2e-18
 Identities = 48/257 (18%), Positives = 83/257 (32%), Gaps = 7/257 (2%)

Query: 342 TDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRI 401
                    L  +V + +      + L  N ++        +C  L +            
Sbjct: 14  VTTSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72

Query: 402 LKWGNIEYLDLSRNH-----LTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLR 456
                   L    +      L    P       RL+ L+L    L    P +      L+
Sbjct: 73  AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132

Query: 457 VLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGY 516
            L L  N L         +   L  L L  N ++ V + +   + +L  L L  NR+   
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192

Query: 517 FPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPN-NLPNSLET 575
            P     L  L  L L  NN+S     ++A + +L  L ++ N +        L   L+ 
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQK 252

Query: 576 FNVSYNDFSGAVPENLR 592
           F  S ++   ++P+ L 
Sbjct: 253 FRGSSSEVPCSLPQRLA 269

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.4 bits (186), Expect = 1e-15
 Identities = 59/268 (22%), Positives = 91/268 (33%), Gaps = 11/268 (4%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNN 191
            ++P GI    + Q + L GN  S +   S     ++  L L  N  +     A T L  
Sbjct: 24  QAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81

Query: 192 LVYLNLSSNGFSKRI-PRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMF 250
           L  L+LS N   + + P  F  +  L  L      L     G F  L    ++    N  
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141

Query: 251 VGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-F 309
                  F      ++ +L L  N+++   V     +   +L  L L  N++    P  F
Sbjct: 142 QALPDDTF--RDLGNLTHLFLHGNRISS--VPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197

Query: 310 NFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMI-LSTNLHMLNL 368
             +  L  L L  N  S      L    +L    L L+ N          L   L     
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRAL--QYLRLNDNPWVCDCRARPLWAWLQKFRG 255

Query: 369 SSNGLTGELPLLTGSCAVLDLSNNQFEG 396
           SS+ +   LP       +  L+ N  +G
Sbjct: 256 SSSEVPCSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.5 bits (181), Expect = 6e-15
 Identities = 51/279 (18%), Positives = 81/279 (29%), Gaps = 11/279 (3%)

Query: 290 ENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSAN 349
           E           L   +P        Q + L  NR S           +L +  L  +  
Sbjct: 11  EPKVTTSCPQQGLQ-AVPV-GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68

Query: 350 NLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCA----VLDLSNNQFEG-NLSRILKW 404
               + +      L  L+LS N     +   T         L L     +          
Sbjct: 69  ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128

Query: 405 GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNH 464
             ++YL L  N L     +       L HL L  N +SS   +       L  L L  N 
Sbjct: 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188

Query: 465 LDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSL 524
           +         +   L  L+L  N L+ +   +   +  LQ L L+ N             
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLW 247

Query: 525 TGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTG 563
             L+    + + +  SLP  +A         ++ N   G
Sbjct: 248 AWLQKFRGSSSEVPCSLPQRLAGRDLKR---LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.1 bits (167), Expect = 3e-13
 Identities = 47/262 (17%), Positives = 80/262 (30%), Gaps = 12/262 (4%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLK 319
            G+  + Q + L  N+++   V     +   NL +L L  N L            L    
Sbjct: 28  VGIPAASQRIFLHGNRISH--VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQL 85

Query: 320 LSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVS--MILSTNLHMLNLSSNGLTGEL 377
             ++       +         L  L L    L             L  L L  N L    
Sbjct: 86  DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145

Query: 378 PLLTGSCA---VLDLSNNQFEGNLSRIL-KWGNIEYLDLSRNHLTGSIPEETPQFLRLNH 433
                       L L  N+      R      +++ L L +N +    P       RL  
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205

Query: 434 LNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVL 493
           L L  N+LS+   + +   + L+ L L+ N             + LQ+   + + +    
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPCS- 263

Query: 494 DFSPPSVSNLQVLDLSHNRLNG 515
              P  ++   +  L+ N L G
Sbjct: 264 --LPQRLAGRDLKRLAANDLQG 283

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.7 bits (211), Expect = 2e-18
 Identities = 42/206 (20%), Positives = 79/206 (38%), Gaps = 19/206 (9%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVA--KQRKEFAKEAKKFANIRHPNVVGLR 838
             +G  ++G+   A   + G+ + VK L          K   +E +   +++H NV+GL 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 839 GYYWGPTQ---HEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYL 895
             +           + L  ++    L +        K   LT      +   + RGL Y+
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNI------VKCQKLTDDHVQFLIYQILRGLKYI 137

Query: 896 HFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAA 955
           H    + H +LK +N+ ++       +          +              YRAPE+  
Sbjct: 138 H-SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT-----RWYRAPEIML 191

Query: 956 SKKPHPSFKSDVYAFGVILLELLTGR 981
           +   + +   D+++ G I+ ELLTGR
Sbjct: 192 NWMHY-NQTVDIWSVGCIMAELLTGR 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.2 bits (194), Expect = 3e-16
 Identities = 33/207 (15%), Positives = 72/207 (34%), Gaps = 21/207 (10%)

Query: 782 EVLGRSSHGTSYRAT-LENGMFLTVKWLREGVAKQ--RKEFAKEAKKFANIRHPNVVGLR 838
           + +G  + G    A        + +K L      Q   K   +E      + H N++ L 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 839 GYYWGPTQHEK----LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNY 894
             +      E+     ++ + +          +            +   +   +  G+ +
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--------HERMSYLLYQMLCGIKH 134

Query: 895 LHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELA 954
           LH    + H +LK +NI++   D   ++ D+ L R    +  +          YRAPE+ 
Sbjct: 135 LHSAGII-HRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPY--VVTRYYRAPEVI 190

Query: 955 ASKKPHPSFKSDVYAFGVILLELLTGR 981
                      D+++ G I+ E++  +
Sbjct: 191 --LGMGYKENVDIWSVGCIMGEMVRHK 215

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 62.1 bits (149), Expect = 1e-10
 Identities = 60/339 (17%), Positives = 103/339 (30%), Gaps = 26/339 (7%)

Query: 167 SIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKL 226
               L+L++   S SLP       +L  L  S N  ++ +P   EL   L+ L    N  
Sbjct: 39  QAHELELNNLGLS-SLPELPP---HLESLVASCNSLTE-LP---ELPQSLKSLLVDNN-- 88

Query: 227 DGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGEL 286
             +L     L     ++  S N        +      + +   N SL +L     +   +
Sbjct: 89  --NLKALSDLPPLLEYLGVSNNQLEKLPELQNSS-FLKIIDVDNNSLKKLPDLPPSLEFI 145

Query: 287 QLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDL 346
               N          L      +     L+ L          +  + +  +         
Sbjct: 146 AAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEE----LPELQ 201

Query: 347 SANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGN 406
           +   L+   +             S                L  S    + + +       
Sbjct: 202 NLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSE 261

Query: 407 IEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLD 466
           +       N  +  I         L  LN+S+N L   LP +     +L  L  SFNHL 
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALP---PRLERLIASFNHLA 317

Query: 467 GPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQV 505
              +  L  +  L++LH+  N L    D  P SV +L++
Sbjct: 318 E--VPELPQN--LKQLHVEYNPLREFPDI-PESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 57.1 bits (136), Expect = 4e-09
 Identities = 19/92 (20%), Positives = 34/92 (36%), Gaps = 9/92 (9%)

Query: 460 LSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPD 519
              N       +      +L+EL++++N L  +    P     L+ L  S N L    P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIEL----PALPPRLERLIASFNHLAE-VPE 321

Query: 520 RLGSLTGLKVLCLAGNNISGSLPTSMANMTSL 551
              +   LK L +  N +    P    ++  L
Sbjct: 322 LPQN---LKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 55.6 bits (132), Expect = 2e-08
 Identities = 23/96 (23%), Positives = 39/96 (40%), Gaps = 10/96 (10%)

Query: 101 MSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPD 160
              N+ S  I        SLE L+VS+N     LP+   +LE    L  + N+ +  +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLE---RLIASFNHLAE-VPE 321

Query: 161 SVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLN 196
               L   + L + +N      P     + +L  +N
Sbjct: 322 LPQNL---KQLHVEYNPLR-EFPDIPESVEDL-RMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.1 bits (128), Expect = 5e-08
 Identities = 22/74 (29%), Positives = 34/74 (45%), Gaps = 7/74 (9%)

Query: 361 TNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGS 420
            +L  LN+S+N L  ELP L      L  S N     +  +    N++ L +  N L   
Sbjct: 284 PSLEELNVSNNKLI-ELPALPPRLERLIASFNHLA-EVPELP--QNLKQLHVEYNPLR-E 338

Query: 421 IPE--ETPQFLRLN 432
            P+  E+ + LR+N
Sbjct: 339 FPDIPESVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.2 bits (118), Expect = 6e-07
 Identities = 18/97 (18%), Positives = 39/97 (40%), Gaps = 10/97 (10%)

Query: 483 HLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLP 542
               N  +  +        +L+ L++S+N+L    P        L+ L  + N+++  +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320

Query: 543 TSMANMTSLSSLVISQNHFTGPLPNNLPNSLETFNVS 579
               N+  L    +  N      P ++P S+E   ++
Sbjct: 321 ELPQNLKQLH---VEYNPLRE-FP-DIPESVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.2 bits (118), Expect = 7e-07
 Identities = 56/340 (16%), Positives = 98/340 (28%), Gaps = 26/340 (7%)

Query: 190 NNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNM 249
                L L++ G S  +P   EL   L+ L    N L   L      L +    + +   
Sbjct: 38  RQAHELELNNLGLSS-LP---ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 250 FVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGF 309
                      G+S +       L   +   +   +    + L  L  S   +       
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 310 NFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLS 369
             + ELQ L      ++       L    L L  +    N L     +     L  +   
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 370 SNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL 429
           +N L                  + +  +L  + +      +  +       +P       
Sbjct: 213 NNLLKTLPD--LPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270

Query: 430 RLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLL 489
             ++   S   L  SL ++ +   KL  L                    L+ L  + N L
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPR--------------LERLIASFNHL 316

Query: 490 TGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKV 529
             V    P    NL+ L + +N L   FPD   S+  L++
Sbjct: 317 AEV----PELPQNLKQLHVEYNPLRE-FPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.2 bits (118), Expect = 8e-07
 Identities = 23/103 (22%), Positives = 43/103 (41%), Gaps = 17/103 (16%)

Query: 221 FHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSL 280
           ++ N     +     L  +   ++ S N  +       LP L   ++ L  S N L    
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE------LPALPPRLERLIASFNHLA--- 317

Query: 281 VNGGEL-QLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSN 322
               E+ +L +NLK L + YN L  E P  +    ++ L++++
Sbjct: 318 ----EVPELPQNLKQLHVEYNPLR-EFP--DIPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.7 bits (114), Expect = 2e-06
 Identities = 17/80 (21%), Positives = 30/80 (37%), Gaps = 9/80 (11%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSL 149
                 L +L++SNN +   +P        LE L  S N   + +P       +L+ L +
Sbjct: 280 CDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHL-AEVPELPQ---NLKQLHV 331

Query: 150 AGNNFSGLIPDSVSGLVSIQ 169
             N      PD    +  ++
Sbjct: 332 EYNPLREF-PDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.7 bits (109), Expect = 1e-05
 Identities = 20/88 (22%), Positives = 32/88 (36%), Gaps = 8/88 (9%)

Query: 508 LSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHFTGPLPN 567
              N  +            L+ L ++ N +   LP   A    L  L+ S NH    +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLAE-VPE 321

Query: 568 NLPNSLETFNVSYNDFSG--AVPENLRK 593
              N L+  +V YN       +PE++  
Sbjct: 322 LPQN-LKQLHVEYNPLREFPDIPESVED 348

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.6 bits (106), Expect = 2e-05
 Identities = 18/74 (24%), Positives = 30/74 (40%), Gaps = 8/74 (10%)

Query: 341 LTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSR 400
           L +L++S N L    ++     L  L  S N L  E+P L  +   L +  N     L  
Sbjct: 286 LEELNVSNNKLIELPALP--PRLERLIASFNHLA-EVPELPQNLKQLHVEYNP----LRE 338

Query: 401 ILKW-GNIEYLDLS 413
                 ++E L ++
Sbjct: 339 FPDIPESVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 4e-04
 Identities = 18/72 (25%), Positives = 25/72 (34%), Gaps = 5/72 (6%)

Query: 479 LQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNIS 538
             EL L +  L+ +    P    +L+ L  S N L    P+   SL  L V       +S
Sbjct: 40  AHELELNNLGLSSL----PELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94

Query: 539 GSLPTSMANMTS 550
              P       S
Sbjct: 95  DLPPLLEYLGVS 106

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.6 bits (93), Expect = 8e-04
 Identities = 20/100 (20%), Positives = 36/100 (36%), Gaps = 14/100 (14%)

Query: 173 LSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDG 232
              N+ S  +        +L  LN+S+N   + +P    L   L+ L    N L   +  
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHL-AEVPE 321

Query: 233 EFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLS 272
              L  N   +    N        +  P + +SV+ L ++
Sbjct: 322 ---LPQNLKQLHVEYNPL------REFPDIPESVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 21/83 (25%), Positives = 36/83 (43%), Gaps = 10/83 (12%)

Query: 501 SNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNH 560
                L+L++  L+   P+       L+ L  + N+++  LP       SL SL++  N+
Sbjct: 38  RQAHELELNNLGLSS-LPE---LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNN 89

Query: 561 FTGPLPNNLPNSLETFNVSYNDF 583
                 ++LP  LE   VS N  
Sbjct: 90  LKA--LSDLPPLLEYLGVSNNQL 110

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 22/95 (23%), Positives = 31/95 (32%), Gaps = 25/95 (26%)

Query: 359 LSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLT 418
           L    H L L++ GL+  LP L                         ++E L  S N LT
Sbjct: 36  LDRQAHELELNNLGLS-SLPEL-----------------------PPHLESLVASCNSLT 71

Query: 419 GSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQ 453
             +PE       L   N +  +LS   P +     
Sbjct: 72  -ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGV 105

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.4 bits (137), Expect = 2e-09
 Identities = 46/246 (18%), Positives = 95/246 (38%), Gaps = 16/246 (6%)

Query: 96  LVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFS-SSLPSGIGKLESLQNLSLAGNNF 154
           ++      + +   + ++   F+ ++ +D+S+++   S+L   + +   LQNLSL G   
Sbjct: 25  VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83

Query: 155 SGLIPDSVSGLVSIQSLDLS--HNSFSGSLPPALTRLNNLVYLNL------SSNGFSKRI 206
           S  I ++++   ++  L+LS        +L   L+  + L  LNL      +       +
Sbjct: 84  SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 143

Query: 207 PRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSV 266
               E I  L +  +  N     L        N  H+D S ++ + +   +        +
Sbjct: 144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF-FQLNYL 202

Query: 267 QYLNLS-LNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRF 325
           Q+L+LS    +    +   EL     LK L +      G L        L  L+++ + F
Sbjct: 203 QHLSLSRCYDIIPETLL--ELGEIPTLKTLQVFGIVPDGTLQ--LLKEALPHLQINCSHF 258

Query: 326 SGFIPN 331
           +     
Sbjct: 259 TTIARP 264

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.3 bits (134), Expect = 6e-09
 Identities = 34/246 (13%), Positives = 76/246 (30%), Gaps = 15/246 (6%)

Query: 366 LNLSSNGLTGELP--LLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTG-SIP 422
           L+L+   L  ++   LL+          +  +  L+       ++++DLS + +   ++ 
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 64

Query: 423 EETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL--------DGPFLTNLL 474
               Q  +L +L+L    LS  +   + +   L  L+LS                 + L 
Sbjct: 65  GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124

Query: 475 NSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAG 534
             +        +  +   +     +++ L +     N         +     L  L L+ 
Sbjct: 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 184

Query: 535 N-NISGSLPTSMANMTSLSSLVISQ-NHFTGPLPNNLPN--SLETFNVSYNDFSGAVPEN 590
           +  +          +  L  L +S+           L    +L+T  V      G +   
Sbjct: 185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL 244

Query: 591 LRKFPS 596
               P 
Sbjct: 245 KEALPH 250

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.9 bits (133), Expect = 8e-09
 Identities = 41/270 (15%), Positives = 90/270 (33%), Gaps = 23/270 (8%)

Query: 295 LDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSG- 353
           LDL+   L  ++ G      +   +   +     +           +  +DLS + +   
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHF---SPFRVQHMDLSNSVIEVS 61

Query: 354 SVSMILS--TNLHMLNLSSNGLTGELPLLTGSCAVL------------DLSNNQFEGNLS 399
           ++  ILS  + L  L+L    L+  +       + L            + +      + S
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 400 RILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLD 459
           R+ +       D +  H+  ++   +    +LN      N   S L  ++ +   L  LD
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181

Query: 460 LSFNHLDGPFLTN-LLNSSTLQELHLAD-NLLTGVLDFSPPSVSNLQVLDLSHNRLNGYF 517
           LS + +            + LQ L L+    +          +  L+ L +     +G  
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241

Query: 518 PDRLGSLTGLKVLCLAGNNISGSLPTSMAN 547
                +L  L++ C   ++ +     ++ N
Sbjct: 242 QLLKEALPHLQINC---SHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 4e-08
 Identities = 47/255 (18%), Positives = 90/255 (35%), Gaps = 20/255 (7%)

Query: 267 QYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFS 326
           Q L+L+   L   +       L + +       + +   L      + +Q + LSN+   
Sbjct: 3   QTLDLTGKNLHPDVT---GRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59

Query: 327 GFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSS----NGLTGELPLLTG 382
               + +L   S L  +L L    LS  +   L+ N +++ L+           L  L  
Sbjct: 60  VSTLHGILSQCSKL-QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118

Query: 383 SCAVLDLSNNQFEGNLSRILKWGNIEY----------LDLSRNHLTGSIPEETPQFLRLN 432
           SC+ LD  N  +  + +       + +              +N     +     +   L 
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178

Query: 433 HLNLSHNSL-SSSLPKVIIQYQKLRVLDLSF-NHLDGPFLTNLLNSSTLQELHLADNLLT 490
           HL+LS + +  +   +   Q   L+ L LS    +    L  L    TL+ L +   +  
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238

Query: 491 GVLDFSPPSVSNLQV 505
           G L     ++ +LQ+
Sbjct: 239 GTLQLLKEALPHLQI 253

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 8e-08
 Identities = 39/270 (14%), Positives = 83/270 (30%), Gaps = 13/270 (4%)

Query: 123 LDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSG-S 181
           LD++       +   +     +       +     + +  S    +Q +DLS++     +
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVST 62

Query: 182 LPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNAS 241
           L   L++ + L  L+L     S  I         L  L+  G         +  L + + 
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 242 HIDFSGNMFVGSSSQKFLPGLSQSVQYLN----LSLNQLTGSLVNGGELQLFENLKVLDL 297
             + + +     + +     ++   + +         +          ++   NL  LDL
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 298 SYNQLTGELPGFNFVYE--LQVLKLSN-NRFSGFIPNDLLKGDSLLLTDLDLSANNLSGS 354
           S + +        F     LQ L LS           +L  G+   L  L +    +   
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLEL--GEIPTLKTLQVF-GIVPDG 239

Query: 355 VSMILSTNLHMLNLSSNGLTGELPLLTGSC 384
              +L   L  L ++ +  T       G+ 
Sbjct: 240 TLQLLKEALPHLQINCSHFTTIARPTIGNK 269

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 5e-07
 Identities = 51/310 (16%), Positives = 93/310 (30%), Gaps = 40/310 (12%)

Query: 169 QSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDG 228
           Q+LDL+  +    +   L     ++      +   + +                      
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLA--------------------- 40

Query: 229 HLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQL 288
               E F      H+D S ++   S+    L   S+ +Q L+L   +L+  +VN   L  
Sbjct: 41  ----EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSK-LQNLSLEGLRLSDPIVN--TLAK 93

Query: 289 FENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSA 348
             NL  L+LS      E      +     L    N    F   +     ++      ++ 
Sbjct: 94  NSNLVRLNLSGCSGFSEFALQTLLSSCSRLD-ELNLSWCFDFTEKHVQVAVAHVSETITQ 152

Query: 349 NNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIE 408
            NLSG    +  ++L  L      L             L  S            +   ++
Sbjct: 153 LNLSGYRKNLQKSDLSTLVRRCPNLV---------HLDLSDSVMLKNDCFQEFFQLNYLQ 203

Query: 409 YLDLSR-NHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDG 467
           +L LSR   +      E  +   L  L +       +L  +      L++    F  +  
Sbjct: 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIAR 263

Query: 468 PFLTNLLNSS 477
           P + N  N  
Sbjct: 264 PTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 0.003
 Identities = 16/75 (21%), Positives = 33/75 (44%), Gaps = 4/75 (5%)

Query: 90  FSNLSMLVKLSMSN-NSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLS 148
           F  L+ L  LS+S    I       +G+  +L+ L V   +   +L       E+L +L 
Sbjct: 196 FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK---EALPHLQ 252

Query: 149 LAGNNFSGLIPDSVS 163
           +  ++F+ +   ++ 
Sbjct: 253 INCSHFTTIARPTIG 267

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.0 bits (136), Expect = 2e-09
 Identities = 45/221 (20%), Positives = 65/221 (29%), Gaps = 14/221 (6%)

Query: 138 IGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNL 197
           + K+ S   ++    N +  +P  +        L LS N         L     L  LNL
Sbjct: 6   VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 198 SSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQK 257
                +K    G      L VL       +          T  +      +    +S   
Sbjct: 63  DRAELTKLQVDGT-----LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117

Query: 258 FLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FNFVYELQ 316
                   +Q L L  N+     +  G L     L+ L L+ N LT    G  N +  L 
Sbjct: 118 GALRGLGELQELYLKGNE--LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175

Query: 317 VLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSM 357
            L L  N     IP       S LL    L  N    +  +
Sbjct: 176 TLLLQENSLY-TIPKGF--FGSHLLPFAFLHGNPWLCNCEI 213

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.3 bits (129), Expect = 2e-08
 Identities = 33/181 (18%), Positives = 51/181 (28%), Gaps = 3/181 (1%)

Query: 288 LFENLKVLDLSYNQLTGELPG-FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDL 346
           L ++  +L LS N L             L  L L     +    +  L     L    + 
Sbjct: 29  LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQ 88

Query: 347 SANNLSGSVSMILSTNLHMLNLSSNGLTG-ELPLLTGSCAVLDLSNNQFEGNLSRILKWG 405
             +      ++   T L +       L    L  L     +    N         +    
Sbjct: 89  LQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148

Query: 406 NIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHL 465
            +E L L+ N+LT            L+ L L  NS   ++PK       L    L  N  
Sbjct: 149 KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS-LYTIPKGFFGSHLLPFAFLHGNPW 207

Query: 466 D 466
            
Sbjct: 208 L 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 8e-08
 Identities = 46/221 (20%), Positives = 78/221 (35%), Gaps = 25/221 (11%)

Query: 341 LTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSR 400
             +++    NL+ ++   L  +  +L+LS N L                         + 
Sbjct: 12  HLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSL--------------------AT 50

Query: 401 ILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDL 460
           ++ +  +  L+L R         +    L +       ++   SLP +      L VLD+
Sbjct: 51  LMPYTRLTQLNLDRAE---LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV 107

Query: 461 SFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDR 520
           SFN L    L  L     LQEL+L  N L  +          L+ L L++N L       
Sbjct: 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167

Query: 521 LGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQNHF 561
           L  L  L  L L  N++  ++P        L    +  N +
Sbjct: 168 LNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.4 bits (111), Expect = 4e-06
 Identities = 31/206 (15%), Positives = 61/206 (29%), Gaps = 49/206 (23%)

Query: 90  FSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSL 149
            S ++  ++++    +++  +P ++   K    L +S+NL  +   + +     L  L+L
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 150 AGNN---------------------------------------------FSGLIPDSVSG 164
                                                             + L   ++ G
Sbjct: 63  DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122

Query: 165 LVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGN 224
           L  +Q L L  N      P  LT    L  L+L++N  ++        +  L  L    N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182

Query: 225 KLDGHLDGEFFLLTNASHIDFSGNMF 250
                +   FF           GN +
Sbjct: 183 S-LYTIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.2 bits (108), Expect = 8e-06
 Identities = 48/226 (21%), Positives = 69/226 (30%), Gaps = 26/226 (11%)

Query: 289 FENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSA 348
             +   ++     LT  LP  +   +  +L LS N    F    L+    L  T L+L  
Sbjct: 9   VASHLEVNCDKRNLT-ALPP-DLPKDTTILHLSENLLYTFSLATLMPYTRL--TQLNLDR 64

Query: 349 NNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIE 408
             L+          L  L+LS                     +NQ +           + 
Sbjct: 65  AELTKLQVDGTLPVLGTLDLS---------------------HNQLQSLPLLGQTLPALT 103

Query: 409 YLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGP 468
            LD+S N LT            L  L L  N L +  P ++    KL  L L+ N+L   
Sbjct: 104 VLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTEL 163

Query: 469 FLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLN 514
               L     L  L L +N L   +         L    L  N   
Sbjct: 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (99), Expect = 1e-04
 Identities = 15/63 (23%), Positives = 24/63 (38%), Gaps = 5/63 (7%)

Query: 475 NSSTLQELHLADNLLTGVLDFSPPSVS-NLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLA 533
             ++  E++     LT +    PP +  +  +L LS N L  +    L   T L  L L 
Sbjct: 8   KVASHLEVNCDKRNLTAL----PPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 534 GNN 536
              
Sbjct: 64  RAE 66

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.4 bits (139), Expect = 2e-09
 Identities = 13/83 (15%), Positives = 34/83 (40%), Gaps = 5/83 (6%)

Query: 502 NLQVLDLSHNRLN-GYFPDRLGSLTGLKVLCLAGNNISG----SLPTSMANMTSLSSLVI 556
           ++Q LD+    L+   + + L  L   +V+ L    ++      + +++    +L+ L +
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 557 SQNHFTGPLPNNLPNSLETFNVS 579
             N       + +   L+T +  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCK 85

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.7 bits (137), Expect = 4e-09
 Identities = 20/94 (21%), Positives = 35/94 (37%), Gaps = 11/94 (11%)

Query: 360 STNLHMLNLSSNGLTGE-----LPLLTGSCAVLDLSNNQFEG----NLSRILKW-GNIEY 409
           S ++  L++    L+       LPLL   C V+ L +         ++S  L+    +  
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQ-QCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 410 LDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSS 443
           L+L  N L         Q L+     +   SL +
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.7 bits (137), Expect = 4e-09
 Identities = 18/89 (20%), Positives = 33/89 (37%), Gaps = 10/89 (11%)

Query: 406 NIEYLDLSRNHLTGS-IPEETPQFLRLNHLNLSHNSLS----SSLPKVIIQYQKLRVLDL 460
           +I+ LD+    L+ +   E  P   +   + L    L+      +   +     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 461 SFNHLDGPFLTNLL-----NSSTLQELHL 484
             N L    +  +L      S  +Q+L L
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.4 bits (131), Expect = 2e-08
 Identities = 12/94 (12%), Positives = 30/94 (31%), Gaps = 10/94 (10%)

Query: 119 SLEFLDVSDNLFSSS-LPSGIGKLESLQNLSLAGNNFSG----LIPDSVSGLVSIQSLDL 173
            ++ LD+     S +     +  L+  Q + L     +      I  ++    ++  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 174 SHNSFSGSLPPALTRL-----NNLVYLNLSSNGF 202
             N         + +        +  L+L +   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.1 bits (125), Expect = 1e-07
 Identities = 24/98 (24%), Positives = 34/98 (34%), Gaps = 23/98 (23%)

Query: 431 LNHLNLSHNSLS----SSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLAD 486
           L  L L+   +S    SSL   ++    LR LDLS N L    +  L+ S       +  
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES-------VRQ 423

Query: 487 NLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSL 524
                           L+ L L     +    DRL +L
Sbjct: 424 PG------------CLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.3 bits (123), Expect = 2e-07
 Identities = 15/93 (16%), Positives = 36/93 (38%), Gaps = 11/93 (11%)

Query: 291 NLKVLDLSYNQLTGE--LPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLL--LTDLDL 346
           +++ LD+   +L+          + + QV++L +   +     D+     +   L +L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 347 SANNLSGSVSMIL-------STNLHMLNLSSNG 372
            +N L       +       S  +  L+L +  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.1 bits (120), Expect = 5e-07
 Identities = 17/92 (18%), Positives = 26/92 (28%), Gaps = 10/92 (10%)

Query: 143 SLQNLSLAGNNFSGL-IPDSVSGLVSIQSLDLSHNSFSG----SLPPALTRLNNLVYLNL 197
            +Q+L +     S     + +  L   Q + L     +      +  AL     L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 198 SSNGFSKRIPRGFELILG-----LQVLDFHGN 224
            SN             L      +Q L     
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.4 bits (118), Expect = 8e-07
 Identities = 18/96 (18%), Positives = 32/96 (33%), Gaps = 9/96 (9%)

Query: 263 SQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGE-----LPGFNFVYELQV 317
           S  +Q L++   +L+ +      L L +  +V+ L    LT                L  
Sbjct: 1   SLDIQSLDIQCEELSDARWAEL-LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 318 LKLSNNRFSGFIPNDL---LKGDSLLLTDLDLSANN 350
           L L +N       + +   L+  S  +  L L    
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 18/114 (15%), Positives = 35/114 (30%), Gaps = 26/114 (22%)

Query: 429 LRLNHLNLSHNSLSSS-LPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADN 487
           L +  L++    LS +   +++   Q+ +V+ L    L      ++  SS L+       
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVN----- 54

Query: 488 LLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSL-----TGLKVLCLAGNN 536
                          L  L+L  N L       +          ++ L L    
Sbjct: 55  -------------PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 18/82 (21%), Positives = 29/82 (35%), Gaps = 9/82 (10%)

Query: 117 FKSLEFLDVSDNLFS----SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLV-----S 167
              L  L ++D   S    SSL + +    SL+ L L+ N         +   V      
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 168 IQSLDLSHNSFSGSLPPALTRL 189
           ++ L L    +S  +   L  L
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 5e-06
 Identities = 14/86 (16%), Positives = 31/86 (36%), Gaps = 9/86 (10%)

Query: 501 SNLQVLDLSHNRLNG----YFPDRLGSLTGLKVLCLAGNNISGSLPTSMA-----NMTSL 551
           S L+VL L+   ++          L +   L+ L L+ N +  +    +          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 552 SSLVISQNHFTGPLPNNLPNSLETFN 577
             LV+   +++  + + L    +   
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKP 454

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 5e-06
 Identities = 16/81 (19%), Positives = 30/81 (37%), Gaps = 9/81 (11%)

Query: 143 SLQNLSLAGNNFSGL----IPDSVSGLVSIQSLDLSHNSFSGSLPPALTR-----LNNLV 193
            L+ L LA  + S      +  ++    S++ LDLS+N    +    L          L 
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 194 YLNLSSNGFSKRIPRGFELIL 214
            L L    +S+ +    + + 
Sbjct: 430 QLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 6e-06
 Identities = 19/86 (22%), Positives = 28/86 (32%), Gaps = 8/86 (9%)

Query: 284 GELQLFENLKVLDLSYNQLTGE-----LPGFNFVYELQVLKLSNNRFSGFIPNDL---LK 335
           G  Q    L+VL L+   ++              + L+ L LSNN         L   ++
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422

Query: 336 GDSLLLTDLDLSANNLSGSVSMILST 361
               LL  L L     S  +   L  
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQA 448

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 7e-06
 Identities = 11/90 (12%), Positives = 28/90 (31%), Gaps = 5/90 (5%)

Query: 96  LVKLSMSNNSISGV-IPDNIGDFKSLEFLDVSDNLFS----SSLPSGIGKLESLQNLSLA 150
           +  L +    +S     + +   +  + + + D   +      + S +    +L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 151 GNNFSGLIPDSVSGLVSIQSLDLSHNSFSG 180
            N    +    V   +   S  +   S   
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 7e-06
 Identities = 16/68 (23%), Positives = 24/68 (35%), Gaps = 5/68 (7%)

Query: 166 VSIQSLDLSHNSFSGS-LPPALTRLNNLVYLNLSSNGFS----KRIPRGFELILGLQVLD 220
           + IQSLD+     S +     L  L     + L   G +    K I     +   L  L+
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 221 FHGNKLDG 228
              N+L  
Sbjct: 62  LRSNELGD 69

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 7e-06
 Identities = 20/107 (18%), Positives = 36/107 (33%), Gaps = 25/107 (23%)

Query: 361 TNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGS 420
           + L +L L+   ++        +     L  N             ++  LDLS N L  +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAAT----LLANH------------SLRELDLSNNCLGDA 412

Query: 421 IPEETPQFLR-----LNHLNLSHNSLSSSLPKVIIQYQK----LRVL 458
              +  + +R     L  L L     S  +   +   +K    LRV+
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 18/79 (22%), Positives = 27/79 (34%), Gaps = 9/79 (11%)

Query: 309 FNFVYELQVLKLSNNRFSGFIPNDLLKGDSLL--LTDLDLSANNLSGSVSMILS------ 360
                 L+VL L++   S    + L         L +LDLS N L  +  + L       
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 361 -TNLHMLNLSSNGLTGELP 378
              L  L L     + E+ 
Sbjct: 425 GCLLEQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 15/69 (21%), Positives = 25/69 (36%), Gaps = 3/69 (4%)

Query: 239 NASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVN--GGELQLFENLKVLD 296
           +   +D        +   + LP L Q  Q + L    LT +        L++   L  L+
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLL-QQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 297 LSYNQLTGE 305
           L  N+L   
Sbjct: 62  LRSNELGDV 70

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 4e-05
 Identities = 13/71 (18%), Positives = 23/71 (32%), Gaps = 9/71 (12%)

Query: 167 SIQSLDLSHNSFSG----SLPPALTRLNNLVYLNLSSNGFSKRIPRGFELIL-----GLQ 217
            ++ L L+    S     SL   L   ++L  L+LS+N             +      L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 218 VLDFHGNKLDG 228
            L  +      
Sbjct: 430 QLVLYDIYWSE 440

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 5e-05
 Identities = 16/85 (18%), Positives = 32/85 (37%), Gaps = 9/85 (10%)

Query: 90  FSNLSMLVKLSMSNNSISGV----IPDNIGDFKSLEFLDVSDNLFSSSLPSGIGK----- 140
               S+L  L +++  +S      +   +    SL  LD+S+N    +    + +     
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 141 LESLQNLSLAGNNFSGLIPDSVSGL 165
              L+ L L    +S  + D +  L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 6e-05
 Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 12/80 (15%)

Query: 264 QSVQYLNLSLNQLTGSLVN--GGELQLFENLKVLDLSYNQLTGELPGFNFVYE------- 314
             ++ L L+   ++ S  +     L    +L+ LDLS N L     G   + E       
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA--GILQLVESVRQPGC 426

Query: 315 -LQVLKLSNNRFSGFIPNDL 333
            L+ L L +  +S  + + L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 1e-04
 Identities = 19/78 (24%), Positives = 30/78 (38%), Gaps = 11/78 (14%)

Query: 527 LKVLCLAGNNISG----SLPTSMANMTSLSSLVISQNHFTGPLPNNLPNS-------LET 575
           L+VL LA  ++S     SL  ++    SL  L +S N         L  S       LE 
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 576 FNVSYNDFSGAVPENLRK 593
             +    +S  + + L+ 
Sbjct: 431 LVLYDIYWSEEMEDRLQA 448

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.002
 Identities = 20/116 (17%), Positives = 42/116 (36%), Gaps = 12/116 (10%)

Query: 45  NSWNEESIDFDGCPSSWNGIVCNGGNVAGVVLDNLGLS---AAADLSVFSNLSMLVKLSM 101
              +   ++  G      G+   G  +  + L +  +S    ++  +       L +L +
Sbjct: 345 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 404

Query: 102 SNNSISGVIPDNIGDF-----KSLEFLDVSDNLFSSSLPSGIGKLE----SLQNLS 148
           SNN +       + +        LE L + D  +S  +   +  LE    SL+ +S
Sbjct: 405 SNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 55.4 bits (132), Expect = 5e-09
 Identities = 27/231 (11%), Positives = 69/231 (29%), Gaps = 21/231 (9%)

Query: 92  NLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAG 151
            L+  +K++   ++++  +     D   +  L       ++    G+  L +L  L L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 152 NNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFE 211
           N  + L P      ++   L  +      ++    +     +     ++          +
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 212 LILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNL 271
           ++        + + L G                   ++     S          +  L  
Sbjct: 133 VLYLDLNQITNISPLAGL------------TNLQYLSIGNAQVSDLTPLANLSKLTTLKA 180

Query: 272 SLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSN 322
             N+++        L    NL  + L  NQ++  +        L ++ L+N
Sbjct: 181 DDNKISDIS----PLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.8 bits (120), Expect = 2e-07
 Identities = 28/218 (12%), Positives = 60/218 (27%), Gaps = 21/218 (9%)

Query: 141 LESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN 200
           L +   ++   +N +  +  + + L  I +L       +      +  LNNL+ L L  N
Sbjct: 18  LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73

Query: 201 GFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP 260
                +     L    ++        +         +                +    L 
Sbjct: 74  QI-TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 261 GLSQSVQYLNL-----------SLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGF 309
            L   +  +              L+     + +   L     L  L    N+++  +   
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPL 191

Query: 310 NFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLS 347
             +  L  + L NN+ S   P          L  + L+
Sbjct: 192 ASLPNLIEVHLKNNQISDVSPLANTSN----LFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.6 bits (117), Expect = 5e-07
 Identities = 41/219 (18%), Positives = 76/219 (34%), Gaps = 14/219 (6%)

Query: 314 ELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGL 373
               +    +  +  +    L G    +T L      ++    +    NL  L L  N +
Sbjct: 20  NAIKIAAGKSNVTDTVTQADLDG----ITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQI 75

Query: 374 TGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNH 433
           T   PL   +       +     N+S I    +I+ LDL+   +T          L    
Sbjct: 76  TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT------DVTPLAGLS 129

Query: 434 LNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVL 493
                    + +  +        +  LS  +     LT L N S L  L   DN ++ + 
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189

Query: 494 DFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCL 532
             +  S+ NL  + L +N+++   P  L + + L ++ L
Sbjct: 190 PLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 2e-06
 Identities = 30/224 (13%), Positives = 68/224 (30%), Gaps = 21/224 (9%)

Query: 157 LIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGL 216
           + PD    L +   +    ++ + ++      L+ +  L+    G +  I  G + +  L
Sbjct: 12  IFPDP--ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNL 65

Query: 217 QVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQL 276
             L+   N++      +         +  +    V + +                 +  L
Sbjct: 66  IGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPL 125

Query: 277 TGSLVNGGELQLFENLKV-----------LDLSYNQLTGELPGFNFVYELQVLKLSNNRF 325
            G             +                  N    +L     + +L  LK  +N+ 
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKI 185

Query: 326 SGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLS 369
           S   P   L      L ++ L  N +S    +  ++NL ++ L+
Sbjct: 186 SDISPLASLPN----LIEVHLKNNQISDVSPLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.3 bits (111), Expect = 3e-06
 Identities = 35/232 (15%), Positives = 65/232 (28%), Gaps = 21/232 (9%)

Query: 70  NVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNL 129
            +A  +    G S   D    ++L  +  LS     ++ +  + +    +L  L++ DN 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74

Query: 130 FSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRL 189
            +   P       +   LS         I    S      +     +    +    L  L
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134

Query: 190 NNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNM 249
                          +I     L     +                  L+  + +    N 
Sbjct: 135 YL----------DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184

Query: 250 FVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQ 301
               S    LP L      ++L  NQ++        L    NL ++ L+ NQ
Sbjct: 185 ISDISPLASLPNL----IEVHLKNNQISDV----SPLANTSNLFIVTLT-NQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.6 bits (109), Expect = 5e-06
 Identities = 37/219 (16%), Positives = 81/219 (36%), Gaps = 16/219 (7%)

Query: 341 LTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTG--ELPLLTGSCAVLDLSNNQFEGNL 398
              +    +N++ +V+      +  L+    G+T    +  L  +   L+L +NQ     
Sbjct: 21  AIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEGVQYLN-NLIGLELKDNQ----- 74

Query: 399 SRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVL 458
             I     ++ L           P +    +       + +  S+ +  V        + 
Sbjct: 75  --ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 459 DLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFP 518
            L  +      ++ L   + LQ L + +  ++ +   +  ++S L  L    N+++   P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKADDNKISDISP 190

Query: 519 DRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVIS 557
             L SL  L  + L  N IS   P  +AN ++L  + ++
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 6e-06
 Identities = 44/225 (19%), Positives = 79/225 (35%), Gaps = 17/225 (7%)

Query: 237 LTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLD 296
           L NA  I    +    + +Q  L G+      L+     +T        +Q   NL  L+
Sbjct: 18  LANAIKIAAGKSNVTDTVTQADLDGI----TTLSAFGTGVT----TIEGVQYLNNLIGLE 69

Query: 297 LSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVS 356
           L  NQ+T   P  N     ++    N   +      L          LDL++  ++    
Sbjct: 70  LKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIK-----TLDLTSTQITDVTP 124

Query: 357 MILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNH 416
           +   +NL +L L  N +T   PL   +        N    +L+ +     +  L    N 
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184

Query: 417 LTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLS 461
           ++   P        L  ++L +N +S   P  +     L ++ L+
Sbjct: 185 ISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 5e-04
 Identities = 32/221 (14%), Positives = 60/221 (27%), Gaps = 16/221 (7%)

Query: 361 TNLHMLNLSSNGLTGELPLLT-GSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTG 419
            N   +    + +T  +          L          +  +    N+  L+L  N +  
Sbjct: 19  ANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQI-- 75

Query: 420 SIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTL 479
                  + L          +   ++  +        +   S    D   L  L N   L
Sbjct: 76  -TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134

Query: 480 QELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISG 539
                        +    P      +  LS           L +L+ L  L    N IS 
Sbjct: 135 YLDL-------NQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187

Query: 540 SLPTSMANMTSLSSLVISQNHFTGPLP-NNLPNSLETFNVS 579
             P  +A++ +L  + +  N  +   P  N  N L    ++
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVSPLANTSN-LFIVTLT 225

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 53.2 bits (127), Expect = 2e-08
 Identities = 20/147 (13%), Positives = 44/147 (29%), Gaps = 21/147 (14%)

Query: 782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRK----------EFAKEAKKFANIRH 831
           +++G       +    E      VK+ + G    +K           F+  A + A    
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 832 PNVVGLRGYYWGPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARG 891
             +  L+G    P  +            ++   L D        +       +   +   
Sbjct: 66  RALQKLQGLAV-PKVYA-------WEGNAVLMELIDAKELYRVRVENPDE--VLDMILEE 115

Query: 892 LNYLHFDRAVPHGNLKATNILLDGPDL 918
           +   +  R + HG+L   N+L+    +
Sbjct: 116 VAKFY-HRGIVHGDLSQYNVLVSEEGI 141

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.2 bits (121), Expect = 1e-07
 Identities = 36/211 (17%), Positives = 67/211 (31%), Gaps = 21/211 (9%)

Query: 91  SNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLA 150
              +  +K ++   S++  +  N  +  S++ +  +++   S    GI  L ++  L L 
Sbjct: 21  DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLN 76

Query: 151 GNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGF 210
           GN  + + P        + +L      F              +    S +     I    
Sbjct: 77  GNKLTDIKP--------LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128

Query: 211 ELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLN 270
            L+   Q+   +              LT    +    N          L  L    Q L 
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKL----QNLY 184

Query: 271 LSLNQLTGSLVNGGELQLFENLKVLDLSYNQ 301
           LS N ++        L   +NL VL+L  +Q
Sbjct: 185 LSKNHISDL----RALAGLKNLDVLELF-SQ 210

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.4 bits (119), Expect = 2e-07
 Identities = 37/226 (16%), Positives = 72/226 (31%), Gaps = 23/226 (10%)

Query: 101 MSNNSISGVIPDNIGDFKSLEFL--DVSDNLFSSSLPSGIGK--LESLQNLSLAGNNFSG 156
           + + +I+  +P  I    S +     + DNL   S+   + +  L S+  +    ++   
Sbjct: 3   LGSETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKS 60

Query: 157 LIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGL 216
           +    +  L ++  L L+ N  +         L NL  L       +K         L  
Sbjct: 61  VQG--IQYLPNVTKLFLNGNKLTDI-----KPLANLKNLGWLFLDENKVKDLSSLKDLKK 113

Query: 217 QVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQL 276
                  +     ++G    L     +    N     +    L  L       N      
Sbjct: 114 LKSLSLEHNGISDING-LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDN------ 166

Query: 277 TGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSN 322
              + +   L     L+ L LS N ++ +L     +  L VL+L +
Sbjct: 167 --QISDIVPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.2 bits (116), Expect = 6e-07
 Identities = 31/196 (15%), Positives = 60/196 (30%), Gaps = 12/196 (6%)

Query: 314 ELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGL 373
           E     L     +  +  + L      +  +  + +++     +    N+  L L+ N L
Sbjct: 25  ETIKDNLKKKSVTDAVTQNELNS----IDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKL 80

Query: 374 TGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNH 433
           T   PL   +   L                    +   LS  H   S         +L  
Sbjct: 81  TDIKPL--ANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138

Query: 434 LNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVL 493
           L L +N ++       +                   +  L   + LQ L+L+ N ++ + 
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLS----LEDNQISDIVPLAGLTKLQNLYLSKNHISDLR 194

Query: 494 DFSPPSVSNLQVLDLS 509
             +   + NL VL+L 
Sbjct: 195 ALA--GLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 1e-05
 Identities = 35/202 (17%), Positives = 79/202 (39%), Gaps = 14/202 (6%)

Query: 260 PGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLK 319
              +++++  NL    +T ++          ++  +  + + +   + G  ++  +  L 
Sbjct: 21  DAFAETIK-DNLKKKSVTDAV----TQNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLF 74

Query: 320 LSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPL 379
           L+ N+ +   P   LK        L L  N +    S+     L  L+L  NG++    L
Sbjct: 75  LNGNKLTDIKPLANLKNLGW----LFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL 130

Query: 380 LTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHN 439
           +           N    +++ + +   ++ L L  N ++  +P       +L +L LS N
Sbjct: 131 VHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKN 188

Query: 440 SLSSSLPKVIIQYQKLRVLDLS 461
            +S    + +   + L VL+L 
Sbjct: 189 HISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 5e-04
 Identities = 31/196 (15%), Positives = 70/196 (35%), Gaps = 14/196 (7%)

Query: 341 LTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPL--LTGSCAVLDLSNNQFEGNL 398
               +L   +++ +V+     ++  +  +++ +     +  L  +   L L+ N+     
Sbjct: 26  TIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLP-NVTKLFLNGNKLTDIK 84

Query: 399 SRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVL 458
                  N++ L              + + L+        ++  S +  ++   Q   + 
Sbjct: 85  ----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLY 140

Query: 459 DLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFP 518
             +    D   L+ L    TL    L DN ++ ++  +   ++ LQ L LS N ++    
Sbjct: 141 LGNNKITDITVLSRLTKLDTL---SLEDNQISDIVPLA--GLTKLQNLYLSKNHISD--L 193

Query: 519 DRLGSLTGLKVLCLAG 534
             L  L  L VL L  
Sbjct: 194 RALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.003
 Identities = 43/199 (21%), Positives = 79/199 (39%), Gaps = 16/199 (8%)

Query: 361 TNLHMLNLSSNGLTGELPL--LTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLT 418
                 NL    +T  +    L  S   +  +N+  + ++  I    N+  L L+ N LT
Sbjct: 24  AETIKDNLKKKSVTDAVTQNELN-SIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKLT 81

Query: 419 GSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSST 478
              P    + L    L+ +          +       ++  LS  H     +  L++   
Sbjct: 82  DIKPLANLKNLGWLFLDENKV------KDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135

Query: 479 LQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNIS 538
           L+ L+L +N +T         ++ L  L L  N+++   P  L  LT L+ L L+ N+IS
Sbjct: 136 LESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191

Query: 539 GSLPTSMANMTSLSSLVIS 557
             L  ++A + +L  L + 
Sbjct: 192 -DLR-ALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 34/214 (15%), Positives = 68/214 (31%), Gaps = 21/214 (9%)

Query: 157 LIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGL 216
           +  D           +L   S + ++      LN++  +  +++       +G + +  +
Sbjct: 17  IFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYLPNV 70

Query: 217 QVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQL 276
             L  +GNKL                +D +    + S                   +N L
Sbjct: 71  TKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL 130

Query: 277 TGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKG 336
                                  N    ++   + + +L  L L +N+ S  +P   L  
Sbjct: 131 V-----------HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTK 179

Query: 337 DSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSS 370
               L +L LS N++S   ++    NL +L L S
Sbjct: 180 ----LQNLYLSKNHISDLRALAGLKNLDVLELFS 209

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.9 bits (116), Expect = 2e-07
 Identities = 26/123 (21%), Positives = 43/123 (34%), Gaps = 7/123 (5%)

Query: 386 VLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSL 445
           VL L++      L  + +   + +LDLS N L    P        L  L +   S ++  
Sbjct: 2   VLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNALE 56

Query: 446 -PKVIIQYQKLRVLDLSFNHL-DGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNL 503
               +    +L+ L L  N L     +  L++   L  L+L  N L             L
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 504 QVL 506
             +
Sbjct: 117 PSV 119

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.8 bits (113), Expect = 4e-07
 Identities = 25/137 (18%), Positives = 37/137 (27%), Gaps = 32/137 (23%)

Query: 169 QSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDG 228
           + L L+H   +      L +L  + +L+LS N      P                     
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP--------------------- 37

Query: 229 HLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQL 288
                   L     +  S N                 +Q L L  N+L         L  
Sbjct: 38  ----ALAALRCLEVLQASDNALENVDGVAN----LPRLQELLLCNNRLQ-QSAAIQPLVS 88

Query: 289 FENLKVLDLSYNQLTGE 305
              L +L+L  N L  E
Sbjct: 89  CPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.4 bits (112), Expect = 5e-07
 Identities = 24/102 (23%), Positives = 38/102 (37%), Gaps = 2/102 (1%)

Query: 344 LDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSN-NQFEGNLSRIL 402
           L L+  +L+    +     +  L+LS N L    P L     +  L   +    N+  + 
Sbjct: 3   LHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62

Query: 403 KWGNIEYLDLSRNHLTG-SIPEETPQFLRLNHLNLSHNSLSS 443
               ++ L L  N L   +  +      RL  LNL  NSL  
Sbjct: 63  NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.9 bits (108), Expect = 2e-06
 Identities = 30/113 (26%), Positives = 45/113 (39%), Gaps = 11/113 (9%)

Query: 267 QYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFS 326
           + L+L+   LT        L+    +  LDLS+N+L    P    +  L+VL+ S+N   
Sbjct: 1   RVLHLAHKDLTVL----CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE 56

Query: 327 GFIPNDLLKGDSLLLTDLDLSANNLSGSV---SMILSTNLHMLNLSSNGLTGE 376
                  L        +L L  N L  S     ++    L +LNL  N L  E
Sbjct: 57  NVDGVANLPRL----QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.3 bits (104), Expect = 6e-06
 Identities = 28/124 (22%), Positives = 48/124 (38%), Gaps = 14/124 (11%)

Query: 456 RVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNG 515
           RVL L+   L    L +L     +  L L+ N L  +    PP+++ L+ L++     N 
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRAL----PPALAALRCLEVLQASDNA 54

Query: 516 Y-FPDRLGSLTGLKVLCLAGNNI-SGSLPTSMANMTSLSSLVISQNHFTGP------LPN 567
               D + +L  L+ L L  N +   +    + +   L  L +  N           L  
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114

Query: 568 NLPN 571
            LP+
Sbjct: 115 MLPS 118

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.0 bits (98), Expect = 4e-05
 Identities = 28/131 (21%), Positives = 47/131 (35%), Gaps = 12/131 (9%)

Query: 147 LSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRI 206
           L LA  + + L    +  L+ +  LDLSHN      PPAL  L  L  L   ++  +   
Sbjct: 3   LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQ--ASDNALEN 57

Query: 207 PRGFELILGLQVLDFHGNKL-DGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQS 265
             G   +  LQ L    N+L                 ++  GN            G+ + 
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ------EEGIQER 111

Query: 266 VQYLNLSLNQL 276
           +  +  S++ +
Sbjct: 112 LAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.6 bits (84), Expect = 0.003
 Identities = 19/111 (17%), Positives = 37/111 (33%), Gaps = 25/111 (22%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIP---------------------DNIGDFKSLEFLD 124
            L     L ++  L +S+N +  + P                     D + +   L+ L 
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELL 71

Query: 125 VSDNLFSS-SLPSGIGKLESLQNLSLAGNNFS---GLIPDSVSGLVSIQSL 171
           + +N     +    +     L  L+L GN+     G+       L S+ S+
Sbjct: 72  LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 51.8 bits (122), Expect = 2e-07
 Identities = 41/328 (12%), Positives = 79/328 (24%), Gaps = 19/328 (5%)

Query: 143 SLQNLSLAGNNFSG----LIPDSVSGLVSIQSLDLSHNSFSG----SLPPALTRLNNLVY 194
           S++  SL  +  +      +   +    S++ + LS N+        L   +    +L  
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 195 LNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSS 254
              S     +      E +  L        KL      +      A              
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123

Query: 255 SQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYE 314
              +L       Q        L        + +    L+ +    N+L            
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQEL-AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182

Query: 315 LQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT 374
                L   +          +G   LL +       L        +      +  +  L 
Sbjct: 183 QSHRLLHTVKMVQNGIRP--EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240

Query: 375 GELPLLTGSCAVLDLSNNQFEGNLSRILKWGN--IEYLDLSRNHLTGSIPEETPQFL--- 429
               L         LS       +    K  N  ++ L L  N +           +   
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300

Query: 430 --RLNHLNLSHNSLSSSLPKVIIQYQKL 455
              L  L L+ N   S    V+ + +++
Sbjct: 301 MPDLLFLELNGNRF-SEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.6 bits (106), Expect = 2e-05
 Identities = 43/349 (12%), Positives = 92/349 (26%), Gaps = 37/349 (10%)

Query: 167 SIQSLDLSHNSFSG----SLPPALTRLNNLVYLNLSSNGFS----KRIPRGFELILGLQV 218
           SI+   L  ++ +     S+   L   +++  + LS N       + +         L++
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 219 LDFHGN---KLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQ 275
            +F      ++   +     LL  A       +    S +          + +L+     
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123

Query: 276 LTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLK 335
               L N G            L    +  +      +  +   +      S        +
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183

Query: 336 GDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFE 395
              LL T            +         + +L   GL     L          ++    
Sbjct: 184 SHRLLHTV----------KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS 233

Query: 396 GNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFL------RLNHLNLSHNSLSSSLPKVI 449
                +  W N+  L L+   L+                  L  L L +N +     + +
Sbjct: 234 ALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL 293

Query: 450 IQ-----YQKLRVLDLSFNHLDG-----PFLTNLLNSSTLQELHLADNL 488
                     L  L+L+ N           +  + ++    EL   D++
Sbjct: 294 KTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDM 342

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 43.3 bits (100), Expect = 9e-05
 Identities = 35/324 (10%), Positives = 86/324 (26%), Gaps = 30/324 (9%)

Query: 98  KLSMSNNSISGV--IPDNIGDFKSLEFLDVSDNLFS----SSLPSGIGKLESLQNLSLAG 151
            L +   +      +   + +  S++ + +S N         L   I   + L+    + 
Sbjct: 9   SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 152 N---NFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPR 208
                    IP+++  L+         ++   S           +   LS +   + +  
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 209 GFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMF--VGSSSQKFLPGLSQSV 266
               +             +  ++ +         I    N                 + +
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 267 QYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQL--------TGELPGFNFVYELQVL 318
             + +  N +    +    L+     + L +   Q         +           L+ L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 319 KLSNNRFSG----FIPNDLLKGDSLLLTDLDLSANNLSGSVSMILS-------TNLHMLN 367
            L++   S      + +   K +++ L  L L  N +       L         +L  L 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 368 LSSNGLTGELPLLTGSCAVLDLSN 391
           L+ N  + E  ++     V     
Sbjct: 309 LNGNRFSEEDDVVDEIREVFSTRG 332

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.6 bits (93), Expect = 7e-04
 Identities = 58/312 (18%), Positives = 93/312 (29%), Gaps = 38/312 (12%)

Query: 265 SVQYLNLSLNQLTGSLVNG--GELQLFENLKVLDLSYNQLTGEL-----PGFNFVYELQV 317
           S++  +L L+ +T          L   +++K + LS N +  E             +L++
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 318 LKLSNN---RFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLT 374
            + S+    R    IP  L      LL    L    LS +     +    +  LS +   
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123

Query: 375 GELPLLTGSCAVLDLSNNQFEGNLSRILKWG----NIEYLDLSRNHLT-GSIPEETPQFL 429
             L L          +          + K       +  +   RN L  GS+ E    F 
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183

Query: 430 RLNHLNLSHNSLSS------------SLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSS 477
               L+      +              L             +   +         L +  
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243

Query: 478 TLQELHLADNLLTG------VLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGS-----LTG 526
            L+EL L D LL+       V  FS      LQ L L +N +       L +     +  
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303

Query: 527 LKVLCLAGNNIS 538
           L  L L GN  S
Sbjct: 304 LLFLELNGNRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.6 bits (93), Expect = 8e-04
 Identities = 48/304 (15%), Positives = 88/304 (28%), Gaps = 53/304 (17%)

Query: 76  LDNLGLSAAADL-SVFSNLSMLVKLSMSNNSISG----VIPDNIGDFKSLEFLDVSDNLF 130
           LD +       + +V      + ++ +S N+I       + +NI   K LE  + SD   
Sbjct: 12  LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71

Query: 131 SS----------SLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSG 180
                        L   + K   L  + L+ N F     + +   +S  +        + 
Sbjct: 72  GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 131

Query: 181 SLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNA 240
            L P            L+ N  +K  P    +I G   L+    K          LL   
Sbjct: 132 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTV 191

Query: 241 SHIDFSGNMFVGSSSQKFL----------------------------PGLSQSVQYLNLS 272
             +                                                 +++ L L+
Sbjct: 192 KMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251

Query: 273 LNQLTG----SLVNGGELQLFENLKVLDLSYNQLTGELPG------FNFVYELQVLKLSN 322
              L+     ++V+         L+ L L YN++  +            + +L  L+L+ 
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311

Query: 323 NRFS 326
           NRFS
Sbjct: 312 NRFS 315

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 49.8 bits (117), Expect = 3e-07
 Identities = 29/178 (16%), Positives = 49/178 (27%), Gaps = 10/178 (5%)

Query: 342 TDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLT-GSCAVLDLSNNQFEGNLSR 400
           T +D +   L   +   +  +   L L+ N L         G    L     +       
Sbjct: 11  TTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69

Query: 401 ILKWGNI---EYLDLSRNHLTGSIPEETPQFLR-LNHLNLSHNSLSSSLPKVIIQYQKLR 456
                             +    I  +    L  L  LNL  N +S  +P        L 
Sbjct: 70  EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129

Query: 457 VLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLN 514
            L+L+ N  +             +   L           +P  V ++Q+ DL H+   
Sbjct: 130 SLNLASNPFNCNCHLAWFAEWLRK-KSLNGGAARCG---APSKVRDVQIKDLPHSEFK 183

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.2 bits (92), Expect = 5e-04
 Identities = 30/173 (17%), Positives = 68/173 (39%), Gaps = 11/173 (6%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVS-IQSLDLSHNSFSGSLPPALTRLN 190
             +P  I        L L  N    +  D + G +  +  L+L  N  +G  P A    +
Sbjct: 21  KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78

Query: 191 NLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMF 250
           ++  L L  N   +   + F  +  L+ L+ + N++   + G F  L + + ++ + N F
Sbjct: 79  HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138

Query: 251 VGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLT 303
             +     L   ++ ++  +L+           G      ++++ DL +++  
Sbjct: 139 NCNCH---LAWFAEWLRKKSLNGGAARC-----GAPSKVRDVQIKDLPHSEFK 183

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (105), Expect = 8e-06
 Identities = 28/145 (19%), Positives = 54/145 (37%), Gaps = 10/145 (6%)

Query: 417 LTGSIPEETPQF---LRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNL 473
           LT  + E+  Q+   +R   L+L    +   +  +     +   +D S N +    L   
Sbjct: 3   LTAELIEQAAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGF 59

Query: 474 LNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGY-FPDRLGSLTGLKVLCL 532
                L+ L + +N +  + +    ++ +L  L L++N L      D L SL  L  LC+
Sbjct: 60  PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 119

Query: 533 AGNN---ISGSLPTSMANMTSLSSL 554
             N            +  +  +  L
Sbjct: 120 LRNPVTNKKHYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (103), Expect = 1e-05
 Identities = 23/140 (16%), Positives = 42/140 (30%), Gaps = 7/140 (5%)

Query: 86  DLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQ 145
             + ++N     +L +    I  VI +        + +D SDN        G   L  L+
Sbjct: 10  QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLK 66

Query: 146 NLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKR 205
            L +  N    +       L  +  L L++NS               +            
Sbjct: 67  TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126

Query: 206 IPRGFELILG----LQVLDF 221
                  ++     ++VLDF
Sbjct: 127 KKHYRLYVIYKVPQVRVLDF 146

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (89), Expect = 9e-04
 Identities = 23/152 (15%), Positives = 42/152 (27%), Gaps = 8/152 (5%)

Query: 141 LESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN 200
               + L L G      I +  + L    ++D S N            L  L  L +++N
Sbjct: 17  AVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTLLVNNN 73

Query: 201 GFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP 260
              +      +      + D     L  +   E   L   + +     + +  +      
Sbjct: 74  RICRIGEGLDQ-----ALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 261 GLSQSVQYLNLSLNQLTGSLVNGGELQLFENL 292
                V Y    +  L    V   E Q  E +
Sbjct: 129 HYRLYVIYKVPQVRVLDFQKVKLKERQEAEKM 160

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (86), Expect = 0.003
 Identities = 17/101 (16%), Positives = 35/101 (34%), Gaps = 5/101 (4%)

Query: 346 LSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCA---VLDLSNNQFEGNLSRIL 402
           L+A  +  +     +     L+L    +   +  L  +      +D S+N+    L    
Sbjct: 3   LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFP 60

Query: 403 KWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSS 443
               ++ L ++ N +             L  L L++NSL  
Sbjct: 61  LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 101

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (103), Expect = 2e-05
 Identities = 34/255 (13%), Positives = 79/255 (30%), Gaps = 25/255 (9%)

Query: 291 NLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLDLSANN 350
           + +V     +++T E+P  +       L+    +                        + 
Sbjct: 9   SNRVFLCQESKVT-EIPS-DLPRNAIELRFVLTKLRVIQKGAF---------------SG 51

Query: 351 LSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYL 410
                 + +S N  +  + ++  +            ++ +NN    N        N++YL
Sbjct: 52  FGDLEKIEISQNDVLEVIEADVFSNLPK---LHEIRIEKANNLLYINPEAFQNLPNLQYL 108

Query: 411 DLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLR--VLDLSFNHLDGP 468
            +S   +           L+   L++  N    ++ +           +L L+ N +   
Sbjct: 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 168

Query: 469 FLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLK 528
                  +   +     +N L  + +      S   +LD+S  R++      L +L  L+
Sbjct: 169 HNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR 228

Query: 529 VLCLAGNNISGSLPT 543
                  N+   LPT
Sbjct: 229 ARST--YNLK-KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (96), Expect = 2e-04
 Identities = 24/223 (10%), Positives = 64/223 (28%), Gaps = 9/223 (4%)

Query: 132 SSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNN 191
           + +PS +    +   L         +   + SG   ++ +++S N     +   +     
Sbjct: 21  TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 78

Query: 192 LVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFV 251
            ++        +              +     +        +   + +   +       +
Sbjct: 79  KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 138

Query: 252 GSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPG-FN 310
              + +    +  S + + L LN+     ++       +  ++     N L       F+
Sbjct: 139 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFH 198

Query: 311 FVYELQVLKLSNNRFSGFIPNDLLKGDSLLLTDLD-LSANNLS 352
                 +L +S  R    +P+  L+     L  L   S  NL 
Sbjct: 199 GASGPVILDISRTRIHS-LPSYGLEN----LKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (96), Expect = 2e-04
 Identities = 5/47 (10%), Positives = 12/47 (25%), Gaps = 3/47 (6%)

Query: 138 IGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP 184
                    L ++      L    +  L  +++    +      LP 
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (95), Expect = 3e-04
 Identities = 13/56 (23%), Positives = 18/56 (32%), Gaps = 3/56 (5%)

Query: 152 NNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIP 207
           NN   L  D   G      LD+S           L  L  L   +  +    K++P
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 4e-04
 Identities = 38/223 (17%), Positives = 63/223 (28%), Gaps = 4/223 (1%)

Query: 158 IPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQ 217
           IP  +    +   L             A +   +L  + +S N   + I       L   
Sbjct: 23  IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 218 VLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLT 277
                    +             +      +              S     L++  N   
Sbjct: 81  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140

Query: 278 GSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFSGFIPNDLLKGD 337
            ++     + L     +L L+ N +           +L  L LS+N     +PND+  G 
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200

Query: 338 SLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLL 380
           S     LD+S   +    S  L  NL  L   S     +LP L
Sbjct: 201 SGP-VILDISRTRIHSLPSYGLE-NLKKLRARSTYNLKKLPTL 241

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 5e-04
 Identities = 13/48 (27%), Positives = 18/48 (37%), Gaps = 3/48 (6%)

Query: 89  VFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPS 136
           VF   S  V L +S   I  +    + + K L       NL    LP+
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY-NL--KKLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.003
 Identities = 13/63 (20%), Positives = 21/63 (33%), Gaps = 2/63 (3%)

Query: 95  MLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNF 154
           +       NN++  +  D          LD+S     S    G+  L+ L+  S    N 
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL 235

Query: 155 SGL 157
             L
Sbjct: 236 KKL 238

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (98), Expect = 7e-05
 Identities = 27/134 (20%), Positives = 48/134 (35%), Gaps = 5/134 (3%)

Query: 388 DLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPK 447
           +L   Q E     + K  +     L    L      +         LN   + ++++L  
Sbjct: 3   ELKPEQVEQLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSS-MAATLRI 59

Query: 448 VIIQYQKLRVLDLSFNHLDG--PFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQV 505
           +     +L  L+LS N L       + +  +  L+ L+L+ N L    +        L+ 
Sbjct: 60  IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119

Query: 506 LDLSHNRLNGYFPD 519
           L L  N L+  F D
Sbjct: 120 LWLDGNSLSDTFRD 133

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (98), Expect = 7e-05
 Identities = 23/128 (17%), Positives = 46/128 (35%), Gaps = 10/128 (7%)

Query: 78  NLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFS--SSLP 135
            L L            ++ V L+  ++  +  +     +   L  L++S+N       + 
Sbjct: 26  ALDLKGLRSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMS 84

Query: 136 SGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPA-------LTR 188
           S + K  +L+ L+L+GN             + ++ L L  NS S +             R
Sbjct: 85  SIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144

Query: 189 LNNLVYLN 196
              L+ L+
Sbjct: 145 FPKLLRLD 152

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.3 bits (96), Expect = 1e-04
 Identities = 23/110 (20%), Positives = 39/110 (35%), Gaps = 7/110 (6%)

Query: 119 SLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSF 178
           S + LD+        L +          L+   ++ +  +      +  + SL+LS+N  
Sbjct: 23  SQQALDLKGLRSDPDLVA----QNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRL 77

Query: 179 SG--SLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKL 226
                +   + +  NL  LNLS N             L L+ L   GN L
Sbjct: 78  YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (91), Expect = 6e-04
 Identities = 33/152 (21%), Positives = 57/152 (37%), Gaps = 13/152 (8%)

Query: 319 KLSNNRFSGFIPNDLLKGDSLLLTDLDLSANN-LSGSVSMILSTNLHMLNLSSNGLTGEL 377
           +L   +    +   + K        LDL         V+  +   L+  +  +  L    
Sbjct: 3   ELKPEQVEQ-LKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIE 61

Query: 378 PLLTGSCAVLDLSNNQ---FEGNLSRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHL 434
             +      L+LSNN+    +   S + K  N++ L+LS N L      +  + L+L  L
Sbjct: 62  ENIP-ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120

Query: 435 NLSHNSLSSSLP-------KVIIQYQKLRVLD 459
            L  NSLS +          +  ++ KL  LD
Sbjct: 121 WLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 3e-04
 Identities = 33/192 (17%), Positives = 69/192 (35%), Gaps = 20/192 (10%)

Query: 344 LDLSANNLSGSVSMILSTNLHMLNLSSNGLT-----GELPLLTGSCAVLDLSNNQFEGNL 398
             L   N++ +VS      +  L     G+        L  LT     ++ SNNQ     
Sbjct: 23  TVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLT----QINFSNNQLTD-- 76

Query: 399 SRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVL 458
                   ++ L    + L  +        L            ++ +  +        + 
Sbjct: 77  -----ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 459 DLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFP 518
            L  +      ++ L   ++LQ+L+ + N +T +   +  +++ L+ LD+S N+++    
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLA--NLTTLERLDISSNKVSD--I 187

Query: 519 DRLGSLTGLKVL 530
             L  LT L+ L
Sbjct: 188 SVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 6e-04
 Identities = 29/189 (15%), Positives = 58/189 (30%), Gaps = 17/189 (8%)

Query: 141 LESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSN 200
           L       L   N +  +  S + L  + +L         S+   +  LNNL  +N S+N
Sbjct: 17  LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 72

Query: 201 GFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP 260
             +   P      L   +++ +              LT  +  +          +   L 
Sbjct: 73  QLTDITPLKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 261 GLSQSVQYLNLSLNQLTG-----------SLVNGGELQLFENLKVLDLSYNQLTGELPGF 309
            L  S   ++                    + +   L     L+ LD+S N+++  +   
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD-ISVL 190

Query: 310 NFVYELQVL 318
             +  L+ L
Sbjct: 191 AKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 9/66 (13%), Positives = 24/66 (36%), Gaps = 4/66 (6%)

Query: 91  SNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLA 150
           + L+  +K  +   +++  +     D   +  L        S    G+  L +L  ++ +
Sbjct: 15  TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 70

Query: 151 GNNFSG 156
            N  + 
Sbjct: 71  NNQLTD 76

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (92), Expect = 3e-04
 Identities = 19/110 (17%), Positives = 35/110 (31%), Gaps = 3/110 (2%)

Query: 119 SLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNF-SGLIPDSVSGLVSIQSLDLSHNS 177
               L  + +         +   E+L  L +        L    + GL  +++L +  + 
Sbjct: 9   GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 178 FSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLD 227
                P A      L  LNLS N       +  + +   ++    GN L 
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQEL-VLSGNPLH 116

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1060
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.97
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.96
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.95
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.94
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.92
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.92
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.91
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.91
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.89
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.89
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.88
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.88
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.86
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.78
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.75
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.75
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.75
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.73
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.7
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.68
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.64
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.62
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.6
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.58
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.86
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.67
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.27
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.16
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.09
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.94
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.82
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.38
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.86

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=374.27  Aligned_cols=253  Identities=26%  Similarity=0.393  Sum_probs=198.4

Q ss_pred             CCEECCCCCEEEEEEEECCCCEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECCC
Q ss_conf             8700122664999999949939999993322--18889999999999733999802220128967899803999971389
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .++||+|+||+||+|++++  .||||+++..  .....+.|.+|++++++++|||||+++|++.   ....++||||+++
T Consensus        13 ~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~---~~~~~lv~Ey~~~   87 (276)
T d1uwha_          13 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAIVTQWCEG   87 (276)
T ss_dssp             CSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEEEECCCE
T ss_pred             EEEEEECCCCEEEEEEECC--EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE---CCEEEEEEECCCC
T ss_conf             8898307885899999999--8999999734699899999999999998479987864567971---5589999965899


Q ss_pred             CCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCC-E
Q ss_conf             996787611999999998999999999999999999844999624898999868518999759900211100025775-2
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT-I  937 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~-~  937 (1060)
                      |+|.+++....    ..+++.+++.|+.|+|.||+||| +++|+||||||+|||++ .++.+||+|||+|+....... .
T Consensus        88 g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH-~~~ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          88 SSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             EEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEE-TTSSEEECCCCCSCC--------
T ss_pred             CCHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHH-CCCEECCCCCHHHEEEC-CCCCEEECCCCCEEECCCCCCCC
T ss_conf             88899985235----78999999999999999988875-09995161478997981-89978875002213335567763


Q ss_pred             EEECCCCCCCCCCHHCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             3431685445452010147887-899833069899999999909988888889998657578999998518998422223
Q 001527          938 EQILDAGVLGYRAPELAASKKP-HPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~-~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      ......||+.|+|||++.+... .++.++|||||||++|||+||+.||....       ..+.+......+.......  
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-------~~~~~~~~~~~~~~~p~~~--  232 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------NRDQIIFMVGRGYLSPDLS--  232 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHHHHHHTSCCCCGG--
T ss_pred             CCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHHCCCCCCCCH--
T ss_conf             1256655743179999950568999953151635999999997889989989-------6999999996588898600--


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             45523793578889999999988004-999999977899985049
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                             ......+..+.+++.+||+ +|.+||||+||+++|+.|
T Consensus       233 -------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         233 -------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             -------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------HCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             -------03655549999999997588976892999999999999

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=373.65  Aligned_cols=261  Identities=25%  Similarity=0.366  Sum_probs=204.3

Q ss_pred             CCCCCCCHHHHHCCCCCEECCCCCEEEEEEEECCCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC
Q ss_conf             67777895654026787001226649999999499399999933221888999999999973399980222012896789
Q 001527          766 DDTLTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT  845 (1060)
Q Consensus       766 ~~~~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~  845 (1060)
                      ++.+.+..+++..  .+.||+|+||.||+|+++++..||||+++... ...+.|.+|++++++++|||||+++|++.   
T Consensus         5 ~~~wei~~~~~~~--~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~---   78 (272)
T d1qpca_           5 EDEWEVPRETLKL--VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT---   78 (272)
T ss_dssp             TCTTBCCGGGEEE--EEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             CCCEECCHHHEEE--EEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEC---
T ss_conf             8770038899388--67981079828999999999999999986476-88899999999998679998857873104---


Q ss_pred             CCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCC
Q ss_conf             98039999713899967876119999999989999999999999999998449996248989998685189997599002
Q 001527          846 QHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADY  925 (1060)
Q Consensus       846 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Df  925 (1060)
                      ....++||||+++|+|.+++....   ...+++.++++|+.|++.||.||| +++|+||||||+|||++ .++.+||+||
T Consensus        79 ~~~~~iv~Ey~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH-~~~ivHrDiKp~NIll~-~~~~~Kl~DF  153 (272)
T d1qpca_          79 QEPIYIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVS-DTLSCKIADF  153 (272)
T ss_dssp             SSSCEEEEECCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEC-TTSCEEECCC
T ss_pred             CCCEEEEEEECCCCCHHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCHHHEEEE-CCCCEEECCC
T ss_conf             597699999578982888875147---898878899999999999999997-48954675642251562-0244042341


Q ss_pred             CCCEEECCCCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             11100025775234316854454520101478878998330698999999999099888888899986575789999985
Q 001527          926 CLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA 1005 (1060)
Q Consensus       926 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 1005 (1060)
                      |+|+..............|+..|+|||++.+..+  +.++|||||||++|||+||..|+....      ...+..+.. .
T Consensus       154 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~--~~~sDvwS~Gvvl~ellt~~~~~~~~~------~~~~~~~~i-~  224 (272)
T d1qpca_         154 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF--TIKSDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNL-E  224 (272)
T ss_dssp             TTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEE--CHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHHH-H
T ss_pred             CCEEECCCCCCCCCCCCCCCCCCCCHHHHHCCCC--CCHHHHHHHHHHHHHHHHCCCCCCCCC------CHHHHHHHH-H
T ss_conf             0147735886442035677444458289837999--824564525799999996898888888------999999999-7


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHC
Q ss_conf             1899842222345523793578889999999988004-99999997789998504
Q 001527         1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1006 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      .+....      .+       ......+.+++.+||+ +|++||||+||+++|+.
T Consensus       225 ~~~~~~------~p-------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         225 RGYRMV------RP-------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             TTCCCC------CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HCCCCC------CC-------CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf             068888------96-------5571999999999758897689399999998611

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=369.46  Aligned_cols=260  Identities=26%  Similarity=0.369  Sum_probs=204.8

Q ss_pred             CCCCHHHHHCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCC
Q ss_conf             778956540267870012266499999994-9939999993322188899999999997339998022201289678998
Q 001527          769 LTLTPEELSRAPAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQH  847 (1060)
Q Consensus       769 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~  847 (1060)
                      +.+..+++..  .+.||+|+||+||+|++. +++.||+|+++... ...++|.+|++++++++|||||+++|+|.  +..
T Consensus        12 wei~~~~~~~--~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~   86 (287)
T d1opja_          12 WEMERTDITM--KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REP   86 (287)
T ss_dssp             TBCCGGGEEE--EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSS
T ss_pred             CEECHHHEEE--EEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEE--ECC
T ss_conf             1745799398--659820888089999999999699999977761-03999999999998679998826775274--578


Q ss_pred             CEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCC
Q ss_conf             03999971389996787611999999998999999999999999999844999624898999868518999759900211
Q 001527          848 EKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCL  927 (1060)
Q Consensus       848 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgl  927 (1060)
                      ..++||||+++|+|.+++....   ...+++..++.|+.|++.||.||| +++|+||||||+|||++ .++.+||+|||+
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlKp~NILl~-~~~~~Kl~DFG~  161 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVG-ENHLVKVADFGL  161 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEC-GGGCEEECCCCC
T ss_pred             EEEEEEECCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCEEEEC-CCCCEEECCCCC
T ss_conf             5478763146760677753035---541579999999999999788898-78930576045768998-999289832445


Q ss_pred             CEEECCCCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             10002577523431685445452010147887899833069899999999909988888889998657578999998518
Q 001527          928 HRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEG 1007 (1060)
Q Consensus       928 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~ 1007 (1060)
                      |+..............|+..|+|||++.+..+  +.++|||||||++|||++|..|+...      ....+.. .....+
T Consensus       162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~k~DiwS~Gv~l~ell~~~~p~~~~------~~~~~~~-~~i~~~  232 (287)
T d1opja_         162 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF--SIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVY-ELLEKD  232 (287)
T ss_dssp             TTTCCSSSSEEETTEEECGGGCCHHHHHHCCC--SHHHHHHHHHHHHHHHHTTSCCSSTT------CCHHHHH-HHHHTT
T ss_pred             EEECCCCCCEEECCCCCCCCCCCHHHHCCCCC--CCHHHHHHHHHHHHHHHHCCCCCCCC------CHHHHHH-HHHHCC
T ss_conf             46537887221035566546669278727999--81043021789999998679988774------2599999-998558


Q ss_pred             CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             99842222345523793578889999999988004-999999977899985049
Q 001527         1008 HGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1008 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ....             ........+.+++.+||+ +|++||||.||++.|+.+
T Consensus       233 ~~~~-------------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         233 YRME-------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             CCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCC-------------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             8888-------------8743309999999997577976893999999999999

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.36  Aligned_cols=248  Identities=21%  Similarity=0.352  Sum_probs=199.4

Q ss_pred             CCEECCCCCEEEEEEEECCCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECCCCC
Q ss_conf             87001226649999999499399999933221888999999999973399980222012896789980399997138999
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .+.||+|+||+||+|++.++..||||+++... ...++|.+|++++++++|||||+++|+|.  .....++||||+++|+
T Consensus        10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~--~~~~~~lv~E~~~~g~   86 (263)
T d1sm2a_          10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL--EQAPICLVFEFMEHGC   86 (263)
T ss_dssp             EEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEEEECCTTCB
T ss_pred             EEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEEC--CCCCEEEEEEECCCCC
T ss_conf             88982088829999998899999999987886-76899999999999668997565352431--5993379998369991


Q ss_pred             HHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCCEEEE
Q ss_conf             67876119999999989999999999999999998449996248989998685189997599002111000257752343
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~  940 (1060)
                      |.+++...    ...+++..+..|+.|+|.||.||| +++|+||||||+|||++ .++.+||+|||+++...........
T Consensus        87 L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH-~~~iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          87 LSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             HHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCTTCSGGGEEEC-GGGCEEECSCC--------------
T ss_pred             HHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHH-CCCEEECCCCHHHEEEC-CCCCEEECCCCHHEECCCCCCEEEC
T ss_conf             89975201----347889999999999999877653-16431044315326666-8877686553210023688733504


Q ss_pred             CCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             1685445452010147887899833069899999999909988-888889998657578999998518998422223455
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCA-GDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...||..|+|||++.+..+  +.++|||||||++|||+|+..| +...       ...+..... ..+...  ..+    
T Consensus       161 ~~~gt~~y~aPE~l~~~~~--~~k~DVwS~Gvil~el~t~~~~~~~~~-------~~~~~~~~i-~~~~~~--~~p----  224 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFSRY--SSKSDVWSFGVLMWEVFSEGKIPYENR-------SNSEVVEDI-STGFRL--YKP----  224 (263)
T ss_dssp             ----CTTSCCHHHHTTCCC--CHHHHHHHHHHHHHHHHTTSCCTTCSC-------CHHHHHHHH-HHTCCC--CCC----
T ss_pred             CEECCCCCCCHHHHCCCCC--CCHHHHCCHHHHHHHHHHCCCCCCCCC-------CHHHHHHHH-HHCCCC--CCC----
T ss_conf             3001766678578607999--840332105999999987898887789-------999999999-806888--995----


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             23793578889999999988004-999999977899985049
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                             .....++.+++.+||+ +|++||||+||+++|++|
T Consensus       225 -------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         225 -------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             -------43679999999997657976891999999999999

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=364.57  Aligned_cols=249  Identities=26%  Similarity=0.436  Sum_probs=197.9

Q ss_pred             CCEECCCCCEEEEEEEECC-C---CEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEE
Q ss_conf             8700122664999999949-9---39999993322-18889999999999733999802220128967899803999971
Q 001527          781 AEVLGRSSHGTSYRATLEN-G---MFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~  855 (1060)
                      .++||+|+||+||+|+++. +   ..||+|++... .....+.|.+|++++++++|||||+++|++.  .....++||||
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~--~~~~~~iv~Ey  108 (299)
T d1jpaa_          31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT--KSTPVMIITEF  108 (299)
T ss_dssp             EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSSCEEEEEC
T ss_pred             EEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEEEEE
T ss_conf             5698027882999999957997889999999784459899999999999998579988861899996--28877999972


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCC
Q ss_conf             38999678761199999999899999999999999999984499962489899986851899975990021110002577
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~  935 (1060)
                      +++|+|.+++...    ...++|.++++++.|+|.||.||| +++|+||||||+|||++ .++.+||+|||+++......
T Consensus       109 ~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         109 MENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLA-DMNYVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             CTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEC-TTCCEEECCC----------
T ss_pred             CCCCCCEEEECCC----CCCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCEEEEC-CCCCEEECCCCCCEECCCCC
T ss_conf             2798530021045----679999999999999999889885-27983576150448988-99919988844315756777


Q ss_pred             CEEE----ECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf             5234----3168544545201014788789983306989999999990-9988888889998657578999998518998
Q 001527          936 TIEQ----ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGS 1010 (1060)
Q Consensus       936 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 1010 (1060)
                      ....    ....|++.|+|||++.+..+  +.++|||||||++|||+| |+.||....       ..+.+.... .+...
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-------~~~~~~~i~-~~~~~  252 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKF--TSASDVWSYGIVMWEVMSYGERPYWDMT-------NQDVINAIE-QDYRL  252 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCC--CHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHH-TTCCC
T ss_pred             CCCEEEECCCCCCCCCCCCHHHHHCCCC--CCCCCCCCCHHHHHHHHHCCCCCCCCCC-------HHHHHHHHH-CCCCC
T ss_conf             7653650256668830038788836997--8612144535789999867999999999-------999999997-37889


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             42222345523793578889999999988004-999999977899985049
Q 001527         1011 DCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1011 ~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                                   +...+.+..+.+++.+||+ +|.+||||.||++.|+.|
T Consensus       253 -------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         253 -------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             -------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             -------------99742269999999997587976892999999999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.79  Aligned_cols=262  Identities=23%  Similarity=0.324  Sum_probs=202.5

Q ss_pred             CCCCHHHHHCCCCCEECCCCCEEEEEEEECC-C-----CEEEEEECCCCH-HHHHHHHHHHHHHHHCC-CCCCEEEEEEE
Q ss_conf             7789565402678700122664999999949-9-----399999933221-88899999999997339-99802220128
Q 001527          769 LTLTPEELSRAPAEVLGRSSHGTSYRATLEN-G-----MFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGY  840 (1060)
Q Consensus       769 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~g~  840 (1060)
                      +.++.+++..  .++||+|+||+||+|++.. +     ..||+|.+.... ......+.+|+.++.++ +|||||+++|+
T Consensus        32 wei~~~~~~l--~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~  109 (325)
T d1rjba_          32 WEFPRENLEF--GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA  109 (325)
T ss_dssp             GBCCGGGEEE--EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCHHHEEE--EEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf             6577899397--01983078819999998578855420499999966335878999999999999971589968687788


Q ss_pred             EECCCCCCEEEEEEECCCCCHHHHHHCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf             9678998039999713899967876119999------------------9999899999999999999999984499962
Q 001527          841 YWGPTQHEKLILSDYISPGSLASFLYDRPGR------------------KGPPLTWAQRLKIAVDVARGLNYLHFDRAVP  902 (1060)
Q Consensus       841 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~ii  902 (1060)
                      +.  +....++||||+++|+|.++++.....                  ....+++..++.|+.|++.||+||| +++|+
T Consensus       110 ~~--~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH-~~~Ii  186 (325)
T d1rjba_         110 CT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCV  186 (325)
T ss_dssp             EC--SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH-HTTEE
T ss_pred             EE--ECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEE
T ss_conf             86--2995899997279995999998625777510221000012220012577899999999999999999997-39905


Q ss_pred             CCCCCCCCEEEECCCCCEEECCCCCCEEECCCCCEE-EECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHH-C
Q ss_conf             489899986851899975990021110002577523-43168544545201014788789983306989999999990-9
Q 001527          903 HGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-G  980 (1060)
Q Consensus       903 HrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~ellt-G  980 (1060)
                      ||||||+|||++ .++.+||+|||+|+......... .....||+.|+|||++.+..+  +.++|||||||++|||+| |
T Consensus       187 HRDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         187 HRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             ETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC--CHHHHHHHHHHHHHHHTTTS
T ss_pred             ECCCCHHCCCCC-CCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCC--CCCEECCCHHHHHHHHHHCC
T ss_conf             052703214434-598289851422220457786156234357876578388727999--96330300039999998389


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHH
Q ss_conf             98888888999865757899999851899842222345523793578889999999988004-9999999778999850
Q 001527          981 RCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLS 1058 (1060)
Q Consensus       981 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~ 1058 (1060)
                      +.||......       +.+......+...+             ........+.+++.+||+ +|++||||+||+++|.
T Consensus       264 ~~Pf~~~~~~-------~~~~~~~~~~~~~~-------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         264 VNPYPGIPVD-------ANFYKLIQNGFKMD-------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSSTTCCCS-------HHHHHHHHTTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCHH-------HHHHHHHHCCCCCC-------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             9999998989-------99999985699899-------------88767899999999975889668939999999974

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=361.49  Aligned_cols=245  Identities=22%  Similarity=0.378  Sum_probs=196.4

Q ss_pred             EECCCCCEEEEEEEEC---CCCEEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECCC
Q ss_conf             0012266499999994---99399999933221-8889999999999733999802220128967899803999971389
Q 001527          783 VLGRSSHGTSYRATLE---NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       783 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~  858 (1060)
                      +||+|+||+||+|.++   ++..||||+++... ....++|.+|++++++++|||||+++|++..   +..++||||+++
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~lvmE~~~~   92 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGG   92 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECCTT
T ss_pred             EEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC---CEEEEEEEECCC
T ss_conf             87306080999999960897689999998820397899999999999986799888068656036---807999980789


Q ss_pred             CCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCCEE
Q ss_conf             99678761199999999899999999999999999984499962489899986851899975990021110002577523
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~  938 (1060)
                      |+|.+++...    ...+++.++.+++.|+|.||.||| +++|+||||||+|||++ .++.+||+|||+++.........
T Consensus        93 g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH-~~~iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~  166 (285)
T d1u59a_          93 GPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYY  166 (285)
T ss_dssp             EEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEE-ETTEEEECCCTTCEECTTCSCEE
T ss_pred             CCHHHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHH-HCCEECCCCCHHHEEEC-CCCCEEECCCHHHHCCCCCCCCC
T ss_conf             9689975212----569999999999999999878998-68810576764660454-68854203313421155434321


Q ss_pred             E--ECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf             4--3168544545201014788789983306989999999990-998888888999865757899999851899842222
Q 001527          939 Q--ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       939 ~--~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      .  ....||+.|+|||++.+..+  +.++|||||||++|||+| |+.||.....       .+.. ..+..+...+.   
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~--~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-------~~~~-~~i~~~~~~~~---  233 (285)
T d1u59a_         167 TARSAGKWPLKWYAPECINFRKF--SSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PEVM-AFIEQGKRMEC---  233 (285)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHCEE--CHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------HHHH-HHHHTTCCCCC---
T ss_pred             CCCCCCCCCCCCCCHHHHHCCCC--CCCCHHHCCHHHHHHHHHCCCCCCCCCCH-------HHHH-HHHHCCCCCCC---
T ss_conf             13562113743358688727999--95412322017899999389999999799-------9999-99981899999---


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHC
Q ss_conf             345523793578889999999988004-99999997789998504
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                                ....+..+.+++.+||+ +|++||+|.+|++.|+.
T Consensus       234 ----------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         234 ----------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf             ----------97678999999999757797689099999999999

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.00  Aligned_cols=245  Identities=20%  Similarity=0.312  Sum_probs=196.9

Q ss_pred             CCCCEECCCCCEEEEEEEE-CCCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECC
Q ss_conf             6787001226649999999-499399999933221888999999999973399980222012896789980399997138
Q 001527          779 APAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       779 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~  857 (1060)
                      ...+.||+|+||+||+|+. .+|+.||+|+++.......+.+.+|++++++++|||||++++++.  +....++||||++
T Consensus        23 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~ivmEy~~  100 (293)
T d1yhwa1          23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVMEYLA  100 (293)
T ss_dssp             CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEEEEEECCT
T ss_pred             EEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--ECCEEEEEEEECC
T ss_conf             88789812858299999998999899999984301727999999999998679998805857798--8999899997037


Q ss_pred             CCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCCE
Q ss_conf             99967876119999999989999999999999999998449996248989998685189997599002111000257752
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~  937 (1060)
                      +|+|.+++...      .+++.++..++.|++.||.||| +++|+||||||+|||++ .++.+||+|||+|+........
T Consensus       101 gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH-~~~iiHrDiKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1         101 GGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             TCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCHHHEEEC-CCCCEEECCCHHHEEECCCCCC
T ss_conf             98089886415------9999999999999999999999-87972267768886887-8996864251564132136664


Q ss_pred             EEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             34316854454520101478878998330698999999999099888888899986575789999985189984222234
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      . ....||+.|+|||++.+..+  +.++||||+||++|||+||+.||...       ...+............      .
T Consensus       173 ~-~~~~gt~~Y~aPE~~~~~~~--~~~~DiwSlGvilyemltG~~Pf~~~-------~~~~~~~~~~~~~~~~------~  236 (293)
T d1yhwa1         173 R-STMVGTPYWMAPEVVTRKAY--GPKVDIWSLGIMAIEMIEGEPPYLNE-------NPLRALYLIATNGTPE------L  236 (293)
T ss_dssp             B-CCCCSCGGGCCHHHHSSSCB--CTHHHHHHHHHHHHHHHHSSCTTTTS-------CHHHHHHHHHHHCSCC------C
T ss_pred             C-CCCCCCCCCCCHHHHCCCCC--CCHHCEEHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHHCCCCC------C
T ss_conf             4-44444777368266447998--80120313729999980488998997-------9999999998579998------8


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHH
Q ss_conf             5523793578889999999988004-9999999778999
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                            +........+.+++.+|++ +|.+|||+.|+++
T Consensus       237 ------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 ------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ------885537999999999986699668909999964

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=361.83  Aligned_cols=259  Identities=25%  Similarity=0.353  Sum_probs=203.8

Q ss_pred             CCCCHHHHHCCCCCEECCCCCEEEEEEEECCCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCC
Q ss_conf             77895654026787001226649999999499399999933221888999999999973399980222012896789980
Q 001527          769 LTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHE  848 (1060)
Q Consensus       769 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~  848 (1060)
                      +.++.+++..  .+.||+|+||.||+|+++++..||+|+++... ...+.|.+|+.++++++|||||+++|++.   .+.
T Consensus        12 ~~i~~~~~~i--~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~---~~~   85 (285)
T d1fmka3          12 WEIPRESLRL--EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEP   85 (285)
T ss_dssp             SBCCGGGEEE--EEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSS
T ss_pred             EECCHHHEEE--EEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEE---CCC
T ss_conf             0747799798--46993079809999999999999999988044-88899999999998666678868999982---397


Q ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCC
Q ss_conf             39999713899967876119999999989999999999999999998449996248989998685189997599002111
Q 001527          849 KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLH  928 (1060)
Q Consensus       849 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla  928 (1060)
                      .++||||+++|++..++....   ...++|.+++.|+.|++.||+||| +.+|+||||||+|||++ .++.+||+|||++
T Consensus        86 ~~lv~Ey~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH-~~~ivH~DlKp~NIll~-~~~~~kl~DfGla  160 (285)
T d1fmka3          86 IYIVTEYMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVG-ENLVCKVADFGLA  160 (285)
T ss_dssp             CEEEECCCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEC-GGGCEEECCCCTT
T ss_pred             EEEEEEECCCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHH-HHHEECCCCCCEEEEEC-CCCCEEECCCCHH
T ss_conf             599999447994354200003---553059999999999999999875-41143353123079998-9992998442555


Q ss_pred             EEECCCCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             00025775234316854454520101478878998330698999999999099888888899986575789999985189
Q 001527          929 RLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008 (1060)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 1008 (1060)
                      +..............|++.|+|||++....+  +.++||||||+++|||+||..|+...      ....+....... +.
T Consensus       161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~ksDI~S~Giil~el~t~~~p~~~~------~~~~~~~~~i~~-~~  231 (285)
T d1fmka3         161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRF--TIKSDVWSFGILLTELTTKGRVPYPG------MVNREVLDQVER-GY  231 (285)
T ss_dssp             C--------------CCGGGSCHHHHHHCCC--CHHHHHHHHHHHHHHHHTTTCCSSTT------CCHHHHHHHHHT-TC
T ss_pred             HHCCCCCCEEECCCCCCCCCCCHHHHHCCCC--CCHHHHHCCHHHHHHHHHCCCCCCCC------CCHHHHHHHHHH-CC
T ss_conf             4256887335245455665458089837998--91774132358999998689999988------889999999982-68


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             9842222345523793578889999999988004-999999977899985049
Q 001527         1009 GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1009 ~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ...             .......++.+++.+||+ +|++||+|++|+++|+.+
T Consensus       232 ~~~-------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         232 RMP-------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             CCC-------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             CCC-------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             999-------------9832379999999997566975891999999987666

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.14  Aligned_cols=248  Identities=24%  Similarity=0.397  Sum_probs=202.8

Q ss_pred             CCEECCCCCEEEEEEEECCCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECCCCC
Q ss_conf             87001226649999999499399999933221888999999999973399980222012896789980399997138999
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPGS  860 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~gs  860 (1060)
                      .++||+|+||+||+|++++++.||+|+++.... ..++|.+|++++++++|||||+++|+|.  +....++||||+++|+
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~--~~~~~~iv~Ey~~~g~   85 (258)
T d1k2pa_           9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIFIITEYMANGC   85 (258)
T ss_dssp             CCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEC--CSSSEEEEEECCTTEE
T ss_pred             EEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEE--ECCCEEEEEECCCCCC
T ss_conf             689820788399999988998999999874757-7899999999999668986015889985--0781699997048993


Q ss_pred             HHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCCEEEE
Q ss_conf             67876119999999989999999999999999998449996248989998685189997599002111000257752343
Q 001527          861 LASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQI  940 (1060)
Q Consensus       861 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~  940 (1060)
                      +.+++....    ..+++..+.+++.|+++||.||| +++|+||||||+|||++ .+..+||+|||+++...........
T Consensus        86 l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH-~~~iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          86 LLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             HHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHH-HTTBCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             HHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCEEEEEC-CCCCEEECCCHHHEECCCCCCEEEC
T ss_conf             888641024----67768999999999999999875-46843466541358876-9984798861442023578722524


Q ss_pred             CCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             168544545201014788789983306989999999990-9988888889998657578999998518998422223455
Q 001527          941 LDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMP 1019 (1060)
Q Consensus       941 ~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 1019 (1060)
                      ...|+..|+|||++.+..+  +.++||||||+++|||+| |+.||....       ..+. ...+..+...  ..+    
T Consensus       160 ~~~~t~~y~aPE~~~~~~~--~~ksDiwS~G~~l~el~t~g~~Pf~~~~-------~~~~-~~~i~~~~~~--~~p----  223 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKF--SSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSET-AEHIAQGLRL--YRP----  223 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCC--CHHHHHHHHHHHHHHHHTTSCCTTTTSC-------HHHH-HHHHHTTCCC--CCC----
T ss_pred             CCCCCCCCCCCHHHCCCCC--CCCEEECCCCHHHHHHHHCCCCCCCCCC-------HHHH-HHHHHHCCCC--CCC----
T ss_conf             6578877578078637998--8521033643246739755999988999-------9999-9999807978--996----


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             23793578889999999988004-999999977899985049
Q 001527         1020 EMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1020 ~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                             ......+.+++.+||+ +|++||||.|+++.|.+|
T Consensus       224 -------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         224 -------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf             -------54659999999997668976893999999874188

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.27  Aligned_cols=245  Identities=21%  Similarity=0.317  Sum_probs=195.8

Q ss_pred             CEECCCCCEEEEEEEECC---CCEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEEC
Q ss_conf             700122664999999949---9399999933221--88899999999997339998022201289678998039999713
Q 001527          782 EVLGRSSHGTSYRATLEN---GMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~  856 (1060)
                      ++||+|+||+||+|.+++   ++.||+|+++...  ....++|.+|++++++++|||||+++|+|.   .+..++||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~---~~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AESWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SSSEEEEEECC
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEC---CCCEEEEEECC
T ss_conf             783458782999999816973859999998801089899999999999998679989852777750---59779999747


Q ss_pred             CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCC
Q ss_conf             89996787611999999998999999999999999999844999624898999868518999759900211100025775
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++.++.+|+.|++.||.||| +++|+||||||+|||++ .++.+|++|||+++.......
T Consensus        90 ~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH-~~~iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          90 ELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             TTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCS
T ss_pred             CCCCHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCHHHCCC-CCCCCCCCCHHHHHHCCCCCC
T ss_conf             889689997522-----57899999999999999976687-47955677761131023-567512341345331343234


Q ss_pred             EEE--ECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf             234--3168544545201014788789983306989999999990-9988888889998657578999998518998422
Q 001527          937 IEQ--ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013 (1060)
Q Consensus       937 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 1013 (1060)
                      ...  ....||+.|+|||++.+..+  +.++|||||||++|||+| |+.||....       ..+. ...+..+....  
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~~~~--~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-------~~~~-~~~i~~~~~~~--  230 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINYYKF--SSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEV-TAMLEKGERMG--  230 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEE--EHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHH-HHHHHTTCCCC--
T ss_pred             CCCCCCCCCCCCEECCCHHHCCCCC--CCHHHHCCCHHHHHHHHHCCCCCCCCCC-------HHHH-HHHHHCCCCCC--
T ss_conf             4322445677842039166537999--8434430340313289658999999989-------9999-99998289999--


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHC
Q ss_conf             22345523793578889999999988004-99999997789998504
Q 001527         1014 DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1014 d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                                 .....+..+.+++.+||+ +|++||||.||+++|+.
T Consensus       231 -----------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         231 -----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             -----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             -----------986567999999999758897689098999998528

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.43  Aligned_cols=250  Identities=24%  Similarity=0.407  Sum_probs=196.9

Q ss_pred             CCEECCCCCEEEEEEEECCC-----CEEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEE
Q ss_conf             87001226649999999499-----399999933221-888999999999973399980222012896789980399997
Q 001527          781 AEVLGRSSHGTSYRATLENG-----MFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e  854 (1060)
                      .++||+|+||.||+|.++++     ..||||+++... .....+|.+|++++++++|||||+++|++.  .....++|+|
T Consensus        12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~--~~~~~~~v~e   89 (283)
T d1mqba_          12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--KYKPMMIITE   89 (283)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSEEEEEE
T ss_pred             EEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--CCCCEEEEEE
T ss_conf             15981177909999999689987879999999884459689999999999998568987832367783--3880389997


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCC
Q ss_conf             13899967876119999999989999999999999999998449996248989998685189997599002111000257
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~  934 (1060)
                      |+.+|++.+++....    ..++|.++.+++.|++.||.||| +++|+||||||+|||++ .++.+||+|||+++.....
T Consensus        90 ~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH-~~~iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          90 YMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA-NMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             CCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEC-TTCCEEECCCCC-------
T ss_pred             ECCCCCCHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCCCCCCEEEEC-CCCEEEECCCCHHHCCCCC
T ss_conf             213574022210234----54208999999999998541212-12342576564427888-9984998455103003578


Q ss_pred             CCE--EEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf             752--343168544545201014788789983306989999999990998888888999865757899999851899842
Q 001527          935 GTI--EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       935 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ...  ......||..|+|||++.+..+  +.++|||||||++|||++|..|+....      ...+... .+..+...  
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~--~~~sDI~S~Gvil~el~t~~~~~~~~~------~~~~~~~-~i~~~~~~--  232 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKF--TSASDVWSFGIVMWEVMTYGERPYWEL------SNHEVMK-AINDGFRL--  232 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCC--CHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHH-HHHTTCCC--
T ss_pred             CCCCEEECCCCCCCCCCCHHHHCCCCC--CCCCCCCCCHHHHHHHHHCCCCCCCCC------CHHHHHH-HHHCCCCC--
T ss_conf             765267426777734348888704999--973556344898999996798865568------9999999-98635789--


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             222345523793578889999999988004-999999977899985049
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                                 +...+.+..+.+++.+||+ +|++||||.||+++|+.|
T Consensus       233 -----------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         233 -----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             -----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----------CCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             -----------98504579999999997767976893999999999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=353.59  Aligned_cols=247  Identities=19%  Similarity=0.293  Sum_probs=199.5

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECCCC
Q ss_conf             870012266499999994-9939999993322188899999999997339998022201289678998039999713899
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++|||||++++++.  +....++||||+++|
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~ivmE~~~gg  108 (350)
T d1koaa2          31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE--DDNEMVMIYEFMSGG  108 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE--ETTEEEEEECCCCSC
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEEEECCCCC
T ss_conf             889840768199999988999899999984524316999999999998679979992999999--899999999857998


Q ss_pred             CHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC-CCCCEEECCCCCCEEECCCCCEE
Q ss_conf             96787611999999998999999999999999999844999624898999868518-99975990021110002577523
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG-PDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~-~~~~~kl~Dfgla~~~~~~~~~~  938 (1060)
                      +|.+++...    ...+++..+..|+.|++.||.||| +.+|+||||||+|||++. .+..+||+|||+++.........
T Consensus       109 ~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH-~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  183 (350)
T d1koaa2         109 ELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  183 (350)
T ss_dssp             BHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred             CHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHH-HCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCCCCC
T ss_conf             899999762----378999999999999999999997-569760001546736416889869995452104425654320


Q ss_pred             EECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             43168544545201014788789983306989999999990998888888999865757899999851899842222345
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      .  ..||+.|+|||++.+..+  +.++||||+||++|||++|+.||...       ...+...........   ++.   
T Consensus       184 ~--~~gT~~Y~aPEv~~~~~~--~~~~DiwSlGvilyell~G~~Pf~~~-------~~~~~~~~i~~~~~~---~~~---  246 (350)
T d1koaa2         184 V--TTGTAEFAAPEVAEGKPV--GYYTDMWSVGVLSYILLSGLSPFGGE-------NDDETLRNVKSCDWN---MDD---  246 (350)
T ss_dssp             E--ECSCTTTCCHHHHHTCCB--CHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHHTCCC---SCC---
T ss_pred             E--ECCCCCCCCHHHHCCCCC--CHHHHHHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHHCCCC---CCC---
T ss_conf             0--068624218899758998--72676554659999998598998997-------999999999847889---894---


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             523793578889999999988004-99999997789998
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                           .........+.+++.+|++ +|++|||+.|+++.
T Consensus       247 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 -----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             -----2235899999999999756896679089998629

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=360.33  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=196.9

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECC
Q ss_conf             870012266499999994-99399999933221--888999999999973399980222012896789980399997138
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||+||+|+.. +|+.||+|.++...  ....+.+.+|++++++++|||||++++++.+......++||||++
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~   88 (269)
T d2java1           9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE   88 (269)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEECCC
T ss_conf             67983088919999999999979999998746579799999999999999778999824899999178998999995689


Q ss_pred             CCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-----CCCCCCCCCCCEEEECCCCCEEECCCCCCEEEC
Q ss_conf             999678761199999999899999999999999999984499-----962489899986851899975990021110002
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDR-----AVPHGNLKATNILLDGPDLNARVADYCLHRLMT  932 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~  932 (1060)
                      +|+|.+++.... +....+++..+..++.|++.||.||| +.     +|+||||||+|||++ .+..+||+|||+|+...
T Consensus        89 ~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH-~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~  165 (269)
T d2java1          89 GGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECH-RRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILN  165 (269)
T ss_dssp             TEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHH-HHCC---------CCGGGEEEC-TTSCEEECCHHHHHHC-
T ss_pred             CCCHHHHHHHCC-CCCCCCCHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEECCCCHHHCCCC-CCCCEEEEECCCEEECC
T ss_conf             993899998515-45789999999999999999999999-7167788788586765425747-88857980010003224


Q ss_pred             CCCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf             57752343168544545201014788789983306989999999990998888888999865757899999851899842
Q 001527          933 QAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       933 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ....... ...||+.|+|||++.+..+  +.++|||||||++|||+||+.||...       ...+... .+..+.....
T Consensus       166 ~~~~~~~-~~~gt~~Y~APE~l~~~~~--~~~~DIwSlGvilyel~tg~~Pf~~~-------~~~~~~~-~i~~~~~~~~  234 (269)
T d2java1         166 HDTSFAK-AFVGTPYYMSPEQMNRMSY--NEKSDIWSLGCLLYELCALMPPFTAF-------SQKELAG-KIREGKFRRI  234 (269)
T ss_dssp             -----------CCCSCCCHHHHTTCCC--CHHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHH-HHHHTCCCCC
T ss_pred             CCCCCCC-CCCCCCCCCCHHHHCCCCC--CHHHHHHHHCHHHHHHHHCCCCCCCC-------CHHHHHH-HHHCCCCCCC
T ss_conf             5777556-6778823279999839999--93898875278999980188998998-------9999999-9971899889


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHH
Q ss_conf             222345523793578889999999988004-9999999778999
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                            +       .....++.+++.+|++ +|.+|||+.|+++
T Consensus       235 ------~-------~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         235 ------P-------YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ------C-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------C-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             ------7-------435999999999976799557918999972

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.32  Aligned_cols=246  Identities=21%  Similarity=0.208  Sum_probs=194.1

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHH-HHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECCC
Q ss_conf             870012266499999994-993999999332218-889999999999733999802220128967899803999971389
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .++||+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++++++|||||++++++.  +....++||||+++
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~--~~~~~~ivmEy~~g   87 (271)
T d1nvra_          10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR--EGNIQYLFLEYCSG   87 (271)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE--ETTEEEEEEECCTT
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEC--CCCEEEEEEECCCC
T ss_conf             9897217480999999999997999999845664127999999999998579988846965404--67436798864589


Q ss_pred             CCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCCE-
Q ss_conf             9967876119999999989999999999999999998449996248989998685189997599002111000257752-
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI-  937 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~-  937 (1060)
                      |+|.+++..     ...+++.++..++.|++.||.||| +++|+||||||+|||++ .+..+||+|||+|+........ 
T Consensus        88 g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH-~~~IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          88 GELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             EEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEC-TTCCEEECCCTTCEECEETTEEC
T ss_pred             CCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCHHHEEEC-CCCCEEECCCHHHEEECCCCCCC
T ss_conf             808999753-----799999999999999999999999-75983575468997887-89987983231422404688653


Q ss_pred             EEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             34316854454520101478878998330698999999999099888888899986575789999985189984222234
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAV 1017 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 1017 (1060)
                      ......||+.|+|||++.+..+ +++++||||+||++|||+||+.||+......      .............       
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~-~~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~~~~~~~~~~-------  226 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREF-HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYL-------  226 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSB-CHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS------HHHHHHHTTCTTS-------
T ss_pred             CCCCEEECCCCCCHHHHCCCCC-CCCCEEEEHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHHCCCCCC-------
T ss_conf             1113255747428728618999-9971016173799999982997888898599------9999986388878-------


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHH
Q ss_conf             5523793578889999999988004-9999999778999
Q 001527         1018 MPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1018 ~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                            +........+.+++.+|++ +|++|||++|+++
T Consensus       227 ------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ------864469999999999976799668909999961

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=349.46  Aligned_cols=243  Identities=24%  Similarity=0.386  Sum_probs=190.8

Q ss_pred             CEECCCCCEEEEEEEEC-CCCEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC--CCCCEEEEEEEC
Q ss_conf             70012266499999994-9939999993322--188899999999997339998022201289678--998039999713
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGP--TQHEKLILSDYI  856 (1060)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~--~~~~~~lv~e~~  856 (1060)
                      ++||+|+||+||+|+.. +++.||+|++...  .....+.+.+|++++++++|||||++++++...  .....++||||+
T Consensus        15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~   94 (270)
T d1t4ha_          15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM   94 (270)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred             EEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEEECC
T ss_conf             69700828499999999999599999985122798999999999999985799985069999840334588899999578


Q ss_pred             CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC--CCCCCCCCCCEEEECCCCCEEECCCCCCEEECCC
Q ss_conf             89996787611999999998999999999999999999844999--6248989998685189997599002111000257
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRA--VPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~--iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~  934 (1060)
                      ++|+|.+++...     ..+++..+..++.|++.||+||| +++  |+||||||+|||+++++..+||+|||+|+.....
T Consensus        95 ~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH-~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          95 TSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH-TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             CCCCHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHH-HCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECCCC
T ss_conf             989489997513-----55469999999999999999999-789979968767435116679998898005765423687


Q ss_pred             CCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf             75234316854454520101478878998330698999999999099888888899986575789999985189984222
Q 001527          935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      ..   ....||+.|+|||++.+.   ++.++||||+||++|||++|+.||....      ......+ .+..+.....+ 
T Consensus       169 ~~---~~~~GT~~Y~aPE~~~~~---~~~~~DIwSlGvilyel~~g~~Pf~~~~------~~~~~~~-~i~~~~~~~~~-  234 (270)
T d1t4ha_         169 FA---KAVIGTPEFMAPEMYEEK---YDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYR-RVTSGVKPASF-  234 (270)
T ss_dssp             SB---EESCSSCCCCCGGGGGTC---CCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHH-HHTTTCCCGGG-
T ss_pred             CC---CCCCCCCCCCCHHHHCCC---CCCCCCHHHHHHHHHHHHHCCCCCCCCC------CHHHHHH-HHHCCCCCCCC-
T ss_conf             66---775538130089884789---9986711007999999987889998765------5999999-99738998656-


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHH
Q ss_conf             2345523793578889999999988004-9999999778999
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                                 ......++.+++.+|++ +|++|||+.|+++
T Consensus       235 -----------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         235 -----------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -----------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -----------7557899999999976379758929999967

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=350.71  Aligned_cols=247  Identities=17%  Similarity=0.275  Sum_probs=198.4

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECCCC
Q ss_conf             870012266499999994-9939999993322188899999999997339998022201289678998039999713899
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|+||.||+|+.. +|+.||+|+++.......+.+.+|++++++++|||||++++++.  +....++||||+++|
T Consensus        34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~ivmE~~~gg  111 (352)
T d1koba_          34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKYEMVLILEFLSGG  111 (352)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE--CSSEEEEEEECCCCC
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEEEECCCCC
T ss_conf             899931778299999998999799999988726467999999999998679979891999999--899999999828998


Q ss_pred             CHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC-CCCCEEECCCCCCEEECCCCCEE
Q ss_conf             96787611999999998999999999999999999844999624898999868518-99975990021110002577523
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG-PDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~-~~~~~kl~Dfgla~~~~~~~~~~  938 (1060)
                      +|.+++...    ...+++.++..|+.|++.||.||| +++|+||||||+|||++. .+..+||+|||+|+.........
T Consensus       112 ~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH-~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~  186 (352)
T d1koba_         112 ELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  186 (352)
T ss_dssp             BHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             HHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHH-HCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCCCEE
T ss_conf             088889863----899899999999999999999999-779265131445531134678848995256303437887201


Q ss_pred             EECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             43168544545201014788789983306989999999990998888888999865757899999851899842222345
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      .  ..|++.|+|||++.+..+  +.++||||+||++|||+||+.||...       ...+........ ...  +.... 
T Consensus       187 ~--~~gt~~y~aPE~~~~~~~--~~~~DiwSlGvilyelltG~~Pf~~~-------~~~~~~~~i~~~-~~~--~~~~~-  251 (352)
T d1koba_         187 V--TTATAEFAAPEIVDREPV--GFYTDMWAIGVLGYVLLSGLSPFAGE-------DDLETLQNVKRC-DWE--FDEDA-  251 (352)
T ss_dssp             E--ECSSGGGCCHHHHTTCCB--CHHHHHHHHHHHHHHHHHSCCSSCCS-------SHHHHHHHHHHC-CCC--CCSST-
T ss_pred             E--CCCCCCCCCHHHHCCCCC--CCCCCHHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHHC-CCC--CCCCC-
T ss_conf             0--047645348999747998--97633389899999999688998997-------999999999847-889--89300-


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             523793578889999999988004-99999997789998
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                             .......+.+++.+|++ +|.+|||+.|+++.
T Consensus       252 -------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         252 -------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             -------24799999999999756996689189999609

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.08  Aligned_cols=263  Identities=19%  Similarity=0.296  Sum_probs=192.7

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECCC
Q ss_conf             870012266499999994-99399999933221-8889999999999733999802220128967899803999971389
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .++||+|+||+||+|+.. +++.||+|+++... ....+.+.+|++++++++|||||+++++|.  +....++||||+++
T Consensus        11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~iVmEy~~g   88 (322)
T d1s9ja_          11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDG   88 (322)
T ss_dssp             EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE--CSSEEEEEEECCTT
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEEEECCCC
T ss_conf             7897127780999999989996999999875409789999999999998679999994999999--89999999976799


Q ss_pred             CCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCCEE
Q ss_conf             99678761199999999899999999999999999984499962489899986851899975990021110002577523
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~  938 (1060)
                      |+|.+++...     ..+++..+..++.|++.||.|||+.++|+||||||+|||++ .++.+||+|||+|+........ 
T Consensus        89 g~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~~~~-  161 (322)
T d1s9ja_          89 GSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-  161 (322)
T ss_dssp             EEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHHTC--
T ss_pred             CCHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEC-CCCCEEEEECCCCCCCCCCCCC-
T ss_conf             8689987424-----99999999999999999999999859997144577994687-8998999548776256788621-


Q ss_pred             EECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHH--------CCCC-
Q ss_conf             4316854454520101478878998330698999999999099888888899986575789999985--------1899-
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA--------EGHG- 1009 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~--------~~~~- 1009 (1060)
                        ...||..|+|||++.+..+  +.++||||+||++|||++|+.||.....................        .... 
T Consensus       162 --~~~GT~~Y~APEvl~~~~y--~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         162 --SFVGTRSYMSPERLQGTHY--SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             ----CCSSCCCCHHHHHCSCC--CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             --CCCCCCCCCCCHHHCCCCC--CCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf             --1137714119468758998--948889989999999998889989988789999998875177545774212333221


Q ss_pred             -CCCCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             -8422223------------45523793578889999999988004-99999997789998
Q 001527         1010 -SDCFDAA------------VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1010 -~~~~d~~------------l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                       ....+..            ...............++.+++.+|++ +|.+|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf             1112223541347788766502687667644489999999999868994679089999609

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=351.33  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=201.0

Q ss_pred             CCEECCCCCEEEEEEEEC------CCCEEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEE
Q ss_conf             870012266499999994------99399999933221-88899999999997339998022201289678998039999
Q 001527          781 AEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~  853 (1060)
                      .+.||+|+||+||+|+++      +++.||||+++... ....++|.+|++++++++||||++++++|.  .....++|+
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~--~~~~~~~v~   95 (301)
T d1lufa_          18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA--VGKPMCLLF   95 (301)
T ss_dssp             EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSCEEEE
T ss_pred             EEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC--CCCCEEEEE
T ss_conf             679820788399999988876577882999999882108579999999999999668997655246660--598038999


Q ss_pred             EECCCCCHHHHHHCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEE
Q ss_conf             71389996787611999-------------------99999899999999999999999984499962489899986851
Q 001527          854 DYISPGSLASFLYDRPG-------------------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD  914 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~  914 (1060)
                      ||+++|+|.++++....                   .....+++.+++.|+.|++.||+||| +++|+||||||+|||++
T Consensus        96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH-~~~ivHrDlKp~NILld  174 (301)
T d1lufa_          96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCLVG  174 (301)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEC
T ss_pred             EECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCEEEEEECCCCEEEC
T ss_conf             81589929999985275542100001110012103467889899999999999999855413-57868548840116898


Q ss_pred             CCCCCEEECCCCCCEEECCCCCE-EEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCCCCCC
Q ss_conf             89997599002111000257752-34316854454520101478878998330698999999999099-88888889998
Q 001527          915 GPDLNARVADYCLHRLMTQAGTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR-CAGDVISGEGA  992 (1060)
Q Consensus       915 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~-~p~~~~~~~~~  992 (1060)
                       .++.+||+|||+++........ ......|+..|+|||++.+..+  +.++|||||||++|||++|. +||...     
T Consensus       175 -~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--t~ksDVwS~Gvvl~ell~~~~~p~~~~-----  246 (301)
T d1lufa_         175 -ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIFSYGLQPYYGM-----  246 (301)
T ss_dssp             -GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC--CHHHHHHHHHHHHHHHHTTTCCTTTTS-----
T ss_pred             -CCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCC--CHHHHHCCCHHHHHHHHCCCCCCCCCC-----
T ss_conf             -999289833144211367764111577776767679899726889--805630252362999980689999998-----


Q ss_pred             CCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             65757899999851899842222345523793578889999999988004-999999977899985049
Q 001527          993 GVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus       993 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                        ...+.... +.++...+.             ....+..+.+++.+||+ +|++||||.||+++|+.|
T Consensus       247 --~~~e~~~~-v~~~~~~~~-------------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         247 --AHEEVIYY-VRDGNILAC-------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             --CHHHHHHH-HHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             --CHHHHHHH-HHCCCCCCC-------------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             --99999999-973997888-------------732529999999997488965793999999999984

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.18  Aligned_cols=239  Identities=21%  Similarity=0.349  Sum_probs=193.1

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHH---HHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEEC
Q ss_conf             870012266499999994-993999999332218---8899999999997339998022201289678998039999713
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||+||+|+.. +++.||+|++.....   ...+.+.+|++++++++|||||++++++.  +....++||||+
T Consensus        11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~ivmEy~   88 (263)
T d2j4za1          11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH--DATRVYLILEYA   88 (263)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEEEECC
T ss_pred             EEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE--ECCEEEEEEEEC
T ss_conf             889851778589999998999499999981688567689999999999998568888885999999--899989998504


Q ss_pred             CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCC
Q ss_conf             89996787611999999998999999999999999999844999624898999868518999759900211100025775
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++..+..++.|++.||+||| +++|+||||||+|||++ .+..+||+|||+|+.......
T Consensus        89 ~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH-~~~ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~~~  161 (263)
T d2j4za1          89 PLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH-SKRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRR  161 (263)
T ss_dssp             TTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCCCC
T ss_pred             CCCCHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHH-HCCEEEEEECCCCCEEC-CCCCEEECCCCEEEECCCCCC
T ss_conf             798589887504-----89999999999999999999999-88946522023441466-899871155563354488852


Q ss_pred             EEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             23431685445452010147887899833069899999999909988888889998657578999998518998422223
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                         ....||+.|+|||++.+..+  +.++||||+||++|||++|+.||+..       ...+..... ......      
T Consensus       162 ---~~~~Gt~~Y~APE~~~~~~~--~~~~DiwSlGvilyell~G~~Pf~~~-------~~~~~~~~i-~~~~~~------  222 (263)
T d2j4za1         162 ---TTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFEAN-------TYQETYKRI-SRVEFT------  222 (263)
T ss_dssp             ---EETTEEGGGCCHHHHTTCCC--CTTHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHH-HTTCCC------
T ss_pred             ---CCCCCCCCCCCHHHHCCCCC--CCHHHHHHHHHHHHHHHCCCCCCCCC-------CHHHHHHHH-HCCCCC------
T ss_conf             ---35578876349999758998--93144046759999983299998889-------999999999-718999------


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHH
Q ss_conf             45523793578889999999988004-9999999778999
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                       .+.       .....+.+++.+|++ +|++|||+.|+++
T Consensus       223 -~p~-------~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 -FPD-------FVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -CCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCC-------CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -986-------68999999999976479768909999971

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=352.42  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=197.3

Q ss_pred             CCEECCCCCEEEEEEEECCC----CEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEE
Q ss_conf             87001226649999999499----39999993322-18889999999999733999802220128967899803999971
Q 001527          781 AEVLGRSSHGTSYRATLENG----MFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~  855 (1060)
                      .++||+|+||+||+|++.++    ..||||+++.. .....++|.+|++++++++|||||+++|++.. .....++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE-TTTEEEEEEEC
T ss_pred             CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCCCEEEEEEE
T ss_conf             66981368809999999779987999999998843697899999999999986789998678678980-69943899987


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCC
Q ss_conf             38999678761199999999899999999999999999984499962489899986851899975990021110002577
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~  935 (1060)
                      +++|+|.+++....    ...++..+++++.|++.||.|+| +++|+||||||+|||++ +++.+||+|||+++......
T Consensus       111 ~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH-~~~iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         111 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA-SKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEC-TTCCEEECSSGGGCCTTTTT
T ss_pred             EECCCHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHC-CCCCCCCCCCHHHEEEC-CCCCEEEECCCCHHHCCCCC
T ss_conf             40674144210134----54048999999999887652003-36762577668757677-99988991065232255665


Q ss_pred             CEE---EECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf             523---43168544545201014788789983306989999999990998888888999865757899999851899842
Q 001527          936 TIE---QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       936 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ...   .....||..|+|||++.+..+  +.++||||||+++|||+||+.|+.....   ..++..+   .. .+.... 
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~ksDI~SfGivl~El~t~~~p~~~~~~---~~~~~~~---i~-~g~~~~-  254 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKF--TTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITVY---LL-QGRRLL-  254 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCC--CHHHHHHHHHHHHHHHHTTSCCSCC---------CHHH---HH-TTCCCC-
T ss_pred             CCCCEECCCCCCCCCCCCHHHHHCCCC--CCHHHHHHHHHHHHHHHHCCCCCCCCCC---HHHHHHH---HH-CCCCCC-
T ss_conf             553100256555645567688743799--9745746619999999978999988899---9999999---98-089889-


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             222345523793578889999999988004-999999977899985049
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                           .+       ......+.+++.+||+ +|++||+|.||+++|++|
T Consensus       255 -----~p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         255 -----QP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             -----CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CC-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             -----96-------44759999999997688976893999999999999

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.19  Aligned_cols=247  Identities=20%  Similarity=0.313  Sum_probs=194.6

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECCCC
Q ss_conf             870012266499999994-9939999993322188899999999997339998022201289678998039999713899
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++.......+.+.+|++++++++|||||++++++.  +....++||||+++|
T Consensus        17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lvmEy~~~g   94 (288)
T d2jfla1          17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY--YENNLWILIEFCAGG   94 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE--ETTEEEEEEECCTTE
T ss_pred             EEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE--ECCEEEEEEECCCCC
T ss_conf             479930778199999999999399999987289999999999999998679999884988980--099589999627998


Q ss_pred             CHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCCEEE
Q ss_conf             96787611999999998999999999999999999844999624898999868518999759900211100025775234
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIEQ  939 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~  939 (1060)
                      +|.+++...    ...+++.++..++.|++.||.||| +++|+||||||+|||++ .++.+||+|||+|+......... 
T Consensus        95 ~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH-~~~ivHrDiKp~NIll~-~~~~~Kl~DFG~a~~~~~~~~~~-  167 (288)
T d2jfla1          95 AVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLH-DNKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRR-  167 (288)
T ss_dssp             EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECHHHHHHH-
T ss_pred             CHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHH-HCCEEEEECCHHHEEEC-CCCCEEEEECHHHHCCCCCCCCC-
T ss_conf             188999862----899999999999999999999999-88988714070031487-89998997161230357786410-


Q ss_pred             ECCCCCCCCCCHHCCCCC---CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             316854454520101478---87899833069899999999909988888889998657578999998518998422223
Q 001527          940 ILDAGVLGYRAPELAASK---KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       940 ~~~~gt~~y~aPE~~~~~---~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      ....||+.|+|||++...   ...++.++||||+||++|||+||+.||.....       .+......... ...     
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-------~~~~~~i~~~~-~~~-----  234 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-------MRVLLKIAKSE-PPT-----  234 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-------GGHHHHHHHSC-CCC-----
T ss_pred             CCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHCCC-CCC-----
T ss_conf             01025626479999832025788888066578789999998208899999899-------99999997079-987-----


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHH
Q ss_conf             45523793578889999999988004-9999999778999
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      +      +........+.+++.+|++ +|.+|||+.|+++
T Consensus       235 ~------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 L------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             C------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             7------765669999999999976699668919999962

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=351.83  Aligned_cols=246  Identities=20%  Similarity=0.277  Sum_probs=195.0

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHH-HHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECCC
Q ss_conf             870012266499999994-993999999332218-889999999999733999802220128967899803999971389
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA-KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .++||+|+||+||+|+.. +++.||+|++..... ...+.+.+|++++++++|||||++++++.  +....++||||+++
T Consensus        14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lvmE~~~g   91 (307)
T d1a06a_          14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE--SGGHLYLIMQLVSG   91 (307)
T ss_dssp             EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEEECCCCS
T ss_pred             EEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEEEECCCC
T ss_conf             8899406583999999999998999999815773128999999999998679989991989999--89988898852689


Q ss_pred             CCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC--CCCCEEECCCCCCEEECCCCC
Q ss_conf             996787611999999998999999999999999999844999624898999868518--999759900211100025775
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG--PDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~--~~~~~kl~Dfgla~~~~~~~~  936 (1060)
                      |+|.+++..     ...+++.++..++.|++.||.||| +++|+||||||+|||+..  ++..+||+|||+++.......
T Consensus        92 g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH-~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          92 GELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             CBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             CCHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHH-HCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCCCE
T ss_conf             848886530-----367887899999999999987524-13055687046300110468882499831543587258970


Q ss_pred             EEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             23431685445452010147887899833069899999999909988888889998657578999998518998422223
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      ..  ...||+.|+|||++.+..+  +.++||||+||++|||++|+.||....       ..+....... +...  ++  
T Consensus       166 ~~--~~~GT~~y~APE~~~~~~~--~~~~DiwSlGvilyell~g~~Pf~~~~-------~~~~~~~i~~-~~~~--~~--  229 (307)
T d1a06a_         166 LS--TACGTPGYVAPEVLAQKPY--SKAVDCWSIGVIAYILLCGYPPFYDEN-------DAKLFEQILK-AEYE--FD--  229 (307)
T ss_dssp             ---------CTTSCHHHHTTCCC--CTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHT-TCCC--CC--
T ss_pred             EE--EEEECCCCCCCHHHCCCCC--CCHHHHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHC-CCCC--CC--
T ss_conf             44--0032842259188737999--807873451599999985979999989-------9999999861-6877--78--


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             45523793578889999999988004-99999997789998
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                            .+........+.+++.+|++ +|++|||+.|+++.
T Consensus       230 ------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         230 ------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             ------76666789999999999760897579189998629

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=355.85  Aligned_cols=244  Identities=20%  Similarity=0.288  Sum_probs=191.8

Q ss_pred             CCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCH---HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEE
Q ss_conf             267870012266499999994-99399999933221---88899999999997339998022201289678998039999
Q 001527          778 RAPAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~  853 (1060)
                      +...+.||+|+||+||+|+.. +++.||+|+++...   ....+.+.+|++++++++|||||+++|++.  +....++||
T Consensus        17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~iv~   94 (309)
T d1u5ra_          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHTAWLVM   94 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTEEEEEE
T ss_pred             CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--ECCEEEEEE
T ss_conf             676279701888099999998999399999984444358899999999999999778999823899999--899889999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECC
Q ss_conf             71389996787611999999998999999999999999999844999624898999868518999759900211100025
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~  933 (1060)
                      ||+++|++..++...     ..+++.++..++.|++.||.||| +++|+||||||+|||++ .++.+||+|||+|+....
T Consensus        95 E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH-~~~iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS
T ss_pred             EECCCCCHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHH-HCCEECCCCCCCEEEEC-CCCCEEEEECCCCCCCCC
T ss_conf             806999457899737-----99999999999999999999998-68976667884217987-999789844365334677


Q ss_pred             CCCEEEECCCCCCCCCCHHCCCCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf             7752343168544545201014788-789983306989999999990998888888999865757899999851899842
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKK-PHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ..     ...||+.|+|||++.+.. ..++.++|||||||++|||++|+.||...       ...+......... ..  
T Consensus       168 ~~-----~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-------~~~~~~~~i~~~~-~~--  232 (309)
T d1u5ra_         168 AN-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-------NAMSALYHIAQNE-SP--  232 (309)
T ss_dssp             BC-----CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-------CHHHHHHHHHHSC-CC--
T ss_pred             CC-----CCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHHCC-CC--
T ss_conf             87-----313476636889983467888672145455899999998788999997-------9999999998289-99--


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHH
Q ss_conf             222345523793578889999999988004-9999999778999
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                         ....       ......+.+++.+|++ +|.+|||+.|+++
T Consensus       233 ---~~~~-------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 ---ALQS-------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ---CCSC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCC-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             ---8887-------888999999999977379657918999971

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=346.50  Aligned_cols=264  Identities=22%  Similarity=0.266  Sum_probs=197.2

Q ss_pred             CCEECCCCCEEEEEEEECCCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCC--CCEEEEEEECCC
Q ss_conf             870012266499999994993999999332218889999999999733999802220128967899--803999971389
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ--HEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~--~~~~lv~e~~~~  858 (1060)
                      .+.||+|+||.||+|++ +|+.||+|+++.... ....++.|+..+.+++|||||+++|++..+..  ...++||||+++
T Consensus         8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~   85 (303)
T d1vjya_           8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEEECCCEEEEEEEE-CCEEEEEEEECCCCH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEEECCCC
T ss_conf             88982078819999999-998999999872004-6799999999996279986832688998379860489999964669


Q ss_pred             CCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC-------CCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEE
Q ss_conf             996787611999999998999999999999999999844-------9996248989998685189997599002111000
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF-------DRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-------~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~  931 (1060)
                      |+|.++++..      .++|.++.+++.|+|.||+|+|.       .++|+||||||+|||++ .++.+||+|||+++..
T Consensus        86 g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRH  158 (303)
T ss_dssp             CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCTTCEEE
T ss_pred             CCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEEC-CCCCEEEEECCCCCCC
T ss_conf             8989998658------99989999999999999999887665204689866153173135786-8877688763866234


Q ss_pred             CCCCCEE---EECCCCCCCCCCHHCCCCCCC----CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCC-------CCHH
Q ss_conf             2577523---431685445452010147887----8998330698999999999099888888899986-------5757
Q 001527          932 TQAGTIE---QILDAGVLGYRAPELAASKKP----HPSFKSDVYAFGVILLELLTGRCAGDVISGEGAG-------VDLT  997 (1060)
Q Consensus       932 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~----~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~-------~~l~  997 (1060)
                      .......   .....||+.|+|||++.+...    .++.++|||||||++|||+||..|+.........       ....
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             CCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCHH
T ss_conf             67776200135525035476782210565454677767501220159999999628998876631124101225564309


Q ss_pred             HHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             899999851899842222345523793578889999999988004-999999977899985049
Q 001527          998 DWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus       998 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      +...........    +|.+....   ...+.+..+.+++.+||+ +|++||||.||+++|++|
T Consensus       239 ~~~~~~~~~~~~----~p~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         239 EEMRKVVCEQKL----RPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             HHHHHHHTTSCC----CCCCCGGG---GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHCCCC----CCCCCCCC---CCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             999998750246----88877655---7768999999999997606985895999999999988

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.84  Aligned_cols=248  Identities=22%  Similarity=0.342  Sum_probs=198.4

Q ss_pred             CCEECCCCCEEEEEEEECC----CCEEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEE
Q ss_conf             8700122664999999949----9399999933221-8889999999999733999802220128967899803999971
Q 001527          781 AEVLGRSSHGTSYRATLEN----GMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~  855 (1060)
                      .+.||+|+||.||+|++..    +..||+|.++... ....+.+.+|++++++++|||||+++|++.   ....++||||
T Consensus        12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~~~~iv~E~   88 (273)
T d1mp8a_          12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPVWIIMEL   88 (273)
T ss_dssp             EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSCEEEEEC
T ss_pred             EEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE---CCEEEEEEEE
T ss_conf             7799307882999999936996449999999365668799999999999998689999856988995---3747999984


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCC
Q ss_conf             38999678761199999999899999999999999999984499962489899986851899975990021110002577
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~  935 (1060)
                      +++|++.+++....    ..+++.+++.++.|++.||.||| +++|+||||||+||+++ .+..+|++|||+|+......
T Consensus        89 ~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH-~~~iiHrDlKp~NIll~-~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          89 CTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             CTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEE-ETTEEEECC-----------
T ss_pred             CCCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHC-CCCEECCCCCHHHEEEC-CCCCEEECCCHHHEECCCCC
T ss_conf             06980776542247----89999999999999987752302-26744141026553206-78967876503421336776


Q ss_pred             CEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf             52343168544545201014788789983306989999999990-99888888899986575789999985189984222
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      ........||+.|+|||++.+..+  +.++|||||||++|||+| |++||.....    .++..    .+..+....   
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~--~~~~DiwSlGvil~e~lt~g~~P~~~~~~----~~~~~----~i~~~~~~~---  229 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRF--TSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVIG----RIENGERLP---  229 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCC--SHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHHH----HHHTTCCCC---
T ss_pred             CEECCCEECCCCCCHHHHHCCCCC--CCCCCCCCCHHHHHHHHHCCCCCCCCCCH----HHHHH----HHHCCCCCC---
T ss_conf             233054005831032667516998--87452444247899998269999888999----99999----998189998---


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             2345523793578889999999988004-999999977899985049
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                                .....+..+.+++.+||. +|++|||+.||++.|+.|
T Consensus       230 ----------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         230 ----------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             ----------9877799999999997687976892999999999999

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=352.82  Aligned_cols=247  Identities=25%  Similarity=0.393  Sum_probs=195.3

Q ss_pred             CCEECCCCCEEEEEEEEC-CCC----EEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEE
Q ss_conf             870012266499999994-993----99999933221-888999999999973399980222012896789980399997
Q 001527          781 AEVLGRSSHGTSYRATLE-NGM----FLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e  854 (1060)
                      .++||+|+||+||+|++. +|+    .||+|+++... ....++|.+|++++++++|||||+++|+|..   ...++++|
T Consensus        14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~~~~~v~e   90 (317)
T d1xkka_          14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLITQ   90 (317)
T ss_dssp             EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEE
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC---CCEEEEEE
T ss_conf             319820899299999995899889899999996513497999999999999986799888158999961---98369998


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCC
Q ss_conf             13899967876119999999989999999999999999998449996248989998685189997599002111000257
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~  934 (1060)
                      |+.+|+|.+++...    ...+++..+++++.|+|.||.||| +++|+||||||+|||++ .++.+||+|||+++.....
T Consensus        91 ~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH-~~~iiHrDlKp~NIll~-~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          91 LMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             CCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEE-ETTEEEECCCSHHHHTTTT
T ss_pred             ECCCCCCCCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCHHHCCEEC-CCCCEEEECCCCCEECCCC
T ss_conf             42687401011133----457999999999999999999998-76950476212031167-9987586025522233544


Q ss_pred             CCEE-EECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf             7523-43168544545201014788789983306989999999990-998888888999865757899999851899842
Q 001527          935 GTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       935 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      .... .....||..|+|||++.+..+  +.++|||||||++|||+| |+.||+....    ..+...    +..+...  
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~--~~~sDvwS~Gvil~el~t~g~~p~~~~~~----~~~~~~----i~~~~~~--  232 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISSI----LEKGERL--  232 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCC--CHHHHHHHHHHHHHHHHTTSCCTTTTSCG----GGHHHH----HHHTCCC--
T ss_pred             CCCCCCCCCCCCCCCCCHHHHHCCCC--CHHHHHHHHHHHHHHHHHCCCCCCCCCCH----HHHHHH----HHCCCCC--
T ss_conf             45322365105864467088746999--83565440799999999779999999998----999999----9759989--


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHC
Q ss_conf             222345523793578889999999988004-99999997789998504
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                                 +........+.+++.+||+ +|.+|||+.||++.|+.
T Consensus       233 -----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         233 -----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             -----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf             -----------9985568999999998478993469199999999999

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.14  Aligned_cols=254  Identities=27%  Similarity=0.405  Sum_probs=199.9

Q ss_pred             CCCCHHHHHCCCCCEECCCCCEEEEEEEECCCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCC
Q ss_conf             77895654026787001226649999999499399999933221888999999999973399980222012896789980
Q 001527          769 LTLTPEELSRAPAEVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHE  848 (1060)
Q Consensus       769 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~  848 (1060)
                      +.++.+++..  .++||+|+||.||+|+++ |..||+|+++...  ..+.+.+|++++++++|||||+++|+|.+ ....
T Consensus         2 w~i~~~~~~~--~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~   75 (262)
T d1byga_           2 WALNMKELKL--LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGG   75 (262)
T ss_dssp             CBCCGGGEEE--EEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC-C--C
T ss_pred             CCCCHHHEEE--EEEEECCCCEEEEEEEEC-CEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCCC
T ss_conf             9557899488--579820798089999999-9099999988577--79999999999986789898549878872-3892


Q ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCC
Q ss_conf             39999713899967876119999999989999999999999999998449996248989998685189997599002111
Q 001527          849 KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLH  928 (1060)
Q Consensus       849 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla  928 (1060)
                      .++||||+++|+|.+++....   ...++|..+++|+.|++.||.||| +++|+||||||+|||++ .++.+|++|||++
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH-~~~ivH~dlkp~Nil~~-~~~~~kl~dfg~s  150 (262)
T d1byga_          76 LYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVS-EDNVAKVSDFGLT  150 (262)
T ss_dssp             CEEEECCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEC-TTSCEEECCCCC-
T ss_pred             EEEEEECCCCCCHHHHHHHCC---CCCCCHHHHHHHHHHHHHHCCCCC-CCCEECCCCCHHHHEEC-CCCCEEECCCCCC
T ss_conf             899996369998999987457---888899999999999985232113-37655366656760146-8997763245600


Q ss_pred             EEECCCCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf             000257752343168544545201014788789983306989999999990-9988888889998657578999998518
Q 001527          929 RLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEG 1007 (1060)
Q Consensus       929 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~ 1007 (1060)
                      +.......    ...++..|+|||++.+..+  +.++||||||+++|||+| |+.|+...    ...++..++    ..+
T Consensus       151 ~~~~~~~~----~~~~~~~y~aPE~l~~~~~--t~~sDIwSfG~il~el~t~~~~p~~~~----~~~~~~~~i----~~~  216 (262)
T d1byga_         151 KEASSTQD----TGKLPVKWTAPEALREKKF--STKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRV----EKG  216 (262)
T ss_dssp             ---------------CCTTTSCHHHHHHCCC--CHHHHHHHHHHHHHHHHTTSCCSCTTS----CGGGHHHHH----TTT
T ss_pred             EECCCCCC----CCCCCCCCCCHHHHHCCCC--CHHHHHHHHHHHHHHHHHCCCCCCCCC----CHHHHHHHH----HCC
T ss_conf             34478776----5566646778178727988--858877757999999997899999999----999999999----808


Q ss_pred             CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             99842222345523793578889999999988004-999999977899985049
Q 001527         1008 HGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1008 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ...+.             ......++.+++.+||+ +|.+||||.||+++|+.|
T Consensus       217 ~~~~~-------------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         217 YKMDA-------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             CCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCC-------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             99999-------------765799999999997566976893999999999999

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=347.57  Aligned_cols=255  Identities=24%  Similarity=0.346  Sum_probs=196.9

Q ss_pred             CCEECCCCCEEEEEEEEC------CCCEEEEEECCCCH-HHHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCCCCCEEEE
Q ss_conf             870012266499999994------99399999933221-88899999999997339-99802220128967899803999
Q 001527          781 AEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~g~~~~~~~~~~~lv  852 (1060)
                      .++||+|+||.||+|++.      +++.||+|+++... ....+.+.+|++.+.++ +|+|||.+++++.. .....++|
T Consensus        18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~~iv   96 (299)
T d1ywna1          18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-PGGPLMVI   96 (299)
T ss_dssp             EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TTSCCEEE
T ss_pred             EEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECC-CCCEEEEE
T ss_conf             44984167839999998677755578399999986001717899999999998861499849974115404-79757999


Q ss_pred             EEECCCCCHHHHHHCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEE
Q ss_conf             971389996787611999-----------999998999999999999999999844999624898999868518999759
Q 001527          853 SDYISPGSLASFLYDRPG-----------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNAR  921 (1060)
Q Consensus       853 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~k  921 (1060)
                      |||+++|+|.++++....           .....+++.+++.++.|++.||.||| +++|+||||||+|||++ .++.+|
T Consensus        97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH-~~~ivHrDlKp~NILl~-~~~~~K  174 (299)
T d1ywna1          97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVK  174 (299)
T ss_dssp             EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEC-GGGCEE
T ss_pred             EEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCCEEEC-CCCCEE
T ss_conf             9845899299999853666665322202332146899999999999999999887-37971786773106577-998289


Q ss_pred             ECCCCCCEEECCCCCE-EEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCCCCCCCCCHHHH
Q ss_conf             9002111000257752-34316854454520101478878998330698999999999099-888888899986575789
Q 001527          922 VADYCLHRLMTQAGTI-EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR-CAGDVISGEGAGVDLTDW  999 (1060)
Q Consensus       922 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~-~p~~~~~~~~~~~~l~~~  999 (1060)
                      |+|||+|+........ ......||+.|+|||++.+..+  +.++|||||||++|||+||. .||.....       .+.
T Consensus       175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~--~~~sDiwS~Gvil~ellt~~~~p~~~~~~-------~~~  245 (299)
T d1ywna1         175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFSLGASPYPGVKI-------DEE  245 (299)
T ss_dssp             ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC--CHHHHHHHHHHHHHHHHTTSCCSSTTCCC-------SHH
T ss_pred             ECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCC--CCCCCEEEHHHHHHHHHHCCCCCCCCCCH-------HHH
T ss_conf             845752001135665222475166721020368646889--96632213678999998688999989998-------999


Q ss_pred             HHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             9999851899842222345523793578889999999988004-999999977899985049
Q 001527         1000 MQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus      1000 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      .......+.....      +       ......+.+++.+||+ +|++||||.||+++|+.|
T Consensus       246 ~~~~~~~~~~~~~------~-------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         246 FCRRLKEGTRMRA------P-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             HHHHHHHTCCCCC------C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHCCCCCCC------C-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             9999963898888------8-------65789999999997677966791999999999799

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.75  Aligned_cols=245  Identities=19%  Similarity=0.296  Sum_probs=193.8

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHH------HHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEE
Q ss_conf             870012266499999994-993999999332218------8899999999997339998022201289678998039999
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA------KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~  853 (1060)
                      .+.||+|+||+||+|+.. +|+.||+|+++....      ...+.+.+|++++++++|||||++++++.  +....++||
T Consensus        15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~iv~   92 (293)
T d1jksa_          15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--NKTDVILIL   92 (293)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEE--ECCEEEEEE
T ss_conf             279811789599999999999899999987566321340689999999999998679989993889999--799899999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCC---CCEEECCCCCCEE
Q ss_conf             7138999678761199999999899999999999999999984499962489899986851899---9759900211100
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPD---LNARVADYCLHRL  930 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~---~~~kl~Dfgla~~  930 (1060)
                      ||+++|+|.+++...     ..+++..+..++.|++.||.||| +.+|+||||||+|||++..+   ..+|++|||+++.
T Consensus        93 E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH-~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          93 ELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             ECCCCCCCCCHHCCC-----CCCCHHHHHHHHHHHHHHHHHHH-HCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHH
T ss_conf             867786431001035-----64215578999999999987666-254221133301279825898666469643344210


Q ss_pred             ECCCCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf             02577523431685445452010147887899833069899999999909988888889998657578999998518998
Q 001527          931 MTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGS 1010 (1060)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 1010 (1060)
                      ........  ...|++.|+|||++.+..+  +.++||||+||++|||++|+.||...       ...+.... +......
T Consensus       167 ~~~~~~~~--~~~~t~~y~APE~~~~~~~--~~~~DiwSlGvilyell~g~~Pf~~~-------~~~~~~~~-i~~~~~~  234 (293)
T d1jksa_         167 IDFGNEFK--NIFGTPEFVAPEIVNYEPL--GLEADMWSIGVITYILLSGASPFLGD-------TKQETLAN-VSAVNYE  234 (293)
T ss_dssp             CTTSCBCS--CCCCCGGGCCHHHHTTCCB--CTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHH-HHTTCCC
T ss_pred             CCCCCCCC--CCCCCCCCCCHHHHCCCCC--CCCCCCHHHHHHHHHHHCCCCCCCCC-------CHHHHHHH-HHHCCCC
T ss_conf             57776312--2477774309999818999--97665221409999997088998899-------99999999-9816888


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHH
Q ss_conf             42222345523793578889999999988004-9999999778999
Q 001527         1011 DCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1011 ~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                                ...+........+.+++.+|++ +|.+|||+.|+++
T Consensus       235 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 ----------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----------CCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ----------870104788999999999986389668919999961

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.94  Aligned_cols=264  Identities=20%  Similarity=0.318  Sum_probs=205.6

Q ss_pred             CCCCCCHHHHHCCCCCEECCCCCEEEEEEEEC------CCCEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf             77778956540267870012266499999994------9939999993322-1888999999999973399980222012
Q 001527          767 DTLTLTPEELSRAPAEVLGRSSHGTSYRATLE------NGMFLTVKWLREG-VAKQRKEFAKEAKKFANIRHPNVVGLRG  839 (1060)
Q Consensus       767 ~~~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~g  839 (1060)
                      +.+.+..+++..  .+.||+|+||+||+|++.      ++..||||+++.. .......|.+|++++++++|||||+++|
T Consensus        13 ~~~ei~~~~~~l--~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~   90 (308)
T d1p4oa_          13 DEWEVAREKITM--SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   90 (308)
T ss_dssp             CTTBCCGGGEEE--EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             CCEEECHHHEEE--EEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf             100426899188--359820788189999987864477896899999870128689999999999999769998841254


Q ss_pred             EEECCCCCCEEEEEEECCCCCHHHHHHCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEE
Q ss_conf             896789980399997138999678761199-----999999899999999999999999984499962489899986851
Q 001527          840 YYWGPTQHEKLILSDYISPGSLASFLYDRP-----GRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD  914 (1060)
Q Consensus       840 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~  914 (1060)
                      ++.  .....++||||+++|+|.+++....     ......+++.++.+++.|+|+||.||| +++|+||||||+|||++
T Consensus        91 ~~~--~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH-~~~ivHrDlk~~NiLld  167 (308)
T d1p4oa_          91 VVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVA  167 (308)
T ss_dssp             EEC--SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCSGGGEEEC
T ss_pred             EEE--CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEEECEECCCCEEEC
T ss_conf             784--288106777604899889998750332113444688799999999999999999876-47965432867754035


Q ss_pred             CCCCCEEECCCCCCEEECCCCCEEE-ECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCC-CCCCCCCCCCC
Q ss_conf             8999759900211100025775234-316854454520101478878998330698999999999099-88888889998
Q 001527          915 GPDLNARVADYCLHRLMTQAGTIEQ-ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGR-CAGDVISGEGA  992 (1060)
Q Consensus       915 ~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~-~p~~~~~~~~~  992 (1060)
                       .++.+||+|||+++.......... ....|++.|+|||.+.+..+  +.++||||||+++|||+||+ .||...     
T Consensus       168 -~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~--~~~~Dv~S~G~il~El~t~~~~p~~~~-----  239 (308)
T d1p4oa_         168 -EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF--TTYSDVWSFGVVLWEIATLAEQPYQGL-----  239 (308)
T ss_dssp             -TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC--CHHHHHHHHHHHHHHHHHTSCCTTTTS-----
T ss_pred             -CCCEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCC--CCCCCCCCHHHHHHHHHHCCCCCCCCC-----
T ss_conf             -996499942454202357763031340231632378888736998--833344437899999996899999998-----


Q ss_pred             CCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHC
Q ss_conf             65757899999851899842222345523793578889999999988004-99999997789998504
Q 001527          993 GVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       993 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                        ...++...... +...+.      +       ......+.+++.+||+ +|.+||||.||+++|++
T Consensus       240 --~~~~~~~~i~~-~~~~~~------p-------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  291 (308)
T d1p4oa_         240 --SNEQVLRFVME-GGLLDK------P-------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  291 (308)
T ss_dssp             --CHHHHHHHHHT-TCCCCC------C-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred             --CHHHHHHHHHH-CCCCCC------C-------CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf             --99999999980-888888------6-------3353999999999757796589399999999787

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.67  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=202.9

Q ss_pred             CCCCHHHHHCCCCCEECCCCCEEEEEEEEC------CCCEEEEEECCCCH-HHHHHHHHHHHHHHHCC-CCCCEEEEEEE
Q ss_conf             778956540267870012266499999994------99399999933221-88899999999997339-99802220128
Q 001527          769 LTLTPEELSRAPAEVLGRSSHGTSYRATLE------NGMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGY  840 (1060)
Q Consensus       769 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~g~  840 (1060)
                      +.+..+++..  .++||+|+||.||+|++.      +++.||||+++... ......+.+|+.+++++ +|||||+++|+
T Consensus        18 ~~~~~~~~~l--~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          18 WEFPRNRLSF--GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GBCCGGGEEE--EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCHHHEEE--EEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEE
T ss_conf             6377899698--54982068829999998066447788699999987424877999999999998762699988789989


Q ss_pred             EECCCCCCEEEEEEECCCCCHHHHHHCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             967899803999971389996787611999-------------9999989999999999999999998449996248989
Q 001527          841 YWGPTQHEKLILSDYISPGSLASFLYDRPG-------------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLK  907 (1060)
Q Consensus       841 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlk  907 (1060)
                      |.  .....++||||+++|+|.++++....             .....+++..+.+++.|++.|++||| +.+++|||||
T Consensus        96 ~~--~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH-~~~ivHrDLK  172 (311)
T d1t46a_          96 CT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDLA  172 (311)
T ss_dssp             EC--SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCS
T ss_pred             EE--ECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEEECCCC
T ss_conf             83--19978999973799879999985356654444453322233458899999999999999999887-5792666241


Q ss_pred             CCCEEEECCCCCEEECCCCCCEEECCCCC-EEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHC-CCCCC
Q ss_conf             99868518999759900211100025775-23431685445452010147887899833069899999999909-98888
Q 001527          908 ATNILLDGPDLNARVADYCLHRLMTQAGT-IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTG-RCAGD  985 (1060)
Q Consensus       908 p~NILl~~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG-~~p~~  985 (1060)
                      |+||+++ .+..+|++|||.++....... .......|++.|+|||++.+..+  +.++|||||||++|||+|+ ++|+.
T Consensus       173 p~NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DIwS~G~~l~ellt~g~p~~~  249 (311)
T d1t46a_         173 ARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY--TFESDVWSYGIFLWELFSLGSSPYP  249 (311)
T ss_dssp             GGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC--CHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CCCCCCC-CCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCC--CCCCCCCCHHHHHHHHHHCCCCCCC
T ss_conf             0210000-257521023401023367886158620135968767788617999--9740010258999999858998877


Q ss_pred             CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHC
Q ss_conf             888999865757899999851899842222345523793578889999999988004-99999997789998504
Q 001527          986 VISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus       986 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      ....       .+.+...+..+....      .+       ......+.+++.+||+ +|.+||||.||+++|++
T Consensus       250 ~~~~-------~~~~~~~i~~~~~~~------~~-------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         250 GMPV-------DSKFYKMIKEGFRML------SP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             TCCS-------SHHHHHHHHHTCCCC------CC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCH-------HHHHHHHHHCCCCCC------CC-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf             8998-------999999986689889------85-------4365999999999757796579299999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=344.37  Aligned_cols=259  Identities=24%  Similarity=0.367  Sum_probs=199.1

Q ss_pred             CCHHHHHCCCCCEECCCCCEEEEEEEEC-CCC--EEEEEECCCCH-HHHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCC
Q ss_conf             8956540267870012266499999994-993--99999933221-88899999999997339-9980222012896789
Q 001527          771 LTPEELSRAPAEVLGRSSHGTSYRATLE-NGM--FLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLRGYYWGPT  845 (1060)
Q Consensus       771 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~g~~~~~~  845 (1060)
                      ++.+|+..  .++||+|+||+||+|++. ++.  .||||+++... ....+.|.+|+++++++ +|||||+++|+|.  .
T Consensus         7 i~~~~~~~--~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~   82 (309)
T d1fvra_           7 LDWNDIKF--QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--H   82 (309)
T ss_dssp             CCGGGCEE--EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE--E
T ss_pred             CCHHHCEE--EEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--C
T ss_conf             68799688--7798207882899999989996999999997823385799999999999986228998836788884--1


Q ss_pred             CCCEEEEEEECCCCCHHHHHHCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEE
Q ss_conf             980399997138999678761199-----------999999899999999999999999984499962489899986851
Q 001527          846 QHEKLILSDYISPGSLASFLYDRP-----------GRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLD  914 (1060)
Q Consensus       846 ~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~  914 (1060)
                      ....++||||+++|+|.++++...           ......+++.++.+++.|+|.||.|+| +++|+||||||+|||++
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH-~~~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVG  161 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEC
T ss_pred             CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEEEC
T ss_conf             87369999802898699998640355555123101234578999999999999999987663-08954555052048986


Q ss_pred             CCCCCEEECCCCCCEEECCCCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCC-CCCCCCCCCCC
Q ss_conf             89997599002111000257752343168544545201014788789983306989999999990998-88888899986
Q 001527          915 GPDLNARVADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRC-AGDVISGEGAG  993 (1060)
Q Consensus       915 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~-p~~~~~~~~~~  993 (1060)
                       .+..+||+|||+++.........  ...||..|+|||.+.+..+  +.++|||||||++|||++|.. ||...      
T Consensus       162 -~~~~~kl~DfG~a~~~~~~~~~~--~~~gt~~y~aPE~l~~~~~--~~~sDvwSfGvil~ell~~~~~p~~~~------  230 (309)
T d1fvra_         162 -ENYVAKIADFGLSRGQEVYVKKT--MGRLPVRWMAIESLNYSVY--TTNSDVWSYGVLLWEIVSLGGTPYCGM------  230 (309)
T ss_dssp             -GGGCEEECCTTCEESSCEECCC------CCTTTCCHHHHHHCEE--CHHHHHHHHHHHHHHHHTTSCCTTTTC------
T ss_pred             -CCCCEEECCCCCCCCCCCCCCCC--CEECCCCCCCHHHHCCCCC--CCCCEEEHHHHHHHHHHHCCCCCCCCC------
T ss_conf             -88763874344322444223455--3013775555387526999--962215313889999983689999999------


Q ss_pred             CCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             5757899999851899842222345523793578889999999988004-999999977899985049
Q 001527          994 VDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus       994 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                       ...+.... +..+...+             ........+.+++.+||+ +|++||||+||++.|++|
T Consensus       231 -~~~~~~~~-i~~~~~~~-------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         231 -TCAELYEK-LPQGYRLE-------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             -CHHHHHHH-GGGTCCCC-------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CHHHHHHH-HHHCCCCC-------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             -99999999-98268888-------------8766789999999997678966894999999999999

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.05  Aligned_cols=263  Identities=26%  Similarity=0.376  Sum_probs=204.1

Q ss_pred             CCCCHHHHHCCCCCEECCCCCEEEEEEEECC--------CCEEEEEECCCCH-HHHHHHHHHHHHHHHCC-CCCCEEEEE
Q ss_conf             7789565402678700122664999999949--------9399999933221-88899999999997339-998022201
Q 001527          769 LTLTPEELSRAPAEVLGRSSHGTSYRATLEN--------GMFLTVKWLREGV-AKQRKEFAKEAKKFANI-RHPNVVGLR  838 (1060)
Q Consensus       769 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~  838 (1060)
                      +.+..+++..  .+.||+|+||.||+|+...        +..||+|+++... .....++.+|+..+.++ +|||||+++
T Consensus         8 ~~i~~~~~~l--~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~   85 (299)
T d1fgka_           8 WELPRDRLVL--GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL   85 (299)
T ss_dssp             TBCCGGGEEE--EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCCCHHHEEE--EEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECC
T ss_conf             7225899697--00985167828999998578755566754999999881128688999999999999813999697346


Q ss_pred             EEEECCCCCCEEEEEEECCCCCHHHHHHCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             28967899803999971389996787611999-----------9999989999999999999999998449996248989
Q 001527          839 GYYWGPTQHEKLILSDYISPGSLASFLYDRPG-----------RKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLK  907 (1060)
Q Consensus       839 g~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlk  907 (1060)
                      |+|.  +....++||||+++|+|.+++..+..           .....+++.++++++.|++.||+||| +++|+|||||
T Consensus        86 ~~~~--~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH-~~~ivHrDiK  162 (299)
T d1fgka_          86 GACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLA  162 (299)
T ss_dssp             EEEC--SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCS
T ss_pred             CCCC--CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEEEEEEC
T ss_conf             5220--188689999736999099999860677643222334574346799999999999999998766-3797863022


Q ss_pred             CCCEEEECCCCCEEECCCCCCEEECCCCCEE-EECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCC
Q ss_conf             9986851899975990021110002577523-43168544545201014788789983306989999999990-998888
Q 001527          908 ATNILLDGPDLNARVADYCLHRLMTQAGTIE-QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGD  985 (1060)
Q Consensus       908 p~NILl~~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~ellt-G~~p~~  985 (1060)
                      |+|||++ .++.+||+|||+++......... .....|++.|+|||.+.+..+  +.++||||||+++|||++ |+.||.
T Consensus       163 p~NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y--~~k~DiwS~Gvvl~ell~~g~~p~~  239 (299)
T d1fgka_         163 ARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYP  239 (299)
T ss_dssp             GGGEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC--CHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCCEEEC-CCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCC--CCHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             1022454-789767622111011355555431466788846632667517988--8255547758888874017989899


Q ss_pred             CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHCC
Q ss_conf             888999865757899999851899842222345523793578889999999988004-999999977899985049
Q 001527          986 VISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSSI 1060 (1060)
Q Consensus       986 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~i 1060 (1060)
                      ..       ...+ +...+..+.....      +       ......+.+++.+||+ +|.+||||.||+++|+.|
T Consensus       240 ~~-------~~~~-~~~~i~~~~~~~~------p-------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         240 GV-------PVEE-LFKLLKEGHRMDK------P-------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             TC-------CHHH-HHHHHHTTCCCCC------C-------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-------CHHH-HHHHHHCCCCCCC------C-------CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             99-------9999-9999972888898------7-------43529999999997667976793999999999888

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.42  Aligned_cols=241  Identities=20%  Similarity=0.269  Sum_probs=192.8

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHH---HHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEEC
Q ss_conf             870012266499999994-993999999332218---8899999999997339998022201289678998039999713
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||+||+|+.. +++.||+|+++....   ...+.+.+|++++++++|||||++++++.  +....++||||+
T Consensus        13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~ivmEy~   90 (288)
T d1uu3a_          13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ--DDEKLYFGLSYA   90 (288)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE--CSSEEEEEECCC
T ss_pred             EEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE--ECCEEEEEEECC
T ss_conf             889850879099999998999799999986577557778999999999998768888617999999--899889999704


Q ss_pred             CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCC
Q ss_conf             89996787611999999998999999999999999999844999624898999868518999759900211100025775
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++..+..++.|++.||.||| +++|+||||||+|||++ .++.+||+|||+|+.......
T Consensus        91 ~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH-~~~iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          91 KNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH-GKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             TTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEC-TTSCEEECCCTTCEECC----
T ss_pred             CCCCHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHC-CCCEECCCCCCCCCCCC-CCCEEEECCCCCCEECCCCCC
T ss_conf             898777765315-----99999999999999999997621-65088476774123668-885388603210242256776


Q ss_pred             -EEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf             -2343168544545201014788789983306989999999990998888888999865757899999851899842222
Q 001527          937 -IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       937 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                       .......||+.|+|||++.+..+  +.++||||+||++|||+||+.||...       +..+..... ..+...  +  
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~--~~~~DiwSlGvilyell~g~~Pf~~~-------~~~~~~~~i-~~~~~~--~--  229 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSA--CKSSDLWALGCIIYQLVAGLPPFRAG-------NEYLIFQKI-IKLEYD--F--  229 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCC--CHHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHH-HTTCCC--C--
T ss_pred             CCCCCCCCCCCCCCCCEEECCCCC--CCCCCEEHHHHHHHHHHHCCCCCCCC-------CHHHHHHHH-HCCCCC--C--
T ss_conf             433355567755258440026898--96662304569999980388998995-------999999999-718999--9--


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHH
Q ss_conf             345523793578889999999988004-999999977899
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIY 1054 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl 1054 (1060)
                         +.       .....+.+++.+|++ +|.+|||++|++
T Consensus       230 ---p~-------~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         230 ---PE-------KFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ---CT-------TCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ---CC-------CCCHHHHHHHHHHCCCCHHHCCCHHHHC
T ss_conf             ---85-------4799999999998557976891978973

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=338.86  Aligned_cols=241  Identities=22%  Similarity=0.322  Sum_probs=192.4

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHH---HHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEEC
Q ss_conf             870012266499999994-993999999332218---8899999999997339998022201289678998039999713
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +++.||+|++++...   ...+.+.+|++++++++|||||++++++.  +....++||||+
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~iv~ey~   87 (337)
T d1o6la_          10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLCFVMEYA   87 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE--CSSEEEEEEECC
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEC--CCCCCCCCEECC
T ss_conf             889831768499999998999899999981565449799999999999998679998877876403--564211100035


Q ss_pred             CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCC
Q ss_conf             89996787611999999998999999999999999999844999624898999868518999759900211100025775
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~  936 (1060)
                      ++|+|.+++...     ..+++..+..++.|++.||.||| +++|+||||||+|||++ .++.+||+|||+|+.......
T Consensus        88 ~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH-~~~iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          88 NGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             TTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTC
T ss_pred             CCCCHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCHHHEEEC-CCCCEEEEECCCCCCCCCCCC
T ss_conf             798605555325-----67759999999999965211343-15962246477784765-899888820565200356786


Q ss_pred             EEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             23431685445452010147887899833069899999999909988888889998657578999998518998422223
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                      . ....+||+.|+|||++.+..+  +.++||||+||++|||++|+.||...       +..+....... +...      
T Consensus       161 ~-~~~~~GT~~Y~aPE~~~~~~y--~~~~DiwSlGvilyeml~G~~pf~~~-------~~~~~~~~i~~-~~~~------  223 (337)
T d1o6la_         161 T-MKTFCGTPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLPFYNQ-------DHERLFELILM-EEIR------  223 (337)
T ss_dssp             C-BCCCEECGGGCCGGGGSSSCB--CTTHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHH-CCCC------
T ss_pred             C-CCCCEECHHHHHHHHCCCCCC--CHHHCCCCHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHC-CCCC------
T ss_conf             2-055100889966665048988--83331022306788998789999996-------99999999852-8998------


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCC-----HHHHHH
Q ss_conf             45523793578889999999988004-9999999-----778999
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPG-----IKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs-----~~evl~ 1055 (1060)
                       .+.       .....+.+++.+|++ +|.+||+     +.|+++
T Consensus       224 -~p~-------~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 -FPR-------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -CCT-------TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CCC-------CCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf             -986-------6899999999866638934422565234999972

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.65  Aligned_cols=249  Identities=20%  Similarity=0.289  Sum_probs=191.6

Q ss_pred             CCEECCCCCEEEEEEEE-CCCCEEEEEECCCCHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEEC--CCCCCEEEEEEEC
Q ss_conf             87001226649999999-49939999993322188899999999997339-99802220128967--8998039999713
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANI-RHPNVVGLRGYYWG--PTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~g~~~~--~~~~~~~lv~e~~  856 (1060)
                      .++||+|+||+||+|+. .+++.||+|+++..     +.+.+|++++.++ +|||||++++++.+  ......++|||||
T Consensus        17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~   91 (335)
T d2ozaa1          17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   91 (335)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             EEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEEEEECC
T ss_conf             07965454869999998899989999998974-----7799999999986699997829899950346897899999778


Q ss_pred             CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC--CCCCEEECCCCCCEEECCC
Q ss_conf             89996787611999999998999999999999999999844999624898999868518--9997599002111000257
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG--PDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~--~~~~~kl~Dfgla~~~~~~  934 (1060)
                      ++|+|.+++..+.   ...+++.++..|+.|++.||.||| +.+|+||||||+|||++.  ....+||+|||+|+.....
T Consensus        92 ~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH-~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~  167 (335)
T d2ozaa1          92 DGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  167 (335)
T ss_dssp             CSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred             CCCCHHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCC
T ss_conf             9984999998627---877579999999999999999999-769864441002201135555663113545512333688


Q ss_pred             CCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf             75234316854454520101478878998330698999999999099888888899986575789999985189984222
Q 001527          935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFD 1014 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 1014 (1060)
                      ....  ...||+.|+|||++.+..+  +.++||||+||++|||+||+.||.......    ...........+.      
T Consensus       168 ~~~~--~~~gt~~y~aPE~~~~~~y--~~~~DiwSlGvily~lltg~~Pf~~~~~~~----~~~~~~~~i~~~~------  233 (335)
T d2ozaa1         168 NSLT--TPCYTPYYVAPEVLGPEKY--DKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKTRIRMGQ------  233 (335)
T ss_dssp             CCCC--CCSCCCSSCCCCCCCGGGG--SHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCS------
T ss_pred             CCCC--CCCCCCCCCCCHHHCCCCC--CHHHHHHHHCHHHHHHHHCCCCCCCCCHHH----HHHHHHHHHHCCC------
T ss_conf             8643--2267756379277748988--888888764516778865889988988778----8999999985388------


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             2345523793578889999999988004-99999997789998
Q 001527         1015 AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1015 ~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                          ..+..+........+.+++.+|++ +|++|||+.|+++.
T Consensus       234 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         234 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             ----888985434699999999999756996579099999709

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=336.22  Aligned_cols=239  Identities=23%  Similarity=0.337  Sum_probs=191.9

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHH---HHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEEC
Q ss_conf             870012266499999994-993999999332218---8899999999997339998022201289678998039999713
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||+||+|+.. +|+.||+|+++....   ...+.+.+|++++++++|||||++++++.  +....++||||+
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~ivmE~~   86 (316)
T d1fota_           9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--DAQQIFMIMDYI   86 (316)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--CSSEEEEEECCC
T ss_pred             EEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEE--ECCEEEEEEEEC
T ss_conf             889720768089999998999799999984577548899999999999998636967533035685--288005676503


Q ss_pred             CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCC
Q ss_conf             89996787611999999998999999999999999999844999624898999868518999759900211100025775
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~  936 (1060)
                      ++|++..++...     ..+++..+..++.|++.||.||| +++|+||||||+|||++ .++.+||+|||+|+.......
T Consensus        87 ~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH-~~~iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~~~  159 (316)
T d1fota_          87 EGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH-SKDIIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVTY  159 (316)
T ss_dssp             CSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEEC-TTSCEEECCCSSCEECSSCBC
T ss_pred             CCCCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHHHC-CCCEECCCCCCHHEEEC-CCCCEEEECCCCCEEECCCCC
T ss_conf             786322343222-----21110079999999987655412-47677055681050386-899889831752167124564


Q ss_pred             EEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             23431685445452010147887899833069899999999909988888889998657578999998518998422223
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                          ...||+.|+|||++.+..+  +.++||||+||++|||+||+.||...       ...+........ ...      
T Consensus       160 ----~~~Gt~~Y~APE~l~~~~y--~~~~DiwSlGvilyemltG~~Pf~~~-------~~~~~~~~i~~~-~~~------  219 (316)
T d1fota_         160 ----TLCGTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTPFYDS-------NTMKTYEKILNA-ELR------  219 (316)
T ss_dssp             ----CCCSCTTTCCHHHHTTCCB--CTTHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHHHHC-CCC------
T ss_pred             ----CCCCCCCCCCHHHHCCCCC--CCHHHCCCCCHHHHHHHHCCCCCCCC-------CHHHHHHHHHCC-CCC------
T ss_conf             ----3457634359999838999--80430465333689997598999996-------999999999708-988------


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCC-----CHHHHHHH
Q ss_conf             45523793578889999999988004-999999-----97789998
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-----GIKTIYED 1056 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RP-----s~~evl~~ 1056 (1060)
                       .+.       .....+.+++.+|+. +|.+||     |++|+++.
T Consensus       220 -~p~-------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         220 -FPP-------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             -CCT-------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -CCC-------CCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf             -997-------78999999999995449976664310219999819

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=335.91  Aligned_cols=243  Identities=21%  Similarity=0.261  Sum_probs=186.1

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHHH---HHHHH---HHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEE
Q ss_conf             870012266499999994-9939999993322188---89999---9999997339998022201289678998039999
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAK---QRKEF---AKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~---~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~  853 (1060)
                      .++||+|+||.||+|+.. +|+.||+|++......   ....+   ..++++++.++|||||++++++.  +....++||
T Consensus         9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~--~~~~~~ivm   86 (364)
T d1omwa3           9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDKLSFIL   86 (364)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--ECCEEEEEE
T ss_conf             018842889099999999999799999984587542667999999999999985089985889999999--899889999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECC
Q ss_conf             71389996787611999999998999999999999999999844999624898999868518999759900211100025
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~  933 (1060)
                      ||+++|+|.+++...     ..+++..+..++.|++.||.||| +++|+||||||+|||++ .++.+||+|||+|+....
T Consensus        87 E~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH-~~~iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          87 DLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             CCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEC-SSSCEEECCCTTCEECSS
T ss_pred             EECCCCCHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHH-HCCCCCEEECCCEEEEC-CCCCEEEEEECEEEECCC
T ss_conf             914898389998732-----55327899999999999999999-77962204442216785-889679822010233378


Q ss_pred             CCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf             77523431685445452010147887899833069899999999909988888889998657578999998518998422
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 1013 (1060)
                      ...   ....||+.|+|||++..... ++.++||||+||++|||+||+.||......    +.....+ ....  ...  
T Consensus       160 ~~~---~~~~GT~~y~APE~~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~~~-~~~~--~~~--  226 (364)
T d1omwa3         160 KKP---HASVGTHGYMAPEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEIDR-MTLT--MAV--  226 (364)
T ss_dssp             SCC---CSCCSCGGGCCHHHHSTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCSSCSS----CHHHHHH-HSSS--CCC--
T ss_pred             CCC---CCCCCCCCCCHHHHHHCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHH-HCCC--CCC--
T ss_conf             864---33113455421687603899-984410467789999998599988889989----9999998-6046--888--


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCC-----HHHHHH
Q ss_conf             22345523793578889999999988004-9999999-----778999
Q 001527         1014 DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPG-----IKTIYE 1055 (1060)
Q Consensus      1014 d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs-----~~evl~ 1055 (1060)
                         ..+       ......+.+++.+|++ +|.+|||     ++|+++
T Consensus       227 ---~~~-------~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         227 ---ELP-------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---CCC-------SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---CCC-------CCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf             ---788-------77899999999998566988808874357999974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.93  Aligned_cols=246  Identities=17%  Similarity=0.204  Sum_probs=194.6

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECCCC
Q ss_conf             870012266499999994-9939999993322188899999999997339998022201289678998039999713899
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|+||+||+|... +++.||+|+++... .+...+.+|++++++++|||||++++++.  +....++||||+++|
T Consensus        10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~lvmE~~~gg   86 (321)
T d1tkia_          10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE--SMEELVMIFEFISGL   86 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE--ETTEEEEEECCCCCC
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEE--ECCEEEEEEECCCCC
T ss_conf             789831778399999998999699999975786-65999999999998579979890989998--899889999538998


Q ss_pred             CHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC-CCCCEEECCCCCCEEECCCCCEE
Q ss_conf             96787611999999998999999999999999999844999624898999868518-99975990021110002577523
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG-PDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~-~~~~~kl~Dfgla~~~~~~~~~~  938 (1060)
                      +|.+++...    ...+++.++..|+.|++.||.||| +.+|+||||||+|||++. ....+|++|||+++.........
T Consensus        87 ~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH-~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~  161 (321)
T d1tkia_          87 DIFERINTS----AFELNEREIVSYVHQVCEALQFLH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR  161 (321)
T ss_dssp             BHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred             CHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCCCCC
T ss_conf             088998753----899999999999999999999998-769975135544434437885189976441110034677532


Q ss_pred             EECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             43168544545201014788789983306989999999990998888888999865757899999851899842222345
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAAVM 1018 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 1018 (1060)
                      .  ..|++.|+|||...+..+  +.++||||+||++|||++|+.||...       ...+...........   ++.   
T Consensus       162 ~--~~~t~~y~ape~~~~~~~--~~~~DiWSlGvily~ll~G~~Pf~~~-------~~~~~~~~i~~~~~~---~~~---  224 (321)
T d1tkia_         162 L--LFTAPEYYAPEVHQHDVV--STATDMWSLGTLVYVLLSGINPFLAE-------TNQQIIENIMNAEYT---FDE---  224 (321)
T ss_dssp             E--EESCGGGSCHHHHTTCEE--CHHHHHHHHHHHHHHHHHSSCTTCCS-------SHHHHHHHHHHTCCC---CCH---
T ss_pred             C--CCCCCCCCCCHHCCCCCC--CCHHHCCCHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHHCCCC---CCH---
T ss_conf             1--223322234021048777--84011302799999998289999998-------999999999838999---880---


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             523793578889999999988004-99999997789998
Q 001527         1019 PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1019 ~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                           +........+.+++.+|+. +|.+|||+.|+++.
T Consensus       225 -----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         225 -----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             -----2236789999999999866996689099999639

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=338.60  Aligned_cols=248  Identities=23%  Similarity=0.336  Sum_probs=195.9

Q ss_pred             CCEECCCCCEEEEEEEECC--C--CEEEEEECCCCH---HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEE
Q ss_conf             8700122664999999949--9--399999933221---88899999999997339998022201289678998039999
Q 001527          781 AEVLGRSSHGTSYRATLEN--G--MFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILS  853 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~  853 (1060)
                      .+.||+|+||.||+|++..  +  ..||+|+++...   ....+.|.+|++++++++|||||+++|++.+   ...++|+
T Consensus        13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~~~lv~   89 (273)
T d1u46a_          13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PPMKMVT   89 (273)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEE
T ss_pred             EEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE---CCHHEEE
T ss_conf             7898038883999999988999079999999983555798999999999999986899998789877740---1001146


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECC
Q ss_conf             71389996787611999999998999999999999999999844999624898999868518999759900211100025
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~  933 (1060)
                      ||+++|++.+++....    ..+++..+++++.|+|.||.||| +++|+||||||+||+++ .+..+|++|||+++....
T Consensus        90 e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH-~~~iiHrDikp~NIll~-~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          90 ELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE-SKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             ECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEE-ETTEEEECCCTTCEECCC
T ss_pred             EEECCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHH-HCCEEEEEECHHHHCCC-CCCCEEECCCHHHHHCCC
T ss_conf             5423861254442126----89999999999999999998752-17875205668881565-565433256115553035


Q ss_pred             CCCEEE--ECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf             775234--3168544545201014788789983306989999999990-9988888889998657578999998518998
Q 001527          934 AGTIEQ--ILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLT-GRCAGDVISGEGAGVDLTDWMQLKVAEGHGS 1010 (1060)
Q Consensus       934 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 1010 (1060)
                      ......  ....|+..|+|||++.+..+  +.++||||||+++|||+| |+.||...       ...+........+...
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~Di~S~Gvil~emlt~G~~Pf~~~-------~~~~~~~~i~~~~~~~  234 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTF--SHASDTWMFGVTLWEMFTYGQEPWIGL-------NGSQILHKIDKEGERL  234 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEE--EHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHHHTSCCCC
T ss_pred             CCCCCEECCCCCCCCCCCCHHHHHCCCC--CCCHHHHHHHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHHCCCCC
T ss_conf             8875265476325731079999837999--942156614899999996899999996-------9999999998479999


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHC
Q ss_conf             42222345523793578889999999988004-99999997789998504
Q 001527         1011 DCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1011 ~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                      +             .....+..+.+++.+||+ +|++||||.||++.|++
T Consensus       235 ~-------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         235 P-------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             C-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C-------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf             9-------------854453999999999768896679299999999996

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=335.79  Aligned_cols=238  Identities=19%  Similarity=0.242  Sum_probs=191.4

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHH---HHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEEC
Q ss_conf             870012266499999994-993999999332218---8899999999997339998022201289678998039999713
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYI  856 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~  856 (1060)
                      .+.||+|+||.||+|+.. +|+.||+|++.....   ...+.+.+|++++++++|||||++++++.  .....++|+||+
T Consensus        46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~~v~e~~  123 (350)
T d1rdqe_          46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK--DNSNLYMVMEYV  123 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEEEEECC
T ss_pred             EEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCC--CCCCCCCCCCCC
T ss_conf             889611768089999998999899999982677458899999999999999748772740344443--222223222233


Q ss_pred             CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCC
Q ss_conf             89996787611999999998999999999999999999844999624898999868518999759900211100025775
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~  936 (1060)
                      .+|+|.+++...     ..+++.++..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||+|+.......
T Consensus       124 ~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH-~~~iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~~~~  196 (350)
T d1rdqe_         124 AGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW  196 (350)
T ss_dssp             TTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEC-TTSCEEECCCTTCEECSSCBC
T ss_pred             CCCCHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHH-HCCEECCCCCHHHCCCC-CCCCEEEEECEEEEECCCCCC
T ss_conf             466226667515-----89899999999999999899998-59986176799993607-789788610103332256664


Q ss_pred             EEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             23431685445452010147887899833069899999999909988888889998657578999998518998422223
Q 001527          937 IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDAA 1016 (1060)
Q Consensus       937 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 1016 (1060)
                          ...||+.|+|||++.+..+  +.++||||+||++|||+||+.||...       ........... +...      
T Consensus       197 ----~~~Gt~~Y~APE~~~~~~~--~~~~DiwSlGvilyemltG~~Pf~~~-------~~~~~~~~i~~-~~~~------  256 (350)
T d1rdqe_         197 ----TLCGTPEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGYPPFFAD-------QPIQIYEKIVS-GKVR------  256 (350)
T ss_dssp             ----CCEECGGGCCHHHHTTCCB--CTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHHHHH-CCCC------
T ss_pred             ----CCCCCCCCCCHHHHCCCCC--CCCCCCCCHHHHHHHHHHCCCCCCCC-------CHHHHHHHHHC-CCCC------
T ss_conf             ----3367635678899717998--85331145007899997588998995-------99999999861-7988------


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCC-----CCHHHHHH
Q ss_conf             45523793578889999999988004-99999-----99778999
Q 001527         1017 VMPEMVNPAAEKGMKEVLGIALRCIR-SVSER-----PGIKTIYE 1055 (1060)
Q Consensus      1017 l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~R-----Ps~~evl~ 1055 (1060)
                       .+       ......+.+++.+|++ +|.+|     ||+.|+++
T Consensus       257 -~p-------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 -FP-------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CC-------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CC-------CCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf             -97-------66899999999998340998606553454999971

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=335.54  Aligned_cols=261  Identities=20%  Similarity=0.239  Sum_probs=190.6

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHHHH-----HHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEE
Q ss_conf             870012266499999994-99399999933221888-----999999999973399980222012896789980399997
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQ-----RKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSD  854 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e  854 (1060)
                      .++||+|+||+||+|+.. +++.||+|+++......     .+.+.+|++++++++|||||++++++.  .....++|||
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~--~~~~~~ivmE   80 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--HKSNISLVFD   80 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--CTTCCEEEEE
T ss_pred             CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEC--CCCCEEEHHH
T ss_conf             63851272829999999999969999998420212456799999999999998679999868985422--5874022045


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCC
Q ss_conf             13899967876119999999989999999999999999998449996248989998685189997599002111000257
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~  934 (1060)
                      |+.++++....     .....+++.++..++.|++.||.||| +++|+||||||+|||++ .+..+||+|||+++.....
T Consensus        81 ~~~~~~~~~~~-----~~~~~l~~~~~~~~~~qil~aL~~lH-~~~iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          81 FMETDLEVIIK-----DNSLVLTPSHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSP  153 (299)
T ss_dssp             CCSEEHHHHHT-----TCCSSCCSSHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSC
T ss_pred             HHCCHHHHHHH-----HCCCCCCHHHHHHHHHHHHHHHHHHH-CCCEECCCCCCCEEEEC-CCCCCCCCCCCCCCCCCCC
T ss_conf             53450776554-----12667789999999999999998863-16355035776258853-7784114657610005787


Q ss_pred             CCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC--
Q ss_conf             752343168544545201014788789983306989999999990998888888999865757899999851899842--
Q 001527          935 GTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC-- 1012 (1060)
Q Consensus       935 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-- 1012 (1060)
                      ..... ...||+.|+|||++.+... ++.++||||+||++|||+||+.||....    ..+....+............  
T Consensus       154 ~~~~~-~~~gt~~y~aPE~~~~~~~-~~~~~DiwSlGvil~el~~g~~pf~~~~----~~~~l~~i~~~~~~~~~~~~~~  227 (299)
T d1ua2a_         154 NRAYT-HQVVTRWYRAPELLFGARM-YGVGVDMWAVGCILAELLLRVPFLPGDS----DLDQLTRIFETLGTPTEEQWPD  227 (299)
T ss_dssp             CCCCC-CSCCCCTTCCHHHHTTCSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHCCCCTTTSSS
T ss_pred             CCCCC-CEECCHHHCCHHHHCCCCC-CCHHHHHHHCCHHHHHHHHCCCCCCCCC----HHHHHHHHHHHCCCCCHHHCCC
T ss_conf             55433-0204733363999726778-8805643630428999985969999999----9999999998518997254521


Q ss_pred             ----CCCCCCCCCCC-H---HHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             ----22234552379-3---578889999999988004-99999997789998
Q 001527         1013 ----FDAAVMPEMVN-P---AAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1013 ----~d~~l~~~~~~-~---~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                          ........... +   ........+.+++.+|++ +|++|||++|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             00021344303478988678565689999999999763894569089999679

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=335.43  Aligned_cols=253  Identities=22%  Similarity=0.289  Sum_probs=198.4

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCH---HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCC--CCEEEEEE
Q ss_conf             870012266499999994-99399999933221---8889999999999733999802220128967899--80399997
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ--HEKLILSD  854 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~--~~~~lv~e  854 (1060)
                      .+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|++++++++|||||++++++.....  ...++|||
T Consensus        12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE   91 (277)
T d1o6ya_          12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME   91 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEEEEEEE
T ss_conf             68996089929999999999989999998556646989999999999999856999887311435432688766999997


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCC
Q ss_conf             13899967876119999999989999999999999999998449996248989998685189997599002111000257
Q 001527          855 YISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       855 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~  934 (1060)
                      |+++|+|.+++...     ..+++.++..++.|++.||.||| +++|+||||||+|||++ .+...+++|||.++.....
T Consensus        92 ~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH-~~~iiHrDiKP~NIll~-~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          92 YVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMIS-ATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             CCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEE-TTSCEEECCCTTCEECC--
T ss_pred             CCCCCEEHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCCCCCC-CCCCCEEEHHHHHHHHCCC
T ss_conf             78898710112035-----89999999999999999999998-57952763467556657-5432010034443221235


Q ss_pred             CC--EEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf             75--2343168544545201014788789983306989999999990998888888999865757899999851899842
Q 001527          935 GT--IEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDC 1012 (1060)
Q Consensus       935 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 1012 (1060)
                      ..  .......||+.|+|||++.+..+  +.++||||+||++|||+||+.||...       ...+............  
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~--~~~~DiwSlGvilyelltG~~Pf~~~-------~~~~~~~~~~~~~~~~--  233 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSV--DARSDVYSLGCVLYEVLTGEPPFTGD-------SPVSVAYQHVREDPIP--  233 (277)
T ss_dssp             --------------TTCCHHHHTTCCC--CHHHHHHHHHHHHHHHHHSSCSCCCS-------SHHHHHHHHHHCCCCC--
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHCCCCC--CCCEECCCCHHHHHHHHHCCCCCCCC-------CHHHHHHHHHHCCCCC--
T ss_conf             443333464257624369999839999--96632026528999997697998996-------9999999998469999--


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCC-CHHHHHHHHHCC
Q ss_conf             222345523793578889999999988004-999999-977899985049
Q 001527         1013 FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERP-GIKTIYEDLSSI 1060 (1060)
Q Consensus      1013 ~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RP-s~~evl~~L~~i 1060 (1060)
                        +...       .......+.+++.+|++ +|.+|| |++++++.|..+
T Consensus       234 --~~~~-------~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         234 --PSAR-------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             --GGGT-------SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --CCHH-------CCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHH
T ss_conf             --7100-------3478999999999986679767773999999999997

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=332.74  Aligned_cols=247  Identities=22%  Similarity=0.293  Sum_probs=194.3

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCH---------HHHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCCCCCE
Q ss_conf             870012266499999994-99399999933221---------888999999999973399-9802220128967899803
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV---------AKQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEK  849 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-Hpniv~l~g~~~~~~~~~~  849 (1060)
                      .+.||+|+||+||+|+.. +++.||+|+++...         ....+.+.+|++++++++ |||||++++++.  +....
T Consensus         8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--~~~~~   85 (277)
T d1phka_           8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--TNTFF   85 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEE
T ss_pred             CEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECC--CCCCE
T ss_conf             5288417684999999999998999999962446411478889999999999999998507997479976214--67605


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCE
Q ss_conf             99997138999678761199999999899999999999999999984499962489899986851899975990021110
Q 001527          850 LILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHR  929 (1060)
Q Consensus       850 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~  929 (1060)
                      ++||||+++|+|.+++...     ..+++.++..++.|++.||.||| +++|+||||||+|||++ .+..+||+|||+++
T Consensus        86 ~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nill~-~~~~~kl~DFG~a~  158 (277)
T d1phka_          86 FLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENILLD-DDMNIKLTDFGFSC  158 (277)
T ss_dssp             EEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEC-TTCCEEECCCTTCE
T ss_pred             EEEEECCCCCHHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCEEEEC-CCCCEEECCCHHEE
T ss_conf             9999768986689999865-----99999999999999999999998-75994323462548986-89983871240316


Q ss_pred             EECCCCCEEEECCCCCCCCCCHHCCCCC----CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             0025775234316854454520101478----878998330698999999999099888888899986575789999985
Q 001527          930 LMTQAGTIEQILDAGVLGYRAPELAASK----KPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVA 1005 (1060)
Q Consensus       930 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~ 1005 (1060)
                      ........  ....||..|+|||++.+.    ...++.++||||+||++|||++|+.||...       ...+..+. +.
T Consensus       159 ~~~~~~~~--~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~-------~~~~~~~~-i~  228 (277)
T d1phka_         159 QLDPGEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-------KQMLMLRM-IM  228 (277)
T ss_dssp             ECCTTCCB--CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHHH-HH
T ss_pred             ECCCCCCE--EEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCC-------CHHHHHHH-HH
T ss_conf             72688721--3452467888988860534456788992331856560231032288898899-------99999999-98


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             1899842222345523793578889999999988004-99999997789998
Q 001527         1006 EGHGSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1006 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .+...          ...+.......++.+++.+|++ +|.+|||+.||++.
T Consensus       229 ~~~~~----------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         229 SGNYQ----------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HTCCC----------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HCCCC----------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             18988----------8985434689999999999765896689199999739

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=333.75  Aligned_cols=241  Identities=22%  Similarity=0.343  Sum_probs=189.1

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHH---HHHHHHHHHHHHHH-CCCCCCEEEEEEEEECCCCCCEEEEEEE
Q ss_conf             870012266499999994-993999999332218---88999999999973-3999802220128967899803999971
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA---KQRKEFAKEAKKFA-NIRHPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~Hpniv~l~g~~~~~~~~~~~lv~e~  855 (1060)
                      .++||+|+||+||+|+.. +++.||+|++++...   ...+.+..|+.++. .++|||||++++++.  +....++||||
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~--~~~~~yivmEy   84 (320)
T d1xjda_           7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TKENLFFVMEY   84 (320)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEEEEEEEC
T ss_pred             EEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEC--CCCCEEEEEEE
T ss_conf             6589408782899999999998999999805553384899999999999998479996878988970--49831677750


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCC
Q ss_conf             38999678761199999999899999999999999999984499962489899986851899975990021110002577
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~  935 (1060)
                      +++|+|.+++...     ..+++.++..++.|++.||.||| +++|+||||||+|||++ .+..+|++|||+++......
T Consensus        85 ~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH-~~~iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          85 LNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             CTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTT
T ss_pred             CCCCCHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHH-HCCEEECCCCCCCEEEC-CCCCEECCCCCHHHHCCCCC
T ss_conf             3798089986404-----78999999999999999999998-68934034765404444-89963015553023235665


Q ss_pred             CEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf             52343168544545201014788789983306989999999990998888888999865757899999851899842222
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCFDA 1015 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 1015 (1060)
                      ... ....||+.|+|||++.+..+  +.++||||+||++|||+||+.||...       ...+... .+..+...     
T Consensus       158 ~~~-~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlGvilyemltG~~PF~~~-------~~~~~~~-~i~~~~~~-----  221 (320)
T d1xjda_         158 AKT-NTFCGTPDYIAPEILLGQKY--NHSVDWWSFGVLLYEMLIGQSPFHGQ-------DEEELFH-SIRMDNPF-----  221 (320)
T ss_dssp             CCB-CCCCSCGGGCCHHHHTTCCB--CTHHHHHHHHHHHHHHHHSSCSSCCS-------SHHHHHH-HHHHCCCC-----
T ss_pred             CCC-CCCCCCCCCCCHHHHCCCCC--CCHHHHHHHHHHHHHHHHCCCCCCCC-------CHHHHHH-HHHCCCCC-----
T ss_conf             334-54578777689999827998--83232011227898987388999998-------9999999-99718998-----


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHH-HHHH
Q ss_conf             345523793578889999999988004-999999977-8999
Q 001527         1016 AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIK-TIYE 1055 (1060)
Q Consensus      1016 ~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~-evl~ 1055 (1060)
                        .+.       .....+.+++.+|+. +|++||++. |+++
T Consensus       222 --~p~-------~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 --YPR-------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --CCT-------TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --CCC-------CCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf             --975-------679999999999654489878388999980

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=331.75  Aligned_cols=267  Identities=19%  Similarity=0.237  Sum_probs=187.0

Q ss_pred             HCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC----CCCCEEE
Q ss_conf             0267870012266499999994-9939999993322188899999999997339998022201289678----9980399
Q 001527          777 SRAPAEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGP----TQHEKLI  851 (1060)
Q Consensus       777 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~----~~~~~~l  851 (1060)
                      .|...++||+|+||+||+|+.. +++.||+|+++...    ....+|++++++++||||+++++++...    +....++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCC----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf             7675169821768399999999999799999988160----689999999986689898738789974476577318999


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEE
Q ss_conf             99713899967876119999999989999999999999999998449996248989998685189997599002111000
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~  931 (1060)
                      ||||+++|.+.......  .....+++.++..++.|++.||.||| +++|+||||||+|||++.++..+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH-~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEECCCCCCHHHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf             98416886078888631--03689999999999999999999998-6687645788603787358971167336605440


Q ss_pred             CCCCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHH-------HH
Q ss_conf             25775234316854454520101478878998330698999999999099888888899986575789999-------98
Q 001527          932 TQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQL-------KV 1004 (1060)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~ 1004 (1060)
                      ........  ..|+..|+|||.+.+... ++.++||||+||++|||++|+.||......+   .+....+.       ..
T Consensus       174 ~~~~~~~~--~~gt~~y~aPE~~~~~~~-~~~~~DIwSlG~il~el~~g~~pf~~~~~~~---~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         174 VRGEPNVS--YICSRYYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CTTSCCCS--CCSCTTSCCHHHHTTCSS-CCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCCCHHHH
T ss_pred             CCCCCCCC--CCCCCCCCCHHHHHCCCC-CCCCEEECCCCEEEEEHHHCCCCCCCCCHHH---HHHHHHHHHCCCHHHHH
T ss_conf             47765320--025555568277640468-8821000246527785502879989879999---99999997489817765


Q ss_pred             --HCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             --5189984222234552-3793578889999999988004-99999997789998
Q 001527         1005 --AEGHGSDCFDAAVMPE-MVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1005 --~~~~~~~~~d~~l~~~-~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                        ......+..-+..... ............+.+++.+|++ +|++|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             43062101103554456744443156899999999999765895579299999669

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=328.45  Aligned_cols=259  Identities=19%  Similarity=0.247  Sum_probs=191.0

Q ss_pred             CCEECCCCCEEEEEEEE-CCCCEEEEEECCCCHHH--HHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECC
Q ss_conf             87001226649999999-49939999993322188--8999999999973399980222012896789980399997138
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAK--QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~  857 (1060)
                      .+.||+|+||+||+|+. .+++.||+|+++.....  ..+.+.+|++++++++|||||++++++.  +....++||||+.
T Consensus         7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~--~~~~~~iv~e~~~   84 (298)
T d1gz8a_           7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLVFEFLH   84 (298)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE--ETTEEEEEEECCS
T ss_pred             CCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCC--CCCCEEEEEEECC
T ss_conf             51772376809999999999979999998022257589999999999998679983887445332--2432037886237


Q ss_pred             CCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCCE
Q ss_conf             99967876119999999989999999999999999998449996248989998685189997599002111000257752
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~  937 (1060)
                      + ++.+++...   ....+++..+..++.|++.||.||| +.+|+||||||+|||++ .+..+|++|||.|+........
T Consensus        85 ~-~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH-~~~IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          85 Q-DLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             E-EHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCCCSBC
T ss_pred             C-CHHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHH-CCCEECCCCCCHHEEEC-CCCCCEECCCCCCEECCCCCCC
T ss_conf             7-445554420---2568888999999999999999865-28899213571140113-4676210357861343688641


Q ss_pred             EEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHH-HHHCCCCCCCCCCC
Q ss_conf             34316854454520101478878998330698999999999099888888899986575789999-98518998422223
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQL-KVAEGHGSDCFDAA 1016 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~d~~ 1016 (1060)
                       .....|++.|+|||++....+ .+.++||||+||++|||++|+.||....       -.+.... ....+...+...+.
T Consensus       159 -~~~~~gt~~y~apE~~~~~~~-~~~~~DiwSlGvily~m~~G~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~  229 (298)
T d1gz8a_         159 -YTHEVVTLWYRAPEILLGCKY-YSTAVDIWSLGCIFAEMVTRRALFPGDS-------EIDQLFRIFRTLGTPDEVVWPG  229 (298)
T ss_dssp             -TTCCBCCCTTCCHHHHTTCSS-CCTHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHHHCCCCTTTSTT
T ss_pred             -CEEECCCCEEEEHHHHCCCCC-CCCCCCCCCCCHHHHHHHHCCCCCCCCC-------HHHHHHHHHHHCCCCCHHHCCC
T ss_conf             -001036521541122136657-7742210333313427966879989889-------9999999998328983331444


Q ss_pred             ------CCC---CCCCH----HHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             ------455---23793----578889999999988004-99999997789998
Q 001527         1017 ------VMP---EMVNP----AAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1017 ------l~~---~~~~~----~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                            ...   .....    ........+.+++.+|++ +|.+|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             222421243454322220444166789999999999763995579189999678

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=321.73  Aligned_cols=260  Identities=19%  Similarity=0.239  Sum_probs=191.6

Q ss_pred             CCEECCCCCEEEEEEEECCCCEEEEEECCCCHHH--HHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECCC
Q ss_conf             8700122664999999949939999993322188--89999999999733999802220128967899803999971389
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVAK--QRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .++||+|+||+||+|+.++++.||+|+++.....  ..+.+.+|+.++++++|||||++++++.  .....++++|++.+
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~i~~e~~~~   84 (286)
T d1ob3a_           7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH--TKKRLVLVFEHLDQ   84 (286)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE--CSSCEEEEEECCSE
T ss_pred             CCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECC--CCCCEEEEEEEEHH
T ss_conf             3187227781899999689999999998123268589999999999998679986876601204--67731589974004


Q ss_pred             CCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCCEE
Q ss_conf             99678761199999999899999999999999999984499962489899986851899975990021110002577523
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTIE  938 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~~  938 (1060)
                      +.+..+..     ....+++..+..++.|++.||.||| +.+|+||||||+|||++ .+..+|++|||.+..........
T Consensus        85 ~~~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH-~~~IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          85 DLKKLLDV-----CEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             EHHHHHHT-----STTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC-----
T ss_pred             HHHHHHHH-----HCCCCCHHHHHHHHHHHHHHHHHHC-CCCEEECCCCCCEEEEC-CCCCEEECCCCCCEECCCCCCCC
T ss_conf             56789986-----0477514456899999999999860-57488267877505686-89978732366430114676541


Q ss_pred             EECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCC---CC---
Q ss_conf             431685445452010147887899833069899999999909988888889998657578999998518998---42---
Q 001527          939 QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGS---DC--- 1012 (1060)
Q Consensus       939 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~---~~--- 1012 (1060)
                       ....|++.|+|||.+.+..+ ++.++||||+||++|||++|+.||.....    .+....+..........   ..   
T Consensus       158 -~~~~~~~~y~~pE~~~~~~~-~~~~~DiwslGv~l~el~~G~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         158 -THEIVTLWYRAPDVLMGSKK-YSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFRILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCS-CCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             -CEECCCCHHHHHHHHHCCCC-CCCCEEEHHCCCHHHHHHHCCCCCCCCCH----HHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf             -01024311013788717888-88410021117589999779799898898----9999999986389971104212333


Q ss_pred             --CCCCCC---CCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHH
Q ss_conf             --222345---523793578889999999988004-9999999778999
Q 001527         1013 --FDAAVM---PEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1013 --~d~~l~---~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                        .+....   +.............+.+++.+|++ +|++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             2214333335676466651258999999999986689668909999856

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=318.86  Aligned_cols=262  Identities=19%  Similarity=0.228  Sum_probs=183.9

Q ss_pred             CCEECCCCCEEEEEEEEC-C-CCEEEEEECCCCHHH--HHHHHHHHHHHHHCC---CCCCEEEEEEEEEC---CCCCCEE
Q ss_conf             870012266499999994-9-939999993322188--899999999997339---99802220128967---8998039
Q 001527          781 AEVLGRSSHGTSYRATLE-N-GMFLTVKWLREGVAK--QRKEFAKEAKKFANI---RHPNVVGLRGYYWG---PTQHEKL  850 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~Hpniv~l~g~~~~---~~~~~~~  850 (1060)
                      .+.||+|+||+||+|+.. + ++.||+|+++.....  ....+.+|+++++.+   +||||+++++++..   ......+
T Consensus        12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~   91 (305)
T d1blxa_          12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   91 (305)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred             EEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCEEE
T ss_conf             88992155869999999888998999999802324516799999999999987425898802366322146666674699


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEE
Q ss_conf             99971389996787611999999998999999999999999999844999624898999868518999759900211100
Q 001527          851 ILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       851 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~  930 (1060)
                      +++||+++|.+......    ....+++..+..++.|++.||+||| +++|+||||||+|||++ .+..+|++|||+++.
T Consensus        92 ~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH-~~~ivHrDiKp~NILi~-~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          92 LVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVT-SSGQIKLADFGLARI  165 (305)
T ss_dssp             EEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEC-TTCCEEECSCCSCCC
T ss_pred             EEEEECCCCCHHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH-HCCEEECCCCCCEEEEC-CCCCEEECCHHHHHH
T ss_conf             99974058714444430----3789998999999999999999997-58898357986278985-899754210001011


Q ss_pred             ECCCCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHC----
Q ss_conf             0257752343168544545201014788789983306989999999990998888888999865757899999851----
Q 001527          931 MTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAE---- 1006 (1060)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---- 1006 (1060)
                      .......  ....||+.|+|||++.+..+  +.++||||+||++|||++|+.||.....    .+....+......    
T Consensus       166 ~~~~~~~--~~~~gT~~Y~APE~~~~~~y--~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         166 YSFQMAL--TSVVVTLWYRAPEVLLQSSY--ATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CCGGGGG--CCCCCCCTTCCHHHHTTCCC--CTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCGG
T ss_pred             HCCCCCC--CCCCCCHHHCCCCHHCCCCC--CHHEHHHCHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHHCCCCHH
T ss_conf             0023457--77654851148310017988--8111000328999999878799899898----99999999840799611


Q ss_pred             CCCCCCC-CC----CCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             8998422-22----345523793578889999999988004-99999997789998
Q 001527         1007 GHGSDCF-DA----AVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1007 ~~~~~~~-d~----~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .+..... ..    .................+.+++.+|++ +|++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             05321111033302234564544044589999999999874896679189999669

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=314.57  Aligned_cols=260  Identities=16%  Similarity=0.198  Sum_probs=192.8

Q ss_pred             CCCCCEECCCCCEEEEEEEE-CCCCEEEEEECCCCHHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCCCCCEEEEEEE
Q ss_conf             26787001226649999999-499399999933221888999999999973399-9802220128967899803999971
Q 001527          778 RAPAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       778 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~g~~~~~~~~~~~lv~e~  855 (1060)
                      +...++||+|+||+||+|+. .+++.||+|+++...   .+.+.+|++++++++ ||||+++++++........++||||
T Consensus        37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~  113 (328)
T d3bqca1          37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  113 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred             EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEEEE
T ss_conf             189789831748199999988999799999988899---99999999999851579987679999981687712688863


Q ss_pred             CCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCC
Q ss_conf             38999678761199999999899999999999999999984499962489899986851899975990021110002577
Q 001527          856 ISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAG  935 (1060)
Q Consensus       856 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~  935 (1060)
                      +++|+|..+.        ..+++..+..++.|++.||.||| +++|+||||||+|||++.++..+|++|||+|+......
T Consensus       114 ~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH-~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         114 VNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             CCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             CCCCCHHHHH--------CCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCCC
T ss_conf             1798589974--------68999999999999999998876-43344345644123774899836641565426646887


Q ss_pred             CEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHH---------HHHC
Q ss_conf             5234316854454520101478878998330698999999999099888888899986575789999---------9851
Q 001527          936 TIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQL---------KVAE 1006 (1060)
Q Consensus       936 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~---------~~~~ 1006 (1060)
                      ..  ....||..|+|||.+.+... ++.++||||+||++||+++|+.||......   .+....+..         ....
T Consensus       185 ~~--~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~~l~e~~~g~~pf~~~~~~---~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         185 EY--NVRVASRYFKGPELLVDYQM-YDYSLDMWSLGCMLASMIFRKEPFFHGHDN---YDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CC--CSCCSCGGGCCHHHHTTCCC-CCTHHHHHHHHHHHHHHHHTCSSSSCCSSH---HHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CC--CCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHCCCCCCCCCCCHH---HHHHHHHHHHHCCCHHHHHHHH
T ss_conf             44--43224864247610268888-884523233545558760488999887601---8999999998788415555542


Q ss_pred             C--CCCCCCC--------CCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHH
Q ss_conf             8--9984222--------2345523793578889999999988004-9999999778999
Q 001527         1007 G--HGSDCFD--------AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1007 ~--~~~~~~d--------~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .  .....+.        .........+........+.+++.+|++ +|.+|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             254447430000033343311211552112448999999999986699568908999964

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=314.55  Aligned_cols=256  Identities=17%  Similarity=0.222  Sum_probs=188.8

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC----CCCEEEEE
Q ss_conf             870012266499999994-9939999993322--1888999999999973399980222012896789----98039999
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREG--VAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPT----QHEKLILS  853 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~----~~~~~lv~  853 (1060)
                      .+.||+|+||+||+|+.. +|+.||+|+++..  .....+.+.+|++++++++|||||+++++|....    ....++||
T Consensus        23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  102 (346)
T d1cm8a_          23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  102 (346)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCEEEEEE
T ss_conf             88980177819999999999989999998522259699999999999998668987547999863576555541599998


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECC
Q ss_conf             71389996787611999999998999999999999999999844999624898999868518999759900211100025
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~  933 (1060)
                      ||+ ++++......      ..+++..+..++.|++.||.||| +++|+||||||+|||++ .+..+|++|||+|+....
T Consensus       103 e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH-~~~IiHrDiKp~NIL~~-~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_         103 PFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVN-EDCELKILDFGLARQADS  173 (346)
T ss_dssp             ECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECCS
T ss_pred             ECC-CCCHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCHHHCC-CCCCCCCCCCCCEECCCC
T ss_conf             405-5218999874------02269999999999999999987-37876456685111121-001221134310220687


Q ss_pred             CCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCC-CC
Q ss_conf             77523431685445452010147887899833069899999999909988888889998657578999998518998-42
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGS-DC 1012 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~-~~ 1012 (1060)
                      ...    ...|+..|+|||++.+... ++.++||||+||++|||++|+.||......   ..+.....   ..+... +.
T Consensus       174 ~~~----~~~~t~~y~aPE~~~~~~~-~~~~~DiwSlGvil~ell~g~~pf~~~~~~---~~~~~~~~---~~~~~~~~~  242 (346)
T d1cm8a_         174 EMT----GYVVTRWYRAPEVILNWMR-YTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMK---VTGTPPAEF  242 (346)
T ss_dssp             SCC----SSCSCGGGCCTHHHHTTTC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH---HHCCCCHHH
T ss_pred             CCC----CCCCCCCCCCHHHHCCCCC-CCCCCHHHCCHHHHHHHHHCCCCCCCCCHH---HHHHHHHH---CCCCCCHHH
T ss_conf             631----0245533358899817878-996501030038999999786998889768---99999985---037884888


Q ss_pred             C--------------CCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             2--------------22345523793578889999999988004-99999997789998
Q 001527         1013 F--------------DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1013 ~--------------d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .              .+.................+.+++.+|+. +|.+|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             86530003443311578666556677556899999999999772995579299999639

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=327.26  Aligned_cols=236  Identities=17%  Similarity=0.263  Sum_probs=185.6

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHH------HHHHHHHHHHHHHHCCC--CCCEEEEEEEEECCCCCCEEE
Q ss_conf             870012266499999994-993999999332218------88999999999973399--980222012896789980399
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVA------KQRKEFAKEAKKFANIR--HPNVVGLRGYYWGPTQHEKLI  851 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--Hpniv~l~g~~~~~~~~~~~l  851 (1060)
                      .++||+|+||+||+|+.. +++.||+|+++....      .....+.+|+.++++++  |||||++++++.  +....++
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--~~~~~~l   86 (273)
T d1xwsa_           9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--RPDSFVL   86 (273)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--CSSEEEE
T ss_pred             EEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE--ECCEEEE
T ss_conf             67984087839999999999979999998568844334556799999999999974358988127999983--0996899


Q ss_pred             EEEECCC-CCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEE
Q ss_conf             9971389-996787611999999998999999999999999999844999624898999868518999759900211100
Q 001527          852 LSDYISP-GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       852 v~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~  930 (1060)
                      ||||+.+ +++.+++...     ..+++.++..++.|++.||.||| +++|+||||||+|||++.++..+||+|||+|+.
T Consensus        87 v~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH-~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          87 ILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             EEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEECCCCCHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCCEEEECCCCEEEECCCCCCEE
T ss_conf             998336862289998615-----89999999999999999999998-779755667611147744788489775465353


Q ss_pred             ECCCCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf             02577523431685445452010147887899833069899999999909988888889998657578999998518998
Q 001527          931 MTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGS 1010 (1060)
Q Consensus       931 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 1010 (1060)
                      ......   ....||+.|+|||++.+..+ ++.++||||+||++|||+||+.||...             ..... +.. 
T Consensus       161 ~~~~~~---~~~~GT~~y~aPE~~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~-------------~~i~~-~~~-  221 (273)
T d1xwsa_         161 LKDTVY---TDFDGTRVYSPPEWIRYHRY-HGRSAAVWSLGILLYDMVCGDIPFEHD-------------EEIIR-GQV-  221 (273)
T ss_dssp             CCSSCB---CCCCSCGGGSCHHHHHHSCB-CHHHHHHHHHHHHHHHHHHSSCSCCSH-------------HHHHH-CCC-
T ss_pred             CCCCCC---CCCCCCCCCCCHHHHCCCCC-CCCCCCCCCCEEEEHHHHHCCCCCCCC-------------HHHHH-CCC-
T ss_conf             244455---66565877479999848997-886533255403453675688998873-------------67761-544-


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             42222345523793578889999999988004-99999997789998
Q 001527         1011 DCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1011 ~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                       .+.     .       .....+.+++.+|++ +|++|||++|+++.
T Consensus       222 -~~~-----~-------~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         222 -FFR-----Q-------RVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             -CCS-----S-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -CCC-----C-------CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             -778-----7-------799999999999760897589399998539

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=312.87  Aligned_cols=262  Identities=19%  Similarity=0.217  Sum_probs=189.3

Q ss_pred             CCEECCCCCEEEEEEEE-CCCCEEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCC--CCEEEEEEEC
Q ss_conf             87001226649999999-499399999933221-8889999999999733999802220128967899--8039999713
Q 001527          781 AEVLGRSSHGTSYRATL-ENGMFLTVKWLREGV-AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQ--HEKLILSDYI  856 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~--~~~~lv~e~~  856 (1060)
                      .+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|++++++++||||+++++++..+..  ...+++++++
T Consensus        13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~   92 (345)
T d1pmea_          13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL   92 (345)
T ss_dssp             EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred             EEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEEEEE
T ss_conf             78994064809999999999949999998031095899999999999997689898858889950564554149999962


Q ss_pred             CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCC
Q ss_conf             89996787611999999998999999999999999999844999624898999868518999759900211100025775
Q 001527          857 SPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGT  936 (1060)
Q Consensus       857 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~  936 (1060)
                      .+|+|.+++...      .+++..+..++.|++.||.||| +++|+||||||+|||++ .+..+||+|||+++.......
T Consensus        93 ~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH-~~~iiHRDIKp~NILl~-~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          93 MGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             CCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEC-TTCCEEECCCTTCEECCGGGC
T ss_pred             CCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCEEEEC-CCCCEEECCCCCEEECCCCCC
T ss_conf             598656644058------9999999999999999999999-78986777876437887-999778754570565047776


Q ss_pred             EE--EECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC-
Q ss_conf             23--431685445452010147887899833069899999999909988888889998657578999998518998422-
Q 001527          937 IE--QILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF- 1013 (1060)
Q Consensus       937 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~- 1013 (1060)
                      ..  .....|++.|+|||++..... ++.++||||+||++|||++|+.||.....    .+........... ...... 
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~DiwSlG~il~eml~g~~pf~~~~~----~~~~~~~~~~~~~-~~~~~~~  238 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHY----LDQLNHILGILGS-PSQEDLN  238 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCS-CSTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCS-CCHHHHH
T ss_pred             CCEEECCCCCCCEECHHHHHHCCCC-CCCHHHHHCCCCEEHHHHHCCCCCCCCCH----HHHHHHHHHHCCC-CCHHHHH
T ss_conf             4101011026520003878604788-87410100467013377669799788888----9999987652069-9756642


Q ss_pred             -------------CCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             -------------22345523793578889999999988004-99999997789998
Q 001527         1014 -------------DAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1014 -------------d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                                   .+...+.............+.+++.+|++ +|.+|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             343322220244677557787778378999999999999764895679089998619

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=317.08  Aligned_cols=254  Identities=14%  Similarity=0.140  Sum_probs=190.3

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECCCC
Q ss_conf             870012266499999994-9939999993322188899999999997339998022201289678998039999713899
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+.||+|+||.||+|+.. +++.||+|++....  ..+++..|++++++++|++++..++.+. ......++||||+ +|
T Consensus        12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~-~~~~~~~ivme~~-~~   87 (299)
T d1ckia_          12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG-AEGDYNVMVMELL-GP   87 (299)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEE-EETTEEEEEEECC-CC
T ss_pred             EEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEE-ECCCEEEEEEEEC-CC
T ss_conf             689850788099999998899899999972100--5888999999999703899601799999-5198778999873-87


Q ss_pred             CHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC--CCCCEEECCCCCCEEECCCCCE
Q ss_conf             96787611999999998999999999999999999844999624898999868518--9997599002111000257752
Q 001527          860 SLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG--PDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       860 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~--~~~~~kl~Dfgla~~~~~~~~~  937 (1060)
                      ++...+...    ...+++..+..++.|++.||+||| +++|+||||||+|||++.  .+..+|++|||+|+........
T Consensus        88 ~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          88 SLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             BHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             CHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHH-HCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCCCC
T ss_conf             133324430----688768999999999999999999-799442667876606433577761565046751342554455


Q ss_pred             ------EEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf             ------34316854454520101478878998330698999999999099888888899986575789999985189984
Q 001527          938 ------EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       938 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                            ......||+.|+|||++.+..+  +.++|||||||++|||+||+.||..............+.......  .  
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--~--  236 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQ--SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--P--  236 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCC--CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--C--
T ss_pred             CCEECCCCCCCCCCCCCCCHHHHHCCCC--CCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCC--C--
T ss_conf             4100013577678735329999918998--983218861778999984987665530577999999852356789--8--


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHC
Q ss_conf             2222345523793578889999999988004-99999997789998504
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                        .+.        .....+.++.+++.+|++ +|++||++.++.+.|+.
T Consensus       237 --~~~--------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         237 --IEV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             --HHH--------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             --HHH--------HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHH
T ss_conf             --357--------534788999999999843995579199999999999

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=309.60  Aligned_cols=264  Identities=16%  Similarity=0.167  Sum_probs=188.9

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC------CCCCEEE
Q ss_conf             870012266499999994-99399999933221--88899999999997339998022201289678------9980399
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGP------TQHEKLI  851 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~------~~~~~~l  851 (1060)
                      .+.||+|+||+||+|+.. +|+.||||++....  ....+++.+|++++++++||||+++++++...      .....++
T Consensus        15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i   94 (318)
T d3blha1          15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL   94 (318)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCCCEEEE
T ss_conf             99972274829999999899979999998422246378999999999999835999660676540246544445763899


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEE
Q ss_conf             99713899967876119999999989999999999999999998449996248989998685189997599002111000
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~  931 (1060)
                      ||||+.++.+....     .....++...+..++.|++.||.||| +.+|+||||||+|||++ .+..+|++|||+++..
T Consensus        95 v~e~~~~~~~~~~~-----~~~~~~~~~~~~~i~~qil~~l~~lH-~~~ivHrDlKp~NILl~-~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          95 VFDFCEHDLAGLLS-----NVLVKFTLSEIKRVMQMLLNGLYYIH-RNKILHRDMKAANVLIT-RDGVLKLADFGLARAF  167 (318)
T ss_dssp             EEECCCEEHHHHHT-----CTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred             EEECCCCCCCCHHH-----HCCCCCCCHHHHHHHHHHHHHHHHHC-CCCEEECCCCCHHEEEC-CCCCEEEEECCEEEEC
T ss_conf             98535787410122-----20344330899999999999998852-29988567672220366-8996876313500223


Q ss_pred             CCCCCE---EEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             257752---34316854454520101478878998330698999999999099888888899986575789999985189
Q 001527          932 TQAGTI---EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008 (1060)
Q Consensus       932 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 1008 (1060)
                      ......   ......||..|+|||++.+... ++.++||||+||++|||++|+.||....    .......+......-.
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~-~~~k~DiwSlGvil~el~~g~~pf~~~~----~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERD-YGPPIDLWGAGCIMAEMWTRSPIMQGNT----EQHQLALISQLCGSIT  242 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSS-CCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHHHCCCC
T ss_pred             CCCCCCCCCCCCCEECCHHHHHHHHHCCCCC-CCCHHHCCCCCCEEEEHHHCCCCCCCCC----HHHHHHHHHHHCCCCC
T ss_conf             5544432113566024978742899707999-8917870067864661744879989989----9999999998418998


Q ss_pred             ---CCCC-----CCCCCCCCCCCHHHHH------HHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             ---9842-----2223455237935788------89999999988004-99999997789998
Q 001527         1009 ---GSDC-----FDAAVMPEMVNPAAEK------GMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1009 ---~~~~-----~d~~l~~~~~~~~~~~------~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                         ....     ...............+      ....+.+++.+|++ +|++|||++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             255344320344433201334455503340444599899999999873896589099999749

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=318.97  Aligned_cols=248  Identities=22%  Similarity=0.291  Sum_probs=193.4

Q ss_pred             CCEECCCCCEEEEEEEEC----CCCEEEEEECCCCH----HHHHHHHHHHHHHHHCCCC-CCEEEEEEEEECCCCCCEEE
Q ss_conf             870012266499999994----99399999933221----8889999999999733999-80222012896789980399
Q 001527          781 AEVLGRSSHGTSYRATLE----NGMFLTVKWLREGV----AKQRKEFAKEAKKFANIRH-PNVVGLRGYYWGPTQHEKLI  851 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-pniv~l~g~~~~~~~~~~~l  851 (1060)
                      .++||+|+||+||+|+..    +|+.||+|.++...    ....+.+.+|++++++++| |||+++++++.  +....++
T Consensus        29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~--~~~~~~~  106 (322)
T d1vzoa_          29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TETKLHL  106 (322)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE--ETTEEEE
T ss_pred             EEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC--CCCCEEE
T ss_conf             98983287839999998765887948999998367721016899999999999986467983999620002--4873001


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEE
Q ss_conf             99713899967876119999999989999999999999999998449996248989998685189997599002111000
Q 001527          852 LSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLM  931 (1060)
Q Consensus       852 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~  931 (1060)
                      |+||+.+|+|.+++...     ..+.......++.|++.|+.|+| +.+|+||||||+|||++ .++.+||+|||+++..
T Consensus       107 v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH-~~~ivHrDiKp~Nill~-~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         107 ILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH-KLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEC-TTSCEEESCSSEEEEC
T ss_pred             EEECCCCCHHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHH-CCCEEECCCCCCCEEEC-CCCCEEEEECCCHHHH
T ss_conf             23123411799998730-----45437888888999999998851-49989654773201246-9998887413202220


Q ss_pred             CCCCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf             25775234316854454520101478878998330698999999999099888888899986575789999985189984
Q 001527          932 TQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSD 1011 (1060)
Q Consensus       932 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 1011 (1060)
                      ............|++.|+|||.+.+....++.++||||+||++|||++|+.||.......   ......+..... ..  
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~---~~~~i~~~~~~~-~~--  253 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKS-EP--  253 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHHHHHHC-CC--
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHCCCC-CC--
T ss_conf             344443221222333331068760577688713251777799999976899988887777---999999833568-99--


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCC-----HHHHHH
Q ss_conf             2222345523793578889999999988004-9999999-----778999
Q 001527         1012 CFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPG-----IKTIYE 1055 (1060)
Q Consensus      1012 ~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs-----~~evl~ 1055 (1060)
                                  +........+.+++.+|+. +|++|||     ++|+++
T Consensus       254 ------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         254 ------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------------CCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf             ------------88654799999999997445898819997450999974

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=305.30  Aligned_cols=261  Identities=14%  Similarity=0.159  Sum_probs=191.2

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC----CCCCEEEEE
Q ss_conf             870012266499999994-99399999933221--88899999999997339998022201289678----998039999
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGP----TQHEKLILS  853 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~----~~~~~~lv~  853 (1060)
                      .++||+|+||+||+|+.. +|+.||||+++...  ....+.+.+|+.++++++|||||++++++...    .....|+||
T Consensus        22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~  101 (355)
T d2b1pa1          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM  101 (355)
T ss_dssp             EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCEEEEEE
T ss_conf             88962175859999999999989999998823369799999999999998648987648998970256434576269998


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECC
Q ss_conf             71389996787611999999998999999999999999999844999624898999868518999759900211100025
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~  933 (1060)
                      ||+.++ +.+.+.       ..+++..+..++.|++.||.||| +.||+||||||+|||++ .+...|++|||+++....
T Consensus       102 Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH-~~giiHrDlKP~Nil~~-~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1         102 ELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             ECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEC-TTCCEEECCCCC------
T ss_pred             ECCCHH-HHHHHH-------CCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCCCCCC-CCCCEEEECHHHHHCCCC
T ss_conf             414467-787650-------38999999999999999998865-22112456776321136-544313201023211466


Q ss_pred             CCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCC---------------CHHH
Q ss_conf             7752343168544545201014788789983306989999999990998888888999865---------------7578
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGV---------------DLTD  998 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~---------------~l~~  998 (1060)
                      .....  ...||..|+|||++.+..+  +.++||||+||+++||++|+.||..........               ....
T Consensus       172 ~~~~~--~~~~t~~y~aPE~l~~~~~--~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         172 SFMMT--PYVVTRYYRAPEVILGMGY--KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             -----------CCTTCCHHHHTTCCC--CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             CCCCC--CCCCCCCCCCHHHHCCCCC--CCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_conf             65533--2214655558133147777--8774333566257898659899888977889999997205898799987656


Q ss_pred             HHHHHHHCCC-CCCC-----CCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             9999985189-9842-----222345523793578889999999988004-99999997789998
Q 001527          999 WMQLKVAEGH-GSDC-----FDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus       999 ~~~~~~~~~~-~~~~-----~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                      .......... ....     +..... .............+.+++.+|+. +|++||||+|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLF-PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGS-CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             67777641754356664212643335-43210133379999999999876994579089999669

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=0  Score=307.65  Aligned_cols=187  Identities=30%  Similarity=0.532  Sum_probs=129.5

Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCC--CCCEEEECCCCEEEEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf             9947799999999716689998657888788889999998--62218933997269991588986544742114998874
Q 001527           20 LPSQDILALLEFKKGIKNDPTGFVLNSWNEESIDFDGCPS--SWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLV   97 (1060)
Q Consensus        20 ~~~~~~~aLl~~k~~~~~~p~~~~l~sW~~~~~~~~~~~c--~w~gv~C~~~~~~~~~l~~~~~~~~~~~~~~~~l~~L~   97 (1060)
                      |...|++||++||+++. ||  ..+++|..     ++|||  .|.||+|+.....                     .+++
T Consensus         3 c~~~e~~aLl~~k~~~~-~~--~~l~sW~~-----~~d~C~~~w~gv~C~~~~~~---------------------~~v~   53 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLG-NP--TTLSSWLP-----TTDCCNRTWLGVLCDTDTQT---------------------YRVN   53 (313)
T ss_dssp             SCHHHHHHHHHHHHHTT-CC--GGGTTCCT-----TSCTTTTCSTTEEECCSSSC---------------------CCEE
T ss_pred             CCHHHHHHHHHHHHHCC-CC--CCCCCCCC-----CCCCCCCCCCCEEEECCCCC---------------------EEEE
T ss_conf             89899999999999779-99--86778899-----99998894889697489994---------------------7988


Q ss_pred             EEECCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf             99876884533--4898857999976997579-84466573222456346720033543476457766677755699864
Q 001527           98 KLSMSNNSISG--VIPDNIGDFKSLEFLDVSD-NLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLS  174 (1060)
Q Consensus        98 ~L~l~~n~l~~--~~p~~~~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  174 (1060)
                      .|+|++|++.|  .+|.++++|++|++|+|++ |++.|.+|.+|+++++|++|+|++|++.+..+..+..+.+|+.++++
T Consensus        54 ~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~  133 (313)
T d1ogqa_          54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS  133 (313)
T ss_dssp             EEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECC
T ss_pred             EEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCC
T ss_conf             99898998888887984784675335202026543330024311454200110203564344332222201110011112


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCCHHHH
Q ss_conf             887999998101398976689911584643478222147999-9998318968766855554
Q 001527          175 HNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGL-QVLDFHGNKLDGHLDGEFF  235 (1060)
Q Consensus       175 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~  235 (1060)
                      +|.+.+.+|..+.+++.++.+++++|.+.+.+|..+..+..+ +.+++++|++++..+..+.
T Consensus       134 ~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~  195 (313)
T d1ogqa_         134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA  195 (313)
T ss_dssp             SSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGG
T ss_pred             CCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             24555568512206740000002355335620312144311232310224643533243322

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=304.72  Aligned_cols=259  Identities=17%  Similarity=0.185  Sum_probs=192.5

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCCCCEEEEEEECC
Q ss_conf             870012266499999994-99399999933221--888999999999973399980222012896789980399997138
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGPTQHEKLILSDYIS  857 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~~~~~~~lv~e~~~  857 (1060)
                      .++||+|+||+||+|+.. +++.||+|+++...  ....+.+.+|+.++++++||||+++++++.  +....++|++++.
T Consensus         7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~--~~~~~~iv~~~~~   84 (292)
T d1unla_           7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKLTLVFEFCD   84 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEEEEECCS
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCC--CCCCEEEEEEECC
T ss_conf             26971286819999999999969999998032178689999999999998567578882135444--4431158863023


Q ss_pred             CCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECCCCCE
Q ss_conf             99967876119999999989999999999999999998449996248989998685189997599002111000257752
Q 001527          858 PGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQAGTI  937 (1060)
Q Consensus       858 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~~~~~  937 (1060)
                      ++++..++..     ...+++..+..++.|++.||+||| +.+|+||||||+|||++ .+..+|++|||.++........
T Consensus        85 ~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH-~~~IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          85 QDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEC-TTCCEEECCCTTCEECCSCCSC
T ss_pred             CCCCCCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHH-CCCEEEECCCCCCCCCC-CCCCEEEEECCHHHCCCCCCCC
T ss_conf             3222112123-----565403678999999999987743-39986001467612113-3782665204601104688751


Q ss_pred             EEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHC-CCC-CCCC--
Q ss_conf             343168544545201014788789983306989999999990998888888999865757899999851-899-8422--
Q 001527          938 EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAE-GHG-SDCF-- 1013 (1060)
Q Consensus       938 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~-~~~-~~~~-- 1013 (1060)
                      .. ...++..|+|||++.+... .+.++||||+||++|||++|+.||....      +..+..+..... +.. ....  
T Consensus       158 ~~-~~~~~~~~~~pe~~~~~~~-~~~~~DiwSlG~il~ell~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         158 YS-AEVVTLWYRPPDVLFGAKL-YSTSIDMWSAGCIFAELANAGRPLFPGN------DVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CC-SCCSCGGGCCHHHHTTCSC-CCTHHHHHHHHHHHHHHTTTSCCSCCCS------SHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             CE-EECCCCCHHHHHHHCCCCC-CCCHHHCCCCCHHHHHHHHCCCCCCCCC------CHHHHHHHHHHHCCCCCHHHHHH
T ss_conf             00-1034431014667506988-8804440265418899851899998899------99999999986118997355134


Q ss_pred             -C---------CCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHH
Q ss_conf             -2---------2345523793578889999999988004-99999997789998
Q 001527         1014 -D---------AAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYED 1056 (1060)
Q Consensus      1014 -d---------~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~ 1056 (1060)
                       .         ..................+.+++.+|++ +|.+||||+|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             432221133444544310433065689999999999864996689099999649

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=306.37  Aligned_cols=257  Identities=20%  Similarity=0.245  Sum_probs=188.2

Q ss_pred             CCCEECCCCCEEEEEEEE-CCCCEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC---CCCCEEEEE
Q ss_conf             787001226649999999-499399999933221--88899999999997339998022201289678---998039999
Q 001527          780 PAEVLGRSSHGTSYRATL-ENGMFLTVKWLREGV--AKQRKEFAKEAKKFANIRHPNVVGLRGYYWGP---TQHEKLILS  853 (1060)
Q Consensus       780 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~g~~~~~---~~~~~~lv~  853 (1060)
                      ..++||+|+||+||+|+. .+++.||+|+++...  ....+.+.+|++++++++|||||++++++...   +....++++
T Consensus        22 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~  101 (348)
T d2gfsa1          22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV  101 (348)
T ss_dssp             EEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred             EEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCEEEEE
T ss_conf             88898317883999999999997999999882002868999999999999866898742599999634645668649999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEEECC
Q ss_conf             71389996787611999999998999999999999999999844999624898999868518999759900211100025
Q 001527          854 DYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARVADYCLHRLMTQ  933 (1060)
Q Consensus       854 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~~~~  933 (1060)
                      +|+.+|+|.+++..      ..+++.++..++.|++.||+||| +++|+||||||+|||++ .+..+|++|||.+.....
T Consensus       102 ~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH-~~giiHrDiKp~NILi~-~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1         102 THLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVN-EDCELKILDFGLARHTDD  173 (348)
T ss_dssp             EECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEC-TTCCEEECCC----CCTG
T ss_pred             EEECCCCHHHHCCC------CCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCCCCCCCC-CCCCCCCCCCCHHCCCCC
T ss_conf             96258862320022------45309999999999999999997-38876516677633455-432200132100012575


Q ss_pred             CCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf             77523431685445452010147887899833069899999999909988888889998657578999998518998422
Q 001527          934 AGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGHGSDCF 1013 (1060)
Q Consensus       934 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 1013 (1060)
                      ...    ...|+..|+|||+..+... .+.++||||+||++|+|++|+.||....    .......+...  .+....-.
T Consensus       174 ~~~----~~~g~~~y~apE~~~~~~~-~~~~~DiwSlGv~l~~ll~g~~pF~~~~----~~~~~~~i~~~--~~~~~~~~  242 (348)
T d2gfsa1         174 EMT----GYVATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGRTLFPGTD----HIDQLKLILRL--VGTPGAEL  242 (348)
T ss_dssp             GGS----SSCHHHHTSCHHHHTTCSC-CCTTHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHH--HCCCCHHH
T ss_pred             CCC----CCCCCCCCCCCHHHCCCCC-CCCCCCHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHH--CCCCCHHH
T ss_conf             444----4345435558355337756-7855124320589999976889978898----89999999973--07997577


Q ss_pred             CC------------CCC--CCC-CCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHH
Q ss_conf             22------------345--523-793578889999999988004-9999999778999
Q 001527         1014 DA------------AVM--PEM-VNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1014 d~------------~l~--~~~-~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                      .+            ...  +.. ...........+.+++.+|++ +|.+|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             3200102445444303557875556626789999999999977588345938999855

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=306.38  Aligned_cols=253  Identities=13%  Similarity=0.128  Sum_probs=190.5

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCC-CCEEEEEEEEECCCCCCEEEEEEECCC
Q ss_conf             870012266499999994-993999999332218889999999999733999-802220128967899803999971389
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIRH-PNVVGLRGYYWGPTQHEKLILSDYISP  858 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~l~g~~~~~~~~~~~lv~e~~~~  858 (1060)
                      .++||+|+||+||+|+.. +++.||+|++....  ....+.+|++.++.++| +|++.+++++.  .....++||||+ +
T Consensus        10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~~vme~~-~   84 (293)
T d1csna_          10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVLVIDLL-G   84 (293)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEEEEECC-C
T ss_pred             EEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEE--CCCCCEEEEEEC-C
T ss_conf             799841788299999998899799999975025--82999999999999648999877999960--188117999964-8


Q ss_pred             CCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEEC----CCCCEEECCCCCCEEECCC
Q ss_conf             996787611999999998999999999999999999844999624898999868518----9997599002111000257
Q 001527          859 GSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDG----PDLNARVADYCLHRLMTQA  934 (1060)
Q Consensus       859 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~----~~~~~kl~Dfgla~~~~~~  934 (1060)
                      |+|.+++....    ..+++.++..++.|++.||.||| +.+|+||||||+|||++.    .+..+|++|||+|+.....
T Consensus        85 ~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH-~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~  159 (293)
T d1csna_          85 PSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH-EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  159 (293)
T ss_dssp             CBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             CCHHHHHHHHC----CCHHHHHHHHHHHHHHHHHHHHH-HCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCCC
T ss_conf             88799997520----31106899999999999999999-77966266771315234754344795687236605771467


Q ss_pred             CCE------EEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf             752------34316854454520101478878998330698999999999099888888899986575789999985189
Q 001527          935 GTI------EQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLKVAEGH 1008 (1060)
Q Consensus       935 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 1008 (1060)
                      ...      ......||+.|+|||++.+..+  +.++||||+|+++|||+||+.||......... .....+........
T Consensus       160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~--~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-~~~~~i~~~~~~~~  236 (293)
T d1csna_         160 VTKQHIPYREKKNLSGTARYMSINTHLGREQ--SRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYERIGEKKQSTP  236 (293)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC--CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHHHHHHHHHHHSC
T ss_pred             CCCCCEEECCCCCEEECHHHCCHHHHCCCCC--CHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHHHHCCCCCC
T ss_conf             6654111024676277510267989648888--86999898319999998698767885302199-99999970567999


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHC
Q ss_conf             9842222345523793578889999999988004-99999997789998504
Q 001527         1009 GSDCFDAAVMPEMVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYEDLSS 1059 (1060)
Q Consensus      1009 ~~~~~d~~l~~~~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~~L~~ 1059 (1060)
                           -+.+.        ...++++.+++..|++ +|.+||+++.+.+.|+.
T Consensus       237 -----~~~l~--------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         237 -----LRELC--------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             -----HHHHT--------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             -----HHHHC--------CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf             -----58965--------7998999999999843993008599999999999

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=281.89  Aligned_cols=266  Identities=15%  Similarity=0.168  Sum_probs=185.7

Q ss_pred             CCEECCCCCEEEEEEEEC-CCCEEEEEECCCCHHHHHHHHHHHHHHHHCCC-----------CCCEEEEEEEEECCCCCC
Q ss_conf             870012266499999994-99399999933221888999999999973399-----------980222012896789980
Q 001527          781 AEVLGRSSHGTSYRATLE-NGMFLTVKWLREGVAKQRKEFAKEAKKFANIR-----------HPNVVGLRGYYWGPTQHE  848 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------Hpniv~l~g~~~~~~~~~  848 (1060)
                      .++||+|+||+||+|+.. +|+.||||+++.... ..+.+.+|++++++++           |+||+++++++.......
T Consensus        18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~   96 (362)
T d1q8ya_          18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG   96 (362)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred             EEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEECCCCC
T ss_conf             8997507781899999999997999999834313-368999999999984014555554227676478998763125652


Q ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCC-----CCEEEC
Q ss_conf             399997138999678761199999999899999999999999999984499962489899986851899-----975990
Q 001527          849 KLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPD-----LNARVA  923 (1060)
Q Consensus       849 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~-----~~~kl~  923 (1060)
                      .+++++++..+.........  .....+++..+..++.|++.||.|||+..+|+||||||+|||++..+     ..++++
T Consensus        97 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~  174 (362)
T d1q8ya_          97 VHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA  174 (362)
T ss_dssp             EEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred             EEEEEEECCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCCCCCCEEEEE
T ss_conf             02343200035420000012--2346786899999999999998887640586465677057056305765644305675


Q ss_pred             CCCCCEEECCCCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             02111000257752343168544545201014788789983306989999999990998888888999865757899999
Q 001527          924 DYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILLELLTGRCAGDVISGEGAGVDLTDWMQLK 1003 (1060)
Q Consensus       924 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~ 1003 (1060)
                      |||.+.......    ....|+..|+|||++.+..+  +.++||||+||+++||++|+.||......... ...+.....
T Consensus       175 dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~--~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~-~~~~~~~~~  247 (362)
T d1q8ya_         175 DLGNACWYDEHY----TNSIQTREYRSPEVLLGAPW--GCGADIWSTACLIFELITGDFLFEPDEGHSYT-KDDDHIAQI  247 (362)
T ss_dssp             CCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCC--CTHHHHHHHHHHHHHHHHSSCCC----------CHHHHHHHH
T ss_pred             ECCCCCCCCCCC----CCCCCCCCCCCHHHCCCCCC--CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC-CHHHHHHHH
T ss_conf             314421234454----22366521057132146677--76432012378999998788998987554321-026899999


Q ss_pred             -HHCCCC-----------CCCCC-----CCCCCC----------CCCHHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHH
Q ss_conf             -851899-----------84222-----234552----------3793578889999999988004-9999999778999
Q 001527         1004 -VAEGHG-----------SDCFD-----AAVMPE----------MVNPAAEKGMKEVLGIALRCIR-SVSERPGIKTIYE 1055 (1060)
Q Consensus      1004 -~~~~~~-----------~~~~d-----~~l~~~----------~~~~~~~~~~~~~~~i~~~C~~-~p~~RPs~~evl~ 1055 (1060)
                       ..-+..           ...++     ..+...          ............+.+++.+|++ +|.+|||++|+++
T Consensus       248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             99837998788624532200013201220243235776444210001567435899999999987799457908999966


Q ss_pred             H
Q ss_conf             8
Q 001527         1056 D 1056 (1060)
Q Consensus      1056 ~ 1056 (1060)
                      .
T Consensus       328 H  328 (362)
T d1q8ya_         328 H  328 (362)
T ss_dssp             C
T ss_pred             C
T ss_conf             9

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=7.3e-40  Score=232.23  Aligned_cols=143  Identities=26%  Similarity=0.364  Sum_probs=92.3

Q ss_pred             CCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             96578985067302348998766588986875678675550110003588758815886465820101226877656772
Q 001527          405 GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHL  484 (1060)
Q Consensus       405 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  484 (1060)
                      ++|+.+++++|.+++..  .+..+++|+.|++++|++++..  .+..++.++.+++..|.+.+  ...+..+..++.|++
T Consensus       241 ~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~l  314 (384)
T d2omza2         241 TNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTL  314 (384)
T ss_dssp             TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEEC
T ss_pred             CCCCHHCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC--CCCCCHHCCCCEEEC
T ss_conf             65341004467447877--5355466877545674457877--32356522223323233333--221000024676777


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf             684023338999788988758984687022235842259888768977898250026856637899985865677
Q 001527          485 ADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQN  559 (1060)
Q Consensus       485 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N  559 (1060)
                      ++|++++..+  +..+++|+.|++++|++++ ++ .++++++|++|++++|++++..|  +.++++|+.|++++|
T Consensus       315 s~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         315 YFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCCCCCCC--CCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf             7887789845--3668988989898998999-74-67089999989897995899800--003999999639789

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=4.7e-42  Score=244.26  Aligned_cols=114  Identities=29%  Similarity=0.526  Sum_probs=54.0

Q ss_pred             CCCCEEECCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf             997699757984466--5732224563467200335-4347645776667775569986488799999810139897668
Q 001527          118 KSLEFLDVSDNLFSS--SLPSGIGKLESLQNLSLAG-NNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVY  194 (1060)
Q Consensus       118 ~~L~~L~Ls~n~l~~--~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  194 (1060)
                      .+++.|+|++|++.|  .+|.+|++|++|++|+|++ |++.|.+|.+|.++++|++|+|++|++.+..+..+..+..|+.
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCC
T ss_conf             79889989899888888798478467533520202654333002431145420011020356434433222220111001


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf             9911584643478222147999999831896876685
Q 001527          195 LNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLD  231 (1060)
Q Consensus       195 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  231 (1060)
                      +++++|.+.+.+|..|..++.++.+++++|.+.+.+|
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip  166 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP  166 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECC
T ss_pred             CCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCC
T ss_conf             1112245555685122067400000023553356203

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=5.1e-39  Score=227.59  Aligned_cols=121  Identities=26%  Similarity=0.365  Sum_probs=53.3

Q ss_pred             CCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             96578985067302348998766588986875678675550110003588758815886465820101226877656772
Q 001527          405 GNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHL  484 (1060)
Q Consensus       405 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  484 (1060)
                      ++|++|++++|.+++..  .+..+..++.+.++.|++.+.  ..+..+++++.|++++|++.+..  .+..+++|+.|++
T Consensus       263 ~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L  336 (384)
T d2omza2         263 TKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFF  336 (384)
T ss_dssp             TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC--CCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEEC
T ss_conf             66877545674457877--323565222233232333332--21000024676777788778984--5366898898989


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf             684023338999788988758984687022235842259888768977898
Q 001527          485 ADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGN  535 (1060)
Q Consensus       485 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  535 (1060)
                      ++|+++++.  .+..+++|++|++++|++++..|  +.++++|+.|+|++|
T Consensus       337 ~~n~l~~l~--~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         337 ANNKVSDVS--SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CSSCCCCCG--GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCCCCCH--HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf             899899974--67089999989897995899800--003999999639789

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.5e-33  Score=195.47  Aligned_cols=129  Identities=21%  Similarity=0.331  Sum_probs=65.2

Q ss_pred             CCCCCCCCCEEEECCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf             99999862218933997269991588986544742114998874998768845334898857999976997579844665
Q 001527           54 FDGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSS  133 (1060)
Q Consensus        54 ~~~~~c~w~gv~C~~~~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~  133 (1060)
                      +..|-|.|.+|.|++..                                   ++ .+|..+.  +.+++|+|++|+++..
T Consensus         5 p~~c~c~~~~~~C~~~~-----------------------------------L~-~lP~~l~--~~l~~L~Ls~N~i~~l   46 (305)
T d1xkua_           5 PFRCQCHLRVVQCSDLG-----------------------------------LE-KVPKDLP--PDTALLDLQNNKITEI   46 (305)
T ss_dssp             CTTCEEETTEEECTTSC-----------------------------------CC-SCCCSCC--TTCCEEECCSSCCCCB
T ss_pred             CCCCEECCCEEEECCCC-----------------------------------CC-CCCCCCC--CCCCEEECCCCCCCCC
T ss_conf             99889559999855999-----------------------------------88-5198889--9979897849918986


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf             73222456346720033543476457766677755699864887999998101398976689911584643478222147
Q 001527          134 LPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELI  213 (1060)
Q Consensus       134 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  213 (1060)
                      .+.+|.++++|++|++++|.+....|..|.++++|+.|++++|+++ .+|..+  ...+..|+++.|.+.+..+..+...
T Consensus        47 ~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~  123 (305)
T d1xkua_          47 KDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGL  123 (305)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTC
T ss_pred             CHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCC-CCCCCH--HHHHHHHHCCCCCHHHHHHHHHHCC
T ss_conf             9657604656523112344344523566527985578315687567-676400--1113232102461023444454013


Q ss_pred             CCCCEEECCC
Q ss_conf             9999998318
Q 001527          214 LGLQVLDFHG  223 (1060)
Q Consensus       214 ~~L~~L~Ls~  223 (1060)
                      ..+..++...
T Consensus       124 ~~~~~l~~~~  133 (305)
T d1xkua_         124 NQMIVVELGT  133 (305)
T ss_dssp             TTCCEEECCS
T ss_pred             CCCCCCCCCC
T ss_conf             3110000123

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.8e-33  Score=194.72  Aligned_cols=61  Identities=26%  Similarity=0.293  Sum_probs=22.7

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf             4672003354347645776667775569986488799999810139897668991158464
Q 001527          143 SLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFS  203 (1060)
Q Consensus       143 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  203 (1060)
                      ++++|+|++|+++...+.+|.++++|++|++++|.+....|..|.++++|+.|++++|+++
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~   92 (305)
T d1xkua_          32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK   92 (305)
T ss_dssp             TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCC
T ss_conf             9798978499189869657604656523112344344523566527985578315687567

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-34  Score=199.35  Aligned_cols=206  Identities=21%  Similarity=0.257  Sum_probs=130.2

Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             887499876884533489885799997699757984466573222456346720033-5434764577666777556998
Q 001527           94 SMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLA-GNNFSGLIPDSVSGLVSIQSLD  172 (1060)
Q Consensus        94 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~  172 (1060)
                      +.+++|+|++|.|+...+..|.+++.|++|++++|++.+..+..+..+..+..++.. .|.+....+..|.++++|++|+
T Consensus        32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~  111 (284)
T d1ozna_          32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (284)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEE
T ss_conf             99888977488179879778641421300001344543321112122222222222210223544620101010277875


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEECCCCCCCCC
Q ss_conf             64887999998101398976689911584643478222147999999831896876685555403888700146884456
Q 001527          173 LSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVG  252 (1060)
Q Consensus       173 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  252 (1060)
                      +++|.+....+..+....+|+.+++++|.++++.+..|..+++|+.|++++|+++.+.+..|.++++             
T Consensus       112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~-------------  178 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS-------------  178 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT-------------
T ss_pred             CCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCC-------------
T ss_conf             6885443201353320001211020014314458057404340502231417656625666546563-------------


Q ss_pred             CCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEECCCCCCCC
Q ss_conf             8876767786664449985578563657898644489998799842784645789-86687886599843882766
Q 001527          253 SSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNNRFSG  327 (1060)
Q Consensus       253 ~~~~~~~~~~~~sL~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~  327 (1060)
                                   |+.+++++|++++..+  ..|..+++|+.|++++|++.+..+ .|..+.+|+.|++++|.+.+
T Consensus       179 -------------L~~l~l~~N~l~~i~~--~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         179 -------------LDRLLLHQNRVAHVHP--HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             -------------CCEEECCSSCCCEECT--TTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             -------------CCHHHHHHCCCCCCCH--HHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
T ss_conf             -------------4131421143466281--676653200023333352210000023554656889811998878

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-33  Score=197.94  Aligned_cols=219  Identities=23%  Similarity=0.234  Sum_probs=136.3

Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC-CCCCCC
Q ss_conf             6884533489885799997699757984466573222456346720033543476457766677755699864-887999
Q 001527          102 SNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLS-HNSFSG  180 (1060)
Q Consensus       102 ~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~-~N~l~~  180 (1060)
                      ++++++ .+|..+.  +.+++|+|++|+|++..+.+|.++++|++|++++|++....+..+.++..+..+... .|.++.
T Consensus        19 ~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~   95 (284)
T d1ozna_          19 PQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS   95 (284)
T ss_dssp             CSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCC
T ss_pred             CCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             799989-4497889--9988897748817987977864142130000134454332111212222222222221022354


Q ss_pred             CCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEECCCCCCCCCCCCCCCCC
Q ss_conf             99810139897668991158464347822214799999983189687668555540388870014688445688767677
Q 001527          181 SLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLP  260 (1060)
Q Consensus       181 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  260 (1060)
                      ..+..|.++++|++|++++|.+....+..+....+|+.+++++|+++++.+..|..+++                     
T Consensus        96 l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~---------------------  154 (284)
T d1ozna_          96 VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN---------------------  154 (284)
T ss_dssp             CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT---------------------
T ss_pred             CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCC---------------------
T ss_conf             46201010102778756885443201353320001211020014314458057404340---------------------


Q ss_pred             CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCCHHCCCCC
Q ss_conf             86664449985578563657898644489998799842784645789-86687886599843882766689310104887
Q 001527          261 GLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELP-GFNFVYELQVLKLSNNRFSGFIPNDLLKGDSL  339 (1060)
Q Consensus       261 ~~~~sL~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~~~~  339 (1060)
                           |+.|++++|.++...+  ..|..+++|+.+++++|++++..| .|..+++|++|++++|++.+..+. .+.....
T Consensus       155 -----L~~L~l~~N~l~~l~~--~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~-~~~~~~~  226 (284)
T d1ozna_         155 -----LTHLFLHGNRISSVPE--RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE-ALAPLRA  226 (284)
T ss_dssp             -----CCEEECCSSCCCEECT--TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHH-HHTTCTT
T ss_pred             -----HHHCCCCCCCCCCCCH--HHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCC-CCCCCCC
T ss_conf             -----5022314176566256--6654656341314211434662816766532000233333522100000-2355465


Q ss_pred             CCCEEECCCCCCCC
Q ss_conf             77959877881533
Q 001527          340 LLTDLDLSANNLSG  353 (1060)
Q Consensus       340 ~L~~L~Ls~N~l~~  353 (1060)
                       |+.|++++|.+..
T Consensus       227 -L~~L~l~~N~l~C  239 (284)
T d1ozna_         227 -LQYLRLNDNPWVC  239 (284)
T ss_dssp             -CCEEECCSSCEEC
T ss_pred             -CCEEEECCCCCCC
T ss_conf             -6889811998878

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.2e-30  Score=178.04  Aligned_cols=112  Identities=28%  Similarity=0.283  Sum_probs=41.8

Q ss_pred             CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf             00358875881588646582010122687765677268402333899978898875898468702223584225988876
Q 001527          449 IIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLK  528 (1060)
Q Consensus       449 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  528 (1060)
                      +..+++|+.|++++|.+....+..+..+.+++.|++++|.++.+.+..+..++.++.+++++|++++..+..|..+++|+
T Consensus        96 ~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~  175 (266)
T d1p9ag_          96 GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD  175 (266)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCC
T ss_pred             CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             12222222222222311011001122221111221243421022123332211100000001565223720013421242


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf             897789825002685663789998586567726
Q 001527          529 VLCLAGNNISGSLPTSMANMTSLSSLVISQNHF  561 (1060)
Q Consensus       529 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l  561 (1060)
                      .|+|++|+|+ .+|..+..+++|+.|+|++|++
T Consensus       176 ~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~  207 (266)
T d1p9ag_         176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (266)
T ss_dssp             EEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             EEECCCCCCC-CCCHHHCCCCCCCEEEECCCCC
T ss_conf             3430139785-5686677788899998369998

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.9e-30  Score=177.04  Aligned_cols=196  Identities=26%  Similarity=0.272  Sum_probs=93.7

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf             49987688453348988579999769975798446657322245634672003354347645776667775569986488
Q 001527           97 VKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHN  176 (1060)
Q Consensus        97 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  176 (1060)
                      .+.|.++++++ .+|..+.  +.+++|+|++|++++..+.+|.++++|++|+|++|+++.. + .+..+++|+.|++++|
T Consensus        13 ~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N   87 (266)
T d1p9ag_          13 LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHN   87 (266)
T ss_dssp             CEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSS
T ss_pred             EEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCCC
T ss_conf             69980699988-6196757--6889898849928985977863456552213566544443-1-1111223211111222


Q ss_pred             CCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEECCCCCCCCCCCCC
Q ss_conf             79999981013989766899115846434782221479999998318968766855554038887001468844568876
Q 001527          177 SFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELILGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQ  256 (1060)
Q Consensus       177 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~  256 (1060)
                      +++ ..+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.+..+.+..+..++.                 
T Consensus        88 ~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~-----------------  149 (266)
T d1p9ag_          88 QLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK-----------------  149 (266)
T ss_dssp             CCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTT-----------------
T ss_pred             CCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCC-----------------
T ss_conf             221-11112122222222222223110110011222211112212434210221233322111-----------------


Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             7677866644499855785636578986444899987998427846457898668788659984388276
Q 001527          257 KFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFENLKVLDLSYNQLTGELPGFNFVYELQVLKLSNNRFS  326 (1060)
Q Consensus       257 ~~~~~~~~sL~~L~Ls~N~l~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~  326 (1060)
                               ++.+++++|++++..+  ..+..+++|+.|+|++|+|+..++.+..+++|+.|+|++|.+.
T Consensus       150 ---------l~~l~l~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         150 ---------LEKLSLANNNLTELPA--GLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             ---------CCEEECTTSCCSCCCT--TTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred             ---------CHHCCCCCCCCCCCCC--CCCCCCCCCCEEECCCCCCCCCCHHHCCCCCCCEEEECCCCCC
T ss_conf             ---------0000000156522372--0013421242343013978556866777888999983699987

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.97  E-value=1.3e-25  Score=153.85  Aligned_cols=95  Identities=26%  Similarity=0.353  Sum_probs=53.7

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf             87499876884533489885799997699757984466573222456346720033543476457766677755699864
Q 001527           95 MLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLS  174 (1060)
Q Consensus        95 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  174 (1060)
                      .+++|||++++++ .+|+.   +++|++|+|++|+++ .+|..+   .+|+.|++++|.++. ++..   .+.|++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~  106 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVS  106 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECC
T ss_pred             CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCCH-HHHH---CCCCCCCCCC
T ss_conf             9989993799988-78898---789888989999796-336203---320332665514320-3210---2211111334


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf             88799999810139897668991158464
Q 001527          175 HNSFSGSLPPALTRLNNLVYLNLSSNGFS  203 (1060)
Q Consensus       175 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  203 (1060)
                      +|.+. .+|. ++.+++|+.|++++|.+.
T Consensus       107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~  133 (353)
T d1jl5a_         107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLK  133 (353)
T ss_dssp             SSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred             CCCCC-CCCC-HHHHCCCEEECCCCCCCC
T ss_conf             55432-2210-011013123113565100

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.96  E-value=2.2e-26  Score=158.05  Aligned_cols=97  Identities=26%  Similarity=0.360  Sum_probs=55.8

Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf             99769975798446657322245634672003354347645776667775569986488799999810139897668991
Q 001527          118 KSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNL  197 (1060)
Q Consensus       118 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  197 (1060)
                      .++++|||++|.++ .+|+.   +++|++|+|++|+++ .+|..+   .+|+.|++++|+++ .++...   +.|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEEC
T ss_pred             CCCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC-HHHHHC---CCCCCCCC
T ss_conf             69989993799988-78898---789888989999796-336203---32033266551432-032102---21111133


Q ss_pred             ECCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             1584643478222147999999831896876
Q 001527          198 SSNGFSKRIPRGFELILGLQVLDFHGNKLDG  228 (1060)
Q Consensus       198 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  228 (1060)
                      ++|.+.. +|. ++.+++|+.|++++|.+..
T Consensus       106 ~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~  134 (353)
T d1jl5a_         106 SNNQLEK-LPE-LQNSSFLKIIDVDNNSLKK  134 (353)
T ss_dssp             CSSCCSS-CCC-CTTCTTCCEEECCSSCCSC
T ss_pred             CCCCCCC-CCC-HHHHCCCEEECCCCCCCCC
T ss_conf             4554322-210-0110131231135651001

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.95  E-value=3.9e-28  Score=167.73  Aligned_cols=168  Identities=13%  Similarity=0.144  Sum_probs=118.0

Q ss_pred             CCEECCCCCEEEEEEEECCCCEEEEEECCCCHH------------------HHHHHHHHHHHHHHCCCCCCEEEEEEEEE
Q ss_conf             870012266499999994993999999332218------------------88999999999973399980222012896
Q 001527          781 AEVLGRSSHGTSYRATLENGMFLTVKWLREGVA------------------KQRKEFAKEAKKFANIRHPNVVGLRGYYW  842 (1060)
Q Consensus       781 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~Hpniv~l~g~~~  842 (1060)
                      +++||+|+||+||+|+..+|+.||+|+++....                  .......+|...+.++.|++++..+++. 
T Consensus         5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~-   83 (191)
T d1zara2           5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE-   83 (191)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred             CCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEC-
T ss_conf             7780248565999999799999999998604434666556563000888999999778999999981699914499862-


Q ss_pred             CCCCCCEEEEEEECCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCCEEE
Q ss_conf             78998039999713899967876119999999989999999999999999998449996248989998685189997599
Q 001527          843 GPTQHEKLILSDYISPGSLASFLYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHFDRAVPHGNLKATNILLDGPDLNARV  922 (1060)
Q Consensus       843 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~iiHrDlkp~NILl~~~~~~~kl  922 (1060)
                           ..+++|||++++.+.+            ++......++.|++.|++||| +++|+||||||+|||++ ++ .+++
T Consensus        84 -----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH-~~giiHrDiKP~NILv~-~~-~~~l  143 (191)
T d1zara2          84 -----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFY-HRGIVHGDLSQYNVLVS-EE-GIWI  143 (191)
T ss_dssp             -----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEEE-TT-EEEE
T ss_pred             -----CCEEEEEEECCCCCCC------------HHHHHHHHHHHHHHHHHHHHH-HCCEEECCCCHHHEEEE-CC-CEEE
T ss_conf             -----8889999504565420------------015789999999999999982-68889836890361142-89-8999


Q ss_pred             CCCCCCEEECCCCCEEEECCCCCCCCCCHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             00211100025775234316854454520101478878998330698999999
Q 001527          923 ADYCLHRLMTQAGTIEQILDAGVLGYRAPELAASKKPHPSFKSDVYAFGVILL  975 (1060)
Q Consensus       923 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DV~slGvvl~  975 (1060)
                      +|||.|+...........  ..... .-.+.+. +.+  +.++|+||..--+.
T Consensus       144 iDFG~a~~~~~~~~~~~l--~rd~~-~~~~~f~-r~y--~~~~d~~s~~~~~~  190 (191)
T d1zara2         144 IDFPQSVEVGEEGWREIL--ERDVR-NIITYFS-RTY--RTEKDINSAIDRIL  190 (191)
T ss_dssp             CCCTTCEETTSTTHHHHH--HHHHH-HHHHHHH-HHH--CCCCCHHHHHHHHH
T ss_pred             EECCCCCCCCCCCCHHHH--HHHHH-HHHHHHC-CCC--CCCCCHHHHHHHHH
T ss_conf             877884308998709999--87799-9999975-789--98446899999874

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.6e-29  Score=175.42  Aligned_cols=109  Identities=17%  Similarity=0.186  Sum_probs=42.6

Q ss_pred             CCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCC----CCCCCC-CC
Q ss_conf             769975798446657-3222456346720033543476----4577666777556998648879999----981013-98
Q 001527          120 LEFLDVSDNLFSSSL-PSGIGKLESLQNLSLAGNNFSG----LIPDSVSGLVSIQSLDLSHNSFSGS----LPPALT-RL  189 (1060)
Q Consensus       120 L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~-~l  189 (1060)
                      |+.||++.|++++.. ..-+..+++++.|+|++|.++.    .+...+...++|++|+|++|.++..    +...+. ..
T Consensus         4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~   83 (460)
T d1z7xw1           4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS   83 (460)
T ss_dssp             EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred             CCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCC
T ss_conf             77798208958868999999767799999828999988999999999853999888979598597289999999984378


Q ss_pred             CCCCEEEEECCCCCCC----CCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             9766899115846434----78222147999999831896876
Q 001527          190 NNLVYLNLSSNGFSKR----IPRGFELILGLQVLDFHGNKLDG  228 (1060)
Q Consensus       190 ~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~  228 (1060)
                      .+|+.|++++|+++..    ++..+...++|++|++++|.+..
T Consensus        84 ~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          84 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHH
T ss_conf             8778877888775432210121100003432002444332023

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.9e-27  Score=162.96  Aligned_cols=110  Identities=19%  Similarity=0.290  Sum_probs=66.1

Q ss_pred             CCCEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCC----CCCCCC-C
Q ss_conf             874998768845334-89885799997699757984466----5732224563467200335434764----577666-7
Q 001527           95 MLVKLSMSNNSISGV-IPDNIGDFKSLEFLDVSDNLFSS----SLPSGIGKLESLQNLSLAGNNFSGL----IPDSVS-G  164 (1060)
Q Consensus        95 ~L~~L~l~~n~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~~~-~  164 (1060)
                      .|++||+++|++++. +.+-+..+++++.|+|++|+++.    .+...+...++|+.|||++|+++..    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf             87779820895886899999976779999982899998899999999985399988897959859728999999998437


Q ss_pred             CCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEEEECCCCCC
Q ss_conf             77556998648879999----98101398976689911584643
Q 001527          165 LVSIQSLDLSHNSFSGS----LPPALTRLNNLVYLNLSSNGFSK  204 (1060)
Q Consensus       165 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~  204 (1060)
                      ..+|+.|++++|+++..    ++..+..+++|++|++++|.++.
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHH
T ss_conf             88778877888775432210121100003432002444332023

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=6.4e-25  Score=150.06  Aligned_cols=224  Identities=14%  Similarity=0.128  Sum_probs=123.3

Q ss_pred             CCCCCCCCEEEECCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf             99998622189339972699915889865447421149988749987688453348988579999769975798446657
Q 001527           55 DGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSL  134 (1060)
Q Consensus        55 ~~~~c~w~gv~C~~~~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~  134 (1060)
                      -.|.|....|.|.+...+             .+|... .+.+++|++++|.|+...+.+|.++++|++|+|++|.+...+
T Consensus         4 ~~C~C~~~~i~c~~~~l~-------------~iP~~l-~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i   69 (242)
T d1xwdc1           4 RICHCSNRVFLCQESKVT-------------EIPSDL-PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI   69 (242)
T ss_dssp             SSEEECSSEEEEESCSCS-------------SCCSCS-CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEE
T ss_pred             CCCCCCCCEEEEECCCCC-------------CCCCCC-CCCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEE
T ss_conf             828873999998189988-------------768888-998899987699189649668614643232110221124201


Q ss_pred             C-CCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCEEEEECCCCCCCCCCCCC
Q ss_conf             3-2224563467200335-434764577666777556998648879999981-013989766899115846434782221
Q 001527          135 P-SGIGKLESLQNLSLAG-NNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPP-ALTRLNNLVYLNLSSNGFSKRIPRGFE  211 (1060)
Q Consensus       135 p-~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~  211 (1060)
                      + ..|.++++++.+++.. |.+....+..|.++++|+++++++|.+....+. .+..+..+..+..+++.+....+..|.
T Consensus        70 ~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~  149 (242)
T d1xwdc1          70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV  149 (242)
T ss_dssp             CSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSST
T ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             00112222222221111123432222221222222222234211112554333222111122222221211122222222


Q ss_pred             CCC-CCCEEECCCCCCCCCCCHHHHCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf             479-9999983189687668555540388870014688445688767677866644499855785636578986444899
Q 001527          212 LIL-GLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVGSSSQKFLPGLSQSVQYLNLSLNQLTGSLVNGGELQLFE  290 (1060)
Q Consensus       212 ~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~~sL~~L~Ls~N~l~~~~~~~~~l~~l~  290 (1060)
                      .++ .++.+++++|+++.+.+..|.. .++                         .+.+.+++|+++....  ..|..++
T Consensus       150 ~~~~~l~~L~l~~n~l~~i~~~~~~~-~~l-------------------------~~~~~l~~n~l~~l~~--~~f~~l~  201 (242)
T d1xwdc1         150 GLSFESVILWLNKNGIQEIHNCAFNG-TQL-------------------------DELNLSDNNNLEELPN--DVFHGAS  201 (242)
T ss_dssp             TSBSSCEEEECCSSCCCEECTTTTTT-CCE-------------------------EEEECTTCTTCCCCCT--TTTTTSC
T ss_pred             CCCCCCEEEECCCCCCCCCCCCCCCC-HHH-------------------------HCCCCCCCCCCCCCCH--HHHCCCC
T ss_conf             22331001220012333322222220-111-------------------------0121235432464247--8866899


Q ss_pred             CCCEEECCCCCCCCCCC-CCCCCCCCCEEEC
Q ss_conf             98799842784645789-8668788659984
Q 001527          291 NLKVLDLSYNQLTGELP-GFNFVYELQVLKL  320 (1060)
Q Consensus       291 ~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~L  320 (1060)
                      +|+.|++++|+++..++ .|..+.+|+.+++
T Consensus       202 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         202 GPVILDISRTRIHSLPSYGLENLKKLRARST  232 (242)
T ss_dssp             CCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred             CCCEEECCCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf             9998989799289459779737713414767

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.91  E-value=9.7e-25  Score=149.07  Aligned_cols=111  Identities=27%  Similarity=0.347  Sum_probs=65.0

Q ss_pred             CCCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             99769975798446657-32224563467200335434764577666777556998648879999981013989766899
Q 001527          118 KSLEFLDVSDNLFSSSL-PSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLN  196 (1060)
Q Consensus       118 ~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  196 (1060)
                      +++++|+|++|+|++.+ +..|.++++|+.|+|++|.+....+..|..+++|++|+|++|+++...+..|.++++|++|+
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~  108 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCC
T ss_conf             78788984898775530200257876272130136322121212221122221010035534434979980797465524


Q ss_pred             EECCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             11584643478222147999999831896876
Q 001527          197 LSSNGFSKRIPRGFELILGLQVLDFHGNKLDG  228 (1060)
Q Consensus       197 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  228 (1060)
                      |++|+|+++.+.+|..+++|++++|++|.+..
T Consensus       109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~  140 (192)
T d1w8aa_         109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
T ss_conf             57745353597785687533420003644343

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.91  E-value=3.4e-24  Score=146.09  Aligned_cols=180  Identities=19%  Similarity=0.269  Sum_probs=110.5

Q ss_pred             CCCCCCCCEEEECCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf             9999862218933997269991588986544742114998874998768845334-898857999976997579844665
Q 001527           55 DGCPSSWNGIVCNGGNVAGVVLDNLGLSAAADLSVFSNLSMLVKLSMSNNSISGV-IPDNIGDFKSLEFLDVSDNLFSSS  133 (1060)
Q Consensus        55 ~~~~c~w~gv~C~~~~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~~  133 (1060)
                      ..|.|+|..|.|++...+.+             |..+ -+.+++|+|++|.|++. .+..|.++++|+.|+|++|.+.+.
T Consensus         4 ~~C~C~~~~v~Cs~~~L~~i-------------P~~l-p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~   69 (192)
T d1w8aa_           4 AMCHCEGTTVDCTGRGLKEI-------------PRDI-PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI   69 (192)
T ss_dssp             TTSEEETTEEECTTSCCSSC-------------CSCC-CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCB
T ss_pred             CCCEECCCEEEEECCCCCCC-------------CCCC-CCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCC
T ss_conf             99897699999708996702-------------9898-978788984898775530200257876272130136322121


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf             73222456346720033543476457766677755699864887999998101398976689911584643478222147
Q 001527          134 LPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRGFELI  213 (1060)
Q Consensus       134 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  213 (1060)
                      .+..|..+++|++|+|++|++....+.+|.++++|++|+|++|+|++..+.+|..+++|++|+|++|.+....+..+ ..
T Consensus        70 ~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~  148 (192)
T d1w8aa_          70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FA  148 (192)
T ss_dssp             CTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HH
T ss_pred             CCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCHHH-HH
T ss_conf             21222112222101003553443497998079746552457745353597785687533420003644343530277-76


Q ss_pred             CCCCEEECCCCCCCCCCCHHHHCCCCCCEECCCCCCCCC
Q ss_conf             999999831896876685555403888700146884456
Q 001527          214 LGLQVLDFHGNKLDGHLDGEFFLLTNASHIDFSGNMFVG  252 (1060)
Q Consensus       214 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~  252 (1060)
                      ..++.+.+..|.+....|..   +..++.++++.|.+.+
T Consensus       149 ~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~C  184 (192)
T d1w8aa_         149 EWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKC  184 (192)
T ss_dssp             HHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCCC
T ss_pred             HHHHHHCCCCCCEEECCCHH---HCCCEEEECCHHHCCC
T ss_conf             42354035689827689843---3698861448755758

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.89  E-value=8.7e-22  Score=132.82  Aligned_cols=202  Identities=23%  Similarity=0.334  Sum_probs=0.0

Q ss_pred             ECCCCCCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf             84388276668931010488777959877881533257210148758985687574668989899878974377254324
Q 001527          319 KLSNNRFSGFIPNDLLKGDSLLLTDLDLSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNL  398 (1060)
Q Consensus       319 ~Ls~N~l~~~ip~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~Ls~N~l~~~~  398 (1060)
                      +++.+++.+.+....+..    |+.|++++|.++........++|+.|++++|.++                      .+
T Consensus        25 ~l~~~~~~d~~~~~~l~~----L~~L~l~~~~i~~l~~l~~l~~L~~L~ls~n~i~----------------------~~   78 (227)
T d1h6ua2          25 AAGKSNVTDTVTQADLDG----ITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQIT----------------------DL   78 (227)
T ss_dssp             HTTCSSTTSEECHHHHHT----CCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCC----------------------CC
T ss_pred             HHCCCCCCCCCCHHHCCC----CCEEECCCCCCCCCHHHHCCCCCCEEECCCCEEE----------------------CC
T ss_conf             848887677579878488----6899777999976645744888837635785320----------------------25


Q ss_pred             CCCCCCCCCCEEECCCCEECCCCCCCCCCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf             42237896578985067302348998766588986875678675550110003588758815886465820101226877
Q 001527          399 SRILKWGNIEYLDLSRNHLTGSIPEETPQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSST  478 (1060)
Q Consensus       399 ~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  478 (1060)
                      ..+...++++++++++|.++ .++ .+..+++|+.++++++...+..+  +...+.+..+.++.+.+....+  +.+.++
T Consensus        79 ~~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~--~~~~~~  152 (227)
T d1h6ua2          79 APLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTN  152 (227)
T ss_dssp             GGGTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTT
T ss_pred             CCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCCCCCCCCCH--HCCCCCHHHHHCHHHHHCHHHH--HCCCCC
T ss_conf             43112334320121112222-222-22222222122122244331100--0002301222000000000000--010211


Q ss_pred             CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf             65677268402333899978898875898468702223584225988876897789825002685663789998586567
Q 001527          479 LQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSLVISQ  558 (1060)
Q Consensus       479 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~  558 (1060)
                      |+.|++++|.+.+..+  +..+++|+.|+|++|++++..+  +.++++|++|+|++|++++..|  +.++++|+.|++++
T Consensus       153 L~~L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         153 LQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN  226 (227)
T ss_dssp             CCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred             CCCCCCCCCCCCCCHH--HCCCCCCEECCCCCCCCCCCHH--HCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEEEEC
T ss_conf             1002333333331001--0564633564458884177853--4479999989795996899802--03699989897129

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.5e-21  Score=131.45  Aligned_cols=103  Identities=18%  Similarity=0.296  Sum_probs=44.7

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCC-
Q ss_conf             9987688453348988579999769975798446657322245634672003354347645-77666777556998648-
Q 001527           98 KLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLI-PDSVSGLVSIQSLDLSH-  175 (1060)
Q Consensus        98 ~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~-  175 (1060)
                      .++.+++.++ .+|..+.  +++++|+|++|.++...+..|.++++|++|++++|.+...+ +.+|.++++++++.+.. 
T Consensus        12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~   88 (242)
T d1xwdc1          12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   88 (242)
T ss_dssp             EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred             EEEEECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCC
T ss_conf             9998189988-7688889--988999876991896496686146432321102211242010011222222222111112


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf             8799999810139897668991158464
Q 001527          176 NSFSGSLPPALTRLNNLVYLNLSSNGFS  203 (1060)
Q Consensus       176 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  203 (1060)
                      |.+....+..|.++++|+.+++++|.+.
T Consensus        89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~  116 (242)
T d1xwdc1          89 NNLLYINPEAFQNLPNLQYLLISNTGIK  116 (242)
T ss_dssp             TTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHC
T ss_conf             3432222221222222222234211112

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.88  E-value=9.8e-22  Score=132.54  Aligned_cols=12  Identities=42%  Similarity=0.479  Sum_probs=3.8

Q ss_pred             CCCEEECCCCCC
Q ss_conf             987998427846
Q 001527          291 NLKVLDLSYNQL  302 (1060)
Q Consensus       291 ~L~~L~Ls~N~l  302 (1060)
                      +|+.|++++|++
T Consensus       179 ~L~~L~Ls~N~i  190 (210)
T d1h6ta2         179 KLQNLYLSKNHI  190 (210)
T ss_dssp             TCCEEECCSSCC
T ss_pred             CCCEEECCCCCC
T ss_conf             899998979989

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.88  E-value=1.5e-21  Score=131.54  Aligned_cols=101  Identities=28%  Similarity=0.435  Sum_probs=36.0

Q ss_pred             CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf             00358875881588646582010122687765677268402333899978898875898468702223584225988876
Q 001527          449 IIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQVLDLSHNRLNGYFPDRLGSLTGLK  528 (1060)
Q Consensus       449 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  528 (1060)
                      +..+++|+.|++++|.+..  ...+..++.++.+++++|.+++..  .+..+++|+.+++++|++++. + .+.++++|+
T Consensus       108 l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~~--~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~  181 (210)
T d1h6ta2         108 LKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDIT--VLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQ  181 (210)
T ss_dssp             GTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCCCG--GGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCC
T ss_pred             CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCC
T ss_conf             2122211122345653221--122011111222112223334543--100013321001346430256-4-536789899


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf             89778982500268566378999858656
Q 001527          529 VLCLAGNNISGSLPTSMANMTSLSSLVIS  557 (1060)
Q Consensus       529 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls  557 (1060)
                      .|+|++|+++ .+| .+..+++|+.|+|+
T Consensus       182 ~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         182 NLYLSKNHIS-DLR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             EEECCSSCCC-BCG-GGTTCTTCSEEEEE
T ss_pred             EEECCCCCCC-CCH-HHCCCCCCCEEECC
T ss_conf             9989799899-872-11699998999711

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.86  E-value=1.1e-20  Score=126.66  Aligned_cols=175  Identities=25%  Similarity=0.372  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCEECCCCCCCC
Q ss_conf             77881533257210148758985687574668989899878974377254324422378965789850673023489987
Q 001527          346 LSANNLSGSVSMILSTNLHMLNLSSNGLTGELPLLTGSCAVLDLSNNQFEGNLSRILKWGNIEYLDLSRNHLTGSIPEET  425 (1060)
Q Consensus       346 Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~Ls~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~~  425 (1060)
                      ++.+.+.+.....-..+++.|++++|.++                      .++.+-..++|++|++++|++++..|  +
T Consensus        25 l~~~~~~~~~~~~~l~~l~~L~l~~~~i~----------------------~l~~l~~l~nL~~L~Ls~N~l~~~~~--l   80 (199)
T d2omxa2          25 LGKTNVTDTVSQTDLDQVTTLQADRLGIK----------------------SIDGVEYLNNLTQINFSNNQLTDITP--L   80 (199)
T ss_dssp             TTCSSTTSEECHHHHTTCCEEECTTSCCC----------------------CCTTGGGCTTCCEEECCSSCCCCCGG--G
T ss_pred             HCCCCCCCCCCHHHHCCCCEEECCCCCCC----------------------CCCCCCCCCCCCCCCCCCCCCCCCCC--C
T ss_conf             67787788559879468789989999997----------------------75202137886757545655667640--1


Q ss_pred             CCCCCCCEEECCCCCCCCCCCHHCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf             66588986875678675550110003588758815886465820101226877656772684023338999788988758
Q 001527          426 PQFLRLNHLNLSHNSLSSSLPKVIIQYQKLRVLDLSFNHLDGPFLTNLLNSSTLQELHLADNLLTGVLDFSPPSVSNLQV  505 (1060)
Q Consensus       426 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  505 (1060)
                      ..+++|+.|++++|.+....+  +.+++.|+.|++++|.+....+  +..++.|+.|++++|++....+  +..+++|+.
T Consensus        81 ~~l~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--l~~~~~L~~  154 (199)
T d2omxa2          81 KNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQ  154 (199)
T ss_dssp             TTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred             CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCHHHHHHHHHHHHHHHCCCCC--CCCCCCCCC
T ss_conf             677522311112222222211--1112232221112222223210--0012236776431111002343--332111111


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             9846870222358422598887689778982500268566378999858
Q 001527          506 LDLSHNRLNGYFPDRLGSLTGLKVLCLAGNNISGSLPTSMANMTSLSSL  554 (1060)
Q Consensus       506 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L  554 (1060)
                      |++++|++++..+  ++++++|+.|++++|+++ .++ .++.+++|+.|
T Consensus       155 L~l~~n~l~~l~~--l~~l~~L~~L~ls~N~i~-~i~-~l~~L~~L~~L  199 (199)
T d2omxa2         155 LNFSSNQVTDLKP--LANLTTLERLDISSNKVS-DIS-VLAKLTNLESL  199 (199)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEE
T ss_pred             CCCCCCCCCCCCC--CCCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCC
T ss_conf             2234555567701--167998999978799799-881-01278998949

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=1.2e-19  Score=121.13  Aligned_cols=14  Identities=29%  Similarity=0.221  Sum_probs=4.6

Q ss_pred             CCCCCCCCEEECCC
Q ss_conf             25988876897789
Q 001527          521 LGSLTGLKVLCLAG  534 (1060)
Q Consensus       521 ~~~l~~L~~L~Ls~  534 (1060)
                      +..+++|++|+|++
T Consensus       196 l~~~~~L~~L~L~~  209 (284)
T d2astb2         196 FFQLNYLQHLSLSR  209 (284)
T ss_dssp             GGGCTTCCEEECTT
T ss_pred             HCCCCCCCEEECCC
T ss_conf             21357687798999

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.75  E-value=5.9e-20  Score=122.75  Aligned_cols=12  Identities=33%  Similarity=0.230  Sum_probs=3.9

Q ss_pred             CCCCEEECCCCC
Q ss_conf             887588158864
Q 001527          453 QKLRVLDLSFNH  464 (1060)
Q Consensus       453 ~~L~~L~l~~N~  464 (1060)
                      ++|+.|++++|.
T Consensus       243 ~~L~~L~Ls~n~  254 (344)
T d2ca6a1         243 PNLRELGLNDCL  254 (344)
T ss_dssp             TTCCEEECTTCC
T ss_pred             CCCHHHHHHCCC
T ss_conf             211110300475

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=2.4e-18  Score=113.92  Aligned_cols=110  Identities=15%  Similarity=0.115  Sum_probs=40.8

Q ss_pred             CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf             79999769975798446657322245634672003354347645776667775569986488799999810139897668
Q 001527          115 GDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVY  194 (1060)
Q Consensus       115 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  194 (1060)
                      .+...|++|||++|+|+. ++..+..+++|+.|+|++|++...  ..|..+++|++|++++|+++...+..+..+++|+.
T Consensus        15 ~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~   91 (162)
T d1a9na_          15 TNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   91 (162)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             CCCCCCCEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             685748489788997886-576200414599898979978764--77445761306431021345777632233453443


Q ss_pred             EEEECCCCCCCCC-CCCCCCCCCCEEECCCCCCC
Q ss_conf             9911584643478-22214799999983189687
Q 001527          195 LNLSSNGFSKRIP-RGFELILGLQVLDFHGNKLD  227 (1060)
Q Consensus       195 L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~  227 (1060)
                      |++++|+++.... ..+..+++|+.+++++|.++
T Consensus        92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             CEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf             4203000166542110013653206640799634

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=1.6e-18  Score=114.87  Aligned_cols=127  Identities=22%  Similarity=0.233  Sum_probs=55.7

Q ss_pred             CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf             49988749987688453348988579999769975798446657322245634672003354347645776667775569
Q 001527           91 SNLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQS  170 (1060)
Q Consensus        91 ~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  170 (1060)
                      .+...+++|+|++|+|+. ++..+..+++|+.|||++|+++. ++ .|..+++|+.|++++|+++...+..+..+++|+.
T Consensus        15 ~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~   91 (162)
T d1a9na_          15 TNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   91 (162)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             CCCCCCCEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCCC-CC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             685748489788997886-57620041459989897997876-47-7445761306431021345777632233453443


Q ss_pred             EECCCCCCCCCCC-CCCCCCCCCCEEEEECCCCCCCC---CCCCCCCCCCCEEE
Q ss_conf             9864887999998-10139897668991158464347---82221479999998
Q 001527          171 LDLSHNSFSGSLP-PALTRLNNLVYLNLSSNGFSKRI---PRGFELILGLQVLD  220 (1060)
Q Consensus       171 L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~  220 (1060)
                      |++++|+++.... ..+..+++|++|++++|.++...   +..+..+++|+.||
T Consensus        92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             CEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHCCCCCEEC
T ss_conf             420300016654211001365320664079963456106999998789958337

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.73  E-value=9.7e-20  Score=121.57  Aligned_cols=12  Identities=33%  Similarity=0.440  Sum_probs=4.1

Q ss_pred             CCCEEECCCCCC
Q ss_conf             998586567726
Q 001527          550 SLSSLVISQNHF  561 (1060)
Q Consensus       550 ~L~~L~ls~N~l  561 (1060)
                      .|+.|++++|++
T Consensus       303 ~L~~L~l~~N~~  314 (344)
T d2ca6a1         303 DLLFLELNGNRF  314 (344)
T ss_dssp             TCCEEECTTSBS
T ss_pred             CCCEEECCCCCC
T ss_conf             999897879808

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.70  E-value=1.4e-16  Score=104.17  Aligned_cols=87  Identities=22%  Similarity=0.346  Sum_probs=30.8

Q ss_pred             CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCC-CCCCCCCCC
Q ss_conf             2456346720033543476457766677755699864887999998101398976689911584643478-222147999
Q 001527          138 IGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIP-RGFELILGL  216 (1060)
Q Consensus       138 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L  216 (1060)
                      +..+++|++|++++|+++ .+|..|..+++|+.|++++|.++. +| .+..+++|+.|++++|+++.... ..+..+++|
T Consensus        16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L   92 (124)
T d1dcea3          16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL   92 (124)
T ss_dssp             GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred             CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCC
T ss_conf             105898898979787168-652156554313545324321123-57-412335557688889865888882565379999


Q ss_pred             CEEECCCCCCC
Q ss_conf             99983189687
Q 001527          217 QVLDFHGNKLD  227 (1060)
Q Consensus       217 ~~L~Ls~N~l~  227 (1060)
                      +.+++++|+++
T Consensus        93 ~~L~l~~N~i~  103 (124)
T d1dcea3          93 VLLNLQGNSLC  103 (124)
T ss_dssp             CEEECTTSGGG
T ss_pred             CEEECCCCCCC
T ss_conf             99989799688

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.68  E-value=1.8e-16  Score=103.61  Aligned_cols=101  Identities=25%  Similarity=0.379  Sum_probs=45.6

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf             99876884533489885799997699757984466573222456346720033543476457766677755699864887
Q 001527           98 KLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNS  177 (1060)
Q Consensus        98 ~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  177 (1060)
                      .|+|++|+++. ++ .+..+++|++||+++|+++ .+|..|+.+++|+.|++++|+++.. | .+..+++|++|++++|+
T Consensus         2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred             EEECCCCCCCC-CC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCC-C-CCCCCCCCCEEECCCCC
T ss_conf             89868998988-71-0105898898979787168-6521565543135453243211235-7-41233555768888986


Q ss_pred             CCCCC-CCCCCCCCCCCEEEEECCCCC
Q ss_conf             99999-810139897668991158464
Q 001527          178 FSGSL-PPALTRLNNLVYLNLSSNGFS  203 (1060)
Q Consensus       178 l~~~~-p~~~~~l~~L~~L~Ls~N~l~  203 (1060)
                      ++... ...+..+++|+.|++++|.++
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             CCCCCCCHHHCCCCCCCEEECCCCCCC
T ss_conf             588888256537999999989799688

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.64  E-value=1.4e-18  Score=115.16  Aligned_cols=84  Identities=25%  Similarity=0.326  Sum_probs=29.5

Q ss_pred             CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf             57999976997579844665732224563467200335434764577666777556998648879999981013989766
Q 001527          114 IGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTRLNNLV  193 (1060)
Q Consensus       114 ~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  193 (1060)
                      +..+++|++|+|++|+++. ++ .|.++++|+.|+|++|.++ .+|..+..+++|+.|++++|+++. + ..+..+++|+
T Consensus        44 l~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~  118 (198)
T d1m9la_          44 LSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLR  118 (198)
T ss_dssp             HHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSS
T ss_pred             HHCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCC
T ss_conf             7626046151994468998-64-4247825357341353432-100003322123333333322222-2-2222222341


Q ss_pred             EEEEECCCC
Q ss_conf             899115846
Q 001527          194 YLNLSSNGF  202 (1060)
Q Consensus       194 ~L~Ls~N~l  202 (1060)
                      .|++++|++
T Consensus       119 ~L~L~~N~i  127 (198)
T d1m9la_         119 VLYMSNNKI  127 (198)
T ss_dssp             EEEESEEEC
T ss_pred             CCCCCCCHH
T ss_conf             112341021

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=8.6e-16  Score=99.85  Aligned_cols=92  Identities=20%  Similarity=0.200  Sum_probs=45.1

Q ss_pred             CCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf             8988579999769975798-446657322245634672003354347645776667775569986488799999810139
Q 001527          110 IPDNIGDFKSLEFLDVSDN-LFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSLDLSHNSFSGSLPPALTR  188 (1060)
Q Consensus       110 ~p~~~~~l~~L~~L~Ls~n-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  188 (1060)
                      .|..+..+++|++|++++| .++.+.+.+|.++++|+.|+|++|+++...+.+|.++++|++|+|++|+++...+..|..
T Consensus        23 ~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~  102 (156)
T d2ifga3          23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG  102 (156)
T ss_dssp             TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS
T ss_pred             CCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCC
T ss_conf             86002576565743168986644369212256666672162021247742011124554333322678785157456335


Q ss_pred             CCCCCEEEEECCCC
Q ss_conf             89766899115846
Q 001527          189 LNNLVYLNLSSNGF  202 (1060)
Q Consensus       189 l~~L~~L~Ls~N~l  202 (1060)
                      + .|+.|+|++|.+
T Consensus       103 ~-~l~~L~L~~Np~  115 (156)
T d2ifga3         103 L-SLQELVLSGNPL  115 (156)
T ss_dssp             C-CCCEEECCSSCC
T ss_pred             C-CCCCCCCCCCCC
T ss_conf             3-212433579863

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.60  E-value=1.1e-17  Score=110.21  Aligned_cols=106  Identities=23%  Similarity=0.339  Sum_probs=38.7

Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             99887499876884533489885799997699757984466573222456346720033543476457766677755699
Q 001527           92 NLSMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSL  171 (1060)
Q Consensus        92 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  171 (1060)
                      .++.|++|+|++|.|+.. + .+..+++|++|+|++|+++ .+|..+..+++|+.|++++|+++..  ..+..+++|+.|
T Consensus        46 ~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~~L  120 (198)
T d1m9la_          46 TLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVL  120 (198)
T ss_dssp             HTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSSEE
T ss_pred             CCCCCCEEECCCCCCCCC-C-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCC
T ss_conf             260461519944689986-4-4247825357341353432-1000033221233333333222222--222222234111


Q ss_pred             ECCCCCCCCCCC-CCCCCCCCCCEEEEECCCC
Q ss_conf             864887999998-1013989766899115846
Q 001527          172 DLSHNSFSGSLP-PALTRLNNLVYLNLSSNGF  202 (1060)
Q Consensus       172 ~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l  202 (1060)
                      ++++|+++.... ..+..+++|+.|++++|.+
T Consensus       121 ~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l  152 (198)
T d1m9la_         121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPL  152 (198)
T ss_dssp             EESEEECCCHHHHHHHTTTTTCSEEEECSSHH
T ss_pred             CCCCCHHCCCCCCCCCCCCCCCCEEECCCCCC
T ss_conf             23410212554221236777630234279843

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=1.1e-14  Score=93.81  Aligned_cols=85  Identities=24%  Similarity=0.266  Sum_probs=30.3

Q ss_pred             CCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             988749987688-4533489885799997699757984466573222456346720033543476457766677755699
Q 001527           93 LSMLVKLSMSNN-SISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGLIPDSVSGLVSIQSL  171 (1060)
Q Consensus        93 l~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  171 (1060)
                      ++.|++|++++| .++.+.+.+|.++++|+.|+|++|+++.+.+.+|..+++|++|+|++|+++...+..|..+ +|+.|
T Consensus        30 l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~-~l~~L  108 (156)
T d2ifga3          30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQEL  108 (156)
T ss_dssp             CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC-CCCEE
T ss_pred             CCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCCC-CCCCC
T ss_conf             65657431689866443692122566666721620212477420111245543333226787851574563353-21243


Q ss_pred             ECCCCCC
Q ss_conf             8648879
Q 001527          172 DLSHNSF  178 (1060)
Q Consensus       172 ~L~~N~l  178 (1060)
                      +|++|.+
T Consensus       109 ~L~~Np~  115 (156)
T d2ifga3         109 VLSGNPL  115 (156)
T ss_dssp             ECCSSCC
T ss_pred             CCCCCCC
T ss_conf             3579863

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.86  E-value=3.6e-11  Score=74.44  Aligned_cols=122  Identities=18%  Similarity=0.121  Sum_probs=0.0

Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCCCCCEE
Q ss_conf             8874998768845334898857999976997579844665732224563467200335434764--57766677755699
Q 001527           94 SMLVKLSMSNNSISGVIPDNIGDFKSLEFLDVSDNLFSSSLPSGIGKLESLQNLSLAGNNFSGL--IPDSVSGLVSIQSL  171 (1060)
Q Consensus        94 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L  171 (1060)
                      ...+.|++++....    ..+..+..+..+++.++... .++..+..+++|++|+|++|+++..  ++..+..+++|+.|
T Consensus        22 ~~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L   96 (162)
T d1koha1          22 GSQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL   96 (162)
T ss_dssp             SSSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred             HHHCEEECCCCCCC----CHHHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCC
T ss_conf             33086534359898----21554664011225556766-60788974878788637776666773158898658856100


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCC-------CCCCCCCCEEE
Q ss_conf             86488799999810139897668991158464347822-------21479999998
Q 001527          172 DLSHNSFSGSLPPALTRLNNLVYLNLSSNGFSKRIPRG-------FELILGLQVLD  220 (1060)
Q Consensus       172 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-------~~~l~~L~~L~  220 (1060)
                      ++++|.++...+-.+.....|+.|++++|.++......       +..+++|+.||
T Consensus        97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             CCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf             04357213423442220331042664899767676661569999999889978799

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.67  E-value=6.3e-08  Score=56.60  Aligned_cols=131  Identities=15%  Similarity=0.054  Sum_probs=77.4

Q ss_pred             CCCCEEEEEEEECCCCEEEEEECCCCHHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCCCCCEEEEEEECCCCCHHHH
Q ss_conf             226649999999499399999933221888999999999973399-9802220128967899803999971389996787
Q 001527          786 RSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLILSDYISPGSLASF  864 (1060)
Q Consensus       786 ~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~g~~~~~~~~~~~lv~e~~~~gsL~~~  864 (1060)
                      .++.+.||+.... +..+++|+...........+.+|...+..+. +--+.++++++.  ..+..++||+++++.++.+.
T Consensus        24 G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~--~~~~~~lv~~~l~G~~~~~~  100 (263)
T d1j7la_          24 GMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDGWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             CCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETTEEEEEEECCSSEEHHHH
T ss_pred             CCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEE--CCCCEEEEEEECCCCCCCCC
T ss_conf             9987718999908-98699998488765325569999999998760699872899975--08964999986043343543


Q ss_pred             HHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q ss_conf             611999999998999999999999999999844-----------------------------------------------
Q 001527          865 LYDRPGRKGPPLTWAQRLKIAVDVARGLNYLHF-----------------------------------------------  897 (1060)
Q Consensus       865 l~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-----------------------------------------------  897 (1060)
                      ....       ..   ...++.++++.++.||.                                               
T Consensus       101 ~~~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (263)
T d1j7la_         101 YEDE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL  170 (263)
T ss_dssp             TTTC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHH
T ss_pred             CCCC-------CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
T ss_conf             3440-------26---9999998999999985568421435764465655577899877655554303323200579999


Q ss_pred             -----------CCCCCCCCCCCCCEEEECCCCCEEECCCCCCEE
Q ss_conf             -----------999624898999868518999759900211100
Q 001527          898 -----------DRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       898 -----------~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~  930 (1060)
                                 ...++|+|+.|.|||++ ++...-+.||+.+..
T Consensus       171 ~~~l~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         171 YDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHSCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred             HHHHHHCCCCCCCEEEEEECCCCCEEEC-CCCEEEEEECHHCCC
T ss_conf             9999844986781789860047642364-996599960231441

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.27  E-value=3.2e-06  Score=47.18  Aligned_cols=141  Identities=17%  Similarity=0.112  Sum_probs=76.0

Q ss_pred             EECCCCC-EEEEEEEECCCCEEEEEECCCCHHHHHHHHHHHHHHHHCCC--CCCEEEEEEEEECCCCCCEEEEEEECCCC
Q ss_conf             0012266-49999999499399999933221888999999999973399--98022201289678998039999713899
Q 001527          783 VLGRSSH-GTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR--HPNVVGLRGYYWGPTQHEKLILSDYISPG  859 (1060)
Q Consensus       783 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--Hpniv~l~g~~~~~~~~~~~lv~e~~~~g  859 (1060)
                      .+..|.. +.||+....++..+++|.......   ..+..|+..++.+.  .-.+.+++++..  +....++||+++++.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~--~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEEEECCSSE
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECC--CCCCEEEEEEEEECC
T ss_conf             76786547758999938987899995896677---6899999999999865999886132224--566159998744135


Q ss_pred             CHHHH-----------------HHCCCCCCCCCC--CHHHHHHHHH--------------------HHHHHHHHHHC---
Q ss_conf             96787-----------------611999999998--9999999999--------------------99999999844---
Q 001527          860 SLASF-----------------LYDRPGRKGPPL--TWAQRLKIAV--------------------DVARGLNYLHF---  897 (1060)
Q Consensus       860 sL~~~-----------------l~~~~~~~~~~l--~~~~~~~i~~--------------------~ia~gL~~LH~---  897 (1060)
                      ++.+.                 +|.... ....+  .+.....-..                    .....+..+..   
T Consensus        92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  170 (255)
T d1nd4a_          92 DLLSSHLAPAEKVSIMADAMRRLHTLDP-ATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMP  170 (255)
T ss_dssp             ETTTSCCCHHHHHHHHHHHHHHHTTSCG-GGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHCCCCH-HHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCC
T ss_conf             5432212689999999999998736885-448875541246889999998754110113401121379999999987187


Q ss_pred             ---CCCCCCCCCCCCCEEEECCCCCEEECCCCCCEE
Q ss_conf             ---999624898999868518999759900211100
Q 001527          898 ---DRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       898 ---~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~  930 (1060)
                         ...++|+|+.|.|||+++ +..+-+.||+.+..
T Consensus       171 ~~~~~~liHgD~~~~Nvl~~~-~~~~~iID~~~~~~  205 (255)
T d1nd4a_         171 DGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLGV  205 (255)
T ss_dssp             SSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred             CCCCCEEEECCCCCCCEEEEC-CCEEEEEECHHCCC
T ss_conf             657956786788876357737-96589998533265

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.16  E-value=5.7e-06  Score=45.85  Aligned_cols=75  Identities=11%  Similarity=0.000  Sum_probs=46.1

Q ss_pred             CEECCCCCEEEEEEEEC-CCCEEEEEECCCCH-------HHHHHHHHHHHHHHHCC-CC-C-CEEEEEEEEECCCCCCEE
Q ss_conf             70012266499999994-99399999933221-------88899999999997339-99-8-022201289678998039
Q 001527          782 EVLGRSSHGTSYRATLE-NGMFLTVKWLREGV-------AKQRKEFAKEAKKFANI-RH-P-NVVGLRGYYWGPTQHEKL  850 (1060)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l-~H-p-niv~l~g~~~~~~~~~~~  850 (1060)
                      +.||.|....||+.... +++.+++|.-....       .....+...|.+.++.+ .+ | .+.+++.+.    ....+
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d----~~~~~  107 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEMAV  107 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTTTE
T ss_pred             EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC----CCCCE
T ss_conf             98079852768999957998489996177130346777888778999999999986505798855289985----98877


Q ss_pred             EEEEECCCCC
Q ss_conf             9997138999
Q 001527          851 ILSDYISPGS  860 (1060)
Q Consensus       851 lv~e~~~~gs  860 (1060)
                      +|||++++..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEECCCCCC
T ss_conf             9871357765

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.09  E-value=6.1e-07  Score=51.17  Aligned_cols=110  Identities=17%  Similarity=0.145  Sum_probs=0.0

Q ss_pred             CCCCCCEEECCC-CCCCCC----CCCCCCCCCCCCEEECCCCCCC----CCCCCCCCCCCCCCEEECCCCCCCC----CC
Q ss_conf             998874998768-845334----8988579999769975798446----6573222456346720033543476----45
Q 001527           92 NLSMLVKLSMSN-NSISGV----IPDNIGDFKSLEFLDVSDNLFS----SSLPSGIGKLESLQNLSLAGNNFSG----LI  158 (1060)
Q Consensus        92 ~l~~L~~L~l~~-n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~----~~~p~~l~~l~~L~~L~Ls~N~l~~----~~  158 (1060)
                      +-+.|++|+|++ +.+...    +-..+...+.|++|+|++|.+.    ..+...+...+.|+.|+|++|.+..    .+
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l   92 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL   92 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             CCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHHH
T ss_conf             89998197827999989899999999976377645401201562156798875310002343300330102145999999


Q ss_pred             CCCCCCCCCCCEEECCCCCCCCC-------CCCCCCCCCCCCEEEEECCC
Q ss_conf             77666777556998648879999-------98101398976689911584
Q 001527          159 PDSVSGLVSIQSLDLSHNSFSGS-------LPPALTRLNNLVYLNLSSNG  201 (1060)
Q Consensus       159 p~~~~~l~~L~~L~L~~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~  201 (1060)
                      -.++..-++|++|++++|.+...       +...+...+.|+.|+++.+.
T Consensus        93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             99998489389877887768886579999999999729985386486888

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.94  E-value=1.6e-05  Score=43.33  Aligned_cols=137  Identities=16%  Similarity=0.090  Sum_probs=71.4

Q ss_pred             EEEEEEEECCCCEEEEEECCCCHHHHHHHHHHHHHHHHCCCC---C--CEEEEEEEEECCCCCCEEEEEEECCCCCHH--
Q ss_conf             499999994993999999332218889999999999733999---8--022201289678998039999713899967--
Q 001527          790 GTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIRH---P--NVVGLRGYYWGPTQHEKLILSDYISPGSLA--  862 (1060)
Q Consensus       790 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---p--niv~l~g~~~~~~~~~~~lv~e~~~~gsL~--  862 (1060)
                      -.||+++..+|..|++|+.+.+. ...+++..|...+..|..   |  ..+..-|-.........+.++++++|..+.  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             CEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCC
T ss_conf             02699983899979999847877-88999999999999998559987875206898056653479999865277688999


Q ss_pred             ----------------HHHHCCCCCCCCCCCHH----------------------HHHHHHHHHHHHHHHHH---CCCCC
Q ss_conf             ----------------87611999999998999----------------------99999999999999984---49996
Q 001527          863 ----------------SFLYDRPGRKGPPLTWA----------------------QRLKIAVDVARGLNYLH---FDRAV  901 (1060)
Q Consensus       863 ----------------~~l~~~~~~~~~~l~~~----------------------~~~~i~~~ia~gL~~LH---~~~~i  901 (1060)
                                      ..............++.                      .....+.++...+.-.-   ...++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCEE
T ss_conf             99999998999999886303578655677897887665689998747699889899999999999999984545687120


Q ss_pred             CCCCCCCCCEEEECCCCCEEECCCCCCEE
Q ss_conf             24898999868518999759900211100
Q 001527          902 PHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       902 iHrDlkp~NILl~~~~~~~kl~Dfgla~~  930 (1060)
                      +|+|+.+.|||+++ +  ..+.||+-+..
T Consensus       195 iHgDlh~~NvL~~~-~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRD-G--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESS-S--EEECCCTTCCE
T ss_pred             ECCCCCCCCEEEEC-C--CEEEECHHCCC
T ss_conf             24788804287838-9--35886520146

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.82  E-value=5.1e-05  Score=40.62  Aligned_cols=72  Identities=13%  Similarity=0.109  Sum_probs=46.1

Q ss_pred             CEECCCCCEEEEEEEECCC--------CEEEEEECCCCHHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCCCCCEEEE
Q ss_conf             7001226649999999499--------399999933221888999999999973399-9802220128967899803999
Q 001527          782 EVLGRSSHGTSYRATLENG--------MFLTVKWLREGVAKQRKEFAKEAKKFANIR-HPNVVGLRGYYWGPTQHEKLIL  852 (1060)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~g~~~~~~~~~~~lv  852 (1060)
                      +.|+.|-.-.+|++...++        ..|.+++.... . ......+|.++++.+. +.-..++++++  +    -..|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~--~----~g~I  119 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIF--S----GGRL  119 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEE--T----TEEE
T ss_pred             EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC-C-HHHHHHHHHHHHHHHHHCCCCCEEEEEC--C----CCEE
T ss_conf             99178533434899968877544578981799965996-1-1658999999999997579998089981--8----9569


Q ss_pred             EEECCCCCH
Q ss_conf             971389996
Q 001527          853 SDYISPGSL  861 (1060)
Q Consensus       853 ~e~~~~gsL  861 (1060)
                      +||+++..+
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEECCCCC
T ss_conf             997345548

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.38  E-value=7.8e-06  Score=45.09  Aligned_cols=122  Identities=14%  Similarity=0.096  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCCCCCCCCCEEECCC-CCCCC----CCCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEEEE
Q ss_conf             844665732224563467200335-43476----4577666777556998648879999----98101398976689911
Q 001527          128 NLFSSSLPSGIGKLESLQNLSLAG-NNFSG----LIPDSVSGLVSIQSLDLSHNSFSGS----LPPALTRLNNLVYLNLS  198 (1060)
Q Consensus       128 n~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls  198 (1060)
                      ..+...+.....+.+.|++|+|++ +.++.    .+-.++...++|++|++++|.+...    +-..+...+.++.++++
T Consensus         3 ~~i~~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~   82 (166)
T d1io0a_           3 TDVEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVE   82 (166)
T ss_dssp             CCHHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECC
T ss_pred             CCHHHHHHHHHHCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHC
T ss_conf             63999999999559998688768999989899999998884198257430158961177899999877521221012102


Q ss_pred             CCCCCC----CCCCCCCCCCCCCE--EECCCCCCCC----CCCHHHHCCCCCCEECCCCCC
Q ss_conf             584643----47822214799999--9831896876----685555403888700146884
Q 001527          199 SNGFSK----RIPRGFELILGLQV--LDFHGNKLDG----HLDGEFFLLTNASHIDFSGNM  249 (1060)
Q Consensus       199 ~N~l~~----~~p~~~~~l~~L~~--L~Ls~N~l~~----~~~~~~~~l~~L~~L~ls~N~  249 (1060)
                      +|.+..    .+...+...+.|+.  |++++|.+..    .+...+...+.|+.|+++.+.
T Consensus        83 ~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          83 SNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             SSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             CCCCCCHHHHHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             5432201478899999848652477321677867679999999999849984788581898

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.86  E-value=0.024  Score=25.94  Aligned_cols=145  Identities=11%  Similarity=0.052  Sum_probs=69.7

Q ss_pred             CEECCCCCEEEEEEEECCCCEEEEEECCCCHHHHHHHHHHHHHHHHCCC-----CCCEEEE-EEEEECCCCCCEEEEEEE
Q ss_conf             7001226649999999499399999933221888999999999973399-----9802220-128967899803999971
Q 001527          782 EVLGRSSHGTSYRATLENGMFLTVKWLREGVAKQRKEFAKEAKKFANIR-----HPNVVGL-RGYYWGPTQHEKLILSDY  855 (1060)
Q Consensus       782 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----Hpniv~l-~g~~~~~~~~~~~lv~e~  855 (1060)
                      +.|..|---+.|+.+..+|+ +++|++....  ..++...|++.+..+.     -|..+.. -|............++.+
T Consensus        24 ~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~  100 (316)
T d2ppqa1          24 KGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  100 (316)
T ss_dssp             EEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             ECCCCCCCCCEEEEEECCCC-EEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEECCCCEEEEE
T ss_conf             23788852673899978972-8999807899--98899999999875430255545564104897621341255024531


Q ss_pred             CCCCCHHH--------------HHHC----CCCCCCCCCC-H-H----------------HHHHHHHHHHHHHHHHH---
Q ss_conf             38999678--------------7611----9999999989-9-9----------------99999999999999984---
Q 001527          856 ISPGSLAS--------------FLYD----RPGRKGPPLT-W-A----------------QRLKIAVDVARGLNYLH---  896 (1060)
Q Consensus       856 ~~~gsL~~--------------~l~~----~~~~~~~~l~-~-~----------------~~~~i~~~ia~gL~~LH---  896 (1060)
                      ..+.....              .++.    .......... + .                .....+......+...+   
T Consensus       101 ~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  180 (316)
T d2ppqa1         101 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  180 (316)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHCCCCCC
T ss_conf             14655333204678888899876454443202453101110120024567777653114127999999987642048554


Q ss_pred             CCCCCCCCCCCCCCEEEECCCCCEEECCCCCCEE
Q ss_conf             4999624898999868518999759900211100
Q 001527          897 FDRAVPHGNLKATNILLDGPDLNARVADYCLHRL  930 (1060)
Q Consensus       897 ~~~~iiHrDlkp~NILl~~~~~~~kl~Dfgla~~  930 (1060)
                      ...++||+|+.+.||++++ +...-+.||+.+..
T Consensus       181 L~~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLG-DELSGLIDFYFACN  213 (316)
T ss_dssp             SCEEEECSCCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred             CCCCCCCCCCCHHHHHCCC-CCCEEEECCCCCCC
T ss_conf             5450333786365640204-54126742221236